PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	da Palma, JR; Burri, DJ; Oppliger, J; Salamina, M; Cendron, L; de Laureto, PP; Seidah, NG; Kunz, S; Pasquato, A				da Palma, Joel Ramos; Burri, Dominique Julien; Oppliger, Joel; Salamina, Marco; Cendron, Laura; de Laureto, Patrizia Polverino; Seidah, Nabil Georges; Kunz, Stefan; Pasquato, Antonella			Zymogen Activation and Subcellular Activity of Subtilisin Kexin Isozyme 1/Site 1 Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; CHORIOMENINGITIS VIRUS GLYCOPROTEIN; PROPROTEIN CONVERTASE SKI-1/S1P; CHOLESTEROL-METABOLISM; SUBTILASE SKI-1/S1P; SITE-1 PROTEASE; CLEAVAGE; BIOSYNTHESIS; PROPEPTIDE; PRECURSOR	The proprotein convertase subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P) plays crucial roles in cellular homeostatic functions and is hijacked by pathogenic viruses for the processing of their envelope glycoproteins. Zymogen activation of SKI1/S1P involves sequential autocatalytic processing of its N-terminal prodomain at sites B'/B followed by the herein newly identified C'/C sites. We found that SKI-1/S1P autoprocessing results in intermediates whose catalytic domain remains associated with prodomain fragments of different lengths. In contrast to other zymogen proprotein convertases, all incompletely matured intermediates of SKI-1/S1P showed full catalytic activity toward cellular substrates, whereas optimal cleavage of viral glycoproteins depended on B'/B processing. Incompletely matured forms of SKI-1/S1P further process cellular and viral substrates in distinct subcellular compartments. Using a cell-based sensor for SKI-1/S1P activity, we found that 9 amino acid residues at the cleavage site (P1-P8) and P1' are necessary and sufficient to define the subcellular location of processing and to determine to what extent processing of a substrate depends on SKI-1/S1P maturation. In sum, our study reveals novel and unexpected features of SKI-1/S1P zymogen activation and subcellular specificity of activity toward cellular and pathogen-derived substrates.	[da Palma, Joel Ramos; Burri, Dominique Julien; Oppliger, Joel; Kunz, Stefan; Pasquato, Antonella] Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland; [da Palma, Joel Ramos; Burri, Dominique Julien; Oppliger, Joel; Kunz, Stefan; Pasquato, Antonella] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Salamina, Marco; Cendron, Laura] Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Dept Biol, I-35121 Padua, Italy; [de Laureto, Patrizia Polverino] Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Dept Pharmaceut Sci, I-35121 Padua, Italy; [Seidah, Nabil Georges] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	University of Lausanne; University of Padua; University of Padua; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Kunz, S (corresponding author), Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland.	Stefan.Kunz@chuv.ch; Antonella.Pasquato@chuv.ch	Seidah, Nabil/I-3596-2013; Kunz, Stefan/K-5840-2017	Seidah, Nabil/0000-0001-6503-9342; Pasquato, Antonella/0000-0002-9428-0722; Cendron, Laura/0000-0002-0125-0461; Kunz, Stefan/0000-0001-6030-9550	Swiss National Science Foundation [FN 31003A-135536]; University of Lausanne; Canadian Institutes of Health Research Grant [93792]; Canada Chair Grant [216684]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lausanne; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canada Chair Grant	This work was supported by Swiss National Science Foundation Grant FN 31003A-135536 (to S. K.), funds from the University of Lausanne (to S. K.), Canadian Institutes of Health Research Grant 93792 (to N. G. S.), and Canada Chair Grant 216684 (to N. G. S.). The authors declare that the cell-based sensor SS-LASV is patented.	Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Burri DJ, 2013, J VIROL, V87, P6406, DOI 10.1128/JVI.00072-13; Burri DJ, 2012, J VIROL, V86, P4935, DOI 10.1128/JVI.00024-12; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Goerke AR, 2008, METAB ENG, V10, P187, DOI 10.1016/j.ymben.2008.04.001; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Kunz S, 2003, VIROLOGY, V314, P168, DOI 10.1016/S0042-6822(03)00421-5; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; OHTA Y, 1991, MOL MICROBIOL, V5, P1507, DOI 10.1111/j.1365-2958.1991.tb00797.x; OHTA Y, 1991, MOL MICROBIOL, V5, P3090; Pasquato A, 2006, J BIOL CHEM, V281, P23471, DOI 10.1074/jbc.M513675200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Pullikotil P, 2004, J BIOL CHEM, V279, P17338, DOI 10.1074/jbc.M313764200; Pullikotil P, 2007, J BIOL CHEM, V282, P27402, DOI 10.1074/jbc.M703200200; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; REHEMTULLA A, 1992, P NATL ACAD SCI USA, V89, P8235, DOI 10.1073/pnas.89.17.8235; Reiling JH, 2013, NAT CELL BIOL, V15, P1473, DOI 10.1038/ncb2865; Rojek JM, 2008, J VIROL, V82, P6045, DOI 10.1128/JVI.02392-07; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Sone M, 2005, BBA-PROTEINS PROTEOM, V1749, P15, DOI 10.1016/j.bbapap.2005.01.011; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; WEBER EL, 1988, VIROLOGY, V164, P30, DOI 10.1016/0042-6822(88)90616-2; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zandberg WF, 2011, GLYCOBIOLOGY, V21, P1290, DOI 10.1093/glycob/cwr060	39	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35743	35756		10.1074/jbc.M114.588525	http://dx.doi.org/10.1074/jbc.M114.588525			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378398	hybrid, Green Published			2022-12-26	WOS:000346897900007
J	Barton, SK; Moss, TJM; Hooper, SB; Crossley, KJ; Gill, AW; Kluckow, M; Zahra, V; Wong, FY; Pichler, G; Galinsky, R; Miller, SL; Tolcos, M; Polglase, GR				Barton, Samantha K.; Moss, Timothy J. M.; Hooper, Stuart B.; Crossley, Kelly J.; Gill, Andrew W.; Kluckow, Martin; Zahra, Valerie; Wong, Flora Y.; Pichler, Gerhard; Galinsky, Robert; Miller, Suzanne L.; Tolcos, Mary; Polglase, Graeme R.			Protective Ventilation of Preterm Lambs Exposed to Acute Chorioamnionitis Does Not Reduce Ventilation-Induced Lung or Brain Injury	PLOS ONE			English	Article							SPATIALLY-RESOLVED SPECTROSCOPY; END-EXPIRATORY PRESSURE; WHITE-MATTER INJURY; CEREBRAL-BLOOD-FLOW; BRONCHOPULMONARY DYSPLASIA; TIDAL VOLUME; INTRAAMNIOTIC ENDOTOXIN; SYSTEMIC INFLAMMATION; RISK-FACTOR; DELIVERY	Background: The onset of mechanical ventilation is a critical time for the initiation of cerebral white matter (WM) injury in preterm neonates, particularly if they are inadvertently exposed to high tidal volumes (V-T) in the delivery room. Protective ventilation strategies at birth reduce ventilation-induced lung and brain inflammation and injury, however its efficacy in a compromised newborn is not known. Chorioamnionitis is a common antecedent of preterm birth, and increases the risk and severity of WM injury. We investigated the effects of high V-T ventilation, after chorioamnionitis, on preterm lung and WM inflammation and injury, and whether a protective ventilation strategy could mitigate the response. Methods: Pregnant ewes (n = 18) received intra-amniotic lipopolysaccharide (LPS) 2 days before delivery, instrumentation and ventilation at 12 +/- 1 days gestation. Lambs were either immediately euthanased and used as unventilated controls (LPSUVC; n = 6), or were ventilated using an injurious high V-T strategy (LPSINJ; n = 5) or a protective ventilation strategy (LPSPROT; n = 7) for a total of 90 min. Mean arterial pressure, heart rate and cerebral haemodynamics and oxygenation were measured continuously. Lungs and brains underwent molecular and histological assessment of inflammation and injury. Results: LPSINJ lambs had poorer oxygenation than LPSPROT lambs. Ventilation requirements and cardiopulmonary and systemic haemodynamics were not different between ventilation strategies. Compared to unventilated lambs, LPSINJ and LPSPROT lambs had increases in pro-inflammatory cytokine expression within the lungs and brain, and increased astrogliosis (p<0.02) and cell death (p<0.05) in the WM, which were equivalent in magnitude between groups. Conclusions: Ventilation after acute chorioamnionitis, irrespective of strategy used, increases haemodynamic instability and lung and cerebral inflammation and injury. Mechanical ventilation is a potential contributor to WM injury in infants exposed to chorioamnionitis.	[Barton, Samantha K.; Moss, Timothy J. M.; Hooper, Stuart B.; Crossley, Kelly J.; Zahra, Valerie; Wong, Flora Y.; Galinsky, Robert; Miller, Suzanne L.; Tolcos, Mary; Polglase, Graeme R.] Monash Univ, Inst Med Res, MIMR PHI, Ritchie Ctr, Clayton, Vic 3168, Australia; [Moss, Timothy J. M.; Hooper, Stuart B.; Miller, Suzanne L.; Polglase, Graeme R.] Monash Univ, Dept Obstet & Gynecol, Clayton, Vic 3168, Australia; [Gill, Andrew W.] Univ Western Australia, Sch Womens & Infants Hlth, Nedlands, WA 6009, Australia; [Kluckow, Martin] Royal N Shore Hosp, Dept Neonatal Med, Sydney, NSW 2065, Australia; [Kluckow, Martin] Univ Sydney, Sydney, NSW 2065, Australia; [Pichler, Gerhard] Med Univ Graz, Dept Pediat, A-8036 Graz, Austria	Monash University; Prince Henry's Institute of Medical Research; University of Sydney; Westmead Institute for Medical Research; Monash University; University of Western Australia; Royal North Shore Hospital; University of Sydney; University of Sydney; Medical University of Graz	Polglase, GR (corresponding author), Monash Univ, Inst Med Res, MIMR PHI, Ritchie Ctr, Clayton, Vic 3168, Australia.	graeme.polglase@monash.edu	Moss, Timothy/A-6633-2008; Crossley, Kelly J/I-7407-2013	Moss, Timothy/0000-0002-9408-4027; Crossley, Kelly J/0000-0002-1580-1156; Hooper, Stuart/0000-0003-1676-4825; Pichler, Gerhard/0000-0003-2405-7143; Miller, Suzanne/0000-0002-0451-8304; Kluckow, Martin/0000-0003-1875-7530; Tolcos, Mary/0000-0001-6105-4553; Galinsky, Robert/0000-0002-6374-9372; Barton, Samantha/0000-0001-7601-0238; Polglase, Graeme/0000-0002-8906-614X	Avant Innovative Research Grant - Research Foundation of Cerebral Palsy Alliance; North Shore Heart Research Foundation; National Health and Medical Research Council Research Fellowship [1026890, APP1043294, 545921]; Rebecca L. Cooper Medical Research Foundation Fellowship; Victorian Government's Operational Infrastructure Support Program	Avant Innovative Research Grant - Research Foundation of Cerebral Palsy Alliance; North Shore Heart Research Foundation; National Health and Medical Research Council Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation Fellowship; Victorian Government's Operational Infrastructure Support Program	This research was supported by an Avant Innovative Research Grant awarded by the Research Foundation of Cerebral Palsy Alliance, North Shore Heart Research Foundation, National Health and Medical Research Council Research Fellowship (GRP, 1026890: TJMM, APP1043294: SBH, 545921), Rebecca L. Cooper Medical Research Foundation Fellowship (GRP) and the Victorian Government's Operational Infrastructure Support Program. Chiesi Farmaceutica generously donated the surfactant used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atik A, 2014, PEDIATR RES, V76, P54, DOI 10.1038/pr.2014.55; Bennet L, 2012, P AUSTR PHYSL SOC, V43, P81; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; Di Palma S, 2012, COMP IMMUNOL MICROB, V35, P429, DOI 10.1016/j.cimid.2012.03.009; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Eklind S, 2005, PEDIATR RES, V58, P112, DOI 10.1203/01.PDR.0000163513.03619.8D; Quilez ME, 2011, CRIT CARE, V15, DOI 10.1186/cc10230; Fahey JO, 2008, J MIDWIFERY WOM HEAL, V53, P227, DOI 10.1016/j.jmwh.2008.01.001; Feng YS, 2008, AM J PHYSIOL-REG I, V296, pR640; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Fox WW, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.5.e5; Gagliardi L, 2009, PAEDIATR PERINAT EP, V23, P582, DOI 10.1111/j.1365-3016.2009.01069.x; Galinsky R, 2013, J PHYSL, V15, P2127; GLEASON CA, 1988, AM J PHYSIOL, V255, pR1049, DOI 10.1152/ajpregu.1988.255.6.R1049; Greisen G, 2005, EARLY HUM DEV, V81, P423, DOI 10.1016/j.earlhumdev.2005.03.005; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Hagino K, 2005, J THORAC CARDIOV SUR, V130, P384, DOI 10.1016/j.jtcvs.2005.02.058; Hansen A, 1999, AM J OBSTET GYNECOL, V181, P997, DOI 10.1016/S0002-9378(99)70339-X; Herder V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062939; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V301, pL712, DOI 10.1152/ajplung.00157.2011; Hillman NH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-151; Hillman NH, 2010, PEDIATR RES, V67, P60, DOI 10.1203/PDR.0b013e3181c1b09e; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Jobe AH, 2008, NEONATOLOGY, V94, P190, DOI 10.1159/000143721; Kallapur SG, 2011, AM J PHYSIOL-LUNG C, V301, pL285, DOI 10.1152/ajplung.00446.2010; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kramer BW, 2002, AM J RESP CRIT CARE, V165, P463, DOI 10.1164/ajrccm.165.4.2011118; Kramer BW, 2002, AM J PHYSIOL-LUNG C, V283, pL452, DOI 10.1152/ajplung.00407.2001; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Lahra MM, 2004, AM J OBSTET GYNECOL, V190, P147, DOI 10.1016/j.ajog.2003.07.012; McAdams RM, 2012, ROLE CYTOKINES INFLA; Moss TJM, 2002, AM J RESP CRIT CARE, V165, P805, DOI 10.1164/ajrccm.165.6.2108053; Newnham JP, 2001, AM J OBSTET GYNECOL, V185, P190, DOI 10.1067/mob.2001.114500; Nitsos I, 2006, J SOC GYNECOL INVEST, V13, P239, DOI 10.1016/j.jsgi.2006.02.011; O'Donnell CPF, 2005, ARCH DIS CHILD-FETAL, V90, pF392, DOI 10.1136/adc.2004.064691; Polglase GR, 2008, PEDIAT RES; Polglase GR, 2008, PEDIATR RES, V64, P517, DOI 10.1203/PDR.0b013e3181841363; Polglase GR, 2008, J APPL PHYSIOL, V105, P603, DOI 10.1152/japplphysiol.00041.2008; Polglase GR, 2014, PEDIATR RES, V75, P682, DOI 10.1038/pr.2014.40; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Polglase GR, 2012, J APPL PHYSIOL, V112, P481, DOI 10.1152/japplphysiol.00995.2011; Polglase GR, 2010, PEDIATR RES, V67, P630, DOI 10.1203/PDR.0b013e3181dbbd18; Polglase GR, 2009, PEDIATR RES, V65, P67, DOI 10.1203/PDR.0b013e318189487e; Poulton DA, 2011, RESUSCITATION, V82, P175, DOI 10.1016/j.resuscitation.2010.10.012; Roehr CC, 2010, RESUSCITATION, V81, P202, DOI 10.1016/j.resuscitation.2009.10.008; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF393, DOI 10.1136/adc.2009.174003; Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004; Stonestreet BS, 2000, J APPL PHYSIOL, V88, P1672, DOI 10.1152/jappl.2000.88.5.1672; van den Heuij LG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-89; VANBEL F, 1994, PEDIATR RES, V35, P329; Vigneswaran R, 2000, J PAEDIATR CHILD H, V36, P293, DOI 10.1046/j.1440-1754.2000.00536.x; Viscardi RM, 2010, CLIN PERINATOL, V37, P393, DOI 10.1016/j.clp.2009.12.003; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Wallace MJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-19; Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002; Wong FY, 2008, PEDIATRICS, V121, pE604, DOI 10.1542/peds.2007-1487; Wong FY, 2010, ANESTHESIOLOGY, V113, P1385, DOI 10.1097/ALN.0b013e3181fc5567; Wong FY, 2009, INTENS CARE MED, V35, P1464, DOI 10.1007/s00134-009-1486-4; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Yanowitz TD, 2006, PEDIATR RES, V59, P299, DOI 10.1203/01.pdr.0000196738.03171.f1; Yanowitz TD, 2004, PEDIATR RES, V55, p524A; Yanowitz TD, 2002, PEDIATR RES, V51, P310, DOI 10.1203/00006450-200203000-00008; Yanowitz TD, 2004, J PERINATOLOGY, V24, P229	65	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112402	10.1371/journal.pone.0112402	http://dx.doi.org/10.1371/journal.pone.0112402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379714	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100083
J	Elsherif, L; Ozler, M; Zayed, MA; Shen, JH; Chernoff, J; Faber, JE; Parise, LV				Elsherif, Laila; Ozler, Mehmet; Zayed, Mohamed A.; Shen, Jessica H.; Chernoff, Jonathan; Faber, James E.; Parise, Leslie V.			Potential Compensation among Group I PAK Members in Hindlimb Ischemia and Wound Healing	PLOS ONE			English	Article							SIGNAL-REGULATED-KINASE; P21-ACTIVATED KINASE; ENDOTHELIAL-CELL; ERK ACTIVATION; INFLAMMATORY RESPONSE; TARGETED DISRUPTION; UP-REGULATION; MICE LACKING; ANGIOGENESIS; GROWTH	PAKs are serine/threonine kinases that regulate cytoskeletal dynamics and cell migration. PAK1 is activated by binding to the small EF hand protein, CIB1, or to the Rho GTPases Rac1 or Cdc42. The role of PAK1 in angiogenesis was established based only on in vitro studies and its role in angiogenesis in vivo has never been examined. Here we tested the hypothesis that PAK1 is an essential regulator of ischemic neovascularization (arteriogenesis and angiogenesis) and wound healing using a global PAK1 knockout mouse. Neovascularization was assessed using unilateral hindlimb ischemia. We found that plantar perfusion, limb use and appearance were not significantly different between 6-8 week old PAK1(-/-) and PAK1(+/+) mice throughout the 21-day period following hindlimb ischemia; however a slightly delayed healing was observed in 16 week old PAK1(-/-) mice. In addition, the wound healing rate, as assessed with an ear punch assay, was unchanged in PAK1(-/-) mice. Surprisingly, however, we observed a notable increase in PAK2 expression and phosphorylation in ischemic gastrocnemius tissue from PAK1(-/-) but not PAK1(+/+) mice. Furthermore, we observed higher levels of activated ERK2, but not AKT, in ischemic and non-ischemic muscle of PAK1(-/-) mice upon hindlimb ischemic injury. A group I PAK inhibitor, IPA3, significantly inhibited endothelial cell sprouting from aortic rings in both PAK1(-/-) and PAK1(+/+) mice, implying that PAK2 is a potential contributor to this process. Taken together, our data indicate that while PAK1 has the potential to contribute to neovascularization and wound healing, PAK2 may functionally compensate when PAK1 is deficient.	[Elsherif, Laila; Ozler, Mehmet; Zayed, Mohamed A.; Shen, Jessica H.; Parise, Leslie V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Faber, James E.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Faber, James E.; Parise, Leslie V.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Parise, Leslie V.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Fox Chase Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Parise, LV (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA.	parise@med.unc.edu	Chernoff, Jonathan/I-7631-2014; Elsherif, Laila/AAT-9307-2021	Chernoff, Jonathan/0000-0002-4803-7836; 	National Institute of Health [5R01HL092544, 01CA148805, 5R01HL111070]; NATIONAL CANCER INSTITUTE [R01CA148805] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111070, R01HL092544] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health grants 5R01HL092544 (LVP), 01CA148805 (JC) and 5R01HL111070 (JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah A, 2004, MATRIX BIOL, V22, P539, DOI 10.1016/j.matbio.2003.09.004; Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Bagheri-Yarmand R, 2000, J BIOL CHEM, V275, P39451, DOI 10.1074/jbc.M006150200; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; Chalothorn D, 2005, AM J PHYSIOL-HEART C, V289, pH947, DOI 10.1152/ajpheart.00952.2004; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Cho CH, 2006, P NATL ACAD SCI USA, V103, P4946, DOI 10.1073/pnas.0506352103; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Dorrance AM, 2013, BLOOD, V121, P2474, DOI 10.1182/blood-2012-10-460709; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Faber JE, 2011, ARTERIOSCL THROM VAS, V31, P1748, DOI 10.1161/ATVBAHA.111.227314; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Goc A, 2013, J BIOL CHEM, V288, P3025, DOI 10.1074/jbc.M112.424770; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Huang MT, 2005, BLOOD, V106, P1636, DOI 10.1182/blood-2004-12-4716; Huang WN, 2011, MOL CELL BIOL, V31, P388, DOI 10.1128/MCB.00969-10; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kelly Mollie L, 2012, Cell Logist, V2, P84; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Kiosses WB, 2002, CIRC RES, V90, P697, DOI 10.1161/01.RES.0000014227.76102.5D; Koike T, 2003, J GERONTOL A-BIOL, V58, P798; Kosoff R, 2013, J BIOL CHEM, V288, P974, DOI 10.1074/jbc.M112.422295; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Li LH, 2010, INT J ONCOL, V37, P951, DOI 10.3892/ijo_00000746; Li XF, 2003, MOL CELL BIOL, V23, P7134, DOI 10.1128/MCB.23.20.7134-7142.2003; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lu W, 2013, ONCOL REP, V29, P1547, DOI 10.3892/or.2013.2237; Ma YH, 2013, J CLIN ENDOCR METAB, V98, pE1314, DOI 10.1210/jc.2012-3937; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Master Z, 2001, EMBO J, V20, P5919, DOI 10.1093/emboj/20.21.5919; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Meng JS, 2005, J NEUROSCI, V25, P6641, DOI 10.1523/JNEUROSCI.0028-05.2005; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Park JH, 2014, HEAD NECK; Pascual G, 2007, J VASC RES, V44, P192, DOI 10.1159/000100375; Puolakkainen Pauli A., 1995, Wound Repair and Regeneration, V3, P330, DOI 10.1046/j.1524-475X.1995.t01-1-30314.x; Ramos E, 1997, RECEPT SIGNAL TRANS, V7, P99; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Roig J, 2000, P NATL ACAD SCI USA, V97, P14346, DOI 10.1073/pnas.97.26.14346; Sadoun E, 2003, J HISTOCHEM CYTOCHEM, V51, P1119, DOI 10.1177/002215540305100902; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Stockton R, 2007, MOL BIOL CELL, V18, P2346, DOI 10.1091/mbc.E06-07-0584; Sundberg-Smith LJ, 2005, J BIOL CHEM, V280, P2055, DOI 10.1074/jbc.M406013200; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Swift ME, 2001, J INVEST DERMATOL, V117, P1027, DOI 10.1046/j.0022-202x.2001.01539.x; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vasa-Nicotera M, 2011, ATHEROSCLEROSIS, V217, P326, DOI 10.1016/j.atherosclerosis.2011.03.034; Wang HJ, 2014, AGING CELL, V13, P254, DOI 10.1111/acel.12169; Wang ZP, 2013, J BIOL CHEM, V288, P20093, DOI 10.1074/jbc.M112.426023; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586; Zayed MA, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-17; Zegers MMP, 2003, EMBO J, V22, P4155, DOI 10.1093/emboj/cdg398; Zhang XP, 2013, BIOCHEM BIOPH RES CO, V431, P404, DOI 10.1016/j.bbrc.2012.12.157	83	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112239	10.1371/journal.pone.0112239	http://dx.doi.org/10.1371/journal.pone.0112239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379771	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100067
J	Lauer, A; Talamantes, J; Olivares, LRC; Medina, LJ; Baal, JDH; Casimiro, K; Shroff, N; Emery, KW				Lauer, Antje; Talamantes, Jorge; Castanon Olivares, Laura Rosio; Medina, Luis Jaime; Baal, Joe Daryl Hugo; Casimiro, Kayla; Shroff, Natasha; Emery, Kirt W.			Combining Forces - The Use of Landsat TM Satellite Imagery, Soil Parameter Information, and Multiplex PCR to Detect Coccidioides immitis Growth Sites in Kern County, California	PLOS ONE			English	Article							VALLEY FEVER; CLIMATE; POPULATION; DIVERSITY; POSADASII; ARIZONA	Coccidioidomycosis is a fungal disease acquired through the inhalation of spores of Coccidioides spp., which afflicts primarily humans and other mammals. It is endemic to areas in the southwestern United States, including the San Joaquin Valley portion of Kern County, California, our region of interest (ROI). Recently, incidence of coccidioidomycosis, also known as valley fever, has increased significantly, and several factors including climate change have been suggested as possible drivers for this observation. Up to date details about the ecological niche of C. immitis have escaped full characterization. In our project, we chose a three-step approach to investigate this niche: 1) We examined Landsat-5-Thematic-Mapper multispectral images of our ROI by using training pixels at a 750 mx750 m section of Sharktooth Hill, a site confirmed to be a C. immitis growth site, to implement a Maximum Likelihood Classification scheme to map out the locations that could be suitable to support the growth of the pathogen; 2) We used the websoilsurvey database of the US Department of Agriculture to obtain soil parameter data; and 3) We investigated soil samples from 23 sites around Bakersfield, California using a multiplex Polymerase Chain Reaction (PCR) based method to detect the pathogen. Our results indicated that a combination of satellite imagery, soil type information, and multiplex PCR are powerful tools to predict and identify growth sites of C. immitis. This approach can be used as a basis for systematic sampling and investigation of soils to detect Coccidioides spp.	[Lauer, Antje; Baal, Joe Daryl Hugo; Casimiro, Kayla; Shroff, Natasha] Calif State Univ, Dept Biol, Bakersfield, CA 93311 USA; [Talamantes, Jorge; Medina, Luis Jaime] Calif State Univ, Dept Phys & Engn, Bakersfield, CA USA; [Castanon Olivares, Laura Rosio] Univ Nacl Autonoma Mexico, Fac Med, Lab Micol Med, Mexico City 04510, DF, Mexico; [Emery, Kirt W.] Cty Kern Publ Hlth Serv Dept, Bakersfield, CA USA	California State University System; California State University Bakersfield; California State University System; California State University Bakersfield; Universidad Nacional Autonoma de Mexico	Lauer, A (corresponding author), Calif State Univ, Dept Biol, Bakersfield, CA 93311 USA.	alauer@csub.edu			National Science Foundation [HRD-0331537]; Chevron (Research Experience Vitalizing Science Undergraduate Program (REVS-UP) at CSUB	National Science Foundation(National Science Foundation (NSF)); Chevron (Research Experience Vitalizing Science Undergraduate Program (REVS-UP) at CSUB	The work was supported by National Science Foundation grant HRD-0331537, and support from Chevron (Research Experience Vitalizing Science Undergraduate Program (REVS-UP) at CSUB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptista-Rosas RC, 2012, FUNGAL ECOL, V5, P177, DOI 10.1016/j.funeco.2011.08.004; Barker BM, 2012, FUNGAL ECOL, V5, P163, DOI 10.1016/j.funeco.2011.07.010; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P109; Chander G, 2003, IEEE T GEOSCI REMOTE, V41, P2674, DOI 10.1109/TGRS.2003.818464; Comrie AC, 2005, ENVIRON HEALTH PERSP, V113, P688, DOI 10.1289/ehp.7786; Comrie AC, 2007, ANN NY ACAD SCI, V1111, P83, DOI 10.1196/annals.1406.024; Craglia M, 2008, INT J SPAT DATA INFR, V3, P146, DOI 10.2902/1725-0463.2008.03.art9; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; EGEBERG RO, 1956, AM J MED SCI, V231, P151, DOI 10.1097/00000441-195623120-00005; Fisher FS, 2007, ANN NY ACAD SCI, V1111, P47, DOI 10.1196/annals.1406.031; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Fisher MC, 2001, P NATL ACAD SCI USA, V98, P4558, DOI 10.1073/pnas.071406098; Goetz SJ, 2000, ADV PARASIT, V47, P289, DOI 10.1016/S0065-308X(00)47012-0; Greene DR, 2000, MYCOLOGIA, V92, P406, DOI 10.2307/3761498; Greer A, 2008, CMAJ, V11, P178; Hector RF, 2011, INT J ENV RES PUB HE, V8, P1150, DOI 10.3390/ijerph8041150; Hugenholtz P., 1957, P S COCC, P136; Jinadu BA, 1994, MMWR-MORBID MORTAL W, V43, P421; Kemp R, 1974, THESIS CALIFORNIA ST; Kirkland TN, 1996, EMERG INFECT DIS, V2, P192, DOI 10.3201/eid0203.960305; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Kolivras KN, 2003, INT J BIOMETEOROL, V47, P87, DOI 10.1007/s00484-002-0155-x; Kolivras KN, 2001, AEROBIOLOGIA, V17, P31, DOI DOI 10.1023/A:1007619813435; Lauer A, 2012, MYCOLOGIA, V104, P62, DOI 10.3852/11-127; Lee Russel V., 1944, CALIFORNIA AND WEST MED, V61, P133; Maddy K., 1957, P S COCCIDIOIDOMYCOS, P144; MADDY K. T., 1959, Veterinary Medicine, V54, P233; MADDY K T, 1958, Ariz Med, V15, P178; Marsden-Haug N, 2013, BRIEFREPORT COCCIDIO, V2013, P56; Merriam CH, 1898, B 10 DIVISION BIOL S; MOSLEY D, 1996, MMWR-MORBID MORTAL W, V45, P1069; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Neafsey DE, 2010, GENOME RES, V20, P938, DOI 10.1101/gr.103911.109; Negroni R, 2008, REV ARGENT MICROBIOL, V40, P246; Nguyen C, 2013, CLIN MICROBIOL REV, V26, P505, DOI 10.1128/CMR.00005-13; Nuckols JR, 2004, ENVIRON HEALTH PERSP, V112, P1007, DOI 10.1289/ehp.6738; Pappagianis D, 1988, Curr Top Med Mycol, V2, P199; PAPPAGIANIS D, 1994, CLIN INFECT DIS, V19, pS14, DOI 10.1093/clinids/19.Supplement_1.14; PAPPAGIANIS D, 1978, WESTERN J MED, V129, P527; Richards J. A., 2006, REMOTE SENSING DIGIT; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rogers DJ, 2000, ADV PARASIT, V47, P129, DOI 10.1016/S0065-308X(00)47008-9; Schneider E, 1997, JAMA-J AM MED ASSOC, V277, P904, DOI 10.1001/jama.277.11.904; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; SMITH CE, 1946, JAMA-J AM MED ASSOC, V132, P833, DOI 10.1001/jama.1946.02870490011003; SWATEK FE, 1970, MYCOPATH MYCOL APPL, V41, P3, DOI 10.1007/BF02051479; Talamantes J, 2007, ANN NY ACAD SCI, V1111, P73, DOI 10.1196/annals.1406.028; Talamantes J, 2007, INT J BIOMETEOROL, V51, P307, DOI 10.1007/s00484-006-0065-4; Tamerius JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021009; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zender CS, 2006, INT J BIOMETEOROL, V50, P174, DOI 10.1007/s00484-005-0007-6	52	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111921	10.1371/journal.pone.0111921	http://dx.doi.org/10.1371/journal.pone.0111921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380290	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100045
J	Barman, RK; Saha, S; Das, S				Barman, Ranjan Kumar; Saha, Sudipto; Das, Santasabuj			Prediction of Interactions between Viral and Host Proteins Using Supervised Machine Learning Methods	PLOS ONE			English	Article							HEPATITIS-E VIRUS; INFORMATION; SEQUENCES; NETWORK; SWINE; MODEL; INDIA	Background: Viral-host protein-protein interaction plays a vital role in pathogenesis, since it defines viral infection of the host and regulation of the host proteins. Identification of key viral-host protein-protein interactions (PPIs) has great implication for therapeutics. Methods: In this study, a systematic attempt has been made to predict viral-host PPIs by integrating different features, including domain-domain association, network topology and sequence information using viral-host PPIs from VirusMINT. The three well-known supervised machine learning methods, such as SVM, Naive Bayes and Random Forest, which are commonly used in the prediction of PPIs, were employed to evaluate the performance measure based on five-fold cross validation techniques. Results: Out of 44 descriptors, best features were found to be domain-domain association and methionine, serine and valine amino acid composition of viral proteins. In this study, SVM-based method achieved better sensitivity of 67% over Naive Bayes (37.49%) and Random Forest (55.66%). However the specificity of Naive Bayes was the highest (99.52%) as compared with SVM (74%) and Random Forest (89.08%). Overall, the SVM and Random Forest achieved accuracy of 71% and 72.41%, respectively. The proposed SVM-based method was evaluated on blind dataset and attained a sensitivity of 64%, specificity of 83%, and accuracy of 74%. In addition, unknown potential targets of hepatitis B virus-human and hepatitis E virus-human PPIs have been predicted through proposed SVM model and validated by gene ontology enrichment analysis. Our proposed model shows that, hepatitis B virus "C protein'' binds to membrane docking protein, while "X protein'' and "P protein'' interacts with cell-killing and metabolic process proteins, respectively. Conclusion: The proposed method can predict large scale interspecies viral-human PPIs. The nature and function of unknown viral proteins (HBV and HEV), interacting partners of host protein were identified using optimised SVM model.	[Barman, Ranjan Kumar; Das, Santasabuj] Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata, W Bengal, India; [Das, Santasabuj] Natl Inst Cholera & Enter Dis, Div Clin Med, Kolkata, W Bengal, India; [Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Science & Technology (India); Bose Institute	Saha, S (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India.	ssaha4@jcbose.ac.in; dasss@icmr.org.in	Saha, Sudipto/AAF-1034-2020; Barman, Ranjan Kumar/GXZ-8073-2022	Barman, Ranjan Kumar/0000-0001-9901-3108; Saha, Sudipto/0000-0001-9433-8894	Council of Medical Research [2013-1551G]; Department of Biotechnology [BT/RLF/Re-entry/11/2011]	Council of Medical Research; Department of Biotechnology	This project was supported by the Indian Council of Medical Research [extramural project (IRIS ID: 2013-1551G)]. SS thanks the Department of Biotechnology for a Ramalingaswami fellowship (BT/RLF/Re-entry/11/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Arnold R, 2012, METHODS, V57, P508, DOI 10.1016/j.ymeth.2012.06.011; Begum N, 2010, INDIAN J MED RES, V132, P504; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Caron M, 2006, J CLIN MICROBIOL, V44, P3440, DOI 10.1128/JCM.00939-06; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Cui G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S5; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; Davis FP, 2007, PROTEIN SCI, V16, P2585, DOI 10.1110/ps.073228407; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; Doolittle JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000954; Dyer MD, 2011, INFECT GENET EVOL, V11, P917, DOI 10.1016/j.meegid.2011.02.022; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Hall M., 2009, SIGKDD EXPLORATIONS, V11; Hayashida M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S8; Hernandez-Toro J, 2007, BIOINFORMATICS, V23, P2495, DOI 10.1093/bioinformatics/btm373; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Joachims T., 2002, THESIS KLUWER; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; Memisevic V, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-154; Priya SB, 2013, J THEOR BIOL, V326, P36, DOI 10.1016/j.jtbi.2013.02.016; Qi YJ, 2010, BIOINFORMATICS, V26, pi645, DOI 10.1093/bioinformatics/btq394; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; WILSON DW, 1994, J VIROL, V68, P6985, DOI 10.1128/JVI.68.11.6985-6993.1994; Wu XM, 2006, NUCLEIC ACIDS RES, V34, P2137, DOI 10.1093/nar/gkl219; Zhou HF, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720012300018	34	47	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112034	10.1371/journal.pone.0112034	http://dx.doi.org/10.1371/journal.pone.0112034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375323	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600092
J	Bassiony, H; Sabet, S; El-Din, TAS; Mohamed, MM; El-Ghor, AA				Bassiony, Heba; Sabet, Salwa; El-Din, Taher A. Salah; Mohamed, Mona M.; El-Ghor, Akmal A.			Magnetite Nanoparticles Inhibit Tumor Growth and Upregulate the Expression of P53/P16 in Ehrlich Solid Carcinoma Bearing Mice	PLOS ONE			English	Article							P53; CANCER; GENE; CELLS	Background: Magnetite nanoparticles (MNPs) have been widely used as contrast agents and have promising approaches in cancer treatment. In the present study we used Ehrlich solid carcinoma (ESC) bearing mice as a model to investigate MNPs antitumor activity, their effect on expression of p53 and p16 genes as an indicator for apoptotic induction in tumor tissues. Method: MNPs coated with ascorbic acid (size: 25.0 +/- 5.0 nm) were synthesized by co-precipitation method and characterized. Ehrlich mice model were treated with MNPs using 60 mg/Kg day by day for 14 injections; intratumorally (IT) or intraperitoneally (IP). Tumor size, pathological changes and iron content in tumor and normal muscle tissues were assessed. We also assessed changes in expression levels of p53 and p16 genes in addition to p53 protein level by immunohistochemistry. Results: Our results revealed that tumor growth was significantly reduced by IT and IP MNPs injection compared to untreated tumor. A significant increase in p53 and p16 mRNA expression was detected in Ehrlich solid tumors of IT and IP treated groups compared to untreated Ehrlich solid tumor. This increase was accompanied with increase in p53 protein expression. It is worth mentioning that no significant difference in expression of p53 and p16 could be detected between IT ESC and control group. Conclusion: MNPs might be more effective in breast cancer treatment if injected intratumorally to be directed to the tumor tissues.	[Bassiony, Heba; Sabet, Salwa; Mohamed, Mona M.; El-Ghor, Akmal A.] Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt; [El-Din, Taher A. Salah] Agr Res Ctr, Nanotechnol & Adv Mat Cent Lab, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	El-Ghor, AA (corresponding author), Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt.	akmalelghor@gmail.com		Sabet, Salwa/0000-0002-4097-7866				Al-Raawi D, 2011, INT J CLIN EXP MED, V4, P265; Berry CC, 2003, BIOMATERIALS, V24, P4551, DOI 10.1016/S0142-9612(03)00237-0; Fouad DM, 2011, J NANOTECHNOL, V2011, DOI 10.1155/2011/416060; Gasco M, 2002, BREAST CANC RES, V4; Hartman KB, 2008, MOL DIAGN THER, V12, P1; Hartmann A, 1997, TRENDS GENET, V13, P27, DOI 10.1016/S0168-9525(96)10043-3; Heath JR, 2008, ANNU REV MED, V59, P251, DOI 10.1146/annurev.med.59.061506.185523; Huang JZ, 2003, WORLD J GASTROENTERO, V9, P84, DOI 10.3748/wjg.v9.i1.84; Jaganathan SK, 2010, J BIOMEDICINE BIOTEC, V2010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin C, 2008, CANCER BIOL THER, V7, P911, DOI 10.4161/cbt.7.6.5912; Johannsen M, 2007, INT J HYPERTHER, V23, P315, DOI 10.1080/02656730601175479; Kabel AM, 2014, AM J MED, V2, P12; Klien K, 2012, ARH HIG RADA TOKSIKO, V63, P133, DOI 10.2478/10004-1254-63-2012-2213; Laurent S, 2011, INT J MOL EPIDEMIOL, V2, P367; Levison DA, 1997, J PATHOL, V183, P243, DOI DOI 10.1002/(SICI)1096-9896(199710)183:2<243::AID-PATH770>3; Lozano G, 2010, COLD SPRING HARBOR P, V2; MAEDA H, 1989, CRIT REV THER DRUG, V6, P193; Markides H, 2012, J NANOMATER, V2012, DOI 10.1155/2012/614094; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; McGill G, 1999, J CLIN INVEST, V104, P223, DOI 10.1172/JCI7861; Mondal N, 2010, INT J PHARMACEUT, V397, P194, DOI 10.1016/j.ijpharm.2010.06.049; Peng X-H, 2008, INT J NANOMEDICINE, V3; Ruiz A, 2013, NANOSCALE, V5, P11400, DOI 10.1039/c3nr01412f; Salah El-Din TA, 2010, MAGNETITE NANOPARTIC; Sharpless NE, 2002, CANCER RES, V62, P2761; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009; STOKINGER HE, 1984, AM IND HYG ASSOC J, V45, P127, DOI 10.1080/15298668491399497; Stone V, 2007, IEEE T NANOBIOSCIENC, V6; Szalay B, 2012, IRON OXIDE NANOPARTI; Vieira J, 2010, BRAZ ARCH BIOL TECHN, V53, P609, DOI 10.1590/S1516-89132010000300014; Wahajuddin SA, 2012, INT J NANOMEDICINE, V7; WILLIAMS JF, 1989, BIOTECHNIQUES, V7, P762; Wu J, 2010, INEC: 2010 3RD INTERNATIONAL NANOELECTRONICS CONFERENCE, VOLS 1 AND 2, P842; Wu WW, 2010, INT J NANOMED, V5, P1079, DOI 10.2147/IJN.S15660; Ye WP, 2011, INT J MOL SCI, V12, P1519, DOI 10.3390/ijms12031519; Zaklina K, 2012, VITAMINS TRACE ELEME; Zhao Q, 2012, THERANOSTICS, V2, P113, DOI 10.7150/thno.3854	40	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111960	10.1371/journal.pone.0111960	http://dx.doi.org/10.1371/journal.pone.0111960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375144	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600080
J	Butler, CA; Dashper, SG; Zhang, LY; Seers, CA; Mitchell, HL; Catmull, DV; Glew, MD; Heath, JE; Tan, Y; Khan, HSG; Reynolds, EC				Butler, Catherine A.; Dashper, Stuart G.; Zhang, Lianyi; Seers, Christine A.; Mitchell, Helen L.; Catmull, Deanne V.; Glew, Michelle D.; Heath, Jacqueline E.; Tan, Yan; Khan, Hasnah S. G.; Reynolds, Eric C.			The Porphyromonas gingivalis Ferric Uptake Regulator Orthologue Binds Hemin and Regulates Hemin-Responsive Biofilm Development	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; STRAIN ATCC 33277; ESCHERICHIA-COLI; IRON-METABOLISM; GENE-EXPRESSION; FUR REPRESSOR; METAL UPTAKE; BACTEROIDES; DEGRADATION; TRANSPORT	Porphyromonas gingivalis is a Gram-negative pathogen associated with the biofilm-mediated disease chronic periodontitis. P. gingivalis biofilm formation is dependent on environmental heme for which P. gingivalis has an obligate requirement as it is unable to synthesize protoporphyrin IX de novo, hence P. gingivalis transports iron and heme liberated from the human host. Homeostasis of a variety of transition metal ions is often mediated in Gram-negative bacteria at the transcriptional level by members of the Ferric Uptake Regulator (Fur) superfamily. P. gingivalis has a single predicted Fur superfamily orthologue which we have designated Har (heme associated regulator). Recombinant Har formed dimers in the presence of Zn2+ and bound one hemin molecule per monomer with high affinity (K-d of 0.23 mu M). The binding of hemin resulted in conformational changes of Zn(II) Har and residue (97)Cys was involved in hemin binding as part of a predicted -C-97-P-98-L-99-hemin binding motif. The expression of 35 genes was down-regulated and 9 up-regulated in a Har mutant (ECR455) relative to wild-type. Twenty six of the down-regulated genes were previously found to be up-regulated in P. gingivalis grown as a biofilm and 11 were up-regulated under hemin limitation. A truncated Zn(II) Har bound the promoter region of dnaA (PGN_0001), one of the up-regulated genes in the ECR455 mutant. This binding decreased as hemin concentration increased which was consistent with gene expression being regulated by hemin availability. ECR455 formed significantly less biofilm than the wild-type and unlike wild-type biofilm formation was independent of hemin availability. P. gingivalis possesses a hemin-binding Fur orthologue that regulates hemin-dependent biofilm formation.	[Butler, Catherine A.; Dashper, Stuart G.; Zhang, Lianyi; Seers, Christine A.; Mitchell, Helen L.; Catmull, Deanne V.; Glew, Michelle D.; Heath, Jacqueline E.; Tan, Yan; Khan, Hasnah S. G.; Reynolds, Eric C.] Univ Melbourne, Inst Bio21, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia	University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Inst Bio21, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia.	e.reynolds@unimelb.edu.au	Glew, Michelle/AAW-9955-2020; Zhang, Lianyi/H-7491-2014	Glew, Michelle/0000-0002-0690-6079; Butler, Catherine/0000-0001-6371-3954; Khan, Hasnah/0000-0001-9807-438X; Reynolds, Eric/0000-0002-6618-4856; Dashper, Stuart/0000-0003-0106-8691; Mitchell, Helen/0000-0002-8359-9279; Seers, Christine/0000-0002-7777-443X	Australian National Health and Medical Research Council [1008055]; Australian Dental Research Foundation [22/2002]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Dental Research Foundation	Financial assistance was received from The Australian National Health and Medical Research Council (https://www.nhmc.gov.au/) project grant 1008055 and Australian Dental Research Foundation (http://www.ada.org.au/about/adrfgrants.aspx) grant 22/2002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Ahmad R, 2009, PROTEINS, V75, P373, DOI 10.1002/prot.22247; Ahn BE, 2006, MOL MICROBIOL, V59, P1848, DOI 10.1111/j.1365-2958.2006.05065.x; Althaus EW, 1999, BIOCHEMISTRY-US, V38, P6559, DOI 10.1021/bi982788s; Anaya-Bergman C, 2015, MOL ORAL MICROBIOL, V30, P39, DOI 10.1111/omi.12066; Ang CS, 2008, PROTEOMICS, V8, P1645, DOI 10.1002/pmic.200700557; Berlutti F, 2004, BIOMETALS, V17, P271; Bsat N, 1999, J BACTERIOL, V181, P4299, DOI 10.1128/JB.181.14.4299-4307.1999; CALDERWOOD SB, 1987, J BACTERIOL, V169, P4759, DOI 10.1128/jb.169.10.4759-4764.1987; Carpenter BM, 2013, J BACTERIOL, V195, P5526, DOI 10.1128/JB.01026-13; Dashper SG, 2005, J BIOL CHEM, V280, P28095, DOI 10.1074/jbc.M503896200; Dashper SG, 2012, ANTIMICROB AGENTS CH, V56, P1548, DOI 10.1128/AAC.05100-11; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; Delany I, 2001, MOL MICROBIOL, V42, P1297, DOI 10.1046/j.1365-2958.2001.02696.x; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fleischhacker AS, 2011, CURR OPIN CHEM BIOL, V15, P335, DOI 10.1016/j.cbpa.2011.01.006; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gao JL, 2010, J BIOL CHEM, V285, P40028, DOI 10.1074/jbc.M110.163535; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; Hansen RE, 2009, ANAL BIOCHEM, V394, P147, DOI 10.1016/j.ab.2009.07.051; HANTKE K, 1981, MOL GEN GENET, V182, P288, DOI 10.1007/BF00269672; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; HANTKE K, 1987, FEMS MICROBIOL LETT, V44, P53, DOI 10.1111/j.1574-6968.1987.tb02241.x; He J, 2006, INFECT IMMUN, V74, P4214, DOI 10.1128/IAI.00014-06; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hindre T, 2008, MICROBIOL-SGM, V154, P30, DOI 10.1099/mic.0.2007/008698-0; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; James CE, 2006, INFECT IMMUN, V74, P3834, DOI 10.1128/IAI.01768-05; Johnson M, 2005, J BACTERIOL, V187, P8211, DOI 10.1128/JB.187.23.8211-8215.2005; KARJALAINEN TK, 1991, MICROB PATHOGENESIS, V11, P317, DOI 10.1016/0882-4010(91)90017-5; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Kuhl T, 2013, ACS CHEM BIOL, V8, P1785, DOI 10.1021/cb400317x; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; LEBEK G, 1985, INFECT IMMUN, V50, P682, DOI 10.1128/IAI.50.3.682-686.1985; Lee HJ, 2007, J BACTERIOL, V189, P2629, DOI 10.1128/JB.01791-06; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; Lewis JP, 2006, MICROBIOL-SGM, V152, P3367, DOI 10.1099/mic.0.29011-0; Lewis JP, 2010, PERIODONTOL 2000, V52, P94, DOI 10.1111/j.1600-0757.2009.00329.x; Lo AW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-18; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LOESCHE WJ, 1981, J CLIN PERIODONTOL, V8, P29, DOI 10.1111/j.1600-051X.1981.tb02022.x; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; Olczak T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-134; OSTROY F, 1978, BIOCHIM BIOPHYS ACTA, V527, P56, DOI 10.1016/0005-2744(78)90255-3; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pidot SJ, 2010, MOL MICROBIOL, V78, P1216, DOI 10.1111/j.1365-2958.2010.07401.x; Robertson KP, 2006, INFECT IMMUN, V74, P2304, DOI 10.1128/IAI.74.4.2304-2316.2006; Roper JM, 2000, J BIOL CHEM, V275, P40316, DOI 10.1074/jbc.M007146200; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; SHIZUKUISHI S, 1995, FEMS MICROBIOL LETT, V131, P313; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; SLOTS J, 1977, SCAND J DENT RES, V85, P247; SPIEGEL CA, 1979, J PERIODONTAL RES, V14, P376, DOI 10.1111/j.1600-0765.1979.tb00234.x; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Toney JH, 2006, JALA, V11, P30; Vajrala N, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-37; VANDYKE TE, 1988, J PERIODONTOL, V59, P184, DOI 10.1902/jop.1988.59.3.184; Vitale S, 2009, BIOCHEMISTRY-US, V48, P5582, DOI 10.1021/bi9004396; WHITE D, 1981, J PERIODONTAL RES, V16, P259, DOI 10.1111/j.1600-0765.1981.tb00974.x; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yamamoto R, 2011, APPL ENVIRON MICROB, V77, P6733, DOI 10.1128/AEM.00746-11; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	77	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111168	10.1371/journal.pone.0111168	http://dx.doi.org/10.1371/journal.pone.0111168			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375181	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600027
J	Kosmidis, EK; Moschou, V; Ziogas, G; Boukovinas, I; Albani, M; Laskaris, NA				Kosmidis, Efstratios K.; Moschou, Vasiliki; Ziogas, Georgios; Boukovinas, Ioannis; Albani, Maria; Laskaris, Nikolaos A.			Functional Aspects of the EGF-Induced MAP Kinase Cascade: A Complex Self-Organizing System Approach	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ERBB SIGNALING NETWORK; MATHEMATICAL-MODEL; ACTIVATION; DYNAMICS; RESPONSES; INFORMATION; CANCER; TRANSDUCTION; MECHANISMS	The EGF-induced MAP kinase cascade is one of the most important and best characterized networks in intracellular signalling. It has a vital role in the development and maturation of living organisms. However, when deregulated, it is involved in the onset of a number of diseases. Based on a computational model describing a "surface" and an "internalized" parallel route, we use systems biology techniques to characterize aspects of the network's functional organization. We examine the re-organization of protein groups from low to high external stimulation, define functional groups of proteins within the network, determine the parameter best encoding for input intensity and predict the effect of protein removal to the system's output response. Extensive functional re-organization of proteins is observed in the lower end of stimulus concentrations. As we move to higher concentrations the variability is less pronounced. 6 functional groups have emerged from a consensus clustering approach, reflecting different dynamical aspects of the network. Mutual information investigation revealed that the maximum activation rate of the two output proteins best encodes for stimulus intensity. Removal of each protein of the network resulted in a range of graded effects, from complete silencing to intense activation. Our results provide a new "vista" of the EGF-induced MAP kinase cascade, from the perspective of complex self-organizing systems. Functional grouping of the proteins reveals an organizational scheme contrasting the current understanding of modular topology. The six identified groups may provide the means to experimentally follow the dynamics of this complex network. Also, the vulnerability analysis approach may be used for the development of novel therapeutic targets in the context of personalized medicine.	[Kosmidis, Efstratios K.; Moschou, Vasiliki; Albani, Maria] Aristotle Univ Thessaloniki, Dept Med, Physiol Lab, GR-54006 Thessaloniki, Greece; [Ziogas, Georgios; Laskaris, Nikolaos A.] Aristotle Univ Thessaloniki, Dept Informat, AIIA Lab, GR-54006 Thessaloniki, Greece; [Boukovinas, Ioannis] Bioclin Oncol Unit, Thessaloniki, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Kosmidis, EK (corresponding author), Aristotle Univ Thessaloniki, Dept Med, Physiol Lab, Univ Campus, GR-54006 Thessaloniki, Greece.	kosmidef@med.auth.gr		Laskaris, Nikos/0000-0002-1960-394X	AUTH research committee [89347]; Amgen Hellas [89547]	AUTH research committee; Amgen Hellas	This research was partially funded by AUTH research committee (grant 89347, www.rc.auth.gr) and Amgen Hellas (grant 89547, www.amgen.gr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamos DA, 2010, J NEUROSCI METH, V190, P129, DOI 10.1016/j.jneumeth.2010.04.018; Araujo RP, 2005, BIOSYSTEMS, V80, P57, DOI 10.1016/j.biosystems.2004.10.002; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; BATZER AG, 1995, MOL CELL BIOL, V15, P4403; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Blinov ML, 2006, BIOSYSTEMS, V83, P136, DOI 10.1016/j.biosystems.2005.06.014; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Castagnino N, 2010, LECT N BIOINFORMAT, V6160, P151; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cooper GM, 2000, CELL MOL APPROACH; El-Masri HA, 1999, B MATH BIOL, V61, P379, DOI 10.1006/bulm.1998.0077; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Hubbard SR, 2005, CANCER CELL, V7, P287, DOI 10.1016/j.ccr.2005.04.004; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iyengar R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003563; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kinney JB, 2014, P NATL ACAD SCI USA, V111, P3354, DOI 10.1073/pnas.1309933111; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Laskaris NA, 2004, IEEE SIGNAL PROC MAG, V21, P66, DOI 10.1109/MSP.2004.1296544; Laskaris NA, 2002, CLIN NEUROPHYSIOL, V113, P1209, DOI 10.1016/S1388-2457(02)00124-4; Laskaris NA, 2008, IEEE ENG MED BIOL, V27, P69, DOI 10.1109/EMB.2007.913555; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030140; Liu G, 2005, BIOINFORMATICS, V21, P1194, DOI 10.1093/bioinformatics/bti118; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Nielsen UB, 2005, IDRUGS, V8, P822; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Pavan M, 2007, IEEE T PATTERN ANAL, V29, P167, DOI 10.1109/TPAMI.2007.250608; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schoeberl Birgit, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P53; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Shankaran H, 2012, MOL BIOSYST, V8, P2868, DOI 10.1039/c2mb25190f; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; STARBUCK C, 1992, BIOTECHNOL PROGR, V8, P132, DOI 10.1021/bp00014a007; Sun XQ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-218; Tasaki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013926; Wang DYQ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-118; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	46	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111612	10.1371/journal.pone.0111612	http://dx.doi.org/10.1371/journal.pone.0111612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372488	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900056
J	Skala, V; Cernikova, A; Jindrova, Z; Kasny, M; Vostry, M; Walker, AJ; Horak, P				Skala, Vladimir; Cernikova, Alena; Jindrova, Zuzana; Kasny, Martin; Vostry, Martin; Walker, Anthony J.; Horak, Petr			Influence of Trichobilharzia regenti (Digenea: Schistosomatidae) on the Defence Activity of Radix lagotis (Lymnaeidae) Haemocytes	PLOS ONE			English	Article							RESISTANT BIOMPHALARIA-GLABRATA; PROTEIN-KINASE; AVIAN SCHISTOSOME; IMMUNE-RESPONSES; MANSONI; STAGNALIS; SNAIL; PHAGOCYTOSIS; SPOROCYSTS; CELLS	Radix lagotis is an intermediate snail host of the nasal bird schistosome Trichobilharzia regenti. Changes in defence responses in infected snails that might be related to host-parasite compatibility are not known. This study therefore aimed to characterize R. lagotis haemocyte defence mechanisms and determine the extent to which they are modulated by T. regenti. Histological observations of R. lagotis infected with T. regenti revealed that early phases of infection were accompanied by haemocyte accumulation around the developing larvae 2-36 h post exposure (p. e.) to the parasite. At later time points, 44-92 h p. e., no haemocytes were observed around T. regenti. Additionally, microtubular aggregates likely corresponding to phagocytosed ciliary plates of T. regenti miracidia were observed within haemocytes by use of transmission electron microscopy. When the infection was in the patent phase, haemocyte phagocytic activity and hydrogen peroxide production were significantly reduced in infected R. lagotis when compared to uninfected counterparts, whereas haemocyte abundance increased in infected snails. At a molecular level, protein kinase C (PKC) and extracellular-signal regulated kinase (ERK) were found to play an important role in regulating these defence reactions in R. lagotis. Moreover, haemocytes from snails with patent infection displayed lower PKC and ERK activity in cell adhesion assays when compared to those from uninfected snails, which may therefore be related to the reduced defence activities of these cells. These data provide the first integrated insight into the immunobiology of R. lagotis and demonstrate modulation of haemocyte-mediated responses in patent T. regenti infected snails. Given that immunomodulation occurs during patency, interference of snail-host defence by T. regenti might be important for the sustained production and/or release of infective cercariae.	[Skala, Vladimir; Jindrova, Zuzana; Kasny, Martin; Vostry, Martin; Horak, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic; [Cernikova, Alena] Charles Univ Prague, Fac Sci, Inst Appl Math & Informat Technol, Prague, Czech Republic; [Jindrova, Zuzana] Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Prague, Czech Republic; [Kasny, Martin] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Vostry, Martin] Inst Hematol & Blood Transfus, Prague, Czech Republic; [Walker, Anthony J.] Univ Kingston, Sch Life Sci, Mol Parasitol Lab, Kingston Upon Thames KT1 2EE, Surrey, England	Charles University Prague; Charles University Prague; Charles University Prague; Masaryk University Brno; Institute of Hematology Prague; Kingston University	Skala, V (corresponding author), Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic.	mich007@email.cz	Cernikova, Alena/V-4090-2017; Fremuntova, Zuzana/G-3859-2017; Skála, Vladimír/J-7405-2017; Horák, Petr/AGF-2029-2022; Horák, Petr/C-6482-2009; Skala, Vladimir/J-7405-2017	Cernikova, Alena/0000-0001-6954-9075; Fremuntova, Zuzana/0000-0002-7910-5344; Skála, Vladimír/0000-0003-0898-5708; Horák, Petr/0000-0001-9820-5044; Horák, Petr/0000-0001-9820-5044; Vostry, Martin/0000-0002-7557-2543; Skala, Vladimir/0000-0001-9113-3658	Charles University in Prague [435911, PRVOUK - P41/PrF, UNCE 204017, SVV 260074/2014]	Charles University in Prague	The study was financially supported by the Charles University in Prague (Grant GAUK no. 435911, research programmes PRVOUK - P41/PrF, UNCE 204017 and SVV 260074/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-El-Naga IF, 2012, REV BIOL TROP, V60, P1195; ADEMA CM, 1991, DEV COMP IMMUNOL, V15, P17, DOI 10.1016/0145-305X(91)90043-X; Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; ADEMA CM, 1994, J PARASITOL, V80, P719, DOI 10.2307/3283251; AMEN RI, 1992, PARASITOLOGY, V104, P33, DOI 10.1017/S0031182000060777; Arumugam M, 2000, EUR J CELL BIOL, V79, P513, DOI 10.1078/0171-9335-00068; BAYNE CJ, 1980, J PARASITOL, V66, P413, DOI 10.2307/3280740; BAYNE CJ, 1980, EXP PARASITOL, V50, P409, DOI 10.1016/0014-4894(80)90043-0; Bender RC, 2005, J PARASITOL, V91, P275, DOI 10.1645/GE-415R; Chen QM, 1996, J BIOL CHEM, V271, P18122, DOI 10.1074/jbc.271.30.18122; CONNORS VA, 1990, J PARASITOL, V76, P895, DOI 10.2307/3282811; de Jong-Brink M, 2001, PARASITOLOGY, V123, pS129, DOI 10.1017/S0031182001008149; DIKKEBOOM R, 1988, DEV COMP IMMUNOL, V12, P509, DOI 10.1016/0145-305X(88)90068-7; Flye-Sainte-Marie J, 2009, J EXP MAR BIOL ECOL, V377, P1, DOI 10.1016/j.jembe.2009.06.003; Garcia-Garcia E, 2008, DEV COMP IMMUNOL, V32, P637, DOI 10.1016/j.dci.2007.10.004; Gorbushin AM, 2008, FISH SHELLFISH IMMUN, V24, P745, DOI 10.1016/j.fsi.2008.01.018; Hahn UK, 2001, J PARASITOL, V87, P292, DOI 10.1645/0022-3395(2001)087[0292:KOSMSB]2.0.CO;2; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Horak P, 1998, PARASITE, V5, P349, DOI 10.1051/parasite/1998054349; Horak P, 2002, ADV PARASIT, V52, P155, DOI 10.1016/S0065-308X(02)52012-1; Humphries JE, 2003, INTEGR COMP BIOL, V43, P305, DOI 10.1093/icb/43.2.305; Humphries JE, 2008, DEV COMP IMMUNOL, V32, P554, DOI 10.1016/j.dci.2007.09.001; Hunova K, 2012, ACTA PARASITOL, V57, P273, DOI 10.2478/s11686-012-0040-7; Iakovleva NV, 2006, EXP PARASITOL, V113, P24, DOI 10.1016/j.exppara.2005.12.002; ITO T, 1992, DEV COMP IMMUNOL, V16, P287, DOI 10.1016/0145-305X(92)90003-U; Kolarova L, 2013, CLIN REV ALLERG IMMU, V45, P63, DOI 10.1007/s12016-012-8334-y; Lacchini AH, 2006, J EXP BIOL, V209, P4829, DOI 10.1242/jeb.02561; Lehmacher W, 1999, BIOMETRICS, V55, P1286, DOI 10.1111/j.0006-341X.1999.01286.x; LIE KJ, 1981, J PARASITOL, V67, P790, DOI 10.2307/3280701; LOKER ES, 1987, J PARASITOL, V73, P1090, DOI 10.2307/3282286; LOKER ES, 1982, J PARASITOL, V68, P84, DOI 10.2307/3281328; Mitta G, 2012, DEV COMP IMMUNOL, V37, P1, DOI 10.1016/j.dci.2011.09.002; Mohamed AH, 2011, EXP PARASITOL, V127, P789, DOI 10.1016/j.exppara.2011.01.020; MOUNKASSA JB, 1990, J INVERTEBR PATHOL, V55, P306, DOI 10.1016/0022-2011(90)90071-D; Nacif-Pimenta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045637; NODA S, 1989, J PARASITOL, V75, P261, DOI 10.2307/3282775; NUNEZ PE, 1994, PARASITOLOGY, V109, P299, DOI 10.1017/S0031182000078331; Plows LD, 2006, J INVERTEBR PATHOL, V91, P74, DOI 10.1016/j.jip.2005.10.011; Plows LD, 2005, INT J PARASITOL, V35, P293, DOI 10.1016/j.ijpara.2004.11.012; Plows LD, 2004, BBA-MOL CELL RES, V1692, P25, DOI 10.1016/j.bbamer.2004.03.002; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RILEY EM, 1992, J INVERTEBR PATHOL, V59, P190, DOI 10.1016/0022-2011(92)90032-Y; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; SMINIA T, 1972, Z ZELLFORSCH MIK ANA, V130, P497, DOI 10.1007/BF00307004; SURESH PG, 1994, COMP HAEMATOL INT, V4, P17, DOI 10.1007/BF00368261; Theron A, 1997, EXP PARASITOL, V85, P1, DOI 10.1006/expr.1996.4106; VANDERKNAAP WPW, 1993, COMP HAEMATOL INT, V3, P20, DOI 10.1007/BF00394923; Walker AJ, 2006, TRENDS PARASITOL, V22, P154, DOI 10.1016/j.pt.2006.02.003; Walker AJ, 2003, BIOL CELL, V95, P527, DOI 10.1016/j.biolcel.2003.09.001; Zahoor Z, 2008, DEV COMP IMMUNOL, V32, P1561, DOI 10.1016/j.dci.2008.05.014; Zelck UE, 2007, DEV COMP IMMUNOL, V31, P321, DOI 10.1016/j.dci.2006.06.006	51	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111696	10.1371/journal.pone.0111696	http://dx.doi.org/10.1371/journal.pone.0111696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372492	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000344556900065
J	Tsen, SWD; Kingsley, DH; Kibler, K; Jacobs, B; Sizemore, S; Vaiana, SM; Anderson, J; Tsen, KT; Achilefu, S				Tsen, Shaw-Wei D.; Kingsley, David H.; Kibler, Karen; Jacobs, Bert; Sizemore, Sara; Vaiana, Sara M.; Anderson, Jeanne; Tsen, Kong-Thon; Achilefu, Samuel			Pathogen Reduction in Human Plasma Using an Ultrashort Pulsed Laser	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; HEPATITIS-A VIRUS; INACTIVATION; FIBRINOGEN	Pathogen reduction is a viable approach to ensure the continued safety of the blood supply against emerging pathogens. However, the currently licensed pathogen reduction techniques are ineffective against non-enveloped viruses such as hepatitis A virus, and they introduce chemicals with concerns of side effects which prevent their widespread use. In this report, we demonstrate the inactivation of both enveloped and non-enveloped viruses in human plasma using a novel chemical-free method, a visible ultrashort pulsed laser. We found that laser treatment resulted in 2-log, 1-log, and 3-log reductions in human immunodeficiency virus, hepatitis A virus, and murine cytomegalovirus in human plasma, respectively. Laser-treated plasma showed >= 70% retention for most coagulation factors tested. Furthermore, laser treatment did not alter the structure of a model coagulation factor, fibrinogen. Ultrashort pulsed lasers are a promising new method for chemical-free, broad-spectrum pathogen reduction in human plasma.	[Tsen, Shaw-Wei D.; Achilefu, Samuel] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Kingsley, David H.] Delaware State Univ, James WW Baker Ctr, Food Safety & Intervent Technol Res Unit, USDA ARS, Delaware, OH USA; [Kibler, Karen; Jacobs, Bert] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Sizemore, Sara; Vaiana, Sara M.; Tsen, Kong-Thon] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Anderson, Jeanne] Barnes Jewish Hosp, Dept Hematol, St Louis, MO 63110 USA; [Sizemore, Sara; Vaiana, Sara M.; Tsen, Kong-Thon] Arizona State Univ, Ctr Biophys, Tempe, AZ USA; [Achilefu, Samuel] Washington Univ, Sch Med, St Louis, MO USA	Washington University (WUSTL); United States Department of Agriculture (USDA); Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Barnes-Jewish Hospital; Washington University (WUSTL); Arizona State University; Arizona State University-Tempe; Washington University (WUSTL)	Achilefu, S (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	achilefus@mir.wustl.edu	Achilefu, Samuel/AAC-2401-2019	Achilefu, Samuel/0000-0002-3133-6717	National Heart, Lung, and Blood Institute Ruth L. Kirschstein NRSA F30 [HL116183-01]; Mallinckrodt Institute of Radiology Development Fund; National Institutes of Health [R01 EB008111, R33 CA123537, S10 OD016237]; NATIONAL CANCER INSTITUTE [R33CA123537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL116183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008111] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016237] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute Ruth L. Kirschstein NRSA F30; Mallinckrodt Institute of Radiology Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Heart, Lung, and Blood Institute Ruth L. Kirschstein NRSA F30 grant HL116183-01 (SDT), by the Mallinckrodt Institute of Radiology Development Fund, and resources from National Institutes of Health grants R01 EB008111, R33 CA123537, and S10 OD016237 (SA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JP, 2005, TRANSFUS MED REV, V19, P110, DOI 10.1016/j.tmrv.2004.11.005; AuBuchon J, 2011, ISBT SCI SERIES, V6, P181; Bhadri PR, 2008, ANALOG INTEGR CIRC S, V56, P127, DOI 10.1007/s10470-007-9076-2; Bryant BJ, 2007, ARCH PATHOL LAB MED, V131, P719; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Feng L, 1995, ACS SYM SER, V602, P66; Garwood M, 2003, TRANSFUSION, V43, P1238, DOI 10.1046/j.1537-2995.2003.00485.x; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Hellstern P, 2004, CURR OPIN HEMATOL, V11, P346, DOI 10.1097/01.moh.0000137915.88478.23; Hellstern P, 2011, TRANSFUS MED HEMOTH, V38, P65, DOI 10.1159/000323552; Kingsley DH, 2009, INT J FOOD MICROBIOL, V130, P61, DOI 10.1016/j.ijfoodmicro.2009.01.004; LEMON SM, 1991, J VIROL, V65, P2056, DOI 10.1128/JVI.65.4.2056-2065.1991; Musso D, 2014, TRANSFUSION; Qian ZK, 2012, J VIROL, V86, P6712, DOI 10.1128/JVI.00200-12; Rock G, 2011, VOX SANG, V100, P169, DOI 10.1111/j.1423-0410.2010.01374.x; ROSSI E, 1988, THROMB RES, V52, P453, DOI 10.1016/0049-3848(88)90029-1; Schmaier AH, 2012, HEMATOLOGY BASIC PRI; Singh Y, 2006, TRANSFUSION, V46, P1168, DOI 10.1111/j.1537-2995.2006.00867.x; Tsen KT, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/47/472201; Tsen KT, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/32/322102; Tsen KT, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/25/252205; Tsen KT, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600771; Tsen KT, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275477; Tsen KT, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2821713; Tsen SWD, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-20; Tsen SWD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.128002; Tsen SWD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-62; ZEILER T, 1994, TRANSFUSION, V34, P685, DOI 10.1046/j.1537-2995.1994.34894353464.x	28	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111673	10.1371/journal.pone.0111673	http://dx.doi.org/10.1371/journal.pone.0111673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372037	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900061
J	Kumar, J; Gurav, R; Kale, V; Limaye, L				Kumar, Jeetendra; Gurav, Rupali; Kale, Vaijayanti; Limaye, Lalita			Exogenous Addition of Arachidonic Acid to the Culture Media Enhances the Functionality of Dendritic Cells for Their Possible Use in Cancer Immunotherapy	PLOS ONE			English	Article							CORD BLOOD; CD34(+) PROGENITORS; PROSTAGLANDIN E-2; GENERATION; MIGRATION; MATURATION; MATURE; PRECURSORS; IMMUNITY; SPEED	The development of dendritic cell based vaccines is a promising approach in cancer immunotherapy. For their successful use in the clinics, the propagation and functionality of DCs is crucial. We earlier established a two-step method for the large scale generation of DCs from umbilical cord blood derived MNCs/CD34+ cells. This work aims at improving their functionality based on the following observations: in vitro generated DCs can be less efficient in migration and other functional activities due to lower eicosanoid levels. The production of eicosanoids from Arachidonic Acid (AA) can be hampered due to suppression of the enzyme phospholipase A2 by IL-4, an essential cytokine required for the differentiation of DCs. We hypothesized that exogenous addition of AA to the culture media during DC generation may result in DCs with improved functionality. DCs were generated with and without AA. The two DC sets were compared by phenotypic analysis, morphology and functional assays like antigen uptake, MLR, CTL assay and in vitro and in vivo migration. Though there were no differences between the two types of DCs in terms of morphology, phenotype and antigen uptake, AA(+) DCs exhibited an enhanced in vitro and in vivo migration, T cell stimulatory capacity, CTL activity and significantly higher transcript levels of COX-2. AA(+) DCs also show a favorable Th1 cytokine profile than AA(-) DCs. Thus addition of AA to the culture media is skewing the DCs towards the secretion of more IL-12 and less of IL-10 along with the restoration of eicosanoids levels in a COX-2 mediated pathway thereby enhancing the functionality of these cells to be used as a potent cellular vaccine. Taken together, these findings will be helpful in the better contriving of DC based vaccines for cancer immunotherapy.	[Kumar, Jeetendra; Gurav, Rupali; Kale, Vaijayanti; Limaye, Lalita] Natl Ctr Cell Sci, Stem Cell Lab, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Limaye, L (corresponding author), Natl Ctr Cell Sci, Stem Cell Lab, Pune, Maharashtra, India.	lslimaye@nccs.res.in	Kale, Vaijayanti/R-9342-2019	Kale, Vaijayanti/0000-0001-7498-7563	Department of Biotechnology (DBT), Government of India [BT/PR13565/MED/31/89/2010]; Council of Scientific and Industrial Research (CSIR) India; DBT [PR-4930/31]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India)	The project received funds from Department of Biotechnology (DBT), Government of India via grant no. BT/PR13565/MED/31/89/2010. JK received his fellowship from Council of Scientific and Industrial Research (CSIR) India and from DBT (PR-4930/31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Arrighi JF, 1999, BLOOD, V93, P2244, DOI 10.1182/blood.V93.7.2244.407a29_2244_2252; Balan S, 2010, TRANSFUSION, V50, P2413, DOI 10.1111/j.1537-2995.2010.02706.x; Balan S, 2009, TRANSFUSION, V49, P2109, DOI 10.1111/j.1537-2995.2009.02231.x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; Bontkes HJ, 2002, J LEUKOCYTE BIOL, V72, P321; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Encabo A, 2004, STEM CELLS, V22, P725, DOI 10.1634/stemcells.22-5-725; Fong L, 2000, ANNU REV IMMUNOL, V18, P245, DOI 10.1146/annurev.immunol.18.1.245; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P1111, DOI 10.4161/onci.21494; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Harizi H, 2013, CELL MOL IMMUNOL, V10, P213, DOI 10.1038/cmi.2013.1; Hsu AKW, 2006, BIOL BLOOD MARROW TR, V12, P855, DOI 10.1016/j.bbmt.2006.05.004; Kalinski P, 1998, J IMMUNOL, V161, P2804; Kalinski P, 2011, IMMUNOL RES, V50, P235, DOI 10.1007/s12026-011-8224-z; Lee H, 2008, CANCER IMMUNOL IMMUN, V57, P1; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Morse MA, 1999, CANCER RES, V59, P56; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Perroud Jr MW, 2011, J EXP CLIN CANC RES, V17, P30; Ridgway D, 2003, CANCER INVEST, V21, P873, DOI 10.1081/CNV-120025091; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Ryan EP, 2006, J IMMUNOL, V177, P7811, DOI 10.4049/jimmunol.177.11.7811; Ryu KH, 2004, INT J HEMATOL, V80, P281, DOI 10.1532/IJH97.A10406; SANTIAGOSCHWARZ F, 1995, STEM CELLS, V13, P186, DOI 10.1002/stem.5530130210; Saraya K, 1996, BRIT J HAEMATOL, V93, P258, DOI 10.1046/j.1365-2141.1996.5131053.x; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Soruri A, 2005, INT J BIOCHEM CELL B, V37, P241, DOI 10.1016/j.biocel.2004.07.003; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; Thurnher M, 2001, FASEB J, V15, P1054, DOI 10.1096/fj.00-0508hyp; Usharauli D, 2006, NAT PROTOC, V1, P673, DOI 10.1038/nprot.2006.107; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; Verdijk P, 2009, CLIN CANCER RES, V15, P2531, DOI 10.1158/1078-0432.CCR-08-2729	38	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111759	10.1371/journal.pone.0111759	http://dx.doi.org/10.1371/journal.pone.0111759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369453	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000097
J	Ulrichsen, SP; Mor, A; Svensson, E; Larsen, FB; Thomsen, RW				Ulrichsen, Sinna P.; Mor, Anil; Svensson, Elisabeth; Larsen, Finn B.; Thomsen, Reimar W.			Lifestyle Factors Associated with Type 2 Diabetes and Use of Different Glucose-Lowering Drugs: Cross-Sectional Study	PLOS ONE			English	Article							DIETARY QUALITY; HEALTH SURVEY; MORTALITY; METFORMIN; COHORT; RISK; VALIDATION; REGISTER; MELLITUS; INDEX	Aims: To examine the lifestyle profile among persons with and without Type 2 diabetes mellitus (DM) and among users of different glucose-lowering drugs. Methods: We used questionnaire data from a Danish health survey and identified presence of Type 2 DM and use of medications through medical databases. We calculated age-and gender-standardized prevalence ratios (PRs) of lifestyle factors according to Type 2 DM and different glucose-lowering drugs. Results: Of 21,637 survey participants aged 25-79 years, 680 (3%) had Type 2 DM (median age 63 years) with a median diabetes duration of 5 years. Participants with Type 2 DM had a substantially higher prevalence of obesity (36% vs. 13%, PR: 3.1, 95% confidence interval (CI): 2.8-3.6), yet more reported to eat a very healthy diet (25% vs. 21%, PR: 1.2, 95% CI: 1.0-1.4) and to exercise regularly (67% vs. 53%, PR: 1.3, 95% CI: 1.2-1.4). Also, fewer were current smokers or had high alcohol intake. When compared with metformin users, obesity was substantially less prevalent in users of sulfonylurea (PR: 0.5, 95% CI: 0.40-8), and insulin and analogues (PR: 0.4, 95% CI: 0.3-0.7). Tobacco smoking was more prevalent in sulfonylurea users (PR: 1.4, 95% CI: 0.9-2.1) compared with metformin users. We found no material differences in physical exercise, diet or alcohol intake according to type of glucose-lowering drug. Conclusions: Type 2 DM patients are substantially more obese than other individuals, but otherwise report to have a healthier lifestyle. Metformin use is strongly associated with obesity, whereas sulfonylurea use tends to be associated with tobacco smoking.	[Ulrichsen, Sinna P.; Mor, Anil; Svensson, Elisabeth; Thomsen, Reimar W.] Aarhus Univ Hosp, Fac Hlth, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Larsen, Finn B.] Cent Denmark Reg, Ctr Publ Hlth & Qual Improvement, Aarhus, Denmark	Aarhus University	Mor, A (corresponding author), Aarhus Univ Hosp, Fac Hlth, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.	anil.mor@clin.au.dk	Mor, Anil/ABH-9147-2020; Svensson, Elisabeth/L-2493-2013	Mor, Anil/0000-0002-4002-0618; Thomsen, Reimar/0000-0001-9135-3474; Svensson, Elisabeth/0000-0001-6706-6336	Clinical Epidemiology Research Foundation, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Epidemiology, Aarhus University Hospital	Clinical Epidemiology Research Foundation, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Epidemiology, Aarhus University Hospital	This research was supported by the Clinical Epidemiology Research Foundation, Aarhus University Hospital, Aarhus, Denmark. The Department of Clinical Epidemiology, Aarhus University Hospital, receives funding for other studies from companies in the form of research grants to (and administered by) Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bo S, 2012, DIABETES OBES METAB, V14, P23, DOI 10.1111/j.1463-1326.2011.01480.x; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Carstensen B, 2012, DIABETOLOGIA, V55, P948, DOI 10.1007/s00125-011-2381-4; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen AI, 2012, SCAND J PUBLIC HEALT, V40, P391, DOI 10.1177/1403494812451412; Christiansen CF, 2013, CRIT CARE, V17, DOI 10.1186/cc12886; Cichosz SL, 2013, DIABETIC MED, V30, P1063, DOI 10.1111/dme.12199; de Leeuw E. D., 2008, INT HDB SURVEY METHO; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Ekstrom N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001076; Garg SK, 2014, DIABETES OBES METAB, V16, P97, DOI 10.1111/dom.12124; Horsdal HT, 2012, J STROKE CEREBROVASC, V21, P717, DOI 10.1016/j.jstrokecerebrovasdis.2011.03.007; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Larsen F, 2008, HVORDAN HAR SUNDHEDS; Laugesen K, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen,2013-003024, DOI 10.1136/BMJOPEN,2013-003024]; Leegaard A, 2011, DIABETES CARE, V34, P2530, DOI 10.2337/dc11-0902; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Magas S, 2009, COLLEGIUM ANTROPOL, V33, P115; Mor A, 2014, DIABETOLOGIA, V57, pS139; Murray AE, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-110; Nichols M., 2012, EUROPEAN CARDIOVASCU; Nwaneri C, 2013, BR J DIABETES VASC D, V13, P192; Samuel-Hodge CD, 2004, DIABETES CARE, V27, P663, DOI 10.2337/diacare.27.3.663; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Tabak AG, 2014, LANCET DIABETES ENDO, V2, P236, DOI 10.1016/S2213-8587(13)70139-6; Thomsen Reimar Wernich, 2012, Clin Epidemiol, V4, P43, DOI 10.2147/CLEP.S30083; Thomsen RW, 2006, DIABETES CARE, V29, P805, DOI 10.2337/diacare.29.04.06.dc05-1748; Thomsen RW, 2012, OPEN INFECT DIS J S1, V6, P27, DOI DOI 10.2174/1874279301206010027; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Toft U, 2007, EUR J CLIN NUTR, V61, P270, DOI 10.1038/sj.ejcn.1602503; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Yannakoulia Mary, 2006, Review of Diabetic Studies, V3, P11, DOI 10.1900/RDS.2006.3.11	37	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111849	10.1371/journal.pone.0111849	http://dx.doi.org/10.1371/journal.pone.0111849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369331	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000112
J	Wang, JY; Sun, J; Huang, MY; Wang, YS; Hou, MF; Sun, Y; He, H; Krishna, N; Chiu, SJ; Lin, S; Yang, S; Chang, WC				Wang, J-Y; Sun, J.; Huang, M-Y; Wang, Y-S; Hou, M-F; Sun, Y.; He, H.; Krishna, N.; Chiu, S-J; Lin, S.; Yang, S.; Chang, W-C			STIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression	ONCOGENE			English	Article							OPERATED CALCIUM INFLUX; GENE ACTIVATION; CA2+ INFLUX; GROWTH; PROLIFERATION; MIGRATION; CHANNELS; FASCIN; ORAI1; INVOLVEMENT	Tumor metastasis is the major cause of death among cancer patients, with >90% of cancer-related death attributable to the spreading of metastatic cells to secondary organs. Store-operated Ca2+ entry (SOCE) is the predominant Ca2+ entry mechanism in most cancer cells, and stromal interaction molecule 1 (STIM1) is the endoplasmic reticulum (ER) Ca2+ sensor for store-operated channels. Here we reported that the STIM1 was overexpressed in colorectal cancer (CRC) patients. STIM1 overexpression in CRC was significantly associated with tumor size, depth of invasion, lymph node metastasis status and serum levels of carcinoembryonic antigen. Furthermore, ectopic expression of STIM1 promoted CRC cell motility, while depletion of STIM1 with short hairpin RNA inhibited CRC cell migration. Our data further suggested that STIM1 promoted CRC cell migration through increasing the expression of cyclooxygenase-2 (COX-2) and production of prostaglandin E2 (PGE2). Importantly, ectopically expressed COX-2 or exogenous PGE2 were able to rescue migration defect in STIM1 knockdown CRC cells, and inhibition of COX-2 with ibuprofen and indomethacin abrogated STIM1-mediated CRC cell motility. In short, our data provided clinicopathological significance for STIM1 and SOCE in CRC progression, and implicated a role for COX-2 in STIM1-mediated CRC metastasis. Our studies also suggested a new approach to inhibit STIM1-mediated metastasis with COX-2 inhibitors.	[Wang, J-Y; Huang, M-Y; Hou, M-F; Chiu, S-J; Chang, W-C] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Wang, J-Y] Kaohsiung Med Univ Hosp, Div Gastrointestinal & Gen Surg, Kaohsiung, Taiwan; [Wang, J-Y] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Dept Surg, Kaohsiung, Taiwan; [Wang, J-Y] Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan; [Sun, J.; He, H.; Krishna, N.; Lin, S.; Yang, S.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Comprehens Melanoma Res Ctr,Dept Tumor Biol, Tampa, FL 33612 USA; [Huang, M-Y; Hou, M-F] Kaohsiung Med Univ Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Huang, M-Y; Hou, M-F] Kaohsiung Med Univ, Fac Med, Dept Radiat Oncol, Kaohsiung, Taiwan; [Wang, Y-S] Kaohsiung Med Univ, Fac Med, Dept Genom Med, Kaohsiung, Taiwan; [Hou, M-F] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan; [Sun, Y.] Tianjin Med Univ, Canc Inst & Hosp, Dept Pathol, Tianjin, Peoples R China; [Chiu, S-J; Chang, W-C] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Chang, W-C] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei 110, Taiwan; [Chang, W-C] Taipei Med Univ, Wanfang Hosp, Dept Pharm, Taipei 110, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Tianjin Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Yang, S (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	shengyu.yang@moffitt.org; wcc@tmu.edu.tw	Huang, Ming-Yii/AAS-8132-2021; Lin, Shengchen/T-3529-2018	Lin, Shengchen/0000-0003-1488-8680; Wang, Yu-Shiuan/0000-0001-7204-1256; Chang, Wei-Chiao/0000-0002-8573-5924; Hou, Ming-Feng/0000-0001-6030-9702	Health and welfare surcharge of tobacco products, Taiwan [DOH102-TD-C-111-002]; National Science Council, Taiwan [NSC98-2320-B-037-028, NSC101-2320-B-038-029-MY3]; Center for Biomarkers and Biotech Drugs, Kaohsiung Medical Universit, Aim for the Top Universities Grant [KMU-TP103C00, KMU-TP103C03]; NIH grant [R01CA175741]; NATIONAL CANCER INSTITUTE [R01CA175741] Funding Source: NIH RePORTER	Health and welfare surcharge of tobacco products, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Center for Biomarkers and Biotech Drugs, Kaohsiung Medical Universit, Aim for the Top Universities Grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Minjung Kim for assistance with IHC staining and we are grateful to Professor Yun Yen (City of Hope National Medical Center) for reading this paper and providing comments. This study was partly supported by funding from Health and welfare surcharge of tobacco products, Taiwan (Grant no. DOH102-TD-C-111-002), National Science Council, Taiwan (Grant no. NSC98-2320-B-037-028; NSC101-2320-B-038-029-MY3) and Center for Biomarkers and Biotech Drugs, Kaohsiung Medical Universit, Aim for the Top Universities Grant (KMU-TP103C00, KMU-TP103C03) WCC; and an NIH grant R01CA175741 to SY.	Aytes A, 2012, MOL CARCINOGEN, V51, P746, DOI 10.1002/mc.20843; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berry PA, 2011, PROSTATE, V71, P1646, DOI 10.1002/pros.21384; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Chantome A, 2013, CANCER RES, V73, P4852, DOI 10.1158/0008-5472.CAN-12-4572; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Fedida-Metula S, 2012, CARCINOGENESIS, V33, P740, DOI 10.1093/carcin/bgs021; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feng ZY, 2009, BIOORGAN MED CHEM, V17, P2147, DOI 10.1016/j.bmc.2008.10.074; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hou MF, 2011, BBA-GEN SUBJECTS, V1810, P1278, DOI 10.1016/j.bbagen.2011.07.001; Hsu WL, 2012, CELL CALCIUM, V52, P161, DOI 10.1016/j.ceca.2012.05.007; Hu JJ, 2011, BIOCHEM BIOPH RES CO, V411, P786, DOI 10.1016/j.bbrc.2011.07.025; Huang WC, 2011, CELL CALCIUM, V50, P27, DOI 10.1016/j.ceca.2011.04.004; Jans R, 2013, J INVEST DERMATOL, V133, P793, DOI 10.1038/jid.2012.370; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; McGarrigle D, 2006, J BIOL CHEM, V281, P10583, DOI 10.1074/jbc.M513002200; Munoz E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198952; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ryu S, 2013, CANCER CELL, V23, P63, DOI 10.1016/j.ccr.2012.11.019; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Shin DH, 2011, J PHARMACOL SCI, V115, P144, DOI 10.1254/jphs.10209FP; Sun JW, 2013, J BIOL CHEM, V288, P36971, DOI 10.1074/jbc.M113.506535; Sun JW, 2011, J BIOL CHEM, V286, P38865, DOI 10.1074/jbc.M111.270413; Wang DZ, 2013, ANNU REV MED, V64, P131, DOI 10.1146/annurev-med-112211-154330; Wang JY, 2012, CELL SIGNAL, V24, P162, DOI 10.1016/j.cellsig.2011.08.017; WOLMARK N, 1984, ANN SURG, V199, P375, DOI 10.1097/00000658-198404000-00001; Yang IH, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-41; Yang N, 2013, CANCER LETT, V330, P163, DOI 10.1016/j.canlet.2012.11.040; Yang Shengyu, 2012, Methods Mol Biol, V928, P221, DOI 10.1007/978-1-62703-008-3_17; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yoshida J, 2012, BIOCHEM PHARMACOL, V84, P1592, DOI 10.1016/j.bcp.2012.09.021	38	95	97	0	26	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2015	34	33					4358	4367		10.1038/onc.2014.366	http://dx.doi.org/10.1038/onc.2014.366			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO9KK	25381814	Green Accepted			2022-12-26	WOS:000359494400007
J	Maslova, K; Kyriakakis, E; Pfaff, D; Frachet, A; Frismantiene, A; Bubendorf, L; Ruiz, C; Vlajnic, T; Erne, P; Resink, TJ; Philippova, M				Maslova, Kseniya; Kyriakakis, Emmanouil; Pfaff, Dennis; Frachet, Audrey; Frismantiene, Agne; Bubendorf, Lukas; Ruiz, Christian; Vlajnic, Tatjana; Erne, Paul; Resink, Therese J.; Philippova, Maria			EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin	FASEB JOURNAL			English	Article						malignant and benign prostate epithelial cell lines; gefitinib; NVP-AEW541	GROWTH-FACTOR-RECEPTOR; FACTOR-I RECEPTOR; PHASE-II; ANDROGEN RECEPTOR; BINDING PROTEIN-3; EXPRESSION; CARCINOMA; PROGRESSION; GEFITINIB; PROMOTES	T-cadherin is an atypical glycosylphosphatidylinsoitol- anchored member of the cadherin superfamily of adhesion molecules. We found that T-cadherin overexpression in malignant (DU145) and benign (BPH-1) prostatic epithelial cell lines or silencing in the BPH-1 cell line, respectively, promoted or inhibited migration and spheroid invasion in collagen I gel and Matrigel. T-cadherin-dependent effects were associated with changes in cell phenotype: overexpression caused cell dissemination and loss of polarity evaluated by relative positioning of the Golgi/nuclei in cell groups, whereas silencing caused formation of compact polarized epithelial-like clusters. Epidermal growth factor receptor (EGFR) and IGF factor-1 receptor (IGF-1R) were identified as mediators of T-cadherin effects. These receptors per se had opposing influences on cell phenotype. EGFR activation with EGF or IGF-1R inhibition with NVP-AEW541 promoted dissemination, invasion, and polarity loss. Conversely, inhibition of EGFR with gefitinib or activation of IGF-1R with IGF-1 rescued epithelial morphology and decreased invasion. T-cadherin silencing enhanced both EGFR and IGF-1R phosphorylation, yet converted cells to the morphology typical for activated IGF-1R. T-cadherin effects were sensitive to modulation of EGFR or IGF-1R activity, suggesting direct involvement of both receptors. We conclude that T-cadherin regulates prostate cancer cell behavior by tuning the balance in EGFR/IGF-1R activity and enhancing the impact of IGF-1R.	[Maslova, Kseniya; Kyriakakis, Emmanouil; Pfaff, Dennis; Frachet, Audrey; Frismantiene, Agne; Resink, Therese J.; Philippova, Maria] Univ Basel, Univ Basel Hosp, Dept Biomed, Lab Signal Transduct, CH-4031 Basel, Switzerland; [Bubendorf, Lukas; Ruiz, Christian; Vlajnic, Tatjana] Univ Basel, Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Erne, Paul] Hirslanden Klin St Anna, Luzern, Switzerland	University of Basel; University of Basel	Resink, TJ (corresponding author), Univ Basel, Univ Basel Hosp, Dept Biomed, Lab Signal Transduct, Hebelstr 20, CH-4031 Basel, Switzerland.	therese-j.resink@unibas.ch	Bubendorfl, Lukas/H-5880-2011; Bubendorf, Lukas/G-5299-2015; Kyriakakis, Emmanouil/AAS-5754-2021; Filippova, Maria/GXH-7313-2022	Bubendorf, Lukas/0000-0001-5970-1803; Filippova, Maria/0000-0003-3124-3155; Frismantiene, Agne/0000-0002-2018-2986; Kyriakakis, Emmanouil/0000-0002-6796-0431	Novartis Foundation for Medical-Biological Research; SwissLife Jubilaumsstiftung; Stiftung fur Herz- und Kreislaufkrankheiten	Novartis Foundation for Medical-Biological Research; SwissLife Jubilaumsstiftung; Stiftung fur Herz- und Kreislaufkrankheiten	The authors thank Boris Dasen for performing quantitative RT-PCR experimentation. This work was supported by the Novartis Foundation for Medical-Biological Research, SwissLife Jubilaumsstiftung, and Stiftung fur Herz- und Kreislaufkrankheiten.	Arcaro A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00030; Bosserhoff AK, 2014, MOL CARCINOGEN, V53, P635, DOI 10.1002/mc.22018; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Canil CM, 2005, J CLIN ONCOL, V23, P455, DOI 10.1200/JCO.2005.02.129; Chen C, 2005, CANCER, V103, P76, DOI 10.1002/cncr.20727; Chi KN, 2012, CLIN CANCER RES, V18, P3407, DOI 10.1158/1078-0432.CCR-12-0482; Chott A, 1999, AM J PATHOL, V155, P1271, DOI 10.1016/S0002-9440(10)65229-7; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; Cui YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055069; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Fredette BJ, 1996, DEVELOPMENT, V122, P3163; Garcia J., 2013, ASCO ANN M S, V31; Gennigens C, 2006, CRIT REV ONCOL HEMAT, V58, P124, DOI 10.1016/j.critrevonc.2005.10.003; Harman SM, 2000, J CLIN ENDOCR METAB, V85, P4258, DOI 10.1210/jc.85.11.4258; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Heidegger I, 2012, ENDOCRINOLOGY, V153, P4633, DOI 10.1210/en.2012-1348; Hellawell GO, 2002, CANCER RES, V62, P2942; Hussain M., 2012, GEN CANC S S5; Jones HE, 2004, ENDOCR-RELAT CANCER, V11, P793, DOI 10.1677/erc.1.00799; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Korcum AF, 2009, UHOD-ULUSLAR HEMATOL, V19, P223; Kuniyasu H, 2000, CLIN CANCER RES, V6, P2295; Kuzmenko YS, 1998, BIOCHEM BIOPH RES CO, V246, P489, DOI 10.1006/bbrc.1998.8645; Kyriakakis E, 2013, CELL SIGNAL, V25, P1044, DOI 10.1016/j.cellsig.2013.02.001; Kyriakakis E, 2012, J INVEST DERMATOL, V132, P2275, DOI 10.1038/jid.2012.131; Leo S, 2011, CHEMOTHERAPY, V57, P115, DOI 10.1159/000323581; Liao YD, 2005, HUM PATHOL, V36, P1186, DOI 10.1016/j.humpath.2005.07.023; Maruyama R, 2002, CLIN CANCER RES, V8, P514; Massoner P, 2011, AM J PATHOL, V179, P2905, DOI 10.1016/j.ajpath.2011.08.026; Ozkan EE, 2011, MOL CELL ENDOCRINOL, V344, P1, DOI 10.1016/j.mce.2011.07.002; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; Pfaff D, 2010, BRIT J DERMATOL, V163, P353, DOI 10.1111/j.1365-2133.2010.09801.x; Pfaff D, 2011, J PATHOL, V225, P512, DOI 10.1002/path.2900; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Philippova M, 2013, EUR J CANCER, V49, P2048, DOI 10.1016/j.ejca.2012.12.026; Philippova M, 2012, CARDIOVASC RES, V93, P498, DOI 10.1093/cvr/cvs004; Philippova M, 2009, CELL SIGNAL, V21, P1035, DOI 10.1016/j.cellsig.2009.01.035; Plymate SR, 1997, ENDOCRINOLOGY, V138, P1728, DOI 10.1210/en.138.4.1728; RANSCHT B, 1991, DEVELOPMENT, V111, P15; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Riou P, 2006, FASEB J, V20, P2291, DOI 10.1096/fj.06-6085com; Roddam AW, 2008, ANN INTERN MED, V149, P461, DOI 10.7326/0003-4819-149-7-200810070-00006; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Salzberg M, 2007, ONKOLOGIE, V30, P355, DOI 10.1159/000102452; Schayek H, 2010, EXP CELL RES, V316, P1479, DOI 10.1016/j.yexcr.2010.03.007; Stavridi F, 2010, CANCER TREAT REV, V36, P122, DOI 10.1016/j.ctrv.2009.06.001; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Sutherland BW, 2008, CANCER RES, V68, P3495, DOI 10.1158/0008-5472.CAN-07-6531; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Wu JD, 2006, J CELL BIOCHEM, V99, P392, DOI 10.1002/jcb.20929; Zhou Q, 2006, FEBS LETT, V580, P5161, DOI 10.1016/j.febslet.2006.08.068	53	13	13	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					494	507		10.1096/fj.14-249367	http://dx.doi.org/10.1096/fj.14-249367			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25381040				2022-12-26	WOS:000349370400014
J	Wi, SM; Moon, G; Kim, J; Kim, ST; Shim, JH; Chun, E; Lee, KY				Wi, Sae Mi; Moon, Gyuyoung; Kim, Juhong; Kim, Seong-Tae; Shim, Jae-Hyuck; Chun, Eunyoung; Lee, Ki-Young			TAK1-ECSIT-TRAF6 Complex Plays a Key Role in the TLR4 Signal to Activate NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Inflammation; Innate Immunity; NF-kappaB; Signal Transduction; ECSIT; TNF Receptor-associated Factor 6; Toll-like Receptors; Transforming Growth Factor--activated Kinase 1	TRANSDUCTION PATHWAY; OXIDATIVE STRESS; ADAPTER PROTEIN; INNATE IMMUNITY; KINASE KINASE; TAK1; RECOGNITION; UBIQUITIN; ECSIT; TAB2	ECSIT (evolutionarily conserved signaling intermediate in Toll pathways) is known as a multifunctional regulator in different signals, including Toll-like receptors (TLRs), TGF-, and BMP. Here, we report a new regulatory role of ECSIT in TLR4-mediated signal. By LPS stimulation, ECSIT formed a high molecular endogenous complex including TAK1 and TRAF6, in which ECSIT interacted with each protein and regulated TAK1 activity, leading to the activation of NF-B. ECSIT-knockdown THP-1 (ECSITKD THP-1) cells exhibited severe impairments in NF-B activity, cytokine production, and NF-B-dependent gene expression, whereas those were dramatically restored by reintroduction of wild type (WT) ECSIT gene. Interestingly, ECSIT mutants, which lack a specific interacting domain for either TAK1 or TRAF6, could not restore these activities. Moreover, no significant changes in both NF-B activity and cytokine production induced by TLR4 could be seen in TAK1(KD) or TRAF6(KD) THP-1 cells transduced by WT ECSIT, strongly suggesting the essential requirement of TAK1-ECSIT-TRAF6 complex in TLR4 signaling. Taken together, our data demonstrate that the ECSIT complex, including TAK1 and TRAF6, plays a pivotal role in TLR4-mediated signals to activate NF-kappa B.	[Wi, Sae Mi; Moon, Gyuyoung; Kim, Juhong; Kim, Seong-Tae; Lee, Ki-Young] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Wi, Sae Mi; Moon, Gyuyoung; Kim, Juhong; Kim, Seong-Tae; Lee, Ki-Young] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Shim, Jae-Hyuck] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Chun, Eunyoung] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Chun, Eunyoung] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Cornell University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Chun, E (corresponding author), 665 Huntington Ave,Bldg 1,Rm 904, Boston, MA 02115 USA.	echun@hsph.harvard.edu; thylee@skku.edu		Shim, Jae-Hyuck/0000-0002-4947-3293	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2012R1A2A2A01005659]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A111636]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2012R1A2A2A01005659) and Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea, Grant A111636.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Irrinki KM, 2011, MOL CELL BIOL, V31, P3745, DOI 10.1128/MCB.05303-11; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Kim SY, 2014, MOL CELL BIOL, V34, P510, DOI 10.1128/MCB.01225-13; Kim SY, 2012, J BIOL CHEM, V287, P3381, DOI 10.1074/jbc.M111.317875; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Soler-Lopez M, 2012, BIOESSAYS, V34, P532, DOI 10.1002/bies.201100193; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603	22	60	67	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35205	35214		10.1074/jbc.M114.597187	http://dx.doi.org/10.1074/jbc.M114.597187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371197	Green Published, hybrid			2022-12-26	WOS:000346660200014
J	Markovetz, MR; Corcoran, TE; Locke, LW; Myerburg, MM; Pilewski, JM; Parker, RS				Markovetz, Matthew R.; Corcoran, Timothy E.; Locke, Landon W.; Myerburg, Michael M.; Pilewski, Joseph M.; Parker, Robert S.			A Physiologically-Motivated Compartment-Based Model of the Effect of Inhaled Hypertonic Saline on Mucociliary Clearance and Liquid Transport in Cystic Fibrosis	PLOS ONE			English	Article							IN-VITRO; BRONCHIAL-MUCOSA; AIRWAY; TC-99M-DTPA; DISPOSITION; ABSORPTION; IVACAFTOR; DELIVERY; CHANNEL; DISEASE	Background: Cystic Fibrosis (CF) lung disease is characterized by liquid hyperabsorption, airway surface dehydration, and impaired mucociliary clearance (MCC). Herein, we present a compartment-based mathematical model of the airway that extends the resolution of functional imaging data. Methods: Using functional imaging data to inform our model, we developed a system of mechanism-motivated ordinary differential equations to describe the mucociliary clearance and absorption of aerosolized radiolabeled particle and small molecules probes from human subjects with and without CF. We also utilized a novel imaging metric in vitro to gauge the fraction of airway epithelial cells that have functional ciliary activity. Results: This model, and its incorporated kinetic rate parameters, captures the MCC and liquid dynamics of the hyperabsorptive state in CF airways and the mitigation of that state by hypertonic saline treatment. Conclusions: We postulate, based on the model structure and its ability to capture clinical patient data, that patients with CF have regions of airway with diminished MCC function that can be recruited with hypertonic saline treatment. In so doing, this model structure not only makes a case for durable osmotic agents used in lung-region specific treatments, but also may provide a possible clinical endpoint, the fraction of functional ciliated airway.	[Markovetz, Matthew R.; Corcoran, Timothy E.; Parker, Robert S.] Univ Pittsburgh, Swanson Sch Engn, Dept Chem & Petr Engn, Pittsburgh, PA 15260 USA; [Corcoran, Timothy E.; Locke, Landon W.; Myerburg, Michael M.; Pilewski, Joseph M.] Univ Pittsburgh, Pittsburgh, PA USA; [Parker, Robert S.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Parker, Robert S.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Parker, Robert S.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Corcoran, Timothy E.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Parker, RS (corresponding author), Univ Pittsburgh, Swanson Sch Engn, Dept Chem & Petr Engn, Pittsburgh, PA 15260 USA.	rparker@pitt.edu	Pilewski, Joseph/AAF-5149-2021	Corcoran, Tim/0000-0003-1069-095X	Graduate Assistantships in Areas of National Need (GAANN) fellowship (U.S. Department of Education) [P200A120195]; National Institutes of Health [R01HL108929, RO1HL112862]; B.P. America Faculty Fellowship in the Swanson School of Engineering; NIH [P30DK072506]; Cystic Fibrosis Foundation Research Development Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112863, T32HL007563, R01HL108929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	Graduate Assistantships in Areas of National Need (GAANN) fellowship (U.S. Department of Education); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); B.P. America Faculty Fellowship in the Swanson School of Engineering; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Research Development Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	MRM is supported by a Graduate Assistantships in Areas of National Need (GAANN) fellowship (U.S. Department of Education (www.ed.gov), P200A120195). The functional imaging project in [6] and TEC were supported by National Institutes of Health (www.nih.gov) R01HL108929. RSP acknowledges support of the B.P. America Faculty Fellowship in the Swanson School of Engineering. MMM acknowledges support from National Institutes of Health (www.nih.gov) RO1HL112862. Work performed in HBE cell cultures was supported by the NIH (www.nih.gov) P30DK072506 and the Cystic Fibrosis Foundation (www.cff.org) Research Development Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BENNETT WD, 1989, AM REV RESPIR DIS, V139, P1132, DOI 10.1164/ajrccm/139.5.1132; Biddiscombe MF, 2011, J AEROSOL MED PULM D, V24, P165, DOI 10.1089/jamp.2010.0845; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; BYRON PR, 1994, J AEROSOL MED, V7, P49, DOI 10.1089/jam.1994.7.49; Corcoran TE, 2010, EUR RESPIR J, V35, P781, DOI 10.1183/09031936.00059009; Corcoran TE, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-14; Donaldson Scott H, 2007, Proc Am Thorac Soc, V4, P399, DOI 10.1513/pats.200703-042BR; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; ILOWITE JS, 1989, AM REV RESPIR DIS, V139, P1139, DOI 10.1164/ajrccm/139.5.1139; Locke L, 2014, EUROPEAN RE IN PRESS; Myerburg MM, 2010, AM J RESP CELL MOL, V43, P712, DOI 10.1165/rcmb.2009-0348OC; Newman S, 2012, J AEROSOL MED PULM D, V25, pS10, DOI 10.1089/jamp.2012.1Su4; O'Reilly R, 2013, DRUG DES DEV THER, V7, P929, DOI 10.2147/DDDT.S30345; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; REGNIS JA, 1994, AM J RESP CRIT CARE, V150, P66, DOI 10.1164/ajrccm.150.1.8025774; Robinson M, 2000, J AEROSOL MED, V13, P73, DOI 10.1089/089426800418604; Sakagami M, 2002, J PHARM SCI, V91, P594, DOI 10.1002/jps.10069; Sakagami M, 2006, ADV DRUG DELIVER REV, V58, P1030, DOI 10.1016/j.addr.2006.07.012; Sturm R, 2012, J THORAC DIS, V4, P48, DOI 10.3978/j.issn.2072-1439.2011.09.09; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Weber B, 2013, AAPS J, V15, P159, DOI 10.1208/s12248-012-9420-z; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450	28	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111972	10.1371/journal.pone.0111972	http://dx.doi.org/10.1371/journal.pone.0111972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383714	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000344816700026
J	Gales, A; Latrille, E; Wery, N; Steyer, JP; Godon, JJ				Gales, Amandine; Latrille, Eric; Wery, Nathalie; Steyer, Jean-Philippe; Godon, Jean-Jacques			Needles of Pinus halepensis as Biomonitors of Bioaerosol Emissions	PLOS ONE			English	Article							PHYLLOSPHERE; MICROBIOLOGY; INDICATORS; DYNAMICS	We propose using the surface of pine trees needles to biomonitor the bioaerosol emissions at a composting plant. Measurements were based on 16S rRNA gene copy numbers of Saccharopolyspora rectivirgula, a bioindicator of composting plant emissions. A sampling plan was established based on 29 samples around the emission source. The abundance of 16S rRNA gene copies of S. rectivirgula per gram of Pinus halepensis needles varied from 10(4) to 10(2) as a function of the distance. The signal reached the background level at distances around the composting plant ranging from 2 km to more than 5.4 km, depending on the local topography and average wind directions. From these values, the impacted area around the source of bioaerosols was mapped.	[Gales, Amandine; Latrille, Eric; Wery, Nathalie; Steyer, Jean-Philippe; Godon, Jean-Jacques] INRA, Lab Biotechnol Environm, UR0050, Narbonne, France	INRAE	Godon, JJ (corresponding author), INRA, Lab Biotechnol Environm, UR0050, Narbonne, France.	jean-jacques.godon@supagro.inra.fr	Wéry, Nathalie/AAR-4215-2020	Steyer, Jean-Philippe/0000-0003-0467-8081				Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Despres V, 2012, PRIMARY BIOL AEROSOL, P64; Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032; Furrer R., 2010, FIELDS TOOLS SPATIAL; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Kinkel LL, 1997, ANNU REV PHYTOPATHOL, V35, P327, DOI 10.1146/annurev.phyto.35.1.327; Le Goff O, 2012, ATMOS ENVIRON, V61, P428, DOI 10.1016/j.atmosenv.2012.07.081; Le Goff O, 2011, ATMOS ENVIRON, V45, P5342, DOI 10.1016/j.atmosenv.2011.06.052; Lighthart B., 2000, AEROBIOLOGIA, V16, P7, DOI [DOI 10.1023/A:1007694618888, 10.1023/A:1007694618888]; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Meyer KM, 2012, OECOLOGIA, V168, P621, DOI 10.1007/s00442-011-2138-2; Nali C, 2007, ENVIRON MONIT ASSESS, V131, P201, DOI 10.1007/s10661-006-9468-2; Noth EM, 2013, ATMOS ENVIRON, V77, P518, DOI 10.1016/j.atmosenv.2013.05.056; R Core Team, 2020, R LANG ENV STAT COMP; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Redford AJ, 2009, MICROB ECOL, V58, P189, DOI 10.1007/s00248-009-9495-y; Schafer J, 2011, ANN OCCUP HYG, V55, P612, DOI 10.1093/annhyg/mer018; Suslow T, 2003, COMPR REV FOOD SCI F, V2, P38; Taha MPM, 2007, ATMOS ENVIRON, V41, P4504, DOI 10.1016/j.atmosenv.2006.12.056; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wuytack T, 2010, ENVIRON MONIT ASSESS, V171, P197, DOI 10.1007/s10661-009-1271-4	22	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112182	10.1371/journal.pone.0112182	http://dx.doi.org/10.1371/journal.pone.0112182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379901	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100059
J	Huang, RX; Wu, D; Yuan, Y; Li, XR; Holm, R; Trope, CG; Nesland, JM; Suo, ZH				Huang, Ruixia; Wu, Dan; Yuan, Yuan; Li, Xiaoran; Holm, Ruth; Trope, Claes G.; Nesland, Jahn M.; Suo, Zhenhe			CD117 Expression in Fibroblasts-Like Stromal Cells Indicates Unfavorable Clinical Outcomes in Ovarian Carcinoma Patients	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; ACTIVATION PROTEIN; STEM-CELLS; C-KIT; CANCER; TUMORS; CHALLENGES; MARKERS; BETA	The stem cell factor (SCF) receptor CD117 (c-kit), is widely used for identification of hematopoietic stem cells and cancer stem cells. Moreover, CD117 expression in carcinoma cells indicates a poor prognosis in a variety of cancers. However the potential expression in tumor microenvironment and the biological and clinical impact are currently not reported. The expression of CD117 was immunohistochemically evaluated in a serial of 242 epithelial ovarian cancer (EOC) cases. Thirty-eight out of 242 cases were CD117 positive in fibroblast-like stromal cells and 22 cases were positive in EOC cells. Four cases were both positive in fibroblast-like stromal cells and EOC cells for CD117. CD117 expression in fibroblast-like stromal cells in ovarian carcinoma was closely linked to advanced FIGO stage, poor differentiation grade and histological subtype (p<0.05), and it was significantly associated with poor overall survival (OS) and progression free survival (PFS) (Kaplan-Meier analysis; p<0.05, log-rank test). CD117 expression in ovarian carcinoma cells was not associated with these clinicopathological variables. The CD117 positive fibroblast-like stromal cells were all positive for mesenchymal stem/stromal cell (MSC) marker CD73 but negative for fibroblast markers fibroblast activation protein (FAP) and alpha smooth muscle actin (alpha-SMA), indicating that the CD117+/CD73+ fibroblast-like stromal cells are a subtype of mesenchymal stem cells in tumor stroma, although further characterization of these cells are needed. It is concluded herewith that the presence of CD117+/CD73+ fibroblast-like stromal cells in ovarian carcinoma is an unfavorable clinical outcome indication.	[Huang, Ruixia; Li, Xiaoran; Holm, Ruth; Nesland, Jahn M.; Suo, Zhenhe] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Huang, Ruixia; Li, Xiaoran; Nesland, Jahn M.; Suo, Zhenhe] Univ Oslo, Fac Med, Inst Clin Med, Dept Pathol, Oslo, Norway; [Wu, Dan] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Med Coll Shanghai, Dept Gynecol, Shanghai 200030, Peoples R China; [Yuan, Yuan] Capital Med Univ, Dept Pathol, Beijing, Peoples R China; [Trope, Claes G.] Univ Oslo, Fac Med, Inst Clin Med, Dept Gynecol, Oslo, Norway; [Trope, Claes G.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Gynecol, Oslo, Norway	University of Oslo; University of Oslo; Shanghai Jiao Tong University; Capital Medical University; University of Oslo; University of Oslo	Suo, ZH (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway.	zhenhes@medisin.uio.no		Huang, Ruixia/0000-0001-7214-647X	Inger and John Fredriksen Foundation; Norwegian Radium Hospital Research Foundation; Norwegian Cancer Society	Inger and John Fredriksen Foundation; Norwegian Radium Hospital Research Foundation; Norwegian Cancer Society(Norwegian Cancer Society)	This study was financially supported by grants from Inger and John Fredriksen Foundation, Norwegian Radium Hospital Research Foundation and The Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Allard B, 2014, INT J CANCER, V134, P1466, DOI 10.1002/ijc.28456; Allard B, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/485156; Anker PSI, 2003, HAEMATOLOGICA, V88, P845; Bae S, 2008, BRIT J HAEMATOL, V142, P827, DOI 10.1111/j.1365-2141.2008.07241.x; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Brennen WN, 2012, MOL CANCER THER, V11, P257, DOI 10.1158/1535-7163.MCT-11-0340; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chatterjee D, 2014, BLOOD, V123, P594, DOI 10.1182/blood-2013-09-524827; Chen DY, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-50; Cheng JD, 2003, CLIN CANCER RES, V9, P1590; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; de Silva MV, 2003, PATHOL ONCOL RES, V9, P13, DOI 10.1007/BF03033708; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Downs LS, 2008, CANCER, V112, P331, DOI 10.1002/cncr.23164; Doyle LA, 2014, HISTOPATHOLOGY, V64, P53, DOI 10.1111/his.12302; Fearon DT, 2014, CANCER IMMUNOL RES, V2, P187, DOI 10.1158/2326-6066.CIR-14-0002; Gallegos I, 2011, APPL IMMUNOHISTO M M, V19, P147, DOI 10.1097/PAI.0b013e3181f05a66; Garrity MM, 2009, HISTOPATHOLOGY, V54, P286, DOI 10.1111/j.1365-2559.2008.03189.x; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Guppy AE, 2005, CLIN ONCOL-UK, V17, P399, DOI 10.1016/j.clon.2005.05.009; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Hermida-Gomez T, 2011, J RHEUMATOL, V38, P339, DOI 10.3899/jrheum.100614; Hung SC, 2006, CELL TISSUE RES, V324, P457, DOI 10.1007/s00441-006-0156-x; Ismail RS, 1999, ONCOGENE, V18, P4734, DOI 10.1038/sj.onc.1202865; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kang Y, 2013, J NUCL MED, V54, P32; Kim DJ, 2006, J KOREAN MED SCI, V21, P81, DOI 10.3346/jkms.2006.21.1.81; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Li O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055319; Liu ET, 2007, NEW ENGL J MED, V357, P2537, DOI 10.1056/NEJMp0707576; Ljujic B, 2013, SCI REP-UK, V3, DOI 10.1038/srep02298; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Ma DQ, 2014, HISTOPATHOLOGY, V64, P218, DOI 10.1111/his.12212; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Park JS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.21; Petrim I, 2010, J THORAC ONCOL, V5, P1447, DOI 10.1097/JTO.0b013e3181e96e30; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pollack IF, 2013, NEW ENGL J MED, V368, P1942, DOI 10.1056/NEJMcibr1302851; Potdar PD, 2010, J STEM CELLS REGEN, V6, P26; Schmandt RE, 2003, CANCER-AM CANCER SOC, V98, P758, DOI 10.1002/cncr.11561; Sleeman JP, 2011, CELL, V145, DOI 10.1016/j.cell.2011.03.029; Song N, 2012, ASIAN PAC J CANCER P, V13, P2745, DOI 10.7314/APJCP.2012.13.6.2745; Stagg J, 2008, STEM CELL REV, V4, P119, DOI 10.1007/s12015-008-9030-4; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tod J, 2013, PANCREATOLOGY, V13, P1, DOI 10.1016/j.pan.2012.11.311; Wang Shumin, 2014, Biomed Res Int, V2014, P507353, DOI 10.1155/2014/507353; Went PT, 2004, J CLIN ONCOL, V22, P4514, DOI 10.1200/JCO.2004.10.125; Wu MH, 2011, CLIN CANCER RES, V17, P1306, DOI 10.1158/1078-0432.CCR-10-1824; Xiong L, 2014, CELL TISSUE RES, V355, P365, DOI 10.1007/s00441-013-1752-1; Zhang XZ, 2014, CANCER LETT, V345, P106, DOI 10.1016/j.canlet.2013.11.020; Zivanovic O, 2010, GYNECOL ONCOL, V116, P351, DOI 10.1016/j.ygyno.2009.11.022	58	20	21	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112209	10.1371/journal.pone.0112209	http://dx.doi.org/10.1371/journal.pone.0112209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380303	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100063
J	Panecka, J; Mura, C; Trylska, J				Panecka, Joanna; Mura, Cameron; Trylska, Joanna			Interplay of the Bacterial Ribosomal A-Site, S12 Protein Mutations and Paromomycin Binding: A Molecular Dynamics Study	PLOS ONE			English	Article							TRANSFER-RNA SELECTION; AMBER FORCE-FIELD; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HELIX 69; STREPTOMYCIN-RESISTANT; THERMUS-THERMOPHILUS; DECODING CENTER; SUBUNIT; RECOGNITION	The conformational properties of the aminoacyl-tRNA binding site (A-site), and its surroundings in the Escherichia coli 30S ribosomal subunit, are of great relevance in designing antibacterial agents. The 30S subunit A-site is near ribosomal protein S12, which neighbors helices h27 and H69; this latter helix, of the 50S subunit, is a functionally important component of an intersubunit bridge. Experimental work has shown that specific point mutations in S12 (K42A, R53A) yield hyper-accurate ribosomes, which in turn confers resistance to the antibiotic 'paromomycin' (even when this aminoglycoside is bound to the A-site). Suspecting that these effects can be elucidated in terms of the local atomic interactions and detailed dynamics of this region of the bacterial ribosome, we have used molecular dynamics simulations to explore the motion of a fragment of the E. coli ribosome, including the A-site. We found that the ribosomal regions surrounding the A-site modify the conformational space of the flexible A-site adenines 1492/93. Specifically, we found that A-site mobility is affected by stacking interactions between adenines A1493 and A1913, and by contacts between A1492 and a flexible side-chain (K43) from the S12 protein. In addition, our simulations reveal possible indirect pathways by which the R53A and K42A mutations in S12 are coupled to the dynamical properties of the A-site. Our work extends what is known about the atomistic dynamics of the A-site, and suggests possible links between the biological effects of hyper-accurate mutations in the S12 protein and conformational properties of the ribosome; the implications for S12 dynamics help elucidate how the miscoding effects of paromomycin may be evaded in antibiotic-resistant mutants of the bacterial ribosome.	[Panecka, Joanna] Univ Warsaw, Inst Expt Phys, Div Biophys, Warsaw, Poland; [Panecka, Joanna] Univ Warsaw, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Mura, Cameron] Univ Virginia, Dept Chem, Charlottesville, VA USA; [Trylska, Joanna] Univ Warsaw, Ctr New Technol, Warsaw, Poland	University of Warsaw; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; University of Virginia; University of Warsaw	Trylska, J (corresponding author), Univ Warsaw, Ctr New Technol, Warsaw, Poland.	joanna@cent.uw.edu.pl	Mura, Cameron/F-5872-2010; Trylska, Joanna/AAI-6785-2021	Mura, Cameron/0000-0001-7985-2561; Trylska, Joanna/0000-0002-1464-5323; Panecka-Hofman, Joanna/0000-0003-4149-9090	University of Warsaw (CeNT/BST) [BST-163500/BF]; National Science Centre [DEC-2012/05/B/NZ1/00035, DEC-2011/01/N/NZ1/01558]; Foundation for Polish Science [TEAM/2009-3/8]; Foundation for Polish Science (European Regional Development Fund operated within Innovative Economy Operational Programme); University of Virginia; Jeffress Memorial Trust [J-971]; US National Science Foundation Career Award [MCB-1350957]; European Social Fund; Direct For Biological Sciences [1350957] Funding Source: National Science Foundation	University of Warsaw (CeNT/BST); National Science Centre(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Foundation for Polish Science (European Regional Development Fund operated within Innovative Economy Operational Programme); University of Virginia; Jeffress Memorial Trust; US National Science Foundation Career Award(National Science Foundation (NSF)); European Social Fund(European Social Fund (ESF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	JP and JT acknowledge support from the University of Warsaw (CeNT/BST, BST-163500/BF), National Science Centre (DEC-2012/05/B/NZ1/00035 and DEC-2011/01/N/NZ1/01558), and Foundation for Polish Science (TEAM/2009-3/8, project co-financed by European Regional Development Fund operated within Innovative Economy Operational Programme). CM acknowledges support from the University of Virginia, the Jeffress Memorial Trust (J-971), and the US National Science Foundation Career Award No. MCB-1350957. Calculations were performed using resources at the University of Warsaw (ICM/KDM/G31-4). JP has been also co-financed with the European Union funds by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aduri R, 2007, J CHEM THEORY COMPUT, V3, P1464, DOI 10.1021/ct600329w; Ali IK, 2006, MOL CELL, V23, P865, DOI 10.1016/j.molcel.2006.08.011; ALKSNE LE, 1993, P NATL ACAD SCI USA, V90, P9538, DOI 10.1073/pnas.90.20.9538; Almlof M, 2007, BIOCHEMISTRY-US, V46, P200, DOI 10.1021/bi061713i; [Anonymous], 2008, AMBER 10; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Asensio JL, 2002, CHEM-EUR J, V8, P5228, DOI 10.1002/1521-3765(20021115)8:22<5228::AID-CHEM5228>3.0.CO;2-L; Barbieri CM, 2007, TETRAHEDRON, V63, P3567, DOI 10.1016/j.tet.2006.08.107; Barthel A, 2006, BIOPHYS J, V90, P2450, DOI 10.1529/biophysj.105.076158; Bock LV, 2013, NAT STRUCT MOL BIOL, V20, P1390, DOI 10.1038/nsmb.2690; BOHMAN K, 1984, MOL GEN GENET, V198, P90, DOI 10.1007/BF00328706; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Brandman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029377; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Bulkley D, 2012, J MOL BIOL, V416, P571, DOI 10.1016/j.jmb.2011.12.055; Casiano-Negroni A, 2010, THESIS U MICHIGAN; Chao PW, 2007, BIOORGAN MED CHEM, V15, P3825, DOI 10.1016/j.bmc.2007.03.025; Chen SY, 2010, J MOL RECOGNIT, V23, P423, DOI 10.1002/jmr.1008; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Demirci H, 2013, RNA, V19, P1791, DOI 10.1261/rna.040030.113; Demirci H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2346; Dunham CM, 2007, RNA, V13, P817, DOI 10.1261/rna.367307; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; FUNATSU G, 1972, J MOL BIOL, V68, P547, DOI 10.1016/0022-2836(72)90108-8; Gagnon MG, 2012, SCIENCE, V335, P1370, DOI 10.1126/science.1217443; Gregory ST, 2001, J MOL BIOL, V309, P333, DOI 10.1006/jmbi.2001.4676; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hirabayashi N, 2006, J BIOL CHEM, V281, P17203, DOI 10.1074/jbc.M511728200; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang N, 2004, PHILOS T R SOC A, V362, P1439, DOI 10.1098/rsta.2004.1383; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaul M, 2006, J AM CHEM SOC, V128, P1261, DOI 10.1021/ja056159z; Kipper K, 2009, J MOL BIOL, V385, P405, DOI 10.1016/j.jmb.2008.10.065; Lescoute A, 2006, BIOCHIMIE, V88, P993, DOI 10.1016/j.biochi.2006.05.018; Meroueh SO, 2007, CHEM BIOL DRUG DES, V69, P291, DOI 10.1111/j.1747-0285.2007.00505.x; Mura C, 2008, NUCLEIC ACIDS RES, V36, P4941, DOI 10.1093/nar/gkn473; O'Connor M, 2009, MOL GENET GENOMICS, V282, P371, DOI 10.1007/s00438-009-0470-6; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Panecka J, 2014, J PHYS CHEM B, V118, P6687, DOI 10.1021/jp5030685; Panecka J, 2012, AIP CONF PROC, V1456, P207, DOI 10.1063/1.4730661; Panecka J, 2011, J PHYS CHEM B, V115, P532, DOI 10.1021/jp106404u; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Reblova K, 2006, BIOPOLYMERS, V82, P504, DOI 10.1002/bip.20503; Romanowska J, 2013, PROTEINS, V81, P63, DOI 10.1002/prot.24163; Romanowska J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002099; Romanowska J, 2008, J PHYS CHEM B, V112, P15227, DOI 10.1021/jp806814s; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakakibara Y, 2012, ACS CHEM BIOL, V7, P871, DOI 10.1021/cb200497q; Sakakibara Y, 2011, J AM CHEM SOC, V133, P8396, DOI 10.1021/ja2005658; Sanbonmatsu KY, 2006, BIOCHIMIE, V88, P1053, DOI 10.1016/j.biochi.2006.06.012; Sanbonmatsu KY, 2003, J MOL BIOL, V328, P33, DOI 10.1016/S0022-2836(03)00236-5; Scheunemann AE, 2010, NUCLEIC ACIDS RES, V38, P3094, DOI 10.1093/nar/gkp1253; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sharma D, 2007, J MOL BIOL, V374, P1065, DOI 10.1016/j.jmb.2007.10.003; SMITH DE, 1994, J CHEM PHYS, V100, P3757, DOI 10.1063/1.466363; Synetos D, 1996, BBA-GENE STRUCT EXPR, V1309, P156, DOI 10.1016/S0167-4781(96)00128-5; Vaiana AC, 2006, BIOCHIMIE, V88, P1061, DOI 10.1016/j.biochi.2006.06.006; Vaiana AC, 2009, J MOL BIOL, V386, P648, DOI 10.1016/j.jmb.2008.12.035; Vicens Q, 2001, STRUCTURE, V9, P647, DOI 10.1016/S0969-2126(01)00629-3; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Whitford PC, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4817212; Whitford PC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003003; Whitford PC, 2011, P NATL ACAD SCI USA, V108, P18943, DOI 10.1073/pnas.1108363108; Whitford PC, 2010, J AM CHEM SOC, V132, P13170, DOI 10.1021/ja1061399; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; Yang G, 2006, J MED CHEM, V49, P5478, DOI 10.1021/jm060288o; Zaher HS, 2010, MOL CELL, V39, P110, DOI 10.1016/j.molcel.2010.06.009; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zeng XC, 2014, J MOL BIOL, V426, P3201, DOI 10.1016/j.jmb.2014.04.029; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	84	19	19	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111811	10.1371/journal.pone.0111811	http://dx.doi.org/10.1371/journal.pone.0111811			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379961	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100041
J	Al-Abd, AM; Al-Abbasi, FA; Nofal, SM; Khalifa, AE; Williams, RO; El-Eraky, WI; Nagy, AA; Abdel-Naim, AB				Al-Abd, Ahmed M.; Al-Abbasi, Fahad A.; Nofal, Salwa M.; Khalifa, Amani E.; Williams, Richard O.; El-Eraky, Wafaa I.; Nagy, Ayman A.; Abdel-Naim, Ashraf B.			Nimesulide Improves the Symptomatic and Disease Modifying Effects of Leflunomide in Collagen Induced Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; COMBINATION THERAPY; BIOLOGICAL THERAPY; ACTIVE METABOLITE; IN-VITRO; MICE; METHOTREXATE; MECHANISM; DRUG; INFLAMMATION	Nimesulide is a COX-2 inhibitor used for symptomatic relief of rheumatoid arthritis. Leflunomide is an anti-pyrimidine used to manage the progression of rheumatoid arthritis. Herein we studied the influence of nimesulide and leflunomide combination in terms of disease symptoms and progression using collagen-induced arthritis model in mice, as a model for rheumatoid arthritis. Collagen induced arthritis was induced by immunization with type II collagen. Assessment of joint stiffness and articular hyperalgesia were evaluated using a locomotor activity cage and the Hargreaves method, respectively. Disease progression was assessed via arthritic index scoring, X-ray imaging, myeloperoxidase enzyme activity and histopathologic examination. Nimesulide induced only transient symptomatic alleviation on the top of decreased leucocytic infiltration compared to arthritis group. However, nimesulide alone failed to induce any significant improvement in the radiological or pathological disease progression. Leflunomide alone moderately alleviates the symptoms of arthritis and moderately retarded the radiological and pathological disease progression. Combination of nimesulide and leflunomide significantly improved symptomatic (analgesia and joint stiffness) and arthritic disease progression (radiological, pathological and Myeloperoxidase enzyme activity) in collagen induced arthritis animal model.	[Al-Abd, Ahmed M.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah 21413, Saudi Arabia; [Al-Abbasi, Fahad A.] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21413, Saudi Arabia; [Nofal, Salwa M.; El-Eraky, Wafaa I.] Natl Res Ctr, Dept Pharmacol, Div Med, Giza, Egypt; [Khalifa, Amani E.; Abdel-Naim, Ashraf B.] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Williams, Richard O.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Nagy, Ayman A.] Tanta Univ, Fac Med, Dept Forens Med & Clin Toxicol, Tanta, Egypt	King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Ain Shams University; University of Oxford; Egyptian Knowledge Bank (EKB); Tanta University	Al-Abd, AM (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah 21413, Saudi Arabia.	amalabd@kau.edu.sa	Nagy, Ayman/K-8956-2012; Abdel-Naim, Ashraf B/J-3199-2012; Al-Abbasi, Fahad/H-8940-2012; Al-Abd, Ahmed/J-2826-2012	Abdel-Naim, Ashraf B/0000-0002-0400-9075; Al-Abd, Ahmed/0000-0001-7872-4867; Nofal, Salwa/0000-0001-5125-8181; Khalifa, Amani/0000-0002-1627-7800; Al-Abbasi, Fahad/0000-0001-5609-4913; Eleraky, Wafaa/0000-0001-5598-6960	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [D9/166/1434]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No (D9/166/1434). The authors, therefore, acknowledge with thanks, DSR for technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abd AM, 2010, EUR J PHARMACOL, V644, P245, DOI 10.1016/j.ejphar.2010.07.006; Asanuma Y, 2002, EUR J PHARMACOL, V435, P253, DOI 10.1016/S0014-2999(01)01555-2; Bartlett RR, 1996, TRANSPLANT P, V28, P3074; Benucci M, 2009, INT J IMMUNOPATH PH, V22, P1147, DOI 10.1177/039463200902200434; BEVILACQUA M, 1994, EUR J PHARM-MOLEC PH, V268, P415, DOI 10.1016/0922-4106(94)90067-1; Bracewell C, 2009, EXPERT OPIN BIOL TH, V9, P909, DOI 10.1517/14712590903033919; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Burger D, 2003, RHEUMATOLOGY, V42, P89, DOI 10.1093/rheumatology/keg038; Cao WW, 1996, TRANSPL P, V28, P3079; CAPECCHI PL, 1993, ARZNEIMITTEL-FORSCH, V43-2, P992; Chillingworth NL, 2003, J NEUROSCI METH, V128, P45, DOI 10.1016/S0165-0270(03)00147-X; CLARK RL, 1979, ARTHRITIS RHEUM, V22, P25, DOI 10.1002/art.1780220105; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; Coulthard LG, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3278; Curnock AP, 1997, J PHARMACOL EXP THER, V282, P339; Araujo FAD, 2012, J CRANIO MAXILL SURG, V40, pE346, DOI 10.1016/j.jcms.2012.01.018; de Mello S B, 1994, Sao Paulo Med J, V112, P489; Dimitrova P, 2002, J IMMUNOL, V169, P3392, DOI 10.4049/jimmunol.169.6.3392; Falgarone G, 2009, JOINT BONE SPINE, V76, P327, DOI 10.1016/j.jbspin.2008.12.007; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Fox RI, 1998, J RHEUMATOL, V25, P20; Hamilton LC, 1999, BRIT J PHARMACOL, V127, P1589, DOI 10.1038/sj.bjp.0702708; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Inotai A, 2012, ACTA POL PHARM, V69, P773; Joosten LAB, 1999, J IMMUNOL, V163, P5049; KENT EF, 1990, J CLIN IMMUNOL, V10, P106, DOI 10.1007/BF00918192; Khalil NA, 2012, ARCH PHARM RES, V35, P995, DOI 10.1007/s12272-012-0606-9; McVey DC, 2001, PEPTIDES, V22, P1439, DOI 10.1016/S0196-9781(01)00463-6; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Pelletier J P, 1993, Drugs, V46 Suppl 1, P34; Pincus T, 1999, ANN INTERN MED, V131, P768, DOI 10.7326/0003-4819-131-10-199911160-00009; Ramiro S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008886.pub2; Rozman B, 2002, CLIN PHARMACOKINET, V41, P421, DOI 10.2165/00003088-200241060-00003; Schipper LG, 2011, RHEUMATOLOGY, V50, P1320, DOI 10.1093/rheumatology/ker084; Sengupta S, 1998, INDIAN J PHARM, V31, P322; Tool ATJ, 1996, EUR RESPIR J, V9, pS141; Urakawa K, 2000, IMMUNOPHARMACOLOGY, V48, P137, DOI 10.1016/S0162-3109(00)00197-1; Walker-Bone K, 2007, CLIN EVID; Weinblatt ME, 1996, ANN INTERN MED, V124, P773, DOI 10.7326/0003-4819-124-8-199604150-00012; Wiens A, 2009, SCAND J IMMUNOL, V70, P337, DOI 10.1111/j.1365-3083.2009.02296.x; Williams RO, 1998, SPRINGER SEMIN IMMUN, V20, P165	42	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111843	10.1371/journal.pone.0111843	http://dx.doi.org/10.1371/journal.pone.0111843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375820	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600067
J	Chowanadisai, W				Chowanadisai, Winyoo			Comparative Genomic Analysis of slc39a12/ZIP12: Insight into a Zinc Transporter Required for Vertebrate Nervous System Development	PLOS ONE			English	Article							ACRODERMATITIS-ENTEROPATHICA; FUNCTIONAL EXPRESSION; METAL TRANSPORTER; MESSENGER-RNA; EVOLUTION; IDENTIFICATION; PROTEINS; ZEBRAFISH; XENOPUS; GENES	The zinc transporter ZIP12, which is encoded by the gene slc39a12, has previously been shown to be important for neuronal differentiation in mouse Neuro-2a neuroblastoma cells and primary mouse neurons and necessary for neurulation during Xenopus tropicalis embryogenesis. However, relatively little is known about the biochemical properties, cellular regulation, or the physiological role of this gene. The hypothesis that ZIP12 is a zinc transporter important for nervous system function and development guided a comparative genetics approach to uncover the presence of ZIP12 in various genomes and identify conserved sequences and expression patterns associated with ZIP12. Ortholog detection of slc39a12 was conducted with reciprocal BLAST hits with the amino acid sequence of human ZIP12 in comparison to the human paralog ZIP4 and conserved local synteny between genomes. ZIP12 is present in the genomes of almost all vertebrates examined, from humans and other mammals to most teleost fish. However, ZIP12 appears to be absent from the zebrafish genome. The discrimination of ZIP12 compared to ZIP4 was unsuccessful or inconclusive in other invertebrate chordates and deuterostomes. Splice variation, due to the inclusion or exclusion of a conserved exon, is present in humans, rats, and cows and likely has biological significance. ZIP12 also possesses many putative di-leucine and tyrosine motifs often associated with intracellular trafficking, which may control cellular zinc uptake activity through the localization of ZIP12 within the cell. These findings highlight multiple aspects of ZIP12 at the biochemical, cellular, and physiological levels with likely biological significance. ZIP12 appears to have conserved function as a zinc uptake transporter in vertebrate nervous system development. Consequently, the role of ZIP12 may be an important link to reported congenital malformations in numerous animal models and humans that are caused by zinc deficiency.	Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis	Chowanadisai, W (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	wchowanadisai@ucdavis.edu			University of California, Davis Center for Health and Nutrition Research	University of California, Davis Center for Health and Nutrition Research	Funding for this research was provided by a grant from the University of California, Davis Center for Health and Nutrition Research (to Robert B. Rucker). No additional funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Alfoldi J, 2013, GENOME RES, V23, P1063, DOI 10.1101/gr.157503.113; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Benito-Gutierrez E, 2006, INT J BIOL SCI, V2, P149; Bin BH, 2011, J BIOL CHEM, V286, P40255, DOI 10.1074/jbc.M111.256784; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826; Chalfie M, 1998, TRENDS GENET, V14, P506, DOI 10.1016/S0168-9525(98)01623-0; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chowanadisai W, 2013, P NATL ACAD SCI USA, V110, P9903, DOI 10.1073/pnas.1222142110; Christiaen L., 2009, COLD SPRING HARB PRO, V2009; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; Costello LC, 1999, J BIOL CHEM, V274, P17499, DOI 10.1074/jbc.274.25.17499; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Ehsani S, 2012, J MOL BIOL, V422, P556, DOI 10.1016/j.jmb.2012.06.003; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Feeney GP, 2005, BBA-GENE STRUCT EXPR, V1732, P88, DOI 10.1016/j.bbaexp.2005.12.002; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; FORBES RM, 1984, FED PROC, V43, P2835; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gabaldon Toni, 2008, V439, P387, DOI 10.1007/978-1-59745-188-8_26; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gilchrist MJ, 2012, GENESIS, V50, P143, DOI 10.1002/dvg.22008; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; HIDIROGLOU M, 1979, J DAIRY SCI, V62, P1195, DOI 10.3168/jds.S0022-0302(79)83400-1; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; Hofmann T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010519; Hogstrand C, 2013, BIOCHEM J, V455, P229, DOI 10.1042/BJ20130483; Hong E, 2006, DEVELOPMENT, V133, P3895, DOI 10.1242/dev.02560; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang LP, 2007, FEBS J, V274, P3986, DOI 10.1111/j.1742-4658.2007.05933.x; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Jun J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-630; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kao HT, 1996, MOL BRAIN RES, V43, P174, DOI 10.1016/S0169-328X(96)00173-8; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lichten LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021526; Long YS, 2011, J GENET GENOMICS, V38, P157, DOI 10.1016/j.jgg.2011.03.003; Lowery LA, 2004, MECH DEVELOP, V121, P1189, DOI 10.1016/j.mod.2004.04.022; LUECKE RW, 1984, FED PROC, V43, P2823; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Mathews WR, 2006, DEVELOPMENT, V133, P1143, DOI 10.1242/dev.02256; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Mimoto MS, 2011, METHODS MOL BIOL, V770, P55, DOI 10.1007/978-1-61779-210-6_3; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PRASAD AS, 1988, J AM COLL NUTR, V7, P377, DOI 10.1080/07315724.1988.10720255; Richardson MK, 2003, J MORPHOL, V257, P348, DOI 10.1002/jmor.10119; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Sauka-Spengler T., 2009, COLD SPRING HARB PRO, V2009, pt5122; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Siepel A, 2007, GENOME RES, V17, P1763, DOI 10.1101/gr.7128207; Sive H. L., 2007, CSH PROTOC, V2007; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; SWENERTON H, 1969, SCIENCE, V166, P1014, DOI 10.1126/science.166.3908.1014; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Velthuis AJWT, 2008, CURR GENOMICS, V9, P88, DOI 10.2174/138920208784139537; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Yuzbasiyan-Gurkan V, 2006, GENOMICS, V88, P521, DOI 10.1016/j.ygeno.2006.03.018; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; Zhao H, 2009, GENOME RES, V19, P934, DOI 10.1101/gr.086009.108; Zheng DL, 2008, PHYSIOL GENOMICS, V34, P205, DOI 10.1152/physiolgenomics.90206.2008	91	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111535	10.1371/journal.pone.0111535	http://dx.doi.org/10.1371/journal.pone.0111535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375179	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600046
J	Lancaster, GI; Kraakman, MJ; Kammoun, HL; Langley, KG; Estevez, E; Banerjee, A; Grumont, RJ; Febbraio, MA; Gerondakis, S				Lancaster, Graeme I.; Kraakman, Michael J.; Kammoun, Helene L.; Langley, Katherine G.; Estevez, Emma; Banerjee, Ashish; Grumont, Raelene J.; Febbraio, Mark A.; Gerondakis, Steve			The Dual-Specificity Phosphatase 2 (DUSP2) Does Not Regulate Obesity-Associated Inflammation or Insulin Resistance in Mice	PLOS ONE			English	Article							MAP KINASE PHOSPHATASE-1; T-CELLS; IMMUNE-RESPONSES; SENSITIVITY; ACTIVATION; LACKING; INNATE; PAC-1; PTP1B	Alterations in the immune cell profile and the induction of inflammation within adipose tissue are a hallmark of obesity in mice and humans. Dual-specificity phosphatase 2 (DUSP2) is widely expressed within the immune system and plays a key role promoting immune and inflammatory responses dependent on mitogen-activated protein kinase (MAPK) activity. We hypothesised that the absence of DUSP2 would protect mice against obesity-associated inflammation and insulin resistance. Accordingly, male and female littermate mice that are either wild-type (wt) or homozygous for a germ-line null mutation of the dusp2 gene (dusp2 2/2) were fed either a standard chow diet (SCD) or high fat diet (HFD) for 12 weeks prior to metabolic phenotyping. Compared with mice fed the SCD, all mice consuming the HFD became obese, developed glucose intolerance and insulin resistance, and displayed increased macrophage recruitment and markers of inflammation in epididymal white adipose tissue. The absence of DUSP2, however, had no effect on the development of obesity or adipose tissue inflammation. Whole body insulin sensitivity in male mice was unaffected by an absence of DUSP2 in response to either the SCD or HFD; however, HFD-induced insulin resistance was slightly, but significantly, reduced in female dusp2 2/2 mice. In conclusion, DUSP2 plays no role in regulating obesity-associated inflammation and only a minor role in controlling insulin sensitivity following HFD in female, but not male, mice. These data indicate that rather than DUSP2 being a pan regulator of MAPK dependent immune cell mediated inflammation, it appears to differentially regulate inflammatory responses that have a MAPK component.	[Lancaster, Graeme I.; Kraakman, Michael J.; Kammoun, Helene L.; Langley, Katherine G.; Estevez, Emma; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia; [Grumont, Raelene J.; Gerondakis, Steve] Monash Univ, Cent Clin Sch, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Grumont, Raelene J.; Gerondakis, Steve] Monash Univ, Cent Clin Sch, Dept Clin Hematol, Melbourne, Vic 3004, Australia; [Banerjee, Ashish] Monash Univ, MIMR PHI Inst Med Res, Ctr Canc Res, Clayton, Vic 3800, Australia	Baker Heart and Diabetes Institute; Monash University; Monash University; Monash University; Prince Henry's Institute of Medical Research	Lancaster, GI (corresponding author), Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia.	Graeme.lancaster@bakeridi.edu.au	Febbraio, Mark/AAE-9632-2019	Kraakman, Michael/0000-0002-5755-0447; Febbraio, Mark/0000-0002-9296-4418; Estevez, Emma/0000-0002-5125-2190	Victorian Government; Baker IDI Bright Sparks Stipend; Monash University Faculty of Medicine, Nursing and Health Sciences Postgraduate Research Scholarship; Australian Postgraduate Award	Victorian Government; Baker IDI Bright Sparks Stipend; Monash University Faculty of Medicine, Nursing and Health Sciences Postgraduate Research Scholarship; Australian Postgraduate Award(Australian Government)	This study was supported by the Victorian Government Operational Infrastructure Support Program. M.A.F. and S.G. are Research Fellows of the National Health & Medical Research Council of Australia. K.G.L. is supported by a Baker IDI Bright Sparks Stipend and a Monash University Faculty of Medicine, Nursing and Health Sciences Postgraduate Research Scholarship. M.J.K. is supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger-Messier M, 2013, CIRC RES, V112, P48, DOI 10.1161/CIRCRESAHA.112.272963; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fukushima A, 2010, DIABETES, V59, P1906, DOI 10.2337/db09-1365; Ghisletti S, 2005, MOL CELL BIOL, V25, P2957, DOI 10.1128/MCB.25.8.2957-2968.2005; Grumont RJ, 1996, MOL CELL BIOL, V16, P2913; Haque A, 2011, CELL, V147, P185, DOI 10.1016/j.cell.2011.08.036; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Lancaster GI, 2012, BIOCHEM J, V442, P723, DOI 10.1042/BJ20112037; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Xu E, 2014, REV ENDOCR METAB DIS, V15, P79, DOI 10.1007/s11154-013-9282-4; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111524	10.1371/journal.pone.0111524	http://dx.doi.org/10.1371/journal.pone.0111524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375135	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600044
J	Simental-Rodriguez, SL; Quinones-Perez, CZ; Moya, D; Hernandez-Tecles, E; Lopez-Sanchez, CA; Wehenkel, C				Leonel Simental-Rodriguez, Sergio; Zulema Quinones-Perez, Carmen; Moya, Daniel; Hernandez-Tecles, Enrique; Lopez-Sanchez, Carlos Antonio; Wehenkel, Christian			The Relationship between Species Diversity and Genetic Structure in the Rare Picea chihuahuana Tree Species Community, Mexico	PLOS ONE			English	Article							POPULUS-TREMULOIDES; POPULATION-STRUCTURE; DIFFERENTIATION; CLIMATE; AFLP; POLYMORPHISM; RESPONSES; GENOTYPES; RICHNESS; ECOLOGY	Species diversity and genetic diversity, the most basic elements of biodiversity, have long been treated as separate topics, although populations evolve within a community context. Recent studies on community genetics and ecology have suggested that genetic diversity is not completely independent of species diversity. The Mexican Picea chihuahuana Martinez is an endemic species listed as "Endangered'' on the Red List. Forty populations of Chihuahua spruce have been identified. This species is often associated with tree species of eight genera in gallery forests. This rare Picea chihuahuana tree community covers an area no more than 300 ha and has been subject of several studies involving different topics such as ecology, genetic structure and climate change. The overall aim of these studies was to obtain a dataset for developing management tools to help decision makers implement preservation and conservation strategies. However, this unique forest tree community may also represent an excellent subject for helping us to understand the interplay between ecological and evolutionary processes in determining community structure and dynamics. The AFLP technique and species composition data were used together to test the hypothesis that species diversity is related to the adaptive genetic structure of some dominant tree species (Picea chihuahuana, Pinus strobiformis, Pseudotsuga menziesii and Populus tremuloides) of the Picea chihuahuana tree community at fourteen locations. The Hill numbers were used as a diversity measure. The results revealed a significant correlation between tree species diversity and genetic structure in Populus tremuloides. Because the relationship between the two levels of diversity was found to be positive for the putative adaptive AFLP detected, genetic and species structures of the tree community were possibly simultaneously adapted to a combination of ecological or environmental factors. The present findings indicate that interactions between genetic variants and species diversity may be crucial in shaping tree communities.	[Leonel Simental-Rodriguez, Sergio; Zulema Quinones-Perez, Carmen; Lopez-Sanchez, Carlos Antonio; Wehenkel, Christian] Univ Juarez Estado Durango, Forestry & Wood Ind Inst, Durango, Mexico; [Moya, Daniel; Hernandez-Tecles, Enrique] Univ Castilla La Mancha, Higher Tech Sch Agr & Forestry Engn, Albacete, Spain	Universidad Juarez del Estado de Durango; Universidad de Castilla-La Mancha	Wehenkel, C (corresponding author), Univ Juarez Estado Durango, Forestry & Wood Ind Inst, Durango, Mexico.	wehenkel@ujed.mx	Moya, Daniel/N-1616-2019; Moya, Daniel/B-5979-2015; López-Sánchez, Carlos A./K-6486-2016	Moya, Daniel/0000-0002-1909-1200; Moya, Daniel/0000-0002-1909-1200; López-Sánchez, Carlos A./0000-0002-5135-5739	Mexican Council of Science and Technology (CONACyT); Ministry of Education (SEP) [CB-2010-01 158054]	Mexican Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministry of Education (SEP)	This study was supported by joint funding from the Mexican Council of Science and Technology (CONACyT:http://www.conacyt.gob.mx/) and the Ministry of Education (SEP: http://www.sep.gob.mx/; Project CB-2010-01 158054). CW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1985, J ECOL, V73, P605, DOI 10.2307/2260497; Achere V, 2005, MOL ECOL, V14, P3191, DOI 10.1111/j.1365-294X.2005.02646.x; [Anonymous], 2014, SILVAE GENE IN PRESS; [Anonymous], 2010, DIARIO OFICIAL FEDER; Antonovics J, 2003, ECOLOGY, V84, P598, DOI 10.1890/0012-9658(2003)084[0598:TCG]2.0.CO;2; ANTONOVICS J, 1992, PLANT RESISTANCE HER, P429; Bergmann F, 2013, SILVAE GENET, V62, P25, DOI 10.1515/sg-2013-0004; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; CHAN FJ, 1989, US FOR SERV T R PSW, V110, P428; Dupre C, 2002, J VEG SCI, V13, P505, DOI 10.1111/j.1654-1103.2002.tb02077.x; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2010, MOL ECOL, V19, P4638, DOI 10.1111/j.1365-294X.2010.04820.x; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Gibson DJ, 2012, OIKOS, V121, P496, DOI 10.1111/j.1600-0706.2011.19447.x; GORDON AG, 1968, ECOLOGY, V49, P880, DOI 10.2307/1936540; Gregorius HR, 2007, SILVAE GENET, V56, P190, DOI 10.1515/sg-2007-0029; Gregorius Hans-Rolf, 2010, Diversity, V2, P370; GREGORIUS HR, 1978, MATH BIOSCI, V41, P253, DOI 10.1016/0025-5564(78)90040-8; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; IUCN Red List of Threatened Species, 2013, IUCN RED LIST THREAT; Jaramillo-Correa JP, 2006, MOL ECOL, V15, P2787, DOI 10.1111/j.1365-294X.2006.02974.x; JELINSKI DE, 1992, AM J BOT, V79, P728, DOI 10.2307/2444937; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jump AS, 2006, GLOBAL CHANGE BIOL, V12, P2163, DOI 10.1111/j.1365-2486.2006.01250.x; KARLIN AA, 1984, COPEIA, P343, DOI 10.2307/1445190; Kelly CK, 2003, ECOL LETT, V6, P87, DOI 10.1046/j.1461-0248.2003.00402.x; Krauss SL, 2000, MOL ECOL, V9, P1241, DOI 10.1046/j.1365-294x.2000.01001.x; Kuchma O, 2011, MUTAT RES-GEN TOX EN, V725, P29, DOI 10.1016/j.mrgentox.2011.07.003; Ledig F. Thomas, 2000, Madrono, V47, P71; Ledig FT, 2010, AM J BOT, V97, P970, DOI 10.3732/ajb.0900329; Ledig FT, 1997, EVOLUTION, V51, P1815, DOI [10.2307/2411004, 10.1111/j.1558-5646.1997.tb05105.x]; Lindroth RL, 2013, FOREST ECOL MANAG, V299, P14, DOI 10.1016/j.foreco.2012.11.018; LUMARET R, 1984, HEREDITY, V52, P153, DOI 10.1038/hdy.1984.18; Manly BJF, 1997, RANDOMIZATION BOOTST, P399; Martinez-Antunez P, 2013, POL J ECOL, V61, P283; Mendoza-Maya E, 2014, PROPUESTA C IN PRESS; Narvaez FR, 1984, THESIS U AUTONOMA NU; PINERO D, 2008, DIVERSIDAD GENETICA, V1, P437; Quinones-Perez CZ, 2012, KASTAMONU UNIV J FOR, V12, P180; Richardson BA, 2009, INT J PLANT SCI, V170, P1120, DOI 10.1086/605870; Saenz-Romero C, 2010, CLIMATIC CHANGE, V102, P595, DOI 10.1007/s10584-009-9753-5; Sanchez CJ, 1984, CIENC FOREST, V9, P51; Scotti-Saintagne C, 2004, GENETICS, V168, P1615, DOI 10.1534/genetics.104.026849; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Silva-Flores R, 2014, PLOS ONE IN PRESS; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Vavrek MC, 1998, AM J BOT, V85, P947, DOI 10.2307/2446361; Vellend M, 2005, AM NAT, V166, P199, DOI 10.1086/431318; Vellend M, 2004, ECOLOGY, V85, P3043, DOI 10.1890/04-0435; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang XZ, 2001, NEW PHYTOL, V150, P675, DOI 10.1046/j.1469-8137.2001.00138.x; Wehenkel C., 2012, Forstarchiv, V83, P48; Wehenkel C, 2014, GENETIC ERO IN PRESS; Wehenkel C, 2007, SILVAE GENET, V56, P101, DOI 10.1515/sg-2007-0016; Wehenkel C, 2006, PLANT ECOL, V185, P151, DOI 10.1007/s11258-005-9091-2; Wehenkel C, 2012, TREE GENET GENOMES, V8, P1085, DOI 10.1007/s11295-012-0488-5; Wehenkel C, 2010, PLANT ECOL, V208, P47, DOI 10.1007/s11258-009-9685-1; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Worrall JJ, 2013, FOREST ECOL MANAG, V299, P35, DOI 10.1016/j.foreco.2012.12.033; Wullschleger SD, 2002, PLANT CELL, V14, P2651, DOI 10.1105/tpc.141120; ZANGERL AR, 1984, ECOLOGY, V65, P218, DOI 10.2307/1939473; Quinones-Perez CZ, 2014, POL J ECOL, V62, P55, DOI 10.3161/104.062.0106; Zyczkowski K, 2003, OPEN SYST INF DYN, V10, P297, DOI 10.1023/A:1025128024427	70	13	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111623	10.1371/journal.pone.0111623	http://dx.doi.org/10.1371/journal.pone.0111623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375134	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600054
J	Naganuma, T; Hoshino, W; Shikanai, Y; Sato, R; Liu, KY; Sato, S; Muramoto, K; Osada, M; Yoshimi, K; Ogawa, T				Naganuma, Takako; Hoshino, Wataru; Shikanai, Yukihiro; Sato, Rie; Liu, Kaiyue; Sato, Saho; Muramoto, Koji; Osada, Makoto; Yoshimi, Kyosuke; Ogawa, Tomohisa			Novel Matrix Proteins of Pteria penguin Pearl Oyster Shell Nacre Homologous to the Jacalin-Related beta-Prism Fold Lectins	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; ORGANIC MATRIX; CALCIUM-CARBONATE; MOLECULAR-CLONING; KEY MACROMOLECULE; CRYSTAL-STRUCTURE; LAYER FORMATION; BIOMINERALIZATION; TREHALOSE; PHYLOGENIES	Nacreous layers of pearl oyster are one of the major functional biominerals. By participating in organic compound-crystal interactions, they assemble into consecutive mineral lamellae-like photonic crystals. Their biomineralization mechanisms are controlled by macromolecules; however, they are largely unknown. Here, we report two novel lectins termed PPL2A and PPL2B, which were isolated from the mantle and the secreted fluid of Pteria penguin oyster. PPL2A is a hetero-dimer composed of alpha and gamma subunits, and PPL2B is a homo-dimer of beta subunit, all of which surprisingly shared sequence homology with the jacalin-related plant lectin. On the basis of knockdown experiments at the larval stage, the identification of PPLs in the shell matrix, and in vitro CaCO3 crystallization analysis, we conclude that two novel jacalin-related lectins participate in the biomineralization of P. penguin nacre as matrix proteins. Furthermore, it was found that trehalose, which is specific recognizing carbohydrates for PPL2A and is abundant in the secreted fluid of P. penguin mantle, functions as a regulatory factor for biomineralization via PPL2A. These observations highlight the unique functions, diversity and molecular evolution of this lectin family involved in the mollusk shell formation.	[Naganuma, Takako; Hoshino, Wataru; Shikanai, Yukihiro; Sato, Rie; Liu, Kaiyue; Sato, Saho; Muramoto, Koji; Ogawa, Tomohisa] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808577, Japan; [Naganuma, Takako; Osada, Makoto; Yoshimi, Kyosuke; Ogawa, Tomohisa] Tohoku Univ, Ctr Interdisciplinary Res, Sendai, Miyagi 9808578, Japan; [Osada, Makoto] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Yoshimi, Kyosuke] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808578, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Ogawa, T (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808577, Japan.	ogawa@biochem.tohoku.ac.jp	Osada, Makoto/AAI-9967-2020	Osada, Makoto/0000-0001-6247-5106; Ogawa, Tomohisa/0000-0001-8700-6330	Ministry of Education, Culture, Sports, Science and Technology, Japan [23107505, 20350073]; "Program Research'' in the Center for Interdisciplinary Research, Tohoku University	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Program Research'' in the Center for Interdisciplinary Research, Tohoku University	This work was supported by Grant-in-Aid for Scientific Research (B) (No. 20350073) and Scientific Research on the Innovative Area "Fusion Materials'' (No. 23107505) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and "Program Research'' in the Center for Interdisciplinary Research, Tohoku University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Alvarez-Peral FJ, 2002, MICROBIOL-SGM, V148, P2599, DOI 10.1099/00221287-148-8-2599; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Astoul CH, 2002, BIOCHEM J, V367, P817, DOI 10.1042/BJ20020856; BADMAN DG, 1967, COMP BIOCHEM PHYSIOL, V23, P621, DOI 10.1016/0010-406X(67)90413-6; Baeuerlein Edmund, 2007, P1; Behrens P., 2007, HDB BIOMINERALIZATIO; Bourne Y, 2004, J BIOL CHEM, V279, P527, DOI 10.1074/jbc.M308218200; BROOKS R, 1950, PHILOS T R SOC S-A, V243, P145, DOI 10.1098/rsta.1950.0016; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; CRONSHAGEN U, 1994, EUR J CELL BIOL, V65, P366; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Howard EW, 2001, DEVELOPMENT, V128, P365; Jakob W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000694; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Kanagawa M, 2011, BIOCHEM BIOPH RES CO, V404, P201, DOI 10.1016/j.bbrc.2010.11.093; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Liener I.E., 1986, LECTINS PROPERTIES F; Mann K, 2000, EUR J BIOCHEM, V267, P5257, DOI 10.1046/j.1432-1327.2000.01602.x; Mann K, 2001, EUR J BIOCHEM, V268, P4414, DOI 10.1046/j.1432-1327.2001.02368.x; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marsh ME, 2003, COMP BIOCHEM PHYS B, V136, P743, DOI 10.1016/S1096-4959(03)00180-5; Marshall RD, 1972, GLYCOPROTEINS A, P251; MATSUMOTO I, 1979, J BIOCHEM-TOKYO, V85, P1091, DOI 10.1093/oxfordjournals.jbchem.a132417; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; McGinty EL, 2012, MAR GENOM, V5, P27, DOI 10.1016/j.margen.2011.08.006; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; Michenfelder M, 2003, BIOPOLYMERS, V70, P522, DOI 10.1002/bip.10536; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Naganuma T, 2006, MOL DIVERS, V10, P607, DOI 10.1007/s11030-006-9051-3; Nomura K, 2000, BIOCHEM BIOPH RES CO, V276, P23, DOI 10.1006/bbrc.2000.3420; Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009; Ogawa Tomohisa, 2011, J Amino Acids, V2011, P838914, DOI 10.4061/2011/838914; Peumans WJ, 2000, PLANTA, V211, P546, DOI 10.1007/s004250000307; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Shirai T, 2009, J MOL BIOL, V391, P390, DOI 10.1016/j.jmb.2009.06.027; Smith VJ, 2011, BIOCHEM SOC T, V39, P1403, DOI 10.1042/BST0391403; Smith-Keune C, 2009, AQUAC RES, V40, P1054, DOI 10.1111/j.1365-2109.2009.02199.x; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tateno H, 1998, J BIOL CHEM, V273, P19190, DOI 10.1074/jbc.273.30.19190; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Van Damme EJM, 1999, EUR J BIOCHEM, V259, P135, DOI 10.1046/j.1432-1327.1999.00013.x; Wang N, 2012, MAR BIOTECHNOL, V14, P177, DOI 10.1007/s10126-011-9400-9; WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998; WEINER S, 1983, BIOCHEMISTRY-US, V22, P4139, DOI 10.1021/bi00286a023; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; WORMS D, 1986, J EXP ZOOL, V237, P11, DOI 10.1002/jez.1402370104; Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098; Zhang WL, 2000, PLANTA, V210, P970, DOI 10.1007/s004250050705	69	16	16	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112326	10.1371/journal.pone.0112326	http://dx.doi.org/10.1371/journal.pone.0112326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375177	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600128
J	Ray, P; Knowlton, KF; Shang, C; Xia, K				Ray, Partha; Knowlton, Katharine F.; Shang, Chao; Xia, Kang			Development and Validation of a UPLC-MS/MS Method to Monitor Cephapirin Excretion in Dairy Cows following Intramammary Infusion	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; ANTIBIOTIC-RESISTANCE; TISSUE DISTRIBUTION; VETERINARY ANTIBIOTICS; STAPHYLOCOCCUS-AUREUS; CEFTIOFUR SODIUM; DRUG RESIDUES; BOVINE-MILK; PHARMACOKINETICS; ABSORPTION	Cephapirin, a cephalosporin antibiotic, is used by the majority of dairy farms in the US. Fecal and urinary excretion of cephapirin could introduce this compound into the environment when manure is land applied as fertilizer, and may cause development of bacterial resistance to antibiotics critical for human health. The environmental loading of cephapirin by the livestock industry remains un-assessed, largely due to a lack of appropriate analytical methods. Therefore, this study aimed to develop and validate a cephapirin quantification method to capture the temporal pattern of cephapirin excretion in dairy cows following intramammary infusion. The method includes an extraction with phosphate buffer and methanol, solid-phase extraction (SPE) clean-up, and quantification using ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). The LOQ values of the developed method were 4.02 mu g kg(-1) and 0.96 mu g L-1 for feces and urine, respectively. This robust method recovered >60% and >80% cephapirin from spiked blank fecal and urine samples, respectively, with acceptable intra-and inter-day variation (<10%). Using this method, we detected trace amounts (mu g kg(-1)) of cephapirin in dairy cow feces, and cephapirin in urine was detected at very high concentrations (133 to 480 mu g L-1). Cephapirin was primarily excreted via urine and its urinary excretion was influenced by day (P = 0.03). Peak excretion (2.69 mg) was on day 1 following intramammary infusion and decreased sharply thereafter (0.19, 0.19, 0.08, and 0.17 mg on day 2, 3, 4, and 5, respectively) reflecting a quadratic pattern of excretion (Quadratic: P = 0.03). The described method for quantification of cephapirin in bovine feces and urine is sensitive, accurate, and robust and allowed to monitor the pattern of cephapirin excretion in dairy cows. This data will help develop manure segregation and treatment methods to minimize the risk of antibiotic loading to the environment from dairy farms.	[Ray, Partha; Knowlton, Katharine F.] Virginia Polytech Inst & State Univ, Dept Dairy Sci, Blacksburg, VA 24061 USA; [Shang, Chao; Xia, Kang] Virginia Polytech Inst & State Univ, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Ray, P (corresponding author), Virginia Polytech Inst & State Univ, Dept Dairy Sci, Blacksburg, VA 24061 USA.	drray@vt.edu			Virginia Agricultural Experiment Station, Virginia Cooperative Extension; College of Agriculture and Life Sciences at Virginia Tech	Virginia Agricultural Experiment Station, Virginia Cooperative Extension; College of Agriculture and Life Sciences at Virginia Tech	This activity was funded, in part, with an integrated, internal competitive grant from Virginia Agricultural Experiment Station, Virginia Cooperative Extension, and the College of Agriculture and Life Sciences at Virginia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; AXELROD J, 1971, APPL MICROBIOL, V22, P904, DOI 10.1128/AEM.22.5.904-908.1971; BeconiBarker MG, 1996, J VET PHARMACOL THER, V19, P192, DOI 10.1111/j.1365-2885.1996.tb00038.x; BECONIBARKER MG, 1995, J AGR FOOD CHEM, V43, P1589, DOI 10.1021/jf00054a033; CABANA BE, 1975, J PHARMACOKINET BIOP, V3, P419, DOI 10.1007/BF01059474; CABANA BE, 1976, ANTIMICROB AGENTS CH, V10, P307, DOI 10.1128/AAC.10.2.307; Cortinhas CS, 2013, AM J VET RES, V74, P683, DOI 10.2460/ajvr.74.5.683; Dasenbrock CO, 1998, ANAL CHEM, V70, P2415, DOI 10.1021/ac971375e; du Preez JH, 2000, J S AFR VET ASSOC, V71, P201; Ehinger AM, 2000, J VET MED A, V47, P157, DOI 10.1046/j.1439-0442.2000.00272.x; FASCHING CE, 1982, ANTIMICROB AGENTS CH, V21, P628, DOI 10.1128/AAC.21.4.628; Feng SX, 2012, J CHROMATOGR B, V898, P62, DOI 10.1016/j.jchromb.2012.04.020; Gehring R, 2006, J VET PHARMACOL THER, V29, P237, DOI 10.1111/j.1365-2885.2006.00750.x; GILBERTSON TJ, 1990, J AGR FOOD CHEM, V38, P890, DOI 10.1021/jf00093a064; GOLDSTEIN A, 1949, PHARMACOL REV, V1, P102; Gorden PJ, 2013, J DAIRY SCI, V96, P4455, DOI 10.3168/jds.2012-6487; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Heller DN, 2006, J AGR FOOD CHEM, V54, P5267, DOI 10.1021/jf0605502; Heller DN, 2000, J AGR FOOD CHEM, V48, P6030, DOI 10.1021/jf000046b; Hleba L, 2012, J MICROB BIOTEC FOOD, V2, P253; HORNISH RE, 1992, ACS SYM SER, V503, P132; Hornish Rex E., 2002, Current Topics in Medicinal Chemistry, V2, P717, DOI 10.2174/1568026023393679; Junza A, 2011, J CHROMATOGR B, V879, P2601, DOI 10.1016/j.jchromb.2011.07.018; Junza R, 2010, OVIDIUS U ANAL CHEM, V21, P109; Kaufmann A, 2007, ANAL CHIM ACTA, V586, P13, DOI 10.1016/j.aca.2006.10.026; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Kuchta SL, 2009, ARCH ENVIRON CON TOX, V57, P1, DOI 10.1007/s00244-008-9229-z; Kwon JW, 2009, J AOAC INT, V92, P359; Kwon SI, 2011, WASTE MANAGE, V31, P39, DOI 10.1016/j.wasman.2010.08.018; Lamshoft M, 2010, SCI TOTAL ENVIRON, V408, P1563, DOI 10.1016/j.scitotenv.2009.12.010; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; LEWIS JE, 1972, NATURE-NEW BIOL, V239, P214, DOI 10.1038/newbio239214a0; MAHON WA, 1973, ANTIMICROB AGENTS CH, V3, P585, DOI 10.1128/AAC.3.5.585; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; McDougall S, 2014, NEW ZEAL VET J, V62, P68, DOI 10.1080/00480169.2013.843135; Moats WA, 1998, J CHROMATOGR A, V812, P237, DOI 10.1016/S0021-9673(98)00387-2; Moats WA, 2000, J AGR FOOD CHEM, V48, P498, DOI 10.1021/jf990638y; OWENS WE, 1987, J DAIRY SCI, V70, P1946, DOI 10.3168/jds.S0022-0302(87)80236-9; Pikkemaat MG, 2009, ANAL BIOANAL CHEM, V395, P893, DOI 10.1007/s00216-009-2841-6; PRADES M, 1988, AM J VET RES, V49, P1888; SABATH LD, 1976, HUM PATHOL, V7, P287, DOI 10.1016/S0046-8177(76)80039-1; Sandegren L, 2014, UPSALA J MED SCI, V119, P103, DOI 10.3109/03009734.2014.904457; Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899; SOBACK S, 1990, J DAIRY SCI, V73, P661, DOI 10.3168/jds.S0022-0302(90)78717-6; Stockler RM, 2009, J DAIRY SCI, V92, P4262, DOI 10.3168/jds.2008-1916; Tello A, 2012, ENVIRON HEALTH PERSP, V120, P1100, DOI 10.1289/ehp.1104650; Turnipseed SB, 2008, RAPID COMMUN MASS SP, V22, P1467, DOI 10.1002/rcm.3532; TYCZKOWSKA KL, 1991, J VET PHARMACOL THER, V14, P51, DOI 10.1111/j.1365-2885.1991.tb00804.x; USDA/APHIS/VS/CEAH, ANT US US DAIR OP 20; USDA/APHIS/VS/CEAH, 2007, FAC CHAR COW COMF IU; Wagner RD, 2011, ANTIMICROB AGENTS CH, V55, P4990, DOI 10.1128/AAC.00008-11; WELIKY I, 1974, ANTIMICROB AGENTS CH, V5, P49, DOI 10.1128/AAC.5.1.49; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; WIESNER P, 1972, ANTIMICROB AGENTS CH, V1, P303, DOI 10.1128/AAC.1.4.303; Zhou LJ, 2012, J CHROMATOGR A, V1244, P123, DOI 10.1016/j.chroma.2012.04.076; ZIV G, 1976, BRIT VET J, V132, P318, DOI 10.1016/S0007-1935(17)34692-4; ZIV G, 1973, ANTIMICROB AGENTS CH, V3, P607, DOI 10.1128/AAC.3.5.607; ZIV G, 1986, ACS SYM SER, V320, P8, DOI 10.1021/bk-1986-0320.ch002; ZIV G, 1975, J DAIRY SCI, V58, P1637, DOI 10.3168/jds.S0022-0302(75)84762-X; Zonca A, 2011, J DAIRY SCI, V94, P3455, DOI 10.3168/jds.2010-4109	62	24	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112343	10.1371/journal.pone.0112343	http://dx.doi.org/10.1371/journal.pone.0112343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375097	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000344402600133
J	Zheng, X; Zhang, XY; Ding, LL; Lee, JR; Weinberger, PM; Dynan, WS				Zheng, Xuan; Zhang, Xinyan; Ding, Lingling; Lee, Jeffrey R.; Weinberger, Paul M.; Dynan, William S.			Synergistic Effect of High Charge and Energy Particle Radiation and Chronological Age on Biomarkers of Oxidative Stress and Tissue Degeneration: A Ground-Based Study Using the Vertebrate Laboratory Model Organism Oryzias latipes	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; MEDAKA; DAMAGE; EXPOSURE; IRRADIATION; EXPRESSION; MEMORY; CELLS; FISH; RATS	High charge and energy (HZE) particles are a main hazard of the space radiation environment. Uncertainty regarding their health effects is a limiting factor in the design of human exploration-class space missions, that is, missions beyond low earth orbit. Previous work has shown that HZE exposure increases cancer risk and elicits other aging-like phenomena in animal models. Here, we investigate how a single exposure to HZE particle radiation, early in life, influences the subsequent age-dependent evolution of oxidative stress and appearance of degenerative tissue changes. Embryos of the laboratory model organism, Oryzias latipes (Japanese medaka fish), were exposed to HZE particle radiation at doses overlapping the range of anticipated human exposure. A separate cohort was exposed to reference gamma-radiation. Survival was monitored for 750 days, well beyond the median lifespan. The population was also sampled at intervals and liver tissue was subjected to histological and molecular analysis. HZE particle radiation dose and aging contributed synergistically to accumulation of lipid peroxidation products, which are a marker of chronic oxidative stress. This was mirrored by a decline in PPARGC1A mRNA, which encodes a transcriptional co-activator required for expression of oxidative stress defense genes and for mitochondrial maintenance. Consistent with chronic oxidative stress, mitochondria had an elongated and enlarged ultrastructure. Livers also had distinctive, cystic lesions. Depending on the endpoint, effects of gamma-rays in the same dose range were either lesser or not detected. Results provide a quantitative and qualitative framework for understanding relative contributions of HZE particle radiation exposure and aging to chronic oxidative stress and tissue degeneration.	[Zheng, Xuan; Dynan, William S.] Georgia Regents Univ, Dept Neurosci & Regenerat Med, Augusta, GA 30901 USA; [Zheng, Xuan] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Peoples R China; [Zhang, Xinyan] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Ding, Lingling] Wuhan Univ, Sch Med, Dept Anat & Embryol, Wuhan 430072, Peoples R China; [Lee, Jeffrey R.] Georgia Regents Univ, Dept Pathol, Augusta, GA USA; [Weinberger, Paul M.] Georgia Regents Univ, Dept Otolaryngol, Augusta, GA USA; [Weinberger, Paul M.] Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Dynan, William S.] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Dynan, William S.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA	University System of Georgia; Augusta University; Wuhan University; University of Alabama System; University of Alabama Birmingham; Wuhan University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Emory University; Emory University	Dynan, WS (corresponding author), Georgia Regents Univ, Dept Neurosci & Regenerat Med, Augusta, GA 30901 USA.	wdynan@emory.edu	Weinberger, Paul/B-7007-2008; Zhang, Xinyan/AAC-4406-2019	Weinberger, Paul/0000-0002-5885-2631; Zhang, Xinyan/0000-0002-8274-8711; Dynan, William/0000-0002-4045-5662	US Department of Energy Low Dose Radiation Research Program [DE-SC0002343]; National Aeronautics and Space Administration [NNX11AC30G]	US Department of Energy Low Dose Radiation Research Program(United States Department of Energy (DOE)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was supported by the US Department of Energy Low Dose Radiation Research Program, award number DE-SC0002343 to WSD and the National Aeronautics and Space Administration, award number NNX11AC30G to WSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwood JS, 2010, BONE, V47, P248, DOI 10.1016/j.bone.2010.05.004; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Autsavapromporn N, 2011, J RADIAT RES, V52, P408, DOI 10.1269/jrr.10114; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Bielefeldt-Ohmann H, 2012, HEALTH PHYS, V103, P568, DOI 10.1097/HP.0b013e318265a257; Bladen CL, 2005, NUCLEIC ACIDS RES, V33, P3002, DOI 10.1093/nar/gki613; Boorman GA, 1997, TOXICOL PATHOL, V25, P202, DOI 10.1177/019262339702500210; Britten RA, 2012, RADIAT RES, V177, P146, DOI 10.1667/RR2637.1; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Cheema AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087079; Cherry JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053275; Datta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042224; Ding LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013287; EGAMI N, 1973, EXP GERONTOL, V8, P219, DOI 10.1016/0531-5565(73)90029-6; EGAMI N, 1966, RADIAT RES, V27, P630, DOI 10.2307/3571846; EGAMI NOBUO, 1962, ANNOT ZOOL JAPAN, V35, P188; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Gonon G, 2013, RADIAT RES, V179, P444, DOI 10.1667/RR3017.1; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Johri A, 2013, FREE RADICAL BIO MED, V62, P37, DOI 10.1016/j.freeradbiomed.2013.04.016; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Kim GJ, 2006, CANCER RES, V66, P10377, DOI 10.1158/0008-5472.CAN-05-3036; Kuhne WW, 2009, RADIAT RES, V172, P473, DOI 10.1667/RR1556.1; Li M, 2013, ANTIOXID REDOX SIGNA; Limoli CL, 2007, RADIAT ENVIRON BIOPH, V46, P167, DOI 10.1007/s00411-006-0077-9; Limoli CL, 2003, CANCER RES, V63, P3107; Lonart G, 2012, RADIAT RES, V178, P289, DOI 10.1667/RR2862.1; National Research Council, 2008, MAN SPAC RAD RISK NE; Okihiro MS, 1999, CARCINOGENESIS, V20, P933, DOI 10.1093/carcin/20.6.933; Poulose SM, 2011, RADIAT RES, V176, P761, DOI 10.1667/RR2605.1; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Shukitt-Hale B, 2000, RADIAT RES, V154, P28, DOI 10.1667/0033-7587(2000)154[0028:SLAMDI]2.0.CO;2; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sun C, 2014, J CELL PHYSIOL, V229, P100, DOI 10.1002/jcp.24424; Takeda H, 2010, ANNU REV GENET, V44, P217, DOI 10.1146/annurev-genet-051710-151001; Tao RD, 2014, ANTIOXID REDOX SIGN, V20, P1646, DOI 10.1089/ars.2013.5482; Tseng BP, 2013, ANTIOXID REDOX SIGNA; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villasana L, 2010, HIPPOCAMPUS, V20, P19, DOI 10.1002/hipo.20659; Villasana LE, 2013, PHARMACOL BIOCHEM BE, V103, P487, DOI 10.1016/j.pbb.2012.09.021; Weil MM, 2009, RADIAT RES, V172, P213, DOI 10.1667/RR1648.1; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yu T, 2011, RADIAT RES, V175, P766, DOI 10.1667/RR2482.1; Yumoto K, 2010, RADIAT RES, V173, P494, DOI 10.1667/RR1754.1; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989; Zhang ZB, 2007, TOXICOL SCI, V95, P356, DOI 10.1093/toxsci/kfl161	49	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111362	10.1371/journal.pone.0111362	http://dx.doi.org/10.1371/journal.pone.0111362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375139	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600035
J	Rao, RPN; Stocco, A; Bryan, M; Sarma, D; Youngquist, TM; Wu, J; Prat, CS				Rao, Rajesh P. N.; Stocco, Andrea; Bryan, Matthew; Sarma, Devapratim; Youngquist, Tiffany M.; Wu, Joseph; Prat, Chantel S.			A Direct Brain-to-Brain Interface in Humans	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; COMPUTER INTERFACE; MOTOR; BCI	We describe the first direct brain-to-brain interface in humans and present results from experiments involving six different subjects. Our non-invasive interface, demonstrated originally in August 2013, combines electroencephalography (EEG) for recording brain signals with transcranial magnetic stimulation (TMS) for delivering information to the brain. We illustrate our method using a visuomotor task in which two humans must cooperate through direct brain-to-brain communication to achieve a desired goal in a computer game. The brain-to-brain interface detects motor imagery in EEG signals recorded from one subject (the "sender") and transmits this information over the internet to the motor cortex region of a second subject (the "receiver"). This allows the sender to cause a desired motor response in the receiver (a press on a touchpad) via TMS. We quantify the performance of the brain-to-brain interface in terms of the amount of information transmitted as well as the accuracies attained in (1) decoding the sender's signals, (2) generating a motor response from the receiver upon stimulation, and (3) achieving the overall goal in the cooperative visuomotor task. Our results provide evidence for a rudimentary form of direct information transmission from one human brain to another using non-invasive means.	[Rao, Rajesh P. N.; Bryan, Matthew; Wu, Joseph] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Stocco, Andrea; Prat, Chantel S.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Stocco, Andrea; Prat, Chantel S.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Sarma, Devapratim; Youngquist, Tiffany M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rao, RPN (corresponding author), Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA.	rao@cs.washington.edu; stocco@u.washington.edu	Stocco, Andrea/A-2159-2013	Stocco, Andrea/0000-0001-8919-3934; Rao, Rajesh P. N./0000-0003-0682-8952	Army Research Office [W911NF-11-1-0307]	Army Research Office	This study was funded by a grant from the Army Research Office (grant no. W911NF-11-1-0307) to RPNR and by a grant from the W.M. Keck foundation to AS, CSP, and RPNR (http:// www.arl.army.mil/www/default.cfm?page = 181, http://www.wmkeck.org/grant-programs/research/medical-research-grant-abstracts/science-and-engineering-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Blakely T, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0977; BORKO H, 1992, J RES MATH EDUC, V23, P194, DOI 10.2307/749118; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Cover T. M., 1991, ELEMENTS INFORM THEO; Damasio A., 1994, LARGE SCALE NEURONAL, P61; Fabiani GE, 2004, IEEE T NEUR SYS REH, V12, P331, DOI 10.1109/TNSRE.2004.834627; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; HOUSE WF, 1976, ANN OTO RHINOL LARYN, V85, P3, DOI 10.1177/00034894760850S303; MASTERS RSW, 1992, BRIT J PSYCHOL, V83, P343, DOI 10.1111/j.2044-8295.1992.tb02446.x; Mellinger J, 2007, NEUROIMAGE, V36, P581, DOI 10.1016/j.neuroimage.2007.03.019; Min BK, 2010, TRENDS BIOTECHNOL, V28, P552, DOI 10.1016/j.tibtech.2010.08.002; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Pais-Vieira M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01319; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Rao R., 2013, BRAIN COMPUTER INTER; Rao R. P. N., 2013, DIRECT BRAIN TO BRAI; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Yoo SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060410; Yoo SS, 2011, NEUROIMAGE, V56, P1267, DOI 10.1016/j.neuroimage.2011.02.058; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe	26	63	68	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111332	10.1371/journal.pone.0111332	http://dx.doi.org/10.1371/journal.pone.0111332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372285	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900045
J	Stover, J; Hallett, TB; Wu, Z; Warren, M; Gopalappa, C; Pretorius, C; Ghys, PD; Montaner, J; Schwartlander, B				Stover, John; Hallett, Timothy B.; Wu, Zunyou; Warren, Mitchell; Gopalappa, Chaitra; Pretorius, Carel; Ghys, Peter D.; Montaner, Julio; Schwartlander, Bernhard		New Prevention Technology Study Gr	How Can We Get Close to Zero? The Potential Contribution of Biomedical Prevention and the Investment Framework towards an Effective Response to HIV	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; TRANSMISSION; INFECTION	Background: In 2011 an Investment Framework was proposed that described how the scale-up of key HIV interventions could dramatically reduce new HIV infections and deaths in low and middle income countries by 2015. This framework included ambitious coverage goals for prevention and treatment services resulting in a reduction of new HIV infections by more than half. However, it also estimated a leveling in the number of new infections at about 1 million annually after 2015. Methods: We modeled how the response to AIDS can be further expanded by scaling up antiretroviral treatment (ART) within the framework provided by the 2013 WHO treatment guidelines. We further explored the potential contributions of new prevention technologies: 'Test and Treat', pre-exposure prophylaxis and an HIV vaccine. Findings: Immediate aggressive scale up of existing approaches including the 2013 WHO guidelines could reduce new infections by 80%. A 'Test and Treat' approach could further reduce new infections. This could be further enhanced by a future highly effective pre-exposure prophylaxis and an HIV vaccine, so that a combination of all four approaches could reduce new infections to as low as 80,000 per year by 2050 and annual AIDS deaths to 260,000. Interpretation: In a set of ambitious scenarios, we find that immediate implementation of the 2013 WHO antiretroviral therapy guidelines could reduce new HIV infections by 80%. Further reductions may be achieved by moving to a ' Test and Treat' approach, and eventually by adding a highly effective pre-exposure prophylaxis and an HIV vaccine, if they become available.	[Stover, John; Gopalappa, Chaitra; Pretorius, Carel] Futures Inst, Glastonbury, CT 06033 USA; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, London, England; [Wu, Zunyou] China Ctr Dis Control, Beijing, Peoples R China; [Warren, Mitchell] AIDS Vaccine Advocacy AVAC, New York, NY USA; [Montaner, Julio] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Ghys, Peter D.] UNAIDS, United Nations Joint Programme HIV AIDS, Geneva, Switzerland; [Schwartlander, Bernhard] WHO, Beijing, Peoples R China	Imperial College London; Chinese Center for Disease Control & Prevention; B.C. Centre for Excellence in HIV/AIDS; UNAIDS; World Health Organization	Stover, J (corresponding author), Futures Inst, Glastonbury, CT 06033 USA.	JStover@FuturesInstitute.org	Gopalappa, Chaitra/Y-4031-2018	Gopalappa, Chaitra/0000-0001-8384-6041; Hallett, Timothy/0000-0002-9681-0424; Terris-Prestholt, Fern/0000-0003-1693-5196; Grant, Robert/0000-0002-0851-7085; Cremin, Ide/0000-0003-2560-6247	Bill and Melinda Gates Foundation; UNAIDS; American people through the United States Agency for International Development (USAID); Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UNAIDS; American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was sponsored by the Bill and Melinda Gates Foundation, UNAIDS, and the International AIDS Vaccine Initiative (IAVI) by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Staff from UNAIDS, the Bill and Melinda Gates Foundation and IAVI participated in the New Prevention Technology Study Group which contributed to the study design and review of the manuscript.	[Anonymous], 19 C RETR OPP INF SE; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Eaton JW, 2013, LANCET GLOBAL HLTH; Futures Institute, 2011, GOALS MAN MOD EST EF; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hallett TB, 2014, AIDS, V28, pS1, DOI 10.1097/QAD.0000000000000115; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Joint United Nations Programme on HIV/ AIDS, 2012, GLOB REP UNAIDS REP; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Montaner JSG, 2011, LANCET, V378, P208, DOI 10.1016/S0140-6736(11)60821-0; Nosyk B, 2013, AIDS, V27, P1159, DOI 10.1097/QAD.0b013e32835f1d68; Nosyk B, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001174; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stover J, 2007, HEALTH AFFAIR, V26, P1147, DOI 10.1377/hlthaff.26.4.1147; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Vaccine, 2011, VACCINE, V29, P36	25	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111956	10.1371/journal.pone.0111956	http://dx.doi.org/10.1371/journal.pone.0111956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372770	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000344556900095
J	Levy-Apter, E; Finkelshtein, E; Vemulapalli, V; Li, SSC; Bedford, MT; Elson, A				Levy-Apter, Einat; Finkelshtein, Eynat; Vemulapalli, Vidyasiri; Li, Shawn S. -C.; Bedford, Mark T.; Elson, Ari			Adaptor Protein GRB2 Promotes Src Tyrosine Kinase Activation and Podosomal Organization by Protein-tyrosine Phosphatase epsilon in Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR CELLS; PTP-ALPHA; SH3 DOMAINS; IN-VIVO; RECEPTOR; PHOSPHORYLATION; ASSOCIATION; NEU; CYTOSKELETON; ADHESIONS	The non-receptor isoform of protein-tyrosine phosphatase epsilon (cyt-PTPe) supports adhesion of bone-resorbing osteoclasts by activating Src downstream of integrins. Loss of cyt-PTPe reduces Src activity in osteoclasts, reduces resorption of mineralized matrix both in vivo and in cell culture, and induces mild osteopetrosis in young female PTPe KO mice. Activation of Src by cyt-PTPe is dependent upon this phosphatase undergoing phosphorylation at its C-terminal Tyr-638 by partially active Src. To understand how cyt-PTPe activates Src, we screened 73 Src homology 2 (SH2) domains for binding to Tyr(P)-638 of cyt-PTPe. The SH2 domain of GRB2 bound Tyr(P)-638 of cyt-PTPe most prominently, whereas the Src SH2 domain did not bind at all, suggesting that GRB2 may link PTPe with downstream molecules. Further studies indicated that GRB2 is required for activation of Src by cyt-PTPe in osteoclast-like cells (OCLs) in culture. Overexpression of GRB2 in OCLs increased activating phosphorylation of Src at Tyr-416 and of cyt-PTPe at Tyr-638; opposite results were obtained when GRB2 expression was reduced by shRNA or by gene inactivation. Phosphorylation of cyt-PTPe at Tyr-683 and its association with GRB2 are integrin-driven processes in OCLs, and cyt-PTPe undergoes autodephosphorylation at Tyr-683, thus limiting Src activation by integrins. Reduced GRB2 expression also reduced the ability of bone marrow precursors to differentiate into OCLs and reduced the fraction of OCLs in which podosomal adhesion structures assume organization typical of active, resorbing cells. We conclude that GRB2 physically links cyt-PTPe with Src and enables cyt-PTPe to activate Src downstream of activated integrins in OCLs.	[Levy-Apter, Einat; Finkelshtein, Eynat; Elson, Ari] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Vemulapalli, Vidyasiri; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Li, Shawn S. -C.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada; [Li, Shawn S. -C.] Univ Western Ontario, Schulich Sch Med & Dent, Siebens Drake Med Res Inst, London, ON N6A 5C1, Canada	Weizmann Institute of Science; University of Texas System; UTMD Anderson Cancer Center; Western University (University of Western Ontario); Western University (University of Western Ontario)	Elson, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	ari.elson@weizmann.ac.il		Elson, Ari/0000-0001-9808-9135	Israel Science Foundation; Kekst Family Institute for Medical Genetics, Weizmann Institute; David and Fella Shapell Family Center for Genetic Disorders Research, Weizmann Institute; Cancer Prevention Research Institute of Texas Grant [RP130432]; Centre for Environmental and Molecular Carcinogenesis at M. D. Anderson	Israel Science Foundation(Israel Science Foundation); Kekst Family Institute for Medical Genetics, Weizmann Institute; David and Fella Shapell Family Center for Genetic Disorders Research, Weizmann Institute; Cancer Prevention Research Institute of Texas Grant; Centre for Environmental and Molecular Carcinogenesis at M. D. Anderson	This work was supported by the Israel Science Foundation and by the Kekst Family Institute for Medical Genetics and the David and Fella Shapell Family Center for Genetic Disorders Research, both of the Weizmann Institute (to A. E.).; Directs the Protein Array Core, which is supported by Cancer Prevention Research Institute of Texas Grant RP130432 and by the Centre for Environmental and Molecular Carcinogenesis at M. D. Anderson.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Berman-Golan D, 2007, ONCOGENE, V26, P7028, DOI 10.1038/sj.onc.1210505; Bisson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050996; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Cheng SYS, 2014, MOL CELL BIOL, V34, P348, DOI 10.1128/MCB.00825-13; Chiusaroli R, 2004, MOL BIOL CELL, V15, P234, DOI 10.1091/mbc.e03-04-0207; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; denHertog J, 1996, EMBO J, V15, P3016, DOI 10.1002/j.1460-2075.1996.tb00665.x; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Finkelshtein E, 2014, MOL BIOL CELL, V25, P1808, DOI 10.1091/mbc.E14-03-0788; Georgess D, 2014, CELL ADHES MIGR, V8, P192, DOI 10.4161/cam.27840; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Granot-Attas S, 2009, MOL BIOL CELL, V20, P4324, DOI 10.1091/mbc.E08-11-1158; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Rousso-Noori L, 2011, CELL METAB, V13, P562, DOI 10.1016/j.cmet.2011.02.017; Sines T, 2007, MOL CELL BIOL, V27, P7102, DOI 10.1128/MCB.02096-06; SU J, 1994, J BIOL CHEM, V269, P18731; Sun GB, 2012, MOL CELL BIOL, V32, P3776, DOI 10.1128/MCB.00214-12; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Toledano-Katchalski H, 1999, ONCOGENE, V18, P5024, DOI 10.1038/sj.onc.1202883; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037	36	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36048	36058		10.1074/jbc.M114.603548	http://dx.doi.org/10.1074/jbc.M114.603548			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25381250	hybrid, Green Published			2022-12-26	WOS:000346897900033
J	Miszta, A; Pelkmans, L; Lindhout, T; Krishnamoorthy, G; de Groot, PG; Hemker, CH; Heemskerk, JWM; Kelchtermans, H; de Laat, B				Miszta, Adam; Pelkmans, Leonie; Lindhout, Theo; Krishnamoorthy, Ganeshram; de Groot, Philip G.; Hemker, Coenraad H.; Heemskerk, Johan W. M.; Kelchtermans, Hilde; de Laat, Bas			Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ADHESION; VONWILLEBRAND-FACTOR; POLYMERIZING FIBRIN; FACTOR-XIII; SHEAR; ELLIPSOMETRY; ACTIVATION; DOMAIN; BLOOD; AGGREGATION	Attachment of platelets from the circulation onto a growing thrombus is a process involving multiple platelet receptors, endothelial matrix components, and coagulation factors. It has been indicated previously that during a transglutaminase reaction activated factor XIII (FXIIIa) covalently cross-links von Willebrand factor (VWF) to polymerizing fibrin. Bound VWF further recruits and activates platelets via interactions with the platelet receptor complex glycoprotein Ib (GPIb). In the present study we found proof for binding of VWF to a fibrin monomer layer during the process of fibrinogen-to-fibrin conversion in the presence of thrombin, arvin, or a snake venom from Crotalus atrox. Using a domain deletion mutant we demonstrated the involvement of the C domains of VWF in this binding. Substantial binding of VWF to fibrin monomers persisted in the presence of the FXIIIa inhibitor K9-DON, illustrating that cross-linking via factor XIII is not essential for this phenomenon and suggesting the identification of a second mechanism through which VWF multimers incorporate into a fibrin network. Under high shear conditions, platelets were shown to adhere to fibrin only if VWF had been incorporated. In conclusion, our experiments show that the C domains of VWF and the E domain of fibrin monomers are involved in the incorporation of VWF during the polymerization of fibrin and that this incorporation fosters binding and activation of platelets. Fibrin thus is not an inert end product but partakes in further thrombus growth. Our findings help to elucidate the mechanism of thrombus growth and platelet adhesion under conditions of arterial shear rate.	[Miszta, Adam; Pelkmans, Leonie; Lindhout, Theo; Krishnamoorthy, Ganeshram; Hemker, Coenraad H.; Heemskerk, Johan W. M.; Kelchtermans, Hilde; de Laat, Bas] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6229 EV Maastricht, Netherlands; [Miszta, Adam; Pelkmans, Leonie; Lindhout, Theo; Hemker, Coenraad H.; Kelchtermans, Hilde; de Laat, Bas] Synapse BV, NL-6229 EV Maastricht, Netherlands; [de Groot, Philip G.] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands	Maastricht University; Utrecht University; Utrecht University Medical Center	Miszta, A (corresponding author), Synapse BV, Oxfordlaan 70, NL-6229 EV Maastricht, Netherlands.	adam.miszta@thrombin.com	Miszta, Adam/M-6183-2013; Heemskerk, Johan/AAM-8323-2021; Miszta, Adam/K-3545-2019	Heemskerk, Johan/0000-0002-2848-5121; Hemker, Coen/0000-0003-1669-2358; Kelchtermans, Hilde/0000-0002-2724-3438	Netherlands Heart Foundation Project [2006T5301]	Netherlands Heart Foundation Project	This work was supported by The Netherlands Heart Foundation Project 2006T5301.	Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; BAILEY K, 1951, NATURE, V167, P233, DOI 10.1038/167233a0; Beguin S, 2004, J THROMB HAEMOST, V2, P170, DOI 10.1111/j.1538-7836.2004.00558.x; Beguin S, 1999, BLOOD, V93, P564, DOI 10.1182/blood.V93.2.564; Benes M, 2004, LANGMUIR, V20, P10129, DOI 10.1021/la048811u; BUNCE LA, 1992, J CLIN INVEST, V89, P842, DOI 10.1172/JCI115663; CHURCH FC, 1986, ANAL BIOCHEM, V157, P77, DOI 10.1016/0003-2697(86)90198-3; COLLER BS, 1995, THROMB HAEMOSTASIS, V74, P302; Cosemans JMEM, 2011, BLOOD, V117, P651, DOI 10.1182/blood-2010-01-262683; CUYPERS PA, 1983, J BIOL CHEM, V258, P2426; CUYPERS PA, 1978, ANAL BIOCHEM, V84, P56, DOI 10.1016/0003-2697(78)90483-9; ENDENBURG SC, 1995, BLOOD, V86, P4158, DOI 10.1182/blood.V86.11.4158.bloodjournal86114158; HADA M, 1986, BLOOD, V68, P95; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Keuren JFW, 2004, BLOOD, V103, P1741, DOI 10.1182/blood-2003-07-2267; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; La Corte ALC, 2011, ADV PROTEIN CHEM STR, V83, P75, DOI 10.1016/B978-0-12-381262-9.00003-3; LOSCALZO J, 1986, J CLIN INVEST, V78, P1112, DOI 10.1172/JCI112668; Machan R, 2010, CHEM PHYS LIPIDS, V163, P200, DOI 10.1016/j.chemphyslip.2009.11.005; Matlung HL, 2010, ATHEROSCLEROSIS, V213, P77, DOI 10.1016/j.atherosclerosis.2010.07.054; Miszta A, 2008, J PEPT SCI, V14, P503, DOI 10.1002/psc.938; NIEWIAROWSKI S, 1972, J CLIN INVEST, V51, P685, DOI 10.1172/JCI106857; RIBES JA, 1987, J CLIN INVEST, V79, P117, DOI 10.1172/JCI112771; RIBES JA, 1990, BLOOD, V75, P1460; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Sabo TM, 2007, BIOCHEMISTRY-US, V46, P10089, DOI 10.1021/bi700579z; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Smith EL, 2013, J THROMB HAEMOST, V11, P993, DOI 10.1111/jth.12174; TURITTO VT, 1984, J CLIN INVEST, V74, P1730, DOI 10.1172/JCI111591; Van Kruchten R, 2012, PLATELETS, V23, P229, DOI 10.3109/09537104.2011.630848; Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639; WEISEL JW, 1986, BIOPHYS J, V50, P1079, DOI 10.1016/S0006-3495(86)83552-4; Zhou YF, 2014, BLOOD, V123, P1785, DOI 10.1182/blood-2013-11-523639; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	36	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35979	35986		10.1074/jbc.M114.591677	http://dx.doi.org/10.1074/jbc.M114.591677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25381443	hybrid, Green Published			2022-12-26	WOS:000346897900028
J	Myong, JP; Kim, HR; Jang, TW; Lee, HE; Koo, JW				Myong, Jun-Pyo; Kim, Hyoung-Ryoul; Jang, Tae-Won; Lee, Hye Eun; Koo, Jung-Wan			Association between Blood Cadmium Levels and 10-Year Coronary Heart Disease Risk in the General Korean Population: The Korean National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							LIPID-PEROXIDATION; URINARY COTININE; METALS; HYPERTENSION; EXPOSURE	Background: Non-occupational heavy metals are considered risk factors for coronary heart disease (CHD). Several recent epidemiologic studies have evaluated the relationship between non-occupational cadmium exposure and risk factors for cardiovascular disease (CVD). This study was designed to investigate the relationship between non-occupational cadmium exposure and risk factors for CHD using the Framingham estimate of 10 year CHD risk. Methods: The heavy metal dataset of the Korean National Health and Nutrition Examination Survey for 2008 through 2010, a cross-sectional survey of a representative sample of 4,668 non-institutionalized Koreans, was analyzed. Subjects were stratified into seven age groups to minimize the effects of age. The log-transformed blood cadmium concentrations were compared with the Framingham estimate of 10 year CHD risk in each age stratum. Results: The Framingham estimate of 10 year CHD risk was significantly associated with the log-transformed blood cadmium concentrations (p<0.05) in all age groups of Korean men, with the lowest regression coefficient (0.254) for men aged 20 to <35 years and the highest (3.354) for men aged 55 to <60 years; similar results, however, were not observed in Korean women. After adjusting for survey year, age, and urinary cotinine concentration, the log-transformed blood cadmium levels among men aged 20 to <35, 40 to <45, 50 to <55, and 60 to <65 years were significantly associated with systolic blood pressure (p<0.05), but not with total and high density lipoprotein (HDL) cholesterol concentrations. Conclusions: Cadmium exposure, even at non-occupational levels, may be associated with CHD risk in men. Despite the declines in non-occupational cadmium exposure over the past several decades, more efforts are needed.	[Myong, Jun-Pyo; Kim, Hyoung-Ryoul; Jang, Tae-Won; Lee, Hye Eun; Koo, Jung-Wan] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Myong, Jun-Pyo; Kim, Hyoung-Ryoul; Jang, Tae-Won; Lee, Hye Eun; Koo, Jung-Wan] Catholic Univ Korea, Seoul St Marys Hosp, Ctr Occupat & Environm Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Jang, TW (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Occupat & Environm Med, Seoul, South Korea.	om1024@hanmail.net	Lee, Hye Eun/AAE-6317-2022; Myong, Jun-Pyo/M-7351-2019	Lee, Hye Eun/0000-0003-4648-5042; Myong, Jun-Pyo/0000-0001-8674-1034				Ademuyiwa O, 2009, CHEM-BIOL INTERACT, V179, P314, DOI 10.1016/j.cbi.2008.10.057; Alissa EM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/870125; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Eum KD, 2008, SCI TOTAL ENVIRON, V407, P147, DOI 10.1016/j.scitotenv.2008.08.037; Everett CJ, 2008, ENVIRON RES, V106, P284, DOI 10.1016/j.envres.2007.10.009; Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002, 3 REP EXP PAN DET EV; Haufroid V, 1998, INT ARCH OCC ENV HEA, V71, P162, DOI 10.1007/s004200050266; Houston MC, 2007, ALTERN THER HEALTH M, V13, P128; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jung-Choi KH, 2012, TOB CONTROL, V21, P536, DOI 10.1136/tobaccocontrol-2011-050012; Kim KY, 2014, INT J TUBERC LUNG D, V18, P622, DOI 10.5588/ijtld.13.0677; Korea Center for Disease Control and Prevention, 2011, KOREA NAT HLTH NUTR; Lee MS, 2011, ENVIRON RES, V111, P171, DOI 10.1016/j.envres.2010.10.006; Mudipalli A, 2007, INDIAN J MED RES, V126, P518; National Statistical Information Service, 2012, MAJ CAUS DEATH KOR 2; Navas-Acien A, 2005, ENVIRON HEALTH PERSP, V113, P164, DOI 10.1289/ehp.7329; Nordberg GF, 2007, HDB TOXICOLOGY METAL, P444; Olsen L, 2012, INT J HYG ENVIR HEAL, V215, P411, DOI 10.1016/j.ijheh.2011.11.004; SARKAR S, 1995, J TRACE ELEM MED BIO, V9, P144, DOI 10.1016/S0946-672X(11)80038-6; Satarug S, 2005, TOXICOL LETT, V157, P57, DOI 10.1016/j.toxlet.2005.01.004; Sogawa N, 2001, PHARMACOL RES, V44, P53, DOI 10.1006/phrs.2001.0833; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Tellez-Plaza M, 2008, ENVIRON HEALTH PERSP, V116, P51, DOI 10.1289/ehp.10764; Tellez-Plaza M, 2012, ENVIRON HEALTH PERSP, V120, P204, DOI 10.1289/ehp.1104020; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Varoni MV, 2003, VET RES COMMUN, V27, P807, DOI 10.1023/B:VERC.0000014277.06785.6f; Yiin SJ, 1999, J TOXICOL ENV HEAL A, V57, P403, DOI 10.1080/009841099157601	28	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111909	10.1371/journal.pone.0111909	http://dx.doi.org/10.1371/journal.pone.0111909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383551	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700024
J	Papazachariadis, O; Dante, V; Verschure, PFMJ; Del Giudice, P; Ferraina, S				Papazachariadis, Odysseas; Dante, Vittorio; Verschure, Paul F. M. J.; Del Giudice, Paolo; Ferraina, Stefano			iTBS-Induced LTP-Like Plasticity Parallels Oscillatory Activity Changes in the Primary Sensory and Motor Areas of Macaque Monkeys	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SOMATOSENSORY-EVOKED POTENTIALS; THETA-BURST STIMULATION; LOCAL-FIELD POTENTIALS; MEDIAN NERVE; CORTEX; GAMMA; SYNCHRONIZATION; FREQUENCY; EEG	Recently, neuromodulation techniques based on the use of repetitive transcranial magnetic stimulation (rTMS) have been proposed as a non-invasive and efficient method to induce in vivo long-term potentiation (LTP)-like aftereffects. However, the exact impact of rTMS-induced perturbations on the dynamics of neuronal population activity is not well understood. Here, in two monkeys, we examine changes in the oscillatory activity of the sensorimotor cortex following an intermittent theta burst stimulation (iTBS) protocol. We first probed iTBS modulatory effects by testing the iTBS-induced facilitation of somatosensory evoked potentials (SEP). Then, we examined the frequency information of the electrocorticographic signal, obtained using a custom-made miniaturised multi-electrode array for electrocorticography, after real or sham iTBS. We observed that iTBS induced facilitation of SEPs and influenced spectral components of the signal, in both animals. The latter effect was more prominent on the theta band (4-8 Hz) and the high gamma band (55-90 Hz), de-potentiated and potentiated respectively. We additionally found that the multi-electrode array uniformity of beta (13-26 Hz) and high gamma bands were also afflicted by iTBS. Our study suggests that enhanced cortical excitability promoted by iTBS parallels a dynamic reorganisation of the interested neural network. The effect in the gamma band suggests a transient local modulation, possibly at the level of synaptic strength in interneurons. The effect in the theta band suggests the disruption of temporal coordination on larger spatial scales.	[Papazachariadis, Odysseas; Ferraina, Stefano] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy; [Dante, Vittorio; Del Giudice, Paolo] Ist Super Sanita, I-00161 Rome, Italy; [Verschure, Paul F. M. J.] ICREA Univ Pompeu Fabra, Ctr Autonomous Syst & Neurorobot, Lab Synthet Percept Emot & Cognit Syst, Barcelona, Spain; [Del Giudice, Paolo] Ist Nazl Fis Nucl, Rome, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); ICREA; Pompeu Fabra University; Istituto Nazionale di Fisica Nucleare (INFN)	Papazachariadis, O (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	odysseas.papazachariadis@gmail.com	Dante, Vittorio/E-3730-2015; ferraina, stefano/M-5230-2018; Del Giudice, Paolo/N-4655-2015; Verschure, Paul/AAR-2340-2021	ferraina, stefano/0000-0001-6100-2438; Del Giudice, Paolo/0000-0002-5633-8241; Verschure, Paul/0000-0003-3643-9544	Sapienza University in Neurophysiology; ISS-USA project "Brain reorganization under cortical stimulation - BRUCOS''; ICREA Funding Source: Custom	Sapienza University in Neurophysiology; ISS-USA project "Brain reorganization under cortical stimulation - BRUCOS''; ICREA(ICREA)	OP was supported by a doctoral fellowship of the Sapienza University in Neurophysiology. PDG, SF and VD were supported by the ISS-USA project "Brain reorganization under cortical stimulation - BRUCOS''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OJ, 2012, J NEUROSCI, V32, P7373, DOI 10.1523/JNEUROSCI.5110-11.2012; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; ALLISON T, 1991, BRAIN, V114, P2465, DOI 10.1093/brain/114.6.2465; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Bae EH, 2007, EPILEPSY BEHAV, V10, P521, DOI 10.1016/j.yebeh.2007.03.004; Buia CI, 2008, J NEUROPHYSIOL, V99, P2158, DOI 10.1152/jn.01004.2007; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; BUZSAKI G, 1991, EUR J NEUROSCI, V3, P222, DOI 10.1111/j.1460-9568.1991.tb00083.x; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Casali AG, 2010, NEUROIMAGE, V49, P1459, DOI 10.1016/j.neuroimage.2009.09.026; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fuggetta G, 2005, NEUROIMAGE, V27, P896, DOI 10.1016/j.neuroimage.2005.05.013; GEVINS A, 1994, ELECTROEN CLIN NEURO, V92, P282, DOI 10.1016/0168-5597(94)90096-5; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Huerta PT, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-7; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Izaki Y, 2008, EXP BRAIN RES, V184, P249, DOI 10.1007/s00221-007-1098-6; Kaas JH, 2004, ANAT REC PART A, V281A, P1148, DOI 10.1002/ar.a.20120; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Katayama T, 2007, CLIN NEUROPHYSIOL, V118, P2506, DOI 10.1016/j.clinph.2007.08.011; Katayama T, 2010, CLIN NEUROPHYSIOL, V121, P2097, DOI 10.1016/j.clinph.2010.05.014; Komssi S, 2006, BRAIN RES REV, V52, P183, DOI 10.1016/j.brainresrev.2006.01.008; Kozel FA, 2000, J NEUROPSYCH CLIN N, V12, P376, DOI 10.1176/appi.neuropsych.12.3.376; McAllister SM, 2011, EUR J NEUROSCI, V33, P1916, DOI 10.1111/j.1460-9568.2011.07673.x; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Nasrallah FA, 2014, NEUROIMAGE, V84, P27, DOI 10.1016/j.neuroimage.2013.08.004; Noh NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035080; Oberman L, 2011, J CLIN NEUROPHYSIOL, V28, P67, DOI 10.1097/WNP.0b013e318205135f; Papazachariadis O, 2013, NEUROSCI LETT, V550, P184, DOI 10.1016/j.neulet.2013.06.024; Paus T, 2001, J NEUROPHYSIOL, V86, P1983, DOI 10.1152/jn.2001.86.4.1983; PFURTSCHELLER G, 1975, ELECTROEN CLIN NEURO, V38, P93, DOI 10.1016/0013-4694(75)90215-1; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Saglam M, 2008, CLIN NEUROPHYSIOL, V119, P2829, DOI 10.1016/j.clinph.2008.09.004; Siebner HR, 2010, J PHYSIOL-LONDON, V588, P4851, DOI 10.1113/jphysiol.2010.200857; Sinclair MD, 2003, CAN VET J, V44, P885; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; van Elswijk G, 2010, J NEUROSCI, V30, P4481, DOI 10.1523/JNEUROSCI.2794-09.2010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang XJ, 1996, J NEUROSCI, V16, P6402	53	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112504	10.1371/journal.pone.0112504	http://dx.doi.org/10.1371/journal.pone.0112504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383621	gold, Green Submitted, Green Published			2022-12-26	WOS:000344816700070
J	Poh, YP; Domingues, VS; Hoekstra, HE; Jensen, JD				Poh, Yu-Ping; Domingues, Vera S.; Hoekstra, Hopi E.; Jensen, Jeffrey D.			On the Prospect of Identifying Adaptive Loci in Recently Bottlenecked Populations	PLOS ONE			English	Article							POSITIVE SELECTION; GENOMIC SCANS; HITCHHIKING; EVOLUTION; MOUSE; DOMESTICATION; ADAPTATION; FOOTPRINTS; MUTATIONS; SIGNATURE	Identifying adaptively important loci in recently bottlenecked populations - be it natural selection acting on a population following the colonization of novel habitats in the wild, or artificial selection during the domestication of a breed - remains a major challenge. Here we report the results of a simulation study examining the performance of available population-genetic tools for identifying genomic regions under selection. To illustrate our findings, we examined the interplay between selection and demography in two species of Peromyscus mice, for which we have independent evidence of selection acting on phenotype as well as functional evidence identifying the underlying genotype. With this unusual information, we tested whether population-genetic-based approaches could have been utilized to identify the adaptive locus. Contrary to published claims, we conclude that the use of the background site frequency spectrum as a null model is largely ineffective in bottlenecked populations. Results are quantified both for site frequency spectrum and linkage disequilibrium-based predictions, and are found to hold true across a large parameter space that encompasses many species and populations currently under study. These results suggest that the genomic footprint left by selection on both new and standing variation in strongly bottlenecked populations will be difficult, if not impossible, to find using current approaches.	[Poh, Yu-Ping; Jensen, Jeffrey D.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Poh, Yu-Ping; Domingues, Vera S.; Hoekstra, Hopi E.] Harvard Univ, Howard Hughes Med Inst, Dept Organism & Evolutionary Biol, Dept Mol & Cellular Biol,Museum Comparat Zool, Cambridge, MA 02138 USA; [Jensen, Jeffrey D.] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Poh, Yu-Ping; Jensen, Jeffrey D.] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Howard Hughes Medical Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Poh, YP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA.	elfinpoh@gmail.com	Hoekstra, Hopi E/I-6690-2012; Jensen, Jeffrey/S-1084-2016	Hoekstra, Hopi E/0000-0003-1431-1769; Jensen, Jeffrey/0000-0002-4786-8064	Swiss National Science Foundation; European Research Council (ERC); Howard Hughes Medical Institute	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The work was funded by grants from the Swiss National Science Foundation and a European Research Council (ERC) Starting Grant to JDJ. Work in the Hoekstra Lab is funded by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbrandt T.S., 1980, GEOL SURV PROF PAPER, V1120, P1; Barton NH, 1996, PHILOS T R SOC B, V351, P785, DOI 10.1098/rstb.1996.0073; Barton NH, 1998, GENET RES, V72, P123, DOI 10.1017/S0016672398003462; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Boyko AR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-216; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Chavez-Galarza J, 2013, MOL ECOL, V22, P5890, DOI 10.1111/mec.12537; Crisci Jessica L., 2013, Frontiers in Genetics, V4, P235, DOI 10.3389/fgene.2013.00235; Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Domingues VS, 2012, EVOLUTION, V66, P3209, DOI 10.1111/j.1558-5646.2012.01669.x; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; KAPLAN NL, 1989, GENETICS, V123, P887; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; McNeil FS, 1950, US GEOL SURVEY, V221, P59; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Mullen LM, 2009, P ROY SOC B-BIOL SCI, V276, P3809, DOI 10.1098/rspb.2009.1146; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Ocana-Macchi M, 2012, VIROLOGY, V427, P1, DOI 10.1016/j.virol.2012.01.037; Pavlidis P, 2010, GENETICS, V185, P907, DOI 10.1534/genetics.110.116459; Przeworski M, 2002, GENETICS, V160, P1179; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stephan W, 2006, GENETICS, V172, P2647, DOI 10.1534/genetics.105.050179; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Thornton KR, 2007, GENETICS, V175, P737, DOI 10.1534/genetics.106.064642; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; Tsumura Y, 2012, HEREDITY, V109, P349, DOI 10.1038/hdy.2012.50; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Yoder JB, 2014, GENETICS, V196, P1263, DOI 10.1534/genetics.113.159319	47	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110579	10.1371/journal.pone.0110579	http://dx.doi.org/10.1371/journal.pone.0110579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383711	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700008
J	Chakhaia, T; Magee, MJ; Kempker, RR; Gegia, M; Goginashvili, L; Nanava, U; Blumberg, HM				Chakhaia, Tsira; Magee, Matthew J.; Kempker, Russell R.; Gegia, Medea; Goginashvili, Leila; Nanava, Ucha; Blumberg, Henry M.			High Utility of Contact Investigation for Latent and Active Tuberculosis Case Detection among the Contacts: A Retrospective Cohort Study in Tbilisi, Georgia, 2010-2011	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; PREVALENCE; INFECTION	Setting: The study was conducted at the National Center for Tuberculosis and Lung Diseases (NCTBLD) in Tbilisi, Georgia. Objective: To assess the utility of contact investigation for tuberculosis (TB) case detection. We also assessed the prevalence and risk factors for active TB disease and latent TB infection (LTBI) among contacts of active pulmonary TB cases. Design: A retrospective cohort study was conducted among the contacts of active pulmonary TB cases registered in 20102011 at the NCTBLD in Tbilisi, Georgia. Contacts of active TB patients were investigated according to an "invitation model": they were referred to the NCTBLD by the index case; were queried about clinical symptoms suggestive of active TB disease; tuberculin skin testing and chest radiographs were performed. Demographic, laboratory, and clinical data of TB patients and their contacts were abstracted from existing records up to February 2013. Results: 869 contacts of 396 index cases were enrolled in the study; a median of 2 contacts were referred per index case. Among the 869 contacts, 47 (5.4%) were found to have or developed active TB disease: 30 (63.8%) were diagnosed with TB during the baseline period (co-prevalent cases) and 17 (36.2%) developed active TB disease during the follow-up period (mean follow up of 21 months) (incident TB cases). The incidence rate of active TB disease among contacts was 1126.0 per 100 000 person years (95% CI 655.7-1802.0 per 100,000 person-years). Among the 402 contacts who had a tuberculin skin test (TST) performed, 52.7% (95% CI 47.7-57.7%) had LTBI. Conclusions: A high prevalence of LTBI and active TB disease was found among the contacts of TB cases in Tbilisi, Georgia. Our findings demonstrated that an "invitation" model of contact investigation was an effective method of case detection. Therefore, contact investigation should be scaled up in Georgia.	[Chakhaia, Tsira; Gegia, Medea] Univ Res Co, LLC Branch Georgia, USAID Georgia TB Prevent Project, Tbilisi, Georgia; [Magee, Matthew J.] Georgia State Univ, Sch Publ Hlth, Div Epidemiol & Biostat, Atlanta, GA 30303 USA; [Magee, Matthew J.; Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Magee, Matthew J.; Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Kempker, Russell R.; Blumberg, Henry M.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Goginashvili, Leila; Nanava, Ucha] Natl Ctr TB & Lung Dis, Tbilisi, Georgia	University System of Georgia; Georgia State University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University	Chakhaia, T (corresponding author), Univ Res Co, LLC Branch Georgia, USAID Georgia TB Prevent Project, Tbilisi, Georgia.	tschakhaia@gmail.com	Blumberg, Henry/W-2156-2019; Magee, Matthew/W-1169-2019; Trajman, Anete/C-7679-2016	Blumberg, Henry/0000-0002-3110-2443; Trajman, Anete/0000-0002-4000-4984	National Institutes of Health (NIH) Fogarty International Center [D43TW007124]; NIH NIAID [K23AI103044]; Atlanta Clinical and Translational Science Institute (NIH/NCATS ) [UL1TR000454]; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI103044] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Atlanta Clinical and Translational Science Institute (NIH/NCATS ); Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) (http://nih.gov/) Fogarty International Center (D43TW007124), NIH NIAID (K23AI103044), the Atlanta Clinical and Translational Science Institute (NIH/NCATS UL1TR000454), and the Emory Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arnadottir T., 2009, TUBERCULOSIS PUBLIC; Becerra MC, 2005, PUBLIC HEALTH REP, V120, P271, DOI 10.1177/003335490512000309; Centers for Disease Control and Prevention, 2013, LAT TUB INF GUID PRI; Drobniewski FA, 2006, EUR RESPIR J, V28, P903, DOI 10.1183/09031936.06.00084906; Dye C, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P289; Fair E, 2013, 44 UN WORLD C LUNG H; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Gegia M, 2012, INT J TUBERC LUNG D, V16, P812, DOI 10.5588/ijtld.11.0637; Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X; Ling DL, 2011, INT J TUBERC LUNG D, V15, P50; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Martin DO, 1996, EPIDEMIOLOGY, V7, P29, DOI 10.1097/00001648-199601000-00006; Mdivani N, 2008, INT J INFECT DIS, V12, P635, DOI 10.1016/j.ijid.2008.03.012; Mirtskhulava V WJ, 2012, LATENT TUBERCULOSIS, pS237; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Rieder HL, 2003, INT J TUBERC LUNG D, V7, pS333; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CAR IS; Weinstock DM, 2001, INT J TUBERC LUNG D, V5, P164; Whitaker JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058202; World Health Organization, 2013, EUROSURVEILLANCE, V18, P20455; World Health Organization, 2012, REC INV CONT PERS IN; World Health Organization, 2013, GLOB TUB REP 2013 IR; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033	26	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111773	10.1371/journal.pone.0111773	http://dx.doi.org/10.1371/journal.pone.0111773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379809	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100040
J	Hamdi, NM; Al-Hababi, FH; Eid, AE				Hamdi, Nuha Mahmoud; Al-Hababi, Fadel Hassan; Eid, Amr Ekhlas			HLA Class I and Class II Associations with ESRD in Saudi Arabian Population	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; JAPANESE PATIENTS; POLYMORPHISM; TRANSPLANTATION; PROGRESSION; HAPLOTYPES; FAMILY; REGION; TUMOR	Background: Chronic renal failure (CRF) leads in the majority of instances to end stage renal disease (ESRD) requiring renal replacement therapy. Our interest was to evaluate the possible associations of HLA class I and class II antigens with ESRD independent of other factors, in Saudi Arabia population. Methodology: A retrospective study to determine the HLA class I and class II polymorphisms and their association with ESRD, was performed on 350 patients with ESRD, and 105 healthy unrelated control. Patients and control groups were typed by SSOP lumenix techniques. The alleles positively associated to the ESRD were: HLA-B*15, B*18, B*49 - DRB1*03, negatively associated alleles were A*26, HLA-B*39, B*50. The haplotypes positively associated with ESRD were: HLA-A*01-DRB1*13 and HLA-A*30-DRBI*03. The negatively associated haplotypes were: HLA-A*02-B*39, A*02-B*50, A*24-B*35, A*24-B*58, A*24-DRB1*16, A*68-DRB1*04, A*02-DQB1*03, A*29-DQB1*02, A*29-DOB1*05 and B*27-DRB1*07 and the last one is the most significant protective haplotypes. Conclusion: The high Relative Risk (RR) observed and its statistical correlation reflect the strength of the described association between HLA antigens and ESRD.	[Hamdi, Nuha Mahmoud] King Saud Med Complex, Riyadh Reg Lab, Dept Immunol, Riyadh, Saudi Arabia; [Al-Hababi, Fadel Hassan] King Saud Med Complex, Riyadh Reg Lab, Dept Virol, Riyadh, Saudi Arabia; [Eid, Amr Ekhlas] King Saud Med Complex, Riyadh Med Complex, Dept Nephrol, Riyadh, Saudi Arabia		Al-Hababi, FH (corresponding author), King Saud Med Complex, Riyadh Reg Lab, Dept Virol, Riyadh, Saudi Arabia.	fadelhh@hotmail.com			King Saud Medical City	King Saud Medical City	King Saud Medical City's funding division has supported lab technicians and staff nurses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghighi M, 2009, IRAN J KIDNEY DIS, V3, P192; Al-Nozha MM, 2005, SAUDI MED J, V26, P824; Al-Sayyari AA, 2011, SAUDI MED J, V32, P339; Almogren A, 2012, BRIT J BIOMED SCI, V69, P159, DOI 10.1080/09674845.2012.12069145; Alsuwaida AO, 2010, SAUDI J KIDNEY DIS T, V21, P1066; Barocci S, 2004, EUR J IMMUNOGENET, V31, P115, DOI 10.1111/j.1365-2370.2004.00460.x; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Bloudickova S, 2011, FOLIA BIOL-PRAGUE, V57, P30; Braunwald E., 2001, HARRISONS PRINCIPLES; Crispim JC, 2008, TRANSPL P, V40, P1333, DOI 10.1016/j.transproceed.2008.02.086; Dafalla AM, 2011, SAUDI J KIDNEY DIS T, V22, P834; Davood P.P., 2008, RES J BIOL SCI, V3, P1344; El-Gezawy Ebtesam M, 2011, Egypt J Immunol, V18, P13; Federation ID, 2010, LAT DIAB FIG PAINT G; Fudenberg HH, 1984, BASIC IMMUNOGENETICS; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Hassanien Amal A, 2012, JRSM Short Rep, V3, P38, DOI 10.1258/shorts.2012.011150; Karahan GE, 2010, RENAL FAILURE, V32, P380, DOI 10.3109/08860221003615803; Kitagawa W, 2008, NEPHROL DIAL TRANSPL, V23, P3126, DOI 10.1093/ndt/gfn179; LAYRISSE Z, 1983, HUM IMMUNOL, V7, P177, DOI 10.1016/S0198-8859(83)80005-6; Ma ZJ, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/452537; McClellan W, 2007, J AM SOC NEPHROL, V18, P1344, DOI 10.1681/ASN.2006090952; Modi GK, 2006, KIDNEY INT, V70, P2131; MONOS DS, 1995, HUM IMMUNOL, V44, P70, DOI 10.1016/0198-8859(95)00060-H; Ng SW, 2011, OBES REV, V12, P1, DOI 10.1111/j.1467-789X.2010.00750.x; Obrador GT, 2008, EPIDEMIOLOGY CHRONIC; OGAHARA S, 1992, KIDNEY INT, V41, P175, DOI 10.1038/ki.1992.24; QUNIBI W, 1988, AM J MED, V84, P225, DOI 10.1016/0002-9343(88)90418-4; Ranganath P, 2009, TISSUE ANTIGENS, V74, P147, DOI 10.1111/j.1399-0039.2009.01276.x; Sanchez-Velasco P, 2001, HUM IMMUNOL, V62, P901, DOI 10.1016/S0198-8859(01)00289-0; Sergio Rivera P, 2012, J IMMUNOLOGIA, V31, P37, DOI DOI 10.1016/J.INMUNO.2011.12.001; Shaheen Noha FT, 2013, WORLD C NEPHR 2013 H; Shiina T, 2004, TISSUE ANTIGENS, V64, P631, DOI 10.1111/j.1399-0039.2004.00327.x; Stanevicha V, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2216; Tampe B, 2014, NEPHROL DIAL TRANSPL, V29, P72, DOI 10.1093/ndt/gft025; The Saudi Center for Organ Transplantation (SCOT), 2012, ANN REP SAUD CTR ORG; U.S. Renal Data System, 2008, USRDS ANN DAT REP AT; VAUGHAN RW, 1995, EUR J IMMUNOGENET, V22, P179, DOI 10.1111/j.1744-313X.1995.tb00228.x	38	18	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111403	10.1371/journal.pone.0111403	http://dx.doi.org/10.1371/journal.pone.0111403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380295	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100027
J	Hugosson, F; Sjogren, C; Birve, A; Hedlund, L; Eriksson, T; Palmer, RH				Hugosson, Fredrik; Sjogren, Camilla; Birve, Anna; Hedlund, Ludmilla; Eriksson, Therese; Palmer, Ruth H.			The Drosophila Midkine/Pleiotrophin Homologues Miple1 and Miple2 Affect Adult Lifespan but Are Dispensable for Alk Signaling during Embryonic Gut Formation	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; RECEPTOR TYROSINE KINASE; HEPARIN-BINDING PROTEIN; ELEGANS DAUER FORMATION; ACID-RESPONSIVE GENE; MOLECULE HB-GAM; GROWTH-FACTOR; CAENORHABDITIS-ELEGANS; VISCERAL MUSCLE; MONOCLONAL-ANTIBODIES	Midkine (MDK) and Pleiotrophin (PTN) are small heparin-binding cytokines with closely related structures. The Drosophila genome harbours two genes encoding members of the MDK/PTN family of proteins, known as miple1 and miple2. We have investigated the role of Miple proteins in vivo, in particular with regard to their proposed role as ligands for the Alk receptor tyrosine kinase (RTK). Here we show that Miple proteins are neither required to drive Alk signaling during Drosophila embryogenesis, nor are they essential for development in the fruit fly. Additionally we show that neither MDK nor PTN can activate hALK in vivo when ectopically co-expressed in the fly. In conclusion, our data suggest that Alk is not activated by MDK/PTN related growth factors Miple1 and Miple 2 in vivo.	[Hugosson, Fredrik; Sjogren, Camilla; Birve, Anna; Hedlund, Ludmilla; Eriksson, Therese; Palmer, Ruth H.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Palmer, Ruth H.] Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden	Umea University; University of Gothenburg	Palmer, RH (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	ruth.palmer@gu.se		Hugosson, Fredrik/0000-0002-8332-7011	Swedish Cancer Society [12-0796]; Children's Cancer Foundation [13/049]; Swedish Research Council [621-2011-5181]; Lions Cancer Society, Umea [LP 12-1946]	Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Society, Umea	This work has been supported by grants from the Swedish Cancer Society, http://www.cancerfonden.se/, (Grant number 12-0796 to RHP); the Children's Cancer Foundation, http://www.barncancerfonden.se/, (Grant number 13/049 to RHP); the Swedish Research Council, http://www.vr.se/, (Grant number 621-2011-5181 to RHP); and the Lions Cancer Society, Umea, http://www.cancerforskningsfond-umea.lions.se/, (Grant number LP 12-1946 to RHP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Butchar JP, 2012, GENETICS, V191, P1213, DOI 10.1534/genetics.112.141093; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; COURTY J, 1991, BIOCHEM BIOPH RES CO, V180, P145, DOI 10.1016/S0006-291X(05)81267-7; De Luca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011286; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Englund C, 2006, DEV GENES EVOL, V216, P10, DOI 10.1007/s00427-005-0025-8; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Eriksson T, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-86; FU C, 1994, GENE, V146, P311, DOI 10.1016/0378-1119(94)90312-3; Goddeeris MM, 2003, AGING CELL, V2, P257, DOI 10.1046/j.1474-9728.2003.00060.x; Gouzi JY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002281; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Inoue T, 2000, GENETICS, V156, P1035; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Kadomatsu Kenji, 2004, Tanpakushitsu Kakusan Koso, V49, P2417; Khaliullina H, 2009, DEVELOPMENT, V136, P4111, DOI 10.1242/dev.041392; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Klingseisen A, 2009, DEVELOPMENT, V136, P2393, DOI 10.1242/dev.035451; KOVESDI I, 1990, BIOCHEM BIOPH RES CO, V172, P850, DOI 10.1016/0006-291X(90)90753-A; Lasek AW, 2011, J NEUROSCI, V31, P14134, DOI 10.1523/JNEUROSCI.3415-11.2011; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Leips J, 2006, GENETICS, V172, P1595, DOI 10.1534/genetics.105.048520; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; MAEDA N, 1994, FEBS LETT, V354, P67, DOI 10.1016/0014-5793(94)01093-5; Martinsson T, 2011, CANCER RES, V71, P98, DOI 10.1158/0008-5472.CAN-10-2366; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Mathivet T, 2007, CELL SIGNAL, V19, P2434, DOI 10.1016/j.cellsig.2007.07.011; MERENMIES J, 1990, J BIOL CHEM, V265, P16721; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Mourali J, 2006, MOL CELL BIOL, V26, P6209, DOI 10.1128/MCB.01515-05; Munoz-Soriano V, 2013, DEV BIOL, V377, P113, DOI 10.1016/j.ydbio.2013.02.006; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; Muramatsu H, 2000, BIOCHEM BIOPH RES CO, V270, P936, DOI 10.1006/bbrc.2000.2549; Muramatsu H, 2006, GENES CELLS, V11, P1405, DOI 10.1111/j.1365-2443.2006.01028.x; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Nakanishi T, 1997, J BIOCHEM-TOKYO, V121, P197; Nordin SL, 2012, J ANTIMICROB CHEMOTH, V67, P1927, DOI 10.1093/jac/dks136; Nose A, 1998, DEVELOPMENT, V125, P215; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Pecot MY, 2014, NEURON, V82, P320, DOI 10.1016/j.neuron.2014.02.045; Pfeifer K, 2012, DEV GENES EVOL, V222, P165, DOI 10.1007/s00427-012-0402-z; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; RAULO E, 1994, J BIOL CHEM, V269, P12999; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Reiner DJ, 2008, CURR BIOL, V18, P1101, DOI 10.1016/j.cub.2008.06.060; Rohrbough J, 2013, DEV NEUROBIOL, V73, P189, DOI 10.1002/dneu.22056; Rohrbough J, 2010, DEVELOPMENT, V137, P3523, DOI 10.1242/dev.047878; Sakakima H, 2009, J NEUROSCI RES, V87, P2908, DOI 10.1002/jnr.22127; Schaub C, 2012, DEVELOPMENT, V139, P1001, DOI 10.1242/dev.073890; Schonherr C, 2011, BIOCHEM J, V440, P405, DOI 10.1042/BJ20101796; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Stute C, 2004, DEVELOPMENT, V131, P743, DOI 10.1242/dev.00972; Sugiyama S, 2007, GENETICS, V176, P927, DOI 10.1534/genetics.107.072074; Svensson SL, 2010, J BIOL CHEM, V285, P16105, DOI 10.1074/jbc.M109.081232; TAKE M, 1994, J BIOCHEM-TOKYO, V116, P1063, DOI 10.1093/oxfordjournals.jbchem.a124628; Taravini IRE, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-40; TEZUKA K, 1990, BIOCHEM BIOPH RES CO, V173, P246, DOI 10.1016/S0006-291X(05)81048-4; TOMOMURA M, 1990, J BIOL CHEM, V265, P10765; TSUJIMURA A, 1995, BIOCHEM BIOPH RES CO, V214, P432, DOI 10.1006/bbrc.1995.2305; UNOKI K, 1994, INVEST OPHTH VIS SCI, V35, P4063; Varshney GK, 2006, BIOCHEM BIOPH RES CO, V351, P839, DOI 10.1016/j.bbrc.2006.10.117; VIGNY M, 1989, EUR J BIOCHEM, V186, P733, DOI 10.1111/j.1432-1033.1989.tb15267.x; Walker JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003958; Weiszmann R, 2009, NAT PROTOC, V4, P605, DOI 10.1038/nprot.2009.55; Winkler C, 2014, BRIT J PHARMACOL, V171, P905, DOI 10.1111/bph.12462; Witsell A, 2010, FLY, V4, P137, DOI 10.4161/fly.4.2.10918; Wolfstetter G, 2009, MECH DEVELOP, V126, P721, DOI 10.1016/j.mod.2009.05.001; Yang HL, 2007, J EXP ZOOL PART B, V308B, P269, DOI 10.1002/jez.b.21146	82	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112250	10.1371/journal.pone.0112250	http://dx.doi.org/10.1371/journal.pone.0112250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380037	Green Submitted, gold, Green Published			2022-12-26	WOS:000344863100069
J	Nakai, T; Sakai, KL				Nakai, Tomoya; Sakai, Kuniyoshi L.			Neural Mechanisms Underlying the Computation of Hierarchical Tree Structures in Mathematics	PLOS ONE			English	Article							LEFT PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; LANGUAGE; NUMBER; REPRESENTATION; COMPREHENSION; SYNTAX; SPECIALIZATION; DISSOCIATION; ACQUISITION	Whether mathematical and linguistic processes share the same neural mechanisms has been a matter of controversy. By examining various sentence structures, we recently demonstrated that activations in the left inferior frontal gyrus (L. IFG) and left supramarginal gyrus (L. SMG) were modulated by the Degree of Merger (DoM), a measure for the complexity of tree structures. In the present study, we hypothesize that the DoM is also critical in mathematical calculations, and clarify whether the DoM in the hierarchical tree structures modulates activations in these regions. We tested an arithmetic task that involved linear and quadratic sequences with recursive computation. Using functional magnetic resonance imaging, we found significant activation in the L. IFG, L. SMG, bilateral intraparietal sulcus (IPS), and precuneus selectively among the tested conditions. We also confirmed that activations in the L. IFG and L. SMG were free from memory-related factors, and that activations in the bilateral IPS and precuneus were independent from other possible factors. Moreover, by fitting parametric models of eight factors, we found that the model of DoM in the hierarchical tree structures was the best to explain the modulation of activations in these five regions. Using dynamic causal modeling, we showed that the model with a modulatory effect for the connection from the L. IPS to the L. IFG, and with driving inputs into the L. IFG, was highly probable. The intrinsic, i.e., task-independent, connection from the L. IFG to the L. IPS, as well as that from the L. IPS to the R. IPS, would provide a feedforward signal, together with negative feedback connections. We indicate that mathematics and language share the network of the L. IFG and L. IPS/SMG for the computation of hierarchical tree structures, and that mathematics recruits the additional network of the L. IPS and R. IPS.	[Nakai, Tomoya; Sakai, Kuniyoshi L.] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo, Japan; [Nakai, Tomoya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Sakai, Kuniyoshi L.] Japan Soc Promot Sci, CREST, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST); Japan Society for the Promotion of Science	Sakai, KL (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo, Japan.	sakai@mind.c.u-tokyo.ac.jp			Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology [20220005]; Japan Society for the Promotion of Science (JSPS) [26.9945]	Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST) (to KLS), by a Grant-in-Aid for Scientific Research (S) (No. 20220005) from the Ministry of Education, Culture, Sports, Science and Technology (to KLS), and by a Grant-in-Aid for JSPS Fellows (No. 26.9945) from the Japan Society for the Promotion of Science (JSPS) (to TN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baldo JV, 2007, NEUROPSYCHOLOGIA, V45, P229, DOI 10.1016/j.neuropsychologia.2006.07.014; Benn Y, 2013, BRAIN COGNITION, V82, P254, DOI 10.1016/j.bandc.2013.04.012; Benn Y, 2012, NEUROPSYCHOLOGIA, V50, P1, DOI 10.1016/j.neuropsychologia.2011.09.045; Butterworth B., 2005, HDB MATH COGNITION, V1st, P455; Cappelletti M, 2001, NEUROPSYCHOLOGIA, V39, P1224, DOI 10.1016/S0028-3932(01)00035-5; Chomsky N., 1957, SYNTACTIC STRUCTURES; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky N, 2007, INT J PHILOS STUD, V15, P1, DOI 10.1080/09672550601143078; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; den Ouden DB, 2012, NEUROIMAGE, V59, P815, DOI 10.1016/j.neuroimage.2011.07.057; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; ERNEST P, 1987, BRIT J EDUC PSYCHOL, V57, P343, DOI 10.1111/j.2044-8279.1987.tb00862.x; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Fedorenko E, 2012, CURR BIOL, V22, P2059, DOI 10.1016/j.cub.2012.09.011; Fedorenko E, 2011, P NATL ACAD SCI USA, V108, P16428, DOI 10.1073/pnas.1112937108; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friston KJ, 2006, NEUROIMAGE, V30, P1097, DOI 10.1016/j.neuroimage.2006.02.007; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fukui Naoki., 2011, OXFORD HDB LINGUISTI, P73; Hashimoto R, 2002, NEURON, V35, P589, DOI 10.1016/S0896-6273(02)00788-2; Homae F, 2003, NEUROIMAGE, V20, P578, DOI 10.1016/S1053-8119(03)00272-6; Ischebeck A, 2007, NEUROIMAGE, V36, P993, DOI 10.1016/j.neuroimage.2007.03.051; Kinno R, 2008, HUM BRAIN MAPP, V29, P1015, DOI 10.1002/hbm.20441; Kinno R, 2014, BRAIN, V137, P1193, DOI 10.1093/brain/awu013; Klessinger N, 2007, NEUROPSYCHOLOGIA, V45, P1642, DOI 10.1016/j.neuropsychologia.2007.01.005; Klessinger N, 2012, MEM COGNITION, V40, P1289, DOI 10.3758/s13421-012-0228-y; Krueger F, 2011, HUM BRAIN MAPP, V32, P1419, DOI 10.1002/hbm.21119; KVALSETH TO, 1985, AM STAT, V39, P279, DOI 10.2307/2683704; Lee H, 2007, J NEUROSCI, V27, P1184, DOI 10.1523/JNEUROSCI.4442-06.2007; Makuuchi M, 2012, PHILOS T R SOC B, V367, P2033, DOI 10.1098/rstb.2012.0095; Maruyama M, 2012, NEUROIMAGE, V61, P1444, DOI 10.1016/j.neuroimage.2012.04.020; Monti MM, 2012, PSYCHOL SCI, V23, P914, DOI 10.1177/0956797612437427; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Ohta S, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00204; Ohta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056230; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park J, 2013, CEREB CORTEX, V23, P2127, DOI 10.1093/cercor/bhs193; Pattamadilok C, 2010, J NEUROSCI, V30, P8435, DOI 10.1523/JNEUROSCI.5791-09.2010; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Price GR, 2013, J NEUROSCI, V33, P156, DOI 10.1523/JNEUROSCI.2936-12.2013; Rohrmeier M, 2011, J MATH MUSIC, V5, P35, DOI 10.1080/17459737.2011.573676; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Suzuki K, 2003, CEREB CORTEX, V13, P517, DOI 10.1093/cercor/13.5.517; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Varley RA, 2005, P NATL ACAD SCI USA, V102, P3519, DOI 10.1073/pnas.0407470102; Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697	60	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111439	10.1371/journal.pone.0111439	http://dx.doi.org/10.1371/journal.pone.0111439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379713	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100029
J	West, PR; Amaral, DG; Bais, P; Smith, AM; Egnash, LA; Ross, ME; Palmer, JA; Fontaine, BR; Conard, KR; Corbett, BA; Cezar, GG; Donley, ELR; Burrier, RE				West, Paul R.; Amaral, David G.; Bais, Preeti; Smith, Alan M.; Egnash, Laura A.; Ross, Mark E.; Palmer, Jessica A.; Fontaine, Burr R.; Conard, Kevin R.; Corbett, Blythe A.; Cezar, Gabriela G.; Donley, Elizabeth L. R.; Burrier, Robert E.			Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children	PLOS ONE			English	Article							AMINO-ACIDS; MITOCHONDRIAL; ABNORMALITIES; SPECTROMETRY; PERFORMANCE; ALIGNMENT; PROFILES; SERUM; CHAIN	Background: The diagnosis of autism spectrum disorder (ASD) at the earliest age possible is important for initiating optimally effective intervention. In the United States the average age of diagnosis is 4 years. Identifying metabolic biomarker signatures of ASD from blood samples offers an opportunity for development of diagnostic tests for detection of ASD at an early age. Objectives: To discover metabolic features present in plasma samples that can discriminate children with ASD from typically developing (TD) children. The ultimate goal is to identify and develop blood-based ASD biomarkers that can be validated in larger clinical trials and deployed to guide individualized therapy and treatment. Methods: Blood plasma was obtained from children aged 4 to 6, 52 with ASD and 30 age-matched TD children. Samples were analyzed using 5 mass spectrometry-based methods designed to orthogonally measure a broad range of metabolites. Univariate, multivariate and machine learning methods were used to develop models to rank the importance of features that could distinguish ASD from TD. Results: A set of 179 statistically significant features resulting from univariate analysis were used for multivariate modeling. Subsets of these features properly classified the ASD and TD samples in the 61-sample training set with average accuracies of 84% and 86%, and with a maximum accuracy of 81% in an independent 21-sample validation set. Conclusions: This analysis of blood plasma metabolites resulted in the discovery of biomarkers that may be valuable in the diagnosis of young children with ASD. The results will form the basis for additional discovery and validation research for 1) determining biomarkers to develop diagnostic tests to detect ASD earlier and improve patient outcomes, 2) gaining new insight into the biochemical mechanisms of various subtypes of ASD 3) identifying biomolecular targets for new modes of therapy, and 4) providing the basis for individualized treatment recommendations.	[West, Paul R.; Smith, Alan M.; Egnash, Laura A.; Ross, Mark E.; Palmer, Jessica A.; Fontaine, Burr R.; Conard, Kevin R.; Cezar, Gabriela G.; Donley, Elizabeth L. R.; Burrier, Robert E.] Stemina Biomarker Discovery, Madison, WI 53719 USA; [Amaral, David G.] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA; [Amaral, David G.] Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Bais, Preeti] Univ Connecticut, Ctr Hlth, Jackson Lab Genom Med, Farmington, CT USA; [Corbett, Blythe A.] Vanderbilt Univ, Dept Psychiat Psychol & Kennedy Ctr, Nashville, TN 37235 USA	University of California System; University of California Davis; University of California System; University of California Davis; Jackson Laboratory; University of Connecticut; Vanderbilt University	West, PR (corresponding author), Stemina Biomarker Discovery, Madison, WI 53719 USA.	pwest@stemina.com	Donley, Elizabeth/O-4916-2019	Donley, Elizabeth/0000-0002-3439-4322; Palmer, Jessica/0000-0001-7373-4118	Stemina	Stemina	Stemina funded this study. The funder provided support in the form of salaries for authors (PRW, LAE, AMS, MER, JAP, BRF, KRC, GGC, ELRD, and REB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Adams JB, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-34; American Psychiatric Association, 2000, DESK REF DIAGN CRIT; American Psychiatric Association, 2013, DESK REF DIAGN CRIT; Arnold GL, 2003, J AUTISM DEV DISORD, V33, P449, DOI 10.1023/A:1025071014191; Ashwood P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019299; Belgard TG, 2014, MOL PSYCHIATR, V19, P405, DOI 10.1038/mp.2013.34; Beloborodova N, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-89; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg JM, 2012, GENOME BIOL, V13, DOI [10.1186/gb4034, 10.1186/gb-2012-13-7-247]; Blaylock RL, 2009, ALTERN THER HEALTH M, V15, P60; Bruce SJ, 2008, ANAL BIOCHEM, V372, P237, DOI 10.1016/j.ab.2007.09.037; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; El-Ansary AK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-62; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Ganz ML, 2007, ARCH PEDIAT ADOL MED, V161, P343, DOI 10.1001/archpedi.161.4.343; Ghezzo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066418; GROSS ML, 1994, J AM SOC MASS SPECTR, V5, P57, DOI 10.1016/1044-0305(94)85036-4; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; James SJ, 2009, AM J CLIN NUTR, V89, P425, DOI 10.3945/ajcn.2008.26615; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lee RW, 2011, AUTISM RES TREAT, DOI DOI 10.1155/2011/653570; Marazziti D, 2012, EUR REV MED PHARMACO, V16, P270; Ming X, 2012, J PROTEOME RES, V11, P5856, DOI 10.1021/pr300910n; Moreno-Fuenmayor H, 1996, Invest Clin, V37, P113; Mulle JG, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0337-0; Muller E, 2004, J INHERIT METAB DIS, V27, P903, DOI 10.1023/B:BOLI.0000045775.03183.48; Napolioni V, 2011, MOL NEUROBIOL, V44, P83, DOI 10.1007/s12035-011-8192-2; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; Orchard Sandra, 2007, Proteomics, V7, P3436, DOI 10.1002/pmic.200700658; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Prince JT, 2006, ANAL CHEM, V78, P6140, DOI 10.1021/ac0605344; Priya L, 2011, REDOX REP, V16, P216, DOI 10.1179/1351000211Y.0000000012; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Safiulina D, 2006, TOXICOL SCI, V93, P348, DOI 10.1093/toxsci/kfl064; Shinohe A, 2006, PROG NEURO-PSYCHOPH, V30, P1472, DOI 10.1016/j.pnpbp.2006.06.013; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Skafidas E, 2012, MOL PSYCHIA IN PRESS; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sokoro AAH, 2010, J INHERIT METAB DIS, V33, pS275, DOI 10.1007/s10545-010-9148-9; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; Strous RD, 2005, EUR NEUROPSYCHOPHARM, V15, P305, DOI 10.1016/j.euroneuro.2004.12.004; TORDJMAN S, 1995, J AUTISM DEV DISORD, V25, P295, DOI 10.1007/BF02179290; Valerio A, 2011, AGING-US, V3, P464, DOI 10.18632/aging.100322; Viegas CM, 2011, BRAIN RES, V1369, P235, DOI 10.1016/j.brainres.2010.10.112; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Whitaker-Azmitia PM, 2005, INT J DEV NEUROSCI, V23, P75, DOI 10.1016/j.ijdevneu.2004.07.022; Whiteley P, 2006, PEDIATR INT, V48, P292, DOI 10.1111/j.1442-200X.2006.02207.x; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Wold H., 1985, ENCY STAT SCI, P581, DOI DOI 10.1002/0471667196; Yap IKS, 2010, J PROTEOME RES, V9, P2996, DOI 10.1021/pr901188e; Yin PY, 2013, CLIN CHEM, V59, P833, DOI 10.1373/clinchem.2012.199257	61	118	124	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112445	10.1371/journal.pone.0112445	http://dx.doi.org/10.1371/journal.pone.0112445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380056	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100095
J	Sun, HW; Li, G; Zhang, WJ; Zhou, Q; Yu, YN; Shi, Y; Offermanns, S; Lu, JX; Zhou, NM				Sun, Huawang; Li, Guo; Zhang, Wenjuan; Zhou, Qi; Yu, Yena; Shi, Ying; Offermanns, Stefan; Lu, Jianxin; Zhou, Naiming			Niacin Activates the PI3K/Akt Cascade via PKC- and EGFR-Transactivation-Dependent Pathways through Hydroxyl-Carboxylic Acid Receptor 2	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; EPIDERMAL-GROWTH-FACTOR; CORONARY-ARTERY-DISEASE; NICOTINIC-ACID; KINASE-B; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR-IDENTIFICATION; CELL-PROLIFERATION; SIGNALING PATHWAYS; PI 3-KINASE	Niacin has been demonstrated to activate a PI3K/Akt signaling cascade to prevent brain damage after stroke and UV-induced skin damage; however, the underlying molecular mechanisms for HCA(2)-induced Akt activation remain to be elucidated. Using CHO-K1 cells stably expressing HCA(2) and A431 cells, a human epidermoid cell line with high levels of endogenous expression of functional HCA(2) receptors, we first demonstrated that niacin induced a robust Akt phosphorylation at both Thr(308) and Ser(473) in a time-dependent fashion, with a maximal activation at 5 min and a subsequent reduction to baseline by 30 min through HCA(2), and that the activation was significantly blocked by pertussis toxin. The HCA(2)-mediated activation of Akt was also significantly inhibited by the PKC inhibitors GF109203x and Go6983 in both cell lines, by the PDGFR-selective inhibitor tyrphostin A9 in CHO-HCA(2) cells and by the MMP inhibitor GM6001 and EGFR-specific inhibitor AG1478 in A431 cells. These results suggest that the PKC pathway and PDGFR/EGFR transactivation pathway play important roles in HCA(2)-mediated Akt activation. Further investigation indicated that PI3K and the G(beta gamma) subunit were likely to play an essential role in HCA(2)-induced Akt activation. Moreover, Immunobloting analyses using an antibody that recognizes p70S6K1 phosphorylated at Thr(389) showed that niacin evoked p70S6K1 activation via the PI3K/Akt pathway. The results of our study provide new insight into the signaling pathways involved in HCA(2) activation.	[Sun, Huawang; Zhang, Wenjuan; Zhou, Qi; Yu, Yena; Lu, Jianxin] Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China; [Li, Guo; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Guo] Hangzhou Normal Univ, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany	Wenzhou Medical University; Zhejiang University; Hangzhou Normal University; Max Planck Society	Lu, JX (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China.	jxlu313@163.com; znm2000@yahoo.com	Lu, Jianxin/E-4485-2015; Zhou, Naiming/AHC-1121-2022; Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805	Ministry of Science and Technology of China [2012CB910402, 2012AA020303]; National Natural Science Foundation of China [81173106]; Zhejiang Natural Science Foundation [Z2080207]; German Research Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the Ministry of Science and Technology of China (2012CB910402 and 2012AA020303), the National Natural Science Foundation of China (81173106) and the Zhejiang Natural Science Foundation (Z2080207). Dr. S. Offermanns was supported by the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Antonelli V, 2000, MOL BIOL CELL, V11, P1129, DOI 10.1091/mbc.11.4.1129; Assefa Z, 1999, BIOCHEM BIOPH RES CO, V261, P641, DOI 10.1006/bbrc.1999.1090; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brown BG, 2008, AM J CARDIOL, V101, p58B, DOI 10.1016/j.amjcard.2008.02.039; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; CASHINHEMPHILL L, 1990, JAMA-J AM MED ASSOC, V264, P3013, DOI 10.1001/jama.264.23.3013; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; Digby JE, 2009, CURR OPIN LIPIDOL, V20, P321, DOI 10.1097/MOL.0b013e32832d3b9d; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; KATHER H, 1983, FEBS LETT, V161, P149, DOI 10.1016/0014-5793(83)80749-2; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kong KC, 2006, FASEB J, V20, P1558, DOI 10.1096/fj.05-5622fje; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Lauring B, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003877; Li G, 2011, J BIOL CHEM, V286, P31199, DOI 10.1074/jbc.M111.241372; Li G, 2010, J BIOL CHEM, V285, P22605, DOI 10.1074/jbc.M109.087213; Lin FQ, 2012, INT J MOL MED, V29, P593, DOI 10.3892/ijmm.2012.886; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lukasova M, 2011, TRENDS PHARMACOL SCI, V32, P700, DOI 10.1016/j.tips.2011.08.002; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Punn A, 2006, MOL ENDOCRINOL, V20, P3179, DOI 10.1210/me.2006-0255; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; Riese DJ, 1998, J BIOL CHEM, V273, P11288, DOI 10.1074/jbc.273.18.11288; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schafer B, 2004, J BIOL CHEM, V279, P47929, DOI 10.1074/jbc.M400129200; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Shehadah A, 2010, NEUROBIOL DIS, V40, P277, DOI 10.1016/j.nbd.2010.05.034; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wu EH, 2006, CELL SIGNAL, V18, P285, DOI 10.1016/j.cellsig.2005.04.009; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang YY, 2005, BIOCHEM BIOPH RES CO, V334, P729, DOI 10.1016/j.bbrc.2005.06.141; Zhou LB, 2007, MOL CELL BIOCHEM, V294, P243, DOI 10.1007/s11010-006-9150-6	62	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112310	10.1371/journal.pone.0112310	http://dx.doi.org/10.1371/journal.pone.0112310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375133	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600125
J	Wails, CN; Oswald, SA; Arnold, JM				Wails, Christy N.; Oswald, Stephen A.; Arnold, Jennifer M.			Are Morphometrics Sufficient for Estimating Age of Pre-Fledging Birds in the Field? A Test Using Common Terns (Sterna hirundo)	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; WING LENGTH; GROWTH; PATTERNS; PRODUCTIVITY; ALLOCATION; SURVIVAL; ECOLOGY; CHICKS; DATE	Age is a key component of fitness, affecting survival and reproductive capacities. Where it is not possible to study known individuals from birth, morphometrics (predominantly patterns of plumage development for birds) are most often used to estimate age. Although criteria for age estimations exist for many species, the degree to which these criteria improve the precision of estimates remains to be tested, restricting their widespread acceptance. We develop a photographic tool for estimating ages of Common Tern (Sterna hirundo) chicks and test it using 100 human observers of varying prior experience across four breeding colonies (three North American sites and one European site) and under controlled laboratory conditions. We followed the design approach of other morphometric tools, expanding it to create a user-friendly guide (divided into six age groupings). The majority (86%) of observers improved in chick-aging accuracy when using the tool by an average of 20.1% (+/- 1.4 SE) and correctly estimated 60.3% (+/- 1.4) of chick ages. This was similar to the intrinsic aging ability of our best field observer (63.3%). Observers with limited experience showed the greatest increases in chick-aging accuracy over experienced observers who likely had established a method for estimating chick ages prior to using the tool. Even the best observers only correctly estimated ages of chicks 62.9% (+/- 2.8) of the time in the field and 84.0% (+/- 2.9) of the time in the lab when using the tool and typically underestimated ages. This indicates that developmental variation between individual chicks can prevent completely reliable age estimates and corroborates the few existing data that suggest that morphometric criteria fail to achieve robust levels of accuracy and may introduce error into studies that rely on them. We conclude that novel approaches for estimating age, not only morphometric criteria, must be pursued.	[Wails, Christy N.; Oswald, Stephen A.; Arnold, Jennifer M.] Penn State Univ, Div Sci, Reading, PA 19610 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Wails, CN (corresponding author), Penn State Univ, Div Sci, Berks Campus, Reading, PA 19610 USA.	c.wails@unb.ca	Wails, Christy N./L-9450-2014	Wails, Christy N./0000-0003-2084-5003	Pennsylvania State University Berks Campus; Ned Smith Center for Nature and Art; Friends of Presqu'ile Provincial Park; Baird Ornithological Club; Pennsylvania State University Summer Discovery Grant	Pennsylvania State University Berks Campus; Ned Smith Center for Nature and Art; Friends of Presqu'ile Provincial Park; Baird Ornithological Club; Pennsylvania State University Summer Discovery Grant	Funding for this study was provided by the Pennsylvania State University Berks Campus, Pennsylvania State University Summer Discovery Grant (2013), Ned Smith Center for Nature and Art, Friends of Presqu'ile Provincial Park and Baird Ornithological Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; ANDERSON DW, 1980, BIOL CONSERV, V18, P65, DOI 10.1016/0006-3207(80)90067-1; Arnold JM, 2006, IBIS, V148, P98, DOI 10.1111/j.1474-919X.2006.00487.x; Arnold JM, 2004, J AVIAN BIOL, V35, P33, DOI 10.1111/j.0908-8857.2004.03059.x; Barton K, 2020, MUMIN MULTIMODEL INF; BECHARD MJ, 1985, J WILDLIFE MANAGE, V49, P226, DOI 10.2307/3801875; Becker PH, 2003, BEHAV ECOL SOCIOBIOL, V54, P136, DOI 10.1007/s00265-003-0605-4; Benowitz-Fredericks ZM, 2006, AUK, V123, P722, DOI 10.1642/0004-8038(2006)123[722:GAAICC]2.0.CO;2; Blas J, 2006, GEN COMP ENDOCR, V148, P172, DOI 10.1016/j.ygcen.2006.02.011; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARLSSON BG, 1994, CONDOR, V96, P555, DOI 10.2307/1369336; Carney KM, 1999, WATERBIRDS, V22, P68, DOI 10.2307/1521995; Dahdul WM, 2003, AUK, V120, P1069, DOI 10.1642/0004-8038(2003)120[1069:EAAPGI]2.0.CO;2; DESANTE DF, 1987, CONDOR, V89, P636, DOI 10.2307/1368653; ELIAS P K, 1976, Experimental Aging Research, V2, P165, DOI 10.1080/03610737608257985; ELOWE K D, 1979, Bird-Banding, V50, P49; Erickson Wallace P., 2005, U S Forest Service General Technical Report PSW, V191, P1029; Erwin R.M., 1982, Colonial Waterbirds, V5, P49, DOI 10.2307/1521032; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; HORWICH RH, 1966, BIRD BANDING, V37, P257, DOI 10.2307/4511310; Hunter Janet M., 1995, Wildfowl, V46, P55; MARTIN K, 1995, AM ZOOL, V35, P340; Mayfield H.F., 1961, WILSON B, V73, P225; MAYFIELD HF, 1975, WILSON BULL, V87, P456; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Morales Fernaz Judith, 2012, Ringing & Migration, V27, P65; Morris RD, 2010, J GREAT LAKES RES, V36, P44, DOI 10.1016/j.jglr.2009.09.008; NISBET ICT, 1990, COLON WATERBIRD, V13, P85, DOI 10.2307/1521572; PARR R, 1975, J WILDLIFE MANAGE, V39, P188, DOI 10.2307/3800485; PETERSEN LR, 1977, J WILDLIFE MANAGE, V41, P587, DOI 10.2307/3800538; PRATT HM, 1985, AUK, V102, P49, DOI 10.2307/4086822; Reed LM, 1998, COLON WATERBIRD, V21, P414, DOI 10.2307/1521653; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; RICKLEFS RE, 1977, AUK, V94, P86; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Rodway MS, 1997, J FIELD ORNITHOL, V68, P338; SHANAWANY MM, 1984, BRIT POULTRY SCI, V25, P449, DOI 10.1080/00071668408454886; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; STEARNS SC, 1977, ANNU REV ECOL SYST, V8, P145, DOI 10.1146/annurev.es.08.110177.001045; Steinkamp M., 2003, BREEDING SEASON SURV; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Wendeln H, 2000, BEHAV ECOL SOCIOBIOL, V47, P382, DOI 10.1007/s002650050681	42	7	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111987	10.1371/journal.pone.0111987	http://dx.doi.org/10.1371/journal.pone.0111987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375105	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600088
J	Eggers, F; Slotte, A; Libungan, LA; Johannessen, A; Kvamme, C; Moland, E; Olsen, EM; Nash, RDM				Eggers, Florian; Slotte, Aril; Libungan, Lisa Anne; Johannessen, Arne; Kvamme, Cecilie; Moland, Even; Olsen, Esben M.; Nash, Richard D. M.			Seasonal Dynamics of Atlantic Herring (Clupea harengus L.) Populations Spawning in the Vicinity of Marginal Habitats	PLOS ONE			English	Article							OTOLITH SHAPE-ANALYSIS; NORTH-SEA; MARINE FISH; STOCK IDENTIFICATION; GENETIC-STRUCTURE; DISCRETENESS; RECOVERY; METAPOPULATIONS; DISCRIMINATE; MECHANISMS	Gillnet sampling and analyses of otolith shape, vertebral count and growth indicated the presence of three putative Atlantic herring (Clupea harengus L.) populations mixing together over the spawning season February-June inside and outside an inland brackish water lake (Landvikvannet) in southern Norway. Peak spawning of oceanic Norwegian spring spawners and coastal Skagerrak spring spawners occurred in March-April with small proportions of spawners entering the lake. In comparison, spawning of Landvik herring peaked in May-June with high proportions found inside the lake, which could be explained by local adaptations to the environmental conditions and seasonal changes of this marginal habitat. The 1.85 km 2 lake was characterized by oxygen depletion occurring between 2.5 and 5 m depth between March and June. This was followed by changes in salinity from 1-7% in the 0-1 m surface layer to levels of 20-25% deeper than 10 m. In comparison, outside the 3 km long narrow channel connecting the lake with the neighboring fjord, no anoxic conditions were found. Here salinity in the surface layer increased over the season from 10 to 25%, whereas deeper than 5 m it was stable at around 35%. Temperature at 0-5 m depth increased significantly over the season in both habitats, from 7 to 14 degrees C outside and 5 to 17 degrees C inside the lake. Despite differences in peak spawning and utilization of the lake habitat between the three putative populations, there was an apparent temporal and spatial overlap in spawning stages suggesting potential interbreeding in accordance with the metapopulation concept.	[Eggers, Florian; Slotte, Aril; Kvamme, Cecilie; Nash, Richard D. M.] Inst Marine Res, N-5024 Bergen, Norway; [Eggers, Florian; Johannessen, Arne] Univ Bergen, Dept Biol, Bergen, Norway; [Libungan, Lisa Anne] Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland; [Moland, Even] Inst Marine Res, Flodevigen, Norway; [Olsen, Esben M.] Univ Oslo, CEES, Dept Biosci, Oslo, Norway; [Olsen, Esben M.] Univ Agder, Fac Sci & Engn, Dept Nat Sci, Kristiansand, Norway	Institute of Marine Research - Norway; University of Bergen; University of Iceland; Institute of Marine Research - Norway; University of Oslo; University of Agder	Eggers, F (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	eggersf@t-online.de	Berg, Florian/M-9678-2014; Olsen, Esben Moland/B-1894-2012; Moland, Even/A-7788-2013	Berg, Florian/0000-0003-1543-8112; Olsen, Esben Moland/0000-0003-3807-7524; Nash, Richard/0000-0003-0958-149X				Aasen O, 1952, FISKDIR SKR SER HAVU, V10; Aguera A, 2011, FISH RES, V110, P465, DOI 10.1016/j.fishres.2011.06.003; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; Begg GA, 1999, FISH RES, V43, P1, DOI 10.1016/S0165-7836(99)00062-4; Begg GA, 2001, FISH B-NOAA, V99, P1; Bekkevold D, 2005, EVOLUTION, V59, P2656; Bekkevold D, 2007, MAR ECOL PROG SER, V337, P187, DOI 10.3354/meps337187; Bekkevold D, 2011, MAR ECOL PROG SER, V442, P187, DOI 10.3354/meps09352; Bivand R, 2011, PIXMAP BITMAP IMAGES; BLAXTER J. H. S., 1965, J CONS CONS PERMA INT EXPLOR MER, V30, P40; Blaxter JHS, 1957, MAR RES, V1, P1; Broch H, 1908, BERGEN MUSEUMS ARBOK, V1; Brophy D, 2006, CAN J FISH AQUAT SCI, V63, P607, DOI 10.1139/f05-235; Claude J, 2008, MORPHOMETRICS R; Clausen LAW, 2007, ICES J MAR SCI, V64, P377, DOI 10.1093/icesjms/fsl036; Cochrane KL, 2009, FISHERY MANAGERS GUIDEBOOK, 2ND EDITION, P1, DOI 10.1002/9781444316315.ch1; CORTEN A, 1986, J CONSEIL, V42, P281; Corten A, 2002, REV FISH BIOL FISHER, V11, P339; Dickey-Collas M, 2010, ICES J MAR SCI, V67, P1875, DOI 10.1093/icesjms/fsq033; Directorate of Fisheries, 2013, LAND SAL DOC LAND SL; Dragesund O., 1980, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V177, P43; Eggers F, 2013, METAPOPULATION DYNAM; Eggers F, 2014, MAR ECOL PROG UNPUB; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Geffen AJ, 2011, ICES J MAR SCI, V68, P1447, DOI 10.1093/icesjms/fsr051; HAEGELE CW, 1985, CAN J FISH AQUAT SCI, V42, P39, DOI 10.1139/f85-261; HAMLEY JM, 1975, J FISH RES BOARD CAN, V32, P1943, DOI 10.1139/f75-233; Heincke F, 1898, NATURGESCHICHTE HERI; HEMPEL G, 1953, NATURWISSENSCHAFTEN, V40, P467, DOI 10.1007/BF00628850; Hempel G, 1961, RAPP P VERB REUN CON, V26, P336; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hintzen NT, 2014, ICES J MAR IN PRESS; HOGNESTAD PT, 1994, ICES J MAR SCI, V51, P281, DOI 10.1006/jmsc.1994.1029; HORRALL RM, 1981, CAN J FISH AQUAT SCI, V38, P1481, DOI 10.1139/f81-201; HOURSTON AS, 1959, J FISH RES BOARD CAN, V16, P309, DOI 10.1139/f59-024; HULME TJ, 1995, ICES J MAR SCI, V52, P775, DOI 10.1006/jmsc.1995.0074; Huse G, 2010, MAR ECOL PROG SER, V409, P189, DOI 10.3354/meps08620; Husebo A, 2005, MAR FRESHWATER RES, V56, P763, DOI 10.1071/MF04170; ICES, 2012, REP ICES ADV COMM 20; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Johannessen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102462; Johannessen A, 2009, ICES J MAR SCI, V66, P1740, DOI 10.1093/icesjms/fsp183; Johnston IA, 1997, J EXP BIOL, V200, P849; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Jorstad KE, 1986, 1986H63 ICES CM; Kell LT, 2009, ICES J MAR SCI, V66, P1776, DOI 10.1093/icesjms/fsp181; LIE U, 1978, Fiskeridirektoratets Skrifter Serie Havundersokelser, V16, P369; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Lleonart J, 2000, J THEOR BIOL, V205, P85, DOI 10.1006/jtbi.2000.2043; Longmore C, 2010, ENVIRON BIOL FISH, V89, P591, DOI 10.1007/s10641-010-9674-1; MACLEAN JA, 1981, CAN J FISH AQUAT SCI, V38, P1889, DOI 10.1139/f81-235; McPherson AA, 2001, J FISH BIOL, V59, P356, DOI 10.1006/jfbi.2001.1769; McQuinn IH, 1997, REV FISH BIOL FISHER, V7, P297, DOI 10.1023/A:1018491828875; Meyer HA, 1878, WISS MEER, V2, P227; Mjanger H, 2012, HDB PROVETAKING FISK; Nason G., 2012, WAVETHRESH WAVELETS; NEB KE, 1970, BER DEUT WISS KOMM, V21, P265; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pampoulie C, 2014, MAR ECOL PROG UNPUB; PAVLOV DA, 1998, J ICHTHYOL+, V38, P251; Petitgas P, 2010, ICES J MAR SCI, V67, P1841, DOI 10.1093/icesjms/fsq082; PITCHER TJ, 1985, MAR BIOL, V86, P319, DOI 10.1007/BF00397518; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmussen J., 1942, FISKDIR SKR SER HAVU, VVII, P63; Runnstrom S, 1941, FISKDIR SKR SER HAVU, V6; Russell F. S., 1976, EGGS PLANKTONIC STAG; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Silva FFG, 2013, FISH RES, V138, P71, DOI 10.1016/j.fishres.2012.07.013; Sinclair M, 1988, AQUAT LIVING RESOUR, V1, P71, DOI 10.1051/alr:1988009; Skirnisdottir S, 2012, NORDIC NETWORK STOCK; Slotte A, 1999, SARSIA, V84, P111, DOI 10.1080/00364827.1999.10420439; Slotte A, 2000, J FISH BIOL, V56, P138; Slotte A, 2009, NOTE NSS HERRING FIS; Slotte A, 2001, HERRING EXPECTATIONS, P255; SMITH PJ, 1986, FISH RES, V4, P223, DOI 10.1016/0165-7836(86)90004-4; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Soleim PA, 1942, FISKDIR SKR SER HAVU, V7; Stephenson RL, 2009, ICES J MAR SCI, V66, P1733, DOI 10.1093/icesjms/fsp189; von Bertalanffy L, 1934, ROUX ARCH DEV BIOL, V131, P613, DOI 10.1007/BF00650112; Wallace RK, 1997, UNDERSTANDING FISHER; Winkler, 1888, BER DTSCH CHEM GES, V21, P2843, DOI [10.1002/cber.188802102122, DOI 10.1002/CBER.188802102122]; WOODHEAD PMJ, 1955, NATURE, V176, P349, DOI 10.1038/176349c0	83	19	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111985	10.1371/journal.pone.0111985	http://dx.doi.org/10.1371/journal.pone.0111985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372461	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000344556900101
J	Oguz, T; Macias, D; Garcia-Lafuente, J; Pascual, A; Tintore, J				Oguz, Temel; Macias, Diego; Garcia-Lafuente, Jesus; Pascual, Ananda; Tintore, Joaquin			Fueling Plankton Production by a Meandering Frontal Jet: A Case Study for the Alboran Sea (Western Mediterranean)	PLOS ONE			English	Article							ALMERIA-ORAN FRONT; VERTICAL CIRCULATION; MESOSCALE SUBDUCTION; GEOSTROPHIC FRONT; SIZE-STRUCTURE; ATLANTIC JET; PHYTOPLANKTON; DYNAMICS; VARIABILITY; FRONTOGENESIS	A three dimensional biophysical model was employed to illustrate the biological impacts of a meandering frontal jet, in terms of efficiency and persistency of the autotrophic frontal production, in marginal and semi-enclosed seas. We used the Alboran Sea of the Western Mediterranean as a case study. Here, a frontal jet with a width of 15-20 km, characterized by the relatively low density Atlantic water mass, flows eastward within the upper 100 m as a marked meandering current around the western and the eastern anticyclonic gyres prior to its attachment to the North African shelf/slope topography of the Algerian basin. Its inherent nonlinearity leads to the development of a strong ageostrophic cross-frontal circulation that supplies nutrients into the nutrient-starved euphotic layer and stimulates phytoplankton growth along the jet. Biological production is larger in the western part of the basin and decreases eastwards with the gradual weakening of the jet. The higher production at the subsurface levels suggests that the Alboran Sea is likely more productive than predicted by the satellite chlorophyll data. The Mediterranean water mass away from the jet and the interiors of the western and eastern anticyclonic gyres remain unproductive.	[Oguz, Temel; Tintore, Joaquin] Balearic Isl Coastal Ocean Observing & Forecastin, SOCIB, Palma de Mallorca, Spain; [Oguz, Temel] Middle E Tech Univ, Inst Marine Sci, Mersin, Turkey; [Macias, Diego] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy; [Garcia-Lafuente, Jesus] Univ Malaga, Dept Fis Aplicada 2, E-29071 Malaga, Spain; [Pascual, Ananda; Tintore, Joaquin] UIB, CSIC, IMEDEA, Palma de Mallorca, Spain	Middle East Technical University; European Commission Joint Research Centre; EC JRC ISPRA Site; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Macias, D (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy.	diego.macias-moy@jrc.ec.europa.eu	oguz, temel/J-4252-2017; Macías, Diego/G-1972-2010	Macías, Diego/0000-0002-7772-255X; Garcia Lafuente, Jesus/0000-0001-7816-576X; Pascual, Ananda/0000-0001-9476-9272; Tintore, Joaquin/0000-0002-6311-0093	Perseus EU; Spanish-funded project [CTM2010-21229-C01]	Perseus EU; Spanish-funded project	This study is part of the Ocean Forecasting Facility from SOCIB and is also partially supported by Perseus EU funded Project whose support is gratefully acknowledged. JGL acknowledges partial support from the Spanish-funded project CTM2010-21229-C01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JT, 2001, J MARINE SYST, V30, P263, DOI 10.1016/S0924-7963(01)00062-8; Batteen ML, 1997, J GEOPHYS RES-OCEANS, V102, P985, DOI 10.1029/96JC02803; Berntsen J, 2010, OCEAN DYNAM, V60, P317, DOI 10.1007/s10236-009-0245-y; Capet X, 2008, J PHYS OCEANOGR, V38, P44, DOI 10.1175/2007JPO3672.1; CLAUSTRE H, 1994, J MAR RES, V52, P711, DOI 10.1357/0022240943077000; Delgado J, 2012, SCI MAR, V76, P95, DOI 10.3989/scimar.03609.18E; Fielding S, 2001, J MARINE SYST, V30, P287, DOI 10.1016/S0924-7963(01)00063-X; Garcia-Gorriz E, 2001, J GEOPHYS RES-OCEANS, V106, P16795, DOI 10.1029/1999JC000029; Garcia-Lafuente J., 2004, J PHYS OCEANOGR, V34, P685; Gomis D, 2001, DEEP-SEA RES PT I, V48, P269, DOI 10.1016/S0967-0637(00)00060-1; HAIDVOGEL DB, 1991, J GEOPHYS RES-OCEANS, V96, P15017, DOI 10.1029/91JC00943; Herbaut C, 1996, J PHYS OCEANOGR, V26, P65, DOI 10.1175/1520-0485(1996)026<0065:ASSOTG>2.0.CO;2; L'Helguen S, 2002, DEEP-SEA RES PT I, V49, P83, DOI 10.1016/S0967-0637(01)00044-9; Lafuente JG, 2002, DEEP-SEA RES PT II, V49, P4051, DOI 10.1016/S0967-0645(02)00142-X; Lapeyre G, 2006, J PHYS OCEANOGR, V36, P1577, DOI 10.1175/JPO2923.1; Lazzari P, 2012, BIOGEOSCIENCES, V9, P217, DOI 10.5194/bg-9-217-2012; Leblanc K, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001878; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; Macias D, 2008, ESTUAR COAST SHELF S, V78, P250, DOI 10.1016/j.ecss.2007.12.008; Macias D, 2014, ECOL MODEL, V281, P26, DOI 10.1016/j.ecolmodel.2014.03.002; Mahadevan A, 2012, SCIENCE, V337, P54, DOI 10.1126/science.1218740; Martin AP, 2001, J MARINE SYST, V28, P65, DOI 10.1016/S0924-7963(00)00084-1; MCCALPIN JD, 1994, INT J NUMER METH FL, V18, P361, DOI 10.1002/fld.1650180404; MELLOR GL, 1982, REV GEOPHYS, V20, P851, DOI 10.1029/RG020i004p00851; Mellor GL, 1998, J ATMOS OCEAN TECH, V15, P1122, DOI 10.1175/1520-0426(1998)015<1122:SCPGEA>2.0.CO;2; Mellor GL, 2003, PROG ATMOS OCEAN SCI, P53; Mercado JM, 2007, PROG OCEANOGR, V74, P273, DOI 10.1016/j.pocean.2007.04.013; Moran XAG, 2001, MAR ECOL PROG SER, V212, P53, DOI 10.3354/meps212053; Moran XAG, 2001, DEEP-SEA RES PT I, V48, P405, DOI 10.1016/S0967-0637(00)00042-X; Naranjo C, 2012, DEEP-SEA RES PT I, V63, P157, DOI 10.1016/j.dsr.2011.10.003; Oguz T, 2013, PROG OCEANOGR, V112, P1, DOI 10.1016/j.pocean.2013.03.001; PEINERT R, 1994, J MARINE SYST, V5, P377, DOI 10.1016/0924-7963(94)90057-4; Peliz A, 2013, OCEAN MODEL, V72, P32, DOI 10.1016/j.ocemod.2013.07.002; POLLARD RT, 1992, J PHYS OCEANOGR, V22, P609, DOI 10.1175/1520-0485(1992)022<0609:VAVCAA>2.0.CO;2; PRIEUR L, 1994, J MARINE SYST, V5, P187, DOI 10.1016/0924-7963(94)90046-9; Ramirez T, 2005, ESTUAR COAST SHELF S, V65, P654, DOI 10.1016/j.ecss.2005.07.012; Renault L, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007659; Reul A, 2005, CONT SHELF RES, V25, P589, DOI 10.1016/j.csr.2004.09.016; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; Ruiz J, 2001, J MARINE SYST, V29, P277, DOI 10.1016/S0924-7963(01)00020-3; Sanchez-Garrido JC, 2013, PROG OCEANOGR, V116, P142, DOI 10.1016/j.pocean.2013.07.002; Sarhan T, 2000, J MARINE SYST, V23, P317, DOI 10.1016/S0924-7963(99)00068-8; Sheng JY, 2001, J PHYS OCEANOGR, V31, P3146, DOI 10.1175/1520-0485(2001)031<3146:DOABDC>2.0.CO;2; Skliris N, 2009, OCEAN DYNAM, V59, P489, DOI 10.1007/s10236-009-0185-6; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Soto-Navarro J, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006302; SPALL MA, 1995, J GEOPHYS RES-OCEANS, V100, P2543, DOI 10.1029/94JC02860; Speich S, 1996, J PHYS OCEANOGR, V26, P320, DOI 10.1175/1520-0485(1996)026<0320:ASOCPS>2.0.CO;2; Stips A.K., 2006, GEOPH RES ABSTR, V8; Taupier-Letage I, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/1999JC000117; TINTORE J, 1991, J PHYS OCEANOGR, V21, P811, DOI 10.1175/1520-0485(1991)021<0811:MDAVMI>2.0.CO;2; TINTORE J, 1988, J PHYS OCEANOGR, V18, P1384, DOI 10.1175/1520-0485(1988)018<1384:ASOAID>2.0.CO;2; Tintore J, 2013, MAR TECHNOL SOC J, V47, P101, DOI 10.4031/MTSJ.47.1.10; Uitz J, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004055; Vargas-Yanez M, 2002, J MARINE SYST, V35, P229, DOI 10.1016/S0924-7963(02)00128-8; VIDEAU C, 1994, J MARINE SYST, V5, P235, DOI 10.1016/0924-7963(94)90049-3; Viudez A, 1996, J PHYS OCEANOGR, V26, P684, DOI 10.1175/1520-0485(1996)026<0684:CITASA>2.0.CO;2; Viudez A, 1997, J PHYS OCEANOGR, V27, P175, DOI 10.1175/1520-0485(1997)027<0175:OTRVOT>2.0.CO;2; Viudez A, 1998, J GEOPHYS RES-OCEANS, V103, P21653, DOI 10.1029/98JC01082; Volpe G, 2012, REMOTE SENS ENVIRON, V117, P223, DOI 10.1016/j.rse.2011.09.020; Wang DP, 2011, OCEAN MODEL, V38, P161, DOI 10.1016/j.ocemod.2011.02.012; WANG DP, 1993, J MAR RES, V51, P497, DOI 10.1357/0022240933224034; Yoshikawa Y, 2012, J PHYS OCEANOGR, V42, P991, DOI 10.1175/JPO-D-11-0154.1	63	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111482	10.1371/journal.pone.0111482	http://dx.doi.org/10.1371/journal.pone.0111482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372789	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900050
J	Severino, V; Farina, A; Fleischmann, F; Dalio, RJD; Di Maro, A; Scognamiglio, M; Fiorentino, A; Parente, A; Osswald, W; Chambery, A				Severino, Valeria; Farina, Annarita; Fleischmann, Frank; Dalio, Ronaldo J. D.; Di Maro, Antimo; Scognamiglio, Monica; Fiorentino, Antonio; Parente, Augusto; Osswald, Wolfgang; Chambery, Angela			Molecular Profiling of the Phytophthora plurivora Secretome: A Step towards Understanding the Cross-Talk between Plant Pathogenic Oomycetes and Their Hosts	PLOS ONE			English	Article							EFFECTOR AVR3A; RXLR EFFECTORS; EXPRESSION; ZOOSPORES; DEFENSE; ELICITINS; VIRULENCE; PROTEINS; FAMILY; SOJAE	The understanding of molecular mechanisms underlying host-pathogen interactions in plant diseases is of crucial importance to gain insights on different virulence strategies of pathogens and unravel their role in plant immunity. Among plant pathogens, Phytophthora species are eliciting a growing interest for their considerable economical and environmental impact. Plant infection by Phytophthora phytopathogens is a complex process coordinated by a plethora of extracellular signals secreted by both host plants and pathogens. The characterization of the repertoire of effectors secreted by oomycetes has become an active area of research for deciphering molecular mechanisms responsible for host plants colonization and infection. Putative secreted proteins by Phytophthora species have been catalogued by applying high-throughput genome-based strategies and bioinformatic approaches. However, a comprehensive analysis of the effective secretome profile of Phytophthora is still lacking. Here, we report the first large-scale profiling of P. plurivora secretome using a shotgun LC-MS/MS strategy. To gain insight on the molecular signals underlying the cross-talk between plant pathogenic oomycetes and their host plants, we also investigate the quantitative changes of secreted protein following interaction of P. plurivora with the root exudate of Fagus sylvatica which is highly susceptible to the root pathogen. We show that besides known effectors, the expression and/or secretion levels of cell-wall-degrading enzymes were altered following the interaction with the host plant root exudate. In addition, a characterization of the F. sylvatica root exudate was performed by NMR and amino acid analysis, allowing the identification of the main released low-molecular weight components, including organic acids and free amino acids. This study provides important insights for deciphering the extracellular network involved in the highly susceptible P. plurivora-F. sylvatica interaction.	[Severino, Valeria; Di Maro, Antimo; Scognamiglio, Monica; Fiorentino, Antonio; Parente, Augusto; Chambery, Angela] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Farina, Annarita] Univ Geneva, Dept Human Prot Sci, Geneva, Switzerland; [Fleischmann, Frank; Dalio, Ronaldo J. D.; Osswald, Wolfgang] Tech Univ Munich, Sect Pathol Woody Plants, Freising Weihenstephan, Germany; [Chambery, Angela] IRCCS Multimed, Milan, Italy	Universita della Campania Vanvitelli; University of Geneva; Technical University of Munich; IRCCS Multimedica	Osswald, W (corresponding author), Tech Univ Munich, Sect Pathol Woody Plants, Freising Weihenstephan, Germany.	osswald@wzw.tum.de; angela.chambery@unina2.it	Scognamiglio, Monica/AAJ-6957-2020; Scognamiglio, Monica/U-1116-2017; Farina, Annarita/Y-7835-2019; Fiorentino, Antonio/W-3531-2018; Dalio, Ronaldo J. D./E-8151-2015	Scognamiglio, Monica/0000-0001-9614-0929; Farina, Annarita/0000-0002-0099-4557; Fiorentino, Antonio/0000-0002-9439-7074; Chambery, Angela/0000-0002-5136-0941; Dalio, Ronaldo J. D./0000-0002-1457-4828	German Research Foundation (DFG); Technische Universitat Munchen within the funding programme Open Access Publishing; European project COST Action [FP0801]	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen within the funding programme Open Access Publishing; European project COST Action	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The authors acknowledge the European project COST Action FP0801 for supporting researchers cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075072, 10.1371/journal.pone.0053810]; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch PRJ, 2009, J EXP BOT, V60, P1133, DOI 10.1093/jxb/ern353; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Bircher U, 1997, MYCOL RES, V101, P395, DOI 10.1017/S0953756296002730; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Brummer M, 2002, PHYSIOL MOL PLANT P, V61, P109, DOI [10.1016/S0885-5765(02)90419-4, 10.1006/pmpp.2002.0419]; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CLARKE DD, 1966, NATURE, V211, P649, DOI 10.1038/211649a0; Dalio RJD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087860; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong SM, 2014, SCIENCE, V343, P552, DOI 10.1126/science.1246300; Erwin D. C., 1996, Phytophthora diseases worldwide.; Farina A, 2011, PROTEOMICS, V11, P3972, DOI 10.1002/pmic.201100063; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Fleischmann F, 2005, PLANT BIOLOGY, V7, P650, DOI 10.1055/s-2005-872891; Gaulin E, 2006, PLANT CELL, V18, P1766, DOI 10.1105/tpc.105.038687; Gluck F, 2013, J PROTEOMICS, V79, P146, DOI 10.1016/j.jprot.2012.12.012; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hansen EM, 2012, ANNU REV PHYTOPATHOL, V50, P359, DOI 10.1146/annurev-phyto-081211-172946; Heiser I, 1999, PLANT PHYSIOL BIOCH, V37, P73, DOI 10.1016/S0981-9428(99)80069-2; Henniger H, 1963, Z ALLG MIKROBIOL, V3, P126, DOI DOI 10.1002/JOBM.3630030204; HICKMAN CJ, 1966, ANNU REV PHYTOPATHOL, V14, P195; HUET JC, 1989, FEBS LETT, V257, P302, DOI 10.1016/0014-5793(89)81557-1; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Iriti M, 2009, J AGR FOOD CHEM, V57, P201, DOI 10.1021/jf802819m; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; Judelson HS, 2005, NAT REV MICROBIOL, V3, P47, DOI 10.1038/nrmicro1064; Jung T, 2009, FOREST PATHOL, V39, P73, DOI 10.1111/j.1439-0329.2008.00566.x; Jung T, 2000, PLANT PATHOL, V49, P706, DOI 10.1046/j.1365-3059.2000.00521.x; Jung Thomas, 2005, Mycologist, V19, P159, DOI 10.1017/S0269915X05004052; KAMOUN S, 1994, APPL ENVIRON MICROB, V60, P1593, DOI 10.1128/AEM.60.5.1593-1598.1994; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P1028, DOI 10.1094/MPMI.1997.10.8.1028; Kamoun S, 2009, MYCOTA, P173; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Lackie J, 1981, BIOL CHEMOTACTIC RES; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2006, MOL PLANT MICROBE IN, V19, P1368, DOI 10.1094/MPMI-19-1368; McLeod A, 2003, FUNGAL GENET BIOL, V38, P250, DOI 10.1016/S1087-1845(02)00523-6; Meijer HJG, 2014, MOL CELL PROTEOMICS, V13, P2101, DOI 10.1074/mcp.M113.035873; Mikes V, 1998, BIOCHEM BIOPH RES CO, V245, P133, DOI 10.1006/bbrc.1998.8341; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; MORRIS PF, 1992, PHYSIOL MOL PLANT P, V40, P17, DOI 10.1016/0885-5765(92)90067-6; Osswald W, 2014, FOREST PATHOL, V44, P169, DOI 10.1111/efp.12096; Pemberton CL, 2004, MOL PLANT PATHOL, V5, P353, DOI 10.1111/j.1364-3703.2004.00235.x; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rocco M, 2011, J PROTEOME RES, V10, P4703, DOI 10.1021/pr200511f; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Seidl MF, 2011, PLANT PHYSIOL, V155, P628, DOI 10.1104/pp.110.167841; Severino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.445; Severino V, 2013, BBA-PROTEINS PROTEOM, V1834, P2385, DOI 10.1016/j.bbapap.2012.12.005; Severino Valeria, 2013, Methods Mol Biol, V1002, P37, DOI 10.1007/978-1-62703-360-2_4; Shah P, 2009, PROTEOMICS, V9, P3126, DOI 10.1002/pmic.200800933; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tousson T, 1970, ROOT DIS SOIL BORNE; Tyler BM, 2002, ANNU REV PHYTOPATHOL, V40, P137, DOI 10.1146/annurev.phyto.40.120601.125310; Tyler BM, 1996, APPL ENVIRON MICROB, V62, P2811, DOI 10.1128/AEM.62.8.2811-2817.1996; Valcu CM, 2009, J PROTEOME RES, V8, P4077, DOI 10.1021/pr900456c; YU LM, 1995, P NATL ACAD SCI USA, V92, P4088, DOI 10.1073/pnas.92.10.4088; ZENTMYER GA, 1961, SCIENCE, V133, P1595, DOI 10.1126/science.133.3464.1595	73	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112317	10.1371/journal.pone.0112317	http://dx.doi.org/10.1371/journal.pone.0112317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372870	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900132
J	Fu, YF; Lu, ZJ; Li, PH; Cao, YM; Sun, P; Tian, MN; Wang, N; Bao, HF; Bai, XW; Li, D; Chen, YL; Liu, ZX				Fu, Yuanfang; Lu, Zengjun; Li, Pinghua; Cao, Yimei; Sun, Pu; Tian, Meina; Wang, Na; Bao, Huifang; Bai, Xingwen; Li, Dong; Chen, Yingli; Liu, Zaixin			Development of a Blocking ELISA Based on a Monoclonal Antibody against a Predominant Epitope in Non-Structural Protein 3B2 of Foot-and-Mouth Disease Virus for Differentiating Infected from Vaccinated Animals	PLOS ONE			English	Article							CATTLE; IDENTIFICATION; ASSAY	A monoclonal antibody (McAb) against non-structural protein (NSP) 3B of foot-mouth-disease virus (FMDV) (3B4B1) was generated and shown to recognize a conserved epitope spanning amino acids 24-32 of 3B (GPYAGPMER) by peptide screening ELISA. This epitope was further shown to be a unique and predominant B cell epitope in 3B2, as sera from animals infected with different serotypes of FMDV blocked the ability of McAb 3B4B1 to bind to NSP 2C3AB. Also, a polyclonal antibody against NSP 2C was produced in a rabbit vaccinated with 2C epitope regions expressed in E. coli. Using McAb 3B4B1 and the 2C polyclonal antibody, a solid-phase blocking ELISA (SPB-ELISA) was developed for the detection of antibodies against NSP 2C3AB to distinguish FMDV-infected from vaccinated animals (DIVA test). The parameters for this SPB-ELISA were established by screening panels of sera of different origins. Serum samples with a percent inhibition (PI) greater than or equal to 46% were considered to be from infected animals, and a PI lower than 46% was considered to indicate a non-infected animal. This test showed a similar performance as the commercially available PrioCHECK NS ELISA. This is the first description of the conserved and predominant GPYAGPMER epitope of 3B and also the first report of a DIVA test for FMDV NSP 3B based on a McAb against this epitope.	[Fu, Yuanfang; Lu, Zengjun; Li, Pinghua; Cao, Yimei; Sun, Pu; Tian, Meina; Wang, Na; Bao, Huifang; Bai, Xingwen; Li, Dong; Chen, Yingli; Liu, Zaixin] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Lu, ZJ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	luzengjun@caas.cn; liuzaixin@caas.cn	Li, Ping/GYV-4914-2022		national "863'' research project [2012AA101304]; General Bureau of Quality Supervision, Inspection, and Quarantine of the People's Republic of China [201410061]	national "863'' research project; General Bureau of Quality Supervision, Inspection, and Quarantine of the People's Republic of China	This study was supported by a national "863'' research project (grant no. 2012AA101304) and a research grant for public welfare from the General Bureau of Quality Supervision, Inspection, and Quarantine of the People's Republic of China (grant no. 201410061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010735; Bergmann IE, 2000, ARCH VIROL, V145, P473, DOI 10.1007/s007050050040; Brocchi E, 2006, VACCINE, V24, P6966, DOI 10.1016/j.vaccine.2006.04.050; Clavijo A, 2004, VET J, V167, P9, DOI 10.1016/S1090-0233(03)00087-X; Earley EM, 1985, J TISSUE CULT METHOD, V9, P129; Fu YF, 2011, J VIROL METHODS, V171, P234, DOI 10.1016/j.jviromet.2010.11.006; Gao MC, 2012, APPL MICROBIOL BIOT, V93, P1271, DOI 10.1007/s00253-011-3815-0; Hohlich BJ, 2003, J VIROL, V77, P8633, DOI 10.1128/JVI.77.16.8633-8639.2003; Lu ZJ, 2007, VET MICROBIOL, V125, P157, DOI 10.1016/j.vetmic.2007.05.017; Lu ZJ, 2010, J VIROL METHODS, V170, P128, DOI 10.1016/j.jviromet.2010.09.016; Oem Jae Ku, 2005, J Vet Sci, V6, P317; Oem JK, 2007, J VIROL METHODS, V142, P174, DOI 10.1016/j.jviromet.2007.01.025; Office International des Epizooties OIE, 2012, MAN STAND DIAGN TEST; Paton DJ, 2006, VACCINE, V24, P6503, DOI 10.1016/j.vaccine.2006.06.032; Sorensen KJ, 2005, ARCH VIROL, V150, P805, DOI 10.1007/s00705-004-0455-z; Uddowla S, 2012, J VIROL, V86, P11675, DOI 10.1128/JVI.01254-12; Yang M, 2007, J IMMUNOL METHODS, V321, P174, DOI 10.1016/j.jim.2007.01.016	17	6	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111737	10.1371/journal.pone.0111737	http://dx.doi.org/10.1371/journal.pone.0111737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369323	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000096
J	Yang, SG; Wang, YY; Mei, KR; Zhang, S; Sun, XJ; Ren, FL; Liu, SH; Yang, Z; Wang, XQ; Qin, ZH; Chang, ZJ				Yang, Shigao; Wang, Yinyin; Mei, Kunrong; Zhang, Sen; Sun, Xiaojun; Ren, Fangli; Liu, Sihan; Yang, Zi; Wang, Xinquan; Qin, Zhihai; Chang, Zhijie			Tumor Necrosis Factor Receptor 2 (TNFR2)center dot Interleukin-17 Receptor D (IL-17RD) Heteromerization Reveals a Novel Mechanism for NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF RECEPTOR; LIGAND; KIDNEY; CELLS; HSEF; SEF; LOCALIZATION; EXPRESSION; APOPTOSIS; ALPHA	TNF receptor 2 (TNFR2) exerts diverse roles in the pathogenesis of inflammatory and autoimmune diseases. Here, we report that TNFR2 but not TNFR1 forms a heteromer with interleukin-17 receptor D (IL-17RD), also named Sef, to activate NF-kappa B signaling. TNFR2 associates with IL-17RD, leading to mutual receptor aggregation and TRAF2 recruitment, which further activate the downstream cascade of NF-kappa B signaling. Depletion of IL-17RD impaired TNFR2-mediated activation of NF-kappa B signaling. Importantly, IL-17RD was markedly increased in renal tubular epithelial cells in nephritis rats, and a strong interaction of TNFR2 and IL-17RD was observed in the renal epithelia. The IL-17RD center dot TNFR2 complex in activation of NF-kappa B may explain the role of TNFR2 in inflammatory diseases including nephritis.	[Yang, Shigao; Wang, Yinyin; Sun, Xiaojun; Ren, Fangli; Liu, Sihan; Yang, Zi; Chang, Zhijie] Tsinghua Univ, Sch Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Yang, Shigao; Wang, Yinyin; Sun, Xiaojun; Ren, Fangli; Liu, Sihan; Yang, Zi; Chang, Zhijie] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China; [Yang, Shigao] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China; [Mei, Kunrong; Wang, Xinquan] Tsinghua Univ, Struct Biol Ctr, Sch Life Sci, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Zhang, Sen] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Zhang, Sen] Peking Union Med Coll, Beijing 100050, Peoples R China; [Qin, Zhihai] Chinese Acad Sci, Key Lab Prot & Peptide Pharmaceut, Chinese Acad Sci Univ Tokyo Joint Lab Struct Viro, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Sichuan University; Chinese Academy of Sciences; Institute of Process Engineering, CAS; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chang, ZJ (corresponding author), Tsinghua Univ, Sch Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	zhijiec@tsinghua.edu.cn	SUN, XIAOJUN/I-8018-2014; Mei, Kunrong/F-4553-2019; Chang, Zhijie/AAH-8109-2019	SUN, XIAOJUN/0000-0003-3710-8560; Mei, Kunrong/0000-0001-7827-2944; Chang, Zhijie/0000-0003-1567-3227; Qin, Zhihai/0000-0001-9793-7964; Yang, Shigao/0000-0003-2717-6914	973 Project [2011CB910502]; National Natural Science Foundation of China [30871286, 31071225, 31030040, 91229203]; Tsinghua Science Foundation [20121080018]; Natural Science Foundation of Beijing [511003]; Major Program [2013ZX08011-006]; 863 project in China [2012AA021703]	973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua Science Foundation; Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Major Program; 863 project in China(National High Technology Research and Development Program of China)	This work was supported by grants from the 973 Project (2011CB910502), the National Natural Science Foundation of China (30871286, 31071225, 31030040, and 91229203), the Tsinghua Science Foundation (20121080018), the Natural Science Foundation of Beijing (511003), the Major Program (2013ZX08011-006), and the 863 project (2012AA021703) in China.	Ait-Ali D, 2008, ENDOCRINOLOGY, V149, P2840, DOI 10.1210/en.2007-1192; Akassoglou K, 2003, P NATL ACAD SCI USA, V100, P709, DOI 10.1073/pnas.0236046100; Al-Lamki RS, 2005, FASEB J, V19, P1637, DOI 10.1096/fj.05-3841com; Al-Lamki RS, 2001, LAB INVEST, V81, P1503, DOI 10.1038/labinvest.3780364; Aten J, 2000, J AM SOC NEPHROL, V11, P1426, DOI 10.1681/ASN.V1181426; Bruggeman LA, 2011, LAB INVEST, V91, P413, DOI 10.1038/labinvest.2010.199; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; de Haij S, 2005, J AM SOC NEPHROL, V16, P1603, DOI 10.1681/ASN.2004090781; Douni E, 1998, J EXP MED, V188, P1343, DOI 10.1084/jem.188.7.1343; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Fuchs Y, 2012, DEV CELL, V23, P611, DOI 10.1016/j.devcel.2012.07.013; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Haridas V, 1998, J IMMUNOL, V160, P3152; Horiuchi T, 2007, ANN RHEUM DIS, V66, P320, DOI 10.1136/ard.2006.058917; Ozcan A, 2012, AM J NEPHROL, V35, P356, DOI 10.1159/000337918; Pinckard JK, 1997, J BIOL CHEM, V272, P10784; Ramesh G, 2003, AM J PHYSIOL-RENAL, V285, pF610, DOI 10.1152/ajprenal.00101.2003; Ren YM, 2008, CELL SIGNAL, V20, P518, DOI 10.1016/j.cellsig.2007.11.010; Ren YM, 2007, BIOCHEM BIOPH RES CO, V354, P741, DOI 10.1016/j.bbrc.2007.01.037; Rodriguez M, 2011, J BIOL CHEM, V286, P22814, DOI 10.1074/jbc.M111.225631; Rong ZL, 2009, CELL RES, V19, P208, DOI 10.1038/cr.2008.320; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vielhauer V, 2005, J CLIN INVEST, V115, P1199, DOI 10.1172/JCI200523348; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Xiong SQ, 2003, J BIOL CHEM, V278, P50273, DOI 10.1074/jbc.M306936200; Yang RB, 2003, J BIOL CHEM, V278, P33232, DOI 10.1074/jbc.M305022200; Zhang S, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/819296	30	20	21	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					861	871		10.1074/jbc.M114.586560	http://dx.doi.org/10.1074/jbc.M114.586560			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25378394	Green Published, hybrid			2022-12-26	WOS:000347778200016
J	Lee, EF; Dewson, G; Evangelista, M; Pettikiriarachchi, A; Gold, GJ; Zhu, HR; Colman, PM; Fairlie, WD				Lee, Erinna F.; Dewson, Grant; Evangelista, Marco; Pettikiriarachchi, Anne; Gold, Grace J.; Zhu, Haoran; Colman, Peter M.; Fairlie, W. Douglas			The Functional Differences between Pro-survival and Pro-apoptotic B Cell Lymphoma 2 (Bcl-2) Proteins Depend on Structural Differences in Their Bcl-2 Homology 3 (BH3) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PERMEABILIZATION; PEPTIDE COMPLEX; CRYSTAL-STRUCTURE; BH3-ONLY LIGANDS; FAMILY-MEMBERS; SWAPPED DIMER; HIGH-AFFINITY; X-RAY; BAX; MCL-1	Bcl-2 homology 3 (BH3) domains are short sequence motifs that mediate nearly all protein-protein interactions between B cell lymphoma 2 (Bcl-2) family proteins in the intrinsic apoptotic cell death pathway. These sequences are found on both prosurvival and pro-apoptotic members, although their primary function is believed to be associated with induction of cell death. Here, we identify critical features of the BH3 domains of prosurvival proteins that distinguish them functionally from their pro-apoptotic counterparts. Biochemical and x-ray crystallographic studies demonstrate that these differences reduce the capacity of most pro-survival proteins to form high affinity "BH3-in-groove" complexes that are critical for cell death induction. Switching these residues for the corresponding residues in Bcl-2 homologous antagonist/killer (Bak) increases the binding affinity of isolated BH3 domains for pro-survival proteins; however, their exchange in the context of the parental protein causes rapid proteasomal degradation due to protein destabilization. This is supported by further x-ray crystallographic studies that capture elements of this destabilization in one pro-survival protein, Bcl-w. In pro-apoptotic Bak, we demonstrate that the corresponding distinguishing residues are important for its cell-killing capacity and antagonism by prosurvival proteins.	[Lee, Erinna F.; Dewson, Grant; Evangelista, Marco; Pettikiriarachchi, Anne; Gold, Grace J.; Zhu, Haoran; Colman, Peter M.; Fairlie, W. Douglas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Lee, Erinna F.; Dewson, Grant; Gold, Grace J.; Zhu, Haoran; Colman, Peter M.; Fairlie, W. Douglas] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Fairlie, WD (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol Div, 1G Royal Pde, Parkville, Vic 3052, Australia.	fairlie@wehi.edu.au	Fairlie, Walter/M-8401-2015; Lee, Erinna/N-1523-2015; dewson, grant/C-7646-2013	Fairlie, Walter/0000-0002-2498-1160; Lee, Erinna/0000-0003-1255-9808; dewson, grant/0000-0003-4251-8898	National Health and Medical Research Council (NHMRC) of Australia [1016701, 1041936, 1008329, 1024620, SPRF 1022618]; Australian Research Council Fellowship [FT100100791]; Cancer Council of Victoria [1057949]; NHMRC IRIISS Grant [361646]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Fellowship(Australian Research Council); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NHMRC IRIISS Grant(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants and fellowships from the National Health and Medical Research Council (NHMRC) of Australia (Program Grant 1016701 (to P. M. C.), Project Grants 1041936 and 1008329 (to W. D. F. and P. M. C.), Career Development Fellowship 1024620 (to E. F. L.), and SPRF 1022618 (to P. M. C.)), Australian Research Council Fellowship FT100100791 (to G. D.), and Cancer Council of Victoria Grant-in-aid 1057949. Infrastructure support was provided by NHMRC IRIISS Grant 361646 and the Victorian State Government OIS grant.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brouwer JM, 2014, MOL CELL, V55, P938, DOI 10.1016/j.molcel.2014.07.016; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chang BS, 1999, MOL CELL BIOL, V19, P6673; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen TS, 2013, J MOL BIOL, V425, P171, DOI 10.1016/j.jmb.2012.11.009; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; CLARKE MF, 1995, P NATL ACAD SCI USA, V92, P11024, DOI 10.1073/pnas.92.24.11024; Cosulich SC, 1997, CURR BIOL, V7, P913, DOI 10.1016/S0960-9822(06)00410-6; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Denisov AY, 2003, J BIOL CHEM, V278, P21124, DOI 10.1074/jbc.M301798200; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Dutta S, 2013, ACS CHEM BIOL, V8, P778, DOI 10.1021/cb300679a; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foight GW, 2014, ACS CHEM BIOL, V9, P1962, DOI 10.1021/cb500340w; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Lee EF, 2008, J CELL BIOL, V180, P341, DOI 10.1083/jcb.200708096; Lee EF, 2011, STRUCTURE, V19, P1467, DOI 10.1016/j.str.2011.07.015; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindenboim L, 2005, CELL DEATH DIFFER, V12, P713, DOI 10.1038/sj.cdd.4401638; Lindenboim L, 2001, CELL DEATH DIFFER, V8, P933, DOI 10.1038/sj.cdd.4400888; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Ma S, 2013, J BIOL CHEM, V288, P26027, DOI 10.1074/jbc.M113.490094; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Mitra RS, 2001, NEOPLASIA, V3, P437, DOI 10.1038/sj.neo.7900181; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ofengeim D, 2012, NAT NEUROSCI, V15, P574, DOI 10.1038/nn.3054; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; Oh KJ, 2010, J BIOL CHEM, V285, P28924, DOI 10.1074/jbc.M110.135293; Otwinowski Z, 1997, METHODS ENZYMOL, V276, P307; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Smith BJ, 2013, CHEMBIOCHEM, V14, P1564, DOI 10.1002/cbic.201300351; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Weber A, 2013, APOPTOSIS, V18, P1093, DOI 10.1007/s10495-013-0868-9; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	73	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36001	36017		10.1074/jbc.M114.610758	http://dx.doi.org/10.1074/jbc.M114.610758			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25371206	hybrid, Green Published			2022-12-26	WOS:000346897900030
J	Tucker, AC; Taylor, KC; Rank, KC; Rayment, I; Escalante-Semerena, JC				Tucker, Alex C.; Taylor, Keenan C.; Rank, Katherine C.; Rayment, Ivan; Escalante-Semerena, Jorge C.			Insights into the Specificity of Lysine Acetyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; PROTEIN ACETYLTRANSFERASE; SUBSTRATE-SPECIFICITY; COENZYME-A; IDENTIFICATION; DEACETYLATION; RECOGNITION; VECTORS; HISTONE; CLUSPRO	Reversible lysine acetylation by protein acetyltransferases is a conserved regulatory mechanism that controls diverse cellular pathways. Gcn5-related N-acetyltransferases (GNATs), named after their founding member, are found in all domains of life. GNATs are known for their role as histone acetyltransferases, but non-histone bacterial protein acetytransferases have been identified. Only structures of GNAT complexes with short histone peptide substrates are available in databases. Given the biological importance of this modification and the abundance of lysine in polypeptides, how specificity is attained for larger protein substrates is central to understanding acetyl-lysine-regulated networks. Here we report the structure of a GNAT in complex with a globular protein substrate solved to 1.9 angstrom. GNAT binds the protein substrate with extensive surface interactions distinct from those reported for GNAT-peptide complexes. Our data reveal determinants needed for the recognition of a protein substrate and provide insight into the specificity of GNATs.	[Tucker, Alex C.; Escalante-Semerena, Jorge C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Taylor, Keenan C.; Rank, Katherine C.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University System of Georgia; University of Georgia; University of Wisconsin System; University of Wisconsin Madison	Escalante-Semerena, JC (corresponding author), Univ Georgia, Dept Microbiol, 212C Biol Sci Bldg,120 Cedar St, Athens, GA 30602 USA.	jcescala@uga.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083987, T32GM007215, R01GM062203] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Simon Dove for plasmids and strains. Part of the results shown in this report were obtained at the Argonne National Laboratory Structural Biology Center at the Advanced Photon Source. The University of Chicago Argonne, LLC operates Argonne National Laboratory for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERKOWIT.D, 1968, J BACTERIOL, V96, P215, DOI 10.1128/JB.96.1.215-220.1968; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Castang S, 2010, MOL MICROBIOL, V78, P916, DOI 10.1111/j.1365-2958.2010.07378.x; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Crosby HA, 2014, J BACTERIOL, V196, P1496, DOI 10.1128/JB.00004-14; Crosby HA, 2012, J BIOL CHEM, V287, P41392, DOI 10.1074/jbc.M112.417360; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; Elion E. A., 2007, CURRENT PROTOCOLS MO; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedmann DR, 2013, FEBS J, V280, P5570, DOI 10.1111/febs.12373; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V290, P397, DOI 10.1006/bbrc.2001.6152; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Rayment I, 2002, STRUCTURE, V10, P147, DOI 10.1016/S0969-2126(02)00711-6; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Sasse J., 1991, CURRENT PROTOCOLS MO; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Thao S, 2011, CURR OPIN MICROBIOL, V14, P200, DOI 10.1016/j.mib.2010.12.013; Tucker AC, 2013, MOL MICROBIOL, V87, P152, DOI 10.1111/mmi.12088; Tucker AC, 2010, J BACTERIOL, V192, P6200, DOI 10.1128/JB.00874-10; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181	45	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36249	36262		10.1074/jbc.M114.613901	http://dx.doi.org/10.1074/jbc.M114.613901			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25381442	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000346897900049
J	Zhao, BZ; Shah, P; Budanov, AV; Qiang, L; Ming, M; Aplin, A; Sims, DM; He, YY				Zhao, Baozhong; Shah, Palak; Budanov, Andrei V.; Qiang, Lei; Ming, Mei; Aplin, Andrew; Sims, Diane M.; He, Yu-Ying			Sestrin2 Protein Positively Regulates AKT Enzyme Signaling and Survival in Human Squamous Cell Carcinoma and Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; P53 TUMOR-SUPPRESSOR; DNA-DAMAGE; GENOTOXIC STRESS; NRF2; SKIN; MUTATIONS; APOPTOSIS; AUTOPHAGY; TARGET	Skin cancer is the most common cancer in the United States and is mainly caused by environmental UV radiation. Reducing skin cancer incidence is becoming an urgent issue. The stress-inducible protein Sestrin2 (Sesn2) plays an important role in maintaining redox and metabolic homeostasis and their related pathologies. However, the role of Sesn2 in cancer remains unclear. Here we show that UVB radiation induces Sesn2 expression in normal human keratinocytes, mouse skin, normal human melanocytes, and melanoma cells. In addition, Sesn2 promotes AKT activation through a PTEN-dependent mechanism. Sesn2 deletion or knockdown sensitizes squamous cell carcinoma (SCC) cells to 5-fluorouracil-induced apoptosis and melanoma cells to UVB- and vemurafenib-induced apoptosis. In mice Sesn2 knockdown suppresses tumor growth from injected human SCC and melanoma cells. Last, as compared with normal skin, Sesn2 is up-regulated in both human skin SCC and melanoma. Our findings demonstrate that Sesn2 promotes AKT activation and survival in response to UVB stress and chemotherapeutics and suggest that Sesn2 is oncogenic in skin SCC and melanoma.	[Zhao, Baozhong; Shah, Palak; Qiang, Lei; Ming, Mei; Sims, Diane M.; He, Yu-Ying] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA; [Budanov, Andrei V.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Aplin, Andrew] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Aplin, Andrew] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	University of Chicago; Virginia Commonwealth University; Jefferson University; Jefferson University	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu	Budanov, Andrei V/HGD-5487-2022; Qiang, Lei/B-2763-2012	Budanov, Andrei V/0000-0002-7943-1000; Qiang, Lei/0000-0002-7164-3164	National Institutes of Health (NIEHS) [ES016936]; National Institutes of Health (NCI) [CA172660]; National Institutes of Health (NIGMS) [GM067983]; National Institutes of Health (University of Chicago Cancer Research Center) [P30 CA014599]; National Institutes of Health [UL1 TR000430]; American Cancer Society Grant [RSG-13-078-01]; University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE [R01CA172660, P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016936] Funding Source: NIH RePORTER	National Institutes of Health (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (University of Chicago Cancer Research Center); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Grant(American Cancer Society); University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES016936 (NIEHS; to Y.-Y. H.), CA172660 (NCI; to A. B.), GM067983 (NIGMS; to A. A.), P30 CA014599 (University of Chicago Cancer Research Center, and UL1 TR000430 (Clinical and Translational Science Award). This work was also supported by American Cancer Society Grant RSG-13-078-01 (to Y.-Y. H.) and the University of Chicago Friends of Dermatology Endowment Fund.	Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Ben-Sahra I, 2013, CELL DEATH DIFFER, V20, P611, DOI 10.1038/cdd.2012.157; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2011, ANTIOXID REDOX SIGN, V15, P1679, DOI 10.1089/ars.2010.3530; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Cam M, 2014, J BIOL CHEM, V289, P4083, DOI 10.1074/jbc.M113.530303; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Claerhout S, 2010, INT J CANCER, V127, P2790, DOI 10.1002/ijc.25300; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Han WN, 2012, J BIOL CHEM, V287, P18788, DOI 10.1074/jbc.M112.363614; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Lee SO, 2012, ONCOGENE, V31, P3265, DOI 10.1038/onc.2011.504; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Marionnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012059; Ming M, 2011, CANCER RES, V71, P5287, DOI 10.1158/0008-5472.CAN-10-4614; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Miura S, 2014, J INVEST DERMATOL, V134, P553, DOI 10.1038/jid.2013.343; Qiang L, 2014, AUTOPHAGY, V10, P1864, DOI 10.4161/auto.32171; Qiang L, 2013, J BIOL CHEM, V288, P1603, DOI 10.1074/jbc.M112.415224; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Ragnarsson G, 1999, BRIT J CANCER, V79, P1468, DOI 10.1038/sj.bjc.6690234; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sanli T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032035; Schwab M, 1996, GENE CHROMOSOME CANC, V16, P211, DOI 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu CL, 2013, ONCOGENE, V32, P2682, DOI 10.1038/onc.2012.279; Yang YL, 2013, EXP GERONTOL, V48, P371, DOI 10.1016/j.exger.2012.12.011	40	36	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35806	35814		10.1074/jbc.M114.595397	http://dx.doi.org/10.1074/jbc.M114.595397			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378405	Green Published, hybrid			2022-12-26	WOS:000346897900012
J	Nilsson, S; Sjoberg, J; Amundin, M; Hartmann, C; Buettner, A; Laska, M				Nilsson, Sara; Sjoberg, Johanna; Amundin, Mats; Hartmann, Constanze; Buettner, Andrea; Laska, Matthias			Behavioral Responses to Mammalian Blood Odor and a Blood Odor Component in Four Species of Large Carnivores	PLOS ONE			English	Article							MONKEYS ATELES-GEOFFROYI; OLFACTORY SENSITIVITY; ALIPHATIC ESTERS; URINE-MARKING; ALCOHOLS; RATS; MICE; CONSPECIFICS; ALDEHYDES; BEARS	Only little is known about whether single volatile compounds are as efficient in eliciting behavioral responses in animals as the whole complex mixture of a behaviorally relevant odor. Recent studies analysing the composition of volatiles in mammalian blood, an important prey-associated odor stimulus for predators, found the odorant trans-4,5-epoxy-(E)-2-decenal to evoke a typical "metallic, blood-like'' odor quality in humans. We therefore assessed the behavior of captive Asian wild dogs (Cuon alpinus), African wild dogs (Lycaon pictus), South American bush dogs (Speothos venaticus), and Siberian tigers (Panthera tigris altaica) when presented with wooden logs that were impregnated either with mammalian blood or with the blood odor component trans-4,5-epoxy-(E)-2-decenal, and compared it to their behavior towards a fruity odor (iso-pentyl acetate) and a near-odorless solvent (diethyl phthalate) as control. We found that all four species displayed significantly more interactions with the odorized wooden logs such as sniffing, licking, biting, pawing, and toying, when they were impregnated with the two prey-associated odors compared to the two non-prey-associated odors. Most importantly, no significant differences were found in the number of interactions with the wooden logs impregnated with mammalian blood and the blood odor component in any of the four species. Only one of the four species, the South American bush dogs, displayed a significant decrease in the number of interactions with the odorized logs across the five sessions performed per odor stimulus. Taken together, the results demonstrate that a single blood odor component can be as efficient in eliciting behavioral responses in large carnivores as the odor of real blood, suggesting that trans-4,5-epoxy-(E)2-decenal may be perceived by predators as a "character impact compound'' of mammalian blood odor. Further, the results suggest that odorized wooden logs are a suitable manner of environmental enrichment for captive carnivores.	[Nilsson, Sara; Sjoberg, Johanna; Laska, Matthias] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Amundin, Mats] Kolmarden Wildlife Pk, Kolmarden, Sweden; [Hartmann, Constanze; Buettner, Andrea] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91054 Erlangen, Germany	Linkoping University; University of Erlangen Nuremberg	Laska, M (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden.	malas@ifm.liu.se	Buettner, Andrea/E-2510-2011	Buettner, Andrea/0000-0002-6205-5125; Laska, Matthias/0000-0001-5583-2697	Kolmarden Wildlife Park	Kolmarden Wildlife Park	The animal caretakers at Kolmarden Wildlife Park involved in this study are gratefully acknowledged for their help and support.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Apps P, 2013, CHEM SIGNAL, V12, P417, DOI 10.1007/978-1-4614-5927-9_33; Barja I, 2010, POL J ECOL, V58, P397; Buettner A, 2001, J AGR FOOD CHEM, V49, P3881, DOI 10.1021/jf0104329; Burdock G.A., 2009, FENAROLIS HDB FLAVOR, V6th; Clark F, 2008, CHEM SIGNAL, V11, P391, DOI 10.1007/978-0-387-73945-8_37; Clubb R, 2007, APPL ANIM BEHAV SCI, V102, P303, DOI 10.1016/j.applanim.2006.05.033; Conover R.C., 2007, PREDATOR PREY DYNAMI; Drea CM, 2002, J COMP PSYCHOL, V116, P331, DOI 10.1037//0735-7036.116.4.331; Dunkel A, 2014, ANGEW CHEM INT EDIT, V53, P7124, DOI 10.1002/anie.201309508; Fox M.W., 1984, WHISTLING HUNTERS FI; Gorman M.L., 1989, P57; Gosling L.M., 1990, Chemoecology, V1, P92, DOI 10.1007/BF01241649; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; Hone J., 2007, ANAL VERTEBRATE PEST; HORNBUCKLE PA, 1974, BEHAV BIOL, V12, P573, DOI 10.1016/S0091-6773(74)92531-0; Hutchins M., 1999, 2 NATURE ENV ENRICHM; Laska M, 2006, AM J PHYS ANTHROPOL, V129, P112, DOI 10.1002/ajpa.20252; Laska M, 2002, BEHAV BRAIN RES, V134, P165, DOI 10.1016/S0166-4328(01)00464-8; Laska M, 2006, J CHEM ECOL, V32, P1317, DOI 10.1007/s10886-006-9090-3; Lotvedt PK, 2012, PHARMACOL BIOCHEM BE, V101, P450, DOI 10.1016/j.pbb.2012.02.013; MACKAYSIM A, 1981, PHYSIOL BEHAV, V27, P503, DOI 10.1016/0031-9384(81)90339-5; MARCH KS, 1980, AM ANTHROPOL, V82, P125, DOI 10.1525/aa.1980.82.1.02a00130; McGorrin RJ., 2012, FLAVOR FRAGRANCE ODO, P207; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Nunley MC, 1981, AM ANTHROPOL, V82, P630; PORTON I, 1983, ANIM BEHAV, V31, P1061, DOI 10.1016/S0003-3472(83)80013-X; Rachamadugu S. K, 2012, THESIS LINKOPING U L; ROGERS LL, 1991, J WILDLIFE MANAGE, V55, P632, DOI 10.2307/3809511; RYON J, 1986, CAN J ZOOL, V64, P573, DOI 10.1139/z86-084; Salazar LTH, 2003, BEHAV NEUROSCI, V117, P1142, DOI 10.1037/0735-7044.117.6.1142; Sandnabba NK, 1997, BEHAV PROCESS, V41, P51, DOI 10.1016/S0376-6357(97)00028-4; Sarrafchi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080621; STEVENS DA, 1973, BEHAV BIOL, V8, P75, DOI 10.1016/S0091-6773(73)80008-2; Stoddart DM, 1980, ECOLOGY VERTEBRATE O, P63, DOI DOI 10.1007/978-94-009-5869-2_3; Terlouw EMC, 1998, APPL ANIM BEHAV SCI, V57, P9, DOI 10.1016/S0168-1591(97)00122-6; Wallen H, 2012, AMINO ACIDS, V42, P1475, DOI 10.1007/s00726-011-0951-x; Young RJ, 2003, ENV ENRICHMENT CAPTI, DOI DOI 10.1002/9780470751046	39	23	24	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112694	10.1371/journal.pone.0112694	http://dx.doi.org/10.1371/journal.pone.0112694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383706	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700089
J	Descalzo, VF; Gallego, R; Sanchez-Vives, MV				Descalzo, Vanessa F.; Gallego, Roberto; Sanchez-Vives, Maria V.			Adaptation in the Visual Cortex: Influence of Membrane Trajectory and Neuronal Firing Pattern on Slow Afterpotentials	PLOS ONE			English	Article							UNDERLYING CONTRAST ADAPTATION; NEOCORTICAL PYRAMIDAL NEURONS; CORTICAL-NEURONS; SYNAPTIC DEPRESSION; POTASSIUM CURRENTS; ACTION-POTENTIALS; GAIN-CONTROL; K+ CHANNELS; IN-VITRO; RAT	The input/output relationship in primary visual cortex neurons is influenced by the history of the preceding activity. To understand the impact that membrane potential trajectory and firing pattern has on the activation of slow conductances in cortical neurons we compared the afterpotentials that followed responses to different stimuli evoking similar numbers of action potentials. In particular, we compared afterpotentials following the intracellular injection of either square or sinusoidal currents lasting 20 seconds. Both stimuli were intracellular surrogates of different neuronal responses to prolonged visual stimulation. Recordings from 99 neurons in slices of visual cortex revealed that for stimuli evoking an equivalent number of spikes, sinusoidal current injection activated a slow afterhyperpolarization of significantly larger amplitude (8.5 +/- 3.3 mV) and duration (33 +/- 17 s) than that evoked by a square pulse (6.4 +/- 3.7 mV, 28 +/- 17 s; p<0.05). Spike frequency adaptation had a faster time course and was larger during plateau (square pulse) than during intermittent (sinusoidal) depolarizations. Similar results were obtained in 17 neurons intracellularly recorded from the visual cortex in vivo. The differences in the afterpotentials evoked with both protocols were abolished by removing calcium from the extracellular medium or by application of the L- type calcium channel blocker nifedipine, suggesting that the activation of a calcium- dependent current is at the base of this afterpotential difference. These findings suggest that not only the spikes, but the membrane potential values and firing patterns evoked by a particular stimulation protocol determine the responses to any subsequent incoming input in a time window that spans for tens of seconds to even minutes.	[Descalzo, Vanessa F.; Sanchez-Vives, Maria V.] IDIBAPS Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Gallego, Roberto] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain; [Sanchez-Vives, Maria V.] ICREA, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); ICREA	Sanchez-Vives, MV (corresponding author), IDIBAPS Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain.	msanche3@clinic.ub.es	Sanchez-Vives, Maria/J-8526-2014	Sanchez-Vives, Maria/0000-0002-8437-9083; Fernandez Descalzo, Vanessa/0000-0002-3578-4947	 [BFU2011-27094]; ICREA Funding Source: Custom	; ICREA(ICREA)	This work was supported by BFU2011-27094 to MVSV, http://www.mineco.gob.es/portal/site/mineco/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abolafia JM, 2011, CEREB CORTEX, V21, P977, DOI 10.1093/cercor/bhq163; AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; Benucci A, 2013, NAT NEUROSCI, V16, P724, DOI 10.1038/nn.3382; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Burkitt AN, 2006, BIOL CYBERN, V95, P97, DOI 10.1007/s00422-006-0082-8; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; CONSTANTI A, 1987, J PHYSIOL-LONDON, V387, P173, DOI 10.1113/jphysiol.1987.sp016569; Descalzo VF, 2005, J NEUROPHYSIOL, V93, P1111, DOI 10.1152/jn.00658.2004; Diaz-Quesada M, 2008, J NEUROSCI, V28, P696, DOI 10.1523/JNEUROSCI.4931-07.2008; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FOEHRING RC, 1989, J NEUROPHYSIOL, V61, P245, DOI 10.1152/jn.1989.61.2.245; FRIEDMAN A, 1992, NEUROSCI LETT, V135, P13, DOI 10.1016/0304-3940(92)90125-Q; Haj-Dahmane S, 1998, J NEUROPHYSIOL, V80, P1197, DOI 10.1152/jn.1998.80.3.1197; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Kim U, 1998, J NEUROPHYSIOL, V80, P1222, DOI 10.1152/jn.1998.80.3.1222; KUBOTA M, 1991, J PHYSIOL-LONDON, V440, P131, DOI 10.1113/jphysiol.1991.sp018700; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Patterson CA, 2013, J NEUROSCI, V33, P532, DOI 10.1523/JNEUROSCI.3345-12.2013; PENNEFATHER P, 1985, P NATL ACAD SCI USA, V82, P3040, DOI 10.1073/pnas.82.9.3040; Puccini GD, 2007, PLOS COMPUT BIOL, V3, P813, DOI 10.1371/journal.pcbi.0030082; Puccini GD, 2006, J PHYSIOL-PARIS, V100, P1, DOI 10.1016/j.jphysparis.2006.09.005; Rauch A, 2003, J NEUROPHYSIOL, V90, P1598, DOI 10.1152/jn.00293.2003; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Safronov BV, 1996, J PHYSIOL-LONDON, V497, P727, DOI 10.1113/jphysiol.1996.sp021803; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHWINDT PC, 1992, J NEUROPHYSIOL, V67, P216, DOI 10.1152/jn.1992.67.1.216; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Vogalis F, 2003, EUR J NEUROSCI, V18, P3155, DOI 10.1111/j.1460-9568.2003.03040.x; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	46	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111578	10.1371/journal.pone.0111578	http://dx.doi.org/10.1371/journal.pone.0111578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380063	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100033
J	Ghiabi, P; Jiang, J; Pasquier, J; Maleki, M; Abu-Kaoud, N; Rafii, S; Rafii, A				Ghiabi, Pegah; Jiang, Jie; Pasquier, Jennifer; Maleki, Mahtab; Abu-Kaoud, Nadine; Rafii, Shahin; Rafii, Arash			Endothelial Cells Provide a Notch-Dependent Pro-Tumoral Niche for Enhancing Breast Cancer Survival, Stemness and Pro-Metastatic Properties	PLOS ONE			English	Article							IN-VITRO PROPAGATION; VASCULAR NICHE; MESENCHYMAL TRANSITION; PERIVASCULAR NICHE; COLORECTAL-CANCER; ANGIOGENESIS; GROWTH; INDUCTION; IDENTIFICATION; THERAPY	Treating metastasis has been challenging due to tumors complexity and heterogeneity. This complexity is partly related to the crosstalk between tumor and its microenvironment. Endothelial cells -the building blocks of tumor vasculature-have been shown to have additional roles in cancer progression than angiogenesis and supplying oxygen and nutrients. Here, we show an alternative role for endothelial cells in supporting breast cancer growth and spreading independent of their vascular functions. Using endothelial cells and breast cancer cell lines MDA-MB231 and MCF-7, we developed co-culture systems to study the influence of tumor endothelium on breast tumor development by both in vitro and in vivo approaches. Our results demonstrated that endothelial cells conferred survival advantage to tumor cells under complete starvation and enriched the CD44(High) CD24(Low/-) stem cell population in tumor cells. Moreover, endothelial cells enhanced the pro-metastatic potential of breast cancer cells. The in vitro and in vivo results concordantly confirmed a role for endothelial Jagged1 to promote breast tumor through notch activation. Here, we propose a role for endothelial cells in enhancing breast cancer progression, stemness, and pro-metastatic traits through a perfusion-independent manner. Our findings may be beneficial in developing novel therapeutic approaches.	[Ghiabi, Pegah; Pasquier, Jennifer; Maleki, Mahtab; Abu-Kaoud, Nadine; Rafii, Arash] Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar; [Jiang, Jie; Pasquier, Jennifer; Rafii, Shahin; Rafii, Arash] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University	Rafii, A (corresponding author), Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar.	jat2021@qatar-med.cornell.edu		Pasquier, Jennifer/0000-0002-2465-7942	Qatar National Research Fund under its National Priorities Research Program [NPRP 09-1174-3-291, NPRP 4-640-1-096, NPRP 09-1087-3-274]	Qatar National Research Fund under its National Priorities Research Program(Qatar National Research Fund (QNRF))	This publication was made possible by grants from the Qatar National Research Fund under its National Priorities Research Program award number NPRP 09-1174-3-291, NPRP 4-640-1-096, and NPRP 09-1087-3-274. Its contents are solely the responsibility of the authors and do not necessarily represent the views of the Qatar National Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; BREM S, 1976, CANCER RES, V36, P2807; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Butler Jason M, 2012, Methods Mol Biol, V904, P221, DOI 10.1007/978-1-61779-943-3_18; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Pasquier J, 2014, CANC MICROENVIRON; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ramalingam R, 1999, J VIROL, V73, P10183, DOI 10.1128/JVI.73.12.10183-10190.1999; Raynaud CM, 2013, STEM CELL RES, V11, P1074, DOI 10.1016/j.scr.2013.07.010; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Westerweel PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060357; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zhang ZC, 2014, CANCER RES, V74, P2869, DOI 10.1158/0008-5472.CAN-13-2032	50	56	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112424	10.1371/journal.pone.0112424	http://dx.doi.org/10.1371/journal.pone.0112424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380486	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100090
J	Kasahara, K; Fukuda, I; Nakamura, H				Kasahara, Kota; Fukuda, Ikuo; Nakamura, Haruki			A Novel Approach of Dynamic Cross Correlation Analysis on Molecular Dynamics Simulations and Its Application to Ets1 Dimer-DNA Complex	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ETS-1; STROMELYSIN-1 PROMOTER; BINDING; MOTIONS; DOMAIN; HELIX; AUTOINHIBITION; VISUALIZATION; FLUCTUATION; PARAMETERS	The dynamic cross correlation (DCC) analysis is a popular method for analyzing the trajectories of molecular dynamics (MD) simulations. However, it is difficult to detect correlative motions that appear transiently in only a part of the trajectory, such as atomic contacts between the side-chains of amino acids, which may rapidly flip. In order to capture these multi-modal behaviors of atoms, which often play essential roles, particularly at the interfaces of macromolecules, we have developed the "multi-modal DCC (mDCC)" analysis. The mDCC is an extension of the DCC and it takes advantage of a Bayesian-based pattern recognition technique. We performed MD simulations for molecular systems modeled from the (Ets1)(2)-DNA complex and analyzed their results with the mDCC method. Ets1 is an essential transcription factor for a variety of physiological processes, such as immunity and cancer development. Although many structural and biochemical studies have so far been performed, its DNA binding properties are still not well characterized. In particular, it is not straightforward to understand the molecular mechanisms how the cooperative binding of two Ets1 molecules facilitates their recognition of Stromelysin-1 gene regulatory elements. A correlation network was constructed among the essential atomic contacts, and the two major pathways by which the two Ets1 molecules communicate were identified. One is a pathway via direct protein-protein interactions and the other is that via the bound DNA intervening two recognition helices. These two pathways intersected at the particular cytosine bases (C110/C11), interacting with the H1, H2, and H3 helices. Furthermore, the mDCC analysis showed that both pathways included the transient interactions at their intermolecular interfaces of Tyr396-C11 and Ala327-Asn380 in multi-modal motions of the amino acid side chains and the nucleotide backbone. Thus, the current mDCC approach is a powerful tool to reveal these complicated behaviors and scrutinize intermolecular communications in a molecular system.	[Kasahara, Kota; Fukuda, Ikuo; Nakamura, Haruki] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Osaka University	Kasahara, K (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	kota.kasahara@protein.osaka-u.ac.jp		Kasahara, Kota/0000-0003-0207-6271	JSPS KAKENHI [24118001]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH060220] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research on Innovative Areas, Grant Number 24118001, https://www.jsps.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Tadaaki Mashimo for the implementation of the MD program, myPresto/psygene-G. The software for generating the 3D density maps of Gaussian mixture distributions was provided by Dr. Takeshi Kawabata.; The MD simulations performed on the TSUBAME2.5 supercomputer at the Tokyo Institute of Technology, provided through the HPCI System Research Project (Project ID: hp130061). The numerical computations for post-simulation analyses were performed by using the supercomputer system provided by the National Institute of Genetics, Research Organization of Information and Systems, Japan.	Arakawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076606; Attias H, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P21; Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fukuda Ikuo, 2012, Biophys Rev, V4, P161, DOI 10.1007/s12551-012-0089-4; Fukuda I, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739789; Fukuda I, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3582791; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Gardner Kevin H, 2005, Sci STKE, V2005, ppe44, DOI 10.1126/stke.3012005pe44; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kamberaj H, 2009, BIOPHYS J, V96, P1307, DOI 10.1016/j.bpj.2008.11.019; Karolak A, 2012, BIOPHYS CHEM, V165, P74, DOI 10.1016/j.bpc.2012.03.007; Karplus M, 1996, J MOL BIOL, V263, P120, DOI 10.1006/jmbi.1996.0562; Kasahara K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-12; Kasahara K, 2013, J CHEM INF MODEL, V53, P241, DOI 10.1021/ci300377f; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Mashimo T, 2013, J CHEM THEORY COMPUT, V9, P5599, DOI 10.1021/ct400342e; MCCAMMON JA, 1984, REP PROG PHYS, V47, P1, DOI 10.1088/0034-4885/47/1/001; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reddy SY, 2003, P NATL ACAD SCI USA, V100, P15475, DOI 10.1073/pnas.1936251100; Shaikhibrahim Z, 2012, INT J ONCOL, V40, P1748, DOI 10.3892/ijo.2012.1380; Siggers T, 2014, NUCLEIC ACIDS RES, V42, P2099, DOI 10.1093/nar/gkt1112; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; WASYLYK C, 1992, GENE DEV, V6, P965, DOI 10.1101/gad.6.6.965	41	65	65	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112419	10.1371/journal.pone.0112419	http://dx.doi.org/10.1371/journal.pone.0112419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380315	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100088
J	Pec, GJ; Carlton, GC				Pec, Gregory J.; Carlton, Gary C.			Positive Effects of Non-Native Grasses on the Growth of a Native Annual in a Southern California Ecosystem	PLOS ONE			English	Article							PLANT COEXISTENCE; INVASIVE PLANTS; EXOTIC GRASSES; HYDRAULIC LIFT; ROOT SYSTEMS; RESTORATION; FACILITATION; COMPETITION; PLASTICITY; GRASSLAND	Fire disturbance is considered a major factor in the promotion of non-native plant species. Non-native grasses are adapted to fire and can alter environmental conditions and reduce resource availability in native coastal sage scrub and chaparral communities of southern California. In these communities persistence of non-native grasses following fire can inhibit establishment and growth of woody species. This may allow certain native herbaceous species to colonize and persist beneath gaps in the canopy. A field manipulative experiment with control, litter, and bare ground treatments was used to examine the impact of non-native grasses on growth and establishment of a native herbaceous species, Cryptantha muricata. C. muricata seedling survival, growth, and reproduction were greatest in the control treatment where non-native grasses were present. C. muricata plants growing in the presence of non-native grasses produced more than twice the number of flowers and more than twice the reproductive biomass of plants growing in the treatments where non-native grasses were removed. Total biomass and number of fruits were also greater in the plants growing in the presence of non-native grasses. Total biomass and reproductive biomass was also greater in late germinants than early germinants growing in the presence of non- native grasses. This study suggests a potential positive effect of non-native grasses on the performance of a particular native annual in a southern California ecosystem.	[Pec, Gregory J.; Carlton, Gary C.] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	Pec, GJ (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	gpec@ualberta.ca	Pec, Gregory/L-8542-2013	Pec, Gregory/0000-0002-6781-9112	Ernest Prete Jr. Foundation	Ernest Prete Jr. Foundation	Funding was provided by an Environmental Science Fellowship to GJP from the Ernest Prete Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brandt AJ, 2011, ECOL APPL, V21, P704, DOI 10.1890/10-0485.1; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Buxbaum CAZ, 2007, J ARID ENVIRON, V69, P617, DOI 10.1016/j.jaridenv.2006.11.017; Caldwell MM, 1998, OECOLOGIA, V113, P151, DOI 10.1007/s004420050363; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Cavieres LA, 2005, PERSPECT PLANT ECOL, V7, P217, DOI 10.1016/j.ppees.2005.09.002; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Corbin JD, 2004, ECOLOGY, V85, P1273, DOI 10.1890/02-0744; Cox RD, 2011, PLANT ECOL, V212, P1699, DOI 10.1007/s11258-011-9942-y; D'Antonio C, 2002, RESTOR ECOL, V10, P703, DOI 10.1046/j.1526-100X.2002.01051.x; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; DAWSON TE, 1993, OECOLOGIA, V95, P565, DOI 10.1007/BF00317442; DODORICO P, 2007, J GEOPHYS RES, V112; Dormann CF, 2002, ACTA OECOL, V23, P297, DOI 10.1016/S1146-609X(02)01158-X; Dunn Paul H., 1988, PSW104 US DEP AGR PA; Eliason SA, 1997, RESTOR ECOL, V5, P245, DOI 10.1046/j.1526-100X.1997.09729.x; Elliott Brian A., 2008, Madrono, V55, P76, DOI 10.3120/0024-9637(2008)55[76:HADOCC]2.0.CO;2; Ferrante D, 2014, J ARID ENVIRON, V104, P52, DOI 10.1016/j.jaridenv.2014.01.009; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Goodenough AE, 2010, COMMUNITY ECOL, V11, P13, DOI 10.1556/ComEc.11.2010.1.3; Griffith AB, 2010, ECOLOGY, V91, P141, DOI 10.1890/08-1446.1; GUREVITCH J, 1986, ECOLOGY, V67, P251, DOI 10.2307/1938525; Halpern BS, 2007, FRONT ECOL ENVIRON, V5, P153, DOI 10.1890/1540-9295(2007)5[153:IPIIAR]2.0.CO;2; HIRONAKA M., 1961, JOUR RANGE MANAGEMENT, V14, P263, DOI 10.2307/3894744; Keeley JE, 2006, CONSERV BIOL, V20, P375, DOI 10.1111/J.1523-1739.2006.00339.X; KEELEY JE, 1985, J ECOL, V73, P445, DOI 10.2307/2260486; Keeley JE, 2012, OECOLOGIA, V169, P1043, DOI 10.1007/s00442-012-2253-8; Keeley JE, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P339; KEELEY SC, 1981, ECOLOGY, V62, P1608, DOI 10.2307/1941516; Lambers H., 2008, PLANT PHYSL ECOLOGY; Leffler AJ, 2005, ECOLOGY, V86, P633, DOI 10.1890/04-0854; Leger EA, 2010, PLANT ECOL, V208, P333, DOI 10.1007/s11258-009-9710-4; Lenz TI, 2003, AUSTRAL ECOL, V28, P480, DOI 10.1046/j.1442-9993.2003.01304.x; Lepik M, 2005, OECOLOGIA, V145, P465, DOI 10.1007/s00442-005-0142-0; Lugo AE, 2004, FRONT ECOL ENVIRON, V2, P265, DOI 10.2307/3868267; Lugo AE, 1997, FOREST ECOL MANAG, V99, P9, DOI 10.1016/S0378-1127(97)00191-6; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; MORENO JM, 1991, ECOLOGY, V72, P1993, DOI 10.2307/1941554; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Team, 2013, R LANG ENV STAT COMP; Reynolds Sally A., 2001, Madrono, V48, P230; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; SHMIDA A, 1981, ECOLOGY, V62, P234, DOI 10.2307/1936684; Simpson Michael G., 2009, Crossosoma, V35, P1; Sokal R.R., 2012, BIOMETRY; Stylinski CD, 1999, J APPL ECOL, V36, P544, DOI 10.1046/j.1365-2664.1999.00423.x; Talluto MV, 2008, LANDSCAPE ECOL, V23, P803, DOI 10.1007/s10980-008-9238-3; Wainwright CE, 2012, J APPL ECOL, V49, P234, DOI 10.1111/j.1365-2664.2011.02088.x; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; WEINER J, 1990, J ECOL, V78, P459, DOI 10.2307/2261124; Williams JL, 2006, ECOLOGY, V87, P3200, DOI 10.1890/0012-9658(2006)87[3200:TIOIGO]2.0.CO;2; Wolkovich EM, 2011, FRONT ECOL ENVIRON, V9, P287, DOI 10.1890/100033; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhang MJ, 2011, PLANT ECOL, V212, P1419, DOI 10.1007/s11258-011-9917-z; Zuur Alain F., 2009, P1	62	4	4	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112437	10.1371/journal.pone.0112437	http://dx.doi.org/10.1371/journal.pone.0112437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379790	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100093
J	Severin, I; Lindstrom, ES; Ostman, O				Severin, Ina; Lindstrom, Eva S.; Ostman, Orjan			Relationships between Bacterial Community Composition, Functional Trait Composition and Functioning Are Context Dependent - but What Is the Context?	PLOS ONE			English	Article							ORGANIC-CARBON; RIBOSOMAL-RNA; DIVERSITY; LAKES	Bacterial communities are immensely diverse and drive many fundamental ecosystem processes. However, the role of bacterial community composition (BCC) for functioning is still unclear. Here we evaluate the relative importance of BCC (from 454-sequencing), functional traits (from Biolog Ecoplates) and environmental conditions for per cell biomass production (BPC; H-3-leucine incorporation) in six data sets of natural freshwater bacterial communities. BCC explained significant variation of BPC in all six data sets and most variation in four. BCC measures based on 16S rRNA (active bacteria) did not consistently explain more variation in BPC than measures based on the 16S rRNA-gene (total community), and adding phylogenetic information did not, in general, increase the explanatory power of BCC. In contrast to our hypothesis, the importance of BCC for BPC was not related to the anticipated dispersal rates in and out of communities. Functional traits, most notably the ability to use cyclic and aromatic compounds, as well as local environmental conditions, i.e. stoichiometric relationships of nutrients, explained some variation in all six data sets. In general there were weak associations between variation in BCC and variation in the functional traits contributing to productivity. This indicates that additional traits may be important for productivity as well. By comparing several data sets obtained in a similar way we conclude that no single measure of BCC was obviously better than another in explaining BPC. We identified some key functional traits for productivity, but although there was a coupling between BCC, functional traits and productivity, the strength of the coupling seems context dependent. However, the exact context is still unresolved.	[Severin, Ina; Lindstrom, Eva S.; Ostman, Orjan] Uppsala Univ, Dept Ecol & Genetics Limnol, Uppsala, Sweden	Uppsala University	Severin, I (corresponding author), Uppsala Univ, Dept Ecol & Genetics Limnol, Uppsala, Sweden.	inaseverin@gmx.de	Östman, Örjan/ABF-8714-2020; LindstrÃm, Eva/H-5930-2016	Östman, Örjan/0000-0002-1930-0148; LindstrÃm, Eva/0000-0001-8920-3071	Carl Tryggers Foundation; Olsson-Borgh foundation; Swedish Research Council [2009-5172, 2007-5932]	Carl Tryggers Foundation; Olsson-Borgh foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by a grant from the Carl Tryggers Foundation to ESL and OO, from a grant from the Olsson-Borgh foundation to IS, and by separate grants from the Swedish Research Council to ESL (project number 2009-5172) and OO (2007-5932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BELL RT, 1993, LIMNOL OCEANOGR, V38, P1532, DOI 10.4319/lo.1993.38.7.1532; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Comte J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00112; Comte J, 2009, ENVIRON MICROBIOL, V11, P1704, DOI 10.1111/j.1462-2920.2009.01897.x; del Giorgio P. A., 2008, MICROBIAL ECOLOGY OC, P243, DOI DOI 10.1002/9780470281840.CH8; delGiorgio P, 1996, LIMNOL OCEANOGR, V41, P783, DOI 10.4319/lo.1996.41.4.0783; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Franklin RB, 2013, AQUAT MICROB ECOL, V69, P247, DOI 10.3354/ame01635; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Gravel D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2123; Gravel D, 2011, NATURE, V469, P89, DOI 10.1038/nature09592; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Ives AR, 2010, AM NAT, V176, pE128, DOI 10.1086/656486; Jansson M, 2006, MICROB ECOL, V52, P358, DOI 10.1007/s00248-006-9013-4; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Jonsson A, 2003, ECOSYSTEMS, V6, P224, DOI 10.1007/s10021-002-0200-y; Karlsson J, 2007, LIMNOL OCEANOGR, V52, P603, DOI 10.4319/lo.2007.52.2.0603; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Leflaive J, 2008, FEMS MICROBIOL ECOL, V66, P379, DOI 10.1111/j.1574-6941.2008.00593.x; Lindstrom ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025883; Lindstrom ES, 2010, LIMNOL OCEANOGR, V55, P2052, DOI 10.4319/lo.2010.55.5.2052; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Ostman O, 2010, ECOL LETT, V13, P118, DOI 10.1111/j.1461-0248.2009.01413.x; Peter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023225; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Reed HE, 2013, ISME J, V7, P868, DOI 10.1038/ismej.2012.154; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Severin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080825; Sjostedt J, 2013, AQUAT MICROB ECOL, V71, P15, DOI 10.3354/ame01660; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Tan JQ, 2012, ECOLOGY, V93, P1164, DOI 10.1890/11-1557.1; Thurman EM, 1985, DEV BIOGEOCHEMISTRY, P497; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554	42	2	2	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112409	10.1371/journal.pone.0112409	http://dx.doi.org/10.1371/journal.pone.0112409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380200	Green Submitted, gold, Green Published			2022-12-26	WOS:000344863100086
J	Traser, L; Burdumy, M; Richter, B; Vicari, M; Echternach, M				Traser, Louisa; Burdumy, Michael; Richter, Bernhard; Vicari, Marco; Echternach, Matthias			Weight-Bearing MR Imaging as an Option in the Study of Gravitational Effects on the Vocal Tract of Untrained Subjects in Singing Phonation	PLOS ONE			English	Article							POSITION; UPRIGHT; SUPINE; CONFIGURATIONS	Magnetic Resonance Imaging (MRI) of subjects in a supine position can be used to evaluate the configuration of the vocal tract during phonation. However, studies of speech phonation have shown that gravity can affect vocal tract shape and bias measurements. This is one of the reasons that MRI studies of singing phonation have used professionally trained singers as subjects, because they are generally considered to be less affected by the supine body position and environmental distractions. A study of untrained singers might not only contribute to the understanding of intuitive singing function and aid the evaluation of potential hazards for vocal health, but also provide insights into the effect of the supine position on singers in general. In the present study, an open configuration 0.25 T MRI system with a rotatable examination bed was used to study the effect of body position in 20 vocally untrained subjects. The subjects were asked to sing sustained tones in both supine and upright body positions on different pitches and in different register conditions. Morphometric measurements were taken from the acquired images of a sagittal slice depicting the vocal tract. The analysis concerning the vocal tract configuration in the two body positions revealed differences in 5 out of 10 measured articulatory parameters. In the upright position the jaw was less protruded, the uvula was elongated, the larynx more tilted and the tongue was positioned more to the front of the mouth than in the supine position. The findings presented are in agreement with several studies on gravitational effects in speech phonation, but contrast with the results of a previous study on professional singers of our group where only minor differences between upright and supine body posture were observed. The present study demonstrates that imaging of the vocal tract using weight-bearing MR imaging is a feasible tool for the study of sustained phonation in singing for vocally untrained subjects.	[Traser, Louisa; Burdumy, Michael; Richter, Bernhard; Echternach, Matthias] Univ Med Ctr, Inst Musicians Med, Freiburg, Germany; [Traser, Louisa] Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Freiburg, Germany; [Burdumy, Michael] Univ Med Ctr, Dept Radiol Med Phys, Freiburg, Germany; [Vicari, Marco] Fraunhofer MEVIS, Bremen, Germany; [Vicari, Marco] Esaote SpA, Genoa, Italy	University of Freiburg; University of Freiburg; University of Freiburg	Traser, L (corresponding author), Univ Med Ctr, Inst Musicians Med, Freiburg, Germany.	louisa.traser@uniklinik-freiburg.de	Burdumy, Michael/M-6212-2017; Echternach, Matthias/E-3464-2010	Burdumy, Michael/0000-0003-4577-5515; Echternach, Matthias/0000-0003-0095-5360	German Research Foundation, Deutsche Forschungsgemeinschaft (DFG) [Ri 1050/4-1, EC 409/1-1]; European Research Council, OVOC project [232908]	German Research Foundation, Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council, OVOC project	Bernhard Richter was supported by the German Research Foundation, Deutsche Forschungsgemeinschaft (DFG), grant Ri 1050/4-1. Matthias Echternach was supported by the German Research Foundation, Deutsche Forschungsgemeinschaft (DFG), grant EC 409/1-1. Marco Vicari was supported by the European Research Council, grant #232908 as part of the OVOC project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Echternach M, 2012, CURR OPIN OTOLARYNGO, V20, P450, DOI 10.1097/MOO.0b013e3283585f87; Echternach M, 2011, J ACOUST SOC AM, V129, P3955, DOI 10.1121/1.3589249; Echternach M, 2010, FOLIA PHONIATR LOGO, V62, P278, DOI 10.1159/000312668; Echternach M, 2010, J VOICE, V24, P133, DOI 10.1016/j.jvoice.2008.06.004; Engwall O, 2006, ASSESSING MAGNETIC R; HERTEGARD S, 1990, J VOICE, V4, P220, DOI 10.1016/S0892-1997(05)80017-7; Honda K, 1999, LANG SPEECH, V42, P401, DOI 10.1177/00238309990420040301; Honda Y, 2007, J MAGN RESON IMAGING, V26, P172, DOI 10.1002/jmri.20992; Kitamura T, 2005, ACOUST SCI TECHNOL, V26, P465, DOI 10.1250/ast.26.465; Narayanan S, 2004, J ACOUST SOC AM, V115, P1771, DOI 10.1121/1.1652588; Niebergall A, 2013, MAGN RESON MED, V69, P477, DOI 10.1002/mrm.24276; SHIPP T, 1975, J SPEECH HEAR RES, V18, P707, DOI 10.1044/jshr.1804.707; Steiner I, 2014, P INT SEM SPEECH PRO, P417; Stone M, 2007, J ACOUST SOC AM, V122, P532, DOI 10.1121/1.2715659; Stone M, 2001, J SPEECH LANG HEAR R, V44, P1026, DOI 10.1044/1092-4388(2001/081); Stone M., 2002, J ACOUST SOC AM, V111, P2476, DOI [10.1121/1.4778583, DOI 10.1121/1.4778583]; Sundberg J, 2009, J VOICE, V23, P546, DOI 10.1016/j.jvoice.2008.02.003; Takemoto H, 2006, J ACOUST SOC AM, V119, P1037, DOI 10.1121/1.2151823; Tiede M.K., 2000, P 5 SEMINAR SPEECH P, P25; Traser L, 2013, J VOICE, V27, P141, DOI 10.1016/j.jvoice.2012.11.002; Trequattrini A, 2006, IEEE T APPL SUPERCON, V16, P1505, DOI 10.1109/TASC.2006.871341; Ventura SMR, 2011, J VOICE, V25, P511, DOI 10.1016/j.jvoice.2010.01.014; Williams W, 2010, NOISE HEALTH, V12, P155, DOI 10.4103/1463-1741.64970; Zhang S, 2012, J MAGN RESON IMAGING, V35, P1372, DOI 10.1002/jmri.23591; Zhu YH, 2013, IEEE T MED IMAGING, V32, P838, DOI 10.1109/TMI.2012.2230017	25	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112405	10.1371/journal.pone.0112405	http://dx.doi.org/10.1371/journal.pone.0112405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379885	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100084
J	Wang, XY; Tong, YN; Gao, YM; Gao, PC; Liu, F; Zhao, ZP; Pang, Y				Wang, Xiaoying; Tong, Yanan; Gao, Yimin; Gao, Pengcheng; Liu, Fen; Zhao, Zuoping; Pang, Yan			Spatial and Temporal Variations of Crop Fertilization and Soil Fertility in the Loess Plateau in China from the 1970s to the 2000s	PLOS ONE			English	Article							WHEAT-MAIZE SYSTEM; LONG-TERM FERTILIZATION; NITROGEN USE EFFICIENCY; ORGANIC-CARBON POOLS; ON-FARM EVALUATION; NORTH CHINA; NUTRIENT MANAGEMENT; MANURE APPLICATION; SOUTHERN CHINA; ACID-RAIN	Increased fertilizer input in agricultural systems during the last few decades has resulted in large yield increases, but also in environmental problems. We used data from published papers and a soil testing and fertilization project in Shaanxi province during the years 2005 to 2009 to analyze chemical fertilizer inputs and yields of wheat (Triticum aestivum L.) and maize (Zea mays L.) on the farmers' level, and soil fertility change from the 1970s to the 2000s in the Loess Plateau in China. The results showed that in different regions of the province, chemical fertilizer NPK inputs and yields of wheat and maize increased. With regard to soil nutrient balance, N and P gradually changed from deficit to surplus levels, while K deficiency became more severe. In addition, soil organic matter, total nitrogen, alkali-hydrolysis nitrogen, available phosphorus and available potassium increased during the same period. The PFP of N, NP and NPK on wheat and maize all decreased from the 1970s to the 2000s as a whole. With the increase in N fertilizer inputs, both soil total nitrogen and alkali-hydrolysis nitrogen increased; P fertilizer increased soil available phosphorus and K fertilizer increased soil available potassium. At the same time, soil organic matter, total nitrogen, alkali-hydrolysis nitrogen, available phosphorus and available potassium all had positive impacts on crop yields. In order to promote food safety and environmental protection, fertilizer requirements should be assessed at the farmers' level. In many cases, farmers should be encouraged to reduce nitrogen and phosphate fertilizer inputs significantly, but increase potassium fertilizer and organic manure on cereal crops as a whole.	[Wang, Xiaoying; Tong, Yanan; Gao, Yimin; Gao, Pengcheng; Liu, Fen; Zhao, Zuoping; Pang, Yan] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Peoples R China; [Wang, Xiaoying; Tong, Yanan] Minist Agr, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Tong, YN (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Peoples R China.	tongyanan@nwsuaf.edu.cn	gao, yi/HCI-8298-2022; Gao, Yu/HGE-1937-2022; Gao, Y./GWZ-3665-2022		Special Fund for Agro-scientific Research in the Public Interest of China [201103003]; Soil Quality Foundation of China [2012BAD05B03]	Special Fund for Agro-scientific Research in the Public Interest of China; Soil Quality Foundation of China	The authors thank the Special Fund for Agro-scientific Research in the Public Interest of China (201103003) and the Soil Quality Foundation of China (2012BAD05B03) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ARID METEOROL; Arshad MA, 2002, AGR ECOSYST ENVIRON, V88, P153, DOI 10.1016/S0167-8809(01)00252-3; Banger K, 2009, PLANT SOIL, V318, P27, DOI 10.1007/s11104-008-9813-z; Bierman PM, 2012, AGR SYST, V109, P43, DOI 10.1016/j.agsy.2012.02.004; [蔡艳 Cai Yan], 2013, [麦类作物学报, Journal of Triticeae Crops], V33, P983; Cao N., 2009, CHINESE AGR SCI B, V25, P220; Cui ZL, 2008, AGRON J, V100, P517, DOI 10.2134/agronj2007.0194; Cui ZL, 2008, FIELD CROP RES, V105, P48, DOI 10.1016/j.fcr.2007.07.008; Cui ZL, 2010, AMBIO, V39, P376, DOI 10.1007/s13280-010-0076-6; Dai ZH, 1998, WATER AIR SOIL POLL, V108, P377, DOI 10.1023/A:1005015526022; Department of Rural Surveys National Bureau of Statistics, 1971, CHIN RUR STAT YB; Dobermann A, 2005, SCI CHINA SER C, V48, P745, DOI 10.1360/062005-268; Fan MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074617; Gami SK, 2001, BIOL FERT SOILS, V34, P73, DOI 10.1007/s003740100377; Gao C, 2006, PEDOSPHERE, V16, P253, DOI 10.1016/S1002-0160(06)60051-9; Gao X.Z., 2001, CHINESE J SOIL SCI, V6, P258; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033982; Geng YuHui, 2013, Journal of South China Agricultural University, V34, P470; Gong FuFei, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P120; [龚伟 GONG Wei], 2011, [土壤, Soils], V43, P336; Griffin TS, 2003, SOIL SCI SOC AM J, V67, P645, DOI 10.2136/sssaj2003.0645; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo SL, 2012, GEODERMA, V189, P442, DOI 10.1016/j.geoderma.2012.06.012; Guo SL, 2010, PLANT SOIL, V330, P1, DOI 10.1007/s11104-009-0204-x; Hao MD, 2005, PEDOSPHERE, V15, P189; HOOSBEEK MR, 1992, GEODERMA, V55, P183, DOI 10.1016/0016-7061(92)90083-J; Huang B, 2007, GEODERMA, V139, P336, DOI 10.1016/j.geoderma.2007.02.012; Huang DY, 2009, ENVIRON POLLUT, V157, P35, DOI 10.1016/j.envpol.2008.08.001; [黄国勤 Huang Guoqin], 2004, [生态环境, Ecology and Environment], V13, P656; Huang S, 2010, AGR ECOSYST ENVIRON, V138, P44, DOI 10.1016/j.agee.2010.03.015; [林治安 LIN Zhian], 2009, [中国农业科学, Scientia Agricultura Sinica], V42, P2809; Jiang D, 2006, PEDOSPHERE, V16, P25, DOI 10.1016/S1002-0160(06)60022-2; Ju XT, 2006, ENVIRON POLLUT, V143, P117, DOI 10.1016/j.envpol.2005.11.005; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Ju XT, 2004, AMBIO, V33, P300, DOI 10.1639/0044-7447(2004)033[0300:NFSNAA]2.0.CO;2; Karlen DL, 1997, SOIL SCI SOC AM J, V61, P4, DOI 10.2136/sssaj1997.03615995006100010001x; Kautz T, 2013, SOIL BIOL BIOCHEM, V57, P1003, DOI 10.1016/j.soilbio.2012.09.014; Krusche AV, 2003, ENVIRON POLLUT, V121, P389, DOI 10.1016/S0269-7491(02)00235-X; Li H, 2010, AGR ECOSYST ENVIRON, V135, P24, DOI 10.1016/j.agee.2009.08.003; Li Juan, 2008, Agricultural Sciences in China, V7, P336, DOI 10.1016/S1671-2927(08)60074-7; Li LF, 2009, AGR RES ARID AREAS, V27, p[127, 142]; Li Q, 2013, J PLANT NUTR SOIL SC, V176, P249, DOI 10.1002/jpln.201100395; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Liu GB, 1999, AMBIO, V28, P663; Liu Zhong, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P168; [骆世明 LUO Shiming], 2007, [地理研究, Geographical Research], V26, P609; Ma LiHeng, 2011, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V32, P48; Ma WQ, 1999, THESIS CHINA AGR U B; Majumder B, 2008, BIOL FERT SOILS, V44, P451, DOI 10.1007/s00374-007-0226-6; Mando A, 2005, SOIL USE MANAGE, V21, P25, DOI 10.1079/SUM2005287; Menz FC, 2004, ENVIRON SCI POLICY, V7, P253, DOI 10.1016/j.envsci.2004.05.005; Moharana PC, 2012, FIELD CROP RES, V136, P32, DOI 10.1016/j.fcr.2012.07.002; Mosier AR, 1996, PLANT SOIL, V181, P95, DOI 10.1007/BF00011296; MUNSON RD, 1985, POTASSIUM AGR; Peng SB, 2006, FIELD CROP RES, V96, P37, DOI 10.1016/j.fcr.2005.05.004; Richter J, 2000, NUTR CYCL AGROECOSYS, V57, P33, DOI 10.1023/A:1009802225307; Sharma A, 2010, CATENA, V82, P112, DOI 10.1016/j.catena.2010.05.009; Singh M, 2002, FIELD CROP RES, V77, P81, DOI 10.1016/S0378-4290(01)00206-4; [马文奇 Ma Wenqi], 2008, [生态环境, Ecology and Environment], V17, P1296; Smil V., 2001, ENRICHING EARTH F HA; Tan DS, 2012, AGR ECOSYST ENVIRON, V148, P65, DOI 10.1016/j.agee.2011.11.016; [汤勇华 TANG Yong-hua], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P1070; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tong YN, 1997, NUTR CYCL AGROECOSYS, V48, P225; van Bochove E, 2007, CAN J SOIL SCI, V87, P121, DOI 10.4141/S06-067; Wang HongTing, 2010, Plant Nutrition and Fertilizer Science, V16, P801; Wang SR, 2002, THESIS CHINA AGR U B; Wang XJ, 1998, GEODERMA, V81, P339, DOI 10.1016/S0016-7061(97)00109-2; Witter E, 2001, BIOL AGRIC HORTIC, V19, P127, DOI 10.1080/01448765.2001.9754917; Yan Xiang, 2008, Agricultural Sciences in China, V7, P469, DOI 10.1016/S1671-2927(08)60091-7; Yang SM, 2004, AGRON J, V96, P1039, DOI 10.2134/agronj2004.1039; Yang XY, 2014, J INTEGR AGR, V13, P402, DOI 10.1016/S2095-3119(13)60425-6; Yi Qiong, 2010, Plant Nutrition and Fertilizer Science, V16, P1069; Zhang F, 2007, P 9 GERM SCI C ORG A; Zhang FS, 2002, CHIN J SOIL SCI, V33, P126; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhang HM, 2009, PEDOSPHERE, V19, P199, DOI 10.1016/S1002-0160(09)60109-0; Zhang JF, 2008, ATMOS ENVIRON, V42, P291, DOI 10.1016/j.atmosenv.2007.09.036; [张卫峰 Zhang Weifeng], 2005, [自然资源学报, Journal of Natural Resources], V20, P378; Zhang Wenxue, 2011, J WUHAN I TECHNOLOGY, V33, P1; [张亚丽 Zhang Yali], 2012, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V18, P307; Zhao J. R., 1997, BEIJING AGR SCI, V15, P36; Zhao Jing, 2014, Journal of Maize Sciences, V22, P123; Zhao X, 2009, SOIL BIOL BIOCHEM, V41, P2584, DOI 10.1016/j.soilbio.2009.08.022; Zhen L, 2006, J ENVIRON MANAGE, V79, P409, DOI 10.1016/j.jenvman.2005.08.009; Zhou ZC, 2013, EUR J AGRON, V45, P20, DOI 10.1016/j.eja.2012.11.002; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	87	8	12	8	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112273	10.1371/journal.pone.0112273	http://dx.doi.org/10.1371/journal.pone.0112273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380401	Green Published, Green Submitted			2022-12-26	WOS:000344863100072
J	Chadha, A; Cook, B				Chadha, Abhishek; Cook, Boaz			The Effect of Stress on Motor Function in Drosophila	PLOS ONE			English	Article							PITUITARY-ADRENAL RESPONSES; INTER-LEG COORDINATION; ELEVATED PLUS-MAZE; RESTRAINT STRESS; STICK INSECT; CARAUSIUS-MOROSUS; BEHAVIOR; WALKING; MICE; CORTICOSTERONE	Exposure to unpredictable and uncontrollable conditions causes animals to perceive stress and change their behavior. It is unclear how the perception of stress modifies the motor components of behavior and which molecular pathways affect the behavioral change. In order to understand how stress affects motor function, we developed an experimental platform that quantifies walking motions in Drosophila. We found that stress induction using electrical shock results in backwards motions of the forelegs at the end of walking strides. These leg retrogressions persisted during repeated stimulation, although they habituated substantially. The motions also continued for several strides after the end of the shock, indicating that stress induces a behavioral aftereffect. Such aftereffect could also be induced by restricting the motion of the flies via wing suspension. Further, the long-term effects could be amplified by combining either immobilization or electric shock with additional stressors. Thus, retrogression is a lingering form of response to a broad range of stressful conditions, which cause the fly to search for a foothold when it faces extreme and unexpected challenges. Mutants in the cAMP signaling pathway enhanced the stress response, indicating that this pathway regulates the behavioral response to stress. Our findings identify the effect of stress on a specific motor component of behavior and define the role of cAMP signaling in this stress response.	[Chadha, Abhishek; Cook, Boaz] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA	Scripps Research Institute	Cook, B (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	bcook@scripps.edu						Adamo SA, 2012, HORM BEHAV, V62, P324, DOI 10.1016/j.yhbeh.2012.02.012; Barreto RE, 2014, HORM BEHAV, V65, P394, DOI 10.1016/j.yhbeh.2014.03.007; Berg E, 2013, J EXP BIOL, V216, P1064, DOI 10.1242/jeb.076406; Bhatnagar S, 2003, HORM BEHAV, V43, P158, DOI 10.1016/S0018-506X(02)00011-9; Brewer JA, 2003, STRESS, V6, P121, DOI 10.1080/1025389031000116460; BYRNE JH, 1991, ANN NY ACAD SCI, V627, P124, DOI DOI 10.1111/J.1749-6632.1991.TB25918.X; Carpenter MG, 2004, J NEUROPHYSIOL, V92, P3255, DOI 10.1152/jn.01139.2003; Cham R, 2002, GAIT POSTURE, V15, P159, DOI 10.1016/S0966-6362(01)00150-3; Clark AJ, 2011, J EXP BIOL, V214, P1369, DOI 10.1242/jeb.051136; CRUSE H, 1976, J COMP PHYSIOL, V112, P235, DOI 10.1007/BF00606541; DEBOER SF, 1990, PHYSIOL BEHAV, V47, P1117, DOI 10.1016/0031-9384(90)90361-7; Diegelmann S, 2013, J EXP BIOL, V216, P939, DOI 10.1242/jeb.076208; Durr V, 2001, J EXP BIOL, V204, P1589; Elenkov IJ, 2006, NEUROIMMUNOMODULAT, V13, P257, DOI 10.1159/000104853; Garcia A, 2000, NEUROENDOCRINOLOGY, V72, P114, DOI 10.1159/000054578; Gonzalo-Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036477; Grabowska M, 2012, J EXP BIOL, V215, P4255, DOI 10.1242/jeb.073643; GRAHAM D, 1972, J COMP PHYSIOL, V81, P23, DOI 10.1007/BF00693548; Grissom N, 2007, HORM BEHAV, V51, P95, DOI 10.1016/j.yhbeh.2006.08.011; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; Hashiguchi H, 1997, PHYSIOL BEHAV, V61, P731, DOI 10.1016/S0031-9384(96)00527-6; HAUGER RL, 1990, BRAIN RES, V532, P34, DOI 10.1016/0006-8993(90)91738-3; Iwamoto T, 2003, J BIOL CHEM, V278, P16936, DOI 10.1074/jbc.C300075200; Keller BR, 2007, J COMP PHYSIOL A, V193, P881, DOI 10.1007/s00359-007-0241-y; Kim KS, 2009, J NEUROSCI RES, V87, P2983, DOI 10.1002/jnr.22119; Klenerova V, 2007, J PHYSIOL PHARMACOL, V58, P83; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; MacNeil G, 1997, PHARMACOL BIOCHEM BE, V58, P737, DOI 10.1016/S0091-3057(97)00037-3; Marquez C, 2002, BRAIN RES, V926, P181, DOI 10.1016/S0006-8993(01)03112-2; McVea DA, 2007, J NEUROPHYSIOL, V97, P659, DOI 10.1152/jn.00921.2006; Mendes CS, 2013, ELIFE, V2, DOI 10.7554/eLife.00231; Mercier S, 2003, BEHAV BRAIN RES, V139, P167, DOI 10.1016/S0166-4328(02)00265-6; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; Michels B, 2011, LEARN MEMORY, V18, P332, DOI 10.1101/lm.2101411; Min VA, 2005, J NEUROSCI METH, V145, P63, DOI 10.1016/j.jneumeth.2004.11.022; Padovan CM, 2000, BRAZ J MED BIOL RES, V33, P79, DOI 10.1590/S0100-879X2000000100011; Patton ZJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P783, DOI 10.1086/323327; PEARSON KG, 1984, INT J ROBOT RES, V3, P101, DOI 10.1177/027836498400300209; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; Pomerantz O, 2012, BEHAV BRAIN RES, V230, P274, DOI 10.1016/j.bbr.2012.02.019; Preat T, 1998, J NEUROSCI, V18, P8534; Razzoli M, 2010, NEUROSCIENCE, V170, P429, DOI 10.1016/j.neuroscience.2010.07.022; Sarenac O, 2011, EXP PHYSIOL, V96, P574, DOI 10.1113/expphysiol.2010.055970; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shakiryanova D, 2011, P NATL ACAD SCI USA, V108, P4477, DOI 10.1073/pnas.1017837108; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; Trompeter WP, 2011, HORM BEHAV, V60, P152, DOI 10.1016/j.yhbeh.2011.04.001; Vittone MaP, 2006, SCENE J US COAST GUA; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wosnitza A, 2013, J EXP BIOL, V216, P480, DOI 10.1242/jeb.078139; Wust S, 2005, PSYCHONEUROENDOCRINO, V30, P591, DOI 10.1016/j.psyneuen.2005.01.008	54	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112076	10.1371/journal.pone.0112076	http://dx.doi.org/10.1371/journal.pone.0112076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375106	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600097
J	Leighton, GO; Konnova, TA; Idiyatullin, B; Hurr, SH; Zuev, YF; Nesmelova, IV				Leighton, Gage O.; Konnova, Tatiana A.; Idiyatullin, Bulat; Hurr, Sophia H.; Zuev, Yuriy F.; Nesmelova, Irina V.			The Folding of the Specific DNA Recognition Subdomain of the Sleeping Beauty Transposase Is Temperature-Dependent and Is Required for Its Binding to the Transposon DNA	PLOS ONE			English	Article							INDUCED-FIT; CONFORMATIONAL SELECTION; SELF-DIFFUSION; GENE-THERAPY; PROTEIN; SYSTEM; VIEW; SPECTROSCOPY; ENSEMBLES; MOS1	The reaction of DNA transposition begins when the transposase enzyme binds to the transposon DNA. Sleeping Beauty is a member of the mariner family of DNA transposons. Although it is an important tool in genetic applications and has been adapted for human gene therapy, its molecular mechanism remains obscure. Here, we show that only the folded conformation of the specific DNA recognition subdomain of the Sleeping Beauty transposase, the PAI subdomain, binds to the transposon DNA. Furthermore, we show that the PAI subdomain is well folded at low temperatures, but the presence of unfolded conformation gradually increases at temperatures above 15 degrees C, suggesting that the choice of temperature may be important for the optimal transposase activity. Overall, the results provide a molecular-level insight into the DNA recognition by the Sleeping Beauty transposase.	[Leighton, Gage O.; Konnova, Tatiana A.; Hurr, Sophia H.; Nesmelova, Irina V.] Univ N Carolina, Dept Phys & Opt Sci, Charlotte, NC 28223 USA; [Konnova, Tatiana A.; Idiyatullin, Bulat; Zuev, Yuriy F.] Kazan Inst Biochem & Biophys, Kazan, Russia; [Nesmelova, Irina V.] Univ N Carolina, Ctr Biomed Engn & Sci, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; Russian Academy of Sciences; Kazan Scientific Centre of the Russian Academy of Sciences; Kazan Institute of Biochemistry & Biophysics; University of North Carolina; University of North Carolina Charlotte	Nesmelova, IV (corresponding author), Univ N Carolina, Dept Phys & Opt Sci, Charlotte, NC 28223 USA.	Irina.Nesmelova@uncc.edu	Leighton, Gage/AAG-6122-2020; Zuev, Yuriy/A-7761-2016; Zuev, Yuriy/O-6307-2019; Konnova, Tatiana/AAQ-9183-2021; Nesmelova, Irina/D-6033-2015	Leighton, Gage/0000-0003-4636-0370; Zuev, Yuriy/0000-0002-6715-2530; Zuev, Yuriy/0000-0002-6715-2530; Nesmelova, Irina/0000-0002-1835-1533; Konnova, Tatiana/0000-0002-9173-7854	North Carolina Biotechnology Center [2012-BRG-1206]; National Institute of General Medical Sciences of the National Institutes of Health [R15GM112076]; Charlotte Research Scholar award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM112076] Funding Source: NIH RePORTER	North Carolina Biotechnology Center; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Charlotte Research Scholar award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by North Carolina Biotechnology Center (2012-BRG-1206, http://www.ncbiotech.org/research-grants/research-funding/biotechnology-research) and National Institute of General Medical Sciences of the National Institutes of Health (R15GM112076, http://www.nigms.nih.gov/Pages/default.aspx) to IVN, and Charlotte Research Scholar award (http://graduateschool.uncc.edu/current-students/charlotte-research-scholars) to GOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bire S, 2013, GENE, V530, P165, DOI 10.1016/j.gene.2013.08.039; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bouuaert CC, 2010, GENETICA, V138, P473, DOI 10.1007/s10709-009-9391-x; Bouuaert CC, 2010, NUCLEIC ACIDS RES, V38, P190, DOI 10.1093/nar/gkp891; BUSHUEVA TL, 1978, BIOCHIM BIOPHYS ACTA, V534, P141, DOI 10.1016/0005-2795(78)90484-1; Carpentier CE, 2014, PROTEIN SCI, V23, P23, DOI 10.1002/pro.2386; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Dehner A, 2005, CHEMBIOCHEM, V6, P1550, DOI 10.1002/cbic.200500093; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Farber PJ, 2011, J MOL BIOL, V405, P819, DOI 10.1016/j.jmb.2010.11.016; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014; Gueguen E, 2006, MOL MICROBIOL, V62, P1102, DOI 10.1111/j.1365-2958.2006.05424.x; Hackett PB, 2013, TRANSL RES, V161, P265, DOI 10.1016/j.trsl.2012.12.005; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Haren L, 1997, MOL MICROBIOL, V25, P531, DOI 10.1046/j.1365-2958.1997.4951854.x; Hashida S, 2003, PLANT PHYSIOL, V132, P1207, DOI 10.1104/pp.102.017533; Ilyina E, 1997, BIOCHEMISTRY-US, V36, P3383, DOI 10.1021/bi9622229; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2007, MOL THER, V15, P1137, DOI 10.1038/sj.mt.6300169; Izsvak Z, 2002, J BIOL CHEM, V277, P34581, DOI 10.1074/jbc.M204001200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Keller R., 2004, COMPUTER AIDED RESON, V1; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KRETSCHMER PJ, 1979, J BACTERIOL, V139, P515, DOI 10.1128/JB.139.2.515-519.1979; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Lawler JF, 2002, J VIROL, V76, P4233, DOI 10.1128/JVI.76.9.4233-4240.2002; MCCALL DW, 1959, J CHEM PHYS, V31, P1555, DOI 10.1063/1.1730651; Menter JM, 2006, PHOTOCH PHOTOBIO SCI, V5, P403, DOI 10.1039/b516429j; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Nesmelova IV, 2002, BIOPOLYMERS, V63, P132, DOI 10.1002/bip.10023; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; PAQUIN CE, 1984, SCIENCE, V226, P53, DOI 10.1126/science.226.4670.53; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Sinzelle L, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-106; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; TSAI MM, 1987, J BACTERIOL, V169, P5556, DOI 10.1128/jb.169.12.5556-5562.1987; TURNER AK, 1990, J GEN MICROBIOL, V136, P65, DOI 10.1099/00221287-136-1-65; VandenDriessche T, 2009, BLOOD, V114, P1461, DOI 10.1182/blood-2009-04-210427; Voigt K, 2012, MOL THER, V20, P1852, DOI 10.1038/mt.2012.126; Williams DA, 2008, MOL THER, V16, P1515, DOI 10.1038/mt.2008.169; Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089	49	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112114	10.1371/journal.pone.0112114	http://dx.doi.org/10.1371/journal.pone.0112114			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375127	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600106
J	Lu, J; Hu, SJ; Ma, XY; Chen, JM; Li, QQ; Ye, H				Lu, Jun; Hu, Shao-ji; Ma, Xue-yu; Chen, Jin-min; Li, Qing-qing; Ye, Hui			Origin and Expansion of the Yunnan Shoot Borer, Tomicus yunnanensis (Coleoptera: Scolytinae): A Mixture of Historical Natural Expansion and Contemporary Human-Mediated Relocation	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; EVOLUTIONARY GENETICS; MAXIMUM-LIKELIHOOD; POPULATION-GROWTH; GLACIATION; WOLBACHIA; SEQUENCES; SOFTWARE; DISTANCE; TESTS	The Yunnan shoot borer, Tomicus yunnanensis, is a recently-discovered, aggressive pest of the Yunnan pine stands in southwestern China. Despite many bionomics studies and massive controlling efforts, research on its population genetics is extremely limited. The present study, aimed at investigating the origin and dispersal of this important forestry pest, analyzed the population genetic structure and demographic history using a mitochondrial cox1 gene fragment. Our results showed that T. yunnanensis most likely originated from the Central-Yunnan Altiplano, and the divergence time analysis placed the origin approximately 0.72 million-years ago. Host separation and specialization might have caused the speciation of T. yunnanensis. Genetic structure analyses identified two population groups, with six populations near the origin area forming one group and the remaining six populations from western and eastern Yunnan and southwestern Sichuan comprising the other. Divergence time analysis placed the split of the two groups at approximately 0.60 million-years ago, and haplotype phylogenetic tree, network, as well as migration rate suggested that populations of the latter group were established via a small number of individuals from the former one. Migration analysis also showed a certain degree of recent expansion from southwestern Sichuan to eastern Yunnan. Our findings implied that T. yunnanensis underwent both historical expansion and recent dispersal. The historical expansion may relate to the oscillation of regional climate due to glacial and interglacial periods in the Pleistocene, while human-mediated transportation of pine-wood material might have assisted the relocation and establishment of this pest in novel habitats.	[Lu, Jun; Hu, Shao-ji; Ma, Xue-yu; Ye, Hui] Yunnan Univ, Lab Biol Invas & Ecosecur, Kunming 650091, Peoples R China; [Lu, Jun; Hu, Shao-ji; Ye, Hui] Yunnan Univ, Yunnan Key Lab Int Rivers & Transboundary Ecosecu, Kunming 650091, Peoples R China; [Ma, Xue-yu] Yunnan Univ Nationalities, Sch Math & Comp Sci, Kunming 650031, Peoples R China; [Chen, Jin-min] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China; [Li, Qing-qing] Yunnan Normal Univ, Life Sci Coll, Kunming 650092, Peoples R China	Yunnan University; Yunnan University; Yunnan Minzu University; Yunnan University; Yunnan Normal University	Ye, H (corresponding author), Yunnan Univ, Lab Biol Invas & Ecosecur, Kunming 650091, Peoples R China.	yehui@ynu.edu.cn	Hu, Shao-Ji/AAO-6247-2021; Chen, Jinmin/GXN-4326-2022	Hu, Shao-Ji/0000-0002-1615-9601; 	National Natural Science Foundation of China [31360183]; Applied Basic Research Foundation of Yunnan Province [2013FA055]; Applied Basic Research Foundation for Young Scientists of Yunnan Province [2014FD025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Foundation of Yunnan Province; Applied Basic Research Foundation for Young Scientists of Yunnan Province	The present study was supported by the National Natural Science Foundation of China (31360183), the Applied Basic Research Foundation of Yunnan Province (2013FA055), and the Applied Basic Research Foundation for Young Scientists of Yunnan Province (2014FD025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerli P, 1999, GENETICS, V152, P763; Bertheau C, 2011, MOL ECOL RESOUR, V11, P1056, DOI 10.1111/j.1755-0998.2011.03050.x; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Dai XX, 2006, FOR PEST DIS, V25, P31; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duan W., 1980, GEOJOURNAL, V4, P515, DOI [10.1007/BF00214217, DOI 10.1007/BF00214217]; Duan Y, 2004, HEREDITY, V93, P416, DOI 10.1038/sj.hdy.6800518; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Eckert AJ, 2006, MOL PHYLOGENET EVOL, V40, P166, DOI 10.1016/j.ympev.2006.03.009; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He DM, 2005, ADV EARTH SCI, V20, P932; He YH, 2009, FOR INVENTORY PLANN, V34, P98; Hu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057568; HUI Y, 1991, J APPL ENTOMOL, V112, P366, DOI 10.1111/j.1439-0418.1991.tb01069.x; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jin ZZ, 2004, YUNNAN PINE; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirkendall LR, 2008, ZOOTAXA, P25, DOI 10.11646/zootaxa.1819.1.2; Langstrom B., 1983, Studia Forestalia Suecica; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; LESSA EP, 1990, SYST ZOOL, V39, P242, DOI 10.2307/2992184; Li X, 2010, ZOOTAXA, P57; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu H, 2010, J ECON ENTOMOL, V103, P95, DOI 10.1603/EC09080; Liu ZZ, 2007, GUIZHOU FOR SCI TECH, V35, P57; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pons J, 2010, MOL PHYLOGENET EVOL, V56, P796, DOI 10.1016/j.ympev.2010.02.007; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2009, FIGTREE TREE FIGURE; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2011, MRBAYES VER IN PRESS; Rui RJ, 2007, J SW FOR COLL, V27, P56; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SLATKIN M, 1991, GENETICS, V129, P555; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; [童国榜 Tong Guobang], 2002, [第四纪研究, Quaternary Sciences], V22, P332; Wang XD, 2005, CHINESE AGR SCI B, V21, P276; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wood Stephen L., 1992, Great Basin Naturalist Memoirs, V13, P835; Yang JQ, 2007, SCI CHINA SER D, V50, P1685, DOI 10.1007/s11430-007-01149; Yang JQ, 2006, QUATERN INT, V154, P52, DOI 10.1016/j.quaint.2006.02.003; Ye H, 2012, YUNNAN SHOOT BORER; Ye H, 1992, J YUNNAN U, V14, P211; Ye H., 1986, J YUNNAN U, V8, P218; [赵希涛 Zhao Xitao], 2007, [第四纪研究, Quaternary Sciences], V27, P35; ZUCKERKANDL EMILE, 1965, P97	56	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111940	10.1371/journal.pone.0111940	http://dx.doi.org/10.1371/journal.pone.0111940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372458	gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900092
J	Pastorino, L; Dellacasa, E; Noor, MR; Soulimane, T; Bianchini, P; D'Autilia, F; Antipov, A; Diaspro, A; Tofail, SAM; Ruggiero, C				Pastorino, Laura; Dellacasa, Elena; Noor, Mohamed R.; Soulimane, Tewfik; Bianchini, Paolo; D'Autilia, Francesca; Antipov, Alexei; Diaspro, Alberto; Tofail, Syed A. M.; Ruggiero, Carmelina			Multilayered Polyelectrolyte Microcapsules: Interaction with the Enzyme Cytochrome C Oxidase	PLOS ONE			English	Article							THERMUS-THERMOPHILUS; POLYMERIC CAPSULES; FILMS; ENCAPSULATION; STABILITY; NEUTRON; DENSITY	Cell-sized polyelectrolyte capsules functionalized with a redox-driven proton pump protein were assembled for the first time. The interaction of polyelectrolyte microcapsules, fabricated by electrostatic layer-by-layer assembly, with cytochrome c oxidase molecules was investigated. We found that the cytochrome c oxidase retained its functionality, that the functionalized microcapsules interacting with cytochrome c oxidase were permeable and that the permeability characteristics of the microcapsule shell depend on the shell components. This work provides a significant input towards the fabrication of an integrated device made of biological components and based on specific biomolecular functions and properties.	[Pastorino, Laura; Dellacasa, Elena; Ruggiero, Carmelina] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn, Genoa, Italy; [Noor, Mohamed R.; Soulimane, Tewfik] Univ Limerick, Dept Chem & Environm Sci, Limerick, Ireland; [Bianchini, Paolo; D'Autilia, Francesca; Diaspro, Alberto] Ist Italiano Tecnol, Genoa, Italy; [Antipov, Alexei] PlasmaChem GmbH, Berlin, Germany; [Noor, Mohamed R.; Soulimane, Tewfik; Tofail, Syed A. M.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland	University of Genoa; University of Limerick; Istituto Italiano di Tecnologia - IIT; University of Limerick	Pastorino, L (corresponding author), Univ Genoa, Dept Informat Bioengn Robot & Syst Engn, Genoa, Italy.	laura.pastorino@unige.it	Bianchini, Paolo/A-9500-2008; D'Autilia, Francesca/AAA-8957-2019; Diaspro, Alberto/E-7833-2010; Ruggiero, Carmelina/B-6038-2015; Pastorino, Laura/M-1770-2015	Bianchini, Paolo/0000-0001-6457-751X; D'Autilia, Francesca/0000-0002-3675-9196; Diaspro, Alberto/0000-0002-4916-5928; Ruggiero, Carmelina/0000-0002-5275-2074; Pastorino, Laura/0000-0002-5928-3856; Syed, Tofail/0000-0003-4212-3351; DELLACASA, ELENA/0000-0001-6260-2216	European Community's Seventh Framework Programme: LANIR (FP7) [280804]	European Community's Seventh Framework Programme: LANIR (FP7)	The research leading to these results has received funding from the European Community's Seventh Framework Programme: LANIR (FP7/20012-2015) under grant agreement no. 280804. This article reflects the views of the authors only, and the Commission cannot be held responsible for any use, which may be made of the information contained therein. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandhakumar S, 2010, COLLOID SURFACE B, V78, P266, DOI 10.1016/j.colsurfb.2010.03.016; Antipov AA, 2002, COLLOID SURFACE A, V198, P535, DOI 10.1016/S0927-7757(01)00956-6; Antipov AA, 2004, ADV COLLOID INTERFAC, V111, P49, DOI 10.1016/j.cis.2004.07.006; Balabushevitch NG, 2001, BIOTECHNOL BIOENG, V76, P207, DOI 10.1002/bit.1184; Caruso F, 2000, LANGMUIR, V16, P9595, DOI 10.1021/la000942h; Caruso F, 1998, LANGMUIR, V14, P4559, DOI 10.1021/la971288h; De Geest BG, 2009, SOFT MATTER, V5, P282, DOI 10.1039/b808262f; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E; Erokhina S, 2009, J AM CHEM SOC, V131, P9800, DOI 10.1021/ja903066s; FACCI P, 1993, THIN SOLID FILMS, V230, P86, DOI 10.1016/0040-6090(93)90496-C; Giuffre A, 1999, BIOCHEMISTRY-US, V38, P1057, DOI 10.1021/bi9815389; Ho D, 2004, NANOTECHNOLOGY, V15, P1084, DOI 10.1088/0957-4484/15/8/038; Kannisto K, 2011, COLLOID SURFACE B, V86, P298, DOI 10.1016/j.colsurfb.2011.04.012; Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087; Losche M, 1998, MACROMOLECULES, V31, P8893, DOI 10.1021/ma980910p; LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026; Lvov Y, 2001, NANO LETT, V1, P125, DOI 10.1021/nl0100015; Lvov Y., 2002, ENCY SURFACE COLLOID, P321; Muhonen J, 2008, ANAL BIOCHEM, V374, P133, DOI 10.1016/j.ab.2007.10.014; NOSSOL B, 1993, BIOELECTROMAGNETICS, V14, P361, DOI 10.1002/bem.2250140408; Onda M, 1999, J BIOSCI BIOENG, V87, P69, DOI 10.1016/S1389-1723(99)80010-3; Pastorino L, 2013, CURR ORG CHEM, V17, P58, DOI 10.2174/138527213805289088; Pastorino L, 2011, J COLLOID INTERF SCI, V357, P56, DOI 10.1016/j.jcis.2011.02.010; Pastorino L, 2009, J NANOSCI NANOTECHNO, V9, P6753, DOI 10.1166/jnn.2009.1580; Robin S, 2011, J BACTERIOL, V193, P3988, DOI 10.1128/JB.05186-11; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Schoeler B, 2002, MACROMOLECULES, V35, P889, DOI 10.1021/ma011349p; Skirtach AG, 2004, LANGMUIR, V20, P6988, DOI 10.1021/la048873k; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Soulimane T, 1997, BIOCHEM BIOPH RES CO, V237, P572, DOI 10.1006/bbrc.1997.7041; Soulimane T, 2000, PROTEIN SCI, V9, P2068, DOI 10.1110/ps.9.11.2068; Sukhorukov GB, 1998, COLLOID SURFACE A, V137, P253, DOI 10.1016/S0927-7757(98)00213-1; Sukhorukov GB, 1998, POLYM ADVAN TECHNOL, V9, P759, DOI 10.1002/(SICI)1099-1581(1998100)9:10/11<759::AID-PAT846>3.0.CO;2-Q; Sukhorukov GB, 2007, TRENDS BIOTECHNOL, V25, P93, DOI 10.1016/j.tibtech.2006.12.007; Tarabia M, 1998, J APPL PHYS, V83, P725, DOI 10.1063/1.366744; Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391; Volodkin DV, 2004, BIOMACROMOLECULES, V5, P1962, DOI 10.1021/bm049669e; Volodkin DV, 2004, LANGMUIR, V20, P3398, DOI 10.1021/la036177z	39	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112192	10.1371/journal.pone.0112192	http://dx.doi.org/10.1371/journal.pone.0112192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372607	gold, Green Published			2022-12-26	WOS:000344556900120
J	Tang, Y; Hu, CJ; Yang, HP; Cao, LP; Li, YY; Deng, PB; Huang, L				Tang, Yongjun; Hu, Chengping; Yang, Huaping; Cao, Liming; Li, Yuanyuan; Deng, Pengbo; Huang, Li			Rnd3 Regulates Lung Cancer Cell Proliferation through Notch Signaling	PLOS ONE			English	Article							RHO-KINASE INHIBITOR; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; DOWN-REGULATION; ROCK-I; PATHWAY; GROWTH; SUPPRESSION; PROGRESSION; EXPRESSION	Rnd3/RhoE is a small Rho GTPase involved in the regulation of different cell behaviors. Dysregulation of Rnd3 has been linked to tumorigenesis and metastasis. Lung cancers are the leading cause of cancer-related death in the West and around the world. The expression of Rnd3 and its ectopic role in non-small cell lung cancer (NSCLC) remain to be explored. Here, we reported that Rnd3 was down-regulated in three NSCLC cell lines: H358, H520 and A549. The down-regulation of Rnd3 led to hyper-activation of Rho Kinase and Notch signaling. The reintroduction of Rnd3 or selective inhibition of Notch signaling, but not Rho Kinase signaling, blocked the proliferation of H358 and H520 cells. Mechanistically, Notch intracellular domain (NICD) protein abundance in H358 cells was regulated by Rnd3-mediated NICD proteasome degradation. Rnd3 regulated H358 and H520 cell proliferation through a Notch1/NICD/Hes1 signaling axis independent of Rho Kinase.	[Tang, Yongjun; Hu, Chengping; Yang, Huaping; Cao, Liming; Li, Yuanyuan; Deng, Pengbo; Huang, Li] Cent S Univ, Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China	Central South University	Hu, CJ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China.	tyj7736@163.com	XIANG, HAOYUE/AAY-8862-2021; li, yuanyuan/GZA-4435-2022		Key cite of National Clincial Research Center for Respiratory Disease, National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer [2013BAI09B09]	Key cite of National Clincial Research Center for Respiratory Disease, National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer	This work was supported by the Key cite of National Clincial Research Center for Respiratory Disease, National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer, No. 2013BAI09B09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2000, INT J CANCER, V88, P873, DOI 10.1002/1097-0215(20001215)88:6<873::AID-IJC6>3.0.CO;2-B; Bektic J, 2005, PROSTATE, V64, P332, DOI 10.1002/pros.20243; Belgiovine C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014154; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Dai Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.137; Gress TM, 1996, ONCOGENE, V13, P1819; Grimwood S, 2005, NEUROPHARMACOLOGY, V48, P1002, DOI 10.1016/j.neuropharm.2005.01.016; Grise F, 2012, HEPATOLOGY, V55, P1766, DOI 10.1002/hep.25568; Jiang Xin, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P1031; Katiyar P, 2011, MOL CANCER RES, V9, P545, DOI 10.1158/1541-7786.MCR-10-0454; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Li JJ, 2011, DEV CELL, V20, P409, DOI 10.1016/j.devcel.2011.04.001; Lin X, 2013, P NATL ACAD SCI US; Lin X, 2013, P NATL ACAD SCI USA, V110, P8236, DOI 10.1073/pnas.1219995110; Liu JT, 2014, BIOCHEM BIOPH RES CO, V444, P670, DOI 10.1016/j.bbrc.2014.01.164; Luo HS, 2012, J SURG ONCOL, V105, P699, DOI 10.1002/jso.23019; Ma W, 2013, HEPATOLOGY, V57, P152, DOI 10.1002/hep.25987; Marcelo KL, 2013, DEV CELL, V27, P504, DOI 10.1016/j.devcel.2013.11.004; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1002.105938; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Satoh S, 2001, LIFE SCI, V69, P1441, DOI 10.1016/S0024-3205(01)01229-2; vanGroningen JJM, 1996, BIOCHEM BIOPH RES CO, V225, P808, DOI 10.1006/bbrc.1996.1255; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Xia HW, 2013, INT J MOL MED, V31, P1081, DOI 10.3892/ijmm.2013.1321; Zhang CY, 2007, ANN SURG ONCOL, V14, P2628, DOI 10.1245/s10434-007-9457-x; Zhang CY, 2007, CANCER BIOL THER, V6, P335, DOI 10.4161/cbt.6.3.3663; Zhao H, 2012, TUMOR BIOL, V33, P1363, DOI 10.1007/s13277-012-0384-5; Zheng QJ, 2007, ONCOL REP, V17, P847; Zhou JF, 2013, ANN SURG ONCOL, V20, P175, DOI 10.1245/s10434-012-2472-6; Zhu ZH, 2014, CANCER RES, V74, P2082, DOI 10.1158/0008-5472.CAN-12-0452	36	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111897	10.1371/journal.pone.0111897	http://dx.doi.org/10.1371/journal.pone.0111897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372032	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900088
J	Li, J; Yuan, HH; Wu, MS; Dong, LA; Zhang, L; Shi, HL; Luo, SQ				Li, Jun; Yuan, Huihui; Wu, Mingshu; Dong, Linan; Zhang, Lu; Shi, Hongli; Luo, Shuqian			Quantitative Assessment of Murine Articular Cartilage and Bone Using X-Ray Phase-Contrast Imaging	PLOS ONE			English	Article							SUBCHONDRAL BONE; COLLAGEN; OSTEOARTHRITIS; TOMOGRAPHY; TISSUE; MRI; CT	Murine models for rheumatoid arthritis (RA) research can provide important insights for understanding RA pathogenesis and evaluating the efficacy of novel treatments. However, simultaneously imaging both murine articular cartilage and subchondral bone using conventional techniques is challenging because of low spatial resolution and poor soft tissue contrast. X-ray phase-contrast imaging (XPCI) is a new technique that offers high spatial resolution for the visualisation of cartilage and skeletal tissues. The purpose of this study was to utilise XPCI to observe articular cartilage and subchondral bone in a collagen-induced arthritis (CIA) murine model and quantitatively assess changes in the joint microstructure. XPCI was performed on the two treatment groups (the control group and CIA group, n = 9 per group) to monitor the progression of damage to the femur from the knee joint in a longitudinal study (at 0, 4 and 8 weeks after primary injection). For quantitative assessment, morphologic parameters were measured in three-dimensional (3D) images using appropriate image analysis software. Our results showed that the average femoral cartilage volume, surface area and thickness were significantly decreased (P<0.05) in the CIA group compared to the control group. Meanwhile, these decreases were accompanied by obvious destruction of the surface of subchondral bone and a loss of trabecular bone in the CIA group. This study confirms that XPCI technology has the ability to qualitatively and quantitatively evaluate microstructural changes in mouse joints. This technique has the potential to become a routine analysis method for accurately monitoring joint damage and comprehensively assessing treatment efficacy.	[Li, Jun; Wu, Mingshu; Dong, Linan; Zhang, Lu; Shi, Hongli; Luo, Shuqian] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China; [Yuan, Huihui] Capital Med Univ, Dept Rheumatol & Immunol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Luo, SQ (corresponding author), Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China.	shuqian_luo@aliyun.com			National Natural Science Foundation of China [61227802]; 7th Framework Program of the European Community [PIRSES-GA-2009-269124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 7th Framework Program of the European Community	This work was supported by the National Natural Science Foundation of China (grant No. 61227802) and by the 7th Framework Program of the European Community (grant No. PIRSES-GA-2009-269124). SL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamanos Y, 2008, J RHEUMATOL, V35, P1354; Bech M, 2009, PHYS MED BIOL, V54, P2747, DOI 10.1088/0031-9155/54/9/010; Blair-Levy JM, 2008, ARTHRITIS RHEUM, V58, P1096, DOI 10.1002/art.23277; Bolbos R, 2008, NMR BIOMED, V21, P366, DOI 10.1002/nbm.1198; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Carmona L, 2010, BEST PRACT RES CL RH, V24, P733, DOI 10.1016/j.berh.2010.10.001; Dai CL, 2011, BIOMATERIALS, V32, P8506, DOI 10.1016/j.biomaterials.2011.07.090; Dusad A, 2014, IMMUNOL RES, V58, P51, DOI 10.1007/s12026-013-8479-7; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goebel JC, 2010, BIO-MED MATER ENG, V20, P189, DOI 10.3233/BME-2010-0631; Grandl S, 2013, Z MED PHYS, V23, P212, DOI 10.1016/j.zemedi.2013.02.005; Hegen M, 2008, ANN RHEUM DIS, V67, P1505, DOI 10.1136/ard.2007.076430; Imhof H, 2000, INVEST RADIOL, V35, P581, DOI 10.1097/00004424-200010000-00004; Kotwal N, 2012, OSTEOARTHR CARTILAGE, V20, P887, DOI 10.1016/j.joca.2012.04.012; Lee YS, 2010, ACAD RADIOL, V17, P244, DOI 10.1016/j.acra.2009.09.015; LeRoux MA, 2000, J ORTHOP RES, V18, P383, DOI 10.1002/jor.1100180309; Ley-Zaporozhan J, 2010, EUR J RADIOL, V73, P43, DOI 10.1016/j.ejrad.2008.09.029; Li J, 2009, OSTEOARTHR CARTILAGE, V17, P1193, DOI 10.1016/j.joca.2009.03.005; Marenzana M, 2012, PHYS MED BIOL, V24, P8171; Mrosek EH, 2006, OSTEOARTHR CARTILAGE, V14, P171, DOI 10.1016/j.joca.2005.08.004; Perry D, 2005, J RHEUMATOL, V32, P256; Peterfy CG, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4202; Pinzer BR, 2012, NEUROIMAGE, V61, P1336, DOI 10.1016/j.neuroimage.2012.03.029; Piscaer TM, 2008, BIORHEOLOGY, V45, P355, DOI 10.3233/BIR-2008-0482; Rengle A, 2009, IEEE T BIO-MED ENG, V56, P2891, DOI 10.1109/TBME.2008.2006015; Rieppo J, 2003, CELLS TISSUES ORGANS, V175, P121, DOI 10.1159/000074628; Roemer FW, 2011, RADIOLOGY, V260, P332, DOI 10.1148/radiol.11101359; Roemer FW, 2005, ARTHRIT RHEUM-ARTHR, V53, P491, DOI 10.1002/art.21318; Roemhildt ML, 2006, J BIOMECH, V39, P2331, DOI 10.1016/j.jbiomech.2005.07.017; Ruan MZC, 2013, ARTHRITIS RHEUM-US, V65, P388, DOI 10.1002/art.37766; SMITH JW, 2009, ARCH AM ART J, V48, P1; Smolen JS, 2012, NAT REV RHEUMATOL, V8, P235, DOI 10.1038/nrrheum.2012.23; Stutman D, 2011, PHYS MED BIOL, V56, P5697, DOI 10.1088/0031-9155/56/17/015; Yang F, 2013, BIOMATERIALS, V34, P1514, DOI 10.1016/j.biomaterials.2012.10.058	34	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111939	10.1371/journal.pone.0111939	http://dx.doi.org/10.1371/journal.pone.0111939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369528	Green Submitted, gold, Green Published			2022-12-26	WOS:000344402000129
J	Raman, S; Srinivasan, K; Kurpad, A; Razee, H; Ritchie, J				Raman, Shanti; Srinivasan, Krishnamachari; Kurpad, Anura; Razee, Husna; Ritchie, Jan			"Nothing Special, Everything Is Maamuli'': Socio-Cultural and Family Practices Influencing the Perinatal Period in Urban India	PLOS ONE			English	Article							NEWBORN-CARE PRACTICES; DEVELOPING-COUNTRIES; CHILDBIRTH PRACTICES; SYSTEMATIC ANALYSIS; NEONATAL HEALTH; BIRTH-WEIGHT; SOUTH-INDIA; INFERTILITY; SURVIVAL; BANGLADESH	Background: Globally, India contributes the largest share in sheer numbers to the burden of maternal and infant under-nutrition, morbidity and mortality. A major gap in our knowledge is how socio-cultural practices and beliefs influence the perinatal period and thus perinatal outcomes, particularly in the rapidly growing urban setting. Methods and Findings: Using data from a qualitative study in urban south India, including in-depth interviews with 36 women who had recently been through childbirth as well as observations of family life and clinic encounters, we explored the territory of familial, cultural and traditional practices and beliefs influencing women and their families through pregnancy, childbirth and infancy. We found that while there were some similarities in cultural practices to those described before in studies from low resource village settings, there are changing practices and ideas. Fertility concerns dominate women's experience of married life; notions of gender preference and ideal family size are changing rapidly in response to the urban context; however inter-generational family pressures are still considerable. While a rich repertoire of cultural practices persists throughout the perinatal continuum, their existence is normalised and even underplayed. In terms of diet and nutrition, traditional messages including notions of 'hot' and 'cold' foods, are stronger than health messages; however breastfeeding is the cultural norm and the practice of delayed breastfeeding appears to be disappearing in this urban setting. Marriage, pregnancy and childbirth are so much part of the norm for women, that there is little expectation of individual choice in any of these major life events. Conclusions: A greater understanding is needed of the dynamic factors shaping the perinatal period in urban India, including an acknowledgment of the health promoting as well as potentially harmful cultural practices and the critical role of the family. This will help plan culturally appropriate integrated perinatal health care.	[Raman, Shanti] Liverpool Hosp, South Western Sydney Local Hlth Dist, Dept Community Paediat, Liverpool, NSW, England; [Srinivasan, Krishnamachari] St Johns Med Coll, Dept Psychiat, Bangalore, Karnataka, India; [Kurpad, Anura] St Johns Med Coll, Dept Physiol, Bangalore, Karnataka, India; [Razee, Husna; Ritchie, Jan] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Medical College; University of New South Wales Sydney	Raman, S (corresponding author), Liverpool Hosp, South Western Sydney Local Hlth Dist, Dept Community Paediat, Liverpool, NSW, England.	shanti.raman@sswahs.nsw.gov.au		Razee, Husna/0000-0002-6845-8136				Aborigo RA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-76; Bandyopadhyay Mridula, 2003, Health Care Women Int, V24, P910, DOI 10.1080/07399330390244220; Barnett S, 2006, J HEALTH POPUL NUTR, V24, P394; Bharadwaj A, 2003, SOC SCI MED, V56, P1867, DOI 10.1016/S0277-9536(02)00210-1; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bhutta ZA, 2010, LANCET, V375, P1142, DOI 10.1016/S0140-6736(10)60324-8; Blanchet T., 1984, WOMEN POLLUTION MARG; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Callaghan-Koru JA, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-198; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chatterjee N, 2013, THIS IS NORMAL PREGN; Chi Z, 2013, INDIAN J GEND STUD, V20, P51, DOI 10.1177/0971521512465936; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; Dwarkanath P, 2007, ASIA PAC J CLIN NUTR, V16, P704; FELDMANSAVELSBERG P, 1994, SOC SCI MED, V39, P463, DOI 10.1016/0277-9536(94)90090-6; Fikree FF, 2005, SOC SCI MED, V60, P911, DOI 10.1016/j.socscimed.2004.06.034; FITZGERALD MH, 1997, QUALITATIVE RES DISC, P48; Forsey MG, 2010, ETHNOGRAPHY, V11, P558, DOI 10.1177/1466138110372587; Galloway R, 2002, SOC SCI MED, V55, P529, DOI 10.1016/S0277-9536(01)00185-X; GIDEON H, 1962, AM ANTHROPOL, V64, P1220, DOI 10.1525/aa.1962.64.6.02a00060; Gragnolati M, 2005, INDIAS UNDERNOURISHE; Grbich C., 2003, QUALITATIVE RES HLTH; Green J, 2009, QUALITATIVE METHODS; Holder Kelly, 2011, East Afr J Public Health, V8, P38; Hollos M, 2008, CULT HEALTH SEX, V10, P159, DOI 10.1080/13691050701656789; Inhorn MC, 2009, INT J GYNECOL OBSTET, V106, P172, DOI 10.1016/j.ijgo.2009.03.034; INHORN MC, 1994, SOC SCI MED, V39, P459, DOI 10.1016/0277-9536(94)90089-2; Iyengar SD, 2008, J PERINATOL, V28, pS23, DOI 10.1038/jp.2008.174; Kassebaum N.J, 2014, LANCET; Kesterton AJ, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-20; Kimani-Murage EW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-396; Kodzi IA, 2012, SOC SCI MED, V74, P966, DOI 10.1016/j.socscimed.2011.12.035; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee HMH, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-223; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maimbolwa MC, 2003, J ADV NURS, V43, P263, DOI 10.1046/j.1365-2648.2003.02709.x; Ministry of Health and Family Welfare, 2008, 2005 2006 NAT FAM HL; Moran AC, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-54; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Muthayya S, 2006, ASIA PAC J CLIN NUTR, V15, P538; Nachtigall RD, 2006, FERTIL STERIL, V85, P871, DOI 10.1016/j.fertnstert.2005.08.066; NEFF DL, 1994, SOC SCI MED, V39, P475, DOI 10.1016/0277-9536(94)90091-4; NICHTER M, 1983, HUM ORGAN, V42, P235, DOI 10.17730/humo.42.3.43081445235366lk; NICHTER M, 1985, SOC SCI MED, V21, P667, DOI 10.1016/0277-9536(85)90206-0; NICHTER M, 1987, SOC SCI MED, V25, P377, DOI 10.1016/0277-9536(87)90276-0; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Papreen N, 2000, REPROD HEALTH MATTER, V8, P33, DOI 10.1016/S0968-8080(00)90004-1; Puri S, 2011, SOC SCI MED, V72, P1169, DOI 10.1016/j.socscimed.2011.01.027; Ram K., 1994, Reproductive Health Matters, P20, DOI 10.1016/0968-8080(94)90004-3; Raman S., 2014, Health, Culture and Society, V6, P73; Raman S, 2014, MIDWIFERY, V30, P130, DOI 10.1016/j.midw.2013.03.003; Rodrigues M, 2003, SOC SCI MED, V57, P1797, DOI 10.1016/S0277-9536(03)00062-5; ROWE PJ, 1987, FERTIL STERIL, V47, P964; Rozario S., 1998, MATERNITIES MODERNIT, P144; Sahni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002224; Tabong PTN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054429; Thomas T., 2009, RAISING MINIMUM ED G; UNFPA, 1994, PROGR ACT AD INT C P, DOI UNFPA; Veena SR, 2010, ARCH DIS CHILD, V95, P347, DOI 10.1136/adc.2009.165159	62	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111900	10.1371/journal.pone.0111900	http://dx.doi.org/10.1371/journal.pone.0111900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369447	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000120
J	Cho, JA; Zhang, X; Miller, GM; Lencer, WI; Nery, FC				Cho, Jin A.; Zhang, Xuan; Miller, Gregory M.; Lencer, Wayne I.; Nery, Flavia C.			4-Phenylbutyrate Attenuates the ER Stress Response and Cyclic AMP Accumulation in DYT1 Dystonia Cell Models	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEPENDENT PROTEIN-KINASE; CYCLOHYDROLASE-I GENE; TORSION DYSTONIA; TYROSINE-HYDROXYLASE; CHEMICAL CHAPERONES; HUNTINGTONS-DISEASE; PHARMACOLOGICAL STRATEGY; DOPAMINE-RECEPTORS; CERVICAL DYSTONIA	Dystonia is a neurological disorder in which sustained muscle contractions induce twisting and repetitive movements or abnormal posturing. DYT1 early-onset primary dystonia is the most common form of hereditary dystonia and is caused by deletion of a glutamic acid residue (302/303) near the carboxyl-terminus of encoded torsinA. TorsinA is localized primarily within the contiguous lumen of the endoplasmic reticulum (ER) and nuclear envelope (NE), and is hypothesized to function as a molecular chaperone and an important regulator of the ER stress-signaling pathway, but how the mutation in torsinA causes disease remains unclear. Multiple lines of evidence suggest that the clinical symptoms of dystonia result from abnormalities in dopamine (DA) signaling, and possibly involving its down-stream effector adenylate cyclase that produces the second messenger cyclic adenosine-3', 5'-monophosphate (cAMP). Here we find that mutation in torsinA induces ER stress, and inhibits the cyclic adenosine-3', 5'-monophosphate (cAMP) response to the adenylate cyclase agonist forskolin. Both defective mechanins are corrected by the small molecule 4-phenylbutyrate (4-PBA) that alleviates ER stress. Our results link torsinA, the ER-stress-response, and cAMP-dependent signaling, and suggest 4-PBA could also be used in dystonia treatment. Other pharmacological agents known to modulate the cAMP cascade, and ER stress may also be therapeutic in dystonia patients and can be tested in the models described here, thus supplementing current efforts centered on the dopamine pathway.	[Cho, Jin A.; Lencer, Wayne I.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gastroenterol Cell Biol, Boston, MA USA; [Zhang, Xuan; Nery, Flavia C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Neurosci,Dept Neurol, Boston, MA 02114 USA; [Zhang, Xuan; Nery, Flavia C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res,Dept Radiol, Boston, MA USA; [Zhang, Xuan; Nery, Flavia C.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA USA; [Miller, Gregory M.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Miller, Gregory M.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Lencer, Wayne I.] Harvard Univ, Sch Med, Harvard Digest Dis Ctr, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Northeastern University; Northeastern University; Harvard University; Harvard Medical School	Nery, FC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Neurosci,Dept Neurol, Boston, MA 02114 USA.	nery.flavia@mgh.harvard.edu		Lencer, Wayne/0000-0001-7346-2730	National Institute of Neurological Disorders and Stroke [NS037409]; Harvard Digestive Diseases Center [P30 DK34854]; CCFA;  [DK48106];  [DK084424];  [DK090603];  [DK083894]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048106, R01DK084424, P30DK034854, F32DK083894, R21DK090603, R37DK048106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS037409, P01NS037409] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Harvard Digestive Diseases Center; CCFA; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke, Grant NS037409 (F.C.N.; investigator); DK48106 (W.I.L., PI), DK084424 (W.I.L., PI), DK090603 (W.I.L., PI) and the Harvard Digestive Diseases Center P30 DK34854 (W.I.L., PI); DK083894 (W.I.L., PI) and CCFA Fellowship (J.A.C.; postdoc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi C, 2004, EUR J HUM GENET, V12, P59, DOI 10.1038/sj.ejhg.5201102; Atai NA, 2012, INT J CELL BIOL, V2012; Augood Sarah J, 2004, Adv Neurol, V94, P53; Augood SJ, 2002, NEUROLOGY, V59, P445, DOI 10.1212/WNL.59.3.445; Bakowska JC, 2003, GENE THER, V10, P1691, DOI 10.1038/sj.gt.3302061; Batshaw ML, 2001, J PEDIATR-US, V138, pS46, DOI 10.1067/mpd.2001.111836; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bragg DC, 2011, NEUROBIOL DIS, V42, P136, DOI 10.1016/j.nbd.2010.11.015; Brashear A, 1999, MOVEMENT DISORD, V14, P132, DOI 10.1002/1531-8257(199901)14:1<132::AID-MDS1022>3.0.CO;2-J; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; BREAKEFIELD XO, 1981, J NEUROSCI RES, V6, P349, DOI 10.1002/jnr.490060310; Bronte-Stewart Helen, 2003, Curr Neurol Neurosci Rep, V3, P296, DOI 10.1007/s11910-003-0006-0; BURKE RE, 1986, NEUROLOGY, V36, P160, DOI 10.1212/WNL.36.2.160; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cao SS, 2010, DIS MODEL MECH, V3, P386, DOI 10.1242/dmm.003715; Chen P, 2010, HUM MOL GENET, V19, P3502, DOI 10.1093/hmg/ddq266; Chen XQ, 2008, MOL PHARMACOL, V73, P1816, DOI 10.1124/mol.107.043968; Cherry JA, 2001, BBA-GENE STRUCT EXPR, V1518, P27, DOI 10.1016/S0167-4781(01)00164-6; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Cousin MA, 2011, J PHYSIOL-LONDON, V589, P1943, DOI 10.1113/jphysiol.2010.200477; Dang MT, 2006, NEUROSCI RES, V56, P470, DOI 10.1016/j.neures.2006.09.005; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; DARFLER FJ, 1982, J BIOL CHEM, V257, P1901; Del Signore SJ, 2009, AMYOTROPH LATERAL SC, V10, P85, DOI 10.1080/17482960802226148; Esapa CT, 2007, HUM MOL GENET, V16, P327, DOI 10.1093/hmg/ddl472; Fonseca SG, 2012, NAT CELL BIOL, V14, P1105, DOI 10.1038/ncb2578; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Fujiwara M, 2013, J PHARMACOL SCI, V122, P71, DOI 10.1254/jphs.12194FP; Furukawa Y, 2001, NEUROLOGY, V56, P260, DOI 10.1212/WNL.56.2.260; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gatti R, 1997, J INHERIT METAB DIS, V20, P803, DOI 10.1023/A:1005323918923; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Herve D, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00048; Hettich J, 2014, HUM MUTAT; Hewett JW, 2008, HUM MOL GENET, V17, P1436, DOI 10.1093/hmg/ddn032; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; Hirayama K, 2001, J NEUROCHEM, V79, P576, DOI 10.1046/j.1471-4159.2001.00583.x; Huang NK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020934; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Kachi T, 2001, Rinsho Shinkeigaku, V41, P1181; Kanellopoulos AK, 2012, J NEUROSCI, V32, P13111, DOI 10.1523/JNEUROSCI.1347-12.2012; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Kelley DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000931; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Kouraklis G, 2006, ONCOL REP, V15, P489; Kubota K, 2006, J NEUROCHEM, V97, P1259, DOI 10.1111/j.1471-4159.2006.03782.x; Lin JT, 2013, MOL CELL BIOL, V33, P1073, DOI 10.1128/MCB.01434-12; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Mezaki Takahiro, 2005, Rinsho Shinkeigaku, V45, P634; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Naumann M, 1998, MOVEMENT DISORD, V13, P319, DOI 10.1002/mds.870130219; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Nery FC, 2014, J NEUROSCI METH, V232, P181, DOI 10.1016/j.jneumeth.2014.05.027; Nery FC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1383; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oliveira RF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002383; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Perlmutter Joel S, 2004, Adv Neurol, V94, P163; Perlmutter JS, 1997, J NEUROSCI, V17, P843; Placzek MR, 2001, J NEUROL NEUROSUR PS, V71, P262, DOI 10.1136/jnnp.71.2.262; POLLOCK RJ, 1981, J NEUROCHEM, V37, P855, DOI 10.1111/j.1471-4159.1981.tb04471.x; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Sancesario G, 2004, EUR J NEUROSCI, V20, P989, DOI 10.1111/j.1460-9568.2004.03566.x; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Sharma N, 2001, AM J PATHOL, V159, P339, DOI 10.1016/S0002-9440(10)61700-2; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Walker RH, 2003, MOVEMENT DISORD, V18, P1102, DOI 10.1002/mds.10549; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	80	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e110086	10.1371/journal.pone.0110086	http://dx.doi.org/10.1371/journal.pone.0110086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379658	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100010
J	McCall-Hosenfeld, JS; Mukherjee, S; Lehman, EB				McCall-Hosenfeld, Jennifer S.; Mukherjee, Sucharita; Lehman, Erik B.			The Prevalence and Correlates of Lifetime Psychiatric Disorders and Trauma Exposures in Urban and Rural Settings: Results from the National Comorbidity Survey Replication (NCS-R)	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; MENTAL-HEALTH; EPIDEMIOLOGY; DISPARITIES	Introduction: Distinctions between rural and urban environments produce different frequencies of traumatic exposures and psychiatric disorders. We examine the prevalence of psychiatric disorders and frequency of trauma exposures by position on the rural-urban continuum. Methods: The National Comorbidity Survey Replication (NCS-R) was used to evaluate psychiatric disorders among a nationally-representative sample of the U.S. population. Rurality was designated using the Department of Agriculture's 2003 rural-urban continuum codes (RUCC), which differentiate counties into levels of rurality by population density and adjacency to metropolitan areas. Lifetime psychiatric disorders included post-traumatic stress disorder (PTSD), anxiety disorders, major depressive disorder, mood disorders, impulse-control disorders, and substance abuse. Trauma exposures were classified as war-related, accident-related, disaster-related, interpersonal or other. Weighted logistic regression models examined the odds of psychiatric disorders and trauma exposures by position on the rural-urban continuum, adjusted for relevant covariates. Results: 75% of participants were metropolitan, 12.2% were suburban, and 12.8% were from rural counties. The most common disorder reported was any anxiety disorder (38.5%). Drug abuse was more common among metropolitan (8.7%, p = 0.018), compared to nonmetropolitan (5.1% suburban, 6.1% rural) participants. A one-category increase in rurality was associated with decreased odds for war-related trauma (aOR = 0.86, 95% CI 0.78-0.95). Rurality was not associated with risk for any other lifetime psychiatric disorders or trauma exposure. Discussion/Conclusions: Contrary to the expectation of some rural primary care providers, the frequencies of most psychiatric disorders and trauma exposures are similar across the rural-urban continuum, reinforcing calls to improve mental healthcare access in resource-poor rural communities.	[McCall-Hosenfeld, Jennifer S.] Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA; [McCall-Hosenfeld, Jennifer S.; Lehman, Erik B.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Mukherjee, Sucharita] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Rochester	McCall-Hosenfeld, JS (corresponding author), Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA.	jmccallhosenfeld@hmc.psu.edu			National Institute of Mental Health [U01-MH60220]; National Institute of Drug Abuse; Substance Abuse and Mental Health Services Administration; Robert Wood Johnson Foundation [044780]; Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH060220] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Substance Abuse and Mental Health Services Administration(United States Department of Health & Human Services); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The parent study, The National Comorbidity study replication (NCS-R) was supported by the National Institute of Mental Health U01-MH60220, with supplemental support from the National Institute of Drug Abuse, the Substance Abuse and Mental Health Services Administration, and the Robert Wood Johnson Foundation (grant 044780). A stipend from the Pennsylvania State University College of Medicine Supported this secondary analysis. No funder had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	BLAZER D, 1985, ARCH GEN PSYCHIAT, V42, P651; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Breslau J, 2014, ARE MENTAL DISORDERS; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Burris JL, 2010, PSYCHO-ONCOLOGY, V19, P637, DOI 10.1002/pon.1600; Colon-Gonzalez Maria C, 2013, Ment Health Fam Med, V10, P191; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; Gamm LD, 2003, RURAL HLTH PEOPLE 20; Hinton WL, 1997, J NERV MENT DIS, V185, P39, DOI 10.1097/00005053-199701000-00007; HUMAN J, 1991, AM PSYCHOL, V46, P232, DOI 10.1037/0003-066X.46.3.232; Insel TR, 2008, AM J PSYCHIAT, V165, P663, DOI 10.1176/appi.ajp.2008.08030366; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; KENDLER KS, 1986, AM J PSYCHIAT, V143, P279; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2004, INT J METH PSYCH RES, V13, P69, DOI 10.1002/mpr.167; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; McGuive TG, 2008, HEALTH AFFAIR, V27, P393, DOI 10.1377/hlthaff.27.2.393; McQuaid JR, 2001, PSYCHOL MED, V31, P1249, DOI 10.1017/S0033291701004202; Merwin E, 2003, ARCH PSYCHIAT NURS, V17, P42, DOI 10.1053/apnu.2003.1; MURRAY JD, 1991, AM PSYCHOL, V46, P220, DOI 10.1037/0003-066X.46.3.220; National Household Survey on Drug Abuse, 2002, ILL DRUG US METR NON; Nickerson A, 2012, PSYCHIAT RES, V197, P128, DOI 10.1016/j.psychres.2012.01.012; ORH: VHA Office of Rural Health, 2014, INF VHA OFF RUR HLTH; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Philbrick JT, 1996, J GEN INTERN MED, V11, P9, DOI 10.1007/BF02603478; President's New Freedom Commission on Mental Health, 2003, ACH PROM TRANSF MENT; Probst JC, 2006, FAM MED, V38, P653; Ricketts TC, 1999, RURAL HEALTH IN THE UNITED STATES, P7; Rueter MA, 2007, COMMUNITY MENT HLT J, V43, P229, DOI 10.1007/s10597-007-9082-y; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Samson AY, 1999, J FAM PRACTICE, V48, P222; Schur CL, 1999, RURAL HEALTH IN THE UNITED STATES, P25; Stein MB, 2000, BEHAV RES THER, V38, P619, DOI 10.1016/S0005-7967(99)00098-4; UNITED NATIONS HIGH COMMISSIONER FOR REFUGEES (UNHCR), 2009, UNHCR POL REF PROT S; United States Department of Agriculture, 2003, USDA ERS RUR CLASS; Vega WA, 1998, ARCH GEN PSYCHIAT, V55, P771, DOI 10.1001/archpsyc.55.9.771; West Bethany A., 2011, Morbidity and Mortality Weekly Report, V60, P52	39	30	30	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112416	10.1371/journal.pone.0112416	http://dx.doi.org/10.1371/journal.pone.0112416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25380277	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100087
J	Qadri, MAJ; Sayde, JM; Cook, RG				Qadri, Muhammad A. J.; Sayde, Justin M.; Cook, Robert G.			Discrimination of Complex Human Behavior by Pigeons (Columba livia) and Humans	PLOS ONE			English	Article							NEURAL MECHANISMS; MOTION; CATEGORIZATION; RECOGNITION; PERCEPTION; SIMULATION; IMITATION; MOVEMENTS; IMAGES; MODEL	The cognitive and neural mechanisms for recognizing and categorizing behavior are not well understood in non-human animals. In the current experiments, pigeons and humans learned to categorize two non-repeating, complex human behaviors ("martial arts" vs. "Indian dance"). Using multiple video exemplars of a digital human model, pigeons discriminated these behaviors in a go/no-go task and humans in a choice task. Experiment 1 found that pigeons already experienced with discriminating the locomotive actions of digital animals acquired the discrimination more rapidly when action information was available than when only pose information was available. Experiments 2 and 3 found this same dynamic superiority effect with naive pigeons and human participants. Both species used the same combination of immediately available static pose information and more slowly perceived dynamic action cues to discriminate the behavioral categories. Theories based on generalized visual mechanisms, as opposed to embodied, species-specific action networks, offer a parsimonious account of how these different animals recognize behavior across and within species.	[Qadri, Muhammad A. J.; Sayde, Justin M.; Cook, Robert G.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	Tufts University	Qadri, MAJ (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.	Muhammad.Qadri@tufts.edu	Qadri, Muhammad A. J./CAI-2467-2022	Qadri, Muhammad A. J./0000-0003-2518-7919	National Eye Institute [RO1EY022655]; NATIONAL EYE INSTITUTE [R01EY022655] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by a grant from the National Eye Institute (#RO1EY022655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asen Y, 2012, PSYCHOL SCI, V23, P617, DOI 10.1177/0956797611433333; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Buccino G, 2004, BRAIN LANG, V89, P370, DOI 10.1016/S0093-934X(03)00356-0; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Cook, 2001, AVIAN VISUAL COGNITI; Cook R G, 2001, Anim Cogn, V4, P137, DOI 10.1007/s100710100097; Cook RG, 2000, CURR DIR PSYCHOL SCI, V9, P83, DOI 10.1111/1467-8721.00066; Cook RG, 2007, J EXP PSYCHOL ANIM B, V33, P287, DOI 10.1037/0097-7403.33.3.287; Cook RG, 2012, COGNITION, V124, P284, DOI 10.1016/j.cognition.2012.05.007; Cook RG, 2011, J EXP PSYCHOL ANIM B, V37, P175, DOI 10.1037/a0022105; COOPER WE, 1981, ANIM BEHAV, V29, P1127, DOI 10.1016/S0003-3472(81)80065-6; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; DITTRICH WH, 1993, J EXP ANAL BEHAV, V59, P115, DOI 10.1901/jeab.1993.59-115; Dittrich WH, 1998, J EXP ANAL BEHAV, V70, P281, DOI 10.1901/jeab.1998.70-281; DOMJAN M, 1988, ANIM BEHAV, V36, P1006, DOI 10.1016/S0003-3472(88)80060-5; Fleischer F, 2013, J NEUROSCI, V33, P6563, DOI 10.1523/JNEUROSCI.4129-12.2013; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Gobbini MI, 2011, J COGNITIVE NEUROSCI, V23, P1911, DOI 10.1162/jocn.2010.21574; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Grezes J, 2009, NEUROPSYCHOLOGIA, V47, P1816, DOI 10.1016/j.neuropsychologia.2009.02.021; HERRNSTEIN RJ, 1976, J EXP PSYCHOL ANIM B, V2, P285, DOI 10.1037/0097-7403.2.4.285; Heyes C, 2010, NEUROIMAGE, V51, P789, DOI 10.1016/j.neuroimage.2010.02.034; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Husband S., 2001, AVIAN VISUAL COGNITI; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jastorff J, 2006, J VISION, V6, P791, DOI 10.1167/6.8.3; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Koban A, 2009, J EXP PSYCHOL ANIM B, V35, P250, DOI 10.1037/a0013874; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; LEA SEG, 2000, PICTURE PERCEPTION A, P143; Nguyen AP, 2004, J NEUROSCI, V24, P4962, DOI 10.1523/JNEUROSCI.0146-04.2004; Polosecki P, 2013, J NEUROSCI, V33, P11768, DOI 10.1523/JNEUROSCI.5402-11.2013; Qadri MAJ, 2014, J VISION, V14, DOI 10.1167/14.5.16; Rees G, 2008, CURR BIOL, V18, P40; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RUGGIERO LF, 1979, AM NAT, V113, P749, DOI 10.1086/283430; Smith JD, 2011, PSYCHON B REV, V18, P414, DOI 10.3758/s13423-010-0047-8; Springer A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00387; Verfaillie K, 2002, VIS COGN, V9, P217, DOI 10.1080/13506280143000403; Weinland D, 2011, COMPUT VIS IMAGE UND, V115, P224, DOI 10.1016/j.cviu.2010.10.002; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460	45	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112342	10.1371/journal.pone.0112342	http://dx.doi.org/10.1371/journal.pone.0112342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379777	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100076
J	Traikov, S; Stange, C; Wassmer, T; Paul-Gilloteaux, P; Salamero, J; Raposo, G; Hoflack, B				Traikov, Sofia; Stange, Christoph; Wassmer, Thomas; Paul-Gilloteaux, Perrine; Salamero, Jean; Raposo, Graca; Hoflack, Bernard			Septin6 and Septin7 GTP Binding Proteins Regulate AP-3-and ESCRT-Dependent Multivesicular Body Biogenesis	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; ADAPTER COMPLEX; FILAMENT FORMATION; MAMMALIAN SEPTIN; BETA-3A SUBUNIT; TRANSPORT; ACTIN; TRAFFICKING; CLATHRIN; RECEPTOR	Septins (SEPTs) form a family of GTP-binding proteins implicated in cytoskeleton and membrane organization, cell division and host/pathogen interactions. The precise function of many family members remains elusive. We show that SEPT6 and SEPT7 complexes bound to F-actin regulate protein sorting during multivesicular body (MVB) biogenesis. These complexes bind AP-3, an adapter complex sorting cargos destined to remain in outer membranes of maturing endosomes, modulate AP-3 membrane interactions and the motility of AP-3-positive endosomes. These SEPT-AP interactions also influence the membrane interaction of ESCRT (endosomal-sorting complex required for transport)-I, which selects ubiquitinated cargos for degradation inside MVBs. Whereas our findings demonstrate that SEPT6 and SEPT7 function in the spatial, temporal organization of AP-3- and ESCRT-coated membrane domains, they uncover an unsuspected coordination of these sorting machineries during MVB biogenesis. This requires the E3 ubiquitin ligase LRSAM1, an AP-3 interactor regulating ESCRT-I sorting activity and whose mutations are linked with Charcot-Marie-Tooth neuropathies.	[Traikov, Sofia; Stange, Christoph; Wassmer, Thomas; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany; [Wassmer, Thomas] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Paul-Gilloteaux, Perrine; Salamero, Jean; Raposo, Graca] Inst Curie, CNRS, Mol Mech Intracellular Transport Lab, F-75231 Paris, France; [Paul-Gilloteaux, Perrine; Salamero, Jean] Inst Curie, CNRS, PICT IBiSA, Cell & Tissue Imaging Facil, F-75231 Paris, France; [Paul-Gilloteaux, Perrine; Salamero, Jean] Inst Curie, CNRS, Nikon Imaging Ctr, F-75231 Paris, France	Technische Universitat Dresden; Aston University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Hoflack, B (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	HOFLACK, Bernard/AAZ-6668-2020; Paul-Gilloteaux, Perrine/L-8287-2018	Paul-Gilloteaux, Perrine/0000-0002-4822-165X; salamero, jean/0000-0002-2610-5826; Raposo, graca/0000-0001-9590-1298	DFG [TRR 83/2-2014, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1]; TU-Dresden; CAMINEMS FP7 project [228980]	DFG(German Research Foundation (DFG)); TU-Dresden(European Commission); CAMINEMS FP7 project	BH's research was supported in part by grants from DFG (TRR 83/2-2014, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1), and TU-Dresden, JS's research by CAMINEMS FP7 project (grant number 228980). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Angenieux C, 2005, TRAFFIC, V6, P286, DOI 10.1111/j.1600-0854.2005.00272.x; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Guernsey DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001081; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hu JL, 2012, CURR BIOL, V22, P1109, DOI 10.1016/j.cub.2012.04.019; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Joberty G, 2001, NAT CELL BIOL, V3, P861, DOI 10.1038/ncb1001-861; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Kural C, 2012, CELL REP, V2, P1111, DOI 10.1016/j.celrep.2012.09.025; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Low C, 2006, J BIOL CHEM, V281, P30697, DOI 10.1074/jbc.M605179200; Mavrakis M, 2014, NAT CELL BIOL, V16, P322, DOI 10.1038/ncb2921; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Mostowy S, 2011, AUTOPHAGY, V7, P780, DOI 10.4161/auto.7.7.15593; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Saarikangas J, 2011, EMBO REP, V12, P1118, DOI 10.1038/embor.2011.193; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Spiliotis ET, 2012, TRAFFIC, V13, P195, DOI 10.1111/j.1600-0854.2011.01268.x; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Tsang CW, 2008, MOL CELL BIOL, V28, P7012, DOI 10.1128/MCB.00035-08; Vaccari I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002319; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338	53	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e109372	10.1371/journal.pone.0109372	http://dx.doi.org/10.1371/journal.pone.0109372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380047	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000344863100006
J	Xu, LD; Muller, S; Thoppe, SR; Hellborg, F; Kanter, L; Lerner, M; Zheng, BY; Lagercrantz, SB; Grander, D; Wallin, KL; Wiman, KG; Larsson, C; Andersson, S				Xu, Li-Di; Muller, Susanne; Thoppe, Srinivasan R.; Hellborg, Fredrik; Kanter, Lena; Lerner, Mikael; Zheng, Biying; Lagercrantz, Svetlana Bajalica; Grander, Dan; Wallin, Keng Ling; Wiman, Klas G.; Larsson, Catharina; Andersson, Sonia			Expression of the p53 Target Wig-1 Is Associated with HPV Status and Patient Survival in Cervical Carcinoma	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; SQUAMOUS-CELL CARCINOMAS; TELOMERASE GENE TERC; ZINC-FINGER PROTEIN; MESSENGER-RNA STABILITY; GENOMIC AMPLIFICATION; CANCER; LUNG; CARCINOGENESIS; ADENOCARCINOMA	The p53 target gene WIG-1 (ZMAT3) is located in chromosomal region 3q26, that is frequently amplified in human tumors, including cervical cancer. We have examined the status of WIG-1 and the encoded Wig-1 protein in cervical carcinoma cell lines and tumor tissue samples. Our analysis of eight cervical cancer lines (Ca Ski, ME-180, MS751, SiHa, SW756, C-4I, C-33A, and HT-3) by spectral karyotype, comparative genomic hybridization and Southern blotting revealed WIG-1 is not the primary target for chromosome 3 gains. However, WIG-1/Wig-1 were readily expressed and WIG-1 mRNA expression was higher in the two HPV-negative cervical cell lines (C33-A, HT-3) than in HPV-positive lines. We then assessed Wig-1 expression by immunohistochemistry in 38 cervical tumor samples. We found higher nuclear Wig-1 expression levels in HPV-negative compared to HPV positive cases (p = 0.002) and in adenocarcinomas as compared to squamous cell lesions (p<0.0001). Cases with moderate nuclear Wig-1 staining and positive cytoplasmic Wig-1 staining showed longer survival than patients with strong nuclear and negative cytoplasmic staining (p = 0.042). Nuclear Wig-1 expression levels were positively associated with age at diagnosis (p = 0.023) and histologic grade (p = 0.034). These results are consistent with a growth-promoting and/or anti-cell death function of nuclear Wig-1 and suggest that Wig-1 expression can serve as a prognostic marker in cervical carcinoma.	[Xu, Li-Di; Hellborg, Fredrik; Kanter, Lena; Lerner, Mikael; Lagercrantz, Svetlana Bajalica; Grander, Dan; Wallin, Keng Ling; Wiman, Klas G.; Larsson, Catharina] Karolinska Univ Hosp Solna, CCK, Dept Oncol Pathol, Stockholm, Sweden; [Muller, Susanne; Andersson, Sonia] Karolinska Univ Hosp Solna, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden; [Thoppe, Srinivasan R.; Zheng, Biying] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Wiman, KG (corresponding author), Karolinska Univ Hosp Solna, CCK, Dept Oncol Pathol, Stockholm, Sweden.	Klas.Wiman@ki.se	Wiman, Klas/AAB-8399-2021	Wiman, Klas/0000-0002-7113-524X	Swedish Research Council (VR) [K2013-66X-15385-09-5, 521-2008-2899, K2014-66X-11622-19-3]; Swedish Cancer Society [13 0623]; Radiumhemmets Forskningsfonder [131271]; Karolinska Institutet DPA-Klas Wiman; StratCan-Klas Wiman; Swedish Cancer Foundatio [110544, CAN 2011/471, 13 0543]	Swedish Research Council (VR)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Radiumhemmets Forskningsfonder; Karolinska Institutet DPA-Klas Wiman; StratCan-Klas Wiman; Swedish Cancer Foundatio	Professor Klas G. Wiman received the following funding: The Swedish Research Council (VR)-number K2013-66X-15385-09-5; The Swedish Cancer Society-number 13 0623; Radiumhemmets Forskningsfonder -number 131271; Karolinska Institutet DPA-Klas Wiman; and StratCan-Klas Wiman. Professor Sonia Andersson received the following funding: Swedish Cancer Foundation (110544, CAN 2011/471) and the Swedish Research Council (521-2008-2899). Professor Catharina Larsson received the following funding: Swedish Research Council K2014-66X-11622-19-3 and Swedish Cancer Foundation 13 0543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2006, BRIT J CANCER, V95, P331, DOI 10.1038/sj.bjc.6603253; Andersson S, 2003, ACTA OBSTET GYN SCAN, V82, P960, DOI 10.1034/j.1600-0412.2003.00263.x; Andersson S, 2003, ONCOL REP, V10, P175; Andersson S, 2001, EUR J CANCER, V37, P246, DOI 10.1016/S0959-8049(00)00376-2; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bersani C, 2014, ONCOGENE, V33, P4407, DOI 10.1038/onc.2013.594; Bosch FX, 2002, VIRUS RES, V89, P183, DOI 10.1016/S0168-1702(02)00187-9; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Farnebo F, 1999, J CLIN ENDOCR METAB, V84, P3775, DOI 10.1210/jc.84.10.3775; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hellborg F, 2004, INT J ONCOL, V24, P1559; Hellborg F, 2001, ONCOGENE, V20, P5466, DOI 10.1038/sj.onc.1204722; HERRINGTON CS, 1992, DIAGNOSTIC MOL PATHO; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; Heselmeyer-Haddad K, 2005, AM J PATHOL, V166, P1229, DOI 10.1016/S0002-9440(10)62341-3; Heselmeyer-Haddad K, 2003, AM J PATHOL, V163, P1405, DOI 10.1016/S0002-9440(10)63498-0; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Kim BC, 2012, EMBO J, V31, P4289, DOI 10.1038/emboj.2012.286; Kytola S, 2000, GENE CHROMOSOME CANC, V28, P308, DOI 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; MANOS M, 1990, LANCET, V335, P734, DOI 10.1016/0140-6736(90)90855-Y; Massion PP, 2003, CANCER RES, V63, P7113; Mendez-Vidal C, 2002, NUCLEIC ACIDS RES, V30, P1991, DOI 10.1093/nar/30.9.1991; Pett MR, 2004, CANCER RES, V64, P1359, DOI 10.1158/0008-5472.CAN-03-3214; Pihan GA, 2003, CANCER RES, V63, P1398; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Soederlund-Strand A, 2009, J CLIN MICROBIOL, V47, P541, DOI 10.1128/JCM.02007-08; Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178; Varmeh-Ziaie S, 2001, CANCER LETT, V174, P179, DOI 10.1016/S0304-3835(01)00699-1; VarmehZiaie S, 1997, ONCOGENE, V15, P2699, DOI 10.1038/sj.onc.1201454; Vilborg A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.33; Vilborg A, 2011, CELL DEATH DIFFER, V18, P1434, DOI 10.1038/cdd.2011.20; Vilborg A, 2010, J MOL MED, V88, P645, DOI 10.1007/s00109-010-0609-2; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Zhang A, 2002, INT J CANCER, V101, P427, DOI 10.1002/ijc.10627; Zielinski GD, 2004, OBSTET GYNECOL SURV, V59, P543, DOI 10.1097/00006254-200407000-00024; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111125	10.1371/journal.pone.0111125	http://dx.doi.org/10.1371/journal.pone.0111125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379706	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100020
J	Hou, XJ; Li, SB; Liu, SR; Hu, CG; Zhang, JZ				Hou, Xiao-Jin; Li, Si-Bei; Liu, Sheng-Rui; Hu, Chun-Gen; Zhang, Jin-Zhi			Genome-Wide Classification and Evolutionary and Expression Analyses of Citrus MYB Transcription Factor Families in Sweet Orange	PLOS ONE			English	Article							GENE DUPLICATION; MOLECULAR CHARACTERIZATION; ARABIDOPSIS; RICE; CELL; IDENTIFICATION; DIVERGENCE; REGULATOR; REVEALS; ENCODES	MYB family genes are widely distributed in plants and comprise one of the largest transcription factors involved in various developmental processes and defense responses of plants. To date, few MYB genes and little expression profiling have been reported for citrus. Here, we describe and classify 177 members of the sweet orange MYB gene (CsMYB) family in terms of their genomic gene structures and similarity to their putative Arabidopsis orthologs. According to these analyses, these CsMYBs were categorized into four groups (4R-MYB, 3R-MYB, 2R-MYB and 1R-MYB). Gene structure analysis revealed that 1R-MYB genes possess relatively more introns as compared with 2R-MYB genes. Investigation of their chromosomal localizations revealed that these CsMYBs are distributed across nine chromosomes. Sweet orange includes a relatively small number of MYB genes compared with the 198 members in Arabidopsis, presumably due to a paralog reduction related to repetitive sequence insertion into promoter and non-coding transcribed region of the genes. Comparative studies of CsMYBs and Arabidopsis showed that CsMYBs had fewer gene duplication events. Expression analysis revealed that the MYB gene family has a wide expression profile in sweet orange development and plays important roles in development and stress responses. In addition, 337 new putative microsatellites with flanking sequences sufficient for primer design were also identified from the 177 CsMYBs. These results provide a useful reference for the selection of candidate MYB genes for cloning and further functional analysis forcitrus.	[Hou, Xiao-Jin; Li, Si-Bei; Liu, Sheng-Rui; Hu, Chun-Gen; Zhang, Jin-Zhi] Huazhong Agr Univ, Coll Hort & Forestry Sci, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China	Huazhong Agricultural University	Hu, CG (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry Sci, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China.	chungen@mail.hzau.edu.cn; jinzhizhang@mail.hzau.edu.cn		Zhang, Jin-Zhi/0000-0002-3820-889X	National Natural Science Foundation of China [31130046, 31372046, 31221062, 31471863, 31360469]; Fundamental Research Funds for the Central Universities [2013PY083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported financially by the National Natural Science Foundation of China (grant nos. 31130046, 31372046, 31221062, 31471863 and 31360469) and the Fundamental Research Funds for the Central Universities (2013PY083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bedell JA, 2000, BIOINFORMATICS, V16, P1040, DOI 10.1093/bioinformatics/16.11.1040; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bhattacharya D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2931; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Cheng YunJiang, 2003, Plant Molecular Biology Reporter, V21, p177a, DOI 10.1007/BF02774246; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cultrone A, 2010, TREE GENET GENOMES, V6, P101, DOI 10.1007/s11295-009-0232-y; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dias AP, 2003, PLANT PHYSIOL, V131, P610, DOI 10.1104/pp.012047; Du H, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1, DOI 10.1134/S0006297909010015; Du H, 2013, DNA RES, V20, P437, DOI 10.1093/dnares/dst021; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Haga N, 2007, DEVELOPMENT, V134, P1101, DOI 10.1242/dev.02801; Hong SH, 2008, PLANT J, V55, P361, DOI 10.1111/j.1365-313X.2008.03508.x; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Jia L, 2004, PLANT PHYSIOL, V134, P575, DOI 10.1104/pp.103.027201; Jiang CH, 2004, GENE, V326, P13, DOI 10.1016/j.gene.2003.09.049; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Karpinska B, 2004, PLANT MOL BIOL, V56, P255, DOI 10.1007/s11103-004-3354-5; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Li ZJT, 2012, TREE GENET GENOMES, V8, P675, DOI 10.1007/s11295-011-0455-6; Lipsick JS, 1996, ONCOGENE, V13, P223; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Liu SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075149; Mandaokar A, 2006, PLANT J, V46, P984, DOI 10.1111/j.1365-313X.2006.02756.x; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Mondragon-Palomino M, 2002, GENOME RES, V12, P1305, DOI 10.1101/gr.159402; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mun JH, 2012, MOL GENET GENOMICS, V287, P765, DOI 10.1007/s00438-012-0718-4; Naz AA, 2013, P NATL ACAD SCI USA, V110, P2401, DOI 10.1073/pnas.1214300110; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Seo PJ, 2010, NEW PHYTOL, V186, P471, DOI 10.1111/j.1469-8137.2010.03183.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang RK, 2014, PHYSIOL PLANTARUM, V150, P76, DOI 10.1111/ppl.12069; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Wen F, 2014, DNA RES, V21, P327, DOI 10.1093/dnares/dst060; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yang Yi, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-330; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2008, TREE PHYSIOL, V28, P1449, DOI 10.1093/treephys/28.10.1449; Zhang JZ, 2011, PLANT MOL BIOL, V76, P187, DOI 10.1007/s11103-011-9780-2; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhang PF, 2000, PLANT CELL, V12, P2311, DOI 10.1105/tpc.12.12.2311; Zhang ZG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r120	77	38	46	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112375	10.1371/journal.pone.0112375	http://dx.doi.org/10.1371/journal.pone.0112375			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375352	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600138
J	Huang, RE; Ren, XL; Qiu, YF; Zhao, ZY				Huang, Ren-E; Ren, Xiaoliang; Qiu, Yifei; Zhao, Zhongying			Description of Caenorhabditis sinica sp n. (Nematoda: Rhabditidae), a Nematode Species Used in Comparative Biology for C-elegans	PLOS ONE			English	Article							EVOLUTION; PHYLOGENY; DIVERSITY; PATTERNS; MUTATION; DNA	We re-isolated in China a relative of the nematode model Caenorhabditis elegans that was previously referred to informally as C. sp. 5. In spite of its importance for comparative biology, C. sp. 5 has remained morphologically uncharacterized. Therefore, we now provide detailed description of morphology and anatomy, assigning the name of Caenorhabditis sinica sp. n. to this nematode that is found frequently in China. C. sinica sp. n. belongs to the Elegans group in the genus Caenorhabditis, being phylogenetically close to C. briggsae although differing in reproductive mode. The gonochoristic C. sinica sp. n. displays two significantly larger distal parts of uteri filled with sperms in the female/hermaphroditic gonad than does the androdioecious C. briggsae. The new species can be differentiated morphologically from all known Caenorhabditis species within the Elegans group by presenting a uniquely shaped, three-pointed hook structure on the male precloacal lip. The lateral field of C. sinica sp. n. is marked by three ridges that are flanked by two additional incisures, sometimes appearing as five ridges in total. This study ends the prolonged period of the 'undescribed' anonymity for C. sinica sp. n. since its discovery and use in comparative biological research. Significant and crossing-direction dependent hybrid incompatibilities in F1 and F2 crossing progeny make C. sinica sp. n. an excellent model for studies of population and speciation genetics. The abundance of nematode species lacking detailed taxonomic characterization deserves renewed attention to address the species description gap for this important yet morphologically 'difficult' group of animals.	[Huang, Ren-E] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Ren-E; Ren, Xiaoliang; Qiu, Yifei; Zhao, Zhongying] Hong Kong Baptist Univ, Fac Sci, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Tsinghua University; Hong Kong Baptist University	Zhao, ZY (corresponding author), Hong Kong Baptist Univ, Fac Sci, Dept Biol, Hong Kong, Hong Kong, Peoples R China.	zyzhao@hkbu.edu.hk	Zhao, Zhongying/C-3261-2015; Zhao, Zhongying/ABF-9458-2021	Zhao, Zhongying/0000-0003-2743-9008	National Natural Science Foundation of China [31201700]; Early Career Scheme (ECS) of Hong Kong Research Grant Council [HKBU263512]; National Institutes of Health - Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Early Career Scheme (ECS) of Hong Kong Research Grant Council; National Institutes of Health - Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Natural Science Foundation of China (Grant No. 31201700) to Ren-E Huang. Dr. Zhongying Zhao was supported by Early Career Scheme (ECS) of Hong Kong Research Grant Council (Grant No. HKBU263512). Some nematode strains were provided by Caenorhabditis Genetics Center, which was supported by National Institutes of Health - Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi C, 2011, CURR BIOL, V21, P1416, DOI 10.1016/j.cub.2011.07.034; Blaxter M, 2012, PARASITE IMMUNOL, V34, P108, DOI 10.1111/j.1365-3024.2011.01342.x; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Brauchle M, 2009, DEV BIOL, V335, P253, DOI 10.1016/j.ydbio.2009.07.033; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; Cutter AD, 2008, GENETICS, V178, P2093, DOI 10.1534/genetics.107.085787; Cutter AD, 2012, MOL ECOL, V21, P1345, DOI 10.1111/j.1365-294X.2012.05475.x; deMan J.G, 1880, TIJDSCHRIFT NEDERLAN, V5, P1; Dey A, 2012, GENETICS, V191, P1257, DOI 10.1534/genetics.112.140418; Dolgin ES, 2008, HEREDITY, V100, P304, DOI 10.1038/sj.hdy.6801079; Felix MA, 2007, CURR BIOL, V17, P103, DOI 10.1016/j.cub.2006.12.024; Felix MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094723; Haber M, 2005, MOL BIOL EVOL, V22, P160, DOI 10.1093/molbev/msh264; Kiontke K, 2007, CURR BIOL, V17, P1925, DOI 10.1016/j.cub.2007.10.061; Kiontke Karin, 2005, P1; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Nadler SA, 1998, MOL PHYLOGENET EVOL, V10, P221, DOI 10.1006/mpev.1998.0514; Nuez I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029811; Pazdernik N, 2013, ADV EXP MED BIOL, V757, P1, DOI 10.1007/978-1-4614-4015-4_1; Penigault JB, 2011, DEV BIOL, V357, P419, DOI 10.1016/j.ydbio.2011.05.675; Raboin MJ, 2010, MOL BIOL EVOL, V27, P1087, DOI 10.1093/molbev/msp318; Ryss AY, 2003, ZOOSYSTEMATICA ROSSI, V11, P257; Sudhaus W., 2003, Journal of Nematode Morphology and Systematics, V6, P43; Sudhaus W, 2007, ZOOTAXA, P45, DOI 10.11646/zootaxa.1456.1.2; Thomas WK, 1997, J NEMATOL, V29, P250; Wang GX, 2010, MOL ECOL, V19, P5022, DOI 10.1111/j.1365-294X.2010.04862.x; Wergin W. P., 1981, Plant parasitic nematodes. Volume III., P175; Yokoo T., 1968, AGR BULL SAGA U, V25, P69	29	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110957	10.1371/journal.pone.0110957	http://dx.doi.org/10.1371/journal.pone.0110957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375770	Green Published, gold			2022-12-26	WOS:000344402600022
J	Buitrago-Florez, FJ; Restrepo, S; Riano-Pacho, DM				Javier Buitrago-Florez, Francisco; Restrepo, Silvia; Riano-Pacho, Diego Mauricio			Identification of Transcription Factor Genes and Their Correlation with the High Diversity of Stramenopiles	PLOS ONE			English	Article							REGRESSION; PHYLOGENY	The biological diversity among Stramenopiles is striking; they range from large multicellular seaweeds to tiny unicellular species, they embrace many ecologically important autothrophic (e.g., diatoms, brown algae), and heterotrophic (e.g., oomycetes) groups. Transcription factors (TFs) and other transcription regulators (TRs) regulate spatial and temporal gene expression. A plethora of transcriptional regulatory proteins have been identified and classified into families on the basis of sequence similarity. The purpose of this work is to identify the TF and TR complement in diverse species belonging to Stramenopiles in order to understand how these regulators may contribute to their observed diversity. We identified and classified 63 TF and TR families in 11 species of Stramenopiles. In some species we found gene families with high relative importance. Taking into account the 63 TF and TR families identified, 28 TF and TR families were established to be positively correlated with specific traits like number of predicted proteins, number of flagella and number of cell types during the life cycle. Additionally, we found gains and losses in TF and TR families specific to some species and clades, as well as, two families with high abundance specific to the autotrophic species and three families with high abundance specific to the heterotropic species. For the first time, there is a systematic search of TF and TR families in Stramenopiles. The attempts to uncover relationships between these families and the complexity of this group may be of great impact, considering that there are several important pathogens of plants and animals, as well as, important species involved in carbon cycling. Specific TF and TR families identified in this work appear to be correlated with particular traits in the Stramenopiles group and may be correlated with the high complexity and diversity in Stramenopiles.	[Javier Buitrago-Florez, Francisco] Univ Los Andes, Grp Computat & Evolutionary Biol, Bogota, Colombia; [Javier Buitrago-Florez, Francisco; Restrepo, Silvia] Univ Los Andes, Micol & Plant Pathol Lab, Bogota, Colombia; [Riano-Pacho, Diego Mauricio] CNPEM, Lab Nacl Ciecancia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Riano-Pacho, DM (corresponding author), CNPEM, Lab Nacl Ciecancia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil.	diego.riano@bioetanol.org.br	Riaño-Pachón, Diego Mauricio/B-4891-2014	Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Restrepo, Silvia/0000-0001-9016-1040	School of Sciences, Universidad de los Andes	School of Sciences, Universidad de los Andes	This work was funded by the program "Support for Assistant Professors" from the School of Sciences, Universidad de los Andes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Andersen RA, 2004, AM J BOT, V91, P1508, DOI 10.3732/ajb.91.10.1508; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Cavalier-Smith T, 2003, EUR J PROTISTOL, V39, P338, DOI 10.1078/0932-4739-00002; Cavalier-Smith T, 2010, PHILOS T R SOC B, V365, P111, DOI 10.1098/rstb.2009.0161; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Felsenstein J, 1985, AM NAT, V125, P15; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Lang D, 2010, GENOME BIOL EVOL, V2, P488, DOI 10.1093/gbe/evq032; Latchman DS, 2001, TRENDS BIOCHEM SCI, V26, P211, DOI 10.1016/S0968-0004(01)01812-6; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Riano-Pachon DM, 2008, GENETICS, V179, P31, DOI 10.1534/genetics.107.086090; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Team RDC, 2019, R LANG ENV STAT COMP; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141	28	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111841	10.1371/journal.pone.0111841	http://dx.doi.org/10.1371/journal.pone.0111841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375671	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600066
J	Nakamae, T; Sakai, Y; Abe, Y; Nishida, S; Fukui, K; Yamada, K; Kubota, M; Denys, D; Narumoto, J				Nakamae, Takashi; Sakai, Yuki; Abe, Yoshinari; Nishida, Seiji; Fukui, Kenji; Yamada, Kei; Kubota, Manabu; Denys, Damiaan; Narumoto, Jin			Altered Fronto-Striatal Fiber Topography and Connectivity in Obsessive-Compulsive Disorder	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; DEEP BRAIN-STIMULATION; SURFACE-BASED ANALYSIS; DIFFUSION-TENSOR; FUNCTIONAL CONNECTIVITY; HUMAN THALAMUS; BASAL GANGLIA; TRACTOGRAPHY; MRI; SEGMENTATION	Fronto-striatal circuits are hypothesized to be involved in the pathophysiology of obsessive-compulsive disorder (OCD). Within this circuitry, ventral frontal regions project fibers to the ventral striatum (VS) and dorsal frontal regions to the dorsal striatum. Resting state fMRI research has shown higher functional connectivity between the orbitofrontal cortex (OFC) and the dorsal part of the VS in OCD patients compared to healthy controls (HC). Therefore, we hypothesized that in OCD the OFC predominantly project fibers to the more dorsal part of the VS, and that the structural connectivity between the OFC and VS is higher compared to HC. A total of 20 non-medicated OCD patients and 20 HC underwent diffusion-weighted imaging. Connectivity-based parcellation analyses were performed with the striatum as seed region and the OFC, dorsolateral prefrontal cortex, and dorsal anterior cingulate cortex as target regions. Obtained connectivity maps for each frontal region of interest (ROI) were normalized into standard space, and Z-component (dorsal-ventral) coordinate of center-of-gravity (COG) were compared between two groups. Probabilistic tractography was performed to investigate diffusion indices of fibers between the striatum and frontal ROIs. COG Z-component coordinates of connectivity maps for OFC ROI were located in the more dorsal part of the VS in OCD patients compared to HC. Fractional anisotropy of fibers between the OFC and the striatum was higher in OCD patients compared to HC. Part of the pathophysiology of OCD might be understood by altered topography and structural connectivity of fibers between the OFC and the striatum.	[Nakamae, Takashi; Sakai, Yuki; Abe, Yoshinari; Nishida, Seiji; Fukui, Kenji; Narumoto, Jin] Kyoto Prefectural Univ Med, Dept Psychiat, Grad Sch Med Sci, Kyoto, Japan; [Nakamae, Takashi; Sakai, Yuki; Narumoto, Jin] Adv Telecommun Res Inst Int, Computat Neurosci Labs, Kyoto, Japan; [Yamada, Kei] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kyoto, Japan; [Kubota, Manabu] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Neuropsychiat, NL-1105 AZ Amsterdam, Netherlands; [Denys, Damiaan] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	Kyoto Prefectural University of Medicine; Advanced Telecommunications Research Institute International; Kyoto Prefectural University of Medicine; Kyoto University; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Nakamae, T (corresponding author), Kyoto Prefectural Univ Med, Dept Psychiat, Grad Sch Med Sci, Kyoto, Japan.	nakamae@koto.kpu-m.ac.jp	Sakai, Yuki/AAV-6231-2021; Yamada, Kei/AAY-8398-2020; Nakamae, Takashi/E-7545-2018	Sakai, Yuki/0000-0003-2475-8548; Nakamae, Takashi/0000-0003-4265-198X; Abe, Yoshinari/0000-0001-8348-0801; Narumoto, Jin/0000-0002-8262-3177	MEXT KAKENHI [24791223, 23591724]; SENSHIN Medical Research Foundation	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	TN received grant support from MEXT KAKENHI (No.24791223, http://www.jsps.go.jp/j-grantsinaid/) and SENSHIN Medical Research Foundation (http://www.mt-pharma.co.jp/zaidan/). JN received grant support from MEXT KAKENHI (No. 23591724, http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors report no financial relationships with commercial interests.	Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Benedetti F, 2013, EUR NEUROPSYCHOPHARM, V23, P581, DOI 10.1016/j.euroneuro.2012.07.002; Beucke JC, 2013, JAMA PSYCHIAT, V70, P619, DOI 10.1001/jamapsychiatry.2013.173; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Wit SJ, 2014, AM J PSYCHIAT, V171, P340, DOI 10.1176/appi.ajp.2013.13040574; Del Casale A, 2011, NEUROPSYCHOBIOLOGY, V64, P61, DOI 10.1159/000325223; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Fan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035889; Figee M, 2013, NAT NEUROSCI, V16, P386, DOI 10.1038/nn.3344; First MB, 1997, STRUCTURES CLIN INTE; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harrison BJ, 2013, BIOL PSYCHIAT, V73, P321, DOI 10.1016/j.biopsych.2012.10.006; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Jakab A, 2012, BRAIN IMAGING BEHAV, V6, P472, DOI 10.1007/s11682-012-9172-5; Jakab A, 2012, BRAIN TOPOGR, V25, P264, DOI 10.1007/s10548-011-0205-y; Jayarajan RN, 2012, DEPRESS ANXIETY, V29, P780, DOI 10.1002/da.21890; Jbabdi S, 2013, J NEUROSCI, V33, P3190, DOI 10.1523/JNEUROSCI.2457-12.2013; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Jung WH, 2013, NEUROIMAGE-CLIN, V3, P27, DOI 10.1016/j.nicl.2013.06.013; Kanaan RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091109; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Lehman JF, 2011, J NEUROSCI, V31, P10392, DOI 10.1523/JNEUROSCI.0595-11.2011; Lochner C, 2012, J PSYCHIATR NEUROSCI, V37, P193, DOI 10.1503/jpn.110059; Marenco S, 2012, NEUROPSYCHOPHARMACOL, V37, P499, DOI 10.1038/npp.2011.215; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; NAKAJIMA T, 1995, PSYCHIAT CLIN NEUROS, V49, P121, DOI 10.1111/j.1440-1819.1995.tb01875.x; Nakamae T, 2011, J PSYCHIATR RES, V45, P687, DOI 10.1016/j.jpsychires.2010.09.016; Piras F, 2013, NEUROSCI BIOBEHAV R, V37, P2856, DOI 10.1016/j.neubiorev.2013.10.008; Posner J, 2014, HUM BRAIN MAPP, V35, P2852, DOI 10.1002/hbm.22371; Putnam MC, 2010, J COGNITIVE NEUROSCI, V22, P1662, DOI 10.1162/jocn.2009.21290; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Sakai Y, 2011, EUR PSYCHIAT, V26, P463, DOI 10.1016/j.eurpsy.2010.09.005; Samanez-Larkin GR, 2012, J NEUROSCI, V32, P5333, DOI 10.1523/JNEUROSCI.5756-11.2012; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Tziortzi AC, 2014, CEREB CORTEX, V24, P1165, DOI 10.1093/cercor/bhs397; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yoo SY, 2007, ACTA PSYCHIAT SCAND, V116, P211, DOI 10.1111/j.1600-0447.2007.01046.x; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032	60	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112075	10.1371/journal.pone.0112075	http://dx.doi.org/10.1371/journal.pone.0112075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375933	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600096
J	Szyniszewska, AM; Tatem, AJ				Szyniszewska, Anna M.; Tatem, Andrew J.			Global Assessment of Seasonal Potential Distribution of Mediterranean Fruit Fly, Ceratitis capitata (Diptera: Tephritidae)	PLOS ONE			English	Article							ANASTREPHA-FRATERCULUS DIPTERA; DOMINANT ANOPHELES VECTORS; FLIES DIPTERA; SPP. DIPTERA; SPATIOTEMPORAL DISTRIBUTION; GEOGRAPHICAL-DISTRIBUTION; POPULATION FLUCTUATIONS; DISTRIBUTION PATTERNS; WIEDEMANN DIPTERA; DISTRIBUTION MAPS	The Mediterranean fruit fly (Medfly) is one of the world's most economically damaging pests. It displays highly seasonal population dynamics, and the environmental conditions suitable for its abundance are not constant throughout the year in most places. An extensive literature search was performed to obtain the most comprehensive data on the historical and contemporary spatio-temporal occurrence of the pest globally. The database constructed contained 2328 unique geolocated entries on Medfly detection sites from 43 countries and nearly 500 unique localities, as well as information on hosts, life stages and capture method. Of these, 125 localities had information on the month when Medfly was recorded and these data were complemented by additional material found in comprehensive databases available online. Records from 1980 until present were used for medfly environmental niche modeling. Maximum Entropy Algorithm (MaxEnt) and a set of seasonally varying environmental covariates were used to predict the fundamental niche of the Medfly on a global scale. Three seasonal maps were also produced: January-April, May-August and September-December. Models performed significantly better than random achieving high accuracy scores, indicating a good discrimination of suitable versus unsuitable areas for the presence of the species.	[Szyniszewska, Anna M.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, Highland Hts, KY USA; [Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Szyniszewska, AM (corresponding author), Univ Florida, Dept Geog, Gainesville, FL 32611 USA.	aniasz@gmail.com	Szyniszewska, Anna/A-3232-2016	Szyniszewska, Anna/0000-0002-4897-3878; Tatem, Andrew/0000-0002-7270-941X	USDA-APHIS-PPQ-CPHST Cooperative Agreement [12-8130-0158-CA]; NIH/NIAID [U19A1089674]; Bill & Melinda Gates Foundation [OPP110642749446, 1032350]; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER	USDA-APHIS-PPQ-CPHST Cooperative Agreement; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was financed by the USDA-APHIS-PPQ-CPHST Cooperative Agreement No. 12-8130-0158-CA titled "Construction of Multi-Disciplinary Tools to Assess Seasonal Risk of Mediterranean Fruit Fly Ceratitis Capitata (Medfly) importation to Florida and California.' AJT is supported by funding from NIH/NIAID (U19A1089674), the Bill & Melinda Gates Foundation (OPP110642749446, 1032350), and the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Galil FA, 2009, ARCH PHYTOPATHOL PLA, V43, DOI [10.1080/03235400R02021272, DOI 10.1080/03235400R02021272]; Aguiar EE, 1996, POPULATION DYNAMICS; Aguiar-Menezes EL, 2001, FLA ENTOMOL, V84, P706, DOI 10.2307/3496405; Alemany A., 2004, BOLET N SANIDAD VEGE, V30, P255; Aluja M, 2005, ENVIRON ENTOMOL, V34, P1507, DOI 10.1603/0046-225X-34.6.1507; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 2012, EEA Technical Report; [Anonymous], 2003, TRAPP GUID AR WID FR; APHIS, 1999, MED FRUIT FLY FACTSH; APHJS, 1992, RISK ASS MED FRUIT F; Argov Y, 2008, BIOL CONTROL, V46, P502, DOI 10.1016/j.biocontrol.2008.04.021; Augier L, 2007, FRUIT FLIES ADULTS M; AVERY JW, 1994, J ENTOMOL SCI, V29, P543, DOI 10.18474/0749-8004-29.4.543; Back EA, 1914, J AGRIC RES, V3, P311; Baker RHA, 2000, AGR ECOSYST ENVIRON, V82, P57, DOI 10.1016/S0167-8809(00)00216-4; Bariani R, OSSERVAZIONI BIOL CO; Barr NB, 2009, J ECON ENTOMOL, V102, P401, DOI 10.1603/029.102.0153; Batllori L., 2008, IOBC/WPRS Bulletin, V37, P73; Bjelis M., 2007, Zbornik predavanj in referatov, 8. Slovenskega postvetovanja o varstvu Rastlin, Radenci, Slovenija, 6-7 Marec, 2007, P321; Bjelis M., 2006, INT S FRUIT FLIES EC; Bjelis M, 2004, TEPHRITID FRUIT FLY, p[325, 329]; Bloem K, 1993, RELATIVE EFFECTIVENE; Bohonak Andrew J., 2001, Biological Invasions, V3, P103, DOI 10.1023/A:1014559617282; Bonizzoni M, 2004, MOL ECOL, V13, P3845, DOI 10.1111/j.1365-294X.2004.02371.x; Borge MNR, 1997, B ENTOMOL RES, V87, P405, DOI 10.1017/S000748530003741X; CABI, 2000, CER CAP DISTR MAPS P; Caceres C, 2007, FLA ENTOMOL, V90, P103, DOI 10.1653/0015-4040(2007)90[103:APFSAL]2.0.CO;2; Carey JR, 2008, AGING CELL, V7, P426, DOI 10.1111/j.1474-9726.2008.00390.x; Carey JR, 2011, EXP GERONTOL, V46, P404, DOI 10.1016/j.exger.2010.09.009; Carey JR, 1996, ECOLOGY, V77, P1690, DOI 10.2307/2265775; Carey JR, 1996, BIOL CONSERV, V78, P35, DOI 10.1016/0006-3207(96)00016-X; CAREY JR, 1991, SCIENCE, V253, P1369, DOI 10.1126/science.1896848; CAYOL JP, 1993, J APPL ENTOMOL, V116, P94, DOI 10.1111/j.1439-0418.1993.tb01172.x; Cayol JP, 2004, FRUIT FLY CONTROL MO, P155; CELEDONIOHURTADO H, 1995, ENVIRON ENTOMOL, V24, P861, DOI 10.1093/ee/24.4.861; Cohen Y, 2008, COMPUT ELECTRON AGR, V62, P107, DOI 10.1016/j.compag.2007.12.005; Copeland RS, 2002, ANN ENTOMOL SOC AM, V95, P672, DOI 10.1603/0013-8746(2002)095[0672:IHOCCD]2.0.CO;2; Cross E, 2004, CUST BORD PROT TODAY; Dantas L, 2004, STT PROGRAMME MEDFLY, P127; Davies N, 1999, GENETICS, V153, P351; De Lima CPF, 2008, ACTA HORTIC, V803, P51; De Meyer M, 2008, J BIOGEOGR, V35, P270, DOI 10.1111/j.1365-2699.2007.01769.x; Demirel N., 2007, Journal of Entomology, V4, P129; Diamantidis AD, 2011, BIOL J LINN SOC, V102, P334, DOI 10.1111/j.1095-8312.2010.01579.x; Dominiak BC, 2012, AUST J ENTOMOL, V51, P104, DOI 10.1111/j.1440-6055.2011.00842.x; Duyck P, 2006, J ANIM ECOL J, V75, P526; Duyck PF, 2006, J ANIM ECOL, V75, P518, DOI 10.1111/j.1365-2656.2006.01072.x; Duyck PF, 2002, B ENTOMOL RES, V92, P461, DOI 10.1079/BER2002188; El Keroumi A, 2010, BIOCONTROL SCI TECHN, V20, P751, DOI 10.1080/09583151003734651; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Enkerlin W, 1997, J ECON ENTOMOL, V90, P1066, DOI 10.1093/jee/90.5.1066; EPPO, 2009, DAT SHEETS QUAR PEST; EPPO, 2001, PQR EPPO DAT QUAR PE; Escudero-Colomar LA, 2008, J APPL ENTOMOL, V132, P714, DOI 10.1111/j.1439-0418.2008.01372.x; Eskafi F, 1990, BIOCONTROL, V35, P355, DOI [DOI 10.1007/BF02375259, 10.1007/BF02375259]; ESKAFI FM, 1990, ENVIRON ENTOMOL, V19, P1371, DOI 10.1093/ee/19.5.1371; ESKAFI FM, 1990, ENVIRON ENTOMOL, V19, P148, DOI 10.1093/ee/19.1.148; Fimiani P., 1989, World Crop Pests, V3A, P39; Fischer-Colbrie P., 1989, World Crop Pests, V3A, P91; Gallejas C, 2004, SOD SEQUENCES CERATI, P435; Gasparich GE, 1997, ANN ENTOMOL SOC AM, V90, P790, DOI 10.1093/aesa/90.6.790; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; Gevrey M, 2006, J ECON ENTOMOL, V99, P979, DOI 10.1603/0022-0493-99.3.979; Gjullin CM, 1931, ECOLOGY, V12, P248, DOI 10.2307/1931632; Grout TG, 2007, ENVIRON ENTOMOL, V36, P1310, DOI 10.1603/0046-225X(2007)36[1310:DRACTO]2.0.CO;2; Gutierrez AP, 2011, BIOL INVASIONS, V13, P2661, DOI 10.1007/s10530-011-9937-6; HARRIS EJ, 1993, ENVIRON ENTOMOL, V22, P404, DOI 10.1093/ee/22.2.404; HARRIS EJ, 1991, ENVIRON ENTOMOL, V20, P174, DOI 10.1093/ee/20.1.174; Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; He M, 1999, MOL ECOL, V8, P1247, DOI 10.1046/j.1365-294X.1999.00685.x; HEDSTROM I, 1993, INT J PEST MANAGE, V39, P400, DOI 10.1080/09670879309371831; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HONEK A, 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P401; Hunt MK, 2004, BIOL J LINN SOC, V81, P347, DOI 10.1111/j.1095-8312.2003.00300.x; (IAEA) International Atomic Energy Agency, 2013, TEPHR WORK DAT; Israely N, 2005, J ECON ENTOMOL, V98, P739, DOI 10.1603/0022-0493-98.3.739; Israely N, 2005, ANN ENTOMOL SOC AM, V98, P77, DOI 10.1603/0013-8746(2005)098[0077:SDPOMF]2.0.CO;2; Israely N, 2004, J ECON ENTOMOL, V97, P33, DOI 10.1603/0022-0493-97.1.33; Israely N, 1997, ENVIRON ENTOMOL, V26, P1263, DOI 10.1093/ee/26.6.1263; Jang EB, 2007, FRUIT ILIES THEIR IM; Katsoyannos BI, 1999, J ECON ENTOMOL, V92, P583, DOI 10.1093/jee/92.3.583; Katsoyannos BI, 1998, ANN ENTOMOL SOC AM, V91, P43, DOI 10.1093/aesa/91.1.43; Katsoyarmos BI, 2004, EFFECTS CITRUS PEEL, P13; KOURTI A, 1992, ENTOMOL EXP APPL, V63, P63, DOI 10.1007/BF00350347; Kwasi W., 2009, J DEV SUSTAIN AGR, V3, P117; Lanzavecchia SB, 2008, ANN ENTOMOL SOC AM, V101, P627, DOI 10.1603/0013-8746(2008)101[627:OADOCC]2.0.CO;2; Larcher-Carvalho A, 2004, COST BENEFIT ANAL SU, P143; Leza MM, 2008, J APPL ENTOMOL, V132, P753, DOI 10.1111/j.1439-0418.2008.01370.x; Li BN, 2009, J ECON ENTOMOL, V102, P1781, DOI 10.1603/029.102.0508; Liquido NJ, 1990, J ECON ENTOMOL, V83, P1863; Livingston MJ, 2007, MEDITERRANEAN FRUIT; Lobo Aguirre C., 1997, DISTRIBUCION REGISTR; Lysandrou M., 2009, Arab Journal of Plant Protection, V27, P236; Maelzer DA, 2004, AUST J EXP AGR, V44, P109, DOI 10.1071/EA01128; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Malacrida AR, 1998, J HERED, V89, P501, DOI 10.1093/jhered/89.6.501; Martinez-Ferrer MT, 2010, SPAN J AGRIC RES, V8, P757, DOI 10.5424/sjar/2010083-1275; Mavrikakis PG, 2000, ENVIRON ENTOMOL, V29, P1180, DOI 10.1603/0046-225X-29.6.1180; McPheron BA, 1996, FRUIT FLY PESTS WORL; Meats A, 2007, J APPL ENTOMOL, V131, P518, DOI 10.1111/j.1439-0418.2007.01168.x; Medeiros Aida, 2007, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, P33; Meixner MD, 2002, MOL ECOL, V11, P891, DOI 10.1046/j.1365-294X.2002.01488.x; Merz B, 2005, REV SUISSE ZOOL, V112, P983, DOI 10.5962/bhl.part.80334; Michelakis SE, 1992, ISRAEL J ENTOMOL, V25, P177; Midgarden D, 2006, P 7 INT S FRUIT FLIE, P10; Mirsardoo S., 2010, Journal of Entomological Research, V2, P143; Mkize N, 2008, BIOCONTROL SCI TECHN, V18, P991, DOI 10.1080/09583150802450154; Mohamed SA, 2006, BIOL CONTROL, V39, P262, DOI 10.1016/j.biocontrol.2006.08.016; Morales P., ENTOMOTROPICA, V19, P51; Muller HG, 2009, P ROY SOC B-BIOL SCI, V276, P4409, DOI 10.1098/rspb.2009.1461; Navarro-Campos C, 2011, ENVIRON ENTOMOL, V40, P931, DOI 10.1603/EN10302; Navarro-Llopis V, 2008, J ECON ENTOMOL, V101, P126, DOI 10.1603/0022-0493(2008)101[126:EOTALF]2.0.CO;2; Nestel D, 2004, SPATIAL ANAL MEDFLY, P35; Nyamukondiwa C, 2009, J THERM BIOL, V34, P406, DOI 10.1016/j.jtherbio.2009.09.002; Orono LE, 2006, P 7 INT S FRUIT FLIE, P10; Oukil S, 1997, B OILBSROP, V20; Ovruski S, 2003, J ECON ENTOMOL, V96, P1108, DOI 10.1603/0022-0493-96.4.1108; Ovruski SM, 2008, FLA ENTOMOL, V91, P220, DOI 10.1653/0015-4040(2008)91[220:NOOHPA]2.0.CO;2; Ovruski SM, 2010, FLA ENTOMOL, V93, P277, DOI 10.1653/024.093.0219; Ovruski SM, 2004, BIOL CONTROL, V29, P43, DOI 10.1016/S1049-9644(03)00127-0; Paini DR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1118; Papadopoulos N. T., 2002, P 6 INT FRUIT FLY S, P19; Papadopoulos NT, 1996, ANN ENTOMOL SOC AM, V89, P526, DOI 10.1093/aesa/89.4.526; Papadopoulos NT, 1998, ANN ENTOMOL SOC AM, V91, P430, DOI 10.1093/aesa/91.4.430; Papadopoulos NT, 2003, ENVIRON ENTOMOL, V32, P319, DOI 10.1603/0046-225X-32.2.319; Papadopoulos NT, 2002, ANN ENTOMOL SOC AM, V95, P564, DOI 10.1603/0013-8746(2002)095[0564:DPOTMF]2.0.CO;2; Papadopoulos NT, 2001, J ECON ENTOMOL, V94, P971, DOI 10.1603/0022-0493-94.4.971; Papadopoulos NT, 2001, ANN ENTOMOL SOC AM, V94, P41, DOI 10.1603/0013-8746(2001)094[0041:SAAOOT]2.0.CO;2; Peck SL, 2000, J ECON ENTOMOL, V93, P280, DOI 10.1603/0022-0493-93.2.280; Penarrubia-Maria E., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/497087; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pires AO, 2004, VARIATION SYMMETRICA, P259; Puche H, 2005, FLA ENTOMOL, V88, P83, DOI 10.1653/0015-4040(2005)088[0083:EOEAHA]2.0.CO;2; Radonjic S, 2006, W PALAEARCTIC REGION, V29, P217; Reboulakis C, 2004, ORANGE FRUIT VOLATIL, P291; Rengifo JA, 2011, FLA ENTOMOL, V94, P91, DOI 10.1653/024.094.0112; Reyes A, 1998, ANN ENTOMOL SOC AM, V91, P222, DOI 10.1093/aesa/91.2.222; Ricalde MP, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.3301; Rigamonti IE, 2004, CONTRIBUTIONS KNOWLE; RIVNAY E, 1950, B ENTOMOL RES, V41, P321, DOI 10.1017/S0007485300027656; Ros J. P., 2004, Proceedings of the 6th International Symposium on fruit flies of economic importance, Stellenbosch, South Africa, 6-10 May 2002, P361; Ros JP, 2000, P AR WID CONTR FRUIT, P639; Saleh A., 2004, AN NAJAH U J RES N S, V18, P249; Schliserman P, 2004, REV MANEJO INTEGRADO, V72, P52; Sciarretta A, 2011, J APPL ENTOMOL, V135, P241, DOI 10.1111/j.1439-0418.2010.01515.x; Segura DF, 2006, ANN ENTOMOL SOC AM, V99, P70, DOI 10.1603/0013-8746(2006)099[0070:RAOCCA]2.0.CO;2; Segura DF, 2004, HOST UTILIZATION MED, P83; Segura Diego F, 2004, Ecol. austral, V14, P3; Siebert J. B., 1995, California Agriculture, V49, P7, DOI 10.3733/ca.v049n04p7; Silva JG, 2003, J ECON ENTOMOL, V96, P1711, DOI 10.1603/0022-0493-96.6.1711; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Slioukrv A, 1979, ENTOMOL EXP APPL, V26, P33, DOI [10.1007/BF02996633, DOI 10.1007/BF02996633]; Souza SAS, 2005, NEOTROP ENTOMOL, V34, P639, DOI 10.1590/S1519-566X2005000400015; Souza MF, 2009, BRAZ J BIOL, V69, P31, DOI 10.1590/S1519-69842009000100004; Souza-Filho ZA, 2007, FLA ENTOMOL, V90, P783, DOI 10.1653/0015-4040(2007)90[783:EPAWAS]2.0.CO;2; Staub CG, 2008, AUST J ENTOMOL, V47, P184, DOI 10.1111/j.1440-6055.2008.00646.x; Suckling DM, 2008, PEST MANAG SCI, V64, P848, DOI 10.1002/ps.1578; Sugayama RL, 1997, ENTOMOL EXP APPL, V83, P239, DOI 10.1023/A:1002913018833; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Tormos J, 2010, ANN APPL BIOL, V156, P179, DOI 10.1111/j.1744-7348.2009.00377.x; Toth M., 2009, Protezione delle Colture, P34; UCHÔA-FERNANDES MANOEL A., 2002, Neotrop. entomol., V31, P515, DOI 10.1590/S1519-566X2002000400002; Vadora ML, 1993, PREDICTION CERATITIS; Vargas RI., 1989, SPATIAL DISTRIBUTION; Vargas RI, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.13501; Vayssieres JF, 2009, CROP PROT, V28, P477, DOI 10.1016/j.cropro.2009.01.010; Vera MT, 2002, ENVIRON ENTOMOL, V31, P1009, DOI 10.1603/0046-225X-31.6.1009; Villablanca FX, 1998, MOL ECOL, V7, P547, DOI 10.1046/j.1365-294x.1998.00351.x; Weldon CW, 2011, J THERM BIOL, V36, P479, DOI 10.1016/j.jtherbio.2011.08.005; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x; Yuval B, 1998, ECOL ENTOMOL, V23, P211, DOI 10.1046/j.1365-2311.1998.00118.x; Zaborowski A, 2008, EVALUATION DUNE NOUV; Zeki Cevdet, 2008, Munis Entomology & Zoology, V3, P231	180	47	50	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111582	10.1371/journal.pone.0111582	http://dx.doi.org/10.1371/journal.pone.0111582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375649	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600049
J	Zhang, DD; Hua, YP; Wang, XH; Zhao, H; Shi, L; Xu, FS				Zhang, Didi; Hua, Yingpeng; Wang, Xiaohua; Zhao, Hua; Shi, Lei; Xu, Fangsen			A High-Density Genetic Map Identifies a Novel Major QTL for Boron Efficiency in Oilseed Rape (Brassica napus L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RHAMNOGALACTURONAN-II; MICROSATELLITE MARKERS; TRANSPORT MECHANISMS; PLANT-CELL; BORIC-ACID; GENOME; DEFICIENCY; EXPRESSION; BARLEY	Low boron (B) seriously limits the growth of oilseed rape (Brassica napus L.), a high B demand species that is sensitive to low B conditions. Significant genotypic variations in response to B deficiency have been observed among B. napus cultivars. To reveal the genetic basis for B efficiency in B. napus, quantitative trait loci (QTLs) for the plant growth traits, B uptake traits and the B efficiency coefficient (BEC) were analyzed using a doubled haploid (DH) population derived from a cross between a B-efficient parent, Qingyou 10, and a B-inefficient parent, Westar 10. A high-density genetic map was constructed based on single nucleotide polymorphisms (SNPs) assayed using Brassica 60 K Infinium BeadChip Array, simple sequence repeats (SSRs) and amplified fragment length polymorphisms (AFLPs). The linkage map covered a total length of 2139.5 cM, with 19 linkage groups (LGs) and an average distance of 1.6 cM between adjacent markers. Based on hydroponic evaluation of six B efficiency traits measured in three separate repeated trials, a total of 52 QTLs were identified, accounting for 6.14-46.27% of the phenotypic variation. A major QTL for BEC, qBEC-A3a, was co-located on A3 with other QTLs for plant growth and B uptake traits under low B stress. Using a subset of substitution lines, qBEC-A3a was validated and narrowed down to the interval between CNU384 and BnGMS436. The results of this study provide a novel major locus located on A3 for B efficiency in B. napus that will be suitable for fine mapping and marker-assisted selection breeding for B efficiency in B. napus.	[Zhang, Didi; Hua, Yingpeng; Wang, Xiaohua; Zhao, Hua; Shi, Lei; Xu, Fangsen] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zhang, Didi; Hua, Yingpeng; Wang, Xiaohua; Zhao, Hua; Shi, Lei; Xu, Fangsen] Huazhong Agr Univ, Microelement Res Ctr, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Xu, FS (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	fangsenxu@mail.hzau.edu.cn	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	Natural Science Foundation of China [31372129, 31172018]; Fundamental Research Funds for the Central Universities, China [2011PY150]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by Natural Science Foundation of China (31372129, 31172018) and the Fundamental Research Funds for the Central Universities (2011PY150), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; CHURCHILL GA, 1994, GENETICS, V138, P963; Dell B, 1997, PLANT SOIL, V193, P103, DOI 10.1023/A:1004264009230; Ding GD, 2011, EUPHYTICA, V181, P305, DOI 10.1007/s10681-011-0428-8; Edwards D, 2013, THEOR APPL GENET, V126, P1, DOI 10.1007/s00122-012-1964-x; Graham R. D., 1984, Advances in Plant Nutrition, V1, P57; GRANER A, 1991, THEOR APPL GENET, V83, P250, DOI 10.1007/BF00226259; Ishii T, 2001, PLANT PHYSIOL, V126, P1698, DOI 10.1104/pp.126.4.1698; Kato Y, 2009, PLANT CELL PHYSIOL, V50, P58, DOI 10.1093/pcp/pcn168; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Leaungthitikanchana S, 2013, PLANT CELL PHYSIOL, V54, P1056, DOI 10.1093/pcp/pct059; Li F, 2014, DNA RES, V21, P355, DOI 10.1093/dnares/dsu002; Li HT, 2011, MOL BREEDING, V28, P585, DOI 10.1007/s11032-010-9509-y; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Meyer M, 2009, AGRARFORSCHUNG, V16, P262; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Miwa K, 2010, ANN BOT-LONDON, V105, P1103, DOI 10.1093/aob/mcq044; Nakagawa Y, 2007, PLANT CELL, V19, P2624, DOI 10.1105/tpc.106.049015; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Shorrocks VM, 1997, PLANT SOIL, V193, P121, DOI 10.1023/A:1004216126069; Snowdon RJ, 2012, PLANT BREEDING, V131, P351, DOI 10.1111/j.1439-0523.2012.01976.x; Stange M, 2013, THEOR APPL GENET, V126, P2563, DOI 10.1007/s00122-013-2155-0; Stangoulis JCR, 2000, PLANT SOIL, V225, P253, DOI 10.1023/A:1026595012326; Stangoulis JCR, 2000, PLANT SOIL, V225, P243, DOI 10.1023/A:1026593528256; Sun JH, 2012, MOL BIOL REP, V39, P1963, DOI 10.1007/s11033-011-0930-z; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Suwabe K, 2002, THEOR APPL GENET, V104, P1092, DOI 10.1007/s00122-002-0875-7; Takano J, 2008, TRENDS PLANT SCI, V13, P451, DOI 10.1016/j.tplants.2008.05.007; Tanaka M, 2008, PFLUG ARCH EUR J PHY, V456, P671, DOI 10.1007/s00424-007-0370-8; Vales MI, 2005, THEOR APPL GENET, V111, P1260, DOI 10.1007/s00122-005-0043-y; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang S, 2012, WINDOWS QTL CARTOGRA; WANG YH, 1995, J HUAZHONG AGR U, V21, P71; Wang YH, 2007, ADVANCES IN PLANT AND ANIMAL BORON NUTRITION, P93, DOI 10.1007/978-1-4020-5382-5_8; Warington K, 1923, ANN BOT-LONDON, V37, P629, DOI 10.1093/oxfordjournals.aob.a089871; Xu FS, 2002, BORON IN PLANT AND ANIMAL NUTRITION, P127; Xu FS, 2002, J PLANT NUTR, V25, P901, DOI 10.1081/PLN-120002968; Xu FS, 2001, PLANT BREEDING, V120, P319, DOI 10.1046/j.1439-0523.2001.00583.x; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Xue JM, 1998, PLANT SOIL, V204, P155, DOI 10.1023/A:1004326217479; Yang L, 2013, PLANT SOIL, V371, P95, DOI 10.1007/s11104-013-1669-1; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang DD, 2014, SOIL SCI PLANT NUTR, V60, P304, DOI 10.1080/00380768.2014.893537; Zhao H, 2008, MOL BREEDING, V22, P495, DOI 10.1007/s11032-008-9193-3; Zhao JJ, 2005, THEOR APPL GENET, V110, P1301, DOI 10.1007/s00122-005-1967-y; Zhao ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045215	53	27	31	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112089	10.1371/journal.pone.0112089	http://dx.doi.org/10.1371/journal.pone.0112089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375356	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600101
J	Zhao, HF; Qu, ML; Wang, Y; Wang, ZY; Shi, WY				Zhao, Haifeng; Qu, Mingli; Wang, Yao; Wang, Zhenyu; Shi, Weiyun			Xenogeneic Acellular Conjunctiva Matrix as a Scaffold of Tissue-Engineered Corneal Epithelium	PLOS ONE			English	Article							DRIED AMNIOTIC MEMBRANE; CROSS-LINKED COLLAGEN; OCULAR SURFACE; CELLS	Amniotic membrane-based tissue-engineered corneal epithelium has been widely used in the reconstruction of the ocular surface. However, it often degrades too early to ensure the success of the transplanted corneal epithelium when treating patients with severe ocular surface disorders. In the present study, we investigated the preparation of xenogeneic acellular conjunctiva matrix (aCM) and evaluated its efficacy and safety as a scaffold of tissue-engineered corneal epithelium. Native porcine conjunctiva was decellularized with 0.1% sodium dodecyl sulfate (SDS) for 12 h at 37 degrees C and sterilized via gamma-cirradiation. Compared with native conjunctiva, more than 92% of the DNA was removed, and more than 90% of the extracellular matrix components (glycosaminoglycan and collagen) remained after the decellularization treatment. Compared with denuded amniotic membrane (dAM), the aCM possessed favorable optical transmittance, tensile strength, stability and biocompatibility as well as stronger resistance to degradation both in vitro and in vivo. The corneal epithelial cells seeded on aCM formed a multilayered epithelial structure and endured longer than did those on dAM. The aCM-based tissue-engineered corneal epithelium was more effective in the reconstruction of the ocular surface in rabbits with limbal stem cell deficiency. These findings support the application of xenogeneic acellular conjunctiva matrix as a scaffold for reconstructing the ocular surface.	[Zhao, Haifeng] Wannan Med Coll, Yijishan Hosp, Dept Ophthalmol, Wuhu, Anhui, Peoples R China; [Zhao, Haifeng; Qu, Mingli; Wang, Yao; Wang, Zhenyu; Shi, Weiyun] Shandong Acad Med Sci, Shandong Eye Inst, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Qingdao, Shandong, Peoples R China	Wannan Medical College; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Shi, WY (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Qingdao, Shandong, Peoples R China.	weiyunshi@163.com			National Basic Research Program of China [2013CB967004]; National High Technology Research and Development Program of China [2006AA02A132]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The National Basic Research Program of China (2013CB967004), the National High Technology Research and Development Program of China (2006AA02A132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; Brown S, 2001, BIOTECHNIQUES, V30, P38, DOI 10.2144/01301bm06; Carlsson David J, 2003, Curr Opin Ophthalmol, V14, P192, DOI 10.1097/00055735-200308000-00004; Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004; Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X; Han B, 2002, CORNEA, V21, P505, DOI 10.1097/00003226-200207000-00013; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Kirkeby S, 2002, XENOTRANSPLANTATION, V9, P260, DOI 10.1034/j.1399-3089.2002.01078.x; Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506; Koizumi N, 2002, INVEST OPHTH VIS SCI, V43, P2114; Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4; Liu L, 2007, BIOMATERIALS, V28, P3807, DOI 10.1016/j.biomaterials.2007.04.025; Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011; Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752; Nakamura T, 2008, BIOMATERIALS, V29, P3729, DOI 10.1016/j.biomaterials.2008.05.023; Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017; Sasaki S, 2009, MOL VIS, V15, P2022; Swift GJ, 1996, TRANSPLANTATION, V62, P568, DOI 10.1097/00007890-199609150-00005; Torbet J, 2007, BIOMATERIALS, V28, P4268, DOI 10.1016/j.biomaterials.2007.05.024; Whitcher John P., 2002, International Ophthalmology Clinics, V42, P71; Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117; Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066	24	14	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111846	10.1371/journal.pone.0111846	http://dx.doi.org/10.1371/journal.pone.0111846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375996	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600069
J	George, J; Blanford, S; Thomas, MB; Baker, TC				George, Justin; Blanford, Simon; Thomas, Matthew B.; Baker, Thomas C.			Malaria Mosquitoes Host-Locate and Feed upon Caterpillars	PLOS ONE			English	Article							CARBON-DIOXIDE; 1-OCTEN-3-OL; REDUVIIDAE; BEHAVIOR	Adult female mosquitoes need blood to develop their eggs and both sexes use nectar and honeydew as carbohydrate resources for flight, survival and to enhance reproduction. However, there are also a few reports in the literature of mosquitoes feeding on haemolymph of soft-bodied insects such as caterpillars. The frequency and significance of this entomophagous behavior is not well understood, but is thought to be a vestige of ancestral feeding behavior or an opportunistic behavior that has evolved over time. In our current paper we investigated the extent to which the malaria mosquito, Anopheles stephensi, is attracted to, and can successfully feed on, larvae of two common moth species, Manduca sexta and Heliothis subflexa. Using y-tube olfactometer assays we found that female An. stephensi readily flew upwind to and landed on the caterpillars of both moth species. The nature of the volatile cues used in host location remains unclear but respirometer studies suggest a possible role of CO2. Laboratory cage assays further showed that the female mosquitoes were able to actively feed on moth larvae and gain sufficient nutritional benefit to influence survival. The extent to which such an opportunistic behavior occurs in the field has yet to be explored but our results suggest that this haemolymph feeding behavior could play a role in malaria mosquito life history and could provide a novel mechanism for horizontal transmission of pathogens and other micro-organisms between hosts.	[George, Justin; Blanford, Simon; Thomas, Matthew B.; Baker, Thomas C.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Blanford, Simon; Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Baker, TC (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	tcb10@psu.edu						Baker T.C., 1984, Springer Series in Experimental Entomology, V1984, P45; Beklemishev V.N., 1957, MEDITSINSKAYA PARAZI, V5, P562; Blanford S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023591; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dekker T, 2002, MED VET ENTOMOL, V16, P91, DOI 10.1046/j.0269-283x.2002.00345.x; DOWNES JA, 1958, ANNU REV ENTOMOL, V3, P249, DOI 10.1146/annurev.en.03.010158.001341; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; George J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062632; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Hagen H, 1883, ENTOMOL MON MAG, V19, P254; HARRIS P, 1969, SCIENCE, V164, P184, DOI 10.1126/science.164.3876.184; HARRIS P, 1969, NATURE, V222, P1264, DOI 10.1038/2221264a0; Hill SR, 2010, ARTHROPOD STRUCT DEV, V39, P322, DOI 10.1016/j.asd.2010.05.005; Howard LO, 1912, MOSQUITOES N CENTRAL, P520; KLINE DL, 1990, MED VET ENTOMOL, V4, P383, DOI 10.1111/j.1365-2915.1990.tb00455.x; KLOWDEN MJ, 1995, BIOSCIENCE, V45, P326, DOI 10.2307/1312493; Lorosa Elias Seixas, 2000, Entomologia y Vectores, V7, P287; Martel V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025658; Mattingly PF, 1965, NEW SCIENTIST, V25, P22; Nyasembe VO, 2014, CURR BIOL, V24, P217, DOI 10.1016/j.cub.2013.12.022; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Pontes GB, 2011, NEOTROP ENTOMOL, V40, P708, DOI 10.1590/S1519-566X2011000600013; Sandoval CM, 2010, MED VET ENTOMOL, V24, P124, DOI 10.1111/j.1365-2915.2010.00868.x; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; WAAGE JK, 1979, BIOL J LINN SOC, V12, P187, DOI 10.1111/j.1095-8312.1979.tb00055.x	25	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e108894	10.1371/journal.pone.0108894	http://dx.doi.org/10.1371/journal.pone.0108894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372720	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900005
J	Shiozaki, A; Yoneda, S; Yoneda, N; Yonezawa, R; Matsubayashi, T; Seo, G; Saito, S				Shiozaki, Arihiro; Yoneda, Satoshi; Yoneda, Noriko; Yonezawa, Rika; Matsubayashi, Takamichi; Seo, Genichiro; Saito, Shigeru			Intestinal Microbiota is Different in Women with Preterm Birth: Results from Terminal Restriction Fragment Length Polymorphism Analysis	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BACTERIAL VAGINOSIS; FECAL MICROBIOTA; PROBIOTIC FOOD; GUT MICROBIOTA; T-RFLP; PREGNANCY; CELLS; RISK; COMMUNITIES	Preterm birth is a leading cause of perinatal morbidity and mortality. Studies using a cultivation method or molecular identification have shown that bacterial vaginosis is one of the risk factors for preterm birth. However, an association between preterm birth and intestinal microbiota has not been reported using molecular techniques, although the vaginal microbiota changes during pregnancy. Our aim here was to clarify the difference in intestinal and vaginal microbiota between women with preterm birth and women without preterm labor. 16S ribosomal ribonucleic acid genes were amplified from fecal and vaginal DNA by polymerase chain reaction. Using terminal restriction fragment length polymorphism (T-RFLP), we compared the levels of operational taxonomic units of both intestinal and vaginal flora among three groups: pregnant women who delivered term babies without preterm labor (non-PTL group) (n = 20), those who had preterm labor but delivered term babies (PTL group) (n = 11), and those who had preterm birth (PTB group) (n = 10). Significantly low levels of Clostridium subcluster XVIII, Clostridium cluster IV, Clostridium subcluster XIVa, and Bacteroides, and a significantly high level of Lactobacillales were observed in the intestinal microbiota in the PTB group compared with those in the non-PTL group. The levels of Clostridium subcluster XVIII and Clostridium subcluster XIVa in the PTB group were significantly lower than those in the PTL group, and these levels in the PTL group were significantly lower than those in non-PTL group. However, there were no significant differences in vaginal microbiota among the three groups. Intestinal microbiota in the PTB group was found to differ from that in the non-PTL group using the T-RFLP method.	[Shiozaki, Arihiro; Yoneda, Satoshi; Yoneda, Noriko; Yonezawa, Rika; Saito, Shigeru] Toyama Univ, Dept Obstet & Gynecol, Toyama 930, Japan; [Matsubayashi, Takamichi] Toa Pharmaceut Co Ltd, Tokyo, Japan; [Seo, Genichiro] Toa Pharmaceut Co Ltd, Gunma, Japan	University of Toyama	Saito, S (corresponding author), Toyama Univ, Dept Obstet & Gynecol, Toyama 930, Japan.	s30saito@med.u-toyama.ac.jp			Toa Pharmaceutical Co., Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan [26670717, 23390386, 24592462]; Grants-in-Aid for Scientific Research [26670717] Funding Source: KAKEN	Toa Pharmaceutical Co., Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The author(s) received no specific funding for this work from Toa Pharmaceutical Co., Ltd. Toa Pharmaceutical Co., Ltd., provided support in the form of salaries for authors TM and GS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan [a Grant-in-Aid for Exploratory Research 26670717, a Grant-in-Aid for Scientific Research (B) 23390386, a Grant-in-Aid for Scientific Research (C) 24592462]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bizargity P, 2009, BIOL REPROD, V80, P874, DOI 10.1095/biolreprod.108.074294; Brantsaeter AL, 2011, AM J EPIDEMIOL, V174, P807, DOI 10.1093/aje/kwr168; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Foxman B, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.003; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez-Lopez N, 2012, IMMUNOL CELL BIOL, V90, P919, DOI 10.1038/icb.2012.48; Hayashi H, 2003, MICROBIOL IMMUNOL, V47, P557, DOI 10.1111/j.1348-0421.2003.tb03418.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kisielewicz A, 2010, CLIN IMMUNOL, V137, P209, DOI 10.1016/j.clim.2010.07.008; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Madianos PN, 2013, J CLIN PERIODONTOL, V40, pS170, DOI [10.1902/jop.2013.1340015, 10.1111/jcpe.12082]; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Myhre R, 2011, AM J CLIN NUTR, V93, P151, DOI 10.3945/ajcn.110.004085; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Reiff C, 2010, INT J MED MICROBIOL, V300, P25, DOI 10.1016/j.ijmm.2009.08.004; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Schober L, 2012, IMMUNOL CELL BIOL, V90, P935, DOI 10.1038/icb.2012.33; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shiozaki A, 2014, J OBSTET GYNAECOL RE, V40, P53, DOI 10.1111/jog.12120; Steinborn A, 2012, CLIN EXP IMMUNOL, V167, P84, DOI 10.1111/j.1365-2249.2011.04493.x; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500	36	44	52	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111374	10.1371/journal.pone.0111374	http://dx.doi.org/10.1371/journal.pone.0111374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372390	gold, Green Submitted, Green Published			2022-12-26	WOS:000344556900046
J	Sohl, TL				Sohl, Terry L.			The Relative Impacts of Climate and Land-Use Change on Conterminous United States Bird Species from 2001 to 2075	PLOS ONE			English	Article							DISTRIBUTION MODELS; SELECTING THRESHOLDS; BREEDING BIRDS; SAMPLING BIAS; COVER DATA; DISTRIBUTIONS; PERFORMANCE; PREDICTION; MAXENT; EBIRD	Species distribution models often use climate data to assess contemporary and/or future ranges for animal or plant species. Land use and land cover (LULC) data are important predictor variables for determining species range, yet are rarely used when modeling future distributions. In this study, maximum entropy modeling was used to construct species distribution maps for 50 North American bird species to determine relative contributions of climate and LULC for contemporary (2001) and future (2075) time periods. Species presence data were used as a dependent variable, while climate, LULC, and topographic data were used as predictor variables. Results varied by species, but in general, measures of model fit for 2001 indicated significantly poorer fit when either climate or LULC data were excluded from model simulations. Climate covariates provided a higher contribution to 2001 model results than did LULC variables, although both categories of variables strongly contributed. The area deemed to be "suitable'' for 2001 species presence was strongly affected by the choice of model covariates, with significantly larger ranges predicted when LULC was excluded as a covariate. Changes in species ranges for 2075 indicate much larger overall range changes due to projected climate change than due to projected LULC change. However, the choice of study area impacted results for both current and projected model applications, with truncation of actual species ranges resulting in lower model fit scores and increased difficulty in interpreting covariate impacts on species range. Results indicate species-specific response to climate and LULC variables; however, both climate and LULC variables clearly are important for modeling both contemporary and potential future species ranges.	US Geol Survey, EROS Ctr, Sioux Falls, SD 57104 USA	United States Department of the Interior; United States Geological Survey	Sohl, TL (corresponding author), US Geol Survey, EROS Ctr, Sioux Falls, SD 57104 USA.	sohl@ugs.gov	Sohl, Terry/W-5486-2019	Sohl, Terry/0000-0002-9771-4231	U.S. Geological Survey's Climate and Land Use (CLU) Mission Area	U.S. Geological Survey's Climate and Land Use (CLU) Mission Area	TLS was supported by the U.S. Geological Survey's Climate and Land Use (CLU) Mission Area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Bahn V, 2013, OIKOS, V122, P321, DOI 10.1111/j.1600-0706.2012.00299.x; Bakker KK, 2002, CONSERV BIOL, V16, P1638, DOI 10.1046/j.1523-1739.2002.01328.x; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Bradley BA, 2012, ECOL MODEL, V244, P57, DOI 10.1016/j.ecolmodel.2012.06.019; Brambilla M, 2012, J ANIM ECOL, V81, P781, DOI 10.1111/j.1365-2656.2012.01970.x; Bucklin DN, 2015, DIVERS DISTRIB, V21, P23, DOI 10.1111/ddi.12247; Conlisk E, 2013, GLOBAL CHANGE BIOL, V19, P858, DOI 10.1111/gcb.12090; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dudik M, 2005, ADV NEURAL INFORM PR, V18, P320; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fearer TM, 2007, FOREST ECOL MANAG, V243, P128, DOI 10.1016/j.foreco.2007.02.016; Fink D, 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1; Hay LE, 2011, EARTH INTERACT, V15, DOI 10.1175/2010EI370.1; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hochachka W, 2012, FRONT BIOGEOGR, V4, P150, DOI DOI 10.21425/F54415350; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; Jimenez-Valverde A, 2011, GLOBAL ECOL BIOGEOGR, V20, P114, DOI 10.1111/j.1466-8238.2010.00574.x; Johnston KM, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00077.1; Jongsomjit D, 2013, LANDSCAPE ECOL, V28, P187, DOI 10.1007/s10980-012-9825-1; Jun Yu, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P1157, DOI 10.1109/ICDM.2010.103; Kery M, 2010, J BIOGEOGR, V37, P1851, DOI 10.1111/j.1365-2699.2010.02345.x; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Lerman SB, 2014, LANDSCAPE URBAN PLAN, V122, P29, DOI 10.1016/j.landurbplan.2013.10.006; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; Melles SJ, 2011, GLOBAL CHANGE BIOL, V17, P17, DOI 10.1111/j.1365-2486.2010.02214.x; Moreno R, 2011, ECOL INFORM, V6, P364, DOI 10.1016/j.ecoinf.2011.07.003; Nakicenovic N., 2000, INTERGOVERNMENTAL PA, P599; Naujokaitis-Lewis IR, 2013, DIVERS DISTRIB, V19, P541, DOI 10.1111/ddi.12063; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Prince K, 2013, ENVIRON SCI POLICY, V33, P120, DOI 10.1016/j.envsci.2013.04.009; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Ridgeby RS, 2003, DIGITAL DISTRIBUTION; Riordan EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086487; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Sohl TL, 2014, ECOL APPL, V24, P1015, DOI 10.1890/13-1245.1; Sohl TL, 2012, APPL GEOGR, V34, P111, DOI 10.1016/j.apgeog.2011.10.019; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Thogmartin WE, 2006, CONDOR, V108, P25, DOI 10.1650/0010-5422(2006)108[0025:PRAORG]2.0.CO;2; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; U.S. Geological Survey, 1999, USGS 30 MET RES 6 DE; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Vogelmann JE, 2001, PHOTOGRAMM ENG REM S, V67, P650; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Watling JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063600; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wu YP, 2012, SCI TOTAL ENVIRON, V430, P150, DOI 10.1016/j.scitotenv.2012.04.058; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	63	61	63	7	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112251	10.1371/journal.pone.0112251	http://dx.doi.org/10.1371/journal.pone.0112251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372571	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900129
J	Zhang, MQ; Guo, Y; Powell, CA; Doud, MS; Yang, CY; Duan, YP				Zhang, Muqing; Guo, Ying; Powell, Charles A.; Doud, Melissa S.; Yang, Chuanyu; Duan, Yongping			Effective Antibiotics against 'Candidatus Liberibacter asiaticus' in HLB-Affected Citrus Plants Identified via the Graft-Based Evaluation	PLOS ONE			English	Article							SAO-PAULO-STATE; DISEASE; PHARMACODYNAMICS; PHYTOPHTHORA; MANAGEMENT; RESISTANCE; MOLECULES; PATHOGEN; MEDIA; ACID	Citrus huanglongbing (HLB), caused by three species of fastidious, phloem-limited 'Candidatus Liberibacter', is one of the most destructive diseases of citrus worldwide. To date, there is no established cure for this century-old and yet, newly emerging disease. As a potential control strategy for citrus HLB, 31 antibiotics were screened for effectiveness and phytotoxicity using the optimized graft-based screening system with 'Candidatus Liberibacter asiaticus' (Las)-infected citrus scions. Actidione and Oxytetracycline were the most phytotoxic to citrus with less than 10% of scions surviving and growing; therefore, this data was not used in additional analyses. Results of principal component (PCA) and hierarchical clustering analyses (HCA) demonstrated that 29 antibiotics were clustered into 3 groups: highly effective, partly effective, and not effective. In spite of different modes of actions, a number of antibiotics such as, Ampicillin, Carbenicillin, Penicillin, Cefalexin, Rifampicin and Sulfadimethoxine were all highly effective in eliminating or suppressing Candidatus Liberibacter asiaticus indicated by both the lowest Las infection rate and titers of the treated scions and inoculated rootstock. The non-effective group, including 11 antibiotics alone with three controls, such as Amikacin, Cinoxacin, Gentamicin, Kasugamycin, Lincomycin, Neomycin, Polymixin B and Tobramycin, did not eliminate or suppress Las in the tested concentrations, resulting in plants with increased titers of Las. The other 12 antibiotics partly eliminated or suppressed Las in the treated and graft-inoculated plants. The effective and non-phytotoxic antibiotics could be potential candidates for control of citrus HLB, either for the rescue of infected citrus germplasm or for restricted field application.	[Zhang, Muqing; Yang, Chuanyu] Guangxi Univ, Nanning 530004, Peoples R China; [Zhang, Muqing; Guo, Ying; Powell, Charles A.; Yang, Chuanyu] Univ Florida, Indian River Res & Educ Ctr, Inst Food & Agr Sci, Ft Pierce, FL 34945 USA; [Doud, Melissa S.; Duan, Yongping] USDA ARS, US Hort Res Lab, Ft Pierce, FL 34945 USA	Guangxi University; State University System of Florida; University of Florida; United States Department of Agriculture (USDA)	Duan, YP (corresponding author), USDA ARS, US Hort Res Lab, Ft Pierce, FL 34945 USA.	Yongping.Duan@ars.usda.gov		zhang, muqing/0000-0003-3138-3422; yang, chuanyu/0000-0003-1194-208X	Citrus Research and Development Foundation, Inc.; Specialty Crop Block Grant, FDACS; ARS [ARS-0423073] Funding Source: Federal RePORTER	Citrus Research and Development Foundation, Inc.; Specialty Crop Block Grant, FDACS; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by grants from the Citrus Research and Development Foundation, Inc. and the Specialty Crop Block Grant, FDACS to Y.P. Duan and C.A. Powell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenderfer MS, 1984, CLUSTER ANAL QUANTIT; Aubert B, 1980, 8TH P C INT ORG CITR, P103; Belasque J, 2010, J PLANT PATHOL, V92, P285; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brain RA, 2008, ENVIRON SCI TECHNOL, V42, P8965, DOI 10.1021/es801611a; Buitendag CH, 2003, 12 C INT ORG CITR VI, P269; Carryn S, 2003, INFECT DIS CLIN N AM, V17, P615, DOI 10.1016/S0891-5520(03)00066-7; Cheema S. S., 1986, Indian Journal of Virology, V2, P104; Chen XueFeng, 2012, Journal of South China Agricultural University, V33, P460; CHIOU CS, 1995, PHYTOPATHOLOGY, V85, P324, DOI 10.1094/Phyto-85-324; Chiu R. J., 1979, P ROC US COOP SCI SE, V1, P43; Christiano RSC, 2010, PLANT DIS, V94, P1213, DOI 10.1094/PDIS-04-10-0282; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; Davis B, 1987, MICROBIOL REV, V51; Ding F, 2008, PLANT CELL REP, V27, P241, DOI 10.1007/s00299-007-0467-8; Doud MS, 2012, PHYTOPATHOLOGY, V102, P31; Garnier M, 2000, W CAPE PROVINCE S AF; GEORGE SW, 1986, PLANT DIS, V70, P1100, DOI 10.1094/PD-70-1100; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Ishikawa R, 2005, PHYTOPATHOLOGY, V95, P1209, DOI 10.1094/PHYTO-95-1209; Iwasa T., 1970, J ANTIBIOT, V23, P595, DOI DOI 10.7164/ANTIBIOTICS.23.595; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; JEFFERS SN, 1986, PLANT DIS, V70, P1038, DOI 10.1094/PD-70-1038; Ji GH, 2008, BIOL CONTROL, V45, P288, DOI 10.1016/j.biocontrol.2008.01.004; Jiang YH, 1987, ACTA PHYTOPATHOL SIN, V3, P007; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Li WB, 2008, PLANT DIS, V92, P854, DOI 10.1094/PDIS-92-6-0854; LIN K. -H., 1956, Acta Phytopathologica Sinica, V2, P1; Lo X. H., 1983, Journal of the South China Agricultural College, V4, P97; MCCOY RE, 1982, PLANT DIS, V66, P539, DOI 10.1094/PD-66-539; McManus PS, 2001, PLANT HLTH PROG, V2, P14, DOI DOI 10.1094/PHP-2001-0327-01-RV; Michelini L, 2013, PLANT PHYSIOL BIOCH, V67, P55, DOI 10.1016/j.plaphy.2013.02.027; Moll J. N., 1977, P INT SOC CITRICULTU, V3, P903; Sachin BS, 2007, PHYTOTHER RES, V21, P157, DOI 10.1002/ptr.2046; SCHWARZ RE, 1971, PLANT DIS REP, V55, P747; SPRATT BG, 1988, REV INFECT DIS, V10, P699; Spreen TH, 2013, ANN M SO AGR EC ASS; STOKSTAD ELR, 1987, J NUTR, V117, P1335, DOI 10.1093/jn/117.7.1335; Su H. J., 1986, Plant virus diseases of horticultural crops in the tropics and subtropics., P142; Supriyanto A, 1991, P 11 C INT ORG CITR, P409; Tang W., 1981, ACTA PHYTOPATHOL SIN, V8, P47; Texeira DC, 2005, PLANT DIS, V89, P107, DOI 10.1094/PD-89-0107A; Van Bambeke F, 2006, CURR OPIN DRUG DISC, V9, P218; VANVUUREN SP, 1977, PLANT DIS REP, V61, P358; YEE Y, 1986, J INFECT DIS, V154, P531, DOI 10.1093/infdis/154.3.531; Zhang MQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-112; Zhang MQ, 2012, PHYTOPATHOLOGY, V102, P567, DOI 10.1094/PHYTO-09-11-0265; Zhang MQ, 2011, PHYTOPATHOLOGY, V101, P1097, DOI 10.1094/PHYTO-09-10-0262; Zhang MQ, 2010, PHYTOPATHOLOGY, V100, P239, DOI 10.1094/PHYTO-100-3-0239; Zhao XY, 1981, CITRUS YELLOW SHOOT, P466; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	53	44	53	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111032	10.1371/journal.pone.0111032	http://dx.doi.org/10.1371/journal.pone.0111032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372135	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900035
J	Li, YG; He, MX				Li, Yaoguo; He, Maoxian			Genetic Mapping and QTL Analysis of Growth-Related Traits in Pinctada fucata Using Restriction-Site Associated DNA Sequencing	PLOS ONE			English	Article							JAPANESE PEARL OYSTER; LINKAGE MAP; AGRONOMIC TRAITS; SSR MARKERS; MICROSATELLITE; AFLP; IDENTIFICATION; SELECTION; GENOME; LOCI	The pearl oyster, Pinctada fucata (P. fucata), is one of the marine bivalves that is predominantly cultured for pearl production. To obtain more genetic information for breeding purposes, we constructed a high-density linkage map of P. fucata and identified quantitative trait loci (QTL) for growth-related traits. One F1 family, which included the two parents, 48 largest progeny and 50 smallest progeny, was sampled to construct a linkage map using restriction site-associated DNA sequencing (RAD-Seq). With low coverage data, 1956.53 million clean reads and 86,342 candidate RAD loci were generated. A total of 1373 segregating SNPs were used to construct a sex-average linkage map. This spanned 1091.81 centimorgans (cM), with 14 linkage groups and an average marker interval of 1.41 cM. The genetic linkage map coverage, Coa, was 97.24%. Thirty-nine QTL-peak loci, for seven growth-related traits, were identified using the single-marker analysis, nonparametric mapping Kruskal-Wallis (KW) test. Parameters included three for shell height, six for shell length, five for shell width, four for hinge length, 11 for total weight, eight for soft tissue weight and two for shell weight. The QTL peak loci for shell height, shell length and shell weight were all located in linkage group 6. The genotype frequencies of most QTL peak loci showed significant differences between the large subpopulation and the small subpopulation (P<0.05). These results highlight the effectiveness of RAD-Seq as a tool for generation of QTL-targeted and genome-wide marker data in the non-model animal, P. fucata, and its possible utility in marker-assisted selection (MAS).	[Li, Yaoguo; He, Maoxian] Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Li, Yaoguo] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, MX (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.	hmx@scsio.ac.cn			National Science and Technology Program of China [2012AA10A410]; Chinese Academy of Sciences [ZCX2-EW-Q21]; Marine Fishery Science and Technology Promotion Program of Guangdong Province, China [A201201A05, A201301A03]	National Science and Technology Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); Marine Fishery Science and Technology Promotion Program of Guangdong Province, China	This work was supported by grants from the National Science and Technology Program of China (2012AA10A410), the Funds of Knowledge Innovation program of Chinese Academy of Sciences (ZCX2-EW-Q21), and the Marine Fishery Science and Technology Promotion Program of Guangdong Province, China (A201201A05, A201301A03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco Carlos, 2006, V323, P79; Atienza SG, 2003, THEOR APPL GENET, V107, P123, DOI 10.1007/s00122-003-1220-5; Baga M, 2007, FUNCT INTEGR GENOMIC, V7, P53, DOI 10.1007/s10142-006-0030-7; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Cervera MT, 2001, GENETICS, V158, P787; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Dirlewanger E, 1999, THEOR APPL GENET, V98, P18, DOI 10.1007/s001220051035; Fishman L, 2001, GENETICS, V159, P1701; Gao HJ, 2006, CHINESE SCI BULL, V51, P1857, DOI 10.1007/s11434-006-2050-z; Guo X, 2012, MAR BIOTECHNOL, V14, P218, DOI 10.1007/s10126-011-9405-4; Gut IG, 2004, NAT GENET, V36, P789, DOI 10.1038/ng0804-789; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; He MX, 2008, AQUAC RES, V39, P801, DOI 10.1111/j.1365-2109.2008.01889.x; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Huang XD, 2013, J GENET, V93, pe1; Hubert S, 2004, GENETICS, V168, P351, DOI 10.1534/genetics.104.027342; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Hulata G, 2001, GENETICA, V111, P155, DOI 10.1023/A:1013776931796; Jiao WQ, 2014, DNA RES, V21, P85, DOI 10.1093/dnares/dst043; Jones DB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-810; Kakioka R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-32; Klimenko I, 2010, THEOR APPL GENET, V120, P1253, DOI 10.1007/s00122-009-1253-5; Knox MR, 2002, GENETICS, V162, P861; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lallias D, 2007, ANIM GENET, V38, P560, DOI 10.1111/j.1365-2052.2007.01647.x; LANDE R, 1990, GENETICS, V124, P743; LANDER ES, 1989, GENETICS, V121, P185; Launey S, 2001, GENETICS, V159, P255; Lebowitz M., 1987, Machine Learning, V2, P103, DOI 10.1023/A:1022800624210; Li HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046926; Liao M, 2007, ANIM GENET, V38, P364, DOI 10.1111/j.1365-2052.2007.01617.x; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Liu WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033679; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Lu X, 2013, MAR BIOTECHNOL, V15, P16, DOI 10.1007/s10126-012-9453-4; Magwene PM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002255; Martinez-Navarro B, 2008, J HUM EVOL, V54, P157, DOI 10.1016/j.jhevol.2007.09.011; Massault C, 2008, AQUACULTURE, V285, P23, DOI 10.1016/j.aquaculture.2008.06.040; Miyazaki T, 1999, DIS AQUAT ORGAN, V37, P1, DOI 10.3354/dao037001; Naciri Y., 1995, Molecular Marine Biology and Biotechnology, V4, P83; Perkel J, 2008, NAT METHODS, V5, P447, DOI 10.1038/nmeth0508-447; Petersen JL, 2012, AQUACULTURE, V350, P200, DOI 10.1016/j.aquaculture.2012.03.039; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Qin YJ, 2007, AQUACULTURE, V272, P281, DOI 10.1016/j.aquaculture.2007.07.214; Sanchez-Molano E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-473; Sauvage C, 2010, ANIM GENET, V41, P390, DOI 10.1111/j.1365-2052.2009.02018.x; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; Shi YH, 2013, MAR BIOTECHNOL, V15, P175, DOI 10.1007/s10126-012-9476-x; Shi YH, 2009, AQUAC RES, V41, P35, DOI 10.1111/j.1365-2109.2009.02299.x; STUBER CW, 1980, GENETICS, V95, P225; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Ulloa M, 2013, THEOR APPL GENET, V126, P1405, DOI 10.1007/s00122-013-2061-5; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; WADA H, 1995, MOL MAR BIOL BIOTECH, V4, P269; Wada K.T., 1976, JAP J MALAC, V35, P9; WADA KT, 1994, AQUACULTURE, V125, P59, DOI 10.1016/0044-8486(94)90282-8; Wada KT, 1996, AQUACULTURE, V142, P25, DOI 10.1016/0044-8486(95)01242-7; Wang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034874; Wang LL, 2005, AQUAC RES, V36, P643, DOI 10.1111/j.1365-2109.2005.01268.x; WELCH S, 1990, J CLIN ENDOCR METAB, V71, P1508, DOI 10.1210/jcem-71-6-1508; Woodhead M, 2013, MOL BREEDING, V31, P111, DOI 10.1007/s11032-012-9775-y; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Yu ZN, 2003, BIOL BULL-US, V204, P327, DOI 10.2307/1543603; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2	67	553	569	4	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111707	10.1371/journal.pone.0111707	http://dx.doi.org/10.1371/journal.pone.0111707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369421	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000088
J	Roche, CJ; Talwar, A; Palmer, AF; Cabrales, P; Gerfen, G; Friedman, JM				Roche, Camille J.; Talwar, Abhinav; Palmer, Andre F.; Cabrales, Pedro; Gerfen, Gary; Friedman, Joel M.			Evaluating the Capacity to Generate and Preserve Nitric Oxide Bioactivity in Highly Purified Earthworm Erythrocruorin A GIANT POLYMERIC HEMOGLOBIN WITH POTENTIAL BLOOD SUBSTITUTE PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hemoglobin; Myoglobin; Nitric Oxide; Oxidation-Reduction (Redox); Reductase; Dinitrogen Trioxide; Erythrocruorin; Nitrite Anhydrase; Nitrite Reductase	LUMBRICUS-TERRESTRIS HEMOGLOBIN; CELL-FREE HEMOGLOBIN; REDUCTASE-ACTIVITY; EXTRACELLULAR HEMOGLOBIN; SUSTAINED-RELEASE; OXYGEN CARRIERS; INVERTEBRATE HEMOGLOBINS; S-NITROSOHEMOGLOBIN; LINKER CHAINS; HEME REDOX	Background: Earthworm hemoglobin (LtHb) is a potential blood substitute. Results: LtHb can generate nitric oxide (NO) and preserve NO bioactivity. Conclusion: LtHb reactions with nitrite and NO are indicative of therapeutic possibilities. Significance: The results further highlight the potential role of hemoglobins in NO homeostasis. The giant extracellular hemoglobin (erythrocruorin) from the earth worm (Lumbricus terrestris) has shown promise as a potential hemoglobin-based oxygen carrier (HBOC) in in vivo animal studies. An important beneficial characteristic of this hemoglobin (LtHb) is the large number of heme-based oxygen transport sites that helps overcome issues of osmotic stress when attempting to provide enough material for efficient oxygen delivery. A potentially important additional property is the capacity of the HBOC either to generate nitric oxide (NO) or to preserve NO bioactivity to compensate for decreased levels of NO in the circulation. The present study compares the NO-generating and NO bioactivity-preserving capability of LtHb with that of human adult hemoglobin (HbA) through several reactions including the nitrite reductase, reductive nitrosylation, and still controversial nitrite anhydrase reactions. An assignment of a heme-bound dinitrogen trioxide as the stable intermediate associated with the nitrite anhydrase reaction in both LtHb and HbA is supported based on functional and EPR spectroscopic studies. The role of the redox potential as a factor contributing to the NO-generating activity of these two proteins is evaluated. The results show that LtHb undergoes the same reactions as HbA and that the reduced efficacy for these reactions for LtHb relative to HbA is consistent with the much higher redox potential of LtHb. Evidence of functional heterogeneity in LtHb is explained in terms of the large difference in the redox potential of the isolated subunits.	[Roche, Camille J.; Talwar, Abhinav; Gerfen, Gary; Friedman, Joel M.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Talwar, Abhinav] Herricks High Sch, New Hyde Pk, NY 11040 USA; [Palmer, Andre F.] Ohio State Univ, William G Lawrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Cabrales, Pedro] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Yeshiva University; Albert Einstein College of Medicine; University System of Ohio; Ohio State University; University of California System; University of California San Diego	Friedman, JM (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	joel.friedman@einstein.yu.edu	Cabrales, Pedro/A-1930-2014	Cabrales, Pedro/0000-0002-8794-2839	National Institutes of Health [P01HL110900-01A1, P01HL071064, R56HL123015, R01HL052684, R01HL62354, R01HL078840, R01DK070862]; FJC, a foundation of philanthropic funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078840, R01HL062354, R56HL123015, P01HL110900, P01HL071064, R01HL052684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FJC, a foundation of philanthropic funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL110900-01A1 and P01HL071064 (to J. M. F.), R56HL123015 and R01HL052684 (to P. C.), R01HL62354, R01HL078840, and R01DK070862. This work was also supported by FJC, a foundation of philanthropic funds.	Alayash AI, 2014, TRENDS BIOTECHNOL, V32, P177, DOI 10.1016/j.tibtech.2014.02.006; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Balcerczyk A, 2005, FREE RADICAL BIO MED, V39, P327, DOI 10.1016/j.freeradbiomed.2005.03.017; Barghaus O., 1992, MEAS SCI TECHNOL, V3, P765; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Buehler PW, 2008, BBA-PROTEINS PROTEOM, V1784, P1378, DOI 10.1016/j.bbapap.2007.12.009; Buerk DG, 2011, ADV EXP MED BIOL, V701, P271, DOI 10.1007/978-1-4419-7756-4_36; Cabrales P, 2013, ANTIOXID REDOX SIGN, V18, P2284, DOI 10.1089/ars.2012.5099; Cabrales P, 2011, AM J PHYSIOL-HEART C, V300, pH49, DOI 10.1152/ajpheart.00665.2010; Cabrales P, 2010, FREE RADICAL BIO MED, V49, P530, DOI 10.1016/j.freeradbiomed.2010.04.034; Cantu-Medellin N, 2011, NITRIC OXIDE-BIOL CH, V25, P59, DOI 10.1016/j.niox.2011.01.006; Corti P, 2013, FREE RADICAL BIO MED, V65, P1518, DOI 10.1016/j.freeradbiomed.2013.09.020; DAVID MM, 1974, J MOL BIOL, V87, P89, DOI 10.1016/0022-2836(74)90561-0; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Dorman SC, 2004, J INORG BIOCHEM, V98, P185, DOI 10.1016/j.jinorgbio.2003.10.004; Dorman SC, 2002, ARTIF CELL BLOOD SUB, V30, P39, DOI 10.1081/BIO-120002726; Elmer J, 2012, LIFE SCI, V91, P852, DOI 10.1016/j.lfs.2012.08.036; Elmer J, 2012, TRANSFUSION, V52, P1729, DOI 10.1111/j.1537-2995.2011.03523.x; FAULKNER KM, 1995, J BIOL CHEM, V270, P13604, DOI 10.1074/jbc.270.23.13604; Fernandez BO, 2003, J AM CHEM SOC, V125, P10510, DOI 10.1021/ja036693b; Ford PC, 2010, INORG CHEM, V49, P6226, DOI 10.1021/ic902073z; Friedman AJ, 2008, NITRIC OXIDE-BIOL CH, V19, P12, DOI 10.1016/j.niox.2008.04.003; FUSHITANI K, 1986, J BIOL CHEM, V261, P8414; FUSHITANI K, 1991, J BIOL CHEM, V266, P10275; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; Gow AJ, 2005, J INORG BIOCHEM, V99, P903, DOI 10.1016/j.jinorgbio.2004.12.001; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Han TH, 2002, P NATL ACAD SCI USA, V99, P7763, DOI 10.1073/pnas.122118299; Harrington JP, 2007, ARTIF CELL BLOOD SUB, V35, P53, DOI 10.1080/10731190600974491; Hirsch RE, 1997, ARTIF CELL BLOOD SUB, V25, P429, DOI 10.3109/10731199709118932; Hopmann KH, 2011, CHEM-EUR J, V17, P6348, DOI 10.1002/chem.201003578; Itoh Y, 2000, ANAL BIOCHEM, V287, P203, DOI 10.1006/abio.2000.4859; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; KAPP OH, 1981, BIOCHEM BIOPH RES CO, V101, P509, DOI 10.1016/0006-291X(81)91289-4; Kim-Shapiro DB, 2014, NITRIC OXIDE-BIOL CH, V38, P58, DOI 10.1016/j.niox.2013.11.002; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Koppenol WH, 2012, INORG CHEM, V51, P5637, DOI 10.1021/ic202561f; KRISTENSEN EW, 1991, J ELECTROANAL CHEM, V309, P61, DOI 10.1016/0022-0728(91)87004-N; Liochev SI, 1996, ARCH BIOCHEM BIOPHYS, V330, P281, DOI 10.1006/abbi.1996.0254; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; Minning DM, 1999, NATURE, V401, P497, DOI 10.1038/46822; Mouche F, 2001, J STRUCT BIOL, V133, P176, DOI 10.1006/jsbi.2001.4362; Nachuraju P, 2011, RESUSCITATION, V82, P607, DOI 10.1016/j.resuscitation.2010.12.025; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Navati MS, 2009, J AM CHEM SOC, V131, P12273, DOI 10.1021/ja903364h; OWNBY DW, 1993, J BIOL CHEM, V268, P13539; Planchet E, 2006, J EXP BOT, V57, P3043, DOI 10.1093/jxb/erl070; Roche CJ, 2006, J BIOL CHEM, V281, P36874, DOI 10.1074/jbc.M603914200; Roche CJ, 2013, J BIOL CHEM, V288, P22408, DOI 10.1074/jbc.M113.482679; Roche CJ, 2012, NITRIC OXIDE-BIOL CH, V27, P32, DOI 10.1016/j.niox.2012.04.002; Roche CJ, 2011, J BIOL CHEM, V286, P23452, DOI 10.1074/jbc.M110.183186; Roche CJ, 2010, NITRIC OXIDE-BIOL CH, V22, P180, DOI 10.1016/j.niox.2009.11.003; Rohlfs RJ, 1998, J BIOL CHEM, V273, P12128, DOI 10.1074/jbc.273.20.12128; Rousselot Morgane, 2006, Biotechnology Journal, V1, P333, DOI 10.1002/biot.200500049; Sheng JZ, 2005, J PHARMACOL EXP THER, V315, P931, DOI 10.1124/jpet.105.087932; Srihirun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030380; Stamler JS, 2008, NAT MED, V14, P1008, DOI 10.1038/nm1008-1008; SZABO A, 1976, BIOCHEMISTRY-US, V15, P4427, DOI 10.1021/bi00665a013; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927; Wust PK, 2009, APPL ENVIRON MICROB, V75, P1852, DOI 10.1128/AEM.02745-08; Yi J, 2009, J AM CHEM SOC, V131, P18119, DOI 10.1021/ja904726q; Yonetani T, 1998, J BIOL CHEM, V273, P20323, DOI 10.1074/jbc.273.32.20323; Zhu H, 1996, J BIOL CHEM, V271, P30007, DOI 10.1074/jbc.271.47.30007	69	9	9	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					99	117		10.1074/jbc.M114.583260	http://dx.doi.org/10.1074/jbc.M114.583260			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25371199	Green Published, hybrid			2022-12-26	WOS:000347231200010
J	Bukiya, AN; McMillan, J; Liu, JX; Shivakumar, B; Parrill, AL; Dopico, AM				Bukiya, Anna N.; McMillan, Jacob; Liu, Jianxi; Shivakumar, Bangalore; Parrill, Abby L.; Dopico, Alex M.			Activation of Calcium- and Voltage-gated Potassium Channels of Large Conductance by Leukotriene B4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Drug Design; Ion Channel; Leukotriene; Patch Clamp	CA2+-ACTIVATED K+ CHANNELS; SMOOTH-MUSCLE; BK CHANNELS; BILE-ACIDS; TRANSMEMBRANE DOMAIN; ARACHIDONIC-ACID; BETA-1 SUBUNIT; MAXIK CHANNEL; FATTY-ACIDS; MODULATION	Calcium/voltage-gated, large conductance potassium (BK) channels control numerous physiological processes, including myogenic tone. BK channel regulation by direct interaction between lipid and channel protein sites has received increasing attention. Leukotrienes (LTA4, LTB4, LTC4, LTD4, and LTE4) are inflammatory lipid mediators. We performed patch clamp studies in Xenopus oocytes that co-expressed BK channel-forming (cbv1) and accessory 1 subunits cloned from rat cerebral artery myocytes. Leukotrienes were applied at 0.1 nm-10 m to either leaflet of cell-free membranes at a wide range of [Ca2+](i) and voltages. Only LTB4 reversibly increased BK steady-state activity (EC50 = 1 nm; E-max reached at 10 nm), with physiological [Ca2+](i) and voltages favoring this activation. Homomeric cbv1 or cbv1-2 channels were LTB4-resistant. Computational modeling predicted that LTB4 docked onto the cholane steroid-sensing site in the BK 1 transmembrane domain 2 (TM2). Co-application of LTB4 and cholane steroid did not further increase LTB4-induced activation. LTB4 failed to activate 1 subunit-containing channels when 1 carried T169A, A176S, or K179I within the docking site. Co-application of LTB4 with LTA4, LTC4, LTD4, or LTE4 suppressed LTB4-induced activation. Inactive leukotrienes docked onto a portion of the site, probably preventing tight docking of LTB4. In summary, we document the ability of two endogenous lipids from different chemical families to share their site of action on a channel accessory subunit. Thus, cross-talk between leukotrienes and cholane steroids might converge on regulation of smooth muscle contractility via BK 1. Moreover, the identification of LTB4 as a highly potent ligand for BK channels is critical for the future development of 1-specific BK channel activators.	[Bukiya, Anna N.; Liu, Jianxi; Shivakumar, Bangalore; Dopico, Alex M.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [McMillan, Jacob; Parrill, Abby L.] Univ Memphis, Dept Chem, Memphis, TN 38152 USA; [McMillan, Jacob; Parrill, Abby L.] Univ Memphis, Computat Res Mat Inst CROMIUM, Memphis, TN 38152 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Memphis	Bukiya, AN (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	abukiya@uthsc.edu; adopico@uthsc.edu	Bukiya, Anna/N-5361-2019	Parrill, Abby/0000-0003-1658-8497	National Institutes of Health [AA020184, HL10463-01, AA11560]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011560, R37AA011560, R29AA011560, R03AA020184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA020184 (to A. B.) and HL10463-01 and AA11560 (to A. D.).	Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Bukiya AN, 2008, J LIPID RES, V49, P2441, DOI 10.1194/jlr.M800286-JLR200; Bukiya AN, 2008, FEBS LETT, V582, P673, DOI 10.1016/j.febslet.2008.01.036; Bukiya AN, 2007, MOL PHARMACOL, V72, P359, DOI 10.1124/mol.107.034330; Bukiya AN, 2013, MOL PHARMACOL, V83, P1030, DOI 10.1124/mol.112.083519; Bukiya AN, 2011, P NATL ACAD SCI USA, V108, P20207, DOI 10.1073/pnas.1112901108; Bukiya AN, 2011, ARTERIOSCL THROM VAS, V31, P2410, DOI 10.1161/ATVBAHA.111.233965; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Bukiya AN, 2009, FEBS LETT, V583, P2779, DOI 10.1016/j.febslet.2009.07.019; CABRAL DJ, 1987, BIOCHEMISTRY-US, V26, P1801, DOI 10.1021/bi00381a002; Clarke AL, 2002, AM J PHYSIOL-CELL PH, V283, pC1441, DOI 10.1152/ajpcell.00035.2002; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Crowley JJ, 2005, MOL PHARMACOL, V68, P4, DOI 10.1124/mol.105.012971; Dopico AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00312; Dopico AM, 2002, J GEN PHYSIOL, V119, P251, DOI 10.1085/jgp.119.3.251; Essin K, 2009, BLOOD, V113, P1326, DOI 10.1182/blood-2008-07-166660; Hoffmann EK, 1999, PFLUG ARCH EUR J PHY, V438, P263, DOI 10.1007/s004240050908; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4822, DOI 10.1073/pnas.1222003110; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Jaggar JH, 2005, CIRC RES, V97, P805, DOI 10.1161/01.RES.0000186180.47148.7b; King JT, 2006, J NEUROPHYSIOL, V95, P2878, DOI 10.1152/jn.01352.2005; KIRBER MT, 1992, FEBS LETT, V297, P24, DOI 10.1016/0014-5793(92)80319-C; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Liu JX, 2008, MOL PHARMACOL, V74, P628, DOI 10.1124/mol.108.048694; Martin P, 2014, PFLUG ARCH EUR J PHY, V466, P1779, DOI 10.1007/s00424-013-1422-x; MCMANUS OB, 1993, BIOCHEMISTRY-US, V32, P6128, DOI 10.1021/bi00075a002; Meera P, 1996, FEBS LETT, V382, P84, DOI 10.1016/0014-5793(96)00151-2; Meng XJ, 1997, J CLIN INVEST, V99, P2915, DOI 10.1172/JCI119486; Morimoto T, 2007, MOL PHARMACOL, V71, P1075, DOI 10.1124/mol.106.031146; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Perez GJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1769, DOI 10.1152/ajpcell.2001.281.6.C1769; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Poveda JA, 2014, BBA-BIOMEMBRANES, V1838, P1560, DOI 10.1016/j.bbamem.2013.10.023; Sasagawa M, 1994, Arerugi, V43, P28; SCHERER RW, 1993, J GEN PHYSIOL, V102, P125, DOI 10.1085/jgp.102.1.125; SHINDO K, 1993, INT J TISSUE REACT, V15, P181; SHIRATSUKI N, 1990, PROSTAG LEUKOTR ESS, V40, P285, DOI 10.1016/0952-3278(90)90051-L; Singh AK, 2012, J BIOL CHEM, V287, P20509, DOI 10.1074/jbc.M112.356261; Snyder PW, 2011, P NATL ACAD SCI USA, V108, P17889, DOI 10.1073/pnas.1114107108; Striggow F, 1997, BIOCHEM BIOPH RES CO, V237, P413, DOI 10.1006/bbrc.1997.7152; Tanaka Y, 2004, J PHARMACOL SCI, V94, P339, DOI 10.1254/jphs.94.339; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; Vigna SR, 2011, PANCREAS, V40, P708, DOI 10.1097/MPA.0b013e318214c8df; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240	49	14	15	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35314	35325		10.1074/jbc.M114.577825	http://dx.doi.org/10.1074/jbc.M114.577825			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371198	Green Published, hybrid			2022-12-26	WOS:000346660200023
J	Wang, HY; Feng, H; Zhang, YR; Chen, H				Wang, Haiyang; Feng, Hui; Zhang, Yanru; Chen, Hong			Contrasting Regeneration Strategies in Climax and Long-Lived Pioneer Tree Species in a Subtropical Forest	PLOS ONE			English	Article							BROAD-LEAVED FOREST; RESPROUTING ABILITY; DESERT ANNUALS; OLD-GROWTH; ALLOCATION; LIFE; COEXISTENCE; PERSISTENCE; EVERGREEN; DYNAMICS	1: This study investigated 15 coexisting dominant species in a humid subtropical evergreen broad-leaved forest in southwest China, consisting of long-lived pioneers and climax species occurring in natural and disturbed regimes. The authors hypothesized that there would be non-tradeoff scaling relationships between sprouting and seed size among species, with the aim of uncovering the ecological relationship between plant sprouting and seed characteristics in the two functional groups. 2: The sprouting variations of the species were initially examined using pairwise comparisons between natural and disturbed habitats within and across species and were noted to show a continuum in persistence niches across the forest dominants, which may underlie the maintenance of plant diversity. Second, a significantly positive, rather than tradeoff, relationship between sprout number and seed size across species within each of the two functional groups was observed, and an obvious elevational shift with a common slope among the two groups in their natural habitat was examined. The results indicate the following: 1) the relationship of seed size vs. sprouts in the natural habitat is more likely to be bet-hedging among species within a guild in a forest; 2) climax species tend to choose seeding rather than sprouting regeneration, and vice versa for the long-lived pioneers; and 3) the negative correlation between sprouting and seed dispersal under disturbed conditions may imply a tradeoff between dispersal and persistence in situ during the process of plant regeneration. 3: These findings may be of potential significance for urban greening using native species.	[Wang, Haiyang; Chen, Hong] Southwest Univ, Inst Landscape Ecol Montane Hort, Chongqing 400716, Peoples R China; [Feng, Hui; Zhang, Yanru; Chen, Hong] Southwest Univ, Dept Bot, Coll Hort & Landscape Architecture, Chongqing 400716, Peoples R China	Southwest University - China; Southwest University - China	Chen, H (corresponding author), Southwest Univ, Inst Landscape Ecol Montane Hort, Chongqing 400716, Peoples R China.	chenh.swu@gmail.com			Special Research Program for Public-Welfare Forestry [201004064]; Southwest University [SWU110032]	Special Research Program for Public-Welfare Forestry; Southwest University(Southwest University - China)	This research was funded by Special Research Program for Public-Welfare Forestry (201004064) and Southwest University (SWU110032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Bellingham PJ, 2000, OIKOS, V89, P409, DOI 10.1034/j.1600-0706.2000.890224.x; Bellingham PJ, 1996, ECOL RES, V11, P229, DOI 10.1007/BF02347781; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Bond WJ, 2003, INT J PLANT SCI, V164, pS103, DOI 10.1086/374191; Bullock J. M., 2000, Seeds: the ecology of regeneration in plant communities, P375, DOI 10.1079/9780851994321.0375; Burrows GE, 2008, AUST J BOT, V56, P254, DOI 10.1071/BT07164; Chen H, 2010, AM J BOT, V97, P611, DOI 10.3732/ajb.0900204; Chen H, 2009, NEW PHYTOL, V183, P1212, DOI 10.1111/j.1469-8137.2009.02878.x; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Clauss MJ, 2000, AM NAT, V155, P168, DOI 10.1086/303314; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Da L, 2003, ACTA PHYTOECOLOGICAL, V28, P376; Del Tredici P, 2001, BOT REV, V67, P121, DOI 10.1007/BF02858075; Dietze MC, 2008, ECOL MONOGR, V78, P331, DOI 10.1890/07-0271.1; Falster D. S., 2006, SMATR STANDARDISED M; Fenner M., 2000, SEEDS ECOLOGY REGENE; Fenner M., 2005, ECOLOGY SEEDS; Gutierrez AG, 2008, J BIOGEOGR, V35, P1674, DOI 10.1111/j.1365-2699.2008.01908.x; Hodgkinson KC, 1998, OECOLOGIA, V115, P64, DOI 10.1007/s004420050492; HOUSSARD C, 1995, OECOLOGIA, V102, P70, DOI 10.1007/BF00333312; Knox KJE, 2005, FUNCT ECOL, V19, P690, DOI 10.1111/j.1365-2435.2005.01006.x; Kruger LM, 1997, FUNCT ECOL, V11, P101, DOI 10.1046/j.1365-2435.1997.00064.x; Lamont BB, 2003, EVOL ECOL, V17, P277, DOI 10.1023/A:1025535223021; Lasso E, 2009, OECOLOGIA, V161, P43, DOI 10.1007/s00442-009-1353-6; Leps J, 2003, MULTIVARIATE ANAL EC; Liu Y, 1988, ECOLOGY STUDY EVERGR; Lohier T, 2014, ANN BOT-LONDON, V114, P513, DOI 10.1093/aob/mcu128; Lusk CH, 1999, PLANT ECOL, V140, P111, DOI 10.1023/A:1009764705942; MARTINS EP, 2004, COMPARE COMPUTER PRO; Meier AR, 2012, TREE PHYSIOL, V32, P565, DOI 10.1093/treephys/tps040; Miura M, 2003, ECOL RES, V18, P115, DOI 10.1046/j.1440-1703.2003.00540.x; Miyawaki A., 1999, PLANT BIOTECHNOLOGY, V16, P15, DOI DOI 10.5511/plantbiotechnology.16.15; Moreira B, 2012, OIKOS, V121, P1577, DOI 10.1111/j.1600-0706.2011.20258.x; Nzunda EF, 2011, PLANT ECOL, V212, P1991, DOI 10.1007/s11258-011-9991-2; Nzunda EF, 2014, EVOL ECOL, V28, P735, DOI 10.1007/s10682-014-9698-7; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; PHILIPPI T, 1993, AM NAT, V142, P488, DOI 10.1086/285551; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Pratt RB, 2012, AM J BOT, V99, P1464, DOI 10.3732/ajb.1200193; SAKAI A, 1995, J PLANT RES, V108, P377, DOI 10.1007/BF02344363; Salk CF, 2011, OECOLOGIA, V166, P485, DOI 10.1007/s00442-010-1850-7; Shibata R, 2014, J ECOL, V102, P209, DOI 10.1111/1365-2745.12174; Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x; Turnbull C., 2005, PLANT ARCHITECTURE I; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Van Bloem SJ, 2007, TREE PHYSIOL, V27, P475, DOI 10.1093/treephys/27.3.475; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; Vesk PA, 2004, J ECOL, V92, P310, DOI 10.1111/j.0022-0477.2004.00871.x; Wang XH, 2007, FOREST ECOL MANAG, V245, P76, DOI 10.1016/j.foreco.2007.03.043; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Wu LC, 2008, NEW FOREST, V36, P239, DOI 10.1007/s11056-008-9096-5; XIONG JH, 2005, PLANT INDEX MT JINYU; Zeng J, 1995, J SW CHINA NORMAL U, V20, P686; Zhong Z, 1988, ECOLOGICAL STUDY EVE, P696; Zhu WZ, 2012, FOREST ECOL MANAG, V278, P118, DOI 10.1016/j.foreco.2012.04.032	61	3	3	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112385	10.1371/journal.pone.0112385	http://dx.doi.org/10.1371/journal.pone.0112385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383688	Green Submitted, gold, Green Published			2022-12-26	WOS:000344816700053
J	Jakovljevic, M; Jovanovic, M; Rancic, N; Vyssoki, B; Djordjevic, N				Jakovljevic, Mihajlo; Jovanovic, Mirjana; Rancic, Nemanja; Vyssoki, Benjamin; Djordjevic, Natasa			LAT Software Induced Savings on Medical Costs of Alcohol Addicts' Care - Results from a Matched-Pairs Case-Control Study	PLOS ONE			English	Article							DEPENDENT PATIENTS; HEALTH-POLICY; GLOBAL BURDEN; GUIDELINES; ABSTINENCE; CONSUMPTION; ACAMPROSATE; PREVENTION; THERAPY; IMPACT	Lesch Alcoholism Typology (LAT) is one of the most widely used clinical typologies of alcohol addiction. Study tested whether introduction of LAT software in clinical practice leaded to improved outcomes and reduced costs. Retrospective matched-pairs case-control cost comparison study was conducted at the Regional Addiction Center of the University Clinic in Serbia involving 250 patients during the four-year period. Mean relapse frequency followed by outpatient detoxification was 0.42 +/- 0.90 vs. 0.70 +/- 1.66 (LAT/non-LAT; p = 0.267). Adding relapses after inpatient treatment total mean-number of relapses per patient was 0.70 +/- 1.74 vs. 0.97 +/- 1.89 (LAT/non-LAT; p = 0.201). However, these relapse frequency differentials were not statistically significant. Total hospital costs of Psychiatry clinic based non-LAT addicts' care (sic54,660) were significantly reduced to sic36,569 after initiation of LAT. Mean total cost per patient was reduced almost by half after initiation of LAT based treatment: sic331 +/- 381 vs. sic626 +/- 795 (LAT/non-LAT; p = 0.001). Mean cost of single psychiatry clinic admission among non-LAT treatment group was sic320 +/- 330 (CI 95% 262-378) and among LAT sic197 +/- 165 (CI 95% 168-226) (p = 0.019). Mean LAT software induced net savings on psychiatric care costs were sic144 per patient. Total net savings on hospital care including F10 associated somatic co-morbidities amounted to sic295 per patient. More sensitive diagnostic assessment and sub-type specific pharmacotherapy and psychotherapy following implementation of LAT software lead to significant savings on costs of hospital care.	[Jakovljevic, Mihajlo; Djordjevic, Natasa] Univ Kragujevac, Fac Med Sci, Dept Pharmacol & Toxicol, Kragujevac, Serbia; [Jovanovic, Mirjana] Univ Kragujevac, Fac Med Sci, Dept Psychiat, Kragujevac, Serbia; [Rancic, Nemanja] Univ Def, Med Fac Mil Med Acad, Ctr Clin Pharmacol, Belgrade, Serbia; [Vyssoki, Benjamin] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria	University of Kragujevac; University of Kragujevac; Medical University of Vienna	Jakovljevic, M (corresponding author), Univ Kragujevac, Fac Med Sci, Dept Pharmacol & Toxicol, Kragujevac, Serbia.	jakovljevicm@medf.kg.ac.rs	Djordjevic, Natasa/K-4692-2019; Jakovljevic, Mihajlo/B-3002-2014; Rancic, Nemanja/L-6271-2019	Djordjevic, Natasa/0000-0003-4525-6723; Jakovljevic, Mihajlo/0000-0002-9160-6846; Rancic, Nemanja/0000-0002-5122-8094	Ministry of Education, Science and Technological Development of the Republic of Serbia through OI Grant [175014]	Ministry of Education, Science and Technological Development of the Republic of Serbia through OI Grant	The Ministry of Education, Science and Technological Development of the Republic of Serbia through OI Grant No 175014, has fully financed this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando B, 2013, SUBST USE MISUSE; BABOR TF, 1992, BRIT J ADDICT, V87, P1415; Bleich S, 2004, ALCOHOL ALCOHOLISM, V39, P493, DOI 10.1093/alcalc/agh094; Caputo F, 2014, J PSYCHOPHARMACOL, V28, P23, DOI 10.1177/0269881113504015; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; Djordjevic ND, 2006, VOJNOSANIT PREGL, p[63, 279]; Drozda JP, 2013, JAMA INTERN MED, V173, P1097, DOI 10.1001/jamainternmed.2013.820; French MT, 2002, HEALTH SERV RES, V37, P433, DOI 10.1111/1475-6773.031; Haas L, 2013, APPL HEALTH ECON HEA, V11, P359, DOI 10.1007/s40258-013-0042-0; Hussey AM, 2013, STAT BIOPHARMACEUTIC, V5; Jakovljevic M, 2013, VALUE HEALTH, V16, pA542, DOI 10.1016/j.jval.2013.08.1376; Jakovljevic M, 2011, SER J EXP CLIN RES, V12, P161, DOI DOI 10.5937/SJECR1104161J; Jakovljevic M, 2011, HLTH BEHAV PUBLIC HL, V1, P1; Jakovljevic Mihajlo, 2013, Value Health Reg Issues, V2, P218, DOI 10.1016/j.vhri.2013.07.002; Jakovljevic M, 2013, ALCOHOL ALCOHOLISM, V48, P505, DOI 10.1093/alcalc/agt011; Jakovljevic MB, 2013, EUR J HEALTH ECON, V14, P153, DOI 10.1007/s10198-012-0439-y; JOHNSON RS, 1992, ADDICT BEHAV, V17, P159, DOI 10.1016/0306-4603(92)90020-V; Jovanovic M, 2011, ALCOHOL ALCOHOLISM, V46, P364, DOI 10.1093/alcalc/agr010; Kiefer F, 2005, EUR ADDICT RES, V11, P83, DOI 10.1159/000083037; Leggio L, 2009, NEUROPSYCHOL REV, V19, P115, DOI 10.1007/s11065-008-9080-z; Lesch OM, 1996, ALCOHOL ALCOHOLISM, V31, P63; Lesch OM, 2011, ALCOHOL AND TOBACCO: MEDICAL AND SOCIOLOGICAL ASPECTS OF USE, ABUSE AND ADDICTION, P1, DOI 10.1007/978-3-7091-0146-9; Lesch W C, 1991, J Health Soc Policy, V2, P23, DOI 10.1300/J045v02n03_02; Neighbors CJ, 2010, J STUD ALCOHOL DRUGS, V71, P384, DOI 10.15288/jsad.2010.71.384; Palmer AJ, 2000, ALCOHOL ALCOHOLISM, V35, P478, DOI 10.1093/alcalc/35.5.478; Picon PD, 2013, INT J TECHNOL ASSESS, V29, P198, DOI 10.1017/S0266462313000056; Perez EJP, 2008, ADICCIONES, V20, P251; Rankovic A, 2013, VOJNOSANIT PREGL, V70, P709; Rychlik R, 2003, EUR ADDICT RES, V9, P59, DOI 10.1159/000068810; Shield KD, 2013, ADDICTION, V108, P912, DOI 10.1111/add.12112; Stockwell T, 1998, ALCOHOL CLIN EXP RES, V22, p63S, DOI 10.1111/j.1530-0277.1998.tb04375.x; Walters D, 2009, J ADDICT DIS, V28, P137, DOI 10.1080/10550880902772456; Westermeyer J, 1999, AM J ADDICTION, V8, P332; WESTERMEYER J, 1977, J NERV MENT DIS, V164, P351, DOI 10.1097/00005053-197705000-00007; Wutzke SE, 2001, SOC SCI MED, V52, P863, DOI 10.1016/S0277-9536(00)00189-1; Zweifel P, 2012, EUR J HEALTH ECON, V13, P677, DOI 10.1007/s10198-012-0420-9	38	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111931	10.1371/journal.pone.0111931	http://dx.doi.org/10.1371/journal.pone.0111931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25379730	gold, Green Published			2022-12-26	WOS:000344863100048
J	Puig, C; Grau, I; Marti, S; Tubau, F; Calatayud, L; Pallares, R; Linares, J; Ardanuy, C				Puig, Carmen; Grau, Imma; Marti, Sara; Tubau, Fe; Calatayud, Laura; Pallares, Roman; Linares, Josefina; Ardanuy, Carmen			Clinical and Molecular Epidemiology of Haemophilus influenzae Causing Invasive Disease in Adult Patients	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEIN-3; AMPICILLIN RESISTANCE GENES; ANTIBIOTIC-RESISTANCE; CHANGING EPIDEMIOLOGY; SUSCEPTIBILITY; INFECTIONS; VACCINATION; MANITOBA; CANADA; SPAIN	Objectives: The epidemiology of invasive Haemophilus influenzae (Hi) has changed since the introduction of the Hi type b (Hib) vaccine. The aim of this study was to analyze the clinical and molecular epidemiology of Hi invasive disease in adults. Methods: Clinical data of the 82 patients with Hi invasive infections were analyzed. Antimicrobial susceptibility, serotyping, and genotyping were studied (2008-2013). Results: Men accounted for 63.4% of patients (whose mean age was 64.3 years). The most frequent comorbidities were immunosuppressive therapy (34.1%), malignancy (31.7%), diabetes, and COPD (both 22%). The 30-day mortality rate was 20.7%. The majority of the strains (84.3%) were nontypeable (NTHi) and serotype f was the most prevalent serotype in the capsulated strains. The highest antimicrobial resistance was for cotrimoxazole (27.1%) and ampicillin (14.3%). Twenty-three isolates (32.9%) had amino acid changes in the PBP3 involved in resistance. Capsulated strains were clonal and belonged to clonal complexes 6 (serotype b), 124 (serotype f), and 18 (serotype e), whereas NTHi were genetically diverse. Conclusions: Invasive Hi disease occurred mainly in elderly and those with underlying conditions, and it was associated with a high mortality rate. NTHi were the most common cause of invasive disease and showed high genetic diversity.	[Puig, Carmen; Marti, Sara; Tubau, Fe; Calatayud, Laura; Linares, Josefina; Ardanuy, Carmen] Univ Barcelona IDIBELL, Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain; [Grau, Imma; Pallares, Roman] Univ Barcelona IDIBELL, Hosp Univ Bellvitge, Dept Infect Dis, Barcelona, Spain; [Puig, Carmen; Grau, Imma; Marti, Sara; Tubau, Fe; Calatayud, Laura; Pallares, Roman; Linares, Josefina; Ardanuy, Carmen] CIBER Enfermedades Resp CIBERes, ISCIII, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Marti, S (corresponding author), Univ Barcelona IDIBELL, Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain.	smartinm@bellvitgehospital.cat; c.ardanuy@bellvitgehospital.cat	Liñares, Josefina/N-9450-2014; Ardanuy, Carmen/C-4463-2015; PALLARES, Roman/B-5710-2008; Marti, Sara/D-4823-2014	PALLARES, Roman/0000-0003-3262-8508; Marti, Sara/0000-0002-0405-2305; Grau, Imma/0000-0002-3040-8184; Ardanuy, Carmen/0000-0003-0225-607X	Fondo de Investigaciones Sanitarias de la Seguridad Social [PI0901904]; CIBER de Enfermedades Respiratorias (CIBERES) [CB06/06/0037]; ISCIII (Instituto de Salud Carlos III, Madrid, Spain); FPU (Formacion de Profesorado Universitario, Ministerio de Educacion, Spain) [AP2010-3202]; Instituto de Salud Carlos III (ISCIII), Madrid, Spain [CD10/00298]	Fondo de Investigaciones Sanitarias de la Seguridad Social(Instituto de Salud Carlos III); CIBER de Enfermedades Respiratorias (CIBERES); ISCIII (Instituto de Salud Carlos III, Madrid, Spain)(Instituto de Salud Carlos III); FPU (Formacion de Profesorado Universitario, Ministerio de Educacion, Spain)(German Research Foundation (DFG)); Instituto de Salud Carlos III (ISCIII), Madrid, Spain(Instituto de Salud Carlos III)	Funding was provided by Fondo de Investigaciones Sanitarias de la Seguridad Social (PI0901904), and by CIBER de Enfermedades Respiratorias (CIBERES - CB06/06/0037), run by the ISCIII (Instituto de Salud Carlos III, Madrid, Spain). CP was supported by an FPU Grant AP2010-3202 (Formacion de Profesorado Universitario, Ministerio de Educacion, Spain). SM was supported by "Sara Borrell postdoctoral contract CD10/00298'' from the Instituto de Salud Carlos III (ISCIII), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, VACCINE, V28, P4073, DOI 10.1016/j.vaccine.2010.03.075; Agrawal A, 2011, J CLIN MICROBIOL, V49, P3728, DOI 10.1128/JCM.05476-11; Bajanca-Lavado MP, 2014, EUR J CLIN MICROBIOL, V33, P603, DOI 10.1007/s10096-013-1994-6; Binks MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034083; Campos J, 2004, J CLIN MICROBIOL, V42, P524, DOI 10.1128/JCM.42.2.524-529.2004; Clinical and Laboratory Standards Institute, 2012, M7A9 CLIN LAB STAND; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Dabernat H, 2002, ANTIMICROB AGENTS CH, V46, P2208, DOI 10.1128/AAC.46.7.2208-2218.2002; Dominguez A, 2004, ANN EPIDEMIOL, V14, P31, DOI 10.1016/S1047-2797(03)00070-X; Dworkin MS, 2007, CLIN INFECT DIS, V44, P810, DOI 10.1086/511861; Eldika N, 2006, CURR OPIN PULM MED, V12, P118, DOI 10.1097/01.mcp.0000208451.50231.8f; Erwin AL, 2007, TRENDS MICROBIOL, V15, P355, DOI 10.1016/j.tim.2007.06.004; FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382, DOI 10.1128/JCM.32.10.2382-2386.1994; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Garcia-Cobos S, 2008, ANTIMICROB AGENTS CH, V52, P2760, DOI 10.1128/AAC.01674-07; Garcia-Cobos S, 2014, J ANTIMICROB CHEMOTH, V69, P111, DOI 10.1093/jac/dkt324; Giufre M, 2011, VACCINE, V29, P3857, DOI 10.1016/j.vaccine.2011.03.059; Heilmann KP, 2005, ANTIMICROB AGENTS CH, V49, P2561, DOI 10.1128/aac.49.6.2561-2564.2005; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P594, DOI 10.1016/j.anl.2010.02.005; Jansen WTM, 2006, J ANTIMICROB CHEMOTH, V58, P873, DOI 10.1093/jac/dkl310; Kim IS, 2007, ANTIMICROB AGENTS CH, V51, P453, DOI 10.1128/AAC.00960-06; Ladhani S, 2008, J ANTIMICROB CHEMOTH, V62, P776, DOI 10.1093/jac/dkn274; Ladhani S, 2010, EMERG INFECT DIS, V16, P455, DOI 10.3201/eid1603.090290; Laupland KB, 2011, J INFECTION, V62, P142, DOI 10.1016/j.jinf.2010.11.009; MacNeil JR, 2011, CLIN INFECT DIS, V53, P1230, DOI 10.1093/cid/cir735; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Perdue DG, 2000, JAMA-J AM MED ASSOC, V283, P3089, DOI 10.1001/jama.283.23.3089; Perez-Trallero E, 2010, ANTIMICROB AGENTS CH, V54, P2953, DOI 10.1128/AAC.01548-09; Puig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082515; Resman F, 2012, ANTIMICROB AGENTS CH, V56, P4408, DOI 10.1128/AAC.00415-12; Rubach MP, 2011, EMERG INFECT DIS, V17, P1645, DOI 10.3201/eid1709.101991; Sarangi J, 2000, EPIDEMIOL INFECT, V124, P441, DOI 10.1017/S0950268899003611; Shuel M, 2011, INT J INFECT DIS, V15, pE167, DOI 10.1016/j.ijid.2010.10.005; Shuel M, 2010, FEMS IMMUNOL MED MIC, V58, P277, DOI 10.1111/j.1574-695X.2009.00634.x; Shuel ML, 2009, DIAGN MICR INFEC DIS, V63, P379, DOI 10.1016/j.diagmicrobio.2008.12.015; Sill ML, 2008, ANTIMICROB AGENTS CH, V52, P1551, DOI 10.1128/AAC.01580-07; Sill ML, 2007, FEMS IMMUNOL MED MIC, V51, P270, DOI 10.1111/j.1574-695X.2007.00299.x; TENOVER FC, 1994, J CLIN MICROBIOL, V32, P2729, DOI 10.1128/JCM.32.11.2729-2737.1994; Tsang RSW, 2007, CLIN INFECT DIS, V44, P1611, DOI 10.1086/518283	40	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112711	10.1371/journal.pone.0112711	http://dx.doi.org/10.1371/journal.pone.0112711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379704	Green Submitted, gold, Green Published			2022-12-26	WOS:000344863100110
J	Ramos, ACS; Shah, A; Augusto, TM; Barbosa, GO; Leiria, LO; de Carvalho, HF; Antunes, E; Grant, AD				Saragossa Ramos-Filho, Antonio Celso; Shah, Ajay; Augusto, Taize Machado; Barbosa, Guilherme Oliveira; Leiria, Luiz Osorio; de Carvalho, Hernandes Faustino; Antunes, Edson; Grant, Andrew Douglas			Menthol Inhibits Detrusor Contractility Independently of TRPM8 Activation	PLOS ONE			English	Article							CALCIUM-CHANNEL; BLADDER; ACETYLCHOLINE; PIG; ATP	Agonists such as icilin and menthol can activate the cool temperature-sensitive ion channel TRPM8. However, biological responses to menthol may occur independently of TRPM8 activation. In the rodent urinary bladder, menthol facilitates the micturition reflex but inhibits muscarinic contractions of the detrusor smooth muscle. The site(s) of TRPM8 expression in the bladder are controversial. In this study we investigated the regulation of bladder contractility in vitro by menthol. Bladder strips from wild type and TRPM8 knockout male mice (25-30 g) were dissected free and mounted in organ baths. Isometric contractions to carbachol (1 nM-30 mu M), CaCl2 (1 mu M to 100 mM) and electrical field stimulation (EFS; 8, 16, 32 Hz) were measured. Strips from both groups contracted similarly in response to both carbachol and EFS. Menthol (300 mu M) or nifedipine (1 mu M) inhibited carbachol and EFS-induced contractions in both wild type and TRPM8 knockout bladder strips. Incubation with the sodium channel blocker tetrodotoxin (1 mu M), replacement of extracellular sodium with the impermeant cation N-Methyl-D-Glucamine, incubation with a cocktail of potassium channel inhibitors (100 nM charybdotoxin, 1 mu M apamin, 10 mu M glibenclamide and 1 mu M tetraethylammonium) or removal of the urothelium did not affect the inhibitory actions of menthol. Contraction to CaCl2 was markedly inhibited by either menthol or nifedipine. In cultured bladder smooth muscle cells, menthol or nifedipine abrogated the carbachol or KCl-induced increases in [Ca2+](i). Intravesical administration of menthol increased voiding frequency while decreasing peak voiding pressure. We conclude that menthol inhibits muscarinic bladder contractions through blockade of L-type calcium channels, independently of TRPM8 activation.	[Saragossa Ramos-Filho, Antonio Celso; Leiria, Luiz Osorio; Antunes, Edson] Univ Estadual Campinas, Dept Pharmacol, Campinas, Brazil; [Shah, Ajay; Grant, Andrew Douglas] Kings Coll London, Wolfson Ctr Age Related Dis, London, England; [Augusto, Taize Machado; Barbosa, Guilherme Oliveira; de Carvalho, Hernandes Faustino] Univ Estadual Campinas, Inst Biol, Dept Anat Cellular Biol Physiol & Biophys, Campinas, Brazil	Universidade Estadual de Campinas; University of London; King's College London; Universidade de Sao Paulo; Universidade Estadual de Campinas	Grant, AD (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London, England.	andrew.2.grant@kcl.ac.uk	ANTUNES, EDSON/F-6731-2012; Barbosa, Guilherme Oliveira/AAB-6855-2019; Grant, Andrew/A-8819-2008; Augusto, Taize/I-8458-2017	ANTUNES, EDSON/0000-0003-2201-8247; Barbosa, Guilherme Oliveira/0000-0002-5881-0896; Grant, Andrew/0000-0002-7032-3716; Augusto, Taize/0000-0001-7824-5102; Shah, Ajay/0000-0002-6547-0631	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [08/57906-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [573913/2008-0]; Capacity Building Award in Integrative Mammalian Biology - (Biotechnology and Biological Sciences Research Council); Capacity Building Award in Integrative Mammalian Biology - (British Pharmacological Society); Capacity Building Award in Integrative Mammalian Biology - (Higher Education Funding Council for England); Capacity Building Award in Integrative Mammalian Biology - (Medical Research Council, UK)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capacity Building Award in Integrative Mammalian Biology - (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Capacity Building Award in Integrative Mammalian Biology - (British Pharmacological Society); Capacity Building Award in Integrative Mammalian Biology - (Higher Education Funding Council for England); Capacity Building Award in Integrative Mammalian Biology - (Medical Research Council, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (08/57906-3), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (573913/2008-0) and by a Capacity Building Award in Integrative Mammalian Biology (funded by the Biotechnology and Biological Sciences Research Council, British Pharmacological Society, Higher Education Funding Council for England and Medical Research Council, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylie RL, 2010, J PHYSIOL PHARMACOL, V61, P543; Birder L, 2013, PHYSIOL REV, V93, P653, DOI 10.1152/physrev.00030.2012; Calixto JB, 2005, PHARMACOL THERAPEUT, V106, P179, DOI 10.1016/j.pharmthera.2004.11.008; Chapple C, 2005, EUR UROL, V48, P5, DOI 10.1016/j.eururo.2005.02.024; Everaerts W, 2010, AM J PHYSIOL-RENAL, V298, pF692, DOI 10.1152/ajprenal.00599.2009; Fry CH, 2010, AUTON NEUROSCI-BASIC, V154, P3, DOI 10.1016/j.autneu.2009.10.006; Gaudioso C, 2012, PAIN, V153, P473, DOI 10.1016/j.pain.2011.11.014; Gopalakrishnan M, 2002, J PHARMACOL EXP THER, V303, P379, DOI 10.1124/jpet.102.034538; Hans M, 2012, CHEM SENSES, V37, P463, DOI 10.1093/chemse/bjr128; Jiang CH, 2002, J PHYSIOL-LONDON, V543, P211, DOI 10.1113/jphysiol.2002.019042; Kullmann FA, 2009, AM J PHYSIOL-RENAL, V296, pF892, DOI 10.1152/ajprenal.90718.2008; Lashinger ESR, 2008, AM J PHYSIOL-RENAL, V0939, P803; Lei Z, 2013, NEUROUROL URODYNAM, V32, P500, DOI 10.1002/nau.22325; Leiria LOS, 2011, BRIT J PHARMACOL, V163, P1276, DOI 10.1111/j.1476-5381.2011.01311.x; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mendes-Silverio CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047223; Mukerji Gaurav, 2006, BMC Urol, V6, P6, DOI 10.1186/1471-2490-6-6; Nomoto Y, 2008, UROLOGY, V72, P701, DOI 10.1016/j.urology.2007.11.137; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Ramos ACS, 2011, NEUROUROL URODYNAM, V30, P1392, DOI 10.1002/nau.21074; Rivera L, 2006, BJU INT, V98, P868, DOI 10.1111/j.1464-410X.2006.06431.x; Soder RP, 2013, AM J PHYSIOL-REG I, V304, pR155, DOI 10.1152/ajpregu.00363.2012; Stein RJ, 2004, J UROLOGY, V172, P1175, DOI 10.1097/01.ju.0000134880.55119.cf; Tong YC, 1997, J AUTON PHARMACOL, V17, P21, DOI 10.1046/j.1365-2680.1997.00436.x; Tsukimi Y, 2005, UROLOGY, V65, P406, DOI 10.1016/j.urology.2004.10.006; Vahabi B, 2013, CAN J PHYSIOL PHARM, V91, P503, DOI 10.1139/cjpp-2012-0406; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Zimmermann H, 2008, NEUROCHEM INT, V52, P634, DOI 10.1016/j.neuint.2007.09.004	30	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111616	10.1371/journal.pone.0111616	http://dx.doi.org/10.1371/journal.pone.0111616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375115	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600053
J	Taricani, L; Shanahan, F; Malinao, MC; Beaumont, M; Parry, D				Taricani, Lorena; Shanahan, Frances; Malinao, Maria-Christina; Beaumont, Maribel; Parry, David			A Functional Approach Reveals a Genetic and Physical Interaction between Ribonucleotide Reductase and CHK1 in Mammalian Cells	PLOS ONE			English	Article							S-PHASE CHECKPOINT; STALLED REPLICATION FORKS; HUMAN-LEUKEMIA-CELLS; DNA-DAMAGE; H2AX PHOSPHORYLATION; STRESS; GEMCITABINE; INHIBITION; ACTIVATION; CANCER	Ribonucleotide reductase (RNR) enzyme is composed of the homodimeric RRM1 and RRM2 subunits, which together form a heterotetramic active enzyme that catalyzes the de novo reduction of ribonucleotides to generate deoxyribonucleotides (dNTPs), which are required for DNA replication and DNA repair processes. In this study, we show that ablation of RRM1 and RRM2 by siRNA induces G1/S phase arrest, phosphorylation of Chk1 on Ser345 and phosphorylation of gamma-H2AX on S139. Combinatorial ablation of RRM1 or RRM2 and Chk1 causes a dramatic accumulation of gamma-H2AX, a marker of double-strand DNA breaks, suggesting that activation of Chk1 in this context is essential for suppression of DNA damage. Significantly, we demonstrate for the first time that Chk1 and RNR subunits co-immunoprecipitate from native cell extracts. These functional genomic studies suggest that RNR is a critical mediator of replication checkpoint activation.	[Taricani, Lorena; Shanahan, Frances; Malinao, Maria-Christina; Beaumont, Maribel; Parry, David] Merck Res Labs, Palo Alto, CA 94304 USA	Merck & Company	Beaumont, M (corresponding author), Merck Res Labs, Palo Alto, CA 94304 USA.	maribel.beaumont@merck.com	Shanahan, Fergus/ABF-2390-2020	Shanahan, Fergus/0000-0003-0467-0936	Merck Research Laboratories; Merck Research Labs	Merck Research Laboratories(Merck & Company); Merck Research Labs	Funding for this work was provided entirely by Merck Research Laboratories. The funder (Merck Research Labs) provided support in the form of salaries for authors [LT, FS, MCM, MB and DP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bolderson E, 2004, HUM MOL GENET, V13, P2937, DOI 10.1093/hmg/ddh316; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chiappori AA, 2010, J THORAC ONCOL, V5, P484, DOI 10.1097/JTO.0b013e3181ccb27b; Cho SH, 2005, CELL CYCLE, V4, P131, DOI 10.4161/cc.4.1.1299; Cooper T, 2005, CANCER CHEMOTH PHARM, V55, P361, DOI 10.1007/s00280-004-0906-y; CORY JG, 1983, MOL CELL BIOCHEM, V53-4, P257; Cory JG, 1988, ADV ENZYME REGUL, V53-54, P257; Decosterd LA, 1999, ANAL BIOCHEM, V270, P59, DOI 10.1006/abio.1999.4066; ENGSTROM Y, 1984, EMBO J, V3, P863, DOI 10.1002/j.1460-2075.1984.tb01897.x; Ewald B, 2007, MOL CANCER THER, V6, P1239, DOI 10.1158/1535-7163.MCT-06-0633; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; GANDHI V, 1995, SEMIN ONCOL, V22, P61; GANDHI V, 1989, BIOCHEM PHARMACOL, V38, P3551, DOI 10.1016/0006-2952(89)90127-5; Goudelock DM, 2003, J BIOL CHEM, V278, P29940, DOI 10.1074/jbc.M301765200; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Guzi TJ, 2011, MOL CANCER THER, V10, P591, DOI 10.1158/1535-7163.MCT-10-0928; Han X, 2014, J BIOL CHEM, V114; HEINEMANN V, 1995, SEMIN ONCOL, V22, P11; Labroli MA, 2014, BIOORGAN MED CHEM, V22, P2303, DOI 10.1016/j.bmc.2014.02.007; LASSMANN G, 1992, BIOCHEM BIOPH RES CO, V188, P879, DOI 10.1016/0006-291X(92)91138-G; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Lien E J, 1987, Prog Drug Res, V31, P101; Lin YF, 2014, NUCLEIC ACIDS RES, V42, P4463, DOI 10.1093/nar/gku116; Liu QH, 2000, GENE DEV, V14, P1448; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Nazarov OB, 2003, RADIAT RES, V160, P309, DOI 10.1667/RR3043; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nocentini G, 1996, CRIT REV ONCOL HEMAT, V22, P89, DOI 10.1016/1040-8428(95)00187-5; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; NYHOLM S, 1993, BIOCHEMISTRY-US, V32, P11569, DOI 10.1021/bi00094a013; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sampath D, 2003, ONCOGENE, V22, P9063, DOI 10.1038/sj.onc.1207229; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Shao JM, 2013, EXPERT OPIN THER TAR, V17, P1423, DOI 10.1517/14728222.2013.840293; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Szekeres T, 1997, CRIT REV CL LAB SCI, V34, P503, DOI 10.3109/10408369709006424; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Taricani L, 2009, CELL CYCLE, V8, P482, DOI 10.4161/cc.8.3.7661; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; THELANDER M, 1985, J BIOL CHEM, V260, P2737; Xie KC, 1996, CANCER RES, V56, P3030; Zachos G, 2005, MOL CELL BIOL, V25, P563, DOI 10.1128/MCB.25.2.563-574.2005; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058091	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111714	10.1371/journal.pone.0111714	http://dx.doi.org/10.1371/journal.pone.0111714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375241	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600057
J	Freisinger, CM; Huttenlocher, A				Freisinger, Christina M.; Huttenlocher, Anna			Live Imaging and Gene Expression Analysis in Zebrafish Identifies a Link between Neutrophils and Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							TRANSGENIC ZEBRAFISH; PANCREATIC-CANCER; RECEPTOR CXCR2; INTERLEUKIN-8; INFLAMMATION; PROGRESSION; TARGET; GROWTH; CELLS; MODEL	Chronic inflammation is associated with epithelial to mesenchymal transition (EMT) and cancer progression however the relationship between inflammation and EMT remains unclear. Here, we have exploited zebrafish to visualize and quantify the earliest events during epithelial cell transformation induced by oncogenic HRas(V12). Live imaging revealed that expression of HRas(V12) in the epidermis results in EMT and chronic neutrophil and macrophage infiltration. We have developed an in vivo system to probe and quantify gene expression changes specifically in transformed cells from chimeric zebrafish expressing oncogenic HRas(V12) using translating ribosomal affinity purification (TRAP). We found that the expression of genes associated with EMT, including slug, vimentin and mmp9, are enriched in HRas(V12) transformed epithelial cells and that this enrichment requires the presence of neutrophils. An early signal induced by HRas(V12) in epithelial cells is the expression of il-8 (cxcl8) and we found that the chemokine receptor, Cxcr2, mediates neutrophil but not macrophage recruitment to the transformed cells. Surprisingly, we also found a cell autonomous role for Cxcr2 signaling in transformed cells for both neutrophil recruitment and EMT related gene expression associated with Ras transformation. Taken together, these findings implicate both autocrine and paracrine signaling through Cxcr2 in the regulation of inflammation and gene expression in transformed epithelial cells.	[Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; Univ Wisconsin, Dept Med Microbiol, Madison, WI USA; Univ Wisconsin, Dept Immunol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA.	huttenlocher@wisc.edu			National Institutes of Health (NIH) [R01 GM074827]; NCI [NIH R01 GM102924-01]; National Institute of Environmental Health Sciences [ES007015]; National Cancer Institute [CA157322]; NATIONAL CANCER INSTITUTE [T32CA157322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074827, R01GM102924] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Grant R01 GM074827 (A. Huttenlocher), NCI Grant NIH R01 GM102924-01 (A. Huttenlocher), National Institute of Environmental Health Sciences grant ES007015 (to C. M. Freisinger) and National Cancer Institute grant CA157322 (to C. M. Freisinger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrile BB, 2008, MOL INTERV, V8, P22, DOI 10.1124/mi.8.1.6; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Asfaha S, 2013, GASTROENTEROLOGY, V144, P155, DOI 10.1053/j.gastro.2012.09.057; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Becker M, 2013, HISTOL HISTOPATHOL; Blackburn JS, 2014, DIS MODEL MECH, V7, P755, DOI 10.1242/dmm.015842; Boppana NB, 2014, EXP BIOL MED, V239, P509, DOI 10.1177/1535370213520110; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Burke RM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.8.086003; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cataisson C, 2009, CANCER RES, V69, P319, DOI 10.1158/0008-5472.CAN-08-2490; Chan AT, 2011, LANCET, V378, P2051, DOI 10.1016/S0140-6736(11)61216-6; Chen CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020654; Cieslewicz M, 2013, P NATL ACAD SCI US; Cossack M, 2013, J GENET COUNS; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; Deng Q, 2013, J LEUKOCYTE BIOL, V93, P761, DOI 10.1189/jlb.1012534; Deng Q, 2011, DEV CELL, V21, P735, DOI 10.1016/j.devcel.2011.07.013; Dodd ME, 2009, DEVELOPMENT, V136, P2591, DOI 10.1242/dev.038448; Dong YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083789; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Downward J, 1996, CANCER SURV, V27, P87; Dumitru CA, 2011, INT J CANC; Eisenhoffer GT, 2011, JOVE-J VIS EXP, DOI 10.3791/2689; Feng Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000562; Gong L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-154; Gong ZY, 2002, DEV DYNAM, V223, P204, DOI 10.1002/dvdy.10051; Grosse-Steffen T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/720768; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hannelien V, 2012, BBA-REV CANCER, V1825, P117, DOI 10.1016/j.bbcan.2011.10.008; Hertzer KM, 2013, EXPERT OPIN THER TAR, V17, P667, DOI 10.1517/14728222.2013.772137; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Kajita M, 2010, J CELL SCI, V123, P171, DOI 10.1242/jcs.057976; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Kennedy BC, 2013, J ONCOL, V2013, DOI 10.1155/2013/486912; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kline M, 2007, LEUKEMIA RES, V31, P591, DOI 10.1016/j.leukres.2006.06.012; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Lam PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084436; Lee YS, 2012, BRIT J CANCER, V106, P1833, DOI 10.1038/bjc.2012.177; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Long S, 2002, BIOTECHNIQUES, V32, P494, DOI 10.2144/02323bm04; Mariani F, 2014, WORLD J GASTROENTERO, V20, P9716, DOI 10.3748/wjg.v20.i29.9716; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mathias JR, 2009, DEV COMP IMMUNOL, V33, P1212, DOI 10.1016/j.dci.2009.07.003; MCKENNA WG, 1990, INT J RADIAT ONCOL, V18, P849, DOI 10.1016/0360-3016(90)90407-B; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Oehlers SHB, 2010, DEV COMP IMMUNOL, V34, P352, DOI 10.1016/j.dci.2009.11.007; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rodriguez D, 2013, CELL IMMUNOL, V283, P51, DOI 10.1016/j.cellimm.2013.06.008; Rogers TL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-177; SATO H, 1992, ONCOGENE, V7, P77; Shen X, 2013, CURR MED CHEM; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Tazzyman S, 2011, INT J CANCER, V129, P847, DOI 10.1002/ijc.25987; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Varney ML, 2003, CLIN EXP METASTAS, V20, P723, DOI 10.1023/B:CLIN.0000006814.48627.bd; Wang DZ, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28581; Wislez M, 2006, CANCER RES, V66, P4198, DOI 10.1158/0008-5472.CAN-05-3842; WITTINGHOFER A, 1993, CIBA F SYMP, V176, P6; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yen J, 2014, CURR OPIN GENET DEV, V24, P38, DOI 10.1016/j.gde.2013.11.003; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Zachos G, 1996, J Exp Ther Oncol, V1, P335	77	43	44	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112183	10.1371/journal.pone.0112183	http://dx.doi.org/10.1371/journal.pone.0112183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372289	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900117
J	Zhang, XL; Li, YX; Liu, B; Wang, J; Feng, CH; Gao, M; Wang, LN				Zhang, Xuelian; Li, Yanxia; Liu, Bei; Wang, Jing; Feng, Chenghong; Gao, Min; Wang, Lina			Prevalence of Veterinary Antibiotics and Antibiotic-Resistant Escherichia coli in the Surface Water of a Livestock Production Region in Northern China	PLOS ONE			English	Article							TREATMENT PLANTS; FEEDING OPERATIONS; CLAY-MINERALS; SOUTH CHINA; RIVER; WASTE; MANURE; GENES; ENVIRONMENT; SOIL	This study investigated the occurrence of 12 veterinary antibiotics (VAs) and the susceptibility of Escherichia coli (E. coli) in a rural water system that was affected by livestock production in northern China. Each of the surveyed sites was determined with at least eight antibiotics with maximum concentration of up to 450 ng L-1. The use of VAs in livestock farming probably was a primary source of antibiotics in the rivers. Increasing total antibiotics were measured from up- to mid- and downstream in the two tributaries. Eighty-eight percent of the 218 E. coli isolates that were derived from the study area exhibited, in total, 48 resistance profiles against the eight examined drugs. Significant correlations were found among the resistance rates of sulfamethoxazole-trimethoprim, chloromycetin and ampicillin as well as between tetracycline and chlortetracycline, suggesting a possible cross-selection for resistance among these drugs. The E. coli resistance frequency also increased from up- to midstream in the three rivers. E. coli isolates from different water systems showed varying drug numbers of resistance. No clear relationship was observed in the antibiotic resistance frequency with corresponding antibiotic concentration, indicating that the antibiotic resistance for E. coli in the aquatic environment might be affected by factors besides antibiotics. High numbers of resistant E. coli were also isolated from the conserved reservoir. These results suggest that rural surface water may become a large pool of VAs and resistant bacteria. This study contributes to current information on VAs and resistant bacteria contamination in aquatic environments particularly in areas under intensive agriculture. Moreover, this study indicates an urgent need to monitor the use of VAs in animal production, and to control the release of animal-originated antibiotics into the environment.	[Zhang, Xuelian; Li, Yanxia; Liu, Bei; Wang, Jing; Feng, Chenghong; Gao, Min; Wang, Lina] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China	Beijing Normal University	Li, YX (corresponding author), Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China.	liyxbnu@bnu.edu.cn		Feng, Chenghong/0000-0002-2130-8851	Natural Science Foundation of China [21277013, 20977010]; Special Fund for Environmental Protection Research in the Public Interest [200909042]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Environmental Protection Research in the Public Interest	The research was funded by the Natural Science Foundation of China (No. 21277013, 20977010) and the Special Fund for Environmental Protection Research in the Public Interest (200909042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi F, 2013, SCI TOTAL ENVIRON, V444, P508, DOI 10.1016/j.scitotenv.2012.11.077; Akiyama T, 2010, SCI TOTAL ENVIRON, V408, P6192, DOI 10.1016/j.scitotenv.2010.08.055; Ali M, 2013, CHEMOSPHERE, V91, P1583, DOI 10.1016/j.chemosphere.2012.12.050; [Anonymous], 2012, CHINA AGR STAT YB; Bao YY, 2009, WASTE MANAGE, V29, P1416, DOI 10.1016/j.wasman.2008.08.022; Batt AL, 2007, CHEMOSPHERE, V68, P428, DOI 10.1016/j.chemosphere.2007.01.008; Bean DC, 2009, ANTIMICROB AGENTS CH, V53, P1088, DOI 10.1128/AAC.00800-08; Blanco G, 2009, ENVIRON RES, V109, P405, DOI 10.1016/j.envres.2009.01.007; Campagnolo ER, 2002, SCI TOTAL ENVIRON, V299, P89, DOI 10.1016/S0048-9697(02)00233-4; China MOA (Ministry of Agriculture of the People Republic of China), 2010, CHIN VET PHARM; CLSI, 2012, M100S16 CLSI NAT COM; CLSI, 2009, M100S16 CLSI NAT COM; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; DANMAP, DANM 2011 US ANT AG; Dolliver H, 2008, J ENVIRON QUAL, V37, P1245, DOI 10.2134/jeq2007.0399; Gao JA, 2005, ENVIRON SCI TECHNOL, V39, P9509, DOI 10.1021/es050644c; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Gutierrez IR, 2010, J SOIL SEDIMENT, V10, P537, DOI 10.1007/s11368-009-0168-8; Hagedorn C, 1999, APPL ENVIRON MICROB, V65, P5522; Ham YS, 2012, ENVIRON POLLUT, V162, P98, DOI 10.1016/j.envpol.2011.11.002; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hong PY, 2013, ANTIBIOTICS-BASEL, V2, P367, DOI 10.3390/antibiotics2030367; Hu JY, 2008, ENVIRON SCI TECHNOL, V42, P3415, DOI 10.1021/es7026746; Garcia-Galan MJ, 2011, ENVIRON INT, V37, P462, DOI 10.1016/j.envint.2010.11.011; Ji XL, 2012, J HAZARD MATER, V235, P178, DOI 10.1016/j.jhazmat.2012.07.040; Jiang L, 2013, SCI TOTAL ENVIRON, V458, P267, DOI 10.1016/j.scitotenv.2013.04.038; Jiang L, 2011, CHEMOSPHERE, V82, P822, DOI 10.1016/j.chemosphere.2010.11.028; Kahle M, 2007, CHEMOSPHERE, V68, P1224, DOI 10.1016/j.chemosphere.2007.01.061; Kay P, 2005, CHEMOSPHERE, V59, P951, DOI 10.1016/j.chemosphere.2004.11.055; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kumar K, 2005, ADV AGRON, V87, P1, DOI 10.1016/S0065-2113(05)87001-4; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Li YX, 2013, ENVIRON MONIT ASSESS, V185, P2211, DOI 10.1007/s10661-012-2702-1; Luo Y, 2011, ENVIRON SCI TECHNOL, V45, P1827, DOI 10.1021/es104009s; Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w; Maal-Bared R, 2013, SCI TOTAL ENVIRON, V443, P315, DOI 10.1016/j.scitotenv.2012.10.106; Marti R, 2013, APPL ENVIRON MICROB, V79, P5701, DOI 10.1128/AEM.01682-13; Martinez-Carballo E, 2007, ENVIRON POLLUT, V148, P570, DOI 10.1016/j.envpol.2006.11.035; Meays CL, 2006, ENVIRON SCI TECHNOL, V40, P5289, DOI 10.1021/es060659q; Motoyama M, 2011, CHEMOSPHERE, V84, P432, DOI 10.1016/j.chemosphere.2011.03.048; Pan X, 2011, CHEMOSPHERE, V84, P695, DOI 10.1016/j.chemosphere.2011.03.022; Parveen S, 1997, APPL ENVIRON MICROB, V63, P2607, DOI 10.1128/AEM.63.7.2607-2612.1997; Pezzotti G, 2003, INT J FOOD MICROBIOL, V82, P281, DOI 10.1016/S0168-1605(02)00314-8; Pils JRV, 2007, ENVIRON SCI TECHNOL, V41, P1928, DOI 10.1021/es062316y; Rahube TO, 2010, AFR J BIOTECHNOL, V9, P9183; Reinthaler FF, 2003, WATER RES, V37, P1685, DOI 10.1016/S0043-1354(02)00569-9; Rooklidge SJ, 2004, SCI TOTAL ENVIRON, V325, P1, DOI 10.1016/j.scitotenv.2003.11.007; Rysz M, 2004, WATER RES, V38, P3705, DOI 10.1016/j.watres.2004.06.015; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Sayah RS, 2005, APPL ENVIRON MICROB, V71, P1394, DOI 10.1128/AEM.71.3.1394-1404.2005; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; Su HC, 2012, ENVIRON POLLUT, V169, P42, DOI 10.1016/j.envpol.2012.05.007; Sun PZ, 2013, J CHROMATOGR A, V1312, P10, DOI 10.1016/j.chroma.2013.08.044; Tamtam F, 2008, SCI TOTAL ENVIRON, V393, P84, DOI 10.1016/j.scitotenv.2007.12.009; Walczak JJ, 2011, WATER AIR SOIL POLL, V219, P579, DOI 10.1007/s11270-010-0729-x; Wei RC, 2011, CHEMOSPHERE, V82, P1408, DOI 10.1016/j.chemosphere.2010.11.067; Whitlock JE, 2002, WATER RES, V36, P4273, DOI 10.1016/S0043-1354(02)00139-2; Wiegel S, 2004, CHEMOSPHERE, V57, P107, DOI 10.1016/j.chemosphere.2004.05.017; Wu CX, 2010, ENVIRON SCI TECHNOL, V44, P6157, DOI 10.1021/es1011115; Xu WH, 2007, ENVIRON POLLUT, V145, P672, DOI 10.1016/j.envpol.2006.05.038; Xu XR, 2010, CHEMOSPHERE, V78, P430, DOI 10.1016/j.chemosphere.2009.10.045; Yan CX, 2013, ENVIRON POLLUT, V175, P22, DOI 10.1016/j.envpol.2012.12.008; Zhao L, 2010, SCI TOTAL ENVIRON, V408, P1069, DOI 10.1016/j.scitotenv.2009.11.014; Zhou LJ, 2011, ENVIRON POLLUT, V159, P1877, DOI 10.1016/j.envpol.2011.03.034; Zou SC, 2011, ENVIRON POLLUT, V159, P2913, DOI 10.1016/j.envpol.2011.04.037	66	35	37	3	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111026	10.1371/journal.pone.0111026	http://dx.doi.org/10.1371/journal.pone.0111026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372873	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900033
J	Eberhard, JM; Hartjen, P; Kummer, S; Schmidt, RE; Bockhorn, M; Lehmann, C; Balagopal, A; Hauber, J; van Lunzen, J; zur Wiesch, JS				Eberhard, Johanna Maria; Hartjen, Philip; Kummer, Silke; Schmidt, Reinhold E.; Bockhorn, Maximilian; Lehmann, Clara; Balagopal, Ashwin; Hauber, Joachim; van Lunzen, Jan; zur Wiesch, Julian Schulze			CD161(+) MAIT Cells Are Severely Reduced in Peripheral Blood and Lymph Nodes of HIV-Infected Individuals Independently of Disease Progression	PLOS ONE			English	Article							INVARIANT T-CELLS; IMMUNE ACTIVATION; SOLUBLE CD163; HETEROGENEITY; EXPRESSION; RESPONSES; THERAPY; PATHWAY; ABSENCE; SUBSET	Mucosal-associated invariant T (MAIT) cells are characterized by the combined expression of the semi-invariant T cell receptor (TCR) V alpha 7.2, the lectin receptor CD161, as well as IL-18R, and play an important role in antibacterial host defense of the gut. The current study characterized CD161(+) MAIT and CD161(-)TCRVa7.2(+) T cell subsets within a large cohort of HIV patients with emphasis on patients with slow disease progression and elite controllers. Mononuclear cells from blood and lymph node samples as well as plasma from 63 patients and 26 healthy donors were analyzed by multicolor flow cytometry and ELISA for IL-18, sCD14 and sCD163. Additionally, MAIT cells were analyzed after in vitro stimulation with different cytokines and/or fixed E. coli. Reduced numbers of CD161(+) MAIT cells during HIV infection were detectable in the blood and lymph nodes of all patient groups, including elite controllers. CD161(+) MAIT cell numbers did not recover even after successful antiretroviral treatment. The loss of CD161(+) MAIT cells was correlated with higher levels of MAIT cell activation; an increased frequency of the CD161(-)TCRV alpha 7.2(+)T cell subset in HIV infection was observed. In vitro stimulation of MAIT cells with IL-18 and IL-12, IL-7 and fixed E. coli also resulted in a rapid and additive reduction of the MAIT cell frequency defined by CD161, IL-18R and CCR6. In summary, the irreversible reduction of the CD161(+) MAIT cell subset seems to be an early event in HIV infection that is independent of later stages of the disease. This loss appears to be at least partially due to the distinctive vulnerability of MAIT cells to the pronounced stimulation by microbial products and cytokines during HIV-infection.	[Eberhard, Johanna Maria; Hartjen, Philip; Kummer, Silke; van Lunzen, Jan; zur Wiesch, Julian Schulze] Univ Med Ctr Hamburg Eppendorf, Dept Med, Infect Dis Unit, Hamburg, Germany; [Hartjen, Philip] Univ Med Ctr Hamburg Eppendorf, Dept Oral & Maxillofacial Surg, Hamburg, Germany; [Bockhorn, Maximilian] Univ Med Ctr Hamburg Eppendorf, Dept Gen Surg, Hamburg, Germany; [Eberhard, Johanna Maria; Hartjen, Philip; Kummer, Silke; Hauber, Joachim; van Lunzen, Jan; zur Wiesch, Julian Schulze] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Schmidt, Reinhold E.] Hannover Med Sch, Dept Immunol & Rheumatol, Hannover, Germany; [Lehmann, Clara] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Balagopal, Ashwin] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Schmidt, Reinhold E.; Hauber, Joachim; van Lunzen, Jan; zur Wiesch, Julian Schulze] Partner Site Hamburg & Hannover, German Ctr Infect Res DZIF, Hamburg, Germany; [Schmidt, Reinhold E.; Hauber, Joachim; van Lunzen, Jan; zur Wiesch, Julian Schulze] Partner Site Hamburg & Hannover, German Ctr Infect Res DZIF, Hannover, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; Hannover Medical School; University of Cologne; Johns Hopkins University; German Center for Infection Research; German Center for Infection Research	van Lunzen, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med, Infect Dis Unit, Hamburg, Germany.	v.lunzen@uke.de	Wiesch, Julian Schulze zur/AAT-8452-2021; Lehmann, Clara/F-9671-2016	Lehmann, Clara/0000-0002-7042-1578; Eberhard, Johanna Maria/0000-0002-8367-3870	Werner Otto Stiftung, the German Research Agency [SFB841]; DZIF (German Center for Infection Research); ECHAM (European Cohort HIV Ageing and Metabolic liver disease); NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016078] Funding Source: NIH RePORTER	Werner Otto Stiftung, the German Research Agency; DZIF (German Center for Infection Research); ECHAM (European Cohort HIV Ageing and Metabolic liver disease); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Werner Otto Stiftung, the German Research Agency (SFB841 project A6; JSzW), the DZIF (German Center for Infection Research; RES, JH, JvL, JSzW) and the ECHAM (European Cohort HIV Ageing and Metabolic liver disease; JvL, JME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2002, J VIROL, V76, P12448, DOI 10.1128/JVI.76.24.12448-12456.2002; Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Bello G, 2009, J MED VIROL, V81, P1681, DOI 10.1002/jmv.21565; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082461; Chun TW, 2013, J INFECT DIS, V208, P1443, DOI 10.1093/infdis/jit306; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Gerart S, 2013, BLOOD, V121, P614, DOI 10.1182/blood-2012-09-456095; Gordon SM, 2011, J IMMUNOL, V186, P4573, DOI 10.4049/jimmunol.1100037; Grimaldi D, 2014, INTENS CARE MED, V40, P192, DOI 10.1007/s00134-013-3163-x; Hartjen P, 2013, J INFECT DIS, V208, P180, DOI 10.1093/infdis/jit141; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; Krishnan S, 2014, J INFECT DIS, V209, P931, DOI 10.1093/infdis/jit581; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lee OJ, 2014, EXP GERONTOL, V49, P47, DOI 10.1016/j.exger.2013.11.003; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Meierovics A, 2013, P NATL ACAD SCI USA, V110, pE3119, DOI 10.1073/pnas.1302799110; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Northfield JW, 2008, HEPATOLOGY, V47, P396, DOI 10.1002/hep.22040; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Sandberg JK, 2013, AIDS, V27, P2501, DOI 10.1097/QAD.0b013e3283620726; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Turtle CJ, 2011, BLOOD, V118, P2752, DOI 10.1182/blood-2011-02-334698; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Wakao H, 2013, CELL CYCLE, V12, P2341, DOI 10.4161/cc.25706; Wakao H, 2013, CELL STEM CELL, V12, P546, DOI 10.1016/j.stem.2013.03.001; Walker Bruce D, 2007, Top HIV Med, V15, P134; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Wilson NL, 2013, J ASSOC NURSE AIDS C, V24, P98, DOI 10.1016/j.jana.2012.04.004; Wong EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083474	48	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111323	10.1371/journal.pone.0111323	http://dx.doi.org/10.1371/journal.pone.0111323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369333	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000048
J	Cui, YM; Jiao, HL; Ye, YP; Chen, CM; Wang, JX; Tang, N; Li, TT; Lin, J; Qi, L; Wu, P; Wang, SY; He, MR; Liang, L; Bian, XW; Liao, WT; Ding, YQ				Cui, Y-M; Jiao, H-L; Ye, Y-P; Chen, C-M; Wang, J-X; Tang, N.; Li, T-T; Lin, J.; Qi, L.; Wu, P.; Wang, S-Y; He, M-R; Liang, L.; Bian, X-W; Liao, W-T; Ding, Y-Q			RETRACTED: FOXC2 promotes colorectal cancer metastasis by directly targeting MET (Retracted article. See vol. 41, pg. 2529, 2022)	ONCOGENE			English	Article; Retracted Publication							HEPATOCYTE GROWTH-FACTOR; PRIMARY COLON-CANCER; CELL LUNG-CANCER; C-MET; FACTOR RECEPTOR; REGULATES EXPRESSION; STAGE; GENE; OVEREXPRESSION; PROTOONCOGENE	Metastasis is the major cause of death in colorectal cancer (CRC). Although multiple genes have been identified to be responsible for the development of CRC, the molecular changes that enable CRC cells to undergo early local invasion and to form distant metastatic colonies still remain largely unknown. Herein, we investigated the role of Forkhead box protein C2 (FOXC2) and explored the underlying mechanisms in invasion and metastasis of CRC. We show that both high FOXC2 expression and nuclear localization of FOXC2 are significantly correlated with advanced TNM (T = primary tumor; N = regional lymph nodes; M= distant metastasis) stages. FOXC2 enhanced the invasive abilities of CRC cells in vitro and promoted local invasion and distant metastasis in an orthotopic mouse metastatic model of CRC. Microarray analysis revealed that overexpression of FOXC2 increased the proto-oncogene MET tyrosine kinase expression and activated the hepatocyte growth factor (HGF)-MET signaling pathway. Furthermore, luciferase reporter assays and chromatin immunoprecipitation assays revealed that FOXC2 directly associated with MET promoter to increase the transcriptional activity of MET. Inhibition of MET attenuates the invasive phenotype and metastatic potential of FOXC2-overexpressing CRC cells, indicating that MET is a major mediator of FOXC2-promoted metastasis. In addition, FOXC2 expression was positively correlated with MET expression in CRC tissue samples. Our findings suggest that FOXC2 has a crucial role in CRC metastasis by regulating HGF-MET signaling via inducing MET expression, highlighting FOXC2 as a potential therapeutic target for preventing or reducing metastasis in CRC.	[Cui, Y-M; Jiao, H-L; Ye, Y-P; Chen, C-M; Wang, J-X; Tang, N.; Li, T-T; Lin, J.; Qi, L.; Wu, P.; Wang, S-Y; Liang, L.; Liao, W-T; Ding, Y-Q] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China; [Cui, Y-M; Jiao, H-L; Ye, Y-P; Chen, C-M; Wang, J-X; Tang, N.; Li, T-T; Lin, J.; Qi, L.; Wu, P.; Wang, S-Y; Liang, L.; Liao, W-T; Ding, Y-Q] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China; [Cui, Y-M; Jiao, H-L; Ye, Y-P; Chen, C-M; Wang, J-X; Tang, N.; Li, T-T; Lin, J.; Qi, L.; Wu, P.; Wang, S-Y; Liang, L.; Liao, W-T; Ding, Y-Q] Guangdong Prov Key Lab Mol Tumor Pathol, Guangzhou, Guangdong, Peoples R China; [He, M-R] Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China; [He, M-R] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China; [Bian, X-W] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Bian, X-W] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Army Medical University; Army Medical University	Liao, WT (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China.	liaowt2002@gmail.com; dyqgz@126.com	liang, li/AAB-9126-2022; Bian, Xiu-Wu/D-4736-2017	Bian, Xiu-Wu/0000-0003-4383-0197	National Basic Research Program of China (973 program) [2015CB554002, 2010CB529403]; National Natural Science Foundation of China (NSFC)-Guangdong Joint Fund [U1201226]; National Natural Science Foundation of China [81090422, 30901791, 81172055, 81472313, 81472710, 81071735]; Guangdong Provincial Natural Science Foundation of China [S2012010009643]; Zhu Jiang Science & Technology New Star Foundation in Guangzhou city [2012J2200052, 2012J2200044]; Science and Technology Innovation Foundation of Guangdong Higher Education [CXZD1016]; Key Program of the National Natural Science Foundation of Guangdong, China [2010B031500012]; Guangzhou Science & Technology Plan Project [201300000056]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)-Guangdong Joint Fund(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Zhu Jiang Science & Technology New Star Foundation in Guangzhou city; Science and Technology Innovation Foundation of Guangdong Higher Education; Key Program of the National Natural Science Foundation of Guangdong, China; Guangzhou Science & Technology Plan Project	This work was supported by the National Basic Research Program of China (973 program, nos. 2015CB554002 and 2010CB529403), the National Natural Science Foundation of China (NSFC)-Guangdong Joint Fund (U1201226), the Major Projects of the National Natural Science Foundation of China (no. 81090422), the National Natural Science Foundation of China (nos. 30901791, 81172055, 81472313, 81472710 and 81071735), Guangdong Provincial Natural Science Foundation of China (no. S2012010009643), Zhu Jiang Science & Technology New Star Foundation in Guangzhou city (2012J2200052 and 2012J2200044), the Science and Technology Innovation Foundation of Guangdong Higher Education (CXZD1016), the Key Program of the National Natural Science Foundation of Guangdong, China (2010B031500012), and Guangzhou Science & Technology Plan Project (201300000056).	Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boon EMJ, 2002, CANCER RES, V62, P5126; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Hayashi H, 2008, J BIOL CHEM, V283, P23791, DOI 10.1074/jbc.M800190200; Hollier BG, 2013, CANCER RES, V73, P1981, DOI 10.1158/0008-5472.CAN-12-2962; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang W, 2012, CLIN LUNG CANCER, V13, P280, DOI 10.1016/j.cllc.2011.11.005; Kammula US, 2007, CANCER LETT, V248, P219, DOI 10.1016/j.canlet.2006.07.007; Kume T, 2012, J ONCOL, V2012, DOI 10.1155/2012/204593; Liang HY, 2004, INT J ONCOL, V24, P1057; Liao WT, 2011, CLIN CANCER RES, V17, P3569, DOI 10.1158/1078-0432.CCR-10-2533; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; LIU C, 1992, ONCOGENE, V7, P181; Liu XD, 2008, EXPERT OPIN INV DRUG, V17, P997, DOI [10.1517/13543784.17.7.997, 10.1517/13543784.17.7.997 ]; Liu YH, 1998, GENE, V215, P159, DOI 10.1016/S0378-1119(98)00264-9; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; Mortazavi F, 2010, MOL CANCER RES, V8, P762, DOI 10.1158/1541-7786.MCR-10-0004; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nishida N, 2011, ANN SURG ONCOL, V18, P535, DOI 10.1245/s10434-010-1274-y; Park SJ, 2011, BONE, V49, P428, DOI 10.1016/j.bone.2011.05.012; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; Sano H, 2010, BIOCHEM BIOPH RES CO, V392, P201, DOI 10.1016/j.bbrc.2010.01.015; Sattler Martin, 2007, Curr Oncol Rep, V9, P102, DOI 10.1007/s11912-007-0005-4; Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Stein Ulrike, 2007, V176, P61; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; De Oliveira ATT, 2009, ANTICANCER RES, V29, P4807; Tseng William, 2007, J Vis Exp, P484, DOI 10.3791/484; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Van Cutsem E, 2013, LANCET, V381, P1538, DOI 10.1016/S0140-6736(13)60978-2; Xue Y, 2008, P NATL ACAD SCI USA, V105, P10167, DOI 10.1073/pnas.0802486105; Yu YH, 2013, ONCOGENE, V32, P431, DOI 10.1038/onc.2012.74; Zeng ZS, 2008, CANCER LETT, V265, P258, DOI 10.1016/j.canlet.2008.02.049; Zhu JL, 2013, HISTOPATHOLOGY, V62, P1038, DOI 10.1111/his.12132	43	65	66	0	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2015	34	33					4379	4390		10.1038/onc.2014.368	http://dx.doi.org/10.1038/onc.2014.368			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO9KK	25381815				2022-12-26	WOS:000359494400009
J	Joshi, J; Mueller-Cajar, O; Tsai, YCC; Hartl, FU; Hayer-Hartl, M				Joshi, Jidnyasa; Mueller-Cajar, Oliver; Tsai, Yi-Chin C.; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Role of Small Subunit in Mediating Assembly of Red-type Form I Rubisco	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE/OXYGENASE; CRYSTAL-STRUCTURE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; PROTEIN; OXYGENASE; CHAPERONE; INTERFACE; MECHANISM; EVOLUTION	Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) is the key enzyme involved in photosynthetic carbon fixation, converting atmospheric CO2 to organic compounds. Form I Rubisco is a cylindrical complex composed of eight large (RbcL) subunits that are capped by four small subunits (RbcS) at the top and four at the bottom. Form I Rubiscos are phylogenetically divided into green-and red-type. Some red-type enzymes have catalytically superior properties. Thus, understanding their folding and assembly is of considerable biotechnological interest. Folding of the green-type RbcL subunits in cyanobacteria is mediated by the GroEL/ES chaperonin system, and assembly to holoenzyme requires specialized chaperones such as RbcX and RAF1. Here, we show that the red-type RbcL subunits in the proteobacterium Rhodobacter sphaeroides also fold with GroEL/ES. However, assembly proceeds in a chaperone-independent manner. We find that the C-terminal beta-hairpin extension of red-type RbcS, which is absent in green-type RbcS, is critical for efficient assembly. The beta-hairpins of four RbcS subunits form an eight-stranded beta-barrel that protrudes into the central solvent channel of the RbcL core complex. The two beta-barrels stabilize the complex through multiple interactions with the RbcL subunits. A chimeric green-type RbcS carrying the C-terminal beta-hairpin renders the assembly of a cyanobacterial Rubisco independent of RbcX. Our results may facilitate the engineering of crop plants with improved growth properties expressing red-type Rubisco.	[Joshi, Jidnyasa; Mueller-Cajar, Oliver; Tsai, Yi-Chin C.; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	mhartl@biochem.mpg.de	Mueller-Cajar, Oliver/A-7237-2018; Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Mueller-Cajar, Oliver/0000-0003-2866-5963; Hayer-Hartl, Manajit/0000-0001-8213-6742				Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Andrews TJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Bhattacharya D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2931; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bracher A, 2011, NAT STRUCT MOL BIOL, V18, P875, DOI 10.1038/nsmb.2090; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Feiz L, 2014, PLANT J, V80, P862, DOI 10.1111/tpj.12686; Feiz L, 2012, PLANT CELL, V24, P3435, DOI 10.1105/tpc.112.102012; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; Hansen S, 1999, J MOL BIOL, V288, P609, DOI 10.1006/jmbi.1999.2701; HARTMAN FC, 1994, ANNU REV BIOCHEM, V63, P197, DOI 10.1146/annurev.biochem.63.1.197; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2; Horken KM, 1999, ARCH BIOCHEM BIOPHYS, V361, P183, DOI 10.1006/abbi.1998.0979; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Karkehabadi S, 2005, BIOCHEMISTRY-US, V44, P9851, DOI 10.1021/bi050537v; Kolesinski P, 2014, FEBS J, V281, P3920, DOI 10.1111/febs.12928; Kolesinski P, 2011, PLANT MOL BIOL, V77, P447, DOI 10.1007/s11103-011-9823-8; Kontur WS, 2012, J BACTERIOL, V194, P7016, DOI 10.1128/JB.01214-12; LARIMER FW, 1993, GENE, V126, P85, DOI 10.1016/0378-1119(93)90593-R; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Mueller-Cajar O, 2008, BIOCHEM J, V414, P205, DOI 10.1042/BJ20080668; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; NEWMAN J, 1993, ACTA CRYSTALLOGR D, V49, P548, DOI 10.1107/S090744499300530X; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; READ BA, 1992, BIOCHEMISTRY-US, V31, P5553, DOI 10.1021/bi00139a018; REITH M, 1995, ANNU REV PLANT PHYS, V46, P549, DOI 10.1146/annurev.arplant.46.1.549; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Spreitzer RJ, 2005, P NATL ACAD SCI USA, V102, P17225, DOI 10.1073/pnas.0508042102; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Sugawara H, 1999, J BIOL CHEM, V274, P15655, DOI 10.1074/jbc.274.22.15655; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tsai YCC, 2012, J BIOL CHEM, V287, P20471, DOI 10.1074/jbc.M112.365411; van Lun M, 2011, J MOL BIOL, V411, P1083, DOI 10.1016/j.jmb.2011.06.052; Weiss C, 2009, PLANT MOL BIOL, V69, P227, DOI 10.1007/s11103-008-9432-3; Wheatley NM, 2014, J BIOL CHEM, V289, P7973, DOI 10.1074/jbc.M113.531236; Whitney SM, 2001, PLANT J, V26, P535, DOI 10.1046/j.1365-313x.2001.01056.x; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814	47	24	24	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1066	1074		10.1074/jbc.M114.613091	http://dx.doi.org/10.1074/jbc.M114.613091			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25371207	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000347778200038
J	Hintzpeter, J; Martin, HJ; Maser, E				Hintzpeter, Jan; Martin, Hans-Joerg; Maser, Edmund			Reduction of lipid peroxidation products and advanced glycation end-product precursors by cyanobacterial aldo-keto reductase AKR3G1-a founding member of the AKR3G subfamily	FASEB JOURNAL			English	Article						carbonyl reduction; detoxification; enzyme kinetics	SP PCC 6803; SP STRAIN PCC-6803; ALDEHYDE REDUCTASE; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; OXIDATIVE STRESS; ACTIVE-SITE; FATTY-ACIDS; METHYLGLYOXAL; EXPRESSION	The purpose of this study was to investigate the origin and function of the aldo-keto reductase (AKR) superfamily as enzymes involved in the detoxification of xenobiotics. We used the cyanobacterium Synechocystis sp. PCC 6803 as a model organism and sequence alignments to find bacterial AKRs with highest identity to human enzymes. Disappearance of NADPH was monitored spectrophotometrically to calculate enzymatic activity. The molecular weight of the native protein was determined by size exclusion chromatography. Substrate docking was performed by SwissDock. Sequence alignments identified the NADPH-dependent AKR3G1 having 41.5 and 40% identity with the human enzymes AKR1B1 and AKR1B10, respectively. Highest enzymatic efficiency was observed with 4-oxonon-2-enal (4-ONE; k(cat)/K-m, 561 s(-1) mM(-1)) and 4-hydroxynonenal (k(cat)/K-m, 26.5 s(-1) mM(-1)), respectively. P74308 is the most efficient enzyme for 4-ONE discovered until now. Cooperativity of this monomeric enzyme was observed with some substrates. Enzyme inactivation or oligomerization as possible explanations for nonhyperbolic enzyme kinetics were ruled out by Selwyn's test and gel filtration. The role of the little investigated carbonyl-reducing enzymes in detoxification seems to be in fact a very old process with rarely observed nonhyperbolic enzyme kinetics as an adaptation mechanism to higher concentrations of reactive oxygen species.	[Hintzpeter, Jan; Martin, Hans-Joerg; Maser, Edmund] Univ Med Sch Schleswig Holstein, Inst Toxicol & Pharmacol Nat Scientists, D-24105 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Hintzpeter, J (corresponding author), Univ Med Sch Schleswig Holstein, Inst Toxicol & Pharmacol Nat Scientists, Campus Kiel,Brunswiker Str 10, D-24105 Kiel, Germany.	hintzpeter@toxi.uni-kiel.de	Maser, Edmund/B-1728-2010					Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Asselin C, 2006, FREE RADICAL BIO MED, V41, P97, DOI 10.1016/j.freeradbiomed.2006.03.011; Baba SP, 2009, DIABETES, V58, P2486, DOI 10.2337/db09-0375; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; Bourajjaj M, 2003, BIOCHEM SOC T, V31, P1400; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Copeland RA, 2000, ENZYMES PRACTICAL IN, P109; Doorn JA, 2004, BIOCHEMISTRY-US, V43, P13106, DOI 10.1021/bi049136q; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FLYNN TG, 1982, BIOCHEM PHARMACOL, V31, P2705, DOI 10.1016/0006-2952(82)90123-X; Gemma C, 2002, J NEUROSCI, V22, P6114; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; He YY, 2002, PHOTOCH PHOTOBIO SCI, V1, P729, DOI 10.1039/b110365m; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Horie K, 1997, J CLIN INVEST, V100, P2995, DOI 10.1172/JCI119853; Hyndman D, 2003, CHEM-BIOL INTERACT, V143, P621, DOI 10.1016/S0009-2797(02)00193-X; JAGT DLV, 1995, BBA-PROTEIN STRUCT M, V1249, P117; KANAZU T, 1991, BIOCHEM J, V279, P903, DOI 10.1042/bj2790903; Kaneko T, 1996, DNA Res, V3, P109; Kasting JF, 2002, SCIENCE, V296, P1066, DOI 10.1126/science.1071184; Kobayashi M, 2004, PLANT CELL PHYSIOL, V45, P290, DOI 10.1093/pcp/pch034; Kuhla B, 2005, ANN NY ACAD SCI, V1043, P211, DOI 10.1196/annals.1333.026; Kumar D, 2013, MOL BIOTECHNOL, V54, P292, DOI 10.1007/s12033-012-9567-y; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Lee SH, 2001, SCIENCE, V292, P2083, DOI 10.1126/science.1059501; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Leonarduzzi G, 2005, MOL NUTR FOOD RES, V49, P1044, DOI 10.1002/mnfr.200500090; Lin D, 2005, CHEM RES TOXICOL, V18, P1219, DOI 10.1021/tx050080q; Liu ZF, 2003, CHEM RES TOXICOL, V16, P901, DOI 10.1021/tx0300030; Long F, 2011, PROTEIN EXPRES PURIF, V79, P16, DOI 10.1016/j.pep.2011.05.012; Malatkova P, 2010, CURR DRUG METAB, V11, P639, DOI 10.2174/138920010794233530; Martin HJ, 2009, CHEM-BIOL INTERACT, V178, P145, DOI 10.1016/j.cbi.2008.10.021; Martina HJ, 2011, CHEM-BIOL INTERACT, V191, P48, DOI 10.1016/j.cbi.2010.12.006; Matsunaga T, 2009, BIOCHEM BIOPH RES CO, V389, P128, DOI 10.1016/j.bbrc.2009.08.107; Muthenna P, 2009, FEBS LETT, V583, P3637, DOI 10.1016/j.febslet.2009.10.042; Nanjo Y, 2010, BBA-BIOENERGETICS, V1797, P1483, DOI 10.1016/j.bbabio.2010.03.014; Narawongsanont R, 2012, PROTEIN J, V31, P35, DOI 10.1007/s10930-011-9371-8; Nhan Pham Phuoc, 2007, THESIS U WURZBURG WU; O'Connor T, 1999, BIOCHEM J, V343, P487, DOI 10.1042/0264-6021:3430487; Osanai T, 2013, PLANT J, V76, P456, DOI 10.1111/tpj.12310; Pinero Estrada J. E., 2001, FARMACO, V56, P497, DOI DOI 10.1016/S0014-827X(01)01084-9; PRYOR WA, 1990, FREE RADICAL BIO MED, V8, P541, DOI 10.1016/0891-5849(90)90153-A; Rabbani N, 2012, AMINO ACIDS, V42, P1133, DOI 10.1007/s00726-010-0783-0; REYES JC, 1994, J BACTERIOL, V176, P1260, DOI 10.1128/jb.176.5.1260-1267.1994; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180; SELWYN MJ, 1965, BIOCHIM BIOPHYS ACTA, V105, P193, DOI 10.1016/S0926-6593(65)80190-4; Shimakawa G, 2013, BIOSCI BIOTECH BIOCH, V77, P2441, DOI 10.1271/bbb.130554; Simpson PJ, 2009, J MOL BIOL, V392, P465, DOI 10.1016/j.jmb.2009.07.023; Srivastava S, 1995, BIOCHEM BIOPH RES CO, V217, P741, DOI 10.1006/bbrc.1995.2835; Steiger S, 1999, J PHOTOCH PHOTOBIO B, V52, P14, DOI 10.1016/S1011-1344(99)00094-9; Suzuki K, 1998, J BIOCHEM-TOKYO, V123, P353; Toyokuni S, 2000, ANTIOXID REDOX SIGN, V2, P681, DOI 10.1089/ars.2000.2.4-681; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Wang WX, 2009, ENVIRON TOXICOL CHEM, V28, P1655, DOI 10.1897/08-463.1; Wegener KM, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.000109; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Williams TI, 2006, NEUROBIOL AGING, V27, P1094, DOI 10.1016/j.neurobiolaging.2005.06.004; Wu LY, 2006, CAN J PHYSIOL PHARM, V84, P129, DOI 10.1139/Y05-137; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a	63	7	8	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					263	273		10.1096/fj.14-258327	http://dx.doi.org/10.1096/fj.14-258327			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25376835				2022-12-26	WOS:000347378600025
J	Pepin, E; Higa, A; Schuster-Klein, C; Bernard, C; Sulpice, T; Guardiola, B; Chevet, E; Alquier, T				Pepin, Emilie; Higa, Arisa; Schuster-Klein, Carole; Bernard, Catherine; Sulpice, Thierry; Guardiola, Beatrice; Chevet, Eric; Alquier, Thierry			Deletion of Apoptosis Signal-Regulating Kinase 1 (ASK1) Protects Pancreatic Beta-Cells from Stress-Induced Death but Not from Glucose Homeostasis Alterations under Pro-Inflammatory Conditions	PLOS ONE			English	Article							FACTOR-KAPPA-B; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; ADIPOSE-TISSUE; FATTY-ACID; EXPRESSION; ACTIVATION; SECRETION; MICE; TLR4	Background: Type 2 diabetes is characterized by pancreatic beta-cell dysfunction and is associated with low-grade inflammation. Recent observations suggest that apoptosis signal-regulating kinase 1 (ASK1) is involved in beta-cell death in response to different stressors. In this study, we tested whether ASK1 deficiency protects beta-cells from glucolipotoxic conditions and cytokines treatment or from glucose homeostasis alteration induced by endotoxemia. Methodology/Principal Findings: Insulin secretion was neither affected upon shRNA-mediated downregulation of ASK1 in MIN6 cells nor in islets from ASK1-deficient mice. ASK1 silencing in MIN6 cells and deletion in islets did not prevent the deleterious effect of glucolipotoxic conditions or cytokines on insulin secretion. However, it protected MIN6 cells from death induced by ER stress or palmitate and islets from short term caspase activation in response to cytokines. Moreover, endotoxemia induced by LPS infusion increased insulin secretion during hyperglycemic clamps but the response was similar in wild-type and ASK1-deficient mice. Finally, insulin sensitivity in the presence of LPS was not affected by ASK1-deficiency. Conclusions/Significance: Our study demonstrates that ASK1 is not involved in beta-cell function and dysfunction but controls stress-induced beta-cell death.	[Pepin, Emilie; Sulpice, Thierry] Betagenex Inc, Laval, PQ H7V 5B7, Canada; [Higa, Arisa; Chevet, Eric] Univ Bordeaux, Team Endoplasm Reticulum Stress & Canc, INSERM, U1053, F-33076 Bordeaux, France; [Sulpice, Thierry] Physiogenex SAS, F-31670 Labege, France; [Schuster-Klein, Carole; Bernard, Catherine; Guardiola, Beatrice] Grp Rech Servier, F-92284 Suresnes, France; [Alquier, Thierry] Univ Montreal, Montreal Diabet Res Ctr, Ctr Rech Ctr Hosp Univ Montreal, Montreal, PQ H3T 1J4, Canada; [Alquier, Thierry] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Alquier, Thierry] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Alquier, Thierry] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Servier; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Alquier, T (corresponding author), Univ Montreal, Montreal Diabet Res Ctr, Ctr Rech Ctr Hosp Univ Montreal, Montreal, PQ H3T 1J4, Canada.	thierry.alquier@umontreal.ca	chevet, eric/E-4992-2016; Alquier, Thierry/Z-1917-2019	chevet, eric/0000-0001-5855-4522; Alquier, Thierry/0000-0001-8171-802X	Les Laboratoires Servier (Suresnes, France); Fonds de Recherche Quebec-Sante (FRQS)	Les Laboratoires Servier (Suresnes, France); Fonds de Recherche Quebec-Sante (FRQS)	This work was supported by Les Laboratoires Servier (Suresnes, France). Servier was involved in the study design, data collection and analysis and preparation of the manuscript for publication. Thierry Alquier was supported by a salary award from Fonds de Recherche Quebec-Sante (FRQS).	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Amyot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036200; Nguyen AT, 2014, DIABETES, V63, P471, DOI 10.2337/db13-0903; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Chan JY, 2012, DIABETOLOGIA, V55, P2999, DOI 10.1007/s00125-012-2657-3; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Garay-Malpartida HM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-18; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Kaji T, 2010, BIOCHEM BIOPH RES CO, V395, P213, DOI 10.1016/j.bbrc.2010.03.164; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Larsen L, 2005, DIABETOLOGIA, V48, P2582, DOI 10.1007/s00125-005-0039-9; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Maedler K, 2004, DIABETES, V53, P1706, DOI 10.2337/diabetes.53.7.1706; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Mulligan KX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030160; Nackiewicz D, 2014, DIABETOLOGIA; Nishiki Y, 2013, MOL ENDOCRINOL, V27, P336, DOI 10.1210/me.2012-1230; Park HK, 2011, DIABETES, V60, P775, DOI 10.2337/db10-1416; Pilon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015912; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Shao CL, 2010, J BIOL CHEM, V285, P19710, DOI 10.1074/jbc.M109.087486; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shiizaki Shigeru, 2013, Advances in Biological Regulation, V53, P135, DOI 10.1016/j.jbior.2012.09.006; Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190; Taouji S, 2013, J BIOL CHEM, V288, P17190, DOI 10.1074/jbc.M112.409185; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Widenmaier SB, 2009, J BIOL CHEM, V284, P30372, DOI 10.1074/jbc.M109.060178; Yamaguchi K, 2013, BBA-GEN SUBJECTS, V1830, P3656, DOI 10.1016/j.bbagen.2013.01.029	42	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112714	10.1371/journal.pone.0112714	http://dx.doi.org/10.1371/journal.pone.0112714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383781	gold, Green Submitted, Green Published			2022-12-26	WOS:000344816700090
J	Samuni-Blank, M; Izhaki, I; Gerchman, Y; Dearing, MD; Karasov, WH; Trabelcy, B; Edwards, TM; Arad, Z				Samuni-Blank, Michal; Izhaki, Ido; Gerchman, Yoram; Dearing, M. Denise; Karasov, William H.; Trabelcy, Beny; Edwards, Thea M.; Arad, Zeev			Taste and Physiological Responses to Glucosinolates: Seed Predator versus Seed Disperser	PLOS ONE			English	Article							SECONDARY METABOLITES; BITTER-TASTE; BREAKDOWN PRODUCTS; RIPE FRUIT; BIRDS; ADIPOSITY; DEFENSE; RODENTS; PLANT; BOMB	In contrast to most other plant tissues, fleshy fruits are meant to be eaten in order to facilitate seed dispersal. Although fleshy fruits attract consumers, they may also contain toxic secondary metabolites. However, studies that link the effect of fruit toxins with seed dispersal and predation are scarce. Glucosinolates (GLSs) are a family of bitter-tasting compounds. The fleshy fruit pulp of Ochradenus baccatus was previously found to harbor high concentrations of GLSs, whereas the myrosinase enzyme, which breaks down GLSs to produce foul tasting chemicals, was found only in the seeds. Here we show the differential behavioral and physiological responses of three rodent species to high dose (80%) Ochradenus' fruits diets. Acomys russatus, a predator of Ochradenus' seeds, was the least sensitive to the taste of the fruit and the only rodent to exhibit taste-related physiological adaptations to deal with the fruits' toxins. In contrast, Acomys cahirinus, an Ochradenus seed disperser, was more sensitive to a diet containing the hydrolyzed products of the GLSs. A third rodent (Mus musculus) was deterred from Ochradenus fruits consumption by the GLSs and their hydrolyzed products. We were able to alter M. musculus avoidance of whole fruit consumption by soaking Ochradenus fruits in a water solution containing 1% adenosine monophosphate, which blocks the bitter taste receptor in mice. The observed differential responses of these three rodent species may be due to evolutionary pressures that have enhanced or reduced their sensitivity to the taste of GLSs.	[Samuni-Blank, Michal; Arad, Zeev] Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel; [Samuni-Blank, Michal; Izhaki, Ido; Trabelcy, Beny] Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-3498838 Haifa, Israel; [Gerchman, Yoram] Univ Haifa, Dept Biol & Environm, Fac Nat Sci, IL-3600672 Oranim, Tivon, Israel; [Dearing, M. Denise] Univ Utah, Dept Biol, Salt Lake City, UT 84103 USA; [Karasov, William H.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Edwards, Thea M.] Sewanee Univ South, Dept Biol, Sewanee, TN 37383 USA	Technion Israel Institute of Technology; University of Haifa; University of Haifa; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; Sewanee: University of the South	Samuni-Blank, M (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel.	michal.samuni@gmail.com	Gerchman, Yoram/F-5226-2015; Gerchman, Yoram/H-4698-2019; Izhaki, Ido/I-9712-2019	Gerchman, Yoram/0000-0002-8637-9589; Izhaki, Ido/0000-0002-4525-4683	U.S.-Israel Bi-National Science Foundation [2006043]; Israel Science Foundation [189/08]; Middle East Regional Cooperation [TA-MOU-08-M28-013]	U.S.-Israel Bi-National Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Middle East Regional Cooperation	Support for this study was available through grants from the U.S.-Israel Bi-National Science Foundation Grant (#2006043), Israel Science Foundation (#189/08) and Middle East Regional Cooperation (#TA-MOU-08-M28-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNEA A, 1993, BIOCHEM SYST ECOL, V21, P421, DOI 10.1016/0305-1978(93)90100-6; Burns KC, 2012, CURR BIOL, V22, pR535, DOI 10.1016/j.cub.2012.05.014; Cederroth CR, 2007, ENVIRON HEALTH PERSP, V115, P1467, DOI 10.1289/ehp.10413; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; Cipollini ML, 1997, ECOLOGY, V78, P782; Cipollini ML, 2000, REV CHIL HIST NAT, V73, P421; CORLETT RT, 1990, OECOLOGIA, V82, P166, DOI 10.1007/BF00323531; Dillaway D., 2014, ENDOCR DISRUPTORS AU, V2, DOI [10.4161/endo.28490, DOI 10.4161/ENDO.28490]; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Ehrhardt N, 2005, J COMP PHYSIOL B, V175, P193, DOI 10.1007/s00360-005-0475-3; FENWICK GR, 1983, J SCI FOOD AGR, V34, P73, DOI 10.1002/jsfa.2740340111; FENWICK GR, 1983, FOOD CHEM, V11, P249, DOI 10.1016/0308-8146(83)90074-2; Glendinning J.I., 1990, Chemoecology, V1, P124, DOI 10.1007/BF01241653; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; HERRERA CM, 1982, AM NAT, V120, P218, DOI 10.1086/283984; IZHAKI I, 1989, OIKOS, V54, P23, DOI 10.2307/3565893; IZHAKI I, 1992, CONDOR, V94, P912, DOI 10.2307/1369288; Izhaki I, 2002, NEW PHYTOL, V155, P205, DOI 10.1046/j.1469-8137.2002.00459.x; Janzen DH, 1975, ECOLOGY PLANTS TROPI, V71; Kelt DA, 2004, J BIOGEOGR, V31, P931, DOI 10.1111/j.1365-2699.2004.01045.x; Ming D, 1999, P NATL ACAD SCI USA, V96, P9903, DOI 10.1073/pnas.96.17.9903; Norconk MA, 1998, AM J PRIMATOL, V45, P103, DOI 10.1002/(SICI)1098-2345(1998)45:1<103::AID-AJP8>3.0.CO;2-#; Oka Y, 2014, PLANT PATHOL, V63, P221, DOI 10.1111/ppa.12079; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Samuni-Blank M, 2013, EVOL ECOL, V27, P1069, DOI 10.1007/s10682-013-9655-x; Samuni-Blank M, 2013, J EXP BIOL, V216, P3667, DOI 10.1242/jeb.089664; Samuni-Blank M, 2012, CURR BIOL, V22, P1218, DOI 10.1016/j.cub.2012.04.051; Stanley MC, 2001, AUST J ZOOL, V49, P633, DOI 10.1071/ZO01042; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Torregrossa AM, 2011, FUNCT ECOL, V25, P1232, DOI 10.1111/j.1365-2435.2011.01896.x; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2	33	3	3	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112505	10.1371/journal.pone.0112505	http://dx.doi.org/10.1371/journal.pone.0112505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383693	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700071
J	Wong, JKF; Metcalfe, AD; Wong, R; Bush, J; Platt, C; Garcon, A; Goldspink, N; McGrouther, DA; Ferguson, MWJ				Wong, Jason K. F.; Metcalfe, Anthony D.; Wong, Richard; Bush, Jim; Platt, Chris; Garcon, Arnaud; Goldspink, Nick; McGrouther, Duncan A.; Ferguson, Mark W. J.			Reduction of Tendon Adhesions following Administration of Adaprev, a Hypertonic Solution of Mannose-6-Phosphate: Mechanism of Action Studies	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ZONE-II; TGF-BETA; OSMOTIC-STRESS; ACTIVATION; REPAIR; P38; 5-FLUOROURACIL; EXPRESSION; 2-STRAND	Repaired tendons may be complicated by progressive fibrosis, causing adhesion formation or tendon softening leading to tendon rupture and subsequent reduced range of motion. There are few therapies available which improve the gliding of damaged tendons in the hand. We investigate the role of Mannose 6-phosphate (M6P) in a 600 mM hypertonic solution (Adaprev) on tendon adhesion formation in vivo using a mouse model of severed tendon in conjunction with analysis of collagen synthesis, cellular proliferation and receptors involved in TGF beta signalling. Cytotoxicity was assessed by measuring tissue residency, mechanical strength and cell viability of tendons after treatment with Adaprev. To elicit potential modes of action, in vitro and ex vivo studies were performed investigating phosphorylation of p38, cell migration and proliferation. Adaprev treatment significantly (p<0.05) reduced the development of adhesions and improved collagen organisation without reducing overall collagen synthesis following tendon injury in vivo. The bioavailability of Adaprev saw a 40% reduction at the site of administration over 45 minutes and tendon fibroblasts tolerated up to 120 minutes of exposure without significant loss of cell viability or tensile strength. These favourable effects were independent of CI-MPR and TGF-beta signalling and possibly highlight a novel mechanism of action related to cellular stress demonstrated by phosphorylation of p38. The effect of treatment reduced tendon fibroblast migration and transiently halted tendon fibroblast proliferation in vitro and ex vivo. Our studies demonstrate that the primary mode of action for Adaprev is potentially via a physical, non-chemical, hyperosmotic effect.	[Wong, Jason K. F.; Wong, Richard; McGrouther, Duncan A.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Metcalfe, Anthony D.; Bush, Jim; Platt, Chris; Garcon, Arnaud; Goldspink, Nick; Ferguson, Mark W. J.] Renovo Ltd, Core Technol Facil, Manchester, Lancs, England	University of Manchester; University of Manchester	Wong, JKF (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England.	Jason.k.wong@manchester.ac.uk	Wong, Richard/H-5189-2015; Wong, Jason/AAQ-9239-2020	Wong, Richard/0000-0002-4382-1568; Wong, Jason/0000-0003-2592-3226; Metcalfe, Anthony/0000-0002-1633-6831; Platt, Christopher/0000-0002-0525-3221	UK Centre for Tissue Engineering - Research Councils (EPSRC, BBSRC, MRC); European Commission; National Institute of Health Research (NIHR); National Institute for Health Research [CL-2006-06-004] Funding Source: researchfish	UK Centre for Tissue Engineering - Research Councils (EPSRC, BBSRC, MRC); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Support was received from the UK Centre for Tissue Engineering funded by the Research Councils (EPSRC, BBSRC, MRC), European Commission and small and major biomedical industries, and the National Institute of Health Research (NIHR). Renovo Plc provided support in the form of salaries for authors MWJF, ADM, JB, CP, AG, and NG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section. Experimental design was largely performed by JW and DAM, who are employees of the University of Manchester and independent of Renovo Plc. They have no financial interests to disclose.	Akali A, 1999, PLAST RECONSTR SURG, V103, P151, DOI 10.1097/00006534-199901000-00024; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arsenijevic T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.189; Barnes J, 2012, J BIOL CHEM, V287, P7526, DOI 10.1074/jbc.M111.308825; Bates SJ, 2006, J BONE JOINT SURG AM, V88A, P2465, DOI 10.2106/JBJS.E.00143; Birch HL, 1997, J EXP BIOL, V200, P1703; Bullough R, 2008, DISABIL REHABIL, V30, P1746, DOI 10.1080/09638280701788258; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Caulfield RH, 2008, J HAND SURG-EUR VOL, V33E, P412, DOI 10.1177/1753193408090758; Chang J, 1997, PLAST RECONSTR SURG, V100, P937, DOI 10.1097/00006534-199709001-00016; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cruz-Orive LM, 1999, J MICROSC-OXFORD, V193, P182, DOI 10.1046/j.1365-2818.1999.00460.x; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; Fenn PD, 1995, 10907 IRN 155051; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Finan JD, 2010, J CELL BIOCHEM, V109, P460, DOI 10.1002/jcb.22437; Fujisawa M, 2012, J ENDODONT, V38, P931, DOI 10.1016/j.joen.2012.03.023; Gatidis S, 2011, CELL PHYSIOL BIOCHEM, V28, P1279, DOI 10.1159/000335859; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Golash A, 2003, J HAND SURG-BRIT EUR, V28B, P113, DOI 10.1016/S0266-7681(02)00249-8; Gorvy DA, 2005, AM J PATHOL, V167, P1005, DOI 10.1016/S0002-9440(10)61190-X; Hardwicke JT, 2014, J HAND SURG-AM, V39, P686, DOI 10.1016/j.jhsa.2013.12.037; Heinemeier KM, 2011, J MUSCULOSKEL NEURON, V11, P115; Hoffmann GL, 2008, J HAND SURG-EUR VOL, V33E, P418, DOI 10.1177/1753193408091570; Howell JW, 2013, INJURY; Hsu C, 2004, J HAND SURG-AM, V29A, P551, DOI 10.1016/j.jhsa.2004.04.020; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jiang HY, 2013, BIOPHYS J, V105, P609, DOI 10.1016/j.bpj.2013.06.021; Khan U, 1997, PLAST RECONSTR SURG, V99, P465, DOI 10.1097/00006534-199702000-00023; Lee SH, 2010, J BIOL CHEM, V285, P41280, DOI 10.1074/jbc.M110.182188; Leksa V, 2005, J CELL SCI, V118, P4577, DOI 10.1242/jcs.02587; Lin TW, 2006, J BIOMECH, V39, P61, DOI 10.1016/j.jbiomech.2004.11.009; Lunn JA, 2004, J BIOL CHEM, V279, P45266, DOI 10.1074/jbc.M314132200; Ly DL, 2013, AM J PHYSIOL-CELL PH, V304, pC115, DOI 10.1152/ajpcell.00290.2012; Ngo M, 2001, PLAST RECONSTR SURG, V108, P1260, DOI 10.1097/00006534-200110000-00025; Occleston NL, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/405262; Peck FH, 2004, BRIT J PLAST SURG, V57, P45, DOI 10.1016/j.bjps.2003.10.003; Ponder E, 1944, J GEN PHYSIOL, V27, P273, DOI 10.1085/jgp.27.4.273; Renovo, 2008, SINGL SIT PLAC CONTR; Rosberg HE, 2005, SCAND J PLAST RECONS, V39, P360, DOI 10.1080/02844310500340046; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAH M, 1994, J CELL SCI, V107, P1137; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Strickland JW, 2000, J HAND SURG-AM, V25A, P214; TONG PY, 1989, J BIOL CHEM, V264, P7970; WInter J, 2013, HOSP EPISODE STAT MA; Wong JKF, 2009, AM J PATHOL, V175, P1938, DOI 10.2353/ajpath.2009.090380; Xia CS, 2012, ORTHOPEDICS, V35, pE1056, DOI 10.3928/01477447-20120621-21; Xia Changsuo, 2011, Orthopedics, V34, P21, DOI 10.3928/01477447-20101123-09; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P5620, DOI 10.1073/pnas.0801453105	51	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112672	10.1371/journal.pone.0112672	http://dx.doi.org/10.1371/journal.pone.0112672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383548	Green Published, gold			2022-12-26	WOS:000344816700087
J	Garba, M; Dalecky, A; Kadaoure, I; Kane, M; Hima, K; Veran, S; Gagare, S; Gauthier, P; Tatard, C; Rossi, JP; Dobigny, G				Garba, Madougou; Dalecky, Ambroise; Kadaoure, Ibrahima; Kane, Mamadou; Hima, Karmadine; Veran, Sophie; Gagare, Sama; Gauthier, Philippe; Tatard, Caroline; Rossi, Jean-Pierre; Dobigny, Gauthier			Spatial Segregation between Invasive and Native Commensal Rodents in an Urban Environment: A Case Study in Niamey, Niger	PLOS ONE			English	Article							RATTUS-RATTUS; ECOLOGY; RATS; CITY; GEOSTATISTICS; BIODIVERSITY; INFESTATIONS; NORVEGICUS; ABUNDANCE; ZOONOSES	Invasive rodents have been responsible for the diffusion worldwide of many zoonotic agents, thus representing major threats for public health. Cities are important hubs for people and goods exchange and are thus expected to play a pivotal role in invasive commensal rodent dissemination. Yet, data about urban rodents' ecology, especially invasive vs. native species interactions, are dramatically scarce. Here, we provide results of an extensive survey of urban rodents conducted in Niamey, Niger, depicting the early stages of rodent bioinvasions within a city. We explore the species-specific spatial distributions throughout the city using contrasted approaches, namely field sampling, co-occurrence analysis, occupancy modelling and indicator geostatistics. We show that (i) two species (i. e. rural-like vs. truly commensal) assemblages can be identified, and that (ii) within commensal rodents, invasive (Rattus rattus and Mus musculus) and native (Mastomys natalensis) species are spatially segregated. Moreover, several pieces of arguments tend to suggest that these exclusive distributions reflect an ongoing native-to-invasive species turn over. The underlying processes as well as the possible consequences for humans are discussed.	[Garba, Madougou; Gagare, Sama; Dobigny, Gauthier] Ctr Reg Agrhymet, Dept Format Rech, Niamey, Niger; [Garba, Madougou; Hima, Karmadine] Univ Abdou Moumouni, Fac Sci, Niamey, Niger; [Garba, Madougou] Minist Agr, Direct Generale Protect Vegetaux, Niamey, Niger; [Dalecky, Ambroise] Aix Marseille Univ, IRD, LPED UMR AMU, Marseille, France; [Dalecky, Ambroise; Gauthier, Philippe] IRD, CBGP UMR INRA Cirad SupAgro Montpellier, Montferrier Sur Lez, France; [Kadaoure, Ibrahima] Ctr Reg Agrhymet, USAid Fews Net, Niamey, Niger; [Kane, Mamadou] IRD, CBGP, Dakar, Senegal; [Tatard, Caroline] INRA, CBGP, Montferrier Sur Lez, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); INRAE; Institut de Recherche pour le Developpement (IRD)	Dobigny, G (corresponding author), Ctr Reg Agrhymet, Dept Format Rech, Niamey, Niger.	gauthier.dobigny@ird.fr	Dalecky, Ambroise/AAF-9578-2021	Dalecky, Ambroise/0000-0002-5075-4121; Rossi, Jean-Pierre/0000-0002-8139-1116; GAUTHIER, Philippe/0000-0001-8363-6845	"Institut de Recherche pour le Developpement" (France); "Service de Renforcement des Capacites'' (Institut de Recherche pour le Developpement), France	"Institut de Recherche pour le Developpement" (France); "Service de Renforcement des Capacites'' (Institut de Recherche pour le Developpement), France	Lab and field work were funded by the "Institut de Recherche pour le Developpement" (France). Funding support was partly provided to Mr. Garba by a 'BEST' bursary from the "Service de Renforcement des Capacites'' (Institut de Recherche pour le Developpement), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou A, 2012, THESIS A MOUMOUNI U; Panti-May JA, 2012, INT BIODETER BIODEGR, V66, P77, DOI 10.1016/j.ibiod.2011.10.006; Angelici FM, 2005, J ZOOL, V265, P9, DOI 10.1017/S0952836904005977; [Anonymous], 2013, GLOB INV SPEC DAT; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Audoin-Rouzeau Frederique, 1994, Revue de Paleobiologie, V13, P125; Bastos AD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-26; Belmain SR., 2003, ACIAR MONOGRAPH, V96, P440; Bergmans W., 1999, RONGEURS BENIN ESPEC, P23; Bonhomme F, 2011, P ROY SOC B-BIOL SCI, V278, P1034, DOI 10.1098/rspb.2010.1228; Bradman A, 2005, ENVIRON HEALTH PERSP, V113, P1795, DOI 10.1289/ehp.7588; Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017; Gomez MD, 2008, J PEST SCI, V81, P235, DOI 10.1007/s10340-008-0212-2; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Djidingar D, 1997, B SOC PATHOL EXOT, V90, P27; Dobigny G, 2002, MAMMALIA, V66, P495, DOI 10.1515/mamm.2002.66.4.495; Dobigny G, 2008, J ZOOL, V276, P368, DOI 10.1111/j.1469-7998.2008.00500.x; Dobigny G, 2011, ACTA TROP, V117, P183, DOI 10.1016/j.actatropica.2010.11.004; Duplantier J.M., 1991, RONGEUR ESPACE, P339; Duplantier Jean-Marc, 1997, Journal of African Zoology, V111, P17; Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4; Fernandez IC, 2013, URBAN ECOSYST, V16, P377, DOI 10.1007/s11252-012-0272-1; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Galan M, 2004, MOL ECOL NOTES, V4, P321, DOI 10.1111/j.1471-8286.2004.00681.x; Garba M, 2012, THESIS A MOUMOUNI U; Garba M, 2014, MAMMALIA IN PRESS; Garba M, 2014, URBAN ECOSY IN PRESS; Gilabert A, 2007, CAN J ZOOL, V85, P965, DOI 10.1139/Z07-083; Goovaerts P, 1998, BIOL FERT SOILS, V27, P315, DOI 10.1007/s003740050439; Goovaerts P, 1999, GEODERMA, V89, P1, DOI 10.1016/S0016-7061(98)00078-0; Goovaerts P., 1997, GEOSTATISTICS NATURA, P483; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2006, ECOSIM NULL MODELS S; GRANJON L, 1989, CR ACAD SCI III-VIE, V309, P571; Granjon L., 2009, RONGEURS AFRIQUE SAH; Granjon L, 1986, ETUDES RELATIONS SOC, P628; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270; Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195; Houemenou G, 2013, THESIS LIEGE U BELGI; Houemenou G, 2013, LEPTOSPIRA SPP PREVA, V2013; Howie S, 2006, PLOS MED, V3, P1508, DOI 10.1371/journal.pmed.0030355; Isaaks E.H., 1989, ISA; Journel A. G., 1978, MINING GEOSTATISTICS; Kaleme PK, 2011, AFR ZOOL, V46, P133, DOI 10.3377/004.046.0104; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Konecny A, 2013, MOL ECOL, V22, P286, DOI 10.1111/mec.12112; Lack JB, 2013, BIOL INVASIONS, V15, P1067, DOI 10.1007/s10530-012-0351-5; Langton SD, 2001, J APPL ECOL, V38, P699, DOI 10.1046/j.1365-2664.2001.00631.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lecompte E, 2005, BIOCHEM SYST ECOL, V33, P681, DOI 10.1016/j.bse.2004.12.015; Legendre P., 2012, NUMERICAL ECOLOGY; Loiseau A, 2008, MOL ECOL RESOUR, V8, P916, DOI 10.1111/j.1755-0998.2008.02115.x; Loiseau A, 2007, MOL ECOL NOTES, V7, P684, DOI 10.1111/j.1471-8286.2006.01677.x; Luniak M, 2004, 4 INT URB WILDL S, P50; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Mercier A, 2013, MEM I OSWALDO CRUZ, V108, P399, DOI 10.1590/S0074-0276108042013002; Monadjem A, 2011, WILDLIFE RES, V38, P603, DOI 10.1071/WR10130; Murphy R.G., 2003, ACIAR MONOGR SER, V96, P469; OLASEHA IO, 1994, J ROY SOC HEALTH, V114, P300, DOI 10.1177/146642409411400604; Olayemi A, 2012, ZOOL J LINN SOC-LOND, V165, P700, DOI 10.1111/j.1096-3642.2012.00823.x; Omudu E. A., 2010, Research Journal of Agriculture and Biological Sciences, V6, P144; Pickering Jane, 1996, Australian Mammalogy, V19, P19; Promkerd P, 2008, INTEGR ZOOL, V3, P11, DOI 10.1111/j.1749-4877.2008.00069.x; ROBERTSON GP, 1987, ECOLOGY, V68, P744, DOI 10.2307/1938482; Rosevear D, 1969, RODENTS W AFRICA; Salifou A, 2010, HIST NIGER EPOQUES P; Sidikou HA, 2011, NIAMEYA360; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Taylor PJ, 2008, INTEGR ZOOL, V3, P38, DOI 10.1111/j.1749-4877.2008.00072.x; United Nations Development Program, 2012, WORLD URB PROSP 2011; Veyrunes F, 2005, MOL PHYLOGENET EVOL, V36, P358, DOI 10.1016/j.ympev.2005.02.011; WEBSTER R, 1990, STAT METHODS SOIL LA; Wilson DE, 2005, MAMMAL SPECIES WORL; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602	78	21	22	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e110666	10.1371/journal.pone.0110666	http://dx.doi.org/10.1371/journal.pone.0110666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379785	Green Published, gold			2022-12-26	WOS:000344863100013
J	Iwata, A; Morrison, ML; Roth, MB				Iwata, Akiko; Morrison, Michael L.; Roth, Mark B.			Iodide Protects Heart Tissue from Reperfusion Injury	PLOS ONE			English	Article							ANIMATION-LIKE STATE; OXIDATIVE STRESS; KINETICS; MICE	Iodine is an elemental nutrient that is essential for mammals. Here we provide evidence for an acute therapeutic role for iodine in ischemia reperfusion injury. Infusion of the reduced form, iodide, but not the oxidized form iodate, reduces heart damage by as much as 75% when delivered intravenously following temporary loss of blood flow but prior to reperfusion of the heart in a mouse model of acute myocardial infarction. Normal thyroid function may be required because loss of thyroid activity abrogates the iodide benefit. Given the high degree of protection and the high degree of safety, iodide should be explored further as a therapy for reperfusion injury.	[Iwata, Akiko; Morrison, Michael L.; Roth, Mark B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Roth, MB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	mroth@fhcrc.org			Defense Advanced Research Projects Administration [D12AP00008]	Defense Advanced Research Projects Administration	This work was funded by Defense Advanced Research Projects Administration grant # D12AP00008. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, COMPREHENSIVE HDB IO; Billat LV, 1996, SPORTS MED, V22, P90, DOI 10.2165/00007256-199622020-00004; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; Carpenter KJ, 2005, J NUTR, V135, P675, DOI 10.1093/jn/135.4.675; COFFMAN JD, 1961, AM J PHYSIOL, V201, P881, DOI 10.1152/ajplegacy.1961.201.5.881; COOPER DS, 1984, NEW ENGL J MED, V311, P1353, DOI 10.1056/NEJM198411223112106; Crockford SJ, 2009, INTEGR COMP BIOL, V49, P155, DOI 10.1093/icb/icp053; Dabrowski MJ, 2013, POSTEP KARDIOL INTER, V9, P41, DOI 10.5114/pwki.2013.34027; Kloner RA, 2011, J CARDIOVASC PHARM T, V16, P244, DOI 10.1177/1074248411405990; Leung AM, 2014, NAT REV ENDOCRINOL, V10, P136, DOI 10.1038/nrendo.2013.251; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; Panneels V, 2009, COMPREHENSIVE HDB IO; Pavelka S, 2000, BIOL TRACE ELEM RES, V76, P67, DOI 10.1385/BTER:76:1:67; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Risher J DG, 2004, TOXICOLOGY; Schwartz Longacre L, 2011, CIRCULATION, V124, P1172, DOI 10.1161/CIRCULATIONAHA.111.032698; Senthil SS, 2004, CLIN CHIM ACTA, V348, P131, DOI 10.1016/j.cccn.2004.05.004; Sterling JB, 2000, J AM ACAD DERMATOL, V43, P691, DOI 10.1067/mjd.2000.107247; Tatzber F, 2003, ANAL BIOCHEM, V316, P147, DOI 10.1016/S0003-2697(02)00652-8; TAUROG A, 1966, J BIOL CHEM, V241, P4686; WOLFF J, 1948, ENDOCRINOLOGY, V43, P174, DOI 10.1210/endo-43-3-174; Wong GTF, 2008, MAR CHEM, V111, P22, DOI 10.1016/j.marchem.2007.04.007	23	13	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112458	10.1371/journal.pone.0112458	http://dx.doi.org/10.1371/journal.pone.0112458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379708	Green Submitted, gold, Green Published			2022-12-26	WOS:000344863100101
J	Li, J; Inada, S; Schneider, JE; Zhang, HG; Dobrzynski, H; Boyett, MR				Li, Jue; Inada, Shin; Schneider, Jurgen E.; Zhang, Henggui; Dobrzynski, Halina; Boyett, Mark R.			Three-Dimensional Computer Model of the Right Atrium Including the Sinoatrial and Atrioventricular Nodes Predicts Classical Nodal Behaviours	PLOS ONE			English	Article							RECTIFIER POTASSIUM CURRENT; ACTION-POTENTIAL DURATION; MATHEMATICAL-MODEL; PACEMAKER ACTIVITY; ELECTRICAL-ACTIVITY; IONIC MECHANISMS; SINUS NODE; ELECTROPHYSIOLOGICAL MODEL; REGIONAL DIFFERENCES; MEMBRANE CURRENTS	The aim of the study was to develop a three-dimensional (3D) anatomically-detailed model of the rabbit right atrium containing the sinoatrial and atrioventricular nodes to study the electrophysiology of the nodes. A model was generated based on 3D images of a rabbit heart (atria and part of ventricles), obtained using high-resolution magnetic resonance imaging. Segmentation was carried out semi-manually. A 3D right atrium array model (similar to 3.16 million elements), including eighteen objects, was constructed. For description of cellular electrophysiology, the Rogers-modified FitzHugh-Nagumo model was further modified to allow control of the major characteristics of the action potential with relatively low computational resource requirements. Model parameters were chosen to simulate the action potentials in the sinoatrial node, atrial muscle, inferior nodal extension and penetrating bundle. The block zone was simulated as passive tissue. The sinoatrial node, crista terminalis, main branch and roof bundle were considered as anisotropic. We have simulated normal and abnormal electrophysiology of the two nodes. In accordance with experimental findings: (i) during sinus rhythm, conduction occurs down the interatrial septum and into the atrioventricular node via the fast pathway (conduction down the crista terminalis and into the atrioventricular node via the slow pathway is slower); (ii) during atrial fibrillation, the sinoatrial node is protected from overdrive by its long refractory period; and (iii) during atrial fibrillation, the atrioventricular node reduces the frequency of action potentials reaching the ventricles. The model is able to simulate ventricular echo beats. In summary, a 3D anatomical model of the right atrium containing the cardiac conduction system is able to simulate a wide range of classical nodal behaviours.	[Li, Jue; Inada, Shin; Schneider, Jurgen E.; Zhang, Henggui; Dobrzynski, Halina; Boyett, Mark R.] Univ Manchester, Inst Cardiovasc Sci, Core Technol Facil, Manchester, Lancs, England	University of Manchester	Boyett, MR (corresponding author), Univ Manchester, Inst Cardiovasc Sci, Core Technol Facil, Manchester, Lancs, England.	mark.boyett@manchester.ac.uk	Zhang, Henggui/D-6712-2011; Li, Jue/G-9935-2015; Zhang, Henggui/AAM-1043-2020	Li, Jue/0000-0001-7902-0263; Dobrzynski, Halina/0000-0003-4754-5975; Boyett, Mark/0000-0003-3931-2020	British Heart Foundation [RG/11/18/29257]; BHF Senior Basic Science Research [FS/11/50/29038]; British Heart Foundation [FS/14/5/30533, FS/11/50/29038] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J00958X/1] Funding Source: researchfish; EPSRC [EP/J00958X/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); BHF Senior Basic Science Research; British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study is financially supported by a programme grant from the British Heart Foundation (RG/11/18/29257). Jurgen E. Schneider is a BHF Senior Basic Science Research Fellow (FS/11/50/29038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Aslanidi OV, 2010, BIOPHYS J, V98, P2420, DOI 10.1016/j.bpj.2010.02.033; Aslanidi OV, 2009, BIOPHYS J, V96, P798, DOI 10.1016/j.bpj.2008.09.057; BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; Benson AP, 2008, PROG BIOPHYS MOL BIO, V96, P187, DOI 10.1016/j.pbiomolbio.2007.08.002; Bernus O, 2003, INT J BIFURCAT CHAOS, V13, P3693, DOI 10.1142/S021812740300896X; Bernus O, 2002, AM J PHYSIOL-HEART C, V282, pH2296, DOI 10.1152/ajpheart.00731.2001; BLEEKER WK, 1980, CIRC RES, V46, P11, DOI 10.1161/01.RES.46.1.11; Bondarenko VE, 2004, AM J PHYSIOL-HEART C, V287, pH1378, DOI 10.1152/ajpheart.00185.2003; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; Boyett MR, 2005, J ELECTROCARDIOL, V38, P113, DOI 10.1016/j.jelectrocard.2005.06.102; Boyett MR, 1999, AM J PHYSIOL-HEART C, V276, pH686, DOI 10.1152/ajpheart.1999.276.2.H686; Chandler N, 2011, ANAT REC, V294, P970, DOI 10.1002/ar.21379; Clayton RH, 2009, PHYSICA D, V238, P951, DOI 10.1016/j.physd.2008.06.008; COAKLEY JB, 1959, J ANAT, V93, P30; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; DECARVALHO AP, 1960, CIRC RES, V8, P801, DOI 10.1161/01.RES.8.4.801; DECARVALHO AP, 1959, AM J PHYSIOL, V196, P483, DOI 10.1152/ajplegacy.1959.196.3.483; Decker KF, 2009, AM J PHYSIOL-HEART C, V296, pH1017, DOI 10.1152/ajpheart.01216.2008; Demir SS, 1999, AM J PHYSIOL-HEART C, V276, pH2221, DOI 10.1152/ajpheart.1999.276.6.H2221; DEMIR SS, 1994, AM J PHYSIOL, V266, pC832, DOI 10.1152/ajpcell.1994.266.3.C832; DENYER JC, 1990, J PHYSIOL-LONDON, V428, P405, DOI 10.1113/jphysiol.1990.sp018219; DIFRANCESCO D, 1985, PHILOS T ROY SOC B, V307, P353, DOI 10.1098/rstb.1985.0001; Dobrzynski H, 2005, CIRCULATION, V111, P846, DOI 10.1161/01.CIR.0000152100.04087.DB; Dokos S, 1996, J THEOR BIOL, V181, P245, DOI 10.1006/jtbi.1996.0129; Efimov IR, 2004, ANAT REC PART A, V280A, P952, DOI 10.1002/ar.a.20108; EIFLER WJ, 1981, CIRC RES, V48, P168, DOI 10.1161/01.RES.48.2.168; Fedorov VV, 2006, AM J PHYSIOL-HEART C, V291, pH612, DOI 10.1152/ajpheart.00022.2006; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fink M, 2008, PROG BIOPHYS MOL BIO, V96, P357, DOI 10.1016/j.pbiomolbio.2007.07.011; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Fozzard HA., 1991, HEART CARDIOVASCULAR; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Harrild DM, 2000, CIRC RES, V87, pE25; HILGEMANN DW, 1987, PROC R SOC SER B-BIO, V230, P163, DOI 10.1098/rspb.1987.0015; HOLDEN AV, 1993, J CHEM SOC FARADAY T, V89, P2833, DOI 10.1039/ft9938902833; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Inada S, 2009, BIOPHYS J, V97, P2117, DOI 10.1016/j.bpj.2009.06.056; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; KERR CR, 1980, CIRC RES, V47, P742, DOI 10.1161/01.RES.47.5.742; Kharche S, 2011, AM J PHYSIOL-HEART C, V301, pH945, DOI 10.1152/ajpheart.00143.2010; KIRCHHOF CJHJ, 1992, CIRCULATION, V86, P263, DOI 10.1161/01.CIR.86.1.263; Kneller J, 2002, CIRC RES, V90, pE73, DOI 10.1161/01.RES.0000019783.88094.BA; Kodama I, 1997, AM J PHYSIOL-HEART C, V272, pH2793, DOI 10.1152/ajpheart.1997.272.6.H2793; Kurata Y, 2002, AM J PHYSIOL-HEART C, V283, pH2074, DOI 10.1152/ajpheart.00900.2001; Lei M, 2002, CARDIOVASC RES, V53, P68, DOI 10.1016/S0008-6363(01)00459-X; Li H, 2014, J AGING RES, V2014; Li J, 2005, COMPUT CARDIOL, V32, P603; Li J, 2004, COMPUT CARDIOL, V31, P89, DOI 10.1109/CIC.2004.1442878; Li J, 2009, COMPUT CARDIOL, V36, P65; Li J, 2008, CIRC RES, V102, P975, DOI 10.1161/CIRCRESAHA.108.172403; Lin LJ, 2001, J CARDIOVASC ELECTR, V12, P479, DOI 10.1046/j.1540-8167.2001.00479.x; Lindblad DS, 1996, AM J PHYSIOL-HEART C, V271, pH1666, DOI 10.1152/ajpheart.1996.271.4.H1666; Litchenberg WH, 2000, CARDIOVASC RES, V45, P379, DOI 10.1016/S0008-6363(99)00363-6; LORANGE M, 1993, J ELECTROCARDIOL, V26, P245, DOI 10.1016/0022-0736(93)90047-H; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; MAZGALEV T, 1982, AM J PHYSIOL, V243, pH754, DOI 10.1152/ajpheart.1982.243.5.H754; Mazgalev T., 2000, ATRIAL AV NODAL ELEC; MCALLISTER RE, 1975, J PHYSIOL-LONDON, V251, P1; NAKAYAMA T, 1984, PFLUG ARCH EUR J PHY, V402, P248, DOI 10.1007/BF00585507; NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365, DOI 10.1152/ajpheart.1991.260.4.H1365; Nikolski VP, 2003, CIRC RES, V92, P469, DOI 10.1161/01.RES.0000059304.97120.2F; Noble D, 1998, CAN J CARDIOL, V14, P123; Nygren A, 1998, CIRC RES, V82, P63; Oehmen CS, 2002, J CARDIOVASC ELECTR, V13, P1131, DOI 10.1046/j.1540-8167.2002.01131.x; Oliveira M, 2011, EXP PHYSIOL, V96, P125, DOI 10.1113/expphysiol.2010.053280; ONO K, 1995, AM J PHYSIOL-HEART C, V269, pH453, DOI 10.1152/ajpheart.1995.269.2.H453; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Puglisi JL, 2001, AM J PHYSIOL-CELL PH, V281, pC2049, DOI 10.1152/ajpcell.2001.281.6.C2049; Ramirez RJ, 2000, AM J PHYSIOL-HEART C, V279, pH1767, DOI 10.1152/ajpheart.2000.279.4.H1767; Reid MC, 2003, J CARDIOVASC ELECTR, V14, P1342, DOI 10.1046/j.1540-8167.2003.03382.x; ROGERS JM, 1994, IEEE T BIO-MED ENG, V41, P743, DOI 10.1109/10.310090; Sachse FB, 2000, P 3 US C NAT LIB MED; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shaw RM, 1997, CARDIOVASC RES, V35, P256, DOI 10.1016/S0008-6363(97)00093-X; SPACH MS, 1971, CIRC RES, V29, P156, DOI 10.1161/01.RES.29.2.156; Stephenson RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035299; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Toshida N, 2001, J CARDIOVASC ELECTR, V12, P1256, DOI 10.1046/j.1540-8167.2001.01256.x; VANGINNEKEN ACG, 1991, J PHYSIOL-LONDON, V434, P57, DOI 10.1113/jphysiol.1991.sp018459; VERHEIJCK EE, 1995, CIRC RES, V76, P607, DOI 10.1161/01.RES.76.4.607; Vetter FJ, 1998, PROG BIOPHYS MOL BIO, V69, P157, DOI 10.1016/S0079-6107(98)00006-6; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; Wilders R, 1996, AM J PHYSIOL-HEART C, V271, pH2168, DOI 10.1152/ajpheart.1996.271.5.H2168; WILDERS R, 1991, BIOPHYS J, V60, P1202, DOI 10.1016/S0006-3495(91)82155-5; WINSLOW RL, 1993, P ROY SOC B-BIOL SCI, V254, P55, DOI 10.1098/rspb.1993.0126; Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571; Wu JY, 2001, AM J PHYSIOL-HEART C, V280, pH1232, DOI 10.1152/ajpheart.2001.280.3.H1232; Xianda C., 2003, CHINESE J CARDIAC PA, V17, P22; Xiao JJ, 2010, MED SCI MONITOR, V16, pBR353; Yamamoto M, 1998, CARDIOVASC RES, V39, P360, DOI 10.1016/S0008-6363(98)00091-1; YAMASHITA T, 1995, CIRCULATION, V92, P3061, DOI 10.1161/01.CIR.92.10.3061; YANAGIHARA K, 1980, JPN J PHYSIOL, V30, P841; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140; Zhang H, 2000, AM J PHYSIOL-HEART C, V279, pH397, DOI 10.1152/ajpheart.2000.279.1.H397	96	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112547	10.1371/journal.pone.0112547	http://dx.doi.org/10.1371/journal.pone.0112547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380074	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100106
J	Zheng, XJ; Demirci, FY; Barmada, MM; Richardson, GA; Lopez, OL; Sweet, RA; Kamboh, MI; Feingold, E				Zheng, Xiaojing; Demirci, F. Yesim; Barmada, M. Michael; Richardson, Gale A.; Lopez, Oscar L.; Sweet, Robert A.; Kamboh, M. Ilyas; Feingold, Eleanor			A Rare Duplication on Chromosome 16p11.2 Is Identified in Patients with Psychosis in Alzheimer's Disease	PLOS ONE			English	Article							COPY NUMBER VARIATION; DOWN-REGULATION; MICRODELETION; RISK; SCHIZOPHRENIA; ASSOCIATION; LYMPHOCYTES; EXPRESSION; PRECURSOR; DELETIONS	Epidemiological and genetic studies suggest that schizophrenia and autism may share genetic links. Besides common single nucleotide polymorphisms, recent data suggest that some rare copy number variants (CNVs) are risk factors for both disorders. Because we have previously found that schizophrenia and psychosis in Alzheimer's disease (AD+P) share some genetic risk, we investigated whether CNVs reported in schizophrenia and autism are also linked to AD+P. We searched for CNVs associated with AD+P in 7 recurrent CNV regions that have been previously identified across autism and schizophrenia, using the Illumina HumanOmni1-Quad BeadChip. A chromosome 16p11.2 duplication CNV (chr16: 29,554,843-30,105,652) was identified in 2 of 440 AD+P subjects, but not in 136 AD subjects without psychosis, or in 593 AD subjects with intermediate psychosis status, or in 855 non-AD individuals. The frequency of this duplication CNV in AD+P (0.46%) was similar to that reported previously in schizophrenia (0.46%). This duplication CNV was further validated using the NanoString nCounter CNV Custom CodeSets. The 16p11.2 duplication has been associated with developmental delay, intellectual disability, behavioral problems, autism, schizophrenia (SCZ), and bipolar disorder. These two AD+P patients had no personal of, nor any identified family history of, SCZ, bipolar disorder and autism. To the best of our knowledge, our case report is the first suggestion that 16p11.2 duplication is also linked to AD+P. Although rare, this CNV may have an important role in the development of psychosis.	[Zheng, Xiaojing; Feingold, Eleanor] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Demirci, F. Yesim; Barmada, M. Michael; Kamboh, M. Ilyas; Feingold, Eleanor] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Richardson, Gale A.; Sweet, Robert A.; Kamboh, M. Ilyas] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15261 USA; [Lopez, Oscar L.; Sweet, Robert A.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Lopez, Oscar L.; Sweet, Robert A.; Kamboh, M. Ilyas] VA Pittsburgh Healthcare Syst, VISN Mental Illness Res Educ & Clin Ctr 4, Pittsburgh, PA USA; [Richardson, Gale A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Zheng, Xiaojing] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zheng, XJ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA.	xiaojinz@email.unc.edu		Kamboh, M. Ilyas/0000-0002-3453-1438; Demirci, F. Yesim/0000-0001-6907-9843; Barmada, M Michael/0000-0002-3604-6460; Feingold, Eleanor/0000-0003-2898-6484	National Institute on Aging [AG030653, AG041718, AG005133, AG027224]; NanoString award; NIMH Grant [T32 MH015169]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030653, R01AG041718, P50AG005133, R01AG027224] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NanoString award; NIMH Grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging grants AG030653, AG041718 (MIK), AG005133 (OLL), and AG027224 (RAS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Department of Veterans Affairs or the United States Government. Funding for experimental validation was provided by NanoString award. This work was conducted in partial fulfillment of requirements for the first author's doctoral degree, supported by NIMH Grant T32 MH015169 (G.A.R., Program Director). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacanu SA, 2005, AM J GERIAT PSYCHIAT, V13, P624, DOI 10.1176/appi.ajgp.13.7.624; Bartolome F, 2007, CELL MOL LIFE SCI, V64, P1437, DOI 10.1007/s00018-007-7081-3; Bedoyan JK, 2010, AM J MED GENET A, V152A, P1567, DOI 10.1002/ajmg.a.33415; Bowden NA, 2006, SCHIZOPHR RES, V82, P175, DOI 10.1016/j.schres.2005.11.012; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; Carson R, 2008, NEUROMOL MED, V10, P377, DOI 10.1007/s12017-008-8048-8; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; DeMichele-Sweet MA, 2010, J ALZHEIMERS DIS, V19, P761, DOI 10.3233/JAD-2010-1274; DeMichele-Sweet MAA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.10.003; Esteras N, 2013, NEUROBIOL AGING, V34, P1090, DOI 10.1016/j.neurobiolaging.2012.10.014; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feld M, 2014, J ALZHEIMERS DIS, V40, P69, DOI 10.3233/JAD-131076; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Go RCP, 2005, AM J MED GENET B, V139B, P28, DOI 10.1002/ajmg.b.30219; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Hollingworth P, 2012, MOL PSYCHIATR, V17, P1316, DOI 10.1038/mp.2011.125; Jordan-Sciutto KL, 2000, BIOCHEMISTRY-US, V39, P3206, DOI 10.1021/bi992211q; Kamboh MI, 2012, MOL PSYCHIATR, V17, P1340, DOI 10.1038/mp.2011.135; Kamboh MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.45; Matsuo A, 1996, J NEUROIMMUNOL, V71, P81, DOI 10.1016/S0165-5728(96)00134-8; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miller CL, 2008, NEUROCHEM INT, V52, P1297, DOI 10.1016/j.neuint.2008.01.013; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Morris DW, 2014, HUM MOL GENET, V23, P3316, DOI 10.1093/hmg/ddu025; Poon HF, 2005, MOL BRAIN RES, V138, P8, DOI 10.1016/j.molbrainres.2005.02.020; Quintero-Rivera F, 2010, AM J MED GENET A, V152A, P2459, DOI 10.1002/ajmg.a.33573; R Development Core Team, 2012, R LANG ENV STAT COMP; Ropacki SA, 2005, AM J PSYCHIAT, V162, P2022, DOI 10.1176/appi.ajp.162.11.2022; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Spitzer Philipp, 2011, Int J Alzheimers Dis, V2011, P739847, DOI 10.4061/2011/739847; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Steinberg S, 2014, MOL PSYCHIATR, V19, P108, DOI 10.1038/mp.2012.157; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sweet RA, 2003, MOL PSYCHIATR, V8, P383, DOI 10.1038/sj.mp.4001262; TARIOT PN, 1995, AM J PSYCHIAT, V152, P1349; Ting KK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-36; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	46	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111462	10.1371/journal.pone.0111462	http://dx.doi.org/10.1371/journal.pone.0111462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379732	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000344863100030
J	Pel, MJC; Wintermans, PCA; Cabral, A; Robroek, BJM; Seidl, MF; Bautor, J; Parker, JE; Van den Ackerveken, G; Pieterse, CMJ				Pel, Michiel J. C.; Wintermans, Paul C. A.; Cabral, Adriana; Robroek, Bjorn J. M.; Seidl, Michael F.; Bautor, Jaqueline; Parker, Jane E.; Van den Ackerveken, Guido; Pieterse, Corne M. J.			Functional Analysis of Hyaloperonospora arabidopsidis RXLR Effectors	PLOS ONE			English	Article							POTATO FAMINE PATHOGEN; HOST-TARGETING SIGNAL; PHYTOPHTHORA-INFESTANS; DOWNY MILDEW; SALICYLIC-ACID; PLANT IMMUNITY; BACTERIAL FLAGELLIN; SYSTEMIC RESISTANCE; DISEASE RESISTANCE; OOMYCETE EFFECTORS	The biotrophic plant pathogen Hyaloperonospora arabidopsidis produces a set of putative effector proteins that contain the conserved RXLR motif. For most of these RXLR proteins the role during infection is unknown. Thirteen RXLR proteins from H. arabidopsidis strain Waco9 were analyzed for sequence similarities and tested for a role in virulence. The thirteen RXLR proteins displayed conserved N-termini and this N-terminal conservation was also found in the 134 predicted RXLR genes from the genome of H. arabidopsidis strain Emoy2. To investigate the effects of single RXLR effector proteins on plant defense responses, thirteen H. arabidopsidis Waco9 RXLR genes were expressed in Arabidopsis thaliana. Subsequently, these plants were screened for altered susceptibility to the oomycetes H. arabidopsidis and Phytophthora capsici, and the bacterial pathogen Pseudomonas syringae. Additionally, the effect of the RXLR proteins on flg22-triggered basal immune responses was assessed. Multifactorial analysis of results collated from all experiments revealed that, except for RXLR20, all RXLR effector proteins tested affected plant immunity. For RXLR9 this was confirmed using a P. syringae DCEL-mediated effector delivery system. Together, the results show that many H. arabidopsidis RXLR effectors have small effects on the plant immune response, suggesting that suppression of host immunity by this biotrophic pathogen is likely to be caused by the combined actions of effectors.	[Pel, Michiel J. C.; Wintermans, Paul C. A.; Cabral, Adriana; Robroek, Bjorn J. M.; Seidl, Michael F.; Van den Ackerveken, Guido; Pieterse, Corne M. J.] Univ Utrecht, Fac Sci, Dept Biol, Plant Microbe Interact, Utrecht, Netherlands; [Pel, Michiel J. C.; Seidl, Michael F.; Van den Ackerveken, Guido; Pieterse, Corne M. J.] Ctr BioSyst Genom, Wageningen, Netherlands; [Bautor, Jaqueline; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Cologne, Germany	Utrecht University; Centre for BioSystems Genomics; Max Planck Society	Pieterse, CMJ (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, Plant Microbe Interact, Utrecht, Netherlands.	C.M.J.Pieterse@uu.nl	Seidl, Michael F./ABD-6042-2021; Robroek, Bjorn/P-7929-2016; Pel, Michiel/A-3638-2014; Van den Ackerveken, Guido/B-8568-2011; Pieterse, Corné/A-9326-2011; Cabral, Adriana/AAX-3284-2021	Robroek, Bjorn/0000-0002-6714-0652; Van den Ackerveken, Guido/0000-0002-0183-8978; Pieterse, Corné/0000-0002-5473-4646; Seidl, Michael F/0000-0002-5218-2083	Centre for BioSystems Genomics [CBSG-PG7, CBSG-PG8, CBSG-BB16]; European Research Council (ERC) [269072]	Centre for BioSystems Genomics; European Research Council (ERC)(European Research Council (ERC))	This work was supported by the Centre for BioSystems Genomics [projects CBSG-PG7, CBSG-PG8 and CBSG-BB16] and the European Research Council (ERC) [ERC Advanced Grant agreement number 269072 - PLANTIMMUSYS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARIZTIA EV, 1991, J PHYCOL, V27, P428, DOI 10.1111/j.0022-3646.1991.00428.x; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Cabral A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019328; Caillaud MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001732; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fabro G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002348; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FINCHAM JRS, 1989, MICROBIOL REV, V53, P148, DOI 10.1128/MMBR.53.1.148-170.1989; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Goritschnig S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002502; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Haverkort AJ, 2008, POTATO RES, V51, P47, DOI 10.1007/s11540-008-9089-y; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hoagland DR, 1938, Calif Agric Exp Stn Bull, V347, P36; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Jassey VEJ, 2011, GLOBAL CHANGE BIOL, V17, P2945, DOI 10.1111/j.1365-2486.2011.02437.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; JUDELSON HS, 1993, GENE, V133, P63, DOI 10.1016/0378-1119(93)90225-R; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pel MJC, 2013, J EXP BOT, V64, P1237, DOI 10.1093/jxb/ers262; Perumal R, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-77; Petre B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001801; PIETERSE CMJ, 1991, PLANT MOL BIOL, V17, P799, DOI 10.1007/BF00037062; Pieterse CMJ, 1996, PLANT CELL, V8, P1225, DOI 10.1105/tpc.8.8.1225; PIETERSE CMJ, 1994, MOL GEN GENET, V244, P269, DOI 10.1007/BF00285454; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; R Core Team, 2012, R LANG ENV STAT COMP; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Suzuki R, 2011, PVCLUST HIERARCHICAL; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2009, PLANT CELL, V21, P2179, DOI 10.1105/tpc.109.066811; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; van Wees SCM, 1999, PLANT MOL BIOL, V41, P537, DOI 10.1023/A:1006319216982; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wang Y, 2013, PLANT CELL ENVIRON, V36, P1192, DOI 10.1111/pce.12052; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108	68	10	11	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110624	10.1371/journal.pone.0110624	http://dx.doi.org/10.1371/journal.pone.0110624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375163	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600018
J	Ekwaru, JP; Zwicker, JD; Holick, MF; Giovannucci, E; Veugelers, PJ				Ekwaru, John Paul; Zwicker, Jennifer D.; Holick, Michael F.; Giovannucci, Edward; Veugelers, Paul J.			The Importance of Body Weight for the Dose Response Relationship of Oral Vitamin D Supplementation and Serum 25-Hydroxyvitamin D in Healthy Volunteers	PLOS ONE			English	Article							D DEFICIENCY; WOMEN	Unlike vitamin D recommendations by the Institute of Medicine, the Clinical Practice Guidelines by the Endocrine Society acknowledge body weight differentials and recommend obese subjects be given two to three times more vitamin D to satisfy their body's vitamin D requirement. However, the Endocrine Society also acknowledges that there are no good studies that clearly justify this. In this study we examined the combined effect of vitamin D supplementation and body weight on serum 25-hydroxyvitamin (25(OH)D) and serum calcium in healthy volunteers. We analyzed 22,214 recordings of vitamin D supplement use and serum 25(OH)D from 17,614 healthy adult volunteers participating in a preventive health program. This program encourages the use of vitamin D supplementation and monitors its use and serum 25(OH)D and serum calcium levels. Participants reported vitamin D supplementation ranging from 0 to 55,000 IU per day and had serum 25(OH) D levels ranging from 10.1 to 394 nmol/L. The dose response relationship between vitamin D supplementation and serum 25(OH)D followed an exponential curve. On average, serum 25(OH)D increased by 12.0 nmol/L per 1,000 IU in the supplementation interval of 0 to 1,000 IU per day and by 1.1 nmol/L per 1,000 IU in the supplementation interval of 15,000 to 20,000 IU per day. BMI, relative to absolute body weight, was found to be the better determinant of 25(OH)D. Relative to normal weight subjects, obese and overweight participants had serum 25(OH)D that were on average 19.8 nmol/L and 8.0 nmol/L lower, respectively (P<0.001). We did not observe any increase in the risk for hypercalcemia with increasing vitamin D supplementation. We recommend vitamin D supplementation be 2 to 3 times higher for obese subjects and 1.5 times higher for overweight subjects relative to normal weight subjects. This observational study provides body weight specific recommendations to achieve 25(OH)D targets.	[Ekwaru, John Paul; Veugelers, Paul J.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Zwicker, Jennifer D.] Univ Calgary, Sch Publ Policy, Calgary, AB, Canada; [Holick, Michael F.] Boston Univ, Sch Med, Dept Med, Sect Endocrinol Nutr & Diabet, Boston, MA 02118 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Alberta; University of Calgary; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Veugelers, PJ (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	paul.veugelers@ualberta.ca		Veugelers, Paul/0000-0001-8996-0822	Alberta Innovates Health Scholarship; Canada Research Chair through the Canadian Institutes for Health Research; School of Public Health at the University of Alberta through a thematic research; Alberta provincial government through Alberta Innovates Health Solutions	Alberta Innovates Health Scholarship; Canada Research Chair through the Canadian Institutes for Health Research; School of Public Health at the University of Alberta through a thematic research; Alberta provincial government through Alberta Innovates Health Solutions	This is an analysis of secondary data. The data had been collected for the purpose of lifestyle counseling of participants of a preventive health program. None of the authors are involved in the execution of this program neither do they provide financial support for the data collection. PJV holds a Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention, and an Alberta Innovates Health Scholarship. The funding for the Canada Research Chair is provided through the Canadian Institutes for Health Research to the University of Alberta. The Alberta Research Chair is awarded by the School of Public Health at the University of Alberta through a thematic research contract with the Pure North S'Energy Foundation. The Health Scholarship is funded by the Alberta provincial government through Alberta Innovates Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Bischoff-Ferrari HA, 2010, OSTEOPOROSIS INT, V21, P1121, DOI 10.1007/s00198-009-1119-3; Blum M, 2008, J AM COLL NUTR, V27, P274, DOI 10.1080/07315724.2008.10719700; Chao YS, 2013, OCCUP MED-OXFORD, V63, P485, DOI 10.1093/occmed/kqt106; Chao YS, 2013, NUTRIENTS, V5, P4067, DOI 10.3390/nu5104067; Cianferotti L, 2012, BEST PRACT RES CL EN, V26, P523, DOI 10.1016/j.beem.2011.12.007; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; DiVasta AD, 2011, J CLIN ENDOCR METAB, V96, P2575, DOI 10.1210/jc.2011-0243; Drincic A, 2013, J CLIN ENDOCR METAB, V98, P4845, DOI 10.1210/jc.2012-4103; Ebeling Peter R, 2014, Bonekey Rep, V3, P511, DOI 10.1038/bonekey.2014.6; Gallagher JC, 2012, ANN INTERN MED, V156, P425, DOI 10.7326/0003-4819-156-6-201203200-00005; Gallagher JC, 2013, J BONE MINER RES; Garland CF, 2011, ANTICANCER RES, V31, P607; Hathcock JN, 2007, AM J CLIN NUTR, V85, P6, DOI 10.1093/ajcn/85.1.6; Health Canada, VIT D CALC UPD DIET; Heaney RP, 2013, ADV NUTR, V4, P303, DOI 10.3945/an.113.003731; Heaney RP, 2011, AM J CLIN NUTR, V94, P619, DOI 10.3945/ajcn.111.019539; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Holick MF, 2010, NUTR HEALTH SER, P1, DOI 10.1007/978-1-60327-303-9; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2012, J CLIN ENDOCR METAB, V97, P1153, DOI 10.1210/jc.2011-2601; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Institute of Medicine, 2011, DIETARY REFERENCE IN; Langlois Kellie, 2010, Health Rep, V21, P47; Lee P, 2009, AM J MED, V122, P1056, DOI 10.1016/j.amjmed.2009.06.008; Luxwolda MF, 2012, BRIT J NUTR, V108, P1557, DOI 10.1017/S0007114511007161; Nelson ML, 2009, J NUTR, V139, P540, DOI 10.3945/jn.108.096180; Sanabria Álvaro, 2011, Rev. salud pública, V13, P804; Shab-Bidar S, 2013, EUR J ENDOCRINOL, V169, P597, DOI 10.1530/EJE-13-0068; Tepper S, 2013, J STEROID BIOCH MOL; Vieth R, 2006, J NUTR, V136, P1117, DOI 10.1093/jn/136.4.1117; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Vieth R, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P995; Winzenberg T, 2013, CALCIFIED TISSUE INT, V92, P140, DOI 10.1007/s00223-012-9615-4; World Health Organization, 2006, BMI CLASS INT CLASS; Zittermann A, 2013, EUR J NUTR	37	132	138	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111265	10.1371/journal.pone.0111265	http://dx.doi.org/10.1371/journal.pone.0111265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372709	Green Published, gold			2022-12-26	WOS:000344556900040
J	Pontieri, L; Vojvodic, S; Graham, R; Pedersen, JS; Linksvayer, TA				Pontieri, Luigi; Vojvodic, Svjetlana; Graham, Riley; Pedersen, Jes Soe; Linksvayer, Timothy A.			Ant Colonies Prefer Infected over Uninfected Nest Sites	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; ENTOMOPATHOGENIC FUNGUS; REPELLENCY; AVOIDANCE; VIRULENCE; IMMUNITY	During colony relocation, the selection of a new nest involves exploration and assessment of potential sites followed by colony movement on the basis of a collective decision making process. Hygiene and pathogen load of the potential nest sites are factors worker scouts might evaluate, given the high risk of epidemics in group-living animals. Choosing nest sites free of pathogens is hypothesized to be highly efficient in invasive ants as each of their introduced populations is often an open network of nests exchanging individuals (unicolonial) with frequent relocation into new nest sites and low genetic diversity, likely making these species particularly vulnerable to parasites and diseases. We investigated the nest site preference of the invasive pharaoh ant, Monomorium pharaonis, through binary choice tests between three nest types: nests containing dead nestmates overgrown with sporulating mycelium of the entomopathogenic fungus Metarhizium brunneum (infected nests), nests containing nestmates killed by freezing (uninfected nests), and empty nests. In contrast to the expectation pharaoh ant colonies preferentially (84%) moved into the infected nest when presented with the choice of an infected and an uninfected nest. The ants had an intermediate preference for empty nests. Pharaoh ants display an overall preference for infected nests during colony relocation. While we cannot rule out that the ants are actually manipulated by the pathogen, we propose that this preference might be an adaptive strategy by the host to "immunize'' the colony against future exposure to the same pathogenic fungus.	[Pontieri, Luigi; Pedersen, Jes Soe] Univ Copenhagen, Ctr Social Evolut, Dept Biol, Copenhagen, Denmark; [Vojvodic, Svjetlana] Univ Arizona, Ctr Insect Sci, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Vojvodic, Svjetlana] Rowan Univ, Dept Biol Sci, Glassboro, NJ USA; [Graham, Riley; Linksvayer, Timothy A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Copenhagen; University of Arizona; Rowan University; University of Pennsylvania	Pontieri, L (corresponding author), Univ Copenhagen, Ctr Social Evolut, Dept Biol, Copenhagen, Denmark.	lpontieri@bio.ku.dk	Pedersen, Jes Søe/J-6337-2014	Pedersen, Jes Søe/0000-0002-4439-2638; Linksvayer, Timothy/0000-0001-7034-1546; Pontieri, Luigi/0000-0002-1506-3827; Vojvodic Kruse, Svjetlana/0000-0003-0660-6540	Danish National Research Foundation [DNRF57]; NIH-PERT fellowship [K12GM000708]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	Danish National Research Foundation(Danmarks Grundforskningsfond); NIH-PERT fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LP and JSP were funded by the Danish National Research Foundation (grant DNRF57) to the Centre for Social Evolution. SV was funded by NIH-PERT fellowship K12GM000708. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Boucias DG, 2012, BIOCOMMUNICATION FUN, P305, DOI DOI 10.1007/978-94-007-4264-2_20; Brutsch T, 2014, MYRMECOL NEWS, V20, P71; Buczkowski G, 2009, ETHOLOGY, V115, P1091, DOI 10.1111/j.1439-0310.2009.01698.x; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Davis TS, 2013, J CHEM ECOL, V39, P860, DOI 10.1007/s10886-013-0278-z; Dussutour A, 2008, INSECT SOC, V55, P329, DOI 10.1007/s00040-008-1008-3; Franks NR, 2003, ANIM BEHAV, V65, P215, DOI 10.1006/anbe.2002.2032; Franks NR, 2005, BIOL LETTERS, V1, P190, DOI 10.1098/rsbl.2005.0302; George J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062632; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Jaccoud DB, 1999, ENTOMOL EXP APPL, V93, P51, DOI 10.1023/A:1003830625680; Konrad M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001300; Lacey Lawrence A., 1997, P1, DOI 10.1016/B978-012432555-5/50004-X; Lam K, 2010, J CHEM ECOL, V36, P141, DOI 10.1007/s10886-010-9741-2; Mburu DM, 2009, J INSECT PHYSIOL, V55, P774, DOI 10.1016/j.jinsphys.2009.04.015; Mburu DM, 2011, J EXP BIOL, V214, P956, DOI 10.1242/jeb.050419; McGlynn TP, 2012, ANNU REV ENTOMOL, V57, P291, DOI 10.1146/annurev-ento-120710-100708; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Meyling NV, 2006, ECOL ENTOMOL, V31, P162, DOI 10.1111/j.0307-6946.2006.00781.x; Moore J., 2002, PARASITES BEHAV ANIM; Naug D, 2002, J THEOR BIOL, V215, P427, DOI 10.1006/jtbi.2001.2524; Ormond EL, 2011, FEMS MICROBIOL ECOL, V77, P229, DOI 10.1111/j.1574-6941.2011.01100.x; PASSERA L, 1994, WESTV STUD, P23; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rosengaus RB, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0563; Schmid-Hempel P., 1998, Parasites in social insects.; Schmidt AM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-20; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Ugelvig LV, 2007, CURR BIOL, V17, P1967, DOI 10.1016/j.cub.2007.10.029; Ugelvig LV, 2012, FUNCT ECOL, V26, P1300, DOI 10.1111/1365-2435.12013; Wetterer JK, 2010, MYRMECOL NEWS, V13, P115	34	24	25	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111961	10.1371/journal.pone.0111961	http://dx.doi.org/10.1371/journal.pone.0111961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372856	gold, Green Published			2022-12-26	WOS:000344556900096
J	Wehr, A; Baeck, C; Ulmer, F; Gassler, N; Hittatiya, K; Luedde, T; Neumann, UP; Trautwein, C; Tacke, F				Wehr, Alexander; Baeck, Christer; Ulmer, Florian; Gassler, Nikolaus; Hittatiya, Kanishka; Luedde, Tom; Neumann, Ulf Peter; Trautwein, Christian; Tacke, Frank			Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury	PLOS ONE			English	Article							KILLER T-CELLS; FATTY LIVER; NKT CELLS; NONALCOHOLIC STEATOHEPATITIS; MONOCLONAL-ANTIBODIES; FIBROSIS; DISEASE; INFLAMMATION; RECEPTOR; INTRAPERITONEAL	Non-alcoholic fatty liver disease (NAFLD) is a major cause of morbidity and mortality in developed countries, resulting in steatohepatitis (NASH), fibrosis and eventually cirrhosis. Modulating inflammatory mediators such as chemokines may represent a novel therapeutic strategy for NAFLD. We recently demonstrated that the chemokine receptor CXCR6 promotes hepatic NKT cell accumulation, thereby controlling inflammation in experimental NAFLD. In this study, we first investigated human biopsies (n = 20), confirming that accumulation of inflammatory cells such as macrophages is a hallmark of progressive NAFLD. Moreover, CXCR6 gene expression correlated with the inflammatory activity (ALT levels) in human NAFLD. We then tested the hypothesis that pharmacological inhibition of CXCL16 might hold therapeutic potential in NAFLD, using mouse models of acute carbon tetrachloride (CCl4)- and chronic methionine-choline-deficient (MCD) diet-induced hepatic injury. Neutralizing CXCL16 by i.p. injection of anti-CXCL16 antibody inhibited the early intrahepatic NKT cell accumulation upon acute toxic injury in vivo. Weekly therapeutic anti-CXCL16 administrations during the last 3 weeks of 6 weeks MCD diet significantly decreased the infiltration of inflammatory macrophages into the liver and intrahepatic levels of inflammatory cytokines like TNF or MCP-1. Importantly, anti-CXCL16 treatment significantly reduced fatty liver degeneration upon MCD diet, as assessed by hepatic triglyceride levels, histological steatosis scoring and quantification of lipid droplets. Moreover, injured hepatocytes up-regulated CXCL16 expression, indicating that scavenging functions of CXCL16 might be additionally involved in the pathogenesis of NAFLD. Targeting CXCL16 might therefore represent a promising novel therapeutic approach for liver inflammation and steatohepatitis.	[Wehr, Alexander; Baeck, Christer; Luedde, Tom; Trautwein, Christian; Tacke, Frank] RWTH Univ Hosp, Dept Med 3, Aachen, Germany; [Ulmer, Florian; Neumann, Ulf Peter] RWTH Univ Hosp, Dept Gen Visceral & Transplant Surg, Aachen, Germany; [Gassler, Nikolaus] RWTH Univ Hosp, Inst Pathol, Aachen, Germany; [Hittatiya, Kanishka] Univ Bonn, Dept Pathol, Bonn, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of Bonn	Tacke, F (corresponding author), RWTH Univ Hosp, Dept Med 3, Aachen, Germany.	frank.tacke@gmx.net	Luedde, Tom/AAE-9135-2022; Tacke, Frank/ABF-2212-2020	Luedde, Tom/0000-0002-6288-8821; 	German Research Foundation [DFG Ta434/2-1, DFG SFB/TRR 57]; Interdisciplinary Center for Clinical Research (IZKF) Aachen	German Research Foundation(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) Aachen	This work was supported by the German Research Foundation (DFG Ta434/2-1 to F.T., DFG SFB/TRR 57) and by the Interdisciplinary Center for Clinical Research (IZKF) Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian VG, 2012, ANN SURG, V256, P624, DOI 10.1097/SLA.0b013e31826b4b7e; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; BARRETT JS, 1991, CANCER RES, V51, P3434; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bhala N, 2013, CURR PHARM DESIGN, V19, P5169, DOI 10.2174/13816128113199990336; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Boisvert J, 2003, J HEPATOL, V38, P67, DOI 10.1016/S0168-8278(02)00328-8; Galastri S, 2012, CLIN SCI, V123, P459, DOI 10.1042/CS20110515; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gutwein P, 2009, J CELL MOL MED, V13, P3809, DOI 10.1111/j.1582-4934.2009.00761.x; Gutwein P, 2009, AM J PATHOL, V174, P2061, DOI 10.2353/ajpath.2009.080960; Hammerich L, 2014, HEPATOLOGY, V59, P630, DOI 10.1002/hep.26697; Ishikawa S, 2011, J HEPATOL, V54, P1195, DOI 10.1016/j.jhep.2010.08.022; Jepsen P, 2003, HEPATO-GASTROENTEROL, V50, P2101; Jin ZX, 2011, HEPATOLOGY, V53, P219, DOI 10.1002/hep.23983; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Marra F, 2013, CURR PHARM DESIGN, V19, P5250, DOI 10.2174/13816128113199990344; MATTES MJ, 1987, J NATL CANCER I, V79, P855; Mederacke I, 2013, Z GASTROENTEROL, V51, P55, DOI 10.1055/s-0032-1330422; Park O, 2009, HEPATOLOGY, V49, P1683, DOI 10.1002/hep.22813; Postea O, 2008, J CELL MOL MED, V12, P1700, DOI 10.1111/j.1582-4934.2008.00223.x; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Schuppan D, 2013, J GASTROEN HEPATOL, V28, P68, DOI 10.1111/jgh.12212; Shimaoka T, 2007, J IMMUNOL, V179, P8172, DOI 10.4049/jimmunol.179.12.8172; Syn WK, 2012, GUT, V61, P1323, DOI 10.1136/gutjnl-2011-301857; Syn WK, 2010, HEPATOLOGY, V51, P1998, DOI 10.1002/hep.23599; Tacke F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S27; Tannapfel A, 2011, VIRCHOWS ARCH, V458, P511, DOI 10.1007/s00428-011-1066-1; Tuncer C, 2013, LIVER INT, V33, P852, DOI 10.1111/liv.12182; Uza N, 2011, GUT, V60, P1494, DOI 10.1136/gut.2010.221879; WAHL RL, 1988, CANCER IMMUNOL IMMUN, V26, P187; Wang H, 2013, HEPATOLOGY; Wehr A, 2013, J IMMUNOL, V190, P5226, DOI 10.4049/jimmunol.1202909; Xu HB, 2005, WORLD J GASTROENTERO, V11, P4979, DOI 10.3748/wjg.v11.i32.4979; YOSHIDA K, 1992, SURG TODAY, V22, P155, DOI 10.1007/BF00311341; Zimmermann Henning W., 2011, Inflammation & Allergy Drug Targets, V10, P509; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	44	50	54	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112327	10.1371/journal.pone.0112327	http://dx.doi.org/10.1371/journal.pone.0112327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372401	gold, Green Published			2022-12-26	WOS:000344556900136
J	Ye, Z; Gorman, AA; Uittenbogaard, AM; Myers-Morales, T; Kaplan, AM; Cohen, DA; Straley, SC				Ye, Zhan; Gorman, Amanda A.; Uittenbogaard, Annette M.; Myers-Morales, Tanya; Kaplan, Alan M.; Cohen, Donald A.; Straley, Susan C.			Caspase-3 Mediates the Pathogenic Effect of Yersinia pestis YopM in Liver of C57BL/6 Mice and Contributes to YopM's Function in Spleen	PLOS ONE			English	Article							INNATE IMMUNE DEFENSE; CELL-DEATH; PROTEIN; PLAGUE; INTERLEUKIN-8; MACROPHAGES; INHIBITION; APOPTOSIS; GROWTH	The virulence protein YopM of the plague bacterium Yersinia pestis has different dominant effects in liver and spleen. Previous studies focused on spleen, where YopM inhibits accumulation of inflammatory dendritic cells. In the present study we focused on liver, where PMN function may be directly undermined by YopM without changes in inflammatory cell numbers in the initial days of infection, and foci of inflammation are easily identified. Mice were infected with parent and Delta yopM-1 Y. pestis KIM5, and effects of YopM were assessed by immunohistochemistry and determinations of bacterial viable numbers in organs. The bacteria were found associated with myeloid cells in foci of inflammation and in liver sinusoids. A new in-vivo phenotype of YopM was revealed: death of inflammatory cells, evidenced by TUNEL staining beginning at d 1 of infection. Based on distributions of Ly6G(+), F4/80(+), and iNOS(+) cells within foci, the cells that were killed could have included both PMNs and macrophages. By 2 d post-infection, YopM had no effect on distribution of these cells, but by 3 d cellular decomposition had outstripped acute inflammation in foci due to parent Y. pestis, while foci due to the Delta yopM-1 strain still contained many inflammatory cells. The destruction depended on the presence of both PMNs in the mice and YopM in the bacteria. In mice that lacked the apoptosis mediator caspase-3 the infection dynamics were novel: the parent Y. pestis was limited in growth comparably to the Delta yopM-1 strain in liver, and in spleen a partial growth limitation for parent Y. pestis was seen. This result identified caspase-3 as a co-factor or effector in YopM's action and supports the hypothesis that in liver YopM's main pathogenic effect is mediated by caspase-3 to cause apoptosis of PMNs.	[Ye, Zhan; Gorman, Amanda A.; Uittenbogaard, Annette M.; Myers-Morales, Tanya; Kaplan, Alan M.; Cohen, Donald A.; Straley, Susan C.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA	University of Kentucky	Straley, SC (corresponding author), Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA.	scstra01@uky.edu			United States Public Health Service (NIAID) [R01 AI67869]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026827] Funding Source: NIH RePORTER	United States Public Health Service (NIAID); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant R01 AI67869 from the United States Public Health Service (NIAID; www.niaid.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Caulfield AJ, 2014, CELL HOST MICROBE, V15, P424, DOI 10.1016/j.chom.2014.03.005; Chung LK, 2014, MBIO, V5, DOI 10.1128/mBio.01402-14; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Felek S, 2010, INFECT IMMUN, V78, P4134, DOI 10.1128/IAI.00167-10; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Geering B, 2013, TRENDS IMMUNOL, V34, P398, DOI 10.1016/j.it.2013.04.002; Glynn PC, 2002, PULM PHARMACOL THER, V15, P103, DOI 10.1006/pupt.2001.0323; Gregory SH, 2002, J LEUKOCYTE BIOL, V72, P239; Hentschke M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013165; Heusipp G, 2006, MICROBIOL-SGM, V152, P1327, DOI 10.1099/mic.0.28697-0; Hines J, 2001, MICROB PATHOGENESIS, V30, P193, DOI 10.1006/mpat.2000.0424; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Kettritz R, 1998, KIDNEY INT, V53, P84, DOI 10.1046/j.1523-1755.1998.00741.x; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; McCoy MW, 2010, INFECT IMMUN, V78, P2584, DOI 10.1128/IAI.00141-10; McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Neel NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023813; Nemeth J, 1997, INFECT IMMUN, V65, P924, DOI 10.1128/IAI.65.3.924-930.1997; Pechous RD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003679; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Raczynski AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033099; Ruter C, 2010, J CELL SCI, V123, P2190, DOI 10.1242/jcs.063016; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shannon JG, 2013, MBIO, V4, DOI 10.1128/mBio.00170-13; Skrzypek E, 1998, TARGETING YERSINIA P; Spinner JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009279; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Viboud G. H., 2011, ANNU REV MICROBIOL, V59, P69; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Yasuda M, 2000, J HISTOCHEM CYTOCHEM, V48, P1331, DOI 10.1177/002215540004801004; Ye Z, 2011, INFECT IMMUN, V79, P674, DOI 10.1128/IAI.00808-10; Ye Z, 2009, INFECT IMMUN, V77, P3791, DOI 10.1128/IAI.00284-09	40	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110956	10.1371/journal.pone.0110956	http://dx.doi.org/10.1371/journal.pone.0110956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372388	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900028
J	Pathak, PK; Tripathi, N; Subramanian, SV				Pathak, Praveen Kumar; Tripathi, Niharika; Subramanian, S. V.			Secular Trends in Menarcheal Age in India-Evidence from the Indian Human Development Survey	PLOS ONE			English	Article							PUBERTY; URBAN; HEALTH; GIRLS; DETERMINANTS; NUTRITION; PATTERNS; EARLIER; OSLO	Background: Evidence from a number of countries in Europe and North America point towards the secular declining trend in menarcheal age with considerable spatial variations over the past two centuries. Similar trends were reported in several developing countries from Asia, Africa and Latin America. However, data corroborating any secular trend in the menarcheal age of the Indian population remained sparse and inadequately verified. Methods: We examined secular trends, regional heterogeneity and association of socioeconomic, anthropometric and contextual factors with menarcheal age among ever-married women (15-49 years) in India. Using the pseudo cohort data approach, we fit multiple linear regression models to estimate secular trends in menarcheal age of 91394 ever-married women using the Indian Human Development Survey. Results: The mean age at menarche among Indian women was 13.76 years (95 % CI: 13.75, 13.77) in 2005. It declined by three months from 13.83 years (95% CI: 13.81, 13.85) among women born prior to 1955-1964, to nearly 13.62 years (95% CI: 13.58, 13.67) among women born during late 1985-1989. However, these aggregate national figures mask extensive spatial heterogeneity as mean age at menarche varied from 15.0 years in Himachal Pradesh during 1955-1964 (95% CI: 14.89-15.11) to about 12.1 years in Assam (95% CI: 11.63-12.56) during 1985-1989. Conclusion: The regression analysis established a reduction of nearly one month per decade, suggesting a secular decline in age at menarche among Indian women. Notably, the menarcheal age was significantly associated with the area of residence, geographic region, linguistic groups, educational attainment, wealth status, caste and religious affiliations among Indian women.	[Pathak, Praveen Kumar] Univ Delhi, Delhi Sch Econ, Dept Geog, Delhi 110007, India; [Pathak, Praveen Kumar; Tripathi, Niharika] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Delhi School of Economics; University of Delhi; International Institute for Population Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Pathak, PK (corresponding author), Univ Delhi, Delhi Sch Econ, Dept Geog, Delhi 110007, India.	pkp_pathak@rediffmail.com	Pathak, Praveen Kumar/M-6010-2014; Pathak, Praveen Kumar/GPG-1695-2022	Pathak, Praveen Kumar/0000-0003-1571-7859; Tripathi, Niharika/0000-0002-7502-132X				Adali T, 2011, ANN HUM BIOL, V38, P345, DOI 10.3109/03014460.2011.552891; Adanu R M K, 2006, J Obstet Gynaecol, V26, P550, DOI 10.1080/01443610600811425; [Anonymous], 2011, J INDIAN ACAD FORENS; [Anonymous], 2008, ANAL HLTH EQUITY USI; Bagga Amrita, 2000, Acta Biologica Szegediensis, V44, P53; BAI KI, 1978, J TROP PED ENV CH H, V24, P171, DOI 10.1093/tropej/24.4.171; Bakshi A, 2008, NOTE HOUSEHOLD INCOM; Baldridge J., 1996, RECONCILING LINGUIST; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bellis MA, 2006, J EPIDEMIOL COMMUN H, V60, P910, DOI 10.1136/jech.2006.049379; Bhalla S R, 1983, Z Morphol Anthropol, V73, P323; Bhaskaran Mythili, 2003, Indian J Physiol Pharmacol, V47, P361; Cameron N, 1996, ANN HUM BIOL, V23, P113, DOI 10.1080/03014469600004332; CAMERON N, 1991, AM J HUM BIOL, V3, P251, DOI 10.1002/ajhb.1310030304; Chakravarty K, 1994, J Assam Science Society, V36, P49; Chavarro J, 2004, ANN HUM BIOL, V31, P245, DOI 10.1080/03014460310001652239; Chitnis S., 1997, POLITICS BACKWARDNES, P88; Cho GJ, 2010, EUR J PEDIATR, V169, P89, DOI 10.1007/s00431-009-0993-1; DAMON A, 1974, HUM BIOL, V46, P381; DANN TC, 1973, BRIT MED J, V3, P265, DOI 10.1136/bmj.3.5874.265; Deb R, 2009, ANTHROPOLOGIST, V11, P259, DOI 10.1080/09720073.2009.11891113; Deb R, 2011, INDIAN PEDIATR, V48, P69; Desai S, 2007, 1 U MAR NAT COUNC AP; Desai S, 2010, MARGIN, V4, P293, DOI 10.1177/097380101000400303; do Lago MJ, 2003, ANN HUM BIOL, V30, P347, DOI 10.1080/0301446031000091783; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Facchini F, 2008, ANN HUM BIOL, V35, P50, DOI 10.1080/03014460701784567; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Garg S, 2001, REPROD HEALTH MATTER, V9, P16, DOI 10.1016/S0968-8080(01)90004-7; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Golub MS, 2008, PEDIATRICS, V121, pS218, DOI 10.1542/peds.2007-1813G; Harris MA, 2008, J ADOLESCENT HEALTH, V43, P548, DOI 10.1016/j.jadohealth.2008.07.017; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Huen KF, 1997, ACTA PAEDIATR, V86, P1121, DOI 10.1111/j.1651-2227.1997.tb14820.x; INDIAN COUNCIL OF MEDICAL RESEARCH, 1972, IND COUNC MED RES TE; Jones LL, 2009, AM J HUM BIOL, V21, P130, DOI 10.1002/ajhb.20836; Keizer-Schrama SMPFD, 2001, HUM REPROD UPDATE, V7, P287; Laslett P, 1971, J Interdiscip Hist, V2, P221, DOI 10.2307/202843; LIESTOL K, 1995, ANN HUM BIOL, V22, P199, DOI 10.1080/03014469500003862; LIESTOL K, 1982, ANN HUM BIOL, V9, P521, DOI 10.1080/03014468200006051; Matton L, 2007, AM J HUM BIOL, V19, P345, DOI 10.1002/ajhb.20592; McDowell MA, 2007, J ADOLESCENT HEALTH, V40, P227, DOI 10.1016/j.jadohealth.2006.10.002; Mishra GD, 2009, WOMENS HEALTH, V5, P175, DOI 10.2217/17455057.5.2.175; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Pasquet P, 1999, ANN HUM BIOL, V26, P89, DOI 10.1080/030144699283001; Pierce MB, 2005, AM J CLIN NUTR, V82, P733, DOI 10.1093/ajcn/82.4.733; Planning Commission Government of India, 2011, IND HUM DEV REP 2011; Po JYT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016844; Rah JH, 2009, J HEALTH POPUL NUTR, V27, P802; REES M, 1993, LANCET, V342, P1375, DOI 10.1016/0140-6736(93)92746-G; Rigon F, 2010, J ADOLESCENT HEALTH, V46, P238, DOI 10.1016/j.jadohealth.2009.07.009; Rokade S.A., 2009, INTERNET J BIOL ANTH, V3, P1, DOI [10.5580/115b, DOI 10.5580/115B, https://doi.org/10.5580/115b]; Sanchez-Andres A, 1997, Anthropol Anz, V55, P69; SATYANARAYANA K, 1979, ANN HUM BIOL, V6, P163, DOI 10.1080/03014467900003501; SHARMA K, 1990, ANN HUM BIOL, V17, P159, DOI 10.1080/03014469000000912; Sharma N, 2005, ANTHROPOLOGIST, V8, P55; Silva HP, 2006, AM J HUM BIOL, V18, P83, DOI 10.1002/ajhb.20458; Singh L, 1983, Anthropol Anz, V41, P259; Subramanian SV, 2006, AM J CLIN NUTR, V84, P633, DOI 10.1093/ajcn/84.3.633; Talma H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060056; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; Tanner JM, 1955, GROWTH ADOLESCENCE; Thomas F, 2001, HUM BIOL, V73, P271, DOI 10.1353/hub.2001.0029; Tripathi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071584; Tyagi D, 1983, J Indian Med Assoc, V80, P133; United Nations Children's Fund, 2011, STAT WORLDS CHILDR 2; Viner R, 2002, ARCH DIS CHILD, V86, P8, DOI 10.1136/adc.86.1.8; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walvoord EC, 2010, J ADOLESCENT HEALTH, V47, P433, DOI 10.1016/j.jadohealth.2010.05.018; Wang DL, 2002, J BIOSOC SCI, V34, P349, DOI 10.1017/S0021932002003498; Whincup PH, 2001, BRIT MED J, V322, P1095, DOI 10.1136/bmj.322.7294.1095; World Health Organization, 2007, AD SEX REPR HLTH HIV; Wronka I, 2005, ANN HUM BIOL, V32, P630, DOI 10.1080/03014460500204478; WYSHAK G, 1982, NEW ENGL J MED, V306, P1033, DOI 10.1056/NEJM198204293061707; ZACHARIAS L, 1969, NEW ENGL J MED, V280, P868, DOI 10.1056/NEJM196904172801606	75	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111027	10.1371/journal.pone.0111027	http://dx.doi.org/10.1371/journal.pone.0111027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369507	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000033
J	Yu, XL; Long, YC				Yu, Xinlei; Long, Yun Chau			Autophagy modulates amino acid signaling network in myotubes: differential effects on mTORC1 pathway and the integrated stress response	FASEB JOURNAL			English	Article						skeletal muscle; protein; proteolysis; lysosome; atrophy	UBIQUITIN-PROTEASOME PATHWAY; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; SKELETAL-MUSCLE; DEGRADATION; INHIBITION; DISEASE; CELLS; FOXO3; DEXAMETHASONE	Induction of autophagy and the integrated stress response is important for amino acid homeostasis. It remains unknown whether the autophagy coregulates both mechanistic target of rapamycin complex 1 (mTORC1) signaling and the integrated stress response. In mouse C2C12 myotubes, we found that amino acid limitation induced autophagy and that the subsequent release of amino acid is required to sustain mTORC1 signaling. Inhibition of autophagy by bafilomycin A1 or chloroquine treatment during amino acid scarcity abolished mTORC1 signaling, an effect that could be rescued by inhibiting protein synthesis or amino acid supplementation, respectively. Autophagy is required to sustain the balance of both essential and nonessential amino acids during amino acid starvation, and it has a predominant role over the ubiquitin-proteasome system in the regulation of mTORC1. Inhibition of autophagy was found to activate the integrated stress response, as well as eukaryotic initiation factor 2 alpha (eIF2 alpha) and its target genes independent of amino acid availability. Conversely, autophagy induction via mTOR inhibition is sufficient to reduce eIF2 alpha phosphorylation. Thus, autophagy protects the eIF2 alpha-mediated stress response independent of amino acid supply in cultured myotubes. Our results showed that autophagy uniquely modulates mTORC1 and the integrated stress response in an amino acid-dependent and -independent manner, respectively.	[Yu, Xinlei; Long, Yun Chau] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore	National University of Singapore	Long, YC (corresponding author), Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, MD6,Ctr Translational Med,14 Med Dr,14-01M, Singapore 117597, Singapore.	bchlongy@nus.edu.sg			Singapore Ministry of Health; National Medical Research Council; Cooperative Basic Research Grant [NMRC/BNIG/2013/2013]; Singapore Ministry of Education Academic Research Fund Tier 1 Grant [T1-2011Sep-05]	Singapore Ministry of Health(Ministry of Health-Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cooperative Basic Research Grant; Singapore Ministry of Education Academic Research Fund Tier 1 Grant(Ministry of Education, Singapore)	The authors thank Ai Lee Chow and Dr. Rebecca Anne Jackson for comments on the manuscript. This work was supported by the Singapore Ministry of Health, National Medical Research Council, Cooperative Basic Research Grant NMRC/BNIG/2013/2013, and Singapore Ministry of Education Academic Research Fund Tier 1 Grant T1-2011Sep-05. The authors declare no conflicts of interest.	Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; SCHIAFFINO S, 1972, J CELL BIOL, V52, P41, DOI 10.1083/jcb.52.1.41; Scott SV, 1998, CURR OPIN CELL BIOL, V10, P523, DOI 10.1016/S0955-0674(98)80068-9; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sikalidis AK, 2011, AMINO ACIDS, V41, P159, DOI 10.1007/s00726-010-0571-x; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; SPARGO E, 1979, J ROY SOC MED, V72, P921; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Talvas J, 2006, J NUTR, V136, P1466, DOI 10.1093/jn/136.6.1466; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wong E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a006734; Wasef SZY, 2006, AM J PHYSIOL-ENDOC M, V291, pE1274, DOI 10.1052/ajpendo.00117.2006; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	36	22	24	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					394	407		10.1096/fj.14-252841	http://dx.doi.org/10.1096/fj.14-252841			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25376834				2022-12-26	WOS:000349370400006
J	Colwell, LJ; Brenner, MP; Murray, AW				Colwell, Lucy J.; Brenner, Michael P.; Murray, Andrew W.			Conservation Weighting Functions Enable Covariance Analyses to Detect Functionally Important Amino Acids	PLOS ONE			English	Article							STRUCTURAL BASIS; ALLOSTERIC REGULATION; CORRELATED MUTATIONS; SIGNAL-TRANSDUCTION; PROTEIN FAMILIES; SPECIFICITY; HEMOGLOBIN; DOMAINS; DETERMINANTS; EVOLUTIONARY	The explosive growth in the number of protein sequences gives rise to the possibility of using the natural variation in sequences of homologous proteins to find residues that control different protein phenotypes. Because in many cases different phenotypes are each controlled by a group of residues, the mutations that separate one version of a phenotype from another will be correlated. Here we incorporate biological knowledge about protein phenotypes and their variability in the sequence alignment of interest into algorithms that detect correlated mutations, improving their ability to detect the residues that control those phenotypes. We demonstrate the power of this approach using simulations and recent experimental data. Applying these principles to the protein families encoded by Dscam and Protocadherin allows us to make testable predictions about the residues that dictate the specificity of molecular interactions.	[Colwell, Lucy J.] Univ Cambridge, Univ Chem Lab, Cambridge, England; [Brenner, Michael P.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Murray, Andrew W.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	University of Cambridge; Harvard University; Harvard University	Colwell, LJ (corresponding author), Univ Cambridge, Univ Chem Lab, Cambridge, England.	ljc37@cam.ac.uk			National Science Foundation Division of Mathematical Sciences; National Institute for General Medical Sciences grant for National Centers of Systems Biology [GM068763]; Roche Pharmaceuticals; Engineering and Physical Sciences Research Council Fellowship [EP/H028064/2]; EPSRC [EP/H028064/1, EP/H028064/2] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/H028064/1, EP/H028064/2] Funding Source: researchfish	National Science Foundation Division of Mathematical Sciences(National Science Foundation (NSF)); National Institute for General Medical Sciences grant for National Centers of Systems Biology; Roche Pharmaceuticals(Roche Holding); Engineering and Physical Sciences Research Council Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded by grants from the National Science Foundation Division of Mathematical Sciences (MPB), National Institute for General Medical Sciences grant GM068763 for National Centers of Systems Biology (AWM), and Roche Pharmaceuticals (MPB LJC). LJC acknowledges support from Engineering and Physical Sciences Research Council Fellowship EP/H028064/2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Armitage SAO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-53; Ashenberg O, 2011, J MOL BIOL, V413, P222, DOI 10.1016/j.jmb.2011.08.011; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Capra EJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001220; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Ibrahim BS, 2005, J MOL BIOL, V348, P1191, DOI 10.1016/j.jmb.2005.03.034; Jin XS, 2012, P NATL ACAD SCI USA, V109, pE127, DOI 10.1073/pnas.1117538108; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; KOMIYAMA NH, 1995, NATURE, V373, P244, DOI 10.1038/373244a0; Lo LW, 2003, P NATL ACAD SCI USA, V100, P4463, DOI 10.1073/pnas.0737647100; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Milo R, 2007, P NATL ACAD SCI USA, V104, P16998, DOI 10.1073/pnas.0707673104; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; PERUTZ MF, 1981, NATURE, V291, P682, DOI 10.1038/291682a0; Posy S, 2008, J MOL BIOL, V378, P954, DOI 10.1016/j.jmb.2008.02.063; Ranganathan R, 2011, NOTE 109 SUMMARY SCA; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; White RA, 2007, METHOD ENZYMOL, V422, P75, DOI 10.1016/S0076-6879(06)22004-4; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X	35	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e107723	10.1371/journal.pone.0107723	http://dx.doi.org/10.1371/journal.pone.0107723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379728	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100003
J	Miyata, A; Ishizawa, T; Kamiya, M; Shimizu, A; Kaneko, J; Ijichi, H; Shibahara, J; Fukayama, M; Midorikawa, Y; Urano, Y; Kokudo, N				Miyata, Akinori; Ishizawa, Takeaki; Kamiya, Mako; Shimizu, Atsushi; Kaneko, Junichi; Ijichi, Hideaki; Shibahara, Junji; Fukayama, Masashi; Midorikawa, Yutaka; Urano, Yasuteru; Kokudo, Norihiro			Photoacoustic Tomography of Human Hepatic Malignancies Using Intraoperative Indocyanine Green Fluorescence Imaging	PLOS ONE			English	Article							CHOLANGIOGRAPHY; ULTRASONOGRAPHY; TUMORS	Recently, fluorescence imaging following the preoperative intravenous injection of indocyanine green has been used in clinical settings to identify hepatic malignancies during surgery. The aim of this study was to evaluate the ability of photoacoustic tomography using indocyanine green as a contrast agent to produce representative fluorescence images of hepatic tumors by visualizing the spatial distribution of indocyanine green on ultrasonographic images. Indocyanine green (0.5 mg/kg, intravenous) was preoperatively administered to 9 patients undergoing hepatectomy. Intraoperatively, photoacoustic tomography was performed on the surface of the resected hepatic specimens (n = 10) under excitation with an 800 nm pulse laser. In 4 hepatocellular carcinoma nodules, photoacoustic imaging identified indocyanine green accumulation in the cancerous tissue. In contrast, in one hepatocellular carcinoma nodule and five adenocarcinoma foci (one intrahepatic cholangiocarcinoma and 4 colorectal liver metastases), photoacoustic imaging delineated indocyanine green accumulation not in the cancerous tissue but rather in the peri-cancerous hepatic parenchyma. Although photoacoustic tomography enabled to visualize spatial distribution of ICG on ultrasonographic images, which was consistent with fluorescence images on cut surfaces of the resected specimens, photoacoustic signals of ICG-containing tissues decreased approximately by 40% even at 4 mm depth from liver surfaces. Photoacoustic tomography using indocyanine green also failed to identify any hepatocellular carcinoma nodules from the body surface of model mice with non-alcoholic steatohepatitis. In conclusion, photoacoustic tomography has a potential to enhance cancer detectability and differential diagnosis by ultrasonographic examinations and intraoperative fluorescence imaging through visualization of stasis of bile-excreting imaging agents in and/ or around hepatic tumors. However, further technical advances are needed to improve the visibility of photoacoustic signals emitted from deeply-located lesions.	[Miyata, Akinori; Ishizawa, Takeaki; Shimizu, Atsushi; Kaneko, Junichi; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [Kamiya, Mako; Urano, Yasuteru] Univ Tokyo, Grad Sch Med, Lab Chem Biol & Mol Imaging, Tokyo, Japan; [Ijichi, Hideaki] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Shibahara, Junji; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Midorikawa, Yutaka] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Ishizawa, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan.	tish-tky@umin.ac.jp	Ijichi, Hideaki/V-2720-2019; Ijichi, Hideaki/AAE-6692-2022; IJICHI, Hideaki/AGZ-2874-2022	Ijichi, Hideaki/0000-0002-2379-7986; IJICHI, Hideaki/0000-0002-2379-7986	Takeda Science Foundation, the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	Takeda Science Foundation, the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Takeda Science Foundation, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chino K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045764; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Gotoh K, 2009, J SURG ONCOL, V100, P75, DOI 10.1002/jso.21272; Ishizawa T, 2010, BRIT J SURG, V97, P1369, DOI 10.1002/bjs.7125; Ishizawa T, 2014, ANN SURG ONCOL, V21, P440, DOI 10.1245/s10434-013-3360-4; Ishizawa Takeaki, 2009, J Am Coll Surg, V208, pe1, DOI 10.1016/j.jamcollsurg.2008.09.024; Ishizawa T, 2009, CANCER-AM CANCER SOC, V115, P2491, DOI 10.1002/cncr.24291; Kaneko J, 2014, J GASTROENTEROL, V49, P110, DOI 10.1007/s00535-013-0775-4; Kawaguchi Y, 2013, J HEPATOL, V58, P247, DOI 10.1016/j.jhep.2012.09.028; Kim C, 2010, RADIOLOGY, V255, P442, DOI 10.1148/radiol.10090281; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; KRUGER RA, 1994, MED PHYS, V21, P127, DOI 10.1118/1.597367; Kudo H, 2014, SURG ENDOSC, V28, P2504, DOI 10.1007/s00464-014-3468-z; Mitsuhashi N, 2008, J HEPATO-BILIARY-PAN, V15, P508, DOI 10.1007/s00534-007-1307-5; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nam SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037267; Needles A, 2013, IEEE T ULTRASON FERR, V60, P888, DOI 10.1109/TUFFC.2013.2646; Ogata F, 2007, ANN PLAS SURG, V58, P652, DOI 10.1097/01.sap.0000250896.42800.a2; Oraevsky AA, 1997, APPL OPTICS, V36, P402, DOI 10.1364/AO.36.000402; Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; Rajian JR, 2011, OPT EXPRESS, V19, P14335, DOI 10.1364/OE.19.014335; Ris F, 2014, SURG ENDOSC, V28, P2221, DOI 10.1007/s00464-014-3432-y; Rubens FD, 2002, HEART SURG FORUM, V5, P141; Schols RM, 2013, SURG ENDOSC, V27, P1530, DOI 10.1007/s00464-012-2635-3; Spinoglio G, 2013, SURG ENDOSC, V27, P2156, DOI 10.1007/s00464-012-2733-2; Takahashi M, 2012, BRIT J SURG, V99, P1271, DOI 10.1002/bjs.8844; Taruttis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030491; van der Vorst JR, 2013, CANCER-AM CANCER SOC, V119, P3411, DOI 10.1002/cncr.28203; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Yokoyama N, 2012, CANCER-AM CANCER SOC, V118, P2813, DOI 10.1002/cncr.26594; Zhang K, 2007, ARCH SURG-CHICAGO, V142, P1170, DOI 10.1001/archsurg.142.12.1170	33	27	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112667	10.1371/journal.pone.0112667	http://dx.doi.org/10.1371/journal.pone.0112667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379674	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100109
J	Jung, WY; Lee, SS; Kim, CW; Kim, HS; Min, SR; Moon, JS; Kwon, SY; Jeon, JH; Cho, HS				Jung, Won Yong; Lee, Sang Sook; Kim, Chul Wook; Kim, Hyun-Soon; Min, Sung Ran; Moon, Jae Sun; Kwon, Suk-Yoon; Jeon, Jae-Heung; Cho, Hye Sun			RNA-Seq Analysis and De Novo Transcriptome Assembly of Jerusalem Artichoke (Helianthus tuberosus Linne)	PLOS ONE			English	Article							FALSE DISCOVERY RATE; SEQUENCING TECHNOLOGIES; MICROSATELLITE MARKERS; GENERATION; ANNOTATION; INULIN; BIOSYNTHESIS; DATABASE; GROWTH; L.	Jerusalem artichoke (Helianthus tuberosus L.) has long been cultivated as a vegetable and as a source of fructans (inulin) for pharmaceutical applications in diabetes and obesity prevention. However, transcriptomic and genomic data for Jerusalem artichoke remain scarce. In this study, Illumina RNA sequencing (RNA-Seq) was performed on samples from Jerusalem artichoke leaves, roots, stems and two different tuber tissues (early and late tuber development). Data were used for de novo assembly and characterization of the transcriptome. In total 206,215,632 paired-end reads were generated. These were assembled into 66,322 loci with 272,548 transcripts. Loci were annotated by querying against the NCBI non-redundant, Phytozome and UniProt databases, and 40,215 loci were homologous to existing database sequences. Gene Ontology terms were assigned to 19,848 loci, 15,434 loci were matched to 25 Clusters of Eukaryotic Orthologous Groups classifications, and 11,844 loci were classified into 142 Kyoto Encyclopedia of Genes and Genomes pathways. The assembled loci also contained 10,778 potential simple sequence repeats. The newly assembled transcriptome was used to identify loci with tissue-specific differential expression patterns. In total, 670 loci exhibited tissue-specific expression, and a subset of these were confirmed using RT-PCR and qRT-PCR. Gene expression related to inulin biosynthesis in tuber tissue was also investigated. Exsiting genetic and genomic data for H. tuberosus are scarce. The sequence resources developed in this study will enable the analysis of thousands of transcripts and will thus accelerate marker-assisted breeding studies and studies of inulin biosynthesis in Jerusalem artichoke.	[Jung, Won Yong; Lee, Sang Sook; Kim, Hyun-Soon; Min, Sung Ran; Moon, Jae Sun; Kwon, Suk-Yoon; Jeon, Jae-Heung; Cho, Hye Sun] Korea Res Inst Biosci & Biotechnol, Plant Syst Engn Res Ctr, Taejon, South Korea; [Jung, Won Yong; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Jinju, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Gyeongnam National University of Science and Technology	Jeon, JH (corresponding author), Korea Res Inst Biosci & Biotechnol, Plant Syst Engn Res Ctr, Taejon, South Korea.	jeonjh@kribb.re.kr; hscho@kribb.re.kr		Jung, WonYong/0000-0002-1751-8418	The Cabbage Genomics assisted breeding supporting center (CGsC) research programs - Ministry for Food, Agriculture, Forestry and Fisheries of the Korean Government; Next Generation of Bio Green 21 Project, National Center for GM Crops from RDA [PJ009043]; Bio-industry Technology Development Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [310006-5]; KRIBB Research Initiative Program	The Cabbage Genomics assisted breeding supporting center (CGsC) research programs - Ministry for Food, Agriculture, Forestry and Fisheries of the Korean Government; Next Generation of Bio Green 21 Project, National Center for GM Crops from RDA; Bio-industry Technology Development Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; KRIBB Research Initiative Program	This work was supported by KRIBB Research Initiative Program, The Cabbage Genomics assisted breeding supporting center (CGsC) research programs funded by the Ministry for Food, Agriculture, Forestry and Fisheries of the Korean Government, The Next Generation of Bio Green 21 Project, The National Center for GM Crops (PJ009043) from RDA to HSC, and Bio-industry Technology Development Program (No. 310006-5), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea to J-HJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bock DG, 2014, NEW PHYTOL, V201, P1021, DOI 10.1111/nph.12560; Chow Keng-See, 2014, BMC Res Notes, V7, P69, DOI 10.1186/1756-0500-7-69; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Mastro G, 2004, ACTA HORTIC, P365, DOI 10.17660/ActaHortic.2004.629.47; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; DORRELL DG, 1977, CAN J PLANT SCI, V57, P591, DOI 10.4141/cjps77-084; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Feng C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-732; Fernandez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045899; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Flores HE, 1999, TRENDS PLANT SCI, V4, P220, DOI 10.1016/S1360-1385(99)01411-9; Fuchs A, 1993, INULIN INULIN CONTAI, P309; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-119; HGaW RK, 1993, SCI TECHNOLOGY FRUCT, P119; Hinrichs WLJ, 2001, INT J PHARMACEUT, V215, P163, DOI 10.1016/S0378-5173(00)00677-3; Hisano H, 2007, DNA RES, V14, P271, DOI 10.1093/dnares/dsm025; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kays S.J., 2008, BIOL CHEM JERUSALEM, P478; Kim HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092087; Knapp S, 2014, NEW PHYTOL, V201, P710, DOI 10.1111/nph.12624; KOSARIC N, 1984, BIOMASS, V5, P1, DOI 10.1016/0144-4565(84)90066-0; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Li CQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-552; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057338; Massa AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026801; McLaurin WJ, 1999, J PLANT NUTR, V22, P1303, DOI 10.1080/01904169909365714; Meijer W. J. M., 1992, Industrial Crops and Products, V1, P175, DOI 10.1016/0926-6690(92)90016-O; Monti A, 2005, EUR J AGRON, V23, P136, DOI 10.1016/j.eja.2004.11.001; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Sasaki E, 2013, PHYTOCHEMISTRY, V87, P30, DOI 10.1016/j.phytochem.2012.11.023; Schilling EE, 1998, SYST BOT, V23, P177, DOI 10.2307/2419587; SCHILLING EE, 1981, TAXON, V30, P393, DOI 10.2307/1220139; Schittenhelm S, 1999, CROP SCI, V39, P1815, DOI 10.2135/cropsci1999.3961815x; Schliesky S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00220; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Stevens CV, 2001, BIOMACROMOLECULES, V2, P1, DOI 10.1021/bm005642t; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; SWANTON CJ, 1989, CAN J BOT, V67, P2880, DOI 10.1139/b89-369; SWANTON CJ, 1992, CAN J PLANT SCI, V72, P1367, DOI 10.4141/cjps92-169; Taha H., 2012, J GENET ENG BIOTECHN, V10, P33, DOI DOI 10.1016/J.JGEB.2012.02.002; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Timme RE, 2007, AM J BOT, V94, P1837, DOI 10.3732/ajb.94.11.1837; van Bekkum H., 1996, CARBOHYDRATES ORGANI, P67; Van den Ende Wim, 2002, ScientificWorldJournal, V2, P1281; Van LJ CJ, 1995, CRITICAL REV FOOD SC, V35, pS25; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vervoort L, 1997, PHARM RES-DORDR, V14, P1730, DOI 10.1023/A:1012179813102; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weston LA, 2013, J CHEM ECOL, V39, P283, DOI 10.1007/s10886-013-0248-5; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yildiz G, 2006, CZECH J ANIM SCI, V51, P349, DOI 10.17221/3950-CJAS; Yu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059831; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	72	46	48	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111982	10.1371/journal.pone.0111982	http://dx.doi.org/10.1371/journal.pone.0111982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375764	gold, Green Submitted, Green Published			2022-12-26	WOS:000344402600085
J	Mathiassen, SE; Hallman, DM; Lyskov, E; Hygge, S				Mathiassen, Svend Erik; Hallman, David M.; Lyskov, Eugene; Hygge, Staffan			Can Cognitive Activities during Breaks in Repetitive Manual Work Accelerate Recovery from Fatigue? A Controlled Experiment	PLOS ONE			English	Article							TRAPEZIUS MUSCLE-ACTIVITY; INTERMITTENT STATIC WORK; JOB ROTATION SCHEDULES; HEART-RATE-VARIABILITY; UPPER EXTREMITY; ASSEMBLY WORK; DIVERTING ACTIVITIES; OCCUPATIONAL-HEALTH; PHYSICAL WORKLOAD; MUSCULAR FATIGUE	Neurophysiologic theory and some empirical evidence suggest that fatigue caused by physical work may be more effectively recovered during "diverting'' periods of cognitive activity than during passive rest; a phenomenon of great interest in working life. We investigated the extent to which development and recovery of fatigue during repeated bouts of an occupationally relevant reaching task was influenced by the difficulty of a cognitive activity between these bouts. Eighteen male volunteers performed three experimental sessions, consisting of six 7-min bouts of reaching alternating with 3 minutes of a memory test differing in difficulty between sessions. Throughout each session, recordings were made of upper trapezius muscle activity using electromyography (EMG), heart rate and heart rate variability (HRV) using electrocardiography, arterial blood pressure, and perceived fatigue (Borg CR10 scale and SOFI). A test battery before, immediately after and 1 hour after the work period included measurements of maximal shoulder elevation strength (MVC), pressure pain threshold (PPT) over the trapezius muscles, and a submaximal isometric contraction. As expected, perceived fatigue and EMG amplitude increased during the physical work bouts. Recovery did occur between the bouts, but fatigue accumulated throughout the work period. Neither EMG changes nor recovery of perceived fatigue during breaks were influenced by cognitive task difficulty, while heart rate and HRV recovered the most during breaks with the most difficult task. Recovery of perceived fatigue after the 1 hour work period was also most pronounced for the most difficult cognitive condition, while MVC and PPT showed ambiguous patterns, and EMG recovered similarly after all three cognitive protocols. Thus, we could confirm that cognitive tasks between bouts of fatiguing physical work can, indeed, accelerate recovery of some factors associated with fatigue, even if benefits may be moderate and some responses may be equivocal. Our results encourage further research into combinations of physical and mental tasks in an occupational context.	[Mathiassen, Svend Erik; Hallman, David M.; Lyskov, Eugene] Univ Gavle, Dept Occupat & Publ Hlth Sci, Ctr Musculoskeletal Res, Gavle, Sweden; [Hygge, Staffan] Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden	University of Gavle; University of Gavle	Mathiassen, SE (corresponding author), Univ Gavle, Dept Occupat & Publ Hlth Sci, Ctr Musculoskeletal Res, Gavle, Sweden.	SvendErik.Mathiassen@hig.se	Mathiassen, Svend Erik/ABF-3165-2020	Mathiassen, Svend Erik/0000-0003-1443-6211; Hygge, Staffan/0000-0003-4298-7459	University of Gavle	University of Gavle	The study was funded by internal grants at the University of Gavle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsberg E, 2000, SCAND J PSYCHOL, V41, P231, DOI 10.1111/1467-9450.00192; Arvidsson I, 2006, INT J IND ERGONOM, V36, P613, DOI 10.1016/j.ergon.2006.03.002; Arvidsson I, 2012, APPL ERGON, V43, P1026, DOI 10.1016/j.apergo.2012.03.001; ASMUSSEN E, 1978, EUR J APPL PHYSIOL O, V38, P1, DOI 10.1007/BF00436747; ASMUSSEN E, 1978, EUR J APPL PHYSIOL O, V38, P9, DOI 10.1007/BF00436748; Au AK, 2007, J ELECTROMYOGR KINES, V17, P578, DOI 10.1016/j.jelekin.2006.06.005; Bao SH, 1996, APPL ERGON, V27, P89, DOI 10.1016/0003-6870(95)00063-1; BECHTOLD SE, 1984, MANAGE SCI, V30, P1442, DOI 10.1287/mnsc.30.12.1442; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Birch L, 2000, SCAND J WORK ENV HEA, V26, P299, DOI 10.5271/sjweh.546; Bjorklund M, 2000, EUR J APPL PHYSIOL, V81, P361, DOI 10.1007/s004210050055; Blangsted AK, 2004, EUR J APPL PHYSIOL, V91, P253, DOI 10.1007/s00421-003-0979-z; Borg G., 1998, BORGS PERCEIVED EXER; Bosch T, 2012, ERGONOMICS, V55, P863, DOI 10.1080/00140139.2012.682739; Bunting M, 2006, Q J EXP PSYCHOL, V59, P1691, DOI 10.1080/17470210600848402; Carnahan BJ, 2000, ERGONOMICS, V43, P543, DOI 10.1080/001401300184404; Christensen H, 2000, INT J IND ERGONOM, V25, P367, DOI 10.1016/S0169-8141(99)00025-6; Christmansson M, 1999, APPL ERGON, V30, P463, DOI 10.1016/S0003-6870(98)00060-X; Cote P, 2008, SPINE, V33, pS60, DOI 10.1097/BRS.0b013e3181643ee4; Dababneh AJ, 2001, ERGONOMICS, V44, P164, DOI 10.1080/001401301750048196; Davis K, 2005, J OCCUP ENVIRON HYG, V2, pD1, DOI 10.1080/15459620590894760; Davis KG, 2002, SPINE, V27, P2645, DOI 10.1097/00007632-200212010-00003; Diego-Mas JA, 2009, INT J IND ERGONOM, V39, P23, DOI 10.1016/j.ergon.2008.07.009; Enoka RM, 2012, J BIOMECH, V45, P427, DOI 10.1016/j.jbiomech.2011.11.047; Falla D, 2007, EXP BRAIN RES, V182, P99, DOI 10.1007/s00221-007-0974-4; Farina D, 2002, EUR J APPL PHYSIOL, V86, P469, DOI 10.1007/s00421-001-0574-0; Finsen L, 2001, J ELECTROMYOGR KINES, V11, P373, DOI 10.1016/S1050-6411(01)00015-3; Flodgren GM, 2009, EUR J APPL PHYSIOL, V107, P31, DOI 10.1007/s00421-009-1095-5; Frazer MB, 2003, ERGONOMICS, V46, P904, DOI 10.1080/001401303000090161; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; GANDEVIA SC, 1989, RESP PHYSIOL, V77, P203, DOI 10.1016/0034-5687(89)90007-8; GENAIDY AM, 1995, ERGONOMICS, V38, P326, DOI 10.1080/00140139508925107; HAGG GM, 1991, INT CONGR SER, V949, P141; Hagg GM, 2000, J ELECTROMYOGR KINES, V10, P301, DOI 10.1016/S1050-6411(00)00022-5; Hakkanen M, 1997, APPL ERGON, V28, P99, DOI 10.1016/S0003-6870(96)00040-3; Henning RA, 1997, ERGONOMICS, V40, P78, DOI 10.1080/001401397188396; Hermans V, 1997, CLIN PHYSIOL, V17, P95, DOI 10.1046/j.1365-2281.1997.01515.x; Horton LM, 2012, ERGONOMICS, V55, P1205, DOI 10.1080/00140139.2012.704406; JANARO RE, 1985, HUM FACTORS, V27, P459, DOI 10.1177/001872088502700409; Joyce J, 2009, BRAIN COGNITION, V71, P14, DOI 10.1016/j.bandc.2009.03.004; Keir PJ, 2011, APPL ERGON, V42, P814, DOI 10.1016/j.apergo.2011.01.006; Konz S, 1998, INT J IND ERGONOM, V22, P73, DOI 10.1016/S0169-8141(97)00069-3; Kuijer PPFM, 2005, AM J IND MED, V47, P394, DOI 10.1002/ajim.20159; Leyman ELC, 2004, ERGONOMICS, V47, P625, DOI 10.1080/00140130310001629766; Luger T, 2014, ERGONOMICS, V57, P162, DOI 10.1080/00140139.2014.885088; LUNDBERG U, 1994, INT J BEHAV MED, V1, P354, DOI 10.1207/s15327558ijbm0104_5; Mathiassen SE, 1996, INT ARCH OCC ENV HEA, V68, P94; MATHIASSEN SE, 1993, EUR J APPL PHYSIOL O, V67, P528, DOI 10.1007/BF00241650; Mathiassen SE, 2006, APPL ERGON, V37, P419, DOI 10.1016/j.apergo.2006.04.006; Mehta RK, 2012, ERGONOMICS, V55, P1166, DOI 10.1080/00140139.2012.703695; Mehta RK, 2012, EUR J APPL PHYSIOL, V112, P2891, DOI 10.1007/s00421-011-2264-x; Mehta RK, 2011, INT J IND ERGONOM, V41, P647, DOI 10.1016/j.ergon.2011.07.005; Mital A, 1991, INT J IND ERGON, V8, P165, DOI DOI 10.1016/0169-8141(91)90017-G; MONOD H, 1957, CR SOC BIOL, V151, P1358; Palmer KT, 2007, SCAND J WORK ENV HEA, V33, P165, DOI 10.5271/sjweh.1134; Parent-Thirion A., 2007, 4 EUROPEAN WORKING C; PRICE ADF, 1990, APPL ERGON, V21, P318, DOI 10.1016/0003-6870(90)90203-A; Punnett L, 2000, SCAND J WORK ENV HEA, V26, P283, DOI 10.5271/sjweh.544; ROHMERT W., 1960, INTERNATL ZEITSCHR ANGEW PHYSIOL, V18, P123; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Sechenov I., 1935, SELECTED WORKS, P246; Sjogaard G, 1996, ACTA PHYSIOL SCAND, V156, P257, DOI 10.1046/j.1365-201X.1996.207000.x; Srinivasan D, 2012, CLIN BIOMECH, V27, P979, DOI 10.1016/j.clinbiomech.2012.08.007; Stock MS, 2011, J STRENGTH COND RES, V25, P1911, DOI 10.1519/JSC.0b013e318220d8dc; SUNDELIN G, 1989, ERGONOMICS, V32, P527, DOI 10.1080/00140138908966123; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Togo F, 2009, IND HEALTH, V47, P589, DOI 10.2486/indhealth.47.589; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; van den Heuvel SG, 2003, SCAND J WORK ENV HEA, V29, P106, DOI 10.5271/sjweh.712; van der Windt DAWM, 2000, OCCUP ENVIRON MED, V57, P433, DOI 10.1136/oem.57.7.433; van Rijn RM, 2010, SCAND J WORK ENV HEA, V36, P189, DOI 10.5271/sjweh.2895; Vernon HM, 1924, 2 STUDIES REST PAUSE; Visser B, 2006, J ELECTROMYOGR KINES, V16, P1, DOI 10.1016/j.jelekin.2005.06.005; Vogel K, 2013, APPL ERGON, V44, P996, DOI 10.1016/j.apergo.2013.03.016; Wang YL, 2011, EUR J APPL PHYSIOL, V111, P2791, DOI 10.1007/s00421-011-1908-1; Wells R, 2007, APPL ERGON, V38, P733, DOI 10.1016/j.apergo.2006.12.003; Winkel J, 1995, J ELECTROMYOGR KINES, V5, P195, DOI 10.1016/1050-6411(96)85581-7; Yoon T, 2009, J APPL PHYSIOL, V107, P1486, DOI 10.1152/japplphysiol.00238.2009; Zijdewind I, 2006, CLIN NEUROPHYSIOL, V117, P660, DOI 10.1016/j.clinph.2005.11.016; 1996, EUR HEART J, V93, P1043	80	29	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112090	10.1371/journal.pone.0112090	http://dx.doi.org/10.1371/journal.pone.0112090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375644	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600102
J	Miller, EM				Miller, Elizabeth M.			Iron Status and Reproduction in US Women: National Health and Nutrition Examination Survey, 1999-2006	PLOS ONE			English	Article							SERUM TRANSFERRIN RECEPTOR; DANISH WOMEN; HEMOGLOBIN CONCENTRATION; MULTIPLE IMPUTATION; PREGNANCY; DEFICIENCY; MENSTRUATION; ANEMIA; HOMEOSTASIS; FERRITIN	Women experience significant changes in iron status throughout their reproductive lifespans. While this is evident in regions with high rates of malnutrition and infectious disease, the extent of reproductive-related changes is less well known in countries with low rates of iron deficiency anemia, such as the United States. The goal of this study is determine the relationship between women's reproductive variables (pregnancy, parity, currently breastfeeding, regular menstruation, hormonal contraceptive use, and age at menarche) and iron status (hemoglobin, ferritin, transferrin receptor, and % transferrin saturation) using an anthropological framework for interpreting the results. Data from women aged 18-49 were taken from the 1999-2006 US NHANES, a nationally representative cross-sectional sample of US women. Using multiple imputation and complex survey statistics, women's reproductive variables were regressed against indicators of iron status. Pregnant women had significantly poorer iron status, by most indicators, than non-pregnant women. All biomarkers demonstrated significantly lower iron levels with increasing parity. Women who were having regular periods had iron indicators that suggested decreased iron levels, while women who used hormonal contraceptives had iron indicators that suggested increased iron levels. Despite relatively good iron status and widespread availability of iron-rich foods in the US, women still exhibit patterns of iron depletion across several reproductive variables of interest. These results contribute to an ecological approach to iron status that seeks to understand variation in iron status, with the hopes that appropriate, population-specific recommendations can be developed to improve women's health.	Univ S Florida, Dept Anthropol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Miller, EM (corresponding author), Univ S Florida, Dept Anthropol, Tampa, FL 33620 USA.	emm3@usf.edu		Miller, Elizabeth/0000-0002-5046-380X				Abrams ET, 2009, AM J HUM BIOL, V21, P643, DOI 10.1002/ajhb.20919; Akesson A, 1998, AM J CLIN NUTR, V68, P1241, DOI 10.1093/ajcn/68.6.1241; Allen LH, 1997, NUTR REV, V55, P91, DOI 10.1111/j.1753-4887.1997.tb06460.x; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Allison PD, 2005, SAS US GROUP INT 30; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Beard JL, 2000, J NUTR, V130, p440S, DOI 10.1093/jn/130.2.440S; Beaton GH, 2000, AM J CLIN NUTR, V72, p265S, DOI 10.1093/ajcn/72.1.265S; Berglund PA, 2010, SAS GLOB FOR P; Bothwell TH, 2000, AM J CLIN NUTR, V72, p257S, DOI 10.1093/ajcn/72.1.257S; Cao C, 2013, NUTR REV, V71, P35, DOI 10.1111/j.1753-4887.2012.00550.x; CARRIAGA MT, 1991, AM J CLIN NUTR, V54, P1077, DOI 10.1093/ajcn/54.6.1077; CDC, 2006, AN REP GUID; Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), 2006, NATL HLTH NUTR EXAMI; Chang SC, 2003, J NUTR, V133, P2348, DOI 10.1093/jn/133.7.2348; Choi JW, 2000, CLIN CHEM, V46, P725; Clancy KBH, 2006, AM J HUM BIOL, V18, P710, DOI 10.1002/ajhb.20538; Cook J D, 1992, Nutr Res Rev, V5, P198, DOI 10.1079/NRR19920014; DESALEGN S, 1993, ETHIOPIAN MED J, V31, P251; Dewey KG, 2007, MATERN CHILD NUTR, V3, P151, DOI 10.1111/j.1740-8709.2007.00092.x; Dewey KG, 2004, ADV EXP MED BIOL, V554, P91; FRANSSON GB, 1980, J PEDIATR-US, V96, P380, DOI 10.1016/S0022-3476(80)80676-7; Gambling L, 2011, AM J CLIN NUTR, V94, p1903S, DOI 10.3945/ajcn.110.000885; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Horton NJ, 2003, AM STAT, V57, P229, DOI 10.1198/0003130032314; Hou YL, 2012, GENE, V511, P398, DOI 10.1016/j.gene.2012.09.060; Ikeda Y, 2012, PLOS ONE, V7; JACOBS A, 1972, BRIT MED J, V4, P206, DOI 10.1136/bmj.4.5834.206; Kassebaum NJ, 2013, LANCET, V381, P72; KESSEL E, 1985, ACTA PAEDIATR SCAND, P120; Labbok MH, 2001, PEDIATR CLIN N AM, V48, P143, DOI 10.1016/S0031-3955(05)70290-X; Little R. J. A., 2002, STAT ANAL MISSING DA; Lonnerdal B., 1984, Nestle Nutrition Workshop Series, V4, P95; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; McArdle HJ, 2014, P NUTR SOC, V73, P9, DOI 10.1017/S0029665113003637; Mei ZG, 2012, CLIN CHIM ACTA, V413, P1479, DOI 10.1016/j.cca.2012.05.022; Mei ZG, 2011, AM J CLIN NUTR, V93, P1312, DOI 10.3945/ajcn.110.007195; Miller EM, 2010, AM J HUM BIOL, V22, P768, DOI 10.1002/ajhb.21078; MILMAN N, 1993, ACTA OBSTET GYN SCAN, V72, P601, DOI 10.3109/00016349309021150; Milman N, 1998, ANN HEMATOL, V77, P13, DOI 10.1007/s002770050405; MILMAN N, 1992, ANN HEMATOL, V65, P96, DOI 10.1007/BF01698138; Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2; National Center for Health Statistics, 2005 2006 NAT HLTH N; National Center for Health Statistics, 2001 2002 NAT HLTH N; National Center for Health Statistics, 2003 2004 NAT HLTH N; National Center for Health Statistics, 1999 2000 NAT HLTH N; Pena-Rosas Juan Pablo, 2015, Cochrane Database Syst Rev, pCD009997, DOI [10.1002/14651858.CD009997, 10.1002/14651858.CD009997.pub2]; Quinn EA, 2014, AM J HUM BIOL, V26, P10, DOI 10.1002/ajhb.22476; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Scholl TO, 2000, J NUTR, V130, p443S, DOI 10.1093/jn/130.2.443S; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Strassmann BI, 1997, CURR ANTHROPOL, V38, P123, DOI 10.1086/204592; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Van Santen S, 2011, AM J TROP MED HYG, V84, P148, DOI 10.4269/ajtmh.2011.10-0250; WINKVIST A, 1992, AM J PUBLIC HEALTH, V82, P691, DOI 10.2105/AJPH.82.5.691; Xiong X, 2000, AM J PERINAT, V17, P137, DOI 10.1055/s-2000-9508; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045; Yip R, 2000, AM J CLIN NUTR, V72, p272S, DOI 10.1093/ajcn/72.1.272S	60	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112216	10.1371/journal.pone.0112216	http://dx.doi.org/10.1371/journal.pone.0112216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375360	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600120
J	Zhang, L; Feng, X; Wang, X; Liu, CY				Zhang, Lei; Feng, Xiao; Wang, Xin; Liu, Changyong			On the Constitutive Model of Nitrogen-Containing Austenitic Stainless Steel 316LN at Elevated Temperature	PLOS ONE			English	Article							STRESS-CORROSION CRACKING; BEHAVIOR; DEFORMATION; FLOW	The nitrogen-containing austenitic stainless steel 316LN has been chosen as the material for nuclear main-pipe, which is one of the key parts in 3rd generation nuclear power plants. In this research, a constitutive model of nitrogen-containing austenitic stainless steel is developed. The true stress-true strain curves obtained from isothermal hot compression tests over a wide range of temperatures (900-1250 degrees C) and strain rates (10(-3) - 10 s(-1)), were employed to study the dynamic deformational behavior of and recrystallization in 316LN steels. The constitutive model is developed through multiple linear regressions performed on the experimental data and based on an Arrhenius-type equation and Zener-Hollomon theory. The influence of strain was incorporated in the developed constitutive equation by considering the effect of strain on the various material constants. The reliability and accuracy of the model is verified through the comparison of predicted flow stress curves and experimental curves. Possible reasons for deviation are also discussed based on the characteristics of modeling process.	[Zhang, Lei; Feng, Xiao; Wang, Xin; Liu, Changyong] Tsinghua Univ, Key Lab Adv Mat Proc Technol, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University	Zhang, L (corresponding author), Tsinghua Univ, Key Lab Adv Mat Proc Technol, Minist Educ, Beijing 100084, Peoples R China.	stoneszhang@tsinghua.edu.cn	Liu, Changyong/AAN-8402-2021	Liu, Changyong/0000-0003-3919-0713	National Science and Technology Major Project of China [2012ZX0401008]; National High-tech R&D Program of China (863 Program) [2012AA040202]	National Science and Technology Major Project of China; National High-tech R&D Program of China (863 Program)	This research is supported by the National Science and Technology Major Project of China (Grant No. 2012ZX0401008) and the National High-tech R&D Program of China (863 Program, Grant No. 2012AA040202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YQ, 2009, J TAIYUAN U SCI TECH, V30, P424; Begum Z, 2011, CORROS SCI, V53, P1424, DOI 10.1016/j.corsci.2011.01.003; Chen Mingming, 2010, CHINA METALFONNING E, V45, P83; Gavriljuk V.G., 1999, HIGH NITROGEN STEELS, P323, DOI [10.1007/978-3-662-03760-7_6, DOI 10.1007/978-3-662-03760-7_6]; Japan Stainless Steel Association, 1995, STAINLESS STEEL HDB, P1427; Johnson G.R., 1983, P 7 INT S BALLISTICS, P541; Jones RL, 1996, MATER PERFORMANCE, V35, P63; Kim DW, 2008, INT J PRES VES PIP, V85, P378, DOI 10.1016/j.ijpvp.2007.11.013; Kim DW, 2012, J NUCL MATER, V420, P473, DOI 10.1016/j.jnucmat.2011.11.001; Lin C.G., 2008, ADV PASSIVE PLANT AP; Lorenzetto P, 1996, J NUCL MATER, V233, P1387, DOI 10.1016/S0022-3115(96)00140-7; Momeni A, 2012, APPL MATH MODEL, V36, P5624, DOI 10.1016/j.apm.2012.01.008; Pan Pinli, 2012, China Mechanical Engineering, V23, P1354, DOI 10.3969/j.issn.1004-132X.2012.11.020; [潘品李 Pan Pinli], 2011, [塑性工程学报, Journal of Plasticity Engineering], V18, P13; Shaikh H, 2007, CORROS SCI, V49, P740, DOI 10.1016/j.corsci.2006.06.007; Shaikh H, 2010, CORROS SCI, V52, P1146, DOI 10.1016/j.corsci.2009.12.031; VOCE E, 1948, J I MET, V74, P537; Zener C, 1944, J APPL PHYS, V15, P22, DOI 10.1063/1.1707363; ZERILLI FJ, 1987, J APPL PHYS, V61, P1816, DOI 10.1063/1.338024; Zhou M, 1998, MECH MATER, V27, P63, DOI 10.1016/S0167-6636(97)00035-5	20	17	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e102687	10.1371/journal.pone.0102687	http://dx.doi.org/10.1371/journal.pone.0102687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375345	Green Submitted, gold, Green Published			2022-12-26	WOS:000344402600001
J	Akkerman, S; Prickaerts, J; Bruder, AK; Wolfs, KHM; De Vry, J; Vanmierlo, T; Blokland, A				Akkerman, Sven; Prickaerts, Jos; Bruder, Ann K.; Wolfs, Kevin H. M.; De Vry, Jochen; Vanmierlo, Tim; Blokland, Arjan			PDE5 Inhibition Improves Object Memory in Standard Housed Rats but Not in Rats Housed in an Enriched Environment: Implications for Memory Models?	PLOS ONE			English	Article							INDUCED BEHAVIORAL-RESPONSES; RECOGNITION MEMORY; NEUROTROPHIC FACTOR; SPATIAL MEMORY; BASE-LINE; PHOSPHODIESTERASE INHIBITORS; COGNITIVE DEFICITS; LOCOMOTOR-ACTIVITY; PHYSICAL-EXERCISE; DENTATE GYRUS	Drug effects are usually evaluated in animals housed under maximally standardized conditions. However, it is assumed that an enriched environment (EE) more closely resembles human conditions as compared to maximally standardized laboratory conditions. In the present study, we examined the acute cognition enhancing effects of vardenafil, a PDE5 inhibitor, which stimulates protein kinase G/CREB signaling in cells, in three different groups of male Wistar rats tested in an object recognition task (ORT). Rats were either housed solitarily (SOL) or socially (SOC) under standard conditions, or socially in an EE. Although EE animals remembered object information longer in the vehicle condition, vardenafil only improved object memory in SOL and SOC animals. While EE animals had a heavier dorsal hippocampus, we found no differences between experimental groups in total cell numbers in the dentate gyrus, CA2-3 or CA1. Neither were there any differences in markers for pre-and postsynaptic density. No changes in PDE5 mRNA-and protein expression levels were observed. Basal pCREB levels were increased in EE rats only, whereas beta-catenin was not affected, suggesting specific activation of the MAP kinase signaling pathway and not the AKT pathway. A possible explanation for the inefficacy of vardenafil could be that CREB signaling is already optimally stimulated in the hippocampus of EE rats. Since previous data has shown that acute PDE5 inhibition does not improve memory performance in humans, the use of EE animals could be considered as a more valid model for testing cognition enhancing drugs.	[Akkerman, Sven; Prickaerts, Jos; Wolfs, Kevin H. M.; De Vry, Jochen] Maastricht Univ, European Sch Neurosci EURON, Fac Hlth Med & Life Sci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Blokland, Arjan] Maastricht Univ, European Sch Neurosci EURON, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Vanmierlo, Tim] Hasselt Univ, Biomed Res Inst, Dept Immunol & Biochem, Hasselt, Belgium; [Bruder, Ann K.] Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany	Maastricht University; Maastricht University; Hasselt University; University of Bonn	Blokland, A (corresponding author), Maastricht Univ, European Sch Neurosci EURON, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands.	blokland@maastrichtuniversity.nl	Vanmierlo, Tim/C-7773-2013	Vanmierlo, Tim/0000-0003-2912-0578				Akar F, 2014, DRUG RES ST IN PRESS; Akar F, 2014, MED SCI MONIT BASIC, V20, P105, DOI 10.12659/MSMBR.891149; Akkerman S, 2014, NEUROBIOL LEARN MEM, V109, P139, DOI 10.1016/j.nlm.2014.01.006; Akkerman S, 2012, BEHAV BRAIN RES, V232, P317, DOI 10.1016/j.bbr.2012.03.024; Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Andin J, 2007, BRAIN RES, V1174, P18, DOI 10.1016/j.brainres.2007.06.101; Arndt DL, 2014, EXP CLIN PSYCHOPHARM, V22, P257, DOI 10.1037/a0035273; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bechara RG, 2013, BEHAV BRAIN RES, V245, P96, DOI 10.1016/j.bbr.2013.02.018; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Boccia MM, 2011, BEHAV BRAIN RES, V220, P319, DOI 10.1016/j.bbr.2011.02.016; BOWLING SL, 1993, NEUROPHARMACOLOGY, V32, P885, DOI 10.1016/0028-3908(93)90144-R; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Cao W, 2014, BEHAV BRAIN RES; Chourbaji S, 2012, NEUROSCIENCE, V220, P267, DOI 10.1016/j.neuroscience.2012.06.016; Del Arco A, 2007, J NEURAL TRANSM, V114, P43, DOI 10.1007/s00702-006-0565-8; Devan BD, 2004, PHARMACOL BIOCHEM BE, V79, P691, DOI 10.1016/j.pbb.2004.09.019; Diniz DG, 2010, EUR J NEUROSCI, V32, P509, DOI 10.1111/j.1460-9568.2010.07296.x; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; ESCORIHUELA RM, 1995, NEUROBIOL LEARN MEM, V64, P49, DOI 10.1006/nlme.1995.1043; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Galani R, 2007, NEUROBIOL LEARN MEM, V88, P1, DOI 10.1016/j.nlm.2007.03.009; Gaskin S, 2010, BEHAV PROCESS, V83, P61, DOI 10.1016/j.beproc.2009.10.003; Grass H., 2001, International Urology and Nephrology, V32, P409, DOI 10.1023/A:1017573722074; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gurwitz D, 2001, DRUG DISCOV TODAY, V6, P342, DOI 10.1016/S1359-6446(01)01747-0; Harati H, 2013, AGE, V35, P1027, DOI 10.1007/s11357-012-9424-8; Harati H, 2011, NEUROBIOL AGING, V32, P718, DOI 10.1016/j.neurobiolaging.2009.03.012; Hebb D.O., 1947, AM PSYCHOL, V2, P306; Hellemans KGC, 2005, BEHAV BRAIN RES, V159, P207, DOI 10.1016/j.bbr.2004.10.018; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hosseini-Sharifabad A, 2012, PHARMACOL BIOCHEM BE, V101, P311, DOI 10.1016/j.pbb.2012.01.017; Hutchinson E, 2005, ILAR J, V46, P148, DOI 10.1093/ilar.46.2.148; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jin F, 2014, INT J NEUROPSYCHOPH, V17, P871, DOI 10.1017/S1461145713001533; Kazlauckas V, 2011, PHYSIOL BEHAV, V102, P475, DOI 10.1016/j.physbeh.2010.12.025; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kobilo T, 2011, LEARN MEMORY, V18, P605, DOI 10.1101/lm.2283011; Kobilo T, 2011, LEARN MEMORY, V18, P103, DOI 10.1101/lm.2001611; Laviola G, 2008, NEUROBIOL DIS, V31, P159, DOI 10.1016/j.nbd.2008.05.001; Leger M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048043; Lynch G, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00143; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Myhrer T, 2003, BRAIN RES REV, V41, P268, DOI 10.1016/S0165-0173(02)00268-0; Nithianantharajah J, 2004, NEUROBIOL LEARN MEM, V81, P200, DOI 10.1016/j.nlm.2004.02.002; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Pamplona FA, 2009, PROG NEURO-PSYCHOPH, V33, P1153, DOI 10.1016/j.pnpbp.2009.06.012; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Prickaerts J, 2004, NEUROCHEM INT, V45, P915, DOI 10.1016/j.neuint.2004.03.022; Prickaerts J, 2002, EUR J PHARMACOL, V436, P83, DOI 10.1016/S0014-2999(01)01614-4; Prickaerts J, 2002, NEUROSCIENCE, V113, P351, DOI 10.1016/S0306-4522(02)00199-9; Ramirez-Rodriguez G, 2014, NEUROSCIENCE, V260, P158, DOI 10.1016/j.neuroscience.2013.12.026; Reneerkens OAH, 2013, J PSYCHOPHARMACOL, V27, P600, DOI 10.1177/0269881113477747; Reneerkens OAH, 2012, NEUROBIOL LEARN MEM, V97, P370, DOI 10.1016/j.nlm.2012.02.008; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; ROSENZWEIG MR, 1972, J COMP PHYSIOL PSYCH, V80, P304, DOI 10.1037/h0032978; Rutten K, 2007, EUR J PHARMACOL, V558, P107, DOI 10.1016/j.ejphar.2006.11.041; Rutten K, 2009, NEUROPSYCHOPHARMACOL, V34, P1914, DOI 10.1038/npp.2009.24; Sarter M, 2006, TRENDS PHARMACOL SCI, V27, P602, DOI 10.1016/j.tips.2006.09.004; Schmitz C, 2004, AM J PATHOL, V164, P1495, DOI 10.1016/S0002-9440(10)63235-X; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schultheiss D, 2001, WORLD J UROL, V19, P46, DOI 10.1007/PL00007092; Sierksma ASR, 2012, NEUROCHEM INT, V61, P697, DOI 10.1016/j.neuint.2012.06.022; Simpson J, 2012, BEHAV BRAIN RES, V234, P175, DOI 10.1016/j.bbr.2012.06.015; Simpson J, 2012, PROG NEURO-PSYCHOPH, V37, P252, DOI 10.1016/j.pnpbp.2012.02.008; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Thouvarecq R, 2007, PHYSIOL BEHAV, V90, P155, DOI 10.1016/j.physbeh.2006.09.024; Turner CA, 2003, PHYSIOL BEHAV, V80, P259, DOI 10.1016/j.physbeh.2003.07.008; Uthayathas S, 2013, SYNAPSE, V67, P741, DOI 10.1002/syn.21676; van Donkelaar EL, 2008, EUR J PHARMACOL, V600, P98, DOI 10.1016/j.ejphar.2008.10.027; van Praag H, 2001, DRUG DISCOV TODAY, V6, P615, DOI 10.1016/S1359-6446(01)01844-X; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100; Vedovelli K, 2011, NEUROSCIENCE, V199, P284, DOI 10.1016/j.neuroscience.2011.08.012; Viola GG, 2014, BRAIN STRUCT FUNCT, V219, P1509, DOI 10.1007/s00429-013-0563-1; Viola GG, 2010, PHYSIOL BEHAV, V99, P17, DOI 10.1016/j.physbeh.2009.10.003; Vivar Carmen, 2013, Curr Top Behav Neurosci, V15, P189, DOI 10.1007/7854_2012_220; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a; Yildirim E, 2012, PHARMACOL BIOCHEM BE, V101, P278, DOI 10.1016/j.pbb.2011.12.017; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zeeb FD, 2013, PSYCHOPHARMACOLOGY, V225, P381, DOI 10.1007/s00213-012-2822-x	83	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111692	10.1371/journal.pone.0111692	http://dx.doi.org/10.1371/journal.pone.0111692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372140	Green Published, gold			2022-12-26	WOS:000344556900062
J	Ambelu, A; Mekonen, S; Koch, M; Addis, T; Boets, P; Everaert, G; Goethals, P				Ambelu, Argaw; Mekonen, Seblework; Koch, Magaly; Addis, Taffere; Boets, Pieter; Everaert, Gert; Goethals, Peter			The Application of Predictive Modelling for Determining Bio-Environmental Factors Affecting the Distribution of Blackflies (Diptera: Simuliidae) in the Gilgel Gibe Watershed in Southwest Ethiopia	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; AZOLLA-FILICULOIDES LAM.; ANZALI WETLAND; HABITAT; DIVERSITY; ABUNDANCE; TREES	Blackflies are important macroinvertebrate groups from a public health as well as ecological point of view. Determining the biological and environmental factors favouring or inhibiting the existence of blackflies could facilitate biomonitoring of rivers as well as control of disease vectors. The combined use of different predictive modelling techniques is known to improve identification of presence/absence and abundance of taxa in a given habitat. This approach enables better identification of the suitable habitat conditions or environmental constraints of a given taxon. Simuliidae larvae are important biological indicators as they are abundant in tropical aquatic ecosystems. Some of the blackfly groups are also important disease vectors in poor tropical countries. Our investigations aim to establish a combination of models able to identify the environmental factors and macroinvertebrate organisms that are favourable or inhibiting blackfly larvae existence in aquatic ecosystems. The models developed using macroinvertebrate predictors showed better performance than those based on environmental predictors. The identified environmental and macroinvertebrate parameters can be used to determine the distribution of blackflies, which in turn can help control river blindness in endemic tropical places. Through a combination of modelling techniques, a reliable method has been developed that explains environmental and biological relationships with the target organism, and, thus, can serve as a decision support tool for ecological management strategies.	[Ambelu, Argaw; Mekonen, Seblework] Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia; [Koch, Magaly] Boston Univ, Ctr Remote Sensing, Boston, MA 02215 USA; [Addis, Taffere] Univ Addis Ababa, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia; [Boets, Pieter; Everaert, Gert; Goethals, Peter] Univ Ghent, Lab Environm Toxicol & Aquat Ecol, B-9000 Ghent, Belgium	Jimma University; Boston University; Addis Ababa University; Ghent University	Ambelu, A (corresponding author), Jimma Univ, Dept Environm Hlth Sci & Technol, POB 378, Jimma, Ethiopia.	aambelu@yahoo.com	Everaert, Gert/B-7707-2017; Ambelu, Argaw/GQA-6114-2022; Addis, Taffere/AAC-3460-2019; Goethals, Peter LM/A-1116-2008; Ambelu, Argaw/V-8317-2018; Koch, Magaly/B-3467-2017	Everaert, Gert/0000-0003-4305-0617; Ambelu, Argaw/0000-0003-1898-4100; Addis, Taffere/0000-0003-1647-4131; Ambelu, Argaw/0000-0003-1898-4100; Mekonen, Seblework/0000-0002-4255-6264; Koch, Magaly/0000-0002-6186-1619	Jimma University, Ethiopia; VLIR-UOS, Belgium	Jimma University, Ethiopia; VLIR-UOS, Belgium	This research was supported by Jimma University, Ethiopia and VLIR-UOS, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambelu A, 2009, BIOL MONITORING BASE; Ambelu A, 2010, ECOL INFORM, V5, P147, DOI 10.1016/j.ecoinf.2009.12.004; Andrewartha H.G., 1986, ECOLOGICAL WEB MORE; [Anonymous], 2005, STANDARD METHODS EXA; Austin MP, 2009, J ECOL, V97, P496, DOI 10.1111/j.1365-2745.2009.01494.x; Barbour M. T., 1999, RAPID BIOASSESSMENT, V2; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Bouchard J. R. W, 2004, GUIDE AQUATIC INVERT; Breiman L, 1993, CLASSIFICATION REGRE; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; D'heyere T, 2006, ECOL MODEL, V195, P20, DOI 10.1016/j.ecolmodel.2005.11.005; Dakou E, 2007, AQUAT ECOL, V41, P399, DOI 10.1007/s10452-006-9058-y; Figueiro Ronaldo, 2010, Oecologia Australis, V14, P745; Figueiro R, 2012, MEM I OSWALDO CRUZ, V107, P362, DOI 10.1590/S0074-02762012000300011; Giannoulaki M, 2008, HYDROBIOLOGIA, V612, P225, DOI 10.1007/s10750-008-9498-6; Giannoulaki M, 2011, FISH OCEANOGR, V20, P367, DOI 10.1111/j.1365-2419.2011.00590.x; Gibbins EG, 2009, T ROYAL ENTOMOLOGICA, V82, P51, DOI [10.1111/j.1365-2311.1934.tb00028.x, DOI 10.1111/J.1365-2311.1934.TB00028.X]; Goethals PLM, 2007, AQUAT ECOL, V41, P491, DOI 10.1007/s10452-007-9093-3; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hall MA, 2003, IEEE T KNOWL DATA EN, V15, P1437, DOI 10.1109/TKDE.2003.1245283; Hastie T., 1986, STAT SCI, V1, P297; Hastie T., 1999, GEN ADDITIVE MODELS; Hilborn Ray, 1997, V28; Hoang TH, 2010, ECOL INFORM, V5, P140, DOI 10.1016/j.ecoinf.2009.12.001; Holland J. H., 1992, ADAPTATION NATURAL A; IBN, 1984, T92402 IBN; Jowett IG, 2007, T AM FISH SOC, V136, P428, DOI 10.1577/T06-104.1; Katsanevakis S, 2009, FISH OCEANOGR, V18, P439, DOI 10.1111/j.1365-2419.2009.00523.x; Kazanci Nilgun, 2010, Review of Hydrobiology, V3, P27; Kazanci Nilgun, 2006, Acta Entomologica Serbica, V11, P69; KEELE L, 2008, SEMIPARAMETRIC REGRE; Lechthaler Wolfgang, 2004, Acta Zoologica Universitatis Comenianae, V46, P39; Lock K, 2014, LIMNOLOGICA, V44, P58, DOI 10.1016/j.limno.2013.08.001; Mereta ST, 2012, ECOL INFORM, V7, P52, DOI 10.1016/j.ecoinf.2011.11.005; Palialexis A, 2011, HYDROBIOLOGIA, V670, P241, DOI 10.1007/s10750-011-0673-9; Planque B, 2007, FISH OCEANOGR, V16, P16, DOI 10.1111/j.1365-2419.2006.00411.x; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; R Core Team, 2012, R LANG ENV STAT COMP; Reid JL, 2012, BIOTROPICA, V44, P350, DOI 10.1111/j.1744-7429.2011.00814.x; Sadeghi R, 2013, ECOL MODEL, V251, P44, DOI 10.1016/j.ecolmodel.2012.12.010; Sadeghi R, 2012, ECOL MODEL, V243, P8, DOI 10.1016/j.ecolmodel.2012.06.011; Taylor MJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-7; Vose M.D., 1999, COM ADAP SY; Voshell J.R., 2002, GUIDE COMMON FRESHWA; Witten IH, 2011, MOR KAUF D, P1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Wooley JC, 2005, CATALYZING INQUIRY B; Zarkami R., 2010, Caspian Journal of Environmental Sciences, V8, P55; Zarkami R, 2012, ECOL MODEL, V230, P44, DOI 10.1016/j.ecolmodel.2012.01.011	52	16	16	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112221	10.1371/journal.pone.0112221	http://dx.doi.org/10.1371/journal.pone.0112221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372843	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900122
J	De Buck, J; Shaykhutdinov, R; Barkema, HW; Vogel, HJ				De Buck, Jeroen; Shaykhutdinov, Rustem; Barkema, Herman W.; Vogel, Hans J.			Metabolomic Profiling in Cattle Experimentally Infected with Mycobacterium avium subsp paratuberculosis	PLOS ONE			English	Article							CLINICAL JOHNES-DISEASE; INTERFERON-GAMMA ASSAY; FECAL CULTURE; DAIRY CALVES; H-1-NMR SPECTROSCOPY; BIOMARKER DISCOVERY; PLASMA; TISSUE; SERUM; SUSCEPTIBILITY	The sensitivity of current diagnostics for Johne's disease, a slow, progressing enteritis in ruminants caused by Mycobacterium avium subsp. paratuberculosis (MAP), is too low to reliably detect all infected animals in the subclinical stage. The objective was to identify individual metabolites or metabolite profiles that could be used as biomarkers of early MAP infection in ruminants. In a monthly follow-up for 17 months, calves infected at 2 weeks of age were compared with aged-matched controls. Sera from all animals were analyzed by H-1 nuclear magnetic resonance spectrometry. Spectra were acquired, processed, and quantified for analysis. The concentration of many metabolites changed over time in all calves, but some metabolites only changed over time in either infected or non-infected groups and the change in others was impacted by the infection. Hierarchical multivariate statistical analysis achieved best separation between groups between 300 and 400 days after infection. Therefore, a cross-sectional comparison between 1-year-old calves experimentally infected at various ages with either a high-or a low-dose and age-matched non-infected controls was performed. Orthogonal Projection to Latent Structures Discriminant Analysis (OPLS DA) yielded distinct separation of non-infected from infected cattle, regardless of dose and time (3, 6, 9 or 12 months) after infection. Receiver Operating Curves demonstrated that constructed models were high quality. Increased isobutyrate in the infected cattle was the most important agreement between the longitudinal and cross-sectional analysis. In general, high-and low-dose cattle responded similarly to infection. Differences in acetone, citrate, glycerol and iso-butyrate concentrations indicated energy shortages and increased fat metabolism in infected cattle, whereas changes in urea and several amino acids (AA), including the branched chain AA, indicated increased protein turnover. In conclusion, metabolomics was a sensitive method for detecting MAP infection much sooner than with current diagnostic methods, with individual metabolites significantly distinguishing infected from non-infected cattle.	[De Buck, Jeroen; Barkema, Herman W.] Univ Calgary, Fac Vet Med, Dept Prod Anim Hlth, Calgary, AB, Canada; [Shaykhutdinov, Rustem; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Fac Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	De Buck, J (corresponding author), Univ Calgary, Fac Vet Med, Dept Prod Anim Hlth, Calgary, AB, Canada.	jdebuck@ucalgary.ca	De Buck, Jeroen/H-5509-2018; Barkema, Herman/B-9583-2008	De Buck, Jeroen/0000-0002-4824-9580; Barkema, Herman/0000-0002-9678-8378	Alberta Innovates Technology Futures; Alberta Innovates Biosolutions; Alberta Livestock and Meat Agency; Alberta Milk; Dairy Farmers of Canada; Natural Sciences and Engineering Research Council of Canada; Alberta Cancer Foundation	Alberta Innovates Technology Futures; Alberta Innovates Biosolutions; Alberta Livestock and Meat Agency; Alberta Milk; Dairy Farmers of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Cancer Foundation	The study was funded by the Alberta Innovates Technology Futures, Alberta Innovates Biosolutions, Alberta Livestock and Meat Agency, Alberta Milk, the Dairy Farmers of Canada, the Natural Sciences and Engineering Research Council of Canada and the Alberta Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mubarak R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001303; Borges DC, 2013, IMMUNOLOGY, V138, P145, DOI 10.1111/imm.12022; Casey JL, 2011, PROTEIN ENG DES SEL, V24, P589, DOI 10.1093/protein/gzr026; Chen KH, 2011, AM J PHYSIOL-ENDOC M, V301, pE853, DOI 10.1152/ajpendo.00048.2011; Davis VW, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-271; Denholm JT, 2010, CLIN EXP IMMUNOL, V162, P84, DOI 10.1111/j.1365-2249.2010.04221.x; Durudas A, 2011, CURR HIV RES, V9, P276, DOI 10.2174/157016211797635928; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Fitzpatrick MA, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13743; Hines ME, 2007, VET MICROBIOL, V122, P197, DOI 10.1016/j.vetmic.2007.03.009; Hisamatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031131; Hoerr V, 2012, J PROTEOME IN PRESS; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jungersen G, 2012, VET IMMUNOL IMMUNOP, V148, P48, DOI 10.1016/j.vetimm.2011.05.010; Li JV, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-179; Lin ZY, 2009, NMR BIOMED, V22, P601, DOI 10.1002/nbm.1373; Maertzdorf J, 2012, INT J TUBERC LUNG D, V16, P1140, DOI 10.5588/ijtld.12.0246; McArt JAA, 2012, J DAIRY SCI, V95, P5056, DOI 10.3168/jds.2012-5443; McKenna SLB, 2005, VET MICROBIOL, V110, P105, DOI 10.1016/j.vetmic.2005.07.010; McKenna SLB, 2005, J VET DIAGN INVEST, V17, P463, DOI 10.1177/104063870501700510; Mortier RAR, 2014, VET IMMUNOL IMMUNOP, V161, P205, DOI 10.1016/j.vetimm.2014.08.007; Mortier RAR, 2014, VET RES, V45, DOI 10.1186/s13567-014-0071-1; Mortier RAR, 2014, J DAIRY SCI, V97, P5558, DOI 10.3168/jds.2014-8139; Mortier RAR, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-94; Nielsen SS, 2008, VET MICROBIOL, V129, P217, DOI 10.1016/j.vetmic.2007.12.011; Ooi M, 2011, INFLAMM RES, V60, P831, DOI 10.1007/s00011-011-0340-7; PATTERS.DSP, 1966, VET REC, V78, P364, DOI 10.1136/vr.78.11.364; PATTERSON DS, 1967, VET REC, V81, P435, DOI 10.1136/vr.81.17.435; PATTERSON DS, 1969, J MED MICROBIOL, V2, P327, DOI 10.1099/00222615-2-3-327; Plattner BL, 2011, VET PATHOL, V48, P584, DOI 10.1177/0300985810383874; Pushie MJ, 2011, J TOXICOL ENV HEAL A, V74, P1476, DOI 10.1080/15287394.2011.618977; Raizman EA, 2007, PREV VET MED, V78, P179, DOI 10.1016/j.prevetmed.2006.10.006; Reimer RA, 2012, J PROTEOME RES, V11, P4065, DOI 10.1021/pr300487s; Roe B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023641; Schicho R, 2012, J PROTEOME RES; Schicho R, 2010, J PROTEOME RES, V9, P6265, DOI 10.1021/pr100547y; Schmerler D, 2012, J LIPID RES, V53, P1369, DOI 10.1194/jlr.P023309; Seth M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005478; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616; Skovgaard K, 2006, VET IMMUNOL IMMUNOP, V112, P210, DOI 10.1016/j.vetimm.2006.02.006; Sweeney RW, 2011, VET CLIN N AM-FOOD A, V27, P537, DOI 10.1016/j.cvfa.2011.07.001; Sweeney RW, 2006, RES VET SCI, V80, P253, DOI 10.1016/j.rvsc.2005.07.007; THIEL S, 1992, CLIN EXP IMMUNOL, V90, P31; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weljie AM, 2007, J PROTEOME RES, V6, P3456, DOI 10.1021/pr070123j; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wolfe R R, 1983, Prog Clin Biol Res, V111, P89; You QM, 2012, VET IMMUNOL IMMUNOP, V148, P243, DOI 10.1016/j.vetimm.2012.05.002; Zhong L, 2011, COMP IMMUNOL MICROB, V34, P315, DOI 10.1016/j.cimid.2011.03.001	54	35	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111872	10.1371/journal.pone.0111872	http://dx.doi.org/10.1371/journal.pone.0111872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372282	gold, Green Submitted, Green Published			2022-12-26	WOS:000344556900081
J	Ni, XJ; Zhang, XL; Ou-Yang, QW; Qian, GW; Wang, L; Chen, S; Jiang, YZ; Zuo, WJ; Wu, J; Hu, X; Shao, ZM				Ni, Xiao-Jian; Zhang, Xiao-Lan; Ou-Yang, Qian-Wen; Qian, Guo-Wei; Wang, Lei; Chen, Sheng; Jiang, Yi-Zhou; Zuo, Wen-Jia; Wu, Jiong; Hu, Xin; Shao, Zhi-Ming			An Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Favorable Response and Prognosis in Locally Advanced Breast Cancer following Neoadjuvant Chemotherapy	PLOS ONE			English	Article							ABSOLUTE MONOCYTE; POOR SURVIVAL; COUNT; NEUTROPHIL; SUBTYPES; ADULTS; CELLS; RISK	Purpose: Neoadjuvant chemotherapy (NCT) is a standard treatment option for locally advanced breast cancer. However, the lack of an efficient method to predict treatment response and patient prognosis hampers the clinical evaluation of patient eligibility for NCT. An elevated lymphocyte-to-monocyte ratio (LMR) has been reported to be associated with a favorable prognosis for certain hematologic malignancies and for nasopharyngeal carcinoma; however, this association has not been investigated in breast cancer. The purpose of this study was to evaluate whether pre-NCT LMR analysis could predict the prognosis of patients with locally advanced breast cancer. Methods: A retrospective cohort of 542 locally advanced breast cancer patients (T3/T4 and/or N2/N3 disease) receiving NCT followed by radical surgery was recruited between May 2002 and August 2011 at the Fudan University Shanghai Cancer Center. Counts for pre-NCT peripheral absolute lymphocytes and monocytes were obtained and used to calculate the LMR. Results: Univariate and multivariate analysis revealed that higher LMR levels (>= 4.25) were significantly associated with favorable DFS (P = 0.009 and P = 0.011, respectively). Additionally, univariate analysis revealed that a higher lymphocyte count (>= 1.5x10(9)/L) showed borderline significance for improved DFS (P = 0.054), while a lower monocyte count (,0.4x10(9)/L) was associated with a significantly better DFS (P = 0.010). Conclusions: An elevated pre-NCT peripheral LMR level was a significantly favorable factor for locally advanced breast cancer patient prognosis. This easily obtained variable may serve as a valuable marker to predict the outcomes of locally advanced breast cancer.	[Ni, Xiao-Jian; Qian, Guo-Wei; Wang, Lei; Chen, Sheng; Jiang, Yi-Zhou; Zuo, Wen-Jia; Wu, Jiong; Hu, Xin; Shao, Zhi-Ming] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai 200433, Peoples R China; [Ni, Xiao-Jian; Qian, Guo-Wei; Wang, Lei; Chen, Sheng; Jiang, Yi-Zhou; Zuo, Wen-Jia; Wu, Jiong; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Shao, Zhi-Ming] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhang, Xiao-Lan] Nanjing Med Univ, Changzhou Peoples Hosp Affiliated 2, Nanjing, Jiangsu, Peoples R China; [Ou-Yang, Qian-Wen] Third Hosp Nanchang, Dept Breast Surg, Nanchang, Jiangxi, Peoples R China	Fudan University; Fudan University; Fudan University; Nanjing Medical University	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai 200433, Peoples R China.	zhi_ming_shao@163.com			National Natural Science Foundation of China [81201531]; Shanghai Committee of Science and Technology Funds [12ZR1406200, 12DZ2260100, 12140901502]; Shanghai Committee of Science and Technology Fund [11QA1401400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee); Shanghai Committee of Science and Technology Fund(Shanghai Science & Technology Committee)	The study was supported by grants from the National Natural Science Foundation of China (81201531), the 2012 Shanghai Committee of Science and Technology Funds (12ZR1406200, 12DZ2260100 and 12140901502) and the Shanghai Committee of Science and Technology Fund for 2013 Qimingxing Project (11QA1401400 to XH). The authors also greatly appreciate the assistance of American Journal Experts (AJE) editors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bejon P, 2013, PLOS ONE, V8; Bishara S, 2008, EUR J OBSTET GYN R B, V138, P71, DOI 10.1016/j.ejogrb.2007.05.012; BRUCKNER HW, 1982, JAMA-J AM MED ASSOC, V247, P1004, DOI 10.1001/jama.247.7.1004; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; Dworacki G, 2001, CLIN CANCER RES, V7, p947S; Fogar P, 2006, PANCREAS, V32, P22, DOI 10.1097/01.mpa.0000188305.90290.50; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Hornychova H, 2008, CANCER INVEST, V26, P1024, DOI 10.1080/07357900802098165; HUSSAIN SP, 1994, ONCOGENE, V9, P2277; Iyengar Neil M, 2013, Am Soc Clin Oncol Educ Book, P46, DOI 10.1200/EdBook_AM.2013.33.46; Koh YW, 2012, ONCOLOGIST, V17, P871, DOI 10.1634/theoncologist.2012-0034; Li ZM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041658, 10.1371/journal.pone.0053176]; Mieog JSD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005002.pub2; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; NAKAMURA Y, 1988, CARCINOGENESIS, V9, P203, DOI 10.1093/carcin/9.2.203; Naranbhai V, 2014, J INFECT DIS, V209, P500, DOI 10.1093/infdis/jit494; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; Porrata LF, 2013, BONE MARROW RES, DOI 10.1155/2013/658371; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; RABINOWICH H, 1987, CANCER RES, V47, P173; SALIM AS, 1993, INT J CANCER, V53, P1031; Saroha S, 2013, J UROLOGY, V189, P454, DOI 10.1016/j.juro.2012.09.166; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Shen GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036515; Sun D, 2012, AM J HEMATOL, V87, P957, DOI 10.1002/ajh.23279; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tibaldi C, 2008, J CANCER RES CLIN, V134, P1143, DOI 10.1007/s00432-008-0378-2; Wilcox RA, 2011, LEUKEMIA, V25, P1502, DOI 10.1038/leu.2011.112; Wilcox RA, 2012, LEUKEMIA LYMPHOMA, V53, P575, DOI 10.3109/10428194.2011.637211; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177	33	81	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111886	10.1371/journal.pone.0111886	http://dx.doi.org/10.1371/journal.pone.0111886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372468	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900083
J	Oliveira-Pinto, AV; Santos, RM; Coutinho, RA; Oliveira, LM; Santos, GB; Alho, ATL; Leite, REP; Farfel, JM; Suemoto, CK; Grinberg, LT; Pasqualucci, CA; Jacob, W; Lent, R				Oliveira-Pinto, Ana V.; Santos, Raquel M.; Coutinho, Renan A.; Oliveira, Lays M.; Santos, Glaucia B.; Alho, Ana T. L.; Leite, Renata E. P.; Farfel, Jose M.; Suemoto, Claudia K.; Grinberg, Lea T.; Pasqualucci, Carlos A.; Jacob-Filho, Wilson; Lent, Roberto			Sexual Dimorphism in the Human Olfactory Bulb: Females Have More Neurons and Glial Cells than Males	PLOS ONE			English	Article							CELLULAR SCALING RULES; ISOTROPIC FRACTIONATOR; PERCEIVED INTENSITY; BRAIN ACTIVATION; MITRAL CELLS; NEUROGENESIS; GENDER; ODOR; COMMUNICATION; PERCEPTION	Sex differences in the human olfactory function reportedly exist for olfactory sensitivity, odorant identification and memory, and tasks in which odors are rated based on psychological features such as familiarity, intensity, pleasantness, and others. Which might be the neural bases for these behavioral differences? The number of cells in olfactory regions, and especially the number of neurons, may represent a more accurate indicator of the neural machinery than volume or weight, but besides gross volume measures of the human olfactory bulb, no systematic study of sex differences in the absolute number of cells has yet been undertaken. In this work, we investigate a possible sexual dimorphism in the olfactory bulb, by quantifying postmortem material from 7 men and 11 women (ages 55-94 years) with the isotropic fractionator, an unbiased and accurate method to estimate absolute cell numbers in brain regions. Female bulbs weighed 0.132 g in average, while male bulbs weighed 0.137 g, a non-significant difference; however, the total number of cells was 16.2 million in females, and 9.2 million in males, a significant difference of 43.2%. The number of neurons in females reached 6.9 million, being no more than 3.5 million in males, a difference of 49.3%. The number of non-neuronal cells also proved higher in women than in men: 9.3 million and 5.7 million, respectively, a significant difference of 38.7%. The same differences remained when corrected for mass. Results demonstrate a sex-related difference in the absolute number of total, neuronal and non-euronal cells, favoring women by 40-50%. It is conceivable that these differences in quantitative cellularity may have functional impact, albeit difficult to infer how exactly this would be, without knowing the specific circuits cells make. However, the reported advantage of women as compared to men may stimulate future work on sex dimorphism of synaptic microcircuitry in the olfactory bulb.	[Oliveira-Pinto, Ana V.; Santos, Raquel M.; Coutinho, Renan A.; Oliveira, Lays M.; Lent, Roberto] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Santos, Glaucia B.; Alho, Ana T. L.; Leite, Renata E. P.; Farfel, Jose M.; Suemoto, Claudia K.; Grinberg, Lea T.; Pasqualucci, Carlos A.; Jacob-Filho, Wilson] Univ Sao Paulo, Sch Med, Aging Brain Study Grp, Sao Paulo, Brazil; [Grinberg, Lea T.] Univ Calif San Francisco, Dept Neurol & Pathol, San Francisco, CA 94143 USA; [Lent, Roberto] Natl Inst Translat Neurosci, Minist Sci & Technol, Sao Paulo, Brazil; [Farfel, Jose M.; Suemoto, Claudia K.; Jacob-Filho, Wilson] Univ Sao Paulo, Sch Med, Discipline Geriatr, Sao Paulo, Brazil; [Santos, Glaucia B.; Alho, Ana T. L.] Hosp Israelita Albert Einstein, Inst Brain, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; University of California System; University of California San Francisco; Universidade de Sao Paulo; Hospital Israelita Albert Einstein	Lent, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.	rlent@icb.ufrj.br	Alho, Ana Tereza D L/C-3317-2014; Suemoto, Claudia K/C-7218-2012; Farfel, Jose/C-8936-2012; Suemoto, Claudia Kimie/AAC-7238-2019	Suemoto, Claudia K/0000-0002-5942-4778; Farfel, Jose/0000-0003-2057-3669; grinberg, lea/0000-0002-6809-0618	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Instituto Nacional de Ciencia e Tecnologia em Neurociencia Translacional; Fundacao Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Neurociencia Translacional; Fundacao Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The following Brazilian institutions contributed with research grants of different types, as well as fellowships of different categories to students who participated on the work. The grants are not unified as in the American system, so the total number of formal "grants'' totalize something like 30 or so. This is why they cannot be listed by their protocol numbers in each agency. (1) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (R. Lent) (www.cnpq.br). (2) Instituto Nacional de Ciencia e Tecnologia em Neurociencia Translacional (R. Lent). (3) Fundacao Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (R. Lent, A.V. Oliveira-Pinto) (www.capes.gov.br). (4) Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (R. Lent) (www.faperj.br). (5) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Lea T. Grinberg, C. Pasqualucci, W. Jacob-Filho) (www.fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Moraes CH, 2013, BRAIN, V136, P3738, DOI 10.1093/brain/awt273; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bahney J, 2014, J NEUROSCI METH, V222, P165, DOI 10.1016/j.jneumeth.2013.11.002; Bell EC, 2006, NEUROIMAGE, V30, P529, DOI 10.1016/j.neuroimage.2005.09.049; Bengtsson S, 2001, NEUROREPORT, V12, P2027, DOI 10.1097/00001756-200107030-00048; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BHATNAGAR KP, 1987, ANAT REC, V218, P73, DOI 10.1002/ar.1092180112; Brand G, 2001, Q J EXP PSYCHOL-B, V54, P259, DOI 10.1080/02724990143000045; Brus M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00135; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Crespo C, 2013, ANAT REC, V296, P1401, DOI 10.1002/ar.22732; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; de Groot JHB, 2014, J EXP PSYCHOL GEN, V143, P1515, DOI 10.1037/a0035950; de Sousa AA, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00051; Diamond J, 2005, CHEM SENSES, V30, pI224, DOI 10.1093/chemse/bjh195; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; DOTY RL, 1978, BEHAV BIOL, V23, P373, DOI 10.1016/S0091-6773(78)91393-7; DOTY RL, 1982, HORM BEHAV, V16, P13, DOI 10.1016/0018-506X(82)90002-2; DOTY RL, 1975, SCIENCE, V190, P1316, DOI 10.1126/science.1239080; DOTY RL, 1986, CLIN MEASUREMENT TAS, P377; Doty RL, 2014, FRONT PSYCHOL, V5, P20, DOI [DOI 10.3389/FPSYG.2014.00020, DOI 10.3389/fpsyg.2014.00020]; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; EVANS WJ, 1995, ELECTROEN CLIN NEURO, V95, P293, DOI 10.1016/0013-4694(95)00055-4; Gao Y, 2009, NAT NEUROSCI, V12, P731, DOI 10.1038/nn.2319; Garcia-Falgueras A, 2006, BRAIN RES, V1116, P103, DOI 10.1016/j.brainres.2006.07.115; Gardener EKT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073475; Giessel AJ, 2014, CURR OPIN NEUROBIOL, V24, P120, DOI 10.1016/j.conb.2013.09.010; Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z; Gur RC, 1999, J NEUROSCI, V19, P4065; Hahn CG, 2005, J COMP NEUROL, V483, P154, DOI 10.1002/cne.20424; Harasty J, 1997, ARCH NEUROL-CHICAGO, V54, P171, DOI 10.1001/archneur.1997.00550140045011; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Herculano-Houzel S, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00046; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Huart C, 2013, MOLECULES, V18, P11586, DOI 10.3390/molecules180911586; Hummel T, 2011, EXP BRAIN RES, V214, P285, DOI 10.1007/s00221-011-2832-7; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jacobs LF, 2012, P NATL ACAD SCI USA, V109, P10693, DOI 10.1073/pnas.1201880109; Jafari FH, 2008, ANN PARK I MED SCI, V4, P136; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Knaapila A, 2012, ARCH SEX BEHAV, V41, P1403, DOI 10.1007/s10508-011-9804-7; KOELEGA HS, 1994, PERCEPT MOTOR SKILL, V78, P203, DOI 10.2466/pms.1994.78.1.203; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Lent R, 2012, EUR J NEUROSCI, V35, P1, DOI 10.1111/j.1460-9568.2011.07923.x; LISS L, 1958, ARCHIV OTOLARYNGOL, V67, P167; Lledo PM, 2004, NEUROSCIENTIST, V10, P292, DOI 10.1177/1073858404263460; Lotsch J, 2013, BRAIN STRUCT FUNCT, DOI [10.1007/s00429-013-0618-2, DOI 10.1007/S00429-013-0618-2]; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Maresh A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002640; Matsutani S, 2008, ANAT SCI INT, V83, P218, DOI 10.1111/j.1447-073X.2007.00223.x; Meisami E, 1998, ANN NY ACAD SCI, V855, P708, DOI 10.1111/j.1749-6632.1998.tb10649.x; Migliore M, 2013, FUNCT NEUROL, V28, P241, DOI 10.11138/FNeur/2013.28.3.241; MILLER DI, 2014, SCI ENG ETHICS, V18, P37, DOI DOI 10.1016/J.TICS.2013.10.011; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Ohla K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00607; Olofsson JK, 2004, CHEM SENSES, V29, P629, DOI 10.1093/chemse/bjh066; Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026; Porter RH, 1998, GENETICA, V104, P259, DOI 10.1023/A:1026404319384; Radulescu AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068485; Reilly D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039904; Sama-ul-Haq, 2008, JCPSP-J COLL PHYSICI, V18, P669, DOI 11.2008/JCPSP.669973; Sama-ul-haq, 2008, BIOMEDICA, V24, P12; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; SCHNEIDER RA, 1958, J CLIN ENDOCR METAB, V18, P379, DOI 10.1210/jcem-18-4-379; Segovia S, 1996, HORM BEHAV, V30, P618, DOI 10.1006/hbeh.1996.0065; Segovia S, 1996, NEUROREPORT, V7, P2553, DOI 10.1097/00001756-199611040-00030; Seo HS, 2011, CHEM SENSES, V36, P177, DOI 10.1093/chemse/bjq112; Ship JA, 1996, J GERONTOL A-BIOL, V51, pM86, DOI 10.1093/gerona/51A.2.M86; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P3, DOI 10.1016/j.physbeh.2004.07.018; Thilers PP, 2006, PSYCHONEUROENDOCRINO, V31, P565, DOI 10.1016/j.psyneuen.2005.12.005; Tovar-Moll F, 2014, P NATL ACAD SCI USA, V111, P7843, DOI 10.1073/pnas.1400806111; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Yousem DM, 1999, BRAIN RES, V818, P480, DOI 10.1016/S0006-8993(98)01276-1	81	67	69	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111733	10.1371/journal.pone.0111733	http://dx.doi.org/10.1371/journal.pone.0111733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372872	gold, Green Submitted, Green Published			2022-12-26	WOS:000344556900069
J	Shin, SW; Park, BL; Chang, H; Park, JS; Bae, DJ; Song, HJ; Choi, IS; Kim, MK; Park, HS; Kim, LH; Namgoong, S; Kim, JO; Shin, HD; Park, CS				Shin, Seung-Woo; Park, Byung Lae; Chang, HunSoo; Park, Jong Sook; Bae, Da-Jeong; Song, Hyun-Ji; Choi, Inseon S.; Kim, Mi-Kyeong; Park, Hea-Sim; Kim, Lyoung Hyo; Namgoong, Suhg; Kim, Ji On; Shin, Hyoung Doo; Park, Choon-Sik			Exonic Variants Associated with Development of Aspirin Exacerbated Respiratory Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTOLERANT ASTHMA; GENE POLYMORPHISMS; PROMOTER POLYMORPHISM; NATURAL-HISTORY; SUSCEPTIBILITY; EXPRESSION; MARKER; HYPERSENSITIVITY; THROMBOXANE	Aspirin-exacerbated respiratory disease (AERD) is one phenotype of asthma, often occurring in the form of a severe and sudden attack. Due to the time-consuming nature and difficulty of oral aspirin challenge (OAC) for AERD diagnosis, non-invasive biomarkers have been sought. The aim of this study was to identify AERD-associated exonic SNPs and examine the diagnostic potential of a combination of these candidate SNPs to predict AERD. DNA from 165 AERD patients, 397 subjects with aspirin-tolerant asthma (ATA), and 398 normal controls were subjected to an Exome BeadChip assay containing 240K SNPs. 1,023 models (2(10)-1) were generated from combinations of the top 10 SNPs, selected by the p-values in association with AERD. The area under the curve (AUC) of the receiver operating characteristic (ROC) curves was calculated for each model. SNP Function Portal and PolyPhen-2 were used to validate the functional significance of candidate SNPs. An exonic SNP, exm537513 in HLA-DPB1, showed the lowest p-value (p = 3.40x10(-8)) in its association with AERD risk. From the top 10 SNPs, a combination model of 7 SNPs (exm537513, exm83523, exm1884673, exm538564, exm2264237, exm396794, and exm791954) showed the best AUC of 0.75 (asymptotic p-value of 7.94x10(-21)), with 34% sensitivity and 93% specificity to discriminate AERD from ATA. Amino acid changes due to exm83523 in CHIA were predicted to be "probably damaging" to the structure and function of the protein, with a high score of '1'. A combination model of seven SNPs may provide a useful, non-invasive genetic marker combination for predicting AERD.	[Shin, Seung-Woo; Chang, HunSoo; Park, Jong Sook; Park, Choon-Sik] Soonchunhyang Univ, Bucheon Hosp, Genome Res Ctr Allergy & Resp Dis, Div Allergy & Resp Med, Puchon, South Korea; [Park, Byung Lae; Kim, Lyoung Hyo; Namgoong, Suhg; Kim, Ji On; Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea; [Chang, HunSoo; Bae, Da-Jeong; Song, Hyun-Ji] Soonchunhyang Univ, Major Grad Sch, Dept Interdisciplinary Program Biomed Sci, Asan, South Korea; [Choi, Inseon S.] Chonnam Natl Univ, Sch Med, Dept Allergy, Kwangju, South Korea; [Choi, Inseon S.] Chonnam Natl Univ, Res Inst Med Sci, Kwangju, South Korea; [Kim, Mi-Kyeong] Chungbuk Natl Univ, Dept Internal Med, Div Allergy, Cheongju, South Korea; [Park, Hea-Sim] Ajou Univ Hosp, Dept Allergy & Clin Immunol, Suwoon, South Korea; [Kim, Lyoung Hyo; Namgoong, Suhg; Kim, Ji On; Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea	Soonchunhyang University; SNP Genetics; Soonchunhyang University; Chonnam National University; Chonnam National University; Chungbuk National University; Ajou University; Ajou University Hospital; Sogang University	Park, CS (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Genome Res Ctr Allergy & Resp Dis, Div Allergy & Resp Med, Puchon, South Korea.	hdshin@sogang.ac.kr; mdcspark@unitel.co.kr			Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, and Republic of Korea [HI13C0319]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, and Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, and Republic of Korea (HI13C0319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akahoshi M, 2005, HUM GENET, V117, P16, DOI 10.1007/s00439-005-1285-0; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Berges-Gimeno MP, 2002, ANN ALLERG ASTHMA IM, V89, P474, DOI 10.1016/S1081-1206(10)62084-4; Birben E, 2011, RESP MED, V105, P1160, DOI 10.1016/j.rmed.2011.03.017; Chang HS, 2011, ALLERGY ASTHMA IMMUN, V3, P256, DOI 10.4168/aair.2011.3.4.256; Choi JH, 2004, HUM GENET, V114, P337, DOI 10.1007/s00439-004-1082-1; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; Dekker JW, 1997, CLIN EXP ALLERGY, V27, P574, DOI 10.1046/j.1365-2222.1997.540848.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisner MD, 2007, NICOTINE TOB RES, V9, P53, DOI 10.1080/14622200601078293; Hedman J, 1999, INT J EPIDEMIOL, V28, P717, DOI 10.1093/ije/28.4.717; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Jinnai N, 2004, HUM MOL GENET, V13, P3203, DOI 10.1093/hmg/ddh332; Kim BS, 2010, PHARMACOGENET GENOM, V20, P748, DOI 10.1097/FPC.0b013e3283402155; Kim JH, 2011, J CLIN IMMUNOL, V31, P112, DOI 10.1007/s10875-010-9462-x; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013818; Kim SH, 2006, CLIN EXP ALLERGY, V36, P877, DOI 10.1111/j.1365-2222.2006.02443.x; Kim SH, 2007, PHARMACOGENET GENOM, V17, P295, DOI 10.1097/01.fpc.0000239977.61841.fe; Kim SH, 2009, RESP MED, V103, P356, DOI 10.1016/j.rmed.2008.10.008; Kim SH, 2006, CLIN EXP ALLERGY, V36, P433, DOI 10.1111/j.1365-2222.2006.02457.x; Kim SH, 2005, CLIN EXP ALLERGY, V35, P585, DOI 10.1111/j.1365-2222.2005.02220.x; Kim SH, 2005, CLIN EXP ALLERGY, V35, P339, DOI 10.1111/j.1365-2222.2004.02197.x; Kim TH, 2008, CLIN EXP ALLERGY, V38, P1727, DOI 10.1111/j.1365-2222.2008.03082.x; Lee JS, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-138; Lee RU, 2011, ALLERGY ASTHMA IMMUN, V3, P3, DOI 10.4168/aair.2011.3.1.3; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Nizankowska-Mogilnicka E, 2007, ALLERGY, V62, P1111, DOI 10.1111/j.1398-9995.2007.01409.x; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Oh SH, 2011, PHARMACOGENOMICS, V12, P351, DOI [10.2217/pgs.10.181, 10.2217/PGS.10.181]; Oh SH, 2009, ALLERGY ASTHMA IMMUN, V1, P30, DOI 10.4168/aair.2009.1.1.30; Palikhe NS, 2010, ALLERGY, V65, P338, DOI 10.1111/j.1398-9995.2009.02158.x; Palikhe NS, 2008, RESP MED, V102, P1132, DOI 10.1016/j.rmed.2008.03.017; Palikhe NS, 2011, ALLERGY ASTHMA IMMUN, V3, P123, DOI 10.4168/aair.2011.3.2.123; Park BL, 2013, HUM GENET, V132, P313, DOI 10.1007/s00439-012-1247-2; Park BL, 2010, BMB REP, V43, P445, DOI 10.5483/BMBRep.2010.43.6.445; Park HS, 2004, J ALLERGY CLIN IMMUN, V114, P688, DOI 10.1016/j.jaci.2004.05.051; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; Park SM, 2013, ALLERGY ASTHMA IMMUN, V5, P258, DOI 10.4168/aair.2013.5.5.258; Park TJ, 2011, INT ARCH ALLERGY IMM, V155, P395, DOI 10.1159/000321267; Pasaje CFA, 2010, ANN HUM GENET, V74, P326, DOI 10.1111/j.1469-1809.2010.00584.x; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Sakagami T, 2007, J HUM GENET, V52, P66, DOI 10.1007/s10038-006-0081-6; Sanak M, 2000, AM J RESP CELL MOL, V23, P290, DOI 10.1165/ajrcmb.23.3.4051; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Shin SW, 2012, DNA CELL BIOL, V31, P1604, DOI 10.1089/dna.2012.1688; SPURR NK, 1984, EMBO J, V3, P159, DOI 10.1002/j.1460-2075.1984.tb01777.x; Stevenson DD, 2006, J ALLERGY CLIN IMMUN, V118, P773, DOI 10.1016/j.jaci.2006.07.024; Szczeklik A, 2000, EUR RESPIR J, V16, P432, DOI 10.1034/j.1399-3003.2000.016003432.x; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Wang PL, 2006, BIOINFORMATICS, V22, pE523, DOI 10.1093/bioinformatics/btl241	52	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111887	10.1371/journal.pone.0111887	http://dx.doi.org/10.1371/journal.pone.0111887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372592	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900084
J	Tennant, JP; MacLeod, N				Tennant, Jonathan P.; MacLeod, Norman			Snout Shape in Extant Ruminants	PLOS ONE			English	Article							BODY-SIZE; MAMMALIAN HERBIVORES; NUTRITIONAL ECOLOGY; AFRICAN RUMINANTS; GRAZING RUMINANTS; EXTINCT RUMINANTS; MORPHOMETRIC DATA; RUMEN PHYSIOLOGY; ORAL MORPHOLOGY; LIFE-HISTORIES	Snout shape is a prominent aspect of herbivore feeding ecology, interacting with both forage selectivity and intake rate. Previous investigations have suggested ruminant feeding styles can be discriminated via snout shape, with grazing and browsing species characterised by 'blunt' and 'pointed' snouts respectively, often with specification of an 'intermediate' sub-grouping to represent ambiguous feeding styles and/or morphologies. Snout shape morphology is analysed here using a geometric morphometric approach to compare the two-dimensional profiles of the premaxilla in ventral aspect for a large sample of modern ruminant species, for which feeding modes are known from secondary criteria. Results suggest that, when browsing and grazing ruminants are classified ecologically based on a range of feeding style indicators, they cannot be discriminated unambiguously on the basis of snout profile shape alone. Profile shapes in our sample form a continuum with substantial overlap between groupings and a diverse range of morphologies. Nevertheless, we obtained an 83.8 percent ratio of correct post hoc feeding style categorisations based on the proximity of projected profile shapes to group centroids in the discriminant space. Accordingly, this procedure for identifying species whose feeding strategy is 'unknown' can be used with a reasonable degree of confidence, especially if backed-up by additional information. Based on these results we also refine the definitions of snout shape varieties, taking advantage of the descriptive power that geometric morphometrics offers to characterize the morphological disparities observed. The shape variance exhibited by both browsing and grazing ruminants corresponds strongly to body mass, providing further evidence for an interaction between snout shape, feeding style, and body size evolution. Finally, by exploring the role of phylogenetic similarity in snout shape, we find a slight increase in successful categorisation when repeating the analysis with phylogenetic control on the geometric	[Tennant, Jonathan P.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London, England; [MacLeod, Norman] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Imperial College London; Natural History Museum London	Tennant, JP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London, England.	jonathan.tennant10@imperial.ac.uk	Tennant, Jonathan P./H-2762-2019	Tennant, Jon/0000-0001-7794-0218				Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Bibi F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-166; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; BODMER RE, 1990, OIKOS, V57, P319, DOI 10.2307/3565960; HADLEY M., 1970, Annual review of ecology and systematics., V1, P125, DOI 10.1146/annurev.es.01.110170.001013; CAMPBELL NA, 1981, SYST ZOOL, V30, P268, DOI 10.2307/2413249; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1549, DOI 10.1098/rspb.2008.0262; Clauss M, 2005, MAMMAL REV, V35, P174, DOI 10.1111/j.1365-2907.2005.00062.x; Clauss M, 2003, OIKOS, V102, P253, DOI 10.1034/j.1600-0706.2003.12406.x; Clauss M, 2010, ANIMAL, V4, P979, DOI 10.1017/S1751731110000388; Clauss M, 2008, OECOLOGIA, V157, P377, DOI 10.1007/s00442-008-1093-z; Clauss Marcus, 2008, V195, P47, DOI 10.1007/978-3-540-72422-3_3; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Clauss M, 2009, COMP BIOCHEM PHYS A, V154, P376, DOI 10.1016/j.cbpa.2009.07.016; Clauss M, 2009, J MORPHOL, V270, P929, DOI 10.1002/jmor.10729; Clauss M, 2009, COMP BIOCHEM PHYS A, V152, P398, DOI 10.1016/j.cbpa.2008.11.009; Codron D, 2008, OIKOS, V117, P344, DOI 10.1111/j.2007.0030-1299.16387.x; Codron D, 2007, EUR J WILDLIFE RES, V53, P100, DOI 10.1007/s10344-006-0071-1; Codron D, 2010, CAN J ZOOL, V88, P1129, DOI 10.1139/Z10-077; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; du Toit Johan T., 2003, P292; DUTOIT JT, 1989, AM NAT, V133, P736, DOI 10.1086/284949; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Figueirido B, 2010, J EVOLUTION BIOL, V23, P2579, DOI 10.1111/j.1420-9101.2010.02117.x; Fletcher TM, 2010, PALAEONTOL ELECTRON, V13, P1; Fraser D, 2011, J VERTEBR PALEONTOL, V31, P1366, DOI 10.1080/02724634.2011.605404; Fritz J, 2009, OIKOS, V118, P1623, DOI 10.1111/j.1600-0706.2009.17807.x; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gordon IJ, 1988, FUNCT ECOL, V2, P15, DOI 10.2307/2389455; GORDON IJ, 1994, OECOLOGIA, V98, P167, DOI 10.1007/BF00341469; Gordon IJ, 1996, J ANIM ECOL, V65, P18, DOI 10.2307/5696; Gordon IJ, 2003, FOREST ECOL MANAG, V181, P13, DOI 10.1016/S0378-1127(03)00124-5; Gordon IJ, 1996, FUNCT ECOL, V10, P219, DOI 10.2307/2389846; GWYNNE MD, 1968, NATURE, V220, P390, DOI 10.1038/220390a0; HOFMANN R R, 1972, Mammalia, V36, P226, DOI 10.1515/mamm.1972.36.2.226; Hofmann R. R., 1988, Aspects of digestive physiology in ruminants. Proceedings of a Satellite Symposium of the 30th International Congress of the International Union of Physiological Sciences, July 21-23, 1986. Ithaca, New York, P1; Hofmann R. R, 1999, RANGIFER, V20, P71; Hofmann RR, 2008, J MORPHOL, V269, P240, DOI 10.1002/jmor.10580; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; HOFMANN RR, 1991, RECENT ADV NUTR HERB, P27; Hofmann RR., 1973, RUMINANT STOMACH STO; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Isaac NJB, 2005, AM NAT, V165, P600, DOI 10.1086/429148; JANIS C M, 1990, Memoirs of the Queensland Museum, V28, P349; Janis CM, 2010, J ANIM PHYSIOL AN N, V94, pE402, DOI 10.1111/j.1439-0396.2010.01030.x; JANIS CM, 1988, ZOOL J LINN SOC-LOND, V92, P267, DOI 10.1111/j.1096-3642.1988.tb01513.x; JANIS CM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P76; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; MacFadden BJ, 2000, ANNU REV ECOL SYST, V31, P33, DOI 10.1146/annurev.ecolsys.31.1.33; MACLEOD N, 2007, PALAEONTOLOGICAL ASS, V65, P36; MACLEOD N, 2007, PALAEONTOLOGICAL ASS, V64, P35; MacLeod N., 2009, PALAEONTOLOGICAL ASS, V72, P14; MACLEOD N, 2013, PALAEONTOL NEWSL, V82, P32; MacLeod N., 2005, PALAEONTOL NEWSL, V59, P44; MacLeod Norman, 2013, Palaeontology Newsletter, V84, P20; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Mendoza M, 2002, J ZOOL, V258, P223, DOI 10.1017/S0952836902001346; MILLAR JS, 1983, ECOLOGY, V64, P631, DOI 10.2307/1937181; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; MURRAY MG, 1993, J ANIM ECOL, V62, P380, DOI 10.2307/5369; Owen-Smith N, 1997, Z SAUGETIERKD, V62, P176; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perez-Barberia FJ, 2001, OECOLOGIA, V129, P498, DOI 10.1007/s004420100768; Perez-Barberia FJ, 1999, OECOLOGIA, V118, P157, DOI 10.1007/s004420050714; Perez-Barberia FJ, 2001, EVOL ECOL RES, V3, P221; Perez-Barberia FJ, 2004, P ROY SOC B-BIOL SCI, V271, P1081, DOI 10.1098/rspb.2004.2714; Perez-Barberia FJ, 1998, J ZOOL, V245, P307, DOI 10.1111/j.1469-7998.1998.tb00106.x; Perez-Barberia FJ, 2001, P ROY SOC B-BIOL SCI, V268, P1023, DOI 10.1098/rspb.2001.1619; Perez-Barberia FJ, 2000, EVOL ECOL RES, V2, P667; Polly DP, 2011, HYSTRIX ITALIAN J MA, V24, P33; R Core Team, 2018, R LANG ENV STAT COMP; Raia P, 2011, P ROY SOC B-BIOL SCI, V278, P3474, DOI 10.1098/rspb.2011.0273; Raia P, 2010, EVOLUTION, V64, P1489, DOI 10.1111/j.1558-5646.2009.00921.x; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; ROBBINS CT, 1995, OECOLOGIA, V103, P208, DOI 10.1007/BF00329082; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; SAND H, 1995, OECOLOGIA, V102, P433, DOI 10.1007/BF00341355; Sanson G, 2006, AM J BOT, V93, P1531, DOI 10.3732/ajb.93.10.1531; SATORRA A, 1985, PSYCHOMETRIKA, V50, P83, DOI 10.1007/BF02294150; SHIPLEY LA, 1994, AM NAT, V143, P1055, DOI 10.1086/285648; Shipley LA., 1999, P GRAZING BEHAV LIVE, P20; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; SOLOUNIAS N, 1993, J MAMMAL, V74, P1059, DOI 10.2307/1382445; SOLOUNIAS N, 1988, PALAEOGEOGR PALAEOCL, V65, P149, DOI 10.1016/0031-0182(88)90021-1; SOLOUNIAS N, 1988, PALEOBIOLOGY, V14, P287, DOI 10.1017/S009483730001201X; Sponheimer M, 2003, J MAMMAL, V84, P471, DOI 10.1644/1545-1542(2003)084&lt;0471:DOSABS&gt;2.0.CO;2; Steuer P, 2011, COMP BIOCHEM PHYS A, V160, P355, DOI 10.1016/j.cbpa.2011.07.005; VAN ZYL J. H. M., 1965, ZOOL AFRICANA, V1, P55; Voeten MM, 1999, OECOLOGIA, V120, P287, DOI 10.1007/s004420050860; Walker A., 1984, P119; Zhang WQ, 2012, GENET MOL RES, V11, P628, DOI 10.4238/2012.March.14.6	102	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112035	10.1371/journal.pone.0112035	http://dx.doi.org/10.1371/journal.pone.0112035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372878	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900105
J	Masjkur, J; Arps-Forker, C; Poser, SW; Nikolakopoulou, P; Toutouna, L; Chenna, R; Chavakis, T; Chatzigeorgiou, A; Chen, LS; Dubrovska, A; Choudhary, P; Uphues, I; Mark, M; Bornstein, SR; Androutsellis-Theotokis, A				Masjkur, Jimmy; Arps-Forker, Carina; Poser, Steven W.; Nikolakopoulou, Polyxeni; Toutouna, Louiza; Chenna, Ramu; Chavakis, Triantafyllos; Chatzigeorgiou, Antonios; Chen, Lan-Sun; Dubrovska, Anna; Choudhary, Pratik; Uphues, Ingo; Mark, Michael; Bornstein, Stefan R.; Androutsellis-Theotokis, Andreas			Hes3 Is Expressed in the Adult Pancreatic Islet and Regulates Gene Expression, Cell Growth, and Insulin Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell (B-cell); Cell Culture; Islet; Neural Stem Cell (NSC); Neurodegenerative Disease; Neuroprogenitor Cell; Notch Pathway; Pancreas; Parkinson Disease; Signal Transduction	NEURAL STEM-CELLS; BETA-CELLS; NOTCH; ACTIVATION; RECEPTOR; FATE; PDX1; DIFFERENTIATION; PROLIFERATION; STIMULATION	The transcription factor Hes3 is a component of a signaling pathway that supports the growth of neural stem cells with profound consequences in neurodegenerative disease models. Here we explored whether Hes3 also regulates pancreatic islet cells. We showed that Hes3 is expressed in human and rodent pancreatic islets. In mouse islets it co-localizes with alpha and beta cell markers. We employed the mouse insulinoma cell line MIN6 to perform in vitro characterization and functional studies in conditions known to modulate Hes3 based upon our previous work using neural stem cell cultures. In these conditions, cells showed elevated Hes3 expression and nuclear localization, grew efficiently, and showed higher evoked insulin release responses, compared with serum-containing conditions. They also exhibited higher expression of the transcription factor Pdx1 and insulin. Furthermore, they were responsive to pharmacological treatments with the GLP-1 analog Exendin-4, which increased nuclear Hes3 localization. We employed a transfection approach to address specific functions of Hes3. Hes3 RNA interference opposed cell growth and affected gene expression as revealed by DNA microarrays. Western blotting and PCR approaches specifically showed that Hes3 RNA interference opposes the expression of Pdx1 and insulin. Hes3 overexpression (using a Hes3-GFP fusion construct) confirmed a role of Hes3 in regulating Pdx1 expression. Hes3 RNA interference reduced evoked insulin release. Mice lacking Hes3 exhibited increased islet damage by streptozotocin. These data suggest roles of Hes3 in pancreatic islet function.	[Masjkur, Jimmy; Arps-Forker, Carina; Poser, Steven W.; Nikolakopoulou, Polyxeni; Toutouna, Louiza; Bornstein, Stefan R.; Androutsellis-Theotokis, Andreas] Univ Dresden, Dept Med, D-01307 Dresden, Germany; [Chenna, Ramu] Univ Dresden, BioInnovat Zentrum, Appl Bioinformat Grp, D-01307 Dresden, Germany; [Chavakis, Triantafyllos; Chatzigeorgiou, Antonios; Chen, Lan-Sun] Tech Univ Dresden, Inst Clin Chem & Lab Med, Dept Clin Pathobiochem, D-01307 Dresden, Germany; [Dubrovska, Anna] Tech Univ Dresden, Dept Med, OncoRay Natl Ctr Radiat Res Oncol, Med Fac Carl Gustav Carus, D-01307 Dresden, Germany; [Choudhary, Pratik] Kings Coll London, Diabet Res Grp, London SE5 9RS, England; [Uphues, Ingo; Mark, Michael] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetab Dis Res, D-88400 Biberach, Germany; [Androutsellis-Theotokis, Andreas] Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of London; King's College London; Boehringer Ingelheim; Technische Universitat Dresden	Androutsellis-Theotokis, A (corresponding author), Univ Dresden, Dept Med, Fetscherstr 74, D-01307 Dresden, Germany.	andreas.theotokis@uniklinikum-dresden.de	Chavakis, Triantafyllos/ABE-8845-2020; Nikolakopoulou, Polyxeni/GOV-7024-2022; Choudhary, Pratik/D-7701-2015; Masjkur, Jimmy/CAF-9054-2022; Dubrovska, Anna/AAE-8514-2019	Nikolakopoulou, Polyxeni/0000-0002-1695-9545; Dubrovska, Anna/0000-0002-3375-1500; Choudhary, Pratik/0000-0001-7635-4735; Androutsellis-Theotokis, Andreas/0000-0002-1985-4589; Chen, Lan-Sun/0000-0002-5917-3083; Chatzigeorgiou, Antonios/0000-0002-7039-4223	Boehringer Ingelheim; Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases through Initiative and Network Fund of Helmholtz Association [051_40001]; Deutsche Forschungsgemeinschaft [SFB 655]	Boehringer Ingelheim(Boehringer Ingelheim); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases through Initiative and Network Fund of Helmholtz Association; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Boehringer Ingelheim and in part by the Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of Helmholtz Association Grant 051_40001 and Deutsche Forschungsgemeinschaft Grant SFB 655, "Cells into tissues," Project A24. Ingo Uphues and Michael Mark are employees of Boehringer Ingelheim and thus contributed to study design, data analysis, and preparation of the manuscript.	Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010841; Androutsellis-Theotokis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009414; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; D'Amico E, 2005, J MOL ENDOCRINOL, V34, P377, DOI 10.1677/jme.1.01655; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Fujimoto K, 2009, DIABETES OBES METAB, V11, P30, DOI 10.1111/j.1463-1326.2009.01121.x; Gigoux V, 2008, REGUL PEPTIDES, V146, P88, DOI 10.1016/j.regpep.2007.08.020; GOKE R, 1993, J BIOL CHEM, V268, P19650; Gouti M, 2008, STEM CELLS, V26, P1985, DOI 10.1634/stemcells.2008-0182; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Hirata H, 2000, J BIOL CHEM, V275, P19083, DOI 10.1074/jbc.M001075200; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Imayoshi I, 2011, MOL NEUROBIOL, V44, P7, DOI 10.1007/s12035-011-8186-0; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kageyama R, 2010, CURR TOP DEV BIOL, V92, P311, DOI 10.1016/S0070-2153(10)92010-3; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kwon G, 2004, DIABETES, V53, pS225, DOI 10.2337/diabetes.53.suppl_3.S225; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li YH, 2005, DIABETES, V54, P482, DOI 10.2337/diabetes.54.2.482; Ludwig B, 2013, P NATL ACAD SCI USA, V110, P19054, DOI 10.1073/pnas.1317561110; Masjkur J, 2012, CNS NEUROL DISORD-DR, V11, P805, DOI 10.2174/1871527311201070805; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Norquay LD, 2009, ENDOCRINOLOGY, V150, P4531, DOI 10.1210/en.2009-0395; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Oya S, 2008, NEUROREPORT, V19, P805, DOI 10.1097/WNR.0b013e3282ff8641; Pacioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051630; Park DM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01095; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Phieler J, 2013, J IMMUNOL, V191, P4367, DOI 10.4049/jimmunol.1300038; Poser SW, 2013, JOVE-J VIS EXP, DOI 10.3791/50880; Poser SW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00273; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Rooman I, 2002, DIABETES, V51, P686, DOI 10.2337/diabetes.51.3.686; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Salewski RP, 2013, STEM CELLS DEV, V22, P383, DOI 10.1089/scd.2012.0218; Suarez-Pinzon WL, 2005, J CLIN ENDOCR METAB, V90, P3401, DOI 10.1210/jc.2004-0761; Tanabe K, 1997, BIOCHEM BIOPH RES CO, V241, P765, DOI 10.1006/bbrc.1997.7894; Ueo T, 2012, DEVELOPMENT, V139, P1071, DOI 10.1242/dev.069070; Van de Velde S, 2011, P NATL ACAD SCI USA, V108, P16876, DOI 10.1073/pnas.1114228108; WANG TC, 1993, J CLIN INVEST, V92, P1349, DOI 10.1172/JCI116708; Zhang CC, 2012, CLIN CANCER RES, V18, P5008, DOI 10.1158/1078-0432.CCR-12-1379	51	7	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35503	35516		10.1074/jbc.M114.590687	http://dx.doi.org/10.1074/jbc.M114.590687			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371201	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000346660200039
J	Dhakal, KR; Gu, L; Shivalingaiah, S; Dennis, TS; Morris-Bobzean, SA; Li, T; Perrotti, LI; Mohanty, SK				Dhakal, Kamal R.; Gu, Ling; Shivalingaiah, Shivaranjani; Dennis, Torry S.; Morris-Bobzean, Samara A.; Li, Ting; Perrotti, Linda I.; Mohanty, Samarendra K.			Non-Scanning Fiber-Optic Near-Infrared Beam Led to Two-Photon Optogenetic Stimulation In-Vivo	PLOS ONE			English	Article							MILLISECOND-TIMESCALE; OPTICAL-PROPERTIES; EXCITABLE CELLS; DELTA-FOSB; EXCITATION; BRAIN; LIGHT; ABSORPTION; ACTIVATION; CHANNELRHODOPSIN-2	Stimulation of specific neurons expressing opsins in a targeted region to manipulate brain function has proved to be a powerful tool in neuroscience. However, the use of visible light for optogenetic stimulation is invasive due to low penetration depth and tissue damage owing to larger absorption and scattering. Here, we report, for the first time, in-depth non-scanning fiber-optic two-photon optogenetic stimulation (FO-TPOS) of neurons in-vivo in transgenic mouse models. In order to optimize the deep-brain stimulation strategy, we characterized two-photon activation efficacy at different near-infrared laser parameters. The significantly-enhanced in-depth stimulation efficiency of FO-TPOS as compared to conventional single-photon beam was demonstrated both by experiments and Monte Carlo simulation. The non-scanning FO-TPOS technology will lead to better understanding of the in-vivo neural circuitry because this technology permits more precise and less invasive anatomical delivery of stimulation.	[Dhakal, Kamal R.; Gu, Ling; Shivalingaiah, Shivaranjani; Mohanty, Samarendra K.] Univ Texas Arlington, Biophys & Physiol Lab, Arlington, TX 76019 USA; [Dennis, Torry S.; Morris-Bobzean, Samara A.; Perrotti, Linda I.] Univ Texas Arlington, Dept Psychol, Arlington, TX 76019 USA; [Li, Ting] Univ Elect Sci & Technol China, Minist Educ, Key Lab Neuroinformat, Chengdu, Sichuan, Peoples R China	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington; University of Electronic Science & Technology of China	Mohanty, SK (corresponding author), Univ Texas Arlington, Biophys & Physiol Lab, Arlington, TX 76019 USA.	smohanty@uta.edu		Perrotti, Linda/0000-0002-6297-2572	Office of President and Provost, The University of Texas at Arlington; National Institute of Health [NS084311]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084311] Funding Source: NIH RePORTER	Office of President and Provost, The University of Texas at Arlington; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	SKM is thankful for the support from Office of President and Provost, The University of Texas at Arlington, the National Institute of Health (NS084311), and Mr. Harvey Wiggins (Plexon Inc.) for providing the Plexon Omniplex system and Plexon staff for electrophysiological recording support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albota MA, 1998, APPL OPTICS, V37, P7352, DOI 10.1364/AO.37.007352; Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bestvater F, 2002, J MICROSC-OXFORD, V208, P108, DOI 10.1046/j.1365-2818.2002.01074.x; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Butson CR, 2006, J NEURAL ENG, V3, P1, DOI 10.1088/1741-2560/3/1/001; Butson CR, 2005, CLIN NEUROPHYSIOL, V116, P2490, DOI 10.1016/j.clinph.2005.06.023; Cao H, 2012, IEEE T BIOMED ENG; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Denton ML, 2006, INVEST OPHTH VIS SCI, V47, P3065, DOI 10.1167/iovs.05-1066; Dhakal K, 2013, OPT LETT, V38, P1927, DOI 10.1364/OL.38.001927; Fu L, 2006, OPT EXPRESS, V14, P1027, DOI 10.1364/OE.14.001027; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hirase H, 2002, J NEUROBIOL, V51, P237, DOI 10.1002/neu.10056; JACQUES SL, 1989, APPL OPTICS, V28, P2223, DOI 10.1364/AO.28.002223; Johansson JD, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3495719; Kanneganti A, 2011, BIOPHYS J, V100, P95; Kienle A, 1996, APPL OPTICS, V35, P2304, DOI 10.1364/AO.35.002304; Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Miller G, 2006, SCIENCE, V314, P1674, DOI 10.1126/science.314.5806.1674; Mishra YN, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3643340; Mohanty SK, 2008, BIOPHYS J, V95, P3916, DOI 10.1529/biophysj.108.130187; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Shapiro MG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1742; Shivalingaiah S, 2011, PROC SPIE, V7883, DOI 10.1117/12.875996; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Vivas MG, 2010, J PHYS CHEM A, V114, P3466, DOI 10.1021/jp910010g; Voon V, 2006, MOVEMENT DISORD, V21, pS305, DOI 10.1002/mds.20963; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Wang LH, 1997, COMPUT METH PROG BIO, V54, P141, DOI 10.1016/S0169-2607(97)00021-7; WILSON BC, 1990, IEEE J QUANTUM ELECT, V26, P2186, DOI 10.1109/3.64355; Yamaguchi S, 2003, CHEM PHYS LETT, V376, P237, DOI 10.1016/S0009-2614(03)00984-9; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	44	8	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111488	10.1371/journal.pone.0111488	http://dx.doi.org/10.1371/journal.pone.0111488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383687	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700017
J	Alfonso-Rodriguez, CA; Garzon, I; Garrido-Gomez, J; Oliveira, ACX; Martin-Piedra, MA; Scionti, G; Carriel, V; Hernandez-Cortes, P; Campos, A; Alaminos, M				Alfonso-Rodriguez, Camilo-Andres; Garzon, Ingrid; Garrido-Gomez, Juan; Oliveira, Ana-Celeste-Ximenes; Martin-Piedra, Miguel-Angel; Scionti, Giuseppe; Carriel, Victor; Hernandez-Cortes, Pedro; Campos, Antonio; Alaminos, Miguel			Identification of Histological Patterns in Clinically Affected and Unaffected Palm Regions in Dupuytren's Disease	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CONTRACTURE; CELLS; FIBROBLASTS; COLLAGENASE; MANAGEMENT; MYOFIBROBLASTS; PATHOGENESIS; MIGRATION; VERSICAN	Dupuytren's disease is a fibro-proliferative disease characterized by a disorder of the extracellular matrix (ECM) and high myofibroblast proliferation. However, studies failed to determine if the whole palm fascia is affected by the disease. The objective of this study was to analyze several components of the extracellular matrix of three types of tissues-Dupuytren's diseased contracture cords (DDC), palmar fascia clinically unaffected by Dupuytren's disease contracture (NPF), and normal forehand fascia (NFF). Histological analysis, quantification of cells recultured from each type of tissue, mRNA microarrays and immunohistochemistry for smooth muscle actin (SMA), fibrillar ECM components and non-fibrillar ECM components were carried out. The results showed that DDC samples had abundant fibrosis with reticular fibers and few elastic fibers, high cell proliferation and myofibroblasts, laminin and glycoproteins, whereas NFF did not show any of these findings. Interestingly, NPF tissues had more cells showing myofibroblasts differentiation and more collagen and reticular fibers, laminin and glycoproteins than NFF, although at lower level than DDC, with similar elastic fibers than DDC. Immunohistochemical expression of decorin was high in DDC, whereas versican was highly expressed NFF, with no differences for aggrecan. Cluster analysis revealed that the global expression profile of NPF was very similar to DDC, and reculturing methods showed that cells corresponding to DDC tissues proliferated more actively than NPF, and NPF more actively than NFF. All these results suggest that NPF tissues may be affected, and that a modification of the therapeutic approach used for the treatment of Dupuytren's disease should be considered.	[Alfonso-Rodriguez, Camilo-Andres; Garzon, Ingrid; Oliveira, Ana-Celeste-Ximenes; Martin-Piedra, Miguel-Angel; Scionti, Giuseppe; Carriel, Victor; Campos, Antonio; Alaminos, Miguel] Univ Granada, Dept Histol, Tissue Engn Grp, Granada, Spain; [Alfonso-Rodriguez, Camilo-Andres; Garzon, Ingrid; Oliveira, Ana-Celeste-Ximenes; Martin-Piedra, Miguel-Angel; Scionti, Giuseppe; Carriel, Victor; Campos, Antonio; Alaminos, Miguel] Inst Invest Biosanit Ibs, Granada, Spain; [Alfonso-Rodriguez, Camilo-Andres] Univ Granada, Ph D Programme Biomed, Granada, Spain; [Garrido-Gomez, Juan; Hernandez-Cortes, Pedro] Univ Hosp San Cecilio, Div Trauma & Orthoped Surg, Granada, Spain	University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Hospital Universitario San Cecilio	Alaminos, M (corresponding author), Univ Granada, Dept Histol, Tissue Engn Grp, Granada, Spain.	malaminos@ugr.es	Oliveira, Ana Carolina/GRF-1435-2022; Martin-Piedra, Miguel Angel/F-3664-2019; ARAYA, VICTOR CARRIEL/H-9425-2018; ALAMINOS, MIGUEL/N-9960-2016; Scionti, Giuseppe/I-6454-2013; Hernández-Cortés, Pedro/AAS-7691-2020; Scionti, Giuseppe/I-6454-2013	Martin-Piedra, Miguel Angel/0000-0002-4639-3175; ARAYA, VICTOR CARRIEL/0000-0002-8114-5644; ALAMINOS, MIGUEL/0000-0003-4876-2672; Scionti, Giuseppe/0000-0003-2128-0104; Alfonso Rodriguez, Camilo Andres/0000-0001-7243-9272; Campos, A/0000-0003-4061-8182; Scionti, Giuseppe/0000-0002-1030-6711	Tissue Engineering Group, University of Granada/Spain [CTS-115]	Tissue Engineering Group, University of Granada/Spain	This work was supported by CTS-115 (Tissue Engineering Group), University of Granada/Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; Bainbridge C, 2012, J PLAST SURG HAND SU, V46, P177, DOI 10.3109/2000656X.2012.683795; Berdasco M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003306; BERNDT A, 1994, PATHOBIOLOGY, V62, P55, DOI 10.1159/000163879; Black EM, 2011, J AM ACAD ORTHOP SUR, V19, P746, DOI 10.5435/00124635-201112000-00005; Carriel VS, 2011, J HISTOCHEM CYTOCHEM, V59, P270, DOI 10.1369/0022155410398001; Oliveira AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066538; Couchman JR, 2012, J HISTOCHEM CYTOCHEM, V60, P885, DOI 10.1369/0022155412464638; Dolmans GH, 2011, NEW ENGL J MED, V365, P307, DOI 10.1056/NEJMoa1101029; EKBLOM P, 1996, LAMININS; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Garg M, 2014, J CLIN ENDOCR METAB, V99, pE62, DOI 10.1210/jc.2013-2994; Hindocha S, 2011, BRIT J SURG, V98, P308, DOI 10.1002/bjs.7307; Iqbal SA, 2012, STEM CELLS DEV, V21, P609, DOI 10.1089/scd.2011.0140; Kaplan FTD, 2011, DRUG TODAY, V47, P653, DOI 10.1358/dot.2011.47.9.1656502; Kreis T, 1999, GUIDEBOOK EXTRACELLU; Lam WL, 2010, J HAND SURG-EUR VOL, V35E, P312, DOI 10.1177/1753193410362848; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; LUCK JV, 1959, J BONE JOINT SURG AM, V41, P635, DOI 10.2106/00004623-195941040-00008; Michou L, 2012, JOINT BONE SPINE, V79, P7, DOI 10.1016/j.jbspin.2011.05.027; MILLESI H, 1995, CLIN BIOMECH, V10, P29, DOI 10.1016/0268-0033(95)90434-B; MURRELL GAC, 1991, J HAND SURG-BRIT EUR, V16B, P263, DOI 10.1016/0266-7681(91)90050-X; Ojwang JO, 2010, J HAND SURG-AM, V35A, P2039, DOI 10.1016/j.jhsa.2010.08.008; PASQUALIRONCHETTI I, 1993, J HAND SURG-BRIT EUR, V18B, P262, DOI 10.1016/0266-7681(93)90125-Y; Picardo NE, 2012, SURG-J R COLL SURG E, V10, P151, DOI 10.1016/j.surge.2012.01.004; Plumb DA, 2007, J BIOL CHEM, V282, P12791, DOI 10.1074/jbc.C700021200; Ratkaj I, 2012, CELL PHYSIOL BIOCHEM, V30, P927, DOI 10.1159/000341470; Rayan GM, 1999, HAND CLIN, V15, P73; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Rehman S, 2008, J HAND SURG-AM, V33A, P359, DOI 10.1016/j.jhsa.2007.11.010; Rehman S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3438; Ricard-Blum S., 2011, COLD SPRING HARBOR P, V3; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sampson S, 2011, J AM OSTEOPATH ASSOC, V111, P113; Satish L, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-15; Satish L, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-113; Satish L, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-10; Shih B, 2010, NAT REV RHEUMATOL, V6, P715, DOI 10.1038/nrrheum.2010.180; Thomas A, 2010, THER CLIN RISK MANAG, V6, P557, DOI 10.2147/TCRM.S8591; Verhoekx JSN, 2013, J INVEST DERMATOL, V133, P2664, DOI 10.1038/jid.2013.219; Verjee LS, 2013, P NATL ACAD SCI USA, V110, pE928, DOI 10.1073/pnas.1301100110; Vi L, 2009, EXP CELL RES, V315, P3574, DOI 10.1016/j.yexcr.2009.07.015; Vi L, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-72; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Wilkinson JM, 2012, BBA-MOL BASIS DIS, V1822, P897, DOI 10.1016/j.bbadis.2012.02.001; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342	46	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112457	10.1371/journal.pone.0112457	http://dx.doi.org/10.1371/journal.pone.0112457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379672	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100100
J	Bai, YJ; Zhao, M; Zhang, CF; Li, SS; Qi, Y; Wang, B; Huang, LZ; Li, XX				Bai, Yujing; Zhao, Min; Zhang, Chunfang; Li, Shanshan; Qi, Yun; Wang, Bin; Huang, Lvzhen; Li, Xiaoxin			Anti-Angiogenic Effects of a Mutant Endostatin: A New Prospect for Treating Retinal and Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; POLYETHYLENE-GLYCOL; OCULAR NEOVASCULARIZATION; EYE	Purpose: Pathological fundus angiogenesis is a major cause of vision loss in retina diseases. Endostatin, a C-terminal fragment of collagen XVIII, is an endogenous anti-angiogenic protein. The present study aimed to investigate the in vitro and in vivo anti-angiogenic properties of two proteins: an N-terminal H1D/H3D mutant endostatin (M-ES) and a polyethylene glycol propionaldehyde (PEG) covalent M-ES (PEG-M-ES). Methods: M-ES and PEG-M-ES properties were characterized in vitro using a zinc ion binding assay and a stability test. Activity assays, including migration, proliferation, and tube formation assays, were performed with human retinal microvascular endothelial cells (HRMECs) and human umbilical vein endothelial cells (HUVECs). Mouse oxygen-induced retinopathy (OIR) and choroidal neovascularization (CNV) models were used to evaluate in vivo anti-angiogenic effects. In addition, a rabbit model was used to study the retinal pharmacokinetic profile following an intravitreal injection. Results: The results indicated that the H1D/H3D mutations of endostatin reduced the zinc binding capacity of M-ES and facilitated PEG covalent binding. PEG-M-ES was more stable and persisted longer in the retina compared with M-ES. The in vitro studies demonstrated that M-ES and PEG-M-ES inhibited HRMEC and HUVEC proliferation, migration, and tube formation more efficiently than ES. In vivo, a single intravitreal injection of M-ES and PEG-M-ES significantly decreased neovascularization in both the OIR and CNV animal models. Conclusion: The present study demonstrated for the first time that PEG-M-ES exhibits a long-term inhibitory effect on neovascularization in vitro and in vivo. These data suggest that PEG-M-ES may represent an innovative therapeutic strategy to prevent fundus neovascularization.	[Bai, Yujing; Zhao, Min; Li, Shanshan; Qi, Yun; Wang, Bin; Huang, Lvzhen; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol,Key Lab Vis Loss & Restorat,Minis, Beijing Key Lab Diag & Treatment Retinal & Choroi, Beijing 100871, Peoples R China; [Zhang, Chunfang] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China	Peking University; Peking University	Huang, LZ (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol,Key Lab Vis Loss & Restorat,Minis, Beijing Key Lab Diag & Treatment Retinal & Choroi, Beijing 100871, Peoples R China.	huanglvzhen@sina.com; drlixiaoxin@163.com		Zhao, Min/0000-0003-0521-9186	National Basic Research Program of China [973 Program] [2011CB510200]; Beijing Nova Program [Z131102000413004]; National Natural Science Foundation of China [81200690]	National Basic Research Program of China [973 Program](National Basic Research Program of China); Beijing Nova Program(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China [973 Program, 2011CB510200] to XXL, the Beijing Nova Program (Z131102000413004) to YJB, and the National Natural Science Foundation of China Grant (81200690) to YJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, DRUG RESIST UPDATE, V8, P59, DOI 10.1016/j.drup.2005.03.001; ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582; Avery RL, 2013, BR J OPHTHALMOL; Bai YJ, 2013, J OCUL PHARMACOL TH, V29, P619, DOI 10.1089/jop.2012.0225; Bai YJ, 2012, J PHARMACOL EXP THER, V342, P131, DOI 10.1124/jpet.112.192575; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P2179, DOI 10.1016/j.ophtha.2007.09.012; Barkmeier AJ, 2011, SEMIN OPHTHALMOL, V26, P94, DOI 10.3109/08820538.2011.571055; Boehm T, 1998, BIOCHEM BIOPH RES CO, V252, P190, DOI 10.1006/bbrc.1998.9617; Bressler SB, 2009, OPHTHALMOLOGY, V116, pS1, DOI 10.1016/j.ophtha.2009.06.045; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Cao YH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003149; CHAFFEE S, 1992, J CLIN INVEST, V89, P1643, DOI 10.1172/JCI115761; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; Doguizi S, 2013, RETINA; Folkman J, 1996, Harvey Lect, V92, P65; Fu Y, 2009, IUBMB LIFE, V61, P613, DOI 10.1002/iub.215; Fujita Y, 2008, CURR PHARM DESIGN, V14, P3820, DOI 10.2174/138161208786898680; Fulton AB, 2009, PROG RETIN EYE RES, V28, P452, DOI 10.1016/j.preteyeres.2009.06.003; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Haller JA, 2013, OPHTHALMOLOGY, V120, pS3, DOI 10.1016/j.ophtha.2013.01.057; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Karamouzis MV, 2009, EXPERT OPIN BIOL TH, V9, P641, DOI [10.1517/14712590902882118 , 10.1517/14712590902882118]; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Montero JA, 2010, CURR DRUG TARGETS, V11, P630; Neely KA, 1998, AM J PATHOL, V153, P665, DOI 10.1016/S0002-9440(10)65607-6; Pai SS, 2009, AAPS J, V11, P88, DOI 10.1208/s12248-009-9081-8; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Quaggin SE, 2012, J CLIN INVEST, V122, P3849, DOI 10.1172/JCI65509; Reddy KR, 2000, ANN PHARMACOTHER, V34, P915, DOI 10.1345/aph.10054; Shultz RW, 2011, SEMIN OPHTHALMOL, V26, P361, DOI 10.3109/08820538.2011.585368; Wang F, 2013, GRAEF ARCH CLIN EXP, V251, P2131, DOI 10.1007/s00417-013-2392-6; Xu HL, 2008, CURR PROTEIN PEPT SC, V9, P275, DOI 10.2174/138920308784534050; Yowell SL, 2002, CANCER TREAT REV, V28, P3, DOI 10.1016/S0305-7372(02)80002-0; Yu WZ, 2003, OPHTHALMIC RES, V35, P239, DOI 10.1159/000072143; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301; Zhang SX, 2007, PROG RETIN EYE RES, V26, P1, DOI 10.1016/j.preteyeres.2006.09.002	36	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112448	10.1371/journal.pone.0112448	http://dx.doi.org/10.1371/journal.pone.0112448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380141	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100096
J	Boillot, T; Rosolen, SG; Dulaurent, T; Goulle, F; Thomas, P; Isard, PF; Azoulay, T; Lafarge-Beurlet, S; Woods, M; Lavillegrand, S; Ivkovic, I; Neveux, N; Sahel, JA; Picaud, S; Froger, N				Boillot, Thomas; Rosolen, Serge G.; Dulaurent, Thomas; Goulle, Frederic; Thomas, Philippe; Isard, Pierre-Francois; Azoulay, Thierry; Lafarge-Beurlet, Stephanie; Woods, Mike; Lavillegrand, Sylvie; Ivkovic, Ivana; Neveux, Nathalie; Sahel, Jose-Alain; Picaud, Serge; Froger, Nicolas			Determination of Morphological, Biometric and Biochemical Susceptibilities in Healthy Eurasier Dogs with Suspected Inherited Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PECTINATE LIGAMENT DYSPLASIA; OPTIC-NERVE HEAD; IRIDOCORNEAL ANGLE; INTRAOCULAR-PRESSURE; ULTRASOUND BIOMICROSCOPY; NORMOTENSIVE DOGS; SPRINGER-SPANIEL; CYP1B1 MUTATIONS; CLOSURE GLAUCOMA	In both humans and dogs, the primary risk factor for glaucoma is high intraocular pressure (IOP), which may be caused by iridocorneal angle (ICA) abnormalities. Oxidative stress has also been implicated in retinal ganglion cell damage associated with glaucoma. A suspected inherited form of glaucoma was recently identified in Eurasier dogs (EDs), a breed for which pedigrees are readily available. Because of difficulties in assessing ICA morphology in dogs with advanced glaucoma, we selected a cohort of apparently healthy dogsfor the investigation of ICA morphological status, IOP and plasma concentrations of oxidative stress biomarkers. We aimed to establish correlations between these factors, to identify predictive markers of glaucoma in this dog breed. A cohort of 28 subjects, volunteered for inclusion by their owners, was selected by veterinary surgeons. These dogs were assigned to four groups: young males, young females (1-3 years old), adult males and adult females (4-8 years old). Ocular examination included ophthalmoscopy, tonometry, gonioscopy, biometry and ultrasound biomicroscopy (UBM), and the evaluation of oxidative stress biomarkers consisting of measurements of plasma glutathione peroxidase (GP) activity and taurine and metabolic precursor (methionine and cysteine) concentrations in plasma. The prevalence of pectinate ligament abnormalities was significantly higher in adult EDs than in young dogs. Moreover, in adult females, high IOP was significantly correlated with a short axial globe length, and a particularly large distance between Schwalbe's line and the anterior lens capsule. GP activity levels were significantly lower in EDs than in a randomized control group of dogs, and plasma taurine concentrations were higher. Hence, ICA abnormalities were associated with weaker antioxidant defenses in EDs, potentially counteracted by higher plasma taurine concentrations. This study suggests that EDs may constitute an appropriate canine model for the development of glaucoma. This cohort will be used as a sentinel for longitudinal monitoring.	[Boillot, Thomas] Clin Vet Vetea, Saintes, France; [Rosolen, Serge G.; Ivkovic, Ivana; Sahel, Jose-Alain; Picaud, Serge; Froger, Nicolas] INSERM, Inst Vis, U968, Paris, France; [Rosolen, Serge G.; Ivkovic, Ivana; Sahel, Jose-Alain; Picaud, Serge; Froger, Nicolas] Univ Paris 06, Univ Sorbonne, Inst Vis, UMR S 968, Paris, France; [Rosolen, Serge G.; Ivkovic, Ivana; Sahel, Jose-Alain; Picaud, Serge; Froger, Nicolas] CNRS, Inst Vis, UMR 7210, Paris, France; [Rosolen, Serge G.] Clin Vet Voltaire, Asnieres, France; [Dulaurent, Thomas] Ctr Hosp Vet St Martin, St Martin Bellevue, France; [Goulle, Frederic] Clin Vet Aquivet, Eysines, France; [Thomas, Philippe] Clin Vet St Pierre, St Chamond, France; [Azoulay, Thierry] Clin Vet Halles, Strasbourg, France; [Lafarge-Beurlet, Stephanie] Vebio, Arcueil, France; [Woods, Mike] Pimrose Hill Vet Clin, Dun Laoghaire, Co Dublin, Ireland; [Neveux, Nathalie] Paris Descartes Univ, Fac Pharm, Dept Nutr, Paris, France; [Neveux, Nathalie] Hop Hotel Dieu, Cochin Hosp, AP HP, Clin Chem, Paris, France; [Sahel, Jose-Alain; Picaud, Serge] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Alain] Ctr Hosp Ophtalmol Quize Vingts, Paris, France; [Sahel, Jose-Alain] UCL, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Fondation Adolphe de Rothschild; University of London; University College London	Rosolen, SG (corresponding author), INSERM, Inst Vis, U968, Paris, France.	sg.rosolen@orange.fr; nicolas.froger@inserm.fr	Picaud, Serge/H-4012-2014; Sahel, Jose-Alain/F-3172-2017	Picaud, Serge/0000-0002-0548-5145; Sahel, Jose-Alain/0000-0002-4831-1153; Rosolen, Serge/0000-0003-4419-3257	Institut National de la Sante et de la Recherche Medicale (INSERM); Pierre et Marie Curie University (UPMC); Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale; Fondation Rolland Bailly; Agence Nationale pour la Recherche (ANR:GLAUCOME, VISIOWEST); Federation des Aveugles de France; IRRP; city of Paris; Regional Council of Ile-de-France; French State program "Investissements d'Avenir'' [ANR-10-LABX-65]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Pierre et Marie Curie University (UPMC); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Rolland Bailly; Agence Nationale pour la Recherche (ANR:GLAUCOME, VISIOWEST)(French National Research Agency (ANR)); Federation des Aveugles de France; IRRP; city of Paris(Region Ile-de-France); Regional Council of Ile-de-France(Region Ile-de-France); French State program "Investissements d'Avenir''(French National Research Agency (ANR))	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Pierre et Marie Curie University (UPMC), Centre National de la Recherche Scientifique (CNRS), the Fondation pour la Recherche Medicale and from the Fondation Rolland Bailly, Agence Nationale pour la Recherche (ANR:GLAUCOME, VISIOWEST), the Federation des Aveugles de France, IRRP, the city of Paris, the Regional Council of Ile-de-France, and the French State program "Investissements d'Avenir'' managed by the Agence Nationale de la Recherche [LIFESENSES: ANR-10-LABX-65]. Nicolas Froger received postdoctoral fellowships from the Fondation pour la Recherche Medicale and from the Fondation Rolland Bailly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; BEDFORD PGC, 1977, J SMALL ANIM PRACT, V18, P631, DOI 10.1111/j.1748-5827.1977.tb05831.x; BEDFORD PGC, 1986, RES VET SCI, V41, P172, DOI 10.1016/S0034-5288(18)30595-2; Bjerkas E, 2002, VET OPHTHALMOL, V5, P49, DOI 10.1046/j.1463-5224.2002.00213.x; Boillot T, 2012, ESVO P 2012 VET OPHT, P1, DOI [10.1111/vop.12010, DOI 10.1111/VOP.12010]; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; Ceron JJ, 2005, VET CLIN PATH, V34, P85, DOI 10.1111/j.1939-165X.2005.tb00019.x; Corcoran KA, 1994, VET COMP OPHTHALMOLO, V4, P197; COTTRELL BD, 1988, J SMALL ANIM PRACT, V29, P185, DOI 10.1111/j.1748-5827.1988.tb02276.x; Crumley W, 2009, VET OPHTHALMOL, V12, P22, DOI 10.1111/j.1463-5224.2009.00669.x; Dulaurent T, 2012, VET OPHTHALMOL, V15, P8, DOI 10.1111/j.1463-5224.2011.00898.x; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Ekesten B., 1993, Progress in Veterinary & Comparative Ophthalmology, V3, P67; EKESTEN B, 1995, AM J VET RES, V56, P1138; EKESTEN B, 1991, AM J VET RES, V52, P1875; EKESTEN B, 1995, AM J VET RES, V56, P127; Enserink M, 2007, SCIENCE, V316, P1553; Froger N, 2014, PROG RETIN EYE RES, V41, P44, DOI 10.1016/j.preteyeres.2014.03.001; Froger N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042017; Gelatt K. N., 1998, Veterinary Ophthalmology, V1, P109, DOI 10.1046/j.1463-5224.1998.00024.x; Gelatt KN, 2004, VET OPHTHALMOL, V7, P97, DOI 10.1111/j.1463-5224.2004.04006.x; Gelatt KN, 1999, VETERINARY OPHTHALMOLOGY, 3RD EDITION, P701; Gelatt KN, 2007, VET OPHTHALMOLOGY, P753; Gherghel D, 2005, INVEST OPHTH VIS SCI, V46, P877, DOI 10.1167/iovs.04-0777; Giannetto C, 2009, VET OPHTHALMOL, V12, P302, DOI 10.1111/j.1463-5224.2009.00717.x; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Gorig C, 2006, AM J VET RES, V67, P134, DOI 10.2460/ajvr.67.1.134; HOFFER KJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P914, DOI 10.1001/archopht.1993.01090070032014; Kanemaki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074372; Kato K, 2006, VET OPHTHALMOL, V9, P71, DOI 10.1111/j.1463-5224.2006.00438.x; Kato K, 2009, MOL VIS, V15, P2470; Kawata M, 2013, VET OPHTHALMOL, V16, P169, DOI 10.1111/j.1463-5224.2012.01043.x; Kumar A, 2007, MOL VIS, V13, P667; Leiva M, 2006, VET OPHTHALMOL, V9, P17, DOI 10.1111/j.1463-5224.2005.00429.x; Pearl R, 2013, VET OPHTHALMOL; Pennisi E, 2007, SCIENCE, V317, P1668, DOI 10.1126/science.317.5845.1668; PERKINS ES, 1988, BRIT J OPHTHALMOL, V72, P348, DOI 10.1136/bjo.72.5.348; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Piccione G, 2010, EXP ANIM TOKYO, V59, P215, DOI 10.1538/expanim.59.215; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Read R. A., 1998, Veterinary Ophthalmology, V1, P85, DOI 10.1046/j.1463-5224.1998.00019.x; Rosolen SG, 2013, ADV EXP MED BIOL, V775, P145, DOI 10.1007/978-1-4614-6130-2_12; SAMUELSON DA, 1984, CURR EYE RES, V3, P783, DOI 10.3109/02713688409000790; Samuelson DA, 2007, VET OPHTHALMOLOGY, P37; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; SLATER MR, 1986, J AM VET MED ASSOC, V188, P1028; Strom AR, 2011, VET OPHTHALMOL, V14, P121, DOI 10.1111/j.1463-5224.2010.00855.x; Taylor NR, 2007, VET OPHTHALMOL, V10, P8, DOI 10.1111/j.1463-5224.2007.00485.x; Tsai S, 2012, VET OPHTHALMOL, V15, P60, DOI 10.1111/j.1463-5224.2011.00956.x; Vajaranant TS, 2010, CURR OPIN OPHTHALMOL, V21, P91, DOI 10.1097/ICU.0b013e3283360b7e; VANDERLINDESIPMAN JS, 1987, VET PATHOL, V24, P201, DOI 10.1177/030098588702400301; von Spiessen L, 2013, VET OPHTHALMOL; Williams DL, 2004, VET OPHTHALMOL, V7, P91, DOI 10.1111/j.1463-5224.2004.04005.x; Yang M, 2009, MOL VIS, V15, P432; Yildirim O, 2005, GRAEF ARCH CLIN EXP, V243, P327, DOI 10.1007/s00417-004-1013-9; Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8	59	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111873	10.1371/journal.pone.0111873	http://dx.doi.org/10.1371/journal.pone.0111873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380252	Green Published, gold			2022-12-26	WOS:000344863100044
J	Li, T; Liao, QP; Zhang, H; Gao, XL; Li, XY; Zhang, M				Li, Ting; Liao, Qinping; Zhang, Hong; Gao, Xuelian; Li, Xueying; Zhang, Miao			Anatomic Distribution of Nerves and Microvascular Density in the Human Anterior Vaginal Wall: Prospective Study	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; G-SPOT; SEXUAL FUNCTION; FEMALE EJACULATION; GRAFENBERG SPOT; WOMEN; INNERVATION; SURGERY; STRESS	Background: The presence of the G-spot (an assumed erotic sensitive area in the anterior wall of the vagina) remains controversial. We explored the histomorphological basis of the G-spot. Methods: Biopsies were drawn from a 12 o'clock direction in the distal-and proximal-third areas of the anterior vagina of 32 Chinese subjects. The total number of protein gene product 9.5-immunoreactive nerves and smooth muscle actin-immunoreactive blood vessels in each specimen was quantified using the avidin-biotin-peroxidase assay. Results: Vaginal innervation was observed in the lamina propria and muscle layer of the anterior vaginal wall. The distal-third of the anterior vaginal wall had significantly richer small-nerve-fiber innervation in the lamina propria than the proximal-third (p = 0.000) and in the vaginal muscle layer (p = 0.006). There were abundant microvessels in the lamina propria and muscle layer, but no small vessels in the lamina propria and few in the muscle layer. Significant differences were noted in the number of microvessels when comparing the distal-with proximal-third parts in the lamina propria (p = 0.046) and muscle layer (p = 0.002). Conclusions: Significantly increased density of nerves and microvessels in the distal-third of the anterior vaginal wall could be the histomorphological basis of the G-spot. Distal anterior vaginal repair could disrupt the normal anatomy, neurovascular supply and function of the G-spot, and cause sexual dysfunction.	[Li, Ting; Liao, Qinping; Gao, Xuelian; Zhang, Miao] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Zhang, Hong] Peking Univ, Hosp 1, Dept Pathol, Beijing 100871, Peoples R China; [Li, Xueying] Peking Univ, Hosp 1, Dept Stat, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Zhang, M (corresponding author), Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China.	mm7526@163.com						Battaglia C, 2010, J SEX MED, V7, P2755, DOI 10.1111/j.1743-6109.2009.01651.x; Battaglia C, 2010, J SEX MED, V7, P1445, DOI 10.1111/j.1743-6109.2009.01650.x; Burri AV, 2010, J SEX MED, V7, P1842, DOI 10.1111/j.1743-6109.2009.01671.x; Lara LAD, 2009, J SEX MED, V6, P30, DOI 10.1111/j.1743-6109.2008.01052.x; DAVIDSON JK, 1989, J SEX MARITAL THER, V15, P102; Dwyer PL, 2012, INT UROGYNECOL J, V23, P135, DOI 10.1007/s00192-011-1558-1; GOLDBERG DC, 1983, J SEX MARITAL THER, V9, P27, DOI 10.1080/00926238308405831; Grafenberg E, 1950, INT J SEXOLOGY, P145; HILLIGES M, 1995, ACTA ANAT, V153, P119; Hines TM, 2001, AM J OBSTET GYNECOL, V185, P359, DOI 10.1067/mob.2001.115995; Kilchevsky A, 2012, J SEX MED, V9, P719, DOI 10.1111/j.1743-6109.2011.02623.x; KRANTZ KE, 1958, OBSTET GYNECOL, V12, P382; Liang CC, 2012, INT UROGYNECOL J, V23, P1455, DOI 10.1007/s00192-012-1713-3; Liu B, 2003, HISTOLOGY EMBRYOLOGY; Masters WH., 1966, HUMAN SEXUAL RESPONS; Mohamad S, 2009, J OBSTET GYNAECOL RE, V35, P967, DOI 10.1111/j.1447-0756.2009.01020.x; O'Connell HE, 2008, J SEX MED, V5, P1883, DOI 10.1111/j.1743-6109.2008.00875.x; Occhino JA, 2011, INT UROGYNECOL J, V22, P799, DOI 10.1007/s00192-011-1386-3; Ostrzenski A, 2012, J SEX MED, V9, P1355, DOI 10.1111/j.1743-6109.2012.02668.x; Pauls R, 2006, J SEX MED, V3, P979, DOI 10.1111/j.1743-6109.2006.00325.x; PERRY JD, 1981, J SEX RES, V17, P22, DOI 10.1080/00224498109551095; Pessina MA, 2006, ENDOCRINOLOGY, V147, P61, DOI 10.1210/en.2005-0870; Puppo V, 2012, INT UROGYNECOL J, V23, P1665, DOI 10.1007/s00192-012-1831-y; Puppo V, 2012, INT UROGYNECOL J, V23, P247, DOI 10.1007/s00192-011-1579-9; Satoh JI, 2001, NEUROPATH APPL NEURO, V27, P95, DOI 10.1046/j.1365-2990.2001.00313.x; Sentilhes L, 2008, INT UROGYNECOL J, V19, P763, DOI 10.1007/s00192-007-0521-7; SHERFEY MJ, 1974, J SEX MARITAL THER, V1, P97; Song YB, 2009, J SEX MARITAL THER, V35, P144, DOI 10.1080/00926230802716195; Thabet SMA, 2013, J OBSTET GYNAECOL RE, V39, P1339, DOI 10.1111/jog.12067; Yucel S, 2004, J UROLOGY, V172, P191, DOI 10.1097/01.ju.0000128704.51870.87; Zaviacic M, 2000, HISTOL HISTOPATHOL, V15, P131, DOI 10.14670/HH-15.131; Zhu L, 2004, INT UROGYNECOL J, V15, P272, DOI 10.1007/s00192-004-1155-7	32	15	16	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e110239	10.1371/journal.pone.0110239	http://dx.doi.org/10.1371/journal.pone.0110239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379731	gold, Green Submitted, Green Published			2022-12-26	WOS:000344863100012
J	Munoz-Gomez, A; Corredor, M; Benitez-Paez, A; Pelaez, C				Munoz-Gomez, Amalia; Corredor, Mauricio; Benitez-Paez, Alfonso; Pelaez, Carlos			Development of Quantitative Proteomics Using iTRAQ Based on the Immunological Response of Galleria mellonella Larvae Challenged with Fusarium oxysporum Microconidia	PLOS ONE			English	Article							GREATER WAX MOTH; ALTERNATIVE INFECTION MODEL; ASPERGILLUS-FUMIGATUS; MANDUCA-SEXTA; FAT-BODY; ANTIMICROBIAL PEPTIDES; PATTERN-RECOGNITION; HEMOLYMPH-PROTEINS; APOLIPOPHORIN-III; STORAGE PROTEINS	Galleria mellonella has emerged as a potential invertebrate model for scrutinizing innate immunity. Larvae are easy to handle in host-pathogen assays. We undertook proteomics research in order to understand immune response in a heterologous host when challenged with microconidia of Fusarium oxysporum. The aim of this study was to investigate hemolymph proteins that were differentially expressed between control and immunized larvae sets, tested with F. oxysporum at two temperatures. The iTRAQ approach allowed us to observe the effects of immune challenges in a lucid and robust manner, identifying more than 50 proteins, 17 of them probably involved in the immune response. Changes in protein expression were statistically significant, especially when temperature was increased because this was notoriously affected by F. oxysporum 10(4) or 10(6) microconidia/mL. Some proteins were up-regulated upon immune fungal microconidia challenge when temperature changed from 25 to 37 degrees C. After analysis of identified proteins by bioinformatics and metaanalysis, results revealed that they were involved in transport, immune response, storage, oxide-reduction and catabolism: 20 from G. mellonella, 20 from the Lepidoptera species and 19 spread across bacteria, protista, fungi and animal species. Among these, 13 proteins and 2 peptides were examined for their immune expression, and the hypothetical 3D structures of 2 well-known proteins, unannotated for G. mellonella, i.e., actin and CREBP, were resolved using peptides matched with Bombyx mori and Danaus plexippus, respectively. The main conclusion in this study was that iTRAQ tool constitutes a consistent method to detect proteins associated with the innate immune system of G. mellonella in response to infection caused by F. oxysporum. In addition, iTRAQ was a reliable quantitative proteomic approach to detect and quantify the expression levels of immune system proteins and peptides, in particular, it was found that 10(4) microconidia/mL at 37 degrees C over expressed many more proteins than other treatments.	[Munoz-Gomez, Amalia; Pelaez, Carlos] Univ Antioquia, Inst Quim, GIEM, Medellin, Antioquia, Colombia; [Munoz-Gomez, Amalia; Corredor, Mauricio] Univ Antioquia, Inst Biol, Genet & Biochem Microorganisms Grp GEBIOMIC, Medellin, Antioquia, Colombia; [Munoz-Gomez, Amalia; Benitez-Paez, Alfonso] Ctr Invest & Desarrollo Biotecnol CIDBIO, Bioinformat Anal Grp GABi, Bogota, Distrito Capita, Colombia	Universidad de Antioquia; Universidad de Antioquia	Munoz-Gomez, A (corresponding author), Univ Antioquia, Inst Quim, GIEM, Medellin, Antioquia, Colombia.	amunoz@cidbio.org	Benitez-Paez, Alfonso/A-2018-2011; Benítez-Páez, Alfonso/AAY-7143-2020	Benitez-Paez, Alfonso/0000-0001-5707-4340; Benítez-Páez, Alfonso/0000-0001-5707-4340	University of Antioquia for Interdisciplinary Group of Molecular Studies (GIEM Grupo Interdisciplinario de Estudios Moleculares, Universidad de Antioquia)	University of Antioquia for Interdisciplinary Group of Molecular Studies (GIEM Grupo Interdisciplinario de Estudios Moleculares, Universidad de Antioquia)	This work was supported by the Sustainability Strategy 2011-2012 from University of Antioquia for Interdisciplinary Group of Molecular Studies (GIEM Grupo Interdisciplinario de Estudios Moleculares, Universidad de Antioquia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrejko M, 2009, COMP BIOCHEM PHYS B, V152, P118, DOI 10.1016/j.cbpb.2008.10.008; Aperis G, 2007, MICROBES INFECT, V9, P729, DOI 10.1016/j.micinf.2007.02.016; Applied Biosystems AB Sciex, 2010, PROT ITRAQ REAG 8 PL; Ashida M., 1990, P239; Assaf C, 2000, LANCET, V356, P1185, DOI 10.1016/S0140-6736(00)02774-4; Banville N, 2012, VIRULENCE, V3, P497, DOI 10.4161/viru.21972; Bender Jennifer K, 2013, PLoS One, V8, pe73287, DOI 10.1371/journal.pone.0073287; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Bettencourt R, 1997, EUR J BIOCHEM, V250, P630, DOI 10.1111/j.1432-1033.1997.00630.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; BRUNET PCJ, 1980, INSECT BIOCHEM, V10, P467, DOI 10.1016/0020-1790(80)90082-7; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Casteels Peter, 1998, P92; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chamilos G, 2007, LANCET INFECT DIS, V7, P42, DOI 10.1016/S1473-3099(06)70686-7; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Chaudhuri BN, 1999, ACTA CRYSTALLOGR D, V55, P1850, DOI 10.1107/S0907444999011026; Chomienne C, 1996, FASEB J, V10, P1025, DOI 10.1096/fasebj.10.9.8801163; Ciencialova A, 2008, J PEPT SCI, V14, P670, DOI 10.1002/psc.967; Coleman JJ, 2011, FUNGAL BIOL-UK, V115, P1279, DOI 10.1016/j.funbio.2011.09.005; COURGEON AM, 1993, EXP CELL RES, V204, P30, DOI 10.1006/excr.1993.1005; Cytrynska M, 2007, PEPTIDES, V28, P533, DOI 10.1016/j.peptides.2006.11.010; deKort CAD, 1996, ARCH INSECT BIOCHEM, V33, P1, DOI 10.1002/(SICI)1520-6327(1996)33:1&lt;1::AID-ARCH1&gt;3.0.CO;2-2; Dettloff M, 1999, TECHNIQUES INSECT IM, P243; Ducka AM, 2010, P NATL ACAD SCI USA, V107, P11757, DOI 10.1073/pnas.1005347107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; Fauvarque MO, 2011, J CELL SCI, V124, P1373, DOI 10.1242/jcs.064592; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Geiser DL, 2012, BBA-GEN SUBJECTS, V1820, P437, DOI 10.1016/j.bbagen.2011.07.011; Godlewski J, 2001, J INSECT PHYSIOL, V47, P759, DOI 10.1016/S0022-1910(01)00050-6; Godlewski J, 2003, J INSECT PHYSIOL, V49, P551, DOI 10.1016/S0022-1910(03)00026-X; Hansen IA, 2003, INSECT MOL BIOL, V12, P427, DOI 10.1046/j.1365-2583.2003.00426.x; Harding CR, 2012, INFECT IMMUN, V80, P2780, DOI 10.1128/IAI.00510-12; Hultmark D, 1982, INSECT IMMUNITY ISOL, V217, P207; Jackson JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004224; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim CH, 2010, J BIOL CHEM, V285, P25243, DOI 10.1074/jbc.M110.134940; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; KUMAGAI T, 1992, PATHOL RES PRACT, V188, P931, DOI 10.1016/S0344-0338(11)80254-2; LADENDORFF NE, 1991, ARCH INSECT BIOCHEM, V18, P285, DOI 10.1002/arch.940180410; LanzMendoza H, 1996, CELL IMMUNOL, V169, P47, DOI 10.1006/cimm.1996.0089; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebreton F, 2011, J MOL MICROB BIOTECH, V21, P191, DOI 10.1159/000332737; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Lesch C, 2007, INSECT IMMUNOLOGY ME; Levenbook L., 1985, P307; Li B, 2006, J INSECT PHYSIOL, V52, P936, DOI 10.1016/j.jinsphys.2006.06.002; Li D, 2002, INSECT BIOCHEM MOLEC, V32, P919, DOI 10.1016/S0965-1748(02)00030-9; Lotan R, 1996, ANTICANCER RES, V16, P2415; Mak P, 2001, ACTA BIOCHIM POL, V48, P1191; MANSEAU LJ, 1988, GENETICS, V119, P407; Mansfield SG, 1998, P NATL ACAD SCI USA, V95, P6825, DOI 10.1073/pnas.95.12.6825; Martins Juliana Ramos, 2012, Insects, V3, P1039, DOI 10.3390/insects3041039; MILLER SG, 1982, INSECT BIOCHEM, V12, P277, DOI 10.1016/0020-1790(82)90086-5; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Mowlds P, 2008, MYCOPATHOLOGIA, V165, P5, DOI 10.1007/s11046-007-9069-9; Mowlds P, 2010, MICROBES INFECT, V12, P146, DOI 10.1016/j.micinf.2009.11.004; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Mylonakis E, 2008, MYCOPATHOLOGIA, V165, P1, DOI 10.1007/s11046-007-9082-z; Navarro-Velasco GY, 2011, FUNGAL GENET BIOL, V48, P1124, DOI 10.1016/j.fgb.2011.08.004; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Ott L, 2012, FEMS IMMUNOL MED MIC, V65, P413, DOI 10.1111/j.1574-695X.2012.00963.x; Park SY, 2005, DEV COMP IMMUNOL, V29, P43, DOI 10.1016/j.dci.2004.06.001; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; RAY A, 1987, ROUX ARCH DEV BIOL, V196, P414, DOI 10.1007/BF00399141; Renwick J, 2006, MYCOPATHOLOGIA, V161, P377, DOI 10.1007/s11046-006-0021-1; Richards EH, 1999, INSECT BIOCHEM MOLEC, V29, P557, DOI 10.1016/S0965-1748(99)00031-4; Ryan RO, 2000, ANNU REV ENTOMOL, V45, P233, DOI 10.1146/annurev.ento.45.1.233; Schmidt O, 2008, INSECT IMMUNOLOGY IN; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Seitz V, 2003, DEV COMP IMMUNOL, V27, P207, DOI 10.1016/S0145-305X(02)00097-6; Simpson AA, 1998, STRUCT FOLD DES, V6, P1355, DOI 10.1016/S0969-2126(98)00136-1; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; Sotelo-Mundo RR, 2007, PROTEIN PEPTIDE LETT, V14, P774; Tang B, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-65; Terenius O, 2008, DEV COMP IMMUNOL, V32, P311, DOI 10.1016/j.dci.2007.09.006; Thongboonkerd V, 2007, J PROTEOME RES, V6, P3881, DOI 10.1021/pr070328s; Unwin RD, 2010, METHODS MOL BIOL, V658, P205, DOI 10.1007/978-1-60761-780-8_12; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Weise C, 1998, J PROTEIN CHEM, V17, P633, DOI 10.1007/BF02780964; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Wojda I, 2007, J INSECT PHYSIOL, V53, P1134, DOI 10.1016/j.jinsphys.2007.06.003; Wojtal KA, 2013, TOXICOL IN VITRO, V27, P1525, DOI 10.1016/j.tiv.2013.03.013; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zalewska M, 2009, BBA-BIOMEMBRANES, V1788, P1695, DOI 10.1016/j.bbamem.2009.04.022; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao L, 1996, J INSECT PHYSIOL, V42, P73, DOI 10.1016/0022-1910(95)00084-4	99	17	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112179	10.1371/journal.pone.0112179	http://dx.doi.org/10.1371/journal.pone.0112179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379782	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100058
J	Saito, T; Matsuyama, T; Toya, R; Fukugawa, Y; Toyofuku, T; Semba, A; Oya, N				Saito, Tetsuo; Matsuyama, Tomohiko; Toya, Ryo; Fukugawa, Yoshiyuki; Toyofuku, Takamasa; Semba, Akiko; Oya, Natsuo			Respiratory Gating during Stereotactic Body Radiotherapy for Lung Cancer Reduces Tumor Position Variability	PLOS ONE			English	Article							INTERNAL TARGET VOLUME; GATED RADIOTHERAPY; CINE-IMAGES; MOTION; FEASIBILITY; MODE; TIME; REPRODUCIBILITY; VERIFICATION; REDUCTION	Purpose: We evaluated the effects of respiratory gating on treatment accuracy in lung cancer patients undergoing lung stereotactic body radiotherapy by using electronic portal imaging device (EPID) images. Materials and Methods: Our study population consisted of 30 lung cancer patients treated with stereotactic body radiotherapy (48 Gy/4 fractions/4 to 9 days). Of these, 14 were treated with- (group A) and 16 without gating (group B); typically the patients whose tumors showed three-dimensional respiratory motion >= 5 mm were selected for gating. Tumor respiratory motion was estimated using four-dimensional computed tomography images acquired during treatment simulation. Tumor position variability during all treatment sessions was assessed by measuring the standard deviation (SD) and range of tumor displacement on EPID images. The two groups were compared for tumor respiratory motion and position variability using the Mann-Whitney U test. Results: The median three-dimensional tumor motion during simulation was greater in group A than group B (9 mm, range 3-30 mm vs. 2 mm, range 0-4 mm; p<0.001). In groups A and B the median SD of the tumor position was 1.1 mm and 0.9 mm in the craniocaudal- (p = 0.24) and 0.7 mm and 0.6 mm in the mediolateral direction (p = 0.89), respectively. The median range of the tumor position was 4.0 mm and 3.0 mm in the craniocaudal- (p = 0.21) and 2.0 mm and 1.5 mm in the mediolateral direction (p = 0.20), respectively. Conclusions: Although patients treated with respiratory gating exhibited greater respiratory tumor motion during treatment simulation, tumor position variability in the EPID images was low and comparable to patients treated without gating. This demonstrates the benefit of respiratory gating.	[Saito, Tetsuo; Matsuyama, Tomohiko; Toya, Ryo; Fukugawa, Yoshiyuki; Toyofuku, Takamasa; Semba, Akiko; Oya, Natsuo] Kumamoto Univ Hosp, Dept Radiat Oncol, Kumamoto, Japan	Kumamoto University	Saito, T (corresponding author), Kumamoto Univ Hosp, Dept Radiat Oncol, Kumamoto, Japan.	tsaito@kumamoto-u.ac.jp			Grants-in-Aid for Scientific Research [26861004] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Berbeco RI, 2007, INT J RADIAT ONCOL, V69, P258, DOI 10.1016/j.ijrobp.2007.04.051; Berbeco RI, 2006, MED PHYS, V33, P4149, DOI 10.1118/1.2358197; Butler Laura E, 2004, J Appl Clin Med Phys, V5, P16, DOI 10.1120/jacmp.26.146; Cai J, 2010, MED PHYS, V37, P3927, DOI 10.1118/1.3457329; de Koste JRV, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-32; Dzierma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053799; Erridge SC, 2003, RADIOTHER ONCOL, V66, P75, DOI 10.1016/S0167-8140(02)00287-6; Ford EC, 2002, INT J RADIAT ONCOL, V52, P522, DOI 10.1016/S0360-3016(01)02681-5; Gaede S, 2008, INT J RADIAT ONCOL, V72, pS623, DOI 10.1016/j.ijrobp.2008.06.268; Giraud P, 2006, LUNG CANCER, V51, P41, DOI 10.1016/j.lungcan.2005.08.008; Liu HH, 2007, INT J RADIAT ONCOL, V68, P531, DOI 10.1016/j.ijrobp.2006.12.066; Mageras GS, 2004, INT J RADIAT ONCOL, V60, P933, DOI 10.1016/j.ijrobp.2004.06.021; Muirhead R, 2011, RADIOTHER ONCOL, V99, P155, DOI 10.1016/j.radonc.2011.05.037; Peguret N, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-78; Piermattei A, 2008, ACTA ONCOL, V47, P1414, DOI 10.1080/02841860802304572; Richter A, 2010, INT J RADIAT ONCOL, V78, P618, DOI 10.1016/j.ijrobp.2009.11.028; Saito T, 2011, ACTA ONCOL, V50, P1246, DOI 10.3109/0284186X.2011.566695; Saito T, 2010, J RADIAT RES, V51, P691, DOI 10.1269/jrr.10084; Saito T, 2009, RADIOTHER ONCOL, V93, P430, DOI 10.1016/j.radonc.2009.09.002; Shimizu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094971; Spoelstra FOB, 2008, RADIOTHER ONCOL, V87, P59, DOI 10.1016/j.radonc.2008.02.008; Starkschall G, 2004, INT J RADIAT ONCOL, V60, P1291, DOI 10.1016/j.ijrobp.2004.07.707; Tang XL, 2009, PHYS MED BIOL, V54, pS1, DOI 10.1088/0031-9155/54/18/S01; Ueda Y, 2012, INT J RADIAT ONCOL, V83, P1064, DOI 10.1016/j.ijrobp.2011.07.043; Underberg RWM, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-8; Van de Steene J, 1998, INT J RADIAT ONCOL, V40, P967, DOI 10.1016/S0360-3016(97)00925-5; van der Geld YG, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-43	27	7	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112824	10.1371/journal.pone.0112824	http://dx.doi.org/10.1371/journal.pone.0112824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379729	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100111
J	Clauser, L; Ferroni, L; Gardin, C; Tieghi, R; Galie, M; Elia, G; Piattelli, A; Pinton, P; Bressan, E; Zavan, B				Clauser, Luigi; Ferroni, Letizia; Gardin, Chiara; Tieghi, Riccardo; Galie, Manlio; Elia, Giovanni; Piattelli, Adriano; Pinton, Paolo; Bressan, Eriberto; Zavan, Barbara			Selective Augmentation of Stem Cell Populations in Structural Fat Grafts for Maxillofacial Surgery	PLOS ONE			English	Article							COMPLEX RECONSTRUCTIVE SURGERY; VOLUMETRIC RESTORATION; PROGENITOR CELLS; AUTOLOGOUS FAT; TISSUE; TRANSPLANTS; FILLERS; FACE	Structural fat grafting utilizes the centrifugation of liposuction aspirates to create a graded density of adipose tissue. This study was performed to qualitatively investigate the effects of centrifugation on stem cells present in adipose tissue. Liposuction aspirates were obtained from healthy donors and either not centrifuged or centrifuged at 1,800 rpm for 3 minutes. The obtained fat volumes were divided into three layers and then analyzed. The results demonstrate that centrifugation induces a different distribution of stem cells in the three layers. The high-density layer displays the highest expression of mesenchymal stem cell and endothelial markers. The low-density layer exhibits an enrichment of multipotent stem cells. We conclude that appropriate centrifugation concentrates stem cells. This finding may influence the clinical practice of liposuction aspirate centrifugation and enhance graft uptake.	[Clauser, Luigi; Tieghi, Riccardo; Galie, Manlio; Elia, Giovanni] St Anna Hosp & Univ, Reference Ctr Rare Dis, Ctr Craniofacial Deform & Orbital Surg, Unit Cranio Maxillo Facial Surg, Ferrara, Italy; [Ferroni, Letizia; Gardin, Chiara; Zavan, Barbara] Univ Padua, Dept Biomed Sci, Padua, Italy; [Piattelli, Adriano] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Pinton, Paolo] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Pathol Oncol & Expt Biol, I-44100 Ferrara, Italy; [Bressan, Eriberto] Univ Padua, Dept Neurosci, Padua, Italy	University of Ferrara; Arcispedale Sant'Anna; University of Padua; G d'Annunzio University of Chieti-Pescara; University of Ferrara; University of Padua	Zavan, B (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	barbara.zavan@unipd.it	Pinton, Paolo/J-8025-2012; Galiè, Manlio/ABB-5271-2020	Pinton, Paolo/0000-0001-7108-6508; Galiè, Manlio/0000-0003-4136-7370; Ferroni, Letizia/0000-0002-5457-0338; Gardin, Chiara/0000-0003-3817-0032	Progetto di Ateneo University of Padova, Italy	Progetto di Ateneo University of Padova, Italy	The work was supported by Progetto di Ateneo University of Padova, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bucky LP, 2007, PLAST RECONSTR SURG, V120, p89S, DOI 10.1097/01.prs.0000248866.57638.40; Clauser L, 2004, J CRANIO MAXILL SURG, V32, P279, DOI 10.1016/j.jcms.2004.04.010; Clauser L, 2009, AM SOC PLAST SURG AN; Clauser L, 2009, FAT INJECTION FILLIN, P475; Clauser L, 2008, J CRANIOFAC SURG, V19, P187, DOI 10.1097/scs.0b013e31815c94f5; Clauser LC, 2011, J CRANIOFAC SURG, V22, P1695, DOI 10.1097/SCS.0b013e31822e5d5e; Clauser LC, 2010, J CRANIO MAXILL SURG, V38, P605, DOI 10.1016/j.jcms.2010.02.005; Coleman S, 2009, AESTHET PLAST SURG, V33, P14, DOI 10.1007/s00266-008-9258-z; Coleman S., 2004, STRUCTURAL FAT GRAFT; Coleman SR, 1997, CLIN PLAST SURG, V24, P347; COLEMAN SR, 1995, AESTHET PLAST SURG, V19, P421, DOI 10.1007/BF00453875; Coleman SR, 2001, CLIN PLAST SURG, V28, P111; Consorti G, 2012, J CRANIOFAC SURG, V23, pE263, DOI 10.1097/SCS.0b013e31824ef7e8; Fagrell D, 1996, PLAST RECONSTR SURG, V98, P90, DOI 10.1097/00006534-199607000-00014; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Giugliano C, 2009, PLAST RECONSTR SURG, V124, P134, DOI 10.1097/PRS.0b013e3181a80539; Guallar D, 2012, NUCLEIC ACIDS RES, V40, P8993, DOI 10.1093/nar/gks686; Kawamoto HK, 2009, FAT INJECTION FILLIN, P447; Kokai LE, 2005, PLAST RECONSTR SURG, V116, P1453, DOI 10.1097/01.prs.0000182570.62814.e3; Livaoglu Murat, 2009, J Cutan Aesthet Surg, V2, P21, DOI 10.4103/0974-2077.53095; Mojallal A, 2004, Ann Chir Plast Esthet, V49, P426, DOI 10.1016/j.anplas.2004.08.005; Mojallal A, 2008, BIO-MED MATER ENG, V18, P193, DOI 10.3233/BME-2008-0524; Mojallal A, 2004, ANN CIR PLAST ESTHET, V49, P437; Mojallal A, 2009, PLAST RECONSTR SURG, V124, P471, DOI 10.1097/PRS.0b013e3181af023a; Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e; Perrot P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010999; Pu LLQ, 2008, PLAST RECONSTR SURG, V122, P932, DOI 10.1097/PRS.0b013e3181811ff0; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; Rigotti G, 2009, AESTHET PLAST SURG, V33, P271, DOI 10.1007/s00266-009-9339-7; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132	30	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110796	10.1371/journal.pone.0110796	http://dx.doi.org/10.1371/journal.pone.0110796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375632	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600021
J	Li, CL; Zhao, K; Li, H; Farah, OI; Wang, JJ; Sun, RZ; Zhang, HP				Li, Cui-ling; Zhao, Kai; Li, Hui; Farah, Omar Ibrahim; Wang, Jiao-jiao; Sun, Rong-ze; Zhang, Hui-ping			Free Preconceptual Screening Examination Service in Rural Areas of Hubei Province, China in 2012	PLOS ONE			English	Article							HEALTH-CARE; UNITED-STATES; WOMEN; RECOMMENDATIONS; PREGNANCY; SURVEILLANCE; SUPPLEMENT; PREDICTORS; TRENDS	Objective: This work aims to collect and summarize the outcomes on free preconceptual screening examination in rural areas of Hubei Province in 2012. Moreover, this review promotes further understanding of the status of this activity to provide the Family Planning Commission valid scientific data upon which to construct effective policies. Methods: Couples, who complied with the family planning policy and were the residents in agricultural areas or lived in a local rural area for more than six months, were encouraged to participate in the free preconceptual screening examination service provided by the Hubei Provincial Population and Family Planning Commission. This service included 19 screening tests. All the data, including forms, manuals, and test results, were collected from 1 January 2012 to 31 December 2012 in rural areas in Hubei Province. Results: A total of 497,860 individuals participated in the free preconceptual screening examination service, with a coverage rate of 97.1%. 4.0% and 4.8% of the participants exhibited with abnormal blood levels of ALT and creatinine, respectively; 0.36% of the participants tested positive for syphilis; 0.44% and 3.6% of the female participants tested positive for Neisseria gonorrhoeae and Chlamydia trachomatis, respectively; and 0.84% and 1.8% of the female participants tested positive for cytomegalovirus (IgM) and Toxoplasma gondii (IgM), respectively. After risk assessment, 59,935 participants might have high-risk of adverse pregnancy outcomes. In 2012, the prevalence of birth defects among the parturient who participated in the preconceptual screening examination service was 0.04%, while the prevalence was 0.08% among those who did not participate in the service. Conclusion: Preconceptual screening examination service may help to address the risk factors that can lead to adverse pregnancy outcome. More studies on the relationship between preconceptual screening examination service and prevalence of birth defect or other adverse pregnancy outcomes should be conducted.	[Li, Cui-ling; Zhao, Kai; Farah, Omar Ibrahim; Wang, Jiao-jiao; Zhang, Hui-ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan, Hunan, Peoples R China; [Li, Hui] Hubei Prov Populat & Family Planning Commiss, Dept Sci, Wuhan, Hunan, Peoples R China; [Li, Hui] Hubei Prov Populat & Family Planning Commiss, Technol Serv, Wuhan, Hunan, Peoples R China; [Sun, Rong-ze] Wuhan Univ, Renmin Hosp, Wuhan, Hunan, Peoples R China	Huazhong University of Science & Technology; Wuhan University	Zhang, HP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan, Hunan, Peoples R China.	familyplanning2013@163.com	Zhang, Hui/HHN-8494-2022		Foundation of Hubei Provincial Population and Family Planning Commission [JS-2011011]	Foundation of Hubei Provincial Population and Family Planning Commission	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by the Foundation of Hubei Provincial Population and Family Planning Commission (grant no. JS-2011011).	Allaire AD, 1998, EUR J OBSTET GYN R B, V78, P163, DOI 10.1016/S0301-2115(98)00062-1; Boulet SL, 2006, MATERN CHILD HLTH J, V10, pS13, DOI 10.1007/s10995-006-0106-y; Campbell SK, 2012, MATERN CHILD HLTH J, V16, P1284, DOI 10.1007/s10995-011-0889-3; Centre BSR, 2009, PRECONCEPTION HLTH P; Chen Z, 2011, REPORT WOMEN CHILDRE; de Jong-van den Berg LTW, 2005, AM J OBSTET GYNECOL, V192, P121, DOI 10.1016/j.ajog.2004.05.085; de Weerd S, 2002, OBSTET GYNECOL, V99, P45, DOI 10.1016/S0029-7844(01)01573-3; Dunlop AL, 2007, J AM BOARD FAM MED, V20, P81, DOI 10.3122/jabfm.2007.01.060143; Dunlop AL, 2013, AM J HEALTH PROMOT, V27, pS50, DOI 10.4278/ajhp.120116-QUAN-39; Ebrahim SH, 2006, MATERN CHILD HLTH J, V10, pS37, DOI 10.1007/s10995-006-0096-9; Frey KA, 2006, MATERN CHILD HLTH J, V10, pS73, DOI 10.1007/s10995-006-0110-2; Heyes T, 2004, FAM PRACT, V21, P22, DOI 10.1093/fampra/cmh106; Jack BW, 2008, AM J OBSTET GYNECOL, V199, pS266, DOI 10.1016/j.ajog.2008.07.067; Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1; Li CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072649; Liu Y, 2006, J PERINATOL, V26, P409, DOI 10.1038/sj.jp.7211537; Livingood WC, 2010, MATERN CHILD HLTH J, V14, P382, DOI 10.1007/s10995-009-0471-4; LOBO I, 2008, NATURE ED, V1; Moos MK, 2008, AM J OBSTET GYNECOL, V199, pS280, DOI 10.1016/j.ajog.2008.08.060; Morin P, 2002, PREV MED, V35, P143, DOI 10.1006/pmed.2002.1041; Tu L, 2012, IRAN J PUBLIC HEALTH, V41, P20; Weisman CS, 2011, WOMEN HEALTH ISS, V21, P265, DOI 10.1016/j.whi.2011.03.007; Witters I, 2010, GENET COUNSEL, V21, P169; Xaverius PK, 2013, J WOMENS HEALTH, V22, P203, DOI 10.1089/jwh.2012.3804	24	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111918	10.1371/journal.pone.0111918	http://dx.doi.org/10.1371/journal.pone.0111918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375642	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600075
J	Moser, DA; Braga, L; Raso, A; Zacchigna, S; Giacca, M; Simon, P				Moser, Dirk A.; Braga, Luca; Raso, Andrea; Zacchigna, Serena; Giacca, Mauro; Simon, Perikles			Transgene Detection by Digital Droplet PCR	PLOS ONE			English	Article							GENE-TRANSFER; ATHLETIC PERFORMANCE; AUTOIMMUNE ANEMIA; ERYTHROPOIETIN; DNA; EXPRESSION; BLOOD; LEADS	Somatic gene therapy is a promising tool for the treatment of severe diseases. Because of its abuse potential for performance enhancement in sports, the World Anti-Doping Agency (WADA) included the term 'gene doping' in the official list of banned substances and methods in 2004. Several nested PCR or qPCR-based strategies have been proposed that aim at detecting long-term presence of transgene in blood, but these strategies are hampered by technical limitations. We developed a digital droplet PCR (ddPCR) protocol for Insulin-Like Growth Factor 1 (IGF1) detection and demonstrated its applicability monitoring 6 mice injected into skeletal muscle with AAV9-IGF1 elements and 2 controls over a 33-day period. A duplex ddPCR protocol for simultaneous detection of Insulin-Like Growth Factor 1 (IGF1) and Erythropoietin (EPO) transgenic elements was created. A new DNA extraction procedure with target-orientated usage of restriction enzymes including on-column DNA-digestion was established. In vivo data revealed that IGF1 transgenic elements could be reliably detected for a 33-day period in DNA extracted from whole blood. In vitro data indicated feasibility of IGF1 and EPO detection by duplex ddPCR with high reliability and sensitivity. On-column DNA-digestion allowed for significantly improved target detection in downstream PCR-based approaches. As ddPCR provides absolute quantification, it ensures excellent day-to-day reproducibility. Therefore, we expect this technique to be used in diagnosing and monitoring of viral and bacterial infection, in detecting mutated DNA sequences as well as profiling for the presence of foreign genetic material in elite athletes in the future.	[Moser, Dirk A.] Ruhr Univ Bochum, Fac Psychol Genet Psychol, Bochum, Germany; [Braga, Luca; Raso, Andrea; Zacchigna, Serena; Giacca, Mauro] ICGEB, Trieste, Italy; [Moser, Dirk A.; Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med Dis Prevent & Rehabil, D-55122 Mainz, Germany	Ruhr University Bochum; International Center for Genetic Engineering & Biotechnology (ICGEB); Johannes Gutenberg University of Mainz	Simon, P (corresponding author), Johannes Gutenberg Univ Mainz, Dept Sports Med Dis Prevent & Rehabil, D-55122 Mainz, Germany.	simonpe@uni-mainz.de	Simon, Perikles D/B-2293-2013; Moser, Dirk/ABA-1018-2021; Giacca, Mauro/J-9287-2016; Moser, Dirk A/R-8003-2016; ZACCHIGNA, SERENA/E-9496-2017	Simon, Perikles D/0000-0002-7996-4034; Moser, Dirk/0000-0002-7021-1204; Giacca, Mauro/0000-0003-2927-7225; Moser, Dirk A/0000-0002-7021-1204; Braga, Luca/0000-0002-9827-6755; ZACCHIGNA, SERENA/0000-0001-6705-3076	World Anti-Doping Agency (WADA)	World Anti-Doping Agency (WADA)	Work of PS and MG is carried out with the support of the World Anti-Doping Agency (WADA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S1525-0016(03)00034-0; Baoutina A, 2010, GENE THER, V17, P1022, DOI 10.1038/gt.2010.49; Baoutina A, 2007, MOL THER, V15, P1751, DOI 10.1038/sj.mt.6300278; Baoutina A, 2013, HUM GENE THER METHOD, V24, P345, DOI 10.1089/hgtb.2013.128; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Beiter T, 2011, GENE THER, V18, P225, DOI 10.1038/gt.2010.122; Beiter T, 2008, EXERC IMMUNOL REV, V14, P73; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; Chenuaud P, 2004, BLOOD, V103, P3303, DOI 10.1182/blood-2003-11-3845; Gao GP, 2004, BLOOD, V103, P3300, DOI 10.1182/blood-2003-11-3852; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029101; Lippi G, 2003, CLIN CHEM, V49, P2106, DOI 10.1373/clinchem.2003.025312; Little S, 2001, Curr Protoc Hum Genet, VChapter 9, DOI 10.1002/0471142905.hg0908s07; Macedo A, 2012, HUM GENE THER, V23, P146, DOI 10.1089/hum.2011.157; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morisset D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062583; Moser DA, 2012, DRUG TEST ANAL, V4, P870, DOI 10.1002/dta.1348; Ni W, 2011, GENE THER, V18, P709, DOI 10.1038/gt.2011.19; Ni WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036461; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Schneider AJ, 2006, ADV GENET, V51, P1, DOI 10.1016/S0065-2660(06)51001-6; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Zhou S, 1998, GENE THER, V5, P665, DOI 10.1038/sj.gt.3300648	29	19	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111781	10.1371/journal.pone.0111781	http://dx.doi.org/10.1371/journal.pone.0111781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375130	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600062
J	Shan, XY; Zhang, J; Zhou, HJ; Zhu, BQ; Xu, L; Shao, ZJ; Jiang, BF				Shan, Xiaoying; Zhang, Ji; Zhou, Haijian; Zhu, Bingqing; Xu, Li; Shao, Zhujun; Jiang, Baofa			Genetic Diversity of Neisseria meningitidis Serogroup C ST-4821 in China Based on Multiple-Locus Variable Number Tandem Repeat Analysis	PLOS ONE			English	Article							W135 MENINGOCOCCAL DISEASE; CLONE; IDENTIFICATION; EPIDEMIOLOGY; EMERGENCE; OUTBREAK; SPREAD	Neisseria meningitidis sequence type (ST)-4821 was first reported in China in 2003, and a new hyper-virulent lineage has been designated as the ST-4821 complex. A large number of N. meningitidis ST-4821 strains have been identified in China since 2003; however, the microevolution characteristics of this complex are unclear. Different combinations of variable number of tandem repeats (VNTR) loci were used in multiple-locus VNTR analysis (MLVA) to analyze 118 N. meningitidis serogroup C ST-4821 strains isolated from seventeen provinces between 2003 and 2012. Additionally, MLVA with five VNTR loci was performed due to its high discriminatory power. One hundred and eighteen isolates were found to comprise 112 subtypes based on MLVA, and 16 outbreak-associated strains were clustered into one group. These data indicate a high level of diversity for N. meningitidis ST-4821 due to microevolution in the last decade. In addition, the results revealed high similarity between isolates from the same geographic origins, which is helpful when monitoring the spread of N. meningitidis serogroup C ST-4821 and will provide valuable information for the control and prevention of bacterial meningitis in China.	[Shan, Xiaoying; Jiang, Baofa] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Shandong, Peoples R China; [Shan, Xiaoying; Zhou, Haijian; Zhu, Bingqing; Xu, Li; Shao, Zhujun] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Shan, Xiaoying; Zhang, Ji] Jinan Municipal Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Shan, Xiaoying; Zhou, Haijian; Zhu, Bingqing; Xu, Li; Shao, Zhujun] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Peoples R China	Shandong University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Shao, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	shaozhujun@126.com; bjiang@sdu.edu.cn			National Key Program for Infectious Disease of China [2013ZX10004221]; National Basic Research Program of China (973 Program) [2011CB504900]	National Key Program for Infectious Disease of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Key Program for Infectious Disease of China (Contract No. 2013ZX10004221) and the National Basic Research Program of China (973 Program, 2011CB504900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Fazio C, 2009, EUROSURVEILLANCE, V14, P16; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Hill V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041991; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kilic A, 2006, J CLIN MICROBIOL, V44, P222, DOI 10.1128/JCM.44.1.222-224.2006; Liao JC, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-44; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mayer LW, 2002, J INFECT DIS, V185, P1596, DOI 10.1086/340414; Moodley C, 2012, J CLIN MICROBIOL, V50, P3678, DOI 10.1128/JCM.01079-12; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Schouls LM, 2006, J CLIN MICROBIOL, V44, P1509, DOI 10.1128/JCM.44.4.1509-1518.2006; Shao ZJ, 2006, LANCET, V367, P419, DOI 10.1016/S0140-6736(06)68141-5; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; [田国忠 TIAN Guozhong], 2006, [中华流行病学杂志, Chinese Journal of Epidemiology], V27, P595; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Yakubu DE, 1999, J MED MICROBIOL, V48, P1055, DOI 10.1099/00222615-48-12-1055; Yazdankhah SP, 2005, J CLIN MICROBIOL, V43, P1699, DOI 10.1128/JCM.43.4.1699-1705.2005; Zhang J, 2013, BIOMED ENVIRON SCI, V26, P331, DOI 10.3967/0895-3988.2013.05.002; Zhou H, 2012, EPIDEMIOL INFECT, V140, P1296, DOI 10.1017/S0950268811001865	20	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111866	10.1371/journal.pone.0111866	http://dx.doi.org/10.1371/journal.pone.0111866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375168	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600072
J	Arico, A; Ferraresso, S; Bresolin, S; Marconato, L; Comazzi, S; Kronnie, GT; Aresu, L				Arico, Arianna; Ferraresso, Serena; Bresolin, Silvia; Marconato, Laura; Comazzi, Stefano; Kronnie, Geertruy Te; Aresu, Luca			Array-Based Comparative Genomic Hybridization Analysis Reveals Chromosomal Copy Number Aberrations Associated with Clinical Outcome in Canine Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							IMMUNOGLOBULIN HEAVY; CLONAL EVOLUTION; SUBTYPES; CANCER; GENE; MUTATIONS; MELANOMA; SURVIVAL; TUMORS; DOGS	Canine Diffuse Large B-cell Lymphoma (cDLBCL) is an aggressive cancer with variable clinical response. Despite recent attempts by gene expression profiling to identify the dog as a potential animal model for human DLBCL, this tumor remains biologically heterogeneous with no prognostic biomarkers to predict prognosis. The aim of this work was to identify copy number aberrations (CNAs) by high-resolution array comparative genomic hybridization (aCGH) in 12 dogs with newly diagnosed DLBCL. In a subset of these dogs, the genetic profiles at the end of therapy and at relapse were also assessed. In primary DLBCLs, 90 different genomic imbalances were counted, consisting of 46 gains and 44 losses. Two gains in chr13 were significantly correlated with clinical stage. In addition, specific regions of gains and losses were significantly associated to duration of remission. In primary DLBCLs, individual variability was found, however 14 recurrent CNAs (>30%) were identified. Losses involving IGK, IGL and IGH were always found, and gains along the length of chr13 and chr31 were often observed (>41%). In these segments, MYC, LDHB, HSF1, KIT and PDGFR alpha are annotated. At the end of therapy, dogs in remission showed four new CNAs, whereas three new CNAs were observed in dogs at relapse compared with the previous profiles. One ex novo CNA, involving TCR, was present in dogs in remission after therapy, possibly induced by the autologous vaccine. Overall, aCGH identified small CNAs associated with outcome, which, along with future expression studies, may reveal target genes relevant to cDLBCL.	[Arico, Arianna; Ferraresso, Serena; Aresu, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Bresolin, Silvia; Kronnie, Geertruy Te] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Marconato, Laura] Ctr Oncol Vet, Sasso Marconi, Italy; [Comazzi, Stefano] Univ Milan, Dept Anim Pathol Hyg & Publ Hlth, Milan, Italy	University of Padua; University of Padua; University of Milan	Aresu, L (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy.	luca.aresu@unipd.it	Kronnie, Geertruy te/L-1014-2016; Marconato, Laura/AAD-7263-2020; Bresolin, Silvia/K-6576-2016; Aresu, Luca/J-9788-2018; Comazzi, Stefano/K-8062-2017; Arico, Arianna/J-4873-2018	Marconato, Laura/0000-0002-7843-615X; Bresolin, Silvia/0000-0001-7677-7084; Aresu, Luca/0000-0002-7893-1740; Ferraresso, Serena/0000-0001-5928-9361; /0000-0001-5636-1006; Comazzi, Stefano/0000-0002-1567-8055; Arico, Arianna/0000-0002-2397-0064; te Kronnie, Geertruy/0000-0001-7143-4795	Ministry of Health; University of Padua	Ministry of Health; University of Padua	This work was supported by a grant from Ministry of Health (PRIN 2008) and by a grant from University of Padua (ex-60%). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Aresu L, 2015, VET COMP ONCOL, V13, P348, DOI 10.1111/vco.12048; Arico A, 2014, J COMP PATHOL, V151, P322, DOI 10.1016/j.jcpa.2014.07.001; BAUER TR, 1993, IMMUNOGENETICS, V38, P387, DOI 10.1007/BF00184519; Capello D, 2006, HEMATOL ONCOL, V24, P212, DOI 10.1002/hon.791; DEJONG D, 1989, J EXP MED, V169, P613, DOI 10.1084/jem.169.3.613; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grier DD, 2012, INT J CLIN EXP PATHO, V5, P110; Hashemi J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-505; Kanamori Masahiko, 2012, J Exp Clin Cancer Res, V31, P100, DOI 10.1186/1756-9966-31-100; Kreisel F, 2011, CANCER GENET-NY, V204, P129, DOI 10.1016/j.cancergen.2010.12.010; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Landau DA, 2014, LEUKEMIA, V28, P34, DOI 10.1038/leu.2013.248; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Maekawa M, 2003, CLIN CHEM, V49, P1518, DOI 10.1373/49.9.1518; Manne J, 2002, J IMMUNOL, V169, P3407, DOI 10.4049/jimmunol.169.6.3407; Marconato L, 2014, CLIN CANCER RES, V20, P668, DOI 10.1158/1078-0432.CCR-13-2283; Marconato L, 2011, VET J, V188, P34, DOI 10.1016/j.tvjl.2010.04.027; Marconato L, 2010, JAVMA-J AM VET MED A, V236, P969, DOI 10.2460/javma.236.9.969; Martinez-Climent JA, 2010, METHODS MOL BIOL, V576, P231, DOI 10.1007/978-1-59745-545-9_13; Mudaliar MAV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072591; Paugh BS, 2013, CANCER RES, V73, P6219, DOI 10.1158/0008-5472.CAN-13-1491; Pedersen MO, 2014, EUR J HAEMATOL, V92, P42, DOI 10.1111/ejh.12212; Richards KL, 2013, CANCER RES, V73, P5029, DOI 10.1158/0008-5472.CAN-12-3546; Ristow M, 2006, CURR OPIN CLIN NUTR, V9, P339, DOI 10.1097/01.mco.0000232892.43921.98; Romania P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078481; Schmitt-Graeff AH, 2014, BLOOD, V123, P595, DOI 10.1182/blood-2013-10-530642; Shi ZZ, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-52; Tagawa H, 2005, BLOOD, V106, P1770, DOI 10.1182/blood-2005-02-0542; Tagawa H, 2004, CANCER RES, V64, P5948, DOI 10.1158/0008-5472.CAN-03-4056; Takeuchi I, 2009, HAEMATOL-HEMATOL J, V94, P61, DOI 10.3324/haematol.12986; Thomas R, 2011, LEUKEMIA LYMPHOMA, V52, P1321, DOI 10.3109/10428194.2011.559802; Tirado CA, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-54; Tzankov A, 2014, MODERN PATHOL, V27, P958, DOI 10.1038/modpathol.2013.214; Wang L, 2013, J MOL DIAGN, V15, P581, DOI 10.1016/j.jmoldx.2013.04.001; Wang X, 2012, CARCINOGENESIS, V33, P2228, DOI 10.1093/carcin/bgs245; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zong L, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-71	39	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111817	10.1371/journal.pone.0111817	http://dx.doi.org/10.1371/journal.pone.0111817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372838	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900077
J	Humphreys, GI; Ziegler, YS; Nardulli, AM				Humphreys, Gwendolyn I.; Ziegler, Yvonne S.; Nardulli, Ann M.			17 beta-Estradiol Modulates Gene Expression in the Female Mouse Cerebral Cortex	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BLOOD-BRAIN-BARRIER; ESTROGEN-RESPONSIVE GENES; DIFFERENTIAL EXPRESSION; NEURITE OUTGROWTH; CORTICAL-NEURONS; RECEPTOR-ALPHA; OPITZ-SYNDROME; ESTRADIOL; GROWTH	17 beta-estradiol (E2) plays critical roles in a number of target tissues including the mammary gland, reproductive tract, bone, and brain. Although it is clear that E2 reduces inflammation and ischemia-induced damage in the cerebral cortex, the molecular mechanisms mediating the effects of E2 in this brain region are lacking. Thus, we examined the cortical transcriptome using a mouse model system. Female adult mice were ovariectomized and implanted with silastic tubing containing oil or E2. After 7 days, the cerebral cortices were dissected and RNA was isolated and analyzed using RNA-sequencing. Analysis of the transcriptomes of control and E2-treated animals revealed that E2 treatment significantly altered the transcript levels of 88 genes. These genes were associated with long term synaptic potentiation, myelination, phosphoprotein phosphatase activity, mitogen activated protein kinase, and phosphatidylinositol 3-kinase signaling. E2 also altered the expression of genes linked to lipid synthesis and metabolism, vasoconstriction and vasodilation, cell-cell communication, and histone modification. These results demonstrate the far-reaching and diverse effects of E2 in the cerebral cortex and provide valuable insight to begin to understand cortical processes that may fluctuate in a dynamic hormonal environment.	[Humphreys, Gwendolyn I.; Ziegler, Yvonne S.; Nardulli, Ann M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Nardulli, AM (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	anardull@illinois.edu			National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK053884]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053884] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant (R01 DK053884) from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (www.niddk.nih.gov) to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2001, IEEE COMMUN MAG, V39, P98, DOI 10.1109/35.925676; Aenlle KK, 2010, HIPPOCAMPUS, V20, P1047, DOI 10.1002/hipo.20703; Aenlle KK, 2009, NEUROBIOL AGING, V30, P932, DOI 10.1016/j.neurobiolaging.2007.09.004; Arevalo MA, 2012, J STEROID BIOCHEM, V131, P52, DOI 10.1016/j.jsbmb.2011.09.004; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Belcher SM, 2001, J PHARMACOL EXP THER, V299, P408; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berti C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-9; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Bryant DN, 2005, NEUROSCIENCE, V133, P343, DOI 10.1016/j.neuroscience.2005.02.024; Cerghet M, 2006, J NEUROSCI, V26, P1439, DOI 10.1523/JNEUROSCI.2219-05.2006; Chesik D, 2007, CYTOKINE GROWTH F R, V18, P267, DOI 10.1016/j.cytogfr.2007.04.001; Cipolla M.J., 2009, CEREBRAL CIRCULATION; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Dahlin A, 2009, J PHARMACOL EXP THER, V329, P558, DOI 10.1124/jpet.108.149831; Deroo BJ, 2009, MOL REPROD DEV, V76, P733, DOI 10.1002/mrd.21041; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Fink G, 1996, CELL MOL NEUROBIOL, V16, P325, DOI 10.1007/BF02088099; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonda Y, 2007, GENE EXPR PATTERNS, V7, P431, DOI 10.1016/j.modgep.2006.11.005; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Haneda M, 1999, EUR J PHARMACOL, V365, P1, DOI 10.1016/S0014-2999(98)00857-7; HARLAN RE, 1988, MOL NEUROBIOL, V2, P183, DOI 10.1007/BF02935345; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Keenan PA, 2001, PSYCHONEUROENDOCRINO, V26, P577, DOI 10.1016/S0306-4530(01)00013-0; Keeshan K, 2010, BLOOD, V116, P4948, DOI 10.1182/blood-2009-10-247361; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Krivosheya D, 2008, J BIOL CHEM, V283, P32944, DOI 10.1074/jbc.M800073200; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Law C, 2013, THESIS U MELBOURNE A; Liang KW, 2010, J BIOL CHEM, V285, P935, DOI 10.1074/jbc.M109.051664; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu R, 2005, BRAIN RES, V1060, P55, DOI 10.1016/j.brainres.2005.08.048; Mannella P, 2006, J NEUROSCI, V26, P9439, DOI 10.1523/JNEUROSCI.1443-06.2006; Marin R, 2013, J NEUROENDOCRINOL; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; MCEWEN BS, 1994, EXP GERONTOL, V29, P431, DOI 10.1016/0531-5565(94)90022-1; Mendelsohn ME, 2000, J STEROID BIOCHEM, V74, P337, DOI 10.1016/S0960-0760(00)00110-2; Mhyre AJ, 2006, NEUROSCIENCE, V138, P851, DOI 10.1016/j.neuroscience.2005.10.019; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; NAKAI Y, 1978, ENDOCRINOLOGY, V102, P1008, DOI 10.1210/endo-102-4-1008; NELSON JF, 1992, ENDOCRINOLOGY, V130, P805, DOI 10.1210/en.130.2.805; Nieves JW, 1998, AM J CLIN NUTR, V67, P18, DOI 10.1093/ajcn/67.1.18; Ochsner SA, 2012, PHYSIOL GENOMICS, V44, P853, DOI 10.1152/physiolgenomics.00033.2012; Pechenino AS, 2009, NEUROBIOL LEARN MEM, V91, P313, DOI 10.1016/j.nlm.2008.09.017; Peng ZF, 2007, NEUROPHARMACOLOGY, V53, P687, DOI 10.1016/j.neuropharm.2007.07.016; R Core Team, 2021, R LANGUAGE ENV STAT; Raval AP, 2006, NEUROSCIENCE, V141, P1721, DOI 10.1016/j.neuroscience.2006.05.016; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; RICHELSON LS, 1984, NEW ENGL J MED, V311, P1273, DOI 10.1056/NEJM198411153112002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson MD, 2010, GENOME BIOL, V11; Rozovsky I, 2005, NEUROBIOL AGING, V26, P705, DOI 10.1016/j.neurobiolaging.2004.06.009; Rozovsky I, 2002, ENDOCRINOLOGY, V143, P636, DOI 10.1210/en.143.2.636; Rutkowsky JM, 2011, AM J PHYSIOL-CELL PH, V301, pC204, DOI 10.1152/ajpcell.00399.2010; Sarvari M, 2010, ENDOCRINOLOGY, V151, P3847, DOI 10.1210/en.2010-0375; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Simoncini T, 2000, CIRC RES, V87, P19, DOI 10.1161/01.RES.87.1.19; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Singer CA, 1999, J NEUROSCI, V19, P2455; Singh M, 1999, J NEUROSCI, V19, P1179; Smith P, 2007, CLIN CANCER RES, V13, P4061, DOI 10.1158/1078-0432.CCR-06-3052; Sortino MA, 2004, ENDOCRINOLOGY, V145, P5080, DOI 10.1210/en.2004-0973; Spittau B, 2013, GLIA, V61, P287, DOI 10.1002/glia.22435; Suidan GL, 2013, ARTERIOSCL THROM VAS, V33, P2112, DOI 10.1161/ATVBAHA.113.301362; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Takeo C, 2009, ENDOCR J, V56, P113, DOI 10.1507/endocrj.K08E-220; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tian XC, 2013, REPRODUCTION, V145, P577, DOI 10.1530/REP-13-0042; Topalli I, 2004, BRAIN RES, V1030, P116, DOI 10.1016/j.brainres.2004.09.057; ToranAllerand CD, 1996, DEV NEUROSCI-BASEL, V18, P36, DOI 10.1159/000111393; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Ullrich M, 2011, J BIOL CHEM, V286, P9477, DOI 10.1074/jbc.M110.171306; Vasudevan N, 2008, FRONT NEUROENDOCRIN, V29, P238, DOI 10.1016/j.yfrne.2007.08.003; Wang XF, 2006, MOL PHARMACOL, V70, P395, DOI 10.1124/mol.106.022384; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; Willis CL, 2013, NEUROSCIENCE, V250, P773, DOI 10.1016/j.neuroscience.2013.06.061; WISE PM, 1981, BIOL REPROD, V24, P820, DOI 10.1095/biolreprod24.4.820; Wong T.P., 2002, MJM, V6, P104, DOI DOI 10.1073/PNAS.1016709108; Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801	105	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111975	10.1371/journal.pone.0111975	http://dx.doi.org/10.1371/journal.pone.0111975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372139	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900098
J	Spainhour, JCG; Janech, MG; Schwacke, JH; Velez, JCQ; Ramakrishnan, V				Spainhour, John Christian G.; Janech, Michael G.; Schwacke, John H.; Velez, Juan Carlos Q.; Ramakrishnan, Viswanathan			The Application of Gaussian Mixture Models for Signal Quantification in MALDI-ToF Mass Spectrometry of Peptides	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; COMPLEX PROTEIN MIXTURES; RENIN-ANGIOTENSIN SYSTEM; ABSOLUTE QUANTIFICATION; LC-MS; PROTEOMICS; ENZYME; CARBOXYPEPTIDASE; IDENTIFICATION; QUANTITATION	Matrix assisted laser desorption/ionization time-of-flight (MALDI-TOF) coupled with stable isotope standards (SIS) has been used to quantify native peptides. This peptide quantification by MALDI-TOF approach has difficulties quantifying samples containing peptides with ion currents in overlapping spectra. In these overlapping spectra the currents sum together, which modify the peak heights and make normal SIS estimation problematic. An approach using Gaussian mixtures based on known physical constants to model the isotopic cluster of a known compound is proposed here. The characteristics of this approach are examined for single and overlapping compounds. The approach is compared to two commonly used SIS quantification methods for single compound, namely Peak Intensity method and Riemann sum area under the curve (AUC) method. For studying the characteristics of the Gaussian mixture method, Angiotensin II, Angiotensin-2-10, and Angiotenisn-1-9 and their associated SIS peptides were used. The findings suggest, Gaussian mixture method has similar characteristics as the two methods compared for estimating the quantity of isolated isotopic clusters for single compounds. All three methods were tested using MALDI-TOF mass spectra collected for peptides of the renin-angiotensin system. The Gaussian mixture method accurately estimated the native to labeled ratio of several isolated angiotensin peptides (5.2% error in ratio estimation) with similar estimation errors to those calculated using peak intensity and Riemann sum AUC methods (5.9% and 7.7%, respectively). For overlapping angiotensin peptides, (where the other two methods are not applicable) the estimation error of the Gaussian mixture was 6.8%, which is within the acceptable range. In summary, for single compounds the Gaussian mixture method is equivalent or marginally superior compared to the existing methods of peptide quantification and is capable of quantifying overlapping (convolved) peptides within the acceptable margin of error.	[Spainhour, John Christian G.; Ramakrishnan, Viswanathan] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Janech, Michael G.; Velez, Juan Carlos Q.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Velez, Juan Carlos Q.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Schwacke, John H.] Sci Res Corp, N Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Spainhour, JCG (corresponding author), Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.	jcs21@musc.edu	janech, michael/AAA-1011-2019; Velez, Juan Carlos/N-3782-2016	Janech, Michael/0000-0002-3202-4811	National Institute of General Medicine [5T32GM74934-8]; National Institutes of Health [5DK080944]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074934] Funding Source: NIH RePORTER	National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JCGS was supported under a training grant from the National Institute of General Medicine (5T32GM74934-8) http://www.nigms.nih.gov/Pages/default.aspx. JCQV was supported by a grant from the National Institutes of Health (5DK080944) http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091537; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Barkauskas DA, 2010, ANAL CHIM ACTA, V657, P191, DOI 10.1016/j.aca.2009.10.043; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Benton HP, 2010, BIOINFORMATICS, V26, P2488, DOI 10.1093/bioinformatics/btq441; Bouzegrhane F, 2002, CARDIOVASC RES, V53, P304, DOI 10.1016/S0008-6363(01)00448-5; Bronsema KJ, 2012, J CHROMATOGR B, V893, P1, DOI 10.1016/j.jchromb.2012.02.021; Camenzind AG, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-20; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Cui L, 2007, ANAL BIOCHEM, V369, P27, DOI 10.1016/j.ab.2007.06.045; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deutsch EW, 2008, PHYSIOL GENOMICS, V33, P18, DOI 10.1152/physiolgenomics.00298.2007; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gonzalez-Galarza FF, 2012, OMICS, V16, P431, DOI 10.1089/omi.2012.0022; Grobe N, 2013, AM J PHYSIOL-CELL PH, V304, pC945, DOI 10.1152/ajpcell.00346.2012; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hoffmann E, 2007, MASS SPECTROMETRY PR; HOLLENBERG NK, 1984, J CARDIOVASC PHARM, V6, pS176, DOI 10.1097/00005344-198400061-00028; Jankowski V, 2007, ARTERIOSCL THROM VAS, V27, P297, DOI 10.1161/01.ATV.0000253889.09765.5f; Karpievitch YV, 2007, BIOINFORMATICS, V23, P264, DOI 10.1093/bioinformatics/btl583; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lequin RM, 2005, CLIN CHEM, V51, P2415, DOI 10.1373/clinchem.2005.051532; Li NJ, 2005, AM J PHYSIOL-RENAL, V288, pF353, DOI 10.1152/ajprenal.00144.2004; Lortie M, 2009, ANAL BIOCHEM, V394, P164, DOI 10.1016/j.ab.2009.07.021; Markus K, 2012, METHODS MOL BIOL QUA, P85, DOI [10.1007/978-1-61779-885-6_29, DOI 10.1007/978-1-61779-885-6_]; Melnykov V, 2013, J R STAT SOC C-APPL, V62, P573, DOI 10.1111/rssc.12010; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Parry RM, 2013, J AM SOC MASS SPECTR, V24, P646, DOI 10.1007/s13361-012-0572-y; Plechawska M, 2009, STUD HEALTH TECHNOL, V150, P804, DOI 10.3233/978-1-60750-044-5-804; Polanska J, 2012, EXPERT SYST, V29, P216, DOI 10.1111/j.1468-0394.2011.00582.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ranjbar MRN, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-S1-S13; Reid JD, 2010, J AM SOC MASS SPECTR, V21, P1680, DOI 10.1016/j.jasms.2010.01.024; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Russell DH, 1997, J MASS SPECTROM, V32, P263, DOI 10.1002/(SICI)1096-9888(199703)32:3<263::AID-JMS501>3.3.CO;2-T; Santos RAS, 2007, CURR OPIN NEPHROL HY, V16, P122, DOI 10.1097/MNH.0b013e328031f362; Schwacke JH, 2013, HYPERTENSION, V61, P690, DOI 10.1161/HYPERTENSIONAHA.111.00318; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Velez JCQ, 2007, AM J PHYSIOL-RENAL, V293, pF398, DOI 10.1152/ajprenal.00050.2007; Velez JCQ, 2012, AM J PHYSIOL-RENAL, V302, pF1583, DOI 10.1152/ajprenal.00087.2012; Velez JCQ, 2009, HYPERTENSION, V53, P790, DOI 10.1161/HYPERTENSIONAHA.109.128819; Weir MR, 1999, AM J HYPERTENS, V12, p205S; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c	56	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111016	10.1371/journal.pone.0111016	http://dx.doi.org/10.1371/journal.pone.0111016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372836	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900032
J	Stanley, WT; Rogers, MA; Kihaule, PM; Munissi, MJ				Stanley, William T.; Rogers, Mary Anne; Kihaule, Philip M.; Munissi, Maiko J.			Elevational Distribution and Ecology of Small Mammals on Africa's Highest Mountain	PLOS ONE			English	Article							WEST USAMBARA MOUNTAINS; SPECIES RICHNESS; ABUNDANCE; EAST; INVENTORIES; DIVERSITY; MURIDAE; KILIMANJARO; GRADIENTS; TRANSECT	Mt Kilimanjaro is Africa's highest mountain, and an icon for a country famous for its mammalian fauna. The distribution and abundance of small mammals on the mountain are poorly known. Here we document the distribution of shrews and rodents along an elevational gradient on the southeastern versant of Kilimanjaro. Five sites were sampled with elevational center points of 2000, 2500, 3000, 3500 and 4000 m, using a systematic methodology of standard traps and pitfall lines, to inventory the shrews and rodents of the slope. Sixteen species of mammal were recorded, including 6 shrew and 10 rodent species, and the greatest diversity of both was found at 3000 m, the elevational midpoint of the transect. No species previously unrecorded on Kilimanjaro were observed. Two genera of rodents that occur in nearby mountains (Hylomyscus and Beamys) were not recorded. Myosorex zinki, the only mammal endemic to Mt. Kilimanjaro, which previously was known by only a few specimens collected in the ericaceous or moorland habitat, was found in all but one (the lowest) of the sites sampled, and was one of the most widespread species of small mammal along the gradient. Two shrews (Crocidura allex and Sylvisorex granti) and one rodent (Dendromus insignis) were found throughout the entire transect, with Dendromus being observed at our highest trap point (4240 m). As in similar faunal surveys on other mountains of Tanzania, rainfall influenced the sample success of shrews, but not rodents. Trap success for rodents at 3500 m was notably low. This study contributes further justification for the conservation of the forest habitat of Mt. Kilimanjaro.	[Stanley, William T.; Rogers, Mary Anne] Field Museum Nat Hist, Dept Sci & Educ, Chicago, IL 60605 USA; [Kihaule, Philip M.] Univ Dar Es Salaam, Dept Zool, Dar Es Salaam, Tanzania; [Munissi, Maiko J.] Southern Highlands Conservat Programme, Mbeya, Tanzania	Field Museum of Natural History (Chicago); University of Dar es Salaam	Stanley, WT (corresponding author), Field Museum Nat Hist, Dept Sci & Educ, Chicago, IL 60605 USA.	bstanley@fieldmuseum.org			Field Museum of Natural History; Marshall Field, Barbara Brown and Ellen Thorne Smith Funds of the Field Museum	Field Museum of Natural History; Marshall Field, Barbara Brown and Ellen Thorne Smith Funds of the Field Museum	Funding for this study came from the Field Museum of Natural History, including awards from the Marshall Field, Barbara Brown and Ellen Thorne Smith Funds of the Field Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP IR, 1979, MAMMALIA, V43, P519, DOI 10.1515/mamm.1979.43.4.519; Carleton MD, 2005, P BIOL SOC WASH, V118, P619, DOI 10.2988/0006-324X(2005)118[619:ROTHDC]2.0.CO;2; Carleton MD, 2006, P BIOL SOC WASH, V119, P477, DOI 10.2988/0006-324X(2006)119[477:TSOOOD]2.0.CO;2; Carleton MD, 2012, ZOOL J LINN SOC-LOND, V165, P420, DOI 10.1111/j.1096-3642.2012.00817.x; Child G. S., 1965, Tanganyika Notes and Records, V64, P77; DEMETER A, 1986, Cimbebasia Series A, V8, P199; Dieterlen F, 1979, STUTTGARTER BEITR A, V330, P1; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goodman S.M., 2003, P1159; Goodman Steven M., 1995, Oryx, V29, P212; Grimshaw J.M., 1997, Journal of East African Natural History, V84, P105, DOI 10.2982/0012-8317(1995)84[105:TMOK]2.0.CO;2; Hanby J, 1987, KILIMANJARO NATL PAR; HEANEY LR, 1989, J TROP ECOL, V5, P259, DOI 10.1017/S0266467400003643; HEIDEMAN PD, 1987, J MAMMAL, V68, P884, DOI 10.2307/1381575; Holden ME, 2005, MAMMAL SPECIES WORLD, V2, P819; Hutterer R, 2005, MAMMAL SPECIES WORLD, P220; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mulungu LS, 2008, MAMMALIA, V72, P178, DOI 10.1515/MAMM.2008.021; Musser GG, 2005, MAMMAL SPECIES WORLD, P894; Mwasaga BC, 1991, CONSERVATION MOUNT K, P111; Newmark WD, 1991, CONSERVATION MOUNT K, P111; Nor SM, 2001, GLOBAL ECOL BIOGEOGR, V10, P41, DOI 10.1046/j.1466-822x.2001.00231.x; PATTERSON BD, 1989, J MAMMAL, V70, P67, DOI 10.2307/1381670; RICKART EA, 1991, J MAMMAL, V72, P458, DOI 10.2307/1382128; Sampson DN, 1965, TANGANYIKA NOTES REC, V64, P118; SHORE RF, 1991, MAMMALIA, V55, P601, DOI 10.1515/mamm.1991.55.4.601; Stanley WT, 2005, BELG J ZOOL, V135, P141; Stanley W.T., 2000, Journal of East African Natural History, V87, P91, DOI 10.2982/0012-8317(1998)87[91:SMOTEA]2.0.CO;2; Stanley WT, 2007, ACTA THERIOL, V52, P261, DOI 10.1007/BF03194222; Stanley William T., 2005, Journal of East African Natural History, V94, P203, DOI 10.2982/0012-8317(2005)94[203:SMCITU]2.0.CO;2; Stanley William T., 2002, Journal of East African Natural History, V89, P73, DOI 10.2982/0012-8317(2000)89[73:ASOTSM]2.0.CO;2; Stanley William T., 1998, Zoologische Abhandlungen (Dresden), V50, P145; Stanley William T., 2011, Fieldiana-Life and Earth Sciences, V4, P18; Stanley William T., 2011, Fieldiana-Life and Earth Sciences, V4, P53; Stanley William T., 2011, Fieldiana-Life and Earth Sciences, V4, P1; Stanley William T., 1996, Zoologische Abhandlungen (Dresden), V49, P131; Stanley William T., 2005, Journal of East African Natural History, V94, P223, DOI 10.2982/0012-8317(2005)94[223:ROASOS]2.0.CO;2; Stanley William T., 2007, Journal of East African Natural History, V96, P215, DOI 10.2982/0012-8317(2007)96[215:SMOTFR]2.0.CO;2; Stanley WT, 2003, P 3 ANN SCI C AR DEC; Swynnerton G.H., 1951, Journal of the East Africa Natural History Society, V20, P274; THESIGER W, 1970, East African Wildlife Journal, V8, P202; Thomas O, 1909, ANN MAGAZINE NATUR 8, V8, P98; Thompson LG, 2009, P NATL ACAD SCI USA, V106, P19770, DOI 10.1073/pnas.0906029106; YU HT, 1994, J ZOOL, V234, P577, DOI 10.1111/j.1469-7998.1994.tb04866.x	46	19	19	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109904	10.1371/journal.pone.0109904	http://dx.doi.org/10.1371/journal.pone.0109904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372387	gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900010
J	Zhao, JD; Yuan, YY; Huang, SS; Huang, BQ; Cheng, J; Kang, DY; Wang, GJ; Han, DY; Dai, P				Zhao, Jiandong; Yuan, Yongyi; Huang, Shasha; Huang, Bangqing; Cheng, Jing; Kang, Dongyang; Wang, Guojian; Han, Dongyi; Dai, Pu			KCNJ10 May Not Be a Contributor to Nonsyndromic Enlargement of Vestibular Aqueduct (NSEVA) in Chinese Subjects	PLOS ONE			English	Article							SLC26 GENE FAMILY; PENDRED-SYNDROME; HEARING-LOSS; PDS GENE; MUTATIONS; DEAFNESS; SPECTRUM; SECRETION; DISTINCT; FOXI1	Background: Nonsyndromic enlargement of vestibular aqueduct (NSEVA) is an autosomal recessive hearing loss disorder that is associated with mutations in SLC26A4. However, not all patients with NSEVA carry biallelic mutations in SLC26A4. A recent study proposed that single mutations in both SLC26A4 and KCNJ10 lead to digenic NSEVA. We examined whether KCNJ10 excert a role in the pathogenesis of NSEVA in Chinese patients. Methods: SLC26A4 was sequenced in 1056 Chinese patients with NSEVA. KCNJ10 was screened in 131 patients who lacked mutations in either one or both alleles of SLC26A4. Additionally, KCNJ10 was screened in 840 controls, including 563 patients diagnosed with NSEVA who carried biallelic SLC26A4 mutations, 48 patients with nonsyndromic hearing loss due to inner ear malformations that did not involve enlargement of the vestibular aqueduct (EVA), 96 patients with conductive hearing loss due to various causes, and 133 normal-hearing individuals with no family history of hereditary hearing loss. Results: 925 NSEVA patients were found carrying two- allele pathogenic SLC26A4 mutations. The most frequently detected KCNJ10 mutation was c.812G>A ( p. R271H). Compared with the normal-hearing control subjects, the occurrence rate of c.812>G. A in NSEVA patients with lacking mutations in one or both alleles of SLC26A4 had no significant difference(1.53% vs. 5.30%, x(2) = 2.798, p = 0.172), which suggested that it is probably a nonpathogenic benign variant. KCNJ10 c.1042C > T (p.R348C), the reported EVA-related mutation, was not found in patients with NSEVA who lacked mutations in either one or both alleles of SLC26A4. Furthermore, the normal-hearing parents of patients with NSEVA having two SLC26A4 mutations carried the KCNJ10 c.1042C > T or c.812G. A mutation and a SLC26A4 pathogenic mutation. Conclusion: SLC26A4 is the major genetic cause in Chinese NSEVA patients, accounting for 87.59%. KCNJ10 may not be a contributor to NSEVA in Chinese population. Other genetic or environmental factors are possibly play a role in the etiology of Chinese EVA patients with zero or monoallelic SLC26A4 mutation.	[Zhao, Jiandong; Yuan, Yongyi; Huang, Shasha; Cheng, Jing; Kang, Dongyang; Wang, Guojian; Han, Dongyi; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Yuan, Yongyi; Huang, Bangqing; Wang, Guojian; Dai, Pu] Hainan Branch PLA Gen Hosp, Dept Otolaryngol, Sanya, Peoples R China	Chinese People's Liberation Army General Hospital	Han, DY (corresponding author), Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China.	hdy301@263.net; daipu301@vip.sina.com		Yuan, Yongyi/0000-0002-7936-4776	Minister of Science and Technology [2012BAI09B02]; 12th Five-Year National Key Technologies R D program [2012BAI12B01]; Chinese National Nature Science Foundation Research [30728030, 31071109, 81230020, 81070792, 81371098]; State 863 High Technology R & D Key Project of China [SQ2010AA0221634001]; PLA General Hospital Culturing Foundation [12KMM32]; Beijing Natural Science Foundation [7132177]; Beijing Nova programme [2009B34]	Minister of Science and Technology; 12th Five-Year National Key Technologies R D program; Chinese National Nature Science Foundation Research(National Natural Science Foundation of China (NSFC)); State 863 High Technology R & D Key Project of China(National High Technology Research and Development Program of China); PLA General Hospital Culturing Foundation; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova programme(Beijing Municipal Science & Technology Commission)	This work was supported by funding from a grant from the Minister of Science and Technology (2012BAI09B02) and the 12th Five-Year National Key Technologies R & D program (No. 2012BAI12B01), Chinese National Nature Science Foundation Research Grants (30728030, 31071109, 81230020), and the State 863 High Technology R & D Key Project of China (SQ2010AA0221634001) to Dr. Pu Dai; the PLA General Hospital Culturing Foundation to Dr. Jiandong Zhao (12KMM32); a Chinese National Nature Science Foundation Research Grant (81070792) to Dr. Dongyi Han; and the Beijing Natural Science Foundation (7132177), Beijing Nova programme (2009B34) and Chinese National Nature Science Foundation (81371098) to Dr. Yongyi Yuan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Blons H, 2004, CLIN GENET, V66, P333, DOI 10.1111/j.1399-0004.2004.00296.x; Chen KT, 2012, OTOLARYNG HEAD NECK, V146, P972, DOI 10.1177/0194599812439670; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Dai P, 2009, PHYSIOL GENOMICS, V38, P281, DOI 10.1152/physiolgenomics.00047.2009; Dossena S, 2009, J MOL ENDOCRINOL, V43, P93, DOI 10.1677/JME-08-0175; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Jin Z, 2008, EUR J NEUROSCI, V27, P145, DOI 10.1111/j.1460-9568.2007.05994.x; Jonard L, 2010, INT J PEDIATR OTORHI, V74, P1049, DOI 10.1016/j.ijporl.2010.06.002; Landa P, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-85; Lu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064906; Lu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022150; Maciaszczyk K, 2008, NEUROENDOCRINOL LETT, V29, P29; MAFEE MF, 1992, AM J NEURORADIOL, V13, P805; Marcus DC, 2002, AM J PHYSIOL-CELL PH, V282, pC403, DOI 10.1152/ajpcell.00312.2001; Mercer S, 2011, GENET TEST MOL BIOMA, V15, P365, DOI 10.1089/gtmb.2010.0177; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; Taylor JP, 2002, J CLIN ENDOCR METAB, V87, P1778, DOI 10.1210/jc.87.4.1778; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314; Yang T, 2009, AM J HUM GENET, V84, P651, DOI 10.1016/j.ajhg.2009.04.014; Yoshino T, 2004, HEARING RES, V195, P9, DOI 10.1016/j.heares.2004.05.005; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049984	32	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e108134	10.1371/journal.pone.0108134	http://dx.doi.org/10.1371/journal.pone.0108134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372295	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900001
J	Martinu, K; Nagano-Saito, A; Fogel, S; Monchi, O				Martinu, Kristina; Nagano-Saito, Atsuko; Fogel, Stuart; Monchi, Oury			Asymmetrical Effect of Levodopa on the Neural Activity of Motor Regions in PD	PLOS ONE			English	Article							PRIMATE BASAL GANGLIA; PARKINSONS-DISEASE; INTERNAL GENERATION; ANTERIOR STRIATUM; FINGER MOVEMENTS; FRONTAL-CORTEX; FUNCTIONAL MRI; FMRI; APOMORPHINE; ACTIVATION	Parkinson's disease (PD) is a neurodegenerative illness often characterized by asymmetrical symptoms. However, the reason for this asymmetry and the cerebral correlates underlying symptom asymmetry are still not well understood. Furthermore, the effects of levodopa on the cerebral correlates of disease asymmetry have not been investigated. In this study, right-handed PD patients performed self-initiated, externally triggered and repetitive control finger movements with both their right and left hands during functional magnetic resonance imaging (fMRI) to investigate asymmetrical effects of levodopa on the hemodynamic correlates of finger movements. Patients completed two experimental sessions OFF and ON medication after a minimum of 12 hours medication withdrawal. We compared the effect of levodopa on the neural activation patterns underlying the execution of both the more affected and less affected hand for self-initiated and externally triggered movements. Our results show that levodopa led to larger differences in cerebral activity for movements of the more affected, left side: there were significant differences in activity after levodopa administration in regions of the motor cortico-striatal network when patients performed self-initiated and externally triggered movements with their left hand. By contrast, when patients used their right hand, levodopa led to differences in cerebellar activity only. As our patients were affected more severely on their left side, we propose that levodopa may help provide additional dopaminergic input, improving movements for the more severely affected side. These results suggest that the impact of reduced dopamine in the cortico-striatal system and the action of levodopa is not symmetrical.	[Martinu, Kristina; Nagano-Saito, Atsuko; Fogel, Stuart; Monchi, Oury] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Fogel, Stuart] Western Univ, Brain & Mind Inst, Dept Psychol, London, ON, Canada; [Monchi, Oury] Univ Montreal, Dept Radiol, Montreal, PQ, Canada	Universite de Montreal; Western University (University of Western Ontario); Universite de Montreal	Monchi, O (corresponding author), Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada.	oury.monchi@umontreal.ca	Fogel, Stuart/F-7179-2017; Monchi, Oury/N-8417-2019	Fogel, Stuart/0000-0002-3227-5370; 	Canadian Institutes of Health Research [MOP-81114]; Parkinson Society Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson Society Canada	This study was supported by an operating grant (MOP-81114) from the Canadian Institutes of Health Research to OM. KM received a PhD fellowship from the Parkinson Society Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Djaldetti R, 2006, LANCET NEUROL, V5, P796, DOI 10.1016/S1474-4422(06)70549-X; DUVOISIN RC, 1989, NEUROLOGY, V39, P4; Feigin A, 2002, NEUROLOGY, V59, P220, DOI 10.1212/WNL.59.2.220; Feigin A, 2001, NEUROLOGY, V57, P2083, DOI 10.1212/WNL.57.11.2083; Francois-Brosseau FE, 2009, EUR J NEUROSCI, V29, P1277, DOI 10.1111/j.1460-9568.2009.06671.x; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JENKINS IH, 1992, ANN NEUROL, V32, P749, DOI 10.1002/ana.410320608; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; KEMPSTER PA, 1989, J NEUROL NEUROSUR PS, V52, P72, DOI 10.1136/jnnp.52.1.72; Kraft E, 2009, PARKINSONISM RELAT D, V15, P558, DOI 10.1016/j.parkreldis.2009.02.005; Kumar A, 2003, BRAIN, V126, P2648, DOI 10.1093/brain/awg270; Lewis MM, 2009, EUR J NEUROL, V16, P475, DOI 10.1111/j.1468-1331.2008.02430.x; Martinu K, 2012, EUR J NEUROSCI, V35, P572, DOI 10.1111/j.1460-9568.2011.07979.x; Mattay VS, 1998, PSYCHIAT RES-NEUROIM, V83, P7, DOI 10.1016/S0925-4927(98)00023-7; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ng B, 2010, HUM BRAIN MAPP, V31, P88, DOI 10.1002/hbm.20847; RODRIGUEZ M, 1994, J NEUROL NEUROSUR PS, V57, P562, DOI 10.1136/jnnp.57.5.562; ROMO R, 1992, EXP BRAIN RES, V91, P385, DOI 10.1007/BF00227835; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; Uitti RJ, 2005, NEUROLOGY, V64, P1925, DOI 10.1212/01.WNL.0000163993.82388.C8; van der Hoorn A, 2011, PARKINSONISM RELAT D, V17, P58, DOI 10.1016/j.parkreldis.2010.10.002; Verreyt N, 2011, NEUROPSYCHOL REV, V21, P405, DOI 10.1007/s11065-011-9182-x; Winterer G, 2006, PHARMACOPSYCHIATRY, V39, pS68, DOI 10.1055/s-2006-931498; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 2005, NEUROIMAGE, V28, P1056, DOI 10.1016/j.neuroimage.2005.06.053; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2004, J NEUROPHYSIOL, V91, P1690, DOI 10.1152/jn.01052.2003; Yust-Katz S, 2008, PARKINSONISM RELAT D, V14, P633, DOI 10.1016/j.parkreldis.2008.01.017; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111600	10.1371/journal.pone.0111600	http://dx.doi.org/10.1371/journal.pone.0111600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369523	Green Submitted, gold, Green Published			2022-12-26	WOS:000344402000073
J	Zhao, XM; Liu, C; Jiang, LJ; Li, QY; Zhou, MT; Cheng, TC; Mita, K; Xia, QY				Zhao, Xiao-Ming; Liu, Chun; Jiang, Li-Jun; Li, Qiong-Yan; Zhou, Meng-Ting; Cheng, Ting-Cai; Mita, Kazuei; Xia, Qing-You			A Juvenile Hormone Transcription Factor Bmdimm-Fibroin H Chain Pathway Is Involved in the Synthesis of Silk Protein in Silkworm, Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL HOMOLOG 1; FORK HEAD; GENE-TRANSCRIPTION; GLAND DEVELOPMENT; CRYSTAL-STRUCTURE; DNA-BINDING; DROSOPHILA; EXPRESSION; METAMORPHOSIS; TISSUE	The genes responsible for silk biosynthesis are switched on and off at particular times in the silk glands of Bombyx mori. This switch appears to be under the control of endogenous and exogenous hormones. However, the molecular mechanisms by which silk protein synthesis is regulated by the juvenile hormone (JH) are largely unknown. Here, we report a basic helix-loop-helix transcription factor, Bmdimm, its silk gland-specific expression, and its direct involvement in the regulation of fibroin H-chain (fib-H) by binding to an E-box (CAAATG) element of the fib-H gene promoter. Far-Western blots, enzyme-linked immunosorbent assays, and co-immunoprecipitation assays revealed that Bmdimm protein interacted with another basic helix-loop-helix transcription factor, Bmsage. Immunostaining revealed that Bmdimm and Bmsage proteins are co-localized in nuclei. Bmdimm expression was induced in larval silk glands in vivo, in silk glands cultured in vitro, and in B. mori cell lines after treatment with a JH analog. The JH effect on Bmdimm was mediated by the JH-Met-Kr-h1 signaling pathway, and Bmdimm expression did not respond to JH by RNA interference with double-stranded BmKr-h1 RNA. These data suggest that the JH regulatory pathway, the transcription factor Bmdimm, and the targeted fib-H gene contribute to the synthesis of fibroin H-chain protein in B. mori.	[Zhao, Xiao-Ming; Liu, Chun; Jiang, Li-Jun; Li, Qiong-Yan; Zhou, Meng-Ting; Cheng, Ting-Cai; Mita, Kazuei; Xia, Qing-You] Southwest Univ, Coll Biotechnol, Minist Agr, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Zhao, Xiao-Ming; Liu, Chun; Jiang, Li-Jun; Li, Qiong-Yan; Zhou, Meng-Ting; Cheng, Ting-Cai; Xia, Qing-You] Southwest Univ, Key Sericultural Lab, Minist Agr, Coll Biotechnol, Chongqing 400716, Peoples R China; [Zhao, Xiao-Ming] Shanxi Univ, Res Inst Appl Biol, Taiyuan 030006, Shanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China; Shanxi University	Liu, C (corresponding author), Southwest Univ, Coll Biotechnol, Minist Agr, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.	mlliuchun@163.com; xiaqy@swu.edu.cn	zhao, xiaoming/GNM-5551-2022	cheng, tingcai/0000-0002-3862-0817; Zhao, Xiaoming/0000-0003-2237-3417	National Basic Research Program of China [2012CB114600]; National Hi-Tech Research and Development Program of China [2011AA100306]; Program for New Century Excellent Talents [NCET-11-0699]; National Natural Science Foundation of China [31372380]	National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB114600, National Hi-Tech Research and Development Program of China Grant 2011AA100306, Program for New Century Excellent Talents NCET-11-0699, and the National Natural Science Foundation of China 31372380.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Aslam AFM, 2011, ZOOL SCI, V28, P609, DOI 10.2108/zsj.28.609; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Bobrovnik SA, 2003, J BIOCHEM BIOPH METH, V57, P213, DOI 10.1016/S0165-022X(03)00145-3; Chaitanya RK, 2013, GEN COMP ENDOCR, V181, P10, DOI 10.1016/j.ygcen.2012.08.014; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; DAILLIE J, 1979, BIOCHIMIE, V61, P275, DOI 10.1016/S0300-9084(79)80072-3; DURAND B, 1992, MOL CELL BIOL, V12, P5768, DOI 10.1128/MCB.12.12.5768; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Fox RM, 2013, DEVELOPMENT, V140, P2160, DOI 10.1242/dev.092924; GRZELAK K, 1982, MOL CELL ENDOCRINOL, V26, P341, DOI 10.1016/0303-7207(82)90122-8; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; ISHIZAKI H, 1994, INT J DEV BIOL, V38, P301; Kayukawa T, 2014, DEV BIOL, V388, P48, DOI 10.1016/j.ydbio.2014.01.022; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kethidi DR, 2004, J BIOL CHEM, V279, P19634, DOI 10.1074/jbc.M311647200; Kimoto M, 2012, DEV GENES EVOL, V222, P351, DOI 10.1007/s00427-012-0418-4; Kokubo H, 1996, DEV GENES EVOL, V206, P80, DOI 10.1007/s004270050033; KURATA K, 1984, Journal of Sericultural Science of Japan, V53, P421; KURATA SI, 1978, CHROMOSOMA, V68, P313, DOI 10.1007/BF00327166; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin Y, 2013, J BIOL CHEM, V288, P13345, DOI 10.1074/jbc.M113.462556; Liu QX, 2000, DEV BIOL, V225, P437, DOI 10.1006/dbio.2000.9836; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340; MAEKAWA H, 1980, DEV BIOL, V78, P394, DOI 10.1016/0012-1606(80)90343-7; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Ohno K, 2013, J BIOL CHEM, V288, P31581, DOI 10.1074/jbc.M113.514471; OHTA S, 1988, DEV GROWTH DIFFER, V30, P293; Pan MH, 2007, IN VITRO CELL DEV-AN, V43, P101, DOI 10.1007/s11626-006-9009-x; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Park D, 2008, MOL CELL BIOL, V28, P410, DOI 10.1128/MCB.01104-07; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; SEHNAL F, 1990, INT J INSECT MORPHOL, V19, P79, DOI 10.1016/0020-7322(90)90022-H; SUZUKI Y, 1986, P NATL ACAD SCI USA, V83, P9522, DOI 10.1073/pnas.83.24.9522; Takiya S, 1997, BIOCHEM J, V321, P645, DOI 10.1042/bj3210645; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRIPOULAS NA, 1986, DEV BIOL, V116, P328, DOI 10.1016/0012-1606(86)90136-3; Wang Y, 2007, DEV GENES EVOL, V217, P715, DOI 10.1007/s00427-007-0184-x; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xia QY, 2014, ANNU REV ENTOMOL, V59, P513, DOI 10.1146/annurev-ento-011613-161940; XU PX, 1994, J BIOL CHEM, V269, P2733; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Zhao XM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094091	54	29	35	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					972	986		10.1074/jbc.M114.606921	http://dx.doi.org/10.1074/jbc.M114.606921			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25371208	Green Published, hybrid			2022-12-26	WOS:000347778200031
J	Komaniecka, I; Choma, A; Mazur, A; Duda, KA; Lindner, B; Schwudke, D; Holst, O				Komaniecka, Iwona; Choma, Adam; Mazur, Andrzej; Duda, Katarzyna A.; Lindner, Buko; Schwudke, Dominik; Holst, Otto			Occurrence of an Unusual Hopanoid-containing Lipid A Among Lipopolysaccharides from Bradyrhizobium Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoconjugate; Lipid A; Lipopolysaccharide (LPS); Mass Spectrometry (MS); Nuclear Magnetic Resonance (NMR); Bradyrhizobium; Hopanoid; Long Chain Fatty Acids	D-GALACTURONIC ACID; PHOSPHATE RESIDUES; RHIZOBIUM-ETLI; A COMPONENT; BACTERIAL LIPOPOLYSACCHARIDES; RHODOMICROBIUM-VANNIELII; MESORHIZOBIUM; TRITERPENOIDS; SINORHIZOBIUM; SERIES	The chemical structures of the unusual hopanoid-containing lipid A samples of the lipopolysaccharides (LPS) from three strains of Bradyrhizobium (slow-growing rhizobia) have been established. They differed considerably from other Gram-negative bacteria in regards to the backbone structure, the number of ester-linked long chain hydroxylated fatty acids, as well as the presence of a tertiary residue that consisted of at least one molecule of carboxyl-bacteriohopanediol or its 2-methyl derivative. The structural details of this type of lipid A were established using one- and two-dimensional NMR spectroscopy, chemical composition analyses, and mass spectrometry techniques (electrospray ionization Fourier-transform ion cyclotron resonance mass spectrometry and MALDI-TOF-MS). In these lipid A samples the glucosamine disaccharide characteristic for enterobacterial lipid A was replaced by a 2,3-diamino-2,3-dideoxy-d-glucopyranosyl-(GlcpN3N) disaccharide, deprived of phosphate residues, and substituted by an -d-Manp-(16)--d-Manp disaccharide substituting C-4 of the non-reducing (distal) GlcpN3N, and one residue of galacturonic acid (d-GalpA) -(11)-linked to the reducing (proximal) amino sugar residue. Amide-linked 12:0(3-OH) and 14:0(3-OH) were identified. Some hydroxy groups of these fatty acids were further esterified by long (-1)-hydroxylated fatty acids comprising 26-34 carbon atoms. As confirmed by mass spectrometry techniques, these long chain fatty acids could form two or three acyloxyacyl residues. The triterpenoid derivatives were identified as 34-carboxyl-bacteriohopane-32,33-diol and 34-carboxyl-2-methyl-bacteriohopane-32,33-diol and were covalently linked to the (-1)-hydroxy group of very long chain fatty acid in bradyrhizobial lipid A. Bradyrhizobium japonicum possessed lipid A species with two hopanoid residues.	[Komaniecka, Iwona; Choma, Adam; Mazur, Andrzej] Marie Curie Sklodowska Univ, Dept Genet & Microbiol, PL-20033 Lublin, Poland; [Duda, Katarzyna A.; Holst, Otto] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr Borstel, PL-23845 Borstel, Poland; [Lindner, Buko; Schwudke, Dominik] Leibniz Ctr Med & Biosci, Div Bioanalyt Chem, Res Ctr Borstel, PL-23845 Borstel, Poland	Maria Curie-Sklodowska University	Komaniecka, I (corresponding author), Marie Curie Sklodowska Univ, Dept Genet & Microbiol, PL-20033 Lublin, Poland.	ikoma@hektor.umcs.lublin.pl	Schwudke, Dominik/B-3478-2013; Duda, Katarzyna/M-5274-2018	Schwudke, Dominik/0000-0002-1379-9451; Duda, Katarzyna/0000-0001-7701-3262; Komaniecka, Iwona/0000-0003-0807-8083; Choma, Adam/0000-0002-5454-8640	Polish Ministry of Science and Higher Education Grants [303 109 32/3593, N N303 822840]	Polish Ministry of Science and Higher Education Grants	This work was supported by Polish Ministry of Science and Higher Education Grants 303 109 32/3593 and N N303 822840 (to A. Ch. and I. K.).	Albus U, 2001, NEW PHYTOL, V151, P597, DOI 10.1046/j.0028-646x.2001.00214.x; BERRY AM, 1993, P NATL ACAD SCI USA, V90, P6091, DOI 10.1073/pnas.90.13.6091; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; BHAT UR, 1991, J BACTERIOL, V173, P2155, DOI 10.1128/JB.173.7.2155-2159.1991; BHAT UR, 1994, J BIOL CHEM, V269, P14402; BHAT UR, 1991, INT J SYST BACTERIOL, V41, P213; Bravo JM, 2001, EUR J BIOCHEM, V268, P1323, DOI 10.1046/j.1432-1327.2001.01998.x; Brewin NJ, 1993, ADV MOL GENETICS PLA, V2, P369; Brown DB, 2013, GLYCOBIOLOGY, V23, P546, DOI 10.1093/glycob/cws223; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; Choma A, 2004, EUR J BIOCHEM, V271, P1310, DOI 10.1111/j.1432-1033.2004.04038.x; Choma A, 2008, CARBOHYD RES, V343, P799, DOI 10.1016/j.carres.2008.01.006; Choma A, 2012, CARBOHYD RES, V352, P126, DOI 10.1016/j.carres.2012.03.003; Choma A, 2011, ACTA BIOCHIM POL, V58, P51; DEMAAGD RA, 1989, J BACTERIOL, V171, P1143, DOI 10.1128/jb.171.2.1143-1150.1989; Dow M, 2000, ANNU REV PHYTOPATHOL, V38, P241, DOI 10.1146/annurev.phyto.38.1.241; Fraysse N, 2002, GLYCOBIOLOGY, V12, P741, DOI 10.1093/glycob/cwf078; GILSERRANO AM, 1994, J BACTERIOL, V176, P2454, DOI 10.1128/JB.176.8.2454-2457.1994; HOLST O, 1983, EUR J BIOCHEM, V137, P325, DOI 10.1111/j.1432-1033.1983.tb07832.x; JOHNSON KG, 1976, CAN J MICROBIOL, V22, P29, DOI 10.1139/m76-004; KANNENBERG EL, 1995, FEMS MICROBIOL LETT, V127, P255; Komaniecka I, 2010, MICROBIOL IMMUNOL, V54, P717, DOI 10.1111/j.1348-0421.2010.00269.x; Komaniecka I, 2010, CHEM-EUR J, V16, P2922, DOI 10.1002/chem.200902390; Mathis R, 2005, P NATL ACAD SCI USA, V102, P2655, DOI 10.1073/pnas.0409816102; MORAN AP, 1991, EUR J BIOCHEM, V198, P459, DOI 10.1111/j.1432-1033.1991.tb16036.x; MORENO E, 1990, J BACTERIOL, V172, P3569, DOI 10.1128/jb.172.7.3569-3576.1990; NEUNLIST S, 1985, EUR J BIOCHEM, V147, P561, DOI 10.1111/j.0014-2956.1985.00561.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Plotz BM, 2000, J BIOL CHEM, V275, P11222, DOI 10.1074/jbc.275.15.11222; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Que NLS, 2000, J BIOL CHEM, V275, P28006; Que-Gewirth NLS, 2004, J BIOL CHEM, V279, P25420, DOI 10.1074/jbc.M400598200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reitz M, 2000, APPL ENVIRON MICROB, V66, P3515, DOI 10.1128/AEM.66.8.3515-3518.2000; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; ROHMER M, 1979, P NATL ACAD SCI USA, V76, P847, DOI 10.1073/pnas.76.2.847; ROPPEL J, 1975, CARBOHYD RES, V40, P31, DOI 10.1016/S0008-6215(00)82666-X; RUSSA R, 1995, ARCH MICROBIOL, V163, P345, DOI 10.1007/BF00404207; Schwudke D, 2003, J BIOL CHEM, V278, P27502, DOI 10.1074/jbc.M303012200; Silipo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6106; Simonin P, 1996, EUR J BIOCHEM, V241, P865, DOI 10.1111/j.1432-1033.1996.00865.x; SIMONIN P, 1994, EUR J BIOCHEM, V225, P765, DOI 10.1111/j.1432-1033.1994.00765.x; Smit J, 2008, INNATE IMMUN-LONDON, V14, P25, DOI 10.1177/1753425907087588; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Tsukushi Y, 2004, J ENDOTOXIN RES, V10, P25, DOI 10.1179/096805104225003799; Urbanik-Sypniewska T, 2000, IMMUNOBIOLOGY, V202, P408, DOI 10.1016/S0171-2985(00)80043-1; Vincent M., 1970, HANDBOOK, V15; Welander PV, 2009, J BACTERIOL, V191, P6145, DOI 10.1128/JB.00460-09; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; YOKOTA A, 1987, ARCH MICROBIOL, V149, P106, DOI 10.1007/BF00425074; YOUNG JPW, 1991, J BACTERIOL, V173, P2271; Zahringer U, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P93	52	25	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35644	35655		10.1074/jbc.M114.614529	http://dx.doi.org/10.1074/jbc.M114.614529			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371196	Green Published, hybrid			2022-12-26	WOS:000346660200050
J	Smulik, R; Debski, D; Zielonka, J; Michalowski, B; Adamus, J; Marcinek, A; Kalyanaraman, B; Sikora, A				Smulik, Renata; Debski, Dawid; Zielonka, Jacek; Michalowski, Bartosz; Adamus, Jan; Marcinek, Andrzej; Kalyanaraman, Balaraman; Sikora, Adam			Nitroxyl (HNO) Reacts with Molecular Oxygen and Forms Peroxynitrite at Physiological pH BIOLOGICAL IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiovascular; Ischemia; Nitric Oxide; Oxidative Stress; Vascular; Angeli's Salt; Boronate Probes; Cardioprotection; Nitroxyl; Peroxynitrite	NITRIC-OXIDE; ANGELIS SALT; SODIUM TRIOXODINITRATE; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; ARYLBORONIC ACID; NITROSYL HYDRIDE; L-ARGININE; ANION; NO	Nitroxyl (HNO), the protonated one-electron reduction product of NO, remains an enigmatic reactive nitrogen species. Its chemical reactivity and biological activity are still not completely understood. HNO donors show biological effects different from NO donors. Although HNO reactivity with molecular oxygen is described in the literature, the product of this reaction has not yet been unambiguously identified. Here we report that the decomposition of HNO donors under aerobic conditions in aqueous solutions at physiological pH leads to the formation of peroxynitrite (ONOO-) as a major intermediate. We have specifically detected and quantified ONOO- with the aid of boronate probes, e.g. coumarin-7-boronic acid or 4-boronobenzyl derivative of fluorescein methyl ester. In addition to the major phenolic products, peroxynitrite-specific minor products of oxidation of boronate probes were detected under these conditions. Using the competition kinetics method and a set of HNO scavengers, the value of the second order rate constant of the HNO reaction with oxygen (k = 1.8 x 10(4) m(-1) s(-1)) was determined. The rate constant (k = 2 x 10(4) m(-1) s(-1)) was also determined using kinetic simulations. The kinetic parameters of the reactions of HNO with selected thiols, including cysteine, dithiothreitol, N-acetylcysteine, captopril, bovine and human serum albumins, and hydrogen sulfide, are reported. Biological and cardiovascular implications of nitroxyl reactions are discussed.	[Sikora, Adam] Lodz Univ Technol, Inst Appl Radiat Chem, PL-90924 Lodz, Poland; [Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA	Lodz University of Technology; Medical College of Wisconsin; Medical College of Wisconsin	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	balarama@mcw.edu; adam.sikora@p.lodz.pl	Smulik-Izydorczyk, Renata/T-9352-2019; Sikora, Adam B/I-2756-2014; Zielonka, Jacek/N-9546-2014; Marcinek, Andrzej/M-1775-2018; Michalowski, Bartosz/AAN-3737-2020	Smulik-Izydorczyk, Renata/0000-0002-6509-404X; Sikora, Adam B/0000-0002-4962-8945; Zielonka, Jacek/0000-0002-2524-0145; Marcinek, Andrzej/0000-0002-9852-7593; Michalowski, Bartosz/0000-0002-3955-2924	National Institutes of Health Grant [R01 HL073056]; Polish Ministry of Higher Education within the Iuventus Plus program [IP2011049271]; Jagiellonian Centre for Experimental Therapeutics - European Union [POIG.01.01.02-00-069/09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073056] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Higher Education within the Iuventus Plus program; Jagiellonian Centre for Experimental Therapeutics - European Union; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL073056 (to B. K.). This work was also supported by Grant IP2011049271 from the Polish Ministry of Higher Education within the Iuventus Plus program and by Grant POIG.01.01.02-00-069/09 from Jagiellonian Centre for Experimental Therapeutics(supported by the European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme).	Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Augustyniak A, 2013, CHEM-BIOL INTERACT, V206, P262, DOI 10.1016/j.cbi.2013.09.019; BAZYLINSKI DA, 1985, J AM CHEM SOC, V107, P7982, DOI 10.1021/ja00312a031; Bohle DS, 1996, METHOD ENZYMOL, V269, P302; Chazotte-Aubert L, 1999, J BIOL CHEM, V274, P20909, DOI 10.1074/jbc.274.30.20909; Chin KY, 2014, BRIT J PHARMACOL, V171, P1722, DOI 10.1111/bph.12568; Cline MR, 2011, FREE RADICAL BIO MED, V50, P1274, DOI 10.1016/j.freeradbiomed.2011.02.008; DONALD CE, 1986, INORG CHEM, V25, P2676, DOI 10.1021/ic00236a004; DOYLE MP, 1988, J AM CHEM SOC, V110, P593, DOI 10.1021/ja00210a047; Ellis A, 2000, BRIT J PHARMACOL, V129, P315, DOI 10.1038/sj.bjp.0703058; ELLIS AJ, 1967, GEOCHIM COSMOCHIM AC, V31, P615, DOI 10.1016/0016-7037(67)90038-5; Favaloro JL, 2007, CARDIOVASC RES, V73, P587, DOI 10.1016/j.cardiores.2006.11.018; Fukuto JM, 2005, CHEM RES TOXICOL, V18, P790, DOI 10.1021/tx0496800; FUKUTO JM, 1992, J PHARMACOL EXP THER, V263, P546; Fukuto JM, 2013, J INORG BIOCHEM, V118, P201, DOI 10.1016/j.jinorgbio.2012.08.027; Fukuto JM, 2009, FREE RADICAL BIO MED, V47, P1318, DOI 10.1016/j.freeradbiomed.2009.06.014; Goss SPA, 1997, J BIOL CHEM, V272, P21647, DOI 10.1074/jbc.272.34.21647; Gupta D, 2009, DALTON T, P5730, DOI 10.1039/b905535e; Hewett SJ, 2005, FREE RADICAL BIO MED, V39, P1478, DOI 10.1016/j.freeradbiomed.2005.07.007; HOBBS AJ, 1994, P NATL ACAD SCI USA, V91, P10992, DOI 10.1073/pnas.91.23.10992; HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030; Hughes MN, 1999, METHOD ENZYMOL, V301, P279; Ianni JC, 2003, COMPUTATIONAL FLUID AND SOLID MECHANICS 2003, VOLS 1 AND 2, PROCEEDINGS, P1368; Irvine JC, 2003, HYPERTENSION, V41, P1301, DOI 10.1161/01.HYP.0000072010.54901.DE; Irvine JC, 2007, HYPERTENSION, V49, P885, DOI 10.1161/01.HYP.0000259328.04159.90; Irvine JC, 2008, TRENDS PHARMACOL SCI, V29, P601, DOI 10.1016/j.tips.2008.08.005; JOSEPH J, 1994, FASEB J, V8, pA313; Joseph J., 1996, BIOCHEMISTRY-US, V35, P9287; Kirsch M, 2002, J BIOL CHEM, V277, P13379, DOI 10.1074/jbc.M108079200; Kirsch M, 2003, ARCH BIOCHEM BIOPHYS, V418, P133, DOI 10.1016/j.abb.2003.07.002; Kirsch M, 2009, ORG BIOMOL CHEM, V7, P1954, DOI 10.1039/b901046g; Liochev SI, 2003, FREE RADICAL BIO MED, V34, P1399, DOI 10.1016/S0891-5849(03)00111-4; Liochev SI, 2002, ARCH BIOCHEM BIOPHYS, V402, P166, DOI 10.1016/S0003-9861(02)00074-7; Liochev SI, 2001, J BIOL CHEM, V276, P35253, DOI 10.1074/jbc.M104237200; Lippert AR, 2011, ACCOUNTS CHEM RES, V44, P793, DOI 10.1021/ar200126t; Mao GJ, 2014, CHEM COMMUN, V50, P5790, DOI 10.1039/c4cc01440e; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; Miranda KM, 2005, COORDIN CHEM REV, V249, P433, DOI 10.1016/j.ccr.2004.08.010; Miranda KM, 2001, J BIOL CHEM, V276, P1720, DOI 10.1074/jbc.M006174200; Miranda KM, 2003, P NATL ACAD SCI USA, V100, P9196, DOI 10.1073/pnas.1430507100; Miranda KM, 2002, ARCH BIOCHEM BIOPHYS, V401, P134, DOI 10.1016/S0003-9861(02)00031-0; Morrison DE, 2010, J BIOL INORG CHEM, V15, P1305, DOI 10.1007/s00775-010-0690-6; MURPHY ME, 1991, P NATL ACAD SCI USA, V88, P10860, DOI 10.1073/pnas.88.23.10860; Pagliaro P, 2003, LIFE SCI, V73, P2137, DOI 10.1016/S0024-3205(03)00593-9; Poderoso JJ, 1999, FREE RADICAL BIO MED, V26, P925, DOI 10.1016/S0891-5849(98)00277-9; PUFAHL RA, 1995, BIOCHEMISTRY-US, V34, P1930, DOI 10.1021/bi00006a014; RADI R, 1991, J BIOL CHEM, V266, P4244; Sabbah HN, 2013, CIRC-HEART FAIL, V6, P1250, DOI 10.1161/CIRCHEARTFAILURE.113.000632; Saleem M, 2004, BIOCHEM BIOPH RES CO, V315, P455, DOI 10.1016/j.bbrc.2004.01.081; Samuni A, 2011, J PHYS CHEM A, V115, P3022, DOI 10.1021/jp201796q; Samuni U, 2010, J AM CHEM SOC, V132, P8428, DOI 10.1021/ja101945j; Samuni Y, 2013, J INORG BIOCHEM, V118, P155, DOI 10.1016/j.jinorgbio.2012.10.002; Shafirovich V, 2002, P NATL ACAD SCI USA, V99, P7340, DOI 10.1073/pnas.112202099; Shafirovich V, 2003, J AM CHEM SOC, V125, P6547, DOI 10.1021/ja034378j; Sharpe MA, 1998, BIOCHEM J, V332, P9, DOI 10.1042/bj3320009; Sieracki NA, 2013, FREE RADICAL BIO MED, V61, P40, DOI 10.1016/j.freeradbiomed.2013.02.020; Sikora A, 2013, CHEM RES TOXICOL, V26, P856, DOI 10.1021/tx300499c; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Stoyanovsky DA, 2004, J MED CHEM, V47, P210, DOI 10.1021/jm030192j; Suarez SA, 2007, POLYHEDRON, V26, P4673, DOI 10.1016/j.poly.2007.05.040; Switzer CH, 2009, BBA-BIOENERGETICS, V1787, P835, DOI 10.1016/j.bbabio.2009.04.015; Wanstall JC, 2001, BRIT J PHARMACOL, V134, P463, DOI 10.1038/sj.bjp.0704269; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Wong PSY, 1998, BIOCHEMISTRY-US, V37, P5362, DOI 10.1021/bi973153g; Wrobel AT, 2014, J AM CHEM SOC, V136, P4697, DOI 10.1021/ja500315x; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080	70	55	55	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35570	35581		10.1074/jbc.M114.597740	http://dx.doi.org/10.1074/jbc.M114.597740			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378389	Green Published, hybrid			2022-12-26	WOS:000346660200044
J	Sharma, A; Chandran, R; Barry, ES; Bhomia, M; Hutchison, MA; Balakathiresan, NS; Grunberg, NE; Maheshwari, RK				Sharma, Anuj; Chandran, Raghavendar; Barry, Erin S.; Bhomia, Manish; Hutchison, Mary Anne; Balakathiresan, Nagaraja S.; Grunberg, Neil E.; Maheshwari, Radha K.			Identification of Serum MicroRNA Signatures for Diagnosis of Mild Traumatic Brain Injury in a Closed Head Injury Model	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ACOUSTIC STARTLE REFLEX; C-TERMINAL HYDROLASE; RAT CEREBRAL-CORTEX; FEMALE RATS; ADULT RATS; NEUROSURGICAL INTERVENTION; INTRACRANIAL LESIONS; PHYSICAL-ACTIVITY; BODY-WEIGHT	Wars in Iraq and Afghanistan have highlighted the problems of diagnosis and treatment of mild traumatic brain injury (mTBI). MTBI is a heterogeneous injury that may lead to the development of neurological and behavioral disorders. In the absence of specific diagnostic markers, mTBI is often unnoticed or misdiagnosed. In this study, mice were induced with increasing levels of mTBI and microRNA (miRNA) changes in the serum were determined. MTBI was induced by varying weight and fall height of the impactor rod resulting in four different severity grades of the mTBI. Injuries were characterized as mild by assessing with the neurobehavioral severity scale-revised (NSS-R) at day 1 post injury. Open field locomotion and acoustic startle response showed behavioral and sensory motor deficits in 3 of the 4 injury groups at day 1 post injury. All of the animals recovered after day 1 with no significant neurobehavioral alteration by day 30 post injury. Serum microRNA (miRNA) profiles clearly differentiated injured from uninjured animals. Overall, the number of miRNAs that were significantly modulated in injured animals over the sham controls increased with the severity of the injury. Thirteen miRNAs were found to identify mTBI regardless of its severity within the mild spectrum of injury. Bioinformatics analyses revealed that the more severe brain injuries were associated with a greater number of miRNAs involved in brain related functions. The evaluation of serum miRNA may help to identify the severity of brain injury and the risk of developing adverse effects after TBI.	[Sharma, Anuj; Chandran, Raghavendar; Bhomia, Manish; Balakathiresan, Nagaraja S.; Maheshwari, Radha K.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA; [Chandran, Raghavendar] Birla Inst Technol & Sci, Biol Sci Grp, Pilani, Rajasthan, India; [Barry, Erin S.; Hutchison, Mary Anne; Grunberg, Neil E.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Birla Institute of Technology & Science Pilani (BITS Pilani); Uniformed Services University of the Health Sciences - USA	Maheshwari, RK (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	radha.maheshwari@usuhs.edu	Bhomia, Manish/C-7683-2015; Chandran, Raghavendar/AAB-9402-2019; Balakathiresan, Nagaraja Sethuraman/O-3213-2019	Bhomia, Manish/0000-0003-2808-9927; Chandran, Raghavendar/0000-0002-7915-2810; Balakathiresan, Nagaraja Sethuraman/0000-0001-5756-6070; Sharma, Anuj/0000-0001-6906-190X; Barry, Erin/0000-0003-0788-7153	Congressionally Directed Medical Research Programs (CDMRP) [D10_I_AR_J6_855]	Congressionally Directed Medical Research Programs (CDMRP)(United States Department of Defense)	This study was supported by funding from Congressionally Directed Medical Research Programs (CDMRP), Project# D10_I_AR_J6_855 (PI: Radha K Maheshwari). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACRI JB, 1994, PSYCHOPHARMACOLOGY, V114, P369, DOI 10.1007/BF02244861; ACRI JB, 1991, PSYCHOPHARMACOLOGY, V104, P244, DOI 10.1007/BF02244186; Alain C, 2008, J COGNITIVE NEUROSCI, V20, P285, DOI 10.1162/jocn.2008.20014; Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Allison P. D, 1990, SOCIOL METHODOL, P93; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bao TH, 2014, J MOL NEUROSCIENCE M; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; BOWEN DJ, 1986, PHARMACOL BIOCHEM BE, V25, P1131, DOI 10.1016/0091-3057(86)90099-7; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Choudhury Y, 2012, J CLIN INVEST, V122, P4059, DOI 10.1172/JCI62925; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Deo A, 2011, J BIOINF COMPUT BIOL, V9, P795, DOI 10.1142/S0219720011005793; Ekdahl Y, 2012, GENOME RES, V22, P1477, DOI 10.1101/gr.131912.111; Elliott BM, 2004, PHARMACOL BIOCHEM BE, V77, P21, DOI 10.1016/j.pbb.2003.09.016; Faraday MM, 1998, PHARMACOL BIOCHEM BE, V61, P281, DOI 10.1016/S0091-3057(98)00094-X; Faraday MM, 2003, PHARMACOL BIOCHEM BE, V74, P325, DOI 10.1016/S0091-3057(02)00999-1; Fischer H., 2013, CRS REP C, P1; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Freund Hans-Joachim, 2003, Adv Neurol, V93, P179; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Goh CP, 2014, EXP NEUROL, V252, P37, DOI 10.1016/j.expneurol.2013.11.017; Goossens K, 2013, STEM CELLS DEV; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; GRUNBERG NE, 1985, PHARMACOL BIOCHEM BE, V23, P851, DOI 10.1016/0091-3057(85)90081-4; Grunberg NE, 2011, ANN M SOC NEUR WASH; Hamilton KR, 2012, EXP CLIN PSYCHOPHARM, V20, P345, DOI 10.1037/a0029088; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hanell A, 2012, J NEUROTRAUM, V29, P2660, DOI 10.1089/neu.2012.2376; Hausmann R, 2001, INT J LEGAL MED, V114, P338, DOI 10.1007/s004140000199; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2009, MOL CELL BIOCHEM, V324, P191, DOI 10.1007/s11010-008-0013-1; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Lee YL, 1996, J NEUROSCI, V16, P3775; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Leung AWS, 2011, NEUROIMAGE, V55, P1260, DOI 10.1016/j.neuroimage.2010.12.055; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marti M, 2005, J NEUROSCI, V25, P9591, DOI 10.1523/JNEUROSCI.2546-05.2005; Mayr M, 2013, ARTERIOSCL THROM VAS, V33, P206, DOI 10.1161/ATVBAHA.112.300141; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; Morse DE, 1997, PHARMACOL BIOCHEM BE, V56, P221, DOI 10.1016/S0091-3057(96)00214-6; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V63, P28, DOI 10.1037/h0024166; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Sharma Pushpa, 2012, Int J Crit Illn Inj Sci, V2, P172, DOI 10.4103/2229-5151.100931; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; SWERDLOW NR, 1992, J PSYCHOPHARMACOL, V6, P176, DOI 10.1177/026988119200600210; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P99, DOI 10.1007/978-3-7091-1434-6_17; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Yarnell AM, 2013, BLAST TRAUMATIC BRAI, P9; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zhang L, 2013, INT J MOL MED, V32, P867, DOI 10.3892/ijmm.2013.1456; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	98	43	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112019	10.1371/journal.pone.0112019	http://dx.doi.org/10.1371/journal.pone.0112019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379886	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100050
J	Wang, JF; Sun, DW; Wang, YB; Ren, FH; Pang, SN; Wang, DD; Xu, SD				Wang, Junfeng; Sun, Dawei; Wang, Yanbo; Ren, Fenghai; Pang, Sainan; Wang, Dandan; Xu, Shidong			FOSL2 Positively Regulates TGF-beta 1 Signalling in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; GENE-EXPRESSION; BREAST-CANCER; FRA-2; SMAD3; COACTIVATORS; FIBROBLASTS; METASTASIS; P300/CBP	Fos-related antigen 2 (FRA-2/FOSL2) belongs to the AP-1 transcription factor family. Although FOSL2 has been shown to be involved in diverse physiological and pathological processes, very little is known about the signalling pathways that regulate FOSL2 expression and the mechanisms of FOSL2 function. Here, we show that FOSL2 expression is regulated by TGF-beta 1 and that FOSL2 is required for TGF-beta 1-induced migration. We demonstrate that FOSL2 interacts with Smad3 in vitro and in vivo and thus up-regulates TGF-beta 1-induced signalling responses. Mechanistically, FOSL2 promotes P300 binding to Smad3 and the acetylation of Smad3 by P300. Furthermore, we show that the expression of FOSL2 correlates with activated Smad3 expression in clinical non-small cell lung cancer (NSCLC) samples. In summary, the present study indicates that FOSL2 facilitates TGF-beta 1-induced migration by interaction with Smad3 in NSCLC and suggests FOSL2 as a potential therapeutic target for NSCLC.	[Wang, Junfeng; Sun, Dawei; Wang, Yanbo; Ren, Fenghai; Pang, Sainan; Wang, Dandan; Xu, Shidong] Harbin Med Univ, Canc Hosp, Dept Thorac Surg, Harbin, Peoples R China	Harbin Medical University	Xu, SD (corresponding author), Harbin Med Univ, Canc Hosp, Dept Thorac Surg, Harbin, Peoples R China.	xusd163@163.com			National Natural Science Foundation of China [81172818, 81172215]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81172818; 81172215). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bouyssou JMC, 2014, BBA-REV CANCER, V1845, P255, DOI 10.1016/j.bbcan.2014.02.002; Bozec A, 2013, J CELL SCI, V126, P5432, DOI 10.1242/jcs.134510; Bozec A, 2010, J CELL BIOL, V190, P1093, DOI 10.1083/jcb.201002111; Busnadiego O, 2013, MOL CELL BIOL, V33, P2388, DOI 10.1128/MCB.00036-13; Engel L, 2005, NEUROSCIENCE, V132, P511, DOI 10.1016/j.neuroscience.2004.12.014; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Ko H, 2013, CANCER LETT, V335, P205, DOI 10.1016/j.canlet.2013.02.018; Milde-Langosch K, 2008, BREAST CANCER RES TR, V107, P337, DOI 10.1007/s10549-007-9559-y; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Reich N, 2010, ARTHRITIS RHEUM-US, V62, P280, DOI 10.1002/art.25056; Renaud SJ, 2014, J BIOL CHEM, V289, P5025, DOI 10.1074/jbc.M113.523746; Roy S, 2010, CARDIOVASC RES, V87, P647, DOI 10.1093/cvr/cvq123; Shimmi O, 2013, J BIOCHEM, V154, P11, DOI 10.1093/jb/mvt046; Tian MZ, 2011, CELL SIGNAL, V23, P951, DOI 10.1016/j.cellsig.2010.10.015; Tulchinsky E, 2000, HISTOL HISTOPATHOL, V15, P921, DOI 10.14670/HH-15.921; Warburton D, 2013, AM J PHYSIOL-LUNG C, V304, pL83, DOI 10.1152/ajplung.00258.2012; Zhang XHF, 2013, CLIN CANCER RES, V19, P6389, DOI 10.1158/1078-0432.CCR-13-0838; Zhou LX, 2013, MOL CANCER RES, V11, P272, DOI 10.1158/1541-7786.MCR-12-0395	23	22	22	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112150	10.1371/journal.pone.0112150	http://dx.doi.org/10.1371/journal.pone.0112150			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375657	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600111
J	Kormos, R; Kormos, CF; Humle, T; Lanjouw, A; Rainer, H; Victurine, R; Mittermeier, RA; Diallo, MS; Rylands, AB; Williamson, EA				Kormos, Rebecca; Kormos, Cyril F.; Humle, Tatyana; Lanjouw, Annette; Rainer, Helga; Victurine, Ray; Mittermeier, Russell A.; Diallo, Mamadou S.; Rylands, Anthony B.; Williamson, Elizabeth A.			Great Apes and Biodiversity Offset Projects in Africa: The Case for National Offset Strategies	PLOS ONE			English	Article							NO NET LOSS; FEMALE CHIMPANZEES; LOWLAND GORILLAS; WILD CHIMPANZEES; SEED DISPERSAL; LOPE RESERVE; LOSS POLICY; CONSERVATION; RESTORATION; ENVIRONMENT	The development and private sectors are increasingly considering "biodiversity offsets" as a strategy to compensate for their negative impacts on biodiversity, including impacts on great apes and their habitats in Africa. In the absence of national offset policies in sub-Saharan Africa, offset design and implementation are guided by company internal standards, lending bank standards or international best practice principles. We examine four projects in Africa that are seeking to compensate for their negative impacts on great ape populations. Our assessment of these projects reveals that not all apply or implement best practices, and that there is little standardization in the methods used to measure losses and gains in species numbers. Even if they were to follow currently accepted best-practice principles, we find that these actions may still fail to contribute to conservation objectives over the long term. We advocate for an alternative approach in which biodiversity offset and compensation projects are designed and implemented as part of a National Offset Strategy that (1) takes into account the cumulative impacts of development in individual countries, (2) identifies priority offset sites, (3) promotes aggregated offsets, and (4) integrates biodiversity offset and compensation projects with national biodiversity conservation objectives. We also propose supplementary principles necessary for biodiversity offsets to contribute to great ape conservation in Africa. Caution should still be exercised, however, with regard to offsets until further field-based evidence of their effectiveness is available.	[Kormos, Rebecca] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Kormos, Cyril F.] WILD Fdn, Berkeley, CA USA; [Humle, Tatyana] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Lanjouw, Annette] Arcus Fdn, Strateg Initiat & Great Apes Program, Cambridge, England; [Rainer, Helga] Arcus Fdn, Conservat Program, Cambridge, England; [Victurine, Ray] Wildlife Conservat Soc, Business Conservat Initiat & Conservat Finance, Bronx, NY USA; [Mittermeier, Russell A.] Conservat Int, Arlington, VA USA; [Rylands, Anthony B.] Conservat Int, Arlington, VA USA; [Williamson, Elizabeth A.] Univ Stirling, Sch Nat Sci, Scottish Primate Res Grp, Stirling FK9 4LA, Scotland	University of California System; University of California Berkeley; University of Kent; Wildlife Conservation Society; Conservation International; Conservation International; University of Stirling	Kormos, R (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rebeccakormos@yahoo.com	Williamson, Elizabeth/B-9090-2011; Williamson, Elizabeth/N-8958-2019; Williamson, Elizabeth/E-4727-2016	Williamson, Elizabeth/0000-0001-6848-9154; Williamson, Elizabeth/0000-0001-6848-9154	Arcus Foundation [1104-38]	Arcus Foundation	Funding for part of this study was provided by the Arcus Foundation grant no. 1104-38 (http://www.arcusfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish. They did contribute to discussions of these ideas and preparation of the manuscript.	African Development Bank, 2009, OIL GAS AFR; Ancrenaz M., 2006, J TROP BIOL CONSERV, V2, P65; Ancrenaz M, 2007, PLOS BIOL, V5, P2443, DOI 10.1371/journal.pbio.0050289; Anderson JR, 2011, AM J PRIMATOL, V73, P410, DOI 10.1002/ajp.20922; [Anonymous], 2013, EQUATOR PRINCIPLES; Arcus Foundation, 2014, STAT AP EXTR IND AP; Bean M., 2008, DESIGN US HABITAT BA; Bekessy SA, 2010, CONSERV LETT, V3, P151, DOI 10.1111/j.1755-263X.2010.00110.x; Bendor T, 2009, LANDSCAPE URBAN PLAN, V89, P17, DOI 10.1016/j.landurbplan.2008.09.003; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; Boesch C, 2002, HUM NATURE-INT BIOS, V13, P27, DOI 10.1007/s12110-002-1013-6; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Brncic TM., 2010, SIERRA LEONE NATL CH; Brownlie S., 2009, IMPACT ASSESS PROJ A, V27, P227, DOI DOI 10.3152/146155109X465968; Bull JW, 2013, ORYX, V47, P369, DOI 10.1017/S003060531200172X; Business and and Biodiversity Offsets Programme (BBOP), 2013, NO NET LOSS OV BUS B; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butler RA, 2008, TRENDS ECOL EVOL, V23, P469, DOI 10.1016/j.tree.2008.05.006; Carroll N., 2008, CONSERVATION BIODIVE; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Dinerstein E., 2010, WILDLIFE PREMIUM MAR; Edwards DP, 2014, CONSERV LETT, V7, P302, DOI 10.1111/conl.12076; Endangered Species Act (ESA), 1973, 108 C DEP INT US WAS; Fox J, 2005, CONSERV BIOL, V19, P996, DOI 10.1111/j.1523-1739.2005.00231.x; Gardner A, 1980, SPEAKING APES CRITIC, P287; Gardner TA, 2013, CONSERV BIOL, V27, P1254, DOI 10.1111/cobi.12118; Gibbons Philip, 2007, Ecological Management & Restoration, V8, P26, DOI 10.1111/j.1442-8903.2007.00328.x; Goossens B, 2005, BIOL CONSERV, V123, P461, DOI 10.1016/j.biocon.2005.01.008; Haider SW, 2013, SIERRA LEONE SL BUMB; Ham R, 1998, NATIONWIDE CHIMPANZE; Hockings K., 2009, BEST PRACTICE GUIDEL; Humle T, 2011, INT J PRIMATOL, V32, P456, DOI 10.1007/s10764-010-9482-7; ICMM IUCN, 2012, IND REP BIOD OFFS; IFC, 2012, GUID NOT 6 BIOD CONS; IFC, 2013, GOOD PRACT HDB; International Finance Corporation (IFC), 2012, 6 IFC; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; K?hl H., 2008, BEST PRACTICE GUIDEL; Kahlenberg SM, 2008, ANIM BEHAV, V76, P1497, DOI 10.1016/j.anbehav.2008.05.029; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kormos C., 2011, STRATEGIC NATL PLAN; Kormos R., 2003, W AFRICAN CHIMPANZEE; Kormos R, 2008, CRIT HAB ASS REP GUI; LEADERWILLIAMS N, 2000, PRIORITIES CONSERVAT, P53; Macfie EJ, 2010, BEST PRACTICE GUIDEL; Madsen B., 2010, STATE BIODIVERSITY M; Maisels F, 2011, GORILLA J, V4, P18; Maisels F, 2013, DENG DENG NATL PARK; Maron M, 2012, BIOL CONSERV, V155, P141, DOI 10.1016/j.biocon.2012.06.003; MCGREW WC, 1992, J ZOOL, V228, P689, DOI 10.1111/j.1469-7998.1992.tb04469.x; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Mitani JC, 2010, CURR BIOL, V20, pR507, DOI 10.1016/j.cub.2010.04.021; Mittermeier R., 2013, HDB MAMMALS WORLD, V3; Morgan D., 2007, BEST PRACTICE GUIDEL; Pilgrim JD, 2013, CONSERV LETT, V6, P376, DOI 10.1111/conl.12002; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; PLUMPTRE AJ, 1994, AFR J ECOL, V32, P115, DOI 10.1111/j.1365-2028.1994.tb00563.x; Poulsen JR, 2009, CONSERV BIOL, V23, P1597, DOI 10.1111/j.1523-1739.2009.01251.x; Quetier F, 2014, ENVIRON SCI POLICY, V38, P120, DOI 10.1016/j.envsci.2013.11.009; Reuters, 2014, CORRECTED EM GLOB AL; Rijksen HD, 1999, OUR VANISHING RELATI; Rio Tinto, 2008, RIO TINT BIOD BIOD O; Rogers ME, 1998, AM J PRIMATOL, V45, P45, DOI 10.1002/(SICI)1098-2345(1998)45:1<45::AID-AJP5>3.0.CO;2-W; Ryan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029030; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Stratus Consulting Inc, 2003, NAT SURV CONS BANKS; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; ten Kate K., 2004, BIODIVERSITY OFFSETS; The Biodiversity Consultancy, 2013, GOV POL BIOD OFFS; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; Thompson-Handler N., 1995, ACTION PLAN PAN PANI; TUTIN CEG, 1991, J TROP ECOL, V7, P181, DOI 10.1017/S0266467400005320; U.S. Environmental Protection Agency, 1995, FEDERAL GUIDANCE EST; UN Development Programme (UNDP), 2013, 2013 HUM DEV REP RIS; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Voysey BC, 1999, J TROP ECOL, V15, P39, DOI 10.1017/S0266467499000668; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Warren Y, 2004, ZOO BIOL, V23, P375, DOI 10.1002/zoo.20001; WCF, 2012, ET FAUN MEN AIR PROT; WCF, 2012, OFFS STRAT GUIN ALUM; WCF, 2011, BIOD MAN PLAN GUIN A; Weber A., 1987, RUHENGERI ITS RESOUR; Weng LF, 2013, GLOB FOOD SECUR-AGR, V2, P195, DOI 10.1016/j.gfs.2013.07.003; White A, 2014, STATE APES 2013 EXTR, P197; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wich SA, 2014, CURR BIOL, V24, P1659, DOI 10.1016/j.cub.2014.05.077; Williamson E.A., 2013, P792; World Bank, 2005, SIERR LEON COMPL BUM; ZSL, 2006, BAS PRIM SURV MON PR	94	27	27	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111671	10.1371/journal.pone.0111671	http://dx.doi.org/10.1371/journal.pone.0111671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372894	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000344556900060
J	Ogusu, N; Saruwatari, J; Nakashima, H; Noai, M; Nishimura, M; Deguchi, M; Oniki, K; Yasui-Furukori, N; Kaneko, S; Ishitsu, T; Nakagaswa, K				Ogusu, Naoki; Saruwatari, Junji; Nakashima, Hiroo; Noai, Madoka; Nishimura, Miki; Deguchi, Mariko; Oniki, Kentaro; Yasui-Furukori, Norio; Kaneko, Sunao; Ishitsu, Takateru; Nakagaswa, Kazuko			Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of gamma-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MANGANESE SUPEROXIDE-DISMUTASE; ANTIEPILEPTIC DRUGS; ILAE-COMMISSION; RISK-FACTORS; CHILDREN; ADOLESCENTS; OVERWEIGHT; GENOTYPES; CLOBAZAM	Background: There has been accumulating evidence that there are associations among c-glutamyltransferase (gamma-GT) elevation and all-cause mortality, cardiovascular diseases and metabolic diseases, including nonalcoholic fatty liver disease. The primary objective of this study was to evaluate the impact of the most common and potentially functional polymorphisms of antioxidant enzyme genes, i.e. superoxide dismutase 2 (SOD2), glutathione S-transferase M1 and glutathione S-transferase T1, on the gamma-GT elevation during valproic acid (VPA) therapy. Methods and Findings: This retrospective study included 237 and 169 VPA-treated Japanese patients with epilepsy for population pharmacokinetic and pharmacokinetic-pharmacodynamic analyses, respectively. A nonlinear mixed-effect model represented the pharmacokinetics of VPA and the relationships between VPA exposure and gamma-GT elevation. A one-compartment model of the pharmacokinetic parameters of VPA adequately described the data; while the model for the probability of the gamma-GT elevation was fitted using a logistic regression model, in which the logit function of the probability was a linear function of VPA exposure. The SOD2 Val16Ala polymorphism and complication with intellectual disability were found to be significant covariates influencing the intercept of the logit function for the probability of an elevated gamma-GT level. The predicted mean percentages of the subjects with gamma-GT elevation were about 2- to 3-fold, 3- to 4-fold and 4- to 8-fold greater in patients with the SOD2 Val/Val genotype but without any intellectual disability, those with the SOD2 Val/Ala or Ala/Ala genotype and intellectual disability and those with the SOD2 Val/Val genotype and intellectual disability, respectively, compared to those with the SOD2 Val/Ala or Ala/Ala genotype without intellectual disability. Conclusion: Our results showed that the SOD2 Val16Ala polymorphism has an impact on the relationship between VPA exposure and gamma-GT elevation in patients with epilepsy. These results suggest that determining the SOD2 genotype could be helpful for preventing the VPA-induced gamma-GT elevation.	[Ogusu, Naoki; Saruwatari, Junji; Nakashima, Hiroo; Noai, Madoka; Nishimura, Miki; Deguchi, Mariko; Oniki, Kentaro; Nakagaswa, Kazuko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto, Japan; [Yasui-Furukori, Norio; Kaneko, Sunao] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan; [Ishitsu, Takateru] Kumamoto Saishunso Natl Hosp, Kumamoto, Japan; [Ishitsu, Takateru] Kumamoto Ezuko Ryoiku Iryo Ctr, Kumamoto, Japan; [Nakagaswa, Kazuko] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto, Japan	Kumamoto University; Hirosaki University; Kumamoto University	Saruwatari, J (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto, Japan.	junsaru@gpo.kumamoto-u.ac.jp	Saruwatari, Junji/Q-7748-2019	Saruwatari, Junji/0000-0001-6266-1347	Japan Research Foundation for Clinical Pharmacology and KAKENHI [24590652, 25860117, 26360049]; Smoking Research Foundation; Asteras; Dainippon; Eli Lilly; GlaxoSmithKline; Janssen-Pharma; Meiji; Mochida; Merck Sharp Dohme; Otsuka; Pfizer; Takada; Yoshitomi; Grants-in-Aid for Scientific Research [26360049] Funding Source: KAKEN	Japan Research Foundation for Clinical Pharmacology and KAKENHI; Smoking Research Foundation; Asteras; Dainippon; Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Janssen-Pharma; Meiji; Mochida; Merck Sharp Dohme(Merck & Company); Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Takada; Yoshitomi(Mitsubishi Tanabe Pharma Corporation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Research Foundation for Clinical Pharmacology and KAKENHI (Nos. 24590652, 25860117, 26360049), and in part by a grant from the Smoking Research Foundation. Norio Yasui-Furukori has received grant/research support or honoraria from and spoken for Asteras, Dainippon, Eli Lilly, GlaxoSmithKline, Janssen-Pharma, Meiji, Mochida, Merck Sharp & Dohme, Otsuka, Pfizer, Takada, and Yoshitomi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Shirazi N, 2010, TOXICOL MECH METHOD, V20, P452, DOI 10.3109/15376516.2010.497977; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Birnbaum AK, 2007, THER DRUG MONIT, V29, P571, DOI 10.1097/FTD.0b013e31811f3296; BRAIDE SA, 1987, ANN CLIN BIOCHEM, V24, P391, DOI 10.1177/000456328702400408; Castellano I, 2012, CELL MOL LIFE SCI, V69, P3381, DOI 10.1007/s00018-012-0988-3; Chang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059999; Cronin-Fenton DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087450; Franconi F, 2007, PHARMACOL RES, V55, P81, DOI 10.1016/j.phrs.2006.11.001; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Fukushima Y, 2008, CLIN CHIM ACTA, V389, P98, DOI 10.1016/j.cca.2007.11.035; Ghodke-Puranik Y, 2013, PHARMACOGENET GENOM, V23, P236, DOI 10.1097/FPC.0b013e32835ea0b2; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Irie M, 2012, J INT MED RES, V40, P924, DOI 10.1177/147323001204000311; Jagarinec N, 1998, CLIN CHEM LAB MED, V36, P327, DOI 10.1515/CCLM.1998.055; Jankovic SM, 2010, INT J CLIN PHARM TH, V48, P767; Jiang DC, 2009, EUR J CLIN PHARMACOL, V65, P1187, DOI 10.1007/s00228-009-0712-x; Jiang SY, 2013, EXP CLIN CARDIOL, V18, P53; JIMENEZRODRIGUEZVILA M, 1986, INT J CLIN PHARM RES, V6, P217; Kariz S, 2012, DIABETES RES CLIN PR, V98, P144, DOI 10.1016/j.diabres.2012.07.003; Keizer RJ, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.24; Lioudaki E, 2011, CURR PHARM DESIGN, V17, P3632, DOI 10.2174/138161211798220945; Luef G, 2009, EPILEPSY RES, V86, P42, DOI 10.1016/j.eplepsyres.2009.04.004; Maiano C, 2011, OBES REV, V12, P189, DOI 10.1111/j.1467-789X.2010.00744.x; Nanau RM, 2013, CLIN BIOCHEM, V46, P1323, DOI 10.1016/j.clinbiochem.2013.06.012; Oniki K, 2013, TOXICOL LETT, V220, P143, DOI 10.1016/j.toxlet.2013.04.019; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Perucca E, 2006, BRIT J CLIN PHARMACO, V61, P246, DOI 10.1111/j.1365-2125.2005.02529.x; Petta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051165; Saruwatari J, 2014, THER DRUG MONIT, V36, P302, DOI 10.1097/FTD.0000000000000015; Saruwatari J, 2013, NEUROPSYCH DIS TREAT, V9, P1683, DOI 10.2147/NDT.S52585; Saruwataria J, 2012, EPILEPSY RES, V99, P183, DOI 10.1016/j.eplepsyres.2011.10.033; Suarez-Kurtz G, 2012, PHARMACOGENOMICS J, V12, P267, DOI 10.1038/tpj.2010.89; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; Tan L, 2010, CLIN NEUROL NEUROSUR, V112, P320, DOI 10.1016/j.clineuro.2010.01.002; Targher G, 2010, CLIN CHEM LAB MED, V48, P147, DOI 10.1515/CCLM.2010.031; Theis JGW, 1997, J CHILD NEUROL, V12, P208, DOI 10.1177/088307389701200311; Verrijken A, 2010, INT J OBESITY, V34, P899, DOI 10.1038/ijo.2010.4; Verrotti A, 2011, EPILEPSY BEHAV, V20, P382, DOI 10.1016/j.yebeh.2010.12.012; Wallach J.B., 1996, INTERPRETATION DIAGN, Vsixth; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227	41	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111066	10.1371/journal.pone.0111066	http://dx.doi.org/10.1371/journal.pone.0111066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372290	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900036
J	Socarras, TO; Vasconcelos, AC; Campos, PP; Pereira, NB; Souza, JPC; Andrade, SP				Oviedo Socarras, Teresa; Vasconcelos, Anilton C.; Campos, Paula P.; Pereira, Nubia B.; Souza, Jessica P. C.; Andrade, Silvia P.			Foreign Body Response to Subcutaneous Implants in Diabetic Rats	PLOS ONE			English	Article							INFLAMMATORY ANGIOGENESIS; GROWTH-FACTOR; MICE; MODEL; MECHANISMS; APOPTOSIS; MOUSE	Implantation of synthetic matrices and biomedical devices in diabetic individuals has become a common procedure to repair and/or replace biological tissues. However, an adverse foreign body reaction that invariably occurs adjacent to implant devices impairing their function is poorly characterized in the diabetic environment. We investigated the influence of this condition on the abnormal tissue healing response in implants placed subcutaneously in normoglycemic and streptozotocin-induced diabetes in rats. In polyether-polyurethane sponge discs removed 10 days after implantation, the components of the fibrovascular tissue (angiogenesis, inflammation, fibrogenesis, and apoptosis) were assessed. Intra-implant levels of hemoglobin and vascular endothelial growth factor were not different after diabetes when compared with normoglycemic counterparts. However, there were a lower number of vessels in the fibrovascular tissue from diabetic rats when compared with vessel numbers in implants from non-diabetic animals. Overall, the inflammatory parameters (neutrophil accumulation - myeloperoxidase activity, tumor necrosis factor alpha, and monocyte chemotactic protein-1 levels and mast cell counting) increased in subcutaneous implants after diabetes induction. However, macrophage activation (N-acetyl-beta-D-glucosaminidase activity) was lower in implants from diabetic rats when compared with those from normoglycemic animals. All fibrogenic markers (transforming growth factor beta 1 levels, collagen deposition, fibrous capsule thickness, and foreign body giant cells) decreased after diabetes, whereas apoptosis (TUNEL) increased. Our results showing that hyperglycemia down regulates the main features of the foreign body reaction induced by subcutaneous implants in rats may be relevant in understanding biomaterial integration and performance in diabetes.	[Oviedo Socarras, Teresa; Vasconcelos, Anilton C.; Campos, Paula P.; Pereira, Nubia B.; Souza, Jessica P. C.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil; [Oviedo Socarras, Teresa] Univ Cordoba, Dept Livestock Sci, Monteria, Cordoba, Colombia; [Andrade, Silvia P.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Campos, PP (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil.	paulapc@icb.ufmg.br	CAMPOS, PAULA PEIXOTO/N-9004-2019; Vasconcelos, Anilton ACV/L-9861-2014; Pereira, Nubia Braga/N-9381-2017	CAMPOS, PAULA PEIXOTO/0000-0003-2016-2210; Vasconcelos, Anilton ACV/0000-0001-6202-580X; Pereira, Nubia Braga/0000-0002-6714-3124	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq-processo [481659/2012-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq-processo	The work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq-processo no481659/2012-9 http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altavilla D, 2001, DIABETES, V50, P667, DOI 10.2337/diabetes.50.3.667; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1; Araujo FA, 2011, CLIN EXP PHARMACOL P, V38, P262, DOI 10.1111/j.1440-1681.2011.05496.x; Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4; BAILEY PJ, 1988, METHOD ENZYMOL, V162, P327; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Campos PP, 2006, HISTOL HISTOPATHOL, V21, P1263, DOI 10.14670/HH-21.1263; Campos PP, 2008, WOUND REPAIR REGEN, V16, P416, DOI 10.1111/j.1524-475X.2008.00381.x; Chatzigeorgiou A, 2010, ANN MED, V42, P426, DOI 10.3109/07853890.2010.495951; Darby IA, 1997, INT J BIOCHEM CELL B, V29, P191, DOI 10.1016/S1357-2725(96)00131-8; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Ferreira MAND, 2004, BRIT J PHARMACOL, V141, P1185, DOI 10.1038/sj.bjp.0705731; Gerritsen R, 2000, J MATER SCI-MATER M, V11, P499, DOI 10.1023/A:1008970108339; KAHN AM, 1993, HYPERTENSION, V22, P735, DOI 10.1161/01.HYP.22.5.735; KILZER P, 1985, DIABETES, V34, P333, DOI 10.2337/diabetes.34.4.333; Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399; Le Nga N, 2011, J Diabetes Sci Technol, V5, P605; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; Mendes JB, 2007, J BIOMED MATER RES B, V83B, P408, DOI 10.1002/jbm.b.30810; Mendes JB, 2009, MICROVASC RES, V78, P265, DOI 10.1016/j.mvr.2009.08.008; Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3; Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003; Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011; Rai N K, 2005, J Wound Care, V14, P277; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y; Thomson SE, 2010, DIABETOLOGIA, V53, P572, DOI 10.1007/s00125-009-1610-6; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	30	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110945	10.1371/journal.pone.0110945	http://dx.doi.org/10.1371/journal.pone.0110945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372281	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900027
J	Vossen, T; Towns, A; Ruysschaert, S; Quiroz, D; van Andel, T				Vossen, Tessa; Towns, Alexandra; Ruysschaert, Sofie; Quiroz, Diana; van Andel, Tinde			Consequences of the Trans-Atlantic Slave Trade on Medicinal Plant Selection: Plant Use for Cultural Bound Syndromes Affecting Children in Suriname and Western Africa	PLOS ONE			English	Article							SEXUAL ABSTINENCE; BULGING FONTANEL; HEALTH; CARE; DEFICIENCY; DIARRHEA; ILLNESS; SYMPTOM; BABY	Folk perceptions of health and illness include cultural bound syndromes (CBS), ailments generally confined to certain cultural groups or geographic regions and often treated with medicinal plants. Our aim was to compare definitions and plant use for CBS regarding child health in the context of the largest migration in recent human history: the trans-Atlantic slave trade. We compared definitions of four CBS (walk early, evil eye, atita and fontanels) and associated plant use among three Afro-Surinamese populations and their African ancestor groups in Ghana, Benin and Gabon. We expected plant use to be similar on species level, and assumed the majority to be weedy or domesticated species, as these occur on both continents and were probably recognized by enslaved Africans. Data were obtained by identifying plants mentioned during interviews with local women from the six different populations. To analyse differences and similarities in plant use we used Detrended Component Analysis (DCA) and a Wald Chi-square test. Definitions of the four cultural bound syndromes were roughly the same on both continents. In total, 324 plant species were used. There was little overlap between Suriname and Africa: 15 species were used on two continents, of which seven species were used for the same CBS. Correspondence on family level was much higher. Surinamese populations used significantly more weedy species than Africans, but equal percentages of domesticated plants. Our data indicate that Afro-Surinamers have searched for similar plants to treat their CBS as they remembered from Africa. In some cases, they have found the same species, but they had to reinvent the largest part of their herbal pharmacopeia to treat their CBS using known plant families or trying out new species. Ideas on health and illness appear to be more resilient than the use of plants to treat them.	[Vossen, Tessa] Leiden Univ, Leiden, Netherlands; [Towns, Alexandra; Quiroz, Diana; van Andel, Tinde] Leiden Univ, Nat Biodivers Ctr, Leiden, Netherlands; [Ruysschaert, Sofie] WWF Guianas, Paramaribo, Suriname; [Quiroz, Diana] Wageningen Univ, Biosystemat Grp, NL-6700 AP Wageningen, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; Wageningen University & Research	van Andel, T (corresponding author), Leiden Univ, Nat Biodivers Ctr, Leiden, Netherlands.	tinde.vanandel@naturalis.nl		Towns, Alexandra/0000-0002-1886-9447	Netherlands Organization for Scientific Research (NWO): ALW-Vidi [864.09.007]; Alberta Mennega Foundation; van Eeden Fund	Netherlands Organization for Scientific Research (NWO): ALW-Vidi(Netherlands Organization for Scientific Research (NWO)); Alberta Mennega Foundation; van Eeden Fund	This research was financed by the Netherlands Organization for Scientific Research (NWO): ALW-Vidi grant #864.09.007, the Alberta Mennega Foundation and the van Eeden Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEOKUN LA, 1982, AFRICA, V52, P1, DOI 10.2307/1160091; Akoegninou A, 2006, FLORE ANAL BENIN, DOI DOI 10.1007/s11056-010-9214-z; Algemeen Bureau voor de Statistiek, 2005, ZEV ALG VOLKS WON SU, VI; [Anonymous], 1990, USEFUL PLANTS GHANA; Apostolides A, 2008, HTS TEOL STUD-THEOL, V64, P1021; BASS MH, 1961, NEUROLOGY, V11, P1091, DOI 10.1212/WNL.11.12.1091; Baxerres C, 2012, RIM, V4, P14; Bazzano AN, 2008, TROP MED INT HEALTH, V13, P123, DOI 10.1111/j.1365-3156.2007.01981.x; BLEEK W, 1976, SOC SCI MED, V10, P225, DOI 10.1016/0037-7856(76)90003-2; BOWER BD, 1964, BRIT MED J, V2, P1577, DOI 10.1136/bmj.2.5424.1577; Brav A, 1981, EVIL EYE CASEBOOK, P44; Burkill H, 1985, USEFUL PLANTS W TROP, V1; Dahlberg CG, 1771, CATALOGUS VLESSEN VA; de Medeiros PM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/807452; Desgrees-du-Lou A, 2005, REPROD HEALTH MATTER, V13, P155, DOI 10.1016/S0968-8080(05)25167-4; Donaldson Bess Allen, 1938, WILD RUE STUDY MUHAM; Dundes Alan, 1981, EVIL EYE CASEBOOK; Elliott John H., 1992, BIBLICAL THEOLOGY B, V22, P52, DOI DOI 10.1177/014610799202200203; Eltis D., 2010, ATLAS TRANSATLANTIC; FIELDS JP, 1961, J PEDIATR-US, V58, P74, DOI 10.1016/S0022-3476(61)80061-9; Foster G.M., 1953, J AM FOLKLORE, V66, P2101, DOI [DOI 10.2307/537230, 10.2307/537230]; Funk V., 2007, CHECKLIST PLANTS GUI; Gottlieb Alma, 2004, AFTERLIFE IS WE COME; Guarnaschelli J, 1972, JAMA-J AM MED ASSOC, V222, P1546; Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6; Helman CG, 2007, CULTURE HLTH ILLNESS; HUDELSON PM, 1993, SOC SCI MED, V37, P97, DOI 10.1016/0277-9536(93)90322-U; Idehen CO, 2007, J PAN AFRICAN STUDIE, V1, P114; International Society of Ethnobiology (ISE), ISE COD ETH; Irvine FR, 1961, WOODY PLANTS GHANA S; Jelliffe D B, 1972, J Trop Pediatr Environ Child Health, V18, P25; KRAJEWSKIJAIME ER, 1991, CHILD WELFARE, V70, P157; Lanjouw J, 1935, W INDISCHE GIDS, V17, P173; LOCKWOOD M, 1995, POPUL DEV REV, V21, P1, DOI 10.2307/2137411; LONGE AC, 1984, ACTA PAEDIATR SCAND, V73, P477, DOI 10.1111/j.1651-2227.1984.tb09958.x; Martinez GJ, 2008, MIDWIFERY, V24, P490, DOI 10.1016/j.midw.2006.12.011; MCCLURE SA, 1982, ECON BOT, V36, P291, DOI 10.1007/BF02858552; Moret E. S., 2012, AFRICAN ETHNOBOTANY, P217, DOI DOI 10.1007/978-1-4614-0836-9_9; Mshana N.R., 2000, TRADITIONAL MED PHAR; NEALE G, 1965, BRIT MED J, V2, P1223, DOI 10.1136/bmj.2.5472.1223; Price R, 1976, GUIANA MAROONS HIST; Quiroz D, 2014, J ETHNOPHARMACOL, V151, P1100, DOI 10.1016/j.jep.2013.12.019; REHM S, 1991, CULTIVATED PLANTS TR; RISSER AL, 1995, ARCH PEDIAT ADOL MED, V149, P978, DOI 10.1001/archpedi.1995.02170220044006; De Moraes PLR, 2012, PHYTOTAXA, V41, P1; RUBEL AJ, 1964, ETHNOLOGY, V3, P268, DOI 10.2307/3772883; Ruysschaert S, 2009, J ETHNOPHARMACOL, V121, P148, DOI 10.1016/j.jep.2008.10.020; Sosef MSM, 2006, SCRIPTA BOT BELGICA, V35; Stephen H. J., 1998, WINTI CULTURE MYSTER; Thorne R.F., 1973, TROPICAL FOREST ECOS, P27; Ticktin T, 2005, J ETHNOPHARMACOL, V96, P233, DOI 10.1016/j.jep.2004.09.015; Towns AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105972; Towns AM, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-42; VAN ANDEL T.R., 2011, MEDICINALE RITUELE P; van Andel T, 2012, J ETHNOPHARMACOL, V143, P840, DOI 10.1016/j.jep.2012.08.008; van Andel T, 2012, TAXON, V61, P852, DOI 10.1002/tax.614010; van Andel T, 2012, J ETHNOPHARMACOL, V140, P368, DOI 10.1016/j.jep.2012.01.028; Van der Pijl Y, 2007, BRONNEN STUDIE SURIN, V27; Voeks, 2013, AFRICAN ETHNOBOTANY, DOI 10.1007/978-1-4614-0836-9; Voeks R., 2009, MOBILITY MIGRATION I, P275; Voeks RA, 2004, ANN ASSOC AM GEOGR, V94, P868; Vossen TE, 2013, THESIS LEIDEN U; WEISS MG, 1988, SOC SCI MED, V27, P5, DOI 10.1016/0277-9536(88)90159-1; Wooding CJ, 1979, ISSUE J OPINION, V9, P35; YAP PM, 1967, AUST NZ J PSYCHIAT, V1, P172, DOI 10.3109/00048676709159191; Zulu EM, 2001, DEMOGRAPHY, V38, P467, DOI 10.1353/dem.2001.0042	66	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112345	10.1371/journal.pone.0112345	http://dx.doi.org/10.1371/journal.pone.0112345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372485	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900137
J	Wang, XH; Cai, L; Yu, RJ; Huang, WZ; Zong, ZY				Wang, Xiaohui; Cai, Lin; Yu, Rujia; Huang, Wenzhi; Zong, Zhiyong			ICU-Onset Clostridium difficile Infection in a University Hospital in China: A Prospective Cohort Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; EPIDEMIOLOGY; COLONIZATION; MORTALITY	A prospective study was conducted to investigate the incidence, clinical profiles and outcome of ICU-onset CDI in a 50-bed medical ICU at a university hospital in China. Stools were collected from patients who developed ICU-onset diarrhea and was screened for tcdA (toxin A gene) and tcdB (toxin B gene) by PCR. CDI cases were compared with the ICU-onset non-CDI diarrhea cases for demographics, comorbidities, potential risk factors, major laboratory findings and outcomes. Stool samples from CDI cases were subjected to C. difficile culture and C. difficile isolates were screened for tcdA, tcdB and the binary toxin genes (cdtA and cdtB) using multiplex PCR. Strain typing of toxigenic C. difficile isolates was performed using multilocus sequence typing. There were 1,277 patients in the ICU during the study period and 124 (9.7%) developed ICU-onset diarrhea, of which 31 patients had CDI. The incidence of ICU-onset CDI was 25.2 cases per 10,000 ICU days. ICU-onset CDI cases had similar features with ICU-onset non-CDI diarrhea cases including the use of proton pump inhibitors and antibacterial agents. The crude mortality rate of ICU-onset CDI was 22.6%, but the attributable mortality rate of ICU-onset CDI was only 3.2% here. Toxigenic C. difficile isolates were recovered from 28 out of the 31 patients with CDI. cdtA and cdtB were found in two strains. Seventeen STs including 11 new STs were identified. All of the 11 new STs were single-locus variants of known STs and the 17 STs identified here could be clustered into 3 clades. The incidence of ICU-onset CDI here is similar to those in Europe and North America, suggesting that CDI is likely to be a common problem in China. Toxigenic C. difficile here belonged to a variety of STs, which may represent a significant clonal expansion rather than the true clonal diversity.	[Wang, Xiaohui; Yu, Rujia; Zong, Zhiyong] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China; [Wang, Xiaohui; Yu, Rujia; Zong, Zhiyong] Div Infect Dis, State Key Lab Biotherapy, Chengdu, Peoples R China; [Cai, Lin] Sichuan Univ, West China Hosp, Dept Intens Care Unit, Chengdu 610064, Peoples R China; [Huang, Wenzhi; Zong, Zhiyong] Sichuan Univ, West China Hosp, Dept Infect Control, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Zong, ZY (corresponding author), Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China.	zongzhiy@scu.edu.cn	Wang, Xiaohui/X-3814-2019	, Xiaohui/0000-0003-2780-2823; ZONG, ZHIYONG/0000-0002-7675-260X	Technology support program of Sichuan provincial Science and Technology Agency, China [2011FZ0111]	Technology support program of Sichuan provincial Science and Technology Agency, China	The work was supported by the Technology support program of Sichuan provincial Science and Technology Agency, China (project no. 2011FZ0111). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2008, J INFECTION, V57, P435, DOI 10.1016/j.jinf.2008.10.002; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Bobo LD, 2011, CHEST, V140, P1643, DOI 10.1378/chest.11-0556; Chen YB, 2013, J MED MICROBIOL; Dodek PM, 2013, J CRIT CARE, V28, P335, DOI 10.1016/j.jcrc.2012.11.008; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Huang H, 2011, CHIN J INFECT CHEMOT, V11, P1; Jin K, 2010, J BIOMED RES, V24, P411, DOI 10.1016/S1674-8301(10)60055-3; Lawrence SJ, 2007, INFECT CONT HOSP EP, V28, P123, DOI 10.1086/511793; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Micek ST, 2013, CRIT CARE MED, V41, P1968, DOI 10.1097/CCM.0b013e31828a40d5; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Morrison RH, 2011, CLIN INFECT DIS, V53, P1173, DOI 10.1093/cid/cir668; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Wang P, 2014, INFECT CONT HOSP EP, V35, P95, DOI 10.1086/674405; Yan Q, 2013, EPIDEMIOL INFECT, V141, P195, DOI 10.1017/S0950268812000453; Zahar JR, 2012, CRIT CARE, V16, DOI 10.1186/cc11852	21	23	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111735	10.1371/journal.pone.0111735	http://dx.doi.org/10.1371/journal.pone.0111735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372033	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900070
J	Yang, HK; Choi, JY; Kim, DH; Hwang, JM				Yang, Hee Kyung; Choi, Jung Yeon; Kim, Dae Hyun; Hwang, Jeong-Min			Changes in Refractive Errors Related to Spectacle Correction of Hyperopia	PLOS ONE			English	Article							CHILDREN; EMMETROPIZATION; CHILDHOOD; INFANTS; MYOPIA	Background: Hyperopic undercorrection is a common clinical practice. However, less is known of its effect on the change in refractive errors and emmetropization throughout the later years of childhood. Objectives: To evaluate the effect of spectacle correction on the change in refractive errors in hyperopic children less than 12 years of age with or without strabismus. Data Extraction: A retrospective cohort study was performed by a computer based search of the hospital database of patients with hyperopia, accommodative esotropia or exotropia. A total of 150 hyperopic children under 12 years of age were included. Patients were classified into four groups: 1) accommodative esotropia with full correction of hyperopia, 2) exotropia with undercorrection of hyperopia, 3) orthotropia with full correction of hyperopia, 4) orthotropia with undercorrection of hyperopia. The 4 groups were matched by initial age on examination and spherical equivalent refractive errors (SER). The main outcome measure was the change in SER (Diopter/year) in both eyes after two years of follow-up. Results: An overall negative shift in SER was noted during the follow-up period in all groups, except for the group with esotropia and full correction. The mean negative shift of hyperopia was more rapid in groups receiving undercorrection of hyperopia with or without strabismus. The amount of undercorrection of hyperopia was positively correlated to the magnitude of decrease in hyperopia in all patients (r = 0.289, P<0.001) and in the subgroup of patients with orthotropia (r = 0.304, P = 0.011). The amount of undercorrection of hyperopia was the only factor associated with a more negative shift in SER (OR, 2.414; 95% CI, 1.202-4.849; P = 0.013). Conclusions: The amount of undercorrection is significantly correlated to the change in hyperopic refractive errors. Full correction of hyperopia may inhibit emmetropization during early and late childhood.	[Yang, Hee Kyung; Choi, Jung Yeon; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea; [Kim, Dae Hyun] Chosun Univ, Chosun Univ Hosp, Coll Med, Dept Ophthalmol, Kwangju, South Korea	Seoul National University (SNU); Chosun University	Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea.	hjm@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2010606]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A2010606). The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson J, 2000, INVEST OPHTH VIS SCI, V41, P3726; Black Bradley Charles, 2006, Trans Am Ophthalmol Soc, V104, P303; Chung SA, 2011, J PEDIAT OPHTH STRAB, V48, P278, DOI 10.3928/01913913-20101217-01; Cotter SA, 2007, OPTOMETRY VISION SCI, V84, P103, DOI 10.1097/OPX.0b013e318031b08a; de Paula JS, 2009, ARQ BRAS OFTALMOL, V72, P751, DOI 10.1590/S0004-27492009000600002; Dirani M, 2006, INVEST OPHTH VIS SCI, V47, P4756, DOI 10.1167/iovs.06-0270; Donahue SP, 2007, OPTOMETRY VISION SCI, V84, P110, DOI 10.1097/OPX.0b013e318031b09b; Ekdawi NS, 2010, AM J OPHTHALMOL, V149, P503, DOI 10.1016/j.ajo.2009.10.009; Ingram RM, 2000, BRIT J OPHTHALMOL, V84, P324, DOI 10.1136/bjo.84.3.324; Khan Arif O, 2009, Binocul Vis Strabismus Q, V24, P151; Kulp MT, 2012, AM J OPHTHALMOL, V154, P297, DOI 10.1016/j.ajo.2012.02.035; Kushner BJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P638; Lambert SR, 2006, BRIT J OPHTHALMOL, V90, P357, DOI 10.1136/bjo.2005.078105; Leat SJ, 2011, OPTOMETRY VISION SCI, V88, P1333, DOI 10.1097/OPX.0b013e31822f4b9c; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; Mutti DO, 2007, OPTOMETRY VISION SCI, V84, P97, DOI 10.1097/OPX.0b013e318031b079; Park KA, 2010, OPHTHALMOLOGY, V117, P2196, DOI 10.1016/j.ophtha.2010.02.019; Rah SH, 1997, J KOREAN OPHTHALMOL, V38, P2195; Robaei D, 2005, OPHTHALMOLOGY, V112, P1275, DOI 10.1016/j.ophtha.2005.01.052; Smith EL, 1999, OPHTHAL PHYSL OPT, V19, P90, DOI 10.1046/j.1475-1313.1999.00429.x; TROILO D, 1991, VISION RES, V31, P1237, DOI 10.1016/0042-6989(91)90048-A; Wildsoet CF, 1997, OPHTHAL PHYSL OPT, V17, P279, DOI 10.1111/j.1475-1313.1997.tb00059.x	22	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110663	10.1371/journal.pone.0110663	http://dx.doi.org/10.1371/journal.pone.0110663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372594	Green Submitted, gold, Green Published			2022-12-26	WOS:000344556900021
J	Zhang, T; Chen, HM; Liang, SS; Chen, DC; Zheng, CX; Zeng, CH; Zhang, HT; Liu, ZH				Zhang, Tao; Chen, Huimei; Liang, Shaoshan; Chen, Dacheng; Zheng, Chunxia; Zeng, Caihong; Zhang, Haitao; Liu, Zhihong			A Non-Invasive Laboratory Panel as a Diagnostic and Prognostic Biomarker for Thrombotic Microangiopathy: Development and Application in a Chinese Cohort Study	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; VON-WILLEBRAND-FACTOR; THROMBOCYTOPENIC PURPURA; ADAMTS13 ACTIVITY; KIDNEY-TRANSPLANTATION; PLATELET COUNT; FEATURES; OUTCOMES; DISEASE	Background: Thrombotic microangiopathy (TMA) in the kidney is a histopathologic lesion that occurs in a number of clinical settings and is often associated with poor renal prognosis. The standard test for the diagnosis of TMA is the renal biopsy; noninvasive parameters such as potential biomarkers have not been developed. Methods: We analyzed routine parameters in a cohort of 220 patients with suspected TMA and developed a diagnostic laboratory panel by logistic regression. The levels of candidate markers were validated using an independent cohort (n = 46), a cohort of systemic lupus erythematosus (SLE) (n = 157) and an expanded cohort (n = 113), as well as 9 patients with repeat biopsies. Results: Of the 220 patients in the derivation cohort, 51 patients with biopsy-proven TMA presented with a worse renal prognosis than those with no TMA (P = 0.002). Platelet and L-lactate dehydrogenase (LDH) levels showed an acceptable diagnostic value of TMA (AUC = 0.739 and 0.756, respectively). A panel of 4 variables - creatinine, platelets, ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats 13) activity and LDH - can effectively discriminate patients with TMA (AUC = 0.800). In the validation cohort, the platelet and LDH levels and the 4-variable panel signature robustly distinguished patients with TMA. The discrimination effects of these three markers were confirmed in patients with SLE. Moreover, LDH levels and the 4-variable panel signature also showed discrimination values in an expanded set. Among patients undergoing repeat biopsy, increased LDH levels and panel signatures were associated with TMA status when paired evaluations were performed. Importantly, only the 4-variable panel was an independent prognostic marker for renal outcome (hazard ratio = 3.549; P, 0.001). Conclusions: The noninvasive laboratory diagnostic panel is better for the early detection and prognosis of TMA compared with a single parameter, and may provide a promising biomarker for clinical application.	[Zhang, Tao; Chen, Huimei; Liang, Shaoshan; Chen, Dacheng; Zheng, Chunxia; Zeng, Caihong; Zhang, Haitao; Liu, Zhihong] Nanjing Univ, Jinling Hosp, Sch Med, Natl Clin Res Ctr Kidney Dis, Nanjing 210002, Jiangsu, Peoples R China; [Chen, Huimei] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Chen, HM (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Natl Clin Res Ctr Kidney Dis, Nanjing 210002, Jiangsu, Peoples R China.	chenhuimei@nju.edu.cn; liuzhihong@nju.edu.cn		Liu, Zhi-Hong/0000-0001-6093-0726; Chen, Huimei/0000-0001-7788-1334	National Basic Research Program of China 973 Program [2012CB517600, 2012CB517606]; National Natural Science Foundation (NSF) [81370788]; National Key Technology R D Program [2011BAI10B04]; Six Talent Peaks Project of Jiangsu Province [2012- SN-071]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation (NSF)(National Natural Science Foundation of China (NSFC)); National Key Technology R D Program(National Key Technology R&D Program); Six Talent Peaks Project of Jiangsu Province	This work was supported in part by National Basic Research Program of China 973 Program No.2012CB517600 (No.2012CB517606) (to Z.L.)(http://www. 973.gov.cn/AreaMana.aspx), National Natural Science Foundation (NSF) Grant 81370788 (to H.C.) (http://www.nsfc.gov.cn/),The National Key Technology R& D Program (2011BAI10B04) (to Z.L.) (http://kjzc.jhgl.org/) and Six Talent Peaks Project of Jiangsu Province (2012- SN-071) (to H.C.) (http://archives.nuist.edu.cn/rcgf/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Baliga RS, 2003, AM J MED SCI, V326, P378, DOI 10.1097/00000441-200312000-00015; Cataland SR, 2012, BRIT J HAEMATOL, V157, P501, DOI 10.1111/j.1365-2141.2012.09032.x; Cataland SR, 2009, EUR J HAEMATOL, V83, P559, DOI 10.1111/j.1600-0609.2009.01331.x; Clark WF, 2012, SEMIN DIALYSIS, V25, P214, DOI 10.1111/j.1525-139X.2011.01035.x; Cohen JA, 1998, J CLIN APHERESIS, V13, P16, DOI 10.1002/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C; DANGELO WA, 1969, AM J MED, V46, P428, DOI 10.1016/0002-9343(69)90044-8; Droz D, 2000, Adv Nephrol Necker Hosp, V30, P235; El Karoui K, 2012, J AM SOC NEPHROL, V23, P137, DOI 10.1681/ASN.2010111130; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Galbusera M, 1999, BLOOD, V94, P610, DOI 10.1182/blood.V94.2.610.414k22_610_620; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; George JN, 2007, SOUTH MED J, V100, P512, DOI 10.1097/SMJ.0b013e318046583f; George JN, 2006, NEW ENGL J MED, V354, P1927, DOI 10.1056/NEJMcp053024; Goldberg RJ, 2010, AM J KIDNEY DIS, V56, P1168, DOI 10.1053/j.ajkd.2010.06.006; Hastings MC, 2007, PEDIATR NEPHROL, V22, P742, DOI 10.1007/s00467-006-0392-z; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hu WX, 2010, LUPUS, V19, P1591, DOI 10.1177/0961203310376523; HUGHSON MD, 1992, AM J KIDNEY DIS, V20, P150, DOI 10.1016/S0272-6386(12)80543-9; Kaplan B, 2002, AM J TRANSPLANT, V2, P970, DOI 10.1034/j.1600-6143.2002.21015.x; Laurence J, 2000, LANCET, V355, P497, DOI 10.1016/S0140-6736(00)82052-8; Michael M, 2009, AM J KIDNEY DIS, V53, P259, DOI 10.1053/j.ajkd.2008.07.038; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Noris M, 2010, AM J TRANSPLANT, V10, P1517, DOI 10.1111/j.1600-6143.2010.03156.x; Park YA, 2010, AM J CLIN PATHOL, V133, P460, DOI 10.1309/AJCPPNF63FLIORCI; Peng JH, 2011, MOLECULES, V16, P10709, DOI 10.3390/molecules161210709; Reynolds JC, 2003, AM J KIDNEY DIS, V42, P1058, DOI 10.1016/j.ajkd.2003.07.008; Stiles KP, 2000, AM J KIDNEY DIS, V36, P419, DOI 10.1053/ajkd.2000.8998; SYMMERS WS, 1952, BRIT MED J, V2, P897, DOI 10.1136/bmj.2.4790.897; van den Born BJH, 2008, HYPERTENSION, V51, P862, DOI 10.1161/HYPERTENSIONAHA.107.103127; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193; White LE, 2012, SHOCK, V38, P320, DOI 10.1097/SHK.0b013e31826359d0	33	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111992	10.1371/journal.pone.0111992	http://dx.doi.org/10.1371/journal.pone.0111992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372665	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900103
J	Schoeneberger, H; Belz, K; Schenk, B; Fulda, S				Schoeneberger, H.; Belz, K.; Schenk, B.; Fulda, S.			Impairment of antioxidant defense via glutathione depletion sensitizes acute lymphoblastic leukemia cells for Smac mimetic-induced cell death	ONCOGENE			English	Article							INHIBITOR-MEDIATED SENSITIZATION; KAPPA-B ACTIVATION; APOPTOSIS PROTEINS; BUTHIONINE SULFOXIMINE; MOLECULAR PATHWAYS; LIPID-PEROXIDATION; POTENT INHIBITORS; OXIDATIVE STRESS; REACTIVE OXYGEN; IAP PROTEINS	Evasion of apoptosis in pediatric acute lymphoblastic leukemia (ALL) is linked to aberrant expression of inhibitor of apoptosis (IAP) proteins and dysregulated redox homeostasis, rendering leukemic cells vulnerable to redox-targeting therapies. Here we discover that inhibition of antioxidant defenses via glutathione (GSH) depletion by buthionine sulfoximine (BSO) primes ALL cells for apoptosis induced by the Smac mimetic BV6 that antagonizes IAP proteins. Similarly, BSO cooperates with BV6 to induce cell death in patient-derived primary leukemic samples, underscoring the clinical relevance. In contrast, BSO does not sensitize non-malignant lymphohematopoietic cells from healthy donors toward BV6, pointing to some tumor selectivity. Mechanistically, both agents cooperate to stimulate reactive oxygen species (ROS) production, which is required for BSO/BV6-induced cell death, as ROS inhibitors (that is, N-acetylcysteine, MnTBAP, Trolox) significantly rescue cell death. Further, BSO and BV6 cooperate to trigger lipid peroxidation, which is necessary for cell death, as genetic or pharmacological blockage of lipid peroxidation by GSH peroxidase 4 (GPX4) overexpression or a-tocopherol significantly inhibits BSO/BV6-mediated cell death. Consistently, GPX4 knockdown or GPX4 inhibitor RSL3 enhances lipid peroxidation and cell death by BSO/BV6 cotreatment. The discovery of redox regulation of Smac mimetic-induced cell death has important implications for developing rational Smac mimetic-based combination therapies.	[Schoeneberger, H.; Belz, K.; Schenk, B.; Fulda, S.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany	Goethe University Frankfurt	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3a, D-60528 Frankfurt, Germany.	simone.fulda@kgu.de		Fulda, Simone/0000-0002-0459-6417	Deutsche Forschungsgemeinschaft; IUAP VII	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IUAP VII	We thank D Vucic (Genentech Inc., South San Francisco, CA) for providing BV6, R Brigelius-Flohe for providing the GPX4 vector, T Klingebiel and S Wehner for providing ALL samples, J Leibacher for providing MSCs, PF Angeli and M Conrad for helpful discussions and C Hugenberg for expert secretarial assistance. This work has been partially supported by grants from the Deutsche Forschungsgemeinschaft and IUAP VII (to SF).	Abhari BA, 2013, ONCOGENE, V32, P3263, DOI 10.1038/onc.2012.337; Bailey HH, 1997, J NATL CANCER I, V89, P1789, DOI 10.1093/jnci/89.23.1789; Basit F, 2012, J BIOL CHEM, V287, P38767, DOI 10.1074/jbc.M112.398966; Belz K, 2014, BLOOD, V124, P240, DOI 10.1182/blood-2013-05-500918; Brigelius-Flohe R, 1997, BIOCHEM J, V328, P199, DOI 10.1042/bj3280199; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Caglikulekci M, 2006, J INVEST SURG, V19, P175, DOI 10.1080/08941930600674702; Chen D, 2006, CANCER RES, V66, P11416, DOI 10.1158/0008-5472.CAN-06-0409; CHOU TC, 1980, CARCINOGENESIS, V1, P203, DOI 10.1093/carcin/1.3.203; Curtis J, 2001, HEMAT BLOOD, V40, P257; DAVIES MJ, 1988, BIOCHEM J, V255, P513; Day BJ, 1999, FREE RADICAL BIO MED, V26, P730, DOI 10.1016/S0891-5849(98)00261-5; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Eckhardt I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.457; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Franco R, 2008, J BIOL CHEM, V283, P36071, DOI 10.1074/jbc.M807061200; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2014, LEUKEMIA, V28, P1414, DOI 10.1038/leu.2014.56; Fulda S, 2000, BLOOD, V95, P301, DOI 10.1182/blood.V95.1.301.001k24_301_308; Fulda S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00003; Fulda S, 2014, CLIN CANCER RES, V20, P289, DOI 10.1158/1078-0432.CCR-13-0227; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Fulda S, 2009, BRIT J HAEMATOL, V145, P441, DOI 10.1111/j.1365-2141.2009.07603.x; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hundsdoerfer P, 2010, PEDIATR BLOOD CANCER, V55, P260, DOI 10.1002/pbc.22541; Irwin ME, 2013, ANTIOXID REDOX SIGN, V18, P1349, DOI 10.1089/ars.2011.4258; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kearns PR, 2001, BLOOD, V97, P393, DOI 10.1182/blood.V97.2.393; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Latchoumycandane C, 2012, J BIOL CHEM, V287, P17693, DOI 10.1074/jbc.M111.300012; Loder S, 2012, LEUKEMIA, V26, P1020, DOI 10.1038/leu.2011.353; MAUNG ZT, 1994, LEUKEMIA, V8, P1487; Naguib YMA, 1998, ANAL BIOCHEM, V265, P290, DOI 10.1006/abio.1998.2931; Ni Y, 2012, CLIN CANCER RES, V18, P4954, DOI 10.1158/1078-0432.CCR-12-1055; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Repetto M, 2012, LIPID PEROXIDATION, P3, DOI 10.5772/45943; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Stanulla M, 2009, SEMIN HEMATOL, V46, P52, DOI 10.1053/j.seminhematol.2008.09.007; Tamm I, 2004, CLIN CANCER RES, V10, P3737, DOI 10.1158/1078-0432.CCR-03-0642; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wuchter C, 2004, HAEMATOLOGICA, V89, P363; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010	59	27	29	0	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	31					4032	4043		10.1038/onc.2014.338	http://dx.doi.org/10.1038/onc.2014.338			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CN9PE	25381820				2022-12-26	WOS:000358780500002
J	Cutting, AS; Del Rosario, Y; Mu, R; Rodriguez, A; Till, A; Subramani, S; Gottlieb, RA; Doran, KS				Cutting, Andrew S.; Del Rosario, Yvette; Mu, Rong; Rodriguez, Anthony; Till, Andreas; Subramani, Suresh; Gottlieb, Roberta A.; Doran, Kelly S.			The Role of Autophagy during Group B Streptococcus Infection of Blood-Brain Barrier Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG EPITHELIAL-CELLS; GROUP-A STREPTOCOCCUS; BETA-HEMOLYSIN/CYTOLYSIN; STAPHYLOCOCCUS-AUREUS; LC3-ASSOCIATED PHAGOCYTOSIS; INTRACELLULAR BACTERIA; TRANSGENIC MICE; INVASION; PROTEIN; IMMUNITY	Bacterial meningitis occurs when bloodborne pathogens invade and penetrate the blood-brain barrier (BBB), provoking inflammation and disease. Group B Streptococcus (GBS), the leading cause of neonatal meningitis, can enter human brain microvascular endothelial cells (hBMECs), but the host response to intracellular GBS has not been characterized. Here we sought to determine whether antibacterial autophagy, which involves selective recognition of intracellular organisms and their targeting to autophagosomes for degradation, is activated in BBB endothelium during bacterial infection. GBS infection resulted in increased punctate distribution of GFP-microtubule- associated protein 1 light chain 3 (LC3) and increased levels of endogenous LC3-II and p62 turnover, two hallmark indicators of active autophagic flux. Infection with GBS mutants revealed that bacterial invasion and the GBS pore-forming beta-hemolysin/cytolysin (beta-h/c) trigger autophagic activation. Cell-free bacterial extracts containing beta-h/c activity induced LC3-II conversion, identifying this toxin as a principal provocative factor for autophagy activation. These results were confirmed in vivo using a mouse model of GBS meningitis as infection with WT GBS induced autophagy in brain tissue more frequently than a beta-h/c-deficient mutant. Elimination of autophagy using Atg5-deficient fibroblasts or siRNA-mediated impairment of autophagy in hBMECs led to increased recovery of intracellular GBS. However, electron microscopy revealed that GBS was rarely found within double membrane autophagic structures even though we observed GBS-LC3 co-localization. These results suggest that although autophagy may act as a BBB cellular defense mechanism in response to invading and toxin-producing bacteria, GBS may actively thwart the autophagic pathway.	[Cutting, Andrew S.; Del Rosario, Yvette; Mu, Rong; Rodriguez, Anthony; Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Gottlieb, Roberta A.] San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA; [Till, Andreas; Subramani, Suresh] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Till, Andreas; Subramani, Suresh] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Till, Andreas] Univ Bonn, Life & Brain Ctr, Stem Cell Pathol Grp, D-53127 Bonn, Germany; [Doran, Kelly S.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Bonn; University of California System; University of California San Diego	Doran, KS (corresponding author), San Diego State Univ, Dept Biol, 5500 Campanile Dr,NLS 317, San Diego, CA 92182 USA.	kdoran@mail.sdsu.edu	Till, Andreas/AAO-6375-2021; Till, Andreas/E-9661-2013	Till, Andreas/0000-0002-0139-9143	National Institutes of Health [GM069373, R01-NS051247]; NINDS; seed grant from the San Diego Center for Systems Biology [GM085764]; Rees-Stealy Research Foundation/San Diego State University Heart Institute fellowship; Deutsche Forschungsgemeinschaft (German Research Foundation) [Ti-640 1-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, R01GM069373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); seed grant from the San Diego Center for Systems Biology; Rees-Stealy Research Foundation/San Diego State University Heart Institute fellowship; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069373 (to S. S.), R01-NS051247 and associated supplement from the NINDS (to A. R. and K. S. D.), and GM085764, a seed grant from the San Diego Center for Systems Biology (to A. T. and S. S.). This work was also supported by a Rees-Stealy Research Foundation/San Diego State University Heart Institute fellowship (to A. S. C.) and Deutsche Forschungsgemeinschaft (German Research Foundation) Fellowship Ti-640 1-1.	Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Barnett TC, 2013, CELL HOST MICROBE, V14, P675, DOI 10.1016/j.chom.2013.11.003; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; BETZ AL, 1986, ANNU REV PHYSIOL, V48, P241; BETZ AL, 1985, FED PROC, V44, P2614; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Cai Z, 2012, J NEUROSCI RES, V90, P1105, DOI 10.1002/jnr.23011; CATALDI A, 1990, MOL MICROBIOL, V4, P1111, DOI 10.1111/j.1365-2958.1990.tb00685.x; Lerena MC, 2011, CELL MICROBIOL, V13, P814, DOI 10.1111/j.1462-5822.2011.01581.x; Chang YC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002082; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Doran KS, 2002, J INFECT DIS, V185, P196, DOI 10.1086/338475; Duclos S, 2000, CELL MICROBIOL, V2, P365, DOI 10.1046/j.1462-5822.2000.00066.x; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Ebrahimi CM, 2011, INFECT IMMUN, V79, P2510, DOI 10.1128/IAI.00006-11; Ebrahimi CM, 2009, J BACTERIOL, V191, P7165, DOI 10.1128/JB.00903-09; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gong L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017852; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Huang J, 2009, CURR TOP MICROBIOL, V335, P189, DOI 10.1007/978-3-642-00302-8_9; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Knodler LA, 2011, CELL MICROBIOL, V13, P1319, DOI 10.1111/j.1462-5822.2011.01632.x; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lai Shu-Chin, 2012, Cells, V1, P396, DOI 10.3390/cells1030396; Lembo A, 2010, MOL MICROBIOL, V77, P431, DOI 10.1111/j.1365-2958.2010.07215.x; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li XL, 2013, INFECT IMMUN, V81, P271, DOI 10.1128/IAI.00834-12; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Mehta P, 2014, CURR OPIN IMMUNOL, V26, P69, DOI 10.1016/j.coi.2013.10.012; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Mostowy S, 2013, CELL MICROBIOL, V15, P395, DOI 10.1111/cmi.12063; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; O'Seaghdha M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003394; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; PATTEE PA, 1981, J BACTERIOL, V145, P479, DOI 10.1128/JB.145.1.479-488.1981; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Romao S, 2014, AUTOPHAGY, V10, P526, DOI 10.4161/auto.27606; Sagar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060160; Sakurai A, 2010, J BIOL CHEM, V285, P22666, DOI 10.1074/jbc.M109.100131; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; Sheen TR, 2010, J MOL MED, V88, P633, DOI 10.1007/s00109-010-0630-5; Stins MF, 1997, IN VITRO CELL DEV-AN, V33, P243; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Whidbey C, 2013, J EXP MED, V210, P1265, DOI 10.1084/jem.20122753; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183; WILSON CB, 1985, J INFECT DIS, V152, P323, DOI 10.1093/infdis/152.2.323; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yitzhaki S, 2009, BASIC RES CARDIOL, V104, P157, DOI 10.1007/s00395-009-0006-6; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	81	43	45	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35711	35723		10.1074/jbc.M114.588657	http://dx.doi.org/10.1074/jbc.M114.588657			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25371213	Green Published, hybrid			2022-12-26	WOS:000346897900004
J	Yamaguchi, S; Tanimoto, A; Otsuguro, K; Hibino, H; Ito, S				Yamaguchi, Soichiro; Tanimoto, Akira; Otsuguro, Ken-ichi; Hibino, Hiroshi; Ito, Shigeo			Negatively Charged Amino Acids Near and in Transient Receptor Potential (TRP) Domain of TRPM4 Channel Are One Determinant of Its Ca2+ Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Electrophysiology; Ion Channel; Manganese; Molecular Biology; Phosphoinositide; Physiology; Site-directed Mutagenesis; Transient Receptor Potential Channels (TRP Channels)	NONSELECTIVE CATION; CL-CHANNELS; ION-CHANNEL; ACTIVATION; CALMODULIN; MECHANISM; MEMBRANE; BINDING; BRAIN; DEPENDENCE	Transient receptor potential (TRP) channel melastatin subfamily member 4 (TRPM4) is a broadly expressed nonselective monovalent cation channel. TRPM4 is activated by membrane depolarization and intracellular Ca2+, which is essential for the activation. The Ca2+ sensitivity is known to be regulated by calmodulin and membrane phosphoinositides, such as phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2). Although these regulators must play important roles in controlling TRPM4 activity, mutation analyses of the calmodulin-binding sites have suggested that Ca2+ binds to TRPM4 directly. However, the intrinsic binding sites in TRPM4 remain to be elucidated. Here, by using patch clamp and molecular biological techniques, we show that there are at least two functionally different divalent cation-binding sites, and the negatively charged amino acids near and in the TRP domain in the C-terminal tail of TRPM4 (Asp-1049 and Glu-1062 of rat TRPM4) are required for maintaining the normal Ca2+ sensitivity of one of the binding sites. Applications of Co2+, Mn2+, or Ni2+ to the cytosolic side potentiated TRPM4 currents, increased the Ca2+ sensitivity, but were unable to evoke TRPM4 currents without Ca2+. Mutations of the acidic amino acids near and in the TRP domain, which are conserved in TRPM2, TRPM5, and TRPM8, deteriorated the Ca2+ sensitivity in the presence of Co2+ or PI(4,5)P-2 but hardly affected the sensitivity to Co2+ and PI(4,5)P-2. These results suggest a novel role of the TRP domain in TRPM4 as a site responsible for maintaining the normal Ca2+ sensitivity. These findings provide more insights into the molecular mechanisms of the regulation of TRPM4 by Ca2+.	[Yamaguchi, Soichiro; Tanimoto, Akira; Otsuguro, Ken-ichi; Ito, Shigeo] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Pharmacol Lab, Sapporo, Hokkaido 0600818, Japan; [Yamaguchi, Soichiro; Hibino, Hiroshi] Niigata Univ, Sch Med, Dept Mol Physiol, Niigata 9518510, Japan	Hokkaido University; Niigata University	Yamaguchi, S (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Pharmacol Lab, Sapporo, Hokkaido 0600818, Japan.	souya@vetmed.hokudai.ac.jp	Otsuguro, Ken-ichi/A-4840-2012; Yamaguchi, Soichiro/Q-8563-2019	Otsuguro, Ken-ichi/0000-0002-2481-5592; 	Takeda Science Foundation; Tsukada grant for Niigata University Medical Research	Takeda Science Foundation(Takeda Science Foundation (TSF)); Tsukada grant for Niigata University Medical Research	This work was supported by a grant from the Takeda Science Foundation (to S. Y.) and a Tsukada grant for Niigata University Medical Research (to S. Y.).	Almaraz L, 2014, HANDB EXP PHARMACOL, V222, P547, DOI 10.1007/978-3-642-54215-2_22; Amarouch MY, 2013, NEUROSCI LETT, V541, P105, DOI 10.1016/j.neulet.2013.02.011; Avila Daiana Silva, 2013, Met Ions Life Sci, V13, P199, DOI 10.1007/978-94-007-7500-8_7; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Earley S, 2007, AM J PHYSIOL-HEART C, V292, pH2613, DOI 10.1152/ajpheart.01286.2006; Faouzi M, 2014, HANDB EXP PHARMACOL, V222, P403, DOI 10.1007/978-3-642-54215-2_16; Forrer R, 2001, BIOL TRACE ELEM RES, V80, P77, DOI 10.1385/BTER:80:1:77; Gregorio-Teruel L, 2014, J GEN PHYSIOL, V143, P361, DOI 10.1085/jgp.201311070; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; HABERMANN E, 1983, ARCH TOXICOL, V54, P61, DOI 10.1007/BF00277816; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Liu P, 2004, BIOMETALS, V17, P157, DOI 10.1023/B:BIOM.0000018373.85342.36; Liu Y, 2011, ADV EXP MED BIOL, V704, P185, DOI 10.1007/978-94-007-0265-3_10; Mathar I, 2014, HANDB EXP PHARMACOL, V222, P461, DOI 10.1007/978-3-642-54215-2_18; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; MILOS M, 1989, J INORG BIOCHEM, V36, P11, DOI 10.1016/0162-0134(89)80009-1; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67; PALLEN CJ, 1984, J BIOL CHEM, V259, P6134; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sakuraba M, 2014, J NEUROSCI RES, V92, P1409, DOI 10.1002/jnr.23410; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Simon F, 2010, J BIOL CHEM, V285, P37150, DOI 10.1074/jbc.M110.155390; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; SUNOSE H, 1993, AM J PHYSIOL, V265, pC72, DOI 10.1152/ajpcell.1993.265.1.C72; SUZUKI K, 1968, J INORG NUCL CHEM, V30, P161, DOI 10.1016/0022-1902(68)80075-2; TAKEUCHI S, 1992, HEARING RES, V61, P86, DOI 10.1016/0378-5955(92)90039-P; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; WEDLER FC, 1982, BIOCHEMISTRY-US, V21, P6389, DOI 10.1021/bi00268a011; WOLFF DJ, 1985, J BIOL CHEM, V260, P4195; WOLFF DJ, 1977, J BIOL CHEM, V252, P4108; Yamada Kazuhiro, 2013, Met Ions Life Sci, V13, P295, DOI 10.1007/978-94-007-7500-8_9; Yoo JC, 2010, BIOCHEM BIOPH RES CO, V391, P806, DOI 10.1016/j.bbrc.2009.11.142; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001; Zhou Y, 2012, P NATL ACAD SCI USA, V109, P11413, DOI 10.1073/pnas.1204444109	54	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35265	35282		10.1074/jbc.M114.606087	http://dx.doi.org/10.1074/jbc.M114.606087			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378404	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000346660200020
J	Wang, XH; Tolba, E; Schroder, HC; Neufurth, M; Feng, QL; Diehl-Seifert, B; Muller, WEG				Wang, Xiaohong; Tolba, Emad; Schroeder, Heinz C.; Neufurth, Meik; Feng, Qingling; Diehl-Seifert, Baerbel; Mueller, Werner E. G.			Effect of Bioglass on Growth and Biomineralization of SaOS-2 Cells in Hydrogel after 3D Cell Bioprinting	PLOS ONE			English	Article							BIOACTIVE GLASS; BIO-SILICA; SOL-GEL; BONE; MINERALIZATION; POLYPHOSPHATE; FABRICATION; BIOSILICA; ALGINATE	We investigated the effect of bioglass (bioactive glass) on growth and mineralization of bone-related SaOS-2 cells, encapsulated into a printable and biodegradable alginate/gelatine hydrogel. The hydrogel was supplemented either with polyphosphate (polyP), administered as polyP center dot Ca2+-complex, or silica, or as biosilica that had been enzymatically prepared from ortho-silicate by silicatein. These hydrogels, together with SaOS-2 cells, were bioprinted to computer-designed scaffolds. The results revealed that bioglass (nano) particles, with a size of 55 nm and a molar ratio of SiO2:CaO:P2O5 of 55:40:5, did not affect the growth of the encapsulated cells. If silica, biosilica, or polyP center dot Ca2+-complex is co-added to the cell-containing alginate/gelatin hydrogel the growth behavior of the cells is not changed. Addition of 5 mg/ml of bioglass particles to this hydrogel significantly enhanced the potency of the entrapped SaOS-2 cells to mineralize. If compared with the extent of the cells to form mineral deposits in the absence of bioglass, the cells exposed to bioglass together with 100 mu moles/L polyP center dot Ca2+-complex increased their mineralization activity from 2.1- to 3.9-fold, or with 50 mu moles/L silica from 1.8- to 2.9-fold, or with 50 mu moles/L biosilica from 2.7- to 4.8-fold or with the two components together (100 mu moles/L polyP center dot Ca2+-complex and 50 mu moles/ L biosilica) from 4.1- to 6.8-fold. Element analysis by EDX spectrometry of the mineral nodules formed by SaOS-2 revealed an accumulation of O, P, Ca and C, indicating that the mineral deposits contain, besides Ca-phosphate also Ca-carbonate. The results show that bioglass added to alginate/gelatin hydrogel increases the proliferation and mineralization of bioprinted SaOS-2 cells. We conclude that the development of cell-containing scaffolds consisting of a bioprintable, solid and cell-compatible inner matrix surrounded by a printable hard and flexible outer matrix containing bioglass, provide a suitable strategy for the fabrication of morphogenetically active and biodegradable implants.	[Wang, Xiaohong; Tolba, Emad; Schroeder, Heinz C.; Neufurth, Meik; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, ERC Adv Investigator Grant Res Grp, Mainz, Germany; [Tolba, Emad] Natl Res Ctr, Inorgan Chem Ind Div, Biomat Dept, Cairo, Egypt; [Feng, Qingling] Tsinghua Univ, Sch Mat Sci & Engn, Key Lab Adv Mat, Minist Educ China, Beijing 100084, Peoples R China; [Diehl-Seifert, Baerbel] NanotecMARIN GmbH, Mainz, Germany	Johannes Gutenberg University of Mainz; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Ministry of Education, China; Tsinghua University	Wang, XH (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, ERC Adv Investigator Grant Res Grp, Mainz, Germany.	wang013@uni-mainz.de; wmueller@uni-mainz.de	Wang, Zhong Lin/E-2176-2011; Neufurth, Meik/N-4297-2015; Müller, W. E. G./AAR-8651-2020; wang, jie/GRS-0942-2022; Wang, Xiaohong/AAR-5526-2020; Tolba, Emad/E-1049-2016	Wang, Zhong Lin/0000-0002-5530-0380; Neufurth, Meik/0000-0002-2383-6412; Müller, W. E. G./0000-0002-8223-3689; Tolba, Emad/0000-0002-3422-2344; Schroder, Heinz C./0000-0003-0992-6427	ERC Advanced Investigator Grant [268476 BIOSILICA]; Deutsche Forschungsgemeinschaft [Schr 277/10-3]; European Commission [286059, 604036, 268476, 311848]; International Human Frontier Science Program; NanotecMARIN GmbH	ERC Advanced Investigator Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); International Human Frontier Science Program(Human Frontier Science Program); NanotecMARIN GmbH	WEGM is a holder of an ERC Advanced Investigator Grant (No. 268476 BIOSILICA). This work was supported by grants from the Deutsche Forschungsgemeinschaft (Schr 277/10-3), the European Commission (Industry-Academia Partnerships and Pathways "CoreShell'': No. 286059; "Bio-Scaffolds'': No. 604036; "MarBioTec*EU-CN*'': No. 268476; and "BlueGenics'': No. 311848) and the International Human Frontier Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NanotecMARIN GmbH provided support in the form of salary for author BDS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017; Bose S, 2013, CHARACTERIZATION OF BIOMATERIALS, P1, DOI 10.1016/B978-0-12-415800-9.00001-2; Cattalini JP, 2013, PROCEDIA ENGINEER, V59, P78, DOI 10.1016/j.proeng.2013.05.096; Chen Q., 2008, TOPICS TISSUE ENG, V4, P1; Cohen D. L., 2008, P TERMIS N AM 2008 A; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FUJIKOSHI Y, 1993, DISCRETE MATH, V116, P315, DOI 10.1016/0012-365X(93)90410-U; Gibson I, 2010, ADDITIVE MANUFACTURING TECHNOLOGIES: RAPID PROTOTYPING TO DIRECT DIGITAL MANUFACTURING, P1, DOI 10.1007/978-1-4419-1120-9; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Han PP, 2013, BIOMATER SCI-UK, V1, P379, DOI 10.1039/c2bm00108j; Hench L. L., 2011, NEW MAT TECHNOLOGIES, P25, DOI DOI 10.1142/9781848165595_0003; Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z; Hench LL, 1971, J BIOMED MATER RES S, V5, P117, DOI [10.1002/jbm.820050611, DOI 10.1002/JBM.820050611]; Hong ZK, 2009, J NON-CRYST SOLIDS, V355, P368, DOI 10.1016/j.jnoncrysol.2008.12.003; Hong Z, 2009, J BIOMED MATER RES A, V88A, P304, DOI 10.1002/jbm.a.31848; Jazrawi LM, 1998, J ORTHOP TRAUMA, V12, P111, DOI 10.1097/00005131-199802000-00008; Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023; Kulakovskaya T, 2012, BIOCH PHYSL, V1; Leyhausen G, 1998, J BONE MINER RES, V13, P803, DOI 10.1359/jbmr.1998.13.5.803; Luo YX, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015005; Muller WEG, 2015, J TISSUE ENG REGEN M, V9, pE39, DOI 10.1002/term.1745; Muller WEG, 2013, BIOMATER SCI-UK, V1, P669, DOI 10.1039/c3bm00001j; Muller WEG, 2013, BIOMATERIALS, V34, P8671, DOI 10.1016/j.biomaterials.2013.07.096; Muller WEG, 2011, BBA-GEN SUBJECTS, V1810, P713, DOI 10.1016/j.bbagen.2011.04.009; Muller WEG, 2011, ACTA BIOMATER, V7, P2661, DOI 10.1016/j.actbio.2011.03.007; Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912; POWELL EO, 1956, J GEN MICROBIOL, V15, P492, DOI 10.1099/00221287-15-3-492; Ravarian R, 2013, J MATER CHEM B, V1, P1835, DOI 10.1039/c2tb00251e; SACHS L, 1984, ANGEW STAT, P242; Schlossmacher U, 2013, RSC ADV, V3, P11185, DOI 10.1039/c3ra23341c; Schroder HC, 2005, J BIOMED MATER RES B, V75B, P387, DOI 10.1002/jbm.b.30322; Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I; Smrdel P, 2006, DRUG DEV IND PHARM, V32, P623, DOI 10.1080/03639040600599863; Tasoglu S, 2013, TRENDS BIOTECHNOL, V31, P10, DOI 10.1016/j.tibtech.2012.10.005; Tong X, 2002, J APPL POLYM SCI, V86, P3532, DOI 10.1002/app.11152; Velasquillo C., 2013, J COSMET DERMATOL SC, V03, P85, DOI [DOI 10.4236/JCDSA.2013.31A012, 10.4236/jcdsa.2013.31a012]; Wang XH, 2013, SOFT MATTER, V9, P654, DOI 10.1039/c2sm27109e; Wang XH, 2012, SOFT MATTER, V8, P9501, DOI 10.1039/c2sm25889g; Wang XH, 2012, CURR OPIN BIOTECH, V23, P570, DOI 10.1016/j.copbio.2012.01.018; Wang XH, 2011, CHEMBIOCHEM, V12, P2316, DOI 10.1002/cbic.201100345; Welschoff J, 2014, FASEB J, V5; Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6; Wiens M, 2010, BIOMATERIALS, V31, P7716, DOI 10.1016/j.biomaterials.2010.07.002; Woo YI, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/044109	44	59	64	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112497	10.1371/journal.pone.0112497	http://dx.doi.org/10.1371/journal.pone.0112497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383549	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700069
J	Dong, YC; Li, PF; Ni, YH; Zhao, JJ; Liu, ZQ				Dong, Yingchun; Li, Pengfei; Ni, Yanhong; Zhao, Junjie; Liu, Zhiqiang			Decreased MicroRNA-125a-3p Contributes to Upregulation of p38 MAPK in Rat Trigeminal Ganglions with Orofacial Inflammatory Pain	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; DORSAL-HORN; DIFFERENTIAL EXPRESSION; TEMPOROMANDIBULAR-JOINT; CENTRAL SENSITIZATION; NOCICEPTIVE NEURONS; NEUROPATHIC PAIN; DOWN-REGULATION; NERVE INJURY; MICRORNAS	Orofacial inflammatory pain is a difficult clinical problem, and the specific molecular mechanisms for this pain remain largely unexplained. The present study aimed to determine the differential expression of microRNAs (miRNAs) and disclose the underlying role of miR-125a-3p in orofacial inflammatory pain induced by complete Freund's adjuvant (CFA). Thirty-two differentially expressed miRNAs were first screened using a microarray chip in ipsilateral trigeminal ganglions (TGs) following CFA injection into the orofacial skin innervated by trigeminal nerve, and a portion of them, including miR-23a*, -24-2*, -26a, -92a, -125a-3p, -183 and -299 were subsequently selected and validated by qPCR. The target genes were predicted based on the miRWalk website and were further analyzed by gene ontology (GO). Further studies revealed miR-125a-3p expression was down-regulated, whereas both the expression of p38 MAPK (mitogen-activated protein kinase) alpha and CGRP (calcitonin gene-related peptide) were up-regulated in ipsilateral TGs at different time points after CFA injection compared with control. Furthermore, mechanistic study revealed that miR-125a-3p negatively regulates p38 alpha gene expression and is positively correlated with the head withdrawal threshold reflecting pain. Luciferase assay showed that binding of miR-125a-3p to the 3'UTR of p38 alpha gene suppressed the transcriptional activity, and overexpression of miR-125a-3p significantly inhibited the p38 alpha mRNA level in ND8/34 cells. Taken together, our results show that miR125a-3p is negatively correlated with the development and maintenance of orofacial inflammatory pain via regulating p38 MAPK.	[Dong, Yingchun] Nanjing Univ, Inst & Hosp Stomatol, Sch Med, Dept Anesthesiol, Nanjing 210008, Jiangsu, Peoples R China; [Li, Pengfei] Nanjing Univ Tradit Chinese Med, Affiliated Hosp, Jiangsu Prov Hosp Tradit Chinese Med, Dept Lab, Nanjing, Jiangsu, Peoples R China; [Ni, Yanhong] Nanjing Univ, Inst & Hosp Stomatol, Sch Med, Cent Lab, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Junjie] Nanjing Univ, Inst & Hosp Stomatol, Sch Med, Dept Periodont, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Zhiqiang] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA	Nanjing University; Nanjing University of Chinese Medicine; Nanjing University; Nanjing University; University of Texas System; UTMD Anderson Cancer Center	Dong, YC (corresponding author), Nanjing Univ, Inst & Hosp Stomatol, Sch Med, Dept Anesthesiol, Nanjing 210008, Jiangsu, Peoples R China.	dongyingchun1001@hotmail.com; liuzhiqiang0397@gmail.com	Li, Pengfei/AAQ-6289-2020	Li, Pengfei/0000-0002-5928-1578	National Natural Science Foundation of China [81100768, 81072213, 81171659]; Jiangsu Government Scholarship for Overseas Studies; Nanjing Department of Health [YKK11040, YKK09124, YKK13145, QRX11123]; Jiangsu Health International Exchange Program; Medical Science and Technology Development Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Government Scholarship for Overseas Studies; Nanjing Department of Health; Jiangsu Health International Exchange Program; Medical Science and Technology Development Foundation	The work was supported by National Natural Science Foundation of China (No. 81100768, 81072213 and No. 81171659), Jiangsu Government Scholarship for Overseas Studies, Key Project supported by Medical Science and Technology Development Foundation, Nanjing Department of Health (No. YKK11040; YKK09124; YKK13145; QRX11123) and Jiangsu Health International Exchange Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich BT, 2009, NEUROSCIENCE, V164, P711, DOI 10.1016/j.neuroscience.2009.08.033; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Bali KK, 2013, EMBO MOL MED, V5, P1740, DOI 10.1002/emmm.201302797; Botz B, 2013, PEPTIDES, V43, P105, DOI 10.1016/j.peptides.2013.03.003; Cao Y, 2013, J PAIN, V14, P793, DOI 10.1016/j.jpain.2013.02.005; Cherkas PS, 2012, NEUROSCI LETT, V526, P160, DOI 10.1016/j.neulet.2012.08.007; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Franceschini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052394; Hashiguchi Y, 2012, INT J ONCOL, V40, P1477, DOI 10.3892/ijo.2012.1363; Hutchins B, 2000, ARCH ORAL BIOL, V45, P335, DOI 10.1016/S0003-9969(99)00129-6; Ji Ru-Rong, 2004, Current Drug Targets - Inflammation and Allergy, V3, P299, DOI 10.2174/1568010043343804; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kumar M, 2014, VIROLOGY, V452, P143, DOI 10.1016/j.virol.2014.01.004; Kusuda R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-17; Li HX, 2013, INT J MOL MED, V32, P219, DOI 10.3892/ijmm.2013.1381; Li X, 2013, J BONE MINER RES, V28, P2512, DOI 10.1002/jbmr.2002; Long I, 2013, KOREAN J PAIN, V26, P255, DOI 10.3344/kjp.2013.26.3.255; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Murata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069118; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Obata K, 2004, LIFE SCI, V74, P2643, DOI 10.1016/j.lfs.2004.01.007; Piao ZG, 2006, PAIN, V121, P219, DOI 10.1016/j.pain.2005.12.023; Piovesan EJ, 2008, ARQ NEURO-PSIQUIAT, V66, P837, DOI 10.1590/S0004-282X2008000600012; Poh KW, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2011.02.002; Qiu S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003778; Ren K, 1999, PHYSIOL BEHAV, V67, P711, DOI 10.1016/S0031-9384(99)00136-5; Sakai A, 2013, BIOCHEM BIOPH RES CO, V435, P176, DOI 10.1016/j.bbrc.2013.04.089; Sato J, 2004, ORAL SURG ORAL MED O, V98, P533, DOI 10.1016/j.tripleo.2004.02.057; Tajti Janos, 2009, Neuropsychopharmacol Hung, V11, P15; Takeda M, 2004, NEUROSCIENCE, V125, P995, DOI 10.1016/j.neuroscience.2004.02.029; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; Vause CV, 2010, NEUROSCI LETT, V473, P163, DOI 10.1016/j.neulet.2010.01.074; Wang ZY, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-68; Yu B, 2011, ACTA BIOCH BIOPH SIN, V43, P909, DOI 10.1093/abbs/gmr083; Zhu Dong-wang, 2012, Zhonghua Kou Qiang Yi Xue Za Zhi, V47, P14, DOI 10.3760/cma.j.issn.1002-0098.2012.01.005	36	33	34	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111594	10.1371/journal.pone.0111594	http://dx.doi.org/10.1371/journal.pone.0111594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380251	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100035
J	Kaufmann, S; Frishman, D				Kaufmann, Stefanie; Frishman, Dmitrij			Analysis of Micro-Rearrangements in 25 Eukaryotic Species Pairs by SyntenyMapper	PLOS ONE			English	Article							GENOME REARRANGEMENTS; POLYNOMIAL ALGORITHM; SLEEPING-BEAUTY	High-quality mapping of genomic regions and genes between two organisms is an indispensable prerequisite for evolutionary analyses and comparative genomics. Existing approaches to this problem focus on either delineating orthologs or finding extended sequence regions of common evolutionary origin (syntenic blocks). We propose SyntenyMapper, a novel tool for refining predefined syntenic regions. SyntenyMapper creates a set of blocks with conserved gene order between two genomes and finds all minor rearrangements that occurred since the evolutionary split of the two species considered. We also present TrackMapper, a SyntenyMapper-based tool that allows users to directly compare genome features, such as histone modifications, between two organisms, and identify genes with highly conserved features. We demonstrate SyntenyMapper's advantages by conducting a large-scale analysis of micro-rearrangements within syntenic regions of 25 eukaryotic species. Unsurprisingly, the number and length of syntenic regions is correlated with evolutionary distance, while the number of micro-rearrangements depends only on the size of the harboring region. On the other hand, the size of rearranged regions remains relatively constant regardless of the evolutionary distance between the organisms, implying a length constraint in the rearrangement process. SyntenyMapper is a useful software tool for both large-scale and gene-centric genome comparisons.	[Kaufmann, Stefanie; Frishman, Dmitrij] Tech Univ Munich, Dept Genome Oriented Bioinformat, Freising Weihenstephan, Bavaria, Germany; [Frishman, Dmitrij] German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Neuherberg, Bavaria, Germany; [Frishman, Dmitrij] St Petersburg State Polytechn Univ, Dept Bioinformat, St Petersburg, Russia	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Peter the Great St. Petersburg Polytechnic University	Frishman, D (corresponding author), Tech Univ Munich, Dept Genome Oriented Bioinformat, Freising Weihenstephan, Bavaria, Germany.	d.frishman@wzw.tum.de	Frishman, Dmitrij/AAT-7815-2020		German Research Foundation (DFG) International Research Training Group 'Regulation and Evolution of Cellular Systems' [GRK 1563]; Technische Universitat Munchen; Open Access Publishing	German Research Foundation (DFG) International Research Training Group 'Regulation and Evolution of Cellular Systems'(German Research Foundation (DFG)); Technische Universitat Munchen; Open Access Publishing	This work was supported by the German Research Foundation (DFG, www.dfg.de) International Research Training Group 'Regulation and Evolution of Cellular Systems' (GRK 1563). Publication was supported by the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fu Z, 2007, J COMPUT BIOL, V14, P1160, DOI 10.1089/cmb.2007.0048; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hannenhalli S, 1999, J ACM, V46, P1, DOI 10.1145/300515.300516; Hannenhalli S, 1995, AN S FDN CO, P581, DOI 10.1109/SFCS.1995.492588; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Izsvak Z, 2000, J MOL BIOL, V302, P93, DOI 10.1006/jmbi.2000.4047; Jun J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-630; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Liao BY, 2004, BIOINFORMATICS, V20, P3156, DOI 10.1093/bioinformatics/bth380; Mani RS, 2010, NAT REV GENET, V11, P819, DOI 10.1038/nrg2883; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Peng Q, 2006, PLOS COMPUT BIOL, V2, P100, DOI 10.1371/journal.pcbi.0020014; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; Proost S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr955; Rieck K, 2008, J MACH LEARN RES, V9, P23; Rodelsperger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008861; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Shi GQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-10; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024	34	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112341	10.1371/journal.pone.0112341	http://dx.doi.org/10.1371/journal.pone.0112341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375783	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600132
J	Rangel-Negrin, A; Coyohua-Fuentes, A; Chavira, R; Canales-Espinosa, D; Dias, PAD				Rangel-Negrin, Ariadna; Coyohua-Fuentes, Alejandro; Chavira, Roberto; Canales-Espinosa, Domingo; Dias, Pedro Americo D.			Primates Living Outside Protected Habitats Are More Stressed: The Case of Black Howler Monkeys in the Yucatan Peninsula	PLOS ONE			English	Article							TROPICAL FOREST; ALOUATTA-PIGRA; FECAL GLUCOCORTICOIDS; ADRENAL ACTIVITY; WILD; FRAGMENTATION; RESPONSES; CORTISOL; CONSEQUENCES; POPULATIONS	The non-invasive monitoring of glucocorticoid hormones allows for the assessment of the physiological effects of anthropogenic disturbances on wildlife. Variation in glucocorticoid levels of the same species between protected and unprotect areas seldom has been measured, and the available evidence suggests that this relationship may depend on species-specific habitat requirements and biology. In the present study we focused on black howler monkeys (Alouatta pigra), a canopy-dwelling primate species, as a case study to evaluate the physiological consequences of living in unprotected areas, and relate them with intragroup competition and competition with extragroup individuals. From February 2006 to September 2007 we collected 371 fecal samples from 21 adults belonging to five groups (two from protected and three from unprotected areas) in Campeche, Mexico. We recorded agonistic interactions within groups and encounters with other groups (1,200 h of behavioral observations), and determined fecal glucocorticoid metabolite (FGM) concentrations with radioimmunoassays. We used linear mixed models and Akaike's information criterion to choose the best model explaining variation in FGM concentrations between protected and unprotected areas calculated from five categorical variables: habitat type (protected vs. unprotected), participation in agonistic interactions, intergroup encounters, sex and female reproductive state, and season. The best model included habitat type, the interaction between habitat type and agonism, and the interaction between habitat type and season. FGM concentrations were higher in unprotected habitats, particularly when individuals were involved in agonistic interactions; seasonal variation in FGM concentrations was only detected in protected habitats. High FGM concentrations in black howler monkeys living in unprotected habitats are associated with increased within-group food competition and probably associated with exposure to anthropogenic stressors and overall food scarcity. Because persistent high GC levels can be detrimental to health and fitness, populations living in disturbed unprotected areas may not be viable in the long-term.	[Rangel-Negrin, Ariadna; Coyohua-Fuentes, Alejandro; Canales-Espinosa, Domingo; Dias, Pedro Americo D.] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico; [Chavira, Roberto] Inst Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico	Universidad Veracruzana	Dias, PAD (corresponding author), Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico.	paddias@hotmail.com	Rangel_Negrín, Ariadna/AGR-6540-2022; Dias, Pedro Américo D./C-2035-2009	Dias, Pedro Américo D./0000-0002-2919-6479; Rangel-Negrin, Ariadna/0000-0003-3539-3652	CFE [RGCPTTPUV-001/04]; CONACyT [235839, i010/152/2014, C-133/2014]; Idea Wild; Universidad Veracruzana	CFE; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Idea Wild; Universidad Veracruzana	This work was supported by CFE (RGCPTTPUV-001/04), Universidad Veracruzana, CONACyT (Grant Number: 235839; i010/152/2014 & C-133/2014) and Idea Wild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlering MA, 2013, CONSERV BIOL, V27, P569, DOI 10.1111/cobi.12061; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; Arroyo-Rodriguez V, 2013, LANDSCAPE ECOL, V28, P1717, DOI 10.1007/s10980-013-9929-2; Behie AM, 2009, AM J PRIMATOL, V71, P100; Breuner CW, 2008, GEN COMP ENDOCR, V157, P288, DOI 10.1016/j.ygcen.2008.05.017; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burnham K.P., 2010, MODEL SELECTION MULT; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Canales-Espinosa D., 2011, CONSERVACI N PRIMATE, P81, DOI 10.13140/2.1.2389.9204; Candelero-Rueda R, 2011, PERSPECTIVAS PRIMATO, P289; Cowlishaw G, 1999, CONSERV BIOL, V13, P1183, DOI 10.1046/j.1523-1739.1999.98433.x; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Creel S, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot021; Di Fiore A., 2011, PRIMATES PERSPECTIVE, P155; Dias PAD, 2014, PRIMATES, V55, P1, DOI 10.1007/s10329-013-0383-1; Dias PAD, 2011, AM J PHYS ANTHROPOL, V145, P137, DOI 10.1002/ajpa.21481; Dunn JC, 2013, INT J PRIMATOL, V34, P246, DOI 10.1007/s10764-013-9657-0; Edwards KL, 2013, GEN COMP ENDOCR, V186, P72, DOI 10.1016/j.ygcen.2013.02.023; Edwards MS, 1999, ZOO BIOL, V18, P537, DOI 10.1002/(SICI)1098-2361(1999)18:6&lt;537::AID-ZOO8&gt;3.0.CO;2-F; Escamilla A, 2000, CONSERV BIOL, V14, P1592, DOI 10.1046/j.1523-1739.2000.99069.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foerster S, 2010, HORM BEHAV, V58, P685, DOI 10.1016/j.yhbeh.2010.06.002; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Fowler GS, 1995, AUK, V112, P382, DOI 10.2307/4088725; Girard I, 2002, J APPL PHYSIOL, V92, P1553, DOI 10.1152/japplphysiol.00465.2001; Gobierno del Estado de Campeche, 2012, SIST EST AR NAT PROT; Gomez-Espinosa E, 2014, AM J PRIMATOL, V76, P362, DOI 10.1002/ajp.22240; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; Harcourt AH, 2005, J APPL ECOL, V42, P630, DOI 10.1111/j.1365-2664.2005.01037.x; Hinsley SA, 1999, J AVIAN BIOL, V30, P271, DOI 10.2307/3677353; HORWICH RH, 1986, PRIMATES, V27, P53, DOI 10.1007/BF02382522; Jones Clara B., 2004, Journal of Applied Animal Welfare Science, V7, P127, DOI 10.1207/s15327604jaws0702_4; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Marsh LK, 2008, IUCN 2014 RED LIST T; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Miller WL., 2001, ENDOCRINOLOGY METABO, P387; Muehlenbein MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033357; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Pimbert M. P., 1997, SOCIAL CHANGE CONSER; Pope ML, 2004, WILDLIFE RES, V31, P559, DOI 10.1071/WR02110; Putz F.E., 1990, GARDEN, V14, P18; Rangel-Negrin A, 2009, ANIM CONSERV, V12, P496, DOI 10.1111/j.1469-1795.2009.00280.x; Rangel-Negrin A., 2011, PERSPECTIVAS PRIMATO, P271; Rangel-Negrin A, 2011, HORM BEHAV, V59, P159, DOI 10.1016/j.yhbeh.2010.11.005; Rimbach R, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot031; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schaffner CM, 2012, INT J PRIMATOL, V33, P922, DOI 10.1007/s10764-012-9621-4; Spercoski KM, 2012, GEN COMP ENDOCR, V179, P232, DOI 10.1016/j.ygcen.2012.08.002; Thompson ME, 2012, BEHAV ECOL, V23, P1234, DOI 10.1093/beheco/ars107; Van Belle S, 2006, DEV PRIMATOL-PROG PR, P121; Van Belle S, 2009, AM J PRIMATOL, V71, P153, DOI 10.1002/ajp.20635; Van Meter PE, 2009, HORM BEHAV, V55, P329, DOI 10.1016/j.yhbeh.2008.11.001; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Watts ES, 1986, PRIMATE CONSERV, V7, P17; Wieczkowski J, 2005, AM J PHYS ANTHROPOL, V128, P381, DOI 10.1002/ajpa.20123; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]; Zwijacz-Kozica T, 2013, ACTA THERIOL, V58, P215, DOI 10.1007/s13364-012-0108-7	63	20	21	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112329	10.1371/journal.pone.0112329	http://dx.doi.org/10.1371/journal.pone.0112329			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375243	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600129
J	Yamaguchi, S; Maida, Y; Yasukawa, M; Kato, T; Yoshida, M; Masutomi, K				Yamaguchi, Satoko; Maida, Yoshiko; Yasukawa, Mami; Kato, Tomoyasu; Yoshida, Masayuki; Masutomi, Kenkichi			Eribulin Mesylate Targets Human Telomerase Reverse Transcriptase in Ovarian Cancer Cells	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; TUMOR-INITIATING CELLS; STEM-CELLS; CARCINOMA; HETEROCHROMATIN; PROLIFERATION; ASSOCIATION; EXPRESSION; RESISTANCE; PROTEIN	Treatment of advanced ovarian cancer involves platinum-based chemotherapy. However, chemoresistance is a major obstacle. Cancer stem cells (CSCs) are thought to be one of the causes of chemoresistance, but the underlying mechanism remains elusive. Recently, human telomerase reverse transcriptase (hTERT) has been reported to promote CSC-like traits. In this study, we found that a mitotic inhibitor, eribulin mesylate (eribulin), effectively inhibited growth of platinum-resistant ovarian cancer cell lines. Eribulin-sensitive cells showed a higher efficiency for sphere formation, suggesting that these cells possess an enhanced CSC-like phenotype. Moreover, these cells expressed a higher level of hTERT, and suppression of hTERT expression by siRNA resulted in decreased sensitivity to eribulin, suggesting that hTERT may be a target for eribulin. Indeed, we found that eribulin directly inhibited RNA-dependent RNA polymerase (RdRP) activity, but not telomerase activity of hTERT in vitro. We propose that eribulin targets the RdRP activity of hTERT and may be an effective therapeutic option for CSCs. Furthermore, hTERT may be a useful biomarker to predict clinical responses to eribulin.	[Yamaguchi, Satoko; Maida, Yoshiko; Yasukawa, Mami; Masutomi, Kenkichi] Natl Canc Ctr, Res Inst, Div Canc Stem Cell, Tokyo 104, Japan; [Kato, Tomoyasu] Natl Canc Ctr, Dept Gynecol, Tokyo, Japan; [Yoshida, Masayuki] Natl Canc Ctr, Dept Pathol, Tokyo, Japan; [Yoshida, Masayuki] Natl Canc Ctr, Clin Labs, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Masutomi, K (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Stem Cell, Tokyo 104, Japan.	kmasutom@ncc.go.jp	Kato, Tomoyasu/C-6900-2013		Japan Society for the Promotion of Science [26462544]; Funding program for the Next Generation World-Leading Researchers (NEXT program) from Japan Society for the Promotion of Science; Mitsubishi Foundation; Uehara Memorial Foundation; National Cancer Center Research and Development Funds [26-A-5]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding program for the Next Generation World-Leading Researchers (NEXT program) from Japan Society for the Promotion of Science; Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); National Cancer Center Research and Development Funds	This work was supported by Grant in Aid for Scientific Research (26462544) (to SY) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/), Funding program for the Next Generation World-Leading Researchers (NEXT program) (to KM) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/elisedai/), the Mitsubishi Foundation (to KM) (http://www.mitsubishi-zaidan.jp/en/), the Uehara Memorial Foundation (to KM) (http://www.ueharazaidan.or.jp/), and National Cancer Center Research and Development Funds (26-A-5) (to KM) (http://www.ncc.go.jp/jp/about/rinri/kaihatsu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Chung SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083971; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; GORAI I, 1995, GYNECOL ONCOL, V57, P33, DOI 10.1006/gyno.1995.1097; HAMILTON TC, 1984, SEMIN ONCOL, V11, P285; HAMILTON TC, 1983, CANCER RES, V43, P5379; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kobayashi T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-215; LANGDON SP, 1988, CANCER RES, V48, P6166; LAU DHM, 1991, CANCER RES, V51, P5181; Lin T, 2010, CANCER RES, V70, P9444, DOI 10.1158/0008-5472.CAN-10-2159; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Maida Y, 2014, MOL CELL BIOL, V34, P1576, DOI 10.1128/MCB.00093-14; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Nozawa S, 1988, Hum Cell, V1, P426; Ohta I, 2001, CANCER LETT, V162, P39, DOI 10.1016/S0304-3835(00)00605-4; Okamoto N, 2011, P NATL ACAD SCI USA, V108, P20388, DOI 10.1073/pnas.1015171108; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Sakai W, 2009, CANCER RES, V69, P6381, DOI 10.1158/0008-5472.CAN-09-1178; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Smith JA, 2010, BIOCHEMISTRY-US, V49, P1331, DOI 10.1021/bi901810u; Takano M, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-53; Tamase A, 2009, P NATL ACAD SCI USA, V106, P17163, DOI 10.1073/pnas.0905016106; Towle MJ, 2001, CANCER RES, V61, P1013; Towle MJ, 2011, CANCER RES, V71, P496, DOI 10.1158/0008-5472.CAN-10-1874; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Wang J, 2011, J BIOL CHEM, V286, P22384, DOI 10.1074/jbc.M111.239566; Wu RC, 2014, J PATHOL, V232, P473, DOI 10.1002/path.4315; Yanagibashi T, 1997, BRIT J CANCER, V76, P829, DOI 10.1038/bjc.1997.471; Yoshida T, 2014, BRIT J CANCER, V110, P1497, DOI 10.1038/bjc.2014.80	39	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112438	10.1371/journal.pone.0112438	http://dx.doi.org/10.1371/journal.pone.0112438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375122	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600143
J	Harper, NS; Scott, BH; Semple, MN; McAlpine, D				Harper, Nicol S.; Scott, Brian H.; Semple, Malcolm N.; McAlpine, David			The Neural Code for Auditory Space Depends on Sound Frequency and Head Size in an Optimal Manner	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCE; CENTRAL SPECTRUM THEORY; INFERIOR COLLICULUS; BINAURAL INTERACTION; UNANESTHETIZED RABBIT; DELAY SENSITIVITY; DORSAL NUCLEUS; NERVE DATA; NEURONS; REPRESENTATION	A major cue to the location of a sound source is the interaural time difference (ITD)-the difference in sound arrival time at the two ears. The neural representation of this auditory cue is unresolved. The classic model of ITD coding, dominant for a half-century, posits that the distribution of best ITDs (the ITD evoking a neuron's maximal response) is unimodal and largely within the range of ITDs permitted by head-size. This is often interpreted as a place code for source location. An alternative model, based on neurophysiology in small mammals, posits a bimodal distribution of best ITDs with exquisite sensitivity to ITDs generated by means of relative firing rates between the distributions. Recently, an optimal-coding model was proposed, unifying the disparate features of these two models under the framework of efficient coding by neural populations. The optimal-coding model predicts that distributions of best ITDs depend on head size and sound frequency: for high frequencies and large heads it resembles the classic model, for low frequencies and small head sizes it resembles the bimodal model. The optimal-coding model makes key, yet unobserved, predictions: for many species, including humans, both forms of neural representation are employed, depending on sound frequency. Furthermore, novel representations are predicted for intermediate frequencies. Here, we examine these predictions in neurophysiological data from five mammalian species: macaque, guinea pig, cat, gerbil and kangaroo rat. We present the first evidence supporting these untested predictions, and demonstrate that different representations appear to be employed at different sound frequencies in the same species.	[Harper, Nicol S.; McAlpine, David] UCL, Ear Inst, London, England; [Harper, Nicol S.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA; [Scott, Brian H.] NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; [Scott, Brian H.; Semple, Malcolm N.] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of London; University College London; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); New York University	Harper, NS (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg, Oxford, England.	nicol.harper@eng.ox.ac.uk	Scott, Brian H/G-7932-2012	McAlpine, David/0000-0001-5467-6725; Harper, Nicol/0000-0002-7851-4840	Wellcome Trust [040044, WT076508AIA]; Sir Henry Wellcome Postdoctoral Fellowship; Department of Physiology, Anatomy and Genetics, University of Oxford; Action on Hearing Loss [PA07]; National Institute on Deafness and Other Communication Disorders [DC-05287-01]; New York University; W. M. Keck Foundation; MRC Programme [G0300417]; MRC [G0300417, G1002267] Funding Source: UKRI; Medical Research Council [G0300417, G1002267] Funding Source: researchfish; RNID [PA07] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC005287] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Sir Henry Wellcome Postdoctoral Fellowship; Department of Physiology, Anatomy and Genetics, University of Oxford; Action on Hearing Loss; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); New York University; W. M. Keck Foundation(W.M. Keck Foundation); MRC Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); RNID; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Nicol S. Harper was supported by the Wellcome Trust (040044), (WT076508AIA), including a Sir Henry Wellcome Postdoctoral Fellowship, by the Department of Physiology, Anatomy and Genetics, University of Oxford and by Action on Hearing Loss (PA07). Brian H. Scott was supported by the National Institute on Deafness and Other Communication Disorders (DC-05287-01) and by a James Arthur Fellowship from New York University. Malcolm N. Semple was supported by the W. M. Keck Foundation. David McAlpine was supported by an MRC Programme Grant (G0300417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapiou JP, 2007, THESIS U COLL LONDON; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BILSEN FA, 1977, J ACOUST SOC AM, V61, P150, DOI 10.1121/1.381276; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brette R, 2010, J ACOUST SOC AM, V128, P2965, DOI 10.1121/1.3488311; COLBURN HS, 1977, J ACOUST SOC AM, V61, P525, DOI 10.1121/1.381294; Colburn HS, 1996, AUDITORY COMPUTATION, P332; COLES RB, 1988, J COMP PHYSIOL A, V163, P117, DOI 10.1007/BF00612002; CROW G, 1978, J ACOUST SOC AM, V64, P493, DOI 10.1121/1.381999; FRIJNS JHM, 1986, J ACOUST SOC AM, V80, P442, DOI 10.1121/1.394040; Hancock KE, 2004, J NEUROSCI, V24, P7110, DOI 10.1523/JNEUROSCI.0762-04.2004; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Jiang D, 1997, J NEUROPHYSIOL, V77, P3085, DOI 10.1152/jn.1997.77.6.3085; Joris PX, 2006, P NATL ACAD SCI USA, V103, P12917, DOI 10.1073/pnas.0601396103; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; KUWADA S, 1987, J NEUROPHYSIOL, V57, P1338, DOI 10.1152/jn.1987.57.5.1338; Kuwada S, 2006, J NEUROPHYSIOL, V95, P1309, DOI 10.1152/jn.00901.2005; Rayleigh,, 1907, PHILOS MAG, V13, P214, DOI 10.1080/14786440709463595; Maki K, 2005, J ACOUST SOC AM, V118, P872, DOI 10.1121/1.1944647; Marquardt T, 2007, HEARING - FROM SENSORY PROCESSING TO PERCEPTION, P407, DOI 10.1007/978-3-540-73009-5_44; McAlpine D, 1998, J NEUROSCI, V18, P6026; McAlpine D, 1996, HEARING RES, V97, P136, DOI 10.1016/0378-5955(96)00068-8; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Moore B., 2003, INTRO PSYCHOL HEARIN; PALMER AR, 1990, HEARING RES, V50, P71, DOI 10.1016/0378-5955(90)90034-M; PALMER AR, 1992, PHILOS T R SOC B, V336, P415, DOI 10.1098/rstb.1992.0077; Pecka M, 2008, J NEUROSCI, V28, P6914, DOI 10.1523/JNEUROSCI.1660-08.2008; RAATGEVER J, 1986, J ACOUST SOC AM, V80, P429, DOI 10.1121/1.394039; Raatgever J, 1977, PSYCHOPHYSICS PHYSL, P443; ROTH GL, 1980, J ACOUST SOC AM, V68, P1643, DOI 10.1121/1.385196; SAYERS BM, 1957, J ACOUST SOC AM, V29, P973, DOI 10.1121/1.1914990; Scott BH, 2007, J NEUROSCI, V27, P6489, DOI 10.1523/JNEUROSCI.0016-07.2007; Scott BH, 2009, J NEUROPHYSIOL, V101, P1781, DOI 10.1152/jn.00678.2007; Siveke I, 2006, J NEUROPHYSIOL, V96, P1425, DOI 10.1152/jn.00713.2005; Spezio ML, 2000, HEARING RES, V144, P73, DOI 10.1016/S0378-5955(00)00050-2; Sterbing SJ, 2003, J NEUROPHYSIOL, V90, P2648, DOI 10.1152/jn.00348.2003; STERN RM, 1978, J ACOUST SOC AM, V64, P127, DOI 10.1121/1.381978; STERN RM, 1988, J ACOUST SOC AM, V84, P156, DOI 10.1121/1.396982; STILLMAN RD, 1971, EXP NEUROL, V32, P404, DOI 10.1016/0014-4886(71)90007-0; TAKAHASHI T, 1986, J NEUROSCI, V6, P3413; WAGNER H, 1987, J NEUROSCI, V7, P3105; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; YIN TCT, 1984, J ACOUST SOC AM, V76, P1401, DOI 10.1121/1.391457; YIN TCT, 1983, J NEUROPHYSIOL, V50, P1000, DOI 10.1152/jn.1983.50.4.1000	46	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e108154	10.1371/journal.pone.0108154	http://dx.doi.org/10.1371/journal.pone.0108154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372405	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900002
J	Sartagul, W; Zhou, X; Yamada, Y; Ma, N; Tanaka, K; Furuyashiki, T; Ma, Y				Sartagul, Wugangerile; Zhou, Xin; Yamada, Yuki; Ma, Ning; Tanaka, Katsunori; Furuyashiki, Tomoyuki; Ma, Yan			The MluI Cell Cycle Box (MCB) Motifs, but Not Damage-Responsive Elements (DREs), Are Responsible for the Transcriptional Induction of the rhp51(+) Gene in Response to DNA Replication Stress	PLOS ONE			English	Article							FISSION YEAST; G1-SPECIFIC TRANSCRIPTION; SCHIZOSACCHAROMYCES-POMBE; ACTIVATED KINASE; S PHASE; CHECKPOINT; PHOSPHORYLATION; ASSOCIATION; INHIBITOR; PATHWAYS	DNA replication stress induces the transcriptional activation of rhp51(+), a fission yeast recA homolog required for repair of DNA double strand breaks. However, the mechanism by which DNA replication stress activates rhp51(+) transcription is not understood. The promoter region of rhp51(+) contains two damage-responsive elements (DREs) and two MluI cell cycle box (MCB) motifs. Using luciferase reporter assays, we examined the role of these elements in rhp51(+) transcription. The fulllength rhp51(+) promoter and a promoter fragment containing MCB motifs only, but not a fragment containing DREs, mediated transcriptional activation upon DNA replication stress. Removal of the MCB motifs from the rhp51(+) promoter abolished the induction of rhp51(+) transcription by DNA replication stress. Consistent with a role for MCB motifs in rhp51(+) transcription activation, deletion of the MBF (MCB-binding factor) co-repressors Nrm1 and Yox1 precluded rhp51(+) transcriptional induction in response to DNA replication stress. Using cells deficient in checkpoint signaling molecules, we found that the Rad3-Cds1/Chk1 pathway partially mediated rhp51(+) transcription in response to DNA replication stress, suggesting the involvement of unidentified checkpoint signaling pathways. Because MBF is critical for G1/S transcription, we examined how the cell cycle affected rhp51(+) transcription. The transcription of rhp51(+) and cdc18(+), an MBF-dependent G1/S gene, peaked simultaneously in synchronized cdc25-22 cells. Furthermore, DNA replication stress maintained transcription of rhp51(+) similarly to cdc18(+). Collectively, these results suggest that MBF and its regulators mediate rhp51(+) transcription in response to DNA replication stress, and underlie rhp51(+) transcription at the G1/S transition.	[Zhou, Xin] Liaoning Med Univ, Affiliated Hosp 1, Dept Oncol, Jinzhou, Peoples R China; [Sartagul, Wugangerile; Zhou, Xin; Yamada, Yuki; Ma, Ning; Furuyashiki, Tomoyuki; Ma, Yan] Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan; [Tanaka, Katsunori] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Japan	Jinzhou Medical University; Kobe University; Kwansei Gakuin University	Zhou, X (corresponding author), Liaoning Med Univ, Affiliated Hosp 1, Dept Oncol, Jinzhou, Peoples R China.	xinzhoulmu@gmail.com; mayan@med.kobe-u.ac.jp	Furuyashiki, Tomoyuki/B-8760-2014; Furuyashiki, Tomoyuki/AAG-5283-2019; Tanaka, Katsunori/F-8086-2010; Yamada, Yuki/B-2671-2008	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Tanaka, Katsunori/0000-0001-9692-0968; Yamada, Yuki/0000-0003-1431-568X	National Natural Science Foundation of China [31301158]; Ministry of Education, Culture, Sports, Science and Technology in Japan; Grants-in-Aid for Scientific Research [24689015] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the National Natural Science Foundation of China (grant no. 31301158) (A) (X.Z.) and Grant-in-Aid for Young Scientists (B) (Y.M.) and Grant-in-Aid for Scientific Research (C) (Y.M.) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligianni S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000626; Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Caetano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017211; Cooper K, 2006, ONCOGENE, V25, P5228, DOI 10.1038/sj.onc.1209630; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; De Piccoli G, 2012, MOL CELL, V45, P696, DOI 10.1016/j.molcel.2012.01.007; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Dutta C, 2008, MOL CELL BIOL, V28, P5977, DOI 10.1128/MCB.00596-08; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Gomez-Escoda B, 2011, EMBO REP, V12, P84, DOI 10.1038/embor.2010.187; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; Ivanova T, 2013, MOL BIOL CELL, V24, P3350, DOI 10.1091/mbc.E13-05-0257; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Ma Y, 2006, GENETICS, V174, P1259, DOI 10.1534/genetics.106.064709; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; Purtill FS, 2011, CELL CYCLE, V10, P664, DOI 10.4161/cc.10.4.14824; Rhind N, 2000, J CELL SCI, V113, P3889; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; SAKA Y, 1994, EMBO J, V13, P5319, DOI 10.1002/j.1460-2075.1994.tb06866.x; Shim YS, 2000, MOL CELL BIOL, V20, P8958, DOI 10.1128/MCB.20.23.8958-8968.2000; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111936	10.1371/journal.pone.0111936	http://dx.doi.org/10.1371/journal.pone.0111936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372384	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900091
J	Sun, PZ; Wang, YL; Liu, H; Wang, KL; Wu, DH; Xu, ZP; Zhu, HW				Sun, Pengzhan; Wang, Yanlei; Liu, He; Wang, Kunlin; Wu, Dehai; Xu, Zhiping; Zhu, Hongwei			Structure Evolution of Graphene Oxide during Thermally Driven Phase Transformation: Is the Oxygen Content Really Preserved?	PLOS ONE			English	Article							GRAPHITE OXIDE; MECHANICAL-PROPERTIES; REDUCTION; MEMBRANES; FILMS; WATER; TRANSPARENT; ELECTRONICS; SERIES	A mild annealing procedure was recently proposed for the scalable enhancement of graphene oxide (GO) properties with the oxygen content preserved, which was demonstrated to be attributed to the thermally driven phase separation. In this work, the structure evolution of GO with mild annealing is closely investigated. It reveals that in addition to phase separation, the transformation of oxygen functionalities also occurs, which leads to the slight reduction of GO membranes and furthers the enhancement of GO properties. These results are further supported by the density functional theory based calculations. The results also show that the amount of chemically bonded oxygen atoms on graphene decreases gradually and we propose that the strongly physisorbed oxygen species constrained in the holes and vacancies on GO lattice might be responsible for the preserved oxygen content during the mild annealing procedure. The present experimental results and calculations indicate that both the diffusion and transformation of oxygen functional groups might play important roles in the scalable enhancement of GO properties.	[Sun, Pengzhan; Wang, Kunlin; Zhu, Hongwei] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Key Lab Mat Proc Technol MOE, Beijing 100084, Peoples R China; [Wang, Yanlei; Xu, Zhiping; Zhu, Hongwei] Tsinghua Univ, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China; [Wang, Yanlei; Liu, He; Wu, Dehai; Xu, Zhiping] Tsinghua Univ, Dept Engn Mech, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Zhu, HW (corresponding author), Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Key Lab Mat Proc Technol MOE, Beijing 100084, Peoples R China.	hongweizhu@tsinghua.edu.cn	Wang, Yanlei/F-3253-2019; Zhu, Hongwei/C-4655-2008; Xu, Zhiping/A-1520-2010; Wang, Yanlei/E-8286-2016	Wang, Yanlei/0000-0002-2214-8781; Zhu, Hongwei/0000-0001-6484-3371; Wang, Yanlei/0000-0002-2214-8781	Beijing Natural Science Foundation [2122027]; National Science Foundation of China [51372133]; National Program on Key Basic Research Project [2011CB013000]; Tsinghua University Initiative Scientific Research Program [2012Z02102]; Training Program of Innovation and Entrepreneurship for Undergraduates [201410003B046]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project(National Basic Research Program of China); Tsinghua University Initiative Scientific Research Program; Training Program of Innovation and Entrepreneurship for Undergraduates	This work was supported by Beijing Natural Science Foundation (2122027), National Science Foundation of China (51372133), National Program on Key Basic Research Project (2011CB013000), Tsinghua University Initiative Scientific Research Program (2012Z02102) and the Training Program of Innovation and Entrepreneurship for Undergraduates (201410003B046). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Acik M, 2010, ACS NANO, V4, P5861, DOI 10.1021/nn101844t; Bagri A, 2010, NAT CHEM, V2, P581, DOI [10.1038/NCHEM.686, 10.1038/nchem.686]; Buchsteiner A, 2006, J PHYS CHEM B, V110, P22328, DOI 10.1021/jp0641132; Cabrera-Sanfelix P, 2007, J PHYS CHEM C, V111, P18258, DOI 10.1021/jp076241b; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83; Eda G, 2010, ADV MATER, V22, P2392, DOI 10.1002/adma.200903689; Gao W, 2011, NAT NANOTECHNOL, V6, P496, DOI [10.1038/NNANO.2011.110, 10.1038/nnano.2011.110]; Gao W, 2009, NAT CHEM, V1, P403, DOI [10.1038/NCHEM.281, 10.1038/nchem.281]; HONTORIALUCAS C, 1995, CARBON, V33, P1585, DOI 10.1016/0008-6223(95)00120-3; Hunt A, 2012, ADV FUNCT MATER, V22, P3950, DOI 10.1002/adfm.201200529; Johns JE, 2013, ACCOUNTS CHEM RES, V46, P77, DOI 10.1021/ar300143e; Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711; Kim S, 2012, NAT MATER, V11, P544, DOI [10.1038/NMAT3316, 10.1038/nmat3316]; Kumar PV, 2014, NAT CHEM, V6, P151, DOI [10.1038/nchem.1820, 10.1038/NCHEM.1820]; Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907; Mao S, 2012, RSC ADV, V2, P2643, DOI 10.1039/c2ra00663d; Mattevi C, 2009, ADV FUNCT MATER, V19, P2577, DOI 10.1002/adfm.200900166; Medhekar NV, 2010, ACS NANO, V4, P2300, DOI 10.1021/nn901934u; Ortiz-Young D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3482; Park S, 2008, ACS NANO, V2, P572, DOI 10.1021/nn700349a; Park S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1643; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Rourke JP, 2011, ANGEW CHEM INT EDIT, V50, P3173, DOI 10.1002/anie.201007520; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Sun PZ, 2014, ACS NANO, V8, P850, DOI 10.1021/nn4055682; Sun PZ, 2013, ACS APPL MATER INTER, V5, P9563, DOI 10.1021/am403186r; Sun PZ, 2013, ACS NANO, V7, P428, DOI 10.1021/nn304471w; Szabo T, 2006, CHEM MATER, V18, P2740, DOI 10.1021/cm060258+; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Wei ZQ, 2010, SCIENCE, V328, P1373, DOI 10.1126/science.1188119; Zhou S, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300106; Zhou S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02484	34	24	24	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111908	10.1371/journal.pone.0111908	http://dx.doi.org/10.1371/journal.pone.0111908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372142	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900089
J	Fuchs, H; Theuser, M; Wruck, W; Adjaye, J				Fuchs, Heiko; Theuser, Matthias; Wruck, Wasco; Adjaye, James			miR-27 Negatively Regulates Pluripotency-Associated Genes in Human Embryonal Carcinoma Cells	PLOS ONE			English	Article							LIVER RECEPTOR HOMOLOG-1; STEM-CELLS; TGF-BETA; NEURONAL DIFFERENTIATION; OCT4 EXPRESSION; E-CADHERIN; MICRORNAS; MOUSE; ANGIOGENESIS; REPRESSION	Human embryonic stem cells and human embryonal carcinoma cells have been studied extensively with respect to the transcription factors (OCT4, SOX2 and NANOG), epigenetic modulators and associated signalling pathways that either promote self-renewal or induce differentiation in these cells. The ACTIVIN/NODAL axis (SMAD2/3) of the TGF beta signalling pathway coupled with FGF signalling maintains self-renewal in these cells, whilst the BMP (SMAD1,5,8) axis promotes differentiation. Here we show that miR-27, a somatic-enriched miRNA, is activated upon RNAi-mediated suppression of OCT4 function in human embryonic stem cells. We further demonstrate that miR-27 negatively regulates the expression of the pluripotency-associated ACTIVIN/NODAL axis (SMAD2/3) of the TGF beta signalling pathway by targeting ACVR2A, TGF beta R1 and SMAD2. Additionally, we have identified a number of pluripotency-associated genes such as NANOG, LIN28, POLR3G and NR5A2 as novel miR-27 targets. Transcriptome analysis revealed that miR-27 over-expression in human embryonal carcinoma cells leads indeed to a significant up-regulation of genes involved in developmental pathways such as TGF beta- and WNT-signalling.	[Fuchs, Heiko; Wruck, Wasco; Adjaye, James] Univ Dusseldorf, Fac Med, Inst Stem Cell Res & Regenerat Med, Dusseldorf, Germany; [Theuser, Matthias; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, D-14195 Berlin, Germany	Heinrich Heine University Dusseldorf; Max Planck Society	Adjaye, J (corresponding author), Univ Dusseldorf, Fac Med, Inst Stem Cell Res & Regenerat Med, Dusseldorf, Germany.	james.adjaye@med.uni-duesseldorf.de		Fuchs, Heiko/0000-0001-9142-4084	BMBF Initiative "MedizinischenSystembiologie-MedSys'' [DRUG-iPS/0315398G]; Medical Faculty of Heinrich Heine University, Duesseldorf	BMBF Initiative "MedizinischenSystembiologie-MedSys''; Medical Faculty of Heinrich Heine University, Duesseldorf	This work was funded by the BMBF Initiative "MedizinischenSystembiologie-MedSys'' (DRUG-iPS/0315398G) and partly by the Medical Faculty of Heinrich Heine University, Duesseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Chinchilla A, 2011, CARDIOVASC RES, V89, P98, DOI 10.1093/cvr/cvq264; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feng J, 2009, BRIT J HAEMATOL, V145, P412, DOI 10.1111/j.1365-2141.2009.07632.x; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Jiang JM, 2008, CELL STEM CELL, V3, P127, DOI 10.1016/j.stem.2008.07.011; Jozefczuk J, 2011, STEM CELLS DEV, V20, P1259, DOI 10.1089/scd.2010.0361; Kang H, 2012, J BIOL CHEM, V287, P38656, DOI 10.1074/jbc.M112.390898; Kawasaki H, 2003, NATURE, V423, P838, DOI 10.1038/nature01730; Kim N, 2011, HEPATOL RES, V41, P170, DOI 10.1111/j.1872-034X.2010.00752.x; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Li L, 2012, CELL ADHES MIGR, V6, P59, DOI 10.4161/cam.19583; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Lozano-Velasco E, 2011, DEV BIOL, V357, P165, DOI 10.1016/j.ydbio.2011.06.039; Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34; Mazda M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028688; Miyazaki S, 2012, JPN J CLIN ONCOL, V42, P773, DOI 10.1093/jjco/hys108; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sung B, 2012, BIOCHEM BIOPH RES CO, V427, P315, DOI 10.1016/j.bbrc.2012.09.049; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang W, 2012, PLOS ONE, V7; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Wong RCB, 2011, STEM CELLS, V29, P1517, DOI 10.1002/stem.714; Wong SSY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036121; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhang ZP, 2011, CANCER GENET-NY, V204, P486, DOI 10.1016/j.cancergen.2011.07.004; Zheng YB, 2010, J BIOL CHEM, V285, P35654, DOI 10.1074/jbc.M110.128959; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	64	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111637	10.1371/journal.pone.0111637	http://dx.doi.org/10.1371/journal.pone.0111637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369332	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000080
J	Chen, X; Willette-Brown, J; Wu, XQ; Hu, Y; Howard, MZ; Hu, YL; Oppenheim, JJ				Chen, Xin; Willette-Brown, Jami; Wu, Xueqiang; Hu, Ya; Howard, M. Zack; Hu, Yinling; Oppenheim, Joost J.			IKK alpha is required for the homeostasis of regulatory T cells and for the expansion of both regulatory and effector CD4 T cells	FASEB JOURNAL			English	Article						Foxp3; proliferation; colitis; lymphopenic mouse	NF-KAPPA-B; SIGNALING PATHWAY; KINASE-ALPHA; C-REL; ACTIVATION; TNFR2; DIFFERENTIATION; EXPRESSION; PHOSPHORYLATION; COSTIMULATION	It was reported that TNF receptor type II signaling, which has the capacity to stimulate CD4(+) fork-head box P3(+) (Foxp3(+)) regulatory T cells (Tregs), activated the noncanonical NF-kappa B pathway in an IKK alpha-dependent manner. Therefore, we studied the role of IKK alpha in the homeostasis of Treg population. To this end, we generated a mouse strain with conditional knockout of IKK alpha in CD4 cells (Ikk alpha(f/f): CD4.Cre) that showed a >60% reduction in the number of Tregs in the thymus and peripheral lymphoid tissues, whereas the number of Foxp3(-) effector T cells (Teffs) remained at a normal level. The function of Tregs deficient in IKK alpha was examined using Rag1(-/-) mice cotransferred with naive CD4 cells (nCD4s). Although wild-type (WT) Tregs inhibited colitis induced by transfer of WT nCD4s, IKK alpha-deficient Tregs failed to do so, which was associated with their inability to reconstitute Rag1(-/-) mice. Furthermore, nCD4s deficient in IKK alpha also failed to reconstitute Rag1(-/-) mice and were defective in proliferative responses in vitro and in vivo. Thus, our study reveals a novel role of IKK alpha in the maintenance of a normal Treg population and in the control of expansion of CD4 T cells. These properties of IKK alpha may be exploited as therapeutic strategies in the treatment of major human diseases.	[Chen, Xin] NCI, Leidos Biomed Res Inc, Basic Sci Program, Frederick, MD 21701 USA; [Willette-Brown, Jami; Wu, Xueqiang; Hu, Ya; Howard, M. Zack; Oppenheim, Joost J.] NCI, Mol Immunoregulat Lab, Frederick, MD USA; [Willette-Brown, Jami; Hu, Yinling] NCI, Ctr Canc Res, Canc Inflammat Program, Expt Immunol Lab, Frederick, MD USA; [Chen, Xin] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Macao Sar, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Macau	Chen, X (corresponding author), Univ Macau, Inst Chinese Med Sci, Bldg N22, Taipa, Macao Sar, Peoples R China.	xchen@umac.mo; oppenhej@mail.nih.gov	Chen, Xin n/a/I-6601-2015; Hu, Yinling/G-5682-2015	Chen, Xin n/a/0000-0002-2628-4027; Hu, Yinling/0000-0002-4795-8537	U.S. National Institutes of Health (NIH) NCI [HHSN261200800001E]; Intramural Research Program of the NIHNCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011422, ZIABC009369] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) NCI; Intramural Research Program of the NIHNCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Na-Young Song, Trivett L. Anna, and Czarra T. Kelli for their help in this study. The authors thank the U. S. National Cancer Institute (NCI)-Frederick Cancer Inflammation Program Fluorescence Cytometry Core (Kathleen B. Noer, Roberta M. Matthai, and Guity Mohammadi) for expert technical assistance with flow cytometry. This project has been funded in whole or in part with federal funds from the U.S. National Institutes of Health (NIH) NCI, under contract HHSN261200800001E. This research was supported (in part) by the Intramural Research Program of the NIHNCI, Center for Cancer Research.	Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Chang JH, 2012, NAT IMMUNOL, V13, P481, DOI 10.1038/ni.2267; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chen X, 2013, J IMMUNOL, V190, P1076, DOI 10.4049/jimmunol.1202659; Chen X, 2010, J IMMUNOL, V185, P174, DOI 10.4049/jimmunol.0903548; Chen X, 2010, EUR J IMMUNOL, V40, P1099, DOI 10.1002/eji.200940022; Corn RA, 2005, J IMMUNOL, V175, P2102, DOI 10.4049/jimmunol.175.4.2102; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Griseri T, 2010, J EXP MED, V207, P699, DOI 10.1084/jem.20091618; Guckel E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020003; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hamano R, 2011, EUR J IMMUNOL, V41, P2010, DOI 10.1002/eji.201041205; Housley WJ, 2011, J IMMUNOL, V186, P6779, DOI 10.4049/jimmunol.1003868; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Legarda-Addison D, 2007, J IMMUNOL, V178, P7767, DOI 10.4049/jimmunol.178.12.7767; Li L, 2011, J EXP MED, V208, P787, DOI 10.1084/jem.20091346; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Liu BG, 2008, CANCER CELL, V14, P212, DOI 10.1016/j.ccr.2008.07.017; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; *NAT RES COUNC I L, 1996, GUID CAR US LAB AN; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Rauert H, 2010, J BIOL CHEM, V285, P7394, DOI 10.1074/jbc.M109.037341; Ren H, 2002, J IMMUNOL, V168, P3721, DOI 10.4049/jimmunol.168.8.3721; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sanchez-Valdepenas C, 2006, J IMMUNOL, V176, P4666, DOI 10.4049/jimmunol.176.8.4666; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Torchia MLG, 2013, J IMMUNOL, V190, P549, DOI 10.4049/jimmunol.1201697; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yurchenko E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035572; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	46	34	35	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					443	454		10.1096/fj.14-259564	http://dx.doi.org/10.1096/fj.14-259564			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25376833	Green Published			2022-12-26	WOS:000349370400010
J	Terada, K; Horinouchi, T; Fujioka, Y; Higashi, T; Nepal, P; Horiguchi, M; Karki, S; Hatate, C; Hoshi, A; Harada, T; Mai, Y; Ohba, Y; Miwa, S				Terada, Koji; Horinouchi, Takahiro; Fujioka, Yoichiro; Higashi, Tsunehito; Nepal, Prabha; Horiguchi, Mika; Karki, Sarita; Hatate, Chizuru; Hoshi, Akimasa; Harada, Takuya; Mai, Yosuke; Ohba, Yusuke; Miwa, Soichi			Agonist-promoted Ubiquitination Differentially Regulates Receptor Trafficking of Endothelin Type A and Type B Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Endothelin; Lysosome; Trafficking; Ubiquitination	PROTEASE-ACTIVATED RECEPTOR-1; DOWN-REGULATION; BETA(2)-ADRENERGIC RECEPTOR; CARDIOVASCULAR-DISEASE; COUPLED RECEPTORS; ETA-RECEPTOR; DEGRADATION; EXPRESSION; SUBTYPE; CLONING	Two types of G protein-coupled receptors for endothelin-1 (ET-1), ET type A receptor (ETAR) and ETBR, closely resemble each other, but upon ET-1 stimulation, they follow totally different intracellular trafficking pathways; ETAR is recycled back to plasma membrane, whereas ETBR is targeted to lysosome for degradation. However, the mechanisms for such different fates are unknown. Here we demonstrated that ETBR but not ETAR was ubiquitinated on the cell surface following ET-1 stimulation and that ETBR was internalized and degraded in lysosome more rapidly than ETAR. The mutant ETBR (designated 5KR mutant) in which 5 lysine residues in the C-tail were substituted to arginine was not ubiquitinated, and its rates of internalization and degradation after ET-1 stimulation became slower, being comparable with those of ETAR. Confocal microscopic study showed that following ET-1 stimulation, ETAR and 5KR mutant of ETBR were co-localized mainly with Rab11, a marker of recycling endosome, whereas ETBR was co-localized with Rab7, a marker of late endosome/lysosome. In the 5KR mutant, ET-1-induced ERK phosphorylation and an increase in the intracellular Ca2+ concentration upon repetitive ET-1 stimulation were larger. A series of ETBR mutants (designated 4KR mutant), in which either one of 5 arginine residues of the 5KR mutant was reverted to lysine, were normally ubiquitinated, internalized, and degraded, with ERK phosphorylation being normalized. These results demonstrate that agonist-induced ubiquitination at either lysine residue in the C-tail of ETBR but not ETAR switches intracellular trafficking from recycling to plasma membrane to targeting to lysosome, causing decreases in the cell surface level of ETBR and intracellular signaling.	[Terada, Koji; Horinouchi, Takahiro; Higashi, Tsunehito; Nepal, Prabha; Horiguchi, Mika; Karki, Sarita; Hatate, Chizuru; Hoshi, Akimasa; Harada, Takuya; Mai, Yosuke; Miwa, Soichi] Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Fujioka, Yoichiro; Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Dept Cell Physiol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Hokkaido University; Hokkaido University	Miwa, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	smiwa@med.hokudai.ac.jp	洋輔, 眞井/GVS-5202-2022; Fujioka, Yoichiro/AAF-3313-2019	Fujioka, Yoichiro/0000-0002-5760-9357	Japan Society for the Promotion of Science [24390059, 25670123, 25460326]; Smoking Research Foundation of Japan; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research [25670184, 26293041] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation of Japan; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aids for Scientific Research (B) 24390059 (to S. M.), Challenging Exploratory Research 25670123 (to S. M.), and Scientific Research (C) 25460326 (to K. T.) from the Japan Society for the Promotion of Science and in part by grants from the Smoking Research Foundation of Japan (to S. M.) and the Suzuken Memorial Foundation (to K. T.).	Abe Y, 2000, J BIOL CHEM, V275, P8664, DOI 10.1074/jbc.275.12.8664; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Bohm F, 2002, ARTERIOSCL THROM VAS, V22, P674, DOI 10.1161/01.ATV.0000012804.63152.60; Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Cottrell GS, 2006, J BIOL CHEM, V281, P27773, DOI 10.1074/jbc.M603369200; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; Fujioka Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3763; FUKURODA T, 1994, BIOCHEM BIOPH RES CO, V199, P1461, DOI 10.1006/bbrc.1994.1395; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Henry AG, 2012, DEV CELL, V23, P519, DOI 10.1016/j.devcel.2012.08.003; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Horinouchi T, 2007, EUR J PHARMACOL, V566, P28, DOI 10.1016/j.ejphar.2007.03.019; Horinouchi T, 2013, J PHARMACOL SCI, V123, P85, DOI 10.1254/jphs.13R02CR; Horinouchi T, 2012, BIOCHEM BIOPH RES CO, V428, P252, DOI 10.1016/j.bbrc.2012.10.034; Horinouchi T, 2012, J PHARMACOL EXP THER, V340, P143, DOI 10.1124/jpet.111.187500; Iwasa S, 1999, ATHEROSCLEROSIS, V146, P93, DOI 10.1016/S0021-9150(99)00134-3; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Kawanabe Y, 2002, MOL PHARMACOL, V61, P277, DOI 10.1124/mol.61.2.277; Kobayashi T, 2000, PATHOL INT, V50, P929, DOI 10.1046/j.1440-1827.2000.01152.x; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Li JG, 2008, MOL PHARMACOL, V73, P1319, DOI 10.1124/mol.107.042846; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Nishimoto A, 2010, BIOCHEM BIOPH RES CO, V391, P1616, DOI 10.1016/j.bbrc.2009.12.087; Nishiya T, 2011, J BIOL CHEM, V286, P9009, DOI 10.1074/jbc.M110.190678; Okamoto Y, 1997, J BIOL CHEM, V272, P21589, DOI 10.1074/jbc.272.34.21589; Oksche A, 2000, MOL PHARMACOL, V57, P1104; Paasche JD, 2001, J BIOL CHEM, V276, P34041, DOI 10.1074/jbc.M103243200; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; SAKAMOTO A, 1991, BIOCHEM BIOPH RES CO, V178, P656, DOI 10.1016/0006-291X(91)90158-4; SAKAMOTO A, 1993, J BIOL CHEM, V268, P8547; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; TAKAGI Y, 1995, J BIOL CHEM, V270, P10072, DOI 10.1074/jbc.270.17.10072; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; YANAGISAWA M, 1989, BIOCHEM PHARMACOL, V38, P1877; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	45	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35283	35295		10.1074/jbc.M113.544171	http://dx.doi.org/10.1074/jbc.M113.544171			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25381251	hybrid, Green Published			2022-12-26	WOS:000346660200021
J	Hayley, AC; Williams, LJ; Kennedy, GA; Berk, M; Brennan, SL; Pasco, JA				Hayley, Amie C.; Williams, Lana J.; Kennedy, Gerard A.; Berk, Michael; Brennan, Sharon L.; Pasco, Julie A.			Excessive Daytime Sleepiness and Body Composition: A Population-Based Study of Adults	PLOS ONE			English	Article							RISK-FACTORS; WAIST CIRCUMFERENCE; GENERAL-POPULATION; MASS INDEX; OBESITY; APNEA; PREVALENCE; DISORDERS; OVERWEIGHT; WOMEN	Background: Excessive daytime sleepiness (EDS) is often associated with increased adiposity, particularly when assessed in the context of samples of sleep-disordered patients; however, it is unclear if this relationship is sustained among non-clinical, population-based cohorts. This study aimed to investigate the relationship between EDS and a number of body composition markers among a population-based sample of men and women. Methods: This study assessed 1066 women aged 21-94 yr (median = 51 yr, IQR 35-66), and 911 men aged 24-92 yr (median = 60 yr, IQR 46-73) who participated in the Geelong Osteoporosis Study (GOS) between the years 2001 and 2008. Total body fat mass was determined from whole body dual-energy X-ray absorptiometry scans, and anthropometric parameters (weight, height, and waist circumference) were measured. Lifestyle and health information was collected via self-report. Sleepiness was assessed using the Epworth Sleepiness Scale (ESS). Scores of >= 10 were considered indicative of EDS. Results: Women: After adjusting for age, alcohol intake, antidepressant medication use and physical activity, EDS was associated with greater waist circumference and body mass index (BMI). EDS was also associated with 1.5-1.6-fold increased odds of being overweight or obese. Men: After adjusting for age, alcohol use, physical activity and smoking status, EDS was associated with greater BMI. These findings were not explained by the use of sedative or antidepressant medication. EDS was also associated with 1.5-fold increased likelihood of being obese, independent of these factors. No differences in lean mass, %body fat, or %lean mass were detected between those with and without EDS for men or women. Conclusions: These data suggest that EDS is associated with several anthropometric adiposity profiles, independent of associated lifestyle and health factors. Among women, symptoms of EDS are pervasive at both overweight and obese BMI classifications; suggesting a need for further clinical examination to assess possible temporal associations with underlying sleep pathology.	[Hayley, Amie C.; Williams, Lana J.; Berk, Michael; Pasco, Julie A.] Deakin Univ, IMPACT SRC, Sch Med, Geelong, Vic 3217, Australia; [Hayley, Amie C.; Kennedy, Gerard A.] Austin Hlth, Inst Breathing & Sleep, Melbourne, Vic, Australia; [Williams, Lana J.] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia; [Kennedy, Gerard A.] Cairnmillar Inst, Sch Psychol Counselling & Psychotherapy, Camberwell, Australia; [Brennan, Sharon L.; Pasco, Julie A.] Univ Melbourne, NorthWest Acad Ctr, Dept Med, St Albans, Australia; [Berk, Michael] Orygen Res Ctr, Parkville, Vic, Australia; [Berk, Michael] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Brennan, Sharon L.] Univ Melbourne, Australian Inst Musculoskeletal Sci, North West Acad Ctr, Dept Med, St Albans, Australia	Deakin University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Institute for Breathing & Sleep (IBAS); University of Melbourne; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Hayley, AC (corresponding author), Deakin Univ, IMPACT SRC, Sch Med, Geelong, Vic 3217, Australia.		Berk, Michael/M-3585-2019; Brennan-Olsen, Sharon/AAM-8595-2020; Berk, Michael/M-7891-2013	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946; Brennan-Olsen, Sharon/0000-0003-3269-5401; Williams, Lana/0000-0002-1377-1272; Hayley, Amie/0000-0002-4470-4718	National Institutes of Health (NIH); Simons Foundation; CRC for Mental Health; Stanley Medical Research Institute; MBF; NHMRC; Beyond Blue; Geelong Medical Research Foundation; Bristol Myers Squibb; Eli Lilly; Glaxo SmithKline; Organon; Novartis; Mayne Pharma; Servier; Astra Zeneca; Janssen Cilag; Lundbeck; Pfizer; Sanofi Synthelabo; Solvay; Wyeth; University of Melbourne; Deakin University	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; CRC for Mental Health(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Stanley Medical Research Institute; MBF; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Beyond Blue; Geelong Medical Research Foundation; Bristol Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Glaxo SmithKline(GlaxoSmithKline); Organon; Novartis(Novartis); Mayne Pharma; Servier(Servier); Astra Zeneca(AstraZeneca); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); Sanofi Synthelabo; Solvay(Solvay SA); Wyeth(Wyeth); University of Melbourne(University of Melbourne); Deakin University	The authors have read the journal's policy and have the following competing interests: MB has received Grant/Research Support from the National Institutes of Health (NIH), Simons Foundation, CRC for Mental Health, Stanley Medical Research Institute, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma, Servier and Astra Zeneca. MB has been a paid consultant for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck and Pfizer and a paid speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Organon, Pfizer, Sanofi Synthelabo, Solvay and Wyeth. LJW has received Grant/Research support from Eli Lilly, Pfizer, The University of Melbourne, Deakin University and the NHMRC. ACH, GAK, SLB and JAP have no conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	AusDiab, 2008, RISK FACT DIAB; Baskin ML, 2005, OBES REV, V6, P5, DOI 10.1111/j.1467-789X.2005.00165.x; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Chaput J-P, 2013, PHYSL BEHAV; Dixon JB, 2007, OBESITY, V15, P2504, DOI 10.1038/oby.2007.297; Fogelholm M, 2007, INT J OBESITY, V31, P1713, DOI 10.1038/sj.ijo.0803663; Gami AS, 2003, ENDOCRIN METAB CLIN, V32, P869, DOI 10.1016/S0889-8529(03)00069-0; Giles GG, 1996, DIETARY QUESTIONNAIR; GRUNSTEIN R, 1993, INT J OBESITY, V17, P533; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Hayley AC, 2013, AUST NZ J PSYCHIAT, V47, P772, DOI 10.1177/0004867413490036; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Johns M, 1997, SLEEP, V20, P844, DOI 10.1093/sleep/20.10.844; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kline CE, 2013, SLEEP, V36, P1279, DOI 10.5665/sleep.2946; LEVINSON PD, 1993, CHEST, V103, P1336, DOI 10.1378/chest.103.5.1336; Lindberg E, 2007, RESP MED, V101, P1283, DOI 10.1016/j.rmed.2006.10.015; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Olds TS, 2010, INT J OBESITY, V34, P57, DOI 10.1038/ijo.2009.211; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Pasco JA, 2012, INT J EPIDEMIOL, V41, P1565, DOI 10.1093/ije/dyr148; Pasco JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029580; Pasquali R, 2000, J CLIN ENDOCR METAB, V85, P2767, DOI 10.1210/jc.85.8.2767; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Resta O, 2001, INT J OBESITY, V25, P669, DOI 10.1038/sj.ijo.0801603; Seidell JC, 1999, ACTA PAEDIATR, V88, P46, DOI 10.1111/j.1651-2227.1999.tb14350.x; Serafini FM, 2001, OBES SURG, V11, P28, DOI 10.1381/096089201321454079; Souza JC, 2002, ARQ NEURO-PSIQUIAT, V60, P558, DOI 10.1590/S0004-282X2002000400008; Sowers JR, 2003, AM J MED, V115, P37, DOI 10.1016/j.amjmed.2003.08.012; Strobel RJ, 1996, SLEEP, V19, P104, DOI 10.1093/sleep/19.2.104; Theorell-Haglow J, 2006, SLEEP, V29, P751, DOI 10.1093/sleep/29.6.751; Thorburn AW, 2005, OBES REV, V6, P187, DOI 10.1111/j.1467-789X.2005.00187.x; Vaska VL, 2004, J PAEDIATR CHILD H, V40, P353, DOI 10.1111/j.1034-4810.2004.00401.x; Vgontzas AN, 1998, ARCH INTERN MED, V158, P1333, DOI 10.1001/archinte.158.12.1333; Vgontzas AN, 1997, J CLIN ENDOCR METAB, V82, P1313, DOI 10.1210/jc.82.5.1313; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P517, DOI 10.1210/jc.86.2.517; Williams LJ, 2009, J AFFECT DISORDERS, V118, P173, DOI 10.1016/j.jad.2009.02.001	42	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112238	10.1371/journal.pone.0112238	http://dx.doi.org/10.1371/journal.pone.0112238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383556	gold, Green Published			2022-12-26	WOS:000344816700042
J	Huang, XF; Ren, LY; Ye, P; Cheng, C; Wu, J; Wang, SH; Sun, Y; Liu, Z; Xie, AN; Xia, JH				Huang, Xiaofan; Ren, Lingyun; Ye, Ping; Cheng, Chao; Wu, Jie; Wang, Sihua; Sun, Yuan; Liu, Zheng; Xie, Aini; Xia, Jiahong			Peroxisome Proliferator-Activated Receptor gamma Deficiency in T Cells Accelerates Chronic Rejection by Influencing the Differentiation of CD4+T Cells and Alternatively Activated Macrophages	PLOS ONE			English	Article							CARDIAC ALLOGRAFT-REJECTION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; VASCULOPATHY; MICE; TRANSPLANTATION; SURVIVAL; HEART; ATHEROSCLEROSIS; INFLAMMATION	Background: In a previous study, activation of the peroxisome proliferator-activated receptor gamma (PPAR gamma) inhibited chronic cardiac rejection. However, because of the complexity of chronic rejection and the fact that PPAR gamma is widely expressed in immune cells, the mechanism of the PPAR gamma - induced protective effect was unclear. Materials and Methods: A chronic rejection model was established using B6.C-H-2(bm12)KhEg(H-2(bm12)) mice as donors, and MHC II-mismatched T-cell-specific PPAR gamma knockout mice or wild type (WT) littermates as recipients. The allograft lesion was assessed by histology and immunohistochemistry. T cells infiltrates in the allograft were isolated, and cytokines and subpopulations were detected using cytokine arrays and flow cytometry. Transcription levels in the allograft were measured by RT-PCR. In vitro, the T cell subset differentiation was investigated after culture in various polarizing conditions. PPAR gamma-deficient regularory T cells (Treg) were cocultured with monocytes to test their ability to induce alternatively activated macrophages (AAM). Results: T cell-specific PPAR gamma knockout recipients displayed reduced cardiac allograft survival and an increased degree of pathology compared with WT littermates. T cell-specific PPAR gamma knockout resulted in more CD4+ T cells infiltrating into the allograft and altered the Th1/Th2 and Th17/Treg ratios. The polarization of AAM was also reduced by PPAR gamma deficiency in T cells through the action of Th2 and Treg. PPAR gamma-deficient T cells eliminated the pioglitazone-induced polarization of AAM and reduced allograft survival. Conclusions: PPAR gamma-deficient T cells influenced the T cell subset and AAM polarization in chronic allograft rejection. The mechanism of PPAR gamma activation in transplantation tolerance could yield a novel treatment without side effects.	[Huang, Xiaofan; Ren, Lingyun; Cheng, Chao; Wu, Jie; Sun, Yuan; Liu, Zheng; Xia, Jiahong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiovasc Surg, Wuhan 430074, Peoples R China; [Ye, Ping] Cent Hosp Wuhan, Dept Cardiol, Wuhan, Peoples R China; [Wang, Sihua] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Thorac Surg, Wuhan 430074, Peoples R China; [Xie, Aini] Baylor Coll Med, Dept Med, Div Endocrinol Diabet & Metab, Houston, TX 77030 USA; [Xia, Jiahong] Cent Hosp Wuhan, Dept Cardiovasc Surg, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Baylor College of Medicine	Xia, JH (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiovasc Surg, Wuhan 430074, Peoples R China.	jiahong.xia@mail.hust.edu.cn			National Nature Science Foundation of China [81070205, 81130056, 81100176, 81373170]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Nature Science Foundation of China (Program No: 81070205, 81130056, 81100176 and 81373170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Augstein P, 2003, BIOCHEM BIOPH RES CO, V304, P378, DOI 10.1016/S0006-291X(03)00590-4; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chen Y, 2007, TRANSPLANTATION, V83, P1602, DOI 10.1097/01.tp.0000266994.39480.42; Chen Y, 2011, J HEART LUNG TRANSPL, V30, P698, DOI 10.1016/j.healun.2011.01.704; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; da Rocha Junior LF, 2013, PPAR RES, V2013; Dhakal M, 2013, EUR J IMMUNOL; El-Sawy T, 2002, CURR OPIN IMMUNOL, V14, P562, DOI 10.1016/S0952-7915(02)00382-5; Fischbein MP, 2001, TRANSPLANTATION, V71, P1146, DOI 10.1097/00007890-200104270-00023; Furukawa Y, 2002, AM J PATHOL, V160, P1077, DOI 10.1016/S0002-9440(10)64928-0; Ge W, 2010, AM J TRANSPLANT, V10, P1760, DOI 10.1111/j.1600-6143.2010.03186.x; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; He XY, 1998, TRANSPLANTATION, V65, P1145, DOI 10.1097/00007890-199805150-00001; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Itoh S, 2011, CIRCULATION, V124, pS187, DOI 10.1161/CIRCULATIONAHA.110.014852; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Koglin J, 2000, CIRCULATION, V101, P1034, DOI 10.1161/01.CIR.101.9.1034; Kosuge H, 2006, CIRCULATION, V113, P2613, DOI 10.1161/CIRCULATIONAHA.105.594101; Liu GW, 2013, J CELL PHYSIOL, V228, P502, DOI 10.1002/jcp.24157; Liu ZM, 2013, IMMUNOL REV, V252, P183, DOI 10.1111/imr.12038; Magil Alex B, 2009, Transplant Rev (Orlando), V23, P199, DOI 10.1016/j.trre.2009.06.005; Mannon RB, 2012, CURR OPIN ORGAN TRAN, V17, P20, DOI 10.1097/MOT.0b013e32834ee5b6; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Moraes-Vieira PMM, 2013, AM J TRANSPLANT, V13, P36, DOI 10.1111/j.1600-6143.2012.04283.x; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Park SJ, 2009, J IMMUNOL, V183, P3259, DOI 10.4049/jimmunol.0900231; Piccotti JR, 1999, TRANSPLANTATION, V67, P1548, DOI 10.1097/00007890-199906270-00008; Rahmani M, 2006, CIRC RES, V99, P801, DOI 10.1161/01.RES.0000246086.93555.f3; Schmauss D, 2008, CIRCULATION, V117, P2131, DOI 10.1161/CIRCULATIONAHA.107.711911; Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002; Suzuki J, 2010, CIRC J, V74, P233, DOI 10.1253/circj.CJ-09-0809; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Tay SS, 2009, CURR OPIN ORGAN TRAN, V14, P16, DOI 10.1097/MOT.0b013e32831ebdf5; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tobiasova Z, 2011, CIRCULATION, V124, P196, DOI 10.1161/CIRCULATIONAHA.110.015396; Wang S, 2012, CLIN EXP IMMUNOL, V169, P320, DOI 10.1111/j.1365-2249.2012.04612.x; Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20; Ye P, 2012, J SURG RES, V173, P161, DOI 10.1016/j.jss.2010.08.052; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937	44	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112953	10.1371/journal.pone.0112953	http://dx.doi.org/10.1371/journal.pone.0112953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383620	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700106
J	El-Merahbi, R; Liu, YN; Eid, A; Daoud, G; Hosry, L; Monzer, A; Mouhieddine, TH; Hamade, A; Najjar, F; Abou-Kheir, W				El-Merahbi, Rabih; Liu, Yen-Nien; Eid, Assaad; Daoud, Georges; Hosry, Leina; Monzer, Alissar; Mouhieddine, Tarek H.; Hamade, Aline; Najjar, Fadia; Abou-Kheir, Wassim			Berberis libanotica Ehrenb Extract Shows Anti-Neoplastic Effects on Prostate Cancer Stem/Progenitor Cells	PLOS ONE			English	Article							STEM-CELLS; ANTITUMOR ACTIVITIES; RESISTANCE; APOPTOSIS; DEPLETION; VULGARIS; INVASION; THERAPY; ARREST; TARGET	Cancer stem cells (CSCs), including those of advanced prostate cancer, are a suggested reason for tumor resistance toward conventional tumor therapy. Therefore, new therapeutic agents are urgently needed for targeting CSCs. Despite the minimal understanding of their modes of action, natural products and herbal therapies have been commonly used in the prevention and treatment of many cancers. Berberis libanotica Ehrenb (BLE) is a plant rich in alkaloids which may possess anti-cancer activity and a high potential for eliminating CSCs. We tested the effect of BLE on prostate cancer cells and our data indicated that this extract induced significant reduction in cell viability and inhibited the proliferation of human prostate cancer cell lines (DU145, PC3 and 22Rv1) in a dose- and time-dependent manner. BLE extract induced a perturbation of the cell cycle, leading to a G0-G1 arrest. Furthermore, we noted 50% cell death, characterized by the production of high levels of reactive oxidative species (ROS). Inhibition of cellular migration and invasion was also achieved upon treatment with BLE extract, suggesting a role in inhibiting metastasis. Interestingly, BLE extract had a major effect on CSCs. Cells were grown in a 3D sphere-formation assay to enrich for a population of cancer stem/progenitor cells. Our results showed a significant reduction in sphere formation ability. Three rounds of treatment with BLE extract were sufficient to eradicate the self-renewal ability of highly resistant CSCs. In conclusion, our results suggest a high therapeutic potential of BLE extract in targeting prostate cancer and its CSCs.	[El-Merahbi, Rabih; Eid, Assaad; Daoud, Georges; Monzer, Alissar; Mouhieddine, Tarek H.; Abou-Kheir, Wassim] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon; [Hosry, Leina] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Hamade, Aline] Lebanese Univ, Fac Sci 2, Dept Biol, Fanar, Lebanon; [Najjar, Fadia] Lebanese Univ, Fac Sci 2, Dept Chem & Biochem, Fanar, Lebanon	American University of Beirut; Taipei Medical University; Lebanese University; Lebanese University	Hamade, A (corresponding author), Lebanese Univ, Fac Sci 2, Dept Biol, Fanar, Lebanon.	alinehamade@gmail.com; Fadia.najjar@gmail.com; wa12@aub.edu.lb	Abou-Kheir, Wassim/AAP-2587-2020; Liu, Yen-Nien/AAW-4698-2021	Abou-Kheir, Wassim/0000-0001-9719-9324; Mouhieddine, Tarek/0000-0002-1190-5978; Daoud, Georges/0000-0001-8043-3882	Medical Practice Plan-MPP (AUB-FM); Lebanese National Council for Scientific Research (CNRS)	Medical Practice Plan-MPP (AUB-FM); Lebanese National Council for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This research was supported by funding from the Medical Practice Plan-MPP (AUB-FM) and the Lebanese National Council for Scientific Research (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kheir W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026112; Abou-Kheir WG, 2010, STEM CELLS, V28, P2129, DOI 10.1002/stem.538; Aniszewski T, 2007, ALKALOIDS SECRETS LI; Bonesi M, 2013, J PHARM PHARMACOL, V65, P1726, DOI 10.1111/jphp.12172; Bournine L, 2013, PHYTOMEDICINE; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Corcoran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050999; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Eid AA, 2013, DIABETES, V62, P2935, DOI 10.2337/db12-1504; Esseily F, 2012, MINERVA BIOTECNOL, V24, P129; Fetsch PA, 2006, CANCER LETT, V235, P84, DOI 10.1016/j.canlet.2005.04.024; Foster BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055062; Ho YT, 2009, PHYTOMEDICINE, V16, P887, DOI 10.1016/j.phymed.2009.02.015; Huang M, 2007, CLIN CANCER RES, V13, P1298, DOI 10.1158/1078-0432.CCR-06-1277; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaseb AO, 2007, CANCER RES, V67, P7782, DOI 10.1158/0008-5472.CAN-07-1483; Kim S, 2008, MOLECULES, V13, P2975, DOI 10.3390/molecules13122975; Koncic MZ, 2010, FOOD CHEM TOXICOL, V48, P2176, DOI 10.1016/j.fct.2010.05.025; Li WH, 2007, CANCER BIOL THER, V6, P787, DOI 10.4161/cbt.6.5.4006; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021416; Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200; Luk SU, 2011, INT J CANCER, V128, P2182, DOI 10.1002/ijc.25546; Luk SU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019804; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Marc EB, 2008, J ETHNOPHARMACOL, V120, P315, DOI 10.1016/j.jep.2008.08.024; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Rafi MM, 2002, J AGR FOOD CHEM, V50, P677, DOI 10.1021/jf010774e; Refaat A, 2013, ONCOL LETT, V6, P840, DOI 10.3892/ol.2013.1434; Roberts M. F., 1998, ALKALOIDS BIOCH ECOL; Schroeder A, 2013, CANC RES; Sharifi N, 2006, CANCER BIOL THER, V5, P901, DOI 10.4161/cbt.5.8.2949; Singh J, 2009, J ETHNOPHARMACOL, V123, P22, DOI 10.1016/j.jep.2009.02.038; Singh T, 2011, CARCINOGENESIS, V32, P86, DOI 10.1093/carcin/bgq215; Slaninova I, 2013, PHYTOCHEM REV, P1; Wang Y, 2012, MUTAT RES-FUND MOL M, V734, P20, DOI 10.1016/j.mrfmmm.2012.04.005; Yu Jun, 2013, Curr Ther Res Clin Exp, V75, P8, DOI 10.1016/j.curtheres.2013.04.001; Zhang LL, 2012, CANCER LETT, V323, P48, DOI 10.1016/j.canlet.2012.03.037	39	34	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112453	10.1371/journal.pone.0112453	http://dx.doi.org/10.1371/journal.pone.0112453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380390	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100099
J	Martino, NA; Reshkin, SJ; Ciani, E; Dell'Aquila, ME				Martino, Nicola Antonio; Reshkin, Stephan Joel; Ciani, Elena; Dell'Aquila, Maria Elena			Calcium-Sensing Receptor-Mediated Osteogenic and Early-Stage Neurogenic Differentiation in Umbilical Cord Matrix Mesenchymal Stem Cells from a Large Animal Model	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PHENOTYPIC CHARACTERIZATION; CA2+-SENSING RECEPTOR; AMNIOTIC-FLUID; EQUINE TENDON; STROMAL CELLS; EXPRESSION; BLOOD; PROLIFERATION; THERAPY	Background: Umbilical cord matrix mesenchymal stem cells (UCM-MSCs) present a wide range of potential therapeutical applications. The extracellular calcium-sensing receptor (CaSR) regulates physiological and pathological processes. We investigated, in a large animal model, the involvement of CaSR in triggering osteogenic and neurogenic differentiation of two size-sieved UCM-MSC lines, by using AMG641, a novel potent research calcimimetic acting as CaSR agonist. Methodology/Principal Findings: Large (>8 mu m in diameter) and small (<8 mu m) equine UCM-MSC lines were cultured in medium with high calcium (Ca2+) concentration ([Ca2+](o); 2.87 mM) and dose-response effects of AMG641 (0.01 to 3 mu M) on cell proliferation were evaluated. Both cell lines were then cultured in osteogenic or neurogenic differentiation medium containing: 1) low [Ca2+] o (0.37 mM); 2) high [Ca2+](o) (2.87 mM); 3) AMG641 (0.05, 0.1 or 1 mu M) with high [Ca2+](o) and 4) the CaSR antagonist NPS2390 (10 mM for 30 min) followed by incubation with AMG641 in high [Ca2+](o). Expression of osteogenic or neurogenic differentiation biomarkers was compared among groups. In both cell lines, AMG641 dose-dependently increased cell proliferation (up to P<0.001). Osteogenic molecular markers expression was differentially regulated by AMG641, with stimulatory (OPN up-regulation) in large or inhibitory (RUNX2 and OPN down-regulation) effects in small cells, respectively. AMG641 significantly increased alkaline phosphatase activity and calcium phosphate deposition in both cell lines. Following treatment with AMG641 during osteogenic differentiation, in both cell lines CaSR expression was inversely related to that of osteogenic markers and inhibition of CaSR by NPS2390 blocked AMG641-dependent responses. Early-stage neurogenic differentiation was promoted/triggered by AMG641 in both cell lines, as Nestin and CaSR mRNA transcription up-regulation were observed. Conclusions/Significance: Calcium-and AMG641-induced CaSR stimulation promoted in vitro proliferation and osteogenic and early-stage neurogenic differentiation of UCM-MSCs. CaSR activation may play a fundamental role in selecting specific differentiation checkpoints of these two differentiation routes, as related to cell commitment status.	[Martino, Nicola Antonio; Dell'Aquila, Maria Elena] Univ Bari Aldo Moro, DETO, Sect Vet Clin & Anim Prod, Bari, Italy; [Reshkin, Stephan Joel; Ciani, Elena] Univ Bari Aldo Moro, DBBB, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Martino, NA (corresponding author), Univ Bari Aldo Moro, DETO, Sect Vet Clin & Anim Prod, Bari, Italy.	nicmartino@libero.it	Martino, Nicola/AAP-9891-2020; Reshkin, Stephan/AAI-6680-2020; Martino, Nicola Antonio/N-4096-2014	Reshkin, Stephan/0000-0001-9757-5908; Martino, Nicola Antonio/0000-0001-6853-2757; Dell'Aquila, Maria Elena/0000-0003-3629-7005; ciani, elena/0000-0001-5673-0975	ONEV MIUR [PONa3_00134 - n.254/RC]; ERA-Amgen (Amgen Inc., Thousand Oaks, California, United States of America) [2011568566]	ONEV MIUR(Ministry of Education, Universities and Research (MIUR)); ERA-Amgen (Amgen Inc., Thousand Oaks, California, United States of America)	The study was supported by ONEV MIUR PONa3_00134 - n.254/R&C 18/05/2011. The authors received AMG641 from ERA-Amgen (Amgen Inc., Thousand Oaks, California, United States of America; Research Program Agreement no 2011568566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabzadeh A, 2009, MOL BIOTECHNOL, V43, P264, DOI 10.1007/s12033-009-9196-2; Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020; Borjesson DL, 2011, CLIN LAB MED, V31, P109, DOI 10.1016/j.cll.2010.12.001; Brennan SC, 2013, BBA-MOL CELL RES, V1833, P1732, DOI 10.1016/j.bbamcr.2012.12.011; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Byeon YE, 2010, CYTOTHERAPY, V12, P626, DOI 10.3109/14653249.2010.481665; Corradetti B, 2011, CELL PROLIFERAT, V44, P330, DOI 10.1111/j.1365-2184.2011.00759.x; Cremonesi F, 2008, VET RES COMMUN, V32, pS139, DOI 10.1007/s11259-008-9116-0; De Santis T, 2009, REPRODUCTION, V138, P439, DOI 10.1530/REP-09-0078; de Torres C, 2009, CANCER-AM CANCER SOC, V115, P2792, DOI 10.1002/cncr.24304; Di Tomo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073816; Dvorak MM, 2007, ENDOCRINOLOGY, V148, P3156, DOI 10.1210/en.2007-0147; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Esposito M, 2013, IN VIVO, V27, P495; Gatta V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-635; Gittel C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-221; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Hall MS, 2013, AUST VET J, V91, P102, DOI 10.1111/avj.12015; He YH, 2012, MOL CELL BIOCHEM, V361, P321, DOI 10.1007/s11010-011-1118-5; Henaut L, 2014, CARDIOVASC RES, V101, P256, DOI 10.1093/cvr/cvt249; Henley C, 2009, EUR J PHARMACOL, V616, P306, DOI 10.1016/j.ejphar.2009.05.013; Hinrichs K, 2007, THERIOGENOLOGY, V68, P521, DOI 10.1016/j.theriogenology.2007.04.046; Hobson SA, 2003, MOL CELL ENDOCRINOL, V200, P189, DOI 10.1016/S0303-7207(01)00749-3; Hoynowski SM, 2007, BIOCHEM BIOPH RES CO, V362, P347, DOI 10.1016/j.bbrc.2007.07.182; Hua J, 2014, CELL BIOL INT, V38, P198, DOI 10.1002/cbin.10188; HUANG SX, 1995, BIOCHEM J, V310, P881, DOI 10.1042/bj3100881; Iacono E, 2012, REPRODUCTION, V143, P455, DOI 10.1530/REP-10-0408; Jung SY, 2005, EXP MOL MED, V37, P91, DOI 10.1038/emm.2005.13; Kim DW, 2013, INT J MOL SCI, V14, P11692, DOI 10.3390/ijms140611692; Koori K, 2014, CELL TISSUE RES, V357, P707, DOI 10.1007/s00441-014-1918-5; Kwak JO, 2005, EXP MOL MED, V37, P457, DOI 10.1038/emm.2005.56; Lange-Consiglio A, 2012, J TISSUE ENG REGEN M, V6, P622, DOI 10.1002/term.465; Lange-Consiglio A, 2013, CYTOTHERAPY, V15, P1011, DOI 10.1016/j.jcyt.2013.03.002; Lavreysen H, 2003, MOL PHARMACOL, V63, P1082, DOI 10.1124/mol.63.5.1082; Lee KS, 2013, RES VET SCI, V94, P144, DOI 10.1016/j.rvsc.2012.07.033; Li TX, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/218543; Liu S, 2013, J BIOSCI BIOENG; Lopez I, 2008, KIDNEY INT, V73, P300, DOI 10.1038/sj.ki.5002675; Lopez I, 2009, AM J PHYSIOL-RENAL, V296, pF1376, DOI 10.1152/ajprenal.90737.2008; Mailland M, 1997, ENDOCRINOLOGY, V138, P3601, DOI 10.1210/en.138.9.3601; Marcus AJ, 2008, J CELL MOL MED, V12, P730, DOI 10.1111/j.1582-4934.2008.00221.x; Martino NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017714; McNeil L, 1998, AM J OBSTET GYNECOL, V178, P305, DOI 10.1016/S0002-9378(98)80017-3; Mendoza FJ, 2011, J ANDROL, V33, P96, DOI 10.2164/jandrol.110.011254; Mendoza FJ, 2011, CALCIFIED TISSUE INT, V88, P169, DOI 10.1007/s00223-010-9442-4; Mendoza FJ, 2009, AM J PHYSIOL-RENAL, V296, pF605, DOI 10.1152/ajprenal.90272.2008; Mentaverri R, 2006, FASEB J, V20, P2562, DOI 10.1096/fj.06-6304fje; Mori G, 2012, INT J MED SCI, V9, P480, DOI 10.7150/ijms.4583; Noeske T, 2006, QSAR COMB SCI, V25, P134, DOI 10.1002/qsar.200510139; Pappa KI, 2009, REGEN MED, V4, P423, DOI 10.2217/RME.09.12; Passeri S, 2009, CELL BIOL INT, V33, P100, DOI 10.1016/j.cellbi.2008.10.012; Penny J, 2012, FRONT BIOSCI-LANDMRK, V17, P892, DOI 10.2741/3963; Pipino C, 2014, STEM CELLS DEV, V23, P2959, DOI 10.1089/scd.2013.0627; Reed SA, 2013, J ANIM SCI, V91, P59, DOI 10.2527/jas.2012-5736; Rho GJ, 2009, FRONT BIOSCI-LANDMRK, V14, P3942, DOI [10.2735/3503, 10.2741/3503]; Riccardi D, 2012, ANNU REV PHYSIOL, V74, P271, DOI 10.1146/annurev-physiol-020911-153318; Ricco S, 2013, INT J IMMUNOPATH PH, V26, P61, DOI 10.1177/03946320130260S108; Rodriguez M, 2008, KIDNEY INT, V74, pS50, DOI 10.1038/ki.2008.546; Seo MS, 2009, J VET SCI, V10, P181, DOI 10.4142/jvs.2009.10.3.181; Singh N, 2013, BEST PRACT RES CL EN, V27, P455, DOI 10.1016/j.beem.2013.04.001; Sun J, 2013, DIFFERENTIATION, V85, P32, DOI 10.1016/j.diff.2012.11.002; Tfelt-Hansen J, 2004, ENDOCRINOLOGY, V145, P1211, DOI 10.1210/en.2003-0749; Tondreau T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-166; Uppalapati D, 2011, MOL PHARMACEUT, V8, P1549, DOI 10.1021/mp2001582; Uranio MF, 2011, MOL REPROD DEV, V78, P361, DOI 10.1002/mrd.21311; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Wei FL, 2012, J CELL PHYSIOL, V227, P3216, DOI 10.1002/jcp.24012; Wislet-Gendebien S, 2003, J CELL SCI, V116, P3295, DOI 10.1242/jcs.00639; Wu KH, 2013, CELL TRANSPLANT, V22, P2041, DOI 10.3727/096368912X663533; Yamaguchi T, 2002, BIOCHEM BIOPH RES CO, V299, P532, DOI 10.1016/S0006-291X(02)02690-6	72	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111533	10.1371/journal.pone.0111533	http://dx.doi.org/10.1371/journal.pone.0111533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379789	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100031
J	Nunney, L; Ortiz, B; Russell, SA; Sanchez, RR; Stouthamer, R				Nunney, Leonard; Ortiz, Beatriz; Russell, Stephanie A.; Sanchez, Rebeca Ruiz; Stouthamer, Richard			The Complex Biogeography of the Plant Pathogen Xylella fastidiosa: Genetic Evidence of Introductions and Subspecific Introgression in Central America	PLOS ONE			English	Article							INTERSUBSPECIFIC RECOMBINATION; LEAF SCORCH; 1ST REPORT; CITRUS; STRAINS; DISEASE; COFFEE; BIOLOGY	The bacterium Xylella fastidiosa is a plant pathogen with a history of economically damaging introductions of subspecies to regions where its other subspecies are native. Genetic evidence is presented demonstrating the introduction of two new taxa into Central America and their introgression into the native subspecies, X. fastidiosa subsp. fastidiosa. The data are from 10 genetic outliers detected by multilocus sequence typing (MLST) of isolates from Costa Rica. Six (five from oleander, one from coffee) defined a new sequence type (ST53) that carried alleles at six of the eight loci sequenced (five of the seven MLST loci) diagnostic of the South American subspecies Xylella fastidiosa subsp. pauca which causes two economically damaging plant diseases, citrus variegated chlorosis and coffee leaf scorch. The two remaining loci of ST53 carried alleles from what appears to be a new South American form of X. fastidiosa. Four isolates, classified as X. fastidiosa subsp. fastidiosa, showed a low level of introgression of non-native DNA. One grapevine isolate showed introgression of an allele from X. fastidiosa subsp. pauca while the other three (from citrus and coffee) showed introgression of an allele with similar ancestry to the alleles of unknown origin in ST53. The presence of X. fastidiosa subsp. pauca in Central America is troubling given its disease potential, and establishes another route for the introduction of this economically damaging subspecies into the US or elsewhere, a threat potentially compounded by the presence of a previously unknown form of X. fastidiosa.	[Nunney, Leonard] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Ortiz, Beatriz; Sanchez, Rebeca Ruiz] Univ Costa Rica, Ctr Invest Biol Celular & Mol, San Jose, Costa Rica; [Russell, Stephanie A.; Stouthamer, Richard] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside; Universidad Costa Rica; University of California System; University of California Riverside	Nunney, L (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	leonard.nunney@ucr.edu	Sanchez, Rebeca/GXH-6596-2022	Sanchez, Rebeca/0000-0002-2073-2810; Nunney, Leonard/0000-0002-4315-3694	USDA-CSREES-NRI [2007-55605-17834]; International Foundation for Science [C/5152-1]; Vice-Rector for Research at Universidad de Costa Rica	USDA-CSREES-NRI(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); International Foundation for Science(International Foundation for Science); Vice-Rector for Research at Universidad de Costa Rica	This work was supported in part by USDA-CSREES-NRI grant 2007-55605-17834 to LN and RS. BO was supported by the International Foundation for Science (grant C/5152-1) and Vice-Rector for Research at Universidad de Costa Rica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2005, PLANT DIS, V89, P687, DOI 10.1094/PD-89-0687B; Almeida RPP, 2008, APPL ENVIRON MICROB, V74, P3690, DOI 10.1128/AEM.02388-07; AMARO AA, 1998, CITRUS VARIEGATED CH, P123; Beretta MJG, 1996, PLANT DIS, V80, P821, DOI 10.1094/PD-80-0821D; CHANG CJ, 1993, CURR MICROBIOL, V27, P137, DOI 10.1007/BF01576010; Coletta HD, 2003, PHYTOPATHOLOGY, V93, P28, DOI 10.1094/PHYTO.2003.93.1.28; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Kung SH, 2013, APPL ENVIRON MICROB, V79, P1712, DOI 10.1128/AEM.03525-12; Kung SH, 2011, APPL ENVIRON MICROB, V77, P5278, DOI 10.1128/AEM.00730-11; Li WB, 2001, PLANT DIS, V85, P501, DOI 10.1094/PDIS.2001.85.5.501; Montero-Astua M, 2008, J MICROBIOL, V46, P482, DOI 10.1007/s12275-008-0072-8; Nunney L, 2014, APPL ENVIRON MICROB, V80, P3025, DOI 10.1128/AEM.04112-13; Nunney L, 2014, APPL ENVIRON MICROB, V80, P1159, DOI 10.1128/AEM.02920-13; Nunney L, 2013, APPL ENVIRON MICROB, V79, P2189, DOI 10.1128/AEM.03208-12; Nunney L, 2012, APPL ENVIRON MICROB, V78, P4702, DOI 10.1128/AEM.01126-12; Nunney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015488; Redak RA, 2004, ANNU REV ENTOMOL, V49, P243, DOI 10.1146/annurev.ento.49.061802.123403; Rodriguez C. M., 2001, Plant Disease, V85, P1027, DOI 10.1094/PDIS.2001.85.9.1027A; Scally M, 2005, APPL ENVIRON MICROB, V71, P8491, DOI 10.1128/AEM.71.12.8491-8499.2005; Schaad NW, 2004, SYST APPL MICROBIOL, V27, P290, DOI 10.1078/0723-2020-00263; Schuenzel EL, 2005, APPL ENVIRON MICROB, V71, P3832, DOI 10.1128/AEM.71.7.3832-3839.2005; Su CC, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00166-14; Yuan X, 2010, PHYTOPATHOLOGY, V100, P601, DOI 10.1094/PHYTO-100-6-0601	23	59	60	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							fastidiosa: e112463	10.1371/journal.pone.0112463	http://dx.doi.org/10.1371/journal.pone.0112463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379725	Green Published, gold			2022-12-26	WOS:000344863100102
J	de Plater, L; Vincent-Salomon, A; Berger, F; Nicolas, A; Vacher, S; Gravier, E; Thuleau, A; Karboul, N; Richardson, M; Elbaz, C; Marangoni, E; Bieche, I; Paoletti, X; Roman-Roman, S; Culp, PA; Asselain, B; Dieras, V; Decaudin, D				de Plater, Ludmilla; Vincent-Salomon, Anne; Berger, Frederique; Nicolas, Andre; Vacher, Sophie; Gravier, Eleonore; Thuleau, Aurelie; Karboul, Narjesse; Richardson, Marion; Elbaz, Clement; Marangoni, Elisabetta; Bieche, Ivan; Paoletti, Xavier; Roman-Roman, Sergio; Culp, Patricia A.; Asselain, Bernard; Dieras, Veronique; Decaudin, Didier			Predictive Gene Signature of Response to the Anti-TweakR mAb PDL192 in Patient-Derived Breast Cancer Xenografts	PLOS ONE			English	Article							NECROSIS-FACTOR FAMILY; INHIBITS TUMOR-GROWTH; WEAK INDUCER; KAPPA-B; RECEPTOR; CELLS; FN14; APOPTOSIS; THERAPY; TNF	Purpose: (1) To determine TweakR expression in human breast cancers (BC), (2) evaluate the antitumor effect of the anti-TweakR antibody PDL192, used alone or after chemotherapy-induced complete remission (CR), on patient-derived BC xenografts (PDX) and (3) define predictive markers of response. Experimental Design: TweakR expression was analyzed by IHC on patients and PDXs BC samples. In vivo antitumor effect of PDL192 was evaluated on eight TweakR-positive BC PDXs alone or after complete remission induced by a combination of doxorubicin and cyclophosphamide. Using both responding and resistant PDX tumors after PDL192 administration, RT-QPCR were performed on a wide list of selected candidate genes to identify predictive markers of response. Results: TweakR protein was expressed in about half of human BC samples. In vivo PDL192 treatment had significantly antitumor activity in 4 of 8 TweakR-positive BC PDXs, but no correlation between the expression level of the Tweak receptor and response to therapy was observed. PDL192 also significantly delayed tumor relapse after CR. Finally, an 8 gene signature was defined from sensitive and resistant PDXs. Conclusions: PDL192 was highly efficient in some BC PDXs. We found 8 genes that were differentially expressed in responding and resistant tumors and could constitute a gene expression signature which would need to be extended to other xenograft models for confirmation. These data confirm the therapeutic potential of TweakR targeting in BC and the possibility of prospectively selecting patients who might benefit from therapy.	[de Plater, Ludmilla; Thuleau, Aurelie; Karboul, Narjesse; Elbaz, Clement; Marangoni, Elisabetta; Decaudin, Didier] Inst Curie, Translat Res Dept, Lab Preclin Invest, Paris, France; [Vincent-Salomon, Anne; Nicolas, Andre; Richardson, Marion] Inst Curie, Dept Tumor Biol, Paris, France; [Berger, Frederique; Gravier, Eleonore; Paoletti, Xavier; Asselain, Bernard] Inst Curie, Dept Biostat, Paris, France; [Berger, Frederique; Paoletti, Xavier; Asselain, Bernard] INSERM, U900, Paris, France; [Vacher, Sophie; Bieche, Ivan] Inst Curie, Dept Genet, Paris, France; [Roman-Roman, Sergio] Inst Curie, Translat Res Dept, Paris, France; [Culp, Patricia A.] AbbVie Biotherapeut, Redwood City, CA USA; [Dieras, Veronique; Decaudin, Didier] Inst Curie, Dept Oncogenet, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; AbbVie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Decaudin, D (corresponding author), Inst Curie, Translat Res Dept, Lab Preclin Invest, Paris, France.	didier.decaudin@curie.fr	Bièche, Ivan/O-7399-2017; Marangoni, Elisabetta/GSO-3945-2022; Roman-Roman, Sergio/K-9993-2014; BERGER, Frederique/A-8893-2008	Bièche, Ivan/0000-0002-2430-5429; Marangoni, Elisabetta/0000-0002-3337-6448; Roman-Roman, Sergio/0000-0001-6459-2613; BERGER, Frederique/0000-0002-3251-4060; VACHER, Sophie/0000-0002-0042-6023	AbbVie Biotherapeutics; Institut Curie	AbbVie Biotherapeutics(AbbVie); Institut Curie	The funding was provided both by AbbVie Biotherapeutics (TweakR expression study and in vivo experiments) and by the Institut Curie (determination of predictive genes in the response to PDL192). AbbVie Biotherapeutics provided support in the form of salary for author PC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Bieche I, 2001, CANCER RES, V61, P1652; Bieche I, 1999, CLIN CHEM, V45, P1148; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Briolay A, 2013, BIOCHEM BIOPH RES CO, V430, P1072, DOI 10.1016/j.bbrc.2012.12.036; Chao DT, 2013, J CANCER RES CLIN, V139, P315, DOI 10.1007/s00432-012-1332-x; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chorianopoulos E, 2010, BASIC RES CARDIOL, V105, P301, DOI 10.1007/s00395-009-0046-y; Creighton Chad J, 2013, Cancer Manag Res, V5, P187, DOI 10.2147/CMAR.S35171; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; Currie MJ, 2013, HUM PATHOL, V44, P402, DOI 10.1016/j.humpath.2012.06.004; Decaudin D, 2011, ANTI-CANCER DRUG, V22, P827, DOI 10.1097/CAD.0b013e3283475f70; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Filusch A, 2011, CLIN RES CARDIOL, V100, P879, DOI 10.1007/s00392-011-0318-z; Fortin SP, 2009, MOL CANCER RES, V7, P1871, DOI 10.1158/1541-7786.MCR-09-0194; Han HY, 2002, CANCER RES, V62, P2890; Ho DH, 2004, CANCER RES, V64, P8968, DOI 10.1158/0008-5472.CAN-04-1879; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Marangoni E, 2009, BRIT J CANCER, V100, P918, DOI 10.1038/sj.bjc.6604953; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Michaelson JS, 2012, CANCER BIOL THER, V13, P812, DOI 10.4161/cbt.20564; Michaelson JS, 2011, MABS-AUSTIN, V3, P362, DOI 10.4161/mabs.3.4.16090; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Segal B, 2008, ORAL SURG ORAL MED O, V106, P778, DOI 10.1016/j.tripleo.2008.07.025; Servant N, 2010, BMC RES NOTES, V3; Tamada K, 2006, CANCER IMMUNOL IMMUN, V55, P355, DOI 10.1007/s00262-005-0081-y; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Wang S, 2006, ONCOGENE, V25, P3346, DOI 10.1038/sj.onc.1209357; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Xu Bu-fang, 2011, Zhonghua Fu Chan Ke Za Zhi, V46, P355; Yin XF, 2013, CLIN CANCER RES, V19, P5686, DOI 10.1158/1078-0432.CCR-13-0405; Younes A, 2003, J CLIN ONCOL, V21, P3526, DOI 10.1200/JCO.2003.09.037	43	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e104227	10.1371/journal.pone.0104227	http://dx.doi.org/10.1371/journal.pone.0104227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375638	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600002
J	Limpitikul, W; Henpraserttae, N; Saksawad, R; Laoprasopwattana, K				Limpitikul, Wannee; Henpraserttae, Narong; Saksawad, Rachanee; Laoprasopwattana, Kamolwish			Typhoid Outbreak in Songkhla, Thailand 2009-2011: Clinical Outcomes, Susceptibility Patterns, and Reliability of Serology Tests	PLOS ONE			English	Article							BONE-MARROW; PARATYPHOID FEVER; SALMONELLA-TYPHI; DIPSTICK ASSAY; ENTERIC FEVER; DIAGNOSIS; CHILDREN; BLOOD; CULTURES; AREA	Objective: To determine the clinical manifestations and outcomes, the reliability of Salmonella enterica serotype Typhi (S ser. Typhi) IgM and IgG rapid tests, and the susceptibility patterns and the response to treatment during the 2009-2011 typhoid outbreak in Songkhla province in Thailand. Method: The medical records of children aged <15 years with S ser. Typhi bacteremia were analysed. The efficacy of the typhoid IgM and IgG rapid tests and susceptibility of the S ser. Typhi to the current main antibiotics used for typhoid (amoxicillin, ampicillin, cefotaxime, ceftriaxone, co-trimoxazole, and ciprofloxacin), were evaluated. Results: S ser. Typhi bacteremia was found in 368 patients, and all isolated strains were susceptible to all 6 antimicrobials tested. Most of the patients were treated with ciprofloxacin for 7-14 days. The median time (IQR) of fever before treatment and duration of fever after treatment were 5 (4, 7) days and 4 (3, 5) days, respectively. Complications of ascites, lower respiratory symptoms, anemia (Hct <30%), and ileal perforation were found in 7, 7, 22, and 1 patients, respectively. None of the patients had recurrent infection or died. The sensitivities of the typhoid IgM and IgG tests were 58.3% and 25.6% respectively, and specificities were 74.1% and 50.5%, respectively. Conclusion: Most of the patients were diagnosed at an early stage and treated with a good outcome. All S ser. Typhi strains were susceptible to standard first line antibiotic typhoid treatment. The typhoid IgM and IgG rapid tests had low sensitivity and moderate specificity.	[Limpitikul, Wannee] Songkhla Hosp, Dept Pediat, Songkhla, Thailand; [Henpraserttae, Narong] Minist Publ Hlth Songkhla, Dept Dis Control, Bur Epidemiol, Songkhla, Thailand; [Saksawad, Rachanee] Hat Yai Hosp, Hat Yai Educ Ctr, Dept Pediat, Songkhla, Thailand; [Laoprasopwattana, Kamolwish] Prince Songkla Univ, Fac Med, Dept Pediat, Hat Yai, Thailand	Prince of Songkla University; Prince of Songkla University	Laoprasopwattana, K (corresponding author), Prince Songkla Univ, Fac Med, Dept Pediat, Hat Yai, Thailand.	kamolwish@gmail.com	laoprasopwattana, kamolwish/AAQ-9092-2020		Faculty of Medicine, Prince of Songkla University [56-210-01-1-3]	Faculty of Medicine, Prince of Songkla University	The only funding received for this manuscript was grant no. 56-210-01-1-3 from the Faculty of Medicine, Prince of Songkla University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begum Z, 2009, Mymensingh Med J, V18, P13; Bhutta ZA, 1999, AM J TROP MED HYG, V61, P654, DOI 10.4269/ajtmh.1999.61.654; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; CHOO KE, 1993, J PAEDIATR CHILD H, V29, P36, DOI 10.1111/j.1440-1754.1993.tb00437.x; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Das S, 2013, DIAGN MICR INFEC DIS, V76, P5, DOI 10.1016/j.diagmicrobio.2013.01.012; Dolecek C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002188; Dutta S, 2006, DIAGN MICR INFEC DIS, V56, P359, DOI 10.1016/j.diagmicrobio.2006.06.024; Effa EE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004530.pub4; Emary K, 2012, T ROY SOC TROP MED H, V106, P718, DOI 10.1016/j.trstmh.2012.08.007; FAROOQUI BJ, 1991, J CLIN PATHOL, V44, P258, DOI 10.1136/jcp.44.3.258; Gasem MH, 2002, J MED MICROBIOL, V51, P173, DOI 10.1099/0022-1317-51-2-173; Hatta M, 2002, AM J TROP MED HYG, V66, P416, DOI 10.4269/ajtmh.2002.66.416; Henpraserttae N, 2010, TYPHOID OUTBREAK SON; House D, 2001, J CLIN MICROBIOL, V39, P1002, DOI 10.1128/JCM.39.3.1002-1007.2001; Kawano RL, 2007, J CLIN MICROBIOL, V45, P246, DOI 10.1128/JCM.01403-06; Keddy KH, 2011, B WORLD HEALTH ORGAN, V89, P640, DOI 10.2471/BLT.11.087627; Khanam F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002316; Lewis MD, 2005, CLIN INFECT DIS, V40, P554, DOI 10.1086/427503; Lynch MF, 2009, JAMA-J AM MED ASSOC, V302, P859, DOI 10.1001/jama.2009.1229; Martin LB, 2012, CURR OPIN INFECT DIS, V25, P489, DOI 10.1097/QCO.0b013e328356ffeb; Naheed A, 2008, DIAGN MICR INFEC DIS, V61, P381, DOI 10.1016/j.diagmicrobio.2008.03.018; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Saxe JM, 2005, AM J SURG, V189, P342, DOI 10.1016/j.amjsurg.2004.11.032; SIMANJUNTAK CH, 1991, LANCET, V338, P1055, DOI 10.1016/0140-6736(91)91910-M; Thaver D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1865; THISYAKORN U, 1987, AM J DIS CHILD, V141, P862, DOI 10.1001/archpedi.1987.04460080048025; Thriemer K, 2013, PLOS ONE, V7; Ugwu B T, 2005, West Afr J Med, V24, P1; VALLENAS C, 1985, PEDIATR INFECT DIS J, V4, P496, DOI 10.1097/00006454-198509000-00011; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; WARD LR, 1987, EPIDEMIOL INFECT, V99, P291, DOI 10.1017/S0950268800067765; Yang HH, 2001, J INFECT DIS, V183, P1775, DOI 10.1086/320729	34	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111768	10.1371/journal.pone.0111768	http://dx.doi.org/10.1371/journal.pone.0111768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375784	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600060
J	Salter, C; Brainard, J; McDaid, L; Loke, Y				Salter, Charlotte; Brainard, Julii; McDaid, Lisa; Loke, Yoon			Challenges and Opportunities: What Can We Learn from Patients Living with Chronic Musculoskeletal Conditions, Health Professionals and Carers about the Concept of Health Literacy Using Qualitative Methods of Inquiry?	PLOS ONE			English	Article							SHARED DECISION-MAKING; UNINTENTIONAL NONADHERENCE; COMMUNICATION; FRAMEWORK	The field of health literacy continues to evolve and concern public health researchers and yet remains a largely overlooked concept elsewhere in the healthcare system. We conducted focus group discussions in England UK, about the concept of health literacy with older patients with chronic musculoskeletal conditions (mean age = 73.4 years), carers and health professionals. Our research posed methodological, intellectual and practical challenges. Gaps in conceptualisation and expectations were revealed, reiterating deficiencies in predominant models for understanding health literacy and methodological shortcomings of using focus groups in qualitative research for this topic. Building on this unique insight into what the concept of health literacy meant to participants, we present analysis of our findings on factors perceived to foster and inhibit health literacy and on the issue of responsibility in health literacy. Patients saw health literacy as a result of an inconsistent interactive process and the implications as wide ranging; healthcare professionals had more heterogeneous views. All focus group discussants agreed that health literacy most benefited from good inter-personal communication and partnership. By proposing a needs-based approach to health literacy we offer an alternative way of conceptualising health literacy to help improve the health of older people with chronic conditions.	[Salter, Charlotte; Brainard, Julii; McDaid, Lisa; Loke, Yoon] Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Salter, C (corresponding author), Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	c.salter@uea.ac.uk	Morris, Josephine D./F-3366-2018	Morris, Josephine D./0000-0001-9404-5602; McDaid, Lisa/0000-0001-5032-2380	National Institute for Health Research under its Research for Patient Benefit Programme (RfPB); ESRC [ES/J022497/1] Funding Source: UKRI	National Institute for Health Research under its Research for Patient Benefit Programme (RfPB); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by the National Institute for Health Research under its Research for Patient Benefit Programme (RfPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Sayah F, 2012, CAN J DIABETES, V36, P27, DOI 10.1016/j.jcjd.2011.08.001; Appleby R, 2009, COLD WILL IT BE PROS; Australian Bureau of Statistics, 2009, AUSTR SOC TRENDS CAN; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Baker DW, 2000, J GERONTOL B-PSYCHOL, V55, pS368, DOI 10.1093/geronb/55.6.S368; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Berkman ND, 2010, J HEALTH COMMUN, V15, P9, DOI 10.1080/10810730.2010.499985; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; Chinn D, 2011, SOC SCI MED, V73, P60, DOI 10.1016/j.socscimed.2011.04.004; Collins SA, 2012, J BIOMED INFORM, V45, P598, DOI 10.1016/j.jbi.2012.04.001; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; Easton P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-319; Entwistle VA, 2012, J ROY SOC MED, V105, P416, DOI 10.1258/jrsm.2012.120039; Entwistle VA, 2010, J GEN INTERN MED, V25, P741, DOI 10.1007/s11606-010-1292-2; Gazmararian J, 2010, ANN PHARMACOTHER, V44, P80, DOI 10.1345/aph.1M328; Halkier B, 2010, QUAL RES, V10, P71, DOI 10.1177/1468794109348683; HLS-EU CONSORTIUM, 2012, COMP REP HLTH LIT 8; Jochelson K, 2007, HLTH LITERACY REV PA, P21; Jordan JE, 2011, J CLIN EPIDEMIOL, V64, P366, DOI 10.1016/j.jclinepi.2010.04.005; Joseph-Williams N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3178; Kmietowicz Z, 2004, BRIT MED J, V329, P14; Kramer G, 2013, HLTH LITERACY LETS T; Kwan B., 2006, U BRIT COLUMBIA I HL, P1; Lindquist LA, 2012, J GEN INTERN MED, V27, P173, DOI 10.1007/s11606-011-1886-3; Loke YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040210; Loke YK, 2012, ANN PHARMACOTHER, V46, P863, DOI 10.1345/aph.1Q718; Lupton Deborah, 2012, MED CULTURE ILLNESS, V3rd ed, DOI DOI 10.4135/9781446254530; McCaffery KJ, 2010, MED DECIS MAKING, V30, P35, DOI 10.1177/0272989X09342279; McCann L, 2014, YOU CANT DO BOTH SOM; Mol Annemarie, 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Moser C., 1999, IMPROVING LITERACY N; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D, 2009, INT J PUBLIC HEALTH, V54, P303, DOI 10.1007/s00038-009-0050-x; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Paasche-Orlow MK, 2005, J GEN INTERN MED, V20, P175, DOI 10.1111/j.1525-1497.2005.40245.x; Peerson A, 2009, HEALTH PROMOT INT, V24, P285, DOI 10.1093/heapro/dap014; Protheroe J, 2013, J HEALTH PSYCHOL, V18, P1046, DOI 10.1177/1359105312459876; Raynor DKT, 2012, BMJ, V344; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Salter B.G., 2004, NEW POLITICS MED; Schulz PJ, 2013, PATIENT EDUC COUNS, V90, P4, DOI 10.1016/j.pec.2012.09.006; Sheridan SL, 2011, J HEALTH COMMUN, V16, P30, DOI 10.1080/10810730.2011.604391; Smith SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074373; Smith SK, 2009, SOC SCI MED, V69, P1805, DOI 10.1016/j.socscimed.2009.09.056; Smith SK, 2013, J HLTH PSYCHOL; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Volandes AE, 2007, AM J BIOETHICS, V7, P5, DOI 10.1080/15265160701638520; von Wagner C, 2009, HEALTH EDUC BEHAV, V36, P860, DOI 10.1177/1090198108322819; Weiss B, 2007, HLTH LITERACY PATIEN; Wolf MS, 2007, J HEALTH COMMUN, V12, P721, DOI 10.1080/10810730701672173; Wroe AL, 2002, J BEHAV MED, V25, P355, DOI 10.1023/A:1015866415552	53	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112041	10.1371/journal.pone.0112041	http://dx.doi.org/10.1371/journal.pone.0112041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375767	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000344402600094
J	Sun, X; Zhong, Y; Huang, Z; Yang, YF				Sun, Xian; Zhong, Yu; Huang, Zhi; Yang, Yufeng			Selenium Accumulation in Unicellular Green Alga Chlorella vulgaris and Its Effects on Antioxidant Enzymes and Content of Photosynthetic Pigments	PLOS ONE			English	Article							LIPID-PEROXIDATION; OXIDATIVE STRESS; CHLOROPHYLL-A; GROWTH; DAMAGE; PHYTOPLANKTON; REQUIREMENTS; SPECIATION; NUTRITION; TOXICITY	The aim of the present study was to investigate selenite effects in the unicellular green algae Chlorella vulgaris as a primary producer and the relationship with intracellular bioaccumulation. The effects of selenite were evaluated by measuring the effect of different selenite concentrations on algal growth during a 144 h exposure period. It was found that lower Se concentrations (<75 mg L-1) positively promoted C. vulgaris growth and acted as antioxidant by inhibiting lipid peroxidation (LPO) and intracellular reactive oxygen species (ROS). The antioxidative effect was associated with an increase in guaiacol peroxidase (GPX), catalase (CAT), superoxide dismutase (SOD) and photosynthetic pigments. Meanwhile, significant increase in the cell growth rate and organic Se content was also detected in the algae. In contrast, these changes were opposite in C. vulgaris exposed to Se higher than 100 mg L-1. The antioxidation and toxicity appeared to be correlated to Se bioaccumulation, which suggests the appropriate concentration of Se in the media accumulation of C. vulgaris should be 75 mg L-1. Taken together, C. vulgaris possesses tolerance to Se, and Se-Chlorella could be developed as antioxidative food for aquaculture and human health.	[Sun, Xian; Zhong, Yu; Yang, Yufeng] Jinan Univ, Inst Hydrobiol, Guangzhou 510632, Guangdong, Peoples R China; [Sun, Xian; Zhong, Yu; Yang, Yufeng] Guangdong Higher Educ Inst, Key Lab Aquat Eutrophicat & Control Harmful Algal, Guangzhou 510632, Guangdong, Peoples R China; [Huang, Zhi] Jinan Univ, Dept Biotechnol, Guangzhou 510632, Guangdong, Peoples R China	Chinese Academy of Sciences; Jinan University; Jinan University	Yang, YF (corresponding author), Jinan Univ, Inst Hydrobiol, Guangzhou 510632, Guangdong, Peoples R China.	tyyf@jnu.edu.cn			Nature Science Foundation of China [U1301235, 41173079]; Support Project of the Science and Technology, China [2012BAC07B05, 2012BAD18B01]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Support Project of the Science and Technology, China	This work was supported by Nature Science Foundation of China (U1301235, 41173079) and the Support Project of the Science and Technology, China (2012BAC07B05, 2012BAD18B01). (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuner E, 2004, PROCESS BIOCHEM, V39, P623, DOI 10.1016/S0032-9592(03)00138-9; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Arthur JR, 2003, J NUTR, V133, p1457S, DOI 10.1093/jn/133.5.1457S; Baines SB, 2004, LIMNOL OCEANOGR, V49, P566, DOI 10.4319/lo.2004.49.2.0566; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BEER S, 1985, AUST J MAR FRESH RES, V36, P785; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buege J A, 1978, Methods Enzymol, V52, P302; Candan N, 2003, PLANT PHYSIOL BIOCH, V41, P35, DOI 10.1016/S0981-9428(02)00006-2; Chang WP, 2005, DEV COMP IMMUNOL, V29, P265, DOI 10.1016/j.dci.2004.07.004; Chassaigne H, 2002, J CHROMATOGR A, V976, P409, DOI 10.1016/S0021-9673(02)00945-7; Chen TF, 2008, J INTEGR PLANT BIOL, V50, P40, DOI 10.1111/j.1744-7909.2007.00600.x; Conde JE, 1997, CHEM REV, V97, P1979, DOI 10.1021/cr960100g; Danbara A, 1999, PLANT CELL PHYSIOL, V40, P762, DOI 10.1093/oxfordjournals.pcp.a029603; de Alcantara S., 1998, Indian Journal of Experimental Biology, V36, P1286; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DEVOS CHR, 1989, J PLANT PHYSIOL, V135, P164, DOI 10.1016/S0176-1617(89)80171-3; Doblin MA, 1999, J PLANKTON RES, V21, P1153, DOI 10.1093/plankt/21.6.1153; Donahue JL, 1997, PLANT PHYSIOL, V113, P249, DOI 10.1104/pp.113.1.249; Doucha J, 2009, APPL MICROBIOL BIOT, V83, P1001, DOI 10.1007/s00253-009-2058-9; Douskova I., 2007, SEFS 5 S EUR FRESHW, P197; Ebert R, 2006, STEM CELLS, V24, P1226, DOI 10.1634/stemcells.2005-0117; Ekelund NGA, 2001, AQUAT SCI, V63, P457, DOI 10.1007/s00027-001-8044-7; Fan TWM, 2002, AQUAT TOXICOL, V57, P65, DOI 10.1016/S0166-445X(01)00261-2; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Furness RW, 1990, HEAVY METALS MARINE; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HARRISON PJ, 1988, MAR ECOL PROG SER, V47, P89, DOI 10.3354/meps047089; Hartikainen H, 2000, PLANT SOIL, V225, P193, DOI 10.1023/A:1026512921026; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HEMEDA HM, 1990, J FOOD SCI, V55, P184, DOI 10.1111/j.1365-2621.1990.tb06048.x; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Jeong DW, 2002, FEBS LETT, V517, P225, DOI 10.1016/S0014-5793(02)02628-5; KIFFNEY P, 1990, ARCH ENVIRON CON TOX, V19, P488, DOI 10.1007/BF01059066; Kong LA, 2005, PLANT GROWTH REGUL, V45, P155, DOI 10.1007/s10725-005-1893-7; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lavu RVS, 2013, J PLANT NUTR SOIL SC, V176, P634, DOI 10.1002/jpln.201200339; Letavayova L, 2006, TOXICOLOGY, V227, P1, DOI 10.1016/j.tox.2006.07.017; Levy JL, 2005, ENVIRON TOXICOL CHEM, V24, P2630, DOI 10.1897/04-580R.1; Li ZY, 2003, BIORESOURCE TECHNOL, V89, P171, DOI 10.1016/S0960-8524(03)00041-5; Lin YH, 2007, AQUACULTURE, V267, P38, DOI 10.1016/j.aquaculture.2006.12.015; Liu ZY, 2008, BIORESOURCE TECHNOL, V99, P4717, DOI 10.1016/j.biortech.2007.09.073; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Neumann PM, 2003, PLANT CELL ENVIRON, V26, P897, DOI 10.1046/j.1365-3040.2003.01022.x; Patrick Lyn, 2004, Altern Med Rev, V9, P239; Pedrero Z, 2008, J AGR FOOD CHEM, V56, P266, DOI 10.1021/jf072266w; Pelah D, 2005, PLANT GROWTH REGUL, V45, P225, DOI 10.1007/s10725-005-3230-6; Phang SM, 2001, PHOTOSYNTHETIC MICROORGANISMS IN ENVIRONMENTAL BIOTECHNOLOGY, P51; Polatajko A, 2006, J ANAL ATOM SPECTROM, V21, P639, DOI 10.1039/b605654g; Pronina NA, 2002, RUSS J PLANT PHYSL+, V49, P235, DOI 10.1023/A:1014809825140; Rana SVS, 1997, B ENVIRON CONTAM TOX, V59, P152, DOI 10.1007/s001289900458; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Sager M, 2006, PURE APPL CHEM, V78, P111, DOI 10.1351/pac200678010111; Schomburg L, 2004, CELL MOL LIFE SCI, V61, P1988, DOI 10.1007/s00018-004-4114-z; Srivastava M, 2009, BIORESOURCE TECHNOL, V100, P1115, DOI 10.1016/j.biortech.2008.08.026; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Thomas H, 2001, ADV BOT RES, V35, P1, DOI 10.1016/S0065-2296(01)35003-6; THOMPSON JE, 1987, NEW PHYTOL, V105, P317, DOI 10.1111/j.1469-8137.1987.tb00871.x; Wada O, 1993, JPN J NUTR ASSESS, V10, P199; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; White PJ, 2004, J EXP BOT, V55, P1927, DOI 10.1093/jxb/erh192; Wu QY, 1992, PROG NAT SCI, V3, P435; YAMAOKA Y, 1994, APPL ORGANOMET CHEM, V8, P229, DOI 10.1002/aoc.590080312	68	33	37	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112270	10.1371/journal.pone.0112270	http://dx.doi.org/10.1371/journal.pone.0112270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375113	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600124
J	Yamanaka, Y; Oshima, T; Ishihama, A; Yamamoto, K				Yamanaka, Yuki; Oshima, Taku; Ishihama, Akira; Yamamoto, Kaneyoshi			Characterization of the YdeO Regulon in Escherichia coli	PLOS ONE			English	Article							DEPENDENT ACID RESISTANCE; CYX-APPA OPERON; TRANSCRIPTIONAL ACTIVATOR; BINDING PROFILES; GADE YHIE; GENE; REGULATOR; NETWORK; PROTEIN; SYSTEM	Enterobacteria are able to survive under stressful conditions within animals, such as acidic conditions in the stomach, bile salts during transfer to the intestine and anaerobic conditions within the intestine. The glutamate-dependent ( GAD) system plays a major role in acid resistance in Escherichia coli, and expression of the GAD system is controlled by the regulatory cascade consisting of EvgAS > YdeO > GadE. To understand the YdeO regulon in vivo, we used ChIP-chip to interrogate the E. coli genome for candidate YdeO binding sites. All of the seven operons identified by ChIP-chip as being potentially regulated by YdeO were confirmed as being under the direct control of YdeO using RT-qPCR, EMSA, DNaseI-footprinting and reporter assays. Within this YdeO regulon, we identified four stress-response transcription factors, DctR, NhaR, GadE, and GadW and enzymes for anaerobic respiration. Both GadE and GadW are involved in regulation of the GAD system and NhaR is an activator for the sodium/proton antiporter gene. In conjunction with co-transcribed Slp, DctR is involved in protection against metabolic endoproducts under acidic conditions. Taken all together, we suggest that YdeO is a key regulator of E. coli survival in both acidic and anaerobic conditions.	[Yamanaka, Yuki; Ishihama, Akira; Yamamoto, Kaneyoshi] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan; [Ishihama, Akira; Yamamoto, Kaneyoshi] Hosei Univ, Micronano Technol Res Ctr, Koganei, Tokyo 184, Japan; [Oshima, Taku] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara, Japan	Hosei University; Hosei University; Nara Institute of Science & Technology	Yamamoto, K (corresponding author), Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan.	kanyamam@hosei.ac.jp	Yamanaka, Yuki/AAV-3504-2020	Yamanaka, Yuki/0000-0003-3479-9896	MEXT; Special Coordination Funds for Promoting Science and Technology and JSPS-DST International Collaborations; Grants-in-Aid for Scientific Research [25430173] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology and JSPS-DST International Collaborations; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities and Special Coordination Funds for Promoting Science and Technology and JSPS-DST International Collaborations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATLUNG T, 1994, J BACTERIOL, V176, P5414, DOI 10.1128/JB.176.17.5414-5422.1994; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brondsted L, 1996, J BACTERIOL, V178, P1556, DOI 10.1128/jb.178.6.1556-1564.1996; Burton NA, 2010, J MOL BIOL, V401, P726, DOI 10.1016/j.jmb.2010.06.054; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chumsakul O, 2011, NUCLEIC ACIDS RES, V39, P414, DOI 10.1093/nar/gkq780; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Fried L, 2013, J BACTERIOL, V195, P807, DOI 10.1128/JB.02051-12; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Itou J, 2009, BIOSCI BIOTECH BIOCH, V73, P870, DOI 10.1271/bbb.80795; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Kraxenberger T, 2012, 1 INSIGHTS UNEXPLORE; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Ma Z, 2004, J BACTERIOL, V186, P7378, DOI 10.1128/JB.186.21.7378-7389.2004; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; Nguyen TM, 2012, ARCH MICROBIOL, V194, P637, DOI 10.1007/s00203-012-0798-x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAHAVMANOR O, 1992, J BIOL CHEM, V267, P10433; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Ueda T, 2013, DNA RES, V20, P263, DOI 10.1093/dnares/dst008; Uyar E, 2009, J BACTERIOL, V191, P2388, DOI 10.1128/JB.01594-08; Uzzau S, 2001, P NATL ACAD SCI USA, V94, P13997; Vanaja SK, 2009, J BACTERIOL, V191, P1868, DOI 10.1128/JB.01481-08; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Wadington MC, 2009, BIOCHEMISTRY-US, V48, P6559, DOI 10.1021/bi9008825; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yamamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1688, DOI 10.1271/bbb.60024; Yamamoto K, 2014, BIOSCI BIOTECH BIOCH, V78, P737, DOI 10.1080/09168451.2014.915731; Yamanaka Y, 2012, BIOSCI BIOTECH BIOCH, V76, P1236, DOI 10.1271/bbb.120041	39	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111962	10.1371/journal.pone.0111962	http://dx.doi.org/10.1371/journal.pone.0111962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375160	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600081
J	Adnadevic, T; Jovanovic, VM; Blagojevic, J; Budinski, I; Cabrilo, B; Bijelic-Cabrilo, O; Vujosevic, M				Adnadevic, Tanja; Jovanovic, Vladimir M.; Blagojevic, Jelena; Budinski, Ivana; Cabrilo, Borislav; Bijelic-Cabrilo, Olivera; Vujosevic, Mladen			Possible Influence of B Chromosomes on Genes Included in Immune Response and Parasite Burden in Apodemus flavicollis	PLOS ONE			English	Article							YELLOW-NECKED MOUSE; CLASS-II EXPRESSION; REGULATORY T-CELLS; HELIGMOSOMOIDES-POLYGYRUS; SPECIES RICHNESS; BODY CONDITION; FIELD MICE; WOOD MICE; TGF-BETA; RESISTANCE	Genetic background underlying wild populations immune response to different parasites is still not well understood. We studied immune response to multiple infections and to competition between different parasite species at different developmental stages in population of yellow-necked mouse, Apodemus flavicollis. Quantitative real-time PCR was used to investigate associations of MHC II-DRB, IL-10 and Tgf-beta genes expressions with presence of intestinal parasites at different developmental stages. Furthermore, we were interested whether the host related characteristics (sex, age, body condition, presence of B chromosomes or expression of other genes) or characteristics of present parasites (number of adult parasites of each identified species, egg count of each parasite genus, total number of nematode individuals) affect differential expression of the studied genes. A significant invert association between the expression of MHC II-DRB and Tgf-beta gene was found, which together with absence of IL-10 association confirmed modified Th2 as the main type of immune response to nematode infections. Effect of recorded parasites and parasite life-cycle stage on expression levels of MHC II-DRB gene was detected only through interactions with host-related characteristics such as sex, age, and the presence of B chromosomes. The presence of B chromosomes is associated with lower expression level of Tgf-beta gene. Although the influence of host genetic background on parasite infection has already been well documented, this is the first study in mammals that gave presence of B chromosomes on immune response full consideration.	[Adnadevic, Tanja; Jovanovic, Vladimir M.; Blagojevic, Jelena; Budinski, Ivana; Vujosevic, Mladen] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Genet Res, Belgrade, Serbia; [Cabrilo, Borislav; Bijelic-Cabrilo, Olivera] Univ Novi Sad, Fac Sci, Dept Biol & Ecol, Novi Sad, Serbia	University of Belgrade; University of Novi Sad	Adnadevic, T (corresponding author), Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Genet Res, Belgrade, Serbia.	tanja.adnadjevic@ibiss.bg.ac.rs	Budinski, Ivana/L-5470-2019; Blagojević, Jelena/B-4593-2008; Vujosevic, Mladen/C-3707-2016	Budinski, Ivana/0000-0001-8834-4200; Blagojević, Jelena/0000-0001-7102-5510; Vujosevic, Mladen/0000-0002-5577-4455; Cabrilo, Borislav/0000-0002-6085-3289; Adnadevic, Tanja/0000-0002-6665-861X; Jovanovic, Vladimir/0000-0002-8056-5065	Ministry of Education and Science of Serbia [173003]	Ministry of Education and Science of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education and Science of Serbia (http://www.mpn.gov.rs/nauka), Contract No. 173003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; Axtner J, 2011, INFECT GENET EVOL, V11, P2063, DOI 10.1016/j.meegid.2011.09.020; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; Behnke JM, 2009, PARASITOLOGY, V136, P793, DOI 10.1017/S0031182009006039; Behnke JM, 2005, J ANIM ECOL, V74, P982, DOI 10.1111/j.1365-2656.2005.00995.x; Behnke JM, 1999, J HELMINTHOL, V73, P31, DOI 10.1017/S0022149X99000049; Blagojevic J, 2004, HEREDITY, V93, P249, DOI 10.1038/sj.hdy.6800460; Bordes F, 2009, OIKOS, V118, P801, DOI 10.1111/j.1600-0706.2008.17169.x; Bordes F, 2009, PARASITOL RES, V106, P33, DOI 10.1007/s00436-009-1623-6; Borisavljevic L, 1955, ZBORNIK RADOVA I EKO, V6, P1; Bradley JE, 2008, PARASITOLOGY, V135, P807, DOI 10.1017/S0031182008000322; Bugrov AG, 2007, CHROMOSOME RES, V15, P315, DOI 10.1007/s10577-007-1128-z; Cheng YM, 2003, GENETICS, V164, P299; Danilowicz-Luebert E, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/821578; Degen AA, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P371, DOI 10.1007/978-4-431-36025-4_19; DHERAWAT.A, 1973, CROP SCI, V13, P591, DOI 10.2135/cropsci1973.0011183X001300060002x; Eira C, 2006, ACTA PARASITOL, V51, P300, DOI 10.2478/s11686-006-0046-0; Ferrari N, 2004, ECOL LETT, V7, P88, DOI 10.1046/j.1461-0248.2003.00552.x; Ferrari N, 2009, PARASITOLOGY, V136, P305, DOI 10.1017/S0031182008005404; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; Genov T, 1984, HELMINTI NASEKOMOYAD; Gorlov PI, 2000, HEREDITY EDINB, V84, P209; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hawrylowicz CM, 2005, J EXP MED, V202, P1459, DOI 10.1084/jem.20052211; Hayward AD, 2013, PARASITE IMMUNOL, V35, P362, DOI 10.1111/pim.12054; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Hsu TC, 1969, COMP MAMMALIAN CYTOG, P454; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jackson JA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-16; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Jojic V, 2007, J MAMMAL, V88, P689, DOI 10.1644/06-MAMM-A-019R1.1; Jojic V, 2011, J MAMMAL, V92, P396, DOI 10.1644/10-MAMM-A-158.1; Klein SL, 1998, AM NAT, V151, P59, DOI 10.1086/286102; Klementowicz JE, 2012, SEMIN IMMUNOPATHOL, V34, P815, DOI 10.1007/s00281-012-0348-2; Klimpel S, 2007, PARASITOL RES, V100, P867, DOI 10.1007/s00436-006-0368-8; Knolle PA, 1998, CLIN EXP IMMUNOL, V114, P427; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; MCGIRR SC, 1978, GENETICS, V90, P331; Metwali A, 2006, AM J PHYSIOL-GASTR L, V291, pG253, DOI 10.1152/ajpgi.00409.2005; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Meyer-Lucht Y, 2009, EVOL ECOL RES, V11, P1085; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; MIAO VPW, 1991, MOL GEN GENET, V226, P214, DOI 10.1007/BF00273606; Muller-Graf CDM, 1999, PARASITOLOGY, V118, P425, DOI 10.1017/S003118209800393X; Musolf K, 2004, IMMUNOGENETICS, V56, P420, DOI 10.1007/s00251-004-0715-9; NABAGLO L, 1979, ACTA THERIOL, V24, P118, DOI 10.4098/AT.arch.79-15; Ohta T, 1998, J MOL EVOL, V46, P633, DOI 10.1007/PL00006343; Page BT, 2001, GENETICS, V159, P291; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Pernthaner A, 2005, INFECT IMMUN, V73, P2175, DOI 10.1128/IAI.73.4.2175-2183.2005; Pinheiro J, 2020, R PACKAGE VERSION 31; Poulin R, 1997, ANNU REV ECOL SYST, V28, P341, DOI 10.1146/annurev.ecolsys.28.1.341; R Core Team, 2012, R LANG ENV STAT COMP; Reiczigel J., 2005, QUANTITATIVE PARASIT; Roepstorff A, 1998, 3 FAO, V3; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Ryikov K., 1979, KEY RODENT HELMINTH; Ryikov K., 1978, KEY RODENT HELMINTH; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schwensow N, 2011, INFECT GENET EVOL, V11, P23, DOI 10.1016/j.meegid.2010.10.017; StatSoft Inc, 1997, STAT WIND COMP PROGR; Tanic N, 2005, CHROMOSOMA, V113, P418, DOI 10.1007/s00412-004-0327-z; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vallance BA, 1999, INFECT IMMUN, V67, P6090, DOI 10.1128/IAI.67.11.6090-6097.1999; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vujosevic M, 2007, ITAL J ZOOL, V74, P313, DOI 10.1080/11250000701508578; Vujosevic M, 2004, CYTOGENET GENOME RES, V106, P247, DOI 10.1159/000079295; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Zima J, 2003, CAN J ZOOL, V81, P1312, DOI 10.1139/Z03-128	72	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112260	10.1371/journal.pone.0112260	http://dx.doi.org/10.1371/journal.pone.0112260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372668	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900130
J	Evans, TA; Perdue, B; Beran, MJ				Evans, Theodore A.; Perdue, Bonnie; Beran, Michael J.			The Relationship between Event-Based Prospective Memory and Ongoing Task Performance in Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							SPONTANEOUS RETRIEVAL; LANGUAGE-SKILLS; INTENTION; COST; INTERFERENCE; DEMANDS; RAT	Prospective memory is remembering to do something at a future time. A growing body of research supports that prospective memory may exist in nonhuman animals, but the methods used to test nonhuman prospective memory differ from those used with humans. The current work tests prospective memory in chimpanzees using a method that closely approximates a typical human paradigm. In these experiments, the prospective memory cue was embedded within an ongoing task. Tokens representing food items could be used in one of two ways: in a matching task with pictures of items (the ongoing task) or to request a food item hidden in a different location at the beginning of the trial. Chimpanzees had to disengage from the ongoing task in order to use the appropriate token to obtain a higher preference food item. In Experiment 1, chimpanzees effectively matched tokens to pictures, when appropriate, and disengaged from the ongoing task when the token matched the hidden item. In Experiment 2, performance did not differ when the target item was either hidden or visible. This suggested no effect of cognitive load on either the prospective memory task or the ongoing task, but performance was near ceiling, which may have contributed to this outcome. In Experiment 3, we created a more challenging version of the task. More errors on the matching task occurred before the prospective memory had been carried out, and this difference seemed to be limited to the hidden condition. This finding parallels results from human studies and suggests that working memory load and prospective memory may have a similar relationship in nonhuman primates.	[Evans, Theodore A.; Beran, Michael J.] Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA; [Perdue, Bonnie] Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA	University System of Georgia; Georgia State University	Evans, TA (corresponding author), Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA.	theodore.evans@gmail.com	Beran, Michael J./ABY-1786-2022; Beran, Michael J./M-8743-2016	Beran, Michael J./0000-0002-2504-0338; Beran, Michael J./0000-0002-2504-0338	National Science Foundation [BCS-0924811]; National Institute of Child Health and Human Development [P01HD060563]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD060563] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grant BCS-0924811 from the National Science Foundation and by grant P01HD060563 from the National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beran MJ, 2013, PSYCHOL SCI, V24, P660, DOI 10.1177/0956797612458936; Beran MJ, 2012, LEARN MOTIV, V43, P192, DOI 10.1016/j.lmot.2012.05.002; Beran MJ, 2012, AM J PRIMATOL, V74, P864, DOI 10.1002/ajp.22042; Beran MJ, 1998, EVOLUTION COMMUNICAT, V2, P171; Brakke KE, 1996, LANG COMMUN, V16, P361, DOI 10.1016/S0271-5309(96)00018-3; BRAKKE KE, 1995, LANG COMMUN, V15, P121, DOI 10.1016/0271-5309(95)00001-7; Brewer GA, 2011, APPL COGNITIVE PSYCH, V25, P632, DOI 10.1002/acp.1733; Brosnan SF, 2009, J COMP PSYCHOL, V123, P181, DOI 10.1037/a0015092; Crystal JD, 2013, BEHAV PROCESS, V93, P39, DOI 10.1016/j.beproc.2012.11.014; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 1990, J EXPT PSYCHOL LEARN, V16, P716; Ellis J., 1996, PROSPECTIVE MEMORY T, P1; Evans TA, 2012, COGNITION, V125, P131, DOI 10.1016/j.cognition.2012.07.012; Graf P, 2001, CONSCIOUS COGN, V10, P437, DOI 10.1006/ccog.2001.0504; Guynn MJ, 2003, INT J PSYCHOL, V38, P245, DOI 10.1080/00207590344000178; Hicks JL, 2005, J MEM LANG, V53, P430, DOI 10.1016/j.jml.2005.04.001; Honig WK, 1982, PSYCHOL LEARN MOTIV, V16, P239, DOI DOI 10.1016/S0079-7421(08)60551-4; Kliegel M, 2001, MEMORY, V9, P1, DOI 10.1080/09658210042000003; Kliegel M, 2008, DEV PSYCHOL, V44, P612, DOI 10.1037/0012-1649.44.2.612; Kumar D, 2008, CLIN NEUROPSYCHOL, V22, P497, DOI 10.1080/13854040701396687; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Marsh RL, 2007, AGING NEUROPSYCHOL C, V14, P168, DOI 10.1080/138255891007074; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Marsh RL, 2003, J EXP PSYCHOL LEARN, V29, P861, DOI 10.1037/0278-7393.29.5.861; Marsh RL, 2002, PSYCHON B REV, V9, P604, DOI 10.3758/BF03196319; McDaniel M. A., 2007, PROSPECTIVE MEMORY; McDaniel MA, 2004, APPL COGNITIVE PSYCH, V18, P533, DOI 10.1002/acp.1002; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Menzel CR, 1999, J COMP PSYCHOL, V113, P426, DOI 10.1037/0735-7036.113.4.426; MENZEL EW, 1973, SCIENCE, V182, P943, DOI 10.1126/science.182.4115.943; Perdue BM, 2014, ANIM COGN, V17, P287, DOI 10.1007/s10071-013-0661-8; Rumbaugh D. M., 2003, INTELLIGENCE APES OT; Rumbaugh DM., 1977, LANGUAGE LEARNING CH; Savage-Rumbaugh E.S., 1986, APE LANGUAGE CONDITI, DOI DOI 10.7312/SAVA90374; Scullin MK, 2010, PSYCHOL SCI, V21, P1028, DOI 10.1177/0956797610373373; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P190, DOI 10.1037/a0017732; Scullin MK, 2009, MEM COGNITION, V37, P425, DOI 10.3758/MC.37.4.425; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Suddendorf T, 2003, TRENDS COGN SCI, V7, P391, DOI 10.1016/S1364-6613(03)00187-6; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [10.1093/acprof:oso/9780195161564.003.0001, DOI 10.1093/ACPROF:OSO/9780195161564.003.0001]; Wilson AG, 2013, CURR BIOL, V23, P1089, DOI 10.1016/j.cub.2013.04.067; Wilson AG, 2012, ANIM COGN, V15, P349, DOI 10.1007/s10071-011-0459-5	45	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112015	10.1371/journal.pone.0112015	http://dx.doi.org/10.1371/journal.pone.0112015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372809	Green Published, gold			2022-12-26	WOS:000344556900104
J	Matthies, IE; Malosetti, M; Roder, MS; van Eeuwijk, F				Matthies, Inge E.; Malosetti, Marcos; Roeder, Marion S.; van Eeuwijk, Fred			Genome-Wide Association Mapping for Kernel and Malting Quality Traits Using Historical European Barley Records	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; GRAIN PROTEIN-CONTENT; DOUBLED-HAPLOID POPULATION; BACKCROSS-QTL ANALYSIS; LINKAGE DISEQUILIBRIUM; SPRING BARLEY; YIELD COMPONENTS; GENETIC DIVERSITY; AGRONOMIC TRAITS; LOCI	Malting quality is an important trait in breeding barley (Hordeum vulgare L.). It requires elaborate, expensive phenotyping, which involves micro-malting experiments. Although there is abundant historical information available for different cultivars in different years and trials, that historical information is not often used in genetic analyses. This study aimed to exploit historical records to assist in identifying genomic regions that affect malting and kernel quality traits in barley. This genome-wide association study utilized information on grain yield and 18 quality traits accumulated over 25 years on 174 European spring and winter barley cultivars combined with diversity array technology markers. Marker-trait associations were tested with a mixed linear model. This model took into account the genetic relatedness between cultivars based on principal components scores obtained from marker information. We detected 140 marker-trait associations. Some of these associations confirmed previously known quantitative trait loci for malting quality (on chromosomes 1H, 2H, and 5H). Other associations were reported for the first time in this study. The genetic correlations between traits are discussed in relation to the chromosomal regions associated with the different traits. This approach is expected to be particularly useful when designing strategies for multiple trait improvements.	[Matthies, Inge E.; Roeder, Marion S.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Gene & Genome Mapping, Gatersleben, Sachsen Anhalt, Germany; [Malosetti, Marcos; van Eeuwijk, Fred] Wageningen Univ & Res Ctr, Wageningen, Gelderland, Netherlands	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Wageningen University & Research	Matthies, IE (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Gene & Genome Mapping, Gatersleben, Sachsen Anhalt, Germany.	matthies@ipk-gatersleben.de; marcos.malosetti@wur.nl	Malosetti, Marcos/J-7685-2013	Malosetti, Marcos/0000-0002-8150-1397; Roder, Marion/0000-0002-9313-0650	Federal Ministry of Education and Research (BMBF) within the GABI program (GENOBAR) [0315066C]; Generation Challenge Program (GCP) [221]	Federal Ministry of Education and Research (BMBF) within the GABI program (GENOBAR)(Federal Ministry of Education & Research (BMBF)); Generation Challenge Program (GCP)	This study was supported by a grant from the Federal Ministry of Education and Research (BMBF) within the GABI program (GENOBAR, project No. 0315066C). The work of Marcos Malosetti and Fred van Eeuwijk was supported by the Generation Challenge Program (GCP), project No. 221. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Adetunji I, 2014, THEOR APPL GENET, V127, P559, DOI 10.1007/s00122-013-2239-x; Alsop BP, 2011, MOL BREEDING, V27, P77, DOI 10.1007/s11032-010-9415-3; [Anonymous], 2013, GENSTAT WINDOWS; Barr AR, 2003, AUST J AGR RES, V54, P1117, DOI 10.1071/AR02190; Bauer AM, 2009, THEOR APPL GENET, V119, P105, DOI 10.1007/s00122-009-1021-6; Beattie AD, 2010, CROP SCI, V50, P1649, DOI 10.2135/cropsci2009.06.0334; Bezant J, 1997, MOL BREEDING, V3, P29, DOI 10.1023/A:1009648220852; Blake VC, 2012, PLANT GENOME-US, V5, P81, DOI 10.3835/plantgenome2012.03.0002; Bradbury P, 2011, CROP SCI, V51, P52, DOI 10.2135/cropsci2010.02.0064; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Cai SG, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-35; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Comadran J, 2009, THEOR APPL GENET, V119, P175, DOI 10.1007/s00122-009-1027-0; Dreher K, 2003, MOL BREEDING, V11, P221, DOI 10.1023/A:1022820520673; Edney MJ, 2004, J CEREAL SCI, V39, P283, DOI 10.1016/j.jcs.2003.10.008; Emebiri LC, 2005, J CEREAL SCI, V41, P107, DOI 10.1016/j.jcs.2004.08.012; Fischbeck G, 1992, BARLEY GENET, P887; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fox GP, 2003, AUST J AGR RES, V54, P1081, DOI 10.1071/AR02237; Grewal TS, 2008, THEOR APPL GENET, V116, P529, DOI 10.1007/s00122-007-0688-9; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Han F, 1997, MOL BREEDING, V3, P427, DOI 10.1023/A:1009608312385; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Haseneyer G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-5; HAYES PM, 1993, THEOR APPL GENET, V87, P392, DOI 10.1007/BF01184929; Heuberger AL, 2013, PLANT BIOTECHNOL J, P1; Igartua E, 2000, CROP SCI, V40, P1426, DOI 10.2135/cropsci2000.4051426x; Iwata H, 2011, CROP SCI, V51, P1915, DOI 10.2135/cropsci2010.12.0732; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Kalladan R, 2013, MOL BREEDING, V32, P71, DOI 10.1007/s11032-013-9853-9; Kjaer B, 1996, EUPHYTICA, V90, P39; KOENKER RW, 1987, J R STAT SOC C-APPL, V36, P383; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Kraakman ATW, 2006, MOL BREEDING, V17, P41, DOI 10.1007/s11032-005-1119-8; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Krumnacker K, 2009, THESIS TUM; Lapitan NLV, 2009, THEOR APPL GENET, V118, P937, DOI 10.1007/s00122-008-0951-8; Larson SR, 1996, THEOR APPL GENET, V93, P618, DOI 10.1007/BF00417957; Li J, 2005, THEOR APPL GENET, V110, P356, DOI 10.1007/s00122-004-1847-x; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Marquez-Cedillo LA, 2000, THEOR APPL GENET, V101, P173, DOI 10.1007/s001220051466; Marquez-Cedillo LA, 2001, THEOR APPL GENET, V103, P625, DOI 10.1007/PL00002919; Mather DE, 1997, CROP SCI, V37, P544, DOI 10.2135/cropsci1997.0011183X003700020039x; Matthies IE, 2009, MOL BREEDING, V23, P139, DOI 10.1007/s11032-008-9221-3; Matthies IE, 2012, MOL BREEDING, V30, P951, DOI 10.1007/s11032-011-9678-3; Matthies IE, 2012, EUPHYTICA, V184, P73, DOI 10.1007/s10681-011-0563-2; Matthies IE, 2009, EUPHYTICA, V170, P109, DOI 10.1007/s10681-009-9915-6; Molina-Cano JL, 2007, MOL BREEDING, V19, P275, DOI 10.1007/s11032-006-9075-5; Moralejo M, 2004, THEOR APPL GENET, V110, P116, DOI 10.1007/s00122-004-1805-7; Morris M, 2003, MONEY MATTERS 2 COST; Oliphant A., 2002, BIOTECHNIQUES, V32, pS56, DOI DOI 10.2144/JUN0207; Oziel A, 1996, PLANT BREEDING, V115, P43, DOI 10.1111/j.1439-0523.1996.tb00869.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pswarayi A, 2008, EUPHYTICA, V163, P435, DOI 10.1007/s10681-008-9726-1; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rode J, 2012, MOL BREEDING, V30, P831, DOI 10.1007/s11032-011-9667-6; Romagosa I, 1996, THEOR APPL GENET, V93, P30, DOI 10.1007/BF00225723; Romagosa I, 1999, MOL BREEDING, V5, P143, DOI 10.1023/A:1009684108922; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Roy JK, 2010, MOL BREEDING, V26, P243, DOI 10.1007/s11032-010-9402-8; Schmalenbach I, 2009, THEOR APPL GENET, V118, P483, DOI 10.1007/s00122-008-0915-z; Schmalenbach I, 2009, THEOR APPL GENET, V118, P1411, DOI 10.1007/s00122-009-0991-8; Schmierer DA, 2004, MOL BREEDING, V14, P463, DOI 10.1007/s11032-004-0903-1; Schnaithmann F, 2013, EUPHYTICA, V189, P67, DOI 10.1007/s10681-012-0711-3; See D, 2002, CROP SCI, V42, P680, DOI 10.2135/cropsci2002.0680; Stich B, 2010, THEOR APPL GENET, V120, P553, DOI 10.1007/s00122-009-1175-2; SWANSTON JS, 2002, BARLEY SCI RECENT AD, P85; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tinker NA, 1996, CROP SCI, V36, P1053, DOI 10.2135/cropsci1996.0011183X003600040040x; Tondelli A, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0007; Ullrich E, 2000, THEOR APPL GENET, V101, P173; Varshney RK, 2012, FIELD CROP RES, V126, P171, DOI 10.1016/j.fcr.2011.10.008; Varshney RK, 2010, TRENDS BIOTECHNOL, V28, P452, DOI 10.1016/j.tibtech.2010.06.007; von Korff M, 2008, MOL BREEDING, V21, P81, DOI 10.1007/s11032-007-9110-1; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Weise S., 2009, Barley Genetics Newsletter, V39, P1; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Xu YB, 2012, MOL BREEDING, V29, P833, DOI 10.1007/s11032-012-9699-6; Xue DW, 2010, J ZHEJIANG UNIV-SC B, V11, P169, DOI 10.1631/jzus.B0900332; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang LY, 2009, THEOR APPL GENET, V119, P43, DOI 10.1007/s00122-009-1015-4; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zhu H, 1999, THEOR APPL GENET, V99, P1221, DOI 10.1007/s001220051328	100	38	38	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110046	10.1371/journal.pone.0110046	http://dx.doi.org/10.1371/journal.pone.0110046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372869	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900015
J	Mtatiro, SN; Singh, T; Rooks, H; Mgaya, J; Mariki, H; Soka, D; Mmbando, B; Msaki, E; Kolder, I; Thein, SL; Menzel, S; Cox, SE; Makani, J; Barrett, JC				Mtatiro, Siana Nkya; Singh, Tarjinder; Rooks, Helen; Mgaya, Josephine; Mariki, Harvest; Soka, Deogratius; Mmbando, Bruno; Msaki, Evarist; Kolder, Iris; Thein, Swee Lay; Menzel, Stephan; Cox, Sharon E.; Makani, Julie; Barrett, Jeffrey C.			Genome Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania	PLOS ONE			English	Article							GENETIC-VARIATION; BCL11A; PAIN; EPIDEMIOLOGY; DISEASE	Background: Fetal hemoglobin (HbF) is an important modulator of sickle cell disease (SCD). HbF has previously been shown to be affected by variants at three loci on chromosomes 2, 6 and 11, but it is likely that additional loci remain to be discovered. Methods and Findings: We conducted a genome-wide association study (GWAS) in 1,213 SCA (HbSS/HbS beta(0)) patients in Tanzania. Genotyping was done with Illumina Omni2.5 array and imputation using 1000 Genomes Phase I release data. Association with HbF was analysed using a linear mixed model to control for complex population structure within our study. We successfully replicated known associations for HbF near BCL11A and the HBS1L-MYB intergenic polymorphisms (HMIP), including multiple independent effects near BCL11A, consistent with previous reports. We observed eight additional associations with P < 10(-6). These associations could not be replicated in a SCA population in the UK. Conclusions: This is the largest GWAS study in SCA in Africa. We have confirmed known associations and identified new genetic associations with HbF that require further replication in SCA populations in Africa.	[Mtatiro, Siana Nkya; Mgaya, Josephine; Mariki, Harvest; Soka, Deogratius; Mmbando, Bruno; Msaki, Evarist; Cox, Sharon E.; Makani, Julie] Muhimbili Univ Hlth & Allied Sci, Dept Haematol & Blood Transfus, Muhimbili Wellcome Programme, Dar es salaam, Tanzania; [Mtatiro, Siana Nkya] Dar Es Salaam Univ, Coll Educ, Dept Biol Sci, Dar es salaam, Tanzania; [Singh, Tarjinder; Kolder, Iris; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge, England; [Rooks, Helen; Thein, Swee Lay; Menzel, Stephan] Kings Coll London, Dept Mol Haematol, Div Canc Studies, London, England; [Mmbando, Bruno] Natl Inst Med Res, Tanga Ctr, Tanga, Tanzania; [Thein, Swee Lay] Kings Coll Hosp NHS Fdn Trust, Dept Haematol Med, London, England; [Cox, Sharon E.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, MRC Int Nutr Grp, London WC1, England; [Makani, Julie] Univ Oxford, Nuffield Dept Med, Oxford, England	Muhimbili University of Health & Allied Sciences; University of Dar es Salaam; Wellcome Trust Sanger Institute; University of London; King's College London; National Institute of Medical Research; King's College Hospital NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Mtatiro, SN (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Haematol & Blood Transfus, Muhimbili Wellcome Programme, Dar es salaam, Tanzania.	siana.nkya@muhimbili-wellcome.org	Menzel, Stephan/U-6906-2019; Cox, Sharon E/ABA-7986-2020; Makani, Julie/E-8525-2017	Cox, Sharon E/0000-0002-9908-2936; Makani, Julie/0000-0002-4801-6250; Nkya, Siana/0000-0001-7576-6279; Kolder, Iris/0000-0001-5219-3439; Singh, Tarjinder/0000-0003-0601-6815; Mmbando, Bruno/0000-0001-7232-8708; Barrett, Jeffrey/0000-0002-1152-370X; Menzel, Stephan/0000-0002-1590-9108	Wellcome Trust, UK [098051, 084538]; Commonwealth split-side fellowship, UK [TZCN-2012-361]	Wellcome Trust, UK(Wellcome Trust); Commonwealth split-side fellowship, UK	The work was supported by the following: Wellcome Trust, UK (JCB 098051, J.Makani, SEC; strategic award 084538); and Commonwealth split-side fellowship, UK (SNM; TZCN-2012-361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bhatnagar P, 2011, J HUM GENET, V56, P316, DOI 10.1038/jhg.2011.12; Borg J, 2011, HAEMATOL-HEMATOL J, V96, P635, DOI 10.3324/haematol.2011.043265; Creary LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004218; Dampier C, 2004, PEDIATR BLOOD CANCER, V43, P674, DOI 10.1002/pbc.20162; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Makani J, 2011, BLOOD, V117, P1390, DOI 10.1182/blood-2010-08-302703; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; NAGEL RL, 1992, BAILLIERE CLIN HAEM, V5, P331, DOI 10.1016/S0950-3536(11)80023-5; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sedgewick AE, 2008, BLOOD CELLS MOL DIS; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Wonkam A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092506	24	56	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111464	10.1371/journal.pone.0111464	http://dx.doi.org/10.1371/journal.pone.0111464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372704	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900049
J	Wu, SY; Pan, SL; Xiao, ZY; Hsu, JL; Chen, MC; Lee, KH; Teng, CM				Wu, Szu-Ying; Pan, Shiow-Lin; Xiao, Zhi-Yan; Hsu, Jui-Ling; Chen, Mei-Chuan; Lee, Kuo-Hsiung; Teng, Che-Ming			NPRL-Z-1, as a New Topoisomerase II Poison, Induces Cell Apoptosis and ROS Generation in Human Renal Carcinoma Cells	PLOS ONE			English	Article							MEDIATED DNA-DAMAGE; CANCER-CHEMOTHERAPY; ANTITUMOR AGENTS; CYCLE REGULATION; PROTEIN-KINASE; HISTONE H2AX; CEM CELLS; ETOPOSIDE; ATM; ACTIVATION	NPRL-Z-1 is a 4 beta-[( 4 ''-benzamido)-amino]-4'-O-demethyl-epipodophyllotoxin derivative. Previous reports have shown that NPRL-Z-1 possesses anticancer activity. Here NPRL-Z-1 displayed cytotoxic effects against four human cancer cell lines (HCT 116, A549, ACHN, and A498) and exhibited potent activity in A498 human renal carcinoma cells, with an IC50 value of 2.38 mu M via the MTT assay. We also found that NPRL-Z-1 induced cell cycle arrest in G1-phase and detected DNA double-strand breaks in A498 cells. NPRL-Z-1 induced ataxia telangiectasia-mutated(ATM) protein kinase phosphorylation at serine 1981, leading to the activation of DNA damage signaling pathways, including Chk2, histone H2AX, and p53/p21. By ICE assay, the data suggested that NPRL-Z-1 acted on and stabilized the topoisomerase II(TOP2)-DNA complex, leading to TOP2cc formation. NPRL-Z-1-induced DNA damage signaling and apoptotic death was also reversed by TOP2 alpha or TOP2 beta knockdown. In addition, NPRL-Z-1-inhibited the Akt signaling pathway and induced reactive oxygen species(ROS) generation. These results demonstrated that NPRL-Z-1 appeared to be a novel TOP2 poison and ROS generator. Thus, NPRLZ-1 may present a significant potential anticancer candidate against renal carcinoma.	[Wu, Szu-Ying; Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Pan, Shiow-Lin] Taipei Med Univ, Coll Med Sci & Technol, Ph D Program Canc Biol & Drug Discovery, Taipei, Taiwan; [Xiao, Zhi-Yan] Chinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Act Substance Discovery & Drug, Beijing 100050, Peoples R China; [Xiao, Zhi-Yan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Hsu, Jui-Ling] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Chen, Mei-Chuan] Taipei Med Univ, Coll Pharm, Ph D Program Clin Drug Discovery Bot Herbs, Taipei, Taiwan; [Chen, Mei-Chuan] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan; [Lee, Kuo-Hsiung] Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC USA; [Lee, Kuo-Hsiung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan	National Taiwan University; Taipei Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Taiwan University; Taipei Medical University; Taipei Medical University; University of North Carolina; University of North Carolina Chapel Hill; China Medical University Taiwan; China Medical University Hospital - Taiwan	Teng, CM (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	cmteng@ntu.edu.tw		TENG, CHE-MING/0000-0002-9719-7334	National Science Council of the Republic of China [NSC 98-2320-B-002-009-MY3]; NATIONAL CANCER INSTITUTE [R01CA177584] Funding Source: NIH RePORTER	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Research Grant from the National Science Council of the Republic of China (NSC 98-2320-B-002-009-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Adachi N, 2004, BIOCHEM BIOPH RES CO, V318, P856, DOI 10.1016/j.bbrc.2004.04.099; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Banath JP, 2003, CANCER RES, V63, P4347; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chikamori K, 2010, CURR CANCER DRUG TAR, V10, P758, DOI 10.2174/156800910793605785; Costanzi-Strauss E, 1998, EXP CELL RES, V238, P51, DOI 10.1006/excr.1997.3810; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Delia D, 2003, ONCOGENE, V22, P7866, DOI 10.1038/sj.onc.1207086; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Felix CA, 2006, DNA REPAIR, V5, P1093, DOI 10.1016/j.dnarep.2006.05.031; Fragkos M, 2009, MOL CELL BIOL, V29, P2828, DOI 10.1128/MCB.01830-08; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Gantchev TG, 1997, ANTI-CANCER DRUG, V8, P164, DOI 10.1097/00001813-199702000-00007; Goodarzi Aaron A, 2003, Prog Cell Cycle Res, V5, P393; GOTO T, 1982, J BIOL CHEM, V257, P5866; Guo A, 2002, DRUG METAB DISPOS, V30, P457, DOI 10.1124/dmd.30.4.457; Haglof K.J., 2006, UPDATE CANC THERAP, V1, P117; Hande KR, 1998, BBA-GENE STRUCT EXPR, V1400, P173, DOI 10.1016/S0167-4781(98)00134-1; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Hande KR, 2008, UPDATE CANC THERAPEU, V3, P13, DOI DOI 10.1016/J.UCT.2008.02.001; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hawtin RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010186; Hong Y, 2012, NEUROSCI LETT, V518, P138, DOI 10.1016/j.neulet.2012.04.071; Horiguchi A, 2003, J UROLOGY, V169, P710, DOI 10.1016/S0022-5347(05)63998-5; Hug H, 1997, J BIOL CHEM, V272, P28191, DOI 10.1074/jbc.272.45.28191; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Jin ZY, 2002, CELL CYCLE, V1, P82, DOI 10.4161/cc.1.1.104; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Morgan SE, 2000, MOL PHARMACOL, V57, P296; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Parker AS, 2013, EUROPEAN UROLOGY; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Piret B, 1996, NUCLEIC ACIDS RES, V24, P4242, DOI 10.1093/nar/24.21.4242; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Rashad AE, 2011, EUR J MED CHEM, V46, P1019, DOI 10.1016/j.ejmech.2011.01.013; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Son YS, 1998, CANCER CHEMOTH PHARM, V41, P353, DOI 10.1007/s002800050751; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; Sourbier C, 2006, CANCER RES, V66, P5130, DOI 10.1158/0008-5472.CAN-05-1469; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; van der Veldt AAM, 2010, DISCOV MED, V10, P394; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang HK, 1997, MED RES REV, V17, P367, DOI 10.1002/(SICI)1098-1128(199707)17:4<367::AID-MED3>3.0.CO;2-U; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WINICK NJ, 1993, J CLIN ONCOL, V11, P209, DOI 10.1200/JCO.1993.11.2.209; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Wu SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040727; Xiao ZY, 2004, J MED CHEM, V47, P5140, DOI 10.1021/jm030609l; Ye RQ, 2001, J BIOL CHEM, V276, P4828, DOI 10.1074/jbc.M004894200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	63	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112220	10.1371/journal.pone.0112220	http://dx.doi.org/10.1371/journal.pone.0112220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372714	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900121
J	Ishio, A; Sasamura, T; Ayukawa, T; Kuroda, J; Ishikawa, HO; Aoyama, N; Matsumoto, K; Gushiken, T; Okajima, T; Yamakawa, T; Matsuno, K				Ishio, Akira; Sasamura, Takeshi; Ayukawa, Tomonori; Kuroda, Junpei; Ishikawa, Hiroyuki O.; Aoyama, Naoki; Matsumoto, Kenjiroo; Gushiken, Takuma; Okajima, Tetsuya; Yamakawa, Tomoko; Matsuno, Kenji			O-Fucose Monosaccharide of Drosophila Notch Has a Temperature-sensitive Function and Cooperates with O-Glucose Glycan in Notch Transport and Notch Signaling Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Drosophila; Endoplasmic Reticulum (ER); Glycosylation; Trafficking; Notch; O-Fucose; O-Fucosyltransferase 1; O-Glucose; Rumi	SENSORY ORGAN DEVELOPMENT; MAMMALIAN NOTCH; PROTEIN O-FUCOSYL-TRANSFERASE-1; ENDOPLASMIC-RETICULUM; DELTA INTERACTIONS; ENDOCYTIC PATHWAY; MODIFIES NOTCH; NERVOUS-SYSTEM; IMAGINAL DISC; VENTRAL CELLS	Background: The requirement of O-fucose monosaccharide on Notch is not fully understood. Results: Loss of O-fucose monosaccharide on Notch caused temperature-sensitive loss of Notch signaling. Conclusion:O-Fucose monosaccharide of Notch has a temperature-sensitive function and cooperates with O-glucose glycan in Notch signal activation. Significance: Our findings elucidate how different forms of glycosylation on a protein influence protein functions. Notch (N) is a transmembrane receptor that mediates the cell-cell interactions necessary for many cell fate decisions. N has many epidermal growth factor-like repeats that are O-fucosylated by the protein O-fucosyltransferase 1 (O-Fut1), and the O-fut1 gene is essential for N signaling. However, the role of the monosaccharide O-fucose on N is unclear, because O-Fut1 also appears to have O-fucosyltransferase activity-independent functions, including as an N-specific chaperon. Such an enzymatic activity-independent function could account for the essential role of O-fut1 in N signaling. To evaluate the role of the monosaccharide O-fucose modification in N signaling, here we generated a knock-in mutant of O-fut1 (O-fut1(R245A knock-in)), which expresses a mutant protein that lacks O-fucosyltransferase activity but maintains the N-specific chaperon activity. Using O-fut1(R245A knock-in) and other gene mutations that abolish the O-fucosylation of N, we found that the monosaccharide O-fucose modification of N has a temperature-sensitive function that is essential for N signaling. The O-fucose monosaccharide and O-glucose glycan modification, catalyzed by Rumi, function redundantly in the activation of N signaling. We also showed that the redundant function of these two modifications is responsible for the presence of N at the cell surface. Our findings elucidate how different forms of glycosylation on a protein can influence the protein's functions.	[Ishio, Akira; Ayukawa, Tomonori; Aoyama, Naoki; Gushiken, Takuma] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1251500, Japan; [Ishio, Akira; Sasamura, Takeshi; Kuroda, Junpei; Matsumoto, Kenjiroo; Gushiken, Takuma; Yamakawa, Tomoko; Matsuno, Kenji] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Ishikawa, Hiroyuki O.] Tokyo Univ Sci, Genome & Drug Res Ctr, Noda, Chiba 2788510, Japan; [Ishikawa, Hiroyuki O.] Chiba Univ, Grad Sch Sci, Inage Ku, Chiba, Japan; [Okajima, Tetsuya] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4660065, Japan	Tokyo University of Science; Osaka University; Tokyo University of Science; Chiba University; Nagoya University	Matsuno, K (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	kmatsuno@bio.sci.osaka-u.ac.jp	Tomoko, Yamakawa/GXG-9619-2022; Okajima, Tetsuya/I-7332-2014	Tomoko, Yamakawa/0000-0002-6590-6183; Okajima, Tetsuya/0000-0002-3677-648X	Japanese Ministry of Education, Culture, Sports and Science; PRESTO, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25840031, 25670140] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports and Science (to K. M. and T. A.) and grants from PRESTO, Japan Science and Technology Agency (to K. M.).	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ayukawa T, 2012, P NATL ACAD SCI USA, V109, P15318, DOI 10.1073/pnas.1202369109; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chou TB, 1996, GENETICS, V144, P1673; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Delgehyr N, 2012, P NATL ACAD SCI USA, V109, P5729, DOI 10.1073/pnas.1108537109; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fuerstenberg S, 1998, DEV BIOL, V201, P66, DOI 10.1006/dbio.1998.8944; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Glavic A, 2011, BIOL RES, V44, P25, DOI 10.4067/S0716-97602011000100004; Go MJ, 1998, DEVELOPMENT, V125, P2031; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hiruma-Shimizu K, 2010, J AM CHEM SOC, V132, P14857, DOI 10.1021/ja105216u; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Matsuno K, 2002, DEVELOPMENT, V129, P1049; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Perdigoto CN, 2011, DEVELOPMENT, V138, P4585, DOI 10.1242/dev.065292; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; RULIFSON EJ, 1995, DEVELOPMENT, V121, P2813; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; SIMPSON P, 1990, DEVELOPMENT, V109, P509; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; Tonetti M, 1998, BIOCHIMIE, V80, P923, DOI 10.1016/S0300-9084(00)88889-6; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Weng AP, 2004, CURR OPIN GENET DEV, V14, P48, DOI 10.1016/j.gde.2003.11.004; Whitworth GE, 2010, GLYCOBIOLOGY, V20, P287, DOI 10.1093/glycob/cwp173; WILDER EL, 1995, DEVELOPMENT, V121, P477; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049; XU T, 1993, DEVELOPMENT, V117, P1223; Yamakawa T, 2012, DEVELOPMENT, V139, P558, DOI 10.1242/dev.073858	73	36	36	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					505	519		10.1074/jbc.M114.616847	http://dx.doi.org/10.1074/jbc.M114.616847			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25378397	Green Published, hybrid			2022-12-26	WOS:000347231200044
J	Riffo-Campos, AL; Castillo, J; Tur, G; Gonzalez-Figueroa, P; Georgieva, EI; Rodriguez, JL; Lopez-Rodas, G; Rodrigo, MI; Franco, L				Riffo-Campos, Angela L.; Castillo, Josefa; Tur, Gema; Gonzalez-Figueroa, Paula; Georgieva, Elena I.; Rodriguez, Jose L.; Lopez-Rodas, Gerardo; Rodrigo, M. Isabel; Franco, Luis			Nucleosome-specific, Time-dependent Changes in Histone Modifications during Activation of the Early Growth Response 1 (Egr1) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Remodeling; Histone Modification; Liver; Mouse; Small Interfering RNA (siRNA); Transcription Regulation	H3 LYSINE-9 METHYLATION; RNA-POLYMERASE-II; HUMAN GENOME; TRANSCRIPTIONAL ACTIVATION; CANCER-CELLS; CHROMATIN; PROMOTER; PHOSPHORYLATION; ACETYLATION; RESOLUTION	Background: Chromatin structure and histone modifications regulate transcription in eukaryotes. Results: Activation of the early growth response gene 1 involves sliding and/or eviction of nucleosomes around the transcription start site and nucleosome-specific, time-dependent changes in histone modifications. Conclusion: Remodeling mechanisms and histone modifications are specific for each nucleosome. Significance: Mononucleosomal level studies give unique information on chromatin functions. Histone post-translational modifications and nucleosome remodeling are coordinate events involved in eukaryotic transcriptional regulation. There are relatively few data on the time course with which these events occur in individual nucleosomes. As a contribution to fill this gap, we first describe the nature and time course of structural changes in the nucleosomes -2, -1, and +1 of the murine Egr1 gene upon induction. To initiate the transient activation of the gene, we used the stimulation of MLP29 cells with phorbol esters and the in vivo activation after partial hepatectomy. In both models, nucleosomes -1 and +1 are partially evicted, whereas nucleosomes +1 and -2 slide downstream during transcription. The sliding of the latter nucleosome allows the EGR1 protein to bind its site, resulting in the repression of the gene. To decide whether EGR1 is involved in the sliding of nucleosome -2, Egr1 was knocked down. In the absence of detectable EGR1, the nucleosome still slides and remains downstream longer than in control cells, suggesting that the product of the gene may be rather involved in the returning of the nucleosome to the basal position. Moreover, the presence of eight epigenetic histone marks has been determined at a mononucleosomal level in that chromatin region. H3S10phK14ac, H3K4me3, H3K9me3, and H3K27me3 are characteristic of nucleosome +1, and H3K9ac and H4K16ac are mainly found in nucleosome -1, and H3K27ac predominates in nucleosomes -2 and -1. The temporal changes in these marks suggest distinct functions for some of them, although changes in H3K4me3 may result from histone turnover.	[Riffo-Campos, Angela L.; Castillo, Josefa; Tur, Gema; Gonzalez-Figueroa, Paula; Georgieva, Elena I.; Rodriguez, Jose L.; Lopez-Rodas, Gerardo; Rodrigo, M. Isabel; Franco, Luis] Univ Valencia, Dept Biochem & Mol Biol, E-46100 Burjassot, Spain; [Riffo-Campos, Angela L.; Castillo, Josefa; Lopez-Rodas, Gerardo; Rodrigo, M. Isabel; Franco, Luis] Inst Hlth Res INCLIVA, Valencia 46010, Spain	University of Valencia	Franco, L (corresponding author), Univ Valencia, Dept Biochem & Mol Biol, Dr Moliner 50, E-46100 Burjassot, Spain.	luis.franco@uv.es	Riffo-Campos, Angela L./AAX-8637-2021; Georgieva, Elena/O-1674-2019; Gonzalez-Figueroa, Paula/W-3654-2018; LOPEZ-RODAS, GERARDO/I-1349-2015	Riffo-Campos, Angela L./0000-0001-6300-3338; Gonzalez-Figueroa, Paula/0000-0001-8270-552X; Castillo Aliaga, Josefa/0000-0002-4092-0085; Franco, Luis/0000-0001-9610-6448; LOPEZ-RODAS, GERARDO/0000-0001-8367-653X	FISS Grant [FIS PI12/02110]	FISS Grant	This work was supported in part by FISS Grant FIS PI12/02110 (to G.L.-R.).	Aicher WK, 1999, RHEUMATOL INT, V18, P207, DOI 10.1007/s002960050086; Alkhatib SG, 2011, FEBS LETT, V585, P3197, DOI 10.1016/j.febslet.2011.09.003; ARENTS G, 1993, P NATL ACAD SCI USA, V90, P10489, DOI 10.1073/pnas.90.22.10489; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Chen SZ, 2012, GENE DEV, V26, P1364, DOI 10.1101/gad.186056.111; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Du Z, 2013, MOL PLANT, V6, P1463, DOI 10.1093/mp/sst018; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hondele M, 2013, NUCLEUS-AUSTIN, V4, P443, DOI 10.4161/nucl.27235; Horikoshi Nobuo, 2013, Genome Integr, V4, P3, DOI 10.1186/2041-9414-4-3; Hsieh FK, 2013, P NATL ACAD SCI USA, V110, P7654, DOI 10.1073/pnas.1222198110; JANSSENTIMMEN U, 1989, GENE, V80, P325, DOI 10.1016/0378-1119(89)90296-5; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Kulaeva OI, 2013, BBA-GENE REGUL MECH, V1829, P76, DOI 10.1016/j.bbagrm.2012.08.015; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Kumari Sujata, 2013, Subcell Biochem, V61, P3, DOI 10.1007/978-94-007-4525-4_1; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Lee ER, 2006, J BIOL CHEM, V281, P21162, DOI 10.1074/jbc.M602734200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; LOIDL P, 1988, FEBS LETT, V227, P91, DOI 10.1016/0014-5793(88)80874-3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Murawska M, 2011, TRANSCR-AUSTIN, V2, P244, DOI 10.4161/trns.2.6.17840; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Nozaki T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-416; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Poirier MG, 2009, NAT STRUCT MOL BIOL, V16, P938, DOI 10.1038/nsmb.1650; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Sacilotto N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023318; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Simboeck E, 2010, J BIOL CHEM, V285, P41062, DOI 10.1074/jbc.M110.184481; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Szerlong HJ, 2010, J BIOL CHEM, V285, P31954, DOI 10.1074/jbc.M110.148718; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tur G, 2010, CELL MOL LIFE SCI, V67, P4065, DOI 10.1007/s00018-010-0426-3; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wiencke JK, 2008, ONCOGENE, V27, P2412, DOI 10.1038/sj.onc.1210895; Xi LQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-346; Zheng CG, 2009, CANCER RES, V69, P2324, DOI 10.1158/0008-5472.CAN-08-4113	60	16	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					197	208		10.1074/jbc.M114.579292	http://dx.doi.org/10.1074/jbc.M114.579292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25378406	Green Published, hybrid			2022-12-26	WOS:000347231200017
J	Huang, BF; Yang, CS; Wojton, J; Huang, NJ; Chen, C; Soderblom, EJ; Zhang, LG; Kornbluth, S				Huang, Bofu; Yang, Chih-Sheng; Wojton, Jeffrey; Huang, Nai-Jia; Chen, Chen; Soderblom, Erik J.; Zhang, Liguo; Kornbluth, Sally			Metabolic Control of Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII)-mediated Caspase-2 Suppression by the B55 beta/Protein Phosphatase 2A (PP2A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED APOPTOSIS; LAEVIS EGG EXTRACTS; CAM KINASE; CALMODULIN-BINDING; SMOOTH-MUSCLE; AUTOPHOSPHORYLATION; ACTIVATION; PHOSPHORYLATION; IDENTIFICATION; DOMAINS	High levels of metabolic activity confer resistance to apoptosis. Caspase-2, an apoptotic initiator, can be suppressed by high levels of nutrient flux through the pentose phosphate pathway. This metabolic control is exerted via inhibitory phosphorylation of the caspase-2 prodomain by activated Ca2+/calmodulin-dependent protein kinase II (CaMKII). We show here that this activation of CaMKII depends, in part, on dephosphorylation of CaMKII at novel sites (Thr393/Ser395) and that this is mediated by metabolic activation of protein phosphatase 2A in complex with the B55 beta targeting subunit. This represents a novel locus of CaMKII control and also provides a mechanism contributing to metabolic control of apoptosis. These findings may have implications for metabolic control of the many CaMKII-controlled and protein phosphatase 2A-regulated physiological processes, because both enzymes appear to be responsive to alterations in glucose metabolized via the pentose phosphate pathway.	[Huang, Bofu; Yang, Chih-Sheng; Wojton, Jeffrey; Huang, Nai-Jia; Chen, Chen; Kornbluth, Sally] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27705 USA; [Soderblom, Erik J.] Duke Univ, Med Ctr, Prote & Metabol Core Facil, Durham, NC 27705 USA; [Zhang, Liguo] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27705 USA	Duke University; Duke University; Duke University	Zhang, LG (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27705 USA.	liguo.zhang@duke.edu; sally.kornbluth@duke.edu			National Institutes of Health [RO1 GM080333]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM080333.	Andersen JL, 2011, MOL CELL, V43, P834, DOI 10.1016/j.molcel.2011.07.028; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Cheung HH, 2006, EXP CELL RES, V312, P2347, DOI 10.1016/j.yexcr.2006.03.027; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; COLBRAN RJ, 1989, J BIOL CHEM, V264, P4800; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Kolb SJ, 1998, J BIOL CHEM, V273, P31555, DOI 10.1074/jbc.273.47.31555; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Marganski WA, 2005, CIRC RES, V97, P541, DOI 10.1161/01.RES.0000182630.29093.0d; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Mccoy F, 2013, MOL CELL, V52, P325, DOI 10.1016/j.molcel.2013.08.043; McCoy F, 2013, J BIOL CHEM, V288, P8838, DOI 10.1074/jbc.M112.437186; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Parsons MJ, 2013, CELL DEATH DIFFER, V20, P1174, DOI 10.1038/cdd.2013.38; PATTON BL, 1990, J BIOL CHEM, V265, P11204; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Rokolya A, 2000, AM J PHYSIOL-CELL PH, V278, pC537, DOI 10.1152/ajpcell.2000.278.3.C537; Shen K, 1998, J NEUROCHEM, V70, P96; SHIELDS SM, 1985, J NEUROSCI, V5, P3414; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; WAXHAM MN, 1993, BRAIN RES, V609, P1	31	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35882	35890		10.1074/jbc.M114.585844	http://dx.doi.org/10.1074/jbc.M114.585844			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378403	hybrid, Green Published			2022-12-26	WOS:000346897900020
J	Moustafa, IM; Korboukh, VK; Arnold, JJ; Smidansky, ED; Marcotte, LL; Gohara, DW; Yang, XR; Sanchez-Farran, MA; Filman, D; Maranas, JK; Boehr, DD; Hogle, JM; Colina, CM; Cameron, CE				Moustafa, Ibrahim M.; Korboukh, Victoria K.; Arnold, Jamie J.; Smidansky, Eric D.; Marcotte, Laura L.; Gohara, David W.; Yang, Xiaorong; Antonieta Sanchez-Farran, Maria; Filman, David; Maranas, Janna K.; Boehr, David D.; Hogle, James M.; Colina, Coray M.; Cameron, Craig E.			Structural Dynamics as a Contributor to Error-prone Replication by an RNA-dependent RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE KINETIC-ANALYSIS; DISEASE VIRUS MUTANT; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; RIBONUCLEOTIDE INCORPORATION; LETHAL MUTAGENESIS; MOTIF D; POLIOVIRUS; FIDELITY; RIBAVIRIN	RNA viruses encoding high- or low-fidelity RNA-dependent RNA polymerases (RdRp) are attenuated. The ability to predict residues of the RdRp required for faithful incorporation of nucleotides represents an essential step in any pipeline intended to exploit perturbed fidelity as the basis for rational design of vaccine candidates. We used x-ray crystallography, molecular dynamics simulations, NMRspectroscopy, and pre-steady-state kinetics to compare a mutator (H273R) RdRp from poliovirus to the wild-type (WT) enzyme. We show that the nucleotide-binding site toggles between the nucleotide binding-occluded and nucleotide binding-competent states. The conformational dynamics between these states were enhanced by binding to primed template RNA. For the WT, the occluded conformation was favored; for H273R, the competent conformation was favored. The resonance for Met-187 in our NMR spectra reported on the ability of the enzyme to check the correctness of the bound nucleotide. Kinetic experiments were consistent with the conformational dynamics contributing to the established pre-incorporation conformational change and fidelity checkpoint. For H273R, residues comprising the active site spent more time in the catalytically competent conformation and were more positively correlated than the WT. We propose that by linking the equilibrium between the binding-occluded and binding-competent conformations of the nucleotide-binding pocket and other active-site dynamics to the correctness of the bound nucleotide, faithful nucleotide incorporation is achieved. These studies underscore the need to apply multiple biophysical and biochemical approaches to the elucidation of the physical basis for polymerase fidelity.	[Moustafa, Ibrahim M.; Korboukh, Victoria K.; Arnold, Jamie J.; Smidansky, Eric D.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Yang, Xiaorong; Boehr, David D.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Antonieta Sanchez-Farran, Maria; Maranas, Janna K.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Colina, Coray M.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Marcotte, Laura L.; Gohara, David W.; Filman, David; Hogle, James M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 201, University Pk, PA 16802 USA.	cec9@psu.edu	Hogle, James/HIG-9121-2022	Gohara, David/0000-0001-8799-9125; filman, david/0000-0002-8714-1644; Hogle, James/0000-0002-3655-1504	National Institutes of Health from NIAID [R01 AI045818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020566, R01AI045818, R01AI104878] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI045818 from NIAID (to C. E. C.).	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bull JJ, 2007, J VIROL, V81, P2930, DOI 10.1128/JVI.01624-06; Cameron CE, 2009, CURR OPIN STRUC BIOL, V19, P768, DOI 10.1016/j.sbi.2009.10.012; Case D.A., 2012, AMBER; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Garriga D, 2013, J MOL BIOL, V425, P2279, DOI 10.1016/j.jmb.2013.03.034; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 2004, BIOCHEMISTRY-US, V43, P5149, DOI 10.1021/bi035429s; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Graci JD, 2008, FUTURE VIROL, V3, P553, DOI 10.2217/17460794.3.6.553; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Graham RL, 2012, NAT MED, V18, P1820, DOI 10.1038/nm.2972; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2014, ANGEW CHEM INT EDIT, V53, P9992, DOI 10.1002/anie.201403924; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Korboukh VK, 2014, J BIOL CHEM, V289, P29531, DOI 10.1074/jbc.M114.592303; Liu XR, 2013, J BIOL CHEM, V288, P32753, DOI 10.1074/jbc.M113.484428; Marcotte LL, 2007, J VIROL, V81, P3583, DOI 10.1128/JVI.02306-06; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; R Core Team, 2021, R LANGUAGE ENV STAT; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Shen HJ, 2012, J PHYS CHEM B, V116, P14515, DOI 10.1021/jp302709v; Sholders AJ, 2014, J MOL BIOL, V426, P1407, DOI 10.1016/j.jmb.2013.12.031; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Smidansky ED, 2011, BIOCHEMISTRY-US, V50, P5016, DOI 10.1021/bi200350d; Smidansky ED, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P135, DOI 10.1016/B978-0-12-374153-0.00006-0; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003760; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Weeks SA, 2012, J BIOL CHEM, V287, P31618, DOI 10.1074/jbc.C112.401471; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Yang XR, 2010, BIOCHEMISTRY-US, V49, P9361, DOI 10.1021/bi100833r	66	25	26	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36229	36248		10.1074/jbc.M114.616193	http://dx.doi.org/10.1074/jbc.M114.616193			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378410	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000346897900048
J	Wolf, MTF; An, SW; Nie, MZ; Bal, MS; Huang, CL				Wolf, Matthias T. F.; An, Sung-Wan; Nie, Mingzhu; Bal, Manjot S.; Huang, Chou-Long			Klotho Up-regulates Renal Calcium Channel Transient Receptor Potential Vanilloid 5 (TRPV5) by Intra- and Extracellular N-glycosylation-dependent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTS ENCODING MEMBRANE; VITAMIN-D METABOLISM; FUNCTIONAL VARIANT; BREAST-CANCER; PROTEIN; MICE; GENE; IDENTIFICATION; TRAFFICKING; ENDOCYTOSIS	The anti-aging protein Klotho is a type 1 membrane protein produced predominantly in the distal convoluted tubule. The ectodomain of Klotho is cleaved and secreted into the urine to regulate several ion channels and transporters. Secreted Klotho (sKL) up-regulates the TRPV5 calcium channel from the cell exterior by removing sialic acids from N-glycan of the channel and inhibiting its endocytosis. Because TRPV5 and Klotho coexpress in the distal convoluted tubule, we investigated whether Klotho regulates TRPV5 action from inside the cell. Whole-cell TRPV5-mediated channel activity was recorded in HEK cells coexpressing TRPV5 and sKL or membranous Klotho (mKL). Transfection of sKL, but not mKL, produced detectable Klotho protein in cell culture media. As for sKL, mKL increased TRPV5 current density. The role of sialidase activity of mKL acting inside is supported by findings that mutations of putative sialidase activity sites in sKL and mKL abrogated the regulation of TRPV5 but that the extracellular application of a sialidase inhibitor prevented the regulation of TRPV5 by sKL only. Mechanistically, coexpression with a dominant-negative dynamin II prevented the regulation of TRPV5 by sKL but not by mKL. In contrast, blocking forward trafficking by brefeldin A prevented the effect with mKL but not with sKL. Therefore, Klotho up-regulates TRPV5 from both the inside and outside of cells. The intracellular action of Klotho is likely due to enhanced forward trafficking of channel proteins, whereas the extracellular action is due to inhibition of endocytosis. Both effects involve putative Klotho sialidase activity. These effects of Klotho may play important roles regarding calcium reabsorption in the kidney.	[Wolf, Matthias T. F.; Nie, Mingzhu; Bal, Manjot S.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [An, Sung-Wan; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wolf, MTF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	matthias.wolf@utsouthwestern.edu; chou-long.huang@utsouthwestern.edu			National Institutes of Health [RO1-DK85726, K08-DK095994-02, K12-HD000850]; Children's Clinical Research Advisory Committee, Children's Medical Center, Dallas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085726, K08DK095994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Clinical Research Advisory Committee, Children's Medical Center, Dallas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK85726, K08-DK095994-02, and K12-HD000850. This work was also supported by the Children's Clinical Research Advisory Committee, Children's Medical Center, Dallas.	Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Carlsson MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026560; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Frick KK, 2003, J AM SOC NEPHROL, V14, P1082, DOI 10.1097/01.ASN.0000062960.26868.17; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Huang CL, 2010, KIDNEY INT, V77, P855, DOI 10.1038/ki.2010.73; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kuro-o M, 2008, TRENDS ENDOCRIN MET, V19, P239, DOI 10.1016/j.tem.2008.06.002; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; KUROO M, 1995, CIRC RES, V76, P148, DOI 10.1161/01.RES.76.1.148; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Reynders E, 2011, GLYCOBIOLOGY, V21, P853, DOI 10.1093/glycob/cwq179; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vagin O, 2007, CELL BIOCHEM BIOPHYS, V47, P376, DOI 10.1007/s12013-007-0033-6; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; van de Graaf SFJ, 2008, J BIOL CHEM, V283, P4077, DOI 10.1074/jbc.M706959200; Wolf I, 2010, ONCOGENE, V29, P26, DOI 10.1038/onc.2009.301; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292	42	45	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35849	35857		10.1074/jbc.M114.616649	http://dx.doi.org/10.1074/jbc.M114.616649			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378396	Green Published, hybrid			2022-12-26	WOS:000346897900016
J	Mansoori, N; Timmers, J; Desprez, T; Kamei, CLA; Dees, DCT; Vincken, JP; Visser, RGF; Hofte, H; Vernhettes, S; Trindade, LM				Mansoori, Nasim; Timmers, Jaap; Desprez, Thierry; Kamei, Claire L. A.; Dees, Dianka C. T.; Vincken, Jean-Paul; Visser, Richard G. F.; Hoefte, Herman; Vernhettes, Samantha; Trindade, Luisa M.			KORRIGAN1 Interacts Specifically with Integral Components of the Cellulose Synthase Machinery	PLOS ONE			English	Article							SECONDARY CELL-WALL; ARABIDOPSIS-THALIANA; ENDO-1,4-BETA-GLUCANASE; EXPRESSION; MEMBRANES; PROTEIN; SYSTEM; PLANTS; GENE; ENDO-1,4-BETA-D-GLUCANASE	Cellulose is synthesized by the so called rosette protein complex and the catalytic subunits of this complex are the cellulose synthases (CESAs). It is thought that the rosette complexes in the primary and secondary cell walls each contains at least three different non-redundant cellulose synthases. In addition to the CESA proteins, cellulose biosynthesis almost certainly requires the action of other proteins, although few have been identified and little is known about the biochemical role of those that have been identified. One of these proteins is KORRIGAN (KOR1). Mutant analysis of this protein in Arabidopsis thaliana showed altered cellulose content in both the primary and secondary cell wall. KOR1 is thought to be required for cellulose synthesis acting as a cellulase at the plasma membrane-cell wall interface. KOR1 has recently been shown to interact with the primary cellulose synthase rosette complex however direct interaction with that of the secondary cell wall has never been demonstrated. Using various methods, both in vitro and in planta, it was shown that KOR1 interacts specifically with only two of the secondary CESA proteins. The KOR1 protein domain(s) involved in the interaction with the CESA proteins were also identified by analyzing the interaction of truncated forms of KOR1 with CESA proteins. The KOR1 transmembrane domain has shown to be required for the interaction between KOR1 and the different CESAs, as well as for higher oligomer formation of KOR1.	[Mansoori, Nasim; Timmers, Jaap; Kamei, Claire L. A.; Dees, Dianka C. T.; Vincken, Jean-Paul; Visser, Richard G. F.; Trindade, Luisa M.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Mansoori, Nasim; Timmers, Jaap] Wageningen Univ, Grad Sch Expt Plant Sci, NL-6700 AP Wageningen, Netherlands; [Timmers, Jaap] Univ Wageningen & Res Ctr, Carbohydrate Res Ctr, Wageningen, Netherlands; [Desprez, Thierry; Hoefte, Herman; Vernhettes, Samantha] INRA, Inst Jean Pierre Bourgin, Biol Cellulaire Lab, Versailles, France	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Trindade, LM (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	luisa.trindade@wur.nl	Trindade, Luisa M/F-8824-2010; Visser, Richard GF/B-3423-2012	Visser, Richard GF/0000-0002-0213-4016; Vincken, Jean-Paul/0000-0001-8540-4327				Bhandari S, 2006, PLANTA, V224, P828, DOI 10.1007/s00425-006-0269-1; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Brummell DA, 1997, P NATL ACAD SCI USA, V94, P4794, DOI 10.1073/pnas.94.9.4794; Carroll A, 2011, FRONTIERS PLANT GENE, V2, P1; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Fetchko M, 2004, METHODS, V32, P349, DOI 10.1016/j.ymeth.2003.10.010; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; JOHNSSON N, 1994, EMBO J, V13, P2686, DOI 10.1002/j.1460-2075.1994.tb06559.x; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Maloney VJ, 2010, PLANT BIOTECHNOL J, V8, P294, DOI 10.1111/j.1467-7652.2009.00483.x; Master ER, 2004, BIOCHEMISTRY-US, V43, P10080, DOI 10.1021/bi049453x; MATTHYSSE AG, 1995, J BACTERIOL, V177, P1069, DOI 10.1128/jb.177.4.1069-1075.1995; Molhoj M, 2002, PLANT CELL PHYSIOL, V43, P1399, DOI 10.1093/pcp/pcf163; Molhoj M, 2001, PLANT PHYSIOL, V127, P674, DOI 10.1104/pp.010269; Morel J, 2006, MOL CELL PROTEOMICS, V5, P1396, DOI 10.1074/mcp.M600044-MCP200; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; Reinders A, 2002, STRUCTURE, V10, P763, DOI 10.1016/S0969-2126(02)00773-6; Robert S, 2005, PLANT CELL, V17, P3378, DOI 10.1105/tpc.105.036228; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; STANDAL R, 1994, J BACTERIOL, V176, P665, DOI 10.1128/jb.176.3.665-672.1994; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Timmers J, 2009, FEBS LETT, V583, P978, DOI 10.1016/j.febslet.2009.02.035; Vain T, 2014, PLANT PHYSL IN PRESS; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Yu L, 2014, TREE PHYSIOL, V00, P1; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	34	38	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112387	10.1371/journal.pone.0112387	http://dx.doi.org/10.1371/journal.pone.0112387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383767	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700054
J	Eng, KH; Tsuji, T				Eng, Kevin H.; Tsuji, Takemasa			Differential Antigen Expression Profile Predicts Immunoreactive Subset of Advanced Ovarian Cancers	PLOS ONE			English	Article							T-CELLS; INFILTRATION; SIGNATURES; PROGNOSIS	The presence and composition of lymphocytes characterizing an immune response has been connected to prognosis in advanced ovarian cancer. Our aim is to establish novel associations between prognosis and the expression of immune-related genes through a focused screen utilizing publicly available high-throughput assays. We consider transcriptome profiles from n=1137 advanced ovarian cancer patients observed in four separate studies divided into discovery/validation sets (n=503/n=634). We focus on a subset of lymphocyte markers, antigen presentation and processing genes, T cell receptor associated co-stimulatory/repressor genes and cancer testis (CT) antigens. We modeled differential expression and co-expression using these subsets and tested for association with overall survival. Fifteen of 64 immune-related genes are associated with survival of which 5 are reproduced in the validation set. The expression of these genes defines an immunoreactive (IR) subgroup of patients with a favorable prognosis. Phenotypic characterization of the immune compartment signal includes upregulation of markers of CD8(+) T-cell activation in these patients. Using multivariate model building, we find that the expression of 6 CT antigens can predict IR status in the discovery and validation sets. These analyses confirm that a genomic approach can reproducibly detect lymphocyte signals in tumor tissue suggesting a novel way to study the tumor microenvironment. Our search has identified new candidate prognostic markers associated with immune components and uncovered preliminary evidence of prognostic subgroups associated with different immune mechanisms.	[Eng, Kevin H.] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA; [Tsuji, Takemasa] Roswell Pk Canc Inst, Ctr Immunotherapy, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Eng, KH (corresponding author), Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA.	kevin.eng@roswellpark.org		Tsuji, Takemasa/0000-0001-7563-2211; Eng, Kevin/0000-0001-5636-0812	National Cancer Institute core grant [CA016056]; Roswell Park Alliance Foundation award; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	National Cancer Institute core grant; Roswell Park Alliance Foundation award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CA016056 www.cancer.gov National Cancer Institute core grant to Roswell Park Cancer Institute. Roswell Park Alliance Foundation www.roswellpark.org/giving award to KHE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Baggerly KA, 2008, J CLIN ONCOL, V26, P1186, DOI 10.1200/JCO.2007.15.1951; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Callahan MJ, 2008, CLIN CANCER RES, V14, P7667, DOI 10.1158/1078-0432.CCR-08-0479; Carlson M, 2014, HTHGU133A DB AFFYMET; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Gnjatic S, 2010, P NATL ACAD SCI USA, V107, P5088, DOI 10.1073/pnas.0914213107; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Leffers N, 2010, BRIT J CANCER, V103, P685, DOI 10.1038/sj.bjc.6605820; Matsuzaki J, 2008, CANCER IMMUNOL IMMUN, V57, P1185, DOI 10.1007/s00262-008-0450-4; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Preston CC, 2011, IMMUNOTHERAPY-UK, V3, P539, DOI [10.2217/IMT.11.20, 10.2217/imt.11.20]; Qian Feng, 2004, Cancer Immun, V4, P12; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yoshihara K, 2012, CLIN CANCER RES, V18, P1374, DOI 10.1158/1078-0432.CCR-11-2725; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	25	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111586	10.1371/journal.pone.0111586	http://dx.doi.org/10.1371/journal.pone.0111586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380171	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100034
J	Ranaker, L; Persson, J; Jonsson, M; Nilsson, PA; Bronmark, C				Ranaker, Lynn; Persson, Jens; Jonsson, Mikael; Nilsson, P. Anders; Bronmark, Christer			Piscivore-Prey Fish Interactions: Mechanisms behind Diurnal Patterns in Prey Selectivity in Brown and Clear Water	PLOS ONE			English	Article							PERCH PERCA-FLUVIATILIS; PIKE ESOX-LUCIUS; LIGHT-INTENSITY; VISUAL CONDITIONS; HABITAT CHOICE; TURBIDITY; PIKEPERCH; LUCIOPERCA; EFFICIENCY; PREDATION	Environmental change may affect predator-prey interactions in lakes through deterioration of visual conditions affecting foraging success of visually oriented predators. Environmental change in lakes includes an increase in humic matter causing browner water and reduced visibility, affecting the behavioural performance of both piscivores and prey. We studied diurnal patterns of prey selection in piscivorous pikeperch (Sander lucioperca) in both field and laboratory investigations. In the field we estimated prey selectivity and prey availability during day and night in a clear and a brown water lake. Further, prey selectivity during day and night conditions was studied in the laboratory where we manipulated optical conditions (humic matter content) of the water. Here, we also studied the behaviours of piscivores and prey, focusing on foraging-cycle stages such as number of interests and attacks by the pikeperch as well as the escape distance of the prey fish species. Analyses of gut contents from the field study showed that pikeperch selected perch (Perca fluviatilis) over roach (Rutilus rutilus) prey in both lakes during the day, but changed selectivity towards roach in both lakes at night. These results were corroborated in the selectivity experiments along a brown-water gradient in day and night light conditions. However, a change in selectivity from perch to roach was observed when the optical condition was heavily degraded, from either brown-stained water or light intensity. At longer visual ranges, roach initiated escape at distances greater than pikeperch attack distances, whereas perch stayed inactive making pikeperch approach and attack at the closest range possible. Roach anti-predatory behaviour decreased in deteriorated visual conditions, altering selectivity patterns. Our results highlight the importance of investigating both predator and prey responses to visibility conditions in order to understand the effects of degrading optical conditions on piscivore-prey interaction strength and thereby ecosystem responses to brownification of waters.	[Ranaker, Lynn; Jonsson, Mikael; Nilsson, P. Anders; Bronmark, Christer] Lund Univ, Dept Biol, Lund, Sweden; [Persson, Jens] Swedish Agcy Marin & Water Management, Gothenburg, Sweden; [Nilsson, P. Anders] Karlstad Univ, Dept Environm & Life Sci, Karlstad, Sweden	Lund University; Karlstad University	Ranaker, L (corresponding author), Lund Univ, Dept Biol, Ecol Bldg, Lund, Sweden.	Lynn.Ranaker@biol.lu.se	Jönsson, Mikael/M-7449-2013; Nilsson, Anders/H-6836-2014	Jönsson, Mikael/0000-0002-9799-6435; Nilsson, Anders/0000-0002-3541-9835	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [223-2005-1393]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	This research was funded by a grant from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (grant #223-2005-1393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams M, 1997, BEHAV ECOL SOCIOBIOL, V40, P169, DOI 10.1007/s002650050330; Aksnes DL, 1997, SARSIA, V82, P137, DOI 10.1080/00364827.1997.10413647; ALI MA, 1977, J FISH RES BOARD CAN, V34, P1475, DOI 10.1139/f77-212; Appelberg Magnus, 2000, Fiskeriverket Information, V1, P1; Beauchamp DA, 1999, CAN J FISH AQUAT SCI, V56, P128, DOI 10.1139/cjfas-56-S1-128; Bronmark C., 1995, Ecology of Freshwater Fish, V4, P85, DOI 10.1111/j.1600-0633.1995.tb00121.x; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; CARPENTER SR, 1988, BIOSCIENCE, V38, P764, DOI 10.2307/1310785; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Davies-Colley R. J, 1993, COLOUR CLARITY NATUR; DAVIESCOLLEY RJ, 1988, LIMNOL OCEANOGR, V33, P616, DOI 10.4319/lo.1988.33.4.0616; De Robertis A, 2003, CAN J FISH AQUAT SCI, V60, P1517, DOI 10.1139/F03-123; DOBLER E, 1977, OECOLOGIA, V27, P93, DOI 10.1007/BF00345687; Einfalt LM, 2012, ECOL FRESHW FISH, V21, P560, DOI 10.1111/j.1600-0633.2012.00576.x; EKLOV P, 1989, OIKOS, V56, P149, DOI 10.2307/3565330; EKLOV P, 1995, BEHAV ECOL SOCIOBIOL, V37, P169, DOI 10.1007/s002650050178; Endler J.A., 1991, P169; Engstrom-Ost J, 2008, MAR ECOL PROG SER, V359, P275, DOI 10.3354/meps07345; Erlandsson M, 2008, GLOBAL CHANGE BIOL, V14, P1191, DOI 10.1111/j.1365-2486.2008.01551.x; Graneli W, 2012, BROWNIFICATION LAKES; Greenberg LA, 1995, OIKOS, V74, P522, DOI 10.2307/3545998; HEMMINGS CC, 1966, J EXP BIOL, V45, P449; Holling C. S., 1965, Mem ent Soc Canada Ottawa, Vno. 45, P1; Horky P, 2008, HYDROBIOLOGIA, V614, P151, DOI 10.1007/s10750-008-9503-0; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Janssen J, 1997, J FISH BIOL, V51, P921; Jonsson M, 2011, J FISH BIOL, V79, P290, DOI 10.1111/j.1095-8649.2011.03004.x; Jonsson M, 2013, CAN J FISH AQUAT SCI, V70, P1685, DOI 10.1139/cjfas-2013-0150; Kangur K, 2007, ECOL MODEL, V203, P34, DOI 10.1016/j.ecolmodel.2006.03.039; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Keskinen T, 2003, J FISH BIOL, V63, P1274, DOI 10.1046/j.1095-8649.2003.00249.x; LEHTONEN H, 1984, Aqua Fennica, V14, P189; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Ljunggren L, 2007, J FISH BIOL, V70, P1319, DOI 10.1111/j.1095-8649.2007.01412.x; Luchiari AC, 2006, AQUAC RES, V37, P1572, DOI 10.1111/j.1365-2109.2006.01599.x; Mazur MM, 2003, ENVIRON BIOL FISH, V67, P397, DOI 10.1023/A:1025807711512; Meager JJ, 2006, J EXP BIOL, V209, P4174, DOI 10.1242/jeb.02489; Miner JG, 1996, T AM FISH SOC, V125, P97, DOI 10.1577/1548-8659(1996)125<0097:DOPAHC>2.3.CO;2; Miyazaki T, 2000, MAR ECOL PROG SER, V192, P267, DOI 10.3354/meps192267; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Nurminen L, 2006, LIMNOL OCEANOGR, V51, P1550, DOI 10.4319/lo.2006.51.3.1550; POPOVA OA, 1977, J FISH RES BOARD CAN, V34, P1559, DOI 10.1139/f77-219; Radke R, 2005, NATURWISSENSCHAFTEN, V92, P91, DOI 10.1007/s00114-004-0596-7; Ranaker L, 2012, PISCIVORE PREY FISH, P100; Ranaker L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038411; Reid SM, 1999, CAN J FISH AQUAT SCI, V56, P1362, DOI 10.1139/cjfas-56-8-1362; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; Ryer CH, 1998, MAR ECOL PROG SER, V167, P215, DOI 10.3354/meps167215; Schulze T, 2006, CAN J FISH AQUAT SCI, V63, P2202, DOI 10.1139/F06-099; Shoup DE, 2009, T AM FISH SOC, V138, P1018, DOI 10.1577/T09-015.1; Svanback R, 2011, EVOLUTION, V65, P3515, DOI 10.1111/j.1558-5646.2011.01398.x; SVARDSON G, 1973, Institute of Freshwater Research Drottningholm Report, P112; Turesson H, 2004, J FISH BIOL, V65, P363, DOI 10.1111/j.0022-1112.2004.00455.x; Turesson H, 2003, THESIS LUND U LUND; Turesson H, 2007, OECOLOGIA, V153, P281, DOI 10.1007/s00442-007-0728-9; Utne-Palm AC, 2002, MAR FRESHW BEHAV PHY, V35, P111, DOI 10.1080/10236240290025644; Winfield IJ, 1991, CYPRINID FISHES SYST; Wissel B, 2003, LIMNOL OCEANOGR, V48, P1965, DOI 10.4319/lo.2003.48.5.1965	58	14	15	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e102002	10.1371/journal.pone.0102002	http://dx.doi.org/10.1371/journal.pone.0102002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379665	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100001
J	Cugno, M; Marzano, AV; Lorini, M; Carbonelli, V; Tedeschi, A				Cugno, Massimo; Marzano, Angelo V.; Lorini, Maurizio; Carbonelli, Vincenzo; Tedeschi, Alberto			Enhanced Tissue Factor Expression by Blood Eosinophils from Patients with Hypereosinophilia: A Possible Link with Thrombosis	PLOS ONE			English	Article							CHURG-STRAUSS-SYNDROME; POTENTIAL MECHANISM; CHRONIC URTICARIA; GRANULE PROTEINS; DISEASE; ACTIVATION; LOCALIZATION; COAGULATION; DISORDERS; CLONES	Thrombotic risk is increased in eosinophil-mediated disorders, and several hypotheses have been proposed to link eosinophilia and thrombosis. In particular, eosinophils have been described as source of tissue factor (TF), the main initiator of blood coagulation; however, this aspect is still controversial. This study was aimed to evaluate whether TF expression varies in eosinophils isolated from normal subjects and patients with different hypereosinophilic conditions. Eosinophils were immunologically purified from peripheral blood samples of 9 patients with different hypereosinophilic conditions and 9 normal subjects. Western blot analysis and real-time polymerase chain reaction (RT-PCR) were performed to test eosinophil TF expression. For comparison, TF expression was evaluated in monocytes from blood donors and in human endothelial (ECV304) and fibroblast (IMR90) cell lines. Western blot analysis revealed a major band of 47,000 corresponding to native TF in homogenates of purified eosinophils with a higher intensity in the 9 patients than in the 9 controls (p<0.0001). According to RT-PCR cycle threshold (Ct), TF gene expression was higher in eosinophils from patients than in those from controls, median (range) 35.10 (19.45-36.50) vs 37.17 (35.33-37.87) (p = 0.002), and was particularly abundant in one patient with idiopathic hypereosinophilic syndrome and ischemic heart attacks (Ct: 19.45). TF gene expression was moderate in monocytes, Ct: 31.32 (29.82-33.49) and abundant in endothelial cells, Ct: 28.70 (27.79-29.57) and fibroblasts, Ct: 22.77 (19.22-25.05). Our results indicate that human blood eosinophils contain variable amounts of TF. The higher TF expression in patients with hypereosinophilic disorders may contribute to increase the thrombotic risk.	[Cugno, Massimo; Lorini, Maurizio; Carbonelli, Vincenzo] Univ Milan, Dipartimento Fisiopatol Medicochirurg & Trapianti, Milan, Italy; [Cugno, Massimo] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Milan, Italy; [Marzano, Angelo V.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Unita Operat Dermatol, Milan, Italy; [Tedeschi, Alberto] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Unita Operat Allergol & Immunol Clin, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico	Cugno, M (corresponding author), Univ Milan, Dipartimento Fisiopatol Medicochirurg & Trapianti, Milan, Italy.	massimo.cugno@unimi.it	Cugno, Massimo/K-8106-2016	Cugno, Massimo/0000-0002-9918-0763	"Ricerca corrente'', Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy	"Ricerca corrente'', Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy	This work was supported by "Ricerca corrente'', Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SJ, 2007, IMMUNOL ALLERGY CLIN, V27, P357, DOI 10.1016/j.iac.2007.07.004; Ames PRJ, 2010, CLIN APPL THROMB-HEM, V16, P628, DOI 10.1177/1076029609348647; Asero R, 2007, J ALLERGY CLIN IMMUN, V119, P705, DOI 10.1016/j.jaci.2006.08.043; Basavaraj MG, 2012, THROMB RES, V130, P538, DOI 10.1016/j.thromres.2012.06.001; Blanchard C, 2009, ADV IMMUNOL, V101, P81, DOI 10.1016/S0065-2776(08)01003-1; Caraguel CGB, 2011, J VET DIAGN INVEST, V23, P2, DOI 10.1177/104063871102300102; Chen YYK, 2014, J ALLERGY CLIN IMMUN, V133, P1195, DOI 10.1016/j.jaci.2013.06.037; Cugno M, 2009, INT ARCH ALLERGY IMM, V148, P170, DOI 10.1159/000155748; Egorina EM, 2008, BLOOD, V111, P1208, DOI 10.1182/blood-2007-08-107698; GAUCHAT JF, 1995, EUR J IMMUNOL, V25, P863, DOI 10.1002/eji.1830250335; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Kita H, 2013, INT ARCH ALLERGY IMM, V161, P3, DOI 10.1159/000350662; Langan SM, 2009, BRIT J DERMATOL, V161, P1149, DOI 10.1111/j.1365-2133.2009.09350.x; Maino A, 2012, CURR VASC PHARMACOL, V10, P670, DOI 10.2174/157016112801784594; Mandal SK, 2006, BLOOD, V107, P4746, DOI 10.1182/blood-2005-11-4674; Marzano AV, 2011, CLIN EXP IMMUNOL, V165, P44, DOI 10.1111/j.1365-2249.2011.04391.x; Marzano AV, 2010, J INVEST ALLERG CLIN, V20, P616; Marzano AV, 2009, BRIT J DERMATOL, V160, P266, DOI 10.1111/j.1365-2133.2008.08880.x; Moosbauer C, 2007, BLOOD, V109, P995, DOI 10.1182/blood-2006-02-004945; Ogbogu PU, 2007, IMMUNOL ALLERGY CLIN, V27, P457, DOI 10.1016/j.iac.2007.07.001; OJIMAUCHIYAMA A, 1991, LIPIDS, V26, P1200, DOI 10.1007/BF02536531; Pena E, 2012, J THROMB HAEMOST, V10, P2373, DOI 10.1111/j.1538-7836.2012.04910.x; ROHRBACH MS, 1990, J EXP MED, V172, P1271, DOI 10.1084/jem.172.4.1271; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Roufosse F, 2010, J ALLERGY CLIN IMMUN, V126, P39, DOI 10.1016/j.jaci.2010.04.011; Santilli F, 2007, INTERN EMERG MED, V2, P256, DOI 10.1007/s11739-007-0076-0; SLUNGAARD A, 1993, J CLIN INVEST, V91, P1721, DOI 10.1172/JCI116382; Sovershaev MA, 2008, J THROMB HAEMOST, V6, P1742, DOI 10.1111/j.1538-7836.2008.03105.x; Valent P, 2012, J ALLERGY CLIN IMMUN, V130, P607, DOI 10.1016/j.jaci.2012.02.019; Wang JG, 2006, BLOOD, V107, P558, DOI 10.1182/blood-2005-05-2152; Yang YW, 2011, STROKE, V42, P319, DOI 10.1161/STROKEAHA.110.596361; Zhu L, 2012, CLIN EXP DERMATOL, V37, P395, DOI 10.1111/j.1365-2230.2011.04254.x	32	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111862	10.1371/journal.pone.0111862	http://dx.doi.org/10.1371/journal.pone.0111862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375118	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600070
J	Dheilly, NM; Jouaux, A; Boudry, P; Favrel, P; Lelong, C				Dheilly, Nolwenn M.; Jouaux, Aude; Boudry, Pierre; Favrel, Pascal; Lelong, Christophe			Transcriptomic Profiling of Gametogenesis in Triploid Pacific Oysters Crassostrea gigas: Towards an Understanding of Partial Sterility Associated with Triploidy	PLOS ONE			English	Article							GENE-EXPRESSION; THUNBERG; GROWTH; FISH; SEX; SPERMATOGENESIS; DIFFERENTIATION; IDENTIFICATION; TEMPERATURE; PERFORMANCE	Background: Triploidy can occur in many animal species but is often lethal. Among invertebrates, amphibians and fishes, triploids are viable although often sterile or infertile. Most triploids of the Pacific oyster Crassostrea gigas are almost sterile (named "3n beta'') yet a low but significant proportion show an advanced gametogenesis (named "3n alpha''). These oysters thus constitute an interesting model to study the effect of triploidy on germ cell development. We used microarrays to compare the gonad transcriptomes of diploid 2n and the abovementioned triploid 3n beta and 3n alpha male and female oysters throughout gametogenesis. Results: All triploids displayed an upregulation of genes related to DNA repair and apoptosis and a downregulation of genes associated with cell division. The comparison of 3n alpha and 3n beta transcriptomes with 2n revealed the likely involvement of a cell cycle checkpoint during mitosis in the successful but delayed development of gonads in 3n alpha individuals. In contrast, a disruption of sex differentiation mechanisms may explain the sterility of 3n beta individuals with 3n beta females expressing male-specific genes and 3n beta males expressing female-specific genes. Conclusions: The disruption of sex differentiation and mitosis may be responsible for the impaired gametogenesis of triploid Pacific oysters. The function of the numerous candidate genes identified in our study should now be studied in detail in order to elucidate their role in sex determination, mitosis/meiosis control, pachytene cell cycle checkpoint, and the control of DNA repair/apoptosis.	[Dheilly, Nolwenn M.; Jouaux, Aude; Favrel, Pascal; Lelong, Christophe] UPMC, IRD 207, UMR BOREA Biol ORganismes & Ecosyst Aquat, UNICAEN,MNHN,CNRS 7208, Caen, France; [Dheilly, Nolwenn M.; Boudry, Pierre] IFREMER, UMR LEMAR Lab Sci Environm MARin 6539, UBO CNRS IRD, Plouzane, France	Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite de Caen Normandie; Ifremer; Institut de Recherche pour le Developpement (IRD)	Lelong, C (corresponding author), UPMC, IRD 207, UMR BOREA Biol ORganismes & Ecosyst Aquat, UNICAEN,MNHN,CNRS 7208, Caen, France.	christophe.lelong@unicaen.fr	Boudry, Pierre/M-3213-2019; Dheilly, Nolwenn Marie M/A-7213-2011; Boudry, Pierre/G-2406-2010	Dheilly, Nolwenn Marie M/0000-0002-3675-5013; Boudry, Pierre/0000-0002-5150-2276; Favrel, Pascal/0000-0002-2504-9957	Regional Council of Basse Normandie; National Agency of Research; UNICAEN	Regional Council of Basse Normandie(Region Normandie); National Agency of Research(French National Research Agency (ANR)); UNICAEN	Financial support for this work was provided by the Regional Council of Basse Normandie, National Agency of Research, UNICAEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SK, 1986, J EXP MAR BIOL ECOL, V102, P197, DOI 10.1016/0022-0981(86)90176-0; Allen SK, 1990, PERFORMANCE TRIPLOID; Baron D, 2005, REPROD NUTR DEV, V45, P377, DOI 10.1051/rnd:2005028; Bhalla N, 2005, SCIENCE, V310, P1683, DOI 10.1126/science.1117468; BLOOM SE, 1972, CHROMOSOMA, V37, P309, DOI 10.1007/BF00319873; Boudry P, 2008, GENETIC BASIS SUMMER; Cal RM, 2006, AQUACULTURE, V251, P99, DOI 10.1016/j.aquaculture.2005.05.010; DeLuca JG, 2007, CURR BIOL, V17, pR966, DOI 10.1016/j.cub.2007.09.040; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dheilly NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036353; Dheilly NM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-468; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; EIBEN B, 1990, AM J HUM GENET, V47, P656; Elvin JA, 2000, MOL CELL ENDOCRINOL, V159, P1, DOI 10.1016/S0303-7207(99)00185-9; Emanuele MJ, 2007, CELL, V130, P893, DOI 10.1016/j.cell.2007.07.023; Ernande B, 2004, J EVOLUTION BIOL, V17, P342, DOI 10.1046/j.1420-9101.2003.00674.x; Fabioux C, 2005, AQUACULTURE, V250, P458, DOI 10.1016/j.aquaculture.2005.02.038; Franco A, 2008, TISSUE CELL, V40, P251, DOI 10.1016/j.tice.2007.12.006; Gong N, 2004, HEREDITY, V93, P408, DOI 10.1038/sj.hdy.6800517; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Guo XM, 1996, AQUACULTURE, V142, P149, DOI 10.1016/0044-8486(95)01243-5; GUO XM, 1994, BIOL BULL-US, V187, P309, DOI 10.2307/1542288; Guo XM, 1997, GENOME, V40, P397, DOI 10.1139/g97-053; GUO XM, 2012, J SHELLFISH RES, V31, P292; Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hudson AM, 2002, ANNU REV GENET, V36, P455, DOI 10.1146/annurev.genet.36.052802.114101; Hulata G, 2001, GENETICA, V111, P155, DOI 10.1023/A:1013776931796; Husband BC, 2004, BIOL J LINN SOC, V82, P537, DOI 10.1111/j.1095-8312.2004.00339.x; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Jouaux A, 2010, J EXP MAR BIOL ECOL, V395, P162, DOI 10.1016/j.jembe.2010.08.030; Kim Y, 2012, DEVELOPMENT, V139, P1133, DOI 10.1242/dev.073478; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; LINCOLN RF, 1983, AQUACULTURE, V30, P375, DOI 10.1016/0044-8486(83)90179-5; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Maxime V, 2008, FISH FISH, V9, P67, DOI 10.1111/j.1467-2979.2007.00269.x; Naimi A, 2009, COMP BIOCHEM PHYS B, V154, P134, DOI 10.1016/j.cbpb.2009.05.011; Nell JA, 2005, AQUAC RES, V36, P530, DOI 10.1111/j.1365-2109.2005.01229.x; Nell JA, 2002, AQUACULTURE, V210, P69, DOI 10.1016/S0044-8486(01)00861-4; NIEBUHR E, 1974, HUMANGENETIK, V21, P103, DOI 10.1007/BF00281030; Normand J, 2009, AQUAT BIOL, V7, P229, DOI 10.3354/ab00190; Normand Julien, 2008, COMP HISTOLOGICAL ST; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Piferrer F, 2009, AQUACULTURE, V293, P125, DOI 10.1016/j.aquaculture.2009.04.036; Roig I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001062; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Santerre C, 2012, SEX DEV, V6, P210, DOI 10.1159/000338085; Santerre C, 2013, COMP BIOCHEM PHYS A, V165, P61, DOI 10.1016/j.cbpa.2013.02.007; Sekii K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-62; Shibayama H, 2004, J EXP MED, V199, P581, DOI 10.1084/jem.20031858; Smiley S, 2005, J ELECT MICROSCOP TE, V16, P93; Song HH, 2002, BBA-GEN SUBJECTS, V1573, P241, DOI 10.1016/S0304-4165(02)00390-2; STANLEY JG, 1981, AQUACULTURE, V23, P1, DOI 10.1016/0044-8486(81)90002-8; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Warrillow JA, 1997, CAN J FISH AQUAT SCI, V54, P1808, DOI 10.1139/cjfas-54-8-1808; WOLTERS WR, 1982, T AM FISH SOC, V111, P102, DOI 10.1577/1548-8659(1982)111<102:EOTOGA>2.0.CO;2; Xiao Xiang, 2007, Journal of Zhejiang University-Science B, V8, P498, DOI 10.1631/jzus.2007.B0498; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Ye Y, 2009, MOL CANCER RES, V7, P1984, DOI 10.1158/1541-7786.MCR-09-0119; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zhang QQ, 2010, AQUAC RES, V41, P1658, DOI 10.1111/j.1365-2109.2010.02541.x	62	27	29	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112094	10.1371/journal.pone.0112094	http://dx.doi.org/10.1371/journal.pone.0112094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375782	Green Submitted, gold, Green Published			2022-12-26	WOS:000344402600103
J	Hirai, H; Arai, K; Kariyazono, R; Yamamoto, M; Sato, M				Hirai, Hayato; Arai, Kunio; Kariyazono, Ryo; Yamamoto, Masayuki; Sato, Masamitsu			The Kinetochore Protein Kis1/Eic1/Mis19 Ensures the Integrity of Mitotic Spindles through Maintenance of Kinetochore Factors Mis6/CENP-I and CENP-A	PLOS ONE			English	Article							GAMMA-TUBULIN COMPLEX; YEAST SCHIZOSACCHAROMYCES-POMBE; MICROTUBULE-ORGANIZING CENTERS; SISTER-CHROMATID SEPARATION; FISSION YEAST; POLE BODY; CELL-CYCLE; BIPOLAR SPINDLE; NUCLEAR-ENVELOPE; KINASE 1	Microtubules play multiple roles in a wide range of cellular phenomena, including cell polarity establishment and chromosome segregation. A number of microtubule regulators have been identified, including microtubule-associated proteins and kinases, and knowledge of these factors has contributed to our molecular understanding of microtubule regulation of each relevant cellular process. The known regulators, however, are insufficient to explain how those processes are linked to one another, underscoring the need to identify additional regulators. To find such novel mechanisms and microtubule regulators, we performed a screen that combined genetics and microscopy for fission yeast mutants defective in microtubule organization. We isolated approximately 900 mutants showing defects in either microtubule organization or the nuclear envelope, and these mutants were classified into 12 categories. We particularly focused on one mutant, kis1, which displayed spindle defects in early mitosis. The kis1 mutant frequently failed to assemble a normal bipolar spindle. The responsible gene encoded a kinetochore protein, Mis19 (also known as Eic1), which localized to the interface of kinetochores and spindle poles. We also found that the inner kinetochore proteins Mis6/CENP-I and Cnp1/CENP-A were delocalized from kinetochores in the kis1 cells and that kinetochore-microtubule attachment was defective. Another mutant, mis6, also displayed similar spindle defects. We conclude that Kis1 is required for inner kinetochore organization, through which Kis1 ensures kinetochore-microtubule attachment and spindle integrity. Thus, we propose an unexpected relationship between inner kinetochore organization and spindle integrity.	[Hirai, Hayato; Arai, Kunio; Sato, Masamitsu] Waseda Univ, Grad Sch Adv Sci & Technol, Dept Life Sci & Med Biosci, Lab Cytoskeletal Logist, Tokyo, Japan; [Arai, Kunio; Kariyazono, Ryo; Yamamoto, Masayuki; Sato, Masamitsu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Yamamoto, Masayuki] Natl Inst Basic Biol, Lab Cell Responses, Okazaki, Aichi, Japan; [Sato, Masamitsu] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Waseda University; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST)	Sato, M (corresponding author), Waseda Univ, Grad Sch Adv Sci & Technol, Dept Life Sci & Med Biosci, Lab Cytoskeletal Logist, Tokyo, Japan.	masasato@waseda.jp		Hirai, Hayato/0000-0001-9811-429X	JSPS [21687015, 25291041, 21227007]; Naito Foundation; Senri Life Science Foundation; Sumitomo Foundation; Kato Life Science Foundation; Waseda University Grant for Special Research Projects [2013A-911, 2013B-178, 2013A-6313, 2013A-912, 2013B-181]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Senri Life Science Foundation; Sumitomo Foundation; Kato Life Science Foundation; Waseda University Grant for Special Research Projects	This work was supported by Grants-in-Aid for Young Scientists (A) (Grant Number 21687015) and for Scientific Research (B) (25291041) (to MS) and Grant-in-Aid for Scientific Research (S) (21227007) (to MY) from JSPS (http://www.jsps.go.jp/english/). This work was also supported by the Naito Foundation (https://www.naito-f.or.jp/en/), the Senri Life Science Foundation (http://www.senri-life.or.jp/), the Sumitomo Foundation (http://www.sumitomo.or.jp/e/) and Kato Life Science Foundation (https://www.katokinen.or.jp/) (to MS), and by Waseda University Grant for Special Research Projects (2013A-911, 2013B-178 and 2013A-6313 to MS.; 2013A-912 and 2013B-181 to KA). KA was a research fellow of JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akera T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1725; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; Aoi Y, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140063; Aoki K, 2006, CURR BIOL, V16, P1627, DOI 10.1016/j.cub.2006.06.065; Asakawa K, 2006, MOL BIOL CELL, V17, P1421, DOI 10.1091/mbc.e05-08-0802; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Bai SW, 2004, MOL CELL BIOL, V24, P6379, DOI 10.1128/MCB.24.14.6379-6392.2004; Balasubramanian MK, 1998, GENETICS, V149, P1265; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Blanco G, 2001, HUM MOL GENET, V10, P9, DOI 10.1093/hmg/10.1.9; Bridge AJ, 1998, GENE DEV, V12, P927, DOI 10.1101/gad.12.7.927; Chang L, 2000, P NATL ACAD SCI USA, V97, P5249, DOI 10.1073/pnas.97.10.5249; Chen XQ, 2004, YEAST, V21, P495, DOI 10.1002/yea.1115; DEMETER J, 1995, P NATL ACAD SCI USA, V92, P1436, DOI 10.1073/pnas.92.5.1436; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dischinger S, 2008, J CELL SCI, V121, P843, DOI 10.1242/jcs.021584; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fong CS, 2010, EMBO J, V29, P120, DOI 10.1038/emboj.2009.331; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Fujita A, 2002, MOL BIOL CELL, V13, P2360, DOI 10.1091/mbc.02-01-0603; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Garcia MA, 2002, EMBO J, V21, P6015, DOI 10.1093/emboj/cdf611; Gascoigne KE, 2011, CURR OPIN CELL BIOL, V23, P102, DOI 10.1016/j.ceb.2010.07.007; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; HAGAN IM, 1988, J CELL SCI, V89, P343; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hayashi T, 2014, GENES CELLS; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Heald R, 2000, TRENDS CELL BIOL, V10, P1, DOI 10.1016/S0962-8924(99)01691-8; Hirata D, 1998, EMBO J, V17, P658, DOI 10.1093/emboj/17.3.658; HOFER F, 1979, CURR GENET, V1, P45, DOI 10.1007/BF00413306; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hsu KS, 2011, CURR BIOL, V21, P214, DOI 10.1016/j.cub.2010.12.048; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Kakui Y, 2013, NAT CELL BIOL, V15, P786, DOI 10.1038/ncb2782; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Lehmann A, 2004, FEBS LETT, V566, P77, DOI 10.1016/j.febslet.2004.04.022; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; MATSUMOTO T, 1990, CURR GENET, V18, P323, DOI 10.1007/BF00318213; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; McKinley KL, 2014, CELL, V158, P397, DOI 10.1016/j.cell.2014.06.016; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mori R, 2013, MOL BIOL CELL, V24, P1713, DOI 10.1091/mbc.E12-11-0792; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Ohta M, 2012, MOL BIOL CELL, V23, P1799, DOI 10.1091/mbc.E11-11-0951; Okada Y, 2014, MOL BIOL CELL, V25; Okamoto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030622; Paoletti A, 2003, MOL BIOL CELL, V14, P2793, DOI 10.1091/mbc.E02-10-0661; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Radcliffe P, 1998, MOL BIOL CELL, V9, P1757, DOI 10.1091/mbc.9.7.1757; Radcliffe PA, 1999, MOL BIOL CELL, V10, P2987, DOI 10.1091/mbc.10.9.2987; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Saitoh S, 2005, MOL BIOL CELL, V16, P3666, DOI 10.1091/mbc.E05-01-0014; Saitoh S, 2008, MOL BIOL CELL, V19, P3885, DOI 10.1091/mbc.E08-03-0298; Samejima I, 2005, MOL BIOL CELL, V16, P3040, DOI 10.1091/mbc.e04-11-1003; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Sato M, 2007, NATURE, V447, P334, DOI 10.1038/nature05773; Sato M, 2009, METHODS MOL BIOL, V545, P185, DOI 10.1007/978-1-60327-993-2_11; Sato M, 2009, EMBO REP, V10, P1161, DOI 10.1038/embor.2009.158; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Sawin KE, 2006, YEAST, V23, P1001, DOI 10.1002/yea.1404; Silva MCC, 2012, DEV CELL, V22, P52, DOI 10.1016/j.devcel.2011.10.014; Simanis V, 2003, J CELL SCI, V116, P4261, DOI 10.1242/jcs.00777; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Subramanian L, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140043; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; TANAKA K, 1986, J CELL SCI, V80, P253; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; UMESONO K, 1983, J MOL BIOL, V168, P271, DOI 10.1016/S0022-2836(83)80018-7; Vardy L, 2000, EMBO J, V19, P6098, DOI 10.1093/emboj/19.22.6098; Venkatram S, 2005, MOL BIOL CELL, V16, P3052, DOI 10.1091/mbc.E04-12-1043; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; Vizeacoumar FJ, 2010, J CELL BIOL, V188, P69, DOI 10.1083/jcb.200909013; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; West RR, 2002, J CELL SCI, V115, P931; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wilson-Grady JT, 2008, J PROTEOME RES, V7, P1088, DOI 10.1021/pr7006335; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Xu DZ, 2011, P NATL ACAD SCI USA, V108, P11301, DOI 10.1073/pnas.1107723108; Yaffe MP, 1996, P NATL ACAD SCI USA, V93, P11664, DOI 10.1073/pnas.93.21.11664; Yamada H, 1997, J CELL SCI, V110, P1793; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yamashita A, 1997, GENES CELLS, V2, P155, DOI 10.1046/j.1365-2443.1997.1100307.x; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676; Zimmerman S, 2004, DEV CELL, V6, P497, DOI 10.1016/S1534-5807(04)00096-6	109	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111905	10.1371/journal.pone.0111905	http://dx.doi.org/10.1371/journal.pone.0111905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375240	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600073
J	Durham, NM; Nirschl, CJ; Jackson, CM; Elias, J; Kochel, CM; Anders, RA; Drake, CG				Durham, Nicholas M.; Nirschl, Christopher J.; Jackson, Christopher M.; Elias, Jimmy; Kochel, Christina M.; Anders, Robert A.; Drake, Charles G.			Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T- cells to Be Suppressed In Vivo	PLOS ONE			English	Article							RECEPTOR-GAMMA CHAIN; SELF-TOLERANCE; HOMEOSTATIC MAINTENANCE; FAMILY CYTOKINES; DENDRITIC CELLS; LIFE-SPAN; INTERLEUKIN-2; MOLECULES; NAIVE; SURVIVAL	Lymphocyte Activation Gene - 3 (LAG-3) is an immune checkpoint molecule that regulates both T-cell activation and homeostasis. However, the molecular mechanisms underlying LAG-3's function are generally unknown. Using a model in which LAG-3 blockade or absence reliably augmented homeostatic proliferation in vivo, we found that IL-2 and STAT5 are critical for LAG-3 function. Similarly, LAG-3 blockade was ineffective in the absence of regulatory T-cells (Treg), suggesting an important role for LAG-3 in either the responsiveness of conventional T-cells (Tconv) to regulation, or a relative defect in the ability of LAG-3 KO regulatory T-cells (Treg) to suppress the proliferation of Tconv. In this model, LAG-3 KO Treg suppressed proliferation in a manner fairly similar to wild-type (WT) Treg, but LAG-3 KO Tconv were relatively resistant to suppression. Further studies also identified a role for LAG-3 in the induction/expansion of Treg. Finally, we found that LAG-3 blockade (or knockout) led to a relative skewing of naive CD4 T-cells toward a T(H)1 phenotype both in vitro and in in vivo. Together, these data suggest that LAG-3 expression on Tconv cells makes them more susceptible to Treg based suppression, and also regulates the development of a T(H)1 T-cell response.	[Durham, Nicholas M.; Nirschl, Christopher J.; Jackson, Christopher M.; Elias, Jimmy; Kochel, Christina M.; Anders, Robert A.; Drake, Charles G.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Anders, Robert A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Drake, CG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	cdrake@jhmi.edu			National Institutes of Health [R01 CA127153, 1P50CA58236-15]; Patrick C. Walsh Fund; OneInSix Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA127153, P50CA058236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patrick C. Walsh Fund; OneInSix Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CGD is a Damon Runyon-Lilly Clinical Investigator and is supported by National Institutes of Health R01 CA127153, 1P50CA58236-15, the Patrick C. Walsh Fund, the OneInSix Foundation and the Prostate Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Andreae S, 2003, BLOOD, V102, P2130, DOI 10.1182/blood-2003-01-0273; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boyman O, 2012, CELL MOL LIFE SCI, V69, P1597, DOI 10.1007/s00018-012-0968-7; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; Hannier S, 1998, J IMMUNOL, V161, P4058; Hansen W, 2012, J EXP MED, V209, P2001, DOI 10.1084/jem.20111497; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; He YW, 1997, J IMMUNOL, V158, P2592; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lanoue A, 1997, J EXP MED, V185, P405, DOI 10.1084/jem.185.3.405; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nirschl CJ, 2013, CLIN CANCER RES, V19, P4917, DOI 10.1158/1078-0432.CCR-12-1972; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sakaguchi S, 1996, J AUTOIMMUN, V9, P211, DOI 10.1006/jaut.1996.0026; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sega EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086551; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sprent J, 2008, IMMUNOL CELL BIOL, V86, P312, DOI 10.1038/icb.2008.12; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392; Workman CJ, 2011, METHODS MOL BIOL, V707, P119, DOI 10.1007/978-1-61737-979-6_9; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547	53	90	93	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109080	10.1371/journal.pone.0109080	http://dx.doi.org/10.1371/journal.pone.0109080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372844	gold, Green Submitted, Green Published			2022-12-26	WOS:000344556900006
J	Gao, ZF; Guo, W; Liu, X; Huang, WH; Zhang, HY; Tan, N; Hau, WK; Zhang, YT; Liu, HF				Gao, Zhifan; Guo, Wei; Liu, Xin; Huang, Wenhua; Zhang, Heye; Tan, Ning; Hau, William Kongto; Zhang, Yuan-Ting; Liu, Huafeng			Automated Detection Framework of the Calcified Plaque with Acoustic Shadowing in IVUS Images	PLOS ONE			English	Article							CORONARY-ARTERY CALCIUM; EXPERT CONSENSUS DOCUMENT; INTRAVASCULAR ULTRASOUND; COMPUTED-TOMOGRAPHY; AMERICAN-COLLEGE; PROGNOSTIC VALUE; SEGMENTATION; RISK	Intravascular Ultrasound (IVUS) is one ultrasonic imaging technology to acquire vascular cross-sectional images for the visualization of the inner vessel structure. This technique has been widely used for the diagnosis and treatment of coronary artery diseases. The detection of the calcified plaque with acoustic shadowing in IVUS images plays a vital role in the quantitative analysis of atheromatous plaques. The conventional method of the calcium detection is manual drawing by the doctors. However, it is very time-consuming, and with high inter-observer and intra-observer variability between different doctors. Therefore, the computer-aided detection of the calcified plaque is highly desired. In this paper, an automated method is proposed to detect the calcified plaque with acoustic shadowing in IVUS images by the Rayleigh mixture model, the Markov random field, the graph searching method and the prior knowledge about the calcified plaque. The performance of our method was evaluated over 996 in-vivo IVUS images acquired from eight patients, and the detected calcified plaques are compared with manually detected calcified plaques by one cardiology doctor. The experimental results are quantitatively analyzed separately by three evaluation methods, the test of the sensitivity and specificity, the linear regression and the Bland-Altman analysis. The first method is used to evaluate the ability to distinguish between IVUS images with and without the calcified plaque, and the latter two methods can respectively measure the correlation and the agreement between our results and manual drawing results for locating the calcified plaque in the IVUS image. High sensitivity (94.68%) and specificity (95.82%), good correlation and agreement (>96.82% results fall within the 95% confidence interval in the Student t-test) demonstrate the effectiveness of the proposed method in the detection of the calcified plaque with acoustic shadowing in IVUS images.	[Gao, Zhifan] Univ Chinese Acad Sci, Shenzhen Coll Adv Technol, Shenzhen, Peoples R China; [Gao, Zhifan; Liu, Xin; Zhang, Heye; Zhang, Yuan-Ting] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Gao, Zhifan; Liu, Xin; Zhang, Heye; Zhang, Yuan-Ting] Chinese Acad Sci, Key Lab Biomed Informat & Hlth Engn, Shenzhen, Peoples R China; [Guo, Wei; Tan, Ning] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Huang, Wenhua] Southern Med Univ, Inst Clin Anat, Guangzhou, Guangdong, Peoples R China; [Hau, William Kongto] Univ Hong Kong, LiKaShing Fac Med, Inst Cardiovasc Med & Res, Hong Kong, Hong Kong, Peoples R China; [Zhang, Yuan-Ting] Chinese Univ Hong Kong, Dept Elect Engn, Joint Res Ctr Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Liu, Huafeng] Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou 310027, Zhejiang, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; University of Hong Kong; Chinese University of Hong Kong; Zhejiang University	Zhang, HY (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	hy.zhang@siat.ac.cn; Tanning100@126.com	huang, wenhua/AAO-5990-2020; Gao, Zhifan/O-9082-2019	huang, wenhua/0000-0003-2382-9180; Gao, Zhifan/0000-0002-1576-4439; ZHANG, Yuanting/0000-0003-4150-5470	Research Team Fund for Low-cost Health-care Technologies in China; Enhancing Program of Key Laboratories of Shenzhen City [ZDSY20120617113021359]; National High-tech R & D Program (863 Program) [2012AA02A603]; National Natural Science Foundation of China [81101120]; Inovation funding in Shenzhen [SGLH20131010110119871, GJHZ20140415152115754]	Research Team Fund for Low-cost Health-care Technologies in China; Enhancing Program of Key Laboratories of Shenzhen City; National High-tech R & D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inovation funding in Shenzhen	ZFG, XL, HYZ, YTZ: Research Team Fund for Low-cost Health-care Technologies in China (http://cxtd.gdstc.gov.cn/) and the Enhancing Program of Key Laboratories of Shenzhen City (ZDSY20120617113021359, http://www.szsti.gov.cn/). WHH: the National High-tech R & D Program (863 Program) (No. 2012AA02A603, http://www.most.gov.cn/). HYZ: the National Natural Science Foundation of China (No. 81101120, www.nsfc.gov.cn). HFL: Inovation funding in Shenzhen (SGLH20131010110119871, GJHZ20140415152115754, http://www.szsti.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2012, IEEE T BIO-MED ENG, V59, P1022, DOI 10.1109/TBME.2011.2181372; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; ANTONIOU A, 2007, PRACTICAL OPTIMIZATI; Bishop C. M, 2006, PATTERN RECOGNITION; Brusseau E, 2004, IEEE T MED IMAGING, V23, P554, DOI 10.1109/TMI.2004.825602; Cardinal MHR, 2006, IEEE T MED IMAGING, V25, P590, DOI 10.1109/TMI.2006.872142; Cardinal MHR, 2003, LECT NOTES COMPUT SC, V2879, P432; Dey N., 2012, NAT C COMP COMM SYST, P1; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Filho ES, 2008, ULTRASOUND MED BIOL, V34, P160, DOI 10.1016/j.ultrasmedbio.2007.06.025; Forbes C., 2011, STAT DISTRIBUTIONS; Friedman A., 2011, PARTIAL DIFFERENTIAL; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Gao Z, 2014, IFMBE INT C HLTH INF, P197; Gil D, 2002, C AN SOC ESP ING BIO, P133; Goodman J. W., 2007, SPECKLE PHENOMENA OP; GOODMAN JW, 1976, J OPT SOC AM, V66, P1145, DOI 10.1364/JOSA.66.001145; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Herrington D. M., 1992, Proceedings of Computer in Cardiology 1992 (Cat. No.92CH3259-9), P103, DOI 10.1109/CIC.1992.269436; Kovalski G, 2000, ULTRASOUND MED BIOL, V26, P527, DOI 10.1016/S0301-5629(99)00167-2; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Lakemeyer G., 2003, EXPLORING ARTIFICIAL, P239; Li S. Z., 2009, MARKOV RANDOM FIELD; Meier DS, 1997, AM HEART J, V133, P681, DOI 10.1016/S0002-8703(97)70170-4; Mezard M., 2009, INFORM PHYS COMPUTAT, pp 584, DOI [10.1093/acprof:oso/9780198570837.001.0001, DOI 10.1093/ACPROF:OSO/9780198570837.001, DOI 10.1093/ACPROF:OSO/9780198570837.001.0001]; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Mojsilovic A, 1997, ANN BIOMED ENG, V25, P1059, DOI 10.1007/BF02684141; Nilsson N.J., 1982, PRINCIPLES ARTIFICIA; O'Rourke RA, 2000, J AM COLL CARDIOL, V36, P326, DOI 10.1016/S0735-1097(00)00831-7; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Papadogiorgaki Maria, 2007, Open Biomed Eng J, V1, P53, DOI 10.2174/1874120700701010053; Plissiti ME, 2004, IEEE T INF TECHNOL B, V8, P131, DOI 10.1109/TITB.2004.828889; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Ravindraiah R., 2014, INT J ADV RES COMPUT, V3; Roodaki A, 2009, ADV COMPUTER SCI ENG, P629; Schoenhagen P, 2005, IVUS MADE EASY; Seabra J, 2010, I S BIOMED IMAGING, P1, DOI 10.1109/ISBI.2010.5490428; Seabra JC, 2011, IEEE T BIO-MED ENG, V58, P1314, DOI 10.1109/TBME.2011.2106498; Shaw LJ, 2006, ATHEROSCLEROSIS, V188, P112, DOI 10.1016/j.atherosclerosis.2005.10.010; Shaw LJ, 2006, EUR HEART J, V27, P968, DOI 10.1093/eurheartj/ehi750; Nguyen TM, 2012, IEEE T SYST MAN CY B, V42, P193, DOI 10.1109/TSMCB.2011.2161284; Wayhs R, 2002, J AM COLL CARDIOL, V39, P225, DOI 10.1016/S0735-1097(01)01737-5; Xing D., 2013, WORLD C MED PHYS BIO, P931; Yedidia JS, 2001, BETHE FREE ENERGY KI; Zhang Q, 2010, ULTRASOUND MED BIOL, V36, P111, DOI 10.1016/j.ultrasmedbio.2009.06.1097	46	39	41	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109997	10.1371/journal.pone.0109997	http://dx.doi.org/10.1371/journal.pone.0109997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372784	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900014
J	Nelissen, BGL; van Herwaarden, JA; Moll, FL; van Diest, PJ; Pasterkamp, G				Nelissen, Bastiaan G. L.; van Herwaarden, Joost A.; Moll, Frans L.; van Diest, Paul J.; Pasterkamp, Gerard			SlideToolkit: An Assistive Toolset for the Histological Quantification of Whole Slide Images	PLOS ONE			English	Article								The demand for accurate and reproducible phenotyping of a disease trait increases with the rising number of biobanks and genome wide association studies. Detailed analysis of histology is a powerful way of phenotyping human tissues. Nonetheless, purely visual assessment of histological slides is time-consuming and liable to sampling variation and optical illusions and thereby observer variation, and external validation may be cumbersome. Therefore, within our own biobank, computerized quantification of digitized histological slides is often preferred as a more precise and reproducible, and sometimes more sensitive approach. Relatively few free toolkits are, however, available for fully digitized microscopic slides, usually known as whole slides images. In order to comply with this need, we developed the slideToolkit as a fast method to handle large quantities of low contrast whole slides images using advanced cell detecting algorithms. The slideToolkit has been developed for modern personal computers and high-performance clusters (HPCs) and is available as an open-source project on github.com. We here illustrate the power of slideToolkit by a repeated measurement of 303 digital slides containing CD3 stained (DAB) abdominal aortic aneurysm tissue from a tissue biobank. Our workflow consists of four consecutive steps. In the first step (acquisition), whole slide images are collected and converted to TIFF files. In the second step (preparation), files are organized. The third step (tiles), creates multiple manageable tiles to count. In the fourth step (analysis), tissue is analyzed and results are stored in a data set. Using this method, two consecutive measurements of 303 slides showed an intraclass correlation of 0.99. In conclusion, slideToolkit provides a free, powerful and versatile collection of tools for automated feature analysis of whole slide images to create reproducible and meaningful phenotypic data sets.	[Nelissen, Bastiaan G. L.; van Herwaarden, Joost A.; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Pasterkamp, Gerard] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Nelissen, BGL (corresponding author), Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands.	b.g.l.nelissen@umcutrecht.nl		van Herwaarden, Joost/0000-0003-1165-5179				Belien JAM, 1999, J CLIN PATHOL, V52, P184, DOI 10.1136/jcp.52.3.184; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Hurks R, 2010, EUR SURG RES, V45, P34, DOI 10.1159/000318160; Iyengar JN, 2009, INDIAN J PATHOL MICR, V52, P1, DOI 10.4103/0377-4929.44951; Kalinski T, 2011, AM J CLIN PATHOL, V136, P889, DOI 10.1309/AJCPYI1Z3TGGAIEP; Lopez XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082710; Lovett JK, 2004, CEREBROVASC DIS, V18, P117, DOI 10.1159/000079259; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Osborne JM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003506; Prlic A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002802; Ramos-Vara JA, 2014, VET PATHOL, V51, P42, DOI 10.1177/0300985813505879; Revelle W, 2012, CRAN PACKAGE PSYCH; Scholtes VPW, 2011, CURR CARDIOL REV, V7, P9, DOI 10.2174/157340311795677707; Tange O., 2018, USENIX MAGAZINE, V36, P42; vanDiest PJ, 1997, J CLIN PATHOL, V50, P801, DOI 10.1136/jcp.50.10.801; Vokes Martha S, 2008, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1417s82; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	18	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110289	10.1371/journal.pone.0110289	http://dx.doi.org/10.1371/journal.pone.0110289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372389	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900019
J	Spencer, WC; McWhirter, R; Miller, T; Strasbourger, P; Thompson, O; Hillier, LW; Waterston, RH; Miller, DM				Spencer, W. Clay; McWhirter, Rebecca; Miller, Tyne; Strasbourger, Pnina; Thompson, Owen; Hillier, LaDeana W.; Waterston, Robert H.; Miller, David M., III			Isolation of Specific Neurons from C. elegans Larvae for Gene Expression Profiling	PLOS ONE			English	Article							MOTOR-NEURONS; DIFFERENTIAL EXPRESSION; HOMEOBOX GENES; CAENORHABDITIS; CELL; IDENTIFICATION; NORMALIZATION; CHANNELS; IDENTITY; SYSTEM	Background: The simple and well-described structure of the C. elegans nervous system offers an unprecedented opportunity to identify the genetic programs that define the connectivity and function of individual neurons and their circuits. A correspondingly precise gene expression map of C. elegans neurons would facilitate the application of genetic methods toward this goal. Here we describe a powerful new approach, SeqCeL (RNA-Seq of C. elegans cells) for producing gene expression profiles of specific larval C. elegans neurons. Methods and Results: We have exploited available GFP reporter lines for FACS isolation of specific larval C. elegans neurons for RNA-Seq analysis. Our analysis showed that diverse classes of neurons are accessible to this approach. To demonstrate the applicability of this strategy to rare neuron types, we generated RNA-Seq profiles of the NSM serotonergic neurons that occur as a single bilateral pair of cells in the C. elegans pharynx. These data detected >1,000 NSM enriched transcripts, including the majority of previously known NSM-expressed genes. Significance: This work offers a simple and robust protocol for expression profiling studies of post-embryonic C. elegans neurons and thus provides an important new method for identifying candidate genes for key roles in neuron-specific development and function.	[Spencer, W. Clay; McWhirter, Rebecca; Miller, David M., III] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Miller, Tyne] Vanderbilt Univ, Program Neurosci, Nashville, TN 37235 USA; [Strasbourger, Pnina; Thompson, Owen; Hillier, LaDeana W.; Waterston, Robert H.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA	Vanderbilt University; Vanderbilt University; University of Washington; University of Washington Seattle	Miller, DM (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	david.miller@vanderbilt.edu		Miller-Fleming, Tyne/0000-0002-0398-5162	US National Institutes of Health (NIH) National Center for Research Resources; Vanderbilt Silvio O. Conte Center grant [MH078028]; NIH [R01 NS26115, U01 HG004263]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH078028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026115] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Vanderbilt Silvio O. Conte Center grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The C. elegans Genetics Center is supported by US National Institutes of Health (NIH) National Center for Research Resources. This work was supported by Vanderbilt Silvio O. Conte Center grant MH078028 to TM and NIH Grants R01 NS26115 to DMM and U01 HG004263 to RHW and DMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Bonferroni E, 1935, CALCOLO ASSICURAZION; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Cinar H, 2005, CURR BIOL, V15, P340, DOI 10.1016/j.cub.2005.02.025; Colosimo ME, 2004, CURR BIOL, V14, P2245, DOI 10.1016/j.cub.2004.12.030; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gerstein MB, 2014, NATURE IN PRESS; Guillermin ML, 2011, GENETICS, V189, P1327, DOI 10.1534/genetics.111.133835; Haenni S, 2012, NUCLEIC ACIDS RES, V40, P6304, DOI 10.1093/nar/gks282; Hallem EA, 2011, P NATL ACAD SCI USA, V108, P254, DOI 10.1073/pnas.1017354108; Hillier LW, 2009, GENOME RES; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Husson SJ, 2012, CURR BIOL, V22, P743, DOI 10.1016/j.cub.2012.02.066; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim K, 2010, DEVELOPMENT, V137, P963, DOI 10.1242/dev.044719; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Nelson JC, 2013, J NEUROSCI, V33, P1366, DOI 10.1523/JNEUROSCI.3471-12.2012; Petersen SC, 2011, J NEUROSCI, V31, P15362, DOI 10.1523/JNEUROSCI.3181-11.2011; Pflugrad A, 1997, DEVELOPMENT, V124, P1699; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; SCHACHAT F, 1978, CELL, V15, P405, DOI 10.1016/0092-8674(78)90009-0; Schwarz EM, 2012, P NATL ACAD SCI USA, V109, P16246, DOI 10.1073/pnas.1203045109; Shagina I, 2010, BIOTECHNIQUES, V48, P455, DOI 10.2144/000113422; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shipley FB, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00028; Smith CJ, 2013, NEURON, V79, P266, DOI 10.1016/j.neuron.2013.05.009; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Steiner FA, 2012, GENOME RES, V22, P766, DOI 10.1101/gr.131748.111; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sze JY, 2002, DEVELOPMENT, V129, P3901; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Von Stetina SE, 2007, GENE DEV, V21, P332, DOI 10.1101/gad.1502107; Watson JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-84; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winnier AR, 1999, GENE DEV, V13, P2774, DOI 10.1101/gad.13.21.2774; Zhang FF, 2014, DEVELOPMENT, V141, P422, DOI 10.1242/dev.099721; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zhang Sihui, 2013, WormBook, P1, DOI 10.1895/wormbook.1.157.1; Zhang SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019505; Zhang SY, 2004, DEVELOPMENT, V131, P1629, DOI 10.1242/dev.01047; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	54	50	50	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112102	10.1371/journal.pone.0112102	http://dx.doi.org/10.1371/journal.pone.0112102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372608	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900111
J	Bellanca, S; Summers, RL; Meyrath, M; Dave, A; Nash, MN; Dittmer, M; Sanchez, CP; Stein, WD; Martin, RE; Lanzer, M				Bellanca, Sebastiano; Summers, Robert L.; Meyrath, Max; Dave, Anurag; Nash, Megan N.; Dittmer, Martin; Sanchez, Cecilia P.; Stein, Wilfred D.; Martin, Rowena E.; Lanzer, Michael			Multiple Drugs Compete for Transport via the Plasmodium falciparum Chloroquine Resistance Transporter at Distinct but Interdependent Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN PFCRT; MALARIA PARASITES; DIGESTIVE VACUOLE; ARTEMETHER-LUMEFANTRINE; SIMULTANEOUS BINDING; ANTIMALARIAL-DRUG; SUBSTRATE-BINDING; EFFLUX SYSTEM; H+ LEAK; MUTATIONS	Mutations in the "chloroquine resistance transporter" (PfCRT) are a major determinant of drug resistance in the malaria parasite Plasmodium falciparum. We have previously shown that mutant PfCRT transports the antimalarial drug chloroquine away from its target, whereas the wild-type form of PfCRT does not. However, little is understood about the transport of other drugs via PfCRT or the mechanism by which PfCRT recognizes different substrates. Here we show that mutant PfCRT also transports quinine, quinidine, and verapamil, indicating that the protein behaves as a multidrug resistance carrier. Detailed kinetic analyses revealed that chloroquine and quinine compete for transport via PfCRT in a manner that is consistent with mixed-type inhibition. Moreover, our analyses suggest that PfCRT accepts chloroquine and quinine at distinct but antagonistically interacting sites. We also found verapamil to be a partial mixed-type inhibitor of chloroquine transport via PfCRT, further supporting the idea that PfCRT possesses multiple substrate-binding sites. Our findings provide new mechanistic insights into the workings of PfCRT, which could be exploited to design potent inhibitors of this key mediator of drug resistance.	[Bellanca, Sebastiano; Meyrath, Max; Dave, Anurag; Dittmer, Martin; Sanchez, Cecilia P.; Lanzer, Michael] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany; [Summers, Robert L.; Nash, Megan N.; Martin, Rowena E.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Stein, Wilfred D.] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Ruprecht Karls University Heidelberg; Australian National University; Hebrew University of Jerusalem	Martin, RE (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	rowena.martin@anu.edu.au; michael_lanzer@med.uni-heidelberg.de	Martin, Rowena E/C-9992-2009; Lanzer, Michael/E-9752-2013; Summers, Robert L/E-8982-2012	Martin, Rowena E/0000-0001-7408-5295; Lanzer, Michael/0000-0002-0220-6526; Summers, Robert L/0000-0003-0840-1784; Meyrath, Max/0000-0001-8585-0474	Australian National Health and Medical Research Council (NHMRC) [1007035]; European Community [242095]; Konanz-Stiftung fellowship; NHMRC [520320, 1053082]; L'Oreal Australia For Women in Science fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); European Community(European Commission); Konanz-Stiftung fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); L'Oreal Australia For Women in Science fellowship(L'Oreal Group)	This work was supported by the Australian National Health and Medical Research Council (NHMRC; Grant 1007035 to R. E. M.) and the European Community's Seventh Framework Programme (FP7/2007-2013; Grant 242095 to M. L.).; Supported by a Konanz-Stiftung fellowship.; Supported by NHMRC Fellowships 520320 and 1053082 as well as a L'Oreal Australia For Women in Science fellowship. To whom correspondence may be addressed. Tel.: 61-2-6197-0051; Fax: 61-2-6125-0313; E-mail: rowena.martin@anu.edu.au.	Achan J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-144; Alibert S, 2002, J MED CHEM, V45, P3195, DOI 10.1021/jm011046l; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Breslow R, 2000, PURE APPL CHEM, V72, P333, DOI 10.1351/pac200072030333; Brittain H, 2007, PROFILES DRUG SUBSTA, P33; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CHEVILLARD C, 1993, BIOCHEM J, V289, P599, DOI 10.1042/bj2890599; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; Cornish-Bowden A, 2001, METHODS, V24, P181, DOI 10.1006/meth.2001.1179; Cornish-Bowden A., 2012, FUNDAMENTALS ENZYME; Cornish-Bowden A, 2014, FEBS J, V281, P621, DOI 10.1111/febs.12469; Eastman RT, 2011, ANTIMICROB AGENTS CH, V55, P3908, DOI 10.1128/AAC.01793-10; Ecker A, 2012, TRENDS PARASITOL, V28, P504, DOI 10.1016/j.pt.2012.08.002; Ewers D, 2013, P NATL ACAD SCI USA, V110, P12486, DOI 10.1073/pnas.1300772110; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Folarin OA, 2011, ACTA TROP, V120, P224, DOI 10.1016/j.actatropica.2011.08.013; Harper JN, 2013, AM J PHYSIOL-RENAL, V304, pF56, DOI 10.1152/ajprenal.00486.2012; HASEGAWA J, 1984, J PHARM SCI, V73, P442, DOI 10.1002/jps.2600730405; Hrycyna CA, 2014, ACS CHEM BIOL, V9, P722, DOI 10.1021/cb4008953; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Kuzmic P, 2006, FEBS J, V273, P3054, DOI 10.1111/j.1742-4658.2006.05316.x; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Lehane AM, 2008, ANTIMICROB AGENTS CH, V52, P4374, DOI 10.1128/AAC.00666-08; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Lehane AM, 2010, MOL MICROBIOL, V77, P1039, DOI 10.1111/j.1365-2958.2010.07272.x; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Martinez L, 2014, FEBS J, V281, P673, DOI 10.1111/febs.12613; Naude B, 2005, J BIOL CHEM, V280, P25596, DOI 10.1074/jbc.M503227200; Ohashi R, 2002, J PHARMACOL EXP THER, V302, P1286, DOI 10.1124/jpet.102.036004; Papakrivos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039569; R Core Team, 2021, R LANGUAGE ENV STAT; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Sanchez CP, 2011, MOL MICROBIOL, V82, P865, DOI 10.1111/j.1365-2958.2011.07855.x; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Sanchez CP, 2005, BIOCHEMISTRY-US, V44, P9862, DOI 10.1021/bi050061f; Sanchez CP, 2004, BIOCHEMISTRY-US, V43, P16365, DOI 10.1021/bi048241x; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Segel IH., 1993, ENZYME KINETICS BEHA; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Summers RL, 2014, P NATL ACAD SCI USA, V111, pE1759, DOI 10.1073/pnas.1322965111; Summers RL, 2012, CELL MOL LIFE SCI, V69, P1967, DOI 10.1007/s00018-011-0906-0; Ursing J, 2011, J INFECT DIS, V203, P109, DOI 10.1093/infdis/jiq001; van Schalkwyk DA, 2006, DRUG RESIST UPDATE, V9, P211, DOI 10.1016/j.drup.2006.09.002; Warhurst DC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-31; Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216	52	26	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36336	36351		10.1074/jbc.M114.614206	http://dx.doi.org/10.1074/jbc.M114.614206			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378409	Green Published, hybrid			2022-12-26	WOS:000346897900056
J	Velarde, JJ; Ashbaugh, M; Wessels, MR				Velarde, Jorge J.; Ashbaugh, Melissa; Wessels, Michael R.			The Human Antimicrobial Peptide LL-37 Binds Directly to CsrS, a Sensor Histidine Kinase of Group A Streptococcus, to Activate Expression of Virulence Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYALURONIC-ACID CAPSULE; CATHELICIDIN LL-37; REGULATORY SYSTEM; SKIN; FRAGMENTS; PYOGENES; IDENTIFICATION; KERATINOCYTES; INFECTIONS; MUTATIONS	Group A Streptococcus (GAS) responds to subinhibitory concentrations of LL-37 by up-regulation of virulence factors through the CsrRS (CovRS) two-component system. The signaling mechanism, however, is unclear. To determine whether LL-37 signaling reflects specific binding to CsrS or rather a nonspecific response to LL-37-mediated membrane damage, we tested LL-37 fragments for CsrRS signaling and for GAS antimicrobial activity. We identified a 10-residue fragment (RI-10) of LL-37 as the minimal peptide that retains the ability to signal increased expression of GAS virulence factors, yet it has no detectable antimicrobial activity against GAS. Substitution of individual key amino acids in RI-10 reduced or abrogated signaling. These data do not support the hypothesis that CsrS detects LL-37-induced damage to the bacterial cell membrane but rather suggest that LL-37 signaling is mediated by a direct interaction with CsrS. To test whether LL-37 binds to CsrS, we used the purified CsrS extracellular domain to pull down LL-37 in vitro, a result that provides further evidence that LL-37 binds to CsrS. The dissociation of CsrS-mediated signaling from membrane damage by LL-37 fragments together with in vitro evidence for a direct LL-37-CsrS binding interaction constitute compelling evidence that signal transduction by LL-37 through CsrS reflects a direct ligand/receptor interaction.	[Wessels, Michael R.] Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Wessels, MR (corresponding author), Boston Childrens Hosp, Div Infect Dis, 300 Longwood Ave, Boston, MA 02115 USA.	Michael.Wessels@childrens.harvard.edu			NICHD, National Institutes of Health [K12-HD000850]; Public Health Service from the National Institutes of Health [AI29952]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029952] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Public Health Service from the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NICHD, National Institutes of Health Grant K12-HD000850 (to J. J. V.) and Public Health Service Grant AI29952 from the National Institutes of Health.	Alam FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061655; Benson MA, 2012, J BACTERIOL, V194, P4355, DOI 10.1128/JB.00706-12; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Burton MF, 2009, NAT PROD REP, V26, P1572, DOI 10.1039/b912533g; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Engleberg NC, 2004, INFECT IMMUN, V72, P623, DOI 10.1128/IAI.72.2.623-628.2004; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Epand RF, 2009, ANTIMICROB AGENTS CH, V53, P3705, DOI 10.1128/AAC.00321-09; Feng XR, 2013, PEPTIDES, V49, P131, DOI 10.1016/j.peptides.2013.09.007; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; Hayashi K, 2010, J BIOMOL NMR, V48, P147, DOI 10.1007/s10858-010-9445-5; Hollands A, 2012, J BIOL CHEM, V287, P40891, DOI 10.1074/jbc.M112.404582; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Johansson L, 2008, INFECT IMMUN, V76, P3399, DOI 10.1128/IAI.01392-07; Kim JE, 2005, J KOREAN MED SCI, V20, P649, DOI 10.3346/jkms.2005.20.4.649; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875; Love JF, 2012, MBIO, V3, DOI 10.1128/mBio.00394-12; Mumcu G, 2012, ARCH ORAL BIOL, V57, P642, DOI 10.1016/j.archoralbio.2011.11.003; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; O'Seaghdha M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003394; Porcelli F, 2008, BIOCHEMISTRY-US, V47, P5565, DOI 10.1021/bi702036s; Que YA, 2000, INFECT IMMUN, V68, P3516, DOI 10.1128/IAI.68.6.3516-3522.2000; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Sawai MV, 2002, PROTEIN ENG, V15, P225, DOI 10.1093/protein/15.3.225; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Tao RC, 2005, ANTIMICROB AGENTS CH, V49, P3883, DOI 10.1128/AAC.49.9.3883-3888.2005; Tran-Winkler HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002361; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Wang GS, 2008, J BIOL CHEM, V283, P32637, DOI 10.1074/jbc.M805533200	40	38	38	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36315	36324		10.1074/jbc.M114.605394	http://dx.doi.org/10.1074/jbc.M114.605394			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378408	Green Published, hybrid			2022-12-26	WOS:000346897900054
J	Ainscough, JS; Gerberick, GF; Zahedi-Nejad, M; Lopez-Castejon, G; Brough, D; Kimber, I; Dearman, RJ				Ainscough, Joseph S.; Gerberick, G. Frank; Zahedi-Nejad, Maryam; Lopez-Castejon, Gloria; Brough, David; Kimber, Ian; Dearman, Rebecca J.			Dendritic Cell IL-1 alpha and IL-1 beta Are Polyubiquitinated and Degraded by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dendritic Cell; Inflammation; Interleukin 1 (IL-1); Proteasome; Ubiquitylation (Ubiquitination); IL-1 IL-1	NF-KAPPA-B; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; NLRP3 INFLAMMASOME; IMMUNE-RESPONSES; ACTIVATION; INTERLEUKIN-1; UBIQUITIN; PATHWAY; SECRETION	IL-1 alpha and are key players in the innate immune system. The secretion of these cytokines by dendritic cells (DC) is integral to the development of proinflammatory responses. These cytokines are not secreted via the classical secretory pathway. Instead, 2 independent processes are required; an initial signal to induce up-regulation of the precursor pro-IL-1 and -, and a second signal to drive cleavage and consequent secretion. Pro-IL-1 and - are both cytosolic and thus, are potentially subject to post-translational modifications. These modifications may, in turn, have a functional outcome in the context of IL-1 and - secretion and hence inflammation. We report here that IL-1 and - were degraded intracellularly in murine bone marrow-derived DC and that this degradation was dependent on active cellular processes. In addition, we demonstrate that degradation was ablated when the proteasome was inhibited, whereas autophagy did not appear to play a major role. Furthermore, inhibition of the proteasome led to an accumulation of polyubiquitinated IL-1 and -, indicating that IL-1 and - were polyubiquitinated prior to proteasomal degradation. Finally, our investigations suggest that polyubiquitination and proteasomal degradation are not continuous processes but instead are up-regulated following DC activation. Overall, these data highlight that IL-1 and - polyubiquitination and proteasomal degradation are central mechanisms in the regulation of intracellular IL-1 levels in DC.	[Ainscough, Joseph S.; Zahedi-Nejad, Maryam; Lopez-Castejon, Gloria; Brough, David; Kimber, Ian; Dearman, Rebecca J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Gerberick, G. Frank] Procter & Gamble Co Co, Cincinnati, OH 45253 USA	University of Manchester; Procter & Gamble	Ainscough, JS (corresponding author), Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Joseph.ainscough@postgrad.manchester.ac.uk	Lopez-Castejon, Gloria/F-6985-2015	Lopez-Castejon, Gloria/0000-0002-8585-3381; Brough, David/0000-0002-2250-2381; Ainscough, Joseph/0000-0002-8823-3508	Medical Research Council (MRC); Procter Gamble Company; Medical Research Council [1067566] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Procter Gamble Company(Procter & Gamble); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Medical Research Council (MRC) and The Procter & Gamble Company (to J. S. A.).	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002; BUCHAN G, 1988, CLIN EXP IMMUNOL, V73, P449; CACABELOS R, 1994, METHOD FIND EXP CLIN, V16, P141; CACABELOS R, 1991, METHOD FIND EXP CLIN, V13, P703; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chen FT, 2012, INVEST OPHTH VIS SCI, V53, P3682, DOI 10.1167/iovs.12-9505; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Cumberbatch M, 2002, TOXICOL APPL PHARM, V182, P126, DOI 10.1006/taap.2002.9442; Dearman RJ, 1996, IMMUNOL LETT, V50, P29, DOI 10.1016/0165-2478(96)02512-6; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ferrari D, 1997, J IMMUNOL, V159, P1451; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; KUPPER TS, 1990, J CLIN INVEST, V86, P1783, DOI 10.1172/JCI114907; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lim KL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S13; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Mee JB, 2005, J INVEST DERMATOL, V124, P1267, DOI 10.1111/j.0022-202X.2005.23684.x; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; Moors MA, 2000, J LEUKOCYTE BIOL, V68, P131; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Steinman RM, 2003, PATHOL BIOL, V51, P59, DOI 10.1016/S0369-8114(03)00096-8; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; WATANABE N, 1994, CYTOKINE, V6, P597, DOI 10.1016/1043-4666(94)90046-9; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796	58	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35582	35592		10.1074/jbc.M114.595686	http://dx.doi.org/10.1074/jbc.M114.595686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371210	Green Published, hybrid			2022-12-26	WOS:000346660200045
J	Fischer, MC; Foll, M; Heckel, G; Excoffier, L				Fischer, Martin C.; Foll, Matthieu; Heckel, Gerald; Excoffier, Laurent			Continental-Scale Footprint of Balancing and Positive Selection in a Small Rodent (Microtus arvalis)	PLOS ONE			English	Article							SICKLE-CELL GENE; COMMON VOLE; GENOME SCANS; POPULATION-STRUCTURE; NATURAL-SELECTION; LOCI; AFLP; POLYMORPHISMS; COLONIZATION; DIVERGENCE	Genetic adaptation to different environmental conditions is expected to lead to large differences between populations at selected loci, thus providing a signature of positive selection. Whereas balancing selection can maintain polymorphisms over long evolutionary periods and even geographic scale, thus leads to low levels of divergence between populations at selected loci. However, little is known about the relative importance of these two selective forces in shaping genomic diversity, partly due to difficulties in recognizing balancing selection in species showing low levels of differentiation. Here we address this problem by studying genomic diversity in the European common vole (Microtus arvalis) presenting high levels of differentiation between populations (average F-ST = 0.31). We studied 3,839 Amplified Fragment Length Polymorphism (AFLP) markers genotyped in 444 individuals from 21 populations distributed across the European continent and hence over different environmental conditions. Our statistical approach to detect markers under selection is based on a Bayesian method specifically developed for AFLP markers, which treats AFLPs as a nearly codominant marker system, and therefore has increased power to detect selection. The high number of screened populations allowed us to detect the signature of balancing selection across a large geographic area. We detected 33 markers potentially under balancing selection, hence strong evidence of stabilizing selection in 21 populations across Europe. However, our analyses identified four-times more markers (138) being under positive selection, and geographical patterns suggest that some of these markers are probably associated with alpine regions, which seem to have environmental conditions that favour adaptation. We conclude that despite favourable conditions in this study for the detection of balancing selection, this evolutionary force seems to play a relatively minor role in shaping the genomic diversity of the common vole, which is more influenced by positive selection and neutral processes like drift and demographic history.	[Fischer, Martin C.; Foll, Matthieu; Heckel, Gerald; Excoffier, Laurent] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Fischer, Martin C.] ETH, Inst Integrat Biol, Zurich, Switzerland; [Foll, Matthieu] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Foll, Matthieu; Heckel, Gerald; Excoffier, Laurent] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Fischer, MC (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	martin.fischer@env.ethz.ch	Fischer, Martin C/D-4326-2012; Excoffier, Laurent/D-3498-2013; Foll, Matthieu/A-8561-2014; Fischer, Martin C./AAE-7287-2019	Fischer, Martin C/0000-0002-1888-1809; Excoffier, Laurent/0000-0002-7507-6494; Foll, Matthieu/0000-0001-9006-8436; Fischer, Martin C./0000-0002-1888-1809; Heckel, Gerald/0000-0002-0162-323X	University of Bern Research Foundation; Swiss National Science Foundation [3100A0-126074, 31003A-143393]	University of Bern Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grants from the University of Bern Research Foundation and the Swiss National Science Foundation (grants 3100A0-126074 and 31003A-143393 to LE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Albertson RC, 1999, P NATL ACAD SCI USA, V96, P5107, DOI 10.1073/pnas.96.9.5107; Ali HS, 2014, VIRUSES-BASEL, V6, P340, DOI 10.3390/v6010340; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Asthana S, 2005, TRENDS GENET, V21, P30, DOI 10.1016/j.tig.2004.11.001; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Baum J, 2002, MOL BIOL EVOL, V19, P223, DOI 10.1093/oxfordjournals.molbev.a004075; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beysard M, 2014, MOL ECOL, V23, P673, DOI 10.1111/mec.12613; Braaker S, 2009, MOL ECOL, V18, P2518, DOI 10.1111/j.1365-294X.2009.04189.x; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Calafell F, 2008, HUM GENET, V124, P123, DOI 10.1007/s00439-008-0530-8; Caracristi G, 2003, MOL BIOL EVOL, V20, P792, DOI 10.1093/molbev/msg091; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Cho SC, 2006, GENOME RES, V16, P1366, DOI 10.1101/gr.4695306; Cork JM, 2005, GENETICS, V170, P1897, DOI 10.1534/genetics.104.036152; Cutter AD, 2013, NAT REV GENET, V14, P262, DOI 10.1038/nrg3425; Delph LF, 2014, NEW PHYTOL, V201, P45, DOI 10.1111/nph.12441; DOBZHANSKY T, 1955, COLD SPRING HARB SYM, V20, P1; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Ellegren H, 2008, MOL ECOL, V17, P1629, DOI 10.1111/j.1365-294X.2008.03699.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; FELSENSTEIN J, 1976, ANNU REV GENET, V10, P253, DOI 10.1146/annurev.ge.10.120176.001345; Fink S, 2004, MOL ECOL, V13, P3501, DOI 10.1111/j.1365-294X.2004.02351.x; Fink S, 2010, SYST BIOL, V59, P548, DOI 10.1093/sysbio/syq042; Fischer MC, 2013, MOL ECOL, V22, P5594, DOI 10.1111/mec.12521; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2010, MOL ECOL, V19, P4638, DOI 10.1111/j.1365-294X.2010.04820.x; Gaggiotti OE, 2010, MOL ECOL, V19, P4586, DOI 10.1111/j.1365-294X.2010.04821.x; Garrigan D, 2003, EVOLUTION, V57, P1707; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Hamilton G, 2005, GENETICS, V170, P409, DOI 10.1534/genetics.104.034199; Hausser J., 1995, SAUGETIERE SCHWEIZ, V103; Heckel G, 2005, EVOLUTION, V59, P2231; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; HOLM S, 1979, SCAND J STAT, V6, P65; Huang YH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004527; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M., 1983, P208; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Kosman E, 2003, PLANT PATHOL, V52, P533, DOI 10.1046/j.1365-3059.2003.00923.x; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; LEWONTIN RC, 1973, GENETICS, V74, P175; Lischer HEL, 2014, MOL BIOL EVOL, V31, P817, DOI 10.1093/molbev/mst271; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Makinen HS, 2008, MOL ECOL, V17, P3565, DOI 10.1111/j.1365-294X.2008.03714.x; Martinkova N, 2013, MOL ECOL, V22, P5205, DOI 10.1111/mec.12462; Maruki T, 2012, MOL BIOL EVOL, V29, P3617, DOI 10.1093/molbev/mss187; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Niethammer J., 1982, HDB SAUGETIERE EUROP; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Paris M, 2012, MOL ECOL, V21, P1672, DOI 10.1111/j.1365-294X.2012.05499.x; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raj SM, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-87; Rannala B, 1996, GENET RES, V67, P147, DOI 10.1017/S0016672300033607; Rellstab C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080422; Roesti M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-94; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; Schmidt S, 2014, VECTOR BORN IN PRESS; Schmidt-Chanasit J, 2010, J VIROL, V84, P459, DOI 10.1128/JVI.01226-09; SCHROEDER SA, 1995, NAT MED, V1, P703, DOI 10.1038/nm0795-703; Schweizer M, 2007, MOL ECOL, V16, P2463, DOI 10.1111/j.1365-294X.2007.03284.x; Storz JF, 2010, SCIENCE, V329, P40, DOI 10.1126/science.1192481; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Sutter A, 2013, HEREDITY, V110, P398, DOI 10.1038/hdy.2012.124; Tan Z, 2005, HUM MOL GENET, V14, P3619, DOI 10.1093/hmg/ddi389; Tautz D, 2010, MOL ECOL, V19, P1, DOI 10.1111/j.1365-294X.2009.04489.x; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Thomas JC, 2012, MOL BIOL EVOL, V29, P1175, DOI 10.1093/molbev/msr286; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Ulrich RG, 2009, BUNDESGESUNDHEITSBLA, V52, P352, DOI 10.1007/s00103-009-0798-4; Ulrich RG, 2008, PARASITOL RES, V103, pS121, DOI 10.1007/s00436-008-1054-9; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Vitalis R, 2003, J HERED, V94, P429, DOI 10.1093/jhered/esg083; Vitalis R, 2001, GENETICS, V158, P1811; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Weedall GD, 2010, TRENDS PARASITOL, V26, P363, DOI 10.1016/j.pt.2010.04.002; Wooding S, 2005, AM J HUM GENET, V76, P291, DOI 10.1086/427927	98	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112332	10.1371/journal.pone.0112332	http://dx.doi.org/10.1371/journal.pone.0112332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383542	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700051
J	Babeluk, R; Jutz, S; Mertlitz, S; Matiasek, J; Klaus, C				Babeluk, Rita; Jutz, Sabrina; Mertlitz, Sarah; Matiasek, Johannes; Klaus, Christoph			Hand Hygiene - Evaluation of Three Disinfectant Hand Sanitizers in a Community Setting	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; HEALTH-CARE; ALCOHOL; EFFICACY; INFECTION; INTERVENTION; PROGRAM; RISK; SOAP; RUBS	Hand hygiene is acknowledged as the single most important measure to prevent nosocomial infections in the healthcare setting. Similarly, in non-clinical settings, hand hygiene is recognised as a key element in helping prevent the spread of infectious diseases. The aim of this study was to evaluate the efficacy of three different disinfectant hand sanitizers in reducing the burden of bacterial hand contamination in 60 healthy volunteers in a community setting, both before and after education about the correct use of hand sanitizers. The study is the first to evaluate the efficacy and ease of use of different formulations of hand rubs used by the general population. The products tested were: Sterillium (perfumed, liquid), desderman pure gel (odorless, gel) and Lavit (perfumed, spray). Sterillium and desderman are EN1500 (hygienic hand rub) certified products (available in pharmacy) and Lavit is non EN1500 certified and available in supermarkets. The two EN1500 certified products were found to be significantly superior in terms of reducing bacterial load. desderman pure gel, Sterillium and Lavit reduced the bacterial count to 6.4%, 8.2% and 28.0% respectively. After education in the correct use of each hand rub, the bacterial load was reduced even further, demonstrating the value of education in improving hand hygiene. Information about the testers' perceptions of the three sanitizers, together with their expectations of a hand sanitizer was obtained through a questionnaire. Efficacy, followed by skin compatibility were found to be the two most important attributes of a hand disinfectant in our target group.	[Babeluk, Rita] Med Univ Vienna, Dept Surg, Vienna, Austria; [Jutz, Sabrina; Mertlitz, Sarah] Univ Appl Sci Campus Vienna, Dept Biotechnol, Vienna, Austria; [Matiasek, Johannes] Wilhelminen Hosp Vienna, Dept Plast Aesthet & Reconstruct Surg, Vienna, Austria; [Klaus, Christoph] Schulke & Mayr GmbH, Int Sci Affairs, Vienna, Austria	Medical University of Vienna; Wilhelminenspital	Klaus, C (corresponding author), Schulke & Mayr GmbH, Int Sci Affairs, Vienna, Austria.	christoph.klaus@schuelke.com		Mertlitz, Sarah/0000-0002-7245-5616	Schulke Mayr	Schulke Mayr	HYCON plates PA (Merck) were provided by Schulke & Mayr Ges.m.b.H. Schulke & Mayr provided support in the form of salaries for author CK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; [Anonymous], DIN EN 1500 2013; Barbut F, 2007, J HOSP INFECT, V66, P167, DOI 10.1016/j.jhin.2007.03.021; Best M, 2004, QUAL SAF HEALTH CARE, V13, P233, DOI 10.1136/qshc.2004.010918; Cartner T, 2013, HIGH COMPLIANCE ALCO; COREN S, 1977, SCIENCE, V198, P631, DOI 10.1126/science.335510; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Erasmus V, 2010, J HOSP INFECT, V76, P161, DOI 10.1016/j.jhin.2010.04.024; Harrington G, 2007, INFECT CONT HOSP EP, V28, P837, DOI 10.1086/518844; Hilburn J, 2003, AM J INFECT CONTROL, V31, P109, DOI 10.1067/mic.2003.15; Johnson PDR, 2005, MED J AUSTRALIA, V183, P509, DOI 10.5694/j.1326-5377.2005.tb07151.x; Judah G, 2009, AM J PUBLIC HEALTH, V99, pS405, DOI 10.2105/AJPH.2009.164160; Kampf G, 2004, CLIN MICROBIOL REV, V17, P863, DOI 10.1128/CMR.17.4.863-893.2004; Kramer A, 2002, LANCET, V359, P1489, DOI 10.1016/S0140-6736(02)08426-X; Larson EL, 2000, BEHAV MED, V26, P14, DOI 10.1080/08964280009595749; Larson EL, 1998, AM J INFECT CONTROL, V26, P513, DOI 10.1016/S0196-6553(98)70025-2; LAUHARANTA J, 1991, J HOSP INFECT, V17, P207, DOI 10.1016/0195-6701(91)90232-W; Loffler H, 2007, BRIT J DERMATOL, V157, P74, DOI 10.1111/j.1365-2133.2007.07944.x; Nagtegaal MJC, 2012, CONTACT DERMATITIS, V67, P28, DOI 10.1111/j.1600-0536.2012.02055.x; Neuhauser D, 2003, QUAL SAF HEALTH CARE, V12, P317, DOI 10.1136/qhc.12.4.317; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 2009, INFECT CONT HOSP EP, V30, P611, DOI 10.1086/600379; Randle J, 2013, J HOSP INFECT, V85, P220, DOI 10.1016/j.jhin.2013.07.013; Randle J, 2010, J HOSP INFECT, V76, P252, DOI 10.1016/j.jhin.2010.06.027; Son C, 2011, AM J INFECT CONTROL, V39, P716, DOI 10.1016/j.ajic.2010.12.008; Suchomel M, 2013, J HOSP INFECT, V83, P284, DOI 10.1016/j.jhin.2012.11.030; Tambekar D, 2007, CONT J BIOMED SCI, V1, P6; WHO, 2000, WORLD HLTH REP 2000, P164; Winnefeld M, 2000, BRIT J DERMATOL, V143, P546	29	24	24	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111969	10.1371/journal.pone.0111969	http://dx.doi.org/10.1371/journal.pone.0111969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379773	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100049
J	Clark-Knowles, KV; Dewar-Darch, D; Jardine, KE; McBurney, MW				Clark-Knowles, Katherine V.; Dewar-Darch, Danielle; Jardine, Karen E.; McBurney, Michael W.			Modulation of Tumorigenesis by Dietary Intervention Is Not Mediated by SIRT1 Catalytic Activity	PLOS ONE			English	Article							PROTEIN DEACETYLASE ACTIVITY; BREAST-CANCER; CELL-SURVIVAL; CALORIE RESTRICTION; HISTONE DEACETYLASE; PROSTATE-CANCER; RESVERATROL; MICE; METASTASIS; GROWTH	The protein deacetylase SIRT1 is involved in the regulation of a large number of cellular processes that are thought to be required for cancer initiation and progression. Both SIRT1 activity and tumorigenesis can be influenced by dietary fat and polyphenolics. We set out to determine whether dietary modulations of tumorigenesis are mediated by SIRT1 catalytic functions. We introduced a mammary gland tumor-inducing transgene, MMTV-PyMT, into stocks of mice bearing a H355Y point mutation in the Sirt1 gene that abolishes SIRT1 catalytic activity. Tumor latency was reduced in animals fed a high fat diet but this effect was not dependent on SIRT1 activity. Resveratrol had little effect on tumor formation except in animals heterozygous for the mutant Sirt1 gene. We conclude that the effects of these dietary interventions on tumorigenesis are not mediated by modulation of SIRT1 catalytic activity.	[Clark-Knowles, Katherine V.; Dewar-Darch, Danielle; Jardine, Karen E.; McBurney, Michael W.] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [McBurney, Michael W.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Clark-Knowles, KV (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	kaclark@ohri.ca			Canadian Institute of Health Research [74511]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research #74511 (www.cihr.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2012, AM J HUM BIOL, V24, P101, DOI 10.1002/ajhb.22243; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beane J, 2012, CANCER RES, V72, P5702, DOI 10.1158/0008-5472.CAN-12-1043; BERNSTEIN L, 1993, EPIDEMIOL REV, V15, P48, DOI 10.1093/oxfordjournals.epirev.a036116; Bhat KPL, 2001, CANCER RES, V61, P7456; Block G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-30; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Bugge TH, 1998, ONCOGENE, V16, P3097, DOI 10.1038/sj.onc.1201869; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Caron AZ, 2014, FASEB J, V28, P1306, DOI 10.1096/fj.13-243568; Castillo-Pichardo L, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-6; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Clark-Knowles KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082106; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dabrosin C, 2003, BREAST CANCER RES TR, V78, P1, DOI 10.1023/A:1022133219353; Dai JM, 2007, J CELL PHYSIOL, V210, P161, DOI 10.1002/jcp.20831; Elangovan S, 2011, CANCER RES, V71, P6654, DOI 10.1158/0008-5472.CAN-11-1446; Enns LC, 2012, J CANC THERAPY, V3, P718; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Han J, 2013, CELL CYCLE, V12, P263, DOI 10.4161/cc.23056; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herranz D, 2013, ONCOGENE, V32, P4052, DOI 10.1038/onc.2012.407; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Hsieh TC, 2012, CARCINOGENESIS, V33, P670, DOI 10.1093/carcin/bgs016; Hu Y, 2011, FREE RADICAL BIO MED, V51, P250, DOI 10.1016/j.freeradbiomed.2011.04.034; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Jang SH, 2012, J CLIN PATHOL, V65, P735, DOI 10.1136/jclinpath-2012-200685; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Llaverias G, 2011, AM J PATHOL, V178, P402, DOI 10.1016/j.ajpath.2010.11.005; Longo VD, 2009, EXP GERONTOL, V44, P70, DOI 10.1016/j.exger.2008.06.005; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McBurney Michael W, 2013, Genes Cancer, V4, P125, DOI 10.1177/1947601912474893; Menzies KJ, 2013, J BIOL CHEM, V288, P6968, DOI 10.1074/jbc.M112.431155; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Ming M, 2015, ONCOGENE, V34, P281, DOI 10.1038/onc.2013.583; Moore RL, 2013, J ENDOCRINOL, V216, P273, DOI 10.1530/JOE-12-0102; Morris BJ, 2013, FREE RADICAL BIO MED, V56, P133, DOI 10.1016/j.freeradbiomed.2012.10.525; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Park S, 2012, ENDOCRINOLOGY, V153, P3982, DOI 10.1210/en.2012-1044; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Sestito R, 2011, FASEB J, V25, P916, DOI 10.1096/fj.10-172288; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Song NY, 2012, ANN NY ACAD SCI, V1271, P10, DOI 10.1111/j.1749-6632.2012.06762.x; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Suter MA, 2012, FASEB J, V26, P5106, DOI 10.1096/fj.12-212878; Suzuki K, 2012, ONCOL REP, V27, P1726, DOI 10.3892/or.2012.1750; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Villalba JM, 2012, BIOFACTORS, V38, P349, DOI 10.1002/biof.1032; Wakeling LA, 2012, FASEB J, V26; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Yun JM, 2012, J NUTR BIOCHEM, V23, P699, DOI 10.1016/j.jnutbio.2011.03.012; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977	74	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112406	10.1371/journal.pone.0112406	http://dx.doi.org/10.1371/journal.pone.0112406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380034	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100085
J	Harkonen, L; Pekcan-Hekim, Z; Hellen, N; Ojala, A; Horppila, J				Harkonen, Laura; Pekcan-Hekim, Zeynep; Hellen, Noora; Ojala, Anne; Horppila, Jukka			Combined Effects of Turbulence and Different Predation Regimes on Zooplankton in Highly Colored Water-Implications for Environmental Change in Lakes	PLOS ONE			English	Article							SMALL-SCALE TURBULENCE; DISSOLVED ORGANIC-CARBON; PERCH PERCA-FLUVIATILIS; ROACH RUTILUS-RUTILUS; CLIMATE-CHANGE; LARVAL FISH; INVERTEBRATE PREDATORS; CHAOBORUS-FLAVICANS; COMMUNITY STRUCTURE; ENCOUNTER RATES	In aquatic ecosystems, predation is affected both by turbulence and visibility, but the combined effects are poorly known. Both factors are changing in lakes in the Northern Hemisphere; the average levels of turbulence are predicted to increase due to increasing wind activities, while water transparency is decreasing, e.g., due to variations in precipitation, and sediment resuspension. We explored experimentally how turbulence influenced the effects of planktivorous fish and invertebrate predators on zooplankton when it was combined with low visibility caused by high levels of water color. The study was conducted as a factorial design in 24 outdoor ponds, using the natural zooplankton community as a prey population. Perch and roach were used as vertebrate predators and Chaoborus flavicans larvae as invertebrate predators. In addition to calm conditions, the turbulent dissipation rate used in the experiments was 10(-6) m(2) s(-3), and the water color was 140 mg Pt L-1. The results demonstrated that in a system dominated by invertebrates, predation pressure on cladocerans increased considerably under intermediate turbulence. Under calm conditions, chaoborids caused only a minor reduction in the crustacean biomass. The effect of fish predation on cladocerans was slightly reduced by turbulence, while predation on cyclopoids was strongly enhanced. Surprisingly, under turbulent conditions fish reduced cyclopoid biomass, whereas in calm water it increased in the presence of fish. We thus concluded that turbulence affects fish selectivity. The results suggested that in dystrophic invertebrate-dominated lakes, turbulence may severely affect the abundance of cladocerans. In fish-dominated dystrophic lakes, on the other hand, turbulence-induced changes in planktivory may considerably affect copepods instead of cladocerans. In lakes inhabited by both invertebrates and fish, the response of top-down regulation to turbulence resembles that in fish-dominated systems, due to intraguild predation. The changes in planktivorous predation induced by abiotic factors may possibly cascade to primary producers.	[Harkonen, Laura; Pekcan-Hekim, Zeynep; Hellen, Noora; Ojala, Anne; Horppila, Jukka] Univ Helsinki, Dept Environm Sci, Helsinki, Finland	University of Helsinki	Harkonen, L (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.	laura.harkonen@helsinki.fi		Harkonen, Laura/0000-0003-1399-5978	Academy of Finland [131579]	Academy of Finland(Academy of Finland)	The study was funded by the Academy of Finland (project 131579). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DL, 2004, LIMNOL OCEANOGR, V49, P233, DOI 10.4319/lo.2004.49.1.0233; Arvola L, 2010, AQUAT ECOL SER, V4, P85, DOI 10.1007/978-90-481-2945-4_6; BORKENT A, 1981, CAN J ZOOL, V59, P122, DOI 10.1139/z81-019; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; BRYDSTEN L, 1992, HYDROBIOLOGIA, V235, P71, DOI 10.1007/BF00026201; BUTORINA LG, 1986, ARCH HYDROBIOL, V105, P355; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Carpenter SR, 2001, ECOL MONOGR, V71, P163, DOI 10.1890/0012-9615(2001)071[0163:TCNALP]2.0.CO;2; Clarke RD, 2005, MAR BIOL, V146, P1145, DOI 10.1007/s00227-004-1528-y; CUKER BE, 1993, ECOLOGY, V74, P944, DOI 10.2307/1940818; CULVER DA, 1985, CAN J FISH AQUAT SCI, V42, P1380, DOI 10.1139/f85-173; DILL LM, 1987, CAN J ZOOL, V65, P803, DOI 10.1139/z87-128; Dower JF, 1998, CAN J FISH AQUAT SCI, V55, P128, DOI 10.1139/cjfas-55-1-128; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Eiane K, 1997, ECOL MODEL, V98, P123, DOI 10.1016/S0304-3800(96)01909-6; Eie J. A., 1981, VERH INT VER THEOR A, V21, P1257; ELSER MM, 1987, CAN J ZOOL, V65, P2846, DOI 10.1139/z87-433; Estlander S, 2010, J FISH BIOL, V77, P241, DOI 10.1111/j.1095-8649.2010.02682.x; Estlander S, 2009, HYDROBIOLOGIA, V620, P109, DOI 10.1007/s10750-008-9621-8; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; *FINN STAND ASS, 1993, 5772 FINN STAND ASS; Freeman C, 2004, NATURE, V430, P195, DOI 10.1038/nature02707; George G, 2010, IMPACT CLIMATE CHANG; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; Giorgi F., 2004, MEAN INTERANNUAL VAR; Gosselin A, 2003, J N AM BENTHOL SOC, V22, P575, DOI 10.2307/1468354; Haertel SS, 2002, J FISH BIOL, V60, P876, DOI [10.1006/jfbi.2002.1890, 10.1111/j.1095-8649.2002.tb02415.x]; Harkonen L, 2014, HYDROBIOLOGIA, V722, P9, DOI 10.1007/s10750-013-1670-y; HERZIG A, 1995, HYDROBIOLOGIA, V307, P273, DOI 10.1007/BF00032021; Heuschele J, 2014, MAR BIOL, V161, P1653, DOI 10.1007/s00227-014-2449-z; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Horppila J, 2005, RESTOR ECOL, V13, P242, DOI 10.1111/j.1526-100X.2005.00031.x; Horppila J, 2010, ECOL FRESHW FISH, V19, P257, DOI 10.1111/j.1600-0633.2010.00410.x; Horppila J, 2000, J FISH BIOL, V56, P51, DOI 10.1006/jfbi.1999.1140; Imboden D. M., 1995, PHYS CHEM LAKES, P83, DOI [10.1007/978-3-642-85132-2, DOI 10.1007/978-3-642-85132-2, DOI 10.1007/978-3-642-85132-2_4]; JAMET JL, 1990, ARCH HYDROBIOL, V118, P371; Jeppesen E, 2003, LIMNOL OCEANOGR, V48, P1346; Joensuu L, 2013, FRESHWATER BIOL, V58, P1997, DOI 10.1111/fwb.12186; KAJAK Z, 1970, Polskie Archiwum Hydrobiologii, V17, P225; KIORBOE T, 1995, MAR ECOL PROG SER, V122, P135, DOI 10.3354/meps122135; Koroleff F., 1979, MERI, V7, P1; Kundu RK, 2002, FLUID MECH-SOV RES, Vsecond; Lampert W, 1997, LIMNOECOLOGY ECOLOGY; Liljendahl-Nurminen A, 2003, ARCH HYDROBIOL, V158, P75, DOI 10.1127/0003-9136/2003/0158-0075; LUECKE C, 1987, FRESHWATER BIOL, V18, P185, DOI 10.1111/j.1365-2427.1987.tb01306.x; MacIntyre S, 1999, LIMNOL OCEANOGR, V44, P512, DOI 10.4319/lo.1999.44.3.0512; MACKENZIE BR, 1993, MAR ECOL PROG SER, V94, P207, DOI 10.3354/meps094207; MacKenzie BR, 1995, LIMNOL OCEANOGR, V40, P1278, DOI 10.4319/lo.1995.40.7.1278; MACKENZIE BR, 1991, MAR ECOL PROG SER, V73, P149, DOI 10.3354/meps073149; MACKENZIE BR, 1994, LIMNOL OCEANOGR, V39, P1790, DOI 10.4319/lo.1994.39.8.1790; MacKenzie BR, 2000, LIMNOL OCEANOGR, V45, P1; MARRASE C, 1990, P NATL ACAD SCI USA, V87, P1653, DOI 10.1073/pnas.87.5.1653; Mooij WM, 2005, AQUAT ECOL, V39, P381, DOI 10.1007/s10452-005-9008-0; Moum JN, 1996, J GEOPHYS RES-OCEANS, V101, P14095, DOI 10.1029/96JC00507; Osborn T, 1996, J PLANKTON RES, V18, P185, DOI 10.1093/plankt/18.2.185; Osborn T, 1996, MAR ECOL PROG SER, V139, P302, DOI 10.3354/meps139302; Packard AT, 2001, HYDROBIOLOGIA, V442, P177, DOI 10.1023/A:1017582323631; PASTOROK RA, 1980, LIMNOL OCEANOGR, V25, P910, DOI 10.4319/lo.1980.25.5.0910; PASTOROK RA, 1981, ECOLOGY, V62, P1311, DOI 10.2307/1937295; Pekcan-Hekim Z, 2013, CAN J FISH AQUAT SCI, V70, P854, DOI 10.1139/cjfas-2012-0466; Peters F, 1997, SCI MAR, V61, P205; Pringle JM, 2007, CONT SHELF RES, V27, P670, DOI 10.1016/j.csr.2006.11.011; Pryor SC, 2005, CLIM DYNAM, V25, P815, DOI 10.1007/s00382-005-0072-x; RASK M, 1986, ARCH HYDROBIOL, V106, P351; Read JS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051886; Reiss CS, 2002, FISH OCEANOGR, V11, P156, DOI 10.1046/j.1365-2419.2002.00194.x; RIESSEN HP, 1984, ECOLOGY, V65, P514, DOI 10.2307/1941413; ROSEN RA, 1981, J FRESHWATER ECOL, V1, P225, DOI 10.1080/02705060.1981.9664034; ROTHSCHILD BJ, 1988, J PLANKTON RES, V10, P465, DOI 10.1093/plankt/10.3.465; Saggio A, 1998, LIMNOL OCEANOGR, V43, P1780; SAIZ E, 1992, MAR ECOL PROG SER, V80, P229, DOI 10.3354/meps080229; SAIZ E, 1992, J PLANKTON RES, V14, P1085, DOI 10.1093/plankt/14.8.1085; Salonen K, 1990, ACIDIFICATION FINLAN, P1145; Samuelsson P, 2010, AQUAT ECOL SER, V4, P15, DOI 10.1007/978-90-481-2945-4_2; Sanford LP, 1997, MAR ECOL PROG SER, V161, P265, DOI 10.3354/meps161265; Sarvala Jouko, 1999, P173; SHAPIRO J, 1990, HYDROBIOLOGIA, V200, P13, DOI 10.1007/BF02530325; Sluss TD, 2008, FRESHWATER BIOL, V53, P1999, DOI 10.1111/j.1365-2427.2008.02023.x; SMYLY WJP, 1980, HYDROBIOLOGIA, V70, P179, DOI 10.1007/BF00015504; Sobek S, 2007, LIMNOL OCEANOGR, V52, P1208, DOI 10.4319/lo.2007.52.3.1208; Sorf M, 2014, ANN LIMNOL-INT J LIM, V50, P71, DOI 10.1051/limn/2014001; STENSON JAE, 1990, HYDROBIOLOGIA, V198, P205, DOI 10.1007/BF00048635; SWIFT MC, 1975, LIMNOL OCEANOGR, V20, P418, DOI 10.4319/lo.1975.20.3.0418; Tennekes H., 1972, 1 COURSE TURBULENCE; Tolonen KT, 2000, ECOL FRESHW FISH, V9, P153, DOI 10.1111/j.1600-0633.2000.eff090304.x; Toth LG, 2011, LIMNOL OCEANOGR, V56, P2211, DOI 10.4319/lo.2011.56.6.2211; UNGER PA, 1983, ECOLOGY, V64, P1136, DOI 10.2307/1937824; Utne-Palm AC, 2002, MAR FRESHW BEHAV PHY, V35, P111, DOI 10.1080/10236240290025644; Uusitalo L, 2003, INT REV HYDROBIOL, V88, P34, DOI 10.1002/iroh.200390003; Valonen T., 2009, THESIS U HELSINKI; VANNI MJ, 1988, CAN J FISH AQUAT SCI, V45, P1758, DOI 10.1139/f88-207; VINYARD GL, 1976, J FISH RES BOARD CAN, V33, P2845, DOI 10.1139/f76-342; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; Weyhenmeyer GA, 1998, ERGEB LIMNOL, V51, P185; Wissel B, 2003, LIMNOL OCEANOGR, V48, P1965, DOI 10.4319/lo.2003.48.5.1965; Wrona FJ, 2006, AMBIO, V35, P359, DOI 10.1579/0044-7447(2006)35[359:CCEOAB]2.0.CO;2; ZARET TM, 1980, PREDATION FRESHWATER; [No title captured]	99	20	22	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111942	10.1371/journal.pone.0111942	http://dx.doi.org/10.1371/journal.pone.0111942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375952	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600078
J	Jeong, HW; Heo, JY; Park, JS; Kim, WJ				Jeong, Hye Won; Heo, Jung Yeon; Park, Jung Soo; Kim, Woo Joo			Effect of the Influenza Virus Rapid Antigen Test on a Physician's Decision to Prescribe Antibiotics and on Patient Length of Stay in the Emergency Department	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; A H1N1; DIAGNOSIS; MANAGEMENT	Background: Influenza virus infection is a common reason for visits to the emergency department (ED) during the influenza season. A rapid and accurate diagnosis of influenza virus infection is important to reduce unnecessary antibiotic prescription and to improve patient care. The aim of this study was to examine whether using the Influenza Virus Rapid Antigen Test (IVRAT) in the ED affects the decision to prescribe antibiotics or the length of hospital stay (LOS). Methods: Data from patients suffering from an influenza-like illness (ILI) and who were discharged after visiting the ED at Chungbuk National University Hospital were reviewed over two influenza seasons: 2010-2011, when IVRAT was not used in the ED, and 2011-2012, when it was. The numbers of antibiotic prescriptions issued and the ED LOS during these two seasons were then compared. Results: The number of antibiotic prescriptions was significantly lower in 2011-2012 (54/216, 25.0%) than in 2010-2011 (97/221, 43.9%; P < 0.01). However, the median ED LOS for patients in 2011-2012 was much longer than that of patients in 2010-2011 (213 minutes vs. 257 minutes; P < 0.01). During the 2011-2012 influenza season, 73 ILI patients showed a positive IVRAT result whereas 123 showed a negative result. Upon discharge, antibiotics were given to 42/123 (34.1%) ILI patients with a negative IVRAT result, but to only 7/73 (9.6%) patients with a positive IVRAT result (P < 0.01). Conclusions: Performing IVRAT in the ED reduced the prescription of antibiotics to ILI patients discharged after ED care. However, the ED LOS for patients who underwent IVRAT was longer than that for patients who did not. Thus, performing IVRAT in the ED reduces the unnecessary prescription of antibiotics to ILI patients during the influenza season.	[Jeong, Hye Won; Heo, Jung Yeon] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea; [Park, Jung Soo] Chungbuk Natl Univ, Coll Med, Dept Emergency Med, Cheongju, South Korea; [Kim, Woo Joo] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 136705, South Korea; [Kim, Woo Joo] Transgovt Enterprise Pandem Influenza Korea, Seoul, South Korea	Chungbuk National University; Chungbuk National University; Korea University; Korea University Medicine (KU Medicine)	Jeong, HW (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea.	hwjeong@chungbuk.ac.kr	; Kim, Woo Joo/D-2733-2015	Park, jung soo/0000-0002-4283-5423; Kim, Woo Joo/0000-0002-4546-3880; Heo, Jung Yeon/0000-0002-6548-1939	Health and Medical Technology Research and Development Project of Ministry of Health and Welfare [A103001]	Health and Medical Technology Research and Development Project of Ministry of Health and Welfare	This study was supported by the Health and Medical Technology Research and Development Project of Ministry of Health and Welfare (grant number: A103001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoritsas K, 2006, J CLIN MICROBIOL, V44, P2638, DOI 10.1128/JCM.02644-05; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Cho CH, 2013, J VIROL METHODS, V187, P51, DOI 10.1016/j.jviromet.2012.09.003; Clezen WP, 1991, AM J EPIDEMIOL, V133, P296; DAGAN R, 1984, PEDIATR INFECT DIS J, V3, P218, DOI 10.1097/00006454-198405000-00007; Doan Q, 2012, COCHRANE DB SYST REV, V5; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; He J, 2009, J CLIN MICROBIOL, V47, P2772, DOI 10.1128/JCM.00998-09; Hojat K, 2013, PEDIATR EMERG CARE, V29, P696, DOI 10.1097/PEC.0b013e3182948f11; Kyriacou DN, 1999, ANN EMERG MED, V34, P326, DOI 10.1016/S0196-0644(99)70126-5; Lenzi L, 2013, REV SOC BRAS MED TRO, V46, P135, DOI 10.1590/0037-8682-0024-2012; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Murray Michael, 2004, CJEM, V6, P421; Noyola DE, 2000, PEDIATR INFECT DIS J, V19, P303, DOI 10.1097/00006454-200004000-00008; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Reina J, 1996, DIAGN MICR INFEC DIS, V25, P143, DOI 10.1016/S0732-8893(96)00131-9; Richardson DB, 2002, MED J AUSTRALIA, V177, P492, DOI 10.5694/j.1326-5377.2002.tb04917.x; Sharma V, 2002, ARCH PEDIAT ADOL MED, V156, P41, DOI 10.1001/archpedi.156.1.41; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Smucny J, 2004, COCHRANE DB SYST REV, V18; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub3; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116	23	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110978	10.1371/journal.pone.0110978	http://dx.doi.org/10.1371/journal.pone.0110978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375835	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600023
J	Liu, G; Zhou, LZ; Li, B; Zhang, LL				Liu, Gang; Zhou, Lizhi; Li, Bo; Zhang, Lili			The Complete Mitochondrial Genome of Aix galericulata and Tadorna ferruginea: Bearings on Their Phylogenetic Position in the Anseriformes	PLOS ONE			English	Article							CONTROL REGION; MOLECULAR PHYLOGENY; EVOLUTION; ANATIDAE; GENE; CHARACTERS; DNA; MORPHOLOGY; SEQUENCE; PATTERNS	Aix galericulata and Tadorna ferruginea are two Anatidae species representing different taxonomic groups of Anseriformes. We used a PCR-based method to determine the complete mtDNAs of both species, and estimated phylogenetic trees based on the complete mtDNA alignment of these and 14 other Anseriforme species, to clarify Anseriform phylogenetics. Phylogenetic trees were also estimated using a multiple sequence alignment of three mitochondrial genes (Cyt b, ND2, and COI) from 68 typical species in GenBank, to further clarify the phylogenetic relationships of several groups among the Anseriformes. The new mtDNAs are circular molecules, 16,651 bp (Aix galericulata) and 16,639 bp (Tadorna ferruginea) in length, containing the 37 typical genes, with an identical gene order and arrangement as those of other Anseriformes. Comparing the protein-coding genes among the mtDNAs of 16 Anseriforme species, ATG is generally the start codon, TAA is the most frequent stop codon, one of three, TAA, TAG, and T-, commonly observed. All tRNAs could be folded into canonical cloverleaf secondary structures except for tRNASer (AGY) and tRNALeu (CUN), which are missing the "DHU" arm. Phylogenetic relationships demonstrate that Aix galericula and Tadorna ferruginea are in the same group, the Tadorninae lineage, based on our analyses of complete mtDNAs and combined gene data. Molecular phylogenetic analysis suggests the 68 species of Anseriform birds be divided into three families: Anhimidae, Anatidae, and Anseranatidae. The results suggest Anatidae birds be divided into five subfamilies: Anatinae, Tadorninae, Anserinae, Oxyurinae, and Dendrocygninae. Oxyurinae and Dendrocygninae should not belong to Anserinae, but rather represent independent subfamilies. The Anatinae includes species from the tribes Mergini, Somaterini, Anatini, and Aythyini. The Anserinae includes species from the tribes Anserini and Cygnini.	[Liu, Gang; Zhou, Lizhi; Li, Bo; Zhang, Lili] Anhui Univ, Sch Resources & Environm Engn, Inst Biodivers & Wetland Ecol, Hefei, Anhui, Peoples R China; [Liu, Gang; Zhou, Lizhi; Li, Bo; Zhang, Lili] Anhui Biodivers Informat Ctr, Hefei, Anhui, Peoples R China	Anhui University	Zhou, LZ (corresponding author), Anhui Univ, Sch Resources & Environm Engn, Inst Biodivers & Wetland Ecol, Hefei, Anhui, Peoples R China.	zhoulz@ahu.edu.cn	Zhou, Lizhi/AAF-4535-2021	Zhou, Lizhi/0000-0002-5702-4658	National Natural Science Foundation of China [31172117]; Graduate Student Innovation Research Projects of Anhui University [YQH100111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Innovation Research Projects of Anhui University	This research was supported by the National Natural Science Foundation of China (Grant no. 31172117) and the Graduate Student Innovation Research Projects of Anhui University (YQH100111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 1960, WILDFOWL, V11, P55; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Crochet PA, 2000, MOL BIOL EVOL, V17, P1797, DOI 10.1093/oxfordjournals.molbev.a026280; Delport W, 2002, J MOL EVOL, V54, P794, DOI 10.1007/s00239-001-0083-0; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Dickinson EC, 2003, HAWARD MOORE COMPLET; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Gonzalez J, 2009, J ZOOL, V279, P310, DOI 10.1111/j.1469-7998.2009.00622.x; Guan X, 2009, ANIM GENET, V40, P134, DOI 10.1111/j.1365-2052.2008.01810.x; Hoyo Del, 1992, HDB BIRDS WORLD, V2; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061685; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Liu G, 2013, PLOS ONE, V8; Liu G, 2012, MOL BIOL REP, V39, P2139, DOI 10.1007/s11033-011-0961-5; LIVEZEY BC, 1991, AUK, V108, P471, DOI 10.2307/4088089; LIVEZEY BC, 1995, CONDOR, V97, P233, DOI 10.2307/1368999; Livezey BC, 1997, IBIS, V139, P51, DOI 10.1111/j.1474-919X.1997.tb04504.x; LIVEZEY BC, 1995, WILSON BULL, V107, P214; LIVEZEY BC, 1986, AUK, V103, P737, DOI 10.1093/auk/103.4.737; Masta SE, 2008, MOL BIOL EVOL, V25, P949, DOI 10.1093/molbev/msn051; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Slack KE, 2003, GENE, V302, P43, DOI 10.1016/S0378111902010533; Sraml M, 1996, AUST J ZOOL, V44, P47, DOI 10.1071/ZO9960047; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3	31	15	16	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e109701	10.1371/journal.pone.0109701	http://dx.doi.org/10.1371/journal.pone.0109701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375111	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600007
J	Wang, RZ; Tan, Y; Wang, XY; Ma, LL; Wang, DM; Hu, YH; Qin, YH; Liu, K; Chang, C; Yu, JM				Wang, Ruozheng; Tan, Yao; Wang, Xiyan; Ma, Lingling; Wang, Duoming; Hu, Yunhui; Qin, Yonghui; Liu, Kai; Chang, Cheng; Yu, Jinming			Prognoses and Long-Term Outcomes of Nasopharyngeal Carcinoma in Han and Uyghur Patients Treated with Intensity-Modulated Radiotherapy in the Xinjiang Autonomous Region of China	PLOS ONE			English	Article							SURVIVAL; PATTERNS; FAILURE; AGE	Objectives: The objective of this study was to investigate the long-term outcomes and prognostic factors for nasopharyngeal carcinoma (NPC) in Han and Uyghur patients treated with intensity-modulated radiotherapy (IMRT) in the Xinjiang region of China. Materials and Methods: One hundred twenty-one Han and 60 Uyghur patients with newly diagnosed NPC without distant metastasis received IMRT at the Affiliated Tumor Hospital of Xinjiang Medical University between 2005 and 2008. The Kaplan-Meier method was used to estimate survival rates, and the log-rank test was used to evaluate differences in survival. Results: Comparing Han and Uyghur patients, the 5-year overall survival (OS), disease-free survival (DFS), local control (LC), regional control (RC), and distant metastasis-free survival (DMFS) rates were 81.9% vs 77.6% (P = 0.297), 72.1% vs 65.6% (P = 0.493), 88.3% vs 86.5% (P = 0.759), 95.0% vs 94.6% (P = 0.929), and 79.1% vs 75.2% (P = 0.613), respectively. Multivariate Cox proportional hazards regression identified the following independent prognostic factors in Han patients: N stage (P = 0.007) and age (P = 0.028) for OS, and age (P = 0.028) for DFS. OS differed significantly between Han and Uyghur patients >60 years old group (P = 0.036). Among Uyghur patients, the independent prognostic factors were age for OS (P = 0.033), as well as N stage (P = 0.037) and age (P = 0.021) for DFS. Additionally, Uyghur patients were less likely to experience mucositis and dermatitis than Han patients. Conclusion: Han and Uyghur patients with NPC had statistically significant differences in age, smoking history, and N staging. There was no significant difference in overall treatment outcomes with IMRT between these 2 ethnic populations in Xinjiang, China.	[Wang, Ruozheng] Tianjin Med Univ, Tianjin, Peoples R China; [Wang, Ruozheng; Tan, Yao; Wang, Xiyan; Ma, Lingling; Wang, Duoming; Hu, Yunhui; Qin, Yonghui; Liu, Kai; Chang, Cheng] Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Radiat Oncol, Urumqi, Xinjiang, Peoples R China; [Yu, Jinming] Tumor Hosp Shandong, Dept Radiat Oncol, Jinnan, Shandong, Peoples R China	Tianjin Medical University; Xinjiang Medical University	Yu, JM (corresponding author), Tumor Hosp Shandong, Dept Radiat Oncol, Jinnan, Shandong, Peoples R China.	wrz8526@163.com			Department of International Cooperation Project [2012DFA31560]; Chinese Nature Science Foundation [81160327, 30960432]; Xinjiang International Collaboration Fund [101141038, 20126024]; Special Fund on Urumqi Talent Project [P08131002]; Youth Science Foundation of Xinjiang Uygur Autonomous Region [2011211B22]; Xinjiang Science and Technology Infrastructure Project [PT1401]	Department of International Cooperation Project; Chinese Nature Science Foundation; Xinjiang International Collaboration Fund; Special Fund on Urumqi Talent Project; Youth Science Foundation of Xinjiang Uygur Autonomous Region; Xinjiang Science and Technology Infrastructure Project	This study received funding from the Department of International Cooperation Project (2012DFA31560), the Chinese Nature Science Foundation (81160327, 30960432), the Xinjiang International Collaboration Fund (101141038, 20126024), the Special Fund on Urumqi Talent Project (P08131002), the Youth Science Foundation of Xinjiang Uygur Autonomous Region (2011211B22), and the Xinjiang Science and Technology Infrastructure Project (PT1401). The funders had roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chen R, 1993, Yi Chuan Xue Bao, V20, P389; Han Lu, 2010, Chin J Cancer, V29, P145; Itzhaki O, 2004, BBA-MOL BASIS DIS, V1688, P145, DOI 10.1016/j.bbadis.2003.11.009; Ji XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056208; Jin J, 2010, XINJIANG STAT YB; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Kwong DLW, 2004, CANCER, V101, P1584, DOI 10.1002/cncr.20552; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lin SJ, 2009, INT J RADIAT ONCOL, V75, P1071, DOI 10.1016/j.ijrobp.2008.12.015; MK Su, 2004, J MOD ONCOL, V12, P589; MK Su, 2001, J XINJIANG MED U, V24, P371; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Su Sheng-Fa, 2011, Chin J Cancer, V30, P565, DOI 10.5732/cjc.010.10547; Sze HCK, 2012, ORAL ONCOL, V48, P162, DOI 10.1016/j.oraloncology.2011.08.019; Wang DM, 2008, J XINJIANG MED U, V31, P1504; Wang JH, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-2; Xiao GL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-226; Xue WQ, 2013, AM J EPIDEMIOL, V178, P325, DOI 10.1093/aje/kws479; Yeh SA, 2005, INT J RADIAT ONCOL, V62, P672, DOI 10.1016/j.ijrobp.2004.11.002	20	2	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111145	10.1371/journal.pone.0111145	http://dx.doi.org/10.1371/journal.pone.0111145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375129	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600026
J	Albertine, JM; Manning, WJ; DaCosta, M; Stinson, KA; Muilenberg, ML; Rogers, CA				Albertine, Jennifer M.; Manning, William J.; DaCosta, Michelle; Stinson, Kristina A.; Muilenberg, Michael L.; Rogers, Christine A.			Projected Carbon Dioxide to Increase Grass Pollen and Allergen Exposure Despite Higher Ozone Levels	PLOS ONE			English	Article							RAGWEED AMBROSIA-ARTEMISIIFOLIA; EMERGENCY-DEPARTMENT VISITS; ELEVATED ATMOSPHERIC CO2; CLIMATE-CHANGE; ASTHMA; RESPONSES; NITROGEN; HEALTH; L.	One expected effect of climate change on human health is increasing allergic and asthmatic symptoms through changes in pollen biology. Allergic diseases have a large impact on human health globally, with 10-30% of the population affected by allergic rhinitis and more than 300 million affected by asthma. Pollen from grass species, which are highly allergenic and occur worldwide, elicits allergic responses in 20% of the general population and 40% of atopic individuals. Here we examine the effects of elevated levels of two greenhouse gases, carbon dioxide (CO2), a growth and reproductive stimulator of plants, and ozone (O-3), a repressor, on pollen and allergen production in Timothy grass (Phleum pratense L.). We conducted a fully factorial experiment in which plants were grown at ambient and/or elevated levels of O-3 and CO2, to simulate present and projected levels of both gases and their potential interactive effects. We captured and counted pollen from flowers in each treatment and assayed for concentrations of the allergen protein, Phl p 5. We found that elevated levels of CO2 increased the amount of grass pollen produced by similar to similar to 50% per flower, regardless of O-3 levels. Elevated O-3 significantly reduced the Phl p 5 content of the pollen but the net effect of rising pollen numbers with elevated CO2 indicate increased allergen exposure under elevated levels of both greenhouse gases. Using quantitative estimates of increased pollen production and number of flowering plants per treatment, we estimated that airborne grass pollen concentrations will increase in the future up to,200%. Due to the widespread existence of grasses and the particular importance of P. pratense in eliciting allergic responses, our findings provide evidence for significant impacts on human health worldwide as a result of future climate change.	[Albertine, Jennifer M.] Harvard Univ, Harvard Forest, Petersham, MA 01366 USA; [Manning, William J.; DaCosta, Michelle] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA; [Stinson, Kristina A.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Muilenberg, Michael L.; Rogers, Christine A.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA	Harvard University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Albertine, JM (corresponding author), Harvard Univ, Harvard Forest, Petersham, MA 01366 USA.	jalbertine@fas.harvard.edu; car@ehs.umass.edu	Rogers, Christine A/A-2189-2008; Rogers, Christine A/M-6007-2017	Rogers, Christine A/0000-0003-0887-9606; Rogers, Christine A/0000-0003-0887-9606				Ainsworth EA, 2012, ANNU REV PLANT BIOL, V63, P637, DOI 10.1146/annurev-arplant-042110-103829; Albertine JM, 2013, THESIS U MASSACHUSET; Andersson K, 2003, INT ARCH ALLERGY IMM, V130, P87, DOI 10.1159/000069013; Beggs PJ, 2005, ENVIRON HEALTH PERSP, V113, P915, DOI 10.1289/ehp.7724; Beggs PJ, 2004, CLIN EXP ALLERGY, V34, P1507, DOI 10.1111/j.1365-2222.2004.02061.x; Cecchi L, 2010, ALLERGY, V65, P1073, DOI 10.1111/j.1398-9995.2010.02423.x; Darrow LA, 2012, J ALLERGY CLIN IMMUN, V130, P630, DOI 10.1016/j.jaci.2012.06.020; EPA NAAQS (Environmental Protection Agency National Ambient Air Quality Standards), 2014, NAAQS HOM; Frei T, 1998, GRANA, V37, P172, DOI 10.1080/00173139809362662; Gamble J. L., 2008, REV IMPACTS CLIMATE; Heguy L, 2008, ENVIRON RES, V106, P203, DOI 10.1016/j.envres.2007.10.005; Johnson BG, 1996, J ENVIRON QUAL, V25, P908, DOI 10.2134/jeq1996.00472425002500040036x; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Knox RB, 1996, SEX PLANT REPROD, V9, P318, DOI 10.1007/BF02441949; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Manning WJ, 1992, SURFACE LEVEL OZONE, P111; Masuch G, 1997, ALLERGY, V52, P874, DOI 10.1111/j.1398-9995.1997.tb02163.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Motta AC, 2006, INT ARCH ALLERGY IMM, V139, P294, DOI 10.1159/000091600; Pawankar R., 2011, WORLD ALLERGY ORG WA; PEDEN DB, 1995, AM J RESP CRIT CARE, V151, P1336, DOI 10.1164/ajrccm.151.5.7735583; Rogerieux F, 2007, INT ARCH ALLERGY IMM, V143, P127, DOI 10.1159/000099079; Rogers CA, 2006, ENVIRON HEALTH PERSP, V114, P865, DOI 10.1289/ehp.8549; Roshchina V. V., 2003, OZONE PLANT CELL, P55; Schoene K, 2004, ENVIRON POLLUT, V131, P347, DOI 10.1016/j.envpol.2004.03.014; Shea KM, 2008, J ALLERGY CLIN IMMUN, V122, P443, DOI 10.1016/j.jaci.2008.06.032; Singer BD, 2005, FUNCT PLANT BIOL, V32, P667, DOI 10.1071/FP05039; Stinson KA, 2006, OECOLOGIA, V147, P155, DOI 10.1007/s00442-005-0250-x; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Wayne P, 2002, ANN ALLERG ASTHMA IM, V88, P279, DOI 10.1016/S1081-1206(10)62009-1; White JF, 2003, ANN ALLERG ASTHMA IM, V91, P425, DOI 10.1016/S1081-1206(10)61509-8; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108; Ziska LH, 2008, MITIG ADAPT STRAT GL, V13, P607, DOI 10.1007/s11027-007-9134-1; Ziska LH, 2000, AUST J PLANT PHYSIOL, V27, P893	37	62	63	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111712	10.1371/journal.pone.0111712	http://dx.doi.org/10.1371/journal.pone.0111712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372614	gold, Green Submitted, Green Published			2022-12-26	WOS:000344556900066
J	Berdyyeva, T; Otte, S; Aluisio, L; Ziv, Y; Burns, LD; Dugovic, C; Yun, SJ; Ghosh, KK; Schnitzer, MJ; Lovenberg, T; Bonaventure, P				Berdyyeva, Tamara; Otte, Stephani; Aluisio, Leah; Ziv, Yaniv; Burns, Laurie D.; Dugovic, Christine; Yun, Sujin; Ghosh, Kunal K.; Schnitzer, Mark J.; Lovenberg, Timothy; Bonaventure, Pascal			Zolpidem Reduces Hippocampal Neuronal Activity in Freely Behaving Mice: A Large Scale Calcium Imaging Study with Miniaturized Fluorescence Microscope	PLOS ONE			English	Article							GABA(A) RECEPTOR SUBUNITS; IMMUNOCYTOCHEMICAL DISTRIBUTION; HYPNOTIC ZOLPIDEM; EXTENDED-RELEASE; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; CA1 REGION; SLEEP EEG; REM-SLEEP; MEMORY	Therapeutic drugs for cognitive and psychiatric disorders are often characterized by their molecular mechanism of action. Here we demonstrate a new approach to elucidate drug action on large-scale neuronal activity by tracking somatic calcium dynamics in hundreds of CA1 hippocampal neurons of pharmacologically manipulated behaving mice. We used an adeno-associated viral vector to express the calcium sensor GCaMP3 in CA1 pyramidal cells under control of the CaMKII promoter and a miniaturized microscope to observe cellular dynamics. We visualized these dynamics with and without a systemic administration of Zolpidem, a GABAA agonist that is the most commonly prescribed drug for the treatment of insomnia in the United States. Despite growing concerns about the potential adverse effects of Zolpidem on memory and cognition, it remained unclear whether Zolpidem alters neuronal activity in the hippocampus, a brain area critical for cognition and memory. Zolpidem, when delivered at a dose known to induce and prolong sleep, strongly suppressed CA1 calcium signaling. The rate of calcium transients after Zolpidem administration was significantly lower compared to vehicle treatment. To factor out the contribution of changes in locomotor or physiological conditions following Zolpidem treatment, we compared the cellular activity across comparable epochs matched by locomotor and physiological assessments. This analysis revealed significantly depressive effects of Zolpidem regardless of the animal's state. Individual hippocampal CA1 pyramidal cells differed in their responses to Zolpidem with the majority (similar to 65%) significantly decreasing the rate of calcium transients, and a small subset (3%) showing an unexpected and significant increase. By linking molecular mechanisms with the dynamics of neural circuitry and behavioral states, this approach has the potential to contribute substantially to the development of new therapeutics for the treatment of CNS disorders.	[Berdyyeva, Tamara; Aluisio, Leah; Dugovic, Christine; Yun, Sujin; Lovenberg, Timothy; Bonaventure, Pascal] Janssen Res & Dev LLC, San Diego, CA 92121 USA; [Otte, Stephani; Ziv, Yaniv; Burns, Laurie D.; Ghosh, Kunal K.; Schnitzer, Mark J.] Inscopix, Palo Alto, CA USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Berdyyeva, T (corresponding author), Janssen Res & Dev LLC, San Diego, CA 92121 USA.	tberdyy6@its.jnj.com	Bonaventure, Pascal/K-3052-2015	Bonaventure, Pascal/0000-0003-2971-6152	Inscopix	Inscopix	TB, LA, CD, SY, TL, and PB are paid employees at Janssen Pharmaceutical Research & Development, LLC; SO and KG are paid employees at Inscopix; YZ and LB are paid consultants at Inscopix; KG is a founder and CEO of Inscopix; and MS is a Chief Scientist at Inscopix. The funders provided support in the form of salaries for authors (TB, LA, CD, SY, TL, PB, SO, and KG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Kazuo, 2008, Recent Pat CNS Drug Discov, V3, P55, DOI 10.2174/157488908783421519; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Alexandre C, 2008, SLEEP, V31, P259, DOI 10.1093/sleep/31.2.259; Alivisatos AP, 2013, ACS NANO, V7, P1850, DOI 10.1021/nn4012847; Anaclet C, 2012, SLEEP, V35, P103, DOI 10.5665/sleep.1596; Ban Thomas A, 2006, Dialogues Clin Neurosci, V8, P335; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Behrendt RP, 2013, REV NEUROSCIENCE, V24, P239, DOI 10.1515/revneuro-2012-0088; BENOIT O, 1994, PSYCHOPHARMACOLOGY, V116, P297, DOI 10.1007/BF02245332; BERLIN I, 1993, J CLIN PSYCHOPHARM, V13, P100; Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Working Group, 2013, INT REP; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Buibas M, 2011, NEURAL COMPUT, V23, P183, DOI 10.1162/NECO_a_00065; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Cope DW, 2005, EUR J NEUROSCI, V21, P3002, DOI 10.1111/j.1460-9568.2005.04127.x; Crestani F, 2000, BRIT J PHARMACOL, V131, P1251, DOI 10.1038/sj.bjp.0703717; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Da Settimo F, 2007, CURR MED CHEM, V14, P2680, DOI 10.2174/092986707782023190; Danjou P, 1999, BRIT J CLIN PHARMACO, V48, P367; Deisseroth K, 2013, NEURON, V80, P568, DOI 10.1016/j.neuron.2013.10.032; DEPOORTERE H, 1986, J PHARMACOL EXP THER, V237, P649; Di Lazzaro V, 2006, J PHYSIOL-LONDON, V575, P721, DOI 10.1113/jphysiol.2006.114694; Diezi Leonore, 2014, Rev Med Suisse, V10, P119; Ding JJ, 2014, SCI CHINA LIFE SCI, V57, P269, DOI 10.1007/s11427-013-4599-5; Doble A, 1999, J PSYCHOPHARMACOL, V13, pS11, DOI 10.1177/026988119901304S03; Drover DR, 2004, CLIN PHARMACOKINET, V43, P227, DOI 10.2165/00003088-200443040-00002; Du B, 2014, AM J MED SCI, V347, P178, DOI 10.1097/MAJ.0b013e318287c79c; Dugovic C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00028; Dugovic C, 2009, J PHARMACOL EXP THER, V330, P142, DOI 10.1124/jpet.109.152009; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 1993, MEMORY AMNESIA HIPPO; EVANS SM, 1990, J PHARMACOL EXP THER, V255, P1246; Farber RH, 2008, CURR MED RES OPIN, V24, P837, DOI 10.1185/030079908X273327; Fava M, 2009, J CLIN PSYCHOPHARM, V29, P222, DOI 10.1097/JCP.0b013e3181a390ba; FDA Drug Safety Communication, RISK NEXT MORN IMP U; Fernandez FR, 2010, J NEUROSCI, V30, P230, DOI 10.1523/JNEUROSCI.3995-09.2010; Fitzgerald AC, 2014, PSYCHOPHARMACOLOGY, V231, P1865, DOI 10.1007/s00213-014-3457-x; FOSTER TC, 1989, SCIENCE, V244, P1580, DOI 10.1126/science.2740902; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Goldstein PA, 2002, J NEUROPHYSIOL, V88, P3208, DOI 10.1152/jn.00885.2001; Graham D, 1996, EUR NEUROPSYCHOPHARM, V6, P119, DOI 10.1016/0924-977X(95)00072-W; Greenblatt DJ, 2012, EXPERT OPIN PHARMACO, V13, P879, DOI 10.1517/14656566.2012.667074; Groen MR, 2014, J NEUROPHYSIOL; Gunja N, 2013, J MED TOXICOL, V9, P163, DOI 10.1007/s13181-013-0294-y; Harrison NL, 2007, J CLIN PSYCHIAT, V68, P6; Heja L, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-26; Heldt SA, 2007, NEUROSCIENCE, V150, P370, DOI 10.1016/j.neuroscience.2007.09.008; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; Henson RN, 2010, HIPPOCAMPUS, V20, P1315, DOI 10.1002/hipo.20857; Higashima M, 1998, NEUROSCI LETT, V245, P77, DOI 10.1016/S0304-3940(98)00178-5; Hortnagl H, 2013, NEUROSCIENCE, V236, P345, DOI 10.1016/j.neuroscience.2013.01.008; Huang MP, 2010, BEHAV BRAIN RES, V210, P54, DOI 10.1016/j.bbr.2010.02.018; Inagaki Takuji, 2010, Prim Care Companion J Clin Psychiatry, V12, DOI 10.4088/PCC.09r00849bro; Inostroza M, 2013, ANNU REV NEUROSCI, V36, P79, DOI 10.1146/annurev-neuro-062012-170429; Isawa S, 2000, Nihon Shinkei Seishin Yakurigaku Zasshi, V20, P61; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jessen SB, 2014, CEREB CORTEX; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x; Kemere C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073114; Kleykamp BA, 2012, EXP CLIN PSYCHOPHARM, V20, P28, DOI 10.1037/a0025237; Knopfel T, 2012, NAT REV NEUROSCI, V13, P687, DOI 10.1038/nrn3293; Kopp C, 2004, NEUROREPORT, V15, P2299, DOI 10.1097/00001756-200410050-00031; Kostowski Wojciech, 1995, Polish Journal of Pharmacology, V47, P237; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P645, DOI 10.1001/jama.2013.323; Lee V, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00003; Leufkens TRM, 2009, J SLEEP RES, V18, P387, DOI 10.1111/j.1365-2869.2009.00746.x; Liang J, 2004, J PHARMACOL EXP THER, V310, P1234, DOI 10.1124/jpet.104.067983; Lieberman Joseph A, 2007, Prim Care Companion J Clin Psychiatry, V9, P25; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; Lucchesi LM, 2005, PROG NEURO-PSYCHOPH, V29, P557, DOI 10.1016/j.pnpbp.2005.01.013; Lundahl J, 2012, J PSYCHOPHARMACOL, V26, P1081, DOI 10.1177/0269881111424457; Machado C, 2013, CURR PHARM DES; Manuel NA, 1998, BRIT J PHARMACOL, V125, P1529, DOI 10.1038/sj.bjp.0702237; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mednick SC, 2013, J NEUROSCI, V33, P4494, DOI 10.1523/JNEUROSCI.3127-12.2013; Meskali M, 2009, PSYCHOPHARMACOLOGY, V207, P461, DOI 10.1007/s00213-009-1677-2; Mizumori SJY, 1995, BEHAV NEUROSCI, V109, P1081; Mohammadi B, 2006, MUSCLE NERVE, V33, P778, DOI 10.1002/mus.20531; Mokler DJ, 2001, NUTR NEUROSCI, V4, P109, DOI 10.1080/1028415X.2001.11747355; Monti JM, 2000, SLEEP, V23, P1075; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Mura E, 2013, CURR PHARM DES; Murphy HM, 2011, PHARMACOL BIOCHEM BE, V98, P81, DOI 10.1016/j.pbb.2010.12.012; Nazar M, 1999, J NEURAL TRANSM, V106, P369, DOI 10.1007/s007020050165; Otmani S, 2008, HUM PSYCHOPHARM CLIN, V23, P693, DOI 10.1002/hup.980; Packard MG, 2009, BRAIN RES, V1293, P121, DOI 10.1016/j.brainres.2009.03.029; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Pericic D, 2008, J NEURAL TRANSM, V115, P795, DOI 10.1007/s00702-008-0020-0; Perouansky M, 2011, CAN J ANESTH, V58, P157, DOI 10.1007/s12630-010-9417-y; Perrais D, 1999, J NEUROSCI, V19, P578; Pick CG, 2005, PHARMACOL BIOCHEM BE, V81, P417, DOI 10.1016/j.pbb.2005.02.013; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Pistoia F, 2013, CURR PHARM DES; Ramirez AD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00254; Richey SM, 2011, CURR PHARM DESIGN, V17, P1471; Rode F, 2005, EUR J PHARMACOL, V516, P131, DOI 10.1016/j.ejphar.2005.04.034; ROVIRA C, 1993, J NEUROPHYSIOL, V70, P1076, DOI 10.1152/jn.1993.70.3.1076; Rowlett JK, 2011, PSYCHOPHARMACOLOGY, V214, P855, DOI 10.1007/s00213-010-2093-3; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Saari TI, 2011, PHARMACOL REV, V63, P243, DOI 10.1124/pr.110.002717; Sanger DJ, 2004, CNS DRUGS, V18, P9, DOI 10.2165/00023210-200418001-00004; Sanger DJ, 1996, EUR J PHARMACOL, V313, P35, DOI 10.1016/0014-2999(96)00510-9; Schacter Daniel L, 2012, Dialogues Clin Neurosci, V14, P7; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Shelton J, 2009, NEUROPHARMACOLOGY, V56, P448, DOI 10.1016/j.neuropharm.2008.09.014; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Snyman N, 2010, NEUROPEDIATRICS, V41, P223, DOI 10.1055/s-0030-1269893; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Squire L.R., 2002, NEUROPSYCHOLOGY MEMO; Taketo M, 2000, NEUROSCIENCE, V96, P507, DOI 10.1016/S0306-4522(99)00574-6; Tashjian Robert Z, 2006, J Knee Surg, V19, P105; Thonnard M, 2014, FUNCT NEUROL, V11, P1; Tietz EI, 1999, J NEUROPHYSIOL, V81, P1575, DOI 10.1152/jn.1999.81.4.1575; Ujfalussy B, 2007, NEUROPHARMACOLOGY, V52, P733, DOI 10.1016/j.neuropharm.2006.09.022; Uslaner JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005213; Vargas-Caballero M, 2010, NEUROPHARMACOLOGY, V58, P668, DOI 10.1016/j.neuropharm.2009.11.005; Vermeeren A, 2004, CNS DRUGS, V18, P297, DOI 10.2165/00023210-200418050-00003; Vermeeren A, 2014, SLEEP, V37, P489, DOI 10.5665/sleep.3482; Verster JC, 2007, CURR DRUG SAF, V2, P220, DOI 10.2174/157488607781668882; Vlainic J, 2010, BRAIN RES, V1310, P181, DOI 10.1016/j.brainres.2009.11.018; Vlainic J, 2009, NEUROPHARMACOLOGY, V56, P1124, DOI 10.1016/j.neuropharm.2009.03.010; Vyazovskiy VV, 2013, NAT REV NEUROSCI, V14, P445, DOI 10.1038/nrn3494; Vyazovskiy VV, 2011, PROG BRAIN RES, V193, P17, DOI 10.1016/B978-0-444-53839-0.00002-8; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; WILKINSON CJ, 1995, J CLIN PSYCHIAT, V56, P309; Xu Q, 2014, PHARMACOL BIOCHEM BE, V116, P129, DOI 10.1016/j.pbb.2013.11.029; Yeung JYT, 2003, MOL PHARMACOL, V63, P2, DOI 10.1124/mol.63.1.2; Yoon BE, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-42; Zahreddine N., 2013, CURR CLIN PHARM; Zammit Gary K., 2001, Prim Care Companion J Clin Psychiatry, V3, P53; Zanin KA, 2013, PSYCHOPHARMACOLOGY, V226, P459, DOI 10.1007/s00213-012-2756-3; Zeng XJ, 1999, SYNAPSE, V31, P263, DOI 10.1002/(SICI)1098-2396(19990315)31:4<263::AID-SYN4>3.3.CO;2-A; Zheng F, 2001, NEUROSCIENCE, V103, P985, DOI 10.1016/S0306-4522(01)00006-9; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	141	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112068	10.1371/journal.pone.0112068	http://dx.doi.org/10.1371/journal.pone.0112068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372144	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900107
J	Dong, Y; Shen, XX; Guo, RZ; Liu, BC; Zhu, LY; Wang, J; Zhang, LX; Sun, J; Zhang, XY; Xu, JQ				Dong, Yuan; Shen, Xiaoxing; Guo, Ruizhang; Liu, Baochi; Zhu, Lingyan; Wang, Jing; Zhang, Linxia; Sun, Jun; Zhang, Xiaoyan; Xu, Jianqing			Willingness to Participate in HIV Therapeutic Vaccine Trials among HIV-Infected Patients on ART in China	PLOS ONE			English	Article							INJECTION-DRUG USERS; ANTIRETROVIRAL THERAPY; COGNITIVE-FACTORS; CLINICAL-TRIALS; IMMUNIZATION; AIDS; VIREMIA; ACCEPTABILITY; RESISTANCE; IMMUNOGEN	Background: More and more HIV therapeutic vaccines will enter clinical trials; however, little is known about the willingness to participate (WTP) in HIV therapeutic vaccine trials among HIV-positive individuals. Objective: To investigate the WTP in HIV therapeutic vaccine trials among Chinese HIV-infected patients. Methods: We conducted a cross-sectional survey on HIV-positive inpatients and outpatients at Shanghai Public Health Center. A total of 447 participants were recruited into this study. Following an introduction with general information on HIV therapeutic vaccine and its potential effectiveness and side effects, each participant completed a questionnaire in a self-administered form. The questionnaires covered demographics, high-risk behaviors, clinical characteristics and willingness to participate in HIV therapeutic vaccine trial. Results: The overall willingness to participate in HIV therapeutic vaccine trials was 91.5%. Interestingly, multivariate logistic regression analyses demonstrated that the willingness was higher for those sexually infected by HIV (odds ratio [OR]: 4.36; 95% confidence interval [CI]: 1.53-12.41), diagnosed as HIV-1 infection for greater than 5 years (OR: 7.12, 95% CI: 1.83-27.76), and with the presence of infectious complications (OR: 2.75; 95% CI: 1.02-7.45). The primary reason for participation was to delay or reduce antiretroviral treatment (ART) and to avoid ART side effects (76.6%), and then followed by delaying disease progression (74.9%), increasing immune response to suppress opportunistic infections (57.7%) and preventing the development of drug resistance (37.1%). Reasons for unwillingness to participate mainly included concern for safety (37.0%), lack of knowledge on therapeutic vaccine (33.3%), and satisfaction with ART effectiveness (22.2%). Conclusions: The WTP in HIV therapeutic vaccine trials was high among HIV-infected Chinese patients. HIV+ subjects who acquired infection through sexual contact and who were diagnosed for more than 5 years may represent a good candidate population for enrollment in therapeutic vaccine trials.	[Dong, Yuan; Guo, Ruizhang; Liu, Baochi; Zhu, Lingyan; Wang, Jing; Zhang, Linxia; Sun, Jun; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Dong, Yuan; Guo, Ruizhang; Liu, Baochi; Zhu, Lingyan; Wang, Jing; Zhang, Linxia; Sun, Jun; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol,Minist Educ Hlth, Shanghai 200433, Peoples R China; [Shen, Xiaoxing] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Zhang, Xiaoyan; Xu, Jianqing] China CDC, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Fudan University; Fudan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Chinese Center for Disease Control & Prevention	Zhang, XY (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	jianqingxu2008@gmail.com; zhangxy066@gmail.com		Dong, Yuan/0000-0002-8587-2291	National Grand Program on Key Infectious Disease Control and Prevention of China [2013ZX10001-002]	National Grand Program on Key Infectious Disease Control and Prevention of China	This work was supported by National Grand Program on Key Infectious Disease Control and Prevention (2013ZX10001-002) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel JB, 2011, AIDS, V25, P731, DOI 10.1097/QAD.0b013e328344cea5; [Anonymous], 2012, GLOB REP UNAIDS REP; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Balfour L, 2010, AIDS CARE, V22, P1403, DOI 10.1080/09540121003693522; Bartholow BN, 1997, J ACQ IMMUN DEF SYND, V16, P108, DOI 10.1097/00042560-199710010-00006; Bishai D, 2004, B WORLD HEALTH ORGAN, V82, P652; Boberg A, 2008, EXPERT REV VACCINES, V7, P131, DOI 10.1586/14760584.7.1.131; Carcelain G, 2013, IMMUNOL REV, V254, P355, DOI 10.1111/imr.12083; Chantratita W, 2004, HIV MED, V5, P317, DOI 10.1111/j.1468-1293.2004.00230.x; Chu ZX, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/493128; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das K, 2013, CURR OPIN VIROL, V3, P111, DOI 10.1016/j.coviro.2013.03.012; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Dhalla S, 2007, AIDS CARE, V19, P1118, DOI 10.1080/09540120701352258; Dhalla S, 2012, PSYCHOL HEALTH MED, V17, P223, DOI 10.1080/13548506.2011.608803; Dhalla S, 2010, VACCINE, V28, P1663, DOI 10.1016/j.vaccine.2009.12.023; Evangeli M, 2013, AIDS CARE, V25, P910, DOI 10.1080/09540121.2012.748163; Fernandez-Cruz Eduardo, 2003, Expert Rev Vaccines, V2, P739, DOI 10.1586/14760584.2.6.739; Etcheverry MF, 2011, VACCINE, V29, P1991, DOI 10.1016/j.vaccine.2010.12.043; Etcheverry MF, 2010, AIDS BEHAV, V14, P607, DOI 10.1007/s10461-008-9486-x; Garcia F, 2012, HUM VACC IMMUNOTHER, V8, P569, DOI 10.4161/hv.19555; Golub ET, 2005, AIDS BEHAV, V9, P301, DOI 10.1007/s10461-005-9004-3; Harrer E, 2005, ANTIVIR THER, V10, P285; Joseph J, 2005, AIDS REV, V7, P131; Kahn JO, 2000, JAMA-J AM MED ASSOC, V284, P2193, DOI 10.1001/jama.284.17.2193; Kinloch-de Loes S, 2005, J INFECT DIS, V192, P607, DOI 10.1086/432002; Kiwanuka N, 2004, JAIDS-J ACQ IMM DEF, V36, P721, DOI 10.1097/00126334-200406010-00009; Koff WC, 2013, VACCINE, V31, pB204, DOI 10.1016/j.vaccine.2012.10.115; Kwong PD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17407; Lederman MM, 2000, JAMA-J AM MED ASSOC, V284, P223, DOI 10.1001/jama.284.2.223; Li QC, 2010, VACCINE, V28, P4638, DOI 10.1016/j.vaccine.2010.04.073; Liau A, 2001, AIDS CARE, V13, P643, DOI 10.1080/09540120120075275; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; Metifiot M, 2013, ADV PHARMACOL, V67, P75, DOI 10.1016/B978-0-12-405880-4.00003-2; Newman PA, 2010, AIDS, V24, P1749, DOI 10.1097/QAD.0b013e32833adbe8; Puls RL, 2006, CLIN SCI, V110, P59, DOI 10.1042/CS20050157; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Schooley RT, 2010, J INFECT DIS, V202, P705, DOI 10.1086/655468; Shimada M, 2009, GENE THER, V16, P218, DOI 10.1038/gt.2008.152; Strauss RP, 2001, J ACQ IMMUN DEF SYND, V26, P63, DOI 10.1097/00126334-200101010-00010; Valentin A, 2010, VACCINE, V28, P1962, DOI 10.1016/j.vaccine.2009.10.099; Vanham G, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-72; von Gegerfelt AS, 2007, J VIROL, V81, P1972, DOI 10.1128/JVI.01990-06; Wensing AMJ, 2010, ANTIVIR RES, V85, P59, DOI 10.1016/j.antiviral.2009.10.003; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Yin L, 2008, VACCINE, V26, P762, DOI 10.1016/j.vaccine.2007.11.091; Zimet GD, 1997, J ADOLESCENT HEALTH, V20, P354, DOI 10.1016/S1054-139X(97)00031-1	48	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111321	10.1371/journal.pone.0111321	http://dx.doi.org/10.1371/journal.pone.0111321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372044	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900043
J	Matangila, R; Doua, JY; Linsuke, S; Madinga, J; da Luz, RI; Van Geertruyden, JP; Lutumba, P				Matangila, Junior R.; Doua, Joachim Yorokpa; Linsuke, Sylvie; Madinga, Joule; da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre; Lutumba, Pascal			Malaria, Schistosomiasis and Soil Transmitted Helminth Burden and Their Correlation with Anemia in Children Attending Primary Schools in Kinshasa, Democratic Republic of Congo	PLOS ONE			English	Article							ASYMPTOMATIC MALARIA; INFECTION; EPIDEMIOLOGY; COINFECTION; DURATION; MANSONI	Background: Anaemia reduces cognitive potential in school children, retards their growth and predisposes them to other diseases. As there is a paucity of data on the current burden of P. falciparum, S. mansoni and soil transmitted helminths (STH) infections and their correlation with schoolchildren's anemia in the Democratic Republic of Congo (DRC), we collect these data. Methods: This study reports baseline data collected from a randomized controlled trial investigating the impact of IPT with SP and SP-PQ on anemia and malaria morbidity in Congolese schoolchildren (Trial registration: NCT01722539; PACTR201211000449323). S. mansoni and STH infections were assessed using kato-katz technique. Malaria infection and hemoglobin concentration were assessed using Blood smear and Hemocontrol device, respectively. Results: A total of 616 primary schoolchildren from 4 to 13 years old were enrolled in the study. The prevalence of Plasmodium spp. infection was 18.5% (95%CI:15.6-21.9). Amongst those infected, 24 (21%), 40 (35.1%), 40 (35.1%), 10 (8.8%), had light, moderate, heavy, very high malaria parasite density, respectively. Above 9 years of age (p = 0.02),male and history of fever (p = 0.04) were both associated with malaria infection. The overall prevalence of S. mansoni infection was 6.4% (95%CI:4.4-9.1). Girls were associated with S. mansoni infection (p = 0.04). T. trichiura was the most prevalent STH infection (26.3%), followed by A. lumbricoides (20.1%). Co-infection with malaria-S. mansoni and malaria-STH was, respectively, 1.5% (CI95%:0.7-3.3) and 6.4% (CI95% 4.4-9.1). The prevalence of anemia was found to be 41.6% (95%CI:37.7-45.6) and anemia was strongly related with Plasmodium ssp infection (aOR:4.1; CI95%:2.6-6.5;p<0.001) and S. mansoni infection (aOR:3.3;CI95%:1.4-7.8;p<0.01). Conclusion: Malaria and S. mansoni infection were strongly associated with high prevalence of anemia in schoolchildren. Therefore, specific school-based interventions, such as intermittent preventive treatment or prophylaxis, LLITN distribution, anthelminthic mass treatment and micronutrient supplementation are needed to improve school children's health.	[Matangila, Junior R.; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Matangila, Junior R.; Doua, Joachim Yorokpa; da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre] Univ Antwerp, Dept Epidemiol, B-2020 Antwerp, Belgium; [Linsuke, Sylvie] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Madinga, Joule] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium	Universite de Kinshasa; University of Antwerp; Institute Nacional de Recherche Biomedical; Universite Catholique Louvain	Matangila, R (corresponding author), Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO.	matangilaj@yahoo.fr	Inocencio da Luz, Raquel/ABE-8206-2021; da Luz, Raquel A Inocencio/L-9676-2016; Van geertruyden, Jean-Pierre/K-6425-2014; Van geertruyden, Jean-Pierre/S-3254-2019	Inocencio da Luz, Raquel/0000-0002-2870-0311; da Luz, Raquel A Inocencio/0000-0002-2870-0311; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364	VLIR UOS project [ZRDC2012 70447]; University of Antwerp; Fonds Wetenschappelijk Onderzoek (FWO) [G.0978.11N]	VLIR UOS project; University of Antwerp; Fonds Wetenschappelijk Onderzoek (FWO)(FWO)	This study was financed by the VLIR UOS project (ZRDC2012 70447), University of Antwerp (JPV), and Fonds Wetenschappelijk Onderzoek (FWO) project G.0978.11N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaolu SO, 2003, ACTA TROP, V86, P283, DOI 10.1016/S0001-706X(03)00060-3; Brooker SJ, 2012, J INFECT DIS, V205, P841, DOI 10.1093/infdis/jir844; Bruce MC, 2000, PARASITOLOGY, V121, P247, DOI 10.1017/S0031182099006344; Brutus L, 2007, AM J TROP MED HYG, V77, P1091, DOI 10.4269/ajtmh.2007.77.1091; BUCK AA, 1978, TROPENMED PARASITOL, V29, P61; Bundy DAP, 2000, PARASITOL TODAY, V16, P181, DOI 10.1016/S0169-4758(00)01658-6; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Doua JY, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-311; Ezeamama AE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000245; FAQUIN W C, 1992, Blood, V79, P1987; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Gbadegesin RA, 1997, ANN TROP PAEDIATR, V17, P89, DOI 10.1080/02724936.1997.11747869; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; Hesran J, 2004, T R SOC TROP MED HYG, V98, P397, DOI DOI 10.1016/j.trstmh.2003.10.009; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; JANCLOES MF, 1980, REV EPIDEMIOL SANTE, V28, P89; JELKMANN W, 1992, LIFE SCI, V50, P301, DOI 10.1016/0024-3205(92)90338-P; Kabongo M, 2012, THESIS; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Kazadi W, 2004, AM J TROP MED HYG, V71, P97, DOI 10.4269/ajtmh.2004.71.97; Lelo Nzuzi F, 2008, KINSHASA VILLE ENV; Lemaitre M, 2014, AM J TROP MED HYG, V90, P329, DOI 10.4269/ajtmh.12-0431; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; Mazigoi Humphrey D, 2010, Tanzan J Health Res, V12, P299; Midzi N, 2010, ACTA TROP, V115, P103, DOI 10.1016/j.actatropica.2010.02.010; Okanla EO, 1991, NIG J PURE APPL SCI, V6, P154; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Roper C, 1996, AM J TROP MED HYG, V54, P325, DOI 10.4269/ajtmh.1996.54.325; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Shapiro AE, 2005, T ROY SOC TROP MED H, V99, P18, DOI 10.1016/j.trstmh.2004.02.006; Smith T, 1999, Trans R Soc Trop Med Hyg, V93 Suppl 1, P59, DOI 10.1016/S0035-9203(99)90329-2; Sturrock RF, 1996, T ROY SOC TROP MED H, V90, P48, DOI 10.1016/S0035-9203(96)90477-0; The World's Women, 2010, TREND STAT; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P26, DOI 10.1016/0035-9203(87)90474-3; Vandepitte J, 1988, HELMINTTHOLOGIE MED; Verhoef H, 2010, AM J CLIN NUTR, V92, P1285, DOI 10.3945/ajcn.110.006700; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Wang B, 2014, J CLIN MICROBIOL, V52, P1838, DOI 10.1128/JCM.03615-13; WARREN KS, 1974, AM J TROP MED HYG, V23, P902, DOI 10.4269/ajtmh.1974.23.902; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; World Health Organization, 2008, WORLD MALARIA REPORT; World Health Organization, 2002, WHO TRADITIONAL MED, P1; World Health Organization, 2002, PREV CONTR SCHIST SO; World Health Organization, WORLDWIDE PREVALENCE	45	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110789	10.1371/journal.pone.0110789	http://dx.doi.org/10.1371/journal.pone.0110789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372029	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900025
J	Sutton, ME; op den Dries, S; Karimian, N; Weeder, PD; de Boer, MT; Wiersema-Buist, J; Gouw, ASH; Leuvenink, HGD; Lisman, T; Porte, RJ				Sutton, Michael E.; op den Dries, Sanna; Karimian, Negin; Weeder, Pepijn D.; de Boer, Marieke T.; Wiersema-Buist, Janneke; Gouw, Annette S. H.; Leuvenink, Henri G. D.; Lisman, Ton; Porte, Robert J.			Criteria for Viability Assessment of Discarded Human Donor Livers during Ex Vivo Normothermic Machine Perfusion	PLOS ONE			English	Article							BILE-SALT TOXICITY; BILIARY STRICTURES; COLD-STORAGE; TRANSPLANTATION; PRESERVATION; INJURY; DONATION; GRAFTS; DEATH; DUCTS	Although normothermic machine perfusion of donor livers may allow assessment of graft viability prior to transplantation, there are currently no data on what would be a good parameter of graft viability. To determine whether bile production is a suitable biomarker that can be used to discriminate viable from non-viable livers we have studied functional performance as well as biochemical and histological evidence of hepatobiliary injury during ex vivo normothermic machine perfusion of human donor livers. After a median duration of cold storage of 6.5 h, twelve extended criteria human donor livers that were declined for transplantation were ex vivo perfused for 6 h at 37 degrees C with an oxygenated solution based on red blood cells and plasma, using pressure controlled pulsatile perfusion of the hepatic artery and continuous portal perfusion. During perfusion, two patterns of bile flow were identified: (1) steadily increasing bile production, resulting in a cumulative output of >= 30 g after 6 h (high bile output group), and (2) a cumulative bile production <20 g in 6 h (low bile output group). Concentrations of transaminases and potassium in the perfusion fluid were significantly higher in the low bile output group, compared to the high bile output group. Biliary concentrations of bilirubin and bicarbonate were respectively 4 times and 2 times higher in the high bile output group. Livers in the low bile output group displayed more signs of hepatic necrosis and venous congestion, compared to the high bile output group. In conclusion, bile production could be an easily assessable biomarker of hepatic viability during ex vivo machine perfusion of human donor livers. It could potentially be used to identify extended criteria livers that are suitable for transplantation. These ex vivo findings need to be confirmed in a transplant experiment or a clinical trial.	[Sutton, Michael E.; op den Dries, Sanna; Karimian, Negin; Weeder, Pepijn D.; de Boer, Marieke T.; Lisman, Ton; Porte, Robert J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands; [Sutton, Michael E.; op den Dries, Sanna; Karimian, Negin; Weeder, Pepijn D.; Wiersema-Buist, Janneke; Leuvenink, Henri G. D.; Lisman, Ton] Univ Groningen, Univ Med Ctr Groningen, Surg Res Lab, Groningen, Netherlands; [Gouw, Annette S. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Porte, RJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands.	r.j.porte@umcg.nl		Lisman, Ton/0000-0002-3503-7140; Leuvenink, Henri/0000-0001-5036-2999	Innovatief Actieprogramma Groningen; Jan Kornelis de Cock Stichting; Tekke Huizingafonds	Innovatief Actieprogramma Groningen; Jan Kornelis de Cock Stichting; Tekke Huizingafonds	This work was supported by: 1. Innovatief Actieprogramma Groningen (author SODD), http://www.provinciegroningen.nl/servicelinks-provinciegroningen/english/; 2. Jan Kornelis de Cock Stichting, http://www.decockstichting.nl/subsidies.html (authors: SODD MES); 3. Tekke Huizingafonds, http://tekkehuizingafonds.nl/ (author SODD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae C, 2012, CURR OPIN ORGAN TRAN, V17, P137, DOI 10.1097/MOT.0b013e328351083d; Brockmann J, 2009, ANN SURG, V250, P1, DOI 10.1097/SLA.0b013e3181a63c10; Buis CL, 2009, J HEPATOL, V50, P69, DOI 10.1016/j.jhep.2008.07.032; Dutkowski P, 2008, AM J TRANSPLANT, V8, P917, DOI 10.1111/j.1600-6143.2008.02165.x; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Fondevila C, 2012, TRANSPLANTATION, V94, P22, DOI 10.1097/TP.0b013e31825774d7; Hessheimer AJ, 2012, CURR OPIN ORGAN TRAN, V17, P143, DOI 10.1097/MOT.0b013e328351082a; Hoekstra H, 2006, HEPATOLOGY, V43, P1022, DOI 10.1002/hep.21169; Imber CJ, 2002, AM J TRANSPLANT, V2, P593, DOI 10.1034/j.1600-6143.2002.20703.x; Imber CJ, 2002, TRANSPLANTATION, V73, P701, DOI 10.1097/00007890-200203150-00008; Impedovo Stefano Vittorio, 2012, Arch Ital Urol Androl, V84, P279; Karimian N, 2013, J HEPATOL, V58, P1065, DOI 10.1016/j.jhep.2013.02.023; Markmann JF, 2003, J AM COLL SURGEONS, V196, P566, DOI 10.1016/S1072-7515(02)01907-5; McCormack L, 2011, J HEPATOL, V54, P1055, DOI 10.1016/j.jhep.2010.11.004; Merion RM, 2006, J HEPATOL, V45, P484, DOI 10.1016/j.jhep.2006.07.016; Monbaliu D, 2010, CURR OPIN ORGAN TRAN, V15, P160, DOI 10.1097/MOT.0b013e328337342b; Moon JH, 2013, GASTROENTEROLOGY, V144, P276, DOI 10.1053/j.gastro.2012.10.045; Nyberg SL, 2005, TRANSPLANTATION, V80, P925, DOI 10.1097/01.TP.0000173798.04043.AF; Obara H, 2012, TRANSPL P, V44, P959, DOI 10.1016/j.transproceed.2012.01.104; op den Dries S, 2013, AM J TRANSPLANT, V13, P1327, DOI 10.1111/ajt.12187; op den Dries S, 2011, TRANSPLANTATION, V92, P373, DOI 10.1097/TP.0b013e318223a384; Orman ES, 2013, LIVER TRANSPLANT, V19, P59, DOI 10.1002/lt.23547; Pomfret EA, 2008, AM J TRANSPLANT, V8, P745, DOI 10.1111/j.1600-6143.2007.02146.x; Portincasa P, 2012, MOL ASPECTS MED, V33, P651, DOI 10.1016/j.mam.2012.03.010; Reddy SP, 2004, TRANSPLANTATION, V77, P1328, DOI 10.1097/01.TP.0000119206.63326.56; Schlegel A, 2013, J HEPATOL, V58, P278, DOI 10.1016/j.jhep.2012.10.004; Yska MJ, 2008, TRANSPLANTATION, V85, P1625, DOI 10.1097/TP.0b013e318170f5f7	27	127	132	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110642	10.1371/journal.pone.0110642	http://dx.doi.org/10.1371/journal.pone.0110642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369327	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000024
J	Zhou, Q; Ni, W; Dong, Y; Wang, N; Gan, SR; Wu, ZY				Zhou, Qi; Ni, Wang; Dong, Yi; Wang, Ning; Gan, Shi-Rui; Wu, Zhi-Ying			The Role of Apolipoprotein E as a Risk Factor for an Earlier Age at Onset for Machado-Joseph Disease Is Doubtful	PLOS ONE			English	Article							CAG REPEAT LENGTH; OF-ONSET; HUNTINGTONS-DISEASE; SPINOCEREBELLAR ATAXIA; ALZHEIMERS-DISEASE; GENOTYPES; GENE; EXPANSIONS; FEATURES; KINDREDS	Machado-Joseph disease (MJD) is an inherited neurodegenerative disease caused by an expanded CAG repeat in the ATXN3 gene. Although the principal genetic determinant of the age at onset (AAO) is the length of the expanded CAG repeat, the additional genetic contribution of MJD toward the AAO has mostly not yet been clarified. It was recently suggested in two independent studies that apolipoprotein E (APOE) might be associated with AAO variability in MJD patients. To identify the potential modifier effect of APOE polymorphisms on the AAO of MJD patients, 403 patients with MJD (confirmed by molecular tests) from eastern and southeastern China were enrolled in the present study. CAG repeats in the ATXN3 and APOE polymorphisms were genotyped. Data were analyzed using a statistical package. No contribution of APOE polymorphisms to the variance in disease onset was observed using ANCOVA (F = 0.183, P = 0.947). However, significant effects on the AAO of MJD were found for the normal ATXN3 allele and for the interaction of mutant and normal ATXN3 alleles in a multiple linear regression model (P = 0.043 and P = 0.035, respectively). Our study does not support a role for APOE as a genetic modifier of the AAO of MJD. Additionally, our study presents evidence that the normal ATXN3 allele and its interaction with mutant alleles contribute toward AAO variance in MJD patients.	[Zhou, Qi; Ni, Wang; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Qi; Ni, Wang; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Qi; Ni, Wang; Wang, Ning; Gan, Shi-Rui] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Fujian, Peoples R China; [Zhou, Qi; Ni, Wang; Wang, Ning; Gan, Shi-Rui] Fujian Med Univ, Affiliated Hosp 1, Inst Neurol, Fuzhou, Fujian, Peoples R China; [Dong, Yi; Wu, Zhi-Ying] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurol, Shanghai 200433, Peoples R China; [Dong, Yi; Wu, Zhi-Ying] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Inst Neurol, Shanghai 200433, Peoples R China	Zhejiang University; Zhejiang University; Fujian Medical University; Fujian Medical University; Fudan University; Fudan University	Wu, ZY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China.	ganshirui1981@163.com; zhiyingwu67@yahoo.com			National Natural Science Foundation of China, Beijing [81125009, 81100851]	National Natural Science Foundation of China, Beijing(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to Z-Y Wu (81125009, Beijing) and The National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to S-R Gan (81100851, Beijing). The funding agencies played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Andresen JM, 2007, J MED GENET, V44, P44, DOI 10.1136/jmg.2006.045153; Aziz NA, 2009, NEUROLOGY, V73, P1280, DOI 10.1212/WNL.0b013e3181bd1121; Bettencourt C, 2011, ARCH NEUROL-CHICAGO, V68, P1580, DOI 10.1001/archneurol.2011.636; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeStefano AL, 1996, AM J HUM GENET, V59, P119; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Franca Marcondes C Jr, 2012, Front Neurol, V3, P164, DOI 10.3389/fneur.2012.00164; Gan SR, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-47; Ghaffar O, 2010, NEUROLOGY, V74, P1611, DOI 10.1212/WNL.0b013e3181e074a7; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kehoe P, 1999, J MED GENET, V36, P108; LINLEE YC, 1985, BIOCHEMISTRY-US, V24, P3751, DOI 10.1021/bi00335a050; MACIEL P, 1995, AM J HUM GENET, V57, P54; NAKAGAWA Y, 1995, LANCET, V345, P68, DOI 10.1016/S0140-6736(95)91196-0; Panas M, 1999, J NEUROL, V246, P574, DOI 10.1007/s004150050406; Peng H, 2014, NEUROBIOL AGING, V22; Rubinsztein DC, 1997, P NATL ACAD SCI USA, V94, P3872, DOI 10.1073/pnas.94.8.3872; Saft C, 2004, J NEUROL NEUROSUR PS, V75, P1692, DOI 10.1136/jnnp.2003.022756; Slepko N, 2006, P NATL ACAD SCI USA, V103, P14367, DOI 10.1073/pnas.0602348103; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302, DOI 10.1212/WNL.44.7.1302; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Warrenburg BPCV, 2005, ANN NEUROL, V57, P505, DOI 10.1002/ana.20424; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077	26	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111356	10.1371/journal.pone.0111356	http://dx.doi.org/10.1371/journal.pone.0111356			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369462	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000049
J	Li, J; Ballim, D; Rodriguez, M; Cui, RT; Goding, CR; Teng, HJ; Prince, S				Li, Jarod; Ballim, Deeya; Rodriguez, Mercedes; Cui, Rutao; Goding, Colin R.; Teng, Huajian; Prince, Sharon			The Anti-proliferative Function of the TGF-beta 1 Signaling Pathway Involves the Repression of the Oncogenic TBX2 by Its Homologue TBX3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cell Proliferation; Gene Expression; Transcription Factor; Transforming Growth Factor (TGF-); TBX2; TBX3; p21	MAMMARY-GLAND DEVELOPMENT; CELL-CYCLE ARREST; TGF-BETA; BREAST-CANCER; C-MYC; EXPRESSION; GENE; SENESCENCE; PROLIFERATION; TRANSCRIPTION	A growing body of work has shown that the highly homologous T-box transcription factors TBX2 and TBX3 play critical but distinct roles in embryonic development and cancer progression. For example, TBX2 and TBX3 are up-regulated in several cancers and recent evidence suggests that whereas TBX2 functions as a pro-proliferative factor, TBX3 inhibits cell proliferation but promotes cancer cell migration and invasion. While the molecular mechanisms regulating these functions of TBX2 and TBX3 are poorly understood we recently reported that the TGF-1 signaling pathway up-regulates TBX3 expression to mediate, in part, its well described anti-proliferative and pro-migratory roles. The TBX3 targets responsible for these functions were however not identified. Here we reveal for the first time that the TGF-1 signaling pathway represses TBX2 transcriptionally and we provide a detailed mechanism to show that this is mediated by TBX3. Furthermore, we implicate the down-regulation of TBX2 in the anti-proliferative function of the TGF-1-TBX3 axis. These findings have important implications for our understanding of the regulation of TBX2 and TBX3 and shed light on the mechanisms involved in the anti-proliferative and pro-migratory roles of TGF-beta 1.	[Li, Jarod; Ballim, Deeya; Teng, Huajian; Prince, Sharon] Univ Cape Town, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Rodriguez, Mercedes; Goding, Colin R.] Univ Oxford, Ludwig Inst Canc Res, Oxford OX3 7DQ, England; [Cui, Rutao] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	University of Cape Town; Ludwig Institute for Cancer Research; University of Oxford; Boston University	Prince, S (corresponding author), Univ Cape Town, Dept Human Biol, Fac Hlth Sci, ZA-7925 Observatory, South Africa.	sharon.prince@uct.ac.za	Prince, Sharon/AFU-4911-2022	Prince, Sharon/0000-0002-6975-5255; Goding, Colin/0000-0002-1614-3909; Rodriguez-Teja, Mercedes/0000-0002-7258-301X	SA Medical Research Council; National Research Foundation (NRF); Cancer Association of South Africa (CANSA); Cancer Research Initiative of South Africa (CARISA); University of Cape Town	SA Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation (NRF); Cancer Association of South Africa (CANSA); Cancer Research Initiative of South Africa (CARISA); University of Cape Town	This work was supported by grants from the SA Medical Research Council, the National Research Foundation (NRF), Cancer Association of South Africa (CANSA), Cancer Research Initiative of South Africa (CARISA), and the University of Cape Town.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Baldwin RL, 2003, CANCER RES, V63, P1413; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Davis E, 2008, ONCOGENE, V27, P976, DOI 10.1038/sj.onc.1210701; Douglas NC, 2013, J MAMMARY GLAND BIOL, V18, P143, DOI 10.1007/s10911-013-9282-8; Fan WW, 2004, CANCER RES, V64, P5132, DOI 10.1158/0008-5472.CAN-04-0615; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jahn Stephan Christopher, 2012, Front Biosci (Schol Ed), V4, P749; Jerome-Majewska LA, 2005, DEV DYNAM, V234, P922, DOI 10.1002/dvdy.20575; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Li J, 2013, MOL BIOL CELL, V24, P3569, DOI 10.1091/mbc.E13-05-0273; Lomnytska M, 2006, INT J CANCER, V118, P412, DOI 10.1002/ijc.21332; Lyng H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-268; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Mowla S, 2011, BIOCHEM J, V433, P145, DOI 10.1042/BJ20100886; Peres Jade, 2010, Genes Cancer, V1, P272, DOI 10.1177/1947601910365160; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Prince S, 2003, PIGM CELL RES, V16, P26, DOI 10.1034/j.1600-0749.2003.00008.x; Redmond KL, 2010, ONCOGENE, V29, P3252, DOI 10.1038/onc.2010.84; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Rowley M, 2004, J MAMMARY GLAND BIOL, V9, P109, DOI 10.1023/B:JOMG.0000037156.64331.3f; Sinclair CS, 2002, CANCER RES, V62, P3587; Teng HJ, 2008, GENE, V423, P8, DOI 10.1016/j.gene.2008.06.017; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yoo YD, 1999, INT J CANCER, V83, P512, DOI 10.1002/(SICI)1097-0215(19991112)83:4<512::AID-IJC13>3.0.CO;2-Z	36	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35633	35643		10.1074/jbc.M114.596411	http://dx.doi.org/10.1074/jbc.M114.596411			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371204	hybrid, Green Published			2022-12-26	WOS:000346660200049
J	Singh, SK; Bharati, AP; Singh, N; Pandey, P; Joshi, P; Singh, K; Mitra, K; Gayen, JR; Sarkar, J; Akhtar, MS				Singh, Sudhir Kumar; Bharati, Akhilendra Pratap; Singh, Neha; Pandey, Praveen; Joshi, Pankaj; Singh, Kavita; Mitra, Kalyan; Gayen, Jiaur R.; Sarkar, Jayanta; Akhtar, Md. Sohail			The Prophage-encoded Hyaluronate Lyase Has Broad Substrate Specificity and Is Regulated by the N-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; Enzyme Catalysis; Glycosaminoglycan; Hyaluronate; Streptococcus; Domain; Hyaluronic Acid	STREPTOCOCCUS-EQUI INFECTION; HUMAN PHARYNGEAL CELLS; GROUP-A; BACTERIOPHAGE HYALURONIDASE; ESCHERICHIA-COLI; MOLECULAR-BASIS; PYOGENES; PHAGE; VIRULENCE; ACID	Streptococcus equi is the causative agent of the highly contagious disease strangles in equines and zoonotic meningitis in human. Spreading of infection in host tissues is thought to be facilitated by the bacterial gene encoded extracellular hyaluronate lyase (HL), which degrades hyaluronan (HA), chondroitin 6-sulfate, and dermatan sulfate of the extracellular matrix). The clinical strain S. equi 4047 however, lacks a functional extracellular HL. The prophages of S. equi and other streptococci encode intracellular HLs which are reported to partially degrade HA and do not cleave any other glycosaminoglycans. The phage HLs are thus thought to play a role limited to the penetration of streptococcal HA capsules, facilitating bacterial lysogenization and not in the bacterial pathogenesis. Here we systematically looked into the structure-function relationship of S. equi 4047 phage HL. Although HA is the preferred substrate, this HL has weak activity toward chondroitin 6-sulfate and dermatan sulfate and can completely degrade all of them. Even though the catalytic triple-stranded -helix domain of phage HL is functionally independent, its catalytic efficiency and specificity is influenced by the N-terminal domain. The phage HL also interacts with human transmembrane glycoprotein CD44. The above results suggest that the streptococci can use phage HLs to degrade glycosaminoglycans of the extracellular matrix for spreading virulence factors and toxins while utilizing the disaccharides as a nutrient source for proliferation at the site of infection.	[Singh, Sudhir Kumar; Bharati, Akhilendra Pratap; Singh, Neha; Akhtar, Md. Sohail] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India; [Pandey, Praveen; Sarkar, Jayanta] Cent Drug Res Inst, CSIR, Div Biochem, Lucknow 226031, Uttar Pradesh, India; [Joshi, Pankaj; Gayen, Jiaur R.] Cent Drug Res Inst, CSIR, Pharmacokinet & Metab Div, Lucknow 226031, Uttar Pradesh, India; [Singh, Kavita; Mitra, Kalyan] Cent Drug Res Inst, CSIR, Sophisticated Analyt Instrument Facil, Lucknow 226031, Uttar Pradesh, India; [Mitra, Kalyan; Gayen, Jiaur R.; Sarkar, Jayanta; Akhtar, Md. Sohail] Acad Sci & Innovat Res, Madras 600113, Tamil Nadu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR)	Akhtar, MS (corresponding author), Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10, Lucknow 226031, Uttar Pradesh, India.	sohail@cdri.res.in	Sarkar, Jayanta/C-3250-2009; Bharati, Akhiendra Pratap/GWR-1433-2022	Bharati, Akhiendra Pratap/0000-0001-8711-610X; Sarkar, Jayanta/0000-0002-9905-7722	Council of Scientific and Industrial Research (India) [YSA001]; Department of Biotechnology (India), New Delhi; Council of Scientific and Industrial Research (India), New Delhi	Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (India), New Delhi; Council of Scientific and Industrial Research (India), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Council of Scientific and Industrial Research (India) Grant YSA001 (to M. S. A.). This is Central Drug Research Institute communication number 8839.; Supported in part by Department of Biotechnology (India), New Delhi.; Supported in part by Council of Scientific and Industrial Research (India), New Delhi.	Akhtar MS, 2006, J BIOL CHEM, V281, P28336, DOI 10.1074/jbc.M601165200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Baker JR, 2002, BIOCHEM J, V365, P317, DOI 10.1042/BJ20020149; Banerji S, 1998, PROTEIN EXPRES PURIF, V14, P371, DOI 10.1006/prep.1998.0971; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Broudy TB, 2003, INFECT IMMUN, V71, P3782, DOI 10.1128/IAI.71.7.3782-3786.2003; Broudy TB, 2002, INFECT IMMUN, V70, P2805, DOI 10.1128/IAI.70.6.2805-2811.2002; Broudy TB, 2001, INFECT IMMUN, V69, P1440, DOI 10.1128/IAI.69.3.1440-1443.2001; Canchaya C, 2002, VIROLOGY, V302, P245, DOI 10.1006/viro.2002.1570; Elsayed S, 2003, CLIN MICROBIOL INFEC, V9, P869, DOI 10.1046/j.1469-0691.2003.00663.x; Frobisher M, 1927, B JOHNS HOPKINS HOSP, V41, P167; HALPERIN SA, 1987, J INFECT DIS, V155, P253, DOI 10.1093/infdis/155.2.253; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Harrington DJ, 2002, MICROBES INFECT, V4, P501, DOI 10.1016/S1286-4579(02)01565-4; Hynes WL, 2000, FEMS MICROBIOL LETT, V183, P201, DOI 10.1111/j.1574-6968.2000.tb08958.x; HYNES WL, 1995, INFECT IMMUN, V63, P3015, DOI 10.1128/IAI.63.8.3015-3020.1995; Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar R, 2008, PROTEINS, V72, P892, DOI 10.1002/prot.21984; Lindsay AM, 2009, MICROBIOL-SGM, V155, P443, DOI 10.1099/mic.0.020826-0; Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5; Mishra P, 2009, FEBS J, V276, P3392, DOI 10.1111/j.1742-4658.2009.07065.x; PRITCHARD DG, 1994, ARCH BIOCHEM BIOPHYS, V315, P431, DOI 10.1006/abbi.1994.1521; Proft T, 2003, INFECT IMMUN, V71, P1361, DOI 10.1128/IAI.71.3.1361-1369.2003; Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977; Singh SK, 2014, BIOCHIMIE, V102, P203, DOI 10.1016/j.biochi.2014.03.012; Smith NL, 2005, P NATL ACAD SCI USA, V102, P17652, DOI 10.1073/pnas.0504782102; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; STING R, 1990, ZBL BAKT-INT J MED M, V272, P276; SWEENEY CR, 1987, J AM VET MED ASSOC, V191, P1446; Wagner PL, 2002, MOL MICROBIOL, V44, P957, DOI 10.1046/j.1365-2958.2002.02950.x; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Waller AS, 2007, VET J, V173, P492, DOI 10.1016/j.tvjl.2006.05.011	34	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35225	35236		10.1074/jbc.M113.507673	http://dx.doi.org/10.1074/jbc.M113.507673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378402	Green Published, hybrid			2022-12-26	WOS:000346660200016
J	Atta, H; El-Rehany, M; Hammam, O; Abdel-Ghany, H; Ramzy, M; Roderfeld, M; Roeb, E; Al-Hendy, A; Raheim, SA; Allam, H; Marey, H				Atta, Hussein; El-Rehany, Mahmoud; Hammam, Olfat; Abdel-Ghany, Hend; Ramzy, Maggie; Roderfeld, Martin; Roeb, Elke; Al-Hendy, Ayman; Raheim, Salama Abdel; Allam, Hatem; Marey, Heba			Mutant MMP-9 and HGF Gene Transfer Enhance Resolution of CCl4-Induced Liver Fibrosis in Rats: Role of ASH1 and EZH2 Methyltransferases Repression	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; HEPATIC STELLATE CELLS; ACTIVATED RECEPTOR-GAMMA; TISSUE INHIBITOR; MESSENGER-RNA; C-MET; MYOFIBROBLAST TRANSDIFFERENTIATION; INTRAVENOUS-INJECTION; PARTIAL-HEPATECTOMY; IMPROVES SURVIVAL	Hepatocyte growth factor (HGF) gene transfer inhibits liver fibrosis by regulating aberrant cellular functions, while mutant matrix metalloproteinase-9 (mMMP-9) enhances matrix degradation by neutralizing the elevated tissue inhibitor of metalloproteinase-1 (TIMP-1). It was shown that ASH1 and EZH2 methyltransferases are involved in development of liver fibrosis; however, their role in the resolution phase of liver fibrosis has not been investigated. This study evaluated the role of ASH1 and EZH2 in two mechanistically different therapeutic modalities, HGF and mMMP-9 gene transfer in CCl4 induced rat liver fibrosis. Liver fibrosis was induced in rats with twice a week intraperitoneal injection of CCl4 for 8 weeks. Adenovirus vectors encoding mMMP-9 or HGF genes were injected through tail vein at weeks six and seven and were sacrificed one week after the second injection. A healthy animal group was likewise injected with saline to serve as a negative control. Rats treated with mMMP-9 showed significantly lower fibrosis score, less Sirius red stained collagen area, reduced hydroxyproline and ALT concentration, decreased transforming growth factor beta 1 (TGF-beta 1) mRNA and lower labeling indices of alpha smooth muscle actin (alpha-SMA) and proliferating cell nuclear antigen (PCNA) stained cells compared with HGF- or saline-treated rats. Furthermore, TIMP-1 protein expression in mMMP-9 group was markedly reduced compared with all fibrotic groups. ASH1 and EZH2 protein expression was significantly elevated in fibrotic liver and significantly decreased in mMMP-9- and HGF-treated compared to saline-treated fibrotic livers with further reduction in the mMMP-9 group. Conclusion: Gene transfer of mMMP-9 and HGF reduced liver fibrosis in rats. ASH1 and EZH2 methyltransferases are significantly reduced in mMMP-9 and HGF treated rats which underlines the central role of these enzymes during fibrogenesis. Future studies should evaluate the role of selective pharmacologic inhibitors of ASH1 and EZH2 in resolution of liver fibrosis.	[Atta, Hussein] Menia Univ, Fac Med, Dept Surg, El Minia, Egypt; [El-Rehany, Mahmoud; Abdel-Ghany, Hend; Ramzy, Maggie; Raheim, Salama Abdel; Allam, Hatem; Marey, Heba] Menia Univ, Fac Med, Dept Biochem, El Minia, Egypt; [Hammam, Olfat] Theodor Bilharz Res Inst, Dept Pathol, Giza, Egypt; [Roderfeld, Martin; Roeb, Elke] Univ Giessen, Dept Gastroenterol, Giessen, Germany; [Al-Hendy, Ayman] Georgia Regents Univ, Dept Obstet & Gynecol, Augusta, GA USA	Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Theodor Bilharz Research Institute (TBRI); Justus Liebig University Giessen; University System of Georgia; Augusta University	Atta, H (corresponding author), Menia Univ, Fac Med, Dept Surg, El Minia, Egypt.	atta@mu.edu.eg	Atta, Hussein/B-9059-2009; Al-hendy, Ayman/J-9324-2019; Hammam, Olfat/D-4613-2015; , Martin/AHD-5202-2022	Atta, Hussein/0000-0003-1118-8347; Hammam, Olfat/0000-0002-4965-5804; , Martin/0000-0002-3232-1277; abdelraheim, salama/0000-0002-7544-9510; Ramzy, Maggie/0000-0003-3396-2073	Egyptian Science and Technology Fund [1550/2010]; Deutsche Forschungsgemeinschaft [RO 957/7-1, RO 957/8-1]	Egyptian Science and Technology Fund(Science and Technology Development Fund (STDF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Egyptian Science and Technology Fund (1550/2010) to Dr. Hussein Atta and by grants from the Deutsche Forschungsgemeinschaft to Dr. Elke Roeb (RO 957/7-1 and RO 957/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hendy A, 2000, AM J OBSTET GYNECOL, V182, P553, DOI 10.1067/mob.2000.104837; Atta HM, 2009, LIVER INT, V29, P1022, DOI 10.1111/j.1478-3231.2009.02056.x; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; BOROS P, 1995, LANCET, V345, P293, DOI 10.1016/S0140-6736(95)90279-1; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; DErrico A, 1996, HEPATOLOGY, V24, P60, DOI 10.1002/hep.510240112; Esposito C, 2009, GROWTH FACTORS, V27, P173, DOI 10.1080/08977190902834077; FLAUMENHAFT R, 1992, MOL BIOL CELL, V3, P1057, DOI 10.1091/mbc.3.10.1057; FUJIWARA K, 1993, HEPATOLOGY, V18, P1443, DOI 10.1016/0270-9139(93)90237-H; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; HE CJ, 1995, AM J PHYSIOL-CELL PH, V269, pC554, DOI 10.1152/ajpcell.1995.269.3.C554; Inagaki Y, 2008, GASTROENTEROLOGY, V134, P1180, DOI 10.1053/j.gastro.2008.01.014; Inoue H, 2006, INT J MOL MED, V17, P857; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Kim WH, 2005, AM J PATHOL, V166, P1017, DOI 10.1016/S0002-9440(10)62323-1; Kusumoto K, 2006, INT J MOL MED, V17, P503; Lee HS, 2001, HEPATO-GASTROENTEROL, V48, P1114; Li L, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/560345; Liu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053392; Liu WB, 2003, WORLD J GASTROENTERO, V9, P316, DOI 10.3748/wjg.v9.i2.316; Liu YH, 2000, KIDNEY INT, V58, P2028, DOI 10.1046/j.1523-1755.2000.00375.x; Liu YH, 1998, EXP CELL RES, V242, P174, DOI 10.1006/excr.1998.4107; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Matsuda Y, 1997, HEPATOLOGY, V26, P81; Mizuno S, 2011, CLIN EXP PHARMACOL P, V38, P192, DOI 10.1111/j.1440-1681.2011.05483.x; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; MURPHY G, 1994, ANN NY ACAD SCI, V732, P31, DOI 10.1111/j.1749-6632.1994.tb24722.x; Nishino M, 2008, SURGERY, V144, P374, DOI 10.1016/j.surg.2008.04.011; Nomi T, 2000, BIOCHEM BIOPH RES CO, V278, P338, DOI 10.1006/bbrc.2000.3793; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; Oe H, 2004, HEPATO-GASTROENTEROL, V51, P1641; Ozawa S, 2006, SURGERY, V139, P563, DOI 10.1016/j.surg.2005.10.003; Parsons CJ, 2004, HEPATOLOGY, V40, P1106, DOI 10.1002/hep.20425; Perugorria MJ, 2012, HEPATOLOGY, V56, P1129, DOI 10.1002/hep.25754; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Phaneuf D, 2000, MOL MED, V6, P96, DOI 10.1007/BF03401777; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Prosser CC, 2006, WORLD J GASTROENTERO, V12, P509, DOI 10.3748/wjg.v12.i4.509; Rampino T, 2001, AM J PATHOL, V159, P1275, DOI 10.1016/S0002-9440(10)62514-X; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Roeb E, 2000, FASEB J, V14, P1671; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Seto S, 1998, J SURG RES, V80, P194, DOI 10.1006/jsre.1998.5472; TAKAHARA T, 1995, HEPATOLOGY, V21, P787; TASHIRO K, 1990, P NATL ACAD SCI USA, V87, P3200, DOI 10.1073/pnas.87.8.3200; Tsochatzis EA, 2012, HEPATOLOGY, V56, P1983, DOI 10.1002/hep.25915; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Ueno M, 2007, SURGERY, V141, P511, DOI 10.1016/j.surg.2006.10.006; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Xie GH, 2013, AM J PHYSIOL-GASTR L, V305, pG881, DOI 10.1152/ajpgi.00289.2013; Yang MD, 2012, HEPATOLOGY, V55, P1271, DOI 10.1002/hep.24792; Yasuda H, 1996, HEPATOLOGY, V24, P636, DOI 10.1002/hep.510240328; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625; Yu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074870; Zeybel M, 2013, J HEPATOL, V59, P1349, DOI 10.1016/j.jhep.2013.05.039	60	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112384	10.1371/journal.pone.0112384	http://dx.doi.org/10.1371/journal.pone.0112384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380300	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100081
J	Salloum-Asfar, S; Teruel-Montoya, R; Arroyo, AB; Garcia-Barbera, N; Chaudhry, A; Schuetz, E; Luengo-Gil, G; Vicente, V; Gonzalez-Conejero, R; Martinez, C				Salloum-Asfar, Salam; Teruel-Montoya, Raul; Arroyo, Ana B.; Garcia-Barbera, Nuria; Chaudhry, Amarjit; Schuetz, Erin; Luengo-Gil, Gines; Vicente, Vicente; Gonzalez-Conejero, Rocio; Martinez, Constantino			Regulation of Coagulation Factor XI Expression by MicroRNAs in the Human Liver	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; MESSENGER-RNAS; TARGETS; GENE; HEMOSTASIS; INHIBITION; PREDICTION; SURVIVAL; SEPSIS; RISK	High levels of factor XI (FXI) increase the risk of thromboembolic disease. However, the genetic and environmental factors regulating FXI expression are still largely unknown. The aim of our study was to evaluate the regulation of FXI by microRNAs (miRNAs) in the human liver. In silico prediction yielded four miRNA candidates that might regulate FXI expression. HepG2 cells were transfected with miR-181a-5p, miR-23a-3p, miR-16-5p and miR-195-5p. We used mir-494, which was not predicted to bind to F11, as a negative control. Only miR-181a-5p caused a significant decrease both in FXI protein and F11 mRNA levels. In addition, transfection with a miR-181a-5p inhibitor in PLC/PRF/5 hepatic cells increased both the levels of F11 mRNA and extracellular FXI. Luciferase assays in human colon cancer cells deficient for Dicer (HCT-DK) demonstrated a direct interaction between miR-181a-5p and 39untranslated region of F11. Additionally, F11 mRNA levels were inversely and significantly correlated with miR-181a-5p levels in 114 healthy livers, but not with miR-494. This study demonstrates that FXI expression is directly regulated by a specific miRNA, miR-181a-5p, in the human liver. Future studies are necessary to further investigate the potential consequences of miRNA dysregulation in pathologies involving FXI.	[Salloum-Asfar, Salam; Teruel-Montoya, Raul; Arroyo, Ana B.; Garcia-Barbera, Nuria; Luengo-Gil, Gines; Vicente, Vicente; Gonzalez-Conejero, Rocio; Martinez, Constantino] Univ Murcia, Ctr Reg Hemodonac, Inst Murciano Invest Biosanitaria Virgen Arrixaca, Murcia, Spain; [Chaudhry, Amarjit; Schuetz, Erin] St Jude Childrens Res Hosp, Dept Pharmacol, Memphis, TN 38105 USA	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; St Jude Children's Research Hospital	Gonzalez-Conejero, R (corresponding author), Univ Murcia, Ctr Reg Hemodonac, Inst Murciano Invest Biosanitaria Virgen Arrixaca, Murcia, Spain.	rocio.gonzalez@carm.es; constant@um.es	Martinez, Constantino/R-8972-2019; Luengo-Gil, Ginés/AAB-6780-2019; Rodríguez, Ana Belén Arroyo/AAF-4759-2021; Salloum-Asfar, Salam/AAQ-4772-2021; Vicente, Vicente/L-6185-2019; Teruel-Montoya, Raúl/H-9012-2017; Gonzalez-Conejero, Rocio/H-9254-2017	Luengo-Gil, Ginés/0000-0001-9940-0415; Rodríguez, Ana Belén Arroyo/0000-0002-0150-2331; Salloum-Asfar, Salam/0000-0002-8357-2180; Vicente, Vicente/0000-0002-4278-3264; Teruel-Montoya, Raúl/0000-0002-6741-9725; Gonzalez-Conejero, Rocio/0000-0002-4772-9822; Martinez, Constantino/0000-0002-2976-2354	Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER) [PI11/00566]; Instituto de Salud Carlos III, Red RIC [RD12/0042/0050]; NIH/NIGMS [R01 GM094418]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094418] Funding Source: NIH RePORTER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Instituto de Salud Carlos III, Red RIC; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) [PI11/00566]: CMG, RT-M, NG-B, Instituto de Salud Carlos III, Red RIC (RD12/0042/0050): W, RG-C, CM and NIH/NIGMS R01 GM094418: AC, ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2012, LEUKEMIA, V26, P395, DOI 10.1038/leu.2011.344; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Chen ZY, 2010, HUM GENET, V128, P443, DOI 10.1007/s00439-010-0866-8; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He R, 2012, THROMB RES, V129, P541, DOI 10.1016/j.thromres.2011.11.051; Itakura A, 2011, J LEUKOCYTE BIOL, V90, P923, DOI 10.1189/jlb.0411182; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lamba V, 2010, J PHARMACOL EXP THER, V332, P1088, DOI 10.1124/jpet.109.160804; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marchand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044532; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Muller F, 2011, CURR OPIN HEMATOL, V18, P349, DOI 10.1097/MOH.0b013e3283497e61; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Perez-Andreu V, 2012, MOL MED, V18, P1466, DOI 10.2119/molmed.2012.00062; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; ROSENTHAL RL, 1953, P SOC EXP BIOL MED, V82, P171; Saba R, 2012, MOL CELL BIOL, V32, P619, DOI 10.1128/MCB.05896-11; Sabater-Lleal M, 2012, ARTERIOSCL THROM VAS, V32, P2008, DOI 10.1161/ATVBAHA.112.248492; Salomon O, 2011, THROMB HAEMOSTASIS, V105, P269, DOI 10.1160/TH10-05-0307; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Seligsohn U, 2007, THROMB HAEMOSTASIS, V98, P84, DOI 10.1160/Th07-04-0246; Tay JW, 2013, J THROMB HAEMOST, V11, P1547, DOI 10.1111/jth.12331; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Teruel R, 2011, J THROMB HAEMOST, V9, P1985, DOI 10.1111/j.1538-7836.2011.04451.x; Teruel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017648; Tucker EI, 2008, J INFECT DIS, V198, P271, DOI 10.1086/589514; Tucker EI, 2012, BLOOD, V119, P4762, DOI 10.1182/blood-2011-10-386185; Vlieg AV, 2003, J THROMB HAEMOST, V1, P516, DOI 10.1046/j.1538-7836.2003.00080.x; Whichard ZL, 2011, J BIOL CHEM, V286, P4742, DOI 10.1074/jbc.M110.166348; Witkos TM, 2011, CURR MOL MED, V11, P93; Zhang H, 2010, BLOOD, V116, P4684, DOI 10.1182/blood-2010-04-277798	44	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111713	10.1371/journal.pone.0111713	http://dx.doi.org/10.1371/journal.pone.0111713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379760	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100039
J	Tseng, YR; Wu, JF; Kong, MS; Hu, FC; Yang, YJ; Yeung, CY; Huang, FC; Huang, IF; Ni, YH; Hsu, HY; Chang, MH; Chen, HL				Tseng, Yu-Ru; Wu, Jia-Feng; Kong, Man-Shan; Hu, Fu-Chang; Yang, Yao-Jong; Yeung, Chun-Yan; Huang, Fu-Chen; Huang, I-Fei; Ni, Yen-Hsuan; Hsu, Hong-Yuan; Chang, Mei-Hwei; Chen, Huey-Ling			Infantile Hepatitis B in Immunized Children: Risk for Fulminant Hepatitis and Long-Term Outcomes	PLOS ONE			English	Article							E-ANTIGEN SEROCONVERSION; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; MASS VACCINATION; VIRAL-HEPATITIS; PRECORE REGION; UNITED-STATES; TAIWAN; PROGRAM; HBV	Background: Infantile hepatitis B after neonatal immunoprophylaxis is a rare yet distinct disease. This study aimed to analyze the long-term outcomes and risk factors in immunized infants with hepatitis B. Methods: The clinical parameters and outcomes of 41 infants born after universal immunization, and admitted for HBV-positive hepatitis were studied. All patients were followed for at least 6 months (median = 4.4 years, range 0.6-18.1 years). Patient survival, changes of HBsAg and HBeAg status, and complications were analyzed. Results: Among the 41 cases (32 males, 9 females), 21 presented with fulminant hepatitis (FH), and 20 with non-fulminant hepatitis (NFH). Ninety-five percent (36/38) of the mothers were positive for hepatitis B surface antigen (HBsAg). Multivariate analyses revealed younger age of onset (age <7 months) and negative maternal hepatitis B e antigen (HBeAg) were associated with FH (p = 0.03 and p = 0.01, respectively). An infantile fulminant hepatitis B risk score using maternal/infant HBeAg positivity and onset age was proposed. Among the FH cases, the rate of mortality, HBsAg clearance, and chronic HBV infection were 47.6%, 38.1%, and 14.3%, respectively. Among the NFH cases, 35% developed chronic infection. Of the 9 chronically infected children received long-term follow-up, 8 had HBeAg seroconversion before 4 years of age. One case of FH developed hepatocellular carcinoma 14 years later. Conclusions: Maternal HBsAg + /HBeAg-and early onset age were risk factors for FH in immunized infants. A significant portion of patients with FH or NFH evolve to chronic HBV infection, with HBeAg seroconversion in young childhood. Close surveillance for hepatocellular carcinoma is warranted in patients surviving infantile hepatitis B.	[Tseng, Yu-Ru; Wu, Jia-Feng; Ni, Yen-Hsuan; Hsu, Hong-Yuan; Chang, Mei-Hwei; Chen, Huey-Ling] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Kong, Man-Shan] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Hu, Fu-Chang] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Yang, Yao-Jong] Natl Cheng Kung Univ & Hosp, Coll Med, Inst Clin Med, Dept Pediat, Tainan, Taiwan; [Yeung, Chun-Yan] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Huang, Fu-Chen] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Pediat, Kaohsiung, Taiwan; [Huang, I-Fei] Vet Gen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Hsu, Hong-Yuan; Chen, Huey-Ling] Natl Taiwan Univ, Coll Med, Dept Med Educ & Bioeth, Taipei 10764, Taiwan; [Chang, Mei-Hwei; Chen, Huey-Ling] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Mackay Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chen, HL (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	hueyling@ntu.edu.tw	Wu, Jia-Feng/H-8125-2019	Wu, Jia-Feng/0000-0001-6343-1658; Hsu, Hong-Yuan/0000-0002-5720-4835; Chang, Mei Hwei/0000-0002-3648-9261; Ni, Yen-Hsuan/0000-0002-1158-5249	Center of Disease Control, Ministry of Health and Welfare, Taiwan [DOH-99-DC-1001]	Center of Disease Control, Ministry of Health and Welfare, Taiwan	The study was supported by grants from the Center of Disease Control, Ministry of Health and Welfare, Taiwan (DOH-99-DC-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley RP, 2009, ANN EPIDEMIOL, V19, P231, DOI 10.1016/j.annepidem.2009.01.017; BEASLEY RP, 1982, J INFECT DIS, V146, P198, DOI 10.1093/infdis/146.2.198; BORTOLOTTI F, 1986, INFECTION, V14, P64, DOI 10.1007/BF01644444; Cacciola I, 2002, J HEPATOL, V36, P426, DOI 10.1016/S0168-8278(01)00295-1; Chang MH, 2010, CLIN LIVER DIS, V14, P521, DOI 10.1016/j.cld.2010.05.010; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; CHANG MH, 1995, HEPATOLOGY, V22, P1387, DOI 10.1016/0270-9139(95)90141-8; Chang MH, 2005, CLIN CANCER RES, V11, P7953, DOI 10.1158/1078-0432.CCR-05-1095; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; CHANG MH, 1987, J PEDIATR-US, V111, P34, DOI 10.1016/S0022-3476(87)80338-4; CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; Chen HL, 2004, HEPATOLOGY, V39, P58, DOI 10.1002/hep.20006; Chen HL, 2012, GASTROENTEROLOGY, V142, P773, DOI 10.1053/j.gastro.2011.12.035; Chen SCC, 2013, PEDIATRICS, V131, pE1135, DOI 10.1542/peds.2012-1262; DUPUY JM, 1975, LANCET, V1, P191; FORTUIN M, 1993, LANCET, V341, P1129, DOI 10.1016/0140-6736(93)93137-P; Friedt M, 1999, HEPATOLOGY, V29, P1252, DOI 10.1002/hep.510290418; Haber BA, 2009, PEDIATRICS, V124, pE1007, DOI 10.1542/peds.2009-0567; HSU HY, 1992, HEPATOLOGY, V15, P770, DOI 10.1002/hep.1840150505; HSU HY, 1995, J INFECT DIS, V171, P776, DOI 10.1093/infdis/171.4.776; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Kellerman SE, 2003, J INFECT DIS, V188, P571, DOI 10.1086/377135; LIANG TJ, 1994, J CLIN INVEST, V93, P550, DOI 10.1172/JCI117006; Liaw YF, 2010, DIGEST DIS SCI, V55, P2727, DOI 10.1007/s10620-010-1179-4; LOK ASF, 1985, J HEPATOL, V1, P671, DOI 10.1016/S0168-8278(85)80010-6; McMahon BJ, 2011, HEPATOLOGY, V54, P801, DOI 10.1002/hep.24442; Mu SC, 2009, J HEPATOL, V50, P264, DOI 10.1016/j.jhep.2008.09.017; Ni YH, 2007, GASTROENTEROLOGY, V132, P2340, DOI 10.1053/j.gastro.2007.03.111; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; OMATA M, 1991, NEW ENGL J MED, V324, P1699, DOI 10.1056/NEJM199106133242404; Pollicino T, 1997, HEPATOLOGY, V26, P495, DOI 10.1002/hep.510260235; ROSH JR, 1994, ARCH PEDIAT ADOL MED, V148, P1349, DOI 10.1001/archpedi.1994.02170120111024; Squires RH, 2006, J PEDIATR-US, V148, P652, DOI 10.1016/j.jpeds.2005.12.051; Su WJ, 2012, J INFECT DIS, V205, P757, DOI 10.1093/infdis/jir852; Wasley Annemarie, 2007, MMWR Surveill Summ, V56, P1; Wen WH, 2004, J PEDIATR-US, V144, P397, DOI 10.1016/j.jpeds.2003.11.022; Wirth S, 2002, J PEDIATR GASTR NUTR, V34, P77, DOI 10.1097/00005176-200201000-00018	39	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111825	10.1371/journal.pone.0111825	http://dx.doi.org/10.1371/journal.pone.0111825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380075	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100042
J	Zhang, WW; Tian, DK; Huang, X; Xu, YX; Mo, HB; Liu, YB; Meng, J; Zhang, DS				Zhang, Weiwei; Tian, Daike; Huang, Xiu; Xu, Yuxian; Mo, Haibo; Liu, Yanbo; Meng, Jing; Zhang, Dasheng			Characterization of Flower-Bud Transcriptome and Development of Genic SSR Markers in Asian Lotus (Nelumbo nucifera Gaertn.)	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; EST-DERIVED SSR; SACRED LOTUS; MICROSATELLITE MARKERS; GENETIC DIVERSITY; CD-HIT; L.; DISCOVERY; DNA; GENOMICS	Background: Asian lotus (Nelumbo nucifera Gaertn.) is the national flower of India, Vietnam, and one of the top ten traditional Chinese flowers. Although lotus is highly valued for its ornamental, economic and cultural uses, genomic information, particularly the expressed sequence based (genic) markers is limited. High-throughput transcriptome sequencing provides large amounts of transcriptome data for promoting gene discovery and development of molecular markers. Results: In this study, 68,593 unigenes were assembled from 1.34 million 454 GS-FLX sequence reads of a mixed flower-bud cDNA pool derived from three accessions of N. nucifera. A total of 5,226 SSR loci were identified, and 3,059 primer pairs were designed for marker development. Di-nucleotide repeat motifs were the most abundant type identified with a frequency of 65.2%, followed by tri- (31.7%), tetra- (2.1%), penta- (0.5%) and hexa-nucleotide repeats (0.5%). A total of 575 primer pairs were synthesized, of which 514 (89.4%) yielded PCR amplification products. In eight Nelumbo accessions, 109 markers were polymorphic. They were used to genotype a sample of 44 accessions representing diverse wild and cultivated genotypes of Nelumbo. The number of alleles per locus varied from 2 to 9 alleles and the polymorphism information content values ranged from 0.6 to 0.9. We performed genetic diversity analysis using 109 polymorphic markers. A UPGMA dendrogram was constructed based on Jaccard's similarity coefficients revealing distinct clusters among the 44 accessions. Conclusions: Deep transcriptome sequencing of lotus flower buds developed 3,059 genic SSRs, making a significant addition to the existing SSR markers in lotus. Among them, 109 polymorphic markers were successfully validated in 44 accessions of Nelumbo. This comprehensive set of genic SSR markers developed in our study will facilitate analyses of genetic diversity, construction of linkage maps, gene mapping, and marker-assisted selection breeding for lotus.	[Zhang, Weiwei; Tian, Daike; Huang, Xiu; Xu, Yuxian; Mo, Haibo; Liu, Yanbo; Meng, Jing; Zhang, Dasheng] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Chenshan Bot Garden, Shanghai, Peoples R China; [Xu, Yuxian] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China; [Liu, Yanbo] Northeast Agr Univ, Coll Hort, Harbin, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Normal University; Northeast Agricultural University - China	Tian, DK (corresponding author), Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Chenshan Bot Garden, Shanghai, Peoples R China.	dktian@sibs.ac.cn			Special Fund for Shanghai Landscaping Administration Bureau Program [F112421]	Special Fund for Shanghai Landscaping Administration Bureau Program	This work was supported by the Special Fund for Shanghai Landscaping Administration Bureau Program (grant No. F112421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; Chen YY, 2008, AQUAT BOT, V89, P311, DOI 10.1016/j.aquabot.2008.03.006; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Diao Y, 2006, CARYOLOGIA, V59, P25, DOI 10.1080/00087114.2006.10797894; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; Fu J, 2011, J AM SOC HORTIC SCI, V136, P339, DOI 10.21273/JASHS.136.5.339; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hu JH, 2012, MOL BIOL REP, V39, P3637, DOI 10.1007/s11033-011-1138-y; Huang X. Q., 1992, Acta Horticulturae Sinica, V19, P164; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kubo Nakao, 2009, Plant Genetic Resources Characterization and Utilization, V7, P260, DOI 10.1017/S1479262109356580; Kubo N, 2009, AQUAT BOT, V90, P191, DOI 10.1016/j.aquabot.2008.06.006; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li S, 2004, BIOINFORMATICS, V20, P2865, DOI 10.1093/bioinformatics/bth302; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Z, 2010, SCI HORTIC-AMSTERDAM, V125, P724, DOI 10.1016/j.scienta.2010.05.005; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Liu YL, 2012, J AM SOC HORTIC SCI, V137, P180; Lu FH, 2012, MOL BIOL REP, V39, P3327, DOI 10.1007/s11033-011-1102-x; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Niu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-263; Pan L, 2011, ANN APPL BIOL, V159, P428, DOI 10.1111/j.1744-7348.2011.00509.x; Pan L, 2007, MOL ECOL NOTES, V7, P1054, DOI 10.1111/j.1471-8286.2007.01774.x; Pan L, 2010, J HERED, V101, P71, DOI 10.1093/jhered/esp070; Parra-Gonzalez LB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-425; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Raju NL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-45; Rolf J, 2000, NUMERICAL TAXONOMY M; Rozen S, 2000, Methods Mol Biol, V132, P365; Shen-Miller J, 2002, SEED SCI RES, V12, P131, DOI 10.1079/SSR2002112; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tanase K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-292; Tian HL, 2008, CONSERV GENET, V9, P1385, DOI 10.1007/s10592-007-9503-z; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; VanBuren R, 2013, PLANT OMICS, V6, P311; Varshney RK, 2006, THEOR APPL GENET, V113, P239, DOI 10.1007/s00122-006-0289-z; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Vendramin E, 2007, MOL ECOL NOTES, V7, P307, DOI 10.1111/j.1471-8286.2006.01590.x; Wang Q, 2005, COLORED ILLUSTRATION; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Yang M, 2014, ANN APPL BIOL, V165, P73, DOI 10.1111/aab.12119; Yang M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-653; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang X., 2011, NEW LOTUS FLOWER CUL; Zheng XF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-490; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	70	15	22	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112223	10.1371/journal.pone.0112223	http://dx.doi.org/10.1371/journal.pone.0112223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379700	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100065
J	Gaskell, KM; Rothe, C; Gnanadurai, R; Goodson, P; Jassi, C; Heyderman, RS; Allain, TJ; Harrison, TS; Lalloo, DG; Sloan, DJ; Feasey, NA				Gaskell, Katherine M.; Rothe, Camilla; Gnanadurai, Roshina; Goodson, Patrick; Jassi, Chikondi; Heyderman, Robert S.; Allain, Theresa J.; Harrison, Thomas S.; Lalloo, David G.; Sloan, Derek J.; Feasey, Nicholas A.			A Prospective Study of Mortality from Cryptococcal Meningitis following Treatment Induction with 1200mg Oral Fluconazole in Blantyre, Malawi	PLOS ONE			English	Article							THERAPY; ANTIGEN; MANAGEMENT	Objective: We have previously reported high ten-week mortality from cryptococcal meningitis in Malawian adults following treatment-induction with 800mg oral fluconazole (57% [33/58]). National guidelines in Malawi and other African countries now advocate an increased induction dose of 1200mg. We assessed whether this has improved outcomes. Design: This was a prospective observational study of HIV-infected adults with cryptococcal meningitis confirmed by diagnostic lumbar puncture. Treatment was with fluconazole 1200mg/day for two weeks then 400mg/day for 8 weeks. Mortality within the first 10 weeks was the study end-point, and current results were compared with data from our prior patient cohort who started on fluconazole 800mg/day. Results: 47 participants received fluconazole monotherapy. Despite a treatment-induction dose of 1200mg, ten-week mortality remained 55% (26/47). This was no better than our previous study (Hazard Ratio [HR] of death on 1200mg vs. 800mg fluconazole: 1.29 (95% CI: 0.77-2.16, p = 0.332)). There was some evidence for improved survival in patients who had repeat lumbar punctures during early therapy to lower intracranial pressure (HR: 0.27 [95% CI: 0.07-1.03, p = 0.055]). Conclusion: There remains an urgent need to identify more effective, affordable and deliverable regimens for cryptococcal meningitis.	[Gaskell, Katherine M.; Goodson, Patrick; Jassi, Chikondi; Heyderman, Robert S.; Lalloo, David G.; Sloan, Derek J.; Feasey, Nicholas A.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Gaskell, Katherine M.; Heyderman, Robert S.; Lalloo, David G.; Sloan, Derek J.; Feasey, Nicholas A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Rothe, Camilla; Gnanadurai, Roshina; Goodson, Patrick; Allain, Theresa J.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Rothe, Camilla; Gnanadurai, Roshina; Goodson, Patrick; Allain, Theresa J.] Queen Elizabeth Cent Hosp, Minist Hlth, Blantyre, Malawi; [Harrison, Thomas S.] Univ London, Infect & Immun Res Ctr, St Georges Med Sch, London, England; [Sloan, Derek J.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Malawi; St Georges University London; University of London; Liverpool Heart & Chest Hospital	Gaskell, KM (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	kmgaskell@doctors.org.uk	Gnanadurai, Roshina/ABC-2771-2021	Sloan, Derek James/0000-0002-7888-5449; Harrison, Thomas/0000-0003-3619-4348; Feasey, Nicholas/0000-0003-4041-1405; Lalloo, David/0000-0001-7680-2200; Gaskell, Katherine M/0000-0003-4691-6359; Heyderman, Robert/0000-0003-4573-449X	Wellcome Trust Core Award [084679/Z/08/Z]; Medical Research Council [G1100814] Funding Source: researchfish; National Institute for Health Research [ACF-2014-20-001] Funding Source: researchfish; MRC [G1100814] Funding Source: UKRI	Wellcome Trust Core Award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	There was no specific funding for this research. However MLW is supported by Wellcome Trust Core Award 084679/Z/08/Z. The Wellcome trust had no role in the development of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; de Vedia L, 2013, INFECTION, V41, P1073, DOI 10.1007/s15010-013-0538-4; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Jarvis JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069288; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Loyse A, 2013, LANCET INFECT DIS, V13, P629, DOI 10.1016/S1473-3099(13)70078-1; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; MOH, 2011, CLIN MAN HIV CHILDR; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Rothe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067311; Rugemalila J, 2013, TROP MED INT HEALTH, V18, P1075, DOI 10.1111/tmi.12157; Sloan DJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-490; Sudan A, 2013, ANTIMICROB AGENTS CH, V57, P2793, DOI 10.1128/AAC.00216-13; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Wall EC ED, 2014, CID IN PRESS; Wijewardana I, 2011, J INFECTION, V63, P484, DOI 10.1016/j.jinf.2011.09.002	17	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110285	10.1371/journal.pone.0110285	http://dx.doi.org/10.1371/journal.pone.0110285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375145	Green Accepted, gold, Green Published			2022-12-26	WOS:000344402600009
J	Liberio, MS; Sadowski, MC; Soekmadji, C; Davis, RA; Nelson, CC				Liberio, Michelle S.; Sadowski, Martin C.; Soekmadji, Carolina; Davis, Rohan A.; Nelson, Colleen C.			Differential Effects of Tissue Culture Coating Substrates on Prostate Cancer Cell Adherence, Morphology and Behavior	PLOS ONE			English	Article							ADHESION; FIBRONECTIN; PROLIFERATION; EXPRESSION; FILOPODIA; GROWTH; LNCAP; APOPTOSIS; GENES; TUMOR	Weak cell-surface adhesion of cell lines to tissue culture surfaces is a common problem and presents technical limitations to the design of experiments. To overcome this problem, various surface coating protocols have been developed. However, a comparative and precise real-time measurement of their impact on cell behavior has not been conducted. The prostate cancer cell line LNCaP, derived from a patient lymph node metastasis, is a commonly used model system in prostate cancer research. However, the cells' characteristically weak attachment to the surface of tissue culture vessels and cover slips has impeded their manipulation and analysis and use in high throughput screening. To improve the adherence of LNCaP cells to the culture surface, we compared different coating reagents (poly-L-lysine, poly-L-ornithine, collagen type IV, fibronectin, and laminin) and culturing conditions and analyzed their impact on cell proliferation, adhesion, morphology, mobility and gene expression using real-time technologies. The results showed that fibronectin, poly-L-lysine and poly-L-ornithine improved LNCaP cells adherence and provoked cell morphology alterations, such as increase of nuclear and cellular area. These coating reagents also induced a higher expression of F-actin and reduced cell mobility. In contrast, laminin and collagen type IV did not improve adherence but promoted cell aggregation and affected cell morphology. Cells cultured in the presence of laminin displayed higher mobility than control cells. All the coating conditions significantly affected cell viability; however, they did not affect the expression of androgen receptor-regulated genes. Our comparative findings provide important insight for the selection of the ideal coating reagent and culture conditions for the cancer cell lines with respect to their effect on proliferation rate, attachment, morphology, migration, transcriptional response and cellular cytoskeleton arrangement.	[Liberio, Michelle S.; Davis, Rohan A.] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld 4111, Australia; [Liberio, Michelle S.; Sadowski, Martin C.; Soekmadji, Carolina; Nelson, Colleen C.] Queensland Univ Technol, Princess Alexandra Hosp, Australian Prostate Canc Res Ctr Queensland, Translat Res Inst,Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Griffith University; Queensland University of Technology (QUT)	Nelson, CC (corresponding author), Queensland Univ Technol, Princess Alexandra Hosp, Australian Prostate Canc Res Ctr Queensland, Translat Res Inst,Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	colleen.nelson@qut.edu.au	Soekmadji, Carolina/M-2757-2016; Davis, Rohan A/B-1689-2008	Soekmadji, Carolina/0000-0002-6920-6627; Davis, Rohan A/0000-0003-4291-7573; Sadowski, Martin/0000-0002-5267-1442	Eskitis Institute Griffith University; Australian Prostate Cancer Research Centre-Queensland through the Australian Government Department of Health	Eskitis Institute Griffith University; Australian Prostate Cancer Research Centre-Queensland through the Australian Government Department of Health(Australian Government)	Funding for the study was provided by Eskitis Institute Griffith University and the Australian Prostate Cancer Research Centre-Queensland through funding from the Australian Government Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Atienzar FA, 2011, J BIOMOL SCREEN, V16, P575, DOI 10.1177/1087057111402825; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Collection ATC, 2012, NCIPBCFCRL1740 LNCAP, P24; Cordes N, 2003, INT J RADIAT BIOL, V79, P709, DOI 10.1080/09553000310001610240; Cross SS, 2008, DIAGN PATHOL, V14, P134; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Darrabie MD, 2005, BIOMATERIALS, V26, P6846, DOI 10.1016/j.biomaterials.2005.05.009; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; DIKE LE, 1988, P NATL ACAD SCI USA, V85, P6792, DOI 10.1073/pnas.85.18.6792; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021; Heng BC, 2010, BIOINTERPHASES, V5, pFA53, DOI 10.1116/1.3483218; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579; Jokhadar SZ, 2007, CELL BIOL INT, V31, P1097, DOI 10.1016/j.cellbi.2007.03.019; Kariya Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035546; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim IY, 2002, CANCER RES, V62, P3649; Knudsen BS, 2006, J CELL BIOCHEM, V99, P345, DOI 10.1002/jcb.20934; Kurz A, 1996, J CELL BIOL, V135, P1195, DOI 10.1083/jcb.135.5.1195; LABATROBERT J, 1990, FEBS LETT, V268, P386, DOI 10.1016/0014-5793(90)81291-U; Longhurst CM, 1998, CELL MOL LIFE SCI, V54, P514, DOI 10.1007/s000180050180; LYDON MJ, 1981, EXP CELL RES, V135, P347, DOI 10.1016/0014-4827(81)90170-1; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McHardy LM, 2005, MOL CANCER THER, V4, P772, DOI 10.1158/1535-7163.MCT-04-0310; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Morgan M, 2000, UROL ONCOL, V5, P155, DOI 10.1016/S1078-1439(99)00058-7; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Page K, 1997, J BIOL CHEM, V272, P19339, DOI 10.1074/jbc.272.31.19339; Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069; PARSONS TJ, 1983, ARTERIOSCLEROSIS, V3, P589, DOI 10.1161/01.ATV.3.6.589; Pegueroles M, 2011, J MATER SCI-MATER M, V22, P617, DOI 10.1007/s10856-011-4229-3; Ragetly G, 2010, ACTA BIOMATER, V6, P3988, DOI 10.1016/j.actbio.2010.05.016; Saltzman W.M., 2000, PRINCIPLES TISSUE EN, P995; Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Science RA, 2010, XCELLIGENCE SYSTEM R; Sieh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040217; Sottile J, 1998, J CELL SCI, V111, P2933; Strauss S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053309; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Vergani L, 2004, INT J BIOCHEM CELL B, V36, P1447, DOI 10.1016/j.biocel.2003.11.015; Vleggeert-Lankamp CLAM, 2004, BIOMATERIALS, V25, P2741, DOI 10.1016/j.biomaterials.2003.09.067; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	50	64	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112122	10.1371/journal.pone.0112122	http://dx.doi.org/10.1371/journal.pone.0112122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375165	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600108
J	Suwanpradid, J; Rojas, M; Behzadian, MA; Caldwell, RW; Caldwell, RB				Suwanpradid, Jutamas; Rojas, Modesto; Behzadian, M. Ali; Caldwell, R. William; Caldwell, Ruth B.			Arginase 2 Deficiency Prevents Oxidative Stress and Limits Hyperoxia-Induced Retinal Vascular Degeneration	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; NITRIC-OXIDE; HORIZONTAL CELLS; ENDOTHELIAL DYSFUNCTION; ISCHEMIC RETINOPATHY; MOUSE MODEL; PEROXYNITRITE; SUPEROXIDE; METABOLISM; MICE	Background: Hyperoxia exposure of premature infants causes obliteration of the immature retinal microvessels, leading to a condition of proliferative vitreoretinal neovascularization termed retinopathy of prematurity (ROP). Previous work has demonstrated that the hyperoxia-induced vascular injury is mediated by dysfunction of endothelial nitric oxide synthase resulting in peroxynitrite formation. This study was undertaken to determine the involvement of the ureahydrolase enzyme arginase in this pathology. Methods and Findings: Studies were performed using hyperoxia-treated bovine retinal endothelial cells (BRE) and mice with oxygen-induced retinopathy (OIR) as experimental models of ROP. Treatment with the specific arginase inhibitor 2(S)-amino- 6-boronohexanoic acid (ABH) prevented hyperoxia-induced apoptosis of BRE cells and reduced vaso-obliteration in the OIR model. Furthermore, deletion of the arginase 2 gene protected against hyperoxia-induced vaso-obliteration, enhanced physiological vascular repair, and reduced retinal neovascularization in the OIR model. Additional deletion of one copy of arginase 1 did not improve the vascular pathology. Analyses of peroxynitrite by quantitation of its biomarker nitrotyrosine, superoxide by dihydroethidium imaging and NO formation by diaminofluoroscein imaging showed that the protective actions of arginase 2 deletion were associated with blockade of superoxide and peroxynitrite formation and normalization of NOS activity. Conclusions: Our data demonstrate the involvement of arginase activity and arginase 2 expression in hyperoxia-induced vascular injury. Arginase 2 deletion prevents hyperoxia-induced retinal vascular injury by preventing NOS uncoupling resulting in decreased reactive oxygen species formation and increased nitric oxide bioavailability.	[Suwanpradid, Jutamas; Rojas, Modesto; Behzadian, M. Ali; Caldwell, Ruth B.] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30901 USA; [Suwanpradid, Jutamas; Rojas, Modesto; Caldwell, R. William; Caldwell, Ruth B.] Georgia Regents Univ, Culver Vis Discovery Inst, Augusta, GA USA; [Rojas, Modesto; Caldwell, R. William] Georgia Regents Univ, Dept Cellular Biol & Anat, Dept Pharmacol & Toxicol, Augusta, GA USA; [Caldwell, Ruth B.] Charlie Norwood VA Med Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Caldwell, RB (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30901 USA.	rcaldwel@gru.edu	Suwanpradid, Jutamas/K-5799-2019	Rojas, Modesto/0000-0002-9441-3302; Caldwell, Ruth/0000-0003-0168-0354	National Institutes of Health (NIH) [R01-EY11766]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [BX001233]; Culver Vision Discovery Institute at Georgia Regents University; NATIONAL EYE INSTITUTE [R01EY011766] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001233] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); Culver Vision Discovery Institute at Georgia Regents University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported in part by grants from National Institutes of Health (NIH grant R01-EY11766), the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (BX001233), and the Culver Vision Discovery Institute at Georgia Regents University. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NKM, 2012, NEONATOLOGY, V101, P106, DOI 10.1159/000329540; [Anonymous], 2013, PREM BAB; ASHTON N, 1954, BRIT J OPHTHALMOL, V38, P397, DOI 10.1136/bjo.38.7.397; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Brooks SE, 1998, CURR EYE RES, V17, P875, DOI 10.1076/ceyr.17.9.875.5134; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Chandra S, 2012, BRIT J PHARMACOL, V165, P506, DOI 10.1111/j.1476-5381.2011.01584.x; Christianson DW, 2005, ACCOUNTS CHEM RES, V38, P191, DOI 10.1021/ar040183k; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Deignan JL, 2006, MOL GENET METAB, V89, P87, DOI 10.1016/j.ymgme.2006.04.007; Durante W, 2001, CIRCULATION, V103, P1121, DOI 10.1161/01.CIR.103.8.1121; Edgar K, 2012, INVEST OPHTH VIS SCI, V53, P6833, DOI 10.1167/iovs.12-9797; Elms SC, 2013, DIABETOLOGIA, V56, P654, DOI 10.1007/s00125-012-2789-5; Feng YY, 1999, INVEST OPHTH VIS SCI, V40, P157; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fulton AB, 2009, PROG RETIN EYE RES, V28, P452, DOI 10.1016/j.preteyeres.2009.06.003; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Hardy P, 2000, CARDIOVASC RES, V47, P489, DOI 10.1016/S0008-6363(00)00084-5; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kielczewski JL, 2009, CIRC RES, V105, P897, DOI 10.1161/CIRCRESAHA.109.199059; Knabe W, 1999, CELL TISSUE RES, V298, P33, DOI 10.1007/s004419900072; Krotova K, 2010, AM J PHYSIOL-CELL PH, V299, pC1541, DOI 10.1152/ajpcell.00068.2010; Mojumder DK, 2008, J ANAT SOC INDIA, V57, P34; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Narayanan SP, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.23; Narayanan SP, 2013, PROG RETIN EYE RES; Narayanan SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022460; Neu J, 2006, INVEST OPHTH VIS SCI, V47, P3151, DOI 10.1167/iovs.05-1473; Pandey D, 2014, ARTERIOSCL THROM VAS, V34, P1556, DOI 10.1161/ATVBAHA.114.303685; Patel C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00173; Poche RA, 2009, DEVELOPMENT, V136, P2141, DOI 10.1242/dev.033175; Pourcet B, 2011, CIRC RES, V109, P492, DOI 10.1161/CIRCRESAHA.111.241810; Que LG, 1998, AM J PHYSIOL-LUNG C, V275, pL96, DOI 10.1152/ajplung.1998.275.1.L96; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Romero MJ, 2012, AM J PHYSIOL-HEART C, V302, pH159, DOI 10.1152/ajpheart.00774.2011; Ryoo S, 2008, CIRC RES, V102, P923, DOI 10.1161/CIRCRESAHA.107.169573; Ryoo S, 2006, CIRC RES, V99, P951, DOI 10.1161/01.RES.0000247034.24662.b4; Sahin E, 2014, J IMMUNOL; Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x; Shatanawi A, 2011, AM J PHYSIOL-CELL PH, V300, pC1181, DOI 10.1152/ajpcell.00328.2010; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; Shin W, 2012, EXP MOL MED, V44, P594, DOI 10.3858/emm.2012.44.10.068; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 2008, INVEST OPHTH VIS SCI, V49, P5177, DOI 10.1167/iovs.08-2584; Stevenson L, 2010, INVEST OPHTH VIS SCI, V51, P3291, DOI 10.1167/iovs.09-4344; Wu GY, 2004, J NUTR BIOCHEM, V15, P442, DOI 10.1016/j.jnutbio.2003.11.010; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Zhang WB, 2009, AM J PATHOL, V175, P891, DOI 10.2353/ajpath.2009.081115; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	52	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110604	10.1371/journal.pone.0110604	http://dx.doi.org/10.1371/journal.pone.0110604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375125	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600017
J	Yokota, PKO; Marra, AR; Martino, MDV; Victor, ES; Durao, MS; Edmond, MB; dos Santos, OFP				Yokota, Paula K. O.; Marra, Alexandre R.; Martino, Marines D. V.; Victor, Elivane S.; Durao, Marcelino S.; Edmond, Michael B.; dos Santos, Oscar F. P.			Impact of Appropriate Antimicrobial Therapy for Patients with Severe Sepsis and Septic Shock - A Quality Improvement Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; DEFINITIONS; ANTIBIOTICS; GUIDELINES	Background: There is ample literature available on the association between both time to antibiotics and appropriateness of antibiotics and clinical outcomes from sepsis. In fact, the current state of debate surrounds the balance to be struck between prompt empirical therapy and care in the choice of appropriate antibiotics (both in terms of the susceptibility of infecting organism and minimizing resistance arising from use of broad-spectrum agents). The objective of this study is to determine sepsis bundle compliance and the appropriateness of antimicrobial therapy in patients with severe sepsis and septic shock and its impact on outcomes. Material: This study was conducted in the ICU of a tertiary care, private hospital in Sao Paulo, Brazil. A retrospective cohort study was conducted from July 2005 to December 2012 in patients with severe sepsis and septic shock. Results: A total of 1,279 patients were identified with severe sepsis and septic shock, of which 358 (32.1%) had bloodstream infection (BSI). The inpatient mortality rate was 29%. In evaluation of the sepsis bundle, over time there was a progressive increase in serum arterial lactate collection, obtaining blood cultures prior to antibiotic administration, administration of broad-spectrum antibiotics within 1 hour, and administration of appropriate antimicrobials, with statistically significant differences in the later years of the study. We also observed a significant decrease in mortality. In patients with bloodstream infection, after adjustment for other covariates the administration of appropriate antimicrobial therapy was associated with a decrease in mortality in patients with severe sepsis and septic shock (p = 0.023). Conclusions: The administration of appropriate antimicrobial therapy was independently associated with a decline in mortality in patients with severe sepsis and septic shock due to bloodstream infection. As protocol adherence increased over time, the crude mortality rate decreased, which reinforces the need to implement institutional guidelines and monitor appropriate antimicrobial therapy compliance.	[Yokota, Paula K. O.; Marra, Alexandre R.; Durao, Marcelino S.; dos Santos, Oscar F. P.] Hosp Israelita Albert Einstein, Div Med Practice, Sao Paulo, Brazil; [Martino, Marines D. V.] Hosp Israelita Albert Einstein, Microbiol Lab, Sao Paulo, Brazil; [Victor, Elivane S.] Hosp Israelita Albert Einstein, IIEP, Dept Stat, Sao Paulo, Brazil; [Edmond, Michael B.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA USA	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Virginia Commonwealth University	Marra, AR (corresponding author), Hosp Israelita Albert Einstein, Div Med Practice, Sao Paulo, Brazil.	alexandre.marra@einstein.br	Santos, Oscar Fernando Pavão dos/B-8761-2017	Santos, Oscar Fernando Pavão dos/0000-0002-8731-1201; Edmond, Michael/0000-0002-4144-8974				Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Barochia AV, 2013, CURR INFECT DIS REP, V15, P385, DOI 10.1007/s11908-013-0351-3; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Cardoso T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058418; *CLIN LAB STAND I, 2006, M100S16 CLSI; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Durao MS, 2010, ANAESTH INTENS CARE, V38, P467, DOI 10.1177/0310057X1003800309; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Global Sepsis Alliance, WORLD SEPS DAY; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Marra AR, 2010, AM J INFECT CONTROL, V38, P434, DOI 10.1016/j.ajic.2009.11.012; Marra AR, 2009, AM J INFECT CONTROL, V37, P619, DOI 10.1016/j.ajic.2009.03.009; Ministerio da Saude. Informacoes de Saude. DATASUS, TAX MORT HOSP LOC IN; Nygard ST, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-121; Shiramizo SCPL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026790; Proudfoot AG, 2011, CURR OPIN CRIT CARE, V17, P495, DOI 10.1097/MCC.0b013e32834a4b19; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Goncales PDS, 2012, EINSTEIN-SAO PAULO, V10, P442, DOI 10.1590/S1679-45082012000400009; Zaragoza R, 2003, CLIN MICROBIOL INFEC, V9, P412, DOI 10.1046/j.1469-0691.2003.00656.x; Zubert S, 2010, CRIT CARE MED, V38, P1211, DOI 10.1097/CCM.0b013e3181d69db7	26	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e104475	10.1371/journal.pone.0104475	http://dx.doi.org/10.1371/journal.pone.0104475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375775	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600003
J	Zhang, XZ; Lv, TY; Yang, XY; Zhang, B				Zhang, Xizhe; Lv, Tianyang; Yang, XueYing; Zhang, Bin			Structural Controllability of Complex Networks Based on Preferential Matching	PLOS ONE			English	Article							DYNAMICS	Minimum driver node sets (MDSs) play an important role in studying the structural controllability of complex networks. Recent research has shown that MDSs tend to avoid high-degree nodes. However, this observation is based on the analysis of a small number of MDSs, because enumerating all of the MDSs of a network is a #P problem. Therefore, past research has not been sufficient to arrive at a convincing conclusion. In this paper, first, we propose a preferential matching algorithm to find MDSs that have a specific degree property. Then, we show that the MDSs obtained by preferential matching can be composed of high-and medium-degree nodes. Moreover, the experimental results also show that the average degree of the MDSs of some networks tends to be greater than that of the overall network, even when the MDSs are obtained using previous research method. Further analysis shows that whether the driver nodes tend to be high-degree nodes or not is closely related to the edge direction of the network.	[Zhang, Xizhe; Yang, XueYing; Zhang, Bin] Northeastern Univ, Coll Informat Sci & Engn, Shenyang, Peoples R China; [Lv, Tianyang] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China; [Lv, Tianyang] Tsinghua Univ, Coll Comp Sci & Technol, Beijing 100084, Peoples R China; [Lv, Tianyang] Natl Audit Off, Audit Res Inst, Beijing, Peoples R China	Northeastern University - China; Harbin Engineering University; Tsinghua University	Zhang, XZ (corresponding author), Northeastern Univ, Coll Informat Sci & Engn, Shenyang, Peoples R China.	zhangxizhe@ise.neu.edu.cn	Zhang, Xizhe/H-3429-2019; Zhang, Xizhe/B-9848-2019	Zhang, Xizhe/0000-0002-8684-4591	Fundamental Research Funds for the Central Universities of China [N120404011]; Natural Science Foundation of China [60903009, 60903080, 71272216]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAH08B02]; Supporting Plan Project for Youth Scholar Backbone of General Colleges and Universities of Heilongjiang [1253G017]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Supporting Plan Project for Youth Scholar Backbone of General Colleges and Universities of Heilongjiang	This work is sponsored by the Fundamental Research Funds for the Central Universities of China under grant number N120404011; the Natural Science Foundation of China under grant numbers 60903009, 60903080, and 71272216; the National Key Technology Research and Development Program of the Ministry of Science and Technology of China under grant number 2012BAH08B02; and the Supporting Plan Project for Youth Scholar Backbone of General Colleges and Universities of Heilongjiang under grant number 1253G017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; [Anonymous], [No title captured]; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERGE C, 1957, P NATL ACAD SCI USA, V43, P842, DOI 10.1073/pnas.43.9.842; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; Commault C, 2002, KYBERNETIKA, V38, P503; Cowan NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038398; De Nooy W, 1999, POETICS, V26, P385, DOI 10.1016/S0304-422X(99)00009-1; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Foster JG, 2010, P NATL ACAD SCI USA, V107, P10815, DOI 10.1073/pnas.0912671107; Ghoshal G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1396; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Muller FJ, 2011, NATURE, V478, pE4, DOI 10.1038/nature10543; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; NORLEN K, 2002, P INT TEL SOC 14 BIE; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Papadopoulos F, 2012, NATURE, V489, P537, DOI 10.1038/nature11459; Patricio J, 2004, ESTUAR COAST SHELF S, V60, P23, DOI 10.1016/j.ecss.2003.11.017; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063; SMITH DA, 1992, SOC FORCES, V70, P857, DOI 10.2307/2580193; Stanoev A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046102; Ulanowicz RE, 2005, NETWORK ANAL TROPHIC, P114; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160; Wang WX, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026115; Watts DJ, 1999, AM J SOCIOL, V105, P493, DOI 10.1086/210318; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.218703; Zdeborova L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/05/P05003	39	12	12	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112039	10.1371/journal.pone.0112039	http://dx.doi.org/10.1371/journal.pone.0112039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375628	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600093
J	Buhmann, MT; Poulsen, N; Klemm, J; Kennedy, MR; Sherrill, CD; Kroger, N				Buhmann, Matthias T.; Poulsen, Nicole; Klemm, Jennifer; Kennedy, Matthew R.; Sherrill, C. David; Kroeger, Nils			A Tyrosine-Rich Cell Surface Protein in the Diatom Amphora coffeaeformis Identified through Transcriptome Analysis and Genetic Transformation	PLOS ONE			English	Article							STABLE NUCLEAR TRANSFORMATION; SILICA; ADHESION; ESTABLISHMENT; PEPTIDES; PROMOTER; SYSTEM; DOPA	Diatoms are single-celled eukaryotic microalgae that are ubiquitously found in almost all aquatic ecosystems, and are characterized by their intricately structured SiO2 (silica)-based cell walls. Diatoms with a benthic life style are capable of attaching to any natural or man-made submerged surface, thus contributing substantially to both microbial biofilm communities and economic losses through biofouling. Surface attachment of diatoms is mediated by a carbohydrate-and protein-based glue, yet no protein involved in diatom underwater adhesion has been identified so far. In the present work, we have generated a normalized transcriptome database from the model adhesion diatom Amphora coffeaeformis. Using an unconventional bioinformatics analysis we have identified five proteins that exhibit unique amino acid sequences resembling the amino acid composition of the tyrosine-rich adhesion proteins from mussel footpads. Establishing the first method for the molecular genetic transformation of A. coffeaeformis has enabled investigations into the function of one of these proteins, AC3362, through expression as YFP fusion protein. Biochemical analysis and imaging by fluorescence microscopy revealed that AC3362 is not involved in adhesion, but rather plays a role in biosynthesis and/or structural stability of the cell wall. The methods established in the present study have paved the way for further molecular studies on the mechanisms of underwater adhesion and biological silica formation in the diatom A. coffeaeformis.	[Buhmann, Matthias T.; Poulsen, Nicole; Klemm, Jennifer; Kroeger, Nils] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, D-01062 Dresden, Germany; [Kroeger, Nils] Tech Univ Dresden, Dept Chem & Food Chem, D-01062 Dresden, Germany; [Kennedy, Matthew R.; Sherrill, C. David] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	Technische Universitat Dresden; Technische Universitat Dresden; University System of Georgia; Georgia Institute of Technology	Kroger, N (corresponding author), Tech Univ Dresden, B CUBE Ctr Mol Bioengn, D-01062 Dresden, Germany.	kroeger@bcube-dresden.de		Sherrill, David/0000-0002-5570-7666; Poulsen, Nicole/0000-0002-4533-8860	US Air Force Office of Scientific Research (AFOSR) [FA9550-12-1-0093]; Deutsche Forschungsgemeinschaft (DFG) [KR 1853/5-1]	US Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the US Air Force Office of Scientific Research (AFOSR grant number FA9550-12-1-0093) to NP and NK, and by the Deutsche Forschungsgemeinschaft (DFG grant number KR 1853/5-1) to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Callow JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1251; Cooper CL, 2005, CURR OPIN COLLOID IN, V10, P52, DOI 10.1016/j.cocis.2005.05.007; Davis AK, 2005, J PHYCOL, V41, P577, DOI 10.1111/j.1529-8817.2005.00076.x; de Jong H. G. B., 1932, PROTOPLASMA, V15, P110; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; DHIR SK, 1994, IMPROVEMENT OF CEREAL QUALITY BY GENETIC ENGINEERING, P71; DRUM RW, 1966, PROTOPLASMA, V62, P1, DOI 10.1007/BF01254629; EDGAR LA, 1983, PROC R SOC SER B-BIO, V218, P331, DOI 10.1098/rspb.1983.0042; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Finlay JA, 2002, INTEGR COMP BIOL, V42, P1116, DOI 10.1093/icb/42.6.1116; Fitridge I, 2012, BIOFOULING, V28, P649, DOI 10.1080/08927014.2012.700478; Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110; Hodson OM, 2012, BIOFOULING, V28, P381, DOI 10.1080/08927014.2012.680020; HUDON C, 1981, CAN J FISH AQUAT SCI, V38, P1371, DOI 10.1139/f81-184; Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157; JACOBS JD, 1992, MOL GEN GENET, V233, P302, DOI 10.1007/BF00587592; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Miyagawa A, 2009, PHYCOL RES, V57, P142, DOI 10.1111/j.1440-1835.2009.00531.x; Miyagawa-Yamaguchi A, 2011, PHYCOL RES, V59, P113, DOI 10.1111/j.1440-1835.2011.00607.x; Molino PJ, 2008, BIOFOULING, V24, P365, DOI 10.1080/08927010802254583; Muto M, 2013, MAR BIOTECHNOL, V15, P48, DOI 10.1007/s10126-012-9457-0; Nicklisch SCT, 2012, BIOFOULING, V28, P865, DOI 10.1080/08927014.2012.719023; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; Poulsen N, 2004, J BIOL CHEM, V279, P42993, DOI 10.1074/jbc.M407734200; Poulsen N, 2013, J BIOL CHEM; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Poulsen N, 2014, BIOFOULING, V30, P513, DOI 10.1080/08927014.2014.895895; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sakaue K, 2008, PHYSIOL PLANTARUM, V133, P59, DOI 10.1111/j.1399-3054.2008.01089.x; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; Schultz MP, 2011, BIOFOULING, V27, P87, DOI 10.1080/08927014.2010.542809; Silverman HG, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P273, DOI 10.1007/978-3-7091-0286-2_18; Smith A. M, 2006, BIOL ADHESIVES; Stewart RJ, 2004, J EXP BIOL, V207, P4727, DOI 10.1242/jeb.01330; Stief P, 2011, MARINE MICROBIAL EUK; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Tesson B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061675; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; Vournakis JN, 2012, NANOTECHNOLOGY NANOM, P345; WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038; Wenzl S, 2008, ANGEW CHEM INT EDIT, V120, P1753; Wetherbee R, 1998, J PHYCOL, V34, P9, DOI 10.1046/j.1529-8817.1998.340009.x	49	21	21	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110369	10.1371/journal.pone.0110369	http://dx.doi.org/10.1371/journal.pone.0110369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372470	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900020
J	Fa, JE; Olivero, J; Farfan, MA; Marquez, AL; Vargas, JM; Real, R; Nasi, R				Fa, John E.; Olivero, Jesus; Farfan, Miguel Angel; Marquez, Ana Luz; Vargas, Juan Mario; Real, Raimundo; Nasi, Robert			Integrating Sustainable Hunting in Biodiversity Protection in Central Africa: Hot Spots, Weak Spots, and Strong Spots	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CONGO BASIN; POPULATION-DENSITY; TROPICAL FORESTS; EXTINCTION RISK; BODY-SIZE; BUSHMEAT; RESOLUTION; IMPACTS; MAMMALS	Wild animals are a primary source of protein (bushmeat) for people living in or near tropical forests. Ideally, the effect of bushmeat harvests should be monitored closely by making regular estimates of offtake rate and size of stock available for exploitation. However, in practice, this is possible in very few situations because it requires both of these aspects to be readily measurable, and even in the best case, entails very considerable time and effort. As alternative, in this study, we use high-resolution, environmental favorability models for terrestrial mammals (N = 165) in Central Africa to map areas of high species richness (hot spots) and hunting susceptibility. Favorability models distinguish localities with environmental conditions that favor the species' existence from those with detrimental characteristics for its presence. We develop an index for assessing Potential Hunting Sustainability (PHS) of each species based on their ecological characteristics (population density, habitat breadth, rarity and vulnerability), weighted according to restrictive and permissive assumptions of how species' characteristics are combined. Species are classified into five main hunting sustainability classes using fuzzy logic. Using the accumulated favorability values of all species, and their PHS values, we finally identify weak spots, defined as high diversity regions of especial hunting vulnerability for wildlife, as well as strong spots, defined as high diversity areas of high hunting sustainability potential. Our study uses relatively simple models that employ easily obtainable data of a species' ecological characteristics to assess the impacts of hunting in tropical regions. It provides information for management by charting the geography of where species are more or less likely to be at risk of extinction from hunting.	[Fa, John E.] Univ London Imperial Coll Sci Technol & Med, ICCS, Div Biol, Ascot, Berks, England; [Fa, John E.; Olivero, Jesus; Farfan, Miguel Angel; Marquez, Ana Luz; Vargas, Juan Mario; Real, Raimundo] Univ Malaga, Fac Ciencias, Dept Biol Anim, Grp Biogeog Diversidad & Conservac, E-29071 Malaga, Spain; [Nasi, Robert] CIFOR Headquarters, CGIAR, Bogor, Indonesia	Imperial College London; Universidad de Malaga; CGIAR; Center for International Forestry Research (CIFOR)	Fa, JE (corresponding author), Univ London Imperial Coll Sci Technol & Med, ICCS, Div Biol, Silwood Pk Campus, Ascot, Berks, England.	jfa949@gmail.com	Márquez, Ana Luz/K-8345-2014; Nasi, Robert/A-3549-2015; Real, Raimundo/E-6559-2010; Olivero, Jesús/K-8727-2014; Nasi, Robert/P-2382-2019; Farfan Aguilar, Miguel Angel/K-8783-2014	Márquez, Ana Luz/0000-0001-5586-9334; Nasi, Robert/0000-0001-9739-3135; Real, Raimundo/0000-0002-6642-1284; Olivero, Jesús/0000-0003-1714-0360; Nasi, Robert/0000-0001-9739-3135; FA, Julia Elizabeth/0000-0002-1572-9828; Farfan Aguilar, Miguel Angel/0000-0002-4617-6517	KnowFor (International Forestry Knowledge)	KnowFor (International Forestry Knowledge)	This work is supported by the KnowFor (International Forestry Knowledge) initiative of the UK Department for International Development (UKAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This paper is a contribution of the CIFOR Bushmeat Research Initiative.	Acevedo P, 2012, NATURWISSENSCHAFTEN, V99, P515, DOI 10.1007/s00114-012-0926-0; Acevedo P, 2011, LANDSCAPE ECOL, V26, P19, DOI 10.1007/s10980-010-9538-2; Allebone-Webb SM, 2011, CONSERV BIOL, V25, P597, DOI 10.1111/j.1523-1739.2011.01681.x; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Balmford A., 2008, EC BIODIVERSITY ECOS; Barbosa AM, 2010, CONSERV BIOL, V24, P1378, DOI 10.1111/j.1523-1739.2010.01517.x; Barbosa AM, 2003, BIOL CONSERV, V114, P377, DOI 10.1016/S0006-3207(03)00066-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bierkens M., 2000, UPSCALING DOWNSCALIN; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Bombi P, 2012, J BIOGEOGR, V39, P640, DOI 10.1111/j.1365-2699.2011.02627.x; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brodie JF, 2009, ECOL APPL, V19, P854, DOI 10.1890/08-0955.1; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cowlishaw G, 2005, J APPL ECOL, V42, P460, DOI 10.1111/j.1365-2664.2005.01046.x; Cullen L, 2001, ORYX, V35, P137, DOI 10.1017/S0030605300031690; De Wasseige C., 2012, FORETS BASSIN CONGO; Delibes-Mateos M, 2012, ENVIRON CONSERV, V39, P337, DOI 10.1017/S0376892912000100; Estrada A, 2008, BIODIVERS CONSERV, V17, P857, DOI 10.1007/s10531-008-9328-1; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2003, ENVIRON CONSERV, V30, P71, DOI 10.1017/S0376892903000067; Fa JE, 1997, J ANIM ECOL, V66, P98, DOI 10.2307/5968; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; Fielding AH, 1995, CONSERV BIOL, V9, P1466, DOI 10.1046/j.1523-1739.1995.09061466.x; Franklin J, 2009, MAPPING SPECIES DIST; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Keil P, 2013, METHODS ECOL EVOL, V4, P82, DOI 10.1111/j.2041-210x.2012.00264.x; KINGDON J, 2013, MAMMALS AFRICA; Kuehl HS, 2009, BIOL CONSERV, V142, P1500, DOI 10.1016/j.biocon.2009.02.032; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Levi T, 2009, J APPL ECOL, V46, P804, DOI 10.1111/j.1365-2664.2009.01661.x; Barbosa AM, 2012, SCI WORLD J, DOI 10.1100/2012/428206; Margules C.R., 1986, P297; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Milner-Gulland EJ, 2001, TRENDS ECOL EVOL, V16, P686, DOI 10.1016/S0169-5347(01)02278-9; Munoz AR, 2006, DIVERS DISTRIB, V12, P656, DOI 10.1111/j.1472-4642.2006.00272.x; Munoz AR, 2013, THESIS U MALAGA MALA; Olivero J, 2013, SYST BIOL, V62, P1, DOI 10.1093/sysbio/sys061; Olivero J, 2011, SYST BIOL, V60, P645, DOI 10.1093/sysbio/syr026; Peres CA, 2000, BIOL RESOURCE MANAGE, P31; Real R, 2006, ENVIRON ECOL STAT, V13, P237, DOI 10.1007/s10651-005-0003-3; Real R, 2009, DIVERS DISTRIB, V15, P390, DOI 10.1111/j.1472-4642.2008.00546.x; Remis MJ, 2012, AM J PRIMATOL, V74, P602, DOI 10.1002/ajp.22012; Robinson J.G., 1991, P415; Robinson JG, 2000, BIOL RESOURCE MANAGE, P13; ROBINSON JG, 1986, AM NAT, V128, P665, DOI 10.1086/284596; ROBINSON JG, 1986, OECOLOGIA, V68, P516, DOI 10.1007/BF00378765; Romero D, 2013, ENVIRON CONSERV, V40, P48, DOI 10.1017/S0376892912000227; Rondinini C, 2006, BIOL CONSERV, V133, P358, DOI 10.1016/j.biocon.2006.06.013; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stephens PA, 2002, J ANIM ECOL, V71, P343, DOI 10.1046/j.1365-2656.2002.00605.x; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Taylor G, 2014, BIOL CONSER IN PRESS; TEEB, 2010, EC EC BIOD MAINSTR E; UNEP-WCMC, 2012, DAT STAND WORLD DAT; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; White F., 1983, VEGETATION AFRICA DE, P356; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	69	25	25	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112367	10.1371/journal.pone.0112367	http://dx.doi.org/10.1371/journal.pone.0112367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372705	Green Published, Green Accepted, gold			2022-12-26	WOS:000344556900139
J	McWethy, DB; Wilmshurst, JM; Whitlock, C; Wood, JR; McGlone, MS				McWethy, David B.; Wilmshurst, Janet M.; Whitlock, Cathy; Wood, Jamie R.; McGlone, Matt S.			A High-Resolution Chronology of Rapid Forest Transitions following Polynesian Arrival in New Zealand	PLOS ONE			English	Article							GREAT BARRIER-ISLAND; LANDSCAPE TRANSFORMATION; KAHAROA TEPHRA; CLIMATE-CHANGE; HAWKES BAY; FIRE; VEGETATION; SETTLEMENT; PATTERNS; IMPACTS	Human-caused forest transitions are documented worldwide, especially during periods when land use by dense agriculturally-based populations intensified. However, the rate at which prehistoric human activities led to permanent deforestation is poorly resolved. In the South Island, New Zealand, the arrival of Polynesians c. 750 years ago resulted in dramatic forest loss and conversion of nearly half of native forests to open vegetation. This transformation, termed the Initial Burning Period, is documented in pollen and charcoal records, but its speed has been poorly constrained. High-resolution chronologies developed with a series of AMS radiocarbon dates from two lake sediment cores suggest the shift from forest to shrubland occurred within decades rather than centuries at drier sites. We examine two sites representing extreme examples of the magnitude of human impacts: a drier site that was inherently more vulnerable to human-set fires and a wetter, less burnable site. The astonishing rate of deforestation at the hands of small transient populations resulted from the intrinsic vulnerability of the native flora to fire and from positive feedbacks in post-fire vegetation recovery that increased landscape flammability. Spatially targeting burning in highly-flammable seral vegetation in forests rarely experiencing fire was sufficient to create an alternate fire-prone stable state. The New Zealand example illustrates how seemingly stable forest ecosystems can experience rapid and permanent conversions. Forest loss in New Zealand is among the fastest ecological transitions documented in the Holocene; yet equally rapid transitions can be expected in present-day regions wherever positive feedbacks support alternate fire-inhibiting, fire-prone stable states.	[McWethy, David B.; Whitlock, Cathy] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Wilmshurst, Janet M.; Wood, Jamie R.; McGlone, Matt S.] Landcare Res, Lincoln, New Zealand; [Whitlock, Cathy] Montana State Univ, Inst Ecosyst, Bozeman, MT 59717 USA; [Wilmshurst, Janet M.] Univ Auckland, Sch Environm, Auckland 1, New Zealand	Montana State University System; Montana State University Bozeman; Landcare Research - New Zealand; Montana State University System; Montana State University Bozeman; University of Auckland	McWethy, DB (corresponding author), Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA.	dmcwethy@montana.edu	Wood, Jamie/A-9393-2008; Wilmshurst, Janet M/C-2209-2009; Wood, Jamie/AAU-5530-2021; Wilmshurst, Janet/O-8611-2019	Wood, Jamie/0000-0001-8008-6083; Wilmshurst, Janet M/0000-0002-4474-8569; Wilmshurst, Janet/0000-0002-4474-8569	National Science Foundation [OISE-0966472, BCS-1024413]; New Zealand Foundation for Research Science and Technology; Royal Society of New Zealand Marsden; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Royal Society of New Zealand Marsden(Royal Society of New ZealandMarsden Fund (NZ)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported in part by National Science Foundation Grants OISE-0966472 (DBM, CW), and BCS-1024413 (DBM, CW), New Zealand Foundation for Research Science and Technology funding to JMW, JRW and MSM, and Royal Society of New Zealand Marsden funding to MSM, JMW, and CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Field RD, 2009, NAT GEOSCI, V2, P185, DOI 10.1038/NGEO443; Haslett J, 2008, J R STAT SOC C-APPL, V57, P399, DOI 10.1111/j.1467-9876.2008.00623.x; Higuera PE, 2007, QUATERNARY SCI REV, V26, P1790, DOI 10.1016/j.quascirev.2007.03.010; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Horrocks M, 2001, J ARCHAEOL SCI, V28, P153, DOI 10.1006/jasc.2000.0568; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; Kitzberger T, 2011, ECOSYSTEMS, P1; Kitzberger T, 2007, P NATL ACAD SCI USA, V104, P543, DOI 10.1073/pnas.0606078104; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Mayer AL, 2011, SCIENCE, V334, P188, DOI 10.1126/science.1213908; McGlone MS, 1999, QUATERN INT, V59, P5, DOI 10.1016/S1040-6182(98)00067-6; McGlone MS, 2005, NEW ZEAL J ECOL, V29, P165; McGlone MS, 1995, QUATERNARY SCI REV, V14, P867, DOI 10.1016/0277-3791(95)00068-2; McWethy DB, 2013, GLOBAL ECOL BIOGEOGR, V22, P900, DOI 10.1111/geb.12038; McWethy DB, 2010, P NATL ACAD SCI USA, V107, P21343, DOI 10.1073/pnas.1011801107; McWethy DB, 2009, HOLOCENE, V19, P883, DOI 10.1177/0959683609336563; Moore P.D., 1991, BLACKWELL SCI PUBLI; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; Murray-McIntosh RP, 1998, P NATL ACAD SCI USA, V95, P9047, DOI 10.1073/pnas.95.15.9047; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Newnham RM, 1998, J ARCHAEOL SCI, V25, P533, DOI 10.1006/jasc.1997.0217; Odion DC, 2004, CONSERV BIOL, V18, P927, DOI 10.1111/j.1523-1739.2004.00493.x; Odion DC, 2010, J ECOL, V98, P96, DOI 10.1111/j.1365-2745.2009.01597.x; Ogden J, 1998, ANN BOT-LONDON, V81, P687, DOI 10.1006/anbo.1998.0637; Parnell AC, 2011, QUATERNARY SCI REV, V30, P2948, DOI 10.1016/j.quascirev.2011.07.024; Perry G, 2014, NZ J ECOLOGY, V38; Perry GLW, 2012, GLOBAL CHANGE BIOL, V18, P1609, DOI 10.1111/j.1365-2486.2011.02631.x; Perry GLW, 2010, NEW ZEAL J ECOL, V34, P311; Perry GLW, 2012, GLOBAL ECOLOGY BIOGE; Pfeiffer M, 2013, GEOSCI MODEL DEV, V6, P643, DOI 10.5194/gmd-6-643-2013; Ramsey CB, 2008, QUATERNARY SCI REV, V27, P42, DOI 10.1016/j.quascirev.2007.01.019; Sorensen T., 1948, BIOL SKAR, V5, P1; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Thompson JR, 2007, P NATL ACAD SCI USA, V104, P10743, DOI 10.1073/pnas.0700229104; Veblen TT, 2011, AUSTR ECOLOGY; Wardle P, 2001, NEW ZEAL J BOT, V39, P523; Whitlock C, 2001, TRACKING ENV CHANGE, P75, DOI DOI 10.1007/0-306-47668-1_5; Williams M, 2000, J HIST GEOGR, V26, P28, DOI 10.1006/jhge.1999.0189; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; Wilmshurst JM, 2004, NEW ZEAL J ECOL, V28, P167; Wilmshurst JM, 1997, NEW ZEAL J BOT, V35, P79; Wilmshurst JM, 1997, NEW ZEAL J BOT, V35, P97	46	61	61	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111328	10.1371/journal.pone.0111328	http://dx.doi.org/10.1371/journal.pone.0111328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372150	gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900044
J	Nazeer, W; Tipu, AL; Ahmad, S; Mahmood, K; Mahmood, A; Zhou, BL				Nazeer, Wajad; Tipu, Abdul Latif; Ahmad, Saghir; Mahmood, Khalid; Mahmood, Abid; Zhou, Baoliang			Evaluation of Cotton Leaf Curl Virus Resistance in BC1, BC2, and BC3 Progenies from an Interspecific Cross between Gossypium arboreum and Gossypium hirsutum	PLOS ONE			English	Article							NORTHWESTERN INDIA; FIELD CONDITIONS; SATELLITE DNAS; BUREWALA VIRUS; G. HIRSUTUM; IN-VITRO; DISEASE; HYBRIDIZATION; GENETICS; PAKISTAN	Cotton leaf curl virus disease (CLCuD) is an important constraint to cotton production. The resistance of G. arboreum to this devastating disease is well documented. In the present investigation, we explored the possibility of transferring genes for resistance to CLCuD from G. arboreum (2n = 26) cv 15-Mollisoni into G. hirsutum (2n = 52) cv CRSM-38 through conventional breeding. We investigated the cytology of the BC1 to BC3 progenies of direct and reciprocal crosses of G. arboreum and G. hirsutum and evaluated their resistance to CLCuD. The F-1 progenies were completely resistant to this disease, while a decrease in resistance was observed in all backcross generations. As backcrossing progressed, the disease incidence increased in BC1 (1.7-2.0%), BC2 (1.8-4.0%), and BC3 (4.2-7.0%). However, the disease incidence was much lower than that of the check variety CIM-496, with a CLCuD incidence of 96%. Additionally, the disease incidence percentage was lower in the direct cross 2(G. arboreum) x G. hirsutum than in that of G. hirsutum x G. arboreum. Phenotypic resemblance of BC1, BC3 progenies to G. arboreum confirmed the success of cross between the two species. Cytological studies of CLCuD-resistant plants revealed that the frequency of univalents and multivalents was high in BC1, with sterile or partially fertile plants, but low in BC2 (in both combinations), with shy bearing plants. In BC3, most of the plants exhibited normal bearing ability due to the high frequency of chromosome associations (bivalents). The assessment of CLCuD through grafting showed that the BC1 to BC3 progenies were highly resistant to this disease. Thus, this study successfully demonstrates the possibility of introgressing CLCuD resistance genes from G. arboreum to G. hirsutum.	[Nazeer, Wajad; Zhou, Baoliang] Nanjing Agr Univ, MOE Hybrid Cotton R&D Engn Res Ctr, State Key Lab Crop Genet & Germpalsm Enhancement, Nanjing, Jiangsu, Peoples R China; [Nazeer, Wajad; Tipu, Abdul Latif; Ahmad, Saghir; Mahmood, Khalid] Ayub Agr Res Inst, Cotton Res Stn, Faisalabad, Punjab, Pakistan; [Mahmood, Abid] Ayub Agr Res Inst, Cotton Res Inst, Faisalabad, Punjab, Pakistan	Nanjing Agricultural University	Zhou, BL (corresponding author), Nanjing Agr Univ, MOE Hybrid Cotton R&D Engn Res Ctr, State Key Lab Crop Genet & Germpalsm Enhancement, Nanjing, Jiangsu, Peoples R China.	baoliangzhou@njau.edu.cn	Nazeer, Wajad/P-7943-2014	Nazeer, Wajad/0000-0001-7479-6409	National Key Technology Support Program of China during the twelfth Five-year Plan Period [2013BAD01B03-04]; Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China [CX (14) 2065]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Punjab Agriculture Research Board (PARB) [27]	National Key Technology Support Program of China during the twelfth Five-year Plan Period; Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Punjab Agriculture Research Board (PARB)	This work was supported by the following. Baoliang Zhou: Research was supported partially by National Key Technology Support Program of China during the twelfth Five-year Plan Period (2013BAD01B03-04), the Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China [CX (14) 2065] and the Priority Academic Program Development of Jiangsu Higher Education Institutions. Saghir Ahmad: Punjab Agriculture Research Board (PARB) for providing financial support for these studies under PARB Project no. 27. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, GENET MOL RES, V10, P2404, DOI 10.4238/2011.October.7.2; Ahmad S, 2011, 5 M AS COTT RES DEV; Ahmad S, 2011, PAK J BOT, V43, P725; Ahuja SL, 2007, J HERED, V98, P79, DOI 10.1093/jhered/esl049; Akhtar KP, 2010, ANN APPL BIOL, V157, P135, DOI 10.1111/j.1744-7348.2010.00416.x; Akhtar K.P., 2003, TROP AGR RES EXT, V5, P29; Akhtar KP, 2002, IMPROVED BOTTLE SHOO, P115; Akhtar KP, 2002, PLANT PATHOLOGY J, V18, P179; ALI MAHBUB, 1962, CROP SCI, V2, P20; ALTMAN DW, 1988, PLANT CELL REP, V7, P257, DOI 10.1007/BF00272537; AMIN K. C., 1940, INDIAN JOUR AGRIC SCI, V10, P404; Amrao L, 2010, VIRUS RES, V153, P161, DOI 10.1016/j.virusres.2010.07.003; Azhar MT, 2013, J ANIM PLANT SCI, V23, P1436; Azhar MT, 2010, INT J AGRIC BIOL, V12, P744; Azhar MT, 2012, VIRUS GENES, V45, P402, DOI 10.1007/s11262-012-0766-1; Azhar MT, 2010, VIRUS GENES, V41, P417, DOI 10.1007/s11262-010-0521-4; BLANK LM, 1963, PHYTOPATHOLOGY, V53, P921; Borole V. K., 2000, Indian Journal of Genetics and Plant Breeding, V60, P105; Briddon RW, 2003, MOL PLANT PATHOL, V4, P427, DOI [10.1046/j.1364-3703.2003.00188.x, 10.1046/J.1364-3703.2003.00188.X]; Briddon RW, 2000, VIRUS RES, V71, P151, DOI 10.1016/S0168-1702(00)00195-7; Brubaker CL, 1999, EUPHYTICA, V108, P199, DOI 10.1023/A:1003641217653; Cai JH, 2010, PLANT PATHOL, V59, P794, DOI 10.1111/j.1365-3059.2010.02266.x; Cao Z, 2013, THEOR APPL GENET, P1; Chen Y, 2014, THEOR APPL GENET, V127, P1105, DOI 10.1007/s00122-014-2283-1; Deshpande L. A., 1991, Indian Journal of Genetics and Plant Breeding, V51, P194; Farooq A, 2011, AUST J CROP SCI, V5, P1823; Gerstel D, 1956, EVOLUTION, P408; GILL MS, 1987, EUPHYTICA, V36, P625, DOI 10.1007/BF00041512; Gordillo LF, 2003, EUPHYTICA, V131, P15, DOI 10.1023/A:1023012703471; Guo WZ, 2006, THEOR APPL GENET, V112, P1573, DOI 10.1007/s00122-006-0261-y; Harland SC, 1929, J GENET, V20, P387, DOI 10.1007/BF02983156; Hussain T., 1975, Pakistan Cottons, V19, P71; Hussain T., 1988, Pakistan Cottons, V32, P248; Jafari Mofidabadi A, 2011, COTTON GENOMICS GENE, V2; JORGENSEN RB, 1994, AM J BOT, V81, P1620, DOI 10.2307/2445340; Kalloo G, 1992, DISTANT HYBRIDIZATIO, P149; Kovaleva LV, 2005, RUSS J PLANT PHYSL+, V52, P521, DOI 10.1007/s11183-005-0077-7; LIANG C, 1978, SCI SINICA, V21, P545; Liang Z, 1982, ACTA GENET SIN, V9, P441; Mahmood T., 2003, ASIAN J PLANT SCI, V2, P968; Mann RS, 2011, WHITEFLY, BEMISIA TABACI (HOMOPTERA: ALEYRODIDAE) INTERACTION WITH GEMINIVIRUS-INFECTED HOST PLANTS: BEMISIA TABACI, HOST PLANTS AND GEMINIVIRUSES, P69, DOI 10.1007/978-94-007-1524-04; Mansoor S, 2003, PLANT PATHOL, V52, P784, DOI 10.1111/j.1365-3059.2003.00893.x; Mansoor S, 2006, TRENDS PLANT SCI, V11, P209, DOI 10.1016/j.tplants.2006.03.003; Maqbool A, 2010, BIOTECHNOL PROGR, V26, P21, DOI 10.1002/btpr.306; Matthews REF., 2002, PLANT VIROLOGY; Mergeai G., 1997, BASE: Biotechnologie, Agronomie, Societe et Environnement, V1, P272; Mofidabadi A, 2009, ICAC RECORDER, V27, P10; Nazeer W, 2014, GENET MOL RES, V13, P1133, DOI 10.4238/2014.February.21.2; Nelson R.R., 1973, BREEDING PLANTS DIS; Pundir N, 1972, BOT GAZ, P7; Rahman M, 2005, PLANT PATHOL, V54, P764, DOI 10.1111/j.1365-3059.2005.01280.x; Rajagopalan PA, 2012, ARCH VIROL, V157, P855, DOI 10.1007/s00705-012-1225-y; Roy N. N., 1980, SABRAO Journal, V12, P43; Sacks EJ, 2009, FIELD CROP RES, V112, P1, DOI 10.1016/j.fcr.2009.01.006; Saghir Ahmad, 2012, African Journal of Biotechnology, V11, P4368, DOI 10.5897/AJB11.3075; Sattar MN, 2013, J GEN VIROL, V94, P695, DOI 10.1099/vir.0.049627-0; Sikka S, 1960, BREEDING, P137; Silow RA, 1941, J GENET, V42, P259, DOI 10.1007/BF02982878; Singh D, 2013, J ENVIRON BIOL, V34, P113; SITCH LA, 1987, EUPHYTICA, V36, P483, DOI 10.1007/BF00041492; STEPHENS SG, 1954, GENETICS, V39, P701; Tahir M., 2004, Plant Pathology Journal, V3, P61; Tahir MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020366; Thakur P. D., 2002, Diseases of field crops, P398; THENGANE S, 1986, PLANT CELL TISS ORG, V6, P209, DOI 10.1007/BF00040006; Tiendrebeogo F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-48; Ullah R, 2014, EUROPEAN J PLANT PAT, P1; Zafar Y, 2011, ICAC RECORDER, V29, P7; Zaffalon V, 2012, ARCH VIROL, V157, P483, DOI 10.1007/s00705-011-1201-y; Zahur M, 2009, MOL BIOL REP, V36, P1915, DOI 10.1007/s11033-008-9399-9; Zhang Ling, 2009, BMC Res Notes, V2, P120, DOI 10.1186/1756-0500-2-120	71	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111861	10.1371/journal.pone.0111861	http://dx.doi.org/10.1371/journal.pone.0111861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372141	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900080
J	Santiago, K; Bomfim, GF; Criado, PR; Almeida, SR				Santiago, Karla; Bomfim, Gisele Facholi; Criado, Paulo Ricardo; Almeida, Sandro Rogerio			Monocyte-Derived Dendritic Cells from Patients with Dermatophytosis Restrict the Growth of Trichophyton rubrum and Induce CD4-T Cell Activation	PLOS ONE			English	Article							LECTIN DC-SIGN; ANTIGEN; RECOGNITION; RECEPTOR; CONIDIA	Dermatophytes are the most common agents of superficial mycoses that are caused by mold fungi. Trichophyton rubrum is the most common pathogen causing dermatophytosis. The immunology of dermatophytosis is currently poorly understood. Recently, our group investigated the interaction of T. rubrum conidia with peritoneal mouse macrophages. We found that macrophages phagocytose T. rubrum conidia resulted in a down-modulation of class II major histocompatibility complex (MHC) antigens and in the expression of co-stimulatory molecules. Furthermore, it induced the production of IL-10, and T. rubrum conidia differentiated into hyphae that grew and killed the macrophages after 8 hrs of culture. This work demonstrated that dendritic cells (DCs) and macrophages, from patients or normal individuals, avidly interact with pathogenic fungus T. rubrum. The dermatophyte has two major receptors on human monocyte-derived DC: DC-SIGN and mannose receptor. In contrast macrophage has only mannose receptor that participates in the phagocytosis or bound process. Another striking aspect of this study is that unlike macrophages that permit rapid growth of T. rubrum, human DC inhibited the growth and induces Th activation. The ability of DC from patients to interact and kill T. rubrum and to present Ags to T cells suggests that DC may play an important role in the host response to T. rubrum infection by coordinating the development of cellular immune response.	[Santiago, Karla; Bomfim, Gisele Facholi; Almeida, Sandro Rogerio] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Criado, Paulo Ricardo] Univ Sao Paulo, Fac Med, Dept Dermatol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Almeida, SR (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil.	sandroal@usp.br	almeida, sandro r/F-5816-2012; Criado, Paulo/D-5369-2009	almeida, sandro r/0000-0002-0562-1610; Criado, Paulo/0000-0001-9785-6099; Facholi Bomfim, Gisele/0000-0001-5528-0028	Fundacao de Aparo a Pesquisa do Estado de Sao Paulo (FAPESP); Concelho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Aparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Concelho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by grants from the following: Fundacao de Aparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Concelho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Campos MRM, 2006, MICROBES INFECT, V8, P372, DOI 10.1016/j.micinf.2005.07.028; Claudia Montagnoli, 2002, Current Molecular Medicine (Hilversum), V2, P507, DOI 10.2174/1566524023362203; Sousa MD, 2011, CELL HOST MICROBE, V9, P436, DOI 10.1016/j.chom.2011.04.005; DAHL MV, 1994, J AM ACAD DERMATOL, V31, pS34, DOI 10.1016/S0190-9622(08)81265-0; Erbagci Z, 2002, MYCOPATHOLOGIA, V154, P163, DOI 10.1023/A:1016328001146; Faro-Trindade I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035675; GRUSECK E, 1993, MYCOSES, V36, P275, DOI 10.1111/j.1439-0507.1993.tb00765.x; Hoving JC, 2014, CELL MICROBIOL, V16, P185, DOI 10.1111/cmi.12249; KORTING HC, 1993, MYCOSES, V36, P271, DOI 10.1111/j.1439-0507.1993.tb00764.x; Montagnoli C, 2001, IMMUNOBIOLOGY, V204, P582, DOI 10.1078/0171-2985-00095; Moulin V, 2012, CANCER GENE THER, V19, P303, DOI 10.1038/cgt.2012.2; Newman SL, 2011, MED MYCOL, V49, P356, DOI 10.3109/13693786.2010.531295; Romani L, 1997, CURR OPIN IMMUNOL, V9, P484, DOI 10.1016/S0952-7915(97)80099-4; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 1997, CLIN MICROBIOL REV, V10, P611, DOI 10.1128/CMR.10.4.611; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Schwingshackl P, 2012, ACTA DERM-VENEREOL, V92, P269, DOI 10.2340/00015555-1220; Seebacher C, 2008, MYCOPATHOLOGIA, V166, P335, DOI 10.1007/s11046-008-9100-9; Stevens DA, 1998, MED MYCOL, V36, P174; Summerbell RC, 1997, DERMATOLOGY, V194, P32, DOI 10.1159/000246182; Svajger U, 2010, CELL SIGNAL, V22, P1397, DOI 10.1016/j.cellsig.2010.03.018; WEITZMAN I, 1995, CLIN MICROBIOL REV, V8, P240, DOI 10.1128/CMR.8.2.240; Woodfolk JA, 1998, RES IMMUNOL, V149, P436, DOI 10.1016/S0923-2494(98)80767-0	25	15	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110879	10.1371/journal.pone.0110879	http://dx.doi.org/10.1371/journal.pone.0110879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372145	gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900026
J	van Hooft, P; Greyling, BJ; Getz, WM; van Helden, PD; Zwaan, BJ; Bastos, ADS				van Hooft, Pim; Greyling, Ben J.; Getz, Wayne M.; van Helden, Paul D.; Zwaan, Bas J.; Bastos, Armanda D. S.			Positive Selection of Deleterious Alleles through Interaction with a Sex-Ratio Suppressor Gene in African Buffalo: A Plausible New Mechanism for a High Frequency Anomaly	PLOS ONE			English	Article							HETEROZYGOSITY-FITNESS CORRELATIONS; BOVINE TUBERCULOSIS; SYNCERUS-CAFFER; SOFTWARE; DISEASE; WILD	Although generally rare, deleterious alleles can become common through genetic drift, hitchhiking or reductions in selective constraints. Here we present a possible new mechanism that explains the attainment of high frequencies of deleterious alleles in the African buffalo (Syncerus caffer) population of Kruger National Park, through positive selection of these alleles that is ultimately driven by a sex-ratio suppressor. We have previously shown that one in four Kruger buffalo has a Y-chromosome profile that, despite being associated with low body condition, appears to impart a relative reproductive advantage, and which is stably maintained through a sex-ratio suppressor. Apparently, this sex-ratio suppressor prevents fertility reduction that generally accompanies sex-ratio distortion. We hypothesize that this body-condition-associated reproductive advantage increases the fitness of alleles that negatively affect male body condition, causing genome-wide positive selection of these alleles. To investigate this we genotyped 459 buffalo using 17 autosomal microsatellites. By correlating heterozygosity with body condition (heterozygosity-fitness correlations), we found that most microsatellites were associated with one of two gene types: one with elevated frequencies of deleterious alleles that have a negative effect on body condition, irrespective of sex; the other with elevated frequencies of sexually antagonistic alleles that are negative for male body condition but positive for female body condition. Positive selection and a direct association with a Y-chromosomal sex-ratio suppressor are indicated, respectively, by allele clines and by relatively high numbers of homozygous deleterious alleles among sex-ratio suppressor carriers. This study, which employs novel statistical techniques to analyse heterozygosity-fitness correlations, is the first to demonstrate the abundance of sexually-antagonistic genes in a natural mammal population. It also has important implications for our understanding not only of the evolutionary and ecological dynamics of sex-ratio distorters and suppressors, but also of the functioning of deleterious and sexually-antagonistic alleles, and their impact on population viability.	[van Hooft, Pim] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [van Hooft, Pim; Greyling, Ben J.; Bastos, Armanda D. S.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, South Africa; [Greyling, Ben J.] Agr Res Council, Irene, South Africa; [Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa; [van Helden, Paul D.] Univ Stellenbosch, Fac Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, US MRC Ctr TB Res,Div Mol Biol & Human Genet, ZA-7505 Tygerberg, South Africa; [Zwaan, Bas J.] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; University of Pretoria; Agricultural Research Council of South Africa; University of California System; University of California Berkeley; University of Kwazulu Natal; National Research Foundation - South Africa; Stellenbosch University; Wageningen University & Research	van Hooft, P (corresponding author), Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands.	pim.vanhooft@wur.nl	Bastos, Armanda/B-6357-2009; Zwaan, Bas J/D-8721-2015; Getz, Wayne/I-4521-2013	Bastos, Armanda/0000-0002-9223-4204; Zwaan, Bas J/0000-0002-8221-4998; Getz, Wayne/0000-0001-8784-9354	US NIH/NSF Ecology of Infectious Disease Grant [GM83863]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	US NIH/NSF Ecology of Infectious Disease Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Laboratory analyses were supported by US NIH/NSF Ecology of Infectious Disease Grant GM83863 awarded to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Barreto H., 2006, INTRO ECONOMETRICS U; Beldomenico Pablo M, 2010, Trends Ecol Evol, V25, P21, DOI 10.1016/j.tree.2009.06.015; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Caron A, 2003, ECOL APPL, V13, P1338, DOI 10.1890/02-5266; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Charlesworth B, 2010, MIGRATION MUTATION S, P143; Chun S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002240; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Cross PC, 2009, J APPL ECOL, V46, P467, DOI 10.1111/j.1365-2664.2008.01589.x; de Garine-Wichatitsky M, 2010, EMERG INFECT DIS, V16, P884, DOI 10.3201/eid1605.090710; De Vos V, 1983, POPULATION CONTROL L; Dean R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002917; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Greyling BJ, 2008, AFR J BIOTECHNOL, V7, P655; Hamilton M.B., 2009, POPULATION GENETICS; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HOLLAND BS, 1988, PSYCHOL BULL, V104, P145, DOI 10.1037/0033-2909.104.1.145; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; Lynch M, 1999, GENETICS, V152, P1753; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; MAY RM, 1975, AM NAT, V109, P659, DOI 10.1086/283036; Miller JM, 2014, MOL ECOL, V23, P1899, DOI 10.1111/mec.12707; Mokkonen M, 2011, SCIENCE, V334, P972, DOI 10.1126/science.1208708; Orr HA, 2001, GENETICS, V157, P875; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pennell TM, 2013, ECOL EVOL, V3, P1819, DOI 10.1002/ece3.540; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Poissant J, 2010, EVOLUTION, V64, P97, DOI 10.1111/j.1558-5646.2009.00793.x; Price TAR, 2008, GENETICA, V132, P295, DOI 10.1007/s10709-007-9173-2; Rodwell TC, 2001, J WILDLIFE DIS, V37, P258, DOI 10.7589/0090-3558-37.2.258; Rodwell TC, 2001, J MAMMAL, V82, P231, DOI 10.1644/1545-1542(2001)082&lt;0231:EOPEOB&gt;2.0.CO;2; SLATKIN M, 1973, GENETICS, V75, P733; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; van Hooft P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-106; van Hooft P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001086; van Hooft WF, 2000, MOL ECOL, V9, P2017, DOI 10.1046/j.1365-294X.2000.01101.x; Visscher DR, 2004, J ZOOL, V264, P111, DOI 10.1017/S0952836904005436; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x	52	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111778	10.1371/journal.pone.0111778	http://dx.doi.org/10.1371/journal.pone.0111778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372610	gold, Green Published			2022-12-26	WOS:000344556900075
J	Rudra-Ganguly, N; Lowe, C; Mattie, M; Chang, MS; Satpayev, D; Verlinsky, A; An, ZL; Hu, LP; Yang, P; Challita-Eid, P; Stover, DR; Pereira, DS				Rudra-Ganguly, Nandini; Lowe, Christine; Mattie, Michael; Chang, Mi Sook; Satpayev, Daulet; Verlinsky, Alla; An, Zili; Hu, Liping; Yang, Peng; Challita-Eid, Pia; Stover, David R.; Pereira, Daniel S.			Discoidin Domain Receptor 1 Contributes to Tumorigenesis through Modulation of TGFBI Expression	PLOS ONE			English	Article							COLLAGEN TYPE-I; TYROSINE KINASE; CELL INVASION; BREAST-CANCER; LUNG-CANCER; DDR1; ACTIVATION; INTEGRIN; PATHWAY; BINDING	Discoidin domain receptor 1 (DDR1) is a member of the receptor tyrosine kinase family. The receptor is activated upon binding to its ligand, collagen, and plays a crucial role in many fundamental processes such as cell differentiation, adhesion, migration and invasion. Although DDR1 is expressed in many normal tissues, upregulated expression of DDR1 in a variety of human cancers such as lung, colon and brain cancers is known to be associated with poor prognosis. Using shRNA silencing, we assessed the oncogenic potential of DDR1. DDR1 knockdown impaired tumor cell proliferation and migration in vitro and tumor growth in vivo. Microarray analysis of tumor cells demonstrated upregulation of TGFBI expression upon DDR1 knockdown, which was subsequently confirmed at the protein level. TGFBI is a TGF beta-induced extracellular matrix protein secreted by the tumor cells and is known to act either as a tumor promoter or tumor suppressor, depending on the tumor environment. Here, we show that exogenous addition of recombinant TGFBI to BXPC3 tumor cells inhibited clonogenic growth and migration, thus recapitulating the phenotypic effect observed from DDR1 silencing. BXPC3 tumor xenografts demonstrated reduced growth with DDR1 knockdown, and the same xenograft tumors exhibited an increase in TGFBI expression level. Together, these data suggest that DDR1 expression level influences tumor growth in part via modulation of TGFBI expression. The reciprocal expression of DDR1 and TGFBI may help to elucidate the contribution of DDR1 in tumorigenesis and TGFBI may also be used as a biomarker for the therapeutic development of DDR1 specific inhibitors.	[Rudra-Ganguly, Nandini; Lowe, Christine; Mattie, Michael; Chang, Mi Sook; Verlinsky, Alla; An, Zili; Hu, Liping; Yang, Peng; Challita-Eid, Pia; Stover, David R.; Pereira, Daniel S.] Astellas Pharma Inc, Agensys Inc, Santa Monica, CA 90404 USA; [Satpayev, Daulet] ImaginAb Inc, Inglewood, CA USA	Astellas Pharmaceuticals	Rudra-Ganguly, N (corresponding author), Astellas Pharma Inc, Agensys Inc, Santa Monica, CA 90404 USA.	nganguly@agensys.com			Astellas	Astellas(Astellas Pharmaceuticals)	All authors are employees of Agensys, an affiliate of Astellas Pharma, Inc. Therefore, all of the funding and sources of support have been provided by Astellas including our decision to publish these studies. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Abdulhussein R, 2008, J BIOL CHEM, V283, P12026, DOI 10.1074/jbc.M704592200; Agarwal G, 2007, J MOL BIOL, V367, P443, DOI 10.1016/j.jmb.2006.12.073; Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Borzi RM, 2010, ARTHRITIS RHEUM-US, V62, P2370, DOI 10.1002/art.27512; Cader FZ, 2013, BLOOD, V122, P4237, DOI 10.1182/blood-2013-04-499004; Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012; Castro-Sanchez L, 2011, CLIN EXP METASTAS, V28, P463, DOI 10.1007/s10585-011-9385-9; Curat CA, 2001, J BIOL CHEM, V276, P45952, DOI 10.1074/jbc.M104360200; Das S, 2006, CANCER RES, V66, P8123, DOI 10.1158/0008-5472.CAN-06-1215; Eswaramoorthy R, 2010, J CELL PHYSIOL, V224, P387, DOI 10.1002/jcp.22134; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Hu YC, 2001, CLIN CANCER RES, V7, P3519; Irigoyen M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-130; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Li BY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-239; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Miao LY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0626-4; Ram R, 2006, J NEURO-ONCOL, V76, P239, DOI 10.1007/s11060-005-6874-1; Rilla K, 2002, J CELL SCI, V115, P3633, DOI 10.1242/jcs.00042; Rinehart-Kim J, 2000, INT J CANCER, V88, P180, DOI 10.1002/1097-0215(20001015)88:2<180::AID-IJC6>3.0.CO;2-H; Ruiz PA, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-3; Shelton L, 2009, INVEST OPHTH VIS SCI, V50, P3542, DOI 10.1167/iovs.09-3460; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Slack BE, 2006, J CELL BIOCHEM, V98, P672, DOI 10.1002/jcb.20812; Son HN, 2013, BBA-MOL CELL RES, V1833, P2378, DOI 10.1016/j.bbamcr.2013.06.012; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Wang CZ, 2009, AM J PHYSIOL-CELL PH, V297, pC419, DOI 10.1152/ajpcell.00101.2009; Wen GY, 2011, INT J ONCOL, V39, P1001, DOI 10.3892/ijo.2011.1097; Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209; Yeh YC, 2011, MOL BIOL CELL, V22, P940, DOI 10.1091/mbc.E10-08-0678; Yeung D, 2013, J STRUCT BIOL, V183, P495, DOI 10.1016/j.jsb.2013.06.010; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648	38	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111515	10.1371/journal.pone.0111515	http://dx.doi.org/10.1371/journal.pone.0111515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369402	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000064
J	Manning, CS; Hooper, S; Sahai, EA				Manning, C. S.; Hooper, S.; Sahai, E. A.			Intravital imaging of SRF and Notch signalling identifies a key role for EZH2 in invasive melanoma cells	ONCOGENE			English	Article							CENTROMERE-ASSOCIATED KINESIN; BREAST-CANCER CELLS; STEM-CELLS; PROTEIN EZH2; EXPRESSION; TRANSCRIPTION; METASTASIS; GENE; DIFFERENTIATION; MELANOCYTES	The acquisition of cell motility is an early step in melanoma metastasis. Here we use intravital imaging of signalling reporter cell-lines combined with genome-wide transcriptional analysis to define signalling pathways and genes associated with melanoma metastasis. Intravital imaging revealed heterogeneous cell behaviour in vivo: < 10% of cells were motile and both singly moving cells and streams of cells were observed. Motile melanoma cells had increased Notch- and SRF-dependent transcription. Subsequent genome-wide analysis identified an overlapping set of genes associated with high Notch and SRF activity. We identified EZH2, a histone methyltransferase in the Polycomb repressive complex 2, as a regulator of these genes. Heterogeneity of EZH2 levels is observed in melanoma models, and co-ordinated upregulation of genes positively regulated by EZH2 is associated with melanoma metastasis. EZH2 was also identified as regulating the amelanotic phenotype of motile cells in vivo by suppressing expression of the P-glycoprotein Oca2. Analysis of patient samples confirmed an inverse relationship between EZH2 levels and pigment. EZH2 targeting with siRNA and chemical inhibition reduced invasion in mouse and human melanoma cell lines. The EZH2-regulated genes KIF2C and KIF22 are required for melanoma cell invasion and important for lung colonization. We propose that heterogeneity in EZH2 levels leads to heterogeneous expression of a cohort of genes associated with motile behaviour including KIF2C and KIF22. EZH2-dependent increased expression of these genes promotes melanoma cell motility and early steps in metastasis.	[Manning, C. S.; Hooper, S.; Sahai, E. A.] Canc Res UK London Res Inst, Tumour Cell Biol Lab, London WC2A 3LY, England	Cancer Research UK	Sahai, EA (corresponding author), Canc Res UK London Res Inst, Tumour Cell Biol, 44 Lincolns Inn Fields, London WC2A 3LY, England.	erik.sahai@cancer.org.uk		Manning, Cerys/0000-0001-8656-5878; Sahai, Erik/0000-0002-3932-5086	McGrath Charitable Trust via Cancer Research UK; Cancer Research UK; Cancer Research UK [15154] Funding Source: researchfish	McGrath Charitable Trust via Cancer Research UK; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We thank members of the Tumour Cell Biology laboratory for their discussion and comments. We thank Richard Treisman's laboratory for reagents. We are indebted to the Experimental Histopathology laboratory, FACS laboratory and Biological Resources Unit at the London Research Institute and Rosamond Nuamah and Charles Mein at Barts and The London Genome Centre. We are extremely grateful for PhD sponsorship of CSM from The McGrath Charitable Trust via Cancer Research UK. This study was supported by Cancer Research UK.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Asangani IA, 2012, ONCOTARGET, V3, P1011, DOI 10.18632/oncotarget.622; Bailey CM, 2012, PIGM CELL MELANOMA R, V25, P573, DOI 10.1111/j.1755-148X.2012.01025.x; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chen K, 2002, MOL BIOL CELL, V13, P1953, DOI 10.1091/mbc.02-02-0022; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Donnelly MP, 2012, HUM GENET, V131, P683, DOI 10.1007/s00439-011-1110-x; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Goswami S, 2004, CANCER RES, V64, P7664, DOI 10.1158/0008-5472.CAN-04-2027; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Hou P, 2012, CELL CYCLE, V11, P286, DOI 10.4161/cc.11.2.18707; Ishikawa K, 2008, BRIT J CANCER, V98, P1824, DOI 10.1038/sj.bjc.6604379; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Manning CS, 2013, INTRAVITAL, V2, P33; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McHugh JB, 2007, J CUTAN PATHOL, V34, P597, DOI 10.1111/j.1600-0560.2006.00678.x; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Nakamura Y, 2007, BRIT J CANCER, V97, P543, DOI 10.1038/sj.bjc.6603905; Nuytten M, 2008, ONCOGENE, V27, P1449, DOI 10.1038/sj.onc.1210774; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; ROSEMBLAT S, 1994, P NATL ACAD SCI USA, V91, P12071, DOI 10.1073/pnas.91.25.12071; Sahai E, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-14; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Zabierowski SE, 2011, STEM CELLS, V29, P1752, DOI 10.1002/stem.740; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	42	42	42	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2015	34	33					4320	4332		10.1038/onc.2014.362	http://dx.doi.org/10.1038/onc.2014.362			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO9KK	25381824	Green Accepted			2022-12-26	WOS:000359494400004
J	Khanna, MR; Mattie, FJ; Browder, KC; Radyk, MD; Crilly, SE; Bakerink, KJ; Harper, SL; Speicher, DW; Thomas, GH				Khanna, Mansi R.; Mattie, Floyd J.; Browder, Kristen C.; Radyk, Megan D.; Crilly, Stephanie E.; Bakerink, Katelyn J.; Harper, Sandra L.; Speicher, David W.; Thomas, Graham H.			Spectrin Tetramer Formation Is Not Required for Viable Development in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SPECTRIN; BETA-SPECTRIN; HEREDITARY ELLIPTOCYTOSIS; EPITHELIAL-CELLS; ERYTHROCYTE SPECTRIN; MEMBRANE SKELETON; HEMOLYTIC-ANEMIA; BRUSH-BORDER; ANKYRIN-G; MUTATIONS	The dominant paradigm for spectrin function is that (alpha beta)(2)-spectrin tetramers or higher order oligomers form membrane-associated two-dimensional networks in association with F-actin to reinforce the plasma membrane. Tetramerization is an essential event in such structures. We characterize the tetramerization interaction between alpha-spectrin and beta-spectrins in Drosophila. Wild-type alpha-spectrin binds to both beta- and beta(H)-chains with high affinity, resembling other non-erythroid spectrins. However, alpha-spec(R22S), a tetramerization site mutant homologous to the pathological alpha-spec(R28S) allele in humans, eliminates detectable binding to alpha-spectrin and reduces binding to beta(H)-spectrin similar to 1000-fold. Even though spectrins are essential proteins, alpha-spectrin(R22S) rescues alpha-spectrin mutants to adulthood with only minor phenotypes indicating that tetramerization, and thus conventional network formation, is not the essential function of non-erythroid spectrin. Our data provide the first rigorous test for the general requirement for tetramer-based non-erythroid spectrin networks throughout an organism and find that they have very limited roles, in direct contrast to the current paradigm.	[Khanna, Mansi R.; Mattie, Floyd J.; Browder, Kristen C.; Radyk, Megan D.; Crilly, Stephanie E.; Bakerink, Katelyn J.; Thomas, Graham H.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Khanna, Mansi R.; Mattie, Floyd J.; Browder, Kristen C.; Radyk, Megan D.; Crilly, Stephanie E.; Bakerink, Katelyn J.; Thomas, Graham H.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Harper, Sandra L.; Speicher, David W.] Wistar Inst Anat & Biol, Syst Biol Div, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; The Wistar Institute	Thomas, GH (corresponding author), Penn State Univ, Mueller Lab 208, University Pk, PA 16802 USA.	gxt5@psu.edu		Mattie, Floyd/0000-0001-7121-0206; Radyk, Megan/0000-0002-3660-2906	National Institutes of Health [HL038794]; National Science Foundation [MCB-1122013]; Div Of Molecular and Cellular Bioscience [1122013] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL038794 (to D. W. S.) and National Science Foundation Grant MCB-1122013 (to G. H. T.).	An XL, 2006, BIOCHEMISTRY-US, V45, P13670, DOI 10.1021/bi061368x; An XL, 2011, BBA-PROTEINS PROTEOM, V1814, P420, DOI 10.1016/j.bbapap.2010.12.010; An XL, 2002, J BIOL CHEM, V277, P31796, DOI 10.1074/jbc.M204567200; Ayalon G, 2011, J BIOL CHEM, V286, P7370, DOI 10.1074/jbc.M110.187831; Bignone PA, 2003, BIOCHEM J, V374, P613, DOI 10.1042/BJ20030507; BRAND AH, 1993, DEVELOPMENT, V118, P401; Clyne PJ, 2003, GENETICS, V165, P1433; COETZER TL, 1991, J CLIN INVEST, V88, P743, DOI 10.1172/JCI115371; Das A, 2006, J CELL BIOL, V175, P325, DOI 10.1083/jcb.200602095; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; deCuevas M, 1996, DEVELOPMENT, V122, P3959; Deng H, 1995, BIOCH FUNCTIONAL CHA; DENG HY, 1995, J CELL BIOL, V128, P71, DOI 10.1083/jcb.128.1.71; DESILVA TM, 1992, BIOCHEMISTRY-US, V31, P10872, DOI 10.1021/bi00159a030; Dubreuil RR, 2000, J CELL BIOL, V149, P647, DOI 10.1083/jcb.149.3.647; DUBREUIL RR, 1990, J CELL BIOL, V111, P1849, DOI 10.1083/jcb.111.5.1849; ELGSAETER A, 1986, SCIENCE, V234, P1217, DOI 10.1126/science.3775380; Gaetani M, 2008, BLOOD, V111, P5712, DOI 10.1182/blood-2007-11-122457; Gallagher PG, 1996, BLOOD CELL MOL DIS, V22, P254, DOI 10.1006/bcmd.1996.0105; GALLAGHER PG, 1995, J CLIN INVEST, V95, P1174, DOI 10.1172/JCI117766; Gallagher PG, 1997, J CLIN INVEST, V99, P267, DOI 10.1172/JCI119155; GARBARZ M, 1991, J CLIN INVEST, V88, P76, DOI 10.1172/JCI115307; Garbe DS, 2007, DEVELOPMENT, V134, P273, DOI 10.1242/dev.02653; Harper SL, 2001, BIOCHEMISTRY-US, V40, P9935, DOI 10.1021/bi0107795; HARTWIG JH, 1988, CELL MOTIL CYTOSKEL, V10, P117, DOI 10.1002/cm.970100116; HIROKAWA N, 1983, CELL, V32, P953, DOI 10.1016/0092-8674(83)90080-6; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; KOTULA L, 1993, J BIOL CHEM, V268, P14788; Lee JK, 1997, DEVELOPMENT, V124, P353; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Li DH, 2007, BIOCHEMISTRY-US, V46, P10585, DOI 10.1021/bi7007905; Lighthouse DV, 2008, DEV BIOL, V317, P59, DOI 10.1016/j.ydbio.2008.02.009; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; LUX SE, 1979, SEMIN HEMATOL, V16, P21; Mazock GH, 2010, MOL BIOL CELL, V21, P2860, DOI 10.1091/mbc.E10-03-0180; McKeown C, 1998, DEVELOPMENT, V125, P2087; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; MORROW JS, 1980, P NATL ACAD SCI-BIOL, V77, P6592, DOI 10.1073/pnas.77.11.6592; MORROW JS, 1981, J CELL BIOL, V88, P463, DOI 10.1083/jcb.88.2.463; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Papal S, 2013, HUM MOL GENET, V22, P3773, DOI 10.1093/hmg/ddt228; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Porter GA, 1997, CELL MOTIL CYTOSKEL, V37, P7, DOI 10.1002/(SICI)1097-0169(1997)37:1<7::AID-CM2>3.0.CO;2-7; SLITER TJ, 1989, GENETICS, V123, P327; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; Thomas GH, 1998, DEVELOPMENT, V125, P2125; Thomas GH, 1997, MOL BIOL EVOL, V14, P1285, DOI 10.1093/oxfordjournals.molbev.a025738; Tjota M, 2011, J CELL SCI, V124, P2914, DOI 10.1242/jcs.078667; Wada H, 2004, HEARING RES, V187, P51, DOI 10.1016/S0378-5955(03)00334-4; Weed SA, 1996, LAB INVEST, V74, P1117; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zarnescu DC, 1999, J CELL BIOL, V146, P1075, DOI 10.1083/jcb.146.5.1075	58	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					706	715		10.1074/jbc.M114.615427	http://dx.doi.org/10.1074/jbc.M114.615427			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25381248	Green Published, hybrid			2022-12-26	WOS:000347778200002
J	Shivange, G; Kodipelli, N; Monisha, M; Anindya, R				Shivange, Gururaj; Kodipelli, Naveena; Monisha, Mohan; Anindya, Roy			A Role for Saccharomyces cerevisiae Tpa1 Protein in Direct Alkylation Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DNA-REPAIR; TRANSLATION TERMINATION; OXIDATIVE DEMETHYLATION; METHYLATION DAMAGE; MESSENGER-RNA; ALKB; YEAST; COMPLEX; REPLICATION	Alkylating agents induce cytotoxic DNA base adducts. In this work, we provide evidence to suggest, for the first time, that Saccharomyces cerevisiae Tpa1 protein is involved in DNA alkylation repair. Little is known about Tpa1 as a repair protein beyond the initial observation from a high-throughput analysis indicating that deletion of TPA1 causes methyl methane sulfonate sensitivity in S. cerevisiae. Using purified Tpa1, we demonstrate that Tpa1 repairs both single-and double-stranded methylated DNA. Tpa1 is a member of the Fe(II) and 2-oxoglutarate-dependent dioxygenase family, and we show that mutation of the amino acid residues involved in cofactor binding abolishes the Tpa1 DNA repair activity. Deletion of TPA1 along with the base excision repair pathway DNA glycosylase MAG1 renders the tpa1 Delta mag1 Delta double mutant highly susceptible to methylation-induced toxicity. We further demonstrate that the trans-lesion synthesis DNA polymerase Pol zeta (REV3) plays a key role in tolerating DNA methyl-base lesions and that tpa1 Delta mag1rev Delta 3 triple mutant is extremely susceptible to methylation-induced toxicity. Our results indicate a synergism between the base excision repair pathway and direct alkylation repair by Tpa1 in S. cerevisiae. We conclude that Tpa1 is a hitherto unidentified DNA repair protein in yeast and that it plays a crucial role in reverting alkylated DNA base lesions and cytotoxicity.	[Shivange, Gururaj; Kodipelli, Naveena; Monisha, Mohan; Anindya, Roy] Indian Inst Technol Hyderabad, Dept Biotechnol, Hyderabad 502205, Andhra Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Hyderabad	Anindya, R (corresponding author), Indian Inst Technol Hyderabad, Dept Biotechnol, Hyderabad 502205, Andhra Pradesh, India.	anindya@iith.ac.in	Anindya, Roy/F-8241-2012; Anindya, Roy/ABD-1326-2020	Anindya, Roy/0000-0001-8561-907X; Anindya, Roy/0000-0001-8561-907X	Innovative Young Biotechnologist Award Fellowship from the Department of Biotechnology, Government of India	Innovative Young Biotechnologist Award Fellowship from the Department of Biotechnology, Government of India	This work was supported by Innovative Young Biotechnologist Award Fellowship (2008) from the Department of Biotechnology, Government of India (to A. R.).	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Bjornstad LG, 2011, BIOCHEM J, V434, P391, DOI 10.1042/BJ20101667; Calvo JA, 2012, J CLIN INVEST, V122, P2680, DOI 10.1172/JCI63338; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chen H, 2009, BIOMETALS, V22, P191, DOI 10.1007/s10534-008-9190-3; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Choudhary V, 2012, P NATL ACAD SCI USA, V109, P16882, DOI 10.1073/pnas.1209086109; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Dinglay S, 2000, GENE DEV, V14, P2097; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Hendricks CA, 2002, DNA REPAIR, V1, P645, DOI 10.1016/S1568-7864(02)00072-1; Henri J, 2010, J BIOL CHEM, V285, P30767, DOI 10.1074/jbc.M110.106864; Henshaw TF, 2004, J INORG BIOCHEM, V98, P856, DOI 10.1016/j.jinorgbio.2003.10.021; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer LM, 2001, GENOME BIOL, V2; John S, 2000, GENE DEV, V14, P1196; Johnson RE, 2007, MOL CELL BIOL, V27, P7198, DOI 10.1128/MCB.01079-07; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Keeling KM, 2006, MOL CELL BIOL, V26, P5237, DOI 10.1128/MCB.02448-05; Kim HS, 2010, NUCLEIC ACIDS RES, V38, P2099, DOI 10.1093/nar/gkp1151; Korvald H, 2012, DNA REPAIR, V11, P453, DOI 10.1016/j.dnarep.2012.01.014; Kunz BA, 2000, MUTAT RES-FUND MOL M, V451, P169, DOI 10.1016/S0027-5107(00)00048-8; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Li Q, 2007, ANAL SCI, V23, P413, DOI 10.2116/analsci.23.413; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Ma WJ, 2008, NUCLEIC ACIDS RES, V36, P1836, DOI 10.1093/nar/gkm1148; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Petrov AN, 2008, NUCLEIC ACIDS RES, V36, P6187, DOI 10.1093/nar/gkn643; Rajski SR, 1998, CHEM REV, V98, P2723, DOI 10.1021/cr9800199; Rother S, 2007, GENE DEV, V21, P1409, DOI 10.1101/gad.428407; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shivange G, 2014, ANAL BIOCHEM, V465, P35, DOI 10.1016/j.ab.2014.07.003; SIKORSKI RS, 1989, GENETICS, V122, P19; Simmons JM, 2012, EXP PARASITOL, V131, P92, DOI 10.1016/j.exppara.2012.03.011; Singer B., 1983, MOL BIOL MUTAGENS CA; Spence EL, 1996, J BACTERIOL, V178, P5249, DOI 10.1128/jb.178.17.5249-5256.1996; Svilar D, 2012, MOL CANCER RES, V10, P1580, DOI 10.1158/1541-7786.MCR-12-0168; Taschner M, 2010, MOL CELL BIOL, V30, P436, DOI 10.1128/MCB.00822-09; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Van Sloun PPH, 2002, MOL CELL BIOL, V22, P2159, DOI 10.1128/MCB.22.7.2159-2169.2002; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; VOLKERT MR, 1991, MOL GEN GENET, V229, P319, DOI 10.1007/BF00272173; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; WEI YF, 1995, J BACTERIOL, V177, P5009, DOI 10.1128/jb.177.17.5009-5015.1995; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xiao W, 1996, CURR GENET, V30, P461, DOI 10.1007/s002940050157	70	19	19	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35939	35952		10.1074/jbc.M114.590216	http://dx.doi.org/10.1074/jbc.M114.590216			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25381260	Green Published, hybrid			2022-12-26	WOS:000346897900025
J	Yang, T; Gao, LP; Hu, H; Stoopen, G; Wang, CY; Jongsma, MA				Yang, Ting; Gao, Liping; Hu, Hao; Stoopen, Geert; Wang, Caiyun; Jongsma, Maarten A.			Chrysanthemyl Diphosphate Synthase Operates in Planta as a Bifunctional Enzyme with Chrysanthemol Synthase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYLALLYL DIPHOSPHATE; SQUALENE SYNTHASE; MONOTERPENE SYNTHASE; TERPENE SYNTHASES; BIOSYNTHESIS; EXPRESSION; ARABIDOPSIS; METABOLISM; CLONING; LEAVES	Chrysanthemyl diphosphate synthase (CDS) is the first pathway-specific enzyme in the biosynthesis of pyrethrins, the most widely used plant-derived pesticide. CDS catalyzes c1'-2-3 cyclopropanation reactions of two molecules of dimethylallyl diphosphate (DMAPP) to yield chrysanthemyl diphosphate (CPP). Three proteins are known to catalyze this cyclopropanation reaction of terpene precursors. Two of them, phytoene and squalene synthase, are bifunctional enzymes with both prenyltransferase and terpene synthase activity. CDS, the other member, has been reported to perform only the prenyltransferase step. Here we show that the NDXXD catalytic motif of CDS, under the lower substrate conditions prevalent in plants, also catalyzes the next step, converting CPP into chrysanthemol by hydrolyzing the diphosphate moiety. The enzymatic hydrolysis reaction followed conventional Michaelis-Menten kinetics, with a Km value for CPP of 196 mu M. For the chrysanthemol synthase activity, DMAPP competed with CPP as substrate. The DMAPP concentration required for half-maximal activity to produce chrysanthemol was similar to 100 mu M, and significant substrate inhibition was observed at elevated DMAPP concentrations. The N-terminal peptide of CDS was identified as a plastid-targeting peptide. Transgenic tobacco plants overexpressing CDS emitted chrysanthemol at a rate of 0.12-0.16 mu g h(-1) g(-1) fresh weight. We propose that CDS should be renamed a chrysanthemol synthase utilizing DMAPP as substrate.	[Yang, Ting; Gao, Liping; Stoopen, Geert; Jongsma, Maarten A.] Wageningen UR, Business Unit PRI Biosci, NL-6700 AA Wageningen, Netherlands; [Yang, Ting] Wageningen UR, Entomol Lab, NL-6700 EH Wageningen, Netherlands; [Yang, Ting] Wageningen UR, Lab Plant Physiol, NL-6700 AR Wageningen, Netherlands; [Hu, Hao; Wang, Caiyun] Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Biol Hort Plants, Wuhan 430070, Peoples R China	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Huazhong Agricultural University	Jongsma, MA (corresponding author), Wageningen UR, Plant Res Int, POB 619, NL-6700 AP Wageningen, Netherlands.	maarten.jongsma@wur.nl	Jongsma, Maarten A/A-2118-2010; Yang, Ting/J-1881-2015	Jongsma, Maarten A/0000-0001-5799-2301; Yang, Ting/0000-0001-8872-8749; HU, HAO/0000-0002-0614-3921	Technological Top Institute Green Genetics (Stichting TTI Groene Genetica) of The Netherlands [1C001RP]; National Natural Science Foundation of China [31372103]	Technological Top Institute Green Genetics (Stichting TTI Groene Genetica) of The Netherlands; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Technological Top Institute Green Genetics (Stichting TTI Groene Genetica) of The Netherlands Grant 1C001RP and by National Natural Science Foundation of China Project 31372103.	Aharoni A, 2004, PLANT CELL, V16, P3110, DOI 10.1105/tpc.104.023895; Bouwmeester HJ, 2002, PLANT PHYSIOL, V129, P134, DOI 10.1104/pp.001024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREWER J G, 1973, Pyrethrum Post, V12, P17; Bruggemann N, 2002, PHYSIOL PLANTARUM, V115, P190, DOI 10.1034/j.1399-3054.2002.1150203.x; Burke CC, 1999, P NATL ACAD SCI USA, V96, P13062, DOI 10.1073/pnas.96.23.13062; Casida J.E., 1995, PYRETHRUM FLOWERS PR; Chang TH, 2010, PLANT CELL, V22, P454, DOI 10.1105/tpc.109.071738; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; CROWLEY MP, 1961, NATURE, V191, P281, DOI 10.1038/191281a0; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; DOGBO O, 1988, P NATL ACAD SCI USA, V85, P7054, DOI 10.1073/pnas.85.19.7054; ELLIS JR, 1985, PLANTA, V165, P120, DOI 10.1007/BF00392220; EPSTEIN WW, 1973, PHYTOCHEMISTRY, V12, P737, DOI 10.1016/0031-9422(73)80670-3; Fisher AJ, 2001, ANAL BIOCHEM, V292, P272, DOI 10.1006/abio.2001.5079; Gao Y, 2012, NAT PROD REP, V29, P1153, DOI 10.1039/c2np20059g; Gilg AB, 2005, P NATL ACAD SCI USA, V102, P9760, DOI 10.1073/pnas.0503277102; Gilg AB, 2009, NATURWISSENSCHAFTEN, V96, P731, DOI 10.1007/s00114-009-0521-1; Green S, 2007, PHYTOCHEMISTRY, V68, P176, DOI 10.1016/j.phytochem.2006.10.017; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; HUXLEY PA, 1971, J APPL ECOL, V8, P147, DOI 10.2307/2402133; Iwata-Reuyl D, 2003, BIOCHEMISTRY-US, V42, P3359, DOI 10.1021/bi0206614; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; Kikuta Y, 2012, PLANT J, V71, P183, DOI 10.1111/j.1365-313X.2012.04980.x; Liu PL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-214; Loivamaki M, 2007, PLANT PHYSIOL, V144, P1066, DOI 10.1104/pp.107.098509; Lucker J, 2004, PLANT PHYSIOL, V134, P510, DOI 10.1104/pp.103.030189; Matsuda K, 2005, PHYTOCHEMISTRY, V66, P1529, DOI 10.1016/j.phytochem.2005.05.005; Mrack EM, 1973, PYRETHRUM NATURAL IN, P307; NAKASHIMA T, 1995, P NATL ACAD SCI USA, V92, P2328, DOI 10.1073/pnas.92.6.2328; Ogura K, 1998, CHEM REV, V98, P1263, DOI 10.1021/cr9600464; Orlova I, 2009, PLANT CELL, V21, P4002, DOI 10.1105/tpc.109.071282; Radisky ES, 2000, BIOCHEMISTRY-US, V39, P1748, DOI 10.1021/bi9915014; Ramirez AM, 2012, PLANT CELL, V24, P4252, DOI 10.1105/tpc.112.105031; Rivera SB, 2001, P NATL ACAD SCI USA, V98, P4373, DOI 10.1073/pnas.071543598; Rosenstiel TN, 2002, PLANT PHYSIOL, V129, P1276, DOI 10.1104/pp.002717; SEIICHI F, 1995, BREEDING SCI, V45, P179; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Szkopinska A, 2005, ACTA BIOCHIM POL, V52, P45; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Tholl Dorothea, 2011, Arabidopsis Book, V9, pe0143, DOI 10.1199/tab.0143; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; Vickers CE, 2011, PLANT CELL ENVIRON, V34, P1043, DOI 10.1111/j.1365-3040.2011.02303.x; Wang GD, 2009, P NATL ACAD SCI USA, V106, P9914, DOI 10.1073/pnas.0904069106; Wu SQ, 2006, NAT BIOTECHNOL, V24, P1441, DOI 10.1038/nbt1251; Yang T, 2011, METAB ENG, V13, P414, DOI 10.1016/j.ymben.2011.01.011; ZHANG DL, 1993, ARCH BIOCHEM BIOPHYS, V304, P133, DOI 10.1006/abbi.1993.1331	49	28	29	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36325	36335		10.1074/jbc.M114.623348	http://dx.doi.org/10.1074/jbc.M114.623348			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378387	hybrid, Green Published			2022-12-26	WOS:000346897900055
J	Yu, SF; Zhang, YN; Yang, BY; Wu, CY				Yu, Si-fei; Zhang, Yan-nan; Yang, Bin-yan; Wu, Chang-you			Human Memory, but Not Naive, CD4(+) T Cells Expressing Transcription Factor T-bet Might Drive Rapid Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cytokine; Immunology; T Helper Cells; Transcription Factor; Memory CD4+T Cells; T-bet; Cytokines	ROR-GAMMA-T; INTERFERON-GAMMA; HELPER-CELLS; TH2 CELLS; EFFECTOR; DIFFERENTIATION; RESPONSES; GENERATION; DIRECTS; RECALL	We found that after stimulation for a few hours, memory but not naive CD4(+) T cells produced a large amount of IFN-; however, the mechanism of rapid response of memory CD4(+) T cells remains undefined. We compared the expression of transcription factors in resting or activated naive and memory CD4(+) T cells and found that T-bet, but not pSTAT-1 or pSTAT-4, was highly expressed in resting memory CD4(+) T cells and that phenotypic characteristics of T-bet(+)CD4(+) T cells were CD45RA(low)CD62L(low) CCR7(low). After short-term stimulation, purified memory CD4(+) T cells rapidly produced effector cytokines that were closely associated with the pre-existence of T-bet. By contrast, resting naive CD4(+) T cells did not express T-bet, and they produced cytokines only after sustained stimulation. Our further studies indicated that T-bet was expressed in the nuclei of resting memory CD4(+) T cells, which might have important implications for rapid IFN- production. Our results indicate that the pre-existence and nuclear mobilization of T-bet in resting memory CD4(+) T cells might be a possible transcriptional mechanism for rapid production of cytokines by human memory CD4(+) T cells.	[Yu, Si-fei; Zhang, Yan-nan; Yang, Bin-yan; Wu, Chang-you] Sun Yat Sen Univ, Inst Immunol, Zhongshan Sch Med, Key Lab Trop Dis Control Res,Minist Educ, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University	Wu, CY (corresponding author), Sun Yat Sen Univ, Inst Immunol, Zhongshan Sch Med, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	changyou_wu@yahoo.com			Guangdong Recruitment Program of Creative Research Groups [2009010058]; National Basic Research Program of China (973) [2013CB531500]	Guangdong Recruitment Program of Creative Research Groups; National Basic Research Program of China (973)(National Basic Research Program of China)	This study was supported by grants from Guangdong Recruitment Program of Creative Research Groups (2009010058) and National Basic Research Program of China Grant 2013CB531500 (973).	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Chandok MR, 2007, J IMMUNOL, V179, P3689, DOI 10.4049/jimmunol.179.6.3689; Dooms H, 2002, NAT IMMUNOL, V3, P797, DOI 10.1038/ni0902-797; Frucht DM, 2000, J IMMUNOL, V164, P4659, DOI 10.4049/jimmunol.164.9.4659; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Joshi NS, 2011, J IMMUNOL, V187, P4068, DOI 10.4049/jimmunol.1002145; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Lai W, 2011, J IMMUNOL, V187, P133, DOI 10.4049/jimmunol.1002742; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; McGeachy MJ, 2013, J LEUKOCYTE BIOL, V94, P921, DOI 10.1189/jlb.0313113; Mollo SB, 2014, J LEUKOCYTE BIOL, V95, P705, DOI 10.1189/jlb.0813429; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2011, J EXP MED, V208, P1001, DOI 10.1084/jem.20102144; Patke DS, 2005, J IMMUNOL, V174, P5433, DOI 10.4049/jimmunol.174.9.5433; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	30	13	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35561	35569		10.1074/jbc.M114.608745	http://dx.doi.org/10.1074/jbc.M114.608745			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378399	hybrid, Green Published			2022-12-26	WOS:000346660200043
J	Ibanez, L; Velli, PS; Font, R; Jaen, A; Royo, J; Irigoyen, D; Cairo, M; De la Sierra, A; Arranz, MJ; Gallardo, D; Dalmau, D				Ibanez, Laura; Sebastian Velli, Pablo; Font, Roser; Jaen, Angeles; Royo, Josep; Irigoyen, Daniel; Cairo, Mireia; De la Sierra, Alejandro; Jesus Arranz, Maria; Gallardo, David; Dalmau, David			HIV-Infection, Atherosclerosis and the Inflammatory Pathway: Candidate Gene Study in a Spanish HIV-Infected Population	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; RECEPTOR ANTAGONIST GENE; COAT GLYCOPROTEIN GP120; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HEART-DISEASE; CAROTID ATHEROSCLEROSIS; ARACHIDONATE CASCADE	Background: Higher prevalence of atherosclerosis and higher cardiovascular risk is observed in HIV-infected individuals. The biological mechanisms underlying these processes are unclear. Several studies have implicated genetic variants in the inflammatory genes in cardiovascular disease and in HIV natural course infection. Methods & Findings: In this study we have tested the possible association between genetic variants in several inflammatory genes and asymptomatic cardiovascular disease measured by carotid intima media thickness (cIMT) and atherosclerotic plaque presence as dependent variables in 213 HIV-infected individuals. A total of 101 genetic variants in 25 candidate genes have been genotyped. Results were analyzed using Plink and SPSS statistical packages. We have found several polymorphisms in the genes ALOX5 (rs2115819 p = 0.009), ALOX5AP (rs9578196 p = 0.007; rs4769873 p = 0.004 and rs9315051 p = 0.0004), CX3CL1 (rs4151117 p = 0.040 and rs614230 p = 0.015) and CCL5 (rs3817655 p = 0.018 and rs2107538 p = 0.018) associated with atherosclerotic plaque. cIMT mean has been associated with CRP (1130864 p = 0.0003 and rs1800947 p = 0.008), IL1RN (rs380092 p = 0.002) and ALOX5AP (rs3885907 p = 0.02) genetic variants. Conclusions: In this study we have found modest associations between genetic variants in several inflammatory genes and atherosclerotic plaque or cIMT. Nevertheless, our study adds evidence to the association between inflammatory pathway genetic variants and the atherosclerotic disease in HIV-infected individuals.	[Ibanez, Laura; Jaen, Angeles; Jesus Arranz, Maria; Dalmau, David] Fundacio Docencia & Recerca MutuaTerrassa, Terrassa, Catalonia, Spain; [Sebastian Velli, Pablo; Font, Roser; Royo, Josep; Irigoyen, Daniel; Cairo, Mireia; De la Sierra, Alejandro; Dalmau, David] Hosp Univ MutuaTerrassa, Terrassa, Catalonia, Spain; [Sebastian Velli, Pablo; Font, Roser; Royo, Josep; Irigoyen, Daniel; Cairo, Mireia; De la Sierra, Alejandro; Dalmau, David] Univ Barcelona, Terrassa, Catalonia, Spain; [Gallardo, David] Univ Autonoma Barcelona, Serv Vet Genet Mol, Bellaterra, Catalonia, Spain	Hospital Universitario Mutua Terrassa; University of Barcelona; Autonomous University of Barcelona	Gallardo, D (corresponding author), Univ Autonoma Barcelona, Serv Vet Genet Mol, Bellaterra, Catalonia, Spain.	libanez@mutuaterrassa.es	Jaen, Angeles/J-9780-2013	Jaen, Angeles/0000-0002-6815-2022; mireia, cairo/0000-0003-2386-2765; Ibanez, Laura/0000-0003-2381-7059	Plan Nacional R+D+I [RD12/0017/0027]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); MutuaTerrassa Fundation; Spanish HIV Research Fundation (Fundacion para la Investigacion y la Prevencion del Sida en Espana) [FIPSE-36093410]; Catalan Government (La Generalitat de Catalunya) [FI-DGR-00202]	Plan Nacional R+D+I; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); MutuaTerrassa Fundation; Spanish HIV Research Fundation (Fundacion para la Investigacion y la Prevencion del Sida en Espana); Catalan Government (La Generalitat de Catalunya)	This work has been (partially) funded by the RD12/0017/0027 project as part of the Plan Nacional R+D+I and cofinanced by ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER), a grant from MutuaTerrassa Fundation, and a grant from the Spanish HIV Research Fundation (Fundacion para la Investigacion y la Prevencion del Sida en Espana (FIPSE-36093410)) to Dr. David Dalmau. Laura Ibanez was supported by a PhD studentship from the Catalan Government (La Generalitat de Catalunya (FI-DGR-00202)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Apostolakis S, 2013, ACTA PHARMACOL SIN, V34, P1251, DOI 10.1038/aps.2013.92; Bots ML, 2002, J HYPERTENS, V20, P2317, DOI 10.1097/00004872-200212000-00002; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Debette S, 2009, STROKE, V40, P2212, DOI 10.1161/STROKEAHA.108.537159; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Albuquerque VMG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-274; Guo J, 2013, ACTA NEUROL SCAND; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Henry K, 1998, LANCET, V351, P1328, DOI 10.1016/S0140-6736(05)79053-X; Hileman CO, 2014, JAIDS-J ACQ IMM DEF, V65, P340, DOI 10.1097/QAI.0000000000000063; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Jang Y, 2007, CLIN SCI, V113, P349, DOI 10.1042/CS20070014; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Lee CC, 2009, CLIN CHEM, V55, P351, DOI 10.1373/clinchem.2008.117176; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Longenecker CT, 2012, TRANSL RES, V159, P127, DOI 10.1016/j.trsl.2011.10.007; Maccarrone M, 2000, J NEUROCHEM, V75, P196, DOI 10.1046/j.1471-4159.2000.0750196.x; Maccarrone M, 1998, BIOCHEM J, V333, P45, DOI 10.1042/bj3330045; Maggi P, 2007, CORONARY ARTERY DIS, V18, P23, DOI 10.1097/01.mca.0000236292.86930.e3; Olsson S, 2012, STROKE, V43, P2278, DOI 10.1161/STROKEAHA.111.647446; Piconi S, 2013, AIDS, V27, P1521, DOI 10.1097/QAD.0b013e32835fffb2; Piconi S, 2013, AIDS, V27, P381, DOI 10.1097/QAD.0b013e32835abcc9; Poupel L, 2013, ARTERIOSCL THROM VAS, V33, P2297, DOI 10.1161/ATVBAHA.112.300930; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rotger M, 2013, CLIN INFECT DIS, V57, P112, DOI 10.1093/cid/cit196; Roy H, 2009, HUM GENET, V125, P467, DOI 10.1007/s00439-009-0654-5; Shrestha S, 2012, AIDS, V26, P1571, DOI 10.1097/QAD.0b013e328355359f; Shrestha S, 2010, AIDS, V24, P583, DOI 10.1097/QAD.0b013e3283353c9e; Tarr PE, 2010, PHARMACOGENOMICS, V11, P587, DOI 10.2217/PGS.10.35; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195; van Minkelen R, 2009, ATHEROSCLEROSIS, V203, P201, DOI 10.1016/j.atherosclerosis.2008.06.029; Vohnout B, 2003, HAEMATOLOGICA, V88, P54; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Worrall BB, 2003, STROKE, V34, P790, DOI 10.1161/01.STR.0000057815.79289.EC; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	42	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112279	10.1371/journal.pone.0112279	http://dx.doi.org/10.1371/journal.pone.0112279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383745	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700044
J	Davaadelger, B; Shen, H; Maki, CG				Davaadelger, Batzaya; Shen, Hong; Maki, Carl G.			Novel Roles for P53 in the Genesis and Targeting of Tetraploid Cancer Cells	PLOS ONE			English	Article							EUKARYOTIC DNA-REPLICATION; CYCLIN-E; EXPRESSION; PROMOTES; GEMININ; ARREST; P21; ENDOREDUPLICATION; SENSITIVITY; INHIBITION	Tetraploid (4N) cells are considered important in cancer because they can display increased tumorigenicity, resistance to conventional therapies, and are believed to be precursors to whole chromosome aneuploidy. It is therefore important to determine how tetraploid cancer cells arise, and how to target them. P53 is a tumor suppressor protein and key regulator of tetraploidy. As part of the "tetraploidy checkpoint", p53 inhibits tetraploid cell proliferation by promoting a G1-arrest in incipient tetraploid cells (referred to as a tetraploid G1 arrest). Nutlin-3a is a preclinical drug that stabilizes p53 by blocking the interaction between p53 and MDM2. In the current study, Nutlin-3a promoted a p53-dependent tetraploid G1 arrest in two diploid clones of the HCT116 colon cancer cell line. Both clones underwent endoreduplication after Nutlin removal, giving rise to stable tetraploid clones that showed increased resistance to ionizing radiation (IR) and cisplatin (CP)-induced apoptosis compared to their diploid precursors. These findings demonstrate that transient p53 activation by Nutlin can promote tetraploid cell formation from diploid precursors, and the resulting tetraploid cells are therapy (IR/CP) resistant. Importantly, the tetraploid clones selected after Nutlin treatment expressed approximately twice as much P53 and MDM2 mRNA as diploid precursors, expressed approximately twice as many p53-MDM2 protein complexes (by co-immunoprecipitation), and were more susceptible to p53-dependent apoptosis and growth arrest induced by Nutlin. Based on these findings, we propose that p53 plays novel roles in both the formation and targeting of tetraploid cells. Specifically, we propose that 1) transient p53 activation can promote a tetraploid-G1 arrest and, as a result, may inadvertently promote formation of therapy-resistant tetraploid cells, and 2) therapy-resistant tetraploid cells, by virtue of having higher P53 gene copy number and expressing twice as many p53-MDM2 complexes, are more sensitive to apoptosis and/or growth arrest by anti-cancer MDM2 antagonists (e.g. Nutlin).	[Davaadelger, Batzaya; Shen, Hong; Maki, Carl G.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Rush University	Maki, CG (corresponding author), Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	Carl_Maki@rush.edu			National Institutes of Health from the National Cancer Institute (NCI) [1RO1CA137598-01A1]; NATIONAL CANCER INSTITUTE [R01CA137598] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant 1RO1CA137598-01A1 from the National Cancer Institute (NCI) (to C.G.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylon Y, 2011, MOL ONCOL, V5, P315, DOI 10.1016/j.molonc.2011.07.007; Badie C, 2000, MOL CELL BIOL, V20, P2358, DOI 10.1128/MCB.20.7.2358-2366.2000; Bellanger S, 2007, ONCOGENE, V26, P7175, DOI 10.1038/sj.onc.1210539; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Castedo M, 2006, ANN NY ACAD SCI, V1090, P35, DOI 10.1196/annals.1378.004; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; de Toledo SM, 1998, CELL GROWTH DIFFER, V9, P887; FAN SJ, 1995, CANCER RES, V55, P1649; Fan SJ, 1997, ONCOGENE, V14, P2127, DOI 10.1038/sj.onc.1201052; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Khan SH, 1998, CANCER RES, V58, P396; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Pestell KE, 2000, MOL PHARMACOL, V57, P503, DOI 10.1124/mol.57.3.503; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Reid BJ, 2011, CANCER BIOMARK, V9, P307, DOI 10.3233/CBM-2011-0162; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Shen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059848; Shen H, 2010, J BIOL CHEM, V285, P23103, DOI 10.1074/jbc.M110.124990; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Stewart ZA, 1999, MOL CELL BIOL, V19, P205; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yoshida K, 2004, ONCOGENE, V23, P3802, DOI 10.1038/sj.onc.1207488	34	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e110844	10.1371/journal.pone.0110844	http://dx.doi.org/10.1371/journal.pone.0110844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380055	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100015
J	Nordin, N; Salama, SM; Golbabapour, S; Hajrezaie, M; Hassandarvish, P; Kamalidehghan, B; Majid, NA; Hashim, NM; Omar, H; Fadaienasab, M; Karimian, H; Taha, H; Ali, HM; Abdulla, MA				Nordin, Noraziah; Salama, Suzy Munir; Golbabapour, Shahram; Hajrezaie, Maryam; Hassandarvish, Pouya; Kamalidehghan, Behnam; Majid, Nazia Abdul; Hashim, Najihah Mohd; Omar, Hanita; Fadaienasab, Mehran; Karimian, Hamed; Taha, Hairin; Ali, Hapipah Mohd; Abdulla, Mahmood Ameen			Anti-Ulcerogenic Effect of Methanolic Extracts from Enicosanthellum pulchrum (King) Heusden against Ethanol-Induced Acute Gastric Lesion in Animal Models	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; NITRIC-OXIDE; ANTIOXIDANT PROPERTIES; MUCOSAL DEFENSE; ULCER; PROTEINS; MUCUS; HEAT-SHOCK-PROTEIN-70; PROSTAGLANDINS; LANSOPRAZOLE	A natural source of medicine, Enicosanthellum pulchrum is a tropical plant which belongs to the family Annonaceae. In this study, methanol extract from the leaves and stems of this species was evaluated for its gastroprotective potential against mucosal lesions induced by ethanol in rats. Seven groups of rats were assigned, groups 1 and 2 were given Tween 20 (10% v/v) orally. Group 3 was administered omeprazole 20 mg/kg (10% Tween 20) whilst the remaining groups received the leaf and stem extracts at doses of 150 and 300 mg/kg, respectively. After an additional hour, the rats in groups 2-7 received ethanol (95% v/v; 8 mL/kg) orally while group 1 received Tween 20 (10% v/v) instead. Rats were sacrificed after 1 h and their stomachs subjected to further studies. Macroscopically and histologically, group 2 rats showed extremely severe disruption of the gastric mucosa compared to rats pre-treated with the E. pulchrum extracts based on the ulcer index, where remarkable protection was noticed. Meanwhile, a significant percentage of inhibition was shown with the stem extract at 62% (150 mg/kg) and 65% (300 mg/kg), whilst the percentage with the leaf extract at doses of 150 and 300 mg/kg was 63% and 75%, respectively. An increase in mucus content, nitric oxide, glutathione, prostaglandin E2, superoxide dismutase, protein and catalase, and a decrease in malondialdehyde level compared to group 2 were also obtained. Furthermore, immunohistochemical staining of groups 4-7 exhibited down-regulation of Bax and up-regulation of Hsp70 proteins. The methanol extract from the leaves and the stems showed notable gastroprotective potential against ethanol.	[Nordin, Noraziah; Kamalidehghan, Behnam; Hashim, Najihah Mohd; Karimian, Hamed] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Salama, Suzy Munir; Golbabapour, Shahram; Hajrezaie, Maryam; Hassandarvish, Pouya; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Nordin, Noraziah; Omar, Hanita; Fadaienasab, Mehran; Taha, Hairin; Ali, Hapipah Mohd] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia; [Golbabapour, Shahram; Hajrezaie, Maryam; Majid, Nazia Abdul] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Omar, Hanita] Univ Malaya, Ctr Fdn Studies Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Salama, SM (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia.	s.salama999@hotmail.com; ammeen@um.edu.my	Fadaeinasab, Mehran/A-8810-2016; Hashim, Najihah Mohd/J-5508-2015; Kamalidehghan, Behnam/B-5401-2013; Hassandarvish, Pouya/K-8112-2012; Salama Fanous, Suzy Munir/AAX-6100-2020; MAJID, NAZIA ABDUL/B-9215-2010	Fadaeinasab, Mehran/0000-0002-2501-894X; Hashim, Najihah Mohd/0000-0003-1133-7998; Kamalidehghan, Behnam/0000-0001-8530-8124; Hassandarvish, Pouya/0000-0003-0364-5587; Salama Fanous, Suzy Munir/0000-0003-0430-1436; MAJID, NAZIA ABDUL/0000-0002-6817-8046	University of Malaya; Ministry of Higher Education Malaysia under High Impact Research Grant [UM-MOHE UM.C/625/1/HIR/MOHE/SC/09.]	University of Malaya(Universiti Malaya); Ministry of Higher Education Malaysia under High Impact Research Grant	This research has been supported by University of Malaya and Ministry of Higher Education Malaysia under High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/SC/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2013, J ETHNOPHARMACOL, V148, P277, DOI 10.1016/j.jep.2013.04.027; Abdulla MA, 2009, BIOMED RES-INDIA, V20, P35; Al Batran R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064751; Ali T, 2009, GASTROENTEROL CLIN N, V38, P245, DOI 10.1016/j.gtc.2009.03.002; Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; ALLEN A, 1980, GUT, V21, P249, DOI 10.1136/gut.21.3.249; AlRashdi AS, 2012, EVIDENCE BASED COMPL, V2012; Alvarez-Suarez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025878; [Anonymous], 1950, NATURE; Arafa HMM, 2003, PHARMACOL RES, V48, P285, DOI 10.1016/S1043-6618(03)00154-3; Balamurugan R, 2005, MOL BIOSYST, V1, P36, DOI 10.1039/b503623b; BEHMER O, 1976, MANUAL HISTOLOGIA NO; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Blandizzi C, 2000, FUNDAM CLIN PHARM, V14, P89, DOI 10.1111/j.1472-8206.2000.tb00396.x; Blandizzi C, 2005, WORLD J GASTROENTERO, V11, P4052, DOI 10.3748/wjg.v11.i26.4052; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breinbauer R, 2002, ANGEW CHEM INT EDIT, V41, P2879; Brown Lance F., 1999, Comprehensive Therapy, V25, P30, DOI 10.1007/BF02889832; Brucker MC, 1997, J NURSE-MIDWIFERY, V42, P145, DOI 10.1016/S0091-2182(97)00031-1; Brzozowski T, 2005, WORLD J GASTROENTERO, V11, P6450, DOI 10.3748/wjg.v11.i41.6450; Chemicals D., 2005, OECD GUIDELINE TESTI; Chittchang M, 2010, EUR J MED CHEM, V45, P2165, DOI 10.1016/j.ejmech.2010.01.053; CORNE SJ, 1974, J PHYSIOL-LONDON, V242, pP116; Dotevall G, 1971, CLIN VALUE GASTRIC S; Dursun H, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-36; Falcao HD, 2008, MOLECULES, V13, P3198, DOI 10.3390/molecules13123198; Golbabapour S, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/974185; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Hajrezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051537; HERENDEEN SL, 1979, J BACTERIOL, V139, P185, DOI 10.1128/JB.139.1.185-194.1979; Hirokawa M, 1998, ALCOHOL CLIN EXP RES, V22, p111S, DOI 10.1111/acer.1998.22.s3_part1.111s; Hoogerwerf WA, 2001, GOODMAN GILMANS PHAR, V10th, P1005; Ibrahim IAA, 2012, MOLECULES, V17, P2796, DOI 10.3390/molecules17032796; Ismail IF, 2012, EVIDENCE BASED COMPL, V2012; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jelski W, 2009, DIGEST DIS SCI, V54, P725, DOI 10.1007/s10620-008-0422-8; Junaidi M, 2013, INT J PHARM RES REV, V1, P380; Ketuly KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059296; Khazaei M., 2006, IRAN J PHARM THER, V5, P43; Kong DX, 2009, J CHEM INF MODEL, V49, P2376, DOI 10.1021/ci900229c; Konturek PC, 1999, J PHYSIOL PHARMACOL, V50, P211; La Casa C, 2000, J ETHNOPHARMACOL, V71, P45, DOI 10.1016/S0378-8741(99)00174-9; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; LAVAULT M, 1990, PHYTOCHEMISTRY, V29, P3845, DOI 10.1016/0031-9422(90)85344-F; Li CY, 2008, ALCOHOL, V42, P683, DOI 10.1016/j.alcohol.2008.08.009; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Mcmanus J, 1964, PAS REACTION STAININ; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nassif A, 1996, DIS COLON RECTUM, V39, P217, DOI 10.1007/BF02068079; Nordin N, 2012, PHARM BIOL, V50, P284, DOI 10.3109/13880209.2011.602416; OBERRINGER M, 1995, BIOCHEM BIOPH RES CO, V214, P1009, DOI 10.1006/bbrc.1995.2386; OECD (Organisation for Economic Co-operation and Development), 2002, SER HARM REG OV BIOT, V20, P1; Oh TY, 2005, WORLD J GASTROENTERO, V11, P7450, DOI 10.3748/wjg.v11.i47.7450; Penissi AB, 1999, DIGEST DIS SCI, V44, P708, DOI 10.1023/A:1026601506677; Perry Lily M., 1980, MED PLANTS E SE ASIA; Peskar BM, 1998, DIGEST DIS SCI, V43, p23S; Repetto MG, 2002, BRAZ J MED BIOL RES, V35, P523, DOI 10.1590/S0100-879X2002000500003; Royer M, 2011, FOOD CHEM TOXICOL, V49, P2180, DOI 10.1016/j.fct.2011.06.003; Salama SM, 2012, EVIDENCE BASED COMPL, V2012; Salama SM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/157456; Salama SM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-279; Schneeweiss S, 2006, CLIN PHARMACOL THER, V79, P379, DOI 10.1016/j.clpt.2005.12.304; Sharma RK., 2011, INT J DRUG DEV RES, V3, P351; Shichijo K, 2003, DIGEST DIS SCI, V48, P340, DOI 10.1023/A:1021939829515; Sidahmed H, 2013, EVIDENCE BASED COMPL, V2013; Sidahmed HMA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-183; Singh J., 2012, INT J PHARM SCI, V4, P412; Stermer E, 2002, ISR MED ASSOC J, V4, P200; SZABO S, 1981, SCIENCE, V214, P200, DOI 10.1126/science.7280691; Araujo DAOV, 2011, REV BRAS FARMACOGN, V21, P721, DOI 10.1590/S0102-695X2011005000117; Rios ERV, 2010, CHEM-BIOL INTERACT, V188, P246, DOI 10.1016/j.cbi.2010.07.020; Wallace JL, 1997, AM J PHYSIOL-GASTR L, V273, pG1246, DOI 10.1152/ajpgi.1997.273.6.G1246; WALLACE JL, 1992, GASTROENTEROL CLIN N, V21, P631; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; WEI YQ, 1995, CANCER IMMUNOL IMMUN, V40, P73, DOI 10.1007/s002620050146; Yadav DK, 2011, FITOTERAPIA, V82, P666, DOI 10.1016/j.fitote.2011.02.005	76	35	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111925	10.1371/journal.pone.0111925	http://dx.doi.org/10.1371/journal.pone.0111925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379712	gold, Green Submitted, Green Published			2022-12-26	WOS:000344863100047
J	Wojtal-Frankiewicz, A; Bernasinska, J; Frankiewicz, P; Gwozdzinski, K; Jurczak, T				Wojtal-Frankiewicz, Adrianna; Bernasinska, Joanna; Frankiewicz, Piotr; Gwozdzinski, Krzysztof; Jurczak, Tomasz			Response of Daphnia's Antioxidant System to Spatial Heterogeneity in Cyanobacteria Concentrations in a Lowland Reservoir	PLOS ONE			English	Article							DRINKING-WATER RESERVOIR; TOXIC CYANOBACTERIUM; OXIDATIVE STRESS; MICROCYSTIN-LR; GLUTATHIONE; BLOOMS; PHYTOPLANKTON; POPULATION; RESISTANCE; TOLERANCE	Many species and clones of Daphnia inhabit ecosystems with permanent algal blooms, and they can develop tolerance to cyanobacterial toxins. In the current study, we examined the spatial differences in the response of Daphnia longispina to the toxic Microcystis aeruginosa in a lowland eutrophic dam reservoir between June (before blooms) and September (during blooms). The reservoir showed a distinct spatial pattern in cyanobacteria abundance resulting from the wind direction: the station closest to the dam was characterised by persistently high Microcystis biomass, whereas the upstream stations had a significantly lower biomass of Microcystis. Microcystin concentrations were closely correlated with the cyanobacteria abundance (r = 0.93). The density of daphniids did not differ among the stations. The main objective of this study was to investigate how the distribution of toxic Microcystis blooms affects the antioxidant system of Daphnia. We examined catalase (CAT) activity, the level of the low molecular weight antioxidant glutathione (GSH), glutathione S-transferase (GST) activity and oxidative stress parameters, such as lipid peroxidation (LPO). We found that the higher the abundance (and toxicity) of the cyanobacteria, the lower the values of the antioxidant parameters. The CAT activity and LPO level were always significantly lower at the station with the highest M. aeruginosa biomass, which indicated the low oxidative stress of D. longispina at the site with the potentially high toxic thread. However, the low concentration of GSH and the highest activity of GST indicated the occurrence of detoxification processes at this site. These results demonstrate that daphniids that have coexisted with a high biomass of toxic cyanobacteria have effective mechanisms that protect them against the toxic effects of microcystins. We also conclude that Daphnia's resistance capacity to Microcystis toxins may differ within an ecosystem, depending on the bloom's spatial distribution.	[Wojtal-Frankiewicz, Adrianna; Frankiewicz, Piotr; Jurczak, Tomasz] Univ Lodz, Dept Appl Ecol, PL-90131 Lodz, Poland; [Bernasinska, Joanna; Gwozdzinski, Krzysztof] Univ Lodz, Dept Mol Biophys, PL-90131 Lodz, Poland	University of Lodz; University of Lodz	Wojtal-Frankiewicz, A (corresponding author), Univ Lodz, Dept Appl Ecol, PL-90131 Lodz, Poland.	adwoj@biol.uni.lodz.pl		Jurczak, Tomasz/0000-0002-1576-6741; Gwozdzinski, Krzysztof/0000-0003-2590-7496; Frankiewicz, Piotr/0000-0003-1782-9539; Bernasinska-Slomczewska, Joanna/0000-0002-1915-9834; Wojtal-Frankiewicz, Adrianna/0000-0003-3509-6076	Polish Ministry of Science and Higher Education [3988/B/P01/2010/39]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was supported by the Polish Ministry of Science and Higher Education (Grant No. 3988/B/P01/2010/39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Amado LL, 2010, ENVIRON INT, V36, P226, DOI 10.1016/j.envint.2009.10.010; Benzie JAH, 2005, GUIDES IDENTIFICATIO; Blanchette ML, 2002, UNH CTR FRESHWATER B, V4, P1; Cagnard O, 2006, WAT QUAL TECHN C WQT, P1; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; Dao TS, 2010, TOXICON, V55, P1244, DOI 10.1016/j.toxicon.2010.01.014; Demott WR, 1999, FRESHWATER BIOL, V42, P263, DOI 10.1046/j.1365-2427.1999.444494.x; Gagala I, 2013, THESIS U LODZ POLAND; Gagala I, 2014, MICROB ECOL, V67, P465, DOI 10.1007/s00248-013-0303-3; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; Izydorczyk K, 2008, INT REV HYDROBIOL, V93, P257, DOI 10.1002/iroh.200710959; Izydorczyk K, 2009, WATER RES, V43, P989, DOI 10.1016/j.watres.2008.11.048; Izydorczyk Katarzyna, 2005, Ecohydrology & Hydrobiology, V5, P195; Jiang XD, 2013, J PLANKTON RES, V35, P1177, DOI 10.1093/plankt/fbt062; Jurczak T, 2005, WATER RES, V39, P2394, DOI 10.1016/j.watres.2005.04.031; Jurczak T, 2004, CHROMATOGRAPHIA, V59, P571, DOI 10.1365/s10337-004-0279-8; KOMAREK J, 1991, ARCH HYDROBIOL, P115; Komarek J, 1999, SUSSWASSERFLORA MITT, V19; LAMPERT W, 1982, ARCH HYDROBIOL, V95, P207; Lemaire V, 2012, EVOL APPL, V5, P168, DOI 10.1111/j.1752-4571.2011.00225.x; Livingstone DR, 2003, REV MED VET-TOULOUSE, V154, P427; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Pflugmacher S, 1998, BBA-GEN SUBJECTS, V1425, P527, DOI 10.1016/S0304-4165(98)00107-X; Reichwaldt ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066674; Repka S, 1997, FRESHWATER BIOL, V38, P675, DOI 10.1046/j.1365-2427.1997.00236.x; Rice-Evans CA, 1991, LAB TECHNIQUES BIOCH, P147; Richardson TL, 2010, WATER RES, V44, P2461, DOI 10.1016/j.watres.2010.01.012; Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7; Roy S, 2008, J BIOL PHYS, V34, P459, DOI 10.1007/s10867-008-9100-5; Sarnelle O, 2005, LIMNOL OCEANOGR, V50, P1565, DOI 10.4319/lo.2005.50.5.1565; SARNELLE O, 1993, ECOL MONOGR, V63, P129, DOI 10.2307/2937177; Sarnelle O, 2010, J PLANKTON RES, V32, P471, DOI 10.1093/plankt/fbp151; Senft AP, 2000, ANAL BIOCHEM, V280, P80, DOI 10.1006/abio.2000.4498; Starmach K, 1966, FLORA SLODKOWODNA PO; STOCKS J, 1971, BRIT J HAEMATOL, V20, P95, DOI 10.1111/j.1365-2141.1971.tb00790.x; Tarczynska M, 2001, WA SCI TECHNOL, V1, P237, DOI 10.2166/ws.2001.0043; Tillmanns AR, 2008, FUND APPL LIMNOL, V171, P285, DOI 10.1127/1863-9135/2008/0171-0285; von Elert E, 2012, J EXP BIOL, V215, P2051, DOI 10.1242/jeb.068742; Wagner I., 2009, Ecohydrology and Hydrobiology, V9, P13, DOI 10.2478/V10104-009-0042-8; Wiegand C, 2005, TOXICOL APPL PHARM, V203, P201, DOI 10.1016/j.taap.2004.11.002; Wiegand C, 2002, ENVIRON TOXICOL, V17, P400, DOI 10.1002/tox.10065; Wojtal-Frankiewicz A, 2013, J LIMNOL, V72, P154, DOI 10.4081/jlimnol.2013.e13	46	15	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112597	10.1371/journal.pone.0112597	http://dx.doi.org/10.1371/journal.pone.0112597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380273	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100108
J	den Hartog, G; Jacobino, S; Bont, L; Cox, L; Ulfman, LH; Leusen, JHW; van Neerven, RJJ				den Hartog, Gerco; Jacobino, Shamir; Bont, Louis; Cox, Linda; Ulfman, Laurien H.; Leusen, Jeanette H. W.; van Neerven, R. J. Joost			Specificity and Effector Functions of Human RSV-Specific IgG from Bovine Milk	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; ACUTE OTITIS-MEDIA; IMMUNE-RESPONSE; INVERSE ASSOCIATION; CHILDHOOD ASTHMA; INFLUENZA-VIRUS; INFECTION; ANTIBODY; RECEPTOR; CONSUMPTION	Background: Respiratory syncytial virus (RSV) infection is the second most important cause of death in the first year of life, and early RSV infections are associated with the development of asthma. Breastfeeding and serum IgG have been shown to protect against RSV infection. Yet, many infants depend on bovine milk-based nutrition, which at present lacks intact immunoglobulins. Objective: To investigate whether IgG purified from bovine milk (bIgG) can modulate immune responses against human RSV. Methods: ELISAs were performed to analyse binding of bIgG to human respiratory pathogens. bIgG or hRSV was coated to plates to assess dose-dependent binding of bIgG to human Fc gamma receptors (Fc gamma R) or bIgG-mediated binding of myeloid cells to hRSV respectively. S. Epidermidis and RSV were used to test bIgG-mediated binding and internalisation of pathogens by myeloid cells. Finally, the ability of bIgG to neutralise infection of HEp2 cells by hRSV was evaluated. Results: bIgG recognised human RSV, influenza haemagglutinin and Haemophilus influenza. bIgG bound to Fc gamma RII on neutrophils, monocytes and macrophages, but not to Fc gamma RI and Fc gamma RIII, and could bind simultaneously to hRSV and human Fc gamma RII on neutrophils. In addition, human neutrophils and dendritic cells internalised pathogens that were opsonised with bIgG. Finally, bIgG could prevent infection of HEp2 cells by hRSV. Conclusions: The data presented here show that bIgG binds to hRSV and other human respiratory pathogens and induces effector functions through binding to human Fc gamma RII on phagocytes. Thus bovine IgG may contribute to immune protection against RSV.	[den Hartog, Gerco; Jacobino, Shamir; Bont, Louis; Leusen, Jeanette H. W.] UMC Utrecht, Immunotherapy Grp, Lab Translat Immunol, Utrecht, Netherlands; [den Hartog, Gerco; van Neerven, R. J. Joost] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Bont, Louis] UMC Utrecht, Dept Pediat, Utrecht, Netherlands; [Cox, Linda] Bioceros, Utrecht, Netherlands; [Ulfman, Laurien H.; van Neerven, R. J. Joost] FrieslandCampina, Amersfoort, Netherlands	Utrecht University; Utrecht University Medical Center; Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Leusen, JHW (corresponding author), UMC Utrecht, Immunotherapy Grp, Lab Translat Immunol, Utrecht, Netherlands.	jleusen@umcutrecht.nl	Hartog, Gerco den/AAB-6329-2019; , Jeanette/AAG-3736-2019; van Neerven, Joost/GWZ-3214-2022	Hartog, Gerco den/0000-0002-2103-6315; Leusen, Jeanette/0000-0003-4982-6914; van Neerven, R.J.Joost/0000-0002-3991-5297	FrieslandCampina; Bioceros	FrieslandCampina; Bioceros(Bioceros B.V.)	The study was funded by FrieslandCampina (www.frieslandcampina.com). The funder provided support in the form of salaries for authors LU and RJJvN, but FrieslandCampina did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The salary for author LC was provided by Bioceros. Bioceros did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSON CL, 1990, J EXP MED, V171, P1333, DOI 10.1084/jem.171.4.1333; Banki Z, 2003, J IMMUNOL, V170, P3963, DOI 10.4049/jimmunol.170.8.3963; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; COX RJ, 1994, VACCINE, V12, P993, DOI 10.1016/0264-410X(94)90334-4; den Hartog G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018188; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; EBINA T, 1985, MED MICROBIOL IMMUN, V174, P177, DOI 10.1007/BF02123694; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Elvander M, 1996, VET REC, V138, P101, DOI 10.1136/vr.138.5.101; ESPOSITOFARESE ME, 1995, J IMMUNOL, V155, P1725; GOSSELIN EJ, 1992, J IMMUNOL, V149, P3477; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; HILPERT H, 1987, J INFECT DIS, V156, P158, DOI 10.1093/infdis/156.1.158; Koenderman L, 2010, THROMB HAEMOSTASIS, V104, P599, DOI 10.1160/TH09-10-0740; Korhonen H, 2000, BRIT J NUTR, V84, pS135; Kramski M, 2012, EUROPEAN J IMMUNOLOG, V42; Loss G, 2011, J ALLERGY CLIN IMMUN, V128, P766, DOI 10.1016/j.jaci.2011.07.048; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maijo M, 2012, J NUTR, V142, P264, DOI 10.3945/jn.111.149070; Mohapatra SS, 2008, CLIN MICROBIOL REV, V21, P495, DOI 10.1128/CMR.00054-07; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nishimura T, 2009, PEDIATR INT, V51, P812, DOI 10.1111/j.1442-200X.2009.02877.x; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Oddy WH, 2004, J ASTHMA, V41, P605, DOI 10.1081/JAS-200026402; OGILVIE MM, 1981, J MED VIROL, V7, P263, DOI 10.1002/jmv.1890070403; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Perez-Yarza EG, 2007, PEDIATR INFECT DIS J, V26, P733, DOI 10.1097/INF.0b013e3180618c42; Perkin MR, 2006, J ALLERGY CLIN IMMUN, V117, P1374, DOI 10.1016/j.jaci.2006.03.008; Pitkaranta A, 1998, PEDIATRICS, V102, P291, DOI 10.1542/peds.102.2.291; Regnier SA, 2013, PEDIATR INFECT DIS J, V32, P820, DOI 10.1097/INF.0b013e31829061e8; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; RUUSKANEN O, 1989, PEDIATR INFECT DIS J, V8, P94; STEVENS SK, 1982, J IMMUNOL, V128, P844; van der Poel CE, 2010, BLOOD, V116, P5327, DOI 10.1182/blood-2010-04-280214; van Neerven RJJ, 2012, J ALLERGY CLIN IMMUN, V130, P853, DOI 10.1016/j.jaci.2012.06.050; VANDERPOEL WHM, 1993, ARCH VIROL, V133, P309, DOI 10.1007/BF01313771; Walsh EE, 2004, J INFECT DIS, V190, P373, DOI 10.1086/421524; Waser M, 2007, CLIN EXP ALLERGY, V37, P661, DOI 10.1111/j.1365-2222.2006.02640.x; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Wilson SD, 2000, J MED VIROL, V61, P81, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;81::AID-JMV13&gt;3.0.CO;2-O	47	22	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112047	10.1371/journal.pone.0112047	http://dx.doi.org/10.1371/journal.pone.0112047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375837	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600095
J	Floor, SL; Hebrant, A; Pita, JM; Saiselet, M; Tresallet, C; Libert, F; Andry, G; Dumont, JE; van Staveren, WC; Maenhaut, C				Floor, Sebastien L.; Hebrant, Aline; Pita, Jaime M.; Saiselet, Manuel; Tresallet, Christophe; Libert, Frederick; Andry, Guy; Dumont, Jacques E.; van Staveren, Wilma C.; Maenhaut, Carine			MiRNA Expression May Account for Chronic but Not for Acute Regulation of mRNA Expression in Human Thyroid Tumor Models	PLOS ONE			English	Article							GENE-EXPRESSION; CELL PROLIFERATION; HUMAN THYROCYTES; CANCER-CELLS; IN-VITRO; CARCINOMAS; MICRORNAS; THYROTROPIN; PHENOTYPE; GROWTH	Background: For thyroid tumorigenesis, two main human in vitro models are available: primary cultures of human thyrocytes treated with TSH or EGF/serum as models for autonomous adenomas (AA) or papillary thyroid carcinomas (PTC) respectively, and human thyroid tumor derived cell lines. Previous works of our group have assessed properties of those models, with a special emphasis on mRNA regulations. It is often assumed that miRNA may be one of the primary events inducing these mRNA regulations. Methods: The purpose of this study was to investigate the representativity of those models to study microRNA regulations and their relation with mRNA expression. To achieve this aim, the miRNA expressions profiles of primary cultures treated with TSH or EGF/serum and of 6 thyroid cancer cell lines were compared to the expression profiles of 35 tumor tissues obtained by microarrays. Results: Our data on primary cultures have shown that the TSH or EGF/serum treatment did not greatly modify the microRNA expression profiles, which is contrary to what is observed for mRNA expression profiles, although they still evolved differently according to the treatment. The analysis of miRNA and mRNA expressions profiles in the cell lines has shown that they have evolved into a common, dedifferentiated phenotype, closer to ATC than to the tumors they are derived from. Conclusions: Long-terms TSH or EGF/serum treatments do not mimic AA or PTC respectively in terms of miRNA expression as they do for mRNA, suggesting that the regulations of mRNA expression induced by these physiological agents occur independently of miRNA. The general patterns of miRNA expression in the cell lines suggest that they represent a useful model for undifferentiated thyroid cancer. Mirna probably do not mediate the rapid changes in gene expression in rapid cell biology regulation.	[Floor, Sebastien L.; Hebrant, Aline; Pita, Jaime M.; Saiselet, Manuel; Libert, Frederick; Dumont, Jacques E.; van Staveren, Wilma C.; Maenhaut, Carine] Free Univ Brussels ULB, Inst Interdisciplinary Res IRIBHM, Brussels, Belgium; [Maenhaut, Carine] Free Univ Brussels, Welbio, Brussels, Belgium; [Tresallet, Christophe] Univ Paris 06, Pitie Salpetriere Hosp, Paris, France; [Andry, Guy] Inst J Bordet, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; WELBIO; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut Jules Bordet	Maenhaut, C (corresponding author), Free Univ Brussels ULB, Inst Interdisciplinary Res IRIBHM, Brussels, Belgium.	cmaenhau@ulb.ac.be		andry, guy/0000-0001-7410-6519	Fonds de la Recherche Scientifique FNRS-FRSM; Welbio; Fondation contre le Cancer; FRIA; Fondation Van Buuren; les Amis de l'Institut Bordet	Fonds de la Recherche Scientifique FNRS-FRSM(Fonds de la Recherche Scientifique - FNRS); Welbio(WELBIO); Fondation contre le Cancer; FRIA(Fonds de la Recherche Scientifique - FNRS); Fondation Van Buuren; les Amis de l'Institut Bordet	Funding sources for this study were provided by the Fonds de la Recherche Scientifique FNRS-FRSM, Welbio, Fondation contre le Cancer, FRIA, Fondation Van Buuren, les Amis de l'Institut Bordet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama T, 2012, MOL ENDOCRINOL, V26, P493, DOI 10.1210/me.2011-1004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Corvilain B, 2001, CLIN ENDOCRINOL, V55, P143, DOI 10.1046/j.1365-2265.2001.01365.x; Delys L, 2007, ONCOGENE, V26, P7894, DOI 10.1038/sj.onc.1210588; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hebrant A, 2007, EXP CELL RES, V313, P3276, DOI 10.1016/j.yexcr.2007.06.019; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Leone V, 2012, J CLIN ENDOCR METAB, V97, P3292, DOI 10.1210/jc.2012-1349; Leone V, 2011, MOL ENDOCRINOL, V25, P1819, DOI 10.1210/me.2011-0014; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Pallante P, 2014, NAT REV ENDOCRINOL, V10, P88, DOI 10.1038/nrendo.2013.223; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROGER P, 1988, J CLIN ENDOCR METAB, V66, P1158, DOI 10.1210/jcem-66-6-1158; Roger PP, 2010, MOL CELL ENDOCRINOL, V321, P3, DOI 10.1016/j.mce.2009.11.015; Roger PP, 1997, EUR J ENDOCRINOL, V137, P579, DOI 10.1530/eje.0.1370579; Saiselet Manuel, 2012, Front Endocrinol (Lausanne), V3, P133, DOI 10.3389/fendo.2012.00133; Saito T, 1997, J CLIN ENDOCR METAB, V82, P3331, DOI 10.1210/jc.82.10.3331; Schweppe RE, 2013, J CLIN ENDOCR METAB, V98, P956, DOI 10.1210/jc.2012-4182; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; van Staveren WCG, 2006, P NATL ACAD SCI USA, V103, P413, DOI 10.1073/pnas.0507354102; van Staveren WCG, 2007, CANCER RES, V67, P8113, DOI 10.1158/0008-5472.CAN-06-4026; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Zang SZ, 2007, J BIOMED INFORM, V40, P552, DOI 10.1016/j.jbi.2007.01.002	31	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111581	10.1371/journal.pone.0111581	http://dx.doi.org/10.1371/journal.pone.0111581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375362	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600048
J	Illa, X; Vila, S; Yeste, J; Peralta, C; Gracia-Sancho, J; Villa, R				Illa, Xavi; Vila, Sergi; Yeste, Jose; Peralta, Carmen; Gracia-Sancho, Jordi; Villa, Rosa			A Novel Modular Bioreactor to In Vitro Study the Hepatic Sinusoid	PLOS ONE			English	Article							ORGANS-ON-CHIPS; SHEAR-STRESS; CELL-CULTURE; HEPATOCYTE CULTURE; ENDOTHELIAL-CELLS; DRUG DISCOVERY; BARRIER; STRATEGIES; CIRRHOSIS; RELEASE	We describe a unique, versatile bioreactor consisting of two plates and a modified commercial porous membrane suitable for in vitro analysis of the liver sinusoid. The modular bioreactor allows i) excellent control of the cell seeding process; ii) cell culture under controlled shear stress stimulus, and; iii) individual analysis of each cell type upon completion of the experiment. The advantages of the bioreactor detailed here are derived from the modification of a commercial porous membrane with an elastomeric wall specifically moulded in order to define the cell culture area, to act as a gasket that will fit into the bioreactor, and to provide improved mechanical robustness. The device presented herein has been designed to simulate the in vivo organization of a liver sinusoid and tested by co-culturing endothelial cells (EC) and hepatic stellate cells (HSC). The results show both an optimal morphology of the endothelial cells as well as an improvement in the phenotype of stellate cells, most probably due to paracrine factors released from endothelial cells. This device is proposed as a versatile, easy-to-use co-culture system that can be applied to biomedical research of vascular systems, including the liver.	[Illa, Xavi; Yeste, Jose; Villa, Rosa] CSIC, IMB CNM, Inst Microelect Barcelona, Bellaterra, Spain; [Illa, Xavi; Yeste, Jose; Villa, Rosa] CIBER BBN, Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Barcelona, Spain; [Vila, Sergi; Gracia-Sancho, Jordi] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer, Barcelona Hepat Hemodynam Lab, Barcelona, Spain; [Peralta, Carmen] IDIBAPS, Barcelona, Spain; [Peralta, Carmen] CIBER EHD, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Microelectronica de Barcelona (IMB-CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Illa, X (corresponding author), CSIC, IMB CNM, Inst Microelect Barcelona, Bellaterra, Spain.	xavier.illa@imb-cnm.csic.es; jgracia@clinic.ub.es	Villa, Rosa/AAC-1671-2020; Lozano, Jose Yeste/B-1194-2019; Peralta, Carmen/M-8170-2014; Villa, Rosa/A-6664-2015; Illa, Xavi/A-3523-2013; VILA, SERGI/G-5771-2015; Gracia-Sancho, Jordi/C-8920-2014	Villa, Rosa/0000-0003-2735-3204; Lozano, Jose Yeste/0000-0001-7540-7305; Peralta, Carmen/0000-0002-5767-0676; Villa, Rosa/0000-0003-2735-3204; Illa, Xavi/0000-0002-3212-1128; VILA, SERGI/0000-0003-1706-3916; Gracia-Sancho, Jordi/0000-0001-7736-4089	CSIC [PIE 201450E116]; Instituto de Salud Carlos III [FIS PI11/00235]; Ministerio de Economia y Competitividad [SAF2012-31238]; European Union (Fondos FEDER, "una manera de hacer Europa''); European Community's Seventh Framework Programme (EC FP7) [229673]; CIBER-EHD - Instituto de Salud Carlos III; CIBER-BBN - Instituto de Salud Carlos III	CSIC; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia y Competitividad(Spanish Government); European Union (Fondos FEDER, "una manera de hacer Europa''); European Community's Seventh Framework Programme (EC FP7); CIBER-EHD - Instituto de Salud Carlos III(Instituto de Salud Carlos III); CIBER-BBN - Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This work was supported by: CSIC (PIE 201450E116) (RV); Instituto de Salud Carlos III (FIS PI11/00235) (JGS); Ministerio de Economia y Competitividad (SAF2012-31238) (CP); European Union (Fondos FEDER, "una manera de hacer Europa'') (JGS and CP); European Community's Seventh Framework Programme (EC FP7/2007-2013, grant agreement 229673) (JGS); CIBER-EHD (funded by Instituto de Salud Carlos III) (JGS and CP); and CIBER-BBN (funded by Instituto de Salud Carlos III) (RV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacabac RG, 2005, J BIOMECH, V38, P159, DOI 10.1016/j.jbiomech.2004.03.020; Baker M, 2011, NATURE, V471, P661, DOI 10.1038/471661a; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3; Capulli AK, 2014, LAB CHIP, V14, P3181, DOI 10.1039/c4lc00276h; Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3; Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9; Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Ebrahimkhani MR, 2014, ADV DRUG DELIVER REV, V69, P132, DOI 10.1016/j.addr.2014.02.011; Epshteyn AA, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3647824; Garcia-Pagan JC, 2012, J HEPATOL, V57, P458, DOI 10.1016/j.jhep.2012.03.007; Gemmiti CV, 2006, TISSUE ENG, V12, P469, DOI 10.1089/ten.2006.12.469; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Goral VN, 2010, LAB CHIP, V10, P3380, DOI 10.1039/c01c00135j; Gracia-Sancho J, 2008, HEPATOLOGY, V47, P1248, DOI 10.1002/hep.22166; Gracia-Sancho J, 2010, TRANSPLANTATION, V90, P142, DOI 10.1097/TP.0b013e3181e228db; Griep LM, 2013, BIOMED MICRODEVICES, V15, P145, DOI 10.1007/s10544-012-9699-7; Hennenberg M, 2011, LAB INVEST, V91, P241, DOI 10.1038/labinvest.2010.148; Hide D, 2014, CLIN SCI, V127, P527, DOI 10.1042/CS20140125; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Inamdar NK, 2011, CURR OPIN BIOTECH, V22, P681, DOI 10.1016/j.copbio.2011.05.512; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Kabirian F, 2015, J BIOMED MATER RES A, V103, P1231, DOI 10.1002/jbm.a.35233; Kang Y. B., 2013, 2013 Transducers & Eurosensors XXVII: 17th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS & EUROSENSORS XXVII), P301, DOI 10.1109/Transducers.2013.6626762; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; LeCluyse EL, 1996, ADV DRUG DELIVER REV, V22, P133, DOI 10.1016/S0169-409X(96)00418-8; Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360; Marrone G, 2013, J HEPATOL, V58, P98, DOI 10.1016/j.jhep.2012.08.026; Materne EM, 2013, LAB CHIP, V13, P3481, DOI 10.1039/c3lc50240f; Meissner R, 2011, LAB CHIP, V11, P2352, DOI 10.1039/c1lc20212j; Morimoto Y, 2013, BIOMATER SCI-UK, V1, P257, DOI 10.1039/c2bm00117a; Park J, 2005, BIOTECHNOL BIOENG, V90, P632, DOI 10.1002/bit.20463; Polini A, 2014, EXPERT OPIN DRUG DIS, V9, P335, DOI 10.1517/17460441.2014.886562; Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143; Rosado E, 2012, J CELL MOL MED, V16, P2461, DOI 10.1111/j.1582-4934.2012.01563.x; Sung JH, 2009, LAB CHIP, V9, P1385, DOI 10.1039/b901377f; van de Stolpe A, 2013, LAB CHIP, V13, P3449, DOI 10.1039/c3lc50248a; van der Meer AD, 2012, INTEGR BIOL-UK, V4, P461, DOI 10.1039/c2ib00176d; van Midwoud PM, 2010, BIOTECHNOL BIOENG, V105, P184, DOI 10.1002/bit.22516; Vion AC, 2013, CIRC RES, V112, P1323, DOI 10.1161/CIRCRESAHA.112.300818; Vozzi F, 2014, BIOTECHNOL J, V9, P146, DOI 10.1002/biot.201300016; Yum K, 2014, BIOTECHNOL J, V9, P16, DOI 10.1002/biot.201300187; Zhang MY, 2008, BIOMED MICRODEVICES, V10, P117, DOI 10.1007/s10544-007-9116-9	45	27	28	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111864	10.1371/journal.pone.0111864	http://dx.doi.org/10.1371/journal.pone.0111864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375141	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600071
J	Sato, Y; Miyauchi, Y; Yoshida, S; Morita, M; Kobayashi, T; Kanagawa, H; Katsuyama, E; Fujie, A; Hao, W; Tando, T; Watanabe, R; Miyamoto, K; Morioka, H; Matsumoto, M; Toyama, Y; Miyamoto, T				Sato, Yuiko; Miyauchi, Yoshiteru; Yoshida, Shigeyuki; Morita, Mayu; Kobayashi, Tami; Kanagawa, Hiroya; Katsuyama, Eri; Fujie, Atsuhiro; Hao, Wu; Tando, Toshimi; Watanabe, Ryuichi; Miyamoto, Kana; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi			The Vitamin D Analogue ED71 but Not 1,25(OH)(2)D-3 Targets HIF1 alpha Protein in Osteoclasts	PLOS ONE			English	Article							BODY GIANT-CELLS; D-RECEPTOR; IMMUNOCYTOCHEMICAL LOCALIZATION; OSTEOPOROTIC FRACTURES; BONE; 1,25-DIHYDROXYVITAMIN-D3; DIFFERENTIATION; OSTEOBLASTS; METABOLISM; DISEASE	Although both an active form of the vitamin D metabolite, 1,25(OH)(2)D-3, and the vitamin D analogue, ED71 have been used to treat osteoporosis, anti-bone resorbing activity is reportedly seen only in ED71-but not in 1,25(OH)(2)D-3-treated patients. In addition, how ED71 inhibits osteoclast activity in patients has not been fully characterized. Recently, HIF1 alpha expression in osteoclasts was demonstrated to be required for development of post-menopausal osteoporosis. Here we show that ED71 but not 1,25(OH)(2)D-3, suppress HIF1 alpha protein expression in osteoclasts in vitro. We found that 1,25(OH)(2)D-3 or ED71 function in osteoclasts requires the vitamin D receptor (VDR). ED71 was significantly less effective in inhibiting M-CSF and RANKL-stimulated osteoclastogenesis than was 1,25(OH)(2)D-3 in vitro. Downregulation of c-Fos protein and induction of Ifn beta mRNA in osteoclasts, both of which reportedly block osteoclastogenesis induced by 1,25(OH)(2)D-3 in vitro, were both significantly higher following treatment with 1,25(OH)(2)D-3 than with ED71. Thus, suppression of HIF1 alpha protein activity in osteoclasts in vitro, which is more efficiently achieved by ED71 rather than by 1,25(OH)(2)D-3, could be a reliable read-out in either developing or screening reagents targeting osteoporosis.	[Sato, Yuiko; Miyauchi, Yoshiteru; Kobayashi, Tami; Kanagawa, Hiroya; Katsuyama, Eri; Fujie, Atsuhiro; Hao, Wu; Tando, Toshimi; Watanabe, Ryuichi; Miyamoto, Kana; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan; [Sato, Yuiko] Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Shinjuku Ku, Tokyo, Japan; [Yoshida, Shigeyuki; Morita, Mayu] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, Tokyo, Japan; [Kobayashi, Tami; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Integrated Bone Metab & Immunol, Shinjuku Ku, Tokyo, Japan	Keio University; Keio University; Keio University; Keio University	Miyamoto, T (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan.	miyamoto@z5.keio.jp	hao, wu/HDM-1705-2022					BERGER U, 1988, J CLIN ENDOCR METAB, V67, P607, DOI 10.1210/jcem-67-3-607; BOIVIN G, 1987, BONE MINER, V3, P125; CLEMENS TL, 1988, ENDOCRINOLOGY, V122, P1224, DOI 10.1210/endo-122-4-1224; Ettinger B, 1998, J CLIN ENDOCR METAB, V83, P2239, DOI 10.1210/jc.83.7.2239; Johnson JA, 1996, J BONE MINER RES, V11, P56; Kikuta J, 2013, P NATL ACAD SCI USA, V110, P7009, DOI 10.1073/pnas.1218799110; Langub MC, 2000, BONE, V27, P383, DOI 10.1016/S8756-3282(00)00335-5; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Mee AP, 1996, BONE, V18, P295, DOI 10.1016/8756-3282(96)00011-7; Menaa C, 2000, J BONE MINER RES, V15, P228, DOI 10.1359/jbmr.2000.15.2.228; MERKE J, 1986, J CLIN INVEST, V77, P312, DOI 10.1172/JCI112292; Migliorati CA, 2003, J CLIN ONCOL, V21, P4253, DOI 10.1200/JCO.2003.99.132; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Miyauchi Y, 2013, P NATL ACAD SCI USA, V110, P16568, DOI 10.1073/pnas.1308755110; NARBAITZ R, 1981, J HISTOCHEM CYTOCHEM, V29, P91, DOI 10.1177/29.1.7009732; Nelson ER, 2013, BONE, V53, P42, DOI 10.1016/j.bone.2012.11.011; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Report of a WHO Study Group, 1994, WHO TECH REP SER, V10, P1; Sakai S, 2009, J BONE MINER METAB, V27, P643, DOI 10.1007/s00774-009-0084-4; Sakuma M, 2011, J ORTHOP SCI, V16, P418, DOI 10.1007/s00776-011-0089-4; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803; Wang YJ, 2014, J BONE MINER RES, V29, P685, DOI 10.1002/jbmr.2081; Winzenberg T, 2013, CALCIFIED TISSUE INT, V92, P140, DOI 10.1007/s00223-012-9615-4; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	31	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111845	10.1371/journal.pone.0111845	http://dx.doi.org/10.1371/journal.pone.0111845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375896	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600068
J	Yao, X; Durr, UHN; Gattin, Z; Laukat, Y; Narayanan, RL; Bruckner, AK; Meisinger, C; Lange, A; Becker, S; Zweckstetter, M				Yao, Xuejun; Duerr, Ulrich H. N.; Gattin, Zrinka; Laukat, Yvonne; Narayanan, Rhagavendran L.; Brueckner, Ann-Kathrin; Meisinger, Chris; Lange, Adam; Becker, Stefan; Zweckstetter, Markus			NMR-Based Detection of Hydrogen/Deuterium Exchange in Liposome-Embedded Membrane Proteins	PLOS ONE			English	Article							SOLID-STATE NMR; DEPENDENT ANION CHANNEL; HYDROGEN-DEUTERIUM EXCHANGE; DYNAMIC CHARACTERIZATION; RESONANCE ASSIGNMENT; 2-DIMENSIONAL NMR; MASS-SPECTROMETRY; AMYLOID FIBRILS; APSY-NMR; SPECTROSCOPY	Membrane proteins play key roles in biology. Determination of their structure in a membrane environment, however, is highly challenging. To address this challenge, we developed an approach that couples hydrogen/deuterium exchange of membrane proteins to rapid unfolding and detection by solution-state NMR spectroscopy. We show that the method allows analysis of the solvent protection of single residues in liposome-embedded proteins such as the 349-residue Tom40, the major protein translocation pore in the outer mitochondrial membrane, which has resisted structural analysis for many years.	[Yao, Xuejun; Duerr, Ulrich H. N.; Gattin, Zrinka; Laukat, Yvonne; Narayanan, Rhagavendran L.; Brueckner, Ann-Kathrin; Lange, Adam; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Meisinger, Chris] Univ Freiburg, Inst Biochem & Molekularbiol, ZBMZ, D-79106 Freiburg, Germany; [Meisinger, Chris] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, Goottingen, Germany; [Zweckstetter, Markus] Univ Med Ctr, Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany	Max Planck Society; University of Freiburg; University of Freiburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen	Zweckstetter, M (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.	Markus.Zweckstetter@dzne.de	Meisinger, Chris/J-1110-2014	Meisinger, Chris/0000-0002-8326-3548; Zweckstetter, Markus/0000-0002-2536-6581; Lange, Adam/0000-0002-7534-5973	ERC [282008]; Marie Curie fellowship within the 7th EU Framework Programme; DFG collaborative research center [803]; Emmy Noether fellowship	ERC(European Research Council (ERC)European Commission); Marie Curie fellowship within the 7th EU Framework Programme; DFG collaborative research center(German Research Foundation (DFG)); Emmy Noether fellowship(German Research Foundation (DFG))	ERC (grant agreement number 282008) to M Zweckstetter; Marie Curie fellowship within the 7th EU Framework Programme to Z Gattin; DFG collaborative research center 803 and Emmy Noether fellowship to A Lange. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus M, 1996, J MAGN RESON SER A, V121, P65, DOI 10.1006/jmra.1996.0137; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Bockmann A, 2005, J BIOMOL NMR, V32, P195, DOI 10.1007/s10858-005-8073-y; Catoire LJ, 2010, EUR BIOPHYS J BIOPHY, V39, P623, DOI 10.1007/s00249-009-0513-2; Chill JH, 2007, BBA-BIOMEMBRANES, V1768, P3260, DOI 10.1016/j.bbamem.2007.08.006; Chill JH, 2011, CURR OPIN STRUC BIOL, V21, P627, DOI 10.1016/j.sbi.2011.07.003; Cho MK, 2011, PROTEIN SCI, V20, P387, DOI 10.1002/pro.570; Cross TA, 2011, TRENDS BIOCHEM SCI, V36, P117, DOI 10.1016/j.tibs.2010.07.005; Csizmok V, 2008, J AM CHEM SOC, V130, P16873, DOI 10.1021/ja805510b; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEMPSEY CE, 1994, J BIOMOL NMR, V4, P879, DOI 10.1007/BF00398417; Eddy MT, 2012, J AM CHEM SOC, V134, P6375, DOI 10.1021/ja300347v; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Fernandez C, 2004, J MOL BIOL, V336, P1211, DOI 10.1016/j.jmb.2003.09.014; Fiorito F, 2006, J BIOMOL NMR, V35, P27, DOI 10.1007/s10858-006-0030-x; Gopinath T, 2013, PROG NUCL MAG RES SP, V75, P50, DOI 10.1016/j.pnmrs.2013.07.004; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Hebling CM, 2010, ANAL CHEM, V82, P5415, DOI 10.1021/ac100962c; Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2007, J AM CHEM SOC, V129, P10823, DOI 10.1021/ja072564+; Hong M, 2012, ANNU REV PHYS CHEM, V63, P1, DOI 10.1146/annurev-physchem-032511-143731; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Ippel JH, 2002, P NATL ACAD SCI USA, V99, P8648, DOI 10.1073/pnas.132098999; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Knight MJ, 2012, P NATL ACAD SCI USA, V109, P11095, DOI 10.1073/pnas.1204515109; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Marassi FM, 2011, METHODS, V55, P363, DOI 10.1016/j.ymeth.2011.09.009; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; Murray DT, 2013, ACCOUNTS CHEM RES, V46, P2172, DOI 10.1021/ar3003442; Narayanan RL, 2010, J AM CHEM SOC, V132, P11906, DOI 10.1021/ja105657f; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nietlispach D, 2011, CURR OPIN STRUC BIOL, V21, P497, DOI 10.1016/j.sbi.2011.06.009; Novacek J, 2013, J BIOMOL NMR, V56, P291, DOI 10.1007/s10858-013-9761-7; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Perry AJ, 2008, PLANT PHYSIOL BIOCH, V46, P265, DOI 10.1016/j.plaphy.2007.12.012; Qureshi T, 2012, TOP CURR CHEM, V326, P123, DOI 10.1007/128_2011_306; Radoicic J, 2014, Q REV BIOPHYS, V47, P249, DOI 10.1017/S0033583514000080; Rey M, 2010, J BIOL CHEM, V285, P34981, DOI 10.1074/jbc.M110.146209; Schanda P, 2007, P NATL ACAD SCI USA, V104, P11257, DOI 10.1073/pnas.0702069104; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; Tian CL, 2003, PROTEIN SCI, V12, P2597, DOI 10.1110/ps.03168503; Tong KI, 2008, J BIOMOL NMR, V42, P59, DOI 10.1007/s10858-008-9264-0; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Van Melckebeke H, 2011, J MOL BIOL, V405, P765, DOI 10.1016/j.jmb.2010.11.004; Vilar M, 2012, METHODS MOL BIOL, V849, P185, DOI 10.1007/978-1-61779-551-0_13; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	54	3	3	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112374	10.1371/journal.pone.0112374	http://dx.doi.org/10.1371/journal.pone.0112374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375235	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600137
J	Chen, X; Hirt, H; Li, YP; Gorr, SU; Aparicio, C				Chen, Xi; Hirt, Helmut; Li, Yuping; Gorr, Sven-Ulrik; Aparicio, Conrado			Antimicrobial GL13K Peptide Coatings Killed and Ruptured the Wall of Streptococcus gordonii and Prevented Formation and Growth of Biofilms	PLOS ONE			English	Article							IMPLANT-ASSOCIATED INFECTIONS; SALIVARY FLOW-RATE; PORPHYROMONAS-GINGIVALIS; PERIPROSTHETIC INFECTION; BACTERIAL-COLONIZATION; COATED TITANIUM; TEICHOIC-ACID; SURFACE; ANTIBACTERIAL; DEFICIENCY	Infection is one of the most prevalent causes for dental implant failure. We have developed a novel antimicrobial peptide coating on titanium by immobilizing the antimicrobial peptide GL13K. GL13K was developed from the human salivary protein BPIFA2. The peptide exhibited MIC of 8 mu g/ml against planktonic Pseudonomas aeruginosa and their biofilms were reduced by three orders of magnitude with 100 mu g/ml GL13K. This peptide concentration also killed 100% of Streptococcus gordonii. At 1 mg/ml, GL13K caused less than 10% lysis of human red blood cells, suggesting low toxicity to mammalian cells. Our GL13K coating has also previously showed bactericidal effect and inhibition of biofilm growth against peri-implantitis related pathogens, such as Porphyromonas gingivalis. The GL13K coating was cytocompatible with human fibroblasts and osteoblasts. However, the bioactivity of antimicrobial coatings has been commonly tested under (quasi) static culture conditions that are far from simulating conditions for biofilm formation and growth in the oral cavity. Oral salivary flow over a coating is persistent, applies continuous shear forces, and supplies sustained nutrition to bacteria. This accelerates bacteria metabolism and biofilm growth. In this work, the antimicrobial effect of the coating was tested against Streptococcus gordonii, a primary colonizer that provides attachment for the biofilm accretion by P. gingivalis, using a drip-flow biofilm bioreactor with media flow rates simulating salivary flow. The GL13K peptide coatings killed bacteria and prevented formation and growth of S. gordonii biofilms in the drip-flow bioreactor and under regular mild-agitation conditions. Surprisingly the interaction of the bacteria with the GL13K peptide coatings ruptured the cell wall at their septum or polar areas leaving empty shell-like structures or exposed protoplasts. The cell wall rupture was not detected under regular culture conditions, suggesting that cell wall rupture induced by GL13K peptides also requires media flow and possible attendant biological sequelae of the conditions in the bioreactor.	[Chen, Xi; Li, Yuping; Aparicio, Conrado] Univ Minnesota, Sch Dent, Minnesota Dent Res Ctr Biomat & Biomech, Dept Restorat Sci, Minneapolis, MN 55455 USA; [Hirt, Helmut; Gorr, Sven-Ulrik] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Aparicio, C (corresponding author), Univ Minnesota, Sch Dent, Minnesota Dent Res Ctr Biomat & Biomech, Dept Restorat Sci, Minneapolis, MN 55455 USA.	apari003@umn.edu	Li, Yuping/H-5259-2013; Aparicio, Conrado/J-9903-2012	Li, Yuping/0000-0002-2506-1155; Aparicio, Conrado/0000-0003-2969-6067	3M Foundation; 3M Non-tenured Faculty Award; Office of the Vice-president for Research at the University of Minnesota; Research, Artistry and Scholarship Program [55466]; U.S. Public Health Service - National Institute of Dental and Craniofacial Research [R01DE017989, R90DE023058]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017989, R90DE023058] Funding Source: NIH RePORTER	3M Foundation(3M); 3M Non-tenured Faculty Award(3M); Office of the Vice-president for Research at the University of Minnesota; Research, Artistry and Scholarship Program; U.S. Public Health Service - National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by 3M Foundation (http://solutions.3m.com/wps/portal/3M/en_US/Community-Giving/US-Home), 3M Non-tenured Faculty Award to CA; The Office of the Vice-president for Research at the University of Minnesota (http://www.research.umn.edu), Project #55466 of the Grant-in-Aid of Research, Artistry and Scholarship Program to CA; U.S. Public Health Service - National Institute of Dental and Craniofacial Research, (http://www.nidcr.nih.gov) R01DE017989, to S.U.G; U.S. Public Health Service - National Institute of Dental and Craniofacial Research, (http://www.nidcr.nih.gov; R90DE023058), to XC. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolhosseini M, 2012, PEPTIDES, V35, P231, DOI 10.1016/j.peptides.2012.03.017; Antoci V, 2007, CLIN ORTHOP RELAT R, P81, DOI 10.1097/BLO.0b013e3181123a50; Antoci V, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO.0b013e318073c2b2; Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348; Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016; Balhara V, 2013, BBA-BIOMEMBRANES, V1828, P2193, DOI 10.1016/j.bbamem.2013.05.027; Bazaka K, 2012, APPL MICROBIOL BIOT, V95, P299, DOI 10.1007/s00253-012-4144-7; Biswas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041415; Bizzini A, 2007, MICROBIOL-SGM, V153, P490, DOI 10.1099/mic.0.29256-0; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528; Chan KG, 2007, INFECT IMMUN, V75, P3033, DOI 10.1128/IAI.01549-06; Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003; Chen X., 2013, BIOL MED PHYS BIOMED, P105, DOI DOI 10.1007/978-94-007-2592-8_4; Chen X, 2013, COLLOID SURFACE B, V107, P189, DOI 10.1016/j.colsurfb.2013.02.005; Cook GS, 1998, J PERIODONTAL RES, V33, P323, DOI 10.1111/j.1600-0765.1998.tb02206.x; DAWES C, 1972, J PHYSIOL-LONDON, V220, P529, DOI 10.1113/jphysiol.1972.sp009721; Domingues MM, 2014, NANOMED-NANOTECHNOL, V10, P543, DOI 10.1016/j.nano.2013.11.002; Fenoll-Palomares C, 2004, REV ESP ENFERM DIG, V96, P773; Furst MM, 2007, CLIN ORAL IMPLAN RES, V18, P501, DOI 10.1111/j.1600-0501.2007.01381.x; Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013; Hirt H, 2013, ANTIMICROB AGENTS CH, V57, P4903, DOI 10.1128/AAC.00311-13; Holmberg KV, 2013, ACTA BIOMATER, V9, P8224, DOI 10.1016/j.actbio.2013.06.017; Jahoda D, 2006, Acta Chir Orthop Traumatol Cech, V73, P108; Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036; Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035; Kim WH, 2008, SURF INTERFACE ANAL, V40, P202, DOI 10.1002/sia.2809; Koprivnjak T, 2008, INFECT IMMUN, V76, P2169, DOI 10.1128/IAI.01705-07; Koyanagi T, 2013, J CLIN PERIODONTOL, V40, P218, DOI 10.1111/jcpe.12047; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4; MADIGAN MT, 2002, BROCK BIOL MICROORGA; Moy PK, 2005, INT J ORAL MAX IMPL, V20, P569; Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037; Sawant SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063311; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x	39	53	56	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111579	10.1371/journal.pone.0111579	http://dx.doi.org/10.1371/journal.pone.0111579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372402	gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900055
J	Kacik, M; Olivan-Viguera, A; Kohler, R				Kacik, Michael; Olivan-Viguera, Aida; Koehler, Ralf			Modulation of K(Ca)3.1 Channels by Eicosanoids, Omega-3 Fatty Acids, and Molecular Determinants	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNELS; VASCULAR SMOOTH-MUSCLE; INTERMEDIATE-CONDUCTANCE; EPOXYEICOSATRIENOIC ACIDS; FATTY-ACIDS; DOCOSAHEXAENOIC ACID; K(V)1.3 CHANNELS; KCA3.1; PHARMACOLOGY	Background: Cytochrome P450- and omega-hydrolase products (epoxyeicosatrienoic acids (EETs), hydroxyeicosatetraeonic acid (20-HETE)), natural omega-3 fatty acids (omega 3), and pentacyclic triterpenes have been proposed to contribute to a wide range of vaso-protective and anti-fibrotic/anti-cancer signaling pathways including the modula-tion of membrane ion channels. Here we studied the modulation of intermediate-conductance Ca2+/calmodulin-regulated K+ channels (K(Ca)3.1) by EETs, 20-HETE, omega 3, and pentacyclic triterpenes and the structural requirements of these fatty acids to exert channel blockade. Methodology/Principal Findings: We studied modulation of cloned human hK(Ca)3.1 and the mutant hK(Ca)3.1(V275A) in HEK-293 cells, of rK(Ca)3.1 in aortic endothelial cells, and of mK(Ca)3.1 in 3T3-fibroblasts by inside-out and whole-cell patch-clamp experiments, respectively. In inside-out patches, Ca2+-activated hK(Ca)3.1 were inhibited by the omega 3, DHA and alpha-LA, and the omega 6, AA, in the lower mu molar range and with similar potencies. 5,6-EET, 8,9-EET, 5,6-DiHETE, and saturated arachidic acid, had no appreciable effects. In contrast, 14,15-EET, its stable derivative, 14,15-EEZE, and 20-HETE produced channel inhibition. 11,12-EET displayed less inhibitory activity. The K(Ca)3.1(V275A) mutant channel was insensitive to any of the blocking EETs. Non-blocking 5,6-EET antagonized the inhibition caused by AA and augmented cloned hK(Ca)3.1 and rK(Ca)3.1 whole-cell currents. Pentacyclic triterpenes did not modulate K(Ca)3.1 currents. Conclusions/Significance: Inhibition of K(Ca)3.1 by EETs (14,15-EET), 20-HETE, and omega 3 critically depended on the presence of electron double bonds and hydrophobicity within the 10 carbons preceding the carboxyl-head of the molecules. From the physiological perspective, metabolism of AA to non-blocking 5,6,- and 8,9-EET may cause AA-de-blockade and contribute to cellular signal transduction processes influenced by these fatty acids.	[Kacik, Michael] Univ Marburg, Fac Med, D-48153 Munster, Germany; [Kacik, Michael] Univ Munster, Univ Hosp, Clemenshosp, Med Ctr 1, D-48153 Munster, Germany; [Olivan-Viguera, Aida; Koehler, Ralf] Aragon Inst Hlth Sci I CS IIS, Zaragoza 50009, Spain; [Koehler, Ralf] Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza 50018, Spain	Philipps University Marburg; University of Munster	Kohler, R (corresponding author), Aragon Inst Hlth Sci I CS IIS, Zaragoza 50009, Spain.	rkohler.iacs@aragon.es	Oliván-Viguera, Aida/I-4260-2015; Oliván-Viguera, Aida/ABG-4048-2020	Oliván-Viguera, Aida/0000-0001-5348-924X; Oliván-Viguera, Aida/0000-0001-5348-924X; Kohler, Ralf/0000-0001-9563-2913	Deutsche Forschungsgemeinschaft (DFG) [KO1899/10-1, 11-1]; European Community (FP7-PEOPLE Project) [321721]; Fondo de Investigacion Sanitaria (Red HERACLES) [RD12/0042/0014]; intramural funding of the University Hospital Marburg Giessen	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Community (FP7-PEOPLE Project); Fondo de Investigacion Sanitaria (Red HERACLES)(Instituto de Salud Carlos III); intramural funding of the University Hospital Marburg Giessen	The study was supported by grants of the Deutsche Forschungsgemeinschaft (DFG): KO1899/10-1 and 11-1 to RK (www.dfg.de). European Community (FP7-PEOPLE Project 321721), and the Fondo de Investigacion Sanitaria (Red HERACLES RD12/0042/0014). MK and RK were supported by intramural funding of the University Hospital Marburg & Giessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaqumi M, 2008, KIDNEY INT, V74, P740, DOI 10.1038/ki.2008.246; Balut CM, 2012, CHEMMEDCHEM, V7, P1741, DOI 10.1002/cmdc.201200226; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Bertuccio CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092013; Bi D, 2013, J BIOL CHEM, V288, P15843, DOI 10.1074/jbc.M112.427187; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; Chen C, 2011, J PHARMACOL EXP THER, V336, P344, DOI 10.1124/jpet.110.174805; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081006; D'Alessandro G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.279; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Di L, 2010, P NATL ACAD SCI USA, V107, P1541, DOI 10.1073/pnas.0910133107; Ding Yindi, 2014, J Pharmacol Exp Ther, V350, P14, DOI 10.1124/jpet.114.214254; Earley S, 2011, J CARDIOVASC PHARM, V57, P148, DOI 10.1097/FJC.0b013e3181f580d9; Fan F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082482; Feletou M, 2012, ANN MED, V44, P694, DOI 10.3109/07853890.2011.585658; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Fleming I, 2011, CANCER METAST REV, V30, P541, DOI 10.1007/s10555-011-9302-3; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Grgic I, 2009, TRANSPL P, V41, P2601, DOI 10.1016/j.transproceed.2009.06.025; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Grgic I, 2009, PFLUG ARCH EUR J PHY, V458, P291, DOI 10.1007/s00424-008-0619-x; Hamilton KL, 2003, J BIOL CHEM, V278, P16690, DOI 10.1074/jbc.M212959200; Hua XQ, 2013, TRANSPLANTATION, V95, P285, DOI 10.1097/TP.0b013e318275a2f4; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Keserue B, 2008, FASEB J, V22, P4306, DOI 10.1096/fj.08-112821; KIRBER MT, 1992, FEBS LETT, V297, P24, DOI 10.1016/0014-5793(92)80319-C; Koch Hansen L, 2014, J CROHNS COLITIS; Kohler R, 2005, KIDNEY INT, V67, P2280, DOI 10.1111/j.1523-1755.2005.00331.x; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kohler R, 2010, PFLUG ARCH EUR J PHY, V459, P969, DOI 10.1007/s00424-010-0819-z; Kroigaard C, 2012, BRIT J PHARMACOL, V167, P37, DOI 10.1111/j.1476-5381.2012.01986.x; Lambertsen KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047744; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Lou-Bonafonte JM, 2012, MOL NUTR FOOD RES, V56, P1043, DOI 10.1002/mnfr.201100668; Lu T, 2005, J BIOL CHEM, V280, P19097, DOI 10.1074/jbc.M414065200; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Marquez-Martin A, 2006, CYTOKINE, V36, P211, DOI 10.1016/j.cyto.2006.12.007; Martin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041545; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Nielsen G, 2013, BASIC CLIN PHARMACOL, V113, P250, DOI 10.1111/bcpt.12092; Olivan-Viguera A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058614; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Pena TL, 1999, J MEMBRANE BIOL, V172, P249, DOI 10.1007/s002329900601; Pfister SL, 2010, ADV PHARMACOL, V60, P27, DOI [10.1016/B978-0-12-385061-4.00002-7, 10.1016/S1054-3589(10)60008-7]; Pidkovka N, 2013, J BIOL CHEM, V288, P5223, DOI 10.1074/jbc.M112.407981; Rosa JC, 1998, J MED CHEM, V41, P2; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Siddesha JM, 2014, CELL SIGNAL, V26, P933, DOI 10.1016/j.cellsig.2014.01.005; Sisignano M, 2012, J NEUROSCI, V32, P6364, DOI 10.1523/JNEUROSCI.5793-11.2012; Szekely A, 2007, IMMUNOBIOLOGY, V212, P213, DOI 10.1016/j.imbio.2007.01.005; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Tunctan Bahar, 2013, Antiinflamm Antiallergy Agents Med Chem, V12, P1; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Wang RX, 2011, CARDIOVASC RES, V90, P344, DOI 10.1093/cvr/cvq411; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Wulff H, 2013, J CARDIOVASC PHARM, V61, P102, DOI 10.1097/FJC.0b013e318279ba20; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Xiao YF, 2007, PROSTAG OTH LIPID M, V82, P11, DOI 10.1016/j.prostaglandins.2006.05.023; Zhang GD, 2014, PROG LIPID RES, V53, P108, DOI 10.1016/j.plipres.2013.11.003; Zou AP, 1996, AM J PHYSIOL-RENAL, V270, pF822, DOI 10.1152/ajprenal.1996.270.5.F822	68	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112081	10.1371/journal.pone.0112081	http://dx.doi.org/10.1371/journal.pone.0112081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372486	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900110
J	Lin, LX; Bo, XY; Tan, YZ; Sun, FX; Song, M; Zhao, J; Ma, ZH; Li, M; Zheng, KJ; Xu, SM				Lin, Lai-xiang; Bo, Xiang-yu; Tan, Yuan-zhen; Sun, Feng-xian; Song, Ming; Zhao, Juan; Ma, Zhi-hong; Li, Mei; Zheng, Kai-jun; Xu, Shu-mei			Feasibility of beta-Sheet Breaker Peptide-H102 Treatment for Alzheimer's Disease Based on beta-Amyloid Hypothesis	PLOS ONE			English	Article							CHOLINE-ACETYLTRANSFERASE; PROTEIN CONFORMATION; IN-VITRO; A-BETA; TAU; AGGREGATION; INHIBITION; BRAIN; STRATEGIES; TOXICITY	beta-amyloid hypothesis is the predominant hypothesis in the study of pathogenesis of Alzheimer's disease. This hypothesis claims that aggregation and neurotoxic effects of amyloid beta (A beta) is the common pathway in a variety of etiological factors for Alzheimer's disease. A beta peptide derives from amyloid precursor protein (APP). beta-sheet breaker peptides can directly prevent and reverse protein misfolding and aggregation in conformational disorders. Based on the stereochemical structure of A beta 1-42 and aggregation character, we had designed a series of beta-sheet breaker peptides in our previous work and screened out a 10-residue peptide beta-sheet breaker peptide, H102. We evaluated the effects of H102 on expression of P-tau, several associated proteins, inflammatory factors and apoptosis factors, and examined the cognitive ability of APP transgenic mice by behavioral test. This study aims to validate the beta-amyloid hypothesis and provide an experimental evidence for the feasibility of H102 treatment for Alzheimer's disease.	[Bo, Xiang-yu; Tan, Yuan-zhen; Sun, Feng-xian; Song, Ming; Zhao, Juan; Ma, Zhi-hong; Li, Mei; Zheng, Kai-jun; Xu, Shu-mei] Tianjin Med Univ, Dept Physiol, Tianjin, Peoples R China; [Lin, Lai-xiang] Tianjin Med Univ, Metab Dis Hosp, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Key Lab Hormone & Dev,Minist Hlth, Tianjin, Peoples R China; [Lin, Lai-xiang] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Xu, SM (corresponding author), Tianjin Med Univ, Dept Physiol, Tianjin, Peoples R China.	xushm_ty@126.com			National Major New Drug Creation of China [2009ZX09103-029]; Science and Technology Research Foundation of Tianjin, China [09ZCKFSH00100]	National Major New Drug Creation of China; Science and Technology Research Foundation of Tianjin, China	This work was supported by the National Major New Drug Creation of China (2009ZX09103-029) and the Science and Technology Research Foundation of Tianjin, China (09ZCKFSH00100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adessi C, 2003, J BIOL CHEM, V278, P13905, DOI 10.1074/jbc.M211976200; Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; Akiyama Haruhiko, 2006, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V26, P23; Al-Obeidi E, 1998, MOL BIOTECHNOL, V9, P205, DOI 10.1007/BF02915794; Banks WA, 1996, LIFE SCI, V59, P1923, DOI 10.1016/S0024-3205(96)00380-3; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Casal C, 2004, NEUROSCI RES, V48, P315, DOI 10.1016/j.neures.2003.11.006; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Estrada LD, 2007, CURR TOP MED CHEM, V7, P115, DOI 10.2174/156802607779318262; Estrada LD, 2006, CURR PHARM DESIGN, V12, P2557, DOI 10.2174/138161206777698792; ETIENNE P, 1986, NEUROSCIENCE, V19, P1279, DOI 10.1016/0306-4522(86)90142-9; Fu AL, 2004, NEUROSCI LETT, V368, P258, DOI 10.1016/j.neulet.2004.05.116; GEULA C, 1989, NEUROSCIENCE, V33, P469, DOI 10.1016/0306-4522(89)90399-0; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Inestrose Nibaldo C., 2004, Current Alzheimer Research, V1, P249, DOI 10.2174/1567205043332063; IVERSEN LL, 1995, BIOCHEM J, V311, P1; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Joseph J, 2001, NEUROBIOL AGING, V22, P131, DOI 10.1016/S0197-4580(00)00211-6; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Li Mei, 2009, Zhongguo Xinyao yu Linchuang Zazhi, V28, P106; Li YK, 2003, J NEUROSCI, V23, P1605; [马志红 MA Zhihong], 2008, [天津医药, Tianjin Medical Journal], V36, P198; Nadimpally KC, 2014, ACS CHEM NEUROSCI, V5, P400, DOI 10.1021/cn500064z; Reynolds CH, 1997, J NEUROCHEM, V69, P191; Robinson SR, 2002, NEUROBIOL AGING, V23, P1051, DOI 10.1016/S0197-4580(01)00342-6; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Song M, 2010, J TIANJIN MED U, V16, P566; Soto C, 1999, J MOL MED-JMM, V77, P412, DOI 10.1007/s001090050371; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Soto C, 1999, MOL MED TODAY, V5, P343, DOI 10.1016/S1357-4310(99)01508-7; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Vitiello G, 2012, BIOCHEM BIOPH RES CO, V417, P88, DOI 10.1016/j.bbrc.2011.11.061; Vitiello G, 2010, J PEPT SCI, V16, P115, DOI 10.1002/psc.1207; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang M, 2010, TIANJIN MED J, V38, P405; Wang ZQ, 2004, J MED CHEM, V47, P3329, DOI 10.1021/jm034224e; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Yamada N, 2004, PHARMACOL BIOCHEM BE, V78, P787, DOI 10.1016/j.pbb.2004.05.017; Zhao Juan, 2008, Zhongguo Xinyao yu Linchuang Zazhi, V27, P675	49	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112052	10.1371/journal.pone.0112052	http://dx.doi.org/10.1371/journal.pone.0112052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372040	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900106
J	Shortt, K; Chaudhary, S; Grigoryev, D; Heruth, DP; Venkitachalam, L; Zhang, LQ; Ye, SQ				Shortt, Katherine; Chaudhary, Suman; Grigoryev, Dmitry; Heruth, Daniel P.; Venkitachalam, Lakshmi; Zhang, Li Q.; Ye, Shui Q.			Identification of Novel Single Nucleotide Polymorphisms Associated with Acute Respiratory Distress Syndrome by Exome-Seq	PLOS ONE			English	Article							ACUTE LUNG INJURY; GENOME-WIDE ASSOCIATION; COLONY-ENHANCING FACTOR; GENE POLYMORPHISMS; POPULATION; STRATIFICATION; EPIDEMIOLOGY; OUTCOMES; SEPSIS; XP22.3	Acute respiratory distress syndrome (ARDS) is a lung condition characterized by impaired gas exchange with systemic release of inflammatory mediators, causing pulmonary inflammation, vascular leak and hypoxemia. Existing biomarkers have limited effectiveness as diagnostic and therapeutic targets. To identify disease-associating variants in ARDS patients, whole-exome sequencing was performed on 96 ARDS patients, detecting 1,382,399 SNPs. By comparing these exome data to those of the 1000 Genomes Project, we identified a number of single nucleotide polymorphisms (SNP) which are potentially associated with ARDS. 50,190SNPs were found in all case subgroups and controls, of which89 SNPs were associated with susceptibility. We validated three SNPs (rs78142040, rs9605146 and rs3848719) in additional ARDS patients to substantiate their associations with susceptibility, severity and outcome of ARDS. rs78142040 (C>T) occurs within a histone mark (intron 6) of the Arylsulfatase D gene. rs9605146 (G>A) causes a deleterious coding change (proline to leucine) in the XK, Kell blood group complex subunit-related family, member 3 gene. rs3848719 (G>A) is a synonymous SNP in the Zinc-Finger/Leucine-Zipper Co-Transducer NIF1 gene. rs78142040, rs9605146, and rs3848719 are associated significantly with susceptibility to ARDS. rs3848719 is associated with APACHE II score quartile. rs78142040 is associated with 60-day mortality in the overall ARDS patient population. Exome-seq is a powerful tool to identify potential new biomarkers for ARDS. We selectively validated three SNPs which have not been previously associated with ARDS and represent potential new genetic biomarkers for ARDS. Additional validation in larger patient populations and further exploration of underlying molecular mechanisms are warranted.	[Shortt, Katherine; Chaudhary, Suman; Grigoryev, Dmitry; Heruth, Daniel P.; Zhang, Li Q.; Ye, Shui Q.] Univ Missouri, Sch Med, Childrens Mercy Hosp, Dept Pediat,Div Expt & Translat Genet, Kansas City, MO 64110 USA; [Shortt, Katherine; Grigoryev, Dmitry; Venkitachalam, Lakshmi; Ye, Shui Q.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Ye, SQ (corresponding author), Univ Missouri, Sch Med, Childrens Mercy Hosp, Dept Pediat,Div Expt & Translat Genet, Kansas City, MO 64110 USA.	sqye@cmh.edu	; Grigoryev, Dmitry/C-9422-2015	Shortt, Katherine/0000-0002-6207-1862; Venkitachalam, Lakshmi/0000-0003-0703-3932; Grigoryev, Dmitry/0000-0002-1849-1763	NHLBI/NIH Grant [HL080042, HL080042-S1]; endowments of Children's Mercy Hospitals and Clinics; UMKC; Sarah Morrison Student Research Award of UMKC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080042] Funding Source: NIH RePORTER	NHLBI/NIH Grant; endowments of Children's Mercy Hospitals and Clinics; UMKC; Sarah Morrison Student Research Award of UMKC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was in part provided by NHLBI/NIH Grant (HL080042 & HL080042-S1, Ye, SQ), start-up fund and endowments of Children's Mercy Hospitals and Clinics, UMKC (Ye, SQ), and a Sarah Morrison Student Research Award of UMKC (Shortt, K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anasiewicz A, 1997, Wiad Lek, V50 Suppl 1 Pt 2, P96; ASHBAUGH DG, 1967, LANCET, V2, P319; Bajwa EK, 2007, CRIT CARE MED, V35, P1290, DOI 10.1097/01.CCM.0000260243.22758.4F; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blank R, 2011, CRIT CARE CLIN, V27, P439, DOI 10.1016/j.ccc.2011.05.005; Calenda G, 2006, GENE, V370, P6, DOI 10.1016/j.gene.2005.10.037; Crader KM, 2012, J PULMONAR RESPIRAT, V2; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dooley TP, 2000, BIOCHEM BIOPH RES CO, V277, P236, DOI 10.1006/bbrc.2000.3643; Fang XC, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-9; Flores C, 2010, MINERVA ANESTESIOL, V76, P860; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; Garcia JG, 2005, T AM CLIN CLIMAT ASS, P116; Garcia Joe G N, 2005, Trans Am Clin Climatol Assoc, V116, P205; Goh Gerald, 2012, Genomics & Informatics, V10, P214, DOI 10.5808/GI.2012.10.4.214; Gong MN, 2006, CLIN CHEST MED, V27, P705, DOI 10.1016/j.ccm.2006.07.001; Gullapalli Rama R, 2012, J Pathol Inform, V3, P40, DOI 10.4103/2153-3539.103013; Hinrichs AL, 2009, GENET EPIDEMIOL, V33, pS88, DOI 10.1002/gepi.20478; Khrunin AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058552; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Le Goff GC, 2010, ANAL CHEM, V82, P6185, DOI 10.1021/ac101008d; Lee KA, 2011, CHEST, V140, P382, DOI 10.1378/chest.10-3100; Liu YX, 2012, CLIN CHEM LAB MED, V50, P1917, DOI 10.1515/cclm-2012-0238; Lunetta KL, 2008, CIRCULATION, V118, P96, DOI 10.1161/CIRCULATIONAHA.107.700401; Mahajan MA, 2002, MOL CELL BIOL, V22, P6883, DOI 10.1128/MCB.22.19.6883-6894.2002; McGlothlin JR, 2005, BIOCHEM GENET, V43, P127, DOI 10.1007/s10528-005-1505-2; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Takata A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r92; Trojani A, 2012, CANCER BIOMARK, V11, P15, DOI 10.3233/CBM-2012-0259; Tzouvelekis A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-62; Urbitsch P, 2000, DNA CELL BIOL, V19, P765, DOI 10.1089/104454900750058125; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC	43	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111953	10.1371/journal.pone.0111953	http://dx.doi.org/10.1371/journal.pone.0111953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372662	gold, Green Submitted, Green Published			2022-12-26	WOS:000344556900094
J	Sugawara, SK; Tanaka, S; Tanaka, D; Seki, A; Uchiyama, HT; Okazaki, S; Koeda, T; Sadato, N				Sugawara, Sho K.; Tanaka, Satoshi; Tanaka, Daisuke; Seki, Ayumi; Uchiyama, Hitoshi T.; Okazaki, Shuntaro; Koeda, Tastuya; Sadato, Norihiro			Sleep Is Associated with Offline Improvement of Motor Sequence Skill in Children	PLOS ONE			English	Article							TIME-COURSE; CONSOLIDATION; MEMORY; PERFORMANCE; ADOLESCENCE; ADAPTATION; PARAMETERS; CHILDHOOD; SPINDLES; VALUES	In adults, sleep is necessary for the offline improvement of certain skills, such as sequential finger tapping, but whether children show a similar effect is still debatable. Here, we tested whether sleep is associated with offline performance improvement in children. Nine- and 11-year-old children trained on an explicit sequential finger tapping task. On the night following training, their parents observed and recorded the duration of each child's sleep. The following day, all children performed a surprise retest session on the previously trained sequence. In both 9- and 11-year-old children, skill performance was significantly improved during the first retest session relative to the end of training on the previous day, confirming the offline improvement in performance. There was a significant correlation between the degree of improvement and sleep duration the night after training, suggesting that in children, as in adults, sleep is associated with offline skill enhancement.	[Sugawara, Sho K.; Okazaki, Shuntaro; Sadato, Norihiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan; [Sugawara, Sho K.] Japan Soc Promot Sci, Tokyo, Japan; [Tanaka, Satoshi] Hamamatsu Univ, Sch Med, Psychol Lab, Hamamatsu, Shizuoka, Japan; [Tanaka, Daisuke; Seki, Ayumi; Koeda, Tastuya] Tottori Univ, Fac Reg Sci, Dept Educ, Tottori 680, Japan; [Seki, Ayumi; Koeda, Tastuya] Natl Hosp Org, Tottori Med Ctr, Dept Clin Res, Tottori, Japan; [Uchiyama, Hitoshi T.] Int Univ Hlth & Welf, Sch Hlth Sci, Ohtawara, Japan; [Sadato, Norihiro] Grad Univ Adv Studies, SOKENDAI, Dept Physiol Sci, Hayama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Society for the Promotion of Science; Hamamatsu University School of Medicine; Tottori University; International University of Health & Welfare; Graduate University for Advanced Studies - Japan	Sadato, N (corresponding author), Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan.	sadato@nips.ac.jp	OKAZAKI, SHUNTARO/U-6813-2019	Sadato, Norihiro/0000-0002-9786-3907	Japan Society for the Promotion of Science [S21220005]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research S21220005 to N.S. from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). Part of this study is the result of the project "Development of biomarker candidates for social behavior", carried out under the Strategic Research Program for Brain Science by the Minister of Education, Culture, Sports, Science and Technology of Japan (http://brainprogram.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G., 2012, J SLEEP RES, V22, P144; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Carskadon M.A., 2011, PRINC PRACT SLEEP ME, V4, P16, DOI [10.1016/b978-1-4160-6645-3.00002-5, DOI 10.1016/B978-1-4160-6645-3.00002-5]; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107; Dorfberger S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000240; Dorffierger S, 2009, BEHAV BRAIN RES, V198, P165, DOI 10.1016/j.bbr.2008.10.033; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fischer S, 2007, J COGNITIVE NEUROSCI, V19, P214, DOI 10.1162/jocn.2007.19.2.214; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Largo RH, 2001, DEV MED CHILD NEUROL, V43, P436, DOI 10.1017/S0012162201000810; MERICA H, 1985, SLEEP, V8, P261, DOI 10.1093/sleep/8.3.261; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Scholle S, 2011, SLEEP MED, V12, P542, DOI 10.1016/j.sleep.2010.11.011; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Sugawara SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048174; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Wilhelm I, 2008, LEARN MEMORY, V15, P373, DOI 10.1101/lm.803708; Wilhelm I, 2012, DEVELOPMENTAL SCI, V15, P506, DOI 10.1111/j.1467-7687.2012.01146.x	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111635	10.1371/journal.pone.0111635	http://dx.doi.org/10.1371/journal.pone.0111635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372609	gold, Green Published			2022-12-26	WOS:000344556900057
J	Angers, A; Drapeau, P				Angers, Annie; Drapeau, Pierre			Itch Is Required for Lateral Line Development in Zebrafish	PLOS ONE			English	Article							UBIQUITIN LIGASE ITCH; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL-GROWTH-FACTOR; INTERACTING PROTEIN 4; CELL-MIGRATION; WNT/BETA-CATENIN; DISHEVELLED PHOSPHORYLATION; SIGNAL-TRANSDUCTION; TISSUE MIGRATION; DOWN-REGULATION	The zebrafish posterior lateral line is formed during early development by the deposition of neuromasts from a migrating primordium. The molecular mechanisms regulating the regional organization and migration of the primordium involve interactions between Fgf and Wnt/beta-catenin signaling and the establishment of specific cxcr4b and cxcr7b cytokine receptor expression domains. Itch has been identified as a regulator in several different signaling pathways, including Wnt and Cxcr4 signaling. We identified two homologous itch genes in zebrafish, itcha and itchb, with generalized expression patterns. By reducing itchb expression in particular upon morpholino knockdown, we demonstrated the importance of Itch in regulating lateral line development by perturbing the patterns of cxcr4b and cxcr7b expression. Itch knockdown results in a failure to down-regulate Wnt signaling and overexpression of cxcr4b in the primordium, slowing migration of the posterior lateral line primordium and resulting in abnormal development of the lateral line.	[Angers, Annie] Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada; [Drapeau, Pierre] Univ Montreal, Ctr Hosp, Dept Neurosci, Montreal, PQ, Canada; [Drapeau, Pierre] Univ Montreal, Ctr Hosp, Res Ctr, Montreal, PQ, Canada; [Drapeau, Pierre] Univ Montreal, GRSNC, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Angers, A (corresponding author), Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada.	annie.angers@umontreal.ca	Angers, Annie/P-1217-2018	Angers, Annie/0000-0003-0131-256X	Natural Sciences and Engineering Research Council of Canada [288238]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Neuroscience; Fonds de recherche en sante du Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Neuroscience; Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	Funding provided by AA Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.ca) grant No. 288238, PD Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.ca) grant, PD Canada Research Chair in Neuroscience (http://www.chairs-chaires.gc.ca) and PD Fonds de recherche en sante du Quebec (http://www.frsq.gouv.qc.ca/fr/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov V, 2011, MOL BIOSYST, V7, P3223, DOI 10.1039/c1mb05185g; Alexandre D, 1999, P NATL ACAD SCI USA, V96, P7558, DOI 10.1073/pnas.96.13.7558; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Aman A, 2011, CELL ADHES MIGR, V5, P499, DOI 10.4161/cam.5.6.19113; Aman A, 2011, DEV BIOL, V349, P470, DOI 10.1016/j.ydbio.2010.10.022; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Azakir BA, 2010, FEBS J, V277, P1319, DOI 10.1111/j.1742-4658.2010.07562.x; Azakir BA, 2009, CELL SIGNAL, V21, P1326, DOI 10.1016/j.cellsig.2009.03.020; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Breau MA, 2012, DEVELOPMENT, V139, P2246, DOI 10.1242/dev.080275; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Chitnis AB, 2012, DEV NEUROBIOL, V72, P234, DOI 10.1002/dneu.20962; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COLLAZO A, 1994, SCIENCE, V264, P426, DOI 10.1126/science.8153631; Dambly-Chaudiere C, 2003, BIOL CELL, V95, P579, DOI 10.1016/j.biolcel.2003.10.005; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gamba L, 2010, DEV DYNAM, V239, P3163, DOI 10.1002/dvdy.22469; Gamba L, 2010, P NATL ACAD SCI USA, V107, P6358, DOI 10.1073/pnas.0909998107; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hansen TM, 2007, BIOCHEM BIOPH RES CO, V361, P33, DOI 10.1016/j.bbrc.2007.06.104; Head JR, 2013, DEV DYNAM, V242, P832, DOI 10.1002/dvdy.23973; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Kabashi E, 2010, TRENDS GENET, V26, P373, DOI 10.1016/j.tig.2010.05.004; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Li Q, 2004, DEV BIOL, V269, P123, DOI 10.1016/j.ydbio.2004.01.020; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Lum WM, 2011, ZEBRAFISH, V8, P65, DOI 10.1089/zeb.2011.0691; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2009, METHOD ENZYMOL, V460, P413, DOI 10.1016/S0076-6879(09)05221-5; Matsuda M, 2013, DEVELOPMENT, V140, P2387, DOI 10.1242/dev.091348; Matsuda M, 2010, DEVELOPMENT, V137, P3477, DOI 10.1242/dev.052761; McGraw HF, 2011, DEVELOPMENT, V138, P3921, DOI 10.1242/dev.062554; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Mizoguchi T, 2011, J NEUROSCI, V31, P15522, DOI 10.1523/JNEUROSCI.3948-11.2011; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Parravicini V, 2008, BLOOD, V111, P4273, DOI 10.1182/blood-2007-10-115667; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Pyati UJ, 2011, DEV CELL, V21, P492, DOI 10.1016/j.devcel.2011.07.012; Rathinam C, 2011, NAT IMMUNOL, V12, P399, DOI 10.1038/ni.2021; Rossi M, 2006, CELL CYCLE, V5, P1816, DOI 10.4161/cc.5.16.2861; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Schneider I, 2010, DEV BIOL, V348, P22, DOI 10.1016/j.ydbio.2010.08.040; Schuler S, 2013, J CELL SCI, V126, P196, DOI 10.1242/jcs.111674; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Urbe S, 2006, BIOCHEM SOC T, V34, P754, DOI 10.1042/BST0340754; Valdivia LE, 2011, DEVELOPMENT, V138, P3931, DOI 10.1242/dev.062695; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE	72	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111799	10.1371/journal.pone.0111799	http://dx.doi.org/10.1371/journal.pone.0111799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369329	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000104
J	Trachana, K; Forslund, K; Larsson, T; Powell, S; Doerks, T; von Mering, C; Bork, P				Trachana, Kalliopi; Forslund, Kristoffer; Larsson, Tomas; Powell, Sean; Doerks, Tobias; von Mering, Christian; Bork, Peer			A Phylogeny-Based Benchmarking Test for Orthology Inference Reveals the Limitations of Function-Based Validation	PLOS ONE			English	Article							GENE; EVOLUTION; ARCHAEAL; GENOMES; TREE; RECONSTRUCTION; IDENTIFICATION; CONSERVATION; ARCHITECTURE; PERFORMANCE	Accurate orthology prediction is crucial for many applications in the post-genomic era. The lack of broadly accepted benchmark tests precludes a comprehensive analysis of orthology inference. So far, functional annotation between orthologs serves as a performance proxy. However, this violates the fundamental principle of orthology as an evolutionary definition, while it is often not applicable due to limited experimental evidence for most species. Therefore, we constructed high quality "gold standard" orthologous groups that can serve as a benchmark set for orthology inference in bacterial species. Herein, we used this dataset to demonstrate 1) why a manually curated, phylogeny-based dataset is more appropriate for benchmarking orthology than other popular practices and 2) how it guides database design and parameterization through careful error quantification. More specifically, we illustrate how function-based tests often fail to identify false assignments, misjudging the true performance of orthology inference methods. We also examined how our dataset can instruct the selection of a "core'' species repertoire to improve detection accuracy. We conclude that including more genomes at the proper evolutionary distances can influence the overall quality of orthology detection. The curated gene families, called Reference Orthologous Groups, are publicly available at http://eggnog.embl.de/orthobench2.	[Forslund, Kristoffer; Larsson, Tomas; Powell, Sean; Doerks, Tobias; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Larsson, Tomas] European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany; [Trachana, Kalliopi] Inst Syst Biol, Seattle, WA USA; [von Mering, Christian] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [von Mering, Christian] Swiss Inst Bioinformat, Zurich, Switzerland	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Institute for Systems Biology (ISB); University of Zurich; Swiss Institute of Bioinformatics	Bork, P (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	bork@embl.de	Bork, Peer/F-1813-2013; Powell, Sean/B-2374-2009; Forslund, Sofia K/Y-2393-2019; von Mering, Christian/B-3300-2008	Bork, Peer/0000-0002-2627-833X; Powell, Sean/0000-0002-0994-5911; von Mering, Christian/0000-0001-7734-9102; Forslund, Sofia K/0000-0003-4285-6993	EU-funded IHMS [FP7-HEALTH-2010-261376]; METACARDIS [FP7-HEALTH-2012-305312]; FP7-IDEAS-ERC project CancerBiome [268985]	EU-funded IHMS; METACARDIS; FP7-IDEAS-ERC project CancerBiome	The authors received funding for this work from EU-funded IHMS (FP7-HEALTH-2010-261376) and METACARDIS (FP7-HEALTH-2012-305312) grants, as well as FP7-IDEAS-ERC project CancerBiome (reference: 268985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bapteste E, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-33; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boeckmann B, 2011, BRIEF BIOINFORM, V12, P423, DOI 10.1093/bib/bbr034; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dalquen DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056925; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Forslund K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-326; Gao B, 2009, INT J SYST EVOL MICR, V59, P234, DOI 10.1099/ijs.0.002741-0; Goodstadt L, 2006, PLOS COMPUT BIOL, V2, P1134, DOI 10.1371/journal.pcbi.0020133; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huerta-Cepas J, 2011, NUCLEIC ACIDS RES, V39, pD556, DOI 10.1093/nar/gkq1109; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Milinkovitch MC, 1996, GENETICS, V144, P1817; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Poptsova Maria, 2009, V532, P227, DOI 10.1007/978-1-60327-853-9_13; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Pryszcz LP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq953; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Salichos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018755; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Skunca N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002533; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Susko E, 2005, J MOL EVOL, V61, P351, DOI 10.1007/s00239-004-0352-9; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Waterhouse RM, 2011, NUCLEIC ACIDS RES, V39, pD283, DOI 10.1093/nar/gkq930; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wolf YI, 2012, GENOME BIOL EVOL, V4, P1286, DOI 10.1093/gbe/evs100; Zheng Y, 2002, GENOME RES, V12, P1221, DOI 10.1101/gr.200602	56	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111122	10.1371/journal.pone.0111122	http://dx.doi.org/10.1371/journal.pone.0111122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369365	Green Published, Green Accepted, gold			2022-12-26	WOS:000344402000040
J	Genard-Zielinski, AC; Ormeno, E; Boissard, C; Fernandez, C				Genard-Zielinski, Anne-Cyrielle; Ormeno, Elena; Boissard, Christophe; Fernandez, Catherine			Isoprene Emissions from Downy Oak under Water Limitation during an Entire Growing Season: What Cost for Growth?	PLOS ONE			English	Article							QUERCUS-PUBESCENS; DROUGHT; STRESS; VOLATILE; MODEL; LEAVES; PHOTOSYNTHESIS; TEMPERATURE; PROJECTIONS; MEMBRANES	Increases in the production of terpene- and phenolic-like compounds in plant species under abiotic stress conditions have been interpreted in physiological studies as a supplementary defense system due to their capacity to limit cell oxidation. From an ecological perspective however, these increases are only expected to confer competitive advantages if they do not imply a significant cost for the plant, that is, growth reduction. We investigated shifts of isoprene emissions, and to a lesser extent phenolic compound concentration, of Quercus pubescens Willd. from early leaf development to leaf senescence under optimal watering (control: C), mild and severe water stress (MS, SS). The impact of water stress was concomitantly assessed on plant physiological (chlorophyll fluorescence, stomatal conductance, net photosynthesis, water potential) functional (relative leaf water content, leaf mass per area ratio) and growth (aerial and root biomass) traits. Growth changes allowed to estimate the eventual costs related to the production of isoprene and phenolics. The total phenolic content was not modified under water stress whereas isoprene emissions were promoted under MS over the entire growing cycle despite the decline of P-n by 35%. Under SS, isoprene emissions remained similar to C all over the study despite the decline of Pn by 47% and were thereby clearly uncoupled to Pn leading to an overestimation of the isoprene emission factor by 44%. Under SS, maintenance of isoprene emissions and phenolic compound concentration resulted in very significant costs for the plants as growth rates were very significantly reduced. Under MS, increases of isoprene emission and maintenance of phenolic compound concentration resulted in moderate growth reduction. Hence, it is likely that investment in isoprene emissions confers Q. pubescens an important competitive advantage during moderate but not severe periods of water scarcity. Consequences of this response for air quality in North Mediterranean areas are also discussed.	[Genard-Zielinski, Anne-Cyrielle; Ormeno, Elena; Fernandez, Catherine] Avignon Univ, Aix Marseille Univ, Inst Mediterrane Biodiversite & Ecol Marine & Con, CNRS,IRD, F-84000 Avignon, France; [Genard-Zielinski, Anne-Cyrielle; Boissard, Christophe] Univ Versailles St Quentin En Yvelines, Lab Sci Climat & Environm LSCE IPSL, Unite Mixte CEA CNRS UVSQ, CEA,CNRS, Gif Sur Yvette, France	Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Ormeno, E (corresponding author), Avignon Univ, Aix Marseille Univ, Inst Mediterrane Biodiversite & Ecol Marine & Con, CNRS,IRD, Technopole Arbois Mediterrane, F-84000 Avignon, France.	elena.ormeno-lafuente@imbe.fr	Ormeno, Elena/C-5887-2019; FERNANDEZ, Catherine/A-2556-2009	Ormeno, Elena/0000-0002-3265-5883; FERNANDEZ, Catherine/0000-0002-6868-4774	ADEME (Agence de l'environnement et de la maitrise de l'energie); region Provence-Alpes Cote d'Azur (PACA); European Union; French National Research Agency (ANR) [ANR-12-BSV7-0016-01]	ADEME (Agence de l'environnement et de la maitrise de l'energie); region Provence-Alpes Cote d'Azur (PACA)(Region Provence-Alpes-Cote d'Azur); European Union(European Commission); French National Research Agency (ANR)(French National Research Agency (ANR))	This research was supported by ADEME (Agence de l'environnement et de la maitrise de l'energie), the region Provence-Alpes Cote d'Azur (PACA) and the European Union and was funded by the French National Research Agency (ANR) through the SecPriMe2 project (ANR-12-BSV7-0016-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHERAR M, 1992, VEGETATIO, V100, P177; Affek HP, 2003, PLANT PHYSIOL, V131, P1727, DOI 10.1104/pp.102.012294; Atkinson R, 2000, ATMOS ENVIRON, V34, P2063, DOI 10.1016/S1352-2310(99)00460-4; Boberg F, 2012, NAT CLIM CHANGE, V2, P433, DOI 10.1038/NCLIMATE1454; Brilli F, 2007, NEW PHYTOL, V175, P244, DOI 10.1111/j.1469-8137.2007.02094.x; Bruggemann N, 2002, PLANT BIOLOGY, V4, P456, DOI 10.1055/s-2002-34128; Bussotti F, 2000, TREES-STRUCT FUNCT, V14, P361, DOI 10.1007/s004680000056; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; Contran N, 2013, PLANT BIOLOGY, V15, P157, DOI 10.1111/j.1438-8677.2012.00627.x; ESTIARTE M, 1994, OECOLOGIA, V99, P387, DOI 10.1007/BF00627753; Fang CW, 1996, TREE PHYSIOL, V16, P441; Funk JL, 2004, PLANT CELL ENVIRON, V27, P747, DOI 10.1111/j.1365-3040.2004.01177.x; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Goulden ML, 1996, TREE PHYSIOL, V16, P417; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; GUENTHER AB, 1993, J GEOPHYS RES-ATMOS, V98, P12609, DOI 10.1029/93JD00527; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hernandez I, 2004, TREE PHYSIOL, V24, P1303, DOI 10.1093/treephys/24.11.1303; Hollosy F, 2002, MICRON, V33, P179, DOI 10.1016/S0968-4328(01)00011-7; Keenan T, 2009, ATMOS CHEM PHYS, V9, P4053, DOI 10.5194/acp-9-4053-2009; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Nardini A, 1999, NEW PHYTOL, V143, P485, DOI 10.1046/j.1469-8137.1999.00476.x; Niinemets U, 2010, TRENDS PLANT SCI, V15, P145, DOI 10.1016/j.tplants.2009.11.008; Ogaya R, 2003, FOREST ECOL MANAG, V180, P175, DOI 10.1016/S0378-1127(02)00598-4; Ormeno E, 2009, CHEMOSPHERE, V77, P94, DOI 10.1016/j.chemosphere.2009.05.014; Owen SM, 2002, ATMOS ENVIRON, V36, P3147, DOI 10.1016/S1352-2310(02)00235-2; Pegoraro E, 2006, GLOBAL CHANGE BIOL, V12, P456, DOI 10.1111/j.1365-2486.2006.01112.x; Pegoraro E, 2004, ATMOS ENVIRON, V38, P6149, DOI 10.1016/j.atmosenv.2004.07.028; Penuelas J, 2010, TRENDS PLANT SCI, V15, P133, DOI 10.1016/j.tplants.2009.12.005; Rodriguez-Calcerrada J, 2012, J EXPT BOT, V85, P36; Rosenstiel TN, 2004, PLANT BIOLOGY, V6, P12, DOI 10.1055/s-2003-44722; SHARKEY TD, 1993, OECOLOGIA, V95, P328, DOI 10.1007/BF00320984; Sharkey TD, 2008, ANN BOT-LONDON, V101, P5, DOI 10.1093/aob/mcm240; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Siwko ME, 2007, BBA-BIOMEMBRANES, V1768, P198, DOI 10.1016/j.bbamem.2006.09.023; Tani A, 2011, ATMOS ENVIRON, V45, P6261, DOI 10.1016/j.atmosenv.2011.08.003; TINGEY DT, 1981, PLANTA, V152, P565, DOI 10.1007/BF00380829; Velikova V, 2012, PLANT SIGNAL BEHAV, V7, P139, DOI 10.4161/psb.7.1.18521; Vickers CE, 2009, NAT CHEM BIOL, V5, P283, DOI 10.1038/nchembio.158; Zweifel R, 2009, J VEG SCI, V20, P442, DOI 10.1111/j.1654-1103.2009.05701.x	41	15	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112418	10.1371/journal.pone.0112418	http://dx.doi.org/10.1371/journal.pone.0112418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383554	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700060
J	Ishida, M; Shimabukuro, M; Yagi, S; Nishimoto, S; Kozuka, C; Fukuda, D; Soeki, T; Masuzaki, H; Tsutsui, M; Sata, M				Ishida, Masayoshi; Shimabukuro, Michio; Yagi, Shusuke; Nishimoto, Sachiko; Kozuka, Chisayo; Fukuda, Daiju; Soeki, Takeshi; Masuzaki, Hiroaki; Tsutsui, Masato; Sata, Masataka			MicroRNA-378 Regulates Adiponectin Expression in Adipose Tissue: A New Plausible Mechanism	PLOS ONE			English	Article							METABOLIC DISEASE; GENE-EXPRESSION; ADIPOGENESIS; INFLAMMATION; ADIPOCYTES; PATHWAY; TARGET; CELLS	Aims: Mechanisms regulating adiponectin expression have not been fully clarified. MicroRNAs (miRNAs), small non-coding RNAs that regulate gene expression, are involved in biological processes, including obesity and insulin resistance. We evaluated whether the miRNA-378 pathway is involved in regulating adiponectin expression. Methods and Results: First, we determined a putative target site for miRNA-378 in the 3 prime untranslated region (3'UTR) of the adiponectin gene by in silico analysis. The levels of adiponectin mRNA and protein were decreased in 3T3-L1 cells overexpressing the mimic of miRNA-378. Luminescence activity in HEK293T cells expressing a renilla-luciferase-adiponectin-3'UTR sequence was inhibited by overexpressing the mimic of miRNA-378, and the decrease was reversed by adding the inhibitor of miRNA-378. Moreover, we confirmed the inhibitory effects of the mimic were cancelled in a deleted mutant of the miR-378 3'-UTR binding site. Addition of tumor necrosis factor-alpha (TNF alpha) led a upregulation of miR-378 and downregulation of adiponectin at mRNA and protein levels in 3T3-L1 cells. Level of miR-378 was higher and mRNA level of adiponectin was lower in diabetic ob/ob mice than those of normal C57BL/6 mice and levels of miR378 and adiponectin were negatively well correlated (r = -0.624, p = 0.004). Conclusions: We found that levels of miRNA-378 could modulate adiponectin expression via the 3'UTR sequence-binding site. Our findings warrant further investigations into the role of miRNAs in regulating the adiponectin expression.	[Ishida, Masayoshi; Yagi, Shusuke; Soeki, Takeshi; Sata, Masataka] Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardiovasc Med, Tokushima 770, Japan; [Shimabukuro, Michio; Fukuda, Daiju] Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardio Diabet Med, Tokushima 770, Japan; [Nishimoto, Sachiko] Univ Tokushima, Grad Sch Hlth Biosci, Dept Nutr & Metab, Tokushima 770, Japan; [Ishida, Masayoshi; Tsutsui, Masato] Univ Ryukyus, Grad Sch Med, Dept Pharmacol, Okinawa, Japan; [Kozuka, Chisayo; Masuzaki, Hiroaki] Univ Ryukyus, Grad Sch Med, Dept Internal Med 2, Div Endocrinol Diabet & Metab Hematol & Rheumatol, Okinawa, Japan	Tokushima University; Tokushima University; Tokushima University; University of the Ryukyus; University of the Ryukyus	Shimabukuro, M (corresponding author), Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardio Diabet Med, Tokushima 770, Japan.	mshimabukuro-ur@umin.ac.jp	Fukuda, Daiju/AAO-6752-2021	Shimabukuro, Michio/0000-0001-7835-7665; Kozuka, Chisayo/0000-0002-9567-8361	Program for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry; Ministry of Education, Culture, Sports, Science and Technology [23591314]; Ministry of Health, Labour and Welfare (MHLW), Japan; Grants-in-Aid for Scientific Research [24591338] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare (MHLW), Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Program for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry; the Ministry of Education, Culture, Sports, Science and Technology (#23591314); and the Ministry of Health, Labour and Welfare (MHLW), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gerin I, 2010, AM J PHYSIOL-ENDOC M, V299, pE198, DOI 10.1152/ajpendo.00179.2010; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hiuge-Shimizu A, 2011, ARTERIOSCL THROM VAS, V31, P792, DOI 10.1161/ATVBAHA.110.221747; Kadowaki T, 2011, COLD SH Q B, V76, P257, DOI 10.1101/sqb.2012.76.010587; Kang M, 2013, MOL BIOL REP, V40, P5027, DOI 10.1007/s11033-013-2603-6; Knezevic I, 2012, J BIOL CHEM, V287, P12913, DOI 10.1074/jbc.M111.331751; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071568; Liu ML, 2010, BIOCHEM J, V425, P41, DOI 10.1042/BJ20091045; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Muller G, 2002, INSULIN TARGET CELLS; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Phillips SA, 2010, CURR OPIN PHARMACOL, V10, P676, DOI 10.1016/j.coph.2010.08.002; Rantalainen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027338; Santovito D, 2014, J CLIN ENDOCR METAB, V99, pE1681, DOI 10.1210/jc.2013-3843; Shimabukuro M, 2003, J CLIN ENDOCR METAB, V88, P3236, DOI 10.1210/jc.2002-021883; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299	23	36	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111537	10.1371/journal.pone.0111537	http://dx.doi.org/10.1371/journal.pone.0111537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379946	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100032
J	Petrella, LN				Petrella, Lisa N.			Natural Variants of C. elegans Demonstrate Defects in Both Sperm Function and Oogenesis at Elevated Temperatures	PLOS ONE			English	Article							MALE-STERILITY; CAENORHABDITIS-ELEGANS; CANALIZATION; DROSOPHILA; SPERMATOGENESIS; FERTILITY; GENETICS; POPULATIONS; PGL-1	The temperature sensitivity of the germ line is conserved from nematodes to mammals. Previous studies in C. briggsae and Drosophila showed that isolates originating from temperate latitudes lose fertility at a lower temperature than strains originating from tropical latitudes. In order to investigate these relationships in C. elegans, analysis of the fertility of 22 different wild-type isolates of C. elegans isolated from equatorial, tropical and temperate regions was undertaken. It was found that there are significant temperature, genotype and temperature 6 genotype effects on fertility but region of isolation showed no significant effect on differences in fertility. For most isolates 100% of the population maintained fertility from 20 degrees C to 26 degrees C, but there was a precipitous drop in the percentage of fertile hermaphrodites at 27 degrees C. In contrast, all isolates show a progressive decrease in brood size as temperature increases from 20 degrees C to 26 degrees C, followed by a brood size near zero at 27 degrees C. Temperature shift experiments were performed to better understand the causes of high temperature loss of fertility. Males up-shifted to high temperature maintained fertility, while males raised at high temperature lost fertility. Down-shifting males raised at high temperature generally did not restore fertility. This result differs from that observed in Drosophila and suggested that in C. elegans spermatogenesis or sperm function is irreversibly impaired in males that develop at high temperature. Mating and down-shifting experiments with hermaphrodites were performed to investigate the relative contributions of spermatogenic and oogenic defects to high temperature loss of fertility. It was found that the hermaphrodites of all isolates demonstrated loss in both spermatogenic and oogenic germ lines that differed in their relative contribution by isolate. These studies uncovered unexpectedly high variation in both the loss of fertility and problems with oocyte function in natural variants of C. elegans at high temperature.	[Petrella, Lisa N.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Petrella, Lisa N.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	University of California System; University of California Santa Cruz; Marquette University	Petrella, LN (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	lisa.petrella@marquette.edu			National Institutes of Health [1K99GM098436-01]; University of California, Santa Cruz; Marquette University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM098436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Santa Cruz(University of California System); Marquette University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health 1K99GM098436-01 to LNP, by University of California, Santa Cruz and by start-up funds to LNP from Marquette University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Anderson JL, 2007, J EXP BIOL, V210, P3107, DOI 10.1242/jeb.007351; Araripe LO, 2004, J THERM BIOL, V29, P73, DOI 10.1016/j.jtherbio.2003.11.006; Bilgir C, 2013, G3-GENES GENOM GENET, V3, P585, DOI 10.1534/g3.112.005165; BRENNER S, 1974, GENETICS, V77, P71; Bronikowski A, 2010, INTEGR COMP BIOL, V50, P880, DOI 10.1093/icb/icq132; CAMERON RDA, 1980, J REPROD FERTIL, V59, P173, DOI 10.1530/jrf.0.0590173; Chakir M, 2002, GENETICA, V114, P195, DOI 10.1023/A:1015154329762; Chatterjee I, 2013, EXP GERONTOL, V48, P1156, DOI 10.1016/j.exger.2013.07.014; Chen J, 2006, EXP GERONTOL, V41, P1059, DOI 10.1016/j.exger.2006.07.005; Conine CC, 2010, P NATL ACAD SCI USA, V107, P3588, DOI 10.1073/pnas.0911685107; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Dolgin ES, 2008, HEREDITY, V100, P304, DOI 10.1038/sj.hdy.6801079; Dworkin I, 2005, EVOLUTION, V59, P1500; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Gupta Bhagwati P, 2007, WormBook, P1; Harvey SC, 2007, J EXP ZOOL PART B, V308B, P409, DOI 10.1002/jez.b.21161; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kim B, 2013, CELL MOL LIFE SCI, V70, P2623, DOI 10.1007/s00018-012-1165-4; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; McMullen PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002338; Prasad A, 2011, EVOLUTION, V65, P52, DOI 10.1111/j.1558-5646.2010.01110.x; Ramler D, 2014, J EVOLUTION BIOL, V27, P497, DOI 10.1111/jeb.12311; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jeb.01087; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang C, 2007, J CLIN ENDOCR METAB, V92, P3292, DOI 10.1210/jc.2007-0367; Wong KSK, 2006, CELL RES, V16, P742, DOI 10.1038/sj.cr.7310090; Yaeram J, 2006, REPROD FERT DEVELOP, V18, P647, DOI 10.1071/RD05022	32	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112377	10.1371/journal.pone.0112377	http://dx.doi.org/10.1371/journal.pone.0112377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380048	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100078
J	Sun, JF; Ke, BX; Huang, YH; He, DM; Li, XC; Liang, ZM; Ke, CW				Sun, Jiufeng; Ke, Bixia; Huang, Yanhui; He, Dongmei; Li, Xiaocui; Liang, Zhaoming; Ke, Changwen			The Molecular Epidemiological Characteristics and Genetic Diversity of Salmonella Typhimurium in Guangdong, China, 2007-2011	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; FLUOROQUINOLONE SUSCEPTIBILITY; EVOLUTIONARY RELATIONSHIPS; NONTYPHOID SALMONELLA; ENTERICA; SURVEILLANCE; CIPROFLOXACIN; SEROTYPES; STRAINS	Background: Salmonella enterica serovar Typhimurium is the most important serovar associated with human salmonellosis worldwide. Here we aimed to explore the molecular epidemiology and genetic characteristics of this serovar in Guangdong, China. Methodology: We evaluated the molecular epidemiology and genetic characteristics of 294 endemic Salmonella Typhimurium clinical isolates which were collected from 1977 to 2011 in Guangdong, China, and compared them with a global set of isolates of this serovar using epidemiological data and Multilocus Sequence Typing (MLST) analysis. Principal Finding: The 294 isolates were assigned to 13 Sequencing types (STs) by MLST, of which ST34 and ST19 were the most common in Guangdong. All the STs were further assigned to two eBurst Groups, eBG1 and eBG138. The eBG1 was the major group endemic in Guangdong. Nucleotide and amino acid variability were comparable for all seven MLST loci. Tajima's D test suggested positive selection in hisD and thrA genes (p<0.01), but positive selection was rejected for the five other genes (p>0.05). In addition, The Tajima's D test within each eBG using the global set of isolates showed positive selection in eBG1 and eBG138 (p<0.05), but was rejected in eBG243 (p>0.05). We also analyzed the phylogenetic structure of Salmonella Typhimurium from worldwide sources and found that certain STs are geographically restricted. ACSSuT was the predominant multidrug resistance pattern for this serovar. The resistant profiles ACSSuTTmNaG, ACSSuTTmNa and ACSuTTmNaG seem to be specific for ST34, and ASSuTNa for ST19. Conclusion: Here we presented a genotypic characterization of Salmonella Typhimurium isolates using MLST and found two major STs are endemic in Guangdong. Our analyses indicate that genetic selection may have shaped the Salmonella Typhimurium populations. However, further evaluation with additional isolates from various sources will be essential to reveal the scope of the epidemiological characteristics of Salmonella Typhimurium in Guangdong, China.	[Sun, Jiufeng] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Ke, Bixia; He, Dongmei; Li, Xiaocui; Liang, Zhaoming; Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, Inst Microbiol, Guangzhou, Guangdong, Peoples R China; [Huang, Yanhui] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Southern Medical University - China	Ke, CW (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Inst Microbiol, Guangzhou, Guangdong, Peoples R China.	kecw2011@sina.com	sun, Jiufeng/CAG-6546-2022	sun, jiufeng/0000-0003-1047-929X	China-U.S. Collaborative Program on Emerging and Re-Emerging Infectious Diseases and the Medical Scientific Research Foundation in Guangdong [1U2GGH000018-01]; 12th five-year-major-projects of China's Ministry of Public Health [2012zx10004-213]; Science and Technology Planning Project of Guangdong Province Program [2012B060400012, 2013B060400012]	China-U.S. Collaborative Program on Emerging and Re-Emerging Infectious Diseases and the Medical Scientific Research Foundation in Guangdong; 12th five-year-major-projects of China's Ministry of Public Health; Science and Technology Planning Project of Guangdong Province Program	This project was supported by the China-U.S. Collaborative Program on Emerging and Re-Emerging Infectious Diseases and the Medical Scientific Research Foundation in Guangdong (1U2GGH000018-01), the 12th five-year-major-projects of China's Ministry of Public Health (2012zx10004-213), and Science and Technology Planning Project of Guangdong Province Program (2012B060400012; 2013B060400012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Centers for Disease Control and Prevention, 2012, TRENDS FOODB ILLN US; CLSI, 2012, PERF STAND ANT SUSC; Cui SH, 2008, EMERG INFECT DIS, V14, P493, DOI 10.3201/eid1403.070857; Deng XL, 2012, FOODBORNE PATHOG DIS, V9, P305, DOI 10.1089/fpd.2011.1008; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Hakanen A, 2001, EMERG INFECT DIS, V7, P996, DOI 10.3201/eid0706.010613; Harbottle H, 2006, J CLIN MICROBIOL, V44, P2449, DOI 10.1128/JCM.00019-06; He Dong-mei, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P424; Herikstad H, 2002, EPIDEMIOL INFECT, V129, P1, DOI 10.1017/S0950268802006842; Hu HH, 2006, GENETICS, V172, P743, DOI 10.1534/genetics.105.046466; Ke Bi-xia, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P789; Ke Bi-xia, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P1199; Ke BX, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-338; Lacher DW, 2007, J BACTERIOL, V189, P342, DOI 10.1128/JB.01472-06; Lee HY, 2009, ANTIMICROB AGENTS CH, V53, P2696, DOI 10.1128/AAC.01297-08; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lunguya O, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002103; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; Olsen SJ, 2001, J INFECT DIS, V183, P753, DOI 10.1086/318832; Sangal V, 2010, J BACTERIOL, V192, P6465, DOI 10.1128/JB.00969-10; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tankouo-Sandjong B, 2007, J MICROBIOL METH, V69, P23, DOI 10.1016/j.mimet.2006.11.013; THAMPAPILLAI G, 1994, MOL BIOL EVOL, V11, P813; Torpdahl M, 2013, INT J FOOD MICROBIOL, V161, P69, DOI 10.1016/j.ijfoodmicro.2012.11.022; Wong MHY, 2013, ANTIMICROB AGENTS CH, V57, P4599, DOI 10.1128/AAC.01174-13; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Zhou ZM, 2014, P NATL ACAD SCI USA, V111, P12199, DOI 10.1073/pnas.1411012111; Zhou ZM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003471	39	21	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e113145	10.1371/journal.pone.0113145	http://dx.doi.org/10.1371/journal.pone.0113145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380053	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100114
J	Thompson, IJT; Mann, ER; Stokes, MG; English, NR; Knight, SC; Williamson, D				Thompson, Iain J. T.; Mann, Elizabeth R.; Stokes, Margaret G.; English, Nicholas R.; Knight, Stella C.; Williamson, Diane			Specific Activation of Dendritic Cells Enhances Clearance of Bacillus anthracis following Infection	PLOS ONE			English	Article							MOUSE BONE-MARROW; VACCINE; IMMUNIZATION; PROTECTION; IMMUNITY; STRAIN; MICE	Dendritic cells are potent activators of the immune system and have a key role in linking innate and adaptive immune responses. In the current study we have used ex vivo pulsed bone marrow dendritic cells (BMDC) in a novel adoptive transfer strategy to protect against challenge with Bacillus anthracis, in a murine model. Pre-pulsing murine BMDC with either recombinant Protective Antigen (PA) or CpG significantly upregulated expression of the activation markers CD40, CD80, CD86 and MHC-II. Passive transfusion of mice with pulsed BMDC, concurrently with active immunisation with rPA in alum, significantly enhanced (p<0.001) PA-specific splenocyte responses seven days post-immunisation. Parallel studies using ex vivo DCs expanded from human peripheral blood and activated under the same conditions as the murine DC, demonstrated that human DCs had a PA dose-related significant increase in the markers CD40, CD80 and CCR7 and that the increases in CD40 and CD80 were maintained when the other activating components, CpG and HK B. anthracis were added to the rPA in culture. Mice vaccinated on a single occasion intra-muscularly with rPA and alum and concurrently transfused intra-dermally with pulsed BMDC, demonstrated 100% survival following lethal B. anthracis challenge and had significantly enhanced (p<0.05) bacterial clearance within 2 days, compared with mice vaccinated with rPA and alum alone.	[Thompson, Iain J. T.; Stokes, Margaret G.; Williamson, Diane] Def Sci & Technol Lab, Dept Biomed Sci, Salisbury SP4 0JQ, Wilts, England; [Mann, Elizabeth R.; English, Nicholas R.; Knight, Stella C.] Imperial Coll London, Antigen Presentat Res Grp, Harrow HA1 3UJ, Middx, England	Defence Science & Technology Laboratory; Imperial College London	Williamson, D (corresponding author), Def Sci & Technol Lab, Dept Biomed Sci, Salisbury SP4 0JQ, Wilts, England.	dewilliamson@dstl.gov.uk	Williamson, Ethel Diane/AAQ-8878-2020		United States Army Research Office; Defense Advanced Research Projects Agency (DARPA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007632] Funding Source: NIH RePORTER	United States Army Research Office; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the United States Army Research Office and the Defense Advanced Research Projects Agency (DARPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Do Y, 2010, EUR J IMMUNOL, V40, P2791, DOI 10.1002/eji.201040511; Elvin SJ, 2006, INFECT IMMUN, V74, P1706, DOI 10.1128/IAI.74.3.1706-1711.2006; Flick-Smith HC, 2005, MICROB PATHOGENESIS, V38, P33, DOI 10.1016/j.micpath.2004.10.007; Healey GD, 2005, INFECT IMMUN, V73, P5945, DOI 10.1128/IAI.73.9.5945-5951.2005; Holden NJ, 2008, CLIN EXP ALLERGY, V38, P1148, DOI 10.1111/j.1365-2222.2008.02997.x; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; IVINS BE, 1992, INFECT IMMUN, V60, P662, DOI 10.1128/IAI.60.2.662-668.1992; IVINS BE, 1988, EUR J EPIDEMIOL, V4, P12, DOI 10.1007/BF00152686; KNIGHT SC, 1986, IMMUNOLOGY, V57, P595; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Okinaka R, 1999, J APPL MICROBIOL, V87, P261, DOI 10.1046/j.1365-2672.1999.00883.x; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Reuveny S, 2001, INFECT IMMUN, V69, P2888, DOI 10.1128/IAI.69.5.2888-2893.2001; TURNBULL PCB, 1991, VACCINE, V9, P533, DOI 10.1016/0264-410X(91)90237-Z; Welkos S, 2001, MICROBIOL-SGM, V147, P1677, DOI 10.1099/00221287-147-6-1677; WELKOS SL, 1988, MICROB PATHOGENESIS, V4, P53, DOI 10.1016/0882-4010(88)90048-4; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986	20	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e109720	10.1371/journal.pone.0109720	http://dx.doi.org/10.1371/journal.pone.0109720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380285	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100009
J	Yan, N; Yu, SZ; Hou, TS; Gu, GF; Zhang, HL; Zhao, S; He, SS				Yan, Ning; Yu, Shunzhi; Hou, Tiesheng; Gu, Guangfei; Zhang, Hailong; Zhao, Shan; He, Shisheng			Cervical Spondylotic Myelopathy Caused by Single-Level Vertebral Spontaneous Fusion	PLOS ONE			English	Article							ADJACENT SEGMENT DISEASE; LAMINOPLASTY; SPINE	Purpose: To evaluate the clinical features, imaging characteristics, surgical options, and clinical outcomes of patients with Cervical spondylotic myelopathy (CSM) caused by single-level vertebral spontaneous fusion (SLVSF). Methods: Sixteen consecutive patients with SLVSF who underwent anterior surgery were included in this study and 38 patients with CSM caused by spinal degeneration were enrolled as a control group. Demographic features, clinical presentations, imaging characteristics, surgery strategy, Nurick grade, Japanese Orthopedic Association (JOA) score, neck disability index (NDI), and complications were evaluated. Results: There were significant differences between the two groups in the mean age and the average duration of neck pain. There was no significant difference between the two groups in length of cervical spine. In the SLVSF group, 13 patients had upper segment translational instability and none had rotational instability. Pre- and postoperative Nurick grades were 2.94 +/- 0.77 and 2.19 +/- 0.54 in the SLVSF group, and 2.97 +/- 0.72 and 2.16 +/- 0.64 in the control group. Pre- and postoperative JOA scores were 9.25 +/- 2.02 and 11.69 +/- 1.62 in the SLVSF group, and 9.87 +/- 2.58 and 12.53 +/- 2.69 in the control group. Pre- and postoperative NDI values were 28.5 +/- 7.75 and 15.56 +/- 5.51 in the SLVSF group, and 16 +/- 6.13 and 11.29 +/- 4.58 in the control group. Conclusions: Patients with SLVSF have necks of normal lengths, which can be used to distinguish this disorder from Klippel-Feil syndrome. There are three main features of SLVSF: (1) hypoplasia at both of the spontaneously fused vertebral bodies; (2) a major pathological feature of translational instability of the upper vertebra to the fused level; and (3) severe neck pain. Anterior surgery has a good therapeutic effect for patients with cervical SLVSF.	[Yan, Ning; Yu, Shunzhi; Hou, Tiesheng; Gu, Guangfei; Zhang, Hailong; Zhao, Shan; He, Shisheng] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped Surg, Shanghai 200092, Peoples R China	Tongji University	Hou, TS (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped Surg, Shanghai 200092, Peoples R China.	itslxd@163.com						Bydon M, 2014, NEUROSURGERY, V74, P139, DOI 10.1227/NEU.0000000000000204; CHANDRARAJ S, 1987, J ANAT, V153, P55; Eubanks JD, 2013, ORTHOPEDICS, V36, pE1251, DOI 10.3928/01477447-20130920-15; Gilbert-Barness E, 2005, FETAL PEDIATR PATHOL, V24, P331, DOI 10.1080/15227950500503744; GRAY SW, 1964, SURG GYNECOL OBSTET, V118, P373; GUNDERSON CH, 1967, MEDICINE, V46, P491, DOI 10.1097/00005792-196711000-00003; Hashimoto M, 2010, EUR SPINE J, V19, P1702, DOI 10.1007/s00586-010-1427-5; Hirabayashi K, 1999, CLIN ORTHOP RELAT R, P35; Patil SJ, 2009, INDIAN J PEDIATR, V76, P417, DOI 10.1007/s12098-009-0017-1; RChappell BW, 1988, RADIOLOGY, V167, P282; Samartzis D, 2006, SPINE, V31, pE798, DOI 10.1097/01.brs.0000239222.36505.46; Toledano M, 2013, NEUROL CLIN, V31, P287, DOI 10.1016/j.ncl.2012.09.003; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Tsuzuki N, 1993, Eur Spine J, V2, P197, DOI 10.1007/BF00299446; Wang SJ, 2011, EUR SPINE J, V20, P185, DOI 10.1007/s00586-010-1600-x; WHITE AA, 1975, CLIN ORTHOP RELAT R, P85, DOI 10.1097/00003086-197506000-00011; Yoshida M, 2002, SPINE, V27, P1414, DOI 10.1097/00007632-200207010-00008	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112423	10.1371/journal.pone.0112423	http://dx.doi.org/10.1371/journal.pone.0112423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380388	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100089
J	Chen, SL; Shao, CH; Dong, TF; Chai, H; Xiong, XK; Sun, DY; Zhang, L; Yu, Y; Wang, P; Cheng, F				Chen, Shenglin; Shao, Cunhua; Dong, Tianfu; Chai, Hao; Xiong, Xinkui; Sun, Daoyi; Zhang, Long; Yu, Yue; Wang, Ping; Cheng, Feng			Transplantation of ATP7B-Transduced Bone Marrow Mesenchymal Stem Cells Decreases Copper Overload in Rats	PLOS ONE			English	Article							EVANS CINNAMON RATS; WILSONS-DISEASE; LIVER-TRANSPLANTATION; LENTIVIRAL VECTORS; ANIMAL-MODEL; LEC RAT; GROWTH-FACTOR; GENE-TRANSFER; HEPATOCYTES; DIFFERENTIATION	Background: Recent studies have demonstrated that transplantation of ATP7B-transduced hepatocytes ameliorates disease progression in LEC (Long-Evans Cinnamon) rats, a model of Wilson's disease (WD). However, the inability of transplanted cells to proliferate in a normal liver hampers long-term treatment. In the current study, we investigated whether transplantation of ATP7B-transduced bone marrow mesenchymal stem cells (BM-MSCs) could decrease copper overload in LEC rats. Materials and Methods: The livers of LEC rats were preconditioned with radiation (RT) and/or ischemia-reperfusion (IRP) before portal vein infusion of ATP7B-transduced MSCs (MSCsATP7B). The volumes of MSCsATP7B or saline injected as controls were identical. The expression of ATP7B was analyzed by real-time quantitative polymerase chain reaction (RT-PCR) at 4, 12 and 24 weeks post-transplantation. MSCATP7B repopulation, liver copper concentrations, serum ceruloplasmin levels, and alanine transaminase (ALT) and aspartate transaminase (AST) levels were also analyzed at each time-point post-transplantation. Results: IRP-plus-RT preconditioning was the most effective strategy for enhancing the engraftment and repopulation of transplanted MSCsATP7B. This strategy resulted in higher ATP7B expression and serum ceruloplasmin, and lower copper concentration in this doubly preconditioned group compared with the saline control group, the IRP group, and the RT group at all three time-points post-transplantation (p<0.05 for all). Moreover, 24 weeks post-transplantation, the levels of ALT and AST in the IRP group, the RT group, and the IRP-plus-RT group were all significantly decreased compared to those of the saline group (p<0.05 compared with the IRP group and RT group, p<0.01 compared with IRP-plus-RT group); ALT and AST levels were significantly lower in the IRP-plus-RT group compared to either the IRP group or the RT group (p<0.01 and p<0.05. respectively). Conclusions: These results demonstrate that transplantation of MSCsATP7B into IRP-plus-RT preconditioned LEC rats decreased copper overload and was associated with an increase in MSC engraftment and repopulation.	[Chen, Shenglin] Affiliated Wuhu 2 Peoples Hosp, Wannan Med Coll, Dept Hepatobiliary Surg Ward Gen Surg, Wuhu, Anhui, Peoples R China; [Shao, Cunhua] Dongying Peoples Hosp, Dept Hepatobiliary Surg, Dongying, Shandong, Peoples R China; [Dong, Tianfu; Chai, Hao; Xiong, Xinkui; Sun, Daoyi; Zhang, Long; Yu, Yue; Wang, Ping; Cheng, Feng] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China; [Dong, Tianfu; Chai, Hao; Xiong, Xinkui; Sun, Daoyi; Zhang, Long; Yu, Yue; Wang, Ping; Cheng, Feng] Minist Publ Hlth, Key Lab Living Donor Liver Transplantat, Nanjing, Jiangsu, Peoples R China	Wannan Medical College; Nanjing Medical University	Wang, P (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.	wuwpzhy@163.com; docchengfeng@njmu.edu.cn			National Natural Science Foundation of China [81070324]; Research Foundation of the Department of Health of Jiangsu Province [200906, H201102]; "Summit of the Six Top Talents'' Program of Jiangsu Province [2009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of the Department of Health of Jiangsu Province; "Summit of the Six Top Talents'' Program of Jiangsu Province	This study was financially supported, in part, by the National Natural Science Foundation of China (Grant No. 81070324), the Research Foundation of the Department of Health of Jiangsu Province (Grant No. 200906, H201102) and "Summit of the Six Top Talents'' Program of Jiangsu Province (Grant No. 2009). All fundings mentioned above were received by Feng Cheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067; Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Baccarani U, 2006, GROWTH FACTORS, V24, P107, DOI 10.1080/08977190600560636; Bartee MY, 2007, BIOMETALS, V20, P627, DOI 10.1007/s10534-006-9074-3; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247; Buchschacher GL, 2000, BLOOD, V95, P2499; Chen X, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-75; Enns GM, 2008, MOL GENET METAB, V95, P3, DOI 10.1016/j.ymgme.2008.06.001; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; FREDERIKS WM, 1982, EXP PATHOL-JENA, V22, P245, DOI 10.1016/S0232-1513(82)80015-7; Gao Y, 2010, ONCOGENE, V29, P2784, DOI 10.1038/onc.2010.38; Gollan John L., 1998, Journal of Hepatology, V28, P28, DOI 10.1016/S0168-8278(98)80373-5; Irani AN, 2001, MOL THER, V3, P302, DOI 10.1006/mthe.2001.0271; Kobayashi T, 2008, ARTHROSCOPY, V24, P69, DOI 10.1016/j.arthro.2007.08.017; Lemoli RM, 2006, STEM CELLS, V24, P2817, DOI 10.1634/stemcells.2006-0333; Malhi H, 2002, P NATL ACAD SCI USA, V99, P13114, DOI 10.1073/pnas.192365499; Malhi H, 2008, REGEN MED, V3, P165, DOI 10.2217/17460751.3.2.165; Medici V, 2005, LIVER TRANSPLANT, V11, P1056, DOI 10.1002/lt.20486; Meng Y, 2004, BBA-MOL BASIS DIS, V1690, P208, DOI 10.1016/j.bbadis.2004.06.022; Merle U, 2006, SCAND J GASTROENTERO, V41, P974, DOI 10.1080/00365520600554790; MURAMATSU Y, 1995, RES COMMUN MOL PATH, V89, P421; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nussler A, 2006, J HEPATOL, V45, P144, DOI 10.1016/j.jhep.2006.04.002; Park SM, 2006, CELL TRANSPLANT, V15, P13, DOI 10.3727/000000006783982188; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; POLSON RJ, 1987, Q J MED, V64, P685; Sakai H, 2011, J VET MED SCI, V73, P299, DOI 10.1292/jvms.10-0256; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Sauer V, 2012, LIVER TRANSPLANT, V18, P248, DOI 10.1002/lt.22466; Sauer V, 2010, BIOCHEM BIOPH RES CO, V395, P307, DOI 10.1016/j.bbrc.2010.03.158; SCHEINBERG IH, 1981, J RHEUMATOL, V8, P90; Shao CH, 2014, J SURG RES, V186, P408, DOI 10.1016/j.jss.2013.08.016; Solaiman F, 2000, MOL REPROD DEV, V56, P309, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;309::AID-MRD22&gt;3.0.CO;2-Y; Terada K, 1998, J BIOL CHEM, V273, P1815, DOI 10.1074/jbc.273.3.1815; Wang N, 2008, INT J BIOCHEM CELL B, V40, P294, DOI 10.1016/j.biocel.2007.08.003; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5; Wertheim JA, 2011, AM J TRANSPLANT, V11, P1773, DOI 10.1111/j.1600-6143.2011.03587.x; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; Yagi K, 2008, YAKUGAKU ZASSHI, V128, P3, DOI 10.1248/yakushi.128.3; YAMAMOTO F, 1993, JPN J CANCER RES, V84, P508, DOI 10.1111/j.1349-7006.1993.tb00168.x; Yoshida Y, 1996, GASTROENTEROLOGY, V111, P1654, DOI 10.1016/S0016-5085(96)70029-X; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7; Yu Y, 2010, STEM CELLS DEV, V19, P903, DOI 10.1089/scd.2009.0254; Zhang H, 2012, ASIAN PAC J CANCER P, V13, P5799, DOI 10.7314/APJCP.2012.13.11.5799	46	7	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111425	10.1371/journal.pone.0111425	http://dx.doi.org/10.1371/journal.pone.0111425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375371	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600039
J	Golden, S; Dukas, R				Golden, Shane; Dukas, Reuven			The Value of Patch-Choice Copying in Fruit Flies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; MATE-CHOICE; SOCIAL INFORMATION; SEXUAL SELECTION; SITE SELECTION; BARK BEETLES; COLONIZATION BEHAVIOR; AGGREGATION PHEROMONE; POSTHARVEST DISEASES; SPATIAL AGGREGATION	Many animals copy the choices of others but the functional and mechanistic explanations for copying are still not fully resolved. We relied on novel behavioral protocols to quantify the value of patch-choice copying in fruit flies. In a titration experiment, we quantified how much nutritional value females were willing to trade for laying eggs on patches already occupied by larvae (social patches). Females were highly sensitive to nutritional quality, which was positively associated with their offspring success. Females, however, perceived social, low-nutrition patches (33% of the nutrients) as equally valuable as non-social, high-nutrition ones (100% of the nutrients). In follow-up experiments, we could not, however, either find informational benefits from copying others or detect what females' offspring may gain from developing with older larvae. Because patch-choice copying in fruit flies is a robust phenomenon in spite of potential costs due to competition, we suggest that it is beneficial in natural settings, where fruit flies encounter complex dynamics of microbial communities, which include, in addition to the preferred yeast species they feed on, numerous harmful fungi and bacteria. We suggest that microbial ecology underlies many cases of copying in nature.	[Golden, Shane; Dukas, Reuven] McMaster Univ, Dept Psychol Neurosci & Behav, Anim Behav Grp, Hamilton, ON, Canada	McMaster University	Dukas, R (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Anim Behav Grp, Hamilton, ON, Canada.	dukas@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Ontario Innovation Trust	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust	This research has been funded by the Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation, and Ontario Innovation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, BEHAV ECOL SOCIOBIOL, V51, P33, DOI 10.1007/s002650100401; Allee W.C, 1931, ANIMAL AGGREGATION S; Alonzo SH, 2008, ANIM BEHAV, V75, P1715, DOI 10.1016/j.anbehav.2007.09.031; Arndt C, 1999, MICROBIOL-SGM, V145, P1989, DOI 10.1099/13500872-145-8-1989; ARNOLD W, 1988, J COMP PHYSIOL B, V158, P151, DOI 10.1007/BF01075828; Ashburner M., 1989, DROSOPHILA LAB HDB; ATKINSON WD, 1979, J ANIM ECOL, V48, P91, DOI 10.2307/4102; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Battesti M, 2012, CURR BIOL, V22, P309, DOI 10.1016/j.cub.2011.12.050; Beauchamp G., 2014, SOCIAL PREDATION GRO; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; BEGON M, 1982, GENET BIOL DROSOPHIL, P345; Betts MG, 2008, P ROY SOC B-BIOL SCI, V275, P2257, DOI 10.1098/rspb.2008.0217; Bodenstein D., 1950, BIOL DROSOPHILA, P275; BRIEGER G, 1970, Science (Washington D C), V167, P1262, DOI 10.1126/science.167.3922.1262; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Carton Y., 1986, P347; Crowley S, 2012, J APPL MICROBIOL, V113, P1417, DOI 10.1111/jam.12012; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Demain AL, 2000, ADV BIOCHEM ENG BIOT, V69, P1; DUGATKIN LA, 1992, AM NAT, V139, P1384, DOI 10.1086/285392; Dukas R, 2012, ANIM BEHAV, V84, P1427, DOI 10.1016/j.anbehav.2012.09.010; Durisko Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095495; Durisko Z, 2014, J EXP BIOL, V217, P1193, DOI 10.1242/jeb.097683; Durisko Z, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1398; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Fletcher RJ, 2008, BIOL LETTERS, V4, P482, DOI 10.1098/rsbl.2008.0306; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Galef BG, 1998, ANIM BEHAV, V55, P545, DOI 10.1006/anbe.1997.0616; GRIMALDI D, 1984, ECOLOGY, V65, P1113, DOI 10.2307/1938319; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; IBMCorp, 2011, IBM SPSS STAT WIND V; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; KIRKPATRICK M, 1994, BEHAV ECOL SOCIOBIOL, V34, P443; KREBS JR, 1973, CAN J ZOOL, V51, P1275, DOI 10.1139/z73-181; Krijger CL, 2001, ECOL LETT, V4, P106, DOI 10.1046/j.1461-0248.2001.00200.x; Lacey LA, 2008, ANNU REV ENTOMOL, V53, P121, DOI 10.1146/annurev.ento.53.103106.093419; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Mauch A, 2010, INT J FOOD MICROBIOL, V141, P116, DOI 10.1016/j.ijfoodmicro.2010.05.002; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Prokopy RJ, 2001, ANNU REV ENTOMOL, V46, P631, DOI 10.1146/annurev.ento.46.1.631; Pulliam HR., 1984, BEHAVIOURAL ECOLOGY, P122; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; Raitanen J, 2014, BEHAV ECOL, V25, P110, DOI 10.1093/beheco/art092; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Rohlfs M, 2005, MYCOLOGIA, V97, P996, DOI 10.3852/mycologia.97.5.996; Rohlfs M, 2005, ECOL ENTOMOL, V30, P556, DOI 10.1111/j.0307-6946.2005.00722.x; Rohlfs M, 2004, OECOLOGIA, V140, P654, DOI 10.1007/s00442-004-1629-9; Sarin S, 2009, P ROY SOC B-BIOL SCI, V276, P4323, DOI 10.1098/rspb.2009.1294; Schnurer J, 2005, TRENDS FOOD SCI TECH, V16, P70, DOI 10.1016/j.tifs.2004.02.014; Schwarz S, 2014, NATURWISSENSCHAFTEN, V101, P61, DOI 10.1007/s00114-013-1129-z; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; SHORROCKS B, 1995, P ROY SOC B-BIOL SCI, V260, P305, DOI 10.1098/rspb.1995.0096; Sokolowski MB, 2010, NEURON, V65, P780, DOI 10.1016/j.neuron.2010.03.007; Stafford JW, 2012, J NEUROSCI, V32, P14767, DOI 10.1523/JNEUROSCI.1887-12.2012; STAMPS JA, 1987, AM NAT, V129, P629, DOI 10.1086/284663; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Thorpe W, 1963, LEARNING INSTINCT AN, P56; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Venu I, 2014, J EXP BIOL, V217, P1346, DOI 10.1242/jeb.099648; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; WADE MJ, 1990, P NATL ACAD SCI USA, V87, P5749, DOI 10.1073/pnas.87.15.5749; WAITE RK, 1981, Z TIERPSYCHOL, V57, P15; Wertheim B, 2005, ANNU REV ENTOMOL, V50, P321, DOI 10.1146/annurev.ento.49.061802.123329; Wertheim B, 2002, ENTOMOL EXP APPL, V103, P61, DOI 10.1023/A:1019832101537; Wertheim B, 2002, ECOL ENTOMOL, V27, P608, DOI 10.1046/j.1365-2311.2002.00449.x; Willis CKR, 2007, BEHAV ECOL SOCIOBIOL, V62, P97, DOI 10.1007/s00265-007-0442-y; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	78	9	9	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112381	10.1371/journal.pone.0112381	http://dx.doi.org/10.1371/journal.pone.0112381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375776	gold, Green Submitted, Green Published			2022-12-26	WOS:000344402600140
J	Koltsova, SV; Shilov, B; Birulina, JG; Akimova, OA; Haloui, M; Kapilevich, LV; Gusakova, SV; Tremblay, J; Hamet, P; Orlov, SN				Koltsova, Svetlana V.; Shilov, Boris; Birulina, Julia G.; Akimova, Olga A.; Haloui, Mounsif; Kapilevich, Leonid V.; Gusakova, Svetlana V.; Tremblay, Johanne; Hamet, Pavel; Orlov, Sergei N.			Transcriptomic Changes Triggered by Hypoxia: Evidence for HIF-1 alpha -Independent, [Na+](i)/[K+](i)-Mediated, Excitation-Transcription Coupling	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR; GENE-EXPRESSION; CARDIAC-GLYCOSIDES; CELL; CALCIUM; RECEPTOR; SODIUM; IDENTIFICATION	This study examines the relative impact of canonical hypoxia-inducible factor-1alpha-(HIF-1 alpha and Na-i(+)/K-i(+)-mediated signaling on transcriptomic changes evoked by hypoxia and glucose deprivation. Incubation of RASMC in ischemic conditions resulted in similar to 3-fold elevation of [Na+](i) and 2-fold reduction of [K+](i). Using global gene expression profiling we found that Na+, K+-ATPase inhibition by ouabain or K+-free medium in rat aortic vascular smooth muscle cells (RASMC) led to the differential expression of dozens of genes whose altered expression was previously detected in cells subjected to hypoxia and ischemia/reperfusion. For further investigations, we selected Cyp1a1, Fos, Atf3, Klf10, Ptgs2, Nr4a1, Per2 and Hes1, i. e. genes possessing the highest increments of expression under sustained Na+, K+-ATPase inhibition and whose implication in the pathogenesis of hypoxia was proved in previous studies. In ouabain-treated RASMC, low-Na+, high-K+ medium abolished amplification of the [Na+](i)/[K+](i) ratio as well as the increased expression of all tested genes. In cells subjected to hypoxia and glucose deprivation, dissipation of the transmembrane gradient of Na+ and K+ completely eliminated increment of Fos, Atf3, Ptgs2 and Per2 mRNAs and sharply diminished augmentation expression of Klf10, Edn1, Nr4a1 and Hes1. In contrast to low-Na+, high-K+ medium, RASMC transfection with Hif-1a siRNA attenuated increments of Vegfa, Edn1, Klf10 and Nr4a1 mRNAs triggered by hypoxia but did not impact Fos, Atf3, Ptgs2 and Per2 expression. Thus, our investigation demonstrates, for the first time, that Na-i(+)/K-i(+)-mediated, Hif-1 alpha-independent excitation-transcription coupling contributes to transcriptomic changes evoked in RASMC by hypoxia and glucose deprivation.	[Koltsova, Svetlana V.; Akimova, Olga A.; Orlov, Sergei N.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; [Koltsova, Svetlana V.; Haloui, Mounsif; Tremblay, Johanne; Hamet, Pavel; Orlov, Sergei N.] Ctr Hosp Univ Montreal, Ctr Rech, Dept Med, Montreal, PQ, Canada; [Shilov, Boris] Pirogov Russian Natl Res Med Univ, Dept Physiol, Moscow, Russia; [Birulina, Julia G.; Kapilevich, Leonid V.; Gusakova, Svetlana V.; Orlov, Sergei N.] Siberian State Med Univ, Dept Med Biol, Tomsk, Russia; [Kapilevich, Leonid V.] Tomsk State Univ, Dept Phys Educ, Tomsk 634050, Russia	Lomonosov Moscow State University; Universite de Montreal; Pirogov Russian National Research Medical University; Siberian State Medical University; Tomsk State University	Orlov, SN (corresponding author), Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia.	sergeinorlov@yandex.ru	Orlov, Sergey N./T-3729-2018; Kapilevich, Leonid/AAU-3076-2020; Kapilevich, Leonid V./N-9196-2014; Kapilevich, Leonid V/J-1696-2016; Gusakova, Svetlana/R-8392-2016; Cossette, Suzanne/I-8008-2016; Gusakova, Svetlana/AAR-4165-2021; Julia, Birulina/S-2323-2016; Shilov, Boris/V-7642-2018	Kapilevich, Leonid/0000-0002-2316-576X; Julia, Birulina/0000-0003-1237-9786; Gusakova, Svetlana/0000-0001-5047-8668	Canadian Institutes of Health Research; Kidney Foundation of Canada; Russian Foundation for Fundamental Research; Ministry of Education and Science of the Russian Federation [8477, 8162]; Russian Science Foundation [14-15-00006] Funding Source: Russian Science Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Russian Foundation for Fundamental Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), the Kidney Foundation of Canada (http://www.kidney.ca), the Russian Foundation for Fundamental Research (http://www.rfbr.ru/rffi/eng) and the Ministry of Education and Science of the Russian Federation (http://eng.mon.gov.ru, projects 8477 and 8162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YJ, 2012, BMB REP, V45, P489, DOI 10.5483/BMBRep.2012.45.9.169; Akimova OA, 2005, J BIOL CHEM, V280, P832, DOI 10.1074/jbc.M411011200; Akimova OA, 2006, J BIOL CHEM, V281, P31317, DOI 10.1074/jbc.M602117200; Alarcon R, 1999, CANCER RES, V59, P6046; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Camacho M, 2011, J LIPID RES, V52, P720, DOI 10.1194/jlr.M011007; Castellano J, 2011, ARTERIOSCL THROM VAS, V31, P1411, DOI 10.1161/ATVBAHA.111.225490; Chakravarty A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-249; Chen F, 1999, CLIN CHEM, V45, P7; Coulon V, 2001, M S-MED SCI, V17, P969, DOI 10.4267/10608/1810; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Hamet P, 2006, METABOLISM, V55, pS7, DOI 10.1016/j.metabol.2006.07.006; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hu J, 1998, BIOCHEM BIOPH RES CO, V245, P894, DOI 10.1006/bbrc.1998.8543; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kamphuis W, 2007, MOL VIS, V13, P1020; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim BY, 2008, EXP MOL MED, V40, P71, DOI 10.3858/emm.2008.40.1.71; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; Koltsova SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038032; Koyanagi S, 2003, CANCER RES, V63, P7277; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazzatti D, 2012, ARCH PHYSIOL BIOCHEM, V118, P112, DOI 10.3109/13813455.2012.654611; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nangaku M, 2007, J MOL MED, V85, P1325, DOI 10.1007/s00109-007-0278-y; Okamura Y, 2011, PHYSIOLOGY, V26, P6, DOI 10.1152/physiol.00035.2010; Ong LL, 2010, TISSUE ENG PART C-ME, V16, P1069, DOI [10.1089/ten.tec.2009.0641, 10.1089/ten.TEC.2009.0641]; Orlov SN, 2005, CELL CALCIUM, V38, P53, DOI 10.1016/j.ceca.2005.03.006; Orlov SN, 1996, AM J PHYSIOL-CELL PH, V270, pC1388, DOI 10.1152/ajpcell.1996.270.5.C1388; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Schults MA, 2010, J BIOL CHEM, V285, P14558, DOI 10.1074/jbc.M109.076323; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; Tang Y, 2006, NEUROBIOL DIS, V21, P18, DOI 10.1016/j.nbd.2005.06.002; Taurin S, 2002, J PHYSIOL-LONDON, V543, P835, DOI 10.1113/jphysiol.2002.023259; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; VENDER RL, 1994, CHEST, V106, P236, DOI 10.1378/chest.106.1.236; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Williams RS, 2000, J CLIN INVEST, V106, P813, DOI 10.1172/JCI11205; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Yang DHA, 2013, INT J BIOCHEM CELL B, V45, P419, DOI 10.1016/j.biocel.2012.11.007; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang N, 2007, CARDIOVASC TOXICOL, V7, P282, DOI 10.1007/s12012-007-9007-6; Zhao H, 2012, CURR DRUG TARGETS, V13, P173, DOI 10.2174/138945012799201621; Zuloaga KL, 2011, AM J PHYSIOL-HEART C, V301, pH1882, DOI 10.1152/ajpheart.00446.2011	67	26	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110597	10.1371/journal.pone.0110597	http://dx.doi.org/10.1371/journal.pone.0110597			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375852	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600015
J	Price, JE; Phiri, L; Mulenga, D; Hewett, PC; Topp, SM; Shiliya, N; Hatzold, K				Price, Jessica E.; Phiri, Lyson; Mulenga, Drosin; Hewett, Paul C.; Topp, Stephanie M.; Shiliya, Nicholas; Hatzold, Karin			Behavior Change Pathways to Voluntary Medical Male Circumcision: Narrative Interviews with Circumcision Clients in Zambia	PLOS ONE			English	Article							TRANSTHEORETICAL MODEL; QUALITATIVE RESEARCH; HIV PREVENTION; ACCEPTABILITY; INFECTION; RISK; MEN	As an HIV prevention strategy, the scale-up of voluntary medical male circumcision (VMMC) is underway in 14 countries in Africa. For prevention impact, these countries must perform millions of circumcisions in adolescent and adult men before 2015. Although acceptability of VMMC in the region is well documented and service delivery efforts have proven successful, countries remain behind in meeting circumcision targets. A better understanding of men's VMMC-seeking behaviors and experiences is needed to improve communication and interventions to accelerate uptake. To this end, we conducted semi-structured interviews with 40 clients waiting for surgical circumcision at clinics in Zambia. Based on Stages of Change behavioral theory, men were asked to recount how they learned about adult circumcision, why they decided it was right for them, what they feared most, how they overcame their fears, and the steps they took to make it to the clinic that day. Thematic analysis across all cases allowed us to identify key behavior change triggers while within-case analysis elucidated variants of one predominant behavior change pattern. Major stages included: awareness and critical belief adjustment, norming pressures and personalization of advantages, a period of fear management and finally VMMC-seeking. Qualitative comparative analysis of ever-married and never-married men revealed important similarities and differences between the two groups. Unprompted, 17 of the men described one to four failed prior attempts to become circumcised. Experienced more frequently by older men, failed VMMC attempts were often due to service-side barriers. Findings highlight intervention opportunities to increase VMMC uptake. Reaching uncircumcised men via close male friends and female sex partners and tailoring messages to stage-specific concerns and needs would help accelerate men's movement through the behavior change process. Expanding service access is also needed to meet current demand. Improving clinic efficiencies and introducing time-saving procedures and advance scheduling options should be considered.	[Price, Jessica E.; Phiri, Lyson; Mulenga, Drosin] Populat Council, Zambia Off, Lusaka, Zambia; [Hewett, Paul C.] Populat Council, HIV Div, New York, NY USA; [Hewett, Paul C.] Populat Council, PGY Div, New York, NY USA; [Topp, Stephanie M.] Ctr Infect Dis Res, Lusaka, Zambia; [Topp, Stephanie M.] Univ Alabama Birmingham, Hlth Care Org & Policy Unit, Birmingham, AL USA; [Topp, Stephanie M.] Univ Melbourne, Nossol Inst Global Hlth, Melbourne, Vic, Australia; [Shiliya, Nicholas] Populat Serv Int Res Monitoring & Evaluat, Lusaka, Zambia; [Hatzold, Karin] Populat Serv Int, HIV, Harare, Zimbabwe; [Hatzold, Karin] Populat Serv Int, SRH, Harare, Zimbabwe	Population Council; Population Council; University of Alabama System; University of Alabama Birmingham; University of Melbourne	Price, JE (corresponding author), Populat Council, Zambia Off, Lusaka, Zambia.	ntaljess@gmail.com	Topp, Stephanie M/H-3923-2019	Topp, Stephanie M/0000-0002-3448-7983	Bill and Melinda Gates Foundation via the Population Services International Grant [3889]	Bill and Melinda Gates Foundation via the Population Services International Grant	The study was funded by the Bill and Melinda Gates Foundation via the Population Services International Grant #3889 to Population Council. Population Services International facilitated clinic access and reviewed the draft manuscripts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Ayres L, 2003, QUAL HEALTH RES, V13, P871, DOI 10.1177/1049732303013006008; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Central Statistical Office Ministry of Health University of Zambia MEASURE Evaluation, 2010, ZAMB SEX BEH SURV 20; Cialdini R., 1993, PSYCHOL INFLUENCE; Di Noia J, 2012, AM J HEALTH PROMOT, V26, P381, DOI 10.4278/ajhp.100903-QUAN-302; Dray J, 2012, CLIN PSYCHOL REV, V32, P558, DOI 10.1016/j.cpr.2012.06.005; Everson ES, 2010, PATIENT EDUC COUNS, V78, P53, DOI 10.1016/j.pec.2009.05.004; Galukande Moses, 2012, Pan Afr Med J, V13, P88; Gasasira RA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-134; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2013, SEX TRANSM INFECT, V89, P345, DOI 10.1136/sextrans-2012-050595; Gummerson E, 2013, AIDS, V27, P2657, DOI 10.1097/01.aids.0000433235.55937.10; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018299; Hogben M, 2008, SEX TRANSM DIS, V35, P1009, DOI 10.1097/OLQ.0b013e31818eb752; LUBORSKY MR, 1995, RES AGING, V17, P89, DOI 10.1177/0164027595171005; Luca NR, 2013, J HEALTH COMMUN, V18, P20, DOI 10.1080/10810730.2012.688243; Lukobo MD, 2007, AIDS CARE, V19, P471, DOI 10.1080/09540120601163250; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Plotkin M, 2013, GLOB HEALTH-SCI PRAC, V1, P108, DOI 10.9745/GHSP-D-12-00037; Prochaska J, 2002, HLTH BEHAV THEORY RE, V3rd, P97; Reisenhofer S, 2013, PATIENT EDUC COUNS, V93, P536, DOI 10.1016/j.pec.2013.08.004; Sandelowski M, 2001, RES NURS HEALTH, V24, P230, DOI 10.1002/nur.1025; Sandelowski M, 1996, RES NURS HEALTH, V19, P525, DOI 10.1002/(SICI)1098-240X(199612)19:6<525::AID-NUR8>3.0.CO;2-Q; Tobian AAR, 2014, ANNU REV MED, V65, P293, DOI 10.1146/annurev-med-092412-090539; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WHO/UNAIDS, 2011, JOINT STRAT ACT FRAM; Wouabe ED, 2013, SCOPING REPORT INTER	30	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111602	10.1371/journal.pone.0111602	http://dx.doi.org/10.1371/journal.pone.0111602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375790	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000344402600050
J	Xiong, XL; Zhong, AY; Xu, HJ				Xiong, Xiaolu; Zhong, Anyuan; Xu, Huajun			Effect of Cyanotoxins on the Hypothalamic-Pituitary-Gonadal Axis in Male Adult Mouse	PLOS ONE			English	Article							MICROCYSTIN-LR; REPRODUCTIVE-SYSTEM; SERTOLI-CELLS; IN-VITRO; SPERMATOGENESIS; HORMONE; MICE; RECEPTORS; RAT; TESTOSTERONE	Background: Microcystins LR (MC-LR) are hepatotoxic cyanotoxins that have been shown to induce reproductive toxicity, and Hypothalamic-Pituitary-Gonadal Axis (HPG) is responsible for the control of reproductive functions. However, few studies have been performed to evaluate the effects of MC-LR on HPG axis. This study aimed to investigate the MC-LR-induced toxicity in the reproductive system of mouse and focus on the HPG axis. Methods: Adult male C57BL/6 mice were exposed to various concentrations of MC-LR (0, 3.75, 7.50, 15.00 and 30.00 mu g/kg body weight per day) for 1 to 14 days, and it was found that exposure to different concentrations of MC-LR significantly disturbed sperm production in the mice testes in a dose- and time-dependent manner. To elucidate the associated possible mechanisms, the serum levels of testosterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were assessed. Meanwhile, PCR assays were employed to detect alterations in a series of genes involved in HPG axis, such as FSH, LH, gonadotropin-releasing hormone (GnRH) and their complement receptors. Furthermore, the effect of MC-LR on the viability and testosterone production of Leydig cells were tested in vitro. Results: MC-LR significantly impaired the spermatogenesis of mice possibly through the direct or indirect inhibition of GnRH synthesis at the hypothalamic level, which resulted in reduction of serum levels of LH that lead to suppression of testosterone production in the testis of mice. Conclusions: MC-LR may be a GnRH toxin that would disrupt the reproductive system of mice.	[Xiong, Xiaolu] Nanjing Med Univ, Drum Tower Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Zhong, Anyuan] Soochow Univ, Affiliated Hosp 2, Dept Resp Dis, Suzhou, Peoples R China; [Xu, Huajun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Otolaryngol Inst, Dept Otolaryngol, Shanghai 200030, Peoples R China	Nanjing Medical University; Nanjing University; Soochow University - China; Shanghai Jiao Tong University	Xu, HJ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Otolaryngol Inst, Dept Otolaryngol, Shanghai 200030, Peoples R China.	sunnydayxu2010@163.com			National Natural Science Foundation of China [81200587]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the National Natural Science Foundation of China under the grant 81200587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 1999, MOL ENDOCRINOL, V13, P812, DOI 10.1210/me.13.6.812; BAENZIGER JU, 1988, BIOCHIM BIOPHYS ACTA, V947, P287, DOI 10.1016/0304-4157(88)90012-3; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bischoff K, 2001, VET HUM TOXICOL, V43, P294; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; CARA JF, 1988, ENDOCRINOLOGY, V123, P733, DOI 10.1210/endo-123-2-733; Chen J, 2009, TOXICOL SCI, V108, P81, DOI 10.1093/toxsci/kfp009; Chen Y, 2011, REPROD TOXICOL, V31, P551, DOI 10.1016/j.reprotox.2011.02.006; Ciccone NA, 2009, CURR OPIN ENDOCRINOL, V16, P321, DOI 10.1097/MED.0b013e32832d88fb; CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391; de Kretser DM, 1998, HUM REPROD, V13, P1; Dedes I, 2012, SYST BIOL REPROD MED, V58, P121, DOI 10.3109/19396368.2011.651555; Ding WX, 2003, FEMS MICROBIOL LETT, V220, P1, DOI 10.1016/S0378-1097(03)00100-9; Ding XS, 2006, TOXICON, V48, P973, DOI 10.1016/j.toxicon.2006.07.039; Feurstein D, 2009, TOXICOL APPL PHARM, V234, P247, DOI 10.1016/j.taap.2008.10.011; Fischer WJ, 2005, TOXICOL APPL PHARM, V203, P257, DOI 10.1016/j.taap.2004.08.012; Fischer WJ, 2000, TOXICOL APPL PHARM, V164, P73, DOI 10.1006/taap.1999.8861; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Gupta N, 2003, TOXICOLOGY, V188, P285, DOI 10.1016/S0300-483X(03)00112-4; Haywood M, 2003, ENDOCRINOLOGY, V144, P509, DOI 10.1210/en.2002-220710; Heitman LH, 2008, MED RES REV, V28, P975, DOI 10.1002/med.20129; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; McLachlan RI, 1996, J ENDOCRINOL, V148, P1, DOI 10.1677/joe.0.1480001; Millar RP, 2005, ANIM REPROD SCI, V88, P5, DOI 10.1016/j.anireprosci.2005.05.032; Misrahi M, 1998, BAILLIERE CLIN ENDOC, V12, P35, DOI 10.1016/S0950-351X(98)80444-8; Roth MY, 2010, J ANDROL, V31, P138, DOI 10.2164/jandrol.109.008391; Segaloff Deborah L, 2012, Subcell Biochem, V63, P113, DOI 10.1007/978-94-007-4765-4_7; Shalev Eliezer, 2003, J Obstet Gynaecol Can, V25, P98; Sofikitis N, 2008, J STEROID BIOCHEM, V109, P323, DOI 10.1016/j.jsbmb.2008.03.004; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Wang Q, 2008, TOXICON, V52, P721, DOI 10.1016/j.toxicon.2008.08.004; Wiegand C, 2005, TOXICOL APPL PHARM, V203, P201, DOI 10.1016/j.taap.2004.11.002; Zhang HJ, 2013, AQUAT TOXICOL, V126, P283, DOI 10.1016/j.aquatox.2012.09.017; Zhou Y, 2012, TOXICOL LETT, V212, P48, DOI 10.1016/j.toxlet.2012.05.001	36	14	15	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e106585	10.1371/journal.pone.0106585	http://dx.doi.org/10.1371/journal.pone.0106585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375936	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600005
J	Haslam, M; Cardoso, RM; Visalberghi, E; Fragaszy, D				Haslam, Michael; Cardoso, Raphael Moura; Visalberghi, Elisabetta; Fragaszy, Dorothy			Stone Anvil Damage by Wild Bearded Capuchins (Sapajus libidinosus) during Pounding Tool Use: A Field Experiment	PLOS ONE			English	Article							MONKEYS CEBUS-LIBIDINOSUS; LONG-TAILED MACAQUES; HAMMER TOOLS; NUT-CRACKING; USAGE	We recorded the damage that wild bearded capuchin monkeys (Sapajus libidinosus) caused to a sandstone anvil during pounding stone tool use, in an experimental setting. The anvil was undamaged when set up at the Fazenda Boa Vista (FBV) field laboratory in Piaui, Brazil, and subsequently the monkeys indirectly created a series of pits and destroyed the anvil surface by cracking palm nuts on it. We measured the size and rate of pit formation, and recorded when adult and immature monkeys removed loose material from the anvil surface. We found that new pits were formed with approximately every 10 nuts cracked, (corresponding to an average of 38 strikes with a stone tool), and that adult males were the primary initiators of new pit positions on the anvil. Whole nuts were preferentially placed within pits for cracking, and partially-broken nuts outside the established pits. Visible anvil damage was rapid, occurring within a day of the anvil's introduction to the field laboratory. Destruction of the anvil through use has continued for three years since the experiment, resulting in both a pitted surface and a surrounding archaeological debris field that replicate features seen at natural FBV anvils.	[Haslam, Michael] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Cardoso, Raphael Moura] Univ Sao Paulo, Inst Psychol, Sao Paulo, Brazil; [Visalberghi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, Rome, Italy; [Fragaszy, Dorothy] Univ Georgia, Dept Psychol, Athens, GA 30602 USA	University of Oxford; Universidade de Sao Paulo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University System of Georgia; University of Georgia	Haslam, M (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England.	michael.haslam@rlaha.ox.ac.uk	, Doree/HCI-4354-2022	Visalberghi, Elisabetta/0000-0001-7407-5468; Haslam, Michael/0000-0001-8234-7806; Cardoso, Raphael/0000-0002-4377-4722	OUP John Fell Fund; UK Arts and Humanities Research Council; European Research Council (PRIMARCH) [283959]; CNPq [143014/2009-9]; Short-Term Mobility program - CNR; University of Georgia; National Geographic Society; L.S.B. Leakey Foundation	OUP John Fell Fund; UK Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); European Research Council (PRIMARCH); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Short-Term Mobility program - CNR; University of Georgia; National Geographic Society(National Geographic Society); L.S.B. Leakey Foundation	MH was supported by the OUP John Fell Fund, an UK Arts and Humanities Research Council Early Career Fellowship and European Research Council Starting Grant #283959 (PRIMARCH). RMC was supported by a CNPq scholarship (process: CNPq 143014/2009-9). EV was supported by the Short-Term Mobility program funded by the CNR. DF was funded by the University of Georgia, the National Geographic Society, and the L.S.B. Leakey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOESCH C, 1983, BEHAVIOUR, V83, P265, DOI 10.1163/156853983X00192; Canale GR, 2009, AM J PRIMATOL, V71, P366, DOI 10.1002/ajp.20648; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; de la Torre I, 2013, J ARCHAEOL SCI, V40, P313, DOI 10.1016/j.jas.2012.08.007; Elisabetta V, 2013, J ARCHAEOL SCI, V40, P3222, DOI 10.1016/j.jas.2013.03.021; Emidio RA, 2012, AM J PRIMATOL, V74, P332, DOI 10.1002/ajp.22009; Ferreira RG, 2010, AM J PRIMATOL, V72, P270, DOI 10.1002/ajp.20771; Fragaszy D, 2010, ANIM BEHAV, V79, P321, DOI 10.1016/j.anbehav.2009.11.004; Fragaszy DM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0410; Fragaszy DM, 2010, ANIM BEHAV, V80, P205, DOI 10.1016/j.anbehav.2010.04.018; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Gumert MD, 2009, AM J PRIMATOL, V71, P594, DOI 10.1002/ajp.20694; Haslam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072872; Haslam M, 2012, ANTIQUITY, V86, P299, DOI 10.1017/S0003598X00062773; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Liu Q, 2009, AM J PHYS ANTHROPOL, V138, P210, DOI 10.1002/ajpa.20920; Liu Q, 2011, ANIM BEHAV, V81, P297, DOI 10.1016/j.anbehav.2010.10.021; Malaivijitnond S, 2007, AM J PRIMATOL, V69, P227, DOI 10.1002/ajp.20342; Marchant LF., 2005, STONE KNAPPING NECES, P341; Massaro L, 2012, ANIM COGN, V15, P1065, DOI 10.1007/s10071-012-0530-x; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Mercader J, 2002, SCIENCE, V296, P1452, DOI 10.1126/science.1070268; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Spagnoletti N, 2012, ANIM BEHAV, V83, P1285, DOI 10.1016/j.anbehav.2012.03.002; Spagnoletti N, 2011, J HUM EVOL, V61, P97, DOI 10.1016/j.jhevol.2011.02.010; Visalberghi E, 2008, AM J PRIMATOL, V70, P884, DOI 10.1002/ajp.20578; Visalberghi E, 2007, AM J PHYS ANTHROPOL, V132, P426, DOI 10.1002/ajpa.20546; Visalberghi E, 2009, PRIMATES, V50, P95, DOI 10.1007/s10329-008-0127-9; Visalberghi E, 2009, CURR BIOL, V19, P213, DOI 10.1016/j.cub.2008.11.064	30	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111273	10.1371/journal.pone.0111273	http://dx.doi.org/10.1371/journal.pone.0111273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AS9IQ	25372879	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900042
J	Ilheu, M; Matono, P; Bernardo, JM				Ilheu, Maria; Matono, Paula; Bernardo, Joao Manuel			Invasibility of Mediterranean-Climate Rivers by Non-Native Fish: The Importance of Environmental Drivers and Human Pressures	PLOS ONE			English	Article							FRESH-WATER FISH; PUMPKINSEED LEPOMIS-GIBBOSUS; LIFE-HISTORY TRAITS; BIOTIC INTEGRITY; SPATIAL AUTOCORRELATION; SANDER-LUCIOPERCA; ALQUEVA RESERVOIR; SPECIES RICHNESS; GAMBUSIA-AFFINIS; ALIEN FISH	Invasive species are regarded as a biological pressure to natural aquatic communities. Understanding the factors promoting successful invasions is of great conceptual and practical importance. From a practical point of view, it should help to prevent future invasions and to mitigate the effects of recent invaders through early detection and prioritization of management measures. This study aims to identify the environmental determinants of fish invasions in Mediterranean-climate rivers and evaluate the relative importance of natural and human drivers. Fish communities were sampled in 182 undisturbed and 198 disturbed sites by human activities, belonging to 12 river types defined for continental Portugal within the implementation of the European Union's Water Framework Directive. Pumpkinseed sunfish, Lepomis gibbosus (L.), and mosquitofish, Gambusia holbrooki (Girard), were the most abundant non-native species (NNS) in the southern river types whereas the Iberian gudgeon, Gobio lozanoi Doadrio and Madeira, was the dominant NNS in the north/centre. Small northern mountain streams showed null or low frequency of occurrence and abundance of NNS, while southern lowland river types with medium and large drainage areas presented the highest values. The occurrence of NNS was significantly lower in undisturbed sites and the highest density of NNS was associated with high human pressure. Results from variance partitioning showed that natural environmental factors determine the distribution of the most abundant NNS while the increase in their abundance and success is explained mainly by human-induced disturbance factors. This study stresses the high vulnerability of the warm water lowland river types to non-native fish invasions, which is amplified by human-induced degradation.	[Ilheu, Maria; Matono, Paula; Bernardo, Joao Manuel] Univ Evora, Escola Ciencias & Tecnol, Dept Paisagem Ambiente & Ordenamento, Evora, Portugal; [Ilheu, Maria; Matono, Paula] Univ Evora, Inst Ciencias Agr & Ambientais Mediterran, Evora, Portugal	University of Evora; University of Evora	Ilheu, M (corresponding author), Univ Evora, Escola Ciencias & Tecnol, Dept Paisagem Ambiente & Ordenamento, Evora, Portugal.	milheu@uevora.pt	Ilhéu, Maria/B-5418-2014; Matono, Paula/AFL-5122-2022	Matono, Paula/0000-0002-1665-3298; /0000-0001-5833-0692	INAG (Instituto da Agua); Foundation for Science and Technology (FCT) [PTDC/AAC-AMB/102541/2008, SFRH/BD/23435/2005]; FEDER under the programme COMPETE; National Funds through FCT [PEst-OE/AGR/UI0115/2014]	INAG (Instituto da Agua); Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER under the programme COMPETE; National Funds through FCT(Portuguese Foundation for Science and Technology)	This study was partially funded by INAG (Instituto da Agua) as part of a larger programme on the implementation of the Water Framework Directive and by the Foundation for Science and Technology (FCT) through the research project (PTDC/AAC-AMB/102541/2008). Additional funding was provided by FEDER under the programme COMPETE and by National Funds through FCT under the Strategic Project PEst-OE/AGR/UI0115/2014. P. Matono was supported by a PhD grant from FCT (SFRH/BD/23435/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre CM, 2010, RIVER RES APPL, V26, P977, DOI 10.1002/rra.1308; Allen CR, 2013, GLOBAL ECOL BIOGEOGR, V22, P889, DOI 10.1111/geb.12054; Almeida D, 2009, ECOL FRESHW FISH, V18, P15, DOI 10.1111/j.1600-0633.2008.00317.x; Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; ANDREASEN JK, 1985, ARCH ENVIRON CON TOX, V14, P573, DOI 10.1007/BF01055387; Angermeier PL, 2000, T AM FISH SOC, V129, P962, DOI 10.1577/1548-8659(2000)129<0962:RFACMF>2.3.CO;2; Arthington A. H., 1990, BUREAU RURAL RESOURC, V8, P61; Belote RT, 2008, ECOLOGY, V89, P183, DOI 10.1890/07-0270.1; Benejam Lluis, 2007, Limnetica, V26, P169; Benejam L, 2009, BIOL INVASIONS, V11, P2265, DOI 10.1007/s10530-008-9413-0; Bernardo JM, 2003, RIVER RES APPL, V19, P521, DOI 10.1002/rra.726; Blanchett S, 2009, P ROY SOC B-BIOL SCI, V276, P2385, DOI 10.1098/rspb.2009.0156; Bomford M, 2010, BIOL INVASIONS, V12, P2559, DOI 10.1007/s10530-009-9665-3; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; BROWNPETERSON N, 1990, ENVIRON BIOL FISH, V27, P33, DOI 10.1007/BF00004902; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Caiola N, 2002, J FISH BIOL, V61, P1058, DOI 10.1006/jfbi.2002.2103; CEN, 2003, 140112003 CEN; CIS-WFD, 2003, GUID EST REF COND EC; Clavero M, 2006, ECOL APPL, V16, P2313, DOI 10.1890/1051-0761(2006)016[2313:HDAIRO]2.0.CO;2; Comesana Julian, 2009, Aquatic Invasions, V4, P425, DOI 10.3391/ai.2009.4.2.25; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Copp GH, 2004, FOLIA ZOOL, V53, P237; Daniel WW, 1987, BIOSTATISTICS FDN AN, V4; Davies KF, 2005, ECOLOGY, V86, P1602, DOI 10.1890/04-1196; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Doadrio I., 2004, Graellsia, V60, P107; Drake JA, 1989, BIOL INVASIONS GLOBA; Duncan RP, 2001, J ANIM ECOL, V70, P621, DOI 10.1046/j.1365-2656.2001.00517.x; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Fausch KD, 2001, ECOL APPL, V11, P1438, DOI 10.1890/1051-0761(2001)011[1438:FDRIRT]2.0.CO;2; Filipe AF, 2010, DIVERS DISTRIB, V16, P773, DOI 10.1111/j.1472-4642.2010.00678.x; GALAT DL, 1992, ENVIRON BIOL FISH, V33, P249, DOI 10.1007/BF00005869; Garcia-Berthou E, 2005, CAN J FISH AQUAT SCI, V62, P453, DOI 10.1139/F05-017; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Gido KB, 1999, FRESHWATER BIOL, V42, P387, DOI 10.1046/j.1365-2427.1999.444490.x; GILLER PS, 1998, BIOL STREAMS RIVERS; Godinho Francisco Nunes, 2000, Biological Invasions, V2, P231, DOI 10.1023/A:1010022123669; Gonzalez AL, 2010, OIKOS, V119, P779, DOI 10.1111/j.1600-0706.2009.18549.x; Gozlan RE, 2010, AQUAT INVASIONS, V5, P231, DOI 10.3391/ai.2010.5.3.02; Halliwell DB, 1998, ASSESSING THE SUSTAINABILITY AND BIOLOGICAL INTEGRITY OF WATER RESOURCES USING FISH COMMUNITIES, P301; Harris JH, 1999, FRESHWATER BIOL, V41, P235, DOI 10.1046/j.1365-2427.1999.00428.x; Hermoso V, 2011, ECOL APPL, V21, P175, DOI 10.1890/09-2011.1; HINCH SG, 1994, CAN J FISH AQUAT SCI, V51, P701, DOI 10.1139/f94-070; HUGHES RM, 1988, J WATER POLLUT CON F, V60, P486; Ilheu M, 2004, THESIS U EVORA; INAG IP, 2008, RIV TYP CONT PORT IM; INAG IP, 2008, MAN BIOL ASS WAT QUA; Joy MK, 2004, ENVIRON MANAGE, V34, P415, DOI 10.1007/s00267-004-0083-0; Kennard MJ, 2005, FRESHWATER BIOL, V50, P174, DOI 10.1111/j.1365-2427.2004.01293.x; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Leprieur F, 2009, J BIOGEOGR, V36, P1899, DOI 10.1111/j.1365-2699.2009.02107.x; Leunda PM, 2010, AQUAT INVASIONS, V5, P239, DOI 10.3391/ai.2010.5.3.03; Lloyd LN, 1984, J AUSTR NEW GUINEA F, V1, P31; LOBONCERVIA J, 1991, J FISH BIOL, V39, P285, DOI 10.1111/j.1095-8649.1991.tb04363.x; Perez-Bote JL, 2009, LIMNETICA, V28, P225; Marr SM, 2013, HYDROBIOLOGIA, V719, P317, DOI 10.1007/s10750-013-1486-9; Meador Michael R., 2003, Ecological Indicators, V3, P81, DOI 10.1016/S1470-160X(03)00013-X; MEFFE GK, 1984, ECOLOGY, V65, P1525, DOI 10.2307/1939132; Minckley WL, 1987, COMMUNITY EVOLUTIONA, P96; Miranda R, 2005, ANN LIMNOL-INT J LIM, V41, P7, DOI 10.1051/limn/2005007; Miranda R, 2010, AQUAT INVASIONS, V5, P291, DOI 10.3391/ai.2010.5.3.06; NIEMELA J, 1991, OIKOS, V62, P351, DOI 10.2307/3545500; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Olden JD, 2006, ECOL MONOGR, V76, P25, DOI 10.1890/05-0330; Power ME, 1996, ENVIRON MANAGE, V20, P887, DOI 10.1007/BF01205969; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Ribeiro F, 2009, FISHERIES MANAG ECOL, V16, P255, DOI 10.1111/j.1365-2400.2009.00659.x; Ribeiro F, 2009, CYBIUM, V33, P255; Ribeiro F, 2006, CYBIUM, V30, P283; Ross RM, 2001, BIOL INVASIONS, V3, P347, DOI 10.1023/A:1015847305717; Ruesink JL, 2005, CONSERV BIOL, V19, P1883, DOI 10.1111/j.1523-1739.2005.00267.x-i1; Saiki MK, 2004, ARCH ENVIRON CON TOX, V47, P363, DOI [10.1007/s00244-2051-3, 10.1007/s00244-004-2051-3]; Schmutz S, 2007, FISHERIES MANAG ECOL, V14, P441, DOI 10.1111/j.1365-2400.2007.00582.x; Schmutz Stefan, 2004, DEV EV IMPL STAND FI; Schultz AA, 2003, N AM J FISH MANAGE, V23, P503, DOI 10.1577/1548-8675(2003)023<0503:EOFOAO>2.0.CO;2; Smith K. G., 2006, STATUS DISTRIBUTION; Sterud Erik, 2006, Aquatic Invasions, V1, P278; Townsend CR, 1996, BIOL CONSERV, V78, P13, DOI 10.1016/0006-3207(96)00014-6; Vila-Gispert A, 2005, BIOL INVASIONS, V7, P107, DOI 10.1007/s10530-004-9640-y; Villeneuve F, 2005, J APPL ICHTHYOL, V21, P275, DOI 10.1111/j.1439-0426.2005.00679.x; Williamson M., 1996, BIOL INVASIONS; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	87	18	18	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109694	10.1371/journal.pone.0109694	http://dx.doi.org/10.1371/journal.pone.0109694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372284	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900009
J	Kim, S; Lee, J; Hong, ME; Do, IG; Kang, SY; Ha, SY; Kim, ST; Park, SH; Kang, WK; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, S; Kim, DH; Kim, KM				Kim, Seokhwi; Lee, Jeeyun; Hong, Min Eui; Do, In-Gu; Kang, So Young; Ha, Sang Yun; Kim, Seung Tae; Park, Se Hoon; Kang, Won Ki; Choi, Min-Gew; Lee, Jun Ho; Sohn, Tae Sung; Bae, Jae Moon; Kim, Sung; Kim, Duk-Hwan; Kim, Kyoung-Mee			High-Throughput Sequencing and Copy Number Variation Detection Using Formalin Fixed Embedded Tissue in Metastatic Gastric Cancer	PLOS ONE			English	Article							GENE AMPLIFICATION; MUTATIONS; EXPRESSION; SURVIVAL	In the era of targeted therapy, mutation profiling of cancer is a crucial aspect of making therapeutic decisions. To characterize cancer at a molecular level, the use of formalin-fixed paraffin-embedded tissue is important. We tested the Ion AmpliSeq Cancer Hotspot Panel v2 and nCounter Copy Number Variation Assay in 89 formalin-fixed paraffin-embedded gastric cancer samples to determine whether they are applicable in archival clinical samples for personalized targeted therapies. We validated the results with Sanger sequencing, real-time quantitative PCR, fluorescence in situ hybridization and immunohistochemistry. Frequently detected somatic mutations included TP53 (28.17%), APC (10.1%), PIK3CA (5.6%), KRAS (4.5%), SMO (3.4%), STK11 (3.4%), CDKN2A (3.4%) and SMAD4 (3.4%). Amplifications of HER2, CCNE1, MYC, KRAS and EGFR genes were observed in 8 (8.9%), 4 (4.5%), 2 (2.2%), 1 (1.1%) and 1 (1.1%) cases, respectively. In the cases with amplification, fluorescence in situ hybridization for HER2 verified gene amplification and immunohistochemistry for HER2, EGFR and CCNE1 verified the overexpression of proteins in tumor cells. In conclusion, we successfully performed semiconductor-based sequencing and nCounter copy number variation analyses in formalin-fixed paraffin-embedded gastric cancer samples. High-throughput screening in archival clinical samples enables faster, more accurate and costeffective detection of hotspot mutations or amplification in genes.	[Kim, Seokhwi; Hong, Min Eui; Do, In-Gu; Kang, So Young; Ha, Sang Yun; Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Lee, Jeeyun; Kim, Seung Tae; Park, Se Hoon; Kang, Won Ki] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Choi, Min-Gew; Lee, Jun Ho; Sohn, Tae Sung; Bae, Jae Moon; Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Hong, Min Eui; Kim, Kyoung-Mee] Samsung Med Ctr, Canc Compan Diagnost Ctr, Seoul, South Korea; [Kim, Duk-Hwan] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Kim, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea.	kkmkys@skku.edu	Park, Se Hoon/GMX-1199-2022; kim, st/O-5928-2014; Lee, Jeeyun/I-7171-2015; Kim, Sung/G-4114-2014	Park, Se Hoon/0000-0001-5084-9326; 	Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [A101130]; Samsung Biomedical Research Institute grant [SBRI-SP1B20112]; Samsung Medical Center intramural grant [GFO1140111]	Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea; Samsung Biomedical Research Institute grant(Samsung); Samsung Medical Center intramural grant(Samsung)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (A101130) and a Samsung Biomedical Research Institute grant (#SBRI-SP1B20112). This study was also supported by a Samsung Medical Center intramural grant, 20 x 20 Project (#GFO1140111). Co-authors Seokhwi Kim, Jeeyun Lee, Min Eui Hong, In-Gu Do, So Young Kang, Sang Yun Ha, Seung Tae Kim, Se Hoon Park, Won Ki Kang, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Jae Moon Bae, Sung Kim and Kyoung-Mee Kim are employed by Samsung Medical Center. Co-author Duk-Hwan Kim is employed by Samsung Biomedical Research Institute. Samsung Biomedical Research Institute and Samsung Medical Center provided support in the form of salaries for authors Seokhwi Kim, JL, MEH, IGD, SYK, SYH, STK, SHP, WKK, MGC, JHL, TSS, JMB, Sung Kim, KMK and DHK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bang YJ, 2010, LANCET, V376, P1302; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Cho EY, 2013, MODERN PATHOL, V26, P677, DOI 10.1038/modpathol.2012.205; Cho EY, 2012, PATHOLOGY, V44, P216, DOI 10.1097/PAT.0b013e3283513e8b; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Graziano F, 2011, J CLIN ONCOL; Ha SY, 2013, MODERN PATHOL, V26, P1632, DOI 10.1038/modpathol.2013.108; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082770; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038892; Lee SE, 2014, AM J SURG PATHOL, V38, P784, DOI 10.1097/PAS.0000000000000185; Ma Patrick C, 2012, Cleve Clin J Med, V79 Electronic Suppl 1, peS56, DOI 10.3949/ccjm.79.s2.12; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Nadauld LD, 2013, J CLIN ONCOL, V31, P838, DOI 10.1200/JCO.2012.47.1714; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Shin A, 2011, J GASTRIC CANCER, V11, P135, DOI 10.5230/jgc.2011.11.3.135; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Smyth EC, 2012, CURR TREAT OPTION ON, V13, P377, DOI 10.1007/s11864-012-0192-6; Tanney A, 2010, PERS MED, V7, P205, DOI 10.2217/PME.10.8; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wong H, 2013, THER ADV GASTROENTER, V6, P15, DOI 10.1177/1756283X12453636; Wu YH, 2013, GUT, V62, P1100, DOI 10.1136/gutjnl-2011-301373; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang LH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02992	32	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111693	10.1371/journal.pone.0111693	http://dx.doi.org/10.1371/journal.pone.0111693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372287	gold, Green Submitted, Green Published			2022-12-26	WOS:000344556900063
J	Tanaka, K; Koike, Y; Shimura, T; Okigami, M; Ide, S; Toiyama, Y; Okugawa, Y; Inoue, Y; Araki, T; Uchida, K; Mohri, Y; Mizoguchi, A; Kusunoki, M				Tanaka, Koji; Koike, Yuhki; Shimura, Tadanobu; Okigami, Masato; Ide, Shozo; Toiyama, Yuji; Okugawa, Yoshinaga; Inoue, Yasuhiro; Araki, Toshimitsu; Uchida, Keiichi; Mohri, Yasuhiko; Mizoguchi, Akira; Kusunoki, Masato			In Vivo Characterization of Neutrophil Extracellular Traps in Various Organs of a Murine Sepsis Model	PLOS ONE			English	Article							DNA TRAPS; MICE; BACTERIA; NETOSIS	Neutrophil extracellular traps (NETs) represent extracellular microbial trapping and killing. Recently, it has been implicated in thrombogenesis, autoimmune disease, and cancer progression. The aim of this study was to characterize NETs in various organs of a murine sepsis model in vivo and to investigate their associations with platelets, leukocytes, or vascular endothelium. NETs were classified as two distinct forms; cell-free NETs that were released away from neutrophils and anchored NETs that were anchored to neutrophils. Circulating cell-free NETs were characterized as fragmented or cotton-like structures, while anchored NETs were characterized as linear, reticular, membranous, or spot-like structures. In septic mice, both anchored and cell-free NETs were significantly increased in postcapillary venules of the cecum and hepatic sinusoids with increased leukocyte-endothelial interactions. NETs were also observed in both alveolar space and pulmonary capillaries of the lung. The interactions of NETs with platelet aggregates, leukocyte-platelet aggregates or vascular endothelium of arterioles and venules were observed in the microcirculation of septic mice. Microvessel occlusions which may be caused by platelet aggregates or leukocyte-platelet aggregates and heterogeneously decreased blood flow were also observed in septic mice. NETs appeared to be associated with the formation of platelet aggregates or leukocyte-platelet aggregates. These observational findings may suggest the adverse effect of intravascular NETs on the host during a sepsis.	[Tanaka, Koji; Koike, Yuhki; Shimura, Tadanobu; Okigami, Masato; Ide, Shozo; Toiyama, Yuji; Okugawa, Yoshinaga; Inoue, Yasuhiro; Araki, Toshimitsu; Uchida, Keiichi; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Gastrointestinal, Tsu, Mie 514, Japan; [Tanaka, Koji; Koike, Yuhki; Shimura, Tadanobu; Okigami, Masato; Ide, Shozo; Toiyama, Yuji; Okugawa, Yoshinaga; Inoue, Yasuhiro; Araki, Toshimitsu; Uchida, Keiichi; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Paediat Surg, Tsu, Mie 514, Japan; [Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Neural Regenerat, Tsu, Mie 514, Japan; [Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Cell Commun, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University; Mie University	Tanaka, K (corresponding author), Mie Univ, Grad Sch Med, Dept Gastrointestinal, Tsu, Mie 514, Japan.	qouji@clin.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 25462052, 25462771]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI 25462052 to KT and 25462771 to YK). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Carmona-Rivera C, 2014, NEUTROPHIL EXTRACELL; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Doring Y, 2012, CIRCULATION, V125, P1673, DOI 10.1161/CIRCULATIONAHA.111.046755; Dubois AV, 2012, AM J RESP CELL MOL, V47, P80, DOI 10.1165/rcmb.2011-0380OC; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Koike Y, 2011, J THROMB THROMBOLYS, V32, P138, DOI 10.1007/s11239-011-0600-y; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Lu T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00365; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Megens RTA, 2012, THROMB HAEMOSTASIS, V107, P597, DOI 10.1160/TH11-09-0650; Menegazzi R, 2012, BLOOD, V119, P1214, DOI 10.1182/blood-2011-07-364604; Meng W, 2012, CRIT CARE, V16, DOI 10.1186/cc11442; Morimoto Y, 2011, J GASTROINTEST SURG, V15, P1842, DOI 10.1007/s11605-011-1632-5; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pfeiler S, 2014, THROMB RES, V133, pS35, DOI 10.1016/j.thromres.2014.03.016; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Tanaka K, 2013, SURG TODAY, V43, P123, DOI 10.1007/s00595-012-0283-9; Tanaka K, 2012, ONCOL REP, V28, P1822, DOI 10.3892/or.2012.1983; Tanaka K, 2012, MICROSC RES TECHNIQ, V75, P307, DOI 10.1002/jemt.21059; Toiyama Y, 2010, J GASTROENTEROL, V45, P544, DOI 10.1007/s00535-009-0187-7; Ustione A, 2011, J MICROSC-OXFORD, V243, P221, DOI 10.1111/j.1365-2818.2011.03532.x; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	32	98	100	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111888	10.1371/journal.pone.0111888	http://dx.doi.org/10.1371/journal.pone.0111888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372699	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900085
J	Zheng, LH; Yi, Y; Liu, J; Lin, XK; Yang, KL; Lv, M; Zhou, XW; Hao, JH; Liu, JZ; Zheng, Y; Sun, M				Zheng, Lanhong; Yi, Yao; Liu, Jia; Lin, Xiukun; Yang, Kangli; Lv, Mei; Zhou, Xinwen; Hao, Jianhua; Liu, Junzhong; Zheng, Yuan; Sun, Mi			Isolation and Characterization of Marine Brevibacillus sp S-1 Collected from South China Sea and a Novel Antitumor Peptide Produced by the Strain	PLOS ONE			English	Article							DIDEMNIN-B; DISCOVERY; CANCER; METABOLITES; STRATEGIES; MICROBES; BACTERIA; PATHWAY	A Gram-positive, rod-shaped bacterium, designated as S-1, was isolated from a marine sediment sample collected from South China Sea. Phylogenetic analysis based on 16S rRNA gene sequence showed that S-1 belongs to the genus Brevibacillus. A novel cytotoxic peptide was isolated from the fermentation broth of the marine-derived bacterium Brevibacillus sp. S-1, using ion-exchange chromatography and reverse-phase HPLC chromatography. The molecular weight of this peptide was determined as 1570 Da by MALDI-TOF mass spectrometry, and its structure was proposed as a cyclic peptide elucidated by MALDI-TOF/TOF mass spectrometry and de novo sequencing. 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay showed that this peptide exhibited cytotoxicity against BEL-7402 human hepatocellular carcinoma cells, RKO human colon carcinoma cells, A549 human lung carcinoma cells, U251 human glioma cells and MCF-7 human breast carcinoma cells. Additionally, SBP exhibited low cytotoxicity against HFL1 human normal fibroblast lung cells. The result suggested that the cytotoxic effect of the peptide is specific to tumor cells.	[Zheng, Lanhong; Yi, Yao; Yang, Kangli; Lv, Mei; Hao, Jianhua; Liu, Junzhong; Zheng, Yuan; Sun, Mi] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China; [Liu, Jia] Qingdao Univ, Qingdao 266071, Peoples R China; [Lin, Xiukun] Capital Med Univ, Dept Pharmacol, Beijing, Peoples R China; [Yang, Kangli; Lv, Mei] Qingdao Univ Sci & Technol, Qingdao, Peoples R China; [Zhou, Xinwen] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao University; Capital Medical University; Qingdao University of Science & Technology; Fudan University	Sun, M (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China.	sunmi@ysfri.ac.cn		Lin, Xiukun/0000-0002-0306-4953	Special Scientific Research Funds for Central Non-profit Institutes; Chinese Academy of Fishery Sciences [2013B01YQ01]; Science and Technology Development Plans of Shandong Province [2014GGF01060]; Special Scientific Research Funds for Central Non-profit Institutes, Yellow Sea Fisheries Research Institutes [20603022013017, 20603022012013]; 863 High Technology Project [2014AA093503]	Special Scientific Research Funds for Central Non-profit Institutes; Chinese Academy of Fishery Sciences; Science and Technology Development Plans of Shandong Province; Special Scientific Research Funds for Central Non-profit Institutes, Yellow Sea Fisheries Research Institutes; 863 High Technology Project(National High Technology Research and Development Program of China)	This work was supported by Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2013B01YQ01), Science and Technology Development Plans of Shandong Province (2014GGF01060), and Special Scientific Research Funds for Central Non-profit Institutes, Yellow Sea Fisheries Research Institutes (20603022013017 and 20603022012013). This work was also partly supported by 863 High Technology Project (2014AA093503). The authors are grateful to all members of the laboratory for their continuous technical advice and helpful discussion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Beaglehole R, 2011, PUBLIC HEALTH, V125, P821, DOI 10.1016/j.puhe.2011.09.029; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bredholdt H, 2007, ENVIRON MICROBIOL, V9, P2756, DOI 10.1111/j.1462-2920.2007.01387.x; CAIN JM, 1992, INVEST NEW DRUG, V10, P23, DOI 10.1007/BF01275473; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Depenbrock H, 1998, BRIT J CANCER, V78, P739, DOI 10.1038/bjc.1998.570; El-Sersy NA, 2012, J BASIC MICROB, V52, P513, DOI 10.1002/jobm.201100290; GRUBB DR, 1995, BIOCHEM BIOPH RES CO, V215, P1130, DOI 10.1006/bbrc.1995.2580; Guedes SD, 2003, BIOCHEM BIOPH RES CO, V312, P545, DOI 10.1016/j.bbrc.2003.10.156; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JENSEN PR, 1994, ANNU REV MICROBIOL, V48, P559, DOI 10.1146/annurev.mi.48.100194.003015; Kjer J, 2010, NAT PROTOC, V5, P479, DOI 10.1038/nprot.2009.233; Li X, 2005, TRENDS BIOTECHNOL, V23, P539, DOI 10.1016/j.tibtech.2005.08.006; Liu XY, 2010, J ANTIBIOT, V63, P415, DOI 10.1038/ja.2010.56; MONTGOMERY DW, 1985, TRANSPLANTATION, V40, P49, DOI 10.1097/00007890-198507000-00011; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nalda-Molina R, 2009, CANCER CHEMOTH PHARM, V64, P97, DOI 10.1007/s00280-008-0841-4; Newman DJ, 2006, J IND MICROBIOL BIOT, V33, P539, DOI 10.1007/s10295-006-0115-2; Simmons TL, 2008, P NATL ACAD SCI USA, V105, P4587, DOI 10.1073/pnas.0709851105; Smibert Robert M., 1994, P607; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR SA, 1992, INVEST NEW DRUG, V10, P55, DOI 10.1007/BF01275484; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tindall BJ., 2007, METHODS GEN MOL MICR, V3, P330, DOI DOI 10.1128/9781555817497.CH15; Urdiales JL, 1996, CANCER LETT, V102, P31, DOI 10.1016/0304-3835(96)04151-1; Vater J, 2009, RAPID COMMUN MASS SP, V23, P1493, DOI 10.1002/rcm.4031; Waters AL, 2010, CURR OPIN BIOTECH, V21, P780, DOI 10.1016/j.copbio.2010.09.013; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Xiong ZQ, 2013, MAR DRUGS, V11, P700, DOI 10.3390/md11030700; Yergey AL, 2002, J AM SOC MASS SPECTR, V13, P784, DOI 10.1016/S1044-0305(02)00393-8; Zheng LH, 2011, MAR DRUGS, V9, P1840, DOI 10.3390/md9101840; Zheng LH, 2013, BBA-REV CANCER, V1836, P42, DOI 10.1016/j.bbcan.2013.02.006	33	3	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111270	10.1371/journal.pone.0111270	http://dx.doi.org/10.1371/journal.pone.0111270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372839	gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900041
J	Teremetz, M; Amado, I; Bendjemaa, N; Krebs, MO; Lindberg, PG; Maier, MA				Teremetz, Maxime; Amado, Isabelle; Bendjemaa, Narjes; Krebs, Marie-Odile; Lindberg, Pavel G.; Maier, Marc A.			Deficient Grip Force Control in Schizophrenia: Behavioral and Modeling Evidence for Altered Motor Inhibition and Motor Noise	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; CORTICAL INHIBITION; NEUROLOGICAL SIGNS; INTRACORTICAL INHIBITION; PRECISION; METAANALYSIS; DEXTERITY; CORTEX; STOP	Whether upper limb sensorimotor control is affected in schizophrenia and how underlying pathological mechanisms may potentially intervene in these deficits is still being debated. We tested voluntary force control in schizophrenia patients and used a computational model in order to elucidate potential cerebral mechanisms underlying sensorimotor deficits in schizophrenia. A visuomotor grip force-tracking task was performed by 17 medicated and 6 non-medicated patients with schizophrenia (DSM-IV) and by 15 healthy controls. Target forces in the ramp-hold-and-release paradigm were set to 5N and to 10% maximal voluntary grip force. Force trajectory was analyzed by performance measures and Principal Component Analysis (PCA). A computational model incorporating neural control signals was used to replicate the empirically observed motor behavior and to explore underlying neural mechanisms. Grip task performance was significantly lower in medicated and non-medicated schizophrenia patients compared to controls. Three behavioral variables were significantly higher in both patient groups: tracking error (by 50%), coefficient of variation of force (by 57%) and duration of force release (up by 37%). Behavioral performance did not differ between patient groups. Computational simulation successfully replicated these findings and predicted that decreased motor inhibition, together with an increased signal-dependent motor noise, are sufficient to explain the observed motor deficits in patients. PCA also suggested altered motor inhibition as a key factor differentiating patients from control subjects: the principal component representing inhibition correlated with clinical severity. These findings show that schizophrenia affects voluntary sensorimotor control of the hand independent of medication, and suggest that reduced motor inhibition and increased signal-dependent motor noise likely reflect key pathological mechanisms of the sensorimotor deficit.	[Teremetz, Maxime; Lindberg, Pavel G.; Maier, Marc A.] Univ Paris 05, Sorbonne Paris Cite, CNRS, FR3636, F-75006 Paris, France; [Amado, Isabelle; Bendjemaa, Narjes; Krebs, Marie-Odile] Univ Paris 05, Hop St Anne, SHU, F-75014 Paris, France; [Amado, Isabelle; Bendjemaa, Narjes; Krebs, Marie-Odile] Univ Paris 05, Sorbonne Paris Cite, INSERM, U894,GDR3557, F-75014 Paris, France; [Maier, Marc A.] Univ Paris Diderot, Sorbonne Paris Cite, F-75012 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Maier, MA (corresponding author), Univ Paris 05, Sorbonne Paris Cite, CNRS, FR3636, F-75006 Paris, France.	marc.maier@parisdescartes.fr	Lindberg, Pavel/P-9792-2019; Maier, Marc/HGU-9498-2022; Lindberg, Pavel G/E-5926-2017; Krebs, Marie-Odile/O-2104-2017	Lindberg, Pavel/0000-0001-6976-6387; Lindberg, Pavel G/0000-0001-6976-6387; Krebs, Marie-Odile/0000-0002-4715-9890; Lindberg, Pavel/0000-0002-7507-7817	French national agency for research and technology (ANRT) (CIFRE) [2013/0226]; Sensix (Poitiers, France); French national research agency [ANR-08-MNPS-004]; Fondation Pierre Deniker; European Research Area Net (ERA-NET Neuron); Fondation de France	French national agency for research and technology (ANRT) (CIFRE)(French National Research Agency (ANR)); Sensix (Poitiers, France); French national research agency(French National Research Agency (ANR)); Fondation Pierre Deniker; European Research Area Net (ERA-NET Neuron); Fondation de France(Fondation de France)	MMT was supported by a PhD fellowship (CIFRE #2013/0226) from the French national agency for research and technology (ANRT) and Sensix (Poitiers, France). This project was in part funded by the French national research agency (grant # ANR-08-MNPS-004), by Fondation Pierre Deniker, by the European Research Area Net (ERA-NET Neuron 2010) and by Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badcock JC, 2002, PSYCHOL MED, V32, P287, DOI 10.1017/S0033291701005128; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bleton JP, 2014, MOVEMENT DISORD, V29, P130, DOI 10.1002/mds.25690; Bleuler E., 1911, DEMENTIA PRAECOX GRO, P1950; Bombin I, 2005, SCHIZOPHRENIA BULL, V31, P962, DOI 10.1093/schbul/sbi028; Chan RCK, 2010, SCHIZOPHRENIA BULL, V36, P1089, DOI 10.1093/schbul/sbp011; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Clark LK, 2010, SCHIZOPHR RES, V124, P169, DOI 10.1016/j.schres.2010.08.004; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; Daskalakis ZJ, 2008, J PSYCHOPHARMACOL, V22, P203, DOI 10.1177/0269881107084002; Daskalakis ZJ, 2002, ARCH GEN PSYCHIAT, V59, P347, DOI 10.1001/archpsyc.59.4.347; Davare M, 2011, CURR OPIN NEUROBIOL, V21, P565, DOI 10.1016/j.conb.2011.05.021; Delevoye-Turrell Y, 2003, AM J PSYCHIAT, V160, P134, DOI 10.1176/appi.ajp.160.1.134; Delevoye-Turrell Y, 2002, NEUROREPORT, V13, P1537, DOI 10.1097/00001756-200208270-00010; Delevoye-Turrell Y, 2007, J ABNORM PSYCHOL, V116, P56, DOI 10.1037/0021-843X.116.1.56; Donohoe Gary, 2006, Cogn Neuropsychiatry, V11, P13, DOI 10.1080/13546800444000155; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Frantseva M, 2014, CEREB CORTEX, V24, P211, DOI 10.1093/cercor/bhs304; Giersch A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00620; Grootens KP, 2009, SCHIZOPHR RES, V107, P294, DOI 10.1016/j.schres.2008.09.032; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HEINRICHS DW, 1988, AM J PSYCHIAT, V145, P11; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kraepelin E, 1919, DEMENTIA PRAECOX PAR; Krebs MO, 2010, PSYCHIAT RES, V179, P279, DOI 10.1016/j.psychres.2009.07.008; Krebs MO, 2000, SCHIZOPHR RES, V45, P245, DOI 10.1016/S0920-9964(99)00206-6; Lafargue G, 2006, CORTEX, V42, P711, DOI 10.1016/S0010-9452(08)70409-X; Le Seac'h A, 2012, PSYCHIAT RES, V198, P230, DOI 10.1016/j.psychres.2011.12.039; Lehoux C, 2003, SCHIZOPHR RES, V62, P269, DOI 10.1016/S0920-9964(02)00327-4; Lindberg P, 2009, EXP BRAIN RES, V193, P213, DOI 10.1007/s00221-008-1613-4; Lipszyc J, 2010, J INT NEUROPSYCH SOC, V16, P1064, DOI 10.1017/S1355617710000895; Liu SK, 2009, BIOL PSYCHIAT, V65, P503, DOI 10.1016/j.biopsych.2008.09.012; MAIER MA, 1993, J NEUROPHYSIOL, V69, P772, DOI 10.1152/jn.1993.69.3.772; MANSCHRECK TC, 1982, PSYCHOL MED, V12, P73, DOI 10.1017/S0033291700043300; Manschreck TC, 2004, SCHIZOPHRENIA BULL, V30, P351, DOI 10.1093/oxfordjournals.schbul.a007084; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Midorikawa A, 2008, PSYCHIAT RES, V159, P281, DOI 10.1016/j.psychres.2007.04.004; Motawar B, 2012, EXP BRAIN RES, V221, P299, DOI 10.1007/s00221-012-3173-x; Neely KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058403; Nowak DA, 2006, J NEUROL NEUROSUR PS, V77, P650, DOI 10.1136/jnnp.2005.084749; Prodoehl J, 2009, NEUROSCI BIOBEHAV R, V33, P900, DOI 10.1016/j.neubiorev.2009.03.004; Putzhammer Albert, 2006, Dialogues Clin Neurosci, V8, P123; Radhu N, 2013, CLIN NEUROPHYSIOL, V124, P1309, DOI 10.1016/j.clinph.2013.01.014; Raemaekers M, 2002, ARCH GEN PSYCHIAT, V59, P313, DOI 10.1001/archpsyc.59.4.313; Rantalainen T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00068; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rolls ET, 2011, NEUROSCI BIOBEHAV R, V35, P1644, DOI 10.1016/j.neubiorev.2010.09.001; ROSEN AJ, 1991, J ABNORM PSYCHOL, V100, P583, DOI 10.1037/0021-843X.100.4.583; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Scott SH, 2008, J PHYSIOL-LONDON, V586, P1217, DOI 10.1113/jphysiol.2007.146068; Spitzer M, 1997, SCHIZOPHRENIA BULL, V23, P29, DOI 10.1093/schbul/23.1.29; Stinear CM, 2009, NEUROSCI BIOBEHAV R, V33, P662, DOI 10.1016/j.neubiorev.2008.08.013; Uhlhaas PJ, 2013, CURR OPIN NEUROBIOL, V23, P283, DOI 10.1016/j.conb.2012.11.004; WANNIER TMJ, 1991, J NEUROPHYSIOL, V65, P572, DOI 10.1152/jn.1991.65.3.572; Wolff AL, 1999, J PSYCHIATR NEUROSCI, V24, P304	61	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111853	10.1371/journal.pone.0111853	http://dx.doi.org/10.1371/journal.pone.0111853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369465	Green Submitted, gold, Green Published			2022-12-26	WOS:000344402000113
J	Ting, WY; Huang, SF; Lee, MC; Lin, YY; Lee, YC; Feng, JY; Su, WJ				Ting, Wen-Ying; Huang, Shiang-Fen; Lee, Ming-Che; Lin, Yung-Yang; Lee, Yu-Chin; Feng, Jia-Yih; Su, Wei-Juin			Gender Disparities in Latent Tuberculosis Infection in High-Risk Individuals: A Cross-Sectional Study	PLOS ONE			English	Article							SKIN-TEST; PULMONARY TUBERCULOSIS; TAIWAN; SUSCEPTIBILITY; DIAGNOSIS; OUTCOMES; TOBACCO; COHORT; ASSAY; AREA	Male predominance in active tuberculosis (TB) is widely-reported globally. Gender inequalities in socio-cultural status are frequently regarded as contributing factors for disparities in sex in active TB. The disparities of sex in the prevalence of latent TB infection (LTBI) are less frequently investigated and deserve clarification. In this cross-sectional study conducted in a TB endemic area, we enrolled patients at high-risk for LTBI and progression from LTBI to active TB from 2011 to 2012. Diagnosis of LTBI was made by QuantiFERON-TB Gold In-Tube (QFT-GIT). Differences in sex in terms of prevalence of LTBI and clinical predictors for LTBI were investigated. Associations among age, smoking status, and sex disparities in LTBI were also analyzed. A total of 1018 high-risk individuals with definite QFT-GIT results were included for analysis, including 534 males and 484 females. The proportion of LTBI was significantly higher in males than in females (32.6% vs. 25.2%, p = 0.010). Differences in the proportion of LTBI between sexes were most prominent in older patients (age >= 55 years). In multivariate analysis, independent clinical factors associated with LTBI were age (p = 0.014), smoking (p = 0.048), and fibro-calcified lesions on chest radiogram (p = 0.009). Male sex was not an independent factor for LTBI (p = 0.88). When stratifying patients according to the smoking status, the proportion of LTBI remained comparable between sexes among smokers and nonsmokers. In conclusion, although the proportion of LTBI is higher in men, there is no significant disparity in terms of sex in LTBI among high-risk individuals after adjusting for age, smoking status, and other clinical factors.	[Ting, Wen-Ying; Lee, Ming-Che; Lee, Yu-Chin; Feng, Jia-Yih; Su, Wei-Juin] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Huang, Shiang-Fen] Taipei Vet Gen Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan; [Huang, Shiang-Fen; Lee, Yu-Chin; Su, Wei-Juin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Lin, Yung-Yang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lin, Yung-Yang] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Neurophysiol Lab, Taipei, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Feng, Jia-Yih] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Feng, JY (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.	jyfeng@vghtpe.gov.tw; wjsu@vghtpe.gov.tw	Huang, Shiang-Fen/ABA-5375-2021	Huang, Shiang-Fen/0000-0003-0390-9108; Huang, Shiang-Fen/0000-0002-6685-8259	Institute for Biotechnology and Medicine Industry of Taiwan; Taipei Veterans General Hospital [V99C1-181, V99A-023, V100A-002, V101B-027, V102B-030]	Institute for Biotechnology and Medicine Industry of Taiwan; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was funded by the Institute for Biotechnology and Medicine Industry of Taiwan and by Taipei Veterans General Hospital (V99C1-181, V99A-023, V100A-002, V101B-027, and V102B-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2013, WHO GLOB TUB REP; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Diel R, 2013, EUR RESPIR J, V42, P785, DOI 10.1183/09031936.00205512; Diwan VK, 1999, LANCET, V353, P1000, DOI 10.1016/S0140-6736(99)01318-5; Feng JY, 2012, CLIN MICROBIOL INFEC, V18, pE331, DOI 10.1111/j.1469-0691.2012.03931.x; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023715; Fortun J, 2007, J ANTIMICROB CHEMOTH, V59, P794, DOI 10.1093/jac/dkm025; Jereb J, 2003, INT J TUBERC LUNG D, V7, pS384; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Kim HR, 2008, RESPIROLOGY, V13, P413, DOI 10.1111/j.1440-1843.2008.01282.x; Kim SY, 2013, INFECTION, V41, P103, DOI 10.1007/s15010-012-0291-0; Lin CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063936; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Onifade DA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-381; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Salim MAH, 2004, INT J TUBERC LUNG D, V8, P952; Shaler CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059185; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Soysal A, 2012, NEPHROL DIAL TRANSPL, V27, P1645, DOI 10.1093/ndt/gfr516; Visser ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029588; Vlassoff C, 2002, SOC SCI MED, V54, P1713, DOI 10.1016/S0277-9536(01)00339-2; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P829; YAMAMOTO Y, 1990, AM REV RESPIR DIS, V142, P430, DOI 10.1164/ajrccm/142.2.430; Yamasaki-Nakagawa M, 2001, INT J TUBERC LUNG D, V5, P24; Yen YF, 2013, SCAND J INFECT DIS, V45, P504, DOI 10.3109/00365548.2013.768354; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066412	30	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110104	10.1371/journal.pone.0110104	http://dx.doi.org/10.1371/journal.pone.0110104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369472	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000017
J	Radulovich, N; Leung, L; Ibrahimov, E; Navab, R; Sakashita, S; Zhu, CQ; Kaufman, E; Lockwood, WW; Thu, KL; Fedyshyn, Y; Moffat, J; Lam, WL; Tsao, MS				Radulovich, N.; Leung, L.; Ibrahimov, E.; Navab, R.; Sakashita, S.; Zhu, C-Q; Kaufman, E.; Lockwood, W. W.; Thu, K. L.; Fedyshyn, Y.; Moffat, J.; Lam, W. L.; Tsao, M-S			Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor-suppressive role in pancreatic ductal adenocarcinoma	ONCOGENE			English	Article							DNA COPY NUMBER; HOMOZYGOUS DELETIONS; EXPRESSION; CANCER; GENE; ASSOCIATION; INSTABILITY; METASTASIS; PHENOTYPE	Using integrative genomics and functional screening, we identified coiled-coil domain containing 68 (CCDC68) as a novel putative tumor suppressor gene (TSG) in pancreatic ductal adenocarcinoma (PDAC). CCDC68 allelic losses were documented in 48% of primary PDAC patient tumors, 50% of PDAC cell lines and 30% of primary patient derived xenografts. We also discovered a single nucleotide polymorphism (SNP) variant (SNP rs1344011) that leads to exon skipping and generation of an unstable protein isoform CCDC68 Delta(69-114) in 31% of PDAC patients. Overexpression of full length CCDC68 (CCDC68(wt)) in PANC-1 and Hs.766T PDAC cell lines lacking CDCC68 expression decreased proliferation and tumorigenicity in scid mice. In contrast, the downregulation of endogenous CCDC68 in MIAPaca-2 cells increased tumor growth rate. These effects were not observed with the deletion-containing isoform, CCDC68 Delta(69-114).	[Radulovich, N.; Leung, L.; Ibrahimov, E.; Navab, R.; Sakashita, S.; Zhu, C-Q; Kaufman, E.; Tsao, M-S] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Radulovich, N.; Tsao, M-S] Univ Toronto, Dept Lab Med, Toronto, ON, Canada; [Radulovich, N.; Tsao, M-S] Univ Toronto, Dept Pathobiol, Toronto, ON, Canada; [Leung, L.; Tsao, M-S] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Lockwood, W. W.; Thu, K. L.; Lam, W. L.] Univ British Columbia, British Columbia Canc Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Lockwood, W. W.; Thu, K. L.; Lam, W. L.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [Fedyshyn, Y.; Moffat, J.] Univ Toronto, Banting & Best Dept Med Res, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of Toronto	Tsao, MS (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, 200 Elizabeth St,610 Univ Ave, Toronto, ON M5G 2M9, Canada.	ming.tsao@uhn.on.ca	Navab, Roya/AGD-7380-2022; Tsao, Ming-Sound/M-3503-2017; Moffat, Jason/AAC-1110-2020; Tsao, Ming Sound/AFQ-7332-2022	Moffat, Jason/0000-0002-5663-8586; Tsao, Ming Sound/0000-0002-9160-5405; Zhu, ChangQi/0000-0002-9992-0258; Thu, Kelsie/0000-0001-9262-7238	Canadian Cancer Society Research Institute [700809]; Canadian Institutes of Health Research [MOP-49585]; Ontario Ministry of Health and Long Term Care; Terry Fox Foundation STIHR Program in Molecular Pathology of Cancer at CIHR [STP 53912]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Terry Fox Foundation STIHR Program in Molecular Pathology of Cancer at CIHR(Canadian Institutes of Health Research (CIHR))	Olga Ludkovksy (FISH), Ni Liu (PCR) and Dennis Wang (support in ICGC analysis). This study was supported by the Canadian Cancer Society Research Institute grant#700809, Canadian Institutes of Health Research grant MOP-49585 and the Ontario Ministry of Health and Long Term Care. N. Radulovich and K. Thu are Vanier Canada Graduate Scholars. Dr S. Sakashita is supported by the Terry Fox Foundation STIHR Program in Molecular Pathology of Cancer at CIHR (STP 53912). Dr Tsao is the M. Qasim Choksi Chair in Lung Cancer Translational Research.	Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Calhoun ES, 2006, CANCER RES, V66, P7920, DOI 10.1158/0008-5472.CAN-06-0721; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Devitt G, 2006, INT J CANCER, V118, P2210, DOI 10.1002/ijc.21626; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; Furukawa T, 1996, AM J PATHOL, V148, P1763; Gerhardt A, 2004, CANCER LETT, V208, P197, DOI 10.1016/j.canlet.2003.11.021; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Harada T, 2009, PANCREATOLOGY, V9, P13, DOI 10.1159/000178871; Hassan NZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092553; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hofstetter G, 2010, ONCOGENE, V29, P1997, DOI 10.1038/onc.2009.482; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hruban RH, 2008, INT J CLIN EXP PATHO, V1, P306; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Lefter LP, 2002, GENE CHROMOSOME CANC, V34, P234, DOI 10.1002/gcc.10060; Leung L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084366; Lockwood WW, 2006, EUR J HUM GENET, V14, P139, DOI 10.1038/sj.ejhg.5201531; Mak AB, 2010, MOL CELL PROTEOMICS, V9, P811, DOI 10.1074/mcp.M000002-MCP201; Myhre S, 2013, MOL ONCOL, V7, P704, DOI 10.1016/j.molonc.2013.02.018; Navab R, 2009, NEOPLASIA, V11, P1292, DOI 10.1593/neo.09622; Nowak NJ, 2005, CANCER GENET CYTOGEN, V161, P36, DOI 10.1016/j.cancergencyto.2005.01.009; Qian JY, 2005, CANCER RES, V65, P5045, DOI 10.1158/0008-5472.CAN-04-3208; Radulovich N, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-24; Radulovich N, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-24; Sharrard RM, 2000, BBA-GENE STRUCT EXPR, V1494, P282, DOI 10.1016/S0167-4781(00)00210-4; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Tammaro C, 2012, BIOCHEM SOC T, V40, P768, DOI 10.1042/BST20120140; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Thu KL, 2014, ONCOGENE, V33, P279, DOI 10.1038/onc.2012.595; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	34	21	23	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4238	4247		10.1038/onc.2014.357	http://dx.doi.org/10.1038/onc.2014.357			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25381825	Green Accepted, Bronze			2022-12-26	WOS:000359199800010
J	Shriver, M; Stroka, KM; Vitolo, MI; Martin, S; Huso, DL; Konstantopoulos, K; Kontrogianni-Konstantopoulos, A				Shriver, M.; Stroka, K. M.; Vitolo, M. I.; Martin, S.; Huso, D. L.; Konstantopoulos, K.; Kontrogianni-Konstantopoulos, A.			Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis	ONCOGENE			English	Article							C-HA-RAS; CELL; ADHESION; INVASION; GROWTH; TRANSFORMATION; EXPRESSION; MIGRATION; LOCALIZATION; MECHANISMS	Obscurins, encoded by the single OBSCN gene, are giant cytoskeletal proteins with structural and regulatory roles. The OBSCN gene is highly mutated in different types of cancers. Loss of giant obscurins from breast epithelial cells confers them with a survival and growth advantage, following exposure to DNA-damaging agents. Here we demonstrate that the expression levels and subcellular distribution of giant obscurins are altered in human breast cancer biopsies compared with matched normal samples. Stable clones of non-tumorigenic MCF10A cells lacking giant obscurins fail to form adhesion junctions, undergo epithelial-to-mesenchymal transition and generate >100-mu m mammospheres bearing markers of cancer-initiating cells. Obscurin-knockdown MCF10A cells display markedly increased motility as a sheet in 2-dimensional (2D) substrata and individually in confined spaces and invasion in 3D matrices. In line with these observations, actin filaments redistribute to extending filopodia where they exhibit increased dynamics. MCF10A cells that stably express the K-Ras oncogene and obscurin short hairpin RNA (shRNA), but not scramble control shRNA, exhibit increased primary tumor formation and lung colonization after subcutaneous and tail vein injections, respectively. Collectively, our findings reveal that loss of giant obscurins from breast epithelium results in disruption of the cell-cell contacts and acquisition of a mesenchymal phenotype that leads to enhanced tumorigenesis, migration and invasiveness in vitro and in vivo.	[Shriver, M.; Kontrogianni-Konstantopoulos, A.] Univ Maryland Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Stroka, K. M.; Konstantopoulos, K.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Stroka, K. M.; Konstantopoulos, K.] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD USA; [Stroka, K. M.; Konstantopoulos, K.] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Vitolo, M. I.; Martin, S.; Kontrogianni-Konstantopoulos, A.] Univ Maryland Sch Med, Marlene & Stewart Greenebaum Natl Canc Inst Canc, Baltimore, MD 21201 USA; [Huso, D. L.] Johns Hopkins Univ, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Huso, D. L.] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Kontrogianni-Konstantopoulos, A (corresponding author), Univ Maryland Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	akons001@umaryland.edu		Vitolo, Michele/0000-0001-8055-9645; Shriver, Marey/0000-0002-1644-6408	Pilot Grant from The Johns Hopkins Physical Sciences-Oncology Center; Johns Hopkins Institute for NanoBioTechnology [U54CA143868]; National Science Foundation [NSF-1159823]; National Cancer Institute [U54-CA143868, R01-CA186286, T32-CA130840, F32-CA177756, R01-CA154624, K01-CA166576]; Kleberg Foundation; NATIONAL CANCER INSTITUTE [R01CA154624, P30CA006973, U54CA143868, P30CA134274, R01CA186286, F32CA177756, K01CA166576, T32CA130840] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1159823] Funding Source: National Science Foundation	Pilot Grant from The Johns Hopkins Physical Sciences-Oncology Center; Johns Hopkins Institute for NanoBioTechnology; National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by a Pilot Grant from The Johns Hopkins Physical Sciences-Oncology Center, The Johns Hopkins Institute for NanoBioTechnology (U54CA143868 to AK-K) and by awards from the National Science Foundation (Award NSF-1159823 to KK), the National Cancer Institute (Awards U54-CA143868 to KK; R01-CA186286 to KK; T32-CA130840 to KMS; F32-CA177756 to KMS; R01-CA154624 to SM and K01-CA166576 to MIV) and the Kleberg Foundation (to KK). Portions of this work are included in a United States patent pending, 14/221,755, filed on 21 March 2014.	Ackermann MA, 2009, MOL BIOL CELL, V20, P2963, DOI 10.1091/mbc.E08-12-1251; Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723; Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Borisov AB, 2008, J CELL BIOCHEM, V103, P1621, DOI 10.1002/jcb.21551; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; CIARDIELLO F, 1992, MOL CARCINOGEN, V6, P43, DOI 10.1002/mc.2940060108; Dallas MR, 2012, FASEB J, V26, P2648, DOI 10.1096/fj.12-203786; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Ford-Speelman DL, 2009, MOL BIOL CELL, V20, P3905, DOI 10.1091/mbc.E08-10-1029; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fukuzawa A, 2005, J MUSCLE RES CELL M, V26, P427, DOI 10.1007/s10974-005-9025-6; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Hu LYR, 2013, FASEB J, V27, P2001, DOI 10.1096/fj.12-221317; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; Knights Alexander J, 2012, Trends Cancer Res, V8, P61; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2005, J MUSCLE RES CELL M, V26, P419, DOI 10.1007/s10974-005-9024-7; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Nanda A, 2006, P NATL ACAD SCI USA, V103, P3351, DOI 10.1073/pnas.0511306103; Perry NA, 2013, IUBMB LIFE, V65, P479, DOI 10.1002/iub.1157; Perry NA, 2012, FASEB J, V26, P2764, DOI 10.1096/fj.12-205419; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Price ND, 2007, P NATL ACAD SCI USA, V104, P3414, DOI 10.1073/pnas.0611373104; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Russell MW, 2002, GENE, V282, P237, DOI 10.1016/S0378-1119(01)00795-8; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang B, 1997, ANTICANCER RES, V17, P4387	46	30	31	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4248	4259		10.1038/onc.2014.358	http://dx.doi.org/10.1038/onc.2014.358			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25381817	Green Accepted			2022-12-26	WOS:000359199800011
J	Fahrenkrug, J; Falktoft, B; Georg, B; Hannibal, J; Kristiansen, SB; Klausen, TK				Fahrenkrug, Jan; Falktoft, Birgitte; Georg, Birgitte; Hannibal, Jens; Kristiansen, Sarah B.; Klausen, Thomas K.			Phosphorylation of Rat Melanopsin at Ser-381 and Ser-398 by Light/Dark and Its Importance for Intrinsically Photosensitive Ganglion Cells (ipRGCs) Cellular Ca2+ Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Imaging; G Protein-coupled Receptor (GPCR); Mutant; Phosphorylation; Photoreceptor; Retinal Ganglion Cells	DEPENDENT PHOSPHORYLATION; CARBOXY TAIL; PREDICTION; EXPRESSION; INDUCTION; SITES; FOS	The G protein-coupled light-sensitive receptor melanopsin is involved in non-image-forming light responses including circadian timing. The predicted secondary structure of melanopsin indicates a long cytoplasmic tail with many potential phosphorylation sites. Using bioinformatics, we identified a number of amino acids with a high probability of being phosphorylated. We generated antibodies against melanopsin phosphorylated at Ser-381 and Ser-398, respectively. The antibody specificity was verified by immunoblotting and immunohistochemical staining of HEK-293 cells expressing rat melanopsin mutated in Ser-381 or Ser-398. Using the antibody recognizing phospho-Ser-381 melanopsin, we demonstrated by immunoblotting and immunohistochemical staining in HEK-293 cells expressing rat melanopsin that the receptor is phosphorylated in this position during the dark and dephosphorylated when light is turned on. On the contrary, we found that melanopsin at Ser-398 was unphosphorylated in the dark and became phosphorylated after light stimulation. The light-induced changes in phosphorylation at both Ser-381 and Ser-398 were rapid and lasted throughout the 4-h experimental period. Furthermore, phosphorylation at Ser-381 and Ser-398 was independent of each other. The changes in phosphorylation were confirmed in vivo by immunohistochemical staining of rat retinas during light and dark. We further demonstrated that mutation of Ser-381 and Ser-398 in melanopsin-expressing HEK-293 cells affected the light-induced Ca2+ response, which was significantly reduced as compared with wild type. Examining the light-evoked Ca2+ response in a melanopsin Ser-381 plus Ser-398 double mutant provided evidence that the phosphorylation events were independent.	[Fahrenkrug, Jan; Falktoft, Birgitte; Georg, Birgitte; Hannibal, Jens; Kristiansen, Sarah B.] Bispebjerg Hosp, Dept Clin Biochem, Fac Hlth Sci, DK-2400 Copenhagen NV, Denmark; [Klausen, Thomas K.] Univ Copenhagen, Fac Sci, Dept Biol, DK-2200 Copenhagen N, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Fahrenkrug, J (corresponding author), Bispebjerg Hosp, Dept Clin Biochem, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.	jan.fahrenkrug@regionh.dk	Hannibal, Jens/H-5482-2019	Hannibal, Jens/0000-0001-9416-0125	Danish Biotechnology Center for Cellular Communication; Danish Natural Sciences Research Foundation [DFF 09-073391]; Novo Nordisk Foundation	Danish Biotechnology Center for Cellular Communication; Danish Natural Sciences Research Foundation(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by the Danish Biotechnology Center for Cellular Communication, the Danish Natural Sciences Research Foundation (DFF 09-073391), and The Novo Nordisk Foundation.	Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Blasic JR, 2014, BIOCHEMISTRY-US, V53, P2644, DOI 10.1021/bi401724r; Blasic JR, 2012, CELL MOL LIFE SCI, V69, P1551, DOI 10.1007/s00018-011-0891-3; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Fahrenkrug J, 2009, BIOCHEMISTRY-US, V48, P5142, DOI 10.1021/bi900249n; Falktoft B, 2009, NEUROPEPTIDES, V43, P387, DOI 10.1016/j.npep.2009.08.002; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hannibal J, 2001, J BIOL RHYTHM, V16, P457, DOI 10.1177/074873001129002132; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Hundahl CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034462; Kumbalasiri T, 2007, PHOTOCHEM PHOTOBIOL, V83, P273, DOI 10.1562/2006-07-11-RA-964; Lucas RJ, 2013, CURR BIOL, V23, pR125, DOI 10.1016/j.cub.2012.12.029; Moldrup ML, 2010, J NEUROCHEM, V112, P797, DOI 10.1111/j.1471-4159.2009.06504.x; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Rasband WS, 2014, IMAGEJ; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; Semo M, 2003, EUR J NEUROSCI, V18, P3007, DOI 10.1111/j.1460-9568.2003.03061.x; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; van Koppen CJ, 2004, MOL PHARMACOL, V66, P365, DOI 10.1124/mol.104.003822; Voolstra O, 2010, J BIOL CHEM, V285, P14275, DOI 10.1074/jbc.M110.102053; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094	27	13	13	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35482	35493		10.1074/jbc.M114.586529	http://dx.doi.org/10.1074/jbc.M114.586529			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378407	Green Published, hybrid			2022-12-26	WOS:000346660200037
J	Montgomerie, AM; Chittleborough, CR; Taylor, AW				Montgomerie, Alicia M.; Chittleborough, Catherine R.; Taylor, Anne W.			Physical Inactivity and Incidence of Obesity among South Australian Adults	PLOS ONE			English	Article							WEIGHT-GAIN; BODY-COMPOSITION; LIFE-STYLE; OVERWEIGHT; VALIDITY; RISK; RELIABILITY; PREVENTION; HEALTH; TRENDS		[Montgomerie, Alicia M.; Taylor, Anne W.] Univ Adelaide, Sch Med, Discipline Med, Adelaide, SA, Australia; [Chittleborough, Catherine R.] Univ Adelaide, Discipline Publ Hlth, Sch Populat Hlth, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Montgomerie, AM (corresponding author), Univ Adelaide, Sch Med, Discipline Med, Adelaide, SA, Australia.	alicia.montgomerie@adelaide.edu.au	Chittleborough, Catherine/A-7436-2011; Taylor, Anne w/F-5708-2010	Chittleborough, Catherine/0000-0003-3196-7137; Taylor, Anne w/0000-0002-4422-7974				Adams RJ, 2003, THORAX, V58, P846, DOI 10.1136/thorax.58.10.846; AMPON RD, 2007, ASTHMA AUSTR FINDING; *AUSTR BUR STAT, 1995, AUSTR MEAS; Australian Bureau of Statistics, 2009, NAT HLTH SURV AUSTR; Australian Bureau of Statistics, 2012, NAT HLTH SURV PROF H; Australian Bureau of Statistics, 2012, NAT HLTH SURV 1 RES; Australian Bureau of Statistics, 2001, CENS POP HOUS SEL SO; Australian Bureau of Statistics, 2002, EST RES POP AG SEX 1; Australian Institute of Health and Welfare, 2001, HEART STROK VASC DIS; Australian Institute of Health and Welfare, 2004, HEART STROK VASC DIS; Australian Institute of Health and Welfare, 2012, NAT HLTH PRIOR AR; Australian Institute of Helth and Welfare, 2003, ACT AUSTR SURV GUID; Ball K, 2001, INT J OBESITY, V25, P914, DOI 10.1038/sj.ijo.0801622; BENNETT SA, 1994, MED J AUSTRALIA, V161, P519, DOI 10.5694/j.1326-5377.1994.tb127594.x; Bernstein MS, 2004, PREV MED, V38, P94, DOI 10.1016/j.ypmed.2003.09.032; Brien SE, 2007, CAN J PUBLIC HEALTH, V98, P121, DOI 10.1007/BF03404322; Brown WJ, 2008, AUST NZ J PUBL HEAL, V32, P535, DOI 10.1111/j.1753-6405.2008.00305.x; Brown WJ, 2004, J SCI MED SPORT, V7, P205, DOI 10.1016/S1440-2440(04)80010-0; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Carter KN, 2012, AUST NZ J PUBL HEAL, V36, P218, DOI 10.1111/j.1753-6405.2012.00867.x; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493, DOI 10.1093/ajcn/53.6.1493; Chan CB, 2003, OBES RES, V11, P1563, DOI 10.1038/oby.2003.208; Commonwealth of Australia, 1999, NAT PHYS ACT GUID AD; Cooper AR, 2000, EUR J CLIN NUTR, V54, P887, DOI 10.1038/sj.ejcn.1601116; DiPietro L, 1999, MED SCI SPORT EXER, V31, pS542, DOI 10.1097/00005768-199911001-00009; Economics A, 2008, GROWING COST OBESITY; Erlichman J, 2002, Obes Rev, V3, P273, DOI 10.1046/j.1467-789X.2002.00078.x; Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Grant JF, 2009, INT J EPIDEMIOL, V38, P1479, DOI 10.1093/ije/dyn262; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Heesch KC, 2011, J SCI MED SPORT, V14, P233, DOI 10.1016/j.jsams.2010.11.004; Heitmann BL, 1997, AM J CLIN NUTR, V66, P672, DOI 10.1093/ajcn/66.3.672; Hill JO, 2005, J APPL PHYSIOL, V99, P765, DOI 10.1152/japplphysiol.00137.2005; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P525, DOI 10.1038/sj.ejcn.1600601; Kovalchik S, 2009, PUBLIC HEALTH NUTR, V12, P1072, DOI 10.1017/S1368980008003728; Lafortune G, 2009, HLTH GLANC 2009 OECD; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; McLennan W., 1998, NATL NUTR SURVEY USE; NHMRC, 2009, AUSTR GUID RED HLTH; Nunez-Cordoba JM, 2013, AM J PREV MED, V44, P254, DOI 10.1016/j.amepre.2012.10.019; Pan LP, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-56; Pauwels R, 2001, EUR RESPIR J, V18, P901, DOI 10.1183/09031936.01.0027401; PERRY GS, 1995, EPIDEMIOLOGY, V6, P61, DOI 10.1097/00001648-199501000-00012; Petersen L, 2004, INT J OBESITY, V28, P105, DOI 10.1038/sj.ijo.0802548; Pink B, 2006, SOCIOECONOMIC INDEXE; Ponsonby AL, 2011, DIABETES CARE, V34, P1497, DOI 10.2337/dc10-2386; Pulsford RM, 2013, AM J PREV MED, V44, P132, DOI 10.1016/j.amepre.2012.10.009; Raguso CA, 2006, CLIN NUTR, V25, P573, DOI 10.1016/j.clnu.2005.10.013; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Scarborough P, 2011, BRIT J NUTR, V105, P1399, DOI 10.1017/S0007114510005076; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Taylor AW, 2006, AUST NZ J PUBL HEAL, V30, P238, DOI 10.1111/j.1467-842X.2006.tb00864.x; Taylor AW, 2008, PUBLIC HLTH B SA, V5, P17; Thompson DL, 2004, MED SCI SPORT EXER, V36, P911, DOI 10.1249/01.MSS.0000126787.14165.B3; Unit PRaOS, 2002, 200220 UNIT PRAOS; Walls HL, 2012, J OBES, V2012, DOI 10.1155/2012/107989; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wareham NJ, 2005, P NUTR SOC, V64, P229, DOI 10.1079/PNS2005423; WHO, 2000, OB PREV MAN GLOB EP; WHO, 2003, DIET NUTR PREVENTION, V916; WHO, 1997, PREV MAN GLOB EP	65	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112693	10.1371/journal.pone.0112693	http://dx.doi.org/10.1371/journal.pone.0112693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3DP	25383626	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700088
J	Mariotti, V; Melissari, E; Iofrida, C; Righi, M; Di Russo, M; Donzelli, R; Saba, A; Frascarelli, S; Chiellini, G; Zucchi, R; Pellegrini, S				Mariotti, Veronica; Melissari, Erika; Iofrida, Caterina; Righi, Marco; Di Russo, Manuela; Donzelli, Riccardo; Saba, Alessandro; Frascarelli, Sabina; Chiellini, Grazia; Zucchi, Riccardo; Pellegrini, Silvia			Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern	PLOS ONE			English	Article							LIPOPROTEIN LDL BINDING; ADAPTER PROTEIN ARH; RECEPTOR SR-BI; ADIPOSE-TISSUE; MESSENGER-RNA; SCAVENGER RECEPTOR; APOLIPOPROTEIN-D; THYROID-HORMONE; MALIC ENZYME; RAT-LIVER	3-Iodothyronamine (T(1)AM) is an endogenous biogenic amine, structurally related to thyroid hormone, which is regarded as a novel chemical messenger. The molecular mechanisms underlying T(1)AM effects are not known, but it is possible to envisage changes in gene expression, since delayed and long-lasting phenotypic effects have been reported, particularly with regard to the modulation of lipid metabolism and body weight. To test this hypothesis we analysed gene expression profiles in adipose tissue and liver of eight rats chronically treated with T(1)AM (10 mg/Kg twice a day for five days) as compared with eight untreated rats. In vivo T(1)AM administration produced significant transcriptional effects, since 378 genes were differentially expressed in adipose tissue, and 114 in liver. The reported changes in gene expression are expected to stimulate lipolysis and beta-oxidation, while inhibiting adipogenesis. T(1)AM also influenced the expression of several genes linked to lipoprotein metabolism suggesting that it may play an important role in the regulation of cholesterol homeostasis. No effect on the expression of genes linked to toxicity was observed. The assay of tissue T(1)AM showed that in treated animals its endogenous concentration increased by about one order of magnitude, without significant changes in tissue thyroid hormone concentration. Therefore, the effects that we observed might have physiological or pathophysiological importance. Our results provide the basis for the reported effectiveness of T(1)AM as a lipolytic agent and gain importance in view of a possible clinical use of T(1)AM in obesity and/or dyslipidaemia.	[Mariotti, Veronica; Melissari, Erika; Iofrida, Caterina; Righi, Marco; Di Russo, Manuela; Donzelli, Riccardo; Saba, Alessandro; Frascarelli, Sabina; Chiellini, Grazia; Zucchi, Riccardo; Pellegrini, Silvia] Univ Pisa, Dept Surg Med Mol Pathol & Crit Care, Pisa, Italy	University of Pisa	Pellegrini, S (corresponding author), Univ Pisa, Dept Surg Med Mol Pathol & Crit Care, Pisa, Italy.	silvia.pellegrini@med.unipi.it	Zucchi, Riccardo/AAC-8963-2022; PELLEGRINI, SILVIA/ABG-8822-2021; Saba, Alessandro/AAC-2147-2022; Chiellini, Grazia/AAC-5877-2022; Righi, Marco/B-1595-2016	PELLEGRINI, SILVIA/0000-0003-0556-0165; Saba, Alessandro/0000-0003-0611-5549; ZUCCHI, RICCARDO/0000-0002-6450-3788; Righi, Marco/0000-0002-1448-0960; Mariotti, Veronica/0000-0001-8148-7866				Achouri Y, 2005, BIOCHIMIE, V87, P1149, DOI 10.1016/j.biochi.2005.04.015; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Baxter RC, 2009, TRENDS ENDOCRIN MET, V20, P499, DOI 10.1016/j.tem.2009.07.002; Beh CT, 2001, GENETICS, V157, P1117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERLAN M, 1992, TRENDS PHARMACOL SCI, V13, P277, DOI 10.1016/0165-6147(92)90085-K; BLANCOVACA F, 1992, J LIPID RES, V33, P1785; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bon Gabriele Bittolo, 2008, G Ital Cardiol (Rome), V9, p23S; Braulke LJ, 2008, J COMP PHYSIOL B, V178, P167, DOI 10.1007/s00360-007-0208-x; BUBLITZ C, 1954, J BIOL CHEM, V211, P951; Bujalska IJ, 2006, J MOL ENDOCRINOL, V37, P327, DOI 10.1677/jme.1.02048; Chen Wenming, 2004, Chinese Medical Sciences Journal, V19, P6; Chiellini G, 2007, FASEB J, V21, P1597, DOI 10.1096/fj.06-7474com; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Claudio P, 2002, GENOME BIOL, V3; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; DARIMONT C, 1993, MOL CELL ENDOCRINOL, V98, P67, DOI 10.1016/0303-7207(93)90238-F; Dhillo WS, 2009, DIABETES OBES METAB, V11, P251, DOI 10.1111/j.1463-1326.2008.00935.x; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Fernandez-Alvarez A, 2010, J BIOL CHEM, V285, P11765, DOI 10.1074/jbc.M109.067447; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; Galli E, 2012, J CLIN ENDOCR METAB, V97, pE69, DOI 10.1210/jc.2011-1115; Garitaonandia I, 2009, J RECEPT SIG TRANSD, V29, P67, DOI 10.1080/10799890902729456; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hausman GJ, 2004, J ANIM SCI, V82, P925; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Haviland JA, 2013, OBESITY, V21, P2538, DOI 10.1002/oby.20391; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; JUMP DB, 1990, MOL ENDOCRINOL, V4, P1655, DOI 10.1210/mend-4-11-1655; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; KATSURADA A, 1988, BIOCHIM BIOPHYS ACTA, V950, P113, DOI 10.1016/0167-4781(88)90003-6; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; Klieverik LP, 2009, J ENDOCRINOL, V201, P377, DOI 10.1677/JOE-09-0043; Konishi M, 2006, MOL CELL ENDOCRINOL, V249, P71, DOI 10.1016/j.mce.2006.01.010; KOVANEN PT, 1975, J LIPID RES, V16, P211; Krotkiewski M, 2002, EUR J PHARMACOL, V440, P85, DOI 10.1016/S0014-2999(02)01420-6; LaFave LT, 2006, ENDOCRINOLOGY, V147, P4044, DOI 10.1210/en.2006-0473; LAFONTAN M, 1995, ENDOCR REV, V16, P716, DOI 10.1210/er.16.6.716; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Li L, 2006, FUNCTIONS RAT ACYL C; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Llagostera E, 2009, FEBS LETT, V583, P2121, DOI 10.1016/j.febslet.2009.05.043; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MAGNUSON MA, 1983, J BIOL CHEM, V258, P2712; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Mannaerts GP, 2000, CELL BIOCHEM BIOPHYS, V32, P73, DOI 10.1385/CBB:32:1-3:73; Manni ME, 2013, BRIT J PHARMACOL, V168, P354, DOI 10.1111/j.1476-5381.2012.02137.x; Manni ME, 2012, BRIT J PHARMACOL, V166, P650, DOI 10.1111/j.1476-5381.2011.01823.x; MARIASH CN, 1984, BIOCHEM BIOPH RES CO, V123, P1122; MenendezHurtado A, 1997, BIOCHEM BIOPH RES CO, V234, P605, DOI 10.1006/bbrc.1997.6635; Michaely P, 2004, J BIOL CHEM, V279, P34023, DOI 10.1074/jbc.M405242200; Miyaoka Y, 2006, J BIOL CHEM, V281, P37913, DOI 10.1074/jbc.M606089200; Nanbu-Wakao R, 2002, MOL ENDOCRINOL, V16, P1565, DOI 10.1210/me.16.7.1565; NARKEWICZ MR, 1990, BIOCHEM J, V271, P585, DOI 10.1042/bj2710585; Nielsen TS, 2012, J CLIN ENDOCR METAB, V97, pE1348, DOI 10.1210/jc.2012-1159; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Perdomo G, 2009, AGING-US, V1, P17; Pereira RC, 2000, AM J PHYSIOL-ENDOC M, V279, pE570, DOI 10.1152/ajpendo.2000.279.3.E570; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Pucci E, 2000, INT J OBESITY, V24, pS109, DOI 10.1038/sj.ijo.0801292; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Rehfeldt C, 2010, AM J PHYSIOL-ENDOC M, V299, pE287, DOI 10.1152/ajpendo.00492.2009; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Saba A, 2010, ENDOCRINOLOGY, V151, P5063, DOI 10.1210/en.2010-0491; Safran M, 2003, NUCLEIC ACIDS RES, V31, P142, DOI 10.1093/nar/gkg050; Sato Y, 2007, DIABETOLOGIA, V50, P481, DOI 10.1007/s00125-006-0480-4; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sharma P, 2013, J BIOL CHEM, V288, P16321, DOI 10.1074/jbc.M112.445569; SHUGART EC, 1995, CELL GROWTH DIFFER, V6, P1541; Sirinian MI, 2005, J BIOL CHEM, V280, P38416, DOI 10.1074/jbc.M504343200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Snead AN, 2007, ACS CHEM BIOL, V2, P390, DOI 10.1021/cb700057b; STEYRER E, 1988, BIOCHIM BIOPHYS ACTA, V958, P484, DOI 10.1016/0005-2760(88)90235-4; Sugiyama T, 2000, BIOCHEMISTRY-US, V39, P15817, DOI 10.1021/bi001583s; Takaishi K, 2004, P NATL ACAD SCI USA, V101, P7106, DOI 10.1073/pnas.0401715101; Trigatti B, 2000, CURR OPIN LIPIDOL, V11, P123, DOI 10.1097/00041433-200004000-00004; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varanasi U, 1996, J BIOL CHEM, V271, P2147, DOI 10.1074/jbc.271.4.2147; Viguerie N, 2002, J CLIN ENDOCR METAB, V87, P630, DOI 10.1210/jc.87.2.630; Wang Z, 2009, ENDOCR J, V56, P1019, DOI 10.1507/endocrj.K09E-178; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Wu SY, 2005, THYROID, V15, P943, DOI 10.1089/thy.2005.15.943; Xie Zheng-gao, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P940, DOI 10.3736/jcim20091006; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yu BL, 2010, OBES REV, V11, P560, DOI 10.1111/j.1467-789X.2009.00699.x; Zhang Y, 2010, ONCOGENE, V29, P5404, DOI 10.1038/onc.2010.270; Zucchi R, 2006, BRIT J PHARMACOL, V149, P967, DOI 10.1038/sj.bjp.0706948	102	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e106923	10.1371/journal.pone.0106923	http://dx.doi.org/10.1371/journal.pone.0106923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379707	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100002
J	Kim, B; Lee, H; Kawata, K; Park, JY				Kim, Boa; Lee, Hojun; Kawata, Keisuke; Park, Joon-Young			Exercise-Mediated Wall Shear Stress Increases Mitochondrial Biogenesis in Vascular Endothelium	PLOS ONE			English	Article							LOWER-LIMB EXERCISE; BLOOD-FLOW; OXIDATIVE STRESS; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; HEMODYNAMIC CONDITIONS; NAD(P)H OXIDASE; CELLS; ARTERY; HUMANS	Objective: Enhancing structural and functional integrity of mitochondria is an emerging therapeutic option against endothelial dysfunction. In this study, we sought to investigate the effect of fluid shear stress on mitochondrial biogenesis and mitochondrial respiratory function in endothelial cells (ECs) using in vitro and in vivo complementary studies. Methods and Results: Human aortic- or umbilical vein-derived ECs were exposed to laminar shear stress (20 dyne/cm(2)) for various durations using a cone-and-plate shear apparatus. We observed significant increases in the expression of key genes related to mitochondrial biogenesis and mitochondrial quality control as well as mtDNA content and mitochondrial mass under the shear stress conditions. Mitochondrial respiratory function was enhanced when cells were intermittently exposed to laminar shear stress for 72 hrs. Also, shear-exposed cells showed diminished glycolysis and decreased mitochondrial membrane potential (Delta Psi m). Likewise, in in vivo experiments, mice that were subjected to a voluntary wheel running exercise for 5 weeks showed significantly higher mitochondrial content determined by en face staining in the conduit (greater and lesser curvature of the aortic arch and thoracic aorta) and muscle feed (femoral artery) arteries compared to the sedentary control mice. Interestingly, however, the mitochondrial biogenesis was not observed in the mesenteric artery. This region-specific adaptation is likely due to the differential blood flow redistribution during exercise in the different vessel beds. Conclusion: Taken together, our findings suggest that exercise enhances mitochondrial biogenesis in vascular endothelium through a shear stress-dependent mechanism. Our findings may suggest a novel mitochondrial pathway by which a chronic exercise may be beneficial for vascular function.	[Kim, Boa; Lee, Hojun; Kawata, Keisuke; Park, Joon-Young] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Kim, Boa; Park, Joon-Young] Temple Univ, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Park, JY (corresponding author), Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA.	parkjy@temple.edu		Park, Joon-Young/0000-0002-7705-7086	American Heart Association [12SDG12070327, 12PRE11960049]; Temple University; College of Health Professions and Social Work Research Seed Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126952] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Temple University; College of Health Professions and Social Work Research Seed Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grants 12SDG12070327 (to J-Y. Park) and Predoctoral Fellowship 12PRE11960049 (to B. Kim), Temple University's University Felowships (to B. Kim and H. Lee), and College of Health Professions and Social Work Research Seed Grant (J-Y. Park). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; Addabbo F, 2009, AM J PATHOL, V174, P34, DOI 10.2353/ajpath.2009.080650; Al-Mehdi Abu-Bakr, 2007, V2, P169, DOI 10.1007/978-0-387-69945-5_7; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Boushel R, 2000, J PHYSIOL-LONDON, V524, P305, DOI 10.1111/j.1469-7793.2000.t01-2-00305.x; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Cheng CP, 2004, AM J PHYSIOL-HEART C, V287, pH921, DOI 10.1152/ajpheart.00022.2004; Cheng CP, 2003, ATHEROSCLEROSIS, V168, P323, DOI 10.1016/S0021-9150(03)00099-6; Chistiakov DA, 2012, WORLD J CARDIOL, V4, P148, DOI 10.4330/wjc.v4.i5.148; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Dagher Z, 2001, CIRC RES, V88, P1276, DOI 10.1161/hh1201.092998; Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032; Denvir MA, 2009, J PHYSIOL-LONDON, V587, P4137, DOI 10.1113/jphysiol.2009.178624; DeSouza CA, 2000, CIRCULATION, V102, P1351, DOI 10.1161/01.CIR.102.12.1351; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Duerrschmidt N, 2006, J PHYSIOL-LONDON, V576, P557, DOI 10.1113/jphysiol.2006.111070; Durrant JR, 2009, J PHYSIOL-LONDON, V587, P3271, DOI 10.1113/jphysiol.2009.169771; Eskurza I, 2004, J PHYSIOL-LONDON, V556, P315, DOI 10.1113/jphysiol.2003.057042; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; FLAMM SD, 1990, CIRCULATION, V81, P1550, DOI 10.1161/01.CIR.81.5.1550; Green DJ, 2012, EXP PHYSIOL, V97, P295, DOI 10.1113/expphysiol.2011.058826; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Groschner LN, 2012, PFLUG ARCH EUR J PHY, V464, P63, DOI 10.1007/s00424-012-1085-z; Harrison DG, 2006, J INTERN MED, V259, P351, DOI 10.1111/j.1365-2796.2006.01621.x; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Hjortdal VE, 2003, CIRCULATION, V108, P1227, DOI 10.1161/01.CIR.0000087406.27922.6B; JORFELDT L, 1971, CLIN SCI, V41, P459, DOI 10.1042/cs0410459; Kasikcioglu E, 2005, TOHOKU J EXP MED, V205, P45, DOI 10.1620/tjem.205.45; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Knaub LA, 2013, DIABETES VASC DIS RE, V10, P222, DOI 10.1177/1479164112459664; Krzywanski DM, 2011, LAB INVEST, V91, P1122, DOI 10.1038/labinvest.2011.95; Kudo S, 2000, BIOCHEM BIOPH RES CO, V270, P616, DOI 10.1006/bbrc.2000.2482; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Laughlin MH, 1996, HDB PATHOPHYSIOLOGY; Li RS, 2009, BIOCHEM BIOPH RES CO, V388, P406, DOI 10.1016/j.bbrc.2009.08.022; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Miller MW, 2013, AM J PHYSIOL-HEART C, V304, pH1624, DOI 10.1152/ajpheart.00987.2012; OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502; Ong SB, 2013, ANTIOXID REDOX SIGN, V19, P400, DOI 10.1089/ars.2012.4777; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; ROWELL LB, 1974, PHYSIOL REV, V54, P75, DOI 10.1152/physrev.1974.54.1.75; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Schlager O, 2011, EUR J VASC ENDOVASC, V41, P821, DOI 10.1016/j.ejvs.2011.01.006; Seals DR, 2008, J APPL PHYSIOL, V105, P1323, DOI 10.1152/japplphysiol.90553.2008; SESSA WC, 1994, CIRC RES, V74, P349, DOI 10.1161/01.RES.74.2.349; Shimasaki Y, 2013, CIRC RES, V113, P891, DOI 10.1161/CIRCRESAHA.113.301319; Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006; Spence AL, 2013, J PHYSIOL-LONDON, V591, P1265, DOI 10.1113/jphysiol.2012.247387; Suh GY, 2011, ANN BIOMED ENG, V39, P2186, DOI 10.1007/s10439-011-0313-6; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; Taddei S, 2001, HYPERTENSION, V38, P274, DOI 10.1161/01.HYP.38.2.274; Tang BT, 2006, AM J PHYSIOL-HEART C, V291, pH668, DOI 10.1152/ajpheart.01301.2005; Taylor CA, 1999, J VASC SURG, V29, P1077, DOI 10.1016/S0741-5214(99)70249-1; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; van Duijnhoven NTL, 2010, HYPERTENSION, V56, P240, DOI 10.1161/HYPERTENSIONAHA.110.152868; WADE OL, 1956, CLIN SCI, V15, P457; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P1283, DOI 10.1161/ATVBAHA.107.144659; Yu E, 2012, CARDIOVASC RES, V95, P173, DOI 10.1093/cvr/cvs111; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	61	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111409	10.1371/journal.pone.0111409	http://dx.doi.org/10.1371/journal.pone.0111409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375175	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600037
J	Knutsvik, G; Stefansson, IM; Aziz, S; Arnes, J; Eide, J; Collett, K; Akslen, LA				Knutsvik, Goril; Stefansson, Ingunn M.; Aziz, Sura; Arnes, Jarle; Eide, Johan; Collett, Karin; Akslen, Lars A.			Evaluation of Ki67 Expression across Distinct Categories of Breast Cancer Specimens: A Population-Based Study of Matched Surgical Specimens, Core Needle Biopsies and Tissue Microarrays	PLOS ONE			English	Article							PATHOLOGICAL PROGNOSTIC-FACTORS; INTERNATIONAL EXPERT CONSENSUS; ESTROGEN-RECEPTOR; FORMALIN FIXATION; INTRATUMORAL HETEROGENEITY; MOLECULAR CLASSIFICATION; ADJUVANT CHEMOTHERAPY; PROTEIN EXPRESSION; HISTOLOGICAL GRADE; PRIMARY THERAPY	Introduction: Tumor cell proliferation in breast cancer is strongly prognostic and may also predict response to chemotherapy. However, there is no consensus on counting areas or cut-off values for patient stratification. Our aim was to assess the matched level of proliferation by Ki67 when using different tissue categories (whole sections, WS; core needle biopsies, CNB; tissue microarrays, TMA), and the corresponding prognostic value. Methods: We examined a retrospective, population-based series of breast cancer (n = 534) from the Norwegian Breast Cancer Screening Program. The percentage of Ki67 positive nuclei was evaluated by visual counting on WS (n = 534), CNB (n = 154) and TMA (n = 459). Results: The median percentage of Ki67 expression was 18% on WS (hot-spot areas), 13% on CNB, and 7% on TMA, and this difference was statistically significant in paired cases. Increased Ki67 expression by all evaluation methods was associated with aggressive tumor features (large tumor diameter, high histologic grade, ER negativity) and reduced patient survival. Conclusion: There is a significant difference in tumor cell proliferation by Ki67 across different sample categories. Ki67 is prognostic over a wide range of cut-off points and for different sample types, although Ki67 results derived from TMA sections are lower compared with those obtained using specimens from a clinical setting. Our findings indicate that specimen specific cut-off values should be applied for practical use.	[Knutsvik, Goril; Stefansson, Ingunn M.; Aziz, Sura; Arnes, Jarle; Akslen, Lars A.] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway; [Knutsvik, Goril; Stefansson, Ingunn M.; Aziz, Sura; Arnes, Jarle; Eide, Johan; Collett, Karin; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Akslen, LA (corresponding author), Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway.	lars.akslen@k1.uib.no	Akslen, Lars A/C-1202-2017; Akslen, Lars A./AAG-6097-2021	Akslen, Lars A/0000-0003-2710-9543; Akslen, Lars A./0000-0003-2710-9543	Research Council of Norway through its Centres of Excellence [223250]; Helse Vest Research Fund [911637]; Norwegian Cancer Society; Research Council of Norway; Helse Vest Research Fund	Research Council of Norway through its Centres of Excellence(Research Council of Norway); Helse Vest Research Fund; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Helse Vest Research Fund	This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 223250. GK is supported by grant No 911637 from the Helse Vest Research Fund. LAA is supported by other grants from the Norwegian Cancer Society, the Research Council of Norway and Helse Vest Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badoual C, 2005, BREAST, V14, P22, DOI 10.1016/j.breast.2004.07.005; Batistatou A, 2013, ANTICANCER RES, V33, P2139; Burge CN, 2006, BREAST, V15, P167, DOI 10.1016/j.breast.2005.06.004; Callagy G, 2003, DIAGN MOL PATHOL, V12, P27, DOI 10.1097/00019606-200303000-00004; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen XS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-390; Chung GG, 2007, LAB INVEST, V87, P662, DOI 10.1038/labinvest.3700543; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Collett K, 2005, CANCER EPIDEM BIOMAR, V14, P1108, DOI 10.1158/1055-9965.EPI-04-0394; Connor AJM, 1997, BREAST, V6, P171, DOI 10.1016/S0960-9776(97)90568-3; Connor CS, 2002, AM J SURG, V184, P322, DOI 10.1016/S0002-9610(02)00953-4; Cortesi L, 2012, TUMORI J, V98, P743, DOI 10.1700/1217.13498; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; DiLoreto C, 1996, EUR J CANCER, V32A, P1693, DOI 10.1016/0959-8049(96)00192-X; Dodd LG, 1997, J SURG ONCOL, V64, P280, DOI 10.1002/(SICI)1096-9098(199704)64:4<280::AID-JSO6>3.0.CO;2-5; Douglas-Jones AG, 2001, J CLIN PATHOL, V54, P951, DOI 10.1136/jcp.54.12.951; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Geyer FC, 2012, ADV ANAT PATHOL, V19, P39, DOI 10.1097/PAP.0b013e31823fafa0; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Greer LT, 2013, J AM COLL SURGEONS, V216, P239, DOI 10.1016/j.jamcollsurg.2012.09.007; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Harris GC, 2003, AM J SURG PATHOL, V27, P11, DOI 10.1097/00000478-200301000-00002; Hitchman E, 2011, HISTOPATHOLOGY, V59, P1261, DOI 10.1111/j.1365-2559.2011.03974.x; Honma N, 2013, BREAST CANC, P1; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Iqbal S, 2002, BREAST, V11, P252, DOI 10.1054/brst.2002.0408; Jacquemier J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3051; Khoury T, 2009, MODERN PATHOL, V22, P1457, DOI 10.1038/modpathol.2009.117; Kwok TC, 2010, HISTOPATHOLOGY, V57, P212, DOI 10.1111/j.1365-2559.2010.03620.x; Layfield LJ, 1998, AM J CLIN PATHOL, V110, P758; Lehr HA, 2013, MODERN PATHOL, V26, P336, DOI 10.1038/modpathol.2012.140; McIlhenny C, 2002, BRIT J SURG, V89, P84, DOI 10.1046/j.0007-1323.2001.01950.x; Nassar A, 2010, APPL IMMUNOHISTO M M, V18, P433, DOI 10.1097/PAI.0b013e3181dddb20; Neumeister VM, 2012, JNCI-J NATL CANCER I, V104, P1815, DOI 10.1093/jnci/djs438; O'Leary R, 2004, J CLIN PATHOL, V57, P193, DOI 10.1136/jcp.2003.12914; Otali D, 2009, BIOTECH HISTOCHEM, V84, P223, DOI 10.1080/10520290903039094; Park SY, 2009, AM J SURG, V197, P266, DOI 10.1016/j.amjsurg.2007.11.024; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Rakha EA, 2013, HISTOPATHOLOGY, V62, P695, DOI 10.1111/his.12066; Ricci MD, 2012, REV ASSOC MED BRAS, V58, P532; Romero Q, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-341; Ruiz C, 2006, INT J CANCER, V118, P2190, DOI 10.1002/ijc.21581; Sapino A, 2006, VIRCHOWS ARCH, V449, P288, DOI 10.1007/s00428-006-0233-2; Skarlos P, 2012, CANCER CHEMOTH PHARM, V69, P533, DOI 10.1007/s00280-011-1730-9; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Vance GH, 2009, ARCH PATHOL LAB MED, V133, P611, DOI 10.1043/1543-2165-133.4.611; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; WEIDNER N, 1994, HUM PATHOL, V25, P337, DOI 10.1016/0046-8177(94)90140-6; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648	53	41	42	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112121	10.1371/journal.pone.0112121	http://dx.doi.org/10.1371/journal.pone.0112121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375149	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600107
J	Saito, K; Ishikawa, M; Murayama, M; Urata, M; Senoo, Y; Toyoshima, K; Kumagai, Y; Maekawa, K; Saito, Y				Saito, Kosuke; Ishikawa, Masaki; Murayama, Mayumi; Urata, Masayo; Senoo, Yuya; Toyoshima, Katsuko; Kumagai, Yuji; Maekawa, Keiko; Saito, Yoshiro			Effects of Sex, Age, and Fasting Conditions on Plasma Lipidomic Profiles of Fasted Sprague-Dawley Rats	PLOS ONE			English	Article							MASS-SPECTROMETRIC ANALYSIS; HEPATIC LIPOGENESIS; LUNG-CANCER; SERUM; METABOLOMICS; EXPRESSION; REVEALS; DISEASE; WOMEN	Circulating lipid molecules reflect biological processes in the body and, thus, are useful tools for preclinical estimation of the efficacy and safety of newly developed drugs. However, background information on profiles of circulating lipid molecules in preclinical animal models is limited. Therefore, we examined the effects of multiple factors such as sex (fasted male vs. female), age (fasted 10 vs. 30 weeks old), and feeding conditions (feeding vs. fasting, 16 vs. 22 hr fasting, 10 AM vs. 4 PM blood collection), on the global profiles of lipid molecules in plasma from Sprague-Dawley rats by using a lipidomic approach. Our assay platform determined 262 lipid molecules (68 phospholipids, 20 sphingolipids, 138 neutral lipids, and 36 polyunsaturated fatty acids and their metabolites) in rat plasma. Multivariate discriminant analysis (orthogonal partial least squares discriminant analysis) and heat maps of statistically significant lipid molecules revealed that the plasma lipid profiles in rats are predominantly influenced by feeding conditions, followed by sex and age. In addition, the fasting duration (16 vs. 22 hr fasting) or the time of blood collection (10 AM vs. 4 PM blood collection) has limited or no contribution on the profiles of lipid molecules in rat plasma. Our results provide useful, fundamental information for exploring and validating biomarkers in future preclinical studies and may help to establish regulatory standards for such studies.	[Saito, Kosuke; Ishikawa, Masaki; Murayama, Mayumi; Urata, Masayo; Senoo, Yuya; Toyoshima, Katsuko; Maekawa, Keiko; Saito, Yoshiro] Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo, Japan; [Kumagai, Yuji] Kitasato Univ, Sch Med, Clin Res Ctr, Minami Ku, Sagamihara, Kanagawa 228, Japan	National Institute of Health Sciences - Japan; Kitasato University	Maekawa, K (corresponding author), Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo, Japan.	maekawa@nihs.go.jp	Saito, Kosuke/AAI-2878-2020		Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare [028]; Advanced Research for Products Mining Program from the National Institute of Biomedical Innovation of Japan [10-45]	Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare; Advanced Research for Products Mining Program from the National Institute of Biomedical Innovation of Japan	This work was supported by the Health Labour Sciences Research Grants (grant number 028) from the Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/), and by the Advanced Research for Products Mining Program (grant number 10-45) from the National Institute of Biomedical Innovation of Japan (http://www.nibio.go.jp/). YS received the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2004, MOL ENDOCRINOL, V18, P747, DOI 10.1210/me.2003-0138; Alessandri JM, 2012, EUR J NUTR, V51, P199, DOI 10.1007/s00394-011-0208-1; DASHTI N, 1983, J LIPID RES, V24, P368; Demirkan A, 2013, J PSYCHIATR RES, V47, P357, DOI 10.1016/j.jpsychires.2012.11.001; Gonzalez-Covarrubias V, 2013, METABOLOMICS, V9, P337, DOI 10.1007/s11306-012-0450-4; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hewitt KN, 2003, ENDOCRINOLOGY, V144, P3895, DOI 10.1210/en.2003-0244; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Hori S, 2011, LUNG CANCER, V74, P284, DOI 10.1016/j.lungcan.2011.02.008; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Ikeda A, 2012, BIOMED CHROMATOGR, V26, P548, DOI 10.1002/bmc.1671; Ishikawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091806; Ishikawa M, 2013, BIOL PHARM BULL, V36, P682; Kamp H, 2012, BIOANALYSIS, V4, P2291, DOI [10.4155/BIO.12.214, 10.4155/bio.12.214]; Kotronen A, 2010, OBESITY, V18, P937, DOI 10.1038/oby.2009.326; Liu JY, 2010, P NATL ACAD SCI USA, V107, P17017, DOI 10.1073/pnas.1011278107; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Menni C, 2013, METABOLOMICS, V9, P506, DOI 10.1007/s11306-012-0469-6; Nikkila Janne, 2008, Mol Syst Biol, V4, P197, DOI 10.1038/msb.2008.34; Pei WD, 2006, J ENDOCRINOL, V190, P261, DOI 10.1677/joe.1.06803; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Singh SS, 2006, CURR DRUG METAB, V7, P165, DOI 10.2174/138920006775541552; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Tajima Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-68; TSUCHIYA N, 1995, EXP ANIM TOKYO, V43, P671; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wedge DC, 2011, ANAL CHEM, V83, P6689, DOI 10.1021/ac2012224; Zivkovic AM, 2009, METABOLOMICS, V5, P507, DOI 10.1007/s11306-009-0174-2	30	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112266	10.1371/journal.pone.0112266	http://dx.doi.org/10.1371/journal.pone.0112266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375860	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600123
J	Seebah, S; Fairfield, C; Ullrich, MS; Passow, U				Seebah, Shalin; Fairfield, Caitlin; Ullrich, Matthias S.; Passow, Uta			Aggregation and Sedimentation of Thalassiosira weissflogii (diatom) in a Warmer and More Acidified Future Ocean	PLOS ONE			English	Article							TRANSPARENT EXOPOLYMER PARTICLES; SINKING VELOCITY; EMILIANIA-HUXLEYI; ORGANIC-MATTER; GROWTH-RATE; CARBON; TEP; CO2; PHYTOPLANKTON; COAGULATION	Increasing Transparent Exopolymer Particle (TEP) formation during diatom blooms as a result of elevated temperature and pCO(2) have been suggested to result in enhanced aggregation and carbon flux, therewith potentially increasing the sequestration of carbon by the ocean. We present experimental results on TEP and aggregate formation by Thalassiosira weissflogii (diatom) in the presence or absence of bacteria under two temperature and three pCO(2) scenarios. During the aggregation phase of the experiment TEP formation was elevated at the higher temperature (20 degrees C vs. 15 degrees C), as predicted. However, in contrast to expectations based on the established relationship between TEP and aggregation, aggregation rates and sinking velocity of aggregates were depressed in warmer treatments, especially under ocean acidification conditions. If our experimental findings can be extrapolated to natural conditions, they would imply a reduction in carbon flux and potentially reduced carbon sequestration after diatom blooms in the future ocean.	[Seebah, Shalin; Ullrich, Matthias S.] Jacobs Univ Bremen, Mol Life Sci Res Ctr, D-28759 Bremen, Germany; [Fairfield, Caitlin; Passow, Uta] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	Jacobs University; University of California System; University of California Santa Barbara	Passow, U (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	uta.passow@lifesci.ucsb.edu			National Science Foundation [OCE-0926711, OCE-1041038]; Helmholtz Graduate School for Polar and Marine Research; Jacobs University Bremen; Division Of Ocean Sciences [1041038] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Helmholtz Graduate School for Polar and Marine Research; Jacobs University Bremen; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation grants OCE-0926711 & OCE-1041038 to UP and Helmholtz Graduate School for Polar and Marine Research and Jacobs University Bremen to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; Arrigo KR, 2007, NATURE, V450, P491, DOI 10.1038/450491a; Azetsu-Scott K, 2004, LIMNOL OCEANOGR, V49, P741, DOI 10.4319/lo.2004.49.3.0741; Bhaskar PV, 2005, FEMS MICROBIOL ECOL, V53, P255, DOI 10.1016/j.femsec.2004.12.013; Biermann A, 2010, BIOGEOSCIENCES, V7, P1017, DOI 10.5194/bg-7-1017-2010; Burd AB, 2009, ANNU REV MAR SCI, V1, P65, DOI 10.1146/annurev.marine.010908.163904; Claquin P, 2008, AQUAT MICROB ECOL, V51, P1, DOI 10.3354/ame01187; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Cole, 1993, HDB METHODS AQUATIC, P117; CROCKER KM, 1995, MAR ECOL PROG SER, V117, P249, DOI 10.3354/meps117249; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; DECHO AW, 1995, SCI TOTAL ENVIRON, V165, P33, DOI 10.1016/0048-9697(95)04541-8; Dickson A. G., 2007, PICES SPEC PUB, V3, P1, DOI DOI 10.1159/000331784; Ding YX, 2009, TERR ATMOS OCEAN SCI, V20, P741, DOI 10.3319/TAO.2008.08.26.01(Oc); DURBIN EG, 1977, J PHYCOL, V13, P150, DOI 10.1111/j.1529-8817.1977.tb02904.x; Engel A, 1999, MAR ECOL PROG SER, V182, P69, DOI 10.3354/meps182069; Engel A, 2004, NATURE, V428, P929, DOI 10.1038/nature02453; Engel A, 2009, DEEP-SEA RES PT II, V56, P1408, DOI 10.1016/j.dsr2.2008.11.028; Engel A, 2009, DEEP-SEA RES PT II, V56, P1396, DOI 10.1016/j.dsr2.2008.11.027; Fangue NA, 2010, LIMNOL OCEANOGR-METH, V8, P441, DOI 10.4319/lom.2010.8.441; Frieder CA, 2012, BIOGEOSCIENCES, V9, P3917, DOI 10.5194/bg-9-3917-2012; Fukao T, 2012, J APPL PHYCOL, V24, P181, DOI 10.1007/s10811-011-9666-3; Gardes A, 2012, MAR ECOL PROG SER, V461, P1, DOI 10.3354/meps09894; Gardes A, 2011, ISME J, V5, P436, DOI 10.1038/ismej.2010.145; Gehlen M, 2007, BIOGEOSCIENCES, V4, P505, DOI 10.5194/bg-4-505-2007; Gehlen M, 2006, GEOPH RES ABSTR, V8, P3492; Grossart HP, 2006, ENVIRON MICROBIOL, V8, P1074, DOI 10.1111/j.1462-2920.2006.00999.x; Grossart HP, 2006, AQUAT MICROB ECOL, V42, P19, DOI 10.3354/ame042019; Guillard R.R.L., 1982, CULTURE MARINE INVER, P108; HEISSENBERGER A, 1994, MAR ECOL PROG SER, V111, P129, DOI 10.3354/meps111129; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hoppe CJM, 2012, BIOGEOSCIENCES, V9, P2401, DOI 10.5194/bg-9-2401-2012; HOUGHTON J, 1995, SPECTROCHIM ACTA A, V51, P1391, DOI 10.1016/0584-8539(95)01485-3; Ishida Y, 2000, FISHERIES SCI, V66, P655, DOI 10.1046/j.1444-2906.2000.00105.x; Jackson GA, 1998, ENVIRON SCI TECHNOL, V32, P2805, DOI 10.1021/es980251w; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; JACKSON GA, 1995, DEEP-SEA RES PT II, V42, P215, DOI 10.1016/0967-0645(95)00015-I; Kaeppel EC, 2012, INT J SYST EVOL MICR, V62, P124, DOI 10.1099/ijs.0.030189-0; KESTER DR, 1967, LIMNOL OCEANOGR, V12, P176, DOI 10.4319/lo.1967.12.1.0176; KIORBOE T, 1994, J MAR RES, V52, P297, DOI 10.1357/0022240943077145; Lam PJ, 2007, DEEP-SEA RES PT II, V54, P601, DOI 10.1016/j.dsr2.2007.01.013; Lewis E., 1998, ORNLCDIAC105 US DEP; LOGAN BE, 1995, DEEP-SEA RES PT II, V42, P203, DOI 10.1016/0967-0645(95)00012-F; Mari X, 2008, BIOGEOSCIENCES, V5, P1023, DOI 10.5194/bg-5-1023-2008; Mejia LM, 2013, GEOCHIM COSMOCHIM AC, V123, P322, DOI 10.1016/j.gca.2013.06.011; Montagnes DJS, 2001, LIMNOL OCEANOGR, V46, P2008, DOI 10.4319/lo.2001.46.8.2008; MOPPER K, 1995, DEEP-SEA RES PT II, V42, P47, DOI 10.1016/0967-0645(95)00004-A; Moriceau B, 2007, MAR ECOL PROG SER, V333, P129, DOI 10.3354/meps333129; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; Passow U, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002579; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; Passow U, 2002, MAR ECOL PROG SER, V236, P1, DOI 10.3354/meps236001; Passow U, 2000, MAR ECOL PROG SER, V192, P1, DOI 10.3354/meps192001; PASSOW U, 1994, DEEP-SEA RES PT I, V41, P335, DOI 10.1016/0967-0637(94)90007-8; PASSOW U, 1995, DEEP-SEA RES PT II, V42, P99, DOI 10.1016/0967-0645(95)00006-C; Passow U, 2014, LIMNOL OCEANOGR, V59, P532, DOI 10.4319/lo.2014.59.2.0532; Passow U, 2012, MAR ECOL PROG SER, V470, P249, DOI 10.3354/meps09985; Passow U, 2012, MAR CHEM, V128, P72, DOI 10.1016/j.marchem.2011.10.004; Piontek J, 2009, AQUAT MICROB ECOL, V54, P305, DOI 10.3354/ame01273; Ploug H, 2010, LIMNOL OCEANOGR-METH, V8, P386, DOI 10.4319/lom.2010.8.386; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Raymont J.E.G., 1980, PLANKTON PRODUCTIVIT; Richardson TL, 1995, MAR ECOL PROG SER, V128, P77, DOI 10.3354/meps128077; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; SCHUSTER S, 1995, MAR ECOL PROG SER, V124, P227, DOI 10.3354/meps124227; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; SMITH DC, 1995, DEEP-SEA RES PT II, V42, P75, DOI 10.1016/0967-0645(95)00005-B; Taucher J, 2014, GLOBAL BIOGEOCHEMICA, V28; Thornton DCO, 1998, MAR ECOL PROG SER, V174, P223, DOI 10.3354/meps174223; Venrick EL, 1998, MAR ECOL PROG SER, V167, P73, DOI 10.3354/meps167073; Verdugo P, 2012, ANNU REV MAR SCI, V4, P375, DOI 10.1146/annurev-marine-120709-142759; Verdugo P, 2010, DEEP-SEA RES PT II, V57, P1486, DOI 10.1016/j.dsr2.2010.03.002; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; Zhou J, 1998, LIMNOL OCEANOGR, V43, P1860	76	35	35	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112379	10.1371/journal.pone.0112379	http://dx.doi.org/10.1371/journal.pone.0112379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375640	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600139
J	Cancelliere, EC; DeAngelis, N; Nkurunungi, JB; Raubenheimer, D; Rothman, JM				Cancelliere, Emma C.; DeAngelis, Nicole; Nkurunungi, John Bosco; Raubenheimer, David; Rothman, Jessica M.			Minerals in the Foods Eaten by Mountain Gorillas (Gorilla beringel)	PLOS ONE			English	Article							IMPENETRABLE NATIONAL-PARK; NUTRIENT COMPOSITION; DIETS IMPLICATIONS; ALOUATTA-PIGRA; MONKEYS; SELECTION; CALCIUM; CHIMPANZEES; COLOBUS; SODIUM	Minerals are critical to an individual's health and fitness, and yet little is known about mineral nutrition and requirements in free-ranging primates. We estimated the mineral content of foods consumed by mountain gorillas (Gorilla beringei beringei) in the Bwindi Impenetrable National Park, Uganda. Mountain gorillas acquire the majority of their minerals from herbaceous leaves, which constitute the bulk of their diet. However, less commonly eaten foods were sometimes found to be higher in specific minerals, suggesting their potential importance. A principal component analysis demonstrated little correlation among minerals in food items, which further suggests that mountain gorillas might increase dietary diversity to obtain a full complement of minerals in their diet. Future work is needed to examine the bioavailability of minerals to mountain gorillas in order to better understand their intake in relation to estimated needs and the consequences of suboptimal mineral balance in gorilla foods.	[Cancelliere, Emma C.; Rothman, Jessica M.] CUNY, Grad Ctr, Dept Anthropol, New York, NY 10031 USA; [Cancelliere, Emma C.; Rothman, Jessica M.] New York Consortium Evolutionary Primatol, New York, NY USA; [DeAngelis, Nicole] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Nkurunungi, John Bosco] Mbarara Univ Sci & Technol, Dept Biol, Mbarara, Uganda; [Raubenheimer, David] Univ Sydney, Sch Biol Sci, Fac Vet Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Rothman, Jessica M.] CUNY, Hunter Coll, Dept Anthropol, New York, NY 10021 USA	City University of New York (CUNY) System; Cornell University; Mbarara University of Science & Technology; University of Sydney; City University of New York (CUNY) System; Hunter College (CUNY)	Rothman, JM (corresponding author), CUNY, Grad Ctr, Dept Anthropol, New York, NY 10031 USA.	jessica.rothman@hunter.cuny.edu		Raubenheimer, David/0000-0001-9050-1447	Cornell University; Hunter College	Cornell University; Hunter College	Cornell University and Hunter College funded this research within larger research projects (no specific funding was received for this work). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman C. B., 1995, Bioavailability of nutrients for animals: amino acids, minerals, and vitamins., P83, DOI 10.1016/B978-012056250-3/50031-7; Barboza P.S., 2008, INTEGRATIVE WILDLIFE; Behie AM, 2012, AM J PRIMATOL, V74, P1054, DOI 10.1002/ajp.22059; Blake JG, 2010, INT J PRIMATOL, V31, P471, DOI 10.1007/s10764-010-9407-5; CALVERT JJ, 1985, OECOLOGIA, V65, P236, DOI 10.1007/BF00379223; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chaves OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025070; Cruz-Rivera E, 2000, OECOLOGIA, V123, P252, DOI 10.1007/s004420051012; Dierenfeld ES, 1999, ZOO BIOL, V18, P481, DOI 10.1002/(SICI)1098-2361(1999)18:6&lt;481::AID-ZOO3&gt;3.0.CO;2-9; Doran Diane M., 2001, Cambridge Studies in Biological and Evolutionary Anthropology, V27, P123; Felton AM, 2009, FUNCT ECOL, V23, P70, DOI 10.1111/j.1365-2435.2008.01526.x; Frossard E, 2000, J SCI FOOD AGR, V80, P861, DOI 10.1002/(SICI)1097-0010(20000515)80:7&lt;861::AID-JSFA601&gt;3.0.CO;2-P; Frye FF, 1997, P NUTR SOC, V56, P1105, DOI 10.1079/PNS19970114; Goff JP, 1997, J DAIRY SCI, V80, P176, DOI 10.3168/jds.S0022-0302(97)75925-3; Harris TR, 2007, PRIMATES, V48, P208, DOI 10.1007/s10329-006-0036-8; Hatloy A, 1998, EUR J CLIN NUTR, V52, P891, DOI 10.1038/sj.ejcn.1600662; Heaney RP, 2002, J AM COLL NUTR, V21, P239, DOI 10.1080/07315724.2002.10719216; Hellwig JP, 2006, DIETARY REFERENCE IN; Hockett B, 2003, EVOL ANTHROPOL, V12, P211, DOI 10.1002/evan.10116; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Isbell LA, 2013, AM J PHYS ANTHROPOL, V150, P286, DOI 10.1002/ajpa.22205; Kay Robin N. B., 1994, P229; KLEPPEL GS, 1995, ICES J MAR SCI, V52, P297, DOI 10.1016/1054-3139(95)80045-X; Magliocca F, 2002, AM J PRIMATOL, V57, P67, DOI 10.1002/ajp.10034; MAHANEY WC, 1993, PRIMATES, V34, P85, DOI 10.1007/BF02381284; Mahaney WC, 1999, J TROP ECOL, V15, P565, DOI 10.1017/S0266467499001029; McGarigal K., 2000, MULTIVARIATE STAT WI; MILLS CF, 1985, ANNU REV NUTR, V5, P173, DOI 10.1146/annurev.nu.05.070185.001133; Milton K, 2003, COMP BIOCHEM PHYS A, V136, P47, DOI 10.1016/S1095-6433(03)00084-9; National Research Council, 2003, NUTR REQ NONH PRIM; O'Brien TG, 1998, NATURE, V392, P668, DOI 10.1038/33580; O'Malley RC, 2014, J HUM EVOL, V71, P46, DOI 10.1016/j.jhevol.2013.09.014; OATES JF, 1978, BIOTROPICA, V10, P241, DOI 10.2307/2387676; Oftedal Olav T., 1996, P148; Power ML, 1999, AM J OBSTET GYNECOL, V181, P1560, DOI 10.1016/S0002-9378(99)70404-7; Provenza FD, 2003, SMALL RUMINANT RES, V49, P257, DOI 10.1016/S0921-4488(03)00143-3; Reiner WB, 2014, AM J PRIMATOL, V76, P281, DOI 10.1002/ajp.22232; Reynolds V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006194; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rode KD, 2006, BIOTROPICA, V38, P625, DOI 10.1111/j.1744-7429.2006.00183.x; Rode KD, 2003, INT J PRIMATOL, V24, P541, DOI 10.1023/A:1023788330155; Rothman JM, 2007, J TROP ECOL, V23, P673, DOI 10.1017/S0266467407004555; Rothman JM, 2008, OECOLOGIA, V155, P111, DOI 10.1007/s00442-007-0901-1; Rothman JM, 2006, AM J PRIMATOL, V68, P675, DOI 10.1002/ajp.20243; Rothman JM, 2006, BIOL LETTERS, V2, P321, DOI 10.1098/rsbl.2006.0480; Rothman JM, 2014, J HUM EVOL, V71, P59, DOI 10.1016/j.jhevol.2014.02.016; Rothman JM, 2013, HIGH ALTITUDE PRIMAT; Sandberg AS, 2002, BRIT J NUTR, V88, pS281, DOI 10.1079/BJN/2002718; Schmidt DA, 2010, ZOO BIOL, V29, P375, DOI 10.1002/zoo.20267; Setz EZF, 1999, J ZOOL, V247, P91, DOI 10.1111/j.1469-7998.1999.tb00196.x; Silver SC, 2000, ZOO BIOL, V19, P95, DOI 10.1002/1098-2361(2000)19:2<95::AID-ZOO1>3.0.CO;2-D; SPELMAN LH, 1989, ZOO BIOL, V8, P239, DOI 10.1002/zoo.1430080305; Stanford CB, 2003, INT J PRIMATOL, V24, P901, DOI 10.1023/A:1024689008159; Underwood EJ, 1999, MINERAL NUTR LIVESTO, P3; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; WATTS DP, 1984, AM J PRIMATOL, V7, P323, DOI 10.1002/ajp.1350070403; Weaver C.M., 1999, MODERN NUTR HLTH DIS, P141; WESTOBY M, 1978, AM NAT, V112, P627, DOI 10.1086/283303; WILLIG MR, 1991, J MAMMAL, V72, P314, DOI 10.2307/1382101; WRANGHAM RW, 1991, PHILOS T ROY SOC B, V334, P171, DOI 10.1098/rstb.1991.0106; Yeager CP, 1997, AM J PRIMATOL, V41, P117, DOI 10.1002/(SICI)1098-2345(1997)41:2<117::AID-AJP4>3.3.CO;2-J	61	6	7	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112117	10.1371/journal.pone.0112117	http://dx.doi.org/10.1371/journal.pone.0112117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372712	Green Published, gold			2022-12-26	WOS:000344556900112
J	Kim, DH; Yu, HS				Kim, Dong-Hee; Yu, Hak Sun			Effect of a One-Off Educational Session about Enterobiasis on Knowledge, Preventative Practices, and Infection Rates among Schoolchildren in South Korea	PLOS ONE			English	Article							RISK-FACTORS; PRESCHOOL-CHILDREN; HEALTH-EDUCATION; PREVALENCE; IMPACT; VERMICULARIS; PROGRAMS; TRIAL	Although health education has proven to be cost-effective in slowing the spread of enterobiasis, assessments of the effectiveness of health education to reduce infectious diseases specifically in children are rare. To evaluate the effect of health education on knowledge, preventative practices, and the prevalence of enterobiasis, 319 children from 16 classes were divided into experimental and control groups. Data were collected from May 2012 to March 2013. A 40-minute in-class talk was given once in the experimental group. There were significant differences over the time in the mean scores for children's knowledge of Enterobius vermicularis infection in the intervention group compared to the control group (p<0.001). After the educational session, the score for knowledge about E. vermicularis infection increased from 60.2 +/- 2.32 to 92.7 +/- 1.19 in the experimental group; this gain was partially lost 3 months later, decreasing to 83.6 +/- 1.77 (p<0.001). Children's enterobiasis infection prevention practice scores also increased, from 3.23 +/- 0.27 to 3.73 +/- 0.25, 1 week after the educational session, a gain that was partially lost at 3 months, decreasing to 3.46 +/- 0.36 (p<0.001). The overall E. vermicularis egg detection rate was 4.4%; the rates for each school ranged from 0% to 12.9% at screening. The infection rate at 3 months after the treatment sharply decreased from 12.3% to 0.8% in the experimental group, compared to a decrease from 8.5% to 3.7% in the control group during the same period. We recommend that health education on enterobiasis be provided to children to increase their knowledge about enterobiasis and improve prevention practices.	[Kim, Dong-Hee] Pusan Natl Univ, Coll Nursing, Dept Nursing, Yangsan, Gyeongsangnamdo, South Korea; [Yu, Hak Sun] Pusan Natl Univ, Sch Med, Dept Parasitol, Yangsan, Gyeongsangnamdo, South Korea; [Yu, Hak Sun] Brain Busan 21 project, Immunoregulatory Therapeut Grp, Pusan, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital	Yu, HS (corresponding author), Pusan Natl Univ, Sch Med, Dept Parasitol, Yangsan, Gyeongsangnamdo, South Korea.	hsyu@pusan.ac.kr			National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2013R1A1A1A05012615]	National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A1A05012615). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico M, 2003, ACTA TROP, V86, P233, DOI 10.1016/S0001-706X(03)00043-3; Bager P, 2012, GASTROENTEROLOGY, V142, P55, DOI 10.1053/j.gastro.2011.09.046; Bieri FA, 2013, NEW ENGL J MED, V368, P1603, DOI 10.1056/NEJMoa1204885; COOK GC, 1994, GUT, V35, P1159, DOI 10.1136/gut.35.9.1159; Degerli Serpil, 2009, Turkiye Parazitoloji Dergisi, V33, P95; Dick W, 2005, SYSTEMATIC DESIGN IN, Vxx; Gai L, 1995, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V13, P269; Kang IS, 2012, ACTA TROP, V122, P59, DOI 10.1016/j.actatropica.2011.11.017; Kang Seokha, 2006, Korean Journal of Parasitology, V44, P247, DOI 10.3347/kjp.2006.44.3.247; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Kim Bong Jin, 2003, Korean Journal of Parasitology, V41, P75, DOI 10.3347/kjp.2003.41.1.75; Kim C. H, 1971, Korean J Parasit, V9, P25, DOI 10.3347/kjp.1971.9.1.25; Kim DH, 2010, KOREAN J PARASITOL, V48, P121, DOI 10.3347/kjp.2010.48.2.121; Lee Kyu-Jae, 2001, Korean Journal of Parasitology, V39, P327, DOI 10.3347/kjp.2001.39.4.327; Myint-U A, 2010, HEALTH PROMOT PRACT, V11, P408, DOI 10.1177/1524839908318830; Naldi L, 2007, J INVEST DERMATOL, V127, P1871, DOI 10.1038/sj.jid.5700835; Nithikathkul C, 2005, J HELMINTHOL, V79, P61, DOI 10.1079/JOH2004272; Owais A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-239; Report of Ministry of Health and Welfare of Republic of Korea and the Korea Association of Health, 1971, 1 MIN HLTH WELF REP; Report of Ministry of Health and Welfare of Republic of Korea and the Korea Association of Health, 1997, 6 MIN HLTH WELF REP; Roberts LS, 2009, FDN PARASITOLOGY, Vxvii; Seo Byong Seol, 1969, Kisaengchunghak Chapchi, V7, P53, DOI 10.3347/kjp.1969.7.1.53; Song HJ, 2003, PARASITOL RES, V91, P46, DOI 10.1007/s00436-003-0836-3; St Georgiev V, 2001, Expert Opin Pharmacother, V2, P267, DOI 10.1517/14656566.2.2.267	24	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112149	10.1371/journal.pone.0112149	http://dx.doi.org/10.1371/journal.pone.0112149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372146	Green Submitted, gold, Green Published			2022-12-26	WOS:000344556900116
J	Kim, GA; Oh, HJ; Kim, MJ; Jo, YK; Choi, J; Park, JE; Park, EJ; Lim, SH; Yoon, BI; Kang, SK; Jang, G; Lee, BC				Kim, Geon A.; Oh, Hyun Ju; Kim, Min Jung; Jo, Young Kwang; Choi, Jin; Park, Jung Eun; Park, Eun Jung; Lim, Sang Hyun; Yoon, Byung Il; Kang, Sung Keun; Jang, Goo; Lee, Byeong Chun			Survival of Skin Graft between Transgenic Cloned Dogs and Non-Transgenic Cloned Dogs	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; HISTOCOMPATIBILITY ANTIGEN; NUCLEAR TRANSPLANTATION; FLUORESCENT PROTEIN; GENE-THERAPY; CELL; REJECTION; MICE; PIGS; LYMPHOCYTES	Whereas it has been assumed that genetically modified tissues or cells derived from somatic cell nuclear transfer (SCNT) should be accepted by a host of the same species, their immune compatibility has not been extensively explored. To identify acceptance of SCNT-derived cells or tissues, skin grafts were performed between cloned dogs that were identical except for their mitochondrial DNA (mtDNA) haplotypes and foreign gene. We showed here that differences in mtDNA haplotypes and genetic modification did not elicit immune responses in these dogs: 1) skin tissues from genetically-modified cloned dogs were successfully transplanted into genetically-modified cloned dogs with different mtDNA haplotype under three successive grafts over 63 days; and 2) non-transgenic cloned tissues were accepted into transgenic cloned syngeneic recipients with different mtDNA haplotypes and vice versa under two successive grafts over 63 days. In addition, expression of the inserted gene was maintained, being functional without eliciting graft rejection. In conclusion, these results show that transplanting genetically-modified tissues into normal, syngeneic or genetically-modified recipient dogs with different mtDNA haplotypes do not elicit skin graft rejection or affect expression of the inserted gene. Therefore, therapeutically valuable tissue derived from SCNT with genetic modification might be used safely in clinical applications for patients with diseased tissues.	[Kim, Geon A.; Oh, Hyun Ju; Kim, Min Jung; Jo, Young Kwang; Choi, Jin; Park, Jung Eun; Park, Eun Jung; Jang, Goo; Lee, Byeong Chun] Seoul Natl Univ, Coll Vet Med, Dept Theriogenol & Biotechnol, Seoul, South Korea; [Lim, Sang Hyun] Cent Res Inst, K Stem Cell, Seoul, South Korea; [Yoon, Byung Il] Kangwon Natl Univ, Coll Vet Med, Lab Histol & Mol Pathogenesis, Chunchon, Gangwon Do, South Korea	Seoul National University (SNU); Kangwon National University	Lee, BC (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Theriogenol & Biotechnol, Seoul, South Korea.	bclee@snu.ac.kr			Rural Development Administration [PJ008975022014]; Korea Institute of Planning and Evaluation for Technology [311062-04-3SB010]; NATURE CELL [2014-0082]; Research Institute for Veterinary Science; Nestle Purina PetCare; Natural Balance Korea; BK21 plus program	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Korea Institute of Planning and Evaluation for Technology; NATURE CELL; Research Institute for Veterinary Science; Nestle Purina PetCare(Nestle SA); Natural Balance Korea; BK21 plus program	This study was supported by Rural Development Administration (# PJ008975022014), Korea Institute of Planning and Evaluation for Technology (# 311062-04-3SB010), NATURE CELL (# 2014-0082), Research Institute for Veterinary Science, Nestle Purina PetCare, Natural Balance Korea, and the BK21 plus program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2003, BLOOD, V101, P4305, DOI 10.1182/blood-2002-06-1649; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Burnett RC, 1997, TISSUE ANTIGENS, V49, P484, DOI 10.1111/j.1399-0039.1997.tb02783.x; CHAN T, 1985, TRANSPLANTATION, V39, P477, DOI 10.1097/00007890-198505000-00003; Chang RS, 2011, BIOMATERIALS, V32, P9785, DOI 10.1016/j.biomaterials.2011.09.017; Do M, 2012, BIOCHEM BIOPH RES CO, V424, P765, DOI 10.1016/j.bbrc.2012.07.031; GLUCKMAN JC, 1980, CR ACAD SCI D NAT, V290, P105; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hiendleder S, 2007, ADV EXP MED BIOL, V591, P103; Hong SG, 2009, ANIM REPROD SCI, V115, P334, DOI 10.1016/j.anireprosci.2008.12.005; Hong SG, 2009, GENESIS, V47, P314, DOI 10.1002/dvg.20504; Ishikawa K, 2010, J EXP MED, V207, P2297, DOI 10.1084/jem.20092296; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P269, DOI 10.1111/j.1399-0039.2006.00778.x; Kinoshita Y, 2010, NEUROL RES, V32, P429, DOI 10.1179/174313209X455718; KOLB HJ, 1975, TRANSPLANT P, V7, P461; Kwak HH, 2013, TRANSPL P, V45, P1754, DOI 10.1016/j.transproceed.2013.02.103; Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; Lee CY, 2011, BIOMATERIALS, V32, P6264, DOI 10.1016/j.biomaterials.2011.05.012; LINDAHL KF, 1982, P NATL ACAD SCI-BIOL, V79, P5362, DOI 10.1073/pnas.79.17.5362; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Lu Feng, 2007, Zhonghua Zheng Xing Wai Ke Za Zhi, V23, P412; Martin MJ, 2003, CLONING STEM CELLS, V5, P117, DOI 10.1089/153623003322234713; Ogawa H, 2006, GLYCOCONJUGATE J, V23, P663, DOI 10.1007/s10719-006-9005-0; Oiso N, 2013, J DERMATOL, V40, P330, DOI 10.1111/j.1346-8138.2012.01583.x; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Theoret CL, 2006, THERIOGENOLOGY, V65, P1465, DOI 10.1016/j.theriogenology.2005.08.019; Webb KM, 2009, J FORENSIC SCI, V54, P275, DOI 10.1111/j.1556-4029.2008.00952.x; WIDMER MB, 1972, J EXP MED, V135, P1204, DOI 10.1084/jem.135.5.1204; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	32	2	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e108330	10.1371/journal.pone.0108330	http://dx.doi.org/10.1371/journal.pone.0108330			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372489	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900003
J	Walsh, PM; Byrne, J; Kelly, M; McDevitt, J; Comber, H				Walsh, Paul M.; Byrne, Julianne; Kelly, Maria; McDevitt, Joe; Comber, Harry			Socioeconomic Disparity in Survival after Breast Cancer in Ireland: Observational Study	PLOS ONE			English	Article							PROGNOSTIC FACTORS; WOMEN; STAGE; INEQUALITIES; DEPRIVATION; HEALTH; POPULATION; DIAGNOSIS; MORTALITY; COMORBIDITY	We evaluated the relationship between breast cancer survival and deprivation using data from the Irish National Cancer Registry. Cause-specific survival was compared between five area-based socioeconomic deprivation strata using Cox regression. Patient and tumour characteristics and treatment were compared using modified Poisson regression with robust variance estimation. Based on 21356 patients diagnosed 1999-2008, age-standardized five-year survival averaged 80% in the least deprived and 75% in the most deprived stratum. Age-adjusted mortality risk was 33% higher in the most deprived group (hazard ratio 1.33, 95% CI 1.21-1.45, P<0.001). The most deprived groups were more likely to present with advanced stage, high grade or hormone receptor-negative cancer, symptomatically, or with significant comorbidity, and to be smokers or unmarried, and less likely to have breast-conserving surgery. Cox modelling suggested that the available data on patient, tumour and treatment factors could account for only about half of the survival disparity (adjusted hazard ratio 1.18, 95% CI 0.97-1.43, P = 0.093). Survival disparity did not diminish over time, compared with the period 1994-1998. Persistent survival disparities among Irish breast cancer patients suggest unequal use of or access to services and highlight the need for further research to understand and remove the behavioural or other barriers involved.	[Walsh, Paul M.; Kelly, Maria; McDevitt, Joe; Comber, Harry] Natl Canc Registry, Cork, Ireland; [Byrne, Julianne] Boyne Res Inst, Drogheda, Ireland		Walsh, PM (corresponding author), Natl Canc Registry, Cork, Ireland.	p.walsh@ncri.ie			Department of Health of the Government of Ireland	Department of Health of the Government of Ireland	The authors received no specific funding for this work, but the National Cancer Registry is funded by the Department of Health of the Government of Ireland.	Aarts MJ, 2012, BRIT J CANCER, V107, P12, DOI 10.1038/bjc.2012.205; Aarts MJ, 2011, BREAST CANCER RES TR, V128, P517, DOI 10.1007/s10549-011-1363-z; Agurs-Collins T, 2010, SEMIN ONCOL, V37, P384, DOI 10.1053/j.seminoncol.2010.05.002; [Anonymous], 1997, AJCC CANC STAGING MA; Baker DP, 2011, POPUL DEV REV, V37, P307, DOI 10.1111/j.1728-4457.2011.00412.x; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Breslow RA, 2011, AM J EPIDEMIOL, V174, P1044, DOI 10.1093/aje/kwr210; BRUNNER E, 2006, SOCIAL DETERMINANTS; CARNON AG, 1994, BRIT MED J, V309, P1054, DOI 10.1136/bmj.309.6961.1054; Carsin Sharp L, 2009, ATLAS CANC IRELAND 1; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Downing A, 2007, BRIT J CANCER, V96, P836, DOI 10.1038/sj.bjc.6603622; Ellis L, 2012, EUR J CANCER, V48, P270, DOI 10.1016/j.ejca.2011.10.008; Gillis CR, 1996, BRIT MED J, V312, P145, DOI 10.1136/bmj.312.7024.145; Kaffashian F, 2003, BRIT J CANCER, V89, P1693, DOI 10.1038/sj.bjc.6601339; Kaufman Jay S, 2004, Epidemiol Perspect Innov, V1, P4, DOI 10.1186/1742-5573-1-4; Kelly A, 2007, NATL DEPRIVATION IND; Kim J, 2012, BREAST CANCER RES TR, V131, P527, DOI 10.1007/s10549-011-1836-0; Kogevinas M, 1997, IARC SCI PUBLICATION, V138; Louwman WJ, 2010, BRIT J CANCER, V103, P1742, DOI 10.1038/sj.bjc.6605949; Louwman WJ, 2005, EUR J CANCER, V41, P779, DOI 10.1016/j.ejca.2004.12.025; Lyratzopoulos G, 2011, ANN ONCOL, V22, P1661, DOI 10.1093/annonc/mdq647; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Macleod U, 2000, BRIT MED J, V320, P1442, DOI 10.1136/bmj.320.7247.1442; Macleod U, 2000, ANN ONCOL, V11, P105, DOI 10.1023/A:1008385321476; Morgan K., 2009, SLAN 2007 SURVEY LIF; National Cancer Registry, 2012, BREAST CANC INC MORT; O'Reilly D, 2002, AGE AGEING, V31, P197, DOI 10.1093/ageing/31.3.197; Patnaik JL, 2011, JNCI-J NATL CANCER I, V103, P1101, DOI 10.1093/jnci/djr188; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; SCHRIJVERS CTM, 1995, BRIT J CANCER, V72, P738, DOI 10.1038/bjc.1995.403; SCHRIJVERS CTM, 1995, INT J CANCER, V63, P324, DOI 10.1002/ijc.2910630303; Schrijvers CTM, 1997, CANCER-AM CANCER SOC, V80, P1482; Scottish Cancer Intelligence Unit, 2000, TRENDS CANC SURV SCO; Sprague BL, 2011, CANCER-AM CANCER SOC, V117, P1542, DOI 10.1002/cncr.25589; Teljeur C, 2013, NATL DEPRIVATION IND; Thomson CS, 2001, J EPIDEMIOL COMMUN H, V55, P308, DOI 10.1136/jech.55.5.308; Twelves CJ, 2001, BRIT J CANCER, V85, P637, DOI 10.1054/bjoc.2001.1957; Ugnat AM, 2004, BRIT J CANCER, V90, P1138, DOI 10.1038/sj.bjc.6601662; van Lenthe FJ, 2004, EUR J PUBLIC HEALTH, V14, P63, DOI 10.1093/eurpub/14.1.63; Wiley MM, 2005, IRISH J MED SCI, V174, P52, DOI 10.1007/BF03169130; Woods LM, 2010, AUST NZ J PUBL HEAL, V34, P206, DOI 10.1111/j.1753-6405.2010.00508.x; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yu XQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-364; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111729	10.1371/journal.pone.0111729	http://dx.doi.org/10.1371/journal.pone.0111729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372837	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900068
J	Wu, L; Xu, J; Yuan, WQ; Wu, BJ; Wang, H; Liu, GQ; Wang, XX; Du, J; Cai, SH				Wu, Long; Xu, Jun; Yuan, Weiqi; Wu, Baojian; Wang, Hao; Liu, Guangquan; Wang, Xiaoxiong; Du, Jun; Cai, Shaohui			The Reversal Effects of 3-Bromopyruvate on Multidrug Resistance In Vitro and In Vivo Derived from Human Breast MCF-7/ADR Cells	PLOS ONE			English	Article							EXPRESSION; DOXORUBICIN; BCRP/ABCG2	Purpose: P-glycoprotein mediated efflux is one of the main mechanisms for multidrug resistance in cancers, and 3-Bromopyruvate acts as a promising multidrug resistance reversal compound in our study. To test the ability of 3-Bromopyruvate to overcome P-glycoprotein-mediated multidrug resistance and to explore its mechanisms of multidrug resistance reversal in MCF-7/ADR cells, we evaluate the in vitro and in vivo modulatory activity of this compound. Methods: The in vitro and in vivo activity was determined using the MTT assay and human breast cancer xenograft models. The gene and protein expression of P-glycoprotein were determined using real-time polymerase chain reaction and the Western blotting technique, respectively. ABCB-1 bioactivity was tested by fluorescence microscopy, multi-mode microplate reader, and flow cytometry. The intracellular levels of ATP, HK-II, and ATPase activity were based on an assay kit according to the manufacturer's instructions. Results: 3-Bromopyruvate treatment led to marked decreases in the IC50 values of selected chemotherapeutic drugs [e.g., doxorubicin (283 folds), paclitaxel (85 folds), daunorubicin (201 folds), and epirubicin (171 folds)] in MCF-7/ADR cells. 3-Bromopyruvate was found also to potentiate significantly the antitumor activity of epirubicin against MCF-7/ADR xenografts. The intracellular level of ATP decreased 44%, 46% in the presence of 12.5.25 mu M 3-Bromopyruvate, whereas the accumulation of rhodamine 123 and epirubicin (two typical P-glycoprotein substrates) in cells was significantly increased. Furthermore, we found that the mRNA and the total protein level of P-glycoprotein were slightly altered by 3-Bromopyruvate. Moreover, the ATPase activity was significantly inhibited when 3-Bromopyruvate was applied. Conclusion: We demonstrated that 3-Bromopyruvate can reverse P-glycoprotein-mediated efflux in MCF-7/ADR cells. Multidrug resistance reversal by 3-Bromopyruvate occurred through at least three approaches, namely, a decrease in the intracellular level of ATP and HK-II bioactivity, the inhibition of ATPase activity, and the slight decrease in P-glycoprotein expression in MCF-7/ADR cells.	[Wu, Long; Xu, Jun; Yuan, Weiqi; Liu, Guangquan; Wang, Xiaoxiong; Cai, Shaohui] Jinan Univ, Coll Pharm, Dept Clin Pharmacol, Guangzhou 510632, Guangdong, Peoples R China; [Wu, Baojian] Jinan Univ, Coll Pharm, Div Pharmaceut, Guangzhou 510632, Guangdong, Peoples R China; [Wang, Hao; Du, Jun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China	Jinan University; Jinan University; Sun Yat Sen University	Du, J (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	dujun2345@yahoo.cn; csh5689@sina.com			National Natural Science Foundation of China [30973565, 81273538, 81202461]; Fundamental Research Funds for the Central Universities [21612115]; China Postdoctoral Science Foundation [2013M531906]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by the National Natural Science Foundation of China (No. 30973565, No. 81273538 and No. 81202461) and the Fundamental Research Funds for the Central Universities (No. 21612115) as well as China Postdoctoral Science Foundation (No. 2013M531906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albermann N, 2005, BIOCHEM PHARMACOL, V70, P949, DOI 10.1016/j.bcp.2005.06.018; Allam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051345; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Chen JJ, 2012, CANCER SCI, V103, P1531, DOI 10.1111/j.1349-7006.2012.02328.x; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023; Fang R, 2013, CANCER LETT, V333, P66, DOI 10.1016/j.canlet.2013.01.014; Fernandes AF, 2014, BREAST CANCER RES, V3, P47, DOI DOI 10.4236/ABCR.2014.32007; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Hayashida S, 2010, MOL CELL BIOCHEM, V339, P285, DOI 10.1007/s11010-010-0391-z; Jiang GM, 2010, INT J BIOCHEM CELL B, V42, P1840, DOI 10.1016/j.biocel.2010.07.020; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Ling V, 1997, CANCER CHEMOTH PHARM, V40, pS3, DOI 10.1007/s002800051053; LUK CK, 1989, JNCI-J NATL CANCER I, V81, P55, DOI 10.1093/jnci/81.1.55; MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M; Mathupala SP, 2009, HEXOKINASE 2 BOUND M, P5475; Nakano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027222; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; Ni LN, 2011, MED ONCOL, V28, P265, DOI 10.1007/s12032-010-9456-9; Pedersen PL, 2012, J BIOENERG BIOMEMBR, V44, P1, DOI 10.1007/s10863-012-9425-4; Shoshan MC, 2012, J BIOENERG BIOMEMBR, V44, P7, DOI 10.1007/s10863-012-9419-2; SKOWRONEK P, 1992, BIOCHEM BIOPH RES CO, V187, P991, DOI 10.1016/0006-291X(92)91295-2; Thomas Hilary, 2003, Cancer Control, V10, P159; Touil Y, 2013, STEM CELLS, V31, P641, DOI 10.1002/stem.1333; Trivedi ER, 2012, TETRAHEDRON LETT, V53, P5475, DOI 10.1016/j.tetlet.2012.07.087; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028; Zhang DM, 2012, MOL PHARMACEUT, V9, P3147, DOI 10.1021/mp300249s; Zhang JJ, 2011, CANCER-AM CANCER SOC, V117, P86, DOI 10.1002/cncr.25522	30	22	23	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112132	10.1371/journal.pone.0112132	http://dx.doi.org/10.1371/journal.pone.0112132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372840	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900113
J	Baillon, S; Hamel, JF; Mercier, A				Baillon, Sandrine; Hamel, Jean-Francois; Mercier, Annie			Diversity, Distribution and Nature of Faunal Associations with Deep-Sea Pennatulacean Corals in the Northwest Atlantic	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; STABLE-ISOTOPE ANALYSIS; COLD-WATER CORALS; BENTHIC INVERTEBRATES; GORGONIAN CORALS; PACIFIC-OCEAN; PEN; HABITAT; CANADA; OCTOCORALLIA	Anthoptilum grandiflorum and Halipteris finmarchica are two deep-sea corals (Octocorallia: Pennatulacea) common on soft bottoms in the North Atlantic where they are believed to act as biogenic habitat. The former also has a worldwide distribution. To assist conservation efforts, this study examines spatial and temporal patterns in the abundance, diversity, and nature of their faunal associates. A total of 14 species were found on A. grandiflorum and 6 species on H. finmarchica during a multi-year and multi-site sampling campaign in eastern Canada. Among those, 7 and 5 species, respectively, were attached to the sea pens and categorized as close associates or symbionts. Rarefaction analyses suggest that the most common associates of both sea pens have been sampled. Biodiversity associated with each sea pen is analyzed according to season, depth and region using either close associates or the broader collection of species. Associated biodiversity generally increases from northern to southern locations and does not vary with depth (similar to 100-1400 m). Seasonal patterns in A. grandiflorum show higher biodiversity during spring/summer due to the transient presence of early life stages of fishes and shrimps whereas it peaks in fall for H. finmarchica. Two distinct endoparasitic species of highly modified copepods (families Lamippidae and Corallovexiidae) commonly occur in the polyps of A. grandiflorum and H. finmarchica, and a commensal sea anemone frequently associates with H. finmarchica. Stable isotope analyses (delta C-13 and delta N-15) reveal potential trophic interactions between the parasites and their hosts. Overall, the diversity of obligate/permanent associates of sea pens is moderate; however the presence of mobile/transient associates highlights an ecological role that has yet to be fully elucidated and supports their key contribution to the enhancement of biodiversity in the Northwest Atlantic.	[Baillon, Sandrine; Mercier, Annie] Mem Univ, Dept Ocean Sci, St John, NF, Canada; [Hamel, Jean-Francois] SEVE, St Philips, NF, Canada	Memorial University Newfoundland	Baillon, S (corresponding author), Mem Univ, Dept Ocean Sci, St John, NF, Canada.	sbaillon@mun.ca	Baillon, Sandrine/F-4486-2015; Mercier, Annie/B-4254-2012	Baillon, Sandrine/0000-0002-0781-0706; Mercier, Annie/0000-0003-0807-2378	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Discovery grants from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammons AW, 2008, DEEP-SEA RES PT II, V55, P2657, DOI 10.1016/j.dsr2.2008.07.015; Baillon S, 2014, CHARACTERIZATION ROL, P300; Baillon S, 2014, MAR BIOL, V161, P29, DOI 10.1007/s00227-013-2311-8; Baillon S, 2012, FRONT ECOL ENVIRON, V10, P351, DOI 10.1890/120022; Baillon S, 2011, DEEP-SEA RES PT I, V58, P260, DOI 10.1016/j.dsr.2010.12.010; Baker KD, 2012, MAR ECOL PROG SER, V445, P235, DOI 10.3354/meps09448; BouIIgand Y., 1966, Symposia of the Zoological Society of London, VNo. 16, P267; Bouligand Y., 1965, Crustaceana, V8, P1, DOI 10.1163/156854065X00505; Brodeur RD, 2001, CONT SHELF RES, V21, P207, DOI 10.1016/S0278-4343(00)00083-2; Buhl-Mortensen L, 2005, ERLANGEN EARTH C SER, P849, DOI 10.1007/3-540-27673-4_44; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Buhl-Mortensen L, 2004, J NAT HIST, V38, P1233, DOI 10.1080/0022293031000155205; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Buhl-Mortensen P, 2014, MAR BIOL RES, V10, P253, DOI 10.1080/17451000.2013.810759; Carlier A, 2009, MAR ECOL PROG SER, V397, P125, DOI 10.3354/meps08361; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; COLL JC, 1992, CHEM REV, V92, P613, DOI 10.1021/cr00012a006; Dalyell JG, 1848, RARE REMARKABLE ANIM; de Moura Neves B, 2013, 6 ANN BIOL GRAD STUD; DeWaard Jeremy R., 2008, V410, P275; Donaldson A, 2010, IMPACTS FISHING GEAR, P90; DUBE MA, 1971, J PHYCOL, V7, P218; Edwards DCB, 2008, MAR BIOL, V155, P303, DOI 10.1007/s00227-008-1028-6; Etnoyer P, 2005, ERLANGEN EARTH C SER, P331, DOI 10.1007/3-540-27673-4_16; Fautin D.G., 2013, HEXACORALLIANS WORLD; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Gale KSP, 2013, DEEP-SEA RES PT I, V80, P25, DOI 10.1016/j.dsr.2013.05.016; Gale KSP, 2013, ECOLOGY DEEP SEA AST, P135; Garcia-Matucheski S, 2012, J EXP MAR BIOL ECOL, V416, P208, DOI 10.1016/j.jembe.2011.12.014; Gilkinson K, 2009, CAN TECH REP FISH AQ, P142; Hoare R, 1977, BIOL BENTHIC ORGANIS, P329; HUMES AG, 1978, T AM MICROSC SOC, V97, P524, DOI 10.2307/3226168; HUMES AG, 1985, T AM MICROSC SOC, V104, P313, DOI 10.2307/3226484; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Iken K, 2005, POLAR BIOL, V28, P238, DOI 10.1007/s00300-004-0669-2; Iken K, 2001, PROG OCEANOGR, V50, P383, DOI 10.1016/S0079-6611(01)00062-3; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnstone AK, 1969, PTILOSARCUS GUERNEYI, P84; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Krug PJ, 2006, MAR MOL BIOTECHNOL, V42, P1; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; LAUBIER L, 1972, Crustaceana (Leiden), V22, P285, DOI 10.1163/156854072X00570; Longo C, 2005, J MAR BIOL ASSOC UK, V85, P1341, DOI 10.1017/S0025315405012518; MACKIE AM, 1987, COMP BIOCHEM PHYS A, V86, P629, DOI 10.1016/0300-9629(87)90613-X; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Mercier A, DEEP SEA RES 1, V91, P27; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Murillo FJ, 2011, ICES J MAR SCI, V68, P319, DOI 10.1093/icesjms/fsq071; Muzuka ANN, 1999, MAR GEOL, V160, P251, DOI 10.1016/S0025-3227(99)00022-5; *NAFO, 2008, 0824 NAFO SCS; Nilsen M, 2008, CAN J FISH AQUAT SCI, V65, P2791, DOI 10.1139/F08-180; Nygren A, 2010, J MAR BIOL ASSOC UK, V90, P1441, DOI 10.1017/S0025315409991536; PIELOU EC, 1966, AM NAT, V100, P463, DOI 10.1086/282439; Pires DO, 2009, MAR ECOL PROG SER, V397, P103, DOI 10.3354/meps08322; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rex M.A., 2010, BIOSCIENCE; Rex MA, 1997, MARINE BIODIVERSITY-BOOK, P94, DOI 10.1017/CBO9780511752360.006; Rex MA, 2000, P NATL ACAD SCI USA, V97, P4082, DOI 10.1073/pnas.050589497; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; SANKARANKUTTY C., 1961, JOUR MAR BIOL ASSOC INDIA, V3, P96; Sherwood GD, 2005, ESTUAR COAST SHELF S, V63, P537, DOI 10.1016/j.ecss.2004.12.010; Sherwood OA, 2008, DEEP-SEA RES PT I, V55, P1392, DOI 10.1016/j.dsr.2008.05.013; Soong K, 2005, MAR BIOL, V146, P1103, DOI 10.1007/s00227-004-1509-1; Tissot BN, 2006, FISH B-NOAA, V104, P167; Troffe PM, 2005, AQUAT CONSERV, V15, P523, DOI 10.1002/aqc.685; Wang Changyun, 2008, Acta Ecologica Sinica, V28, P2320; Wareham VE, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P289; Wating L, 2011, ADV MAR BIOL, V60, P41, DOI 10.1016/B978-0-12-385529-9.00002-0; Williams GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022747; WILLIAMS GC, 1995, ZOOL J LINN SOC-LOND, V113, P93, DOI 10.1006/zjls.1995.0004; Williams GC, 2013, HALIPTERIS FINMARCHI; Wilson MT, 2002, HYDROBIOLOGIA, V471, P133, DOI 10.1023/A:1016509506094; [No title captured]	75	32	33	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111519	10.1371/journal.pone.0111519	http://dx.doi.org/10.1371/journal.pone.0111519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369515	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000344402000065
J	Sasaki, S; Futagi, Y; Kobayashi, M; Ogura, J; Iseki, K				Sasaki, Shotaro; Futagi, Yuya; Kobayashi, Masaki; Ogura, Jiro; Iseki, Ken			Functional Characterization of 5-Oxoproline Transport via SLC16A1/MCT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROGLUTAMIC ACID; HORMONE; IDENTIFICATION; BRAIN; GENE; MCT8; POLYMORPHISM; CELLS; LIGHT	Thyrotropin-releasing hormone is a tripeptide that consists of 5-oxoproline, histidine, and proline. The peptide is rapidly metabolized by various enzymes. 5-Oxoproline is produced by enzymatic hydrolysis in a variety of peptides. Previous studies showed that 5-oxoproline could become a possible biomarker for autism spectrum disorders. Here we demonstrate the involvement of SLC16A1 in the transport of 5-oxoproline. An SLC16A1 polymorphism (rs1049434) was recently identified. However, there is no information about the effect of the polymorphism on SLC16A1 function. In this study, the polymorphism caused an observable change in 5-oxoproline and lactate transport via SLC16A1. The Michaelis constant (K-m) was increased in an SLC16A1 mutant compared with that in the wild type. In addition, the proton concentration required to produce half-maximal activation of transport activity (K-0.5, H(+)) was increased in the SLC16A1 mutant compared with that in the wild type. Furthermore, we examined the transport of 5-oxoproline in T98G cells as an astrocyte cell model. Despite the fact that 5-oxoproline is an amino acid derivative, Na+-dependent and amino acid transport systems scarcely contributed to 5-oxoproline transport. Based on our findings, we conclude that H+-coupled 5-oxoproline transport is mediated solely by SLC16A1 in the cells.	[Sasaki, Shotaro; Futagi, Yuya; Kobayashi, Masaki; Ogura, Jiro; Iseki, Ken] Hokkaido Univ, Lab Clin Pharmaceut & Therapeut, Div Pharmasci, Fac Pharmaceut Sci,Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Iseki, Ken] Hokkaido Univ Hosp, Dept Pharm, Sapporo, Hokkaido 0608648, Japan	Hokkaido University; Hokkaido University	Iseki, K (corresponding author), Hokkaido Univ, Lab Clin Pharmaceut & Therapeut, Div Pharmasci, Fac Pharmaceut Sci,Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	ken-i@pharm.hokudai.ac.jp	kobayashi, masaki/B-1638-2015	Futagi, Yuya/0000-0003-2829-2845	Northern Advancement Center for Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan	Northern Advancement Center for Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Northern Advancement Center for Science and Technology and Grant-in-aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arjona FJ, 2011, ENDOCRINOLOGY, V152, P5065, DOI 10.1210/en.2011-1166; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; BASSIRI RM, 1973, J CLIN INVEST, V52, P1616, DOI 10.1172/JCI107339; Ben-Zaken S, 2015, SCAND J MED SCI SPOR, V25, P365, DOI 10.1111/sms.12226; Cupeiro R, 2010, J SCI MED SPORT, V13, P526, DOI 10.1016/j.jsams.2009.07.004; de Souza ECL, 2013, ENDOCRINOLOGY, V154, P1948, DOI 10.1210/en.2012-2101; de Vrieze E, 2014, ENDOCRINOLOGY, V155, P2320, DOI 10.1210/en.2013-1962; Emmett M, 2014, CLIN J AM SOC NEPHRO, V9, P191, DOI 10.2215/CJN.07730713; Fedotovskaya ON, 2014, INT J SPORT PHYSIOL, V9, P173, DOI [10.1123/ijspp.2013-0026, 10.1123/IJSPP.2013-0026]; Foltz M, 2004, FASEB J, V18, P1758, DOI 10.1096/fj.03-1387fje; Fujisawa Y, 2006, ARCH BIOCHEM BIOPHYS, V445, P166, DOI 10.1016/j.abb.2005.10.020; Fujita T, 2004, BRAIN RES, V997, P52, DOI 10.1016/j.brainres.2003.10.049; Ganapathy V, 2008, AAPS J, V10, P193, DOI 10.1208/s12248-008-9022-y; Gasque P, 1996, J IMMUNOL, V156, P2247; GRIOLI S, 1990, FUNDAM CLIN PHARM, V4, P169, DOI 10.1111/j.1472-8206.1990.tb00485.x; Groeneweg S, 2014, ENDOCRINOLOGY, V155, P618, DOI 10.1210/en.2013-1521; Groeneweg S, 2013, ENDOCRINOLOGY, V154, P2525, DOI 10.1210/en.2012-2225; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Hildebrand MS, 2014, EPILEPSIA, V55, pE18, DOI 10.1111/epi.12519; Kumar A, 2012, CURR SCI INDIA, V102, P288; Kuwabara H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073814; Lean CB, 2009, DRUG METAB PHARMACOK, V24, P469, DOI 10.2133/dmpk.24.469; Lee WJ, 1996, J BIOL CHEM, V271, P19129, DOI 10.1074/jbc.271.32.19129; Lengacher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082505; Mao XR, 2006, J BIOL CHEM, V281, P35863, DOI 10.1074/jbc.M604166200; Merezhinskaya N, 2000, MUSCLE NERVE, V23, P90, DOI 10.1002/(SICI)1097-4598(200001)23:1<90::AID-MUS12>3.0.CO;2-M; Miyauchi S, 2010, BBA-BIOMEMBRANES, V1798, P1164, DOI 10.1016/j.bbamem.2010.03.002; PHAROAH POD, 1991, EARLY HUM DEV, V25, P43, DOI 10.1016/0378-3782(91)90205-H; Pillai SM, 2011, J BIOL CHEM, V286, P2455, DOI 10.1074/jbc.M110.172403; Sasaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067690; Sawczuk M., 2014, J SCI MED SPORT; Schindler AE, 2003, GYNECOL ENDOCRINOL, V17, P79, DOI 10.1080/713603177; Seki A, 2007, BIOPHYS J, V92, P2559, DOI 10.1529/biophysj.106.093153; Selmi-Ruby S, 2014, ENDOCRINOLOGY, V155, P635, DOI 10.1210/en.2013-1435; STWERTKA SA, 1992, PHARMACOL BIOCHEM BE, V41, P145, DOI 10.1016/0091-3057(92)90074-P; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Takekuma Y, 2007, J PHARM PHARM SCI, V10, P71; Viljoen J, 2012, METAB BRAIN DIS, V27, P327, DOI 10.1007/s11011-012-9285-y; Weng LX, 2003, MICROBIOL-SGM, V149, P451, DOI 10.1099/mic.0.25942-0	39	36	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2303	2311		10.1074/jbc.M114.581892	http://dx.doi.org/10.1074/jbc.M114.581892			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25371203	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000348588000035
J	Eisenach, PA; Schikora, F; Posern, G				Eisenach, Patricia A.; Schikora, Franziska; Posern, Guido			Inhibition of Arginyltransferase 1 Induces Transcriptional Activity of Myocardin-related Transcription Factor A (MRTF-A) and Promotes Directional Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Adherens Junction; Breast Cancer; Cell Adhesion; Cell Signaling; Myocardin; Rho (Rho GTPase); Transcriptional Co-activator	SRF-MEDIATED TRANSCRIPTION; SERUM RESPONSE FACTOR; END RULE PATHWAY; MEGAKARYOBLASTIC LEUKEMIA; ACTIN DYNAMICS; CELL MOTILITY; ARGINYLATION; PROTEIN; MKL1; PHOSPHORYLATION	Myocardin-related transcription factor A (MRTF-A/MAL/MKL1/BSAC) regulates the expression of serum-response factor (SRF)-dependent target genes in response to the Rho-actin signaling pathway. Overexpression or activation of MRTF-A affects shape, migration, and invasion of cells and contributes to human malignancies, including cancer. In this study, we report that inhibition of arginyltransferase 1 (ATE1), an enzyme mediating post-transcriptional protein arginylation, is sufficient to increase MRTF-A activity in MCF-7 human breast carcinoma cells independently of external growth factor stimuli. In addition, silencing or inhibiting ATE1 disrupted E-cadherin-mediated cell-cell contacts, enhanced formation of actin-rich protrusions, and increased the number of focal adhesions, subsequently leading to elevated chemotactic migration. Although arginylated actin did not differentially affect MRTF-A, a rapid loss of E-cadherin and F-actin reorganization preceded MRTF-A activation upon ATE1 inhibition. Conversely, ectopic ATE1 expression was sufficient to render MRTF-A inactive, both in resting cells and in cells with exogenously activated RhoA-actin pathways. In this study, we provide a critical link between protein arginylation and MRTF-A activity and place ATE1 upstream of myocardin-related transcription factor.	[Eisenach, Patricia A.; Schikora, Franziska; Posern, Guido] Univ Halle Wittenberg, Inst Physiol Chem, D-06114 Halle, Saale, Germany; [Eisenach, Patricia A.] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Martin Luther University Halle Wittenberg; Max Planck Society	Posern, G (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, D-06114 Halle, Saale, Germany.	guido.posern@medizin.uni-halle.de			Department of Reinhard Fassler at the Max Planck Institute of Biochemistry; Department of Axel Ullrich at the Max Planck Institute of Biochemistry	Department of Reinhard Fassler at the Max Planck Institute of Biochemistry; Department of Axel Ullrich at the Max Planck Institute of Biochemistry	We thank Anna Kashina (University of Pennsylvania) for kindly providing the ubiquitin fusion and the ATE1-GFP constructs. Generous support was provided by the Departments of Reinhard Fassler and Axel Ullrich at the Max Planck Institute of Biochemistry.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Becam IE, 2005, NAT CELL BIOL, V7, P510, DOI 10.1038/ncb1253; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Busche S, 2010, J CELL SCI, V123, P2803, DOI 10.1242/jcs.061887; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Eisenach PA, 2012, J BIOL CHEM, V287, P11533, DOI 10.1074/jbc.M111.306340; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Leitner L, 2011, J CELL SCI, V124, P4318, DOI 10.1242/jcs.092791; Lian LR, 2014, HAEMATOLOGICA, V99, P554, DOI 10.3324/haematol.2013.093047; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Rai R, 2005, P NATL ACAD SCI USA, V102, P10123, DOI 10.1073/pnas.0504500102; Saha S, 2012, BIOCHEM PHARMACOL, V83, P866, DOI 10.1016/j.bcp.2012.01.012; Scharenberg MA, 2010, INT J BIOCHEM CELL B, V42, P1911, DOI 10.1016/j.biocel.2010.08.014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebe A, 2008, FEBS LETT, V582, P291, DOI 10.1016/j.febslet.2007.12.021; Shaposhnikov D, 2012, CELL CYCLE, V11, P141, DOI 10.4161/cc.11.1.18499; Speight P, 2013, MOL BIOL CELL, V24, P3326, DOI 10.1091/mbc.E13-04-0220; Terman JR, 2013, CURR OPIN CELL BIOL, V25, P30, DOI 10.1016/j.ceb.2012.10.009; Yang F, 2010, J BIOL CHEM, V285, P39437, DOI 10.1074/jbc.M110.159913; Zhang FL, 2012, J CELL BIOL, V197, P819, DOI 10.1083/jcb.201112129	30	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35376	35387		10.1074/jbc.M114.578674	http://dx.doi.org/10.1074/jbc.M114.578674			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25381249	Green Published, hybrid			2022-12-26	WOS:000346660200028
J	Huang, KC; Sun, W; Wu, Y; Chen, MJ; Mohlke, KL; Lange, LA; Li, Y				Huang, Kuan-Chieh; Sun, Wei; Wu, Ying; Chen, Mengjie; Mohlke, Karen L.; Lange, Leslie A.; Li, Yun			Association Studies with Imputed Variants Using Expectation-Maximization Likelihood-Ratio Tests	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; AFRICAN-AMERICANS; GENETIC-VARIATION; LOCI; METAANALYSIS; UNCERTAINTY; HAPLOTYPES; SEQUENCE; TRAITS	Genotype imputation has become standard practice in modern genetic studies. As sequencing-based reference panels continue to grow, increasingly more markers are being well or better imputed but at the same time, even more markers with relatively low minor allele frequency are being imputed with low imputation quality. Here, we propose new methods that incorporate imputation uncertainty for downstream association analysis, with improved power and/or computational efficiency. We consider two scenarios: I) when posterior probabilities of all potential genotypes are estimated; and II) when only the one-dimensional summary statistic, imputed dosage, is available. For scenario I, we have developed an expectation-maximization likelihood-ratio test for association based on posterior probabilities. When only imputed dosages are available (scenario II), we first sample the genotype probabilities from its posterior distribution given the dosages, and then apply the EM-LRT on the sampled probabilities. Our simulations show that type I error of the proposed EM-LRT methods under both scenarios are protected. Compared with existing methods, EM-LRT-Prob (for scenario I) offers optimal statistical power across a wide spectrum of MAF and imputation quality. EM-LRT-Dose (for scenario II) achieves a similar level of statistical power as EM-LRT-Prob and, outperforms the standard Dosage method, especially for markers with relatively low MAF or imputation quality. Applications to two real data sets, the Cebu Longitudinal Health and Nutrition Survey study and the Women's Health Initiative Study, provide further support to the validity and efficiency of our proposed methods.	[Huang, Kuan-Chieh; Sun, Wei; Chen, Mengjie; Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27514 USA; [Sun, Wei; Wu, Ying; Chen, Mengjie; Mohlke, Karen L.; Lange, Leslie A.; Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Li, Yun] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Li, Y (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27514 USA.	yunli@med.unc.edu			NIH [R01HG006292, R01HG006703, R01DA030976]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006292, R01HG006703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030976] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by NIH funding R01HG006292, R01HG006703, and R01DA030976. This study makes use of GWAS data generated by WHI. A full data collection and analysis, decision to publish, or preparation of the manuscript. listing of WHI investigators can be found at: (https://www.whi.org/researchers/SitePages/WHI%20Investigators.aspx) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar EF, 2013, BIOMETRICS, V69, P427, DOI 10.1111/biom.12006; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bizon C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-85; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Croteau-Chonka DC, 2012, HUM MOL GENET, V21, P463, DOI 10.1093/hmg/ddr480; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Duan Q, 2013, BIOINFORMATICS, V29, P2744, DOI 10.1093/bioinformatics/btt477; Duan Q, 2013, BIOINFORMATICS, V29, P528, DOI 10.1093/bioinformatics/bts724; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Fuchsberger C, 2012, 62 ANN M AM SOC HUM; Futema M, 2012, J MED GENET, V49, P644, DOI 10.1136/jmedgenet-2012-101189; Gao Xiaoyi, 2012, Frontiers in Genetics, V3, P117, DOI 10.3389/fgene.2012.00117; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jiao S, 2011, GENET EPIDEMIOL, V35, P597, DOI 10.1002/gepi.20608; Kang J, 2013, BIOINFORMATICS, V29, P799, DOI 10.1093/bioinformatics/btt041; Kutalik Z, 2011, BIOSTATISTICS, V12, P1, DOI 10.1093/biostatistics/kxq039; LANDER ES, 1989, GENETICS, V121, P185; Lange LA, 2010, HUM MOL GENET, V19, P2050, DOI 10.1093/hmg/ddq062; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Liu KL, 2013, HUM HERED, V75, P2, DOI 10.1159/000349974; Marchini J, 2013, 63 ANN M AM SOC HUM; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Pei YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010827; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanna S, 2012, 62 ANN M AM SOC HUM; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Zhang P, 2013, GENETICS, V195, P319, DOI 10.1534/genetics.113.154591; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552	42	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110679	10.1371/journal.pone.0110679	http://dx.doi.org/10.1371/journal.pone.0110679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383782	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700009
J	Muller, VD; Soares, RO; dos Santos, NN; Trabuco, AC; Cintra, AC; Figueiredo, LT; Caliri, A; Sampaio, SV; Aquino, VH				Muller, Vanessa Danielle; Soares, Ricardo Oliveira; dos Santos-Junior, Nilton Nascimento; Trabuco, Amanda Cristina; Cintra, Adelia Cristina; Figueiredo, Luiz Tadeu; Caliri, Antonio; Sampaio, Suely Vilela; Aquino, Victor Hugo			Phospholipase A(2) Isolated from the Venom of Crotalus durissus terrificus Inactivates Dengue virus and Other Enveloped Viruses by Disrupting the Viral Envelope	PLOS ONE			English	Article							PRODUCT-DERIVED COMPOUNDS; NATURAL-PRODUCTS; INTERFACIAL CATALYSIS; BIOLOGICAL-ACTIVITIES; GLOBAL DISTRIBUTION; CRYSTAL-STRUCTURE; PROTEIN; CROTOXIN; DYNAMICS; ENZYME	The Flaviviridae family includes several virus pathogens associated with human diseases worldwide. Within this family, Dengue virus is the most serious threat to public health, especially in tropical and sub-tropical regions of the world. Currently, there are no vaccines or specific antiviral drugs against Dengue virus or against most of the viruses of this family. Therefore, the development of vaccines and the discovery of therapeutic compounds against the medically most important flaviviruses remain a global public health priority. We previously showed that phospholipase A(2) isolated from the venom of Crotalus durissus terrificus was able to inhibit Dengue virus and Yellow fever virus infection in Vero cells. Here, we present evidence that phospholipase A(2) has a direct effect on Dengue virus particles, inducing a partial exposure of genomic RNA, which strongly suggests inhibition via the cleavage of glycerophospholipids at the virus lipid bilayer envelope. This cleavage might induce a disruption of the lipid bilayer that causes a destabilization of the E proteins on the virus surface, resulting in inactivation. We show by computational analysis that phospholipase A(2) might gain access to the Dengue virus lipid bilayer through the pores found on each of the twenty 3-fold vertices of the E protein shell on the virus surface. In addition, phospholipase A(2) is able to inactivate other enveloped viruses, highlighting its potential as a natural product lead for developing broad-spectrum antiviral drugs.	[Muller, Vanessa Danielle; dos Santos-Junior, Nilton Nascimento; Trabuco, Amanda Cristina; Aquino, Victor Hugo] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Virol Lab, Dept Anal Clin Toxicol & Bromatol, Sao Paulo, Brazil; [Cintra, Adelia Cristina; Sampaio, Suely Vilela] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Lab Toxinol, Dept Anal Clin Toxicol & Bromatol, Sao Paulo, Brazil; [Soares, Ricardo Oliveira; Caliri, Antonio] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Fis & Quim, Sao Paulo, Brazil; [Figueiredo, Luiz Tadeu] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ctr Pesquisa Virol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Aquino, VH (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Virol Lab, Dept Anal Clin Toxicol & Bromatol, Sao Paulo, Brazil.	vhugo@fcfrp.usp.br	Muller, Vanessa/J-8722-2013; caliri, antonio/A-3963-2012; Vilela, Suely/D-7429-2012; Aquino, Victor Hugo/C-1922-2012; Oliveira dos Santos Soares, Ricardo/A-9748-2013; SANTOS-JUNIOR, NILTON NASCIMENTO/C-6439-2015	Vilela, Suely/0000-0003-3274-180X; Aquino, Victor Hugo/0000-0003-1910-0776; SANTOS-JUNIOR, NILTON NASCIMENTO/0000-0003-2155-032X; O. S. Soares, Ricardo/0000-0003-1549-8182; Trabuco, Amanda Cristina/0000-0003-1512-1561	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/54855-0, 2008/50617-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant 2005/54855-0 and 2008/50617-6. VHA, SVS and LTF hold a scholarship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahyayauch H, 2005, BIOCHEMISTRY-US, V44, P11592, DOI 10.1021/bi050715k; Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710; Bailey P, 2001, Emerg Med (Fremantle), V13, P28, DOI 10.1046/j.1442-2026.2001.00174.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERG OG, 1991, BIOCHEMISTRY-US, V30, P7283, DOI 10.1021/bi00243a034; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Borkow G, 1999, BIOCHEM BIOPH RES CO, V264, P63, DOI 10.1006/bbrc.1999.1483; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m; Davidsen J, 2002, BBA-BIOMEMBRANES, V1564, P256, DOI 10.1016/S0005-2736(02)00461-3; de Paula RC, 2009, PROTEIN PEPTIDE LETT, V16, P899, DOI 10.2174/092986609788923365; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DRAYTON HA, 1961, NATURE, V192, P896, DOI 10.1038/192896a0; EGBERTSON MS, 1994, J MED CHEM, V37, P2537, DOI 10.1021/jm00042a007; FAURE G, 1993, EUR J BIOCHEM, V214, P491, DOI 10.1111/j.1432-1033.1993.tb17946.x; Fenard D, 1999, J CLIN INVEST, V104, P611, DOI 10.1172/JCI6915; Fenard D, 2001, MOL PHARMACOL, V60, P341, DOI 10.1124/mol.60.2.341; FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005; Fletcher J.E., 1997, VENOM PHOSPHOLIPASE, pxii; FURUKAWA Y, 1976, BIOCHIM BIOPHYS ACTA, V453, P48, DOI 10.1016/0005-2795(76)90249-X; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; dos Santos HWG, 2008, J MED VIROL, V80, P1426, DOI 10.1002/jmv.21203; GRAINGER DW, 1990, BIOCHIM BIOPHYS ACTA, V1023, P365, DOI 10.1016/0005-2736(90)90128-B; Grandbois M, 1998, BIOPHYS J, V74, P2398, DOI 10.1016/S0006-3495(98)77948-2; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; HENDON RA, 1971, P NATL ACAD SCI USA, V68, P1560, DOI 10.1073/pnas.68.7.1560; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; HUANG HC, 1984, TOXICON, V22, P207, DOI 10.1016/0041-0101(84)90021-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7330, DOI 10.1021/bi00243a038; JAIN MK, 1983, BIOCHIM BIOPHYS ACTA, V736, P157, DOI 10.1016/0005-2736(83)90279-1; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaptein SJF, 2010, ANTIMICROB AGENTS CH, V54, P5269, DOI 10.1128/AAC.00686-10; KENSIL CR, 1985, LIPIDS, V20, P80, DOI 10.1007/BF02534212; Kim JO, 2007, J VIROL, V81, P1444, DOI 10.1128/JVI.01790-06; KING H, 1948, J CHEM SOC, P265, DOI 10.1039/jr9480000265; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KOHN A, 1967, VIROLOGY, V31, P385, DOI 10.1016/0042-6822(67)90183-3; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lee CH, 1997, J PEPT RES, V50, P25; Letson GW, 2010, HUM VACCINES, V6, P802, DOI 10.4161/hv.6.10.13018; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Marchi-Salvador DP, 2008, PROTEINS, V72, P883, DOI 10.1002/prot.21980; Muller VDM, 2012, TOXICON, V59, P507, DOI 10.1016/j.toxicon.2011.05.021; Mitsuishi M, 2006, BIOCHEM J, V393, P97, DOI 10.1042/BJ20050781; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mukherjee AK, 1997, CELL MOL LIFE SCI, V53, P152, DOI 10.1007/PL00000586; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Nozaki Y, 1967, METHOD ENZYMOL, V11, P715, DOI DOI 10.1016/S0076-6879(67)11088-4; ONDETTI MA, 1971, BIOCHEMISTRY-US, V10, P4033, DOI 10.1021/bi00798a004; Pan YH, 2001, BIOCHEMISTRY-US, V40, P609, DOI 10.1021/bi002514g; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; Petricevich VL, 2003, TOXICON, V42, P143, DOI 10.1016/S0041-0101(03)00124-7; Piggot TJ, 2012, J CHEM THEORY COMPUT, V8, P4593, DOI 10.1021/ct3003157; Ray D, 2006, DRUG DISCOV, V1, P45; Russo R.R., 2014, J VIROL ANTIVIR RES, V3, P1, DOI DOI 10.1371/JOURNAL.PONE.0112351; Samy RP, 2012, CURR MED CHEM, V19, P6150; SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359; Soares ROS, 2013, BBA-PROTEINS PROTEOM, V1834, P221, DOI 10.1016/j.bbapap.2012.09.007; THWIN MM, 1995, TOXICON, V33, P63, DOI 10.1016/0041-0101(94)00133-S; TSAI IH, 1987, BIOCHIM BIOPHYS ACTA, V916, P94, DOI 10.1016/0167-4838(87)90215-9; VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V67, P295; VISHWANATH BS, 1988, TOXICON, V26, P713, DOI 10.1016/0041-0101(88)90278-4; Ward RJ, 1998, TOXICON, V36, P1623, DOI 10.1016/S0041-0101(98)00155-X; Wendt A, 2014, CLIN PHARMACOL-ADV A, V6, P1, DOI 10.2147/CPAA.S30338; WILSCHUT JC, 1979, FEBS LETT, V98, P181, DOI 10.1016/0014-5793(79)80179-9; Yasumura Y, 1963, NIHON RINSHO, V21, P15; Yeagle P. L., 2011, STRUCTURE BIOL MEMBR; Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446; Zhang XCG, 2009, ANTIVIR RES, V83, P21, DOI 10.1016/j.antiviral.2009.02.204; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110	83	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112351	10.1371/journal.pone.0112351	http://dx.doi.org/10.1371/journal.pone.0112351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383618	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700052
J	Pathania, AS; Kumar, S; Guru, SK; Bhushan, S; Sharma, PR; Aithagani, SK; Singh, PP; Vishwakarma, RA; Kumar, A; Malik, F				Pathania, Anup S.; Kumar, Suresh; Guru, Santosh K.; Bhushan, Shashi; Sharma, Parduman R.; Aithagani, Sravan K.; Singh, Parvinder P.; Vishwakarma, Ram A.; Kumar, Ajay; Malik, Fayaz			The Synthetic Tryptanthrin Analogue Suppresses STAT3 Signaling and Induces Caspase Dependent Apoptosis via ERK Up Regulation in Human Leukemia HL-60 Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; BREAST-CANCER CELLS; NATURAL-PRODUCTS; SERINE PHOSPHORYLATION; EPITHELIAL-CELLS; DRUG DISCOVERY; DEATH; DEGRADATION; PROLIFERATION; SENSITIZATION	Tryptanthrin is a natural product which has been reported to have several medicinal properties. In this study, we tried to investigate the detailed molecular mechanism of its bromo analogue (TBr), a potent cytotoxic agent in the induction of cancer cell death. It was found that TBr primarily targets STAT3 and ERK signaling during the induction of apoptosis in several human leukemia cell lines. In HL-60 cells, TBr treatment caused early down regulation of p-STAT3 with concomitant up regulation of p-ERK which led to the activation of intrinsic and extrinsic pathways of apoptosis. The mechanism of TBr mediated inhibition of p-STAT3 was found to be due to the activation of ubiquitin dependent degradation of tyrosine 705 and serine 727 p-STAT3. As IL-6 is the main driver of the STAT3 pathway, the effect of TBr on cell death was subdued when treated in the combination with IL-6 in HL60 cells. Interestingly, PD98059 significantly reduced the apoptotic effects of TBr, thus showing the direct involvement of p-ERK in TBr mediated cell death. It was further shown that apoptotic protein Bax silencing in HL-60 cells resists TBr mediated ERK dependent apoptosis. In summary, for the first time we report the mechanism of TBr mediated cell death in human leukemia cell lines by targeting STAT3 and ERK pathways.	[Pathania, Anup S.; Kumar, Suresh; Guru, Santosh K.; Bhushan, Shashi; Sharma, Parduman R.; Kumar, Ajay; Malik, Fayaz] Indian Inst Integrat Med, Dept Canc Pharmacol, Jammu, Jammu & Kashmir, India; [Singh, Parvinder P.; Vishwakarma, Ram A.] Indian Inst Integrat Med, Div Med Chem, Jammu, Jammu & Kashmir, India; [Pathania, Anup S.; Kumar, Suresh; Aithagani, Sravan K.] Acad Sci & Innovat Res AcSIR, New Delhi, India; [Malik, Fayaz] Univ Michigan, Expt Breast Canc Res Lab, Ann Arbor, MI 48109 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Academy of Scientific & Innovative Research (AcSIR); University of Michigan System; University of Michigan	Kumar, A (corresponding author), Indian Inst Integrat Med, Dept Canc Pharmacol, Jammu, Jammu & Kashmir, India.	ajaykmahajan@hotmail.com; fmalik@iiim.ac.in	Guru, Santosh/AAR-1558-2021; KUMAR, AJAY/ABC-6109-2021	Guru, Santosh/0000-0002-9287-1836; KUMAR, AJAY/0000-0002-3889-3049; pathania, Anup/0000-0002-1517-2919; Malik, Fayaz/0000-0001-5475-6610	Indian institute of Integrative Medicine; Council of scientific and Industrial Research Canal road Jammu, Jammu and Kashmir, India [180001]	Indian institute of Integrative Medicine; Council of scientific and Industrial Research Canal road Jammu, Jammu and Kashmir, India	The authors received financial support from the Indian institute of Integrative Medicine; Council of scientific and Industrial Research Canal road Jammu, Jammu and Kashmir 180001, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chan HL, 2009, CELL MOL IMMUNOL, V6, P335, DOI 10.1038/cmi.2009.44; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Daino H, 2000, BLOOD, V95, P2577; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Hamblin T, 2006, LEUKEMIA RES, V30, P649, DOI 10.1016/j.leukres.2005.10.023; HONDA G, 1979, PLANTA MED, V37, P172, DOI 10.1055/s-0028-1097320; Ishihara T, 2000, EUR J PHARMACOL, V407, P197, DOI 10.1016/S0014-2999(00)00674-9; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kimoto T, 2001, PATHOL INT, V51, P315, DOI 10.1046/j.1440-1827.2001.01204.x; Krasilnikov M, 2003, ONCOGENE, V22, P4092, DOI 10.1038/sj.onc.1206598; Krivogorsky B, 2008, ANTIMICROB AGENTS CH, V52, P4466, DOI 10.1128/AAC.00903-08; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Lucas DM, 2010, CURR DRUG TARGETS, V11, P812; Miao S, 2011, INT J MOL SCI, V12, P3831, DOI 10.3390/ijms12063831; Mondal S, 2012, ANTI-CANCER AGENT ME, V12, P49, DOI 10.2174/187152012798764697; Morales-Prieto DM, 2013, SCI WORLD J, DOI 10.1155/2013/259845; Nabeyrat E, 2003, AM J PHYSIOL-LUNG C, V284, pL1112, DOI 10.1152/ajplung.00178.2002; Park BG, 2005, TOXICOLOGY, V215, P115, DOI 10.1016/j.tox.2005.07.003; Pathania AS, 2013, APOPTOSIS, V18, P1561, DOI 10.1007/s10495-013-0889-4; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Recio MC, 2006, PLANTA MED, V72, P539, DOI 10.1055/s-2006-931562; Scovill J, 2002, ANTIMICROB AGENTS CH, V46, P882, DOI 10.1128/AAC.46.3.882-883.2002; Spiekermann K, 2001, EUR J HAEMATOL, V67, P63, DOI 10.1034/j.1600-0609.2001.t01-1-00385.x; Takei Y, 2003, BIOL PHARM BULL, V26, P365, DOI 10.1248/bpb.26.365; Ulane CM, 2003, J VIROL, V77, P6385, DOI 10.1128/JVI.77.11.6385-6393.2003; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu ST, 2007, BIOCHEM BIOPH RES CO, V358, P79, DOI 10.1016/j.bbrc.2007.04.107; Yu ST, 2009, ANTI-CANCER DRUG, V20, P382, DOI 10.1097/CAD.0b013e32832a2cd4; Zheng AP, 2007, ENDOCRINOLOGY, V148, P2764, DOI 10.1210/en.2006-1269	36	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110411	10.1371/journal.pone.0110411	http://dx.doi.org/10.1371/journal.pone.0110411			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383546	Green Submitted, gold, Green Published			2022-12-26	WOS:000344816700006
J	Kouvonen, A; Koskinen, A; Varje, P; Kokkinen, L; De Vogli, R; Vaananen, A				Kouvonen, Anne; Koskinen, Aki; Varje, Pekka; Kokkinen, Lauri; De Vogli, Roberto; Vaananen, Ari			National Trends in Main Causes of Hospitalization: A Multi-Cohort Register Study of the Finnish Working-Age Population, 1976-2010	PLOS ONE			English	Article							SEX-SPECIFIC TRENDS; DISEASE; HEALTH; RATES; MORTALITY; SCOTLAND; DECLINE; BREAST; BACK; RISK	Background: The health transition theory argues that societal changes produce proportional changes in causes of disability and death. The aim of this study was to identify long-term changes in main causes of hospitalization in working-age population within a nation that has experienced considerable societal change. Methodology: National trends in all-cause hospitalization and hospitalizations for the five main diagnostic categories were investigated in the data obtained from the Finnish Hospital Discharge Register. The seven-cohort sample covered the period from 1976 to 2010 and consisted of 3,769,356 randomly selected Finnish residents, each cohort representing 25% sample of population aged 18 to 64 years. Principal Findings: Over the period of 35 years, the risk of hospitalization for cardiovascular diseases and respiratory diseases decreased. Hospitalization for musculoskeletal diseases increased whereas mental and behavioral hospitalizations slightly decreased. The risk of cancer hospitalization decreased marginally in men, whereas in women an upward trend was observed. Conclusions/Significance: A considerable health transition related to hospitalizations and a shift in the utilization of health care services of working-age men and women took place in Finland between 1976 and 2010.	[Kouvonen, Anne] Univ Helsinki, Dept Social Res, Helsinki, Finland; [Kouvonen, Anne] Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland; [Kouvonen, Anne] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth Northern Ireland, Belfast, Antrim, North Ireland; [Koskinen, Aki; Varje, Pekka; Kokkinen, Lauri; Vaananen, Ari] Finnish Inst Occupat Hlth, Helsinki, Finland; [Koskinen, Aki; Varje, Pekka; Kokkinen, Lauri; Vaananen, Ari] Finnish Inst Occupat Hlth, Tampere, Finland; [Varje, Pekka] Univ Helsinki, Dept Philosophy Hist Culture & Art Studies, Helsinki, Finland; [De Vogli, Roberto] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Davis, CA 95616 USA; [De Vogli, Roberto] UCL, Dept Epidemiol & Publ Hlth, London, England	University of Helsinki; SWPS University of Social Sciences & Humanities; Queens University Belfast; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Helsinki; University of California System; University of California Davis; University of London; University College London	Kouvonen, A (corresponding author), Univ Helsinki, Dept Social Res, Helsinki, Finland.	anne.kouvonen@helsinki.fi	Kokkinen, Lauri PM/O-1295-2018	Kokkinen, Lauri PM/0000-0001-5827-6673; Kokkinen, Lauri/0000-0001-7654-3026; Kouvonen, Anne/0000-0001-6997-8312	Academy of Finland [67172]; Medical Research Council (MRC) [MR/K023241/1]; Economic and Social Research Council (ESRC) [ES/L007509/1, RES-070-27-0034]; Economic and Social Research Council [ES/L007509/1] Funding Source: researchfish; Medical Research Council [MR/K023241/1, MC_CF023241] Funding Source: researchfish; ESRC [ES/L007509/1] Funding Source: UKRI; MRC [MR/K023241/1] Funding Source: UKRI	Academy of Finland(Academy of Finland); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Academy of Finland (grant 67172). A. Kouvonen was supported by the Medical Research Council (MRC) (grant MR/K023241/1) and the Economic and Social Research Council (ESRC) (grant ES/L007509/1). R. De Vogli was supported by the Economic and Social Research Council (ESRC) (grant RES-070-27-0034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir H, 2006, OCCUP ENVIRON MED, V63, P290, DOI 10.1136/oem.2005.026047; Briffa T, 2011, HEART, V97, P400, DOI 10.1136/hrt.2010.210138; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Frenk J, 1991, Health Transit Rev, V1, P21; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Getahun D, 2005, J ASTHMA, V42, P373, DOI 10.1081/JAS-200062995; Haldeman GA, 1999, CONGESTIVE HEART FAI; Harper S, 2011, ANNU REV PUBL HEALTH, V32, P39, DOI 10.1146/annurev-publhealth-031210-101234; Hemminki E, 2008, MATURITAS, V61, P299, DOI 10.1016/j.maturitas.2008.09.022; Hjerppe R., 2006, ROAD PROSPERITY EC H; Hoeymans N, 2012, AM J PUBLIC HEALTH, V102, P163, DOI 10.2105/AJPH.2011.300296; Inglis SC, 2012, BRIT J SURG, V99, P680, DOI 10.1002/bjs.8686; Kauppinen T, 2013, ANN OCCUP HYG, V57, P593, DOI 10.1093/annhyg/mes090; Kela [Social Insurance Institution], 2012, STAT YB SOC INS I; Lee JM, 2010, J WOMENS HEALTH, V19, P2033, DOI 10.1089/jwh.2010.2029; Lehto A. M., 2008, TYOOLOJEN KOLME VUOS; Lewsey JD, 2009, CIRC-CARDIOVASC QUAL, V2, P475, DOI 10.1161/CIRCOUTCOMES.108.825968; Lincoln Andrew E, 2002, Work, V18, P99; Lindemann K, 2010, INT J CANCER, V127, P2661, DOI 10.1002/ijc.25267; Liu LJ, 2011, INT J CARDIOL, V149, P39, DOI 10.1016/j.ijcard.2009.11.037; Luepker RV, 2008, CIRCULATION, V117, P592, DOI 10.1161/CIRCULATIONAHA.107.747477; Lykkegaard J, 2012, RESP MED, V106, P549, DOI 10.1016/j.rmed.2011.11.001; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Mattioli S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-374; McCallum AK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-3; Mesle F, 2006, DEMOGRAPHY ANAL SYNT, P247; Moller B, 2005, EUR J CANCER PREV, V14, P117, DOI 10.1097/00008469-200504000-00007; Nedkoff LJ, 2011, CIRC-CARDIOVASC QUAL, V4, P557, DOI 10.1161/CIRCOUTCOMES.110.960005; Nowossadeck E, 2012, DTSCH ARZTEBL INT, V109, P151, DOI 10.3238/arztebl.2012.0151; Nurminen M, 2001, SCAND J WORK ENV HEA, V27, P161, DOI 10.5271/sjweh.605; Pukkala E., 2013, CANC IN FINLAND; Renehan AG, 2010, INT J CANCER, V126, P692, DOI 10.1002/ijc.24803; Schaufelberger M, 2004, EUR HEART J, V25, P300, DOI 10.1016/j.ehj.2003.12.012; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; Schnall P., 2009, UNHEALTHY WORK CAUSE; Straker LM, 2009, ERGONOMICS, V52, P1215, DOI 10.1080/00140130903039101; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; Teppo L, 1999, HLTH IN FINLAND; Thrasher JF, 2009, NICOTINE TOB RES, V11, P591, DOI 10.1093/ntr/ntp039; Towfighi A, 2011, AM J CARDIOL, V108, P1102, DOI 10.1016/j.amjcard.2011.05.046; Tuchsen F, 1996, J CLIN EPIDEMIOL, V49, P791, DOI 10.1016/0895-4356(95)00554-4; Tuchsen F, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001761; Ulmer H, 2007, J INTERN MED, V261, P566, DOI 10.1111/j.1365-2796.2007.01779.x; Vuorenkoski L., 2008, FINLAND HLTH SYSTEM; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100; Wang OJ, 2012, AM J CARDIOL, V109, P1589, DOI 10.1016/j.amjcard.2012.01.381; Wearing SC, 2006, OBES REV, V7, P239, DOI 10.1111/j.1467-789X.2006.00251.x	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112314	10.1371/journal.pone.0112314	http://dx.doi.org/10.1371/journal.pone.0112314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25379723	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100075
J	Ono, C; Yu, ZQ; Kasahara, Y; Kikuchi, Y; Ishii, N; Tomita, H				Ono, Chiaki; Yu, Zhiqian; Kasahara, Yoshiyuki; Kikuchi, Yoshie; Ishii, Naoto; Tomita, Hiroaki			Fluorescently Activated Cell Sorting Followed by Microarray Profiling of Helper T Cell Subtypes from Human Peripheral Blood	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; NETWORK ANALYSIS; IFN-GAMMA; DISEASE; CYTOKINES; TH1; CLASSIFICATION; BIOMARKER; PATTERNS; MARKERS	Background: Peripheral blood samples have been subjected to comprehensive gene expression profiling to identify biomarkers for a wide range of diseases. However, blood samples include red blood cells, white blood cells, and platelets. White blood cells comprise polymorphonuclear leukocytes, monocytes, and various types of lymphocytes. Blood is not distinguishable, irrespective of whether the expression profiles reflect alterations in (a) gene expression patterns in each cell type or (b) the proportion of cell types in blood. CD4(+) Th cells are classified into two functionally distinct subclasses, namely Th1 and Th2 cells, on the basis of the unique characteristics of their secreted cytokines and their roles in the immune system. Th1 and Th2 cells play an important role not only in the pathogenesis of human inflammatory, allergic, and autoimmune diseases, but also in diseases that are not considered to be immune or inflammatory disorders. However, analyses of minor cellular components such as CD4(+) cell subpopulations have not been performed, partly because of the limited number of these cells in collected samples. Methodology/Principal Findings: We describe fluorescently activated cell sorting followed by microarray (FACS-array) technology as a useful experimental strategy for characterizing the expression profiles of specific immune cells in the circulation. We performed reproducible gene expression profiling of Th1 and Th2, respectively. Our data suggest that this procedure provides reliable information on the gene expression profiles of certain small immune cell populations. Moreover, our data suggest that GZMK, GZMH, EOMES, IGFBP3, and STOM may be novel markers for distinguishing Th1 cells from Th2 cells, whereas IL17RB and CNTNAP1 can be Th2-specific markers. Conclusions/Significance: Our approach may help in identifying aberrations and novel therapeutic or diagnostic targets for diseases that affect Th1 or Th2 responses and elucidating the involvement of a subpopulation of immune cells in some diseases.	[Ono, Chiaki; Yu, Zhiqian; Kasahara, Yoshiyuki; Kikuchi, Yoshie; Tomita, Hiroaki] Tohoku Univ, Internal Res Inst Disaster Sci, Dept Disaster Psychiat, Sendai, Miyagi 980, Japan; [Ono, Chiaki; Yu, Zhiqian; Kasahara, Yoshiyuki; Kikuchi, Yoshie; Tomita, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Biol Psychiat, Sendai, Miyagi 980, Japan; [Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan; [Ishii, Naoto; Tomita, Hiroaki] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Tomita, H (corresponding author), Tohoku Univ, Internal Res Inst Disaster Sci, Dept Disaster Psychiat, Sendai, Miyagi 980, Japan.	htomita@med.tohoku.ac.jp	yu, zhiqian/M-5041-2016	yu, zhiqian/0000-0002-4827-5922; Tomita, Hiroaki/0000-0003-2628-880X; Ishii, Naoto/0000-0002-0549-8245; Kasahara, Yoshiyuki/0000-0002-9508-2218; xing zhi, shi zhi/0000-0003-3289-5681	Health and Labour Sciences Research Grants [H19-kokoro-ippan-001]; Japan Research Foundation for Clinical Pharmacology; Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry [21-9];  [24116007]	Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Japan Research Foundation for Clinical Pharmacology; Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry; 	This work was supported by a grant-in-aid for scientific research on innovative areas (No. 24116007), Health and Labour Sciences Research Grants research on psychiatric and neurological diseases and mental health (H19-kokoro-ippan-001), a grant-in-aid from the Japan Research Foundation for Clinical Pharmacology, and an Intramural Research Grant (No. 21-9) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman PL, 1972, BIOL DATA BOOK FEDER; Arasappan D, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-65; Baatar D, 2007, J IMMUNOL, V178, P4891, DOI 10.4049/jimmunol.178.8.4891; Bade B, 2005, INT IMMUNOL, V17, P1419, DOI 10.1093/intimm/dxh320; Baine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017014; Bansard C, 2011, RHEUMATOLOGY, V50, P283, DOI 10.1093/rheumatology/keq344; Beliakova-Bethell N, 2014, CYTOM PART A, V85A, P94, DOI 10.1002/cyto.a.22352; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Chen KD, 2011, NEUROBIOL DIS, V43, P698, DOI 10.1016/j.nbd.2011.05.023; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Dorsam GP, 2010, MICROBIOL IMMUNOL, V54, P558, DOI 10.1111/j.1348-0421.2010.00242.x; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Gardiner E, 2011, MOL PSYCHIAT; Giusti B, 2009, EUR J VASC ENDOVASC, V38, P104, DOI 10.1016/j.ejvs.2009.01.020; Grayson BL, 2011, GENES IMMUN, V12, P341, DOI 10.1038/gene.2011.13; Gurevich M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-46; Hamalainen H, 2001, GENOME BIOL, V2; Haouas H, 2010, HEMATOLOGY, V15, P193, DOI 10.1179/102453310X12647083620769; Heizmann O, 2008, J TRAUMA, V65, P1374, DOI 10.1097/TA.0b013e31818b257d; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kondo T, 2006, CANCER SCI, V97, P780, DOI 10.1111/j.1349-7006.2006.00231.x; LILES WC, 1995, J INFECT DIS, V172, P1573, DOI 10.1093/infdis/172.6.1573; Liu Z, 2005, CLIN EXP ALLERGY, V35, P1581, DOI 10.1111/j.1365-2222.2005.02382.x; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Marsh ED, 2008, DEV NEUROBIOL, V68, P434, DOI 10.1002/dneu.20602; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Myint AM, 2005, J AFFECT DISORDERS, V88, P167, DOI 10.1016/j.jad.2005.07.008; Pavon L, 2006, J NEUROIMMUNOL, V172, P156, DOI 10.1016/j.jneuroim.2005.08.014; Riedel M, 2007, J PSYCHIATR RES, V41, P3, DOI 10.1016/j.jpsychires.2005.11.007; Romagnani S, 2004, J ALLERGY CLIN IMMUN, V113, P395, DOI 10.1016/j.jaci.2003.11.025; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Rook GAW, 1997, LANCET, V349, P1831, DOI 10.1016/S0140-6736(97)01164-1; Saldanha-Araujo F, 2011, J CELL MOL MED; Sedelies KA, 2004, J BIOL CHEM, V279, P26581, DOI 10.1074/jbc.M312481200; Shehadeh LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009104; Staratschek-Jox A, 2009, EXPERT REV MOL DIAGN, V9, P271, DOI 10.1586/ERM.09.9; Stock P, 2009, J IMMUNOL, V182, P5116, DOI 10.4049/jimmunol.0804213; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Suzuki K, 2011, CLIN CANCER RES, V17, P5247, DOI 10.1158/1078-0432.CCR-10-2805; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takahashi M, 2010, SCHIZOPHR RES, V119, P210, DOI 10.1016/j.schres.2009.12.024; Takahashi N, 2008, EXP HEMATOL, V36, P1760, DOI 10.1016/j.exphem.2008.07.007; Takahashi R, 2009, J IMMUNOL, V182, P8071, DOI 10.4049/jimmunol.0804002; Wang H, CLIN EXP ALLERGY	46	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111405	10.1371/journal.pone.0111405	http://dx.doi.org/10.1371/journal.pone.0111405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379667	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100028
J	Thierry, M; Pasquis, B; Acar, N; Gregoire, S; Febvret, V; Buteau, B; Gambert-Nicot, S; Bron, AM; Creuzot-Garcher, CP; Bretillon, L				Thierry, Magalie; Pasquis, Bruno; Acar, Niyazi; Gregoire, Stephane; Febvret, Valerie; Buteau, Benedicte; Gambert-Nicot, Segolene; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel			Metabolic Syndrome Triggered by High-Fructose Diet Favors Choroidal Neovascularization and Impairs Retinal Light Sensitivity in the Rat	PLOS ONE			English	Article							ELECTRORETINOGRAPHIC OSCILLATORY POTENTIALS; INDUCED INSULIN-RESISTANCE; FATTY-ACID PROFILE; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; ANIMAL-MODELS; HEPATIC STEATOSIS; MOUSE; ASSOCIATION; ADIPOSITY	Diabetic retinopathy and age-related macular degeneration are the leading causes of blindness in Western populations. Although it is a matter of controversy, large-scale population-based studies have reported increased prevalence of age-related macular degeneration in patients with diabetes or diabetic retinopathy. We hypothesized that metabolic syndrome, one of the major risk factors for type 2 diabetes, would represent a favorable environment for the development of choroidal neovascularization, the main complication of age-related macular degeneration. The fructose-fed rat was used as a model for metabolic syndrome in which choroidal neovascularization was induced by laser photocoagulation. Male Brown Norway rats were fed for 1, 3, and 6 months with a standard equilibrated chow diet or a 60%-rich fructose diet (n = 24 per time point). The animals expectedly developed significant body adiposity (+17%), liver steatosis at 3 and 6 months, hyperleptinemia at 1 and 3 months (two-fold increase) and hyperinsulinemia at 3 and 6 months (up to two-fold increase), but remained normoglycemic and normolipemic. The fructose-fed animals exhibited partial loss of rod sensitivity to light stimulus and reduced amplitude of oscillatory potentials at 6 months. Fructose-fed rats developed significantly more choroidal neovascularization at 14 and 21 days post-laser photocoagulation after 1 and 3 months of diet compared to animals fed the control diet. These results were consistent with infiltration/activation of phagocytic cells and up-regulation of pro-angiogenic gene expression such as Vegf and Leptin in the retina. Our data therefore suggested that metabolic syndrome would exacerbate the development of choroidal neovascularization in our experimental model.	[Thierry, Magalie; Pasquis, Bruno; Acar, Niyazi; Gregoire, Stephane; Febvret, Valerie; Buteau, Benedicte; Gambert-Nicot, Segolene; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel] INRA, Ctr Sci Gout & Alimentat, Eye & Nutr Res Grp, UMR 1324, F-21034 Dijon, France; [Thierry, Magalie; Pasquis, Bruno; Acar, Niyazi; Gregoire, Stephane; Febvret, Valerie; Buteau, Benedicte; Gambert-Nicot, Segolene; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel] INRA, Ctr Sci Gout & Alimentat, UMR 6265, F-21034 Dijon, France; [Thierry, Magalie; Pasquis, Bruno; Acar, Niyazi; Gregoire, Stephane; Febvret, Valerie; Buteau, Benedicte; Gambert-Nicot, Segolene; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel] Univ Bourgogne, Ctr Sci Gout & Alimentat, Dijon, France; [Gambert-Nicot, Segolene] Univ Hosp, Dept Clin Chem, Dijon, France; [Bron, Alain M.; Creuzot-Garcher, Catherine P.] Univ Hosp, Dept Ophthalmol, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne	Bretillon, L (corresponding author), INRA, Ctr Sci Gout & Alimentat, Eye & Nutr Res Grp, UMR 1324, F-21034 Dijon, France.	lionel.bretillon@dijon.inra.fr	Bron, Alain/AAP-8010-2020	Bron, Alain/0000-0002-7265-931X; Bretillon, Lionel/0000-0002-6957-100X	Laboratoires Horus Pharma (Saint Laurent du Var, France); INRA-AlimH; CNRS; Universite de Bourgogne; Regional Council of Burgundy France (PARI Agrale 1); FEDER (European Funding for Regional Economic Development); French Government [ANR-11-LABX-0021-01-LipSTIC Labex]	Laboratoires Horus Pharma (Saint Laurent du Var, France); INRA-AlimH; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Bourgogne; Regional Council of Burgundy France (PARI Agrale 1)(Region Bourgogne-Franche-Comte); FEDER (European Funding for Regional Economic Development); French Government	This work was supported by Laboratoires Horus Pharma (Saint Laurent du Var, France), INRA-AlimH, CNRS, Universite de Bourgogne, Regional Council of Burgundy France (PARI Agrale 1), FEDER (European Funding for Regional Economic Development), and French Government grant managed by the French National Research Agency (ANR) under the "Investissements d'Avenir'' program with reference ANR-11-LABX-0021-01-LipSTIC Labex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman R G, 1981, Methods Enzymol, V72, P205; Andreoli MF, 2010, LIPIDS, V45, P1035, DOI 10.1007/s11745-010-3466-4; Aung MH, 2013, INVEST OPHTH VIS SCI, V54, P1370, DOI 10.1167/iovs.12-10927; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; BRESNICK GH, 1984, ARCH OPHTHALMOL-CHIC, V102, P1307, DOI 10.1001/archopht.1984.01040031057023; Bretillon L, 2008, INVEST OPHTH VIS SCI, V49, P1307, DOI 10.1167/iovs.07-0808; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; Chiu CJ, 2011, PROG RETIN EYE RES, V30, P18, DOI 10.1016/j.preteyeres.2010.09.001; Cruz-Guilloty F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088201; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Du HJ, 2013, P NATL ACAD SCI USA, V110, P2377, DOI 10.1073/pnas.1221729110; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Ferrannini E, 2011, MED CLIN N AM, V95, P327, DOI 10.1016/j.mcna.2010.11.005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fourgeux C, 2014, BIOCHEM BIOPH RES CO, V446, P775, DOI 10.1016/j.bbrc.2014.01.118; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hahn P, 2013, RETINA-J RET VIT DIS, V33, P911, DOI 10.1097/IAE.0b013e3182831248; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; Holopigian K, 1997, INVEST OPHTH VIS SCI, V38, P2355; HWANG IS, 1989, AM J HYPERTENS, V2, P424, DOI 10.1093/ajh/2.6.424; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; HYMAN LG, 1983, AM J EPIDEMIOL, V118, P213, DOI 10.1093/oxfordjournals.aje.a113629; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; Jesmin S, 2013, THROMB HAEMOSTASIS, V109, P696, DOI 10.1160/TH12-09-0654; JUEN S, 1990, ARCH OPHTHALMOL-CHIC, V108, P372, DOI 10.1001/archopht.1990.01070050070033; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; KAHN HA, 1977, AM J EPIDEMIOL, V106, P33, DOI 10.1093/oxfordjournals.aje.a112429; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; LACHAPELLE P, 1989, DOC OPHTHALMOL, V73, P327, DOI 10.1007/BF00154488; Lutty GA, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12979; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mishra S, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/327079; Mitchell P, 1999, AUST NZ J OPHTHALMOL, V27, P197, DOI 10.1046/j.1440-1606.1999.00211.x; MORRISON WR, 1964, J LIPID RES, V5, P600; Nagai Y, 2002, AM J PHYSIOL-ENDOC M, V282, pE1180, DOI 10.1152/ajpendo.00471.2001; Omarova S, 2012, J CLIN INVEST, V122, P3012, DOI 10.1172/JCI63816; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Reaven G, 2005, CIRCULATION, V112, P3030, DOI 10.1161/CIRCULATIONAHA.105.504670; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; SEBEDIO JL, 1987, J CHROMATOGR, V405, P371, DOI 10.1016/S0021-9673(01)81779-9; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Shirao Y, 1998, PROG RETIN EYE RES, V17, P59, DOI 10.1016/S1350-9462(97)00005-0; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Suganami E, 2004, DIABETES, V53, P2443, DOI 10.2337/diabetes.53.9.2443; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tarr Joanna M, 2013, ISRN Ophthalmol, V2013, P343560, DOI 10.1155/2013/343560; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; TOBEY TA, 1982, METABOLISM, V31, P608, DOI 10.1016/0026-0495(82)90100-7; Topouzis F, 2009, BRIT J OPHTHALMOL, V93, P1037, DOI 10.1136/bjo.2008.146316; Vadala M, 2002, ACTA OPHTHALMOL SCAN, V80, P305, DOI 10.1034/j.1600-0420.2002.800314.x; Vernay M, 2013, INT J PUBLIC HEALTH, V58, P855, DOI 10.1007/s00038-013-0501-2; WACHTMEISTER L, 1978, INVEST OPHTH VIS SCI, V17, P1176; Wu XL, 2011, J AGR FOOD CHEM, V59, P747, DOI 10.1021/jf1038426; ZAVARONI I, 1980, METABOLISM, V29, P970, DOI 10.1016/0026-0495(80)90041-4	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112450	10.1371/journal.pone.0112450	http://dx.doi.org/10.1371/journal.pone.0112450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380250	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100097
J	Kan, MWK; Leung, LHT; Yu, PKN				Kan, Monica W. K.; Leung, Lucullus H. T.; Yu, Peter K. N.			The Use of Biologically Related Model (Eclipse) for the Intensity-Modulated Radiation Therapy Planning of Nasopharyngeal Carcinomas	PLOS ONE			English	Article							GLAND FUNCTION; NECK TUMORS; RADIOTHERAPY; OPTIMIZATION; HEAD; IRRADIATION; DELIVERY; VOLUME; PLANS	Purpose: Intensity-modulated radiation therapy (IMRT) is the most common treatment technique for nasopharyngeal carcinoma (NPC). Physical quantities such as dose/dose-volume parameters are used conventionally for IMRT optimization. The use of biological related models has been proposed and can be a new trend. This work was to assess the performance of the biologically based IMRT optimization model installed in a popular commercial treatment planning system (Eclipse) as compared to its dose/dosevolume optimization model when employed in the clinical environment for NPC cases. Methods: Ten patients of early stage NPC and ten of advanced stage NPC were selected for this study. IMRT plans optimized using biological related approach (BBTP) were compared to their corresponding plans optimized using the dose/dose volume based approach (DVTP). Plan evaluation was performed using both biological indices and physical dose indices such as tumor control probability (TCP), normal tissue complication probability (NTCP), target coverage, conformity, dose homogeneity and doses to organs at risk. The comparison results of the more complex advanced stage cases were reported separately from those of the simpler early stage cases. Results: The target coverage and conformity were comparable between the two approaches, with BBTP plans producing more hot spots. For the primary targets, BBTP plans produced comparable TCP for the early stage cases and higher TCP for the advanced stage cases. BBTP plans reduced the volume of parotid glands receiving doses of above 40 Gy compared to DVTP plans. The NTCP of parotid glands produced by BBTP were 8.0 +/- 65.8 and 7.9 +/- 68.7 for early and advanced stage cases, respectively, while those of DVTP were 21.3 +/- 68.3 and 24.4 +/- 12.8, respectively. There were no significant differences in the NTCP values between the two approaches for the serial organs. Conclusions: Our results showed that the BBTP approach could be a potential alternative approach to the DVTP approach for NPC.	[Kan, Monica W. K.; Leung, Lucullus H. T.] Princess Margaret Hosp, Dept Oncol, Hong Kong, Hong Kong, Peoples R China; [Kan, Monica W. K.; Yu, Peter K. N.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon Tong, Hong Kong, Peoples R China	City University of Hong Kong	Kan, MWK (corresponding author), Princess Margaret Hosp, Dept Oncol, Hong Kong, Hong Kong, Peoples R China.	kanwkm@ha.org.hk	Yu, Peter K.N./C-7051-2013	Yu, Peter K.N./0000-0003-1669-5348				BEDWINEK JM, 1980, CANCER, V45, P2725, DOI 10.1002/1097-0142(19800601)45:11<2725::AID-CNCR2820451105>3.0.CO;2-1; Cheung Ky, 2006, Biomed Imaging Interv J, V2, pe19, DOI 10.2349/biij.2.1.e19; CRONQVIST AKA, 1995, ACTA ONCOL, V34, P851, DOI 10.3109/02841869509127196; Das S, 2009, MED PHYS, V36, P4672, DOI 10.1118/1.3220211; FRANZEN L, 1992, EUR J CANCER, V28A, P457, DOI 10.1016/S0959-8049(05)80076-0; Gressette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091325; Hunt MA, 2001, INT J RADIAT ONCOL, V49, P623, DOI 10.1016/S0360-3016(00)01389-4; International Commission on Radiation Units and Measurement, 2010, 82 ICRU; International Commission on Radiation Units and Measurements, 1993, 50 ICRU; Ji XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056208; KALLMAN P, 1992, INT J RADIAT BIOL, V62, P249, DOI 10.1080/09553009214552071; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; Kong FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091362; KUTCHER GJ, 1991, INT J RADIAT ONCOL, V21, P137, DOI 10.1016/0360-3016(91)90173-2; Kutcher GJ, 1989, INT J RAD BIOL PHYS, V16, P1625; Levin-Plotnik D, 2002, RADIAT RES, V155, P593; Li XA, 2012, MED PHYS, V39, P1386, DOI 10.1118/1.3685447; Lind BK, 1999, ACTA ONCOL, V38, P787; Pow HN, 2006, INT J RADIAT ONCOL, V66, P981; Qi XS, 2009, MED PHYS, V36, P1790, DOI 10.1118/1.3116775; Semenenko VA, 2008, MED PHYS, V35, P5851, DOI 10.1118/1.3013556; Someya M, 2003, JPN J CLIN ONCOL, V33, P336, DOI 10.1093/jjco/hyg066; Stavrev P, 2003, MED PHYS, V30, P2948, DOI 10.1118/1.1617411; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075304; Thieke C, 2003, MED PHYS, V30, P2332, DOI 10.1118/1.1598852; vantRiet A, 1997, INT J RADIAT ONCOL, V37, P731, DOI 10.1016/S0360-3016(96)00601-3; Wildeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063706; Wu QW, 2002, INT J RADIAT ONCOL, V52, P224, DOI 10.1016/S0360-3016(01)02585-8; Wu QW, 2003, PHYS MED BIOL, V48, P279, DOI 10.1088/0031-9155/48/3/301; Zhou GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067488	30	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112229	10.1371/journal.pone.0112229	http://dx.doi.org/10.1371/journal.pone.0112229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372041	gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900124
J	Sang, YM; Bergkamp, J; Blecha, F				Sang, Yongming; Bergkamp, Joseph; Blecha, Frank			Molecular Evolution of the Porcine Type I Interferon Family: Subtype-Specific Expression and Antiviral Activity	PLOS ONE			English	Article							ENDOGENOUS RETROVIRUSES; INFECTION; MACROPHAGES; INDUCTION; BACTERIAL; GENOMES; KAPPA; TIME; PIGS; WEB	Type I interferons (IFNs), key antiviral cytokines, evolve to adapt with ever-changing viral threats during vertebrate speciation. Due to novel pathogenic pressure associated with Suidae speciation and domestication, porcine IFNs evolutionarily engender both molecular and functional diversification, which have not been well addressed in pigs, an important livestock species and animal model for biomedical sciences. Annotation of current swine genome assembly Sscrofa10.2 reveals 57 functional genes and 16 pseudogenes of type I IFNs. Subfamilies of multiple IFNA, IFNW and porcine-specific IFND genes are separated into four clusters with similar to 60 kb intervals within the IFNB/IFNE bordered region in SSC1, and each cluster contains mingled subtypes of IFNA, IFNW and IFND. Further curation of the 57 functional IFN genes indicates that they include 18 potential artifactual duplicates. We performed phylogenetic construction as well as analyses of gene duplication/conversion and natural selection and showed that porcine type I IFN genes have been undergoing active diversification through both gene duplication and conversion. Extensive analyses of the non-coding sequences proximal to all IFN coding regions identified several genomic repetitive elements significantly associated with different IFN subtypes. Family-wide studies further revealed their molecular diversity with respect to differential expression and restrictive activity on the resurgence of a porcine endogenous retrovirus. Based on predicted 3-D structures of representative animal IFNs and inferred activity, we categorized the general functional propensity underlying the structure-activity relationship. Evidence indicates gene expansion of porcine type I IFNs. Genomic repetitive elements that associated with IFN subtypes may serve as molecular signatures of respective IFN subtypes and genomic mechanisms to mediate IFN gene evolution and expression. In summary, the porcine type I IFN profile has been phylogenetically defined family-wide and linked to diverse expression and antiviral activity, which is important information for further biological studies across the porcine type I IFN family.	[Sang, Yongming; Bergkamp, Joseph; Blecha, Frank] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA	Kansas State University	Sang, YM (corresponding author), Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA.	ysang@vet.k-state.edu			USDA AFRI NIFA/DHS [2010-39559-21860]; USDA NIFA [2013-67015-21236]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER	USDA AFRI NIFA/DHS; USDA NIFA(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the USDA AFRI NIFA/DHS 2010-39559-21860 (YS) and USDA NIFA 2013-67015-21236 (YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Carrero JA, 2013, INT IMMUNOL, V25, P663, DOI 10.1093/intimm/dxt050; Cencic A, 2003, PLACENTA, V24, P862, DOI 10.1016/S0143-4004(03)00135-8; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; Detournay O, 2013, J INTERF CYTOK RES, V33, P746, DOI 10.1089/jir.2012.0130; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goossens KE, 2013, DEV COMP IMMUNOL, V41, P370, DOI 10.1016/j.dci.2013.05.020; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Katholnig K, 2013, BIOCHEM SOC T, V41, P927, DOI 10.1042/BST20130032; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Langevin C, 2013, J MOL BIOL, V425, P4904, DOI 10.1016/j.jmb.2013.09.033; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Ma JG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-211; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Paltrinieri S, 2007, VET IMMUNOL IMMUNOP, V118, P68, DOI 10.1016/j.vetimm.2007.04.007; Patience C, 2001, J VIROL, V75, P2771, DOI 10.1128/JVI.75.6.2771-2775.2001; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Prchal M, 2009, VACCINE, V27, pG17, DOI 10.1016/j.vaccine.2009.10.016; Qi ZT, 2010, J IMMUNOL, V184, P5038, DOI 10.4049/jimmunol.0903374; Sang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087613; Sang YM, 2010, PHYSIOL GENOMICS, V42, P248, DOI 10.1152/physiolgenomics.00198.2009; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; van der Laan LJW, 2000, NATURE, V407, P90, DOI 10.1038/35024089; Walker AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-187; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu L, 2013, PROTEIN CELL, V4, P383, DOI 10.1007/s13238-013-3021-1; Yang SA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040003; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599	44	29	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112378	10.1371/journal.pone.0112378	http://dx.doi.org/10.1371/journal.pone.0112378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372927	Green Submitted, gold, Green Published			2022-12-26	WOS:000344556900141
J	Wang, JB; Wang, X; Zhao, MJ; Choo, SP; Ong, SJ; Ong, SYK; Chong, SS; Teo, YY; Lee, CGL				Wang, Jingbo; Wang, Xu; Zhao, Mingjue; Choo, Su Pin; Ong, Sin Jen; Ong, Simon Y. K.; Chong, Samuel S.; Teo, Yik Ying; Lee, Caroline G. L.			Potentially Functional SNPs (pfSNPs) as Novel Genomic Predictors of 5-FU Response in Metastatic Colorectal Cancer Patients	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; REDUCTASE GENE POLYMORPHISMS; HORMONE REPLACEMENT THERAPY; THYMIDYLATE SYNTHASE; EXO1 GENE; LUNG-CANCER; CLINICAL-RESPONSE; COLON-CARCINOMA; DLG5 VARIANTS; RISK	5-Fluorouracil (5-FU) and its pro-drug Capecitabine have been widely used in treating colorectal cancer. However, not all patients will respond to the drug, hence there is a need to develop reliable early predictive biomarkers for 5-FU response. Here, we report a novel potentially functional Single Nucleotide Polymorphism (pfSNP) approach to identify SNPs that may serve as predictive biomarkers of response to 5-FU in Chinese metastatic colorectal cancer (CRC) patients. 1547 pfSNPs and one variable number tandem repeat (VNTR) in 139 genes in 5-FU drug (both PK and PD pathway) and colorectal cancer disease pathways were examined in 2 groups of CRC patients. Shrinkage of liver metastasis measured by RECIST criteria was used as the clinical end point. Four non-responder-specific pfSNPs were found to account for 37.5% of all non-responders (P<0.0003). Five additional pfSNPs were identified from a multivariate model (AUC under ROC = 0.875) that was applied for all other pfSNPs, excluding the non-responder-specific pfSNPs. These pfSNPs, which can differentiate the other nonresponders from responders, mainly reside in tumor suppressor genes or genes implicated in colorectal cancer risk. Hence, a total of 9 novel SNPs with potential functional significance may be able to distinguish non-responders from responders to 5-FU. These pfSNPs may be useful biomarkers for predicting response to 5-FU.	[Wang, Jingbo; Lee, Caroline G. L.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore; [Wang, Xu; Teo, Yik Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Choo, Su Pin; Ong, Sin Jen; Ong, Simon Y. K.] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore; [Zhao, Mingjue; Chong, Samuel S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117548, Singapore; [Lee, Caroline G. L.] Natl Canc Ctr, Div Med Sci, Singapore, Singapore; [Lee, Caroline G. L.] Duke NUS Grad Med Sch, Singapore, Singapore	National University of Singapore; National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore	Teo, YY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	yik_ying_teo@nuhs.edu.sg; bchleec@nus.edu.sg	CHOO, Su Pin/ABB-3892-2020; Lee, Caroline G/M-8918-2019; wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022; Chong, Samuel S./D-8098-2015	Lee, Caroline G/0000-0002-4323-3635; Chong, Samuel S./0000-0002-1872-5937	Singapore BioMedical Research Council - Science and Engineering Research Council (BMRC-SERC) [SERC 112 148 0008]	Singapore BioMedical Research Council - Science and Engineering Research Council (BMRC-SERC)	This work was supported by a grant (SERC 112 148 0008) from Singapore BioMedical Research Council - Science and Engineering Research Council (BMRC-SERC) to A/Professors Caroline Lee, Simon Ong, Yik Ying Teo and Samuel Chong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; [Anonymous], 2011, TRENDS CANC INC SING; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bau DT, 2009, CHINESE J PHYSIOL, V52, P411, DOI 10.4077/CJP.2009.AMH076; Brondello JM, 2008, ONCOGENE, V27, P6093, DOI 10.1038/onc.2008.212; Chang JS, 2008, CANCER EPIDEM BIOMAR, V17, P1368, DOI 10.1158/1055-9965.EPI-07-2830; Cohen V, 2003, CLIN CANCER RES, V9, P1611; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Deng T, 2009, BIOMED PHARMACOTHER, V63, P492, DOI 10.1016/j.biopha.2008.08.013; Etienne MC, 2004, PHARMACOGENETICS, V14, P785, DOI 10.1097/00008571-200412000-00001; Farina-Sarasqueta A, 2010, CANCER CHEMOTH PHARM, V66, P1167, DOI 10.1007/s00280-010-1403-0; Festen EA, 2008, GUT, V57, P1027, DOI 10.1136/gut.2007.144857; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Graziano F, 2008, BRIT J CANCER, V99, P716, DOI 10.1038/sj.bjc.6604555; Gross E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004003; He T, 2013, COLORECTAL DIS, V15, P12, DOI 10.1111/j.1463-1318.2012.02919.x; Hirata K, 1999, PHARMACOL TOXICOL, V85, P33, DOI 10.1111/j.1600-0773.1999.tb01060.x; Hsu NY, 2009, ANTICANCER RES, V29, P725; Ichikawa W, 2006, CLIN CANCER RES, V12, P3928, DOI 10.1158/1078-0432.CCR-05-2665; Jahid S, 2012, CANCER DISCOV, V2, P540, DOI 10.1158/2159-8290.CD-11-0267; Jakobsen A, 2005, J CLIN ONCOL, V23, P1365, DOI 10.1200/JCO.2005.06.219; Jin GF, 2008, LUNG CANCER, V60, P340, DOI 10.1016/j.lungcan.2007.11.003; Kawakami K, 2003, CANCER RES, V63, P6004; Koopman M, 2009, EUR J CANCER, V45, P1935, DOI 10.1016/j.ejca.2009.04.023; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; Luo XP, 2012, INT J GYNECOL CANCER, V22, P220, DOI 10.1097/IGC.0b013e318234fd8a; Marcuello E, 2006, CANCER CHEMOTH PHARM, V57, P835, DOI 10.1007/s00280-005-0089-1; Martinez ME, 2001, J NATL CANCER I, V93, P1764, DOI 10.1093/jnci/93.23.1764; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nanda K, 1999, OBSTET GYNECOL, V93, P880, DOI 10.1016/S0029-7844(98)00424-4; Newman WG, 2006, HUM MUTAT, V27, P353, DOI 10.1002/humu.20301; Pan QR, 2005, CANCER LETT, V217, P139, DOI 10.1016/j.canlet.2004.07.021; Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038; Potocnik U, 2008, CANCER GENET CYTOGEN, V183, P28, DOI 10.1016/j.cancergencyto.2008.01.023; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Potti A, 2011, NAT MED, V17, P135, DOI 10.1038/nm0111-135; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rennert G, 2009, J CLIN ONCOL, V27, P4542, DOI 10.1200/JCO.2009.22.0764; Ruzzo A, 2007, J CLIN ONCOL, V25, P1247, DOI 10.1200/JCO.2006.08.1844; Salgado J, 2007, ONCOL REP, V17, P325; Schwab M, 2008, J CLIN ONCOL, V26, P2131, DOI 10.1200/JCO.2006.10.4182; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Slattery ML, 2011, CANCER CAUSE CONTROL, V22, P955, DOI 10.1007/s10552-011-9768-x; Sobrero AF, 1997, J CLIN ONCOL, V15, P368, DOI 10.1200/JCO.1997.15.1.368; Sohaib A, 2012, CANCER IMAGING, V12, P345, DOI 10.1102/1470-7330.2012.9011; Soong R, 2009, BRIT J CANCER, V100, P676, DOI 10.1038/sj.bjc.6604899; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; Tsai MH, 2009, ORAL ONCOL, V45, pE90, DOI 10.1016/j.oraloncology.2009.03.011; Tsuji T, 2003, CLIN CANCER RES, V9, P3700; Van Cutsem E, 2004, BRIT J CANCER, V90, P1190, DOI 10.1038/sj.bjc.6601676; Vignoli M, 2011, PHARMACOL RES, V64, P242, DOI 10.1016/j.phrs.2011.04.006; Wang HC, 2009, ANTICANCER RES, V29, P3897; Wang JB, 2011, HUM MUTAT, V32, P19, DOI 10.1002/humu.21331; Webb EL, 2006, HUM MOL GENET, V15, P3263, DOI 10.1093/hmg/ddl401; Zhang H, 2007, MED ONCOL, V24, P251, DOI 10.1007/BF02698048; Zhang S, 2013, ONCOGENE, V32, P242, DOI 10.1038/onc.2012.32; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	63	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111694	10.1371/journal.pone.0111694	http://dx.doi.org/10.1371/journal.pone.0111694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372392	Green Submitted, gold, Green Published			2022-12-26	WOS:000344556900064
J	Winardhi, RS; Castang, S; Dove, SL; Yan, J				Winardhi, Ricksen S.; Castang, Sandra; Dove, Simon L.; Yan, Jie			Single-Molecule Study on Histone-Like Nucleoid-Structuring Protein (H-NS) Paralogue in Pseudomonas aeruginosa: MvaU Bears DNA Organization Mode Similarities to MvaT	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; FAMILY-MEMBER MVAT; ORDER OLIGOMERIZATION; GENE; STPA; REGULATOR; EXPRESSION; MECHANISM; FILAMENT; BACTERIA	Pseudomonas aeruginosa contains two distinct members of H-NS family of nucleoid-structuring proteins: MvaT and MvaU. Together, these proteins bind to the same regions of the chromosome and function coordinately in the regulation of hundreds of genes. Due to their structural similarity, they can associate to form heteromeric complexes. These findings left us wondering whether they bear similar DNA binding properties that underlie their gene-silencing functions. Using singlemolecule stretching and imaging experiments, we found striking similarities in the DNA organization modes of MvaU compared to the previously studied MvaT. MvaU can form protective nucleoprotein filaments that are insensitive to environmental factors, consistent with its role as a repressor of gene expression. Similar to MvaT, MvaU filament can mediate DNA bridging while excessive MvaU can cause DNA aggregation. The almost identical DNA organization modes of MvaU and MvaT explain their functional redundancy, and raise an interesting question regarding the evolutionary benefits of having multiple H-NS paralogues in the Pseudomonas genus.	[Winardhi, Ricksen S.] NUS, Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Winardhi, Ricksen S.; Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Winardhi, Ricksen S.; Yan, Jie] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore 117548, Singapore; [Castang, Sandra; Dove, Simon L.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Infect Dis, Boston, MA 02163 USA; [Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Harvard University; Boston Children's Hospital; Harvard Medical School; National University of Singapore	Dove, SL (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Infect Dis, Boston, MA 02163 USA.	simon.dove@childrens.harvard.edu; phyyj@nus.edu.sg	Yan, Jie/G-2725-2012	Yan, Jie/0000-0002-8555-7291	Ministry of Education of Singapore [MOE2008-T2-1-096]; Mechanobiology Institute Singapore; National Institutes of Health [AI069007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069007] Funding Source: NIH RePORTER	Ministry of Education of Singapore(Ministry of Education, Singapore); Mechanobiology Institute Singapore; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants MOE2008-T2-1-096 from the Ministry of Education of Singapore and internal funding from the Mechanobiology Institute Singapore (to JY), and by National Institutes of Health Grant AI069007 (to SLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Atlung T, 1997, MOL MICROBIOL, V24, P7, DOI 10.1046/j.1365-2958.1997.3151679.x; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bertin P, 1999, MOL MICROBIOL, V31, P319, DOI 10.1046/j.1365-2958.1999.01176.x; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Castang S, 2012, J BACTERIOL, V194, P5101, DOI 10.1128/JB.00932-12; Castang S, 2010, MOL MICROBIOL, V78, P916, DOI 10.1111/j.1365-2958.2010.07378.x; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Ceschini S, 2000, J BIOL CHEM, V275, P729, DOI 10.1074/jbc.275.2.729; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dame RT, 2005, J BACTERIOL, V187, P1845, DOI 10.1128/JB.187.5.1845-1848.2005; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Dame RT, 2002, J BIOL CHEM, V277, P2146, DOI 10.1074/jbc.C100603200; Diggle SP, 2002, J BACTERIOL, V184, P2576, DOI 10.1128/JB.184.10.2576-2586.2002; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Free A, 1997, J BACTERIOL, V179, P909, DOI 10.1128/jb.179.3.909-918.1997; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; Li CR, 2009, J BACTERIOL, V191, P6211, DOI 10.1128/JB.00888-09; Lim CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00509; Lim CJ, 2012, NUCLEIC ACIDS RES, V40, P3316, DOI 10.1093/nar/gkr1247; Lin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049885; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; LYUBCHENKO YL, 1993, NUCLEIC ACIDS RES, V21, P1117, DOI 10.1093/nar/21.5.1117; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Qu Y, 2013, NUCLEIC ACIDS RES, V41, P5263, DOI 10.1093/nar/gkt249; Renzi F, 2010, ENVIRON MICROBIOL, V12, P254, DOI 10.1111/j.1462-2920.2009.02064.x; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; Sonden B, 1996, EMBO J, V15, P4970, DOI 10.1002/j.1460-2075.1996.tb00877.x; Tendeng C, 2003, TRENDS MICROBIOL, V11, P511, DOI 10.1016/j.tim.2003.09.005; Tendeng C, 2003, MICROBIOL-SGM, V149, P3047, DOI 10.1099/mic.0.C0125-0; Ueguchi C, 1997, J MOL BIOL, V274, P145, DOI 10.1006/jmbi.1997.1381; Vallet I, 2004, J BACTERIOL, V186, P2880, DOI 10.1128/JB.186.9.2880-2890.2004; Vallet-Gely I, 2005, P NATL ACAD SCI USA, V102, P11082, DOI 10.1073/pnas.0502663102; VanNoort SJT, 1997, ULTRAMICROSCOPY, V69, P117, DOI 10.1016/S0304-3991(97)00037-5; Westfall LW, 2004, MICROBIOL-SGM, V150, P3797, DOI 10.1099/mic.0.27270-0; Winardhi RS, 2014, J BIOL CHEM, V289, P13739, DOI 10.1074/jbc.M113.545954; Winardhi RS, 2012, NUCLEIC ACIDS RES, V40, P8942, DOI 10.1093/nar/gks669; Wolf T, 2006, J BACTERIOL, V188, P6728, DOI 10.1128/JB.00586-06; ZHANG AX, 1992, NUCLEIC ACIDS RES, V20, P6735, DOI 10.1093/nar/20.24.6735; Zhang AX, 1996, EMBO J, V15, P1340, DOI 10.1002/j.1460-2075.1996.tb00476.x	48	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112246	10.1371/journal.pone.0112246	http://dx.doi.org/10.1371/journal.pone.0112246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372370	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900127
J	Ikemori, RY; Machado, CML; Furuzawa, KM; Nonogaki, S; Osinaga, E; Umezawa, K; de Carvalho, MA; Verinaud, L; Chammas, R				Ikemori, Rafael Yamashita; Longo Machado, Camila Maria; Furuzawa, Karina Mie; Nonogaki, Suely; Osinaga, Eduardo; Umezawa, Kazuo; de Carvalho, Marcelo Alex; Verinaud, Liana; Chammas, Roger			Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival	PLOS ONE			English	Article							NF-KAPPA-B; CYTOCHROME-C RELEASE; ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; PROSTATE-CANCER; BINDING-PROTEIN; INDUCIBLE FACTOR-1-ALPHA; PILOCYTIC ASTROCYTOMAS; LGALS3 GALECTIN-3; EPITHELIAL-CELLS	Galectin-3 (gal-3) is a beta-galactoside binding protein related to many tumoral aspects, e. g. angiogenesis, cell growth and motility and resistance to cell death. Evidence has shown its upregulation upon hypoxia, a common feature in solid tumors such as glioblastoma multiformes (GBM). This tumor presents a unique feature described as pseudopalisading cells, which accumulate large amounts of gal-3. Tumor cells far from hypoxic/nutrient deprived areas express little, if any gal-3. Here, we have shown that the hybrid glioma cell line, NG97ht, recapitulates GBM growth forming gal-3 positive pseudopalisades even when cells are grafted subcutaneously in nude mice. In vitro experiments were performed exposing these cells to conditions mimicking tumor areas that display oxygen and nutrient deprivation. Results indicated that gal-3 transcription under hypoxic conditions requires previous protein synthesis and is triggered in a HIF-1 alpha and NF-kappa B dependent manner. In addition, a significant proportion of cells die only when exposed simultaneously to hypoxia and nutrient deprivation and demonstrate ROS induction. Inhibition of gal-3 expression using siRNA led to protein knockdown followed by a 1.7-2.2 fold increase in cell death. Similar results were also found in a human GBM cell line, T98G. In vivo, U87MG gal-3 knockdown cells inoculated subcutaneously in nude mice demonstrated decreased tumor growth and increased time for tumor engraftment. These results indicate that gal-3 protected cells from cell death under hypoxia and nutrient deprivation in vitro and that gal-3 is a key factor in tumor growth and engraftment in hypoxic and nutrient-deprived microenvironments. Overexpression of gal-3, thus, is part of an adaptive program leading to tumor cell survival under these stressing conditions.	[Ikemori, Rafael Yamashita; Longo Machado, Camila Maria; Furuzawa, Karina Mie; Chammas, Roger] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil; [Longo Machado, Camila Maria] Lab Invest Med Med Nucl LIM43, Sao Paulo, Brazil; [Nonogaki, Suely] Adolfo Lutz Inst, Dept Patol, Sao Paulo, Brazil; [Osinaga, Eduardo] La Univ La Republ, Fac Med, Montevideo, Uruguay; [Umezawa, Kazuo] Aichi Med Univ, Nagakute, Aichi 48011, Japan; [de Carvalho, Marcelo Alex] Inst Fed Rio de Janeiro, Inst Nacl Canc, Rio De Janeiro, RJ, Brazil; [Verinaud, Liana] Univ Estadual Campinas, Inst Biol, Dept Microbiol & Immunol, Campinas, SP, Brazil	Universidade de Sao Paulo; Instituto Adolfo Lutz; Universidad de la Republica, Uruguay; Aichi Medical University; Instituto Federal do Rio de Janeiro (IFRJ); National Cancer Institute (Inca); Universidade de Sao Paulo; Universidade Estadual de Campinas	Ikemori, RY (corresponding author), Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil.	rafaelikemori@lim24.fm.usp.br; rchammas@lim24.fm.usp.br	machado, camila/AAH-5488-2019; Carvalho, Marcelo A/J-7144-2012; Carvalho, Marcelo/T-2014-2019; Ikemori, Rafael/F-4075-2016; Chammas, Roger/A-8004-2011; Machado, Camila/C-4077-2012	Carvalho, Marcelo A/0000-0002-7053-0053; Ikemori, Rafael/0000-0002-8825-3947; Chammas, Roger/0000-0003-0342-8726; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes-UDELAR);  [CEPID 98/14247-6];  [FAPESP 2009/10857-0];  [INCT-Redoxoma]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes-UDELAR); ; ; 	Contract grant sponsor: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP www.fapesp.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq www.cnpq.br) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes-UDELAR). Contract grant number: CEPID 98/14247-6, FAPESP 2009/10857-0 and INCT-Redoxoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahani S, 1997, CANCER RES, V57, P5272; Araya R, 1998, FEBS LETT, V439, P168, DOI 10.1016/S0014-5793(98)01363-5; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Brat DJ, 2004, LAB INVEST, V84, P397, DOI 10.1038/labinvest.3700070; Bresalier RS, 1997, CANCER, V80, P776; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Camby I, 2001, BRAIN PATHOL, V11, P12; Carvalho RS, 2014, CANCER BIOL THER, V15, P840, DOI 10.4161/cbt.28873; Celegato M, 2014, CANCER LETT, V349, P26, DOI 10.1016/j.canlet.2014.03.030; Chen HJ, 2012, NEUROSCI LETT, V518, P1, DOI 10.1016/j.neulet.2012.02.065; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; D'Haene N, 2014, GLYCOBIOLOGY, V24, P892, DOI 10.1093/glycob/cwu049; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; de Souza GA, 2006, PROTEOMICS, V6, P1460, DOI 10.1002/pmic.200500243; Debray C, 2004, BIOCHEM BIOPH RES CO, V325, P1393, DOI 10.1016/j.bbrc.2004.10.181; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Dumont P, 2008, LAB INVEST, V88, P896, DOI 10.1038/labinvest.2008.54; Ellerhorst JA, 2002, PROSTATE, V50, P64, DOI 10.1002/pros.10033; Fukumori T, 2006, CANCER RES, V66, P3114, DOI 10.1158/0008-5472.CAN-05-3750; Gordower L, 1999, NEUROPATH APPL NEURO, V25, P319; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Grippo MC, 2001, CELL MOL NEUROBIOL, V21, P421, DOI 10.1023/A:1012662423863; Hill M, 2010, J HISTOCHEM CYTOCHEM, V58, P553, DOI 10.1369/jhc.2010.955237; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Hu R, 2007, PLACENTA, V28, P399, DOI 10.1016/j.placenta.2006.07.005; HUFLEJT ME, 1993, J BIOL CHEM, V268, P26712; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kadrofske MM, 1998, ARCH BIOCHEM BIOPHYS, V349, P7, DOI 10.1006/abbi.1997.0447; Kanaya K, 2003, BIOCHEM BIOPH RES CO, V306, P750, DOI 10.1016/S0006-291X(03)01041-6; Kim DW, 2008, CANCER SCI, V99, P1884, DOI 10.1111/j.1349-7006.2008.00901.x; Kim SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025103; Kobayashi T, 2011, INT J CANCER, V129, P2775, DOI 10.1002/ijc.25946; Kuklinski S, 2000, J NEUROSCI RES, V60, P45, DOI 10.1002/(SICI)1097-4547(20000401)60:1<45::AID-JNR5>3.0.CO;2-Y; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; Le Mercier M, 2010, BRAIN PATHOL, V20, P17, DOI 10.1111/j.1750-3639.2009.00270.x; Li X, 2010, CELL DEATH DIFFER, V17, P1277, DOI 10.1038/cdd.2010.8; Lin HM, 2002, ONCOGENE, V21, P8001, DOI 10.1038/sj.onc.1205820; Machado CML, 2014, CANCER MED-US, V3, P201, DOI 10.1002/cam4.173; Machado CML, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-291; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Matarrese P, 2000, FEBS LETT, V473, P311, DOI 10.1016/S0014-5793(00)01547-7; Mazurek N, 2000, J BIOL CHEM, V275, P36311, DOI 10.1074/jbc.M003831200; Mazurek N, 2005, CANCER RES, V65, P10767, DOI 10.1158/0008-5472.CAN-04-3333; Melvin A, 2011, CELL CYCLE, V10, P879, DOI 10.4161/cc.10.6.14910; Moon BK, 2001, AM J PATHOL, V159, P1055, DOI 10.1016/S0002-9440(10)61780-4; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Neder L, 2004, BRAIN PATHOL, V14, P399; Olbryt M, 2006, GENE EXPRESSION, V13, P191, DOI 10.3727/000000006783991818; Paron I, 2003, BIOCHEM BIOPH RES CO, V302, P545, DOI 10.1016/S0006-291X(03)00151-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccolo E, 2013, J MOL MED, V91, P83, DOI 10.1007/s00109-012-0936-6; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Roskams J, 2002, LAB REF HDB RECIPES; Rovetta F, 2013, TOXICOL APPL PHARM, V271, P196, DOI 10.1016/j.taap.2013.05.005; Silva-Monteiro E, 2007, AM J PATHOL, V170, P546, DOI 10.2353/ajpath.2007.060389; Sondergaard KL, 2002, NEUROPATH APPL NEURO, V28, P210, DOI 10.1046/j.1365-2990.2002.00391.x; Song SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042699; Song YK, 2002, AM J PATHOL, V160, P1069, DOI 10.1016/S0002-9440(10)64927-9; Steinbach JP, 2003, CELL DEATH DIFFER, V10, P823, DOI 10.1038/sj.cdd.4401252; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Stock M, 2003, J BIOL CHEM, V278, P17360, DOI 10.1074/jbc.M207631200; Strik HM, 2001, J NEURO-ONCOL, V53, P13, DOI 10.1023/A:1011874800612; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Umezawa K, 2002, MOL CELLS, V14, P163; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Villa-Verde DMS, 2002, EUR J IMMUNOL, V32, P1434, DOI 10.1002/1521-4141(200205)32:5<1434::AID-IMMU1434>3.0.CO;2-M; Vladimirova V, 2008, J NEUROSCI RES, V86, P2450, DOI 10.1002/jnr.21686; Wagner M, 1997, PATHOBIOLOGY, V65, P241, DOI 10.1159/000164135; Yamazaki K, 2001, BIOCHEM BIOPH RES CO, V280, P1077, DOI 10.1006/bbrc.2000.4193; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620; Zeno S, 2009, BIOCHEMISTRY-US, V48, P4652, DOI 10.1021/bi900064t; Zhang HY, 2009, ENDOCRINE, V35, P101, DOI 10.1007/s12020-008-9129-z; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	82	47	48	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111592	10.1371/journal.pone.0111592	http://dx.doi.org/10.1371/journal.pone.0111592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369297	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000071
J	Bastian, AR; Nangarlia, A; Bailey, LD; Holmes, A; Sundaram, RVK; Ang, C; Moreira, DRM; Freedman, K; Duffy, C; Contarino, M; Abrams, C; Root, M; Chaiken, I				Bastian, Arangassery Rosemary; Nangarlia, Aakansha; Bailey, Lauren D.; Holmes, Andrew; Sundaram, R. Venkat Kalyana; Ang, Charles; Moreira, Diogo R. M.; Freedman, Kevin; Duffy, Caitlin; Contarino, Mark; Abrams, Cameron; Root, Michael; Chaiken, Irwin			Mechanism of Multivalent Nanoparticle Encounter with HIV-1 for Potency Enhancement of Peptide Triazole Virus Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Design; Human Immunodeficiency Virus (HIV); Nanotechnology; Peptides; Virology; Gold Nanoparticles; Microbicide; p24 Release; Virolysis	HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 ENVELOPE GLYCOPROTEIN; ENTRY INHIBITORS; GOLD NANOPARTICLES; ENV GP120; CCR5 ANTAGONISTS; CD4-BOUND STATE; DRUG-DELIVERY; TYPE-1; BINDING	Background: HIV-1 envelope spike protein remains a compelling but elusive target for preventing infection. Results: Gold nanoparticle conjugates of peptide triazole Env inhibitors demonstrated impressive picomolar antiviral potencies. Conclusion: Nanoparticle conjugates enhanced antiviral functions by multivalent attachment to virus Env spikes. Significance: Findings reveal that multispike engagement can exploit the metastability of the virus envelope to irreversibly inactivate HIV-1. Entry of HIV-1 into host cells remains a compelling yet elusive target for developing agents to prevent infection. A peptide triazole (PT) class of entry inhibitor has previously been shown to bind to HIV-1 gp120, suppress interactions of the Env protein at host cell receptor binding sites, inhibit cell infection, and cause envelope spike protein breakdown, including gp120 shedding and, for some variants, virus membrane lysis. We found that gold nanoparticle-conjugated forms of peptide triazoles (AuNP-PT) exhibit substantially more potent antiviral effects against HIV-1 than corresponding peptide triazoles alone. Here, we sought to reveal the mechanism of potency enhancement underlying nanoparticle conjugate function. We found that altering the physical properties of the nanoparticle conjugate, by increasing the AuNP diameter and/or the density of PT conjugated on the AuNP surface, enhanced potency of infection inhibition to impressive picomolar levels. Further, compared with unconjugated PT, AuNP-PT was less susceptible to reduction of antiviral potency when the density of PT-competent Env spikes on the virus was reduced by incorporating a peptide-resistant mutant gp120. We conclude that potency enhancement of virolytic activity and corresponding irreversible HIV-1 inactivation of PTs upon AuNP conjugation derives from multivalent contact between the nanoconjugates and metastable Env spikes on the HIV-1 virus. The findings reveal that multispike engagement can exploit the metastability built into virus the envelope to irreversibly inactivate HIV-1 and provide a conceptual platform to design nanoparticle-based antiviral agents for HIV-1 specifically and putatively for metastable enveloped viruses generally.	[Bastian, Arangassery Rosemary; Nangarlia, Aakansha; Bailey, Lauren D.; Holmes, Andrew; Sundaram, R. Venkat Kalyana; Ang, Charles; Duffy, Caitlin; Contarino, Mark; Chaiken, Irwin] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Bastian, Arangassery Rosemary; Nangarlia, Aakansha; Sundaram, R. Venkat Kalyana; Ang, Charles] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Moreira, Diogo R. M.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil; [Freedman, Kevin; Abrams, Cameron] Drexel Univ, Dept Chem & Biol Engn, Philadelphia, PA 19104 USA; [Root, Michael] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Drexel University; Drexel University; Fundacao Oswaldo Cruz; Drexel University; Jefferson University	Chaiken, I (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,Mail Stop 497, Philadelphia, PA 19102 USA.	Irwin.chaiken@drexelmed.edu	Moreira, Diogo Rodrigo M./S-9071-2019; Kalyana Sundaram, Ramalingam Venkat/T-7840-2018	Moreira, Diogo Rodrigo M./0000-0003-3323-4404; Kalyana Sundaram, Ramalingam Venkat/0000-0002-0232-4186; Holmes, Andrew/0000-0001-5012-4026; Ang, Charles/0000-0002-2368-552X; Nangarlia, Aakansha/0000-0003-2796-9092; Freedman, Kevin/0000-0001-8801-4578	National Institutes of Health [RO1GM11029]; W. W. Smith Foundation Award; National Science Foundation [CBET 0853680]; Schlumberger Foundation Faculty of the Future Award; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111029, P01GM056550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Foundation Award; National Science Foundation(National Science Foundation (NSF)); Schlumberger Foundation Faculty of the Future Award(Schlumberger); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM11029. This work was also supported by a W. W. Smith Foundation Award, National Science Foundation Grant CBET 0853680, and a Schlumberger Foundation Faculty of the Future Award (to A. R. B.).	Bastian AR, 2011, CHEMMEDCHEM, V6, P1335, DOI 10.1002/cmdc.201100177; Bastian AR, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-153; Bennett A, 2007, J BIOL CHEM, V282, P27754, DOI 10.1074/jbc.M702025200; Biorn AC, 2004, BIOCHEMISTRY-US, V43, P1928, DOI 10.1021/bi035088i; Bowman MC, 2008, J AM CHEM SOC, V130, P6896, DOI 10.1021/ja710321g; Champagne K, 2009, J BIOL CHEM, V284, P3619, DOI 10.1074/jbc.M809269200; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; Cocklin S, 2007, J VIROL, V81, P3645, DOI 10.1128/JVI.01778-06; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Contarino M, 2013, ANTIMICROB AGENTS CH, V57, P4743, DOI 10.1128/AAC.00309-13; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; Doyle T, 2012, CURR OPIN INFECT DIS, V25, P17, DOI 10.1097/QCO.0b013e32834ef5d9; Emileh A, 2013, BIOCHEMISTRY-US, V52, P2245, DOI 10.1021/bi400166b; Emmelkamp JM, 2007, EUR J MED RES, V12, P409; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Ferrer M, 1999, J VIROL, V73, P5795, DOI 10.1128/JVI.73.7.5795-5802.1999; Flint S. J., 2008, PRINCIPLES VIROLOGY, P83; Flores A, 2013, CURR MED CHEM, V20, P751; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Gopi H, 2009, J MOL RECOGNIT, V22, P169, DOI 10.1002/jmr.892; Gopi HN, 2006, CHEMMEDCHEM, V1, P54, DOI 10.1002/cmdc.200500037; Granich R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-1; Haiss W, 2007, ANAL CHEM, V79, P4215, DOI 10.1021/ac0702084; Hamidi M, 2013, CRIT REV THER DRUG, V30, P435, DOI 10.1615/CritRevTherDrugCarrierSyst.2013007419; Haqqani AA, 2013, ANTIVIR RES, V98, P158, DOI 10.1016/j.antiviral.2013.03.017; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Heidel JD, 2011, PHARM RES-DORDR, V28, P187, DOI 10.1007/s11095-010-0178-7; Henrich TJ, 2013, CURR OPIN VIROL, V3, P51, DOI 10.1016/j.coviro.2012.12.002; Hermann FG, 2009, J VIROL, V83, P4844, DOI 10.1128/JVI.00666-08; Hughes A, 2008, J INFECTION, V57, P1, DOI 10.1016/j.jinf.2008.05.006; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Joint United Nations Programme on HIV/AIDS, 2013, GLOB REP UNAIDS REP, P198; Kim T, 2005, LANGMUIR, V21, P9524, DOI 10.1021/la0504560; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Madani N, 2008, STRUCTURE, V16, P1689, DOI 10.1016/j.str.2008.09.005; Madani N, 2014, J VIROL, V88, P6542, DOI 10.1128/JVI.00540-14; Mahmoud KA, 2008, ANAL CHEM, V80, P7056, DOI 10.1021/ac801174r; Mamo T, 2010, NANOMEDICINE-UK, V5, P269, DOI [10.2217/nnm.10.1, 10.2217/NNM.10.1]; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; McFadden K, 2012, ANTIMICROB AGENTS CH, V56, P1073, DOI 10.1128/AAC.05555-11; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nakamura M, 2000, HYBRIDOMA, V19, P427, DOI 10.1089/027245700750053913; Nettles RE, 2012, J INFECT DIS, V206, P1002, DOI 10.1093/infdis/jis432; Nichols WG, 2008, ANTIMICROB AGENTS CH, V52, P858, DOI 10.1128/AAC.00821-07; Nichols WK, 2003, TOXICOL SCI, V71, P229, DOI 10.1093/toxsci/71.2.229; Palmisano L, 2011, ANN I SUPER SANITA, V47, P44, DOI 10.4415/ANN_11_01_10; Pan CG, 2010, J FORMOS MED ASSOC, V109, P94, DOI 10.1016/S0929-6646(10)60029-0; Park EJ, 1998, J VIROL, V72, P7099, DOI 10.1128/JVI.72.9.7099-7107.1998; Perry CM, 2010, DRUGS, V70, P1189, DOI 10.2165/11203940-000000000-00000; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Qiu S, 2012, CURR HIV RES, V10, P182, DOI 10.2174/157016212799937191; SUMMERS MF, 1992, PROTEIN SCI, V1, P563, DOI 10.1002/pro.5560010502; Tuzer F, 2013, PROTEINS, V81, P271, DOI 10.1002/prot.24184; Umashankara M, 2010, CHEMMEDCHEM, V5, P1871, DOI 10.1002/cmdc.201000222; Vogt VM, 1999, J VIROL, V73, P7050, DOI 10.1128/JVI.73.8.7050-7055.1999; Wallace BJ, 2011, AUSTRALAS J DERMATOL, V52, P19, DOI 10.1111/j.1440-0960.2010.00717.x; Wallin M, 2005, J VIROL, V79, P1678, DOI 10.1128/JVI.79.3.1678-1685.2005; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Xie H, 2003, ANAL CHEM, V75, P5797, DOI 10.1021/ac034578d; Xu YY, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-123; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhao Q, 2005, VIROLOGY, V339, P213, DOI 10.1016/j.virol.2005.06.008	74	29	30	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					529	543		10.1074/jbc.M114.608315	http://dx.doi.org/10.1074/jbc.M114.608315			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25371202	Green Published, hybrid			2022-12-26	WOS:000347231200046
J	Zomot, E; Gur, M; Bahar, I				Zomot, Elia; Gur, Mert; Bahar, Ivet			Microseconds Simulations Reveal a New Sodium-binding Site and the Mechanism of Sodium-coupled Substrate Uptake by LeuT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Membrane Transport; Neurotransmitter Transport; Sodium Transport; Transport; LeuT; NSS; Mechanism of Binding; Sodium-coupled	DEPENDENT NEUROTRANSMITTER TRANSPORTERS; PROTEIN FORCE-FIELD; MOLECULAR-DYNAMICS; BACTERIAL HOMOLOG; DOPAMINE TRANSPORTER; CRYSTAL-STRUCTURE; ACID TRANSPORTER; PLASMA-MEMBRANE; OUTWARD-OPEN; SYMPORTER	Background: LeuT is a homologue of neurotransmitter transporters. Results: Microseconds simulations disclose multiple translocation sites for Na+, including a new site for initial binding. Conclusion: Coupled Na+- and substrate-binding events are accompanied by local and global (interhelical) rearrangements in the outward facing structure. Significance: New insights are gained into Na+ and substrate uptake/efflux mechanisms of LeuT. The bacterial sodium-coupled leucine/alanine transporter LeuT is broadly used as a model system for studying the transport mechanism of neurotransmitters because of its structural and functional homology to mammalian transporters such as serotonin, dopamine, or norepinephrine transporters, and because of the resolution of its structure in different states. Although the binding sites (S1 for substrate, and Na1 and Na2 for two co-transported sodium ions) have been resolved, we still lack a mechanistic understanding of coupled Na+- and substrate-binding events. We present here results from extensive (>20 s) unbiased molecular dynamics simulations generated using the latest computing technology. Simulations show that sodium binds initially the Na1 site, but not Na2, and, consistently, sodium unbinding/escape to the extracellular (EC) region first takes place at Na2, succeeded by Na1. Na2 diffusion back to the EC medium requires prior dissociation of substrate from S1. Significantly, Na+ binding (and unbinding) consistently involves a transient binding to a newly discovered site, Na1, near S1, as an intermediate state. A robust sequence of substrate uptake events coupled to sodium bindings and translocations between those sites assisted by hydration emerges from the simulations: (i) bindings of a first Na+ to Na1, translocation to Na1, a second Na+ to vacated Na1 and then to Na2, and substrate to S1; (ii) rotation of Phe(253) aromatic group to seclude the substrate from the EC region; and (iii) concerted tilting of TM1b and TM6a toward TM3 and TM8 to close the EC vestibule.	[Zomot, Elia; Gur, Mert; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zomot, E (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, 3064 BST3,3501 Fifth Ave, Pittsburgh, PA 15213 USA.	elia.zumot@gmail.com; bahar@pitt.edu	Gur, Mert/O-5304-2015; Bahar, Ivet/AAH-2921-2020	Gur, Mert/0000-0003-0983-4397; 	National Institutes of Health [P41GM103712, 5R01 GM086238, 1P30 DA035778 01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086238, P41GM103712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA035778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants P41GM103712, 5R01 GM086238, and 1P30 DA035778 01.	Amara S G, 1991, Curr Opin Neurobiol, V1, P84, DOI 10.1016/0959-4388(91)90014-X; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; CLARK JA, 1994, MOL PHARMACOL, V46, P550; Clausen RP, 2006, ADV PHARMACOL, V54, P265, DOI 10.1016/S1054-3589(06)54011-6; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; FULLER RW, 1991, MED RES REV, V11, P17, DOI 10.1002/med.2610110103; Gur M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816375; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Henin J, 2008, J PHYS CHEM B, V112, P7008, DOI 10.1021/jp800687p; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lester HA, 1996, NEURON, V17, P807, DOI 10.1016/S0896-6273(00)80213-5; Norgaard-Nielsen K, 2002, FEBS LETT, V524, P87, DOI 10.1016/S0014-5793(02)03008-9; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; RADIAN R, 1983, BIOCHEMISTRY-US, V22, P1236, DOI 10.1021/bi00274a038; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shaw DE, 2007, CONF PROC INT SYMP C, P1, DOI 10.1145/1273440.1250664; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Wang H, 2012, EMBO REP, V13, P861, DOI 10.1038/embor.2012.110; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Wei H, 2009, NEUROPHARMACOLOGY, V56, P399, DOI 10.1016/j.neuropharm.2008.09.008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	50	37	37	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					544	555		10.1074/jbc.M114.617555	http://dx.doi.org/10.1074/jbc.M114.617555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25381247	Green Published, hybrid			2022-12-26	WOS:000347231200047
J	Tian, Y; Pan, Q; Shang, YY; Zhu, R; Ye, J; Liu, Y; Zhong, XL; Li, SS; He, YH; Chen, L; Zhao, JJ; Chen, WS; Peng, ZH; Wang, RQ				Tian, Yin; Pan, Qiong; Shang, Yangyang; Zhu, Rong; Ye, Jun; Liu, Yun; Zhong, Xiaoli; Li, Shanshan; He, Yonghong; Chen, Lei; Zhao, Jingjing; Chen, Wensheng; Peng, Zhihong; Wang, Rongquan			MicroRNA-200 (miR-200) Cluster Regulation by Achaete Scute-like 2 (Ascl2) IMPACT ON THE EPITHELIAL-MESENCHYMAL TRANSITION IN COLON CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; EXPRESSION; ZEB1; ESTABLISHMENT; MIGRATION; NETWORK	Ascl2, a basic helix-loop-helix transcription factor, is a downstream target of WNT signaling that controls the fate of intestinal cryptic stem cells and colon cancer progenitor cells. However, its involvement in colon cancer and downstream molecular events is largely undefined; in particular, the mechanism by which Ascl2 regulates the plasticity of epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) programs in colon cancer cells remains unknown. In this study, we systematically demonstrate that Ascl2 loss of function in colon cancer cells promotes MET by derepressing the expression of microRNA (miR)-200s (i.e. miR-200b, miR-200a, miR-429, miR-200c, and miR-141) and further activating their expression through a transcriptional mechanism that involves direct binding to the most proximal E-box (E-box2) in the miR-200b-a-429 promoter. Activation of miR-200s due to Ascl2 deficiency led to the inhibition of ZEB1/2 expression and the alteration of epithelial and mesenchymal features. Transfection of miR-200b, miR-200a, and miR-429 inhibitors into Ascl2-deficient colon cancer cells promoted the epithelial-mesenchymal transition in a reversible manner. Transfection of miR-200a or miR-429 inhibitors into Ascl2-deficient colon cancer cells increased cellular proliferation and migration. Ascl2 mRNA levels and the miR-200a, miR-200b, miR-200c, miR-141, or miR-429 levels in the colon cancerous samples were inversely correlated. These results provide the first evidence of a link between Ascl2 and miR-200s in the regulation of EMT-MET plasticity in colon cancer.	[He, Yonghong; Chen, Lei; Zhao, Jingjing; Chen, Wensheng; Peng, Zhihong; Wang, Rongquan] Third Mil Med Univ, Southwest Hosp, Inst Gastroenterol Peoples Liberat Army, Chongqing 400038, Peoples R China; [Zhu, Rong] Zunyi Med Univ, Dept Gastroenterol, Zunyi 563000, Guizhou, Peoples R China	Army Medical University; Zunyi Medical University	Peng, ZH (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing 400038, Peoples R China.	pengzhh@yahoo.com.cn; rongquanw@hotmail.com	Pan, Qiong/ENK-9675-2022	Pan, Qiong/0000-0003-1033-3098; ye, jun/0000-0002-0631-556X; Wang, Rongquan/0000-0001-5307-0086; shang, yangyang/0000-0003-0764-0572	National Natural Science Foundation of China [81201685, 81200268, 81170340, 81372557]; Program for Changjiang Scholars and Innovative Research Team at the Third Military Medical University [IRT 13050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team at the Third Military Medical University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by National Natural Science Foundation of China Grants 81201685 (to R. Z.), 81200268 (to J. Z.), and 81170340 and 81372557 (to R. W.) and the Program for Changjiang Scholars and Innovative Research Team at the Third Military Medical University (Grant IRT 13050).	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Edvardsson K, 2013, CARCINOGENESIS, V34, P1431, DOI 10.1093/carcin/bgt067; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Grassian AR, 2012, J BIOL CHEM, V287, P42180, DOI 10.1074/jbc.M112.417832; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Hill L, 2013, INT J CANCER, V132, P745, DOI 10.1002/ijc.27708; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Jubb AM, 2011, GUT, V60, P1606, DOI 10.1136/gut.2010.231746; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pan Q, 2013, J BIOL CHEM, V288, P5407, DOI 10.1074/jbc.M112.408245; Reed KR, 2012, GUT, V61, P1435, DOI 10.1136/gutjnl-2011-300842; Roy SS, 2014, ONCOGENE, V33, P3707, DOI 10.1038/onc.2013.332; Stange DE, 2010, GUT, V59, P1236, DOI 10.1136/gut.2009.195701; Sureban SM, 2011, CANCER RES, V71, P2328, DOI 10.1158/0008-5472.CAN-10-2738; Teng Y, 2014, ONCOGENE, V33, P203, DOI 10.1038/onc.2012.565; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Zhu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032170; Ziskin JL, 2013, GUT, V62, P1012, DOI 10.1136/gutjnl-2011-301195	33	73	77	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36101	36115		10.1074/jbc.M114.598383	http://dx.doi.org/10.1074/jbc.M114.598383			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25371200	Green Published, hybrid			2022-12-26	WOS:000346897900037
J	Agollah, GD; Gonzalez-Garay, ML; Rasmussen, JC; Tan, IC; Aldrich, MB; Darne, C; Fife, CE; Guilliod, R; Maus, EA; King, PD; Sevick-Muraca, EM				Agollah, Germaine D.; Gonzalez-Garay, Manuel L.; Rasmussen, John C.; Tan, I-Chih; Aldrich, Melissa B.; Darne, Chinmay; Fife, Caroline E.; Guilliod, Renie; Maus, Erik A.; King, Philip D.; Sevick-Muraca, Eva M.			Evidence for SH2 Domain-Containing 5 '-Inositol Phosphatase-2 (SHIP2) Contributing to a Lymphatic Dysfunction	PLOS ONE			English	Article							5'-PHOSPHATASE-2 GENE POLYMORPHISMS; NEAR-INFRARED FLUORESCENCE; SECONDARY LYMPHEDEMA; TRANSCRIPTION FACTOR; FACTOR-RECEPTOR; BREAST-CANCER; B-CELLS; MUTATIONS; GROWTH; LYMPHANGIOGENESIS	The lymphatic vasculature plays a critical role in a number of disease conditions of increasing prevalence, such as autoimmune disorders, obesity, blood vascular diseases, and cancer metastases. Yet, unlike the blood vasculature, the tools available to interrogate the molecular basis of lymphatic dysfunction/disease have been lacking. More recently, investigators have reported that dysregulation of the PI3K pathway is involved in syndromic human diseases that involve abnormal lymphatic vasculatures, but there have been few compelling results that show the direct association of this molecular pathway with lymphatic dysfunction in humans. Using near-infrared fluorescence lymphatic imaging (NIRFLI) to phenotype and next generation sequencing (NGS) for unbiased genetic discovery in a family with non-syndromic lymphatic disease, we discovered a rare, novel mutation in INPPL1 that encodes the protein SHIP2, which is a negative regulator of the PI3K pathway, to be associated with lymphatic dysfunction in the family. In vitro interrogation shows that SHIP2 is directly associated with impairment of normal lymphatic endothelial cell (LEC) behavior and that SHIP2 associates with receptors that are associated in lymphedema, implicating its direct involvement in the lymphatic vasculature.	[Agollah, Germaine D.; Rasmussen, John C.; Tan, I-Chih; Aldrich, Melissa B.; Darne, Chinmay; Sevick-Muraca, Eva M.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Ctr Mol Imaging, Houston, TX 77030 USA; [Agollah, Germaine D.] Univ Texas MD Anderson Canc Ctr, Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Gonzalez-Garay, Manuel L.] Brown Fdn Inst Mol Med, Ctr Mol Imaging, Div Genom & Bioinformat, Houston, TX USA; [Fife, Caroline E.; Guilliod, Renie; Maus, Erik A.] Mem Hermann Hosp Ctr Lymphedema Management, Houston, TX USA; [King, Philip D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan	Sevick-Muraca, EM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Ctr Mol Imaging, Houston, TX 77030 USA.	Eva.Sevick@uth.tmc.edu	Sevick-Muraca, Eva M/A-4152-2017	Sevick-Muraca, Eva M/0000-0002-8152-4847; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Rasmussen, John/0000-0002-0557-6899	National Institutes of Health (NIH) [R01 HL092923, R01 CA128919, U54 CA136404]; Texas Star Award (EMS-M) [R01 HL096498]; Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110776]; NATIONAL CANCER INSTITUTE [U54CA136404, R01CA128919] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092923, R01HL096498] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Star Award (EMS-M); Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in parts by the National Institutes of Health (NIH) grants R01 HL092923, R01 CA128919, U54 CA136404 and The Texas Star Award (EMS-M) and R01 HL096498 (PDK). GDA acknowledges support from The Schissler Foundation Fellowship for Translational Studies of Common Human Diseases. Flow cytometry measurements were supported in part through a Cancer Prevention and Research Institute of Texas (CPRIT) instrumentation grant (RP110776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alders M, 2013, MOL SYNDROMOL, V4, P107, DOI [10.1159/000342486, 10.1159/000354097]; Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Below JE, 2013, AM J HUM GENET, V92, P137, DOI 10.1016/j.ajhg.2012.11.011; Brouillard P, 2014, J CLIN INVEST, V124, P898, DOI 10.1172/JCI71614; Burrows PE, 2013, P NATL ACAD SCI USA, V110, P8621, DOI 10.1073/pnas.1222722110; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Cormier JN, 2010, CANCER-AM CANCER SOC, V116, P5138, DOI 10.1002/cncr.25458; Coso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039558; Deneubourg L, 2010, ADV ENZYME REGUL, V50, P262, DOI 10.1016/j.advenzreg.2009.10.009; Deng Y, 2013, J CLIN INVEST, V123, P1202, DOI 10.1172/JCI63034; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Ferrell RE, 2010, AM J HUM GENET, V86, P943, DOI 10.1016/j.ajhg.2010.04.010; Finegold DN, 2012, CLIN CANCER RES, V18, P2382, DOI 10.1158/1078-0432.CCR-11-2303; Finegold David N., 2008, Lymphatic Research and Biology, V6, P65, DOI 10.1089/lrb.2008.1524; Giuriato S, 2003, BIOCHEM J, V376, P199, DOI 10.1042/BJ20030581; Gordon K, 2013, CIRC RES, V112, P956, DOI 10.1161/CIRCRESAHA.113.300350; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hoey SEH, 2008, CLIN EXP DERMATOL, V33, P234, DOI 10.1111/j.1365-2230.2007.02601.x; Huber C, 2013, AM J HUM GENET, V92, P144, DOI 10.1016/j.ajhg.2012.11.015; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; Ishida S, 2006, PANCREAS, V33, P63, DOI 10.1097/01.mpa.0000222317.82231.16; Kagawa S, 2005, J CLIN ENDOCR METAB, V90, P2911, DOI 10.1210/jc.2004-1724; Kaisaki PJ, 2004, DIABETES, V53, P1900, DOI 10.2337/diabetes.53.7.1900; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Koch A, 2005, ONCOGENE, V24, P3436, DOI 10.1038/sj.onc.1208558; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Lapinski PE, 2012, J CLIN INVEST, V122, P733, DOI 10.1172/JCI46116; Lin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052021; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038182; Mihara M, 2012, ANN VASC SURG, V26, DOI 10.1016/j.avsg.2011.08.007; Moro L, 2007, INT J ONCOL, V30, P217, DOI 10.3892/ijo.30.1.217; Mortimer PS, 2014, J CLIN INVEST, V124, P915, DOI 10.1172/JCI71608; Mouta-Bellum C, 2009, DEV DYNAM, V238, P2670, DOI 10.1002/dvdy.22078; Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Prasad NK, 2008, CARCINOGENESIS, V29, P25, DOI 10.1093/carcin/bgm213; Prasad NK, 2005, J BIOL CHEM, V280, P13129, DOI 10.1074/jbc.M410289200; Rasmussen JC, 2010, TRANSL ONCOL, V3, P362, DOI 10.1593/tlo.10190; Rasmussen JC, 2009, CURR OPIN BIOTECH, V20, P74, DOI 10.1016/j.copbio.2009.01.009; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Saito Y, 2006, CIRCULATION, V114, P1177, DOI 10.1161/CIRCULATIONAHA.105.602953; Sevick-Muraca EM, 2013, TRENDS CARDIOVASC ME; Sevick-Muraca EM, 2014, J CLIN INVEST, V124, P905, DOI 10.1172/JCI71612; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Suwa A, 2010, EXPERT OPIN THER TAR, V14, P727, DOI 10.1517/14728222.2010.492780; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tridandapani S, 1997, IMMUNOL TODAY, V18, P424, DOI 10.1016/S0167-5699(97)01112-2; Zhou F, 2010, AM J PATHOL, V177, P2124, DOI 10.2353/ajpath.2010.091301; Zhou XP, 2000, HUM MOL GENET, V9, P765, DOI 10.1093/hmg/9.5.765	59	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112548	10.1371/journal.pone.0112548	http://dx.doi.org/10.1371/journal.pone.0112548			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383712	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700080
J	Fernandes, KA; Kittelmann, S; Rogers, CW; Gee, EK; Bolwell, CF; Bermingham, EN; Thomas, DG				Fernandes, Karlette A.; Kittelmann, Sandra; Rogers, Christopher W.; Gee, Erica K.; Bolwell, Charlotte F.; Bermingham, Emma N.; Thomas, David G.			Faecal Microbiota of Forage-Fed Horses in New Zealand and the Population Dynamics of Microbial Communities following Dietary Change	PLOS ONE			English	Article							HAY-GRAIN RATIOS; CILIATE COMPOSITION; GASTROINTESTINAL-TRACT; EQUUS-CABALLUS; PASSAGE RATE; DIVERSITY; DISORDERS; DIGESTIBILITY; DIGESTION; LINNAEUS	The effects of abrupt dietary transition on the faecal microbiota of forage-fed horses over a 3-week period were investigated. Yearling Thoroughbred fillies reared as a cohort were exclusively fed on either an ensiled conserved forage-grain diet ("Group A''; n = 6) or pasture ("Group B''; n = 6) for three weeks prior to the study. After the Day 0 faecal samples were collected, horses of Group A were abruptly transitioned to pasture. Both groups continued to graze similar pasture for three weeks, with faecal samples collected at 4-day intervals. DNA was isolated from the faeces and microbial 16S and 18S rRNA gene amplicons were generated and analysed by pyrosequencing. The faecal bacterial communities of both groups of horses were highly diverse (Simpson's index of diversity >0.8), with differences between the two groups on Day 0 (P<0.017 adjusted for multiple comparisons). There were differences between Groups A and B in the relative abundances of four genera, BF311 (family Bacteroidaceae; P = 0.003), CF231 (family Paraprevotellaceae; P = 0.004), and currently unclassified members within the order Clostridiales (P = 0.003) and within the family Lachnospiraceae (P = 0.006). The bacterial community of Group A horses became similar to Group B within four days of feeding on pasture, whereas the structure of the archaeal community remained constant pre- and post-dietary change. The community structure of the faecal microbiota (bacteria, archaea and ciliate protozoa) of pasture-fed horses was also identified. The initial differences observed appeared to be linked to recent dietary history, with the bacterial community of the forage-fed horses responding rapidly to abrupt dietary change.	[Fernandes, Karlette A.; Rogers, Christopher W.; Gee, Erica K.; Bolwell, Charlotte F.; Thomas, David G.] Massey Univ, Coll Sci, Inst Vet Anim & Biomed Sci, Palmerston North 4442, New Zealand; [Kittelmann, Sandra; Bermingham, Emma N.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North 4442, New Zealand	Massey University; AgResearch - New Zealand	Fernandes, KA (corresponding author), Massey Univ, Coll Sci, Inst Vet Anim & Biomed Sci, Palmerston North 4442, New Zealand.	k.a.fernandes@massey.ac.nz	Rogers, Chris W./D-9812-2012; Bolwell, Charlotte/AGZ-4348-2022; Gee, Erica/Y-1999-2018	Rogers, Chris W./0000-0002-4253-1825; Bolwell, Charlotte/0000-0001-9995-8232; Kittelmann, Sandra/0000-0002-6019-9854; Bermingham, Emma/0000-0003-0952-5260; Gee, Erica/0000-0001-5218-6589	Massey University; AgResearch CORE [A17976]; Ministry of Business Innovation and Employment: Science and Innovation Group	Massey University; AgResearch CORE; Ministry of Business Innovation and Employment: Science and Innovation Group	This study was funded by the Massey University Internal Research Funding (DGT) and AgResearch CORE (A17976) funds (ENB). An educational fellowship from the Ministry of Business Innovation and Employment: Science and Innovation Group (www.msi.govt.nz) and a Massey University Doctoral Scholarship (www.massey.ac.nz) provided financial assistance for the duration of the doctoral study (KAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jassim RAM, 2009, VET CLIN N AM-EQUINE, V25, P199, DOI 10.1016/j.cveq.2009.04.005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Biddle AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077599; Bishop L, 2013, THESIS MASSEY U PALM; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Costa Marcio C., 2012, Animal Health Research Reviews, V13, P121, DOI 10.1017/S1466252312000035; CYMBALUK NF, 1990, CAN J ANIM SCI, V70, P601, DOI 10.4141/cjas90-072; de Fombelle A, 2001, J EQUINE VET SCI, V21, P439, DOI 10.1016/S0737-0806(01)70018-4; Dougal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077660; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Drogoul C, 2001, J EQUINE VET SCI, V21, P487, DOI 10.1016/S0737-0806(01)70211-0; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elliott J, 2006, J NUTR, V136, p2103S, DOI 10.1093/jn/136.7.2103S; ESTY WW, 1986, ANN STAT, V14, P1257, DOI 10.1214/aos/1176350066; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; GLINSKY MJ, 1976, J ANIM SCI, V42, P1465, DOI 10.2527/jas1976.4261465x; Gocmen B, 2012, TURK J ZOOL, V36, P163, DOI 10.3906/zoo-1003-141; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gurelli G, 2012, EUR J PROTISTOL, V48, P215, DOI 10.1016/j.ejop.2012.01.002; Gurelli G, 2011, EUR J PROTISTOL, V47, P245, DOI 10.1016/j.ejop.2011.04.005; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hastie PM, 2008, BRIT J NUTR, V100, P561, DOI 10.1017/S0007114508968227; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Hirst R.L., 2011, THESIS MASSEY U PALM; Hoskin SO, 2004, NEW ZEAL VET J, V52, P332, DOI 10.1080/00480169.2004.36449; JANIS C, 1976, EVOLUTION, V30, P757, DOI 10.1111/j.1558-5646.1976.tb00957.x; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Julliand V, 2006, LIVEST SCI, V100, P44, DOI 10.1016/j.livprodsci.2005.11.001; Julliand V, 2001, J EQUINE VET SCI, V21, P543, DOI 10.1016/S0737-0806(01)70159-1; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Litherland AJ, 2002, NZ SOC ANIMAL PRODUC; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Milinovich GJ, 2006, ENVIRON MICROBIOL, V8, P885, DOI 10.1111/j.1462-2920.2005.00975.x; MOORE BE, 1993, J ANIM SCI, V71, P3350, DOI 10.2527/1993.71123350x; Muller CE, 2008, LIVEST SCI, V119, P116, DOI 10.1016/j.livsci.2008.03.007; Murray J, 2010, ADV ANIMAL BIOSCIENC, V1, P365; O' Donnell MM, 2013, LETT APPL MICROBIOL, V57, P492, DOI 10.1111/lam.12137; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rogers CW, 2007, NEW ZEAL VET J, V55, P302, DOI 10.1080/00480169.2007.36785; Rogers CW, 2004, NZ SOC ANIMAL PRODUC; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; St-Pierre B, 2013, ANIMAL, V7, P49, DOI 10.1017/S1751731112000912; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-231; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van den Berg M, 2013, J EQUINE VET SCI, V33, P215, DOI 10.1016/j.jevs.2012.06.004; Van Weyenberg S, 2006, LIVEST SCI, V99, P3, DOI 10.1016/j.livprodsci.2005.04.008; Vermorel M, 1997, LIVEST PROD SCI, V47, P261, DOI 10.1016/S0301-6226(96)01410-8; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806; Yamano H, 2008, ANIM SCI J, V79, P234, DOI 10.1111/j.1740-0929.2008.00522.x	58	87	90	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112846	10.1371/journal.pone.0112846	http://dx.doi.org/10.1371/journal.pone.0112846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383707	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700098
J	Liu, Y; Wen, J; Chen, J; Xu, CY; Hu, YL; Zhou, YH				Liu, Yong; Wen, Jian; Chen, Jie; Xu, Chenyu; Hu, Yali; Zhou, Yi-Hua			Rare Detection of Occult Hepatitis B Virus Infection in Children of Mothers with Positive Hepatitis B Surface Antigen	PLOS ONE			English	Article							RETRACTED ARTICLE. SEE; HBV INFECTION; VACCINATION; PREVALENCE; ADULTS; KOREA; DNA; PCR	The prevalence of occult Hepatitis B virus (HBV) infection in children was considerably varied from 0.1-64% in different reports. In this study we aimed to investigate the prevalence of occult HBV infection among the children born to mothers with positive hepatitis B surface antigen (HBsAg) in Jiangsu, China. Serum samples were collected from 210 children of 207 mothers with positive HBsAg. HBV serological markers were detected by ELISA and HBV DNA was detected by nested PCR. Homology comparison of HBV sequences recovered from the child and mother was used to define the infection. Three children (1.43%) were positive for HBsAg, in whom the HBV pre S and S gene sequence in each child was identical to that in her mother. Of the 207 HBsAg-negative children, nine displayed HBV DNA positive by two nested PCR assays using primers derived from S and C genes. However, the sequence alignment showed that the sequences in each child were considerably different from those in his/her mother. Therefore, the sequences amplified from the children were very likely resultant from the cross-contaminations. Furthermore, the nine children with 'positive HBV DNA' were all negative for anti-HBc, and one had anti-HBs 3.42 mIU/ml and eight others had anti-HBs from 72 to >1000 mIU/ml, indicating that the nine children were less likely infected with HBV. Therefore, none of the 207 HBsAg-negative children of HBV-infected mothers was found to have occult HBV infection. We conclude that the prevalence of occult HBV infection in vaccinated children born to HBsAg positive mothers should be extremely low. We recommend that homology comparison of sequences recovered from the child and mother be used to define the occult HBV infection in children born to HBV infected mothers.	[Liu, Yong; Zhou, Yi-Hua] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Lab Med, Nanjing 210008, Jiangsu, Peoples R China; [Wen, Jian; Xu, Chenyu] Zhenjiang Fourth Peoples Hosp, Dept Obstet & Gynecol, Zhenjiang, Jiangsu, Peoples R China; [Chen, Jie; Hu, Yali] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Obstet & Gynecol, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yi-Hua] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Yong; Hu, Yali; Zhou, Yi-Hua] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Zhou, YH (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Lab Med, Nanjing 210008, Jiangsu, Peoples R China.	yzh20061111@yahoo.com			Nanjing Medical Science and Technique Development Foundation [QRX11024]; Key Laboratory from Department of Health, Jiangsu Province, China [XK201102]	Nanjing Medical Science and Technique Development Foundation; Key Laboratory from Department of Health, Jiangsu Province, China	This study was supported by Nanjing Medical Science and Technique Development Foundation (QRX11024) and by a Research Grant (XK201102) for the Key Laboratory from the Department of Health, Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 1998, HEPATOLOGY, V27, P621, DOI 10.1002/hep.510270242; Chakvetadze C, 2011, VACCINE, V29, P2846, DOI 10.1016/j.vaccine.2011.01.101; Chen SJ, 2012, VIRUS RES, V163, P197, DOI 10.1016/j.virusres.2011.09.029; Duckmanton L, 1999, VIRUS RES, V64, P137, DOI 10.1016/S0168-1702(99)00088-X; Duckmanton L, 2001, VIRUS RES, V81, P167, DOI 10.1016/S0168-1702(01)00372-0; Elrashidy H, 2014, HUM VACCIN IMMUNOTHE, P10; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; He JK, 2006, J CLIN MICROBIOL, V44, P1208, DOI 10.1128/JCM.44.3.1208.2006; He JK, 2002, J CLIN MICROBIOL, V40, P4493, DOI 10.1128/JCM.40.12.4493-4498.2002; Kim SM, 2007, J INFECTION, V54, P185, DOI 10.1016/j.jinf.2006.02.002; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-193; Lopez-Rios F, 2004, LANCET, V364, P1157, DOI 10.1016/S0140-6736(04)17102-X; Mu SC, 2009, J HEPATOL, V50, P264, DOI 10.1016/j.jhep.2008.09.017; Ni YH, 2012, J HEPATOL, V57, P730, DOI 10.1016/j.jhep.2012.05.021; Pande C, 2013, J VIRAL HEPATITIS, V20, P801, DOI 10.1111/jvh.12102; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Shahmoradi S, 2012, J HEPATOL, V57, P515, DOI 10.1016/j.jhep.2012.04.021; Song EY, 2009, INTERVIROLOGY, V52, P57, DOI 10.1159/000214633; Su HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070768; Vilchez RA, 2002, LANCET, V359, P817, DOI 10.1016/S0140-6736(02)07950-3; Xu LB, 2010, VACCINE, V28, P5986, DOI 10.1016/j.vaccine.2010.06.106; Zhou YH, 2009, CHINESE MED J-PEKING, V122, P98, DOI 10.3760/cma.j.issn.0366-6999.2009.01.018	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112803	10.1371/journal.pone.0112803	http://dx.doi.org/10.1371/journal.pone.0112803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383543	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700096
J	Crowley, SJ; Van Reen, E; LeBourgeois, MK; Acebo, C; Tarokh, L; Seifer, R; Barker, DH; Carskadon, MA				Crowley, Stephanie J.; Van Reen, Eliza; LeBourgeois, Monique K.; Acebo, Christine; Tarokh, Leila; Seifer, Ronald; Barker, David H.; Carskadon, Mary A.			A Longitudinal Assessment of Sleep Timing, Circadian Phase, and Phase Angle of Entrainment across Human Adolescence	PLOS ONE			English	Article							RESPONSE CURVE; SOCIAL JETLAG; YOUNG ADULTHOOD; DELAYED PHASE; SCHOOL; PATTERNS; TIME; SEX; HABITS; BED	The aim of this descriptive analysis was to examine sleep timing, circadian phase, and phase angle of entrainment across adolescence in a longitudinal study design. Ninety-four adolescents participated; 38 (21 boys) were 9-10 years ("younger cohort") and 56 (30 boys) were 15-16 years ("older cohort") at the baseline assessment. Participants completed a baseline and then follow-up assessments approximately every six months for 2.5 years. At each assessment, participants wore a wrist actigraph for at least one week at home to measure self-selected sleep timing before salivary dim light melatonin onset (DLMO) phase - a marker of the circadian timing system - was measured in the laboratory. Weekday and weekend sleep onset and offset and weekend-weekday differences were derived from actigraphy. Phase angles were the time durations from DLMO to weekday sleep onset and offset times. Each cohort showed later sleep onset (weekend and weekday), later weekend sleep offset, and later DLMO with age. Weekday sleep offset shifted earlier with age in the younger cohort and later in the older cohort after age 17. Weekend-weekday sleep offset differences increased with age in the younger cohort and decreased in the older cohort after age 17. DLMO to sleep offset phase angle narrowed with age in the younger cohort and became broader in the older cohort. The older cohort had a wider sleep onset phase angle compared to the younger cohort; however, an age-related phase angle increase was seen in the younger cohort only. Individual differences were seen in these developmental trajectories. This descriptive study indicated that circadian phase and self-selected sleep delayed across adolescence, though school-day sleep offset advanced until no longer in high school, whereupon offset was later. Phase angle changes are described as an interaction of developmental changes in sleep regulation interacting with psychosocial factors (e.g., bedtime autonomy).	[Crowley, Stephanie J.] Rush Univ, Med Ctr, Dept Behav Sci, Biol Rhythms Res Lab, Chicago, IL 60612 USA; [Van Reen, Eliza; Acebo, Christine; Tarokh, Leila; Seifer, Ronald; Barker, David H.; Carskadon, Mary A.] Brown Univ, Warren Alpert Med Sch, Dept Psychiat & Human Behav, EP Bradley Hosp Sleep Res Lab, Providence, RI 02912 USA; [LeBourgeois, Monique K.] Univ Colorado, Dept Integrat Physiol, Sleep & Dev Lab, Boulder, CO 80309 USA; [Seifer, Ronald; Barker, David H.] Bradley Hasbro Childrens Res Ctr, Providence, RI USA; [Tarokh, Leila] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Tarokh, Leila] Univ Bern, Univ Hosp Child & Adolescent Psychiat, Bern, Switzerland; [Carskadon, Mary A.] Univ S Australia, Ctr Sleep Res, Adelaide, SA 5001, Australia	Rush University; Brown University; University of Colorado System; University of Colorado Boulder; University of Zurich; University of Bern; University Hospital of Bern; University of South Australia	Crowley, SJ (corresponding author), Rush Univ, Med Ctr, Dept Behav Sci, Biol Rhythms Res Lab, Chicago, IL 60612 USA.	Stephanie_J_Crowley@Rush.edu		Seifer, Ronald/0000-0003-4879-2839; Crowley, Stephanie/0000-0003-2057-9876	National Institutes of Health [AA 13252]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a grant from the National Institutes of Health (AA 13252) to MAC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Institute of Alcohol Abuse and Alcoholism. The National Institute of Alcohol Abuse and Alcoholism and the National Institutes of Health had no involvement in designing the study, data collection, data analysis and interpretation, writing of the manuscript, nor in the decision to submit the manuscript for publication. The authors alone are responsible for the content and writing of the paper.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; ANDRADE MMM, 1993, J ADOLESCENT HEALTH, V14, P401, DOI 10.1016/S1054-139X(08)80016-X; Boergers J, 2014, J DEV BEHAV PEDIATR, V35, P11, DOI 10.1097/DBP.0000000000000018; Burgess HJ, 2013, APPL ERGON, V44, P109, DOI 10.1016/j.apergo.2012.05.007; Burgess HJ, 2005, J SLEEP RES, V14, P229, DOI 10.1111/j.1365-2869.2005.00470.x; Cain SW, 2010, J BIOL RHYTHM, V25, P288, DOI 10.1177/0748730410374943; Campbell IG, 2011, SLEEP, V34, P83, DOI 10.1093/sleep/34.1.83; CARSKADON M A, 1990, Pediatrician, V17, P5; CARSKADON MA, 1993, SLEEP, V16, P258, DOI 10.1093/sleep/16.3.258; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; Carskadon MA, 1997, J BIOL RHYTHM, V12, P278, DOI 10.1177/074873049701200309; Carskadon MA., ALCOHOL DRUGS DRIV, V5/6, P317; Crowley SJ, 2007, SLEEP MED, V8, P602, DOI 10.1016/j.sleep.2006.12.002; Crowley SJ, 2006, SLEEP, V29, P1632, DOI 10.1093/sleep/29.12.1632; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Fredriksen K, 2004, CHILD DEV, V75, P84, DOI 10.1111/j.1467-8624.2004.00655.x; Frey S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005217; Giannotti F, 2002, J SLEEP RES, V11, P191, DOI 10.1046/j.1365-2869.2002.00302.x; Gradisar M, 2013, J CLIN SLEEP MED, V9, P1291, DOI 10.5664/jcsm.3272; Hagenauer MH, 2009, DEV NEUROSCI-BASEL, V31, P276, DOI 10.1159/000216538; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Jenni OG, 2005, SLEEP, V28, P1446, DOI 10.1093/sleep/28.11.1446; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Kraemer HC, 2000, AM J PSYCHIAT, V157, P163, DOI 10.1176/appi.ajp.157.2.163; Kripke Daniel F, 2007, J Circadian Rhythms, V5, P4, DOI 10.1186/1740-3391-5-4; Laberge L, 2001, J SLEEP RES, V10, P59, DOI 10.1046/j.1365-2869.2001.00242.x; LeBourgeois MK, 2013, J BIOL RHYTHM, V28, P322, DOI 10.1177/0748730413506543; Levandovski R, 2011, CHRONOBIOL INT, V28, P771, DOI 10.3109/07420528.2011.602445; Loessl B, 2008, CHILD CARE HLTH DEV, V34, P549, DOI 10.1111/j.1365-2214.2008.00845.x; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Martin SK, 2002, CHRONOBIOL INT, V19, P695, DOI 10.1081/CBI-120006080; Maslowsky J, 2014, J ADOLESCENT HEALTH, V54, P691, DOI 10.1016/j.jadohealth.2013.10.201; MINORS DS, 1991, NEUROSCI LETT, V133, P36, DOI 10.1016/0304-3940(91)90051-T; National Sleep Foundation, 2014, SLEEP AM POLL SLEEP; National Sleep Foundation, 2006, SLEEP AM POLL; O'Brien Erin M, 2005, Behav Sleep Med, V3, P113, DOI 10.1207/s15402010bsm0303_1; Olds T, 2010, SLEEP MED REV, V14, P371, DOI 10.1016/j.smrv.2009.12.002; Randler C, 2008, CHRONOBIOL INT, V25, P565, DOI 10.1080/07420520802257794; Revell VL, 2012, J PHYSIOL-LONDON, V590, P4859, DOI 10.1113/jphysiol.2012.235416; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sadeh A, 2009, SLEEP, V32, P1602, DOI 10.1093/sleep/32.12.1602; SMITH CS, 1989, J APPL PSYCHOL, V74, P728, DOI 10.1037/0021-9010.74.5.728; St Hilaire MA, 2012, J PHYSIOL-LONDON, V590, P3035, DOI 10.1113/jphysiol.2012.227892; STRAUCH I, 1988, SLEEP, V11, P378, DOI 10.1093/sleep/11.4.378; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Tarokh L, 2012, NEUROSCIENCE, V216, P167, DOI 10.1016/j.neuroscience.2012.04.055; Taylor A, 2008, SLEEP BIOL RHYTHMS, V6, P172, DOI 10.1111/j.1479-8425.2008.00356.x; Taylor DJ, 2005, J SLEEP RES, V14, P239, DOI 10.1111/j.1365-2869.2005.00467.x; Thorleifsdottir B, 2002, J PSYCHOSOM RES, V53, P529, DOI 10.1016/S0022-3999(02)00444-0; Urner M, 2009, CHRONOBIOL INT, V26, P1222, DOI 10.1080/07420520903244600; Van den Bulck J, 2004, SLEEP, V27, P101, DOI 10.1093/sleep/27.1.101; Van Reen E, 2013, J BIOL RHYTHM, V28, P425, DOI 10.1177/0748730413511771; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wolfson Amy R, 2007, Behav Sleep Med, V5, P194; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G; Yang CM, 2001, SLEEP, V24, P272, DOI 10.1093/sleep/24.3.272; Yang CM, 2001, PSYCHOL HEALTH, V16, P715, DOI 10.1080/08870440108405869	62	145	148	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112199	10.1371/journal.pone.0112199	http://dx.doi.org/10.1371/journal.pone.0112199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25380248	Green Published, Green Accepted, gold			2022-12-26	WOS:000344863100062
J	Kern, J; Drutel, R; Leanhart, S; Bogacz, M; Pacholczyk, R				Kern, Joanna; Drutel, Robert; Leanhart, Silvia; Bogacz, Marek; Pacholczyk, Rafal			Reduction of T Cell Receptor Diversity in NOD Mice Prevents Development of Type 1 Diabetes but Not Sjogren's Syndrome	PLOS ONE			English	Article							SALIVARY-GLAND; CLASS-II; AUTOIMMUNE EXOCRINOPATHY; POSTTRANSLATIONAL MODIFICATIONS; INSULIN PEPTIDE; MOUSE MODEL; ALPHA-BETA; REPERTOIRE; MHC; SELECTION	Non-obese diabetic (NOD) mice are well-established models of independently developing spontaneous autoimmune diseases, Sjogren's syndrome (SS) and type 1 diabetes (T1D). The key determining factor for T1D is the strong association with particular MHCII molecule and recognition by diabetogenic T cell receptor (TCR) of an insulin peptide presented in the context of I-A(g7) molecule. For SS the association with MHCII polymorphism is weaker and TCR diversity involved in the onset of the autoimmune phase of SS remains poorly understood. To compare the impact of TCR diversity reduction on the development of both diseases we generated two lines of TCR transgenic NOD mice. One line expresses transgenic TCR beta chain originated from a pathogenically irrelevant TCR, and the second line additionally expresses transgenic TCR alpha(mini) locus. Analysis of TCR sequences on NOD background reveals lower TCR diversity on Treg cells not only in the thymus, but also in the periphery. This reduction in diversity does not affect conventional CD4(+) T cells, as compared to the TCRmini repertoire on B6 background. Interestingly, neither transgenic TCR beta nor TCRmini mice develop diabetes, which we show is due to lack of insulin B:9-23 specific T cells in the periphery. Conversely SS develops in both lines, with full glandular infiltration, production of autoantibodies and hyposalivation. It shows that SS development is not as sensitive to limited availability of TCR specificities as T1D, which suggests wider range of possible TCR/peptide/MHC interactions driving autoimmunity in SS.	[Kern, Joanna; Drutel, Robert; Leanhart, Silvia; Bogacz, Marek; Pacholczyk, Rafal] Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30901 USA	University System of Georgia; Augusta University	Pacholczyk, R (corresponding author), Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30901 USA.	rpacholczyk@gru.du			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI081798]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081798] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01AI081798) and Juvenile Diabetes Research Foundation (RP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	ADELMAN MA, 1969, REV ECON STAT, V51, P99, DOI 10.2307/1926955; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Arakaki R, 2003, ARTHRITIS RHEUM-US, V48, P3603, DOI 10.1002/art.11352; ATKINSON JC, 1992, ARTHRITIS RHEUM, V35, P1368, DOI 10.1002/art.1780351119; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; Berglund JP, 2008, MOL IMMUNOL, V45, P3059, DOI 10.1016/j.molimm.2008.03.009; Brayer JB, 2001, SCAND J IMMUNOL, V54, P133, DOI 10.1046/j.1365-3083.2001.00958.x; Burek CL, 2007, J IMMUNOL, V178; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; Cha S, 2002, ARTHRITIS RHEUM-US, V46, P1390, DOI 10.1002/art.10258; Cha S, 2002, CRIT REV ORAL BIOL M, V13, P5, DOI 10.1177/154411130201300103; Chaparro RJ, 2010, EXPERT REV CLIN IMMU, V6, P939, DOI [10.1586/eci.10.68, 10.1586/ECI.10.68]; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; DWYER E, 1993, J CLIN INVEST, V92, P495, DOI 10.1172/JCI116593; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; Ferreira C, 2009, P NATL ACAD SCI USA, V106, P8320, DOI 10.1073/pnas.0808493106; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; FOX RI, 1992, RHEUM DIS CLIN N AM, V18, P517; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gao JH, 2006, J AUTOIMMUN, V26, P90, DOI 10.1016/j.jaut.2005.11.004; Gottenberg JE, 2003, ARTHRITIS RHEUM, V48, P2240, DOI 10.1002/art.11103; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; HARADA M, 1984, DIABETOLOGIA, V27, P604, DOI 10.1007/BF00276978; Iizuka M, 2010, J AUTOIMMUN, V35, P383, DOI 10.1016/j.jaut.2010.08.004; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kisielow J, 2011, BLOOD, V118, P6591, DOI 10.1182/blood-2011-05-352732; Kraj P, 2001, J IMMUNOL, V166, P2251, DOI 10.4049/jimmunol.166.4.2251; Lavoie TN, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/549107; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; LI XP, 1993, DIABETES, V42, P1166, DOI 10.2337/diabetes.42.8.1166; Lindqvist AKB, 2005, SCAND J IMMUNOL, V61, P119, DOI 10.1111/j.0300-9475.2005.01550.x; LIPES MA, 1993, SCIENCE, V259, P1165, DOI 10.1126/science.8267690; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Manoussakis MN, 2004, ARTHRITIS RHEUM-US, V50, P882, DOI 10.1002/art.20093; Marrack P, 2012, COLD SPRING HARBOR P, V2; Marrero I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076546; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Matsumoto I, 1999, INT J MOL MED, V3, P485; Matsumoto I, 1999, INT J MOL MED, V4, P519; Michels AW, 2011, J IMMUNOL, V187, P5921, DOI 10.4049/jimmunol.1100746; Mingueneau M, 2012, J EXP MED, V209, P623, DOI 10.1084/jem.20112593; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; MOUTSOPOULOS HM, 1986, ANN RHEUM DIS, V45, P677, DOI 10.1136/ard.45.8.677; Naito Y, 2006, ANN RHEUM DIS, V65, P269, DOI 10.1136/ard.2005.039065; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nakayama M, 2012, DIABETES, V61, P857, DOI 10.2337/db11-1113; Nguyen CQ, 2009, OCUL SURF, V7, P11, DOI 10.1016/S1542-0124(12)70289-6; Pacholczyk R, 2002, J IMMUNOL, V168, P613, DOI 10.4049/jimmunol.168.2.613; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pivetta B, 1999, J RHEUMATOL, V26, P1101; Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T; Serreze DV, 2001, DIABETES, V50, P1992, DOI 10.2337/diabetes.50.9.1992; Simone E, 1997, P NATL ACAD SCI USA, V94, P2518, DOI 10.1073/pnas.94.6.2518; Singh N, 2012, J AUTOIMMUN, V39, P229, DOI 10.1016/j.jaut.2012.05.019; Skarstein K, 1995, AUTOIMMUNITY, V22, P9, DOI 10.3109/08916939508995294; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; SUMIDA T, 1992, J CLIN INVEST, V89, P681, DOI 10.1172/JCI115635; Sumida T, 2014, J AUTOIMMUN; Sumida T, 2010, AUTOIMMUN REV, V9, P615, DOI 10.1016/j.autrev.2010.05.008; Takada K, 2005, J BIOL CHEM, V280, P3982, DOI 10.1074/jbc.M410157200; WICKER LS, 1992, J EXP MED, V176, P67, DOI 10.1084/jem.176.1.67; Winer S, 2002, LANCET, V360, P1063, DOI 10.1016/S0140-6736(02)11144-5; YONAHA F, 1992, ARTHRITIS RHEUM, V35, P1362, DOI 10.1002/art.1780351118; Zhang L, 2009, J AUTOIMMUN, V33, P42, DOI 10.1016/j.jaut.2009.02.003	67	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112467	10.1371/journal.pone.0112467	http://dx.doi.org/10.1371/journal.pone.0112467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379761	Green Published, gold			2022-12-26	WOS:000344863100103
J	Koy, T; Zange, J; Rittweger, J; Pohle-Frohlich, R; Hackenbroch, M; Eysel, P; Ganse, B				Koy, Timmo; Zange, Jochen; Rittweger, Joern; Pohle-Froehlich, Regina; Hackenbroch, Matthias; Eysel, Peer; Ganse, Bergita			Assessment of Lumbar Intervertebral Disc Glycosaminoglycan Content by Gadolinium-Enhanced MRI before and after 21-Days of Head-Down-Tilt Bedrest	PLOS ONE			English	Article							LOW-BACK-PAIN; NUCLEUS PULPOSUS; BED REST; CARTILAGE; RECOVERY; SYSTEM; RISK	During spaceflight, it has been shown that intervertebral discs (IVDs) increase in height, causing elongation of the spine up to several centimeters. Astronauts frequently report dull lower back pain that is most likely of discogenic origin and may result from IVD expansion. It is unknown whether disc volume solely increases by water influx, or if the content of glycosaminoglycans also changes in microgravity. Aim of this pilot study was to investigate effects of the spaceflight analog of bedrest on the glycosaminoglycan content of human lumbar IVDs. Five healthy, non-smoking, male human subjects of European descent were immobilized in 6 degrees head-down-tilt bedrest for 21 days. Subjects remained in bed 24 h a day with at least one shoulder on the mattress. Magnetic Resonance Imaging (MRI) scans were taken according to the delayed gadolinium-enhanced magnetic resonance imaging (dGEMRIC) protocol before and after bedrest. The outcome measures were T-1 and Delta T-1. Scans were performed before and after administration of the contrast agent Gd-DOTA, and differences between T-1-values of both scans (Delta T-1) were computed. Delta T-1 is the longitudinal relaxation time in the tissue and inversely related to the glycosaminoglycan-content. For data analysis, IVDs L1/2 to L4/5 were semi-automatically segmented. Zones were defined and analyzed separately. Results show a highly significant decrease in Delta T-1 (p < 0.001) after bedrest in all IVDs, and in all areas of the IVDs. The Delta T-1-decrease was most prominent in the nucleus pulposus and in L4/5, and was expressed slightly more in the posterior than anterior IVD. Unexpected negative Delta T-1-values were found in Pfirrmann-grade 2-discs after bedrest. Significantly lower T-1 before contrast agent application was found after bedrest compared to before bedrest. According to the dGEMRIC-literature, the decrease in Delta T-1 may be interpreted as an increase in glycosaminoglycans in healthy IVDs during bedrest. This interpretation seems contradictory to previous findings in IVD unloading.	[Koy, Timmo; Eysel, Peer] Univ Cologne, Dept Orthopaed & Trauma Surg, D-50931 Cologne, Germany; [Zange, Jochen; Rittweger, Joern; Ganse, Bergita] German Aerosp Ctr DLR, Inst Aerosp Med, Dept Space Physiol, Cologne, Germany; [Pohle-Froehlich, Regina] Hsch Niederrhein, Inst Pattern Recognit, Krefeld, Germany; [Hackenbroch, Matthias] Univ Cologne, Dept Radiol, D-50931 Cologne, Germany; [Eysel, Peer] Univ Cologne, Fac Med, CCMB, D-50931 Cologne, Germany; [Ganse, Bergita] Rhein Westfal TH Aachen, Dept Orthopaed, Aachen, Germany	University of Cologne; Helmholtz Association; German Aerospace Centre (DLR); University of Cologne; University of Cologne; RWTH Aachen University	Ganse, B (corresponding author), German Aerosp Ctr DLR, Inst Aerosp Med, Dept Space Physiol, Cologne, Germany.	bergita.ganse@dlr.de	Rittweger, Jörn/A-4308-2009	Rittweger, Jörn/0000-0002-2223-8963; Ganse, Bergita/0000-0002-9512-2910; Zange, Jochen/0000-0003-1822-0952	European Space Agency, "Microgravity Applications Program'' [21381/07/NL/VJ]; German Aerospace Center (DLR Space Program)	European Space Agency, "Microgravity Applications Program''; German Aerospace Center (DLR Space Program)	The NUC-study took place in the Institute of Aerospace Medicine of the German Aerospace Center, Cologne, Germany, and was funded by the European Space Agency (www.esa.int) as part of the "Microgravity Applications Program'' (contract number: 21381/07/NL/VJ) and by institutional funding of the German Aerospace Center (DLR Space Program) (www.dlr.de). The funders had influence on the study design, but had no role in data collection, analysis, decision to publish, or preparation of the manuscript.	Auvinen JP, 2010, EUR SPINE J, V19, P641, DOI 10.1007/s00586-009-1215-2; Belavy DL, 2012, SPINE, V37, P1245, DOI 10.1097/BRS.0b013e3182354d84; Belavy DL, 2011, J APPL PHYSIOL, V111, P1304, DOI 10.1152/japplphysiol.00695.2011; Bittersohl B, 2009, MAGN RESON MED, V62, P1362, DOI 10.1002/mrm.22166; Brisby H, 2006, J BONE JOINT SURG AM, V88A, P68, DOI 10.2106/JBJS.E.01282; Ciavarro C, 2012, J MAGN RESON IMAGING, V35, P1145, DOI 10.1002/jmri.23525; D'Aprile P, 2007, EUR RADIOL, V17, P523, DOI 10.1007/s00330-006-0324-0; Frings-Meuthen P, 2013, J MUSCULOSKEL NEURON, V13, P45; Hanley EN, 2010, J BONE JOINT SURG AM, V92A, P1293, DOI 10.2106/JBJS.I.01439; Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x; HUTCHINSON KJ, 1995, AVIAT SPACE ENVIR MD, V66, P256; Hutton WC, 2002, SPINE, V27, P1286, DOI 10.1097/00007632-200206150-00008; Johnston SL, 2010, AVIAT SPACE ENVIR MD, V81, P566, DOI 10.3357/ASEM.2427.2010; Kelsen J, 2012, CYTOKINE, V59, P403, DOI 10.1016/j.cyto.2012.04.032; Kerstman EL, 2012, AVIAT SPACE ENVIR MD, V83, P2, DOI 10.3357/ASEM.2876.2012; Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004; Mamisch TC, 2008, MAGN RESON MED, V60, P768, DOI 10.1002/mrm.21726; Niinimaki JL, 2006, J MAGN RESON IMAGING, V24, P796, DOI 10.1002/jmri.20693; PAAJANEN H, 1994, J ORTHOPAED RES, V12, P509, DOI 10.1002/jor.1100120407; Perry J, 2006, AM J NEURORADIOL, V27, P337; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Pope MH, 2002, ANNU REV BIOMED ENG, V4, P49, DOI 10.1146/annurev.bioeng.4.092101.122107; Sayson JV, 2008, AVIAT SPACE ENVIR MD, V79, P365, DOI 10.3357/ASEM.1994.2008; Sinha Raj K, 2002, Spine J, V2, P239, DOI 10.1016/S1529-9430(02)00197-3; Tibiletti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076697; Vaga S, 2008, MAGN RESON MED, V59, P85, DOI 10.1002/mrm.21433; Vaga S, 2009, EUR SPINE J, V18, pS40, DOI 10.1007/s00586-009-0996-7; Vaga S, 2009, J MAGN RESON IMAGING, V29, P1443, DOI 10.1002/jmri.21774; WING PC, 1991, ORTHOP CLIN N AM, V22, P255; Zilkens C, 2009, ORTHOPADE, V38, P591, DOI 10.1007/s00132-009-1441-7; Zilkens C, 2010, J PEDIATR ORTHOPED, V30, P147, DOI 10.1097/BPO.0b013e3181cf13e6	31	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112104	10.1371/journal.pone.0112104	http://dx.doi.org/10.1371/journal.pone.0112104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380233	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000344863100053
J	Palma, P; Cano, C; Conde-Muino, R; Comino, A; Bueno, P; Ferron, JA; Cuadros, M				Palma, Pablo; Cano, Carlos; Conde-Muino, Raquel; Comino, Ana; Bueno, Pablo; Ferron, J. Antonio; Cuadros, Marta			Expression Profiling of Rectal Tumors Defines Response to Neoadjuvant Treatment Related Genes	PLOS ONE			English	Article							C-MYC; PREOPERATIVE CHEMORADIOTHERAPY; PATHOLOGICAL RESPONSE; MICROARRAY ANALYSIS; CODING REGION; CANCER; PREDICTION; MUTATIONS; CHEMORADIATION; 5-FLUOROURACIL	To date, no effective method exists that predicts the response to preoperative chemoradiation (CRT) in locally advanced rectal cancer (LARC). Nevertheless, identification of patients who have a higher likelihood of responding to preoperative CRT could be crucial in decreasing treatment morbidity and avoiding expensive and time-consuming treatments. The aim of this study was to identify signatures or molecular markers related to response to pre-operative CRT in LARC. We analyzed the gene expression profiles of 26 pre-treatment biopsies of LARC (10 responders and 16 non-responders) without metastasis using Human WG CodeLink microarray platform. Two hundred and fifty seven genes were differentially over-expressed in the responder patient subgroup. Ingenuity Pathway Analysis revealed a significant ratio of differentially expressed genes related to cancer, cellular growth and proliferation pathways, and c-Myc network. We demonstrated that high Gng4, c-Myc, Pola1, and Rrm1 mRNA expression levels was a significant prognostic factor for response to treatment in LARC patients (p, 0.05). Using this gene set, we were able to establish a new model for predicting the response to CRT in rectal cancer with a sensitivity of 60% and 100% specificity. Our results reflect the value of gene expression profiling to gain insight about the molecular pathways involved in the response to treatment of LARC patients. These findings could be clinically relevant and support the use of mRNA levels when aiming to identify patients who respond to CRT therapy.	[Palma, Pablo; Conde-Muino, Raquel; Ferron, J. Antonio] Virgen de las Nieves Hosp HUVN, Div Colon & Rectal Surg, Granada, Spain; [Cano, Carlos] Univ Granada, Dept Comp Sci & Artificial Intelligence, Granada, Spain; [Comino, Ana; Bueno, Pablo; Ferron, J. Antonio] Virgen de las Nieves Hosp HUVN, Dept Surg Res, Granada, Spain; [Cuadros, Marta] Univ Granada, Junta De Andalucia, Pfizer, Ctr Genom & Oncol Res,GENYO, Granada, Spain	University of Granada; Pfizer; University of Granada	Cuadros, M (corresponding author), Univ Granada, Dept Biochem & Mol Biol & Immunol 3, Granada, Spain.	mcuadros@ugr.es	Gutierrez, Carlos Cano/ABH-2343-2020; Cuadros, Marta/K-1576-2014	Cuadros, Marta/0000-0002-8329-4854; Conde Muino, Raquel/0000-0002-9163-9410; Palma, Pablo/0000-0003-1084-5982	Fundacion Investigacion Biomedica Mutua Madrilena; Consejeria de Innovacion y Ciencia (Proyecto de Excelencia) de la Junta de Andalucia; Junta de Andalucia [CTS2200, PI-0710-2013]; Programa Estatal I+D+i MINECO [TIN2013-41990-R]; GREIB of University of Granada [PYR_2010-02, 2010_05]	Fundacion Investigacion Biomedica Mutua Madrilena; Consejeria de Innovacion y Ciencia (Proyecto de Excelencia) de la Junta de Andalucia; Junta de Andalucia(Junta de Andalucia); Programa Estatal I+D+i MINECO; GREIB of University of Granada	This investigation was supported by the Fundacion Investigacion Biomedica Mutua Madrilena and Consejeria de Innovacion y Ciencia (Proyecto de Excelencia) de la Junta de Andalucia. MC, CC and AB were supported by projects CTS2200 and PI-0710-2013 of Junta de Andalucia, TIN2013-41990-R of Programa Estatal I+D+i MINECO, and GREIB PYR_2010-02 and 2010_05 of University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt R, 2009, GASTROENT RES PRACT, V2009, DOI 10.1155/2009/285830; Akiyoshi T, 2012, SURG TODAY, V42, P713, DOI 10.1007/s00595-012-0223-8; Arango D, 2001, CANCER RES, V61, P4910; BHATIA K, 1994, BLOOD, V84, P883; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brettingham-Moore KH, 2011, CLIN CANCER RES, V17, P3039, DOI 10.1158/1078-0432.CCR-10-2915; CLARK HM, 1994, CANCER RES, V54, P3383; Dang CV, 1999, MOL CELL BIOL, V19, P1; Gantt GA, 2014, COLORECTAL DIS, V16, P57, DOI 10.1111/codi.12395; Ghadimi BM, 2005, J CLIN ONCOL, V23, P1826, DOI 10.1200/JCO.2005.00.406; Glynne-Jones R, 2011, DRUGS, V71, P1153, DOI 10.2165/11591330-000000000-00000; Horisberger K, 2008, INT J COLORECTAL DIS, V23, P257, DOI 10.1007/s00384-007-0408-6; Kim IJ, 2007, DIS COLON RECTUM, V50, P1342, DOI 10.1007/s10350-007-277-7; Lin MS, 2011, HEPATO-GASTROENTEROL, V58, P1937, DOI 10.5754/hge11262; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Nishioka M, 2011, CANCER GENOM PROTEOM, V8, P87; Ojima E, 2007, J GASTROENTEROL, V42, P730, DOI 10.1007/s00535-007-2089-x; Palma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074034; Palma P, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-119; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Rimkus C, 2008, CLIN GASTROENTEROL H, V6, P53, DOI 10.1016/j.cgh.2007.10.022; Saigusa S, 2012, ONCOL REP, V28, P855, DOI 10.3892/or.2012.1863; Sasaki K, 2012, ANTI-CANCER DRUG, V23, P675, DOI 10.1097/CAD.0b013e328353f8c7; Scarpati GD, 2012, INT J RADIAT ONCOL, V83, P1113, DOI 10.1016/j.ijrobp.2011.09.030; SMITH DR, 1993, BRIT J CANCER, V68, P407, DOI 10.1038/bjc.1993.350; Snipstad K, 2010, MOL ONCOL, V4, P52, DOI 10.1016/j.molonc.2009.11.002; van de Wiel MA, 2005, CANCER RES, V65, P10208, DOI 10.1158/0008-5472.CAN-05-0760; Watanabe T, 2006, CANCER RES, V66, P3370, DOI 10.1158/0008-5472.CAN-05-3834; YANO T, 1993, ONCOGENE, V8, P2741	32	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112189	10.1371/journal.pone.0112189	http://dx.doi.org/10.1371/journal.pone.0112189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380052	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100060
J	Adler, J; Parmryd, I				Adler, Jeremy; Parmryd, Ingela			Quantifying Colocalization: Thresholding, Void Voxels and the H-coef	PLOS ONE			English	Article							IMAGE; PROTEINS; COEFFICIENT	A critical step in the analysis of images is identifying the area of interest e. g. nuclei. When the nuclei are brighter than the remainder of the image an intensity can be chosen to identify the nuclei. Intensity thresholding is complicated by variations in the intensity of individual nuclei and their intensity relative to their surroundings. To compensate thresholds can be based on local rather than global intensities. By testing local thresholding methods we found that the local mean performed poorly while the Phansalkar method and a new method based on identifying the local background were superior. A new colocalization coefficient, the H-coef, highlights a number of controversial issues. (i) Are molecular interactions measurable (ii) whether to include voxels without fluorophores in calculations, and (iii) the meaning of negative correlations. Negative correlations can arise biologically (a) because the two fluorophores are in different places or (b) when high intensities of one fluorophore coincide with low intensities of a second. The cases are distinct and we argue that it is only relevant to measure correlation using pixels that contain both fluorophores and, when the fluorophores are in different places, to just report the lack of co-occurrence and omit these uninformative negative correlation. The H-coef could report molecular interactions in a homogenous medium. But biology is not homogenous and distributions also reflect physico-chemical properties, targeted delivery and retention. The H-coef actually measures a mix of correlation and co-occurrence, which makes its interpretation problematic and in the absence of a convincing demonstration we advise caution, favouring separate measurements of correlation and of co-occurrence.	[Adler, Jeremy] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Parmryd, Ingela] Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University	Parmryd, I (corresponding author), Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, Uppsala, Sweden.	ingela.parmryd@mcb.uu.se		Parmryd, Ingela/0000-0003-4834-3611	Magnus Bergvall's Foundation; Signhild Engkvist's Foundation; O. E. and Edla Johansson's Foundation	Magnus Bergvall's Foundation; Signhild Engkvist's Foundation; O. E. and Edla Johansson's Foundation	IP recieved funding from Magnus Bergvall's Foundation (http://www.magnbergvallsstiftelse.nu), Signhild Engkvist's Foundation (http://www.engkviststiftelserna.se/index.php/om-signhild-engkvists-stiftelse) and O. E. and Edla Johansson's Foundation (http://www.stiftelsen.rago.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2008, J MICROSC-OXFORD, V230, P121, DOI 10.1111/j.1365-2818.2008.01967.x; Adler J, 2007, J MICROSC-OXFORD, V227, P83, DOI 10.1111/j.1365-2818.2007.01788.x; Adler Jeremy, 2013, Methods Mol Biol, V931, P97, DOI 10.1007/978-1-62703-056-4_5; Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Agnati LF, 2005, J HISTOCHEM CYTOCHEM, V53, P941, DOI 10.1369/jhc.4A6355.2005; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BLYTH CR, 1972, J AM STAT ASSOC, V67, P364, DOI 10.2307/2284382; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Galton F., 1888, P R SOC LONDON, V45, P135, DOI [DOI 10.1098/RSPL.1888.0082, 10.1098/rspl.1888.0082]; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Herce HD, 2013, J MICROSC-OXFORD, V249, P184, DOI 10.1111/jmi.12008; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; Meijering E, 2012, IEEE SIGNAL PROC MAG, V29, P140, DOI 10.1109/MSP.2012.2204190; Parmryd I, 2013, FEBS J, V280, P2775, DOI 10.1111/febs.12209; PFANNER N, 1988, EUR J BIOCHEM, V175, P205, DOI 10.1111/j.1432-1033.1988.tb14185.x; Phansalkar Neerad, 2011, 2011 International Conference on Communications and Signal Processing (ICCSP), P218, DOI 10.1109/ICCSP.2011.5739305; Rappaz B., 2013, CURR PROTOC CELL BIO; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tsarouhas V, 2014, J CELL SCI, V127, P1829, DOI 10.1242/jcs.143016; WAGNER P, 1990, FEBS LETT, V275, P1, DOI 10.1016/0014-5793(90)81425-N; Wilcox RR, 2001, INT J SELECT ASSESS, V9, P195, DOI 10.1111/1468-2389.00172; Wu Y, 2012, INTERDISCIP SCI, V4, P27, DOI 10.1007/s12539-012-0117-x; Wu Y, 2010, BIOPHYS J, V98, P493, DOI 10.1016/j.bpj.2009.10.037	28	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111983	10.1371/journal.pone.0111983	http://dx.doi.org/10.1371/journal.pone.0111983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375829	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600086
J	Haraguchi, A; Hayashida, N; Kamasaki, T; Miyamoto, I; Usui, T; Ando, T; Abiru, N; Yamasaki, H; Chiba, K; Kudo, T; Kawakami, A; Takamura, N				Haraguchi, Ai; Hayashida, Naomi; Kamasaki, Toshihiko; Miyamoto, Izumi; Usui, Toshiya; Ando, Takao; Abiru, Norio; Yamasaki, Hironori; Chiba, Kenya; Kudo, Takashi; Kawakami, Atsushi; Takamura, Noboru			Uptake of Aortic F-18-FDG Is Correlated with Low-Density Lipoprotein Cholesterol and Leptin in a General Population	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ATHEROSCLEROTIC PLAQUE INFLAMMATION; INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; FDG UPTAKE; RISK; PET/CT; ADIPOKINES; DISEASE	Objective: This study investigated the relationship between aortic F-18-fluoro-2-deoxy-D-glucose (F-18-FDG) uptake and clinical and laboratory findings related to atherosclerosis in a general population. Methods: F-18-FDG uptake in the ascending aorta was measured on the positron emission tomography/computed tomography (PET/CT) scans of 211 Japanese adults. The maximum target-to-background ratio (TBR) was compared with clinical and laboratory atherosclerosis findings. Results: By multivariate regression analysis adjusted for age and sex, TBR-ascending aorta (TBR-A) was significantly correlated with various clinical and laboratory parameters, such as body mass index, log visceral fat area, low-density lipoprotein cholesterol (LDL-C), log fasting immunoreactive insulin, log homeostasis model assessment of insulin resistance, log total adiponectin and log-leptin, in all subjects. Furthermore, by multivariate linear regression analysis adjusted for confounding factors, TBR-A was significantly correlated with LDL-C (beta = 0.001, p = 0.03) and log-leptin (beta = 0.336, p < 0.01) in all subjects. Conclusion: TBR-A was significantly correlated with LDL-C and log-leptin independent from confounding factors. Our results suggest that aortic F-18-FDG uptake is a good marker of atherosclerosis, even in a general population.	[Haraguchi, Ai; Hayashida, Naomi; Kamasaki, Toshihiko; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Haraguchi, Ai; Ando, Takao; Abiru, Norio; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Endocrinol & Metab, Nagasaki 852, Japan; [Kudo, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Yamasaki, Hironori] Nagasaki Univ, Ctr Hlth & Community Med, Nagasaki 852, Japan; [Kamasaki, Toshihiko; Miyamoto, Izumi; Usui, Toshiya; Chiba, Kenya] Nishi Isahaya Hosp, PET CT Diagnost Imaging Ctr, Isahaya, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University	Takamura, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan.	takamura@nagasaki-u.ac.jp		Takamura, Noboru/0000-0002-5552-3234	Grants-in-Aid for Scientific Research [26305025] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Badimon L, 2012, ANN NY ACAD SCI, V1254, P18, DOI 10.1111/j.1749-6632.2012.06480.x; Ben-Haim S, 2004, J NUCL MED, V45, P1816; Bural GG, 2008, EUR J NUCL MED MOL I, V35, P562, DOI 10.1007/s00259-007-0528-9; Chiba K, 2010, INT SURG, V95, P197; Dubey L, 2008, INT J CARDIOL, V126, P183, DOI 10.1016/j.ijcard.2007.03.126; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ference BA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0312-1; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Kamasaki T, 2014, NUCL MED COMMUN, V35, P44, DOI 10.1097/MNM.0000000000000029; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Lago F, 2007, CYTOKINE GROWTH F R, V18, P313, DOI 10.1016/j.cytogfr.2007.04.007; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lindholm H, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-50; LINDHOLM P, 1993, J NUCL MED, V34, P1; Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232; Minami Shigeki, 2007, Acta Medica Nagasakiensia, V52, P59; Montecchi FR, 2001, DIABETES NUTR METAB, V14, P58; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Nichols WW, 1999, NEW ENGL J MED, V340, P1762; Noh TS, 2013, J NUCL MED, V54, P2070, DOI 10.2967/jnumed.113.119602; Pasterkamp G, 1998, J AM COLL CARDIOL, V32, P655, DOI 10.1016/S0735-1097(98)00304-0; Roemmich JN, 1998, AM J PHYSIOL-ENDOC M, V275, pE543, DOI 10.1152/ajpendo.1998.275.3.E543; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothwell PM, 2000, CEREBROVASC DIS, V10, P21, DOI 10.1159/000047601; Rudd JHF, 2007, J AM COLL CARDIOL, V50, P892, DOI 10.1016/j.jacc.2007.05.024; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Schneiderman J, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001727; Sierra-Johnson J, 2007, AM J CARDIOL, V100, P234, DOI 10.1016/j.amjcard.2007.02.088; Tahara N, 2007, J AM COLL CARDIOL, V49, P1533, DOI 10.1016/j.jacc.2006.11.046; Tahara N, 2006, J AM COLL CARDIOL, V48, P1825, DOI 10.1016/j.jacc.2006.03.069; Takamura N, 2010, BIOMARKERS, V15, P340, DOI 10.3109/13547501003735532; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004; Wannamethee SG, 2007, ATHEROSCLEROSIS, V191, P418, DOI 10.1016/j.atherosclerosis.2006.04.012; Yang SJ, 2013, INT J CARDIOL, V163, P277, DOI 10.1016/j.ijcard.2011.06.054; Yoo HJ, 2011, J NUCL MED, V52, P10, DOI 10.2967/jnumed.110.080838; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111990	10.1371/journal.pone.0111990	http://dx.doi.org/10.1371/journal.pone.0111990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375161	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600090
J	Biraro, IA; Egesa, M; Toulza, F; Levin, J; Cose, S; Joloba, M; Smith, S; Dockrell, HM; Katamba, A; Elliott, AM				Biraro, Irene A.; Egesa, Moses; Toulza, Frederic; Levin, Jonathan; Cose, Stephen; Joloba, Moses; Smith, Steven; Dockrell, Hazel M.; Katamba, Achilles; Elliott, Alison M.			Impact of Co-Infections and BCG Immunisation on Immune Responses among Household Contacts of Tuberculosis Patients in a Ugandan Cohort	PLOS ONE			English	Article							T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS; HELMINTHIC INFECTIONS; LATENT TUBERCULOSIS; HIV-INFECTION; PULMONARY TUBERCULOSIS; SCHISTOSOMA-MANSONI; CALMETTE-GUERIN; ANTIGENS	Background: Tuberculosis incidence in resource poor countries remains high. We hypothesized that immune modulating co-infections such as helminths, malaria, and HIV increase susceptibility to latent tuberculosis infection (LTBI), thereby contributing to maintaining the tuberculosis epidemic. Methods: Adults with sputum-positive tuberculosis (index cases) and their eligible household contacts (HHCs) were recruited to a cohort study between May 2011 and January 2012. HHCs were investigated for helminths, malaria, and HIV at enrolment. HHCs were tested using the QuantiFERON-TB Gold In-Tube (QFN) assay at enrolment and six months later. Overnight whole blood culture supernatants from baseline QFN assays were analyzed for cytokine responses using an 11-plex Luminex assay. Associations between outcomes (LTBI or cytokine responses) and exposures (co-infections and other risk factors) were examined using multivariable logistic and linear regression models. Results: We enrolled 101 index cases and 291 HHCs. Among HHCs, baseline prevalence of helminths was 9% (25/291), malaria 16% (47/291), HIV 6% (16/291), and LTBI 65% (179/277). Adjusting for other risk factors and household clustering, there was no association between LTBI and any co-infection at baseline or at six months: adjusted odds ratio (95% confidence interval (CI); p-value) at baseline for any helminth, 1.01 (0.39-2.66; 0.96); hookworm, 2.81 (0.56-14.14; 0.20); malaria, 1.06 (0.48-2.35; 0.87); HIV, 0.74 (0.22-2.47; 0.63). HHCs with LTBI had elevated cytokine responses to tuberculosis antigens but co-infections had little effect on cytokine responses. Exploring other risk factors, Th1 cytokines among LTBI-positive HHCs with BCG scars were greatly reduced compared to those without scars: (adjusted geometric mean ratio) IFN gamma 0.20 (0.09-0.42), <0.0001; IL-2 0.34 (0.20-0.59), <0.0001; and TNF alpha 0.36 (0.16-0.79), 0.01. Conclusions: We found no evidence that co-infections increase the risk of LTBI, or influence the cytokine response profile among those with LTBI. Prior BCG exposure may reduce Th1 cytokine responses in LTBI.	[Biraro, Irene A.; Egesa, Moses; Joloba, Moses; Katamba, Achilles] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Levin, Jonathan; Cose, Stephen; Elliott, Alison M.] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Toulza, Frederic; Smith, Steven; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Cose, Stephen; Elliott, Alison M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	Makerere University; Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Biraro, IA (corresponding author), Makerere Univ, Coll Hlth Sci, Kampala, Uganda.	andiaodanga@yahoo.com	Cose, Stephen/H-4851-2019	Cose, Stephen/0000-0002-5156-037X; Toulza, Frederic/0000-0002-1104-5795; Dockrell, Hazel/0000-0003-1869-9107; Smith, Steven/0000-0001-5623-7806; Egesa, Moses/0000-0001-5136-868X; Joloba, Moses/0000-0002-0334-9983; Elliott, Alison/0000-0003-2818-9549	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award [084344]; European Community's Seventh Framework Programme (FP7) under EC-GA [241642]; Wellcome Trust Senior Fellowship in Clinical Research [095778]	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award; European Community's Seventh Framework Programme (FP7) under EC-GA; Wellcome Trust Senior Fellowship in Clinical Research(Wellcome Trust)	This work was supported by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity held by Dr. Irene Biraro, funded by a Wellcome Trust Strategic Award, grant number 084344, and by the European Community's Seventh Framework Programme (FP7/2007-2013) under EC-GA no 241642 (the IDEA consortium) (http://www.idearesearch.eu/). Professor Elliott is supported by a Wellcome Trust Senior Fellowship in Clinical Research (grant number 095778). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; Borkow G, 2000, B WORLD HEALTH ORGAN, V78, P1368; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Cauthen GM, 1996, AM J EPIDEMIOL, V144, P69, DOI 10.1093/oxfordjournals.aje.a008856; Cellestis, 2011, WHOL BLOOD IFN GAMM, P4; Chene A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026266; Cobelens FG, 2006, CLIN INFECT DIS, V43, P634, DOI 10.1086/506432; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Eisenhut M, 2009, VACCINE, V27, P6116, DOI 10.1016/j.vaccine.2009.08.031; Elias D, 2005, CLIN EXP IMMUNOL, V139, P398, DOI 10.1111/j.1365-2249.2004.02719.x; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; ELLIOTT AM, 1990, BRIT MED J, V301, P412, DOI 10.1136/bmj.301.6749.412; ELLIOTT AM, 1993, AIDS, V7, P981, DOI 10.1097/00002030-199307000-00012; Elliott AM, 1999, INT J TUBERC LUNG D, V3, P239; Engwerda CR, 2005, CURR OPIN IMMUNOL, V17, P381, DOI 10.1016/j.coi.2005.05.010; Eriksen J, 2010, THORAX, V65, P1067, DOI 10.1136/thx.2010.140186; Espinal RA, 2000, LANCET, V355, P275, DOI 10.1016/S0140-6736(99)04402-5; Essa S, 2009, TRANSPL P, V41, P1643, DOI 10.1016/j.transproceed.2008.10.098; Fleiss J.L., 2013, STAT METHODS RATES P; Fletcher JM, 2005, J IMMUNOL, V175, P8218, DOI 10.4049/jimmunol.175.12.8218; Flom Peter L, 2007, P NE SAS US GROUP NE; George PJ, 2013, J IMMUNOL, V190, P5161, DOI 10.4049/jimmunol.1203311; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Gray JM, 2013, SEM RESP CRIT CAR ME, V34; Grinde B, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22766; Kabatereine NB, 2005, TROP MED INT HEALTH, V10, P1187, DOI 10.1111/j.1365-3156.2005.01509.x; Kamal SM, 2006, PARASITE IMMUNOL, V28, P483, DOI 10.1111/j.1365-3024.2006.00909.x; Karo B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-148; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Lalvani A, 2010, THORAX, V65, P1036, DOI 10.1136/thx.2010.140996; Larsen JM, 2007, IMMUNOLOGY, V121, P276, DOI 10.1111/j.1365-2567.2007.02575.x; Leung CC, 2010, ARCH INTERN MED, V170, P287, DOI 10.1001/archinternmed.2009.506; Lienhardt C, 2003, PEDIATRICS, V111, pE608, DOI 10.1542/peds.111.5.e608; Lodi S, 2013, THORAX, V68, P207, DOI 10.1136/thoraxjnl-2012-201740; Mahan CS, 2012, AM J TROP MED HYG, V86, P690, DOI 10.4269/ajtmh.2012.11-0553; MARKOWITZ N, 1993, ANN INTERN MED, V119, P185, DOI 10.7326/0003-4819-119-3-199308010-00002; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; McGuinness D, 1997, J IMMUNOL METHODS, V201, P99, DOI 10.1016/S0022-1759(96)00216-5; Melrose WD, 2000, T ROY SOC TROP MED H, V94, P176, DOI 10.1016/S0035-9203(00)90266-9; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; Ministry of Health, 2010, MAN NAT TUB LEPR PRO; Ministry of Health, 2011, UG MAL PROGR PERF RE; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Nemeth J, 2010, EUR CYTOKINE NETW, V21, P34, DOI 10.1684/ecn.2009.0182; NUNN PP, 1994, THORAX, V49, P511, DOI 10.1136/thx.49.5.511; Oni T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047072; Oni T, 2012, CLIN VACCINE IMMUNOL, V19, P1243, DOI 10.1128/CVI.00166-12; PASS RF, 1985, J INFECT DIS, V152, P243, DOI 10.1093/infdis/152.2.243; Rafi W, 2012, CURR OPIN HIV AIDS, V7, P239, DOI 10.1097/COH.0b013e3283524dc5; Ramos JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-169; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; RILEY EM, 1989, AM J TROP MED HYG, V40, P141, DOI 10.4269/ajtmh.1989.40.141; RILEY EM, 1988, CLIN EXP IMMUNOL, V73, P17; Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Seshadri C, 2008, East Afr Med J, V85, P442; Shaler CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059185; Silveira H, 1997, CLIN EXP IMMUNOL, V110, P26, DOI 10.1046/j.1365-2249.1997.5091407.x; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; U.S. Department of Health and Human Services, 2013, LAT TUB INF GUID PRI; UNAIDS, 2016, GLOB REP GLOB AIDS E; van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000492; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Walton SM, 2008, J IMMUNOL, V181, P1128, DOI 10.4049/jimmunol.181.2.1128; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Whalen CC, 2006, AM J TROP MED HYG, V75, P55, DOI 10.4269/ajtmh.2006.75.55; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 1994, WHOCTDSIP961; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; Woodburn PW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000473; World Health Organization, 2002, PREV CONTR SCHIST SO	76	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111517	10.1371/journal.pone.0111517	http://dx.doi.org/10.1371/journal.pone.0111517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372043	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900052
J	DeGabriel, JL; Moore, BD; Foley, WJ; Johnson, CN				DeGabriel, Jane L.; Moore, Ben D.; Foley, William J.; Johnson, Christopher N.			Male-Biased Predation and Its Effect on Paternity Skew and Life History in a Population of Common Brushtail Possums (Trichosurus vulpecula)	PLOS ONE			English	Article							PYTHONS MORELIA-SPILOTA; MATING SYSTEM; REPRODUCTIVE SKEW; SEX; DISPERSAL; ECOLOGY; SIZE; DIMORPHISM; MORTALITY; RATES	Differences in predation risk may exert strong selective pressures on life history strategies of populations. We investigated the potential for predation to shape male mating strategies in an arboreal folivore, the common brushtail possum (Trichosurus vulpecula Kerr). We predicted that possums in a tropical population exposed to high natural levels of predation would grow faster and reproduce earlier compared to those in temperate populations with lower predation. We trapped a population of possums in eucalypt woodland in northern Australia each month to measure life history traits and used microsatellites to genotype all individuals and assign paternity to all offspring. We observed very high levels of male-biased predation, with almost 60% of marked male possums being eaten by pythons, presumably as a result of their greater mobility due to mate-searching. Male reproductive success was also highly skewed, with younger, larger males fathering significantly more offspring. This result contrasts with previous studies of temperate populations experiencing low levels of predation, where older males were larger and the most reproductively successful. Our results suggest that in populations exposed to high levels of predation, male possums invest in increased growth earlier in life, in order to maximise their mating potential. This strategy is feasible because predation limits competition from older males and means that delaying reproduction carries a risk of failing to reproduce at all. Our results show that life histories are variable traits that can match regional predation environments in mammal species with widespread distributions.	[DeGabriel, Jane L.; Foley, William J.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [DeGabriel, Jane L.; Moore, Ben D.; Johnson, Christopher N.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [DeGabriel, Jane L.; Moore, Ben D.] Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW, Australia; [Johnson, Christopher N.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia	Australian National University; James Cook University; Western Sydney University; University of Tasmania	DeGabriel, JL (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	j.degabriel@uws.edu.au	Moore, Ben/AAE-7885-2020; Foley, William J/C-8069-2009; DeGabriel, Jane/B-3373-2012; Johnson, Christopher/J-7894-2014; Moore, Ben D/C-3447-2008	Moore, Ben/0000-0002-6995-4721; Foley, William J/0000-0001-8587-1814; DeGabriel, Jane/0000-0003-1245-5291; Johnson, Christopher/0000-0002-9719-3771; Moore, Ben D/0000-0002-6995-4721	Australian Research Council [DP0449621, DP0449544]; Australian National University Graduate School Scholarship	Australian Research Council(Australian Research Council); Australian National University Graduate School Scholarship(Australian National University)	This work was supported by the Australian Research Council http://www.arc.gov.au/ Grant number DP0449621 to CNJ, DP0449544 to WJF. JLD was supported by an Australian National University Graduate School Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaine D, 2000, BEHAV PROCESS, V51, P21, DOI 10.1016/S0376-6357(00)00116-9; Arthur AD, 2012, AUSTRAL ECOL, V37, P958, DOI 10.1111/j.1442-9993.2011.02355.x; Christe P, 2006, OIKOS, V114, P381, DOI 10.1111/j.2006.0030-1299.15130.x; Clinchy M, 2004, MOL ECOL, V13, P195, DOI 10.1046/j.1365-294X.2003.02029.x; CLINCHY M, 1999, THESIS U BRIT COLUMB; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; DALY M, 1990, ANIM BEHAV, V40, P380, DOI 10.1016/S0003-3472(05)80934-0; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; Efford M, 1998, J ANIM ECOL, V67, P503, DOI 10.1046/j.1365-2656.1998.00222.x; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fearn S, 2005, WILDLIFE RES, V32, P193, DOI 10.1071/WR04084; Fearn S, 2001, WILDLIFE RES, V28, P573, DOI 10.1071/WR00106; GORDON G, 1995, MAMMALS AUSTR, P174; Handasyde KA, 1996, WILDLIFE RES, V23, P755, DOI 10.1071/WR9960755; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Isaac JL, 2006, AUST J ZOOL, V54, P45, DOI 10.1071/ZO05060; Ji W, 2001, MOL ECOL, V10, P1527, DOI 10.1046/j.1365-294X.2001.01287.x; Kerle J. A, 2001, POSSUMS BRUSHTAILS R; KERLE JA, 1992, AUST J ZOOL, V40, P653, DOI 10.1071/ZO9920653; Kerr SE, 2005, THESIS J COOK U; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Martin JK, 2007, OECOLOGIA, V154, P227, DOI 10.1007/s00442-007-0823-y; Norrdahl K, 1998, ECOLOGY, V79, P226; OWENSMITH N, 1993, J ANIM ECOL, V62, P428, DOI 10.2307/5192; Pearson D, 2002, BIOL J LINN SOC, V77, P113, DOI 10.1046/j.1095-8312.1999.00075.x; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Development Team, 2008, R LANG ENV STAT COMP; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sarre SD, 2000, MOL ECOL, V9, P723, DOI 10.1046/j.1365-294x.2000.00916.x; Say L, 2003, MOL ECOL, V12, P2793, DOI 10.1046/j.1365-294X.2003.01945.x; SLIP DJ, 1988, J HERPETOL, V22, P323, DOI 10.2307/1564156; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Taylor AC, 1998, MOL ECOL, V7, P1780, DOI 10.1046/j.1365-294x.1998.00517.x; Taylor AC, 2000, MOL ECOL, V9, P869, DOI 10.1046/j.1365-294x.2000.00941.x; Tecot SR, 2013, BEHAV ECOL, V24, P987, DOI 10.1093/beheco/art008; Thirgood S, 1999, ADV STUD BEHAV, V28, P333, DOI 10.1016/S0065-3454(08)60220-X; Waser PM, 2006, BEHAV ECOL, V17, P971, DOI 10.1093/beheco/arl034; White AM, 2007, ANIM BEHAV, V74, P349, DOI 10.1016/j.anbehav.2006.12.011; WINTER JW, 1980, AUST WILDLIFE RES, V7, P359, DOI 10.1071/WR9800359; Winter JW, 1976, THESIS U QUEENSLAND	43	1	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111746	10.1371/journal.pone.0111746	http://dx.doi.org/10.1371/journal.pone.0111746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372294	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000344556900072
J	Ortlieb, S; Gorzelniak, L; Nowak, D; Strobl, R; Grill, E; Thorand, B; Peters, A; Kuhn, KA; Karrasch, S; Horsch, A; Schulz, H				Ortlieb, Sandra; Gorzelniak, Lukas; Nowak, Dennis; Strobl, Ralf; Grill, Eva; Thorand, Barbara; Peters, Annette; Kuhn, Klaus A.; Karrasch, Stefan; Horsch, Alexander; Schulz, Holger			Associations between Multiple Accelerometry-Assessed Physical Activity Parameters and Selected Health Outcomes in Elderly People - Results from the KORA-Age Study	PLOS ONE			English	Article							OLDER-ADULTS; ASSESSMENT QUESTIONNAIRE; AMERICAN-COLLEGE; SPORTS-MEDICINE; PUBLIC-HEALTH; UNITED-STATES; DISABILITY; MULTIMORBIDITY; INDEX; RECOMMENDATION	Introduction: Accelerometry is an important method for extending our knowledge about intensity, duration, frequency and patterns of physical activity needed to promote health. This study has used accelerometry to detect associations between intensity levels and related activity patterns with multimorbidity and disability. Moreover, the proportion of people meeting the physical activity recommendations for older people was assessed. Methods: Physical activity was measured in 168 subjects (78 males; 65-89 years of age), using triaxial GT3X accelerometers for ten consecutive days. The associations between physical activity parameters and multimorbidity or disability was examined using multiple logistic regression models, which were adjusted for gender, age, education, smoking, alcohol consumption, lung function, nutrition and multimorbidity or disability. Results: 35.7% of the participants met the physical activity recommendations of at least 150 minutes of moderate to vigorous activity per week. Only 11.9% reached these 150 minutes, when only bouts of at least 10 minutes were counted. Differences in moderate to vigorous activity between people with and without multimorbidity or disability were more obvious when shorter bouts instead of only longer bouts were included. Univariate analyses showed an inverse relationship between physical activity and multimorbidity or disability for light and moderate to vigorous physical activity. A higher proportion of long activity bouts spent sedentarily was associated with higher risk for multimorbidity, whereas a high proportion of long bouts in light activity seemed to prevent disability. After adjustment for covariates, there were no significant associations, anymore. Conclusions: The accumulated time in moderate to vigorous physical activity seems to have a stronger relationship with health and functioning when shorter activity bouts and not only longer bouts were counted. We could not detect an association of the intensity levels or activity patterns with multimorbidity or disability in elderly people after adjustment for covariates.	[Ortlieb, Sandra; Karrasch, Stefan; Schulz, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Ortlieb, Sandra; Gorzelniak, Lukas; Kuhn, Klaus A.; Horsch, Alexander] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Nowak, Dennis; Karrasch, Stefan] Univ Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Nowak, Dennis] CPC M, Munich, Germany; [Strobl, Ralf; Grill, Eva] Univ Munich, Inst Med Informat Proc Biometr & Epidemiol, Munich, Germany; [Strobl, Ralf; Grill, Eva] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Thorand, Barbara; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Karrasch, Stefan] Tech Univ Munich, Univ Hosp, Klinikum Rechts Isar, Inst Gen Practice, D-80290 Munich, Germany; [Horsch, Alexander] Univ Tromso, Dept Comp Sci, Tromso, Norway; [Horsch, Alexander] Univ Tromso, Dept Clin Med, Tromso, Norway	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Schulz, H (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany.	schulz@helmholtz-muenchen.de	Peters, Annette/A-6117-2011; Grill, Eva/D-1875-2010; Karrasch, Stefan/GQI-2691-2022; Schulz, Holger/J-5643-2015; Thorand, Barbara/B-5349-2014; Horsch, Alexander/W-8322-2018; Grill, Eva/AAF-8104-2020	Peters, Annette/0000-0001-6645-0985; Grill, Eva/0000-0002-0273-7984; Schulz, Holger/0000-0002-1157-200X; Thorand, Barbara/0000-0002-8416-6440; Horsch, Alexander/0000-0001-7745-0139; Grill, Eva/0000-0002-0273-7984	Helmholtz Zentrum Munchen; German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria; German Federal Ministry of Education and Research (BMBF) [FKZ 01ET0713]; BMBF [FKZ 01GI0882]; Graduate School of Information Science in Health (GSISH); Technische Universitat Munchen Graduate School	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); Graduate School of Information Science in Health (GSISH); Technische Universitat Munchen Graduate School	The KORA research platform (KORA, Cooperative Health Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (formerly GSF, National Research Center for Environment and Health), which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. KORA Age was financed by the German Federal Ministry of Education and Research (BMBF FKZ 01ET0713). Further support was provided by the BMBF funded Competence Network ASCONET, subnetwork COSYCONET (FKZ 01GI0882). The research was supported by the Graduate School of Information Science in Health (GSISH) and the Technische Universitat Munchen Graduate School. Lukas Gorzelniak received university grant monies as a PhD scholarship from 3/1/2009 to 6/30/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autenrieth CS, 2013, PREV MED, V57, P17, DOI 10.1016/j.ypmed.2013.02.014; Babyak M, 2009, PSYCHOSOM MED, V24, P8; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Bento T, 2012, REV SAUDE PUBL, V46, P561, DOI 10.1590/S0034-89102012005000022; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; Chaudhry S, 2005, MED CARE, V43, P607, DOI 10.1097/01.mlr.0000163658.65008.ec; Fortin M, 2006, ANN FAM MED, V4, P417, DOI 10.1370/afm.528; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; FRIES JF, 1982, J RHEUMATOL, V9, P789; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Harris TJ, 2009, BRIT J SPORT MED, V43, P442, DOI 10.1136/bjsm.2008.048033; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; He XXZ, 2004, AM J PUBLIC HEALTH, V94, P1567, DOI 10.2105/AJPH.94.9.1567; Hudon C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-304; Kaminsky LA, 2012, PHYSIOL MEAS, V33, P1869, DOI 10.1088/0967-3334/33/11/1869; Kaplan MS, 2001, AM J PREV MED, V21, P306, DOI 10.1016/S0749-3797(01)00364-6; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krishnan E, 2004, ARTHRITIS RHEUM-US, V50, P953, DOI 10.1002/art.20048; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Ortlieb S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-28; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Peters A, 2011, Z Gerontol Geriatr, V44 Suppl 2, P41, DOI 10.1007/s00391-011-0245-7; Machado VDS, 2012, MENOPAUSE, V19, P569, DOI 10.1097/gme.0b013e3182455963; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Shah RC, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-63; Sidall C, 2007, EU HLTH POLICY CONTE; Strath SJ, 2012, MED SCI SPORT EXER, V44, pS77, DOI 10.1249/MSS.0b013e3182399eb1; Strath SJ, 2003, INT J SPORTS MED, V24, P298, DOI 10.1055/s-2003-39504; Strobl R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-137; Tak E, 2013, AGEING RES REV, V12, P329, DOI 10.1016/j.arr.2012.10.001; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2005, MED SCI SPORT EXER, V37, pS487, DOI 10.1249/01.mss.0000185473.32846.c3; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Tudor-Locke CE, 2001, SPORTS MED, V31, P91, DOI 10.2165/00007256-200131020-00002; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; van den Bussche H., 2012, Z ALLG MED, V88, P365, DOI [DOI 10.3238/ZFA.2012.365-371, 10.3238/zfa.2012.365-371]; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wilms HU, 2007, COMPR PSYCHIAT, V48, P95, DOI 10.1016/j.comppsych.2006.04.001; Withall J, 2014, INT J ENV RES PUB HE, V11, P643, DOI 10.3390/ijerph110100643	45	22	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111206	10.1371/journal.pone.0111206	http://dx.doi.org/10.1371/journal.pone.0111206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372399	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900037
J	Kushwaha, KP; Sankar, J; Sankar, MJ; Gupta, A; Dadhich, JP; Gupta, YP; Bhatt, GC; Ansari, DA; Sharma, B				Kushwaha, Komal P.; Sankar, Jhuma; Sankar, M. Jeeva; Gupta, Arun; Dadhich, J. P.; Gupta, Y. P.; Bhatt, Girish C.; Ansari, Dilshad A.; Sharma, B.			Effect of Peer Counselling by Mother Support Groups on Infant and Young Child Feeding Practices: The Lalitpur Experience	PLOS ONE			English	Article							INTERVENTIONS; PROMOTION	Objective: Our primary objective was to evaluate the effect of peer counselling by mother support groups (MSG's) in improving the infant and young child feeding (IYCF) practices in the community. Methods: We conducted this repeated-measure before and after study in the Lalitpur district of Uttar Pradesh, India between 2006 and 2011. We assessed the IYCF practices before and after creating MSG's within the community. The feeding practices were reassessed at two time points-2 (T1) and 5 years (T2) after the intervention and compared with that of the pre-intervention phase (T0). Results: The total population covered by the project from the time of its initiation was 105000. A total of 425 (T0), 480 (T1) and 521 (T2) mother infant pairs were selected from this population. There was significant improvement in the following IYCF practices in the community (represented as %; adjOR (95% CI, p) such as initiation of breast feeding within 1 hour at both T1 (71% vs. 11%); 19.6 (13.6, 28.2, p = < 0.0001) and T2 (62% vs. 11%); 13.3 (9.4, 18.9, p = < 0.0001); use of prelacteal feeds at both T1 (67% vs. 15%); 12.6 (CI: 9.0, 17.6, p < 0.0001) and T2 (67% vs. 5%); 44.4 (28.8, 68.4, p = < 0.0001); rates of exclusive breast feeding for 6 months at both T1 (50% vs. 7%); 13.6 (7.6, 25.0, p = < 0.0001) and T2 (60% vs. 7%); 20.5 (11.3, 37.2, p = < 0.0001); initiation of complementary feeding at T1 (85% vs. 54%); 5.6 (3.6, 8.7, p = < 0.0001) and T2 (96% vs. 54%); 22.9 (11.8, 44.1, p = < 0.0001) and complementary feeding along with continued breast feeding at both T1 (36% vs. 4.5%); 6 (1.15, 31.4, p = 0.033) and T2 (42% vs. 4.5%); 8.06 (1.96, 49.1, p = 0.005) as compared to pre-intervention period (T0) after adjusting for important social and demographic variables. Conclusions: Peer counseling by MSG's improved the IYCF practices in the district and could be sustained.	[Kushwaha, Komal P.; Bhatt, Girish C.; Ansari, Dilshad A.; Sharma, B.] BRD Med Coll, Dept Pediat, Gorakhpur, Uttar Pradesh, India; [Sankar, Jhuma; Sankar, M. Jeeva] AIIMS, Dept Pediat, New Delhi, India; [Gupta, Arun] IBFAN Asia, Delhi, India; [Dadhich, J. P.] BPNI, Delhi, India; [Gupta, Y. P.] YG Consultants Pvt Ltd, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Kushwaha, KP (corresponding author), BRD Med Coll, Dept Pediat, Gorakhpur, Uttar Pradesh, India.	komalpkushwaha13@gmail.com	Bhatt, Girish Chandra/AAH-1026-2019; Sankar, Jeeva/Q-1007-2019; Sankar, Jhuma/AAE-7057-2019; DADHICH, JP/R-8705-2019	Sankar, Jeeva/0000-0003-1474-1451; Sankar, Jhuma/0000-0002-9807-6550; 	UNICEF	UNICEF	The project was funded by UNICEF. The funding received was 3000000 INR/year for 5 years for implementation of the project activities only. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrasada GV, 2005, ACTA PAEDIATR, V94, P1109, DOI 10.1080/08035250510025752; Aidam BA, 2005, J NUTR, V135, P1691, DOI 10.1093/jn/135.7.1691; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bland RM, 2008, AIDS, V22, P883, DOI 10.1097/QAD.0b013e3282f768de; BPNI/IBFAN, 2009, 3 1 TRAIN PROGR CAP; CEF, 2007, PROGR CHILDR REP A S; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Hannula L, 2008, J CLIN NURS, V17, P1132, DOI 10.1111/j.1365-2702.2007.02239.x; istrar General of India, 2011, SAMPL REG SYST SRS S; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kushwaha KP, 2010, REACHING 2S UNIVERSA; Malhotra N, 2013, PUBLIC HEALTH NUTR, V16, P1723, DOI 10.1017/S1368980012004065; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Nor B, 2009, J HUM LACT, V25, P427, DOI 10.1177/0890334409341050; Quinn VJ, 2005, J HUM LACT, V21, P345, DOI 10.1177/0890334405278383; Renfrew MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub4; Sudfeld CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045143; WHO, 2003, GLOB STRAT INF YOUNG; WHO/UNICEF, 1991, BAB FRIENDL HOSP IN; WHO UNICEF, 2009, BAB FRIENDL HOSP IN; World Health Organization, BREASTF COUNS TRAIN	24	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109181	10.1371/journal.pone.0109181	http://dx.doi.org/10.1371/journal.pone.0109181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369452	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000008
J	Mavrou, A; Brakspear, K; Hamdollah-Zadeh, M; Damodaran, G; Babaei-Jadidi, R; Oxley, J; Gillatt, DA; Ladomery, MR; Harper, SJ; Bates, DO; Oltean, S				Mavrou, A.; Brakspear, K.; Hamdollah-Zadeh, M.; Damodaran, G.; Babaei-Jadidi, R.; Oxley, J.; Gillatt, D. A.; Ladomery, M. R.; Harper, S. J.; Bates, D. O.; Oltean, S.			Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO EXPRESSION; SPLICE VARIANT; VEGF; ANGIOGENESIS; VEGF(165)B; VIVO; BEVACIZUMAB; PROGRESSION; THERAPIES	Angiogenesis is required for tumour growth and is induced principally by vascular endothelial growth factor A (VEGF-A). VEGF-A pre-mRNA is alternatively spliced at the terminal exon to produce two families of isoforms, pro- and anti-angiogenic, only the former of which is upregulated in prostate cancer (PCa). In renal epithelial cells and colon cancer cells, the choice of VEGF splice isoforms is controlled by the splicing factor SRSF1, phosphorylated by serine-arginine protein kinase 1 (SRPK1). Immunohistochemistry staining of human samples revealed a significant increase in SRPK1 expression both in prostate intraepithelial neoplasia lesions as well as malignant adenocarcinoma compared with benign prostate tissue. We therefore tested the hypothesis that the selective upregulation of pro-angiogenic VEGF in PCa may be under the control of SRPK1 activity. A switch in the expression of VEGF(165) towards the anti-angiogenic splice isoform, VEGF(165)b, was seen in PC-3 cells with SRPK1 knockdown (KD). PC-3 SRPK1-KD cells resulted in tumours that grew more slowly in xenografts, with decreased microvessel density. No effect was seen as a result of SRPK1-KD on growth, proliferation, migration and invasion capabilities of PC-3 cells in vitro. Small-molecule inhibitors of SRPK1 switched splicing towards the anti-angiogenic isoform VEGF(165)b in PC-3 cells and decreased tumour growth when administered intraperitoneally in an orthotopic mouse model of PCa. Our study suggests that modulation of SRPK1 and subsequent inhibition of tumour angiogenesis by regulation of VEGF splicing can alter prostate tumour growth and supports further studies for the use of SRPK1 inhibition as a potential anti-angiogenic therapy in PCa.	[Mavrou, A.; Brakspear, K.; Hamdollah-Zadeh, M.; Damodaran, G.; Harper, S. J.; Bates, D. O.; Oltean, S.] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS1 3NY, Avon, England; [Babaei-Jadidi, R.; Bates, D. O.] Univ Nottingham, Sch Med, Div Canc & Stem Cells, Canc Biol, Nottingham NG2 7QT, England; [Oxley, J.] North Bristol NHS Trust, Dept Cellular Pathol, Bristol, Avon, England; [Gillatt, D. A.] North Bristol NHS Trust, Dept Urol Sci, Bristol, Avon, England; [Ladomery, M. R.] Univ W England, Fac Hlth & Appl Sci, Ctr Res Biosci, Bristol BS16 1QY, Avon, England	University of Bristol; University of Nottingham; North Bristol NHS Trust; North Bristol NHS Trust; University of West England	Bates, DO (corresponding author), Univ Nottingham, Sch Med, Div Canc & Stem Cells, Canc Biol, Nottingham NG2 7QT, England.	david.bates@nottingham.ac.uk; sebastian.oltean@bristol.ac.uk		Bates, David/0000-0003-4850-2360; Oltean, Sebastian/0000-0001-7890-8439; Damodaran, Gopinath/0000-0002-1697-0357	Prostate Cancer Research UK; BBSRC [BB/J007293/1]; Medical Research Council [G10002073]; Cancer Research UK [C11392/A10484]; Richard Bright VEGF Research Trust (North Bristol Cancer Research Projects Fund) [96464]; BBSRC [BB/J007293/2] Funding Source: UKRI; MRC [G1002073, MR/K020366/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J007293/1] Funding Source: researchfish; Medical Research Council [G1002073, MR/K020366/1] Funding Source: researchfish	Prostate Cancer Research UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Richard Bright VEGF Research Trust (North Bristol Cancer Research Projects Fund); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Dr Andrew Armstrong (Duke University) for critical reading of the manuscript and helpful suggestions and the staff from AntiCancer Research Ltd. (San Diego) for training Athina Mavrou in the orthotopic prostate cancer model. This work was supported by Prostate Cancer Research UK, BBSRC (BB/J007293/1), the Medical Research Council (G10002073), Cancer Research UK (C11392/A10484) and Richard Bright VEGF Research Trust (North Bristol Cancer Research Projects Fund no. 96464).	Amin EM, 2011, CANCER CELL, V20, P768, DOI 10.1016/j.ccr.2011.10.016; Bates DO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068399; Bates DO, 2012, CLIN CANCER RES, V18, P6384, DOI 10.1158/1078-0432.CCR-12-2223; Bates DO, 2002, CANCER RES, V62, P4123; Bok RA, 2001, CANCER RES, V61, P2533; Clarke JM, 2013, CURR TREAT OPTION ON, V14, P109, DOI 10.1007/s11864-012-0222-4; Drake CG, 2014, ONCOGENE, V33, P5053, DOI 10.1038/onc.2013.497; Duque JLF, 1999, UROLOGY, V54, P523, DOI 10.1016/S0090-4295(99)00167-3; Duque José Luis Ferreira, 2006, Clinics, V61, P401, DOI 10.1590/S1807-59322006000500006; Ferrer FA, 1998, UROLOGY, V51, P161, DOI 10.1016/S0090-4295(97)00491-3; Ferrer FA, 1997, J UROLOGY, V157, P2329, DOI 10.1016/S0022-5347(01)64775-X; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Gammons MV, 2013, INVEST OPHTH VIS SCI, V54, P6052, DOI 10.1167/iovs.13-12422; Gatta G, 2013, ANN ONCOL, V24, P1660, DOI 10.1093/annonc/mdt030; Gout S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046539; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kelly WK, 2012, J CLIN ONCOL, V30, P1534, DOI 10.1200/JCO.2011.39.4767; Lambrechts D, 2013, J CLIN ONCOL, V31, P1219, DOI 10.1200/JCO.2012.46.2762; Malvezzi M, 2013, ANN ONCOL, V24, P792, DOI 10.1093/annonc/mdt010; Mukherji D, 2013, CRIT REV ONCOL HEMAT, V87, P122, DOI 10.1016/j.critrevonc.2013.01.002; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; Odunsi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051030; Oltean S, 2012, BIOCHEM SOC T, V40, P831, DOI 10.1042/BST20120051; Quaglia A, 2013, SURG ONCOL, V22, pE31, DOI 10.1016/j.suronc.2013.02.010; Rennel ES, 2008, BRIT J CANCER, V98, P1250, DOI 10.1038/sj.bjc.6604309; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Suarez SC, 2006, CELL MOL LIFE SCI, V63, P2067, DOI 10.1007/s00018-006-6254-9; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; WEIDNER N, 1993, AM J PATHOL, V143, P401; Whang YE, 2013, UROL ONCOL-SEMIN ORI, V31, P82, DOI 10.1016/j.urolonc.2010.09.018; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Yang M, 2005, PROSTATE, V62, P374, DOI 10.1002/pros.20125; Zhou B, 2013, MOL CELL BIOCHEM, V379, P191, DOI 10.1007/s11010-013-1641-7; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	39	100	104	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2015	34	33					4311	4319		10.1038/onc.2014.360	http://dx.doi.org/10.1038/onc.2014.360			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO9KK	25381816	Green Accepted			2022-12-26	WOS:000359494400003
J	Koblizek, V; Pecen, L; Zatloukal, J; Kocianova, J; Plutinsky, M; Kolek, V; Novotna, B; Kocova, E; Pracharova, S; Tichopad, A				Koblizek, Vladimir; Pecen, Ladislav; Zatloukal, Jaromir; Kocianova, Jana; Plutinsky, Marek; Kolek, Vitezslav; Novotna, Barbora; Kocova, Eva; Pracharova, Sarka; Tichopad, Ales			Real-Life GOLD 2011 Implementation: The Management of COPD Lacks Correct Classification and Adequate Treatment	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GUIDELINE DEVELOPMENT.; COORDINATING EFFORTS; THORACIC-SOCIETY; PHYSICIANS; RECOMMENDATIONS; PREVALENCE; DIAGNOSIS	Chronic obstructive pulmonary disease (COPD) is a serious, yet preventable and treatable, disease. The success of its treatment relies largely on the proper implementation of recommendations, such as the recently released Global Strategy for Diagnosis, Management, and Prevention of COPD (GOLD 2011, of late December 2011). The primary objective of this study was to examine the extent to which GOLD 2011 is being used correctly among Czech respiratory specialists, in particular with regard to the correct classification of patients. The secondary objective was to explore what effect an erroneous classification has on inadequate use of inhaled corticosteroids (ICS). In order to achieve these goals, a multicenter, cross-sectional study was conducted, consisting of a general questionnaire and patient-specific forms. A subjective classification into the GOLD 2011 categories was examined, and then compared with the objectively computed one. Based on 1,355 patient forms, a discrepancy between the subjective and objective classifications was found in 32.8% of cases. The most common reason for incorrect classification was an error in the assessment of symptoms, which resulted in underestimation in 23.9% of cases, and overestimation in 8.9% of the patients' records examined. The specialists seeing more than 120 patients per month were most likely to misclassify their condition, and were found to have done so in 36.7% of all patients seen. While examining the subjectively driven ICS prescription, it was found that 19.5% of patients received ICS not according to guideline recommendations, while in 12.2% of cases the ICS were omitted, contrary to guideline recommendations. Furthermore, with consideration to the objectively-computed classification, it was discovered that 15.4% of patients received ICS unnecessarily, whereas in 15.8% of cases, ICS were erroneously omitted. It was therefore concluded that Czech specialists tend either to under-prescribe or overuse inhaled corticosteroids.	[Koblizek, Vladimir; Novotna, Barbora; Kocova, Eva; Pracharova, Sarka] Charles Univ Prague, Fac Med Hradec Kralove, Dept Pulm, Hradec Kralove, Czech Republic; [Koblizek, Vladimir; Novotna, Barbora; Kocova, Eva; Pracharova, Sarka] Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Pecen, Ladislav; Tichopad, Ales] CEEOR Inst, Prague, Czech Republic; [Zatloukal, Jaromir; Kolek, Vitezslav] Palacky Univ Olomouc, Fac Med & Dent, Dept Resp Med & TB, Ostrava, Czech Republic; [Zatloukal, Jaromir; Kolek, Vitezslav] Univ Hosp Olomouc, Ostrava, Czech Republic; [Kocianova, Jana] Chest Clin, Ostrava, Czech Republic; [Plutinsky, Marek] Masaryk Univ, Fac Med, Dept Resp Med & TB, Brno, Czech Republic; [Plutinsky, Marek] Univ Hosp Brno, Brno, Czech Republic	Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Palacky University Olomouc; University Hospital Olomouc; Masaryk University Brno; University Hospital Brno	Tichopad, A (corresponding author), CEEOR Inst, Prague, Czech Republic.	tichopad@ceeor.com	Koblizek, Vladimir/AAC-5374-2019; Kocova, Eva/N-1702-2017; Pecen, Ladislav/G-7057-2014; Plutinsky, Marek/ABF-2366-2020	Kocova, Eva/0000-0002-1185-7697; Plutinsky, Marek/0000-0003-1723-3794; Koblizek, Vladimir/0000-0002-2446-2790	Boehringer Ingelheim; Czech Ministry of Health [00179906]	Boehringer Ingelheim(Boehringer Ingelheim); Czech Ministry of Health(Ministry of Health, Czech Republic)	The study was funded by Boehringer Ingelheim. The study was awarded the Czech Ministry of Health grant, number of reference: DRO(UHHK, 00179906). Boehringer Ingelheim has contributed to the study design by providing the outline for data input requested, conceiving the preliminary version of the doctors' questionnaire and supervising the study conduct throughout its course. The Czech Ministry of Health did not intervene in the study design or its conduct, except for its compliance assessment and registration. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellamy David, 2006, Prim Care Respir J, V15, P48, DOI 10.1016/j.pcrj.2005.11.003; Bridevaux PO, 2010, EUR RESPIR J, V36, P1259, DOI 10.1183/09031936.00004110; Buist AS, 2008, INT J TUBERC LUNG D, V12, P703; Burgers Jako S, 2012, Proc Am Thorac Soc, V9, P304, DOI 10.1513/pats.201208-067ST; Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361; Decramer M, 2013, ACTA CLIN BELG, V68, P325, DOI 10.2143/ACB.3403; Desalu OO, 2013, PRIM CARE RESP J, V22, P79, DOI 10.4104/pcrj.2013.00014; Dong Y. H., 2014, CHEST; Ford ES, 2014, COPD; Glaab T, 2006, INT J CHRONIC OBSTR, V3, P141; Glaab T, 2012, INT J CHRONIC OBSTR, V7, P101, DOI 10.2147/COPD.S27887; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Grimshaw Jeremy M, 2012, Proc Am Thorac Soc, V9, P298, DOI 10.1513/pats.201208-066ST; Gupta Dheeraj, 2013, Lung India, V30, P228, DOI 10.4103/0970-2113.116248; Hoonhorst SJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087443; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010844.pub2; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; Koblizek V, 2013, BIOMED PAP, V157, P189, DOI 10.5507/bp.2013.039; Lee H, 2013, AM FAM PHYSICIAN, V88, P655; Lucas AEM, 2008, FAM PRACT, V25, P86, DOI 10.1093/fampra/cmn006; Maio S, 2014, CURR MED RES OPIN; Maly M., 2013, Studia Pneumologica et Phthiseologica, V73, P128; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P1, DOI 10.1016/S0300-2896(14)70070-5; Miravitlles M, 2009, RESP MED, V103, P714, DOI 10.1016/j.rmed.2008.11.019; Montanari Ugo, 2013, Recenti Progressi in Medicina, V104, P23, DOI 10.1701/1226.13591; National Institute of Health and Care Excellence, CHRON OBSTR PULM DIS; O'Donnell DE, 2007, CAN RESPIR J, V14, p5B, DOI 10.1155/2007/830570; Parker DR, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-56; Poznanska Anna, 2011, Przegl Epidemiol, V65, P483; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Roche N, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-56; Sarc I, 2011, J EVAL CLIN PRACT, V17, P737, DOI 10.1111/j.1365-2753.2010.01617.x; Schunemann Holger J, 2012, Proc Am Thorac Soc, V9, P215, DOI 10.1513/pats.201208-053ST; Smidth M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-385; Valipour A, 2014, PHENOTYPES COPD CENT; Vestbo J, 2014, RESP MED, V108, P729, DOI 10.1016/j.rmed.2014.03.002; White P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075221; WHO, WHO EUR DET MORT DAT; Wilt Timothy J, 2012, Proc Am Thorac Soc, V9, P243, DOI 10.1513/pats.201208-058ST; World Health Organisation, BURD COPD; Yawn Barbara P, 2012, Proc Am Thorac Soc, V9, P219, DOI 10.1513/pats.201208-054ST	42	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111078	10.1371/journal.pone.0111078	http://dx.doi.org/10.1371/journal.pone.0111078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380287	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100018
J	Lou, J; Ren, MW; Wang, H				Lou, Jing; Ren, Mingwu; Wang, Huan			Regional Principal Color Based Saliency Detection	PLOS ONE			English	Article							VISUAL-ATTENTION; OBJECT DETECTION; EXTRACTION; FEATURES	Saliency detection is widely used in many visual applications like image segmentation, object recognition and classification. In this paper, we will introduce a new method to detect salient objects in natural images. The approach is based on a regional principal color contrast modal, which incorporates low-level and medium-level visual cues. The method allows a simple computation of color features and two categories of spatial relationships to a saliency map, achieving higher F-measure rates. At the same time, we present an interpolation approach to evaluate resulting curves, and analyze parameters selection. Our method enables the effective computation of arbitrary resolution images. Experimental results on a saliency database show that our approach produces high quality saliency maps and performs favorably against ten saliency detection algorithms.	[Lou, Jing; Ren, Mingwu; Wang, Huan] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Ren, MW (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China.	renmingwu@sina.com	Lou, Jing/B-3258-2011	Lou, Jing/0000-0001-8502-7429	National Natural Science Foundation of China (NSFC) [61231014, 60875010]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (NSFC, Grant nos. 61231014, 60875010) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta R, 2008, LECT NOTES COMPUT SC, V5008, P66; Achanta R, 2009, PROC CVPR IEEE, P1597, DOI 10.1109/CVPRW.2009.5206596; Alexe B, 2010, PROC CVPR IEEE, P73, DOI 10.1109/CVPR.2010.5540226; Chen TC, 2009, PROC EUR SOLID-STATE, P1; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Goferman S, 2010, PROC CVPR IEEE, P2376, DOI 10.1109/CVPR.2010.5539929; Han JW, 2006, IEEE T CIRC SYST VID, V16, P141, DOI 10.1109/TCSVT.2005.859028; Heckbert P., 1982, Computer Graphics, V16, P297, DOI 10.1145/965145.801294; Hiremath P.S., 2008, INT J IMAGE PROCESS, V2, P10; Hou XD, 2007, PROC CVPR IEEE, P2280; Huang H, 2010, COMPUT GRAPH FORUM, V29, P2055, DOI 10.1111/j.1467-8659.2010.01792.x; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jiang HZ, 2013, PROC CVPR IEEE, P2083, DOI 10.1109/CVPR.2013.271; Judd T, 2009, IEEE I CONF COMP VIS, P2106, DOI 10.1109/ICCV.2009.5459462; Kai-Yueh Chang, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2129, DOI 10.1109/CVPR.2011.5995415; Klein DA, 2011, IEEE I CONF COMP VIS, P2214, DOI 10.1109/ICCV.2011.6126499; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Li HL, 2011, IEEE T IMAGE PROCESS, V20, P3365, DOI 10.1109/TIP.2011.2156803; Li J, 2013, IEEE T PATTERN ANAL, V35, P996, DOI 10.1109/TPAMI.2012.147; Liu T, 2007, PROC CVPR IEEE, P596; [马儒宁 Ma Runing], 2012, [自动化学报, Acta Automatica Sinica], V38, P870; Ma Y.-F, 2003, P 11 ACM INT C MULTI, P374; Min Chen, 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P409, DOI 10.1109/INFCOMW.2011.5928847; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Riche N, 2012, IEEE IMAGE PROC, P641, DOI 10.1109/ICIP.2012.6466941; Rother C, 2004, ACM T GRAPHIC, V23, P309, DOI 10.1145/1015706.1015720; Russell B., 2006, COMP VIS PATT REC 20, V2, P1605, DOI DOI 10.1109/CVPR.2006.326; Rutishauser U, 2004, PROC CVPR IEEE, P37; Sharma G, 2012, PROC CVPR IEEE, P3506, DOI 10.1109/CVPR.2012.6248093; Shen XH, 2012, PROC CVPR IEEE, P853, DOI 10.1109/CVPR.2012.6247758; Siagian C, 2007, IEEE T PATTERN ANAL, V29, P300, DOI 10.1109/TPAMI.2007.40; Tang KT, 2011, IEEE IMAGE PROC; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Torralba A, 2011, PROC CVPR IEEE, P1521, DOI 10.1109/CVPR.2011.5995347; Wan X, 1996, P SOC PHOTO-OPT INS, V2670, P8, DOI 10.1117/12.234782; Wang P, 2012, PROC CVPR IEEE, P3194, DOI 10.1109/CVPR.2012.6248054; Xie YL, 2013, IEEE T IMAGE PROCESS, V22, P1689, DOI 10.1109/TIP.2012.2216276; Yan Q, 2013, PROC CVPR IEEE, P1155, DOI 10.1109/CVPR.2013.153; Zhai Y., 2006, PROC14TH ACM INT C M, DOI DOI 10.1145/1180639.1180824	40	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112475	10.1371/journal.pone.0112475	http://dx.doi.org/10.1371/journal.pone.0112475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379960	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100105
J	Nemes, K; Gellert, A; Balazs, E; Salanki, K				Nemes, Katalin; Gellert, Akos; Balazs, Ervin; Salanki, Katalin			Alanine Scanning of Cucumber Mosaic Virus (CMV) 2B Protein Identifies Different Positions for Cell-To-Cell Movement and Gene Silencing Suppressor Activity	PLOS ONE			English	Article							ARABIDOPSIS ARGONAUTE1; RNA-BINDING; I-TASSER; ACCUMULATION; EXPRESSION; VIRULENCE; RESISTANCE; 2B-PROTEIN; INHIBITION; INDUCTION	The multifunctional 2b protein of CMV has a role in the long distance and local movement of the virus, in symptom formation, in evasion of defense mediated by salicylic acid as well as in suppression of RNA silencing. The role of conserved amino acid sequence domains were analyzed previously in the protein function, but comprehensive analysis of this protein was not carried out until recently. We have analyzed all over the 2b protein by alanine scanning mutagenesis changing three consecutive amino acids (aa) to alanine. We have identified eight aa triplets as key determinants of the 2b protein function in virus infection. Four of them (KKQ/22-24/AAA, QNR/31-33/AAA, RER/34-36/AAA, SPS/40-42/AAA) overlap with previously determined regions indispensable in gene silencing suppressor function. We have identified two additional triplets necessary for the suppressor function of the 2b protein (LPF/55-57/AAA, NVE/10-12/AAA), and two other positions were required for cell-to-cell movement of the virus (MEL/1-3/AAA, RHV/70-72/AAA), which are not essential for suppressor activity.	[Nemes, Katalin; Salanki, Katalin] Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Budapest, Hungary; [Nemes, Katalin] Corvinus Univ Budapest, Dept Plant Pathol, Budapest, Hungary; [Gellert, Akos; Balazs, Ervin] Hungarian Acad Sci, Agr Res Ctr, Inst Agr, Dept Appl Genom, Budapest, Hungary; [Salanki, Katalin] Agr Biotechnol Ctr, Godollo, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Corvinus University Budapest; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Salanki, K (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Budapest, Hungary.	salanki.katalin@agrar.mta.hu	Salanki, Katalin/AAY-1834-2021	Salanki, Katalin/0000-0002-0128-4338	Hungarian Scientific Research Fund [OTKA-K75168, OTKA-K109482]; Hungarian Academy of Sciences	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This project was funded by the Hungarian Scientific Research Fund OTKA-K75168 and OTKA-K109482. Akos Gellert was the recipient of Janos Bolyai fellowship from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Chen HY, 2008, EMBO REP, V9, P754, DOI 10.1038/embor.2008.118; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; DING SW, 1995, EMBO J, V14, P5762, DOI 10.1002/j.1460-2075.1995.tb00265.x; DING SW, 1994, VIROLOGY, V198, P593, DOI 10.1006/viro.1994.1071; Diveki Z, 2004, MOL PLANT MICROBE IN, V17, P837, DOI 10.1094/MPMI.2004.17.8.837; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Du ZY, 2014, J VIROL, V88, P5228, DOI 10.1128/JVI.00284-14; Duan CG, 2012, PLANT CELL, V24, P259, DOI 10.1105/tpc.111.092718; Gellert A, 2012, J MOL GRAPH MODEL, V38, P446, DOI 10.1016/j.jmgm.2012.08.005; Gonzalez I, 2012, RNA, V18, P771, DOI 10.1261/rna.031260.111; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; Goto K, 2007, PLANT CELL PHYSIOL, V48, P1050, DOI 10.1093/pcp/pcm074; Guo HS, 2002, EMBO J, V21, P398, DOI 10.1093/emboj/21.3.398; Ham BK, 1999, MOL CELLS, V9, P548; Hamera S, 2012, PLANT J, V69, P104, DOI 10.1111/j.1365-313X.2011.04774.x; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huppert E, 2002, J VIROL, V76, P3554, DOI 10.1128/JVI.76.7.3554-3557.2002; Ji LH, 2001, MOL PLANT MICROBE IN, V14, P715, DOI 10.1094/MPMI.2001.14.6.715; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Lewsey M, 2009, MOL PLANT MICROBE IN, V22, P642, DOI 10.1094/MPMI-22-6-0642; Lewsey MG, 2010, PLANT SIGNAL BEHAV, V5, P705, DOI 10.4161/psb.5.6.11643; Lewsey MG, 2010, MOL PLANT MICROBE IN, V23, P835, DOI 10.1094/MPMI-23-7-0835; Lucy AP, 2000, EMBO J, V19, P1672, DOI 10.1093/emboj/19.7.1672; Mayers CN, 2000, J GEN VIROL, V81, P219, DOI 10.1099/0022-1317-81-1-219; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Netsu O, 2008, ARCH VIROL, V153, P1731, DOI 10.1007/s00705-008-0166-y; PALUKAITIS P, 1992, ADV VIRUS RES, V41, P281, DOI 10.1016/B978-0-12-394314-9.00013-0; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qu J, 2007, J VIROL, V81, P6690, DOI 10.1128/JVI.02457-06; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scholthof HB, 2011, PLANT PHYSIOL, V156, P1548, DOI 10.1104/pp.111.178764; Shi BJ, 2003, MOL PLANT MICROBE IN, V16, P261, DOI 10.1094/MPMI.2003.16.3.261; Shi BJ, 1997, J GEN VIROL, V78, P505, DOI 10.1099/0022-1317-78-3-505; Soards AJ, 2002, MOL PLANT MICROBE IN, V15, P647, DOI 10.1094/MPMI.2002.15.7.647; Sueda K, 2010, FEBS LETT, V584, P945, DOI 10.1016/j.febslet.2010.01.033; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wang YZ, 2004, J GEN VIROL, V85, P3135, DOI 10.1099/vir.0.80250-0; WHITE JL, 1989, J VIROL METHODS, V23, P83, DOI 10.1016/0166-0934(89)90122-5; Ye J, 2009, FEBS LETT, V583, P101, DOI 10.1016/j.febslet.2008.11.031; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou T, 2014, J GEN VIROL, V95, P1408, DOI 10.1099/vir.0.063461-0	52	14	15	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112095	10.1371/journal.pone.0112095	http://dx.doi.org/10.1371/journal.pone.0112095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380036	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100051
J	Wu, J; Zhang, YS; Mu, ZC				Wu, Jing; Zhang, Yusen; Mu, Zengchao			Predicting Nucleosome Positioning Based on Geometrically Transformed Tsallis Entropy	PLOS ONE			English	Article							SEQUENCE; YEAST; OCCUPANCY	As the fundamental unit of eukaryotic chromatin structure, nucleosome plays critical roles in gene expression and regulation by controlling physical access to transcription factors. In this paper, based on the geometrically transformed Tsallis entropy and two index-vectors, a valid nucleosome positioning information model is developed to describe the distribution of A/T-riched and G/C-riched dimeric and trimeric motifs along the DNA duplex. When applied to train the support vector machine, the model achieves high AUCs across five organisms, which have significantly outperformed the previous studies. Besides, we adopt the concept of relative distance to describe the probability of arbitrary DNA sequence covered by nucleosome. Thus, the average nucleosome occupancy profile over the S.cerevisiae genome is calculated. With our peak detection model, the isolated nucleosomes along genome sequence are located. When compared with some published results, it shows that our model is effective for nucleosome positioning. The index-vector component n(WWW)/n(W) is identified to be an important influencing factor of nucleosome organizations.	[Wu, Jing; Zhang, Yusen; Mu, Zengchao] Shandong Univ, Sch Math & Stat, Weihai, Peoples R China	Shandong University	Zhang, YS (corresponding author), Shandong Univ, Sch Math & Stat, Weihai, Peoples R China.	zhangys@sdu.edu.cn	Zhang, Yusen/R-8508-2017; Zhang, Yusen/R-6097-2019	Zhang, Yusen/0000-0003-3842-1153; Zhang, Yusen/0000-0003-3842-1153	Shandong Natural Science Foundation [ZR2010AM020]	Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province)	This work was supported by the Shandong Natural Science Foundation (ZR2010AM020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chung HR, 2009, J MOL BIOL, V386, P1411, DOI 10.1016/j.jmb.2008.11.049; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Gan YL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-49; Gupta S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000134; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; Morozov AV, 2009, NUCLEIC ACIDS RES, V37, P4707, DOI 10.1093/nar/gkp475; Nandy A, 2003, CHEM PHYS LETT, V368, P102, DOI 10.1016/S0009-2614(02)01830-4; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Polishko A, 2012, BIOINFORMATICS, V28, pI242, DOI 10.1093/bioinformatics/bts206; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Tanaka Yoshiaki, 2009, Genome Inform, V23, P169; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; Trifonov EN, 1997, MOL BIOL+, V31, P647; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Yuan GC, 2009, J COMPUT BIOL, V16, P341, DOI 10.1089/cmb.2008.18TT; Zhang YS, 2011, MATCH-COMMUN MATH CO, V65, P477; Zhang YS, 2011, J BIOMOL STRUCT DYN, V28, P557, DOI 10.1080/07391102.2011.10508595; Zhang ZQ, 2012, MATCH-COMMUN MATH CO, V68, P639; Zhang ZQ, 2012, J BIOMOL STRUCT DYN, V29, P1081, DOI 10.1080/073911012010525032	29	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e109395	10.1371/journal.pone.0109395	http://dx.doi.org/10.1371/journal.pone.0109395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380134	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100007
J	Du, Y; Gao, YH; Meng, FG; Liu, SJ; Fan, ZP; Wu, JH; Sun, DJ				Du, Yang; Gao, Yanhui; Meng, Fangang; Liu, Shoujun; Fan, Zhipeng; Wu, Junhua; Sun, Dianjun			Iodine Deficiency and Excess Coexist in China and Induce Thyroid Dysfunction and Disease: A Cross-Sectional Study	PLOS ONE			English	Article							DRINKING-WATER; ENDEMIC GOITER; CHILDREN; EPIDEMIOLOGY; PREVALENCE; GESTATION; PREGNANCY; NUTRITION; NODULES; REGIONS	Background: In spite of the salt iodization, iodine deficiency disorders (IDD) have not been sustainably eliminated in China. There are coastal areas with low iodized salt coverage rates (iodine nutrition is inadequate) and other areas with excessive amounts of iodine in the drinking water. Objective: This study aimed to clarify the association of iodine deficiencies resulting from a low coverage rate of iodized salt, excess iodine intake from drinking water with thyroid function and disease in adults. Design: A cross-sectional study was conducted in adults in different iodine nutrition areas in three provinces in China. Results: The prevalence of thyroid nodules was 15.52%, 8.66% and 22.17% in the iodine excess, sufficient and deficient groups, respectively. The prevalence of subclinical hypothyroidism was 20.09%, 10.41%, and 2.25% in the excess, sufficient and deficient iodine groups, respectively. The prevalence of subclinical hyperthyroidism and overt hyperthyroidism in the iodine deficient group was higher than that in the iodine excess group (chi(2) = 9.302, p = 0.002) and iodine sufficient group (chi(2) = 7.553, p = 0.006). Thyroid-stimulating hormone (TSH) was significantly correlated with excess iodine intake (beta = 1.764, P = 0.001) and deficient iodine intake (beta = -1.219, P = 0.028). Conclusions: Thyroid nodules are more likely to be present in the iodine excess and deficient areas than in the iodine sufficient areas. Subclinical hyperthyroidism and overt hyperthyroidism are more likely to be prevalent in the iodine deficient areas than in the iodine excess or sufficient areas. Subclinical hypothyroidism is more likely to be prevalent in the high iodine intake areas than in the iodine deficient or sufficient areas. Median TSH may be deemed as an alternative indicator for monitoring the iodine nutrition status of the adult population in iodine excess and deficient areas.	[Sun, Dianjun] Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Key Lab Etiol & Epidemiol,Educ Bur Heilongjiang P, Harbin 23618504, Peoples R China; Minist Hlth, Harbin 23618504, Peoples R China	Chinese Center for Disease Control & Prevention; Harbin Medical University	Sun, DJ (corresponding author), Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Key Lab Etiol & Epidemiol,Educ Bur Heilongjiang P, Harbin 23618504, Peoples R China.	hrbmusdj@163.com			Special Fund for National Health Scientific Research in the Public Interest by the Ministry of Health of China [201202012]	Special Fund for National Health Scientific Research in the Public Interest by the Ministry of Health of China	This study was supported by the Special Fund for National Health Scientific Research in the Public Interest by the Ministry of Health of China (No. 201202012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2014, J FAM COMMUNITY MED, V21, P48, DOI 10.4103/2230-8229.128783; Andersen S, 2009, MATURITAS, V64, P126, DOI 10.1016/j.maturitas.2009.08.007; Andersson M, 2010, BEST PRACT RES CL EN, V24, P1, DOI 10.1016/j.beem.2009.08.005; Chen ZX, 2013, AM J CLIN NUTR, V98, P684, DOI 10.3945/ajcn.112.054353; Eltom A, 2001, CLIN ENDOCRINOL, V55, P485, DOI 10.1046/j.1365-2265.2001.01368.x; Evans C, 2014, CLIN ENDOCRINOL, V81, P606, DOI 10.1111/cen.12474; GUTEKUNST R, 1986, ACTA ENDOCRINOL-COP, V112, P494, DOI 10.1530/acta.0.1120494; Henjum S, 2010, PUBLIC HEALTH NUTR, V13, P1472, DOI 10.1017/S1368980010000650; Jin Y, 2006, GBT575052006; Kapil U, 2014, PUBLIC HEALTH NUTR, V17, P1971, DOI 10.1017/S1368980014000226; LI M, 1987, LANCET, V2, P257; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089608; Liu S, 2007, 2762007 WS; Lu Ying-li, 2005, J Zhejiang Univ Sci B, V6, P1200, DOI 10.1631/jzus.2005.B1200; Lv SM, 2014, BRIT J NUTR, V111, P86, DOI 10.1017/S0007114513001906; Lv SM, 2012, PUBLIC HEALTH NUTR, V15, P1168, DOI 10.1017/S1368980012000146; Matthys B, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-50; Medani AMMH, 2013, PUBLIC HEALTH NUTR, V16, P1586, DOI 10.1017/S1368980012004685; Mesele M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-130; Mitka M, 2013, JAMA-J AM MED ASSOC, V309, P2428, DOI 10.1001/jama.2013.7239; Pearce EN, 2013, THYROID, V23, P523, DOI 10.1089/thy.2013.0128; Pearce EN, 2012, J TRACE ELEM MED BIO, V26, P131, DOI 10.1016/j.jtemb.2012.04.005; Roti E, 2001, THYROID, V11, P493, DOI 10.1089/105072501300176453; Sang ZN, 2013, J NUTR, V143, P2038, DOI 10.3945/jn.113.179135; Sang ZN, 2012, J CLIN ENDOCR METAB, V97, pE1363, DOI 10.1210/jc.2011-3438; Shen HM, 2011, BRIT J NUTR, V106, P243, DOI 10.1017/S0007114511000055; Sukkhojaiwaratkul D, 2014, J PERINATOL, V34, P594, DOI 10.1038/jp.2014.62; Szabolcs I, 1997, CLIN ENDOCRINOL, V47, P87, DOI 10.1046/j.1365-2265.1997.2271040.x; Takahashi T, 1999, INT J EPIDEMIOL, V28, P742, DOI 10.1093/ije/28.4.742; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; Tong YK, 2012, 1302572012 GBT; WHO UNICEF ICCIDD, 2007, ASS IOD DEF DIS MON; Yan YQ, 2006, 1072006 WST; Yu X, 2008, J ENDOCRINOL INVEST, V31, P243, DOI 10.1007/BF03345597; Zama SY, 2013, J CLIN DIAGN RES, V7, P2807, DOI 10.7860/JCDR/2013/6878.3702; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3; Zimmermann MB, 2013, ENDOCR PRACT, V19, P839, DOI 10.4158/EP13180.RA; Zimmermann MB, 2012, PAEDIATR PERINAT EP, V26, P108, DOI 10.1111/j.1365-3016.2012.01275.x; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011; Zou SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040718	40	49	61	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111937	10.1371/journal.pone.0111937	http://dx.doi.org/10.1371/journal.pone.0111937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375854	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600077
J	Kalani, K; Kushwaha, V; Sharma, P; Verma, R; Srivastava, M; Khan, F; Murthy, PK; Srivastava, SK				Kalani, Komal; Kushwaha, Vikas; Sharma, Pooja; Verma, Richa; Srivastava, Mukesh; Khan, Feroz; Murthy, P. K.; Srivastava, Santosh Kumar			In Vitro, In Silico and In Vivo Studies of Ursolic Acid as an Anti-Filarial Agent	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; MASTOMYS-NATALENSIS; BRUGIA-MALAYI; SYSTEMS; TOXICITY; PARASITE; LEAVES; ASSAY	As part of our drug discovery program for anti-filarial agents from Indian medicinal plants, leaves of Eucalyptus tereticornis were chemically investigated, which resulted in the isolation and characterization of an anti-filarial agent, ursolic acid (UA) as a major constituent. Antifilarial activity of UA against the human lymphatic filarial parasite Brugia malayi using in vitro and in vivo assays, and in silico docking search on glutathione-s-transferase (GST) parasitic enzyme were carried out. The UA was lethal to microfilariae (mf; LC100: 50; IC50: 8.84 mu M) and female adult worms (LC100: 100; IC50: 35.36 mu M) as observed by motility assay; it exerted 86% inhibition in MTT reduction potential of the adult parasites. The selectivity index (SI) of UA for the parasites was found safe. This was supported by the molecular docking studies, which showed adequate docking (LibDock) scores for UA (-8.6) with respect to the standard antifilarial drugs, ivermectin (IVM -8.4) and diethylcarbamazine (DEC-C -4.6) on glutathione-s-transferase enzyme. Further, in silico pharmacokinetic and drug-likeness studies showed that UA possesses drug-like properties. Furthermore, UA was evaluated in vivo in B. malayi-M. coucha model (natural infection), which showed 54% macrofilaricidal activity, 56% female worm sterility and almost unchanged microfilaraemia maintained throughout observation period with no adverse effect on the host. Thus, in conclusion in vitro, in silico and in vivo results indicate that UA is a promising, inexpensive, widely available natural lead, which can be designed and developed into a macrofilaricidal drug. To the best of our knowledge this is the first ever report on the anti-filarial potential of UA from E. tereticornis, which is in full agreement with the Thomson Reuter's 'Metadrug' tool screening predictions.	[Kalani, Komal; Srivastava, Santosh Kumar] CSIR, Cent Inst Med & Aromat Plants, Dept Med Chem, Lucknow 226015, Uttar Pradesh, India; [Kushwaha, Vikas; Verma, Richa; Murthy, P. K.] CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India; [Sharma, Pooja; Khan, Feroz] CSIR, Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, Lucknow 226015, Uttar Pradesh, India; [Srivastava, Mukesh] CSIR, Cent Drug Res Inst, Biometry Sect, Lucknow 226001, Uttar Pradesh, India; [Kalani, Komal; Khan, Feroz; Srivastava, Santosh Kumar] Anusandhan Bhawan, Acad Sci & Innovat Res AcSIR, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR)	Murthy, PK (corresponding author), CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India.	drpkmurthy@gmail.com; skscimap@gmail.com	Khan, Feroz/AHC-3474-2022; Kushwaha, Vikas/AAA-6987-2021	Khan, Feroz/0000-0002-2704-5925; Kushwaha, Vikas/0000-0003-4365-5720	CSIR-network project [BSC-0121]; CSIR-SPLENDID	CSIR-network project(Council of Scientific & Industrial Research (CSIR) - India); CSIR-SPLENDID	The funding sources are CSIR-network project BSC-0121 and CSIR-SPLENDID and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azeez S, 2012, J MOL MODEL, V18, P151, DOI 10.1007/s00894-011-1035-2; BROPHY PM, 1994, EXP PARASITOL, V79, P89, DOI 10.1006/expr.1994.1067; Bugrim A, 2004, DRUG DISCOV TODAY, V9, P127, DOI 10.1016/S1359-6446(03)02971-4; Burkot T R, 2006, Filaria J, V5, P10, DOI 10.1186/1475-2883-5-10; CHATTERJEE RK, 1992, DRUG DEVELOP RES, V26, P67, DOI 10.1002/ddr.430260106; Dadzie Yankum, 2003, Filaria J, V2, P2, DOI 10.1186/1475-2883-2-2; Gaur RL, 2007, PARASITOLOGY, V134, P537, DOI 10.1017/S0031182006001612; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; HUBER W, 1993, ACTA TROP, V55, P257, DOI 10.1016/0001-706X(93)90083-N; Kalani K, 2014, CURR TOP MED CHEM, V14, P1005, DOI 10.2174/1568026614666140324121606; Kalani K, 2013, BIOORG MED CHEM LETT, V23, P2566, DOI 10.1016/j.bmcl.2013.02.115; Kalani K, 2012, J MOL MODEL, V18, P3389, DOI 10.1007/s00894-011-1327-6; Kushwaha V, 2011, CHRON YOUNG SCI, P202, DOI DOI 10.4103/2229-5186.93025; Lakshmi V, 2010, ACTA TROP, V116, P127, DOI 10.1016/j.actatropica.2010.06.006; LAMMLER G, 1977, TROPENMED PARASITOL, V28, P205; Lanham A, 2013, AM J INFECT DIS MICR, V1, P5; Maurya A, 2012, J BRAZIL CHEM SOC, V23, P468, DOI 10.1590/S0103-50532012000300013; Molyneux DH, 2002, ANN TROP MED PARASIT, V96, pS15, DOI 10.1179/000349802125002374; Molyneux DH, 2003, TRENDS PARASITOL, V19, P516, DOI 10.1016/j.pt.2003.09.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murthy PK, 1999, CURR SCI INDIA, V77, P1084; Murthy PK, 1997, FOLIA PARASIT, V44, P302; MURTHY PK, 1983, INDIAN J MED RES, V77, P623; Murthy PK, 2011, PLANTA MED, V77, P647, DOI 10.1055/s-0030-1250452; Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x; PAGE B, 1993, INT J ONCOL, V3, P473; Sashidhara KV, 2014, EUR J MED CHEM, V81, P473, DOI 10.1016/j.ejmech.2014.05.029; Sommer A, 2001, INFECT IMMUN, V69, P7718, DOI 10.1128/IAI.69.12.7718-7728.2001; WHO, 2006, WEEKLY EPIDEMIOLOGIC; WHO, 2012, WEEKLY EPIDEMIOLOGIC; World Health Organization, 2005, WEEKLY EPIDEMIOLOGIC; Yadav D, 2013, PHYTOMEDICINE, V20, P124, DOI 10.1016/j.phymed.2012.10.017	32	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111244	10.1371/journal.pone.0111244	http://dx.doi.org/10.1371/journal.pone.0111244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375886	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600032
J	Sahu, RP; Rezania, S; Ocana, JA; DaSilva-Arnold, SC; Bradish, JR; Richey, JD; Warren, SJ; Rashid, B; Travers, JB; Konger, RL				Sahu, Ravi P.; Rezania, Samin; Ocana, Jesus A.; DaSilva-Arnold, Sonia C.; Bradish, Joshua R.; Richey, Justin D.; Warren, Simon J.; Rashid, Badri; Travers, Jeffrey B.; Konger, Raymond L.			Topical Application of a Platelet Activating Factor Receptor Agonist Suppresses Phorbol Ester-Induced Acute and Chronic Inflammation and Has Cancer Chemopreventive Activity in Mouse Skin	PLOS ONE			English	Article							MAST-CELLS; HYPERSENSITIVITY REACTIONS; CONTACT HYPERSENSITIVITY; INDUCED APOPTOSIS; PHOSPHOLIPASE-C; FACTOR PAF; MICE; AUGMENTATION; EXPRESSION; MEDIATORS	Platelet activating factor (PAF) has long been associated with acute edema and inflammatory responses. PAF acts by binding to a specific G-protein coupled receptor (PAF-R, Ptafr). However, the role of chronic PAF-R activation on sustained inflammatory responses has been largely ignored. We recently demonstrated that mice lacking the PAF-R (Ptafr-/- mice) exhibit increased cutaneous tumorigenesis in response to a two-stage chemical carcinogenesis protocol. Ptafr-/- mice also exhibited increased chronic inflammation in response to phorbol ester application. In this present study, we demonstrate that topical application of the non-hydrolysable PAF mimetic (carbamoyl-PAF (CPAF)), exerts a potent, dose-dependent, and short-lived edema response in WT mice, but not Ptafr-/- mice or mice deficient in c-Kit (c-Kit(W-sh/W-sh) mice). Using an ear inflammation model, co-administration of topical CPAF treatment resulted in a paradoxical decrease in both acute ear thickness changes associated with a single PMA application, as well as the sustained inflammation associated with chronic repetitive PMA applications. Moreover, mice treated topically with CPAF also exhibited a significant reduction in chemical carcinogenesis. The ability of CPAF to suppress acute and chronic inflammatory changes in response to PMA application(s) was PAF-R dependent, as CPAF had no effect on basal or PMA-induced inflammation in Ptafr-/- mice. Moreover, c-Kit appears to be necessary for the anti-inflammatory effects of CPAF, as CPAF had no observable effect in c-Kit(W-sh/W-sh) mice. These data provide additional evidence that PAF-R activation exerts complex immunomodulatory effects in a model of chronic inflammation that is relevant to neoplastic development.	[Sahu, Ravi P.; Rezania, Samin; DaSilva-Arnold, Sonia C.; Bradish, Joshua R.; Richey, Justin D.; Warren, Simon J.; Rashid, Badri; Konger, Raymond L.] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Ocana, Jesus A.; DaSilva-Arnold, Sonia C.; Travers, Jeffrey B.; Konger, Raymond L.] Indiana Univ, Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Travers, Jeffrey B.] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Konger, RL (corresponding author), Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	rkonger@iupui.edu	Sahu, Ravi Prakash/AFQ-3359-2022	Sahu, Ravi Prakash/0000-0003-3857-9073; DaSilva-Arnold, Sonia/0000-0003-2721-4626; Ocana, Jesus/0000-0003-3124-9282; Travers, Jeffrey/0000-0001-7232-1039	National Institutes of Health [R01 HL062996, R21 ES017497, R21 ES020965]; Veterans Administration (VA Merit) [510BX000853]; Prevent Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017497, R21ES020965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration (VA Merit)(US Department of Veterans Affairs); Prevent Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (www.nih.gov) (R01 HL062996, R21 ES017497, and R21 ES020965), the Veterans Administration (www.research.va.gov/funding)(VA Merit 510BX000853), and the Prevent Cancer Foundation (www.preventcancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin K, 2012, RESP MED, V106, P9, DOI 10.1016/j.rmed.2011.09.007; BOYER JL, 1994, J BIOL CHEM, V269, P2814; Bulger EM, 2000, CRIT CARE MED, V28, pN27, DOI 10.1097/00003246-200004001-00004; CANTWELL ME, 1987, AGENTS ACTIONS, V20, P165, DOI 10.1007/BF02074658; Ch'ng S, 2006, MODERN PATHOL, V19, P149, DOI 10.1038/modpathol.3800474; Chacon-Salinas R, 2013, J LEUKOCYTE BIOL; Chang DZ, 2011, CLIN CANCER RES, V17, P7015, DOI 10.1158/1078-0432.CCR-11-0607; CHURUKIAN C J, 1981, Journal of Histotechnology, V4, P85; Collington SJ, 2011, TRENDS IMMUNOL, V32, P478, DOI 10.1016/j.it.2011.08.002; Darst M, 2004, J IMMUNOL, V172, P6330, DOI 10.4049/jimmunol.172.10.6330; de Oliveira SI, 2006, PROSTAG OTH LIPID M, V80, P62, DOI 10.1016/j.prostaglandins.2006.04.002; de Vries VC, 2010, CURR OPIN IMMUNOL, V22, P643, DOI 10.1016/j.coi.2010.08.015; DEYOUNG LM, 1989, AGENTS ACTIONS, V26, P335; Dougan M, 2008, J EXP MED, V205, P267, DOI 10.1084/jem.20080136; Dupre DJ, 2003, J BIOL CHEM, V278, P48228, DOI 10.1074/jbc.M304082200; Dy LC, 1999, J BIOL CHEM, V274, P26917, DOI 10.1074/jbc.274.38.26917; Dyer KD, 2010, J IMMUNOL, V184, P6327, DOI 10.4049/jimmunol.0904043; Frenzel L, 2013, JOINT BONE SPINE, V80, P141, DOI 10.1016/j.jbspin.2012.08.013; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatton JL, 2007, J INVEST DERMATOL, V127, P1507, DOI 10.1038/sj.jid.5700746; HEIMAN AS, 1985, J IMMUNOL, V134, P548; Kajiwara N, 2010, J ALLERGY CLIN IMMUN, V125, P1137, DOI 10.1016/j.jaci.2010.01.056; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Konger RL, 2008, PROSTAG OTH LIPID M, V87, P1, DOI 10.1016/j.prostaglandins.2008.04.002; Konger RL, 2002, AM J PATHOL, V161, P2065, DOI 10.1016/S0002-9440(10)64485-9; Krause K, 2013, ALLERGY, V68, P256, DOI 10.1111/all.12083; Kripke ML, 2013, J INVEST DERMATOL, V133, P27, DOI 10.1038/jid.2012.234; Li T, 2003, J BIOL CHEM, V278, P16614, DOI 10.1074/jbc.M211287200; Marathe GK, 2000, FREE RADICAL BIO MED, V28, P1762, DOI 10.1016/S0891-5849(00)00234-3; Marathe GK, 2005, J BIOL CHEM, V280, P35448, DOI 10.1074/jbc.M503811200; Michel A, 2013, J IMMUNOL, V190, P5534, DOI 10.4049/jimmunol.1203355; Muehlmann LA, 2012, RES VET SCI, V93, P393, DOI 10.1016/j.rvsc.2011.07.008; Nilsson G, 2000, IMMUNOLOGY, V99, P314, DOI 10.1046/j.1365-2567.2000.00972.x; Norval M, 2006, PROG BIOPHYS MOL BIO, V92, P108, DOI 10.1016/j.pbiomolbio.2006.02.009; PARK DG, 1993, J BIOL CHEM, V268, P4573; Rabenhorst A, 2012, BLOOD, V120, P2042, DOI 10.1182/blood-2012-03-415638; RAO TS, 1993, INFLAMMATION, V17, P723, DOI 10.1007/BF00920477; Rios FJ, 2013, MEDIAT INFLAMM, V2013, P8, DOI DOI 10.1155/2013/198193; Rios FJO, 2011, CELL PHYSIOL BIOCHEM, V27, P363, DOI 10.1159/000327962; Sahu RP, 2013, J IMMUNOL, V190, P2447, DOI 10.4049/jimmunol.1202699; Sahu RP, 2012, INT J CANCER, V131, pE1055, DOI 10.1002/ijc.27562; Sahu RP, 2012, CARCINOGENESIS, V33, P1360, DOI 10.1093/carcin/bgs152; Sahu RP, 2012, PHOTOCHEM PHOTOBIOL, V88, P490, DOI 10.1111/j.1751-1097.2011.01071.x; Sahu RP, 2012, CARCINOGENESIS, V33, P694, DOI 10.1093/carcin/bgr322; Sarchio SNE, 2012, EXP DERMATOL, V21, P241, DOI 10.1111/j.1600-0625.2012.01438.x; Siebenhaar F, 2014, EXP DERMATOL, V23, P159, DOI 10.1111/exd.12328; Sinnamon MJ, 2008, CARCINOGENESIS, V29, P880, DOI 10.1093/carcin/bgn040; Sreevidya CS, 2008, CANCER RES, V68, P3978, DOI 10.1158/0008-5472.CAN-07-6132; St John AL, 2013, J IMMUNOL, V190, P4458, DOI 10.4049/jimmunol.1203420; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; Tanaka T, 2013, SEMIN IMMUNOPATHOL, V35, P245, DOI 10.1007/s00281-012-0343-7; TANOOKA H, 1982, J NATL CANCER I, V69, P1305; TRAVERS JB, 1995, J INVEST DERMATOL, V105, P816, DOI 10.1111/1523-1747.ep12326581; Waskow C, 2007, BLOOD, V109, P5363, DOI 10.1182/blood-2006-08-039131; Yao YX, 2009, J IMMUNOL, V182, P2842, DOI 10.4049/jimmunol.0802689; Zhang QW, 2008, J INVEST DERMATOL, V128, P1780, DOI 10.1038/sj.jid.5701251; Zhang QW, 2005, J CLIN INVEST, V115, P2855, DOI 10.1172/JCI25429	62	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111608	10.1371/journal.pone.0111608	http://dx.doi.org/10.1371/journal.pone.0111608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375862	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600051
J	Sharaf, MR; Al Dhafer, HM; Aldawood, AS				Sharaf, Mostafa R.; Al Dhafer, Hathal M.; Aldawood, Abdulrahman S.			First Record of the Myrmicine Ant Genus Meranoplus Smith, 1853 (Hymenoptera: Formicidae) from the Arabian Peninsula with Description of a New Species and Notes on the Zoogeography of Southwestern Kingdom Saudi Arabia	PLOS ONE			English	Article							RED-SEA; EVOLUTION	The ant genus Meranoplus is reported for the first time from the Arabian Peninsula ( Kingdom of Saudi Arabia) by the new species M. pulcher sp. n., based on the worker caste. Specimens were collected from Al Sarawat and Asir Mountains of southwestern Kingdom of Saudi Arabia using pitfall traps. Meranoplus pulcher sp. n. is included in the Afrotropical M. magretii-group, with greatest similarity to M. magrettii Andre from Sudan. A key to the Afrotropical species of the M. magretii-group is presented. A brief review of the ant taxa with Afrotropical affinities in southwestern region of the Kingdom of Saudi Arabia is given.	[Sharaf, Mostafa R.; Al Dhafer, Hathal M.; Aldawood, Abdulrahman S.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Riyadh, Saudi Arabia	King Saud University	Sharaf, MR (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Riyadh, Saudi Arabia.	antsharaf@gmail.com	Aldawood, Abdulrahman Saad/M-3657-2019; Al Dhafer, Hathal/E-4535-2016	Al Dhafer, Hathal/0000-0002-4911-2332; Aldawood, Abdulrahman Saad/0000-0003-0721-6632	NSTIP Strategic technologies program, in the Kingdom of Saudi Arabia [12-ENV2484-02]	NSTIP Strategic technologies program, in the Kingdom of Saudi Arabia	This project was supported by the NSTIP Strategic technologies program, grant number (12-ENV2484-02), in the Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldawood AS, 2011, ZOOKEYS, P47, DOI 10.3897/zookeys.106.1390; Aldawood AS, 2011, ZOOKEYS, P61, DOI 10.3897/zookeys.92.770; Andersen Alan N., 2006, Myrmecologische Nachrichten, V8, P157; Andersen AN, 2000, J ANIM ECOL, V69, P975, DOI 10.1046/j.1365-2656.2000.00452.x; [Anonymous], 1973, GEOBOTANICAL FDN MID; Bolton B., 1981, Bulletin of the British Museum (Natural History) Entomology, V42, P43; Bolton B., 2003, MEMOIRS AM ENTOMOLOG; Bolton B., 1994, IDENTIFICATION GUIDE; Bosworth W, 2005, J AFR EARTH SCI, V43, P334, DOI 10.1016/j.jafrearsci.2005.07.020; Boudinot BE, 2013, ZOOTAXA, V3635, P301, DOI 10.11646/zootaxa.3635.4.1; Brown WL, 2000, BIOL DIVERSITY HDB S; Collingwood C.A., 1985, Fauna of Saudi Arabia, V7, P230; DAVISON I, 1994, GEOL SOC AM BULL, V106, P1474, DOI 10.1130/0016-7606(1994)106<1474:GEOTSR>2.3.CO;2; Doha Said A., 2009, Egyptian Academic Journal of Biological Sciences E Medical Entomology and Parasitology, V1, P31; Dornhaus A, 2010, ANT ECOLOGY, P210; Eig A., 1938, PALESTINE JOUR BOT SER J, V1, P161; El-Hawagry MS, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.274.4529; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; Fisher BL, 2010, ANT ECOLOGY, P18; HOLLDOBLER B, 1988, Psyche (Cambridge), V95, P139, DOI 10.1155/1988/74829; KUGLER C, 1978, Studia Entomologica, V20, P413; Lehrer Andy Z., 2008, Fragmenta Dipterologica, V14, P1; Mahnert V, 2014, ZOOTAXA, V 3764, P387, DOI 10.11646/zootaxa.3764.3.8; Passerin d'Entreves P, 2004, NOTA LEPIDOPTEROLOGI, V26, P153; Robertson Hamish G., 2000, Journal of Hymenoptera Research, V9, P71; Schoedl S., 1998, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V100, P361; Schoedl S., 2004, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V105B, P349; Schoedl Stefan, 2007, Memoirs of the American Entomological Institute (Gainesville), V80, P370; Schoedl Stefan, 1999, Entomological Problems, V30, P61; Sharaf MR, 2014, SOCIOBIOLOGY, V61, P293; Sharaf MR, 2013, P ENTOMOL SOC WASH, V115, P75, DOI 10.4289/0013-8797.115.1.75; Sharaf MR, 2012, ZOOKEYS, P39, DOI 10.3897/zookeys.228.3559; Sharaf MR, 2012, ZOOKEYS, P35, DOI 10.3897/zookeys.212.3325; Sharaf MR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030811, 10.1371/journal.pone.0049485]; Smith F., 1853, T ENTOMOLOGICAL SOC, V2, P213, DOI DOI 10.1111/J.1365-2311.1854.TB02221.X; Taylor R.W., 1990, GEN APPL ENTOMOLOGY, V22, P31; Taylor Robert W., 2006, Myrmecologische Nachrichten, V8, P21; Wheeler WM, 1935, BERNICE P BISHOP MUS, V11, P2	38	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111298	10.1371/journal.pone.0111298	http://dx.doi.org/10.1371/journal.pone.0111298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375104	Green Submitted, gold, Green Published			2022-12-26	WOS:000344402600034
J	Li, YK; Liao, JJ; Guo, HD; Liu, ZW; Shen, GZ				Li, Yingkui; Liao, Jingjuan; Guo, Huadong; Liu, Zewen; Shen, Guozhuang			Patterns and Potential Drivers of Dramatic Changes in Tibetan Lakes, 1972-2010	PLOS ONE			English	Article							CLIMATE-CHANGE; NAM CO; GAUGE OBSERVATIONS; LEVEL CHANGES; INLAND LAKE; PLATEAU; GLACIER; QINGHAI; PRECIPITATION; PERMAFROST	Most glaciers in the Himalayas and the Tibetan Plateau are retreating, and glacier melt has been emphasized as the dominant driver for recent lake expansions on the Tibetan Plateau. By investigating detailed changes in lake extents and levels across the Tibetan Plateau from Landsat/ICESat data, we found a pattern of dramatic lake changes from 1970 to 2010 (especially after 2000) with a southwest-northeast transition from shrinking, to stable, to rapidly expanding. This pattern is in distinct contrast to the spatial characteristics of glacier retreat, suggesting limited influence of glacier melt on lake dynamics. The plateau-wide pattern of lake change is related to precipitation variation and consistent with the pattern of permafrost degradation induced by rising temperature. More than 79% of lakes we observed on the central-northern plateau (with continuous permafrost) are rapidly expanding, even without glacial contributions, while lakes fed by retreating glaciers in southern regions (with isolated permafrost) are relatively stable or shrinking. Our study shows the limited role of glacier melt and highlights the potentially important contribution of permafrost degradation in predicting future water availability in this region, where understanding these processes is of critical importance to drinking water, agriculture, and hydropower supply of densely populated areas in South and East Asia.	[Li, Yingkui; Liu, Zewen] Univ Tennessee, Dept Geog, Knoxville, TN 37996 USA; [Li, Yingkui; Liao, Jingjuan; Guo, Huadong; Shen, Guozhuang] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Li, YK (corresponding author), Univ Tennessee, Dept Geog, Knoxville, TN 37996 USA.	yli32@utk.edu	Guo, Huadong/G-9388-2017	Guo, Huadong/0000-0003-0337-1862; liao, jing juan/0000-0002-5915-2661	National Basic Research Program of China [2009CB723906]; National Natural Science Foundation of China [41328001]; Open Research Fund of Key Laboratory of Digital Earth, Chinese Academy of Sciences [2011LDE004]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund of Key Laboratory of Digital Earth, Chinese Academy of Sciences	This work was supported by the National Basic Research Program of China (no. 2009CB723906), the National Natural Science Foundation of China (no. 41328001), and the Open Research Fund of Key Laboratory of Digital Earth, Chinese Academy of Sciences (no. 2011LDE004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [边多 BIAN Duo], 2009, [冰川冻土, Journal of Glaciology and Geocryology], V31, P404; [边多 BIAN Duo], 2010, [地理学报, Acta Geographica Sinica], V65, P313; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Chen SB, 2006, CLIMATIC CHANGE, V76, P291, DOI 10.1007/s10584-006-9080-z; Cheng GD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000631; Daly C, 2010, INT J CLIMATOL, V30, P1857, DOI 10.1002/joc.2007; Duong VH, 2008, INT J REMOTE SENS, V29, P1453, DOI 10.1080/01431160701736372; Frankl A, 2013, INT J DIGIT EARTH, V6, P196, DOI 10.1080/17538947.2012.744777; Frazier PS, 2000, PHOTOGRAMM ENG REM S, V66, P1461; Gao YC, 2013, HYDROL EARTH SYST SC, V17, P837, DOI 10.5194/hess-17-837-2013; GLIMS National Snow and Ice Data Center, 2005, GLIMS GLAC DAT; Huang L, 2011, CLIMATIC CHANGE, V109, P479, DOI 10.1007/s10584-011-0032-x; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Jarvis A, 2008, HOLE FILLED SEAMLESS; [贾珅玥 JIA Shen-yue], 2009, [国土资源遥感, Remote Sensing for Land & Resources], P78; Kropacek J, 2012, INT J APPL EARTH OBS, V17, P3, DOI 10.1016/j.jag.2011.10.001; [类延斌 LEI Yan-bin], 2009, [冰川冻土, Journal of Glaciology and Geocryology], V31, P48; Lei YB, 2013, J HYDROL, V483, P61, DOI 10.1016/j.jhydrol.2013.01.003; Lei YB, 2012, J GLACIOL, V58, P177, DOI 10.3189/2012JoG11J025; Li Junli, 2011, Hupo Kexue, V23, P311; Li R, 2012, CHINESE SCI BULL, V57, P4609, DOI 10.1007/s11434-012-5323-8; Li XY, 2007, WATER RESOUR MANAG, V21, P1505, DOI 10.1007/s11269-006-9096-1; Li ZX, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045404; Liao JJ, 2013, INT J DIGIT EARTH, V6, P534, DOI 10.1080/17538947.2012.656290; Liu J, 2010, HYDROL EARTH SYST SC, V14, P481, DOI 10.5194/hess-14-481-2010; Liu JS, 2009, GLOBAL PLANET CHANGE, V67, P209, DOI 10.1016/j.gloplacha.2009.03.010; [鲁安新 LU Anxin], 2006, [遥感技术与应用, Remote sensing Technology and Application], V21, P173; [鲁安新 LU Anxin], 2005, [冰川冻土, Journal of Glaciology and Geocryology], V27, P783; Nan ZT, 2005, SCI CHINA SER D, V48, P797, DOI 10.1360/03yd0258; Niu YiFang, 2008, Arid Land Geography, V31, P284; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Parry M. L., 2007, CLIMATE CHANGE 2007; Qin J, 2009, CLIMATIC CHANGE, V97, P321, DOI 10.1007/s10584-009-9733-9; Scherler D, 2011, NAT GEOSCI, V4, P156, DOI [10.1038/ngeo1068, 10.1038/NGEO1068]; Schutz BE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024009; Smith LC, 2005, SCIENCE, V308, P1429, DOI 10.1126/science.1108142; Solomon S., 2007, PHYS SCI BASIS WORKI; Tong K, 2014, INT J CLIMATOL, V34, P265, DOI 10.1002/joc.3682; Phan VH, 2012, INT J APPL EARTH OBS, V17, P12, DOI 10.1016/j.jag.2011.09.015; Walter IA, 2000, NATIONAL IRRIGATION SYMPOSIUM, PROCEEDINGS, P209; Wang LH, 2007, INT GEOSCI REMOTE SE, P4526; Wang S, 1998, RECORDS CHINA LAKES; Wang WC, 2011, ANN GLACIOL, V52, P9, DOI 10.3189/172756411797252347; [武慧智 WU Huizhi], 2007, [世界地质, World Geology], V26, P66; Wu QB, 2010, GLOBAL PLANET CHANGE, V72, P32, DOI 10.1016/j.gloplacha.2010.03.001; Wu QB, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012974; Wu YH, 2008, J GEOGR SCI, V18, P177, DOI 10.1007/s11442-008-0177-3; Xu BQ, 2009, P NATL ACAD SCI USA, V106, P22114, DOI [10.1073/pnas.0910444106, 10.1073/pnas.pnas.0910444106]; Yang K, 2011, CLIMATIC CHANGE, V109, P517, DOI 10.1007/s10584-011-0099-4; Yang L, 2008, J ARID ENVIRON, V72, P861, DOI 10.1016/j.jaridenv.2007.10.006; Yang YZ, 2013, QUATERN INT, V313, P85, DOI 10.1016/j.quaint.2013.07.037; Yao T, 2007, ARCT ANTARCT ALP RES, V39, P642, DOI 10.1657/1523-0430(07-510)[YAO]2.0.CO;2; Yao TD, 2012, ENVIRON DEV, V3, P52, DOI 10.1016/j.envdev.2012.04.002; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; Ye QH, 2007, J GLACIOL, V53, P673, DOI 10.3189/002214307784409261; Ye QH, 2009, J MT SCI-ENGL, V6, P211, DOI 10.1007/s11629-009-1016-4; [叶庆华 YE Qinghua], 2008, [地理研究, Geographical Research], V27, P1178; Yin ZY, 2008, J HYDROMETEOROL, V9, P301, DOI 10.1175/2007JHM903.1; Yoshikawa K, 2003, PERMAFROST PERIGLAC, V14, P151, DOI 10.1002/ppp.451; Zhang B, 2011, J HYDROL, V405, P161, DOI 10.1016/j.jhydrol.2011.05.018; Zhang G, 2013, CHINESE SCI BULL, V58, P1; Zhang GQ, 2013, GEOPHYS RES LETT, V40, P2125, DOI 10.1002/grl.50462; Zhang GQ, 2011, J APPL REMOTE SENS, V5, DOI 10.1117/1.3601363; Zhang GQ, 2011, REMOTE SENS ENVIRON, V115, P1733, DOI 10.1016/j.rse.2011.03.005; Zhao L, 2004, GLOBAL PLANET CHANGE, V43, P19, DOI 10.1016/j.gloplacha.2004.02.003; [赵林 ZHAO Lin], 2010, [冰川冻土, Journal of Glaciology and Geocryology], V32, P1; ZHAO YY, 2006, DIZHI XUEBAO, V80, P876; Zhu LP, 2010, CHINESE SCI BULL, V55, P1294, DOI 10.1007/s11434-010-0015-8	70	45	51	11	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111890	10.1371/journal.pone.0111890	http://dx.doi.org/10.1371/journal.pone.0111890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372787	gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900086
J	Moon, H; Kim, C; Kwon, M; Chen, YT; Onushko, T; Lodha, N; Christou, EA				Moon, Hwasil; Kim, Changki; Kwon, Minhyuk; Chen, Yen Ting; Onushko, Tanya; Lodha, Neha; Christou, Evangelos A.			Force Control Is Related to Low-Frequency Oscillations in Force and Surface EMG	PLOS ONE			English	Article							MOTOR UNIT DISCHARGE; END-POINT ACCURACY; OLD ADULTS; VOLUNTARY CONTRACTIONS; ISOMETRIC CONTRACTIONS; MUSCLE FORCE; VARIABILITY; FLUCTUATIONS; DRIVE; PERFORMANCE	Force variability during constant force tasks is directly related to oscillations below 0.5 Hz in force. However, it is unknown whether such oscillations exist in muscle activity. The purpose of this paper, therefore, was to determine whether oscillations below 0.5 Hz in force are evident in the activation of muscle. Fourteen young adults (21.07 +/- 2.76 years, 7 women) performed constant isometric force tasks at 5% and 30% MVC by abducting the left index finger. We recorded the force output from the index finger and surface EMG from the first dorsal interosseous (FDI) muscle and quantified the following outcomes: 1) variability of force using the SD of force; 2) power spectrum of force below 2 Hz; 3) EMG bursts; 4) power spectrum of EMG bursts below 2 Hz; and 5) power spectrum of the interference EMG from 10-300 Hz. The SD of force increased significantly from 5 to 30% MVC and this increase was significantly related to the increase in force oscillations below 0.5 Hz (R-2 = 0.82). For both force levels, the power spectrum for force and EMG burst was similar and contained most of the power from 0-0.5 Hz. Force and EMG burst oscillations below 0.5 Hz were highly coherent (coherence = 0.68). The increase in force oscillations below 0.5 Hz from 5 to 30% MVC was related to an increase in EMG burst oscillations below 0.5 Hz (R-2 = 0.51). Finally, there was a strong association between the increase in EMG burst oscillations below 0.5 Hz and the interference EMG from 35-60 Hz (R-2 = 0.95). In conclusion, this finding demonstrates that bursting of the EMG signal contains low-frequency oscillations below 0.5 Hz, which are associated with oscillations in force below 0.5 Hz.	[Moon, Hwasil; Kim, Changki; Kwon, Minhyuk; Chen, Yen Ting; Onushko, Tanya; Lodha, Neha; Christou, Evangelos A.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA; [Christou, Evangelos A.] Univ Florida, Dept Phys Therapy, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Christou, EA (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.	eachristou@hhp.ufl.edu	Kwon, MinHyuk/HCH-5752-2022; Lodha, Neha/AAG-9581-2020		 [R01 AG031769]; NATIONAL INSTITUTE ON AGING [R01AG031769] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by R01 AG031769 to Evangelos A. Christou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baweja HS, 2012, EXP BRAIN RES, V222, P355, DOI 10.1007/s00221-012-3219-0; Brown P, 2000, PROG NEUROBIOL, V60, P97, DOI 10.1016/S0301-0082(99)00029-5; Chao E.Y., 1989, BIOMECHANICS HAND BA; Chen YT, 2012, EXP GERONTOL, V47, P519, DOI 10.1016/j.exger.2012.04.007; Christou EA, 2005, MED SCI SPORT EXER, V37, P2126, DOI 10.1249/01.mss.0000178103.72988.cd; Christou EA, 2003, J APPL PHYSIOL, V95, P373, DOI 10.1152/japplphysiol.00060.2003; Christou EA, 2007, J NEUROPHYSIOL, V97, P3340, DOI 10.1152/jn.01138.2006; Christou EA, 2011, EXERC SPORT SCI REV, V39, P77, DOI 10.1097/JES.0b013e31820b85ab; Coombes SA, 2011, NEUROIMAGE, V54, P2226, DOI 10.1016/j.neuroimage.2010.10.003; Coombes SA, 2010, J NEUROPHYSIOL, V103, P2114, DOI 10.1152/jn.00920.2009; DE LUCA CJ, 1994, TRENDS NEUROSCI, V17, P299, DOI 10.1016/0166-2236(94)90064-7; Deutsch KM, 2001, J EXP CHILD PSYCHOL, V80, P392, DOI 10.1006/jecp.2001.2642; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Fox EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055970; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOMMA T, 1991, ACTA ANAT, V141, P139; Kennedy DM, 2011, EXP BRAIN RES, V213, P351, DOI 10.1007/s00221-011-2777-x; Keogh J, 2006, EUR J APPL PHYSIOL, V97, P76, DOI 10.1007/s00421-006-0151-7; Li S, 2007, NEUROSCI LETT, V412, P243, DOI 10.1016/j.neulet.2006.11.013; Lodha N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083468; Negro F, 2011, J PHYSIOL-LONDON, V589, P629, DOI 10.1113/jphysiol.2010.202473; Negro F, 2009, J PHYSIOL-LONDON, V587, P5925, DOI 10.1113/jphysiol.2009.178509; Neto OP, 2010, MUSCLE NERVE, V42, P348, DOI 10.1002/mus.21687; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Neto OP, 2010, J NEUROPHYSIOL, V103, P1093, DOI 10.1152/jn.00792.2009; Taylor AM, 2003, J NEUROPHYSIOL, V90, P1350, DOI 10.1152/jn.00056.2003; Tracy BL, 2007, HUM MOVEMENT SCI, V26, P796, DOI 10.1016/j.humov.2007.07.001; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Yoshitake Y, 2013, EXP BRAIN RES, V231, P267, DOI 10.1007/s00221-013-3689-8; Yoshitake Y, 2013, MUSCLE NERVE, V47, P577, DOI 10.1002/mus.23628	31	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109202	10.1371/journal.pone.0109202	http://dx.doi.org/10.1371/journal.pone.0109202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372038	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900007
J	Aliferis, KA; Faubert, D; Jabaji, S				Aliferis, Konstantinos A.; Faubert, Denis; Jabaji, Suha			A Metabolic Profiling Strategy for the Dissection of Plant Defense against Fungal Pathogens	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; SIGNAL-TRANSDUCTION; MASS-SPECTROMETRY; SALICYLIC-ACID; BIOSYNTHESIS; ISOFLAVONES; HORMONE; PATHWAY; GROWTH; ROOTS	Here we present a metabolic profiling strategy employing direct infusion Orbitrap mass spectrometry (MS) and gas chromatography-mass spectrometry (GC/MS) for the monitoring of soybean's (Glycine max L.) global metabolism regulation in response to Rhizoctonia solani infection in a time-course. Key elements in the approach are the construction of a comprehensive metabolite library for soybean, which accelerates the steps of metabolite identification and biological interpretation of results, and bioinformatics tools for the visualization and analysis of its metabolome. The study of metabolic networks revealed that infection results in the mobilization of carbohydrates, disturbance of the amino acid pool, and activation of isoflavonoid, alpha-linolenate, and phenylpropanoid biosynthetic pathways of the plant. Components of these pathways include phytoalexins, coumarins, flavonoids, signaling molecules, and hormones, many of which exhibit antioxidant properties and bioactivity helping the plant to counterattack the pathogen's invasion. Unraveling the biochemical mechanism operating during soybean-Rhizoctonia interaction, in addition to its significance towards the understanding of the plant's metabolism regulation under biotic stress, provides valuable insights with potential for applications in biotechnology, crop breeding, and agrochemical and food industries.	[Aliferis, Konstantinos A.; Jabaji, Suha] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Faubert, Denis] Inst Rech Clin Montreal, Montreal, PQ, Canada	McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Jabaji, S (corresponding author), McGill Univ, Dept Plant Sci, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada.	suha.jabaji@mcgill.ca	Jabaji, Suha/D-2479-2016	Jabaji, Suha/0000-0002-7232-9994	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was financially supported by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Aliferis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042576; Aliferis KA, 2011, METABOLOMICS, V7, P35, DOI 10.1007/s11306-010-0231-x; Allwood JW, 2008, PHYSIOL PLANTARUM, V132, P117, DOI 10.1111/j.1399-3054.2007.01001.x; Balmerl D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00082; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bourgaud F., 2006, Phytochemistry Reviews, V5, P293, DOI 10.1007/s11101-006-9040-2; Cheng JY, 2011, PHYTOCHEMISTRY, V72, P875, DOI 10.1016/j.phytochem.2011.03.010; de Pinto MC, 2003, PLANT CELL PHYSIOL, V44, P803, DOI 10.1093/pcp/pcg105; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dixon RA, 2010, PLANT PHYSIOL, V154, P453, DOI 10.1104/pp.110.161430; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Draper J, 2013, METABOLOMICS, V9, pS4, DOI 10.1007/s11306-012-0449-x; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Enkerli J, 1998, MOL PLANT MICROBE IN, V11, P317, DOI 10.1094/MPMI.1998.11.4.317; Fiehn O, 2007, METABOLOMICS, V3, P175, DOI 10.1007/s11306-007-0070-6; Fliegmann J, 2003, BIOL CHEM, V384, P437, DOI 10.1515/BC.2003.049; Gardner HW, 1998, LIPIDS, V33, P745, DOI 10.1007/s11745-998-0265-z; Hartman GL, 2011, FOOD SECUR, V3, P5, DOI 10.1007/s12571-010-0108-x; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hendrawati O, 2006, PLANT SCI, V170, P1118, DOI 10.1016/j.plantsci.2006.01.017; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeon HY, 2012, J AGR FOOD CHEM, V60, P2807, DOI 10.1021/jf204708n; Kim HJ, 2010, J AGR FOOD CHEM, V58, P11633, DOI 10.1021/jf102829z; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kirwan JA, 2013, ANAL BIOANAL CHEM, V405, P5147, DOI 10.1007/s00216-013-6856-7; Komatsu S, 2011, J PROTEOME RES, V10, P3993, DOI 10.1021/pr2001918; Kyle J, 2000, PASTURE PRODUCTION; Lee CH, 2005, FOOD CHEM, V90, P735, DOI 10.1016/j.foodchem.2004.04.034; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Lozovaya VV, 2004, PLANT PHYSIOL BIOCH, V42, P671, DOI 10.1016/j.plaphy.2004.06.007; Lunn JE, 2007, J EXP BOT, V58, P35, DOI 10.1093/jxb/erl134; Lygin AV, 2010, PHYTOPATHOLOGY, V100, P897, DOI 10.1094/PHYTO-100-9-0897; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; McDonald KL, 1999, EUR J PLANT PATHOL, V105, P651, DOI 10.1023/A:1008705321113; Moulin M, 2000, PLANT PHYSIOL BIOCH, V38, P577, DOI 10.1016/S0981-9428(00)00777-4; Nakabayashi R, 2013, ANAL BIOANAL CHEM, P1; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Raman SB, 2004, PLANT SCI, V167, P961, DOI 10.1016/j.plantsci.2004.06.019; Ribeiro APB, 2009, FOOD RES INT, V42, P401, DOI 10.1016/j.foodres.2009.01.012; Sakihama Y, 2002, TOXICOLOGY, V177, P67, DOI 10.1016/S0300-483X(02)00196-8; Sato D, 2013, J CHROMATOGR B, V925, P95, DOI 10.1016/j.jchromb.2013.02.036; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shahidi F, 2009, TRENDS FOOD SCI TECH, V20, P376, DOI 10.1016/j.tifs.2008.08.004; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Takahashi H, 2008, PLANT SIGNAL BEHAV, V3, P945, DOI 10.4161/psb.6112; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Verslues Paul E, 2010, Arabidopsis Book, V8, pe0140, DOI 10.1199/tab.0140; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Walters D, 2003, NEW PHYTOL, V159, P109, DOI 10.1046/j.1469-8137.2003.00802.x; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wrather JA, 2001, CAN J PLANT PATHOL, V23, P115; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109	63	64	67	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111930	10.1371/journal.pone.0111930	http://dx.doi.org/10.1371/journal.pone.0111930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369450	gold, Green Submitted, Green Published			2022-12-26	WOS:000344402000128
J	Mares, J; Hajek, J; Urajova, P; Kopecky, J; Hrouzek, P				Mares, Jan; Hajek, Jan; Urajova, Petra; Kopecky, Jiri; Hrouzek, Pavel			A Hybrid Non-Ribosomal Peptide/Polyketide Synthetase Containing Fatty-Acyl Ligase (FAAL) Synthesizes the beta-Amino Fatty Acid Lipopeptides Puwainaphycins in the Cyanobacterium Cylindrospermum alatosporum	PLOS ONE			English	Article							PEPTIDE SYNTHETASE; GENE-CLUSTER; MOLECULAR CHARACTERIZATION; CYCLIC-PEPTIDES; ITURIN-A; SURFACTIN; BIOSYNTHESIS; MICROCYSTIN; POLYKETIDE; SEQUENCE	A putative operon encoding the biosynthetic pathway for the cytotoxic cyanobacterial lipopeptides puwainphycins was identified in Cylindrospermum alatosporum. Bioinformatics analysis enabled sequential prediction of puwainaphycin biosynthesis; this process is initiated by the activation of a fatty acid residue via fatty acyl-AMP ligase and continued by a multidomain non-ribosomal peptide synthetase/polyketide synthetase. High-resolution mass spectrometry and nuclear magnetic resonance spectroscopy measurements proved the production of puwainaphycin F/G congeners differing in FA chain length formed by either 3-amino-2-hydroxy-4-methyl dodecanoic acid (4-methyl-Ahdoa) or 3-amino-2-hydroxy-4-methyl tetradecanoic acid (4-methyl-Ahtea). Because only one puwainaphycin operon was recovered in the genome, we suggest that the fatty acyl-AMP ligase and one of the amino acid adenylation domains (Asn/Gln) show extended substrate specificity. Our results provide the first insight into the biosynthesis of frequently occurring beta-amino fatty acid lipopeptides in cyanobacteria, which may facilitate analytical assessment and development of monitoring tools for cytotoxic cyanobacterial lipopeptides.	[Mares, Jan; Hajek, Jan; Urajova, Petra; Kopecky, Jiri; Hrouzek, Pavel] Inst Microbiol AS CR, ALGATECH, Dept Phototroph Microorganisms, Vvi, Trebon, Czech Republic; [Mares, Jan; Hajek, Jan] Acad Sci Czech Republ, Inst Hydrobiol, Vvi, Biol Ctr AS CR, Ceske Budejovice, Czech Republic; [Mares, Jan] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Hajek, Jan] Univ South Bohemia, Fac Sci, Dept Mol Biol & Genet, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice	Hrouzek, P (corresponding author), Inst Microbiol AS CR, ALGATECH, Dept Phototroph Microorganisms, Vvi, Trebon, Czech Republic.	hrouzekp@gmail.com	Urajová, Petra/I-1663-2014; Mareš, Jan/B-2395-2009	Mareš, Jan/0000-0002-5745-7023; Hrouzek, Pavel/0000-0002-2061-0266	Grant Agency of the Czech Republic [14-18067S]; Center for Algal Biotechnology Trebon - ALGATECH [CZ. 1.05/21.00/03.0110]; European Union [EFRE RU2-EU-124/100-2010, M00146]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Center for Algal Biotechnology Trebon - ALGATECH; European Union(European Commission)	This study was supported by the Grant Agency of the Czech Republic, project "Toxic potential, Evolution of Toxin Synthesis and Factors Driving Anatoxin-a Production in Benthic and Soil Nostocacean Cyanobacteria'' (No. 14-18067S) and by the Center for Algal Biotechnology Trebon - ALGATECH (CZ. 1.05/21.00/03.0110). The NMR experiments were performed at the Upper Austrian - South Bohemian Research Infrastructure Center in Linz, co-financed by the European Union in the context of the project "RERI-uasb'', EFRE RU2-EU-124/100-2010 (ETC Austria-Czech Republic 2007-2013, project M00146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MB, 1955, PLANT PHYSIOL, V30, P366, DOI 10.1104/pp.30.4.366; An TY, 2007, J NAT PROD, V70, P730, DOI 10.1021/np060389p; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Coates RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085140; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Dittmann E, 2013, FEMS MICROBIOL REV, V37, P23, DOI 10.1111/j.1574-6976.2012.12000.x; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Fewer DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073618; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FRANKMOLLE WP, 1992, J ANTIBIOT, V45, P1458, DOI 10.7164/antibiotics.45.1458; GERWICK WH, 1992, TETRAHEDRON, V48, P2313, DOI 10.1016/S0040-4020(01)88753-6; GREGSON JM, 1992, TETRAHEDRON, V48, P3727, DOI 10.1016/S0040-4020(01)92264-1; HELMS GL, 1988, J ORG CHEM, V53, P1298, DOI 10.1021/jo00241a033; Horgen FD, 2000, J NAT PROD, V63, P461, DOI 10.1021/np990449+; Hrouzek P, 2012, CHEM RES TOXICOL, V25, P1203, DOI 10.1021/tx300044t; Johansen JR, 2014, J PHYCOL, V50, P187, DOI 10.1111/jpy.12150; Jokela J, 2012, PLOS ONE, V7; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jungblut AD, 2006, ARCH MICROBIOL, V185, P107, DOI 10.1007/s00203-005-0073-5; KAKINUMA A, 1969, AGR BIOL CHEM TOKYO, V33, P1669, DOI 10.1080/00021369.1969.10859524; KAKINUMA A, 1969, AGR BIOL CHEM TOKYO, V33, P973, DOI 10.1080/00021369.1969.10859409; KAKINUMA A, 1969, AGR BIOL CHEM TOKYO, V33, P971, DOI 10.1080/00021369.1969.10859408; KAKINUMA A, 1969, AGR BIOL CHEM TOKYO, V33, P1523, DOI 10.1080/00021369.1969.10859499; Kang HS, 2012, BIOORGAN MED CHEM, V20, P6134, DOI 10.1016/j.bmc.2012.08.017; Kellmann R, 2008, J MOL EVOL, V67, P526, DOI 10.1007/s00239-008-9169-2; Kurmayer R, 2002, MICROB ECOL, V43, P107, DOI 10.1007/s00248-001-0039-3; MacMillan JB, 2002, J ORG CHEM, V67, P8210, DOI 10.1021/jo0261909; Maru N, 2010, TETRAHEDRON LETT, V51, P6384, DOI 10.1016/j.tetlet.2010.06.105; Mihali TK, 2008, APPL ENVIRON MICROB, V74, P716, DOI 10.1128/AEM.01988-07; Moffitt MC, 2004, APPL ENVIRON MICROB, V70, P6353, DOI 10.1128/AEM.70.11.6353-6362.2004; MOON SS, 1992, J ORG CHEM, V57, P1097, DOI 10.1021/jo00030a013; Moyne AL, 2004, FEMS MICROBIOL LETT, V234, P43, DOI [10.1016/j.femsle.2004.03.011, 10.1111/j.1574-6968.2004.tb09511.x]; NAKANO MM, 1991, J BACTERIOL, V173, P1770, DOI 10.1128/jb.173.5.1770-1778.1991; Neuhof T, 2005, J NAT PROD, V68, P695, DOI 10.1021/np049671r; Oftedal L, 2012, BBA-BIOMEMBRANES, V1818, P3000, DOI 10.1016/j.bbamem.2012.07.015; PERGAMENT I, 1994, TETRAHEDRON LETT, V35, P8473, DOI 10.1016/S0040-4039(00)74436-4; PEYPOUX F, 1986, J ANTIBIOT, V39, P636, DOI 10.7164/antibiotics.39.636; Plaza A, 2009, J ORG CHEM, V74, P486, DOI 10.1021/jo802553j; Rantala-Ylinen A, 2011, APPL ENVIRON MICROB, V77, P7271, DOI 10.1128/AEM.06022-11; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Rounge TB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-396; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Tsuge K, 2001, J BACTERIOL, V183, P6265, DOI 10.1128/JB.183.21.6265-6273.2001; VANITTANAKOM N, 1986, J ANTIBIOT, V39, P888, DOI 10.7164/antibiotics.39.888; Vestola J, 2014, P NATL ACAD SCI USA, V111, pE1909, DOI 10.1073/pnas.1320913111; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x; Yao SY, 2003, CURR MICROBIOL, V47, P272, DOI 10.1007/s00284-002-4008-y; Zainuddin EN, 2009, J NAT PROD, V72, P1373, DOI 10.1021/np8007792; Zapomelova E, 2008, J PLANKTON RES, V30, P1257, DOI 10.1093/plankt/fbn081; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	54	43	43	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111904	10.1371/journal.pone.0111904	http://dx.doi.org/10.1371/journal.pone.0111904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369527	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000121
J	Takata, K; Kato, H; Shimosegawa, E; Okuno, T; Koda, T; Sugimoto, T; Mochizuki, H; Hatazawa, J; Nakatsuji, Y				Takata, Kazushiro; Kato, Hiroki; Shimosegawa, Eku; Okuno, Tatsusada; Koda, Toru; Sugimoto, Tomoyuki; Mochizuki, Hideki; Hatazawa, Jun; Nakatsuji, Yuji			C-11-Acetate PET Imaging in Patients with Multiple Sclerosis	PLOS ONE			English	Article							APPEARING WHITE-MATTER; COGNITIVE DYSFUNCTION; BRAIN; METABOLISM; ACETATE; LESIONS; ASTROCYTE; BINDING; MS; 1-C-11-ACETATE	Background: Activation of glial cells is a cardinal feature in multiple sclerosis (MS) pathology, and acetate has been reported to be selectively uptaken by astrocytes in the CNS. The aim of this study was to investigate the efficacy of PET with C-11-acetate for MS diagnosis. Materials and Methods: Six patients with relapsing-remitting MS and 6 healthy volunteers (HV) were enrolled. The C-11-acetate brain uptake on PET was measured in patients with MS and HV. Volume-of-interest analysis of cerebral gray and white matter based on the segmentation technique for co-registered MRI and voxel-based statistical parametric analysis were performed. Correlation between C-11-acetate uptake and the lesion number in T1-and T2-weighted MR images were also assessed. Results: The standardized uptake value (SUV) of C-11-acetate was increased in both white and gray matter in MS patients compared to HV. Voxel-based statistical analysis revealed a significantly increased SUV relative to that in the bilateral thalami (SUVt) in a broad area of white matter, particularly in the subcortical white matter of MS patients. The numbers of T2 lesions and T1 black holes were significantly correlated with SUV of C-11-acetate in white and gray matter. Conclusions: The C-11-acetate uptake significantly increased in MS patients and correlated to the number of MRI lesions. These preliminary data suggest that C-11-acetate PET can be a useful clinical examination for MS patients.	[Takata, Kazushiro; Okuno, Tatsusada; Koda, Toru; Mochizuki, Hideki; Nakatsuji, Yuji] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan; [Kato, Hiroki; Shimosegawa, Eku; Hatazawa, Jun] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka, Japan; [Sugimoto, Tomoyuki] Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori, Japan; [Hatazawa, Jun] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan	Osaka University; Osaka University; Hirosaki University; Osaka University	Hatazawa, J (corresponding author), Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka, Japan.	hatazawa@tracer.med.osaka-u.ac.jp; yuji@neurol.med.osaka-u.ac.jp	Sugimoto, Tomoyuki/J-9717-2019		Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science; Japan Society for the Promotion of Science KAKENHI [23592089]; Grants-in-Aid for Scientific Research [25860712] Funding Source: KAKEN	Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan, by a Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (YN and TO) and by the Japan Society for the Promotion of Science KAKENHI Grant Number 23592089 (HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Bjartmar C, 2001, NEUROLOGY, V57, P1248, DOI 10.1212/WNL.57.7.1248; Black JA, 2010, BRAIN, V133, P835, DOI 10.1093/brain/awq003; Blinkenberg M, 2000, NEUROLOGY, V54, P558, DOI 10.1212/WNL.54.3.558; Brosnan CF, 2013, GLIA, V61, P453, DOI 10.1002/glia.22443; BROWN M, 1987, CIRCULATION, V76, P687, DOI 10.1161/01.CIR.76.3.687; BROWNELL B, 1962, J NEUROL NEUROSUR PS, V25, P315, DOI 10.1136/jnnp.25.4.315; Chard DT, 2002, BRAIN, V125, P2342, DOI 10.1093/brain/awf240; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; De Keyser J, 2008, J CEREBR BLOOD F MET, V28, P1645, DOI 10.1038/jcbfm.2008.72; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Fernando KTM, 2004, BRAIN, V127, P1361, DOI 10.1093/brain/awh153; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Ho CL, 2003, J NUCL MED, V44, P213; Hosoi R, 2004, J CEREBR BLOOD F MET, V24, P188, DOI 10.1097/01.WCB.0000098606.42140.02; Hosoi R, 2009, BRAIN RES, V1253, P69, DOI 10.1016/j.brainres.2008.11.068; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; ISHIWATA K, 1995, APPL RADIAT ISOTOPES, V46, P1035, DOI 10.1016/0969-8043(95)00194-I; Kato H, 2012, AM J NEURORADIOL, V33, P1458, DOI 10.3174/ajnr.A3005; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lin C, 2014, EUR J NUCL MED MOL I, V41, P41, DOI 10.1007/s00259-013-2520-x; Liu RS, 2006, EUR J NUCL MED MOL I, V33, P420, DOI 10.1007/s00259-005-0023-0; Naismith RT, 2010, NEUROLOGY, V74, P1694, DOI 10.1212/WNL.0b013e3181e042c4; Nijland PG, 2014, GLIA, V62, P1125, DOI 10.1002/glia.22667; Odenthal A, 2014, AJNR AM J NEURORADIO; Oyama N, 2002, J NUCL MED, V43, P181; Oyama N, 2009, EUR J NUCL MED MOL I, V36, P422, DOI 10.1007/s00259-008-0981-0; Politis M, 2012, NEUROLOGY, V79, P523, DOI 10.1212/WNL.0b013e3182635645; Sahraian MA, 2010, ACTA NEUROL SCAND, V122, P1, DOI 10.1111/j.1600-0404.2009.01221.x; Sharma R, 2010, ACTA NEUROPATHOL, V120, P223, DOI 10.1007/s00401-010-0704-z; Sormani MP, 2013, LANCET NEUROL, V12, P669, DOI 10.1016/S1474-4422(13)70103-0; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; VANDENBERG CJ, 1966, BIOCHEM BIOPH RES CO, V23, P479, DOI 10.1016/0006-291X(66)90753-4; Vercellino M, 2007, J NEUROPATH EXP NEUR, V66, P732, DOI 10.1097/nen.0b013e31812571b0; Wang DW, 2005, GLIA, V51, P235, DOI 10.1002/glia.20199; Waniewski RA, 1998, J NEUROSCI, V18, P5225, DOI 10.1523/JNEUROSCI.18-14-05225.1998; Wyss MT, 2011, J CEREBR BLOOD F MET, V31, P1668, DOI 10.1038/jcbfm.2011.84; Wyss MT, 2009, J CEREBR BLOOD F MET, V29, P44, DOI 10.1038/jcbfm.2008.86	40	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111598	10.1371/journal.pone.0111598	http://dx.doi.org/10.1371/journal.pone.0111598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369426	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000072
J	Mano, T; Suzuki, T; Tsuji, S; Iwata, A				Mano, Tatsuo; Suzuki, Takayoshi; Tsuji, Shoji; Iwata, Atsushi			Differential Effect of HDAC3 on Cytoplasmic and Nuclear Huntingtin Aggregates	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; HISTONE DEACETYLASE INHIBITORS; TRANSGENIC MOUSE MODEL; AUTOPHAGIC DEGRADATION; MUTANT HUNTINGTIN; MOTOR DEFICITS; DISEASE MICE; TRANSCRIPTION; PROTEIN; IMPAIRMENT	Histone deacetylases (HDACs) are potential therapeutic targets of polyglutamine (pQ) diseases including Huntington's disease (HD) that may function to correct aberrant transcriptional deactivation caused by mutant pQ proteins. HDAC3 is a unique class 1 HDAC found in both the cytoplasm and in the nucleus. However, the precise functions of HDAC3 in the two cellular compartments are only vaguely known. HDAC3 directly binds to huntingtin (Htt) with short pQ and this interaction is important for suppressing neurotoxicity induced by HDAC3. With long pQ Htt, the interaction with HDAC3 is inhibited, and this supposedly promotes neuronal death, indicating that HDAC3 would be a good therapeutic target for HD. However, the knockout of one HDAC3 allele did not show any efficacy in reducing neurodegenerative symptoms in a mouse model of HD. Therefore, the role of HDAC3 in the pathogenesis of HD has yet to be fully elucidated. We attempted to resolve this issue by focusing on the different roles of HDAC3 on cytoplasmic and nuclear Htt aggregates. In addition to supporting the previous findings, we found that HDAC3 preferentially binds to nuclear Htt over cytoplasmic ones. Specific HDAC3 inhibitors increased the total amount of Htt aggregates by increasing the amount of nuclear aggregates. Both cytoplasmic and nuclear Htt aggregates were able to suppress endogenous HDAC3 activity, which led to decreased nuclear proteasome activity. Therefore, we concluded that Htt aggregates impair nuclear proteasome activity through the inhibition of HDAC3. Our findings provide new insights regarding cross-compartment proteasome regulation.	[Mano, Tatsuo; Tsuji, Shoji; Iwata, Atsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Suzuki, Takayoshi] Kyoto Prefectural Univ Med, Dept Grad Sch Med Sci, Kyoto, Japan; [Suzuki, Takayoshi; Iwata, Atsushi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan	University of Tokyo; Kyoto Prefectural University of Medicine; Japan Science & Technology Agency (JST)	Iwata, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan.	Iwata-tky@umin.ac.jp	Iwata, Atsushi/AAH-8924-2019; Iwata, Atsushi/A-9598-2013	Iwata, Atsushi/0000-0001-7308-5314; Iwata, Atsushi/0000-0001-7308-5314	Kakenhi (JSPS, Tokyo, Japan) [KB: 24390220]; JST PRESTO (Kawaguchi, Saitama); Cell Science Research Foundation (Osaka, Japan); Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (Tokyo, Japan); Takeda Science Foundation (Osaka, Japan); Janssen Pharmaceutical K.K. (Tokyo, Japan); Eisai Co. (Tokyo, Japan)	Kakenhi (JSPS, Tokyo, Japan); JST PRESTO (Kawaguchi, Saitama); Cell Science Research Foundation (Osaka, Japan); Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (Tokyo, Japan); Takeda Science Foundation (Osaka, Japan)(Takeda Science Foundation (TSF)); Janssen Pharmaceutical K.K. (Tokyo, Japan); Eisai Co. (Tokyo, Japan)	This study was supported by Kakenhi (KB: 24390220, JSPS, Tokyo, Japan), JST PRESTO (Kawaguchi, Saitama), the Cell Science Research Foundation (Osaka, Japan), the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (Tokyo, Japan), the Takeda Science Foundation (Osaka, Japan), Janssen Pharmaceutical K.K. (Tokyo, Japan), and Eisai Co. (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Bardai FH, 2013, J NEUROSCI, V33, P11833, DOI 10.1523/JNEUROSCI.5831-12.2013; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Benn CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005747; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bobrowska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020696; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Duncan CE, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-42; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Hathorn T, 2011, NEUROBIOL DIS, V41, P43, DOI 10.1016/j.nbd.2010.08.017; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jia HQ, 2012, HUM MOL GENET, V21, P5280, DOI 10.1093/hmg/dds379; Jia HQ, 2012, NEUROBIOL DIS, V46, P351, DOI 10.1016/j.nbd.2012.01.016; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Mielcarek M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001717; Moumne L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031080; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Sadri-Vakili G, 2006, NAT CLIN PRACT NEURO, V2, P330, DOI 10.1038/ncpneuro0199; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068669; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200	36	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111277	10.1371/journal.pone.0111277	http://dx.doi.org/10.1371/journal.pone.0111277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380050	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100024
J	Pinol, RA; Jameson, H; Popratiloff, A; Lee, NH; Mendelowitz, D				Pinol, Ramon A.; Jameson, Heather; Popratiloff, Anastas; Lee, Norman H.; Mendelowitz, David			Visualization of Oxytocin Release that Mediates Paired Pulse Facilitation in Hypothalamic Pathways to Brainstem Autonomic Neurons	PLOS ONE			English	Article							PARASYMPATHETIC CARDIAC NEURONS; LONG-TERM POTENTIATION; DORSAL MOTOR NUCLEUS; PARAVENTRICULAR NUCLEUS; HEART-FAILURE; SPINAL-CORD; VASOPRESSIN; TRANSMISSION; INHIBITION; RATIONALE	Recent work has shown that oxytocin is involved in more than lactation and uterine contraction. The paraventricular nucleus of the hypothalamus (PVN) contains neuroendocrine neurons that control the release of hormones, including vasopressin and oxytocin. Other populations of PVN neurons do not release hormones, but rather project to and release neurotransmitters onto other neurons in the CNS involved in fluid retention, thermoregulation, sexual behavior and responses to stress. Activation of oxytocin receptors can be cardioprotective and reduces the adverse cardiovascular consequences of anxiety and stress, yet how oxytocin can affect heart rate and cardiac function is unknown. While anatomical work has shown the presence of peptides, including oxytocin, in the projections from the PVN to parasympathetic nuclei, electrophysiological studies to date have only demonstrated release of glutamate and activation of fast ligand gated receptors in these pathways. In this study, using rats, we directly show, using sniffer CHO cells that express oxytocin receptors and the Ca2+ indicator R-GECO, that optogenetic activation of channelrhodopsin-2 (ChR2) expressing PVN fibers in the brainstem activates oxytocin receptors in the dorsomotor nucleus of the vagus (DMNV). We also demonstrate that while a single photoactivation of PVN terminals only activates glutamatergic receptors in brainstem cardiac vagal neurons (CVNs), neurons that dominate the neural control of heart rate, both the paired pulse facilitation, and sustained enhancement of glutamate release in this pathway is mediated by activation of oxytocin receptors. Our results provide direct evidence that a pathway from the PVN likely releases oxytocin and enhances short-term plasticity of this critical autonomic connection.	[Pinol, Ramon A.; Jameson, Heather; Lee, Norman H.; Mendelowitz, David] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA; [Pinol, Ramon A.; Jameson, Heather] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Popratiloff, Anastas] George Washington Univ, Ctr Microscopy & Image Anal, Washington, DC USA	George Washington University; George Washington University; George Washington University	Mendelowitz, D (corresponding author), George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA.	dmendel@gwu.edu		Pinol, Ramon/0000-0002-8877-8444	National Institutes of Health [HL49965, HL59895, HL72006]; National Institute of Child Health and Human Development [P30 HD040677]; Mental Retardation and Developmental Disabilities Research Center at Children's National Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072006, R01HL049965, R29HL049965, R01HL059895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Mental Retardation and Developmental Disabilities Research Center at Children's National Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health grants HL49965, HL59895 and HL72006 to D.M; National Institute of Child Health and Human Development, P30 HD040677, Mental Retardation and Developmental Disabilities Research Center at Children's National Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouairi E, 2006, J NEUROPHYSIOL, V96, P3266, DOI 10.1152/jn.00590.2006; Breton JD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-19; Coleman CG, 2010, J NEUROSCI, V30, P12103, DOI 10.1523/JNEUROSCI.3367-10.2010; De Ferrari GM, 2014, EUR J HEART FAIL, V16, P692, DOI 10.1002/ejhf.80; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; Fang LY, 2008, NEUROSCI LETT, V438, P133, DOI 10.1016/j.neulet.2007.12.070; Gamer M, 2012, PSYCHONEUROENDOCRINO, V37, P87, DOI 10.1016/j.psyneuen.2011.05.007; Geerling JC, 2010, J COMP NEUROL, V518, P1460, DOI 10.1002/cne.22283; da Silva AQG, 2011, BRAIN RES, V1368, P231, DOI 10.1016/j.brainres.2010.10.087; de Oliveira DCG, 2012, HUM PSYCHOPHARM CLIN, V27, P378, DOI 10.1002/hup.2237; Goncharuk VD, 2011, J COMP NEUROL, V519, P93, DOI 10.1002/cne.22507; Grippo AJ, 2012, STRESS, V15, P149, DOI 10.3109/10253890.2011.605486; Grippo AJ, 2009, PSYCHONEUROENDOCRINO, V34, P1542, DOI 10.1016/j.psyneuen.2009.05.017; Hauptman PJ, 2012, AM HEART J, V163, P954, DOI 10.1016/j.ahj.2012.03.021; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Kamendi H, 2006, HYPERTENSION, V48, P1137, DOI 10.1161/01.HYP.0000246493.00385.94; Kc P, 2010, RESP PHYSIOL NEUROBI, V174, P55, DOI 10.1016/j.resp.2010.08.001; LAROVERE MT, 1988, CIRCULATION, V78, P816, DOI 10.1161/01.CIR.78.4.816; Lin YT, 2012, J NEUROSCI, V32, P15476, DOI 10.1523/JNEUROSCI.2429-12.2012; Mastitskaya S, 2012, CARDIOVASC RES; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; Mendelowitz D, 1996, AM J PHYSIOL-HEART C, V271, pH2609, DOI 10.1152/ajpheart.1996.271.6.H2609; Ninan I, 2011, J NEUROCHEM, V119, P324, DOI 10.1111/j.1471-4159.2011.07430.x; Norman GJ, 2011, BIOL PSYCHOL, V86, P174, DOI 10.1016/j.biopsycho.2010.11.006; Pinol RA, 2012, J NEUROSCI METH, V210, P238, DOI 10.1016/j.jneumeth.2012.07.022; Pyner S, 2009, J CHEM NEUROANAT, V38, P197, DOI 10.1016/j.jchemneu.2009.03.005; RARDON DP, 1983, J AM COLL CARDIOL, V2, P1200, DOI 10.1016/S0735-1097(83)80351-9; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Rinaman L, 1998, J COMP NEUROL, V399, P101, DOI 10.1002/(SICI)1096-9861(19980914)399:1<101::AID-CNE8>3.0.CO;2-5; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; STORNETTA RL, 1987, J AUTONOM NERV SYST, V20, P121, DOI 10.1016/0165-1838(87)90109-3; TOWNEND JN, 1995, LANCET, V345, P937, DOI 10.1016/S0140-6736(95)90694-0; VANOLI E, 1991, CIRC RES, V68, P1471, DOI 10.1161/01.RES.68.5.1471; Wang J, 2002, NEUROSCIENCE, V111, P699, DOI 10.1016/S0306-4522(02)00046-5; WAXMAN MB, 1977, CIRCULATION, V56, P385, DOI 10.1161/01.CIR.56.3.385; WHITESCARVER SA, 1990, AM J PHYSIOL, V259, pR76, DOI 10.1152/ajpregu.1990.259.1.R76; Yang Z, 2001, BRAIN RES, V908, P99, DOI 10.1016/S0006-8993(01)02593-8; Yang Z, 2009, AUTON NEUROSCI-BASIC, V147, P80, DOI 10.1016/j.autneu.2009.01.013; Zhang XG, 2002, J NEUROPHYSIOL, V88, P49, DOI 10.1152/jn.2002.88.1.49; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	45	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112138	10.1371/journal.pone.0112138	http://dx.doi.org/10.1371/journal.pone.0112138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379676	Green Submitted, gold, Green Published			2022-12-26	WOS:000344863100055
J	Vrijsen, JN; Speckens, A; Arias-Vasquez, A; Franke, B; Becker, ES; van Oostrom, I				Vrijsen, Janna N.; Speckens, Anne; Arias-Vasquez, Alejandro; Franke, Barbara; Becker, Eni S.; van Oostrom, Iris			No Evidence for the Association between a Polymorphism in the PCLO Depression Candidate Gene with Memory Bias in Remitted Depressed Patients and Healthy Individuals	PLOS ONE			English	Article							STRUCTURED CLINICAL INTERVIEW; GENOME-WIDE ASSOCIATION; COGNITIVE VULNERABILITY; MAJOR DEPRESSION; EMOTIONAL FACES; LIFE EVENTS; ATTENTION; MOOD; SEROTONIN; REAPPRAISAL	The PCLO rs2522833 candidate polymorphism for depression has been associated to monoaminergic neurotransmission. In healthy and currently depressed individuals, the polymorphism has been found to affect activation of brain areas during memory processing, but no direct association of PCLO with memory bias was found. We hypothesized that the absence of this association might have been obscured by current depressive symptoms or genetically driven individual differences in reactivity to stressful events. Experiencing stressful childhood events fosters dysfunctional assumptions that are related to cognitive biases, and may modulate the predisposition for depression via epigenetic effects. The association between PCLO and memory bias, as well as interaction between PCLO and childhood events was studied in patients remitted from depression (N = 299), as well as a sample of healthy individuals (N = 157). The participants performed an emotional verbal memory task after a sad mood induction. Childhood trauma and adversity were measured with a questionnaire. The Genotype main effect, and Genotype by Childhood Events interaction were analyzed for memory bias in both samples. PCLO risk allele carrying remitted depressed patients did not show more negatively biased memory than non-risk allele carriers, not even patients with stressful childhood events. A similar pattern of results was found in healthy individuals. Memory bias may not be strongly associated with the PCLO rs2522833 polymorphism. We did not find any support for the PCLO-childhood events interaction, but the power of our study was insufficient to exclude this possibility.	[Vrijsen, Janna N.; Speckens, Anne; Arias-Vasquez, Alejandro; Franke, Barbara; van Oostrom, Iris] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Becker, Eni S.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Vrijsen, JN (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands.	Janna.Vrijsen@radboudumc.nl	Vasquez, A. Arias/L-4175-2015; Franke, Barbara/D-4836-2009; Speckens, Anne/H-8093-2014; Oostrom, I./L-4559-2015; Vasquez, Alejandro Arias/E-4762-2012; Becker, Eni S/A-2668-2010; Vrijsen, Janna N/L-4736-2015	Franke, Barbara/0000-0003-4375-6572; Speckens, Anne/0000-0001-5266-1554; Vasquez, Alejandro Arias/0000-0002-4786-0169; Becker, Eni S/0000-0003-3524-426X; Vrijsen, Janna N/0000-0002-7081-9893	department of Psychiatry of the Radboud University Medical Centre	department of Psychiatry of the Radboud University Medical Centre	The study was funded by the department of Psychiatry of the Radboud University Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 1958, STANDARD PROGR MATRI; Aragam N, 2011, J AFFECT DISORDERS, V133, P516, DOI 10.1016/j.jad.2011.04.054; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Beck AT, 1996, PSYCHOL ASSESS; Betts MJ, 2007, BIOINFORMATICS GENET, P289; Bhagwagar Z, 2008, PSYCHOL MED, V38, P307, DOI 10.1017/S0033291707001250; Bochdanovits Z, 2009, MOL PSYCHIATR, V14, P650, DOI 10.1038/mp.2009.37; Bockting CLH, 2006, J CLIN PSYCHIAT, V67, P747, DOI 10.4088/JCP.v67n0508; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037/0033-2909.113.1.82; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50; DENNY EB, 1992, J ABNORM PSYCHOL, V101, P575, DOI 10.1037/0021-843X.101.3.575; Ellwart T, 2003, DEPRESS ANXIETY, V17, P197, DOI 10.1002/da.10102; Firk C, 2007, J PSYCHOPHARMACOL, V21, P538, DOI 10.1177/0269881106075588; First M.B., 2014, STRUCTURED CLIN INTE; Fitzgerald DA, 2011, NEUROIMAGE, V56, P1783, DOI 10.1016/j.neuroimage.2011.02.061; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Gerritsen L, 2012, MOL PSYCHIATR, V17, P597, DOI 10.1038/mp.2011.51; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P386, DOI 10.1037/0021-843x.113.3.386; Gupta Rashmi, 2012, Front Psychiatry, V3, P99, DOI 10.3389/fpsyt.2012.00099; Hek K, 2010, HUM MOL GENET, V19, P731, DOI 10.1093/hmg/ddp529; Joormann J, 2007, J ABNORM PSYCHOL, V116, P80, DOI 10.1037/0021-843X.116.1.80; Kanai T, 2003, PSYCHOL MED, V33, P839, DOI 10.1017/S0033291703007827; Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8; Klein AA, 2013, ADDICT BEHAV, V38, P1687, DOI 10.1016/j.addbeh.2012.10.006; Kuehner C, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.11; LeMoult J, 2012, COGNITIVE THER RES, V36, P47, DOI 10.1007/s10608-010-9322-2; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P; McCabe SB, 2000, COGNITIVE THER RES, V24, P427, DOI 10.1023/A:1005579719849; Minelli A, 2012, J AFFECT DISORDERS, V139, P250, DOI 10.1016/j.jad.2012.01.028; Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030; Perry BD, 1995, INFANT MENT HEALTH J, V16, P271, DOI 10.1002/1097-0355(199524)16:4<271::AID-IMHJ2280160404>3.0.CO;2-B; Phaf RH, 2006, TECHNICAL REPORT; Ridout N, 2009, BEHAV RES THER, V47, P851, DOI 10.1016/j.brat.2009.06.013; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Schott BH, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.10; Schuhmacher A, 2011, INT J NEUROPSYCHOPH, V14, P237, DOI 10.1017/S1461145710000854; Shyn SI, 2010, PSYCHIAT CLIN N AM, V33, P125, DOI 10.1016/j.psc.2009.10.004; SKRE I, 1991, ACTA PSYCHIAT SCAND, V84, P167, DOI 10.1111/j.1600-0447.1991.tb03123.x; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Teasdale JD, 1988, COGNITION EMOTION, V2, P247, DOI 10.1080/02699938808410927; van Oostrom I, 2012, BIOL PSYCHOL, V89, P214, DOI 10.1016/j.biopsycho.2011.10.012; van Tol MJ, 2012, BIOL PSYCHIAT, V71, P593, DOI 10.1016/j.biopsych.2011.11.016; Verbeek EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079921; Vogel S, 2014, PSYCHONEUROENDOCRINO, V40, P181, DOI 10.1016/j.psyneuen.2013.11.010; Vrijsen JN, 2014, GENES BRAIN BEHAV, V13, P508, DOI 10.1111/gbb.12129; Vrijsen JN, 2014, COGNITIVE THER RES, V38, P334, DOI 10.1007/s10608-013-9590-8; Vrijsen JN, 2014, PSYCHIAT RES, V217, P134, DOI 10.1016/j.psychres.2014.02.033; WATKINS PC, 1992, J ABNORM PSYCHOL, V101, P581, DOI 10.1037/0021-843X.101.3.581; Watson DE, 2005, INT J TOXICOL, V24, P139, DOI 10.1080/10915810590948299; Williams J. M., 1996, REMEMBERING OUR STUD; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Williams LM, 2010, NEUROIMAGE, V53, P918, DOI 10.1016/j.neuroimage.2010.01.084; Wingenfeld K, 2013, PSYCHOPATHOLOGY, V46, P22, DOI 10.1159/000338609; Woudstra S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.29; Woudstra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061494	67	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112153	10.1371/journal.pone.0112153	http://dx.doi.org/10.1371/journal.pone.0112153			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379724	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100057
J	Abed, RMM; Polerecky, L; Al-Habsi, A; Oetjen, J; Strous, M; de Beer, D				Abed, Raeid M. M.; Polerecky, Lubos; Al-Habsi, Amal; Oetjen, Janina; Strous, Marc; de Beer, Dirk			Rapid Recovery of Cyanobacterial Pigments in Desiccated Biological Soil Crusts following Addition of Water	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; TOLERANT CYANOBACTERIUM; BACTERIAL DIVERSITY; MICROBIOTIC CRUSTS; NITROGEN-FIXATION; UV; MECHANISMS; MATS; REHYDRATION; SCYTONEMIN	We examined soil surface colour change to green and hydrotaxis following addition of water to biological soil crusts using pigment extraction, hyperspectral imaging, microsensors and C-13 labeling experiments coupled to matrix-assisted laser desorption and ionization time of flight-mass spectrometry (MALD-TOF MS). The topsoil colour turned green in less than 5 minutes following water addition. The concentrations of chlorophyll a (Chl a), scytonemin and echinenon rapidly increased in the top,1 mm layer while in the deeper layer, their concentrations remained low. Hyperspectral imaging showed that, in both wet and dehydrated crusts, cyanobacteria formed a layer at a depth of 0.2-0.4 mm and this layer did not move upward after wetting. C-13 labeling experiments and MALDI TOF analysis showed that Chl a was already present in the desiccated crusts and de novo synthesis of this molecule started only after 2 days of wetting due to growth of cyanobacteria. Microsensor measurements showed that photosynthetic activity increased concomitantly with the increase of Chl a, and reached a maximum net rate of 92 mu mol m(-2) h(-1) approximately 2 hours after wetting. We conclude that the colour change of soil crusts to green upon water addition was not due to hydrotaxis but rather to the quick recovery and reassembly of pigments. Cyanobacteria in crusts can maintain their photosynthetic apparatus intact even under prolonged periods of desiccation with the ability to resume their photosynthetic activities within minutes after wetting.	[Abed, Raeid M. M.; Al-Habsi, Amal] Sultan Qaboos Univ, Coll Sci, Dept Biol, Al Khoud, Oman; [Polerecky, Lubos; Strous, Marc; de Beer, Dirk] Max Planck Inst Marine Microbiol, Bremen, Germany; [Oetjen, Janina] Univ Bremen, MALDI Imaging Lab, D-28359 Bremen, Germany; [Strous, Marc] Univ Calgary, Dept Geosci, Calgary, AB, Canada	Sultan Qaboos University; Max Planck Society; University of Bremen; University of Calgary	Abed, RMM (corresponding author), Sultan Qaboos Univ, Coll Sci, Dept Biol, Al Khoud, Oman.	rabed@mpi-bremen.de	Strous, Marc/B-4064-2017; de Beer, Dirk/L-4840-2013; Polerecky, Lubos/E-1134-2014	Strous, Marc/0000-0001-9600-3828; de Beer, Dirk/0000-0001-5274-1781; Oetjen, Janina/0000-0002-4088-5742; Polerecky, Lubos/0000-0003-4425-585X	Research Council (TRC) of Oman [RC/SCI/BIOL/11/01]; Max-Planck Society; ERC (MASEM) [242635]	Research Council (TRC) of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); Max-Planck Society(Max Planck SocietyFoundation CELLEX); ERC (MASEM)	This research was funded by The Research Council (TRC) of Oman (grant RC/SCI/BIOL/11/01), the Max-Planck Society and the ERC (MASEM, 242635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2008, FEMS MICROBIOL ECOL, V65, P449, DOI 10.1111/j.1574-6941.2008.00537.x; Abed RMM, 2012, FEMS MICROBIOL ECOL, V80, P294, DOI 10.1111/j.1574-6941.2011.01289.x; Abed RMM, 2010, FEMS MICROBIOL ECOL, V72, P418, DOI 10.1111/j.1574-6941.2010.00854.x; BEALE SI, 1993, MOL BIOL CYANOBACTER, P519; BEBOUT BM, 1995, APPL ENVIRON MICROB, V61, P4215, DOI 10.1128/AEM.61.12.4215-4222.1995; Belnap J, 2002, BIOL FERT SOILS, V35, P128, DOI 10.1007/s00374-002-0452-x; CAMERON ROY E., 1962, TRANS AMER MICROSCOP SOC, V81, P379, DOI 10.2307/3223790; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; CAMPBELL SE, 1979, ORIGINS LIFE EVOL B, V9, P335, DOI 10.1007/BF00926826; Dillon JG, 2002, ARCH MICROBIOL, V177, P322, DOI 10.1007/s00203-001-0395-x; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Evans RD, 1999, CRIT REV PLANT SCI, V18, P183, DOI 10.1016/S0735-2689(99)00384-6; Fleming ED, 2007, ENVIRON MICROBIOL, V9, P1448, DOI 10.1111/j.1462-2920.2007.01261.x; Fukuda S, 2008, PLANT CELL PHYSIOL, V49, P488, DOI 10.1093/pcp/pcn018; Garcia-Pichel F, 2001, NATURE, V413, P380, DOI 10.1038/35096640; GarciaPichel F, 1996, J PHYCOL, V32, P774, DOI 10.1111/j.0022-3646.1996.00774.x; GIESKES W W C, 1991, Hydrobiological Bulletin, V25, P65, DOI 10.1007/BF02259591; GOLUBIC S, 1976, J PALEONTOL, V50, P1074; Gossauer A, 1996, J PHOTOCH PHOTOBIO B, V32, P141, DOI 10.1016/1011-1344(95)07257-8; Hader DP., 1987, FAY P, P325; Heber U, 2005, PHOTOSYNTH RES, V84, P85, DOI 10.1007/s11120-005-0413-y; Helm RF, 2000, J BACTERIOL, V182, P974, DOI 10.1128/JB.182.4.974-982.2000; Hortensteiner S, 1999, CELL MOL LIFE SCI, V56, P330, DOI 10.1007/s000180050434; Isichei A. O., 1980, Nitrogen cycling in West African ecosystems., P191; Kohls K, 2010, ENVIRON MICROBIOL, V12, P567, DOI 10.1111/j.1462-2920.2009.02095.x; Kruschel C, 1998, FEMS MICROBIOL ECOL, V27, P53, DOI 10.1016/S0168-6496(98)00056-7; Luttge U, 2008, J PLANT PHYSIOL, V165, P172, DOI 10.1016/j.jplph.2007.03.004; Malam Issa O, 2001, SOIL BIOL BIOCHEM, V33, P1425, DOI 10.1016/S0038-0717(01)00046-3; MARTIN CE, 1984, NEW PHYTOL, V96, P545, DOI 10.1111/j.1469-8137.1984.tb03588.x; Maya Y, 2002, GEOMICROBIOL J, V19, P505, DOI 10.1080/01490450290098469; McKew BA, 2011, ISME J, V5, P30, DOI 10.1038/ismej.2010.91; OLIE JJ, 1986, APPL ENVIRON MICROB, V52, P706, DOI 10.1128/AEM.52.4.706-710.1986; PAERL HW, 1985, SCIENCE, V227, P647, DOI 10.1126/science.227.4687.647; PEAT A, 1988, PROTOPLASMA, V146, P72, DOI 10.1007/BF01405915; Polerecky L, 2009, APPL ENVIRON MICROB, V75, P758, DOI 10.1128/AEM.00819-08; Potts M, 1999, EUR J PHYCOL, V34, P319, DOI 10.1017/S0967026299002267; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; POTTS M, 1986, ARCH MICROBIOL, V146, P87, DOI 10.1007/BF00690164; Pringault O, 2004, MICROBIAL ECOL, V47, P366, DOI 10.1007/s00248-002-0107-3; Proctor MCF, 2000, J EXP BOT, V51, P1695, DOI 10.1093/jexbot/51.351.1695; Proctor MCF, 2000, PLANT ECOL, V151, P41, DOI 10.1023/A:1026517920852; Rajeev L, 2013, ISME J, V7, P2178, DOI 10.1038/ismej.2013.83; Revsbech N. P., 1989, LIMNOL OCEANOGR, V55, P1907; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; Satoh K, 2002, PLANT CELL PHYSIOL, V43, P170, DOI 10.1093/pcp/pcf020; Vavilin D, 2005, BBA-BIOENERGETICS, V1708, P91, DOI 10.1016/j.bbabio.2004.12.011; Vavilin D, 2007, BBA-BIOENERGETICS, V1767, P920, DOI 10.1016/j.bbabio.2007.03.010; Wada N, 2013, METABOLITES, V3, P463, DOI 10.3390/metabo3020463; Zeng XQ, 2013, NOVA HEDWIGIA, V96, P511, DOI 10.1127/0029-5035/2013/0097	49	19	20	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112372	10.1371/journal.pone.0112372	http://dx.doi.org/10.1371/journal.pone.0112372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375172	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600136
J	Bordiuk, OL; Smith, K; Morin, PJ; Semenov, MV				Bordiuk, Olivia L.; Smith, Karen; Morin, Peter J.; Semenov, Mikhail V.			Cell Proliferation and Neurogenesis in Adult Mouse Brain	PLOS ONE			English	Article							NEWLY GENERATED NEURONS; HIPPOCAMPAL NEUROGENESIS; GANGLIONIC EMINENCE; PATTERN SEPARATION; MAMMALIAN BRAIN; NERVOUS-SYSTEM; INTERNEURONS; DOUBLECORTIN; EXPRESSION; CORTEX	Neurogenesis, the formation of new neurons, can be observed in the adult brain of many mammalian species, including humans. Despite significant progress in our understanding of adult neurogenesis, we are still missing data about the extent and location of production of neural precursors in the adult mammalian brain. We used 5-ethynyl-2'-deoxyuridine (EdU) to map the location of proliferating cells throughout the entire adult mouse brain and found that neurogenesis occurs at two locations in the mouse brain. The larger one we define as the main proliferative zone (MPZ), and the smaller one corresponds to the subgranular zone of the hippocampus. The MPZ can be divided into three parts. The caudate migratory stream (CMS) occupies the middle part of the MPZ. The cable of proliferating cells emanating from the most anterior part of the CMS toward the olfactory bulbs forms the rostral migratory stream. The thin layer of proliferating cells extending posteriorly from the CMS forms the midlayer. We have not found any additional aggregations of proliferating cells in the adult mouse brain that could suggest the existence of other major neurogenic zones in the adult mouse brain.	[Bordiuk, Olivia L.; Smith, Karen; Morin, Peter J.; Semenov, Mikhail V.] Edith Nourse Rogers Mem Vet Hosp, New England Geriatr Res Educ & Clin Ctr, Bedford Div, Bedford, MA 01730 USA	Geriatric Research Education & Clinical Center	Semenov, MV (corresponding author), Edith Nourse Rogers Mem Vet Hosp, New England Geriatr Res Educ & Clin Ctr, Bedford Div, Bedford, MA 01730 USA.	mikhail.semenov@va.gov			Janet and Edward Gildea Charitable Foundation; Department of Veterans Affairs	Janet and Edward Gildea Charitable Foundation; Department of Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the Janet and Edward Gildea Charitable Foundation and in part by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Andrews WD, 2007, J ANAT, V211, P188, DOI 10.1111/j.1469-7580.2007.00750.x; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Braun SMG, 2014, DEVELOPMENT, V141, P1983, DOI 10.1242/dev.104596; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cameron HA, 2008, BIOL PSYCHIAT, V63, P650, DOI 10.1016/j.biopsych.2007.09.023; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Del Bigio MR, 2011, BRAIN, V134, P1344, DOI 10.1093/brain/awr052; Feliciano DM, 2013, TRENDS NEUROSCI, V36, P51, DOI 10.1016/j.tins.2012.09.004; Gatome CW, 2010, BRAIN BEHAV EVOLUT, V76, P116, DOI 10.1159/000320210; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Haan N, 2013, J NEUROSCI, V33, P6170, DOI 10.1523/JNEUROSCI.2437-12.2013; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Kim WR, 2011, DEV GROWTH DIFFER, V53, P225, DOI 10.1111/j.1440-169X.2010.01226.x; Kim WR, 2011, EUR J NEUROSCI, V33, P599, DOI 10.1111/j.1460-9568.2010.07557.x; Kostovic I, 2009, SEMIN PERINATOL, V33, P220, DOI 10.1053/j.semperi.2009.04.003; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Luzzati F, 2003, P NATL ACAD SCI USA, V100, P13036, DOI 10.1073/pnas.1735482100; Ma T, 2012, CEREB CORTEX, V22, P2120, DOI 10.1093/cercor/bhr296; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ohira R, 2002, MOL GENET METAB, V77, P179, DOI 10.1016/S1096-7192(02)00126-9; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rudolph J, 2010, CELL ADHES MIGR, V4, P400, DOI 10.4161/cam.4.3.11640; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; Shapiro LA, 2007, BRAIN STRUCT FUNCT, V212, P133, DOI 10.1007/s00429-007-0151-3; Sousa-Ferreira L, 2014, TRENDS ENDOCRIN MET, V25, P80, DOI 10.1016/j.tem.2013.10.005; Takemura NU, 2005, NEUROSCIENCE, V134, P121, DOI 10.1016/j.neuroscience.2005.04.033; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	42	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111453	10.1371/journal.pone.0111453	http://dx.doi.org/10.1371/journal.pone.0111453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375658	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600040
J	Lorenzo-Betancor, O; Ogaki, K; Soto-Ortolaza, A; Labbe, C; Vilarino-Guell, C; Rajput, A; Rajput, AH; Pastor, P; Ortega, S; Lorenzo, E; Strongosky, AJ; van Gerpen, JA; Uitti, RJ; Wszolek, ZK; Ross, OA				Lorenzo-Betancor, Oswaldo; Ogaki, Kotaro; Soto-Ortolaza, Alexandra; Labbe, Catherine; Vilarino-Gueell, Carles; Rajput, Alex; Rajput, Ali H.; Pastor, Pau; Ortega, Sara; Lorenzo, Elena; Strongosky, Audrey J.; van Gerpen, Jay A.; Uitti, Ryan J.; Wszolek, Zbigniew K.; Ross, Owen A.			Analysis of Nuclear Export Sequence Regions of FUS-Related RNA-Binding Proteins in Essential Tremor	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; PRION-LIKE DOMAINS; MUTATIONS; TDP-43; FUS/TLS; TOOL	Background and Objective: Genes encoding RNA-binding proteins, including FUS and TDP43, play a central role in different neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Recently, a mutation located in the nuclear export signal (NES) of the FUS gene has been reported to cause an autosomal dominant form of familial Essential tremor. Material and Methods: We sequenced the exons coding the NES domains of five RNA-binding proteins (TARDBP, hnRNPA2B1, hnRNPA1, TAF15 and EWSR1) that have been previously implicated in neurodegeneration in a series of 257 essential tremor (ET) cases and 376 healthy controls. We genotyped 404 additional ET subjects and 510 healthy controls to assess the frequency of the EWSR1 p.R471C substitution. Results: We identified a rare EWSR1 p.R471C substitution, which is highly conserved, in a single subject with familial ET. The pathogenicity of this substitution remains equivocal, as DNA samples from relatives were not available and the genotyping of 404 additional ET subjects did not reveal any further carriers. No other variants were observed with significant allele frequency differences compared to controls in the NES coding regions. Conclusions: The present study demonstrates that the NES domains of RNA-binding proteins are highly conserved. The role of the EWSR1 p.R471C substitution needs to be further evaluated in future studies.	[Lorenzo-Betancor, Oswaldo; Ogaki, Kotaro; Soto-Ortolaza, Alexandra; Labbe, Catherine; Ross, Owen A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Vilarino-Gueell, Carles] Univ British Columbia, Djavad Mowafaghian Ctr Brain Heath, Dept Med Genet, Vancouver, BC, Canada; [Rajput, Alex; Rajput, Ali H.] Univ Saskatchewan, Div Neurol, Saskatoon, SK, Canada; [Rajput, Alex; Rajput, Ali H.] Saskatoon Hlth Reg, Saskatoon, SK, Canada; [Pastor, Pau; Ortega, Sara; Lorenzo, Elena] Univ Navarra, Ctr Appl Med Res, Sch Med, Neurogenet Lab,Div Neurosci, E-31080 Pamplona, Spain; [Pastor, Pau; Ortega, Sara; Lorenzo, Elena] CIBERNED, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Pastor, Pau] Hosp Univ Mutua Terrassa, Dept Neurol, Barcelona, Spain; [Strongosky, Audrey J.; van Gerpen, Jay A.; Uitti, Ryan J.; Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Ross, Owen A.] Mayo Clin, Mayo Grad Sch, Jacksonville, FL 32224 USA	Mayo Clinic; University of British Columbia; University of Saskatchewan; University of Saskatchewan; University of Navarra; CIBERNED; Instituto de Salud Carlos III; Hospital Universitario Mutua Terrassa; Mayo Clinic; Mayo Clinic	Ross, OA (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	ross.owen@mayo.edu	Wszolek, Zbigniew K./AAB-1431-2019; Lorenzo-Betancor, Oswaldo/J-2753-2019; Vilarino-Guell, Carles/D-8628-2011; Pastor, Pau/C-9834-2009	Lorenzo-Betancor, Oswaldo/0000-0002-5607-8363; Vilarino-Guell, Carles/0000-0002-5612-5940; Pastor, Pau/0000-0002-7493-8777; Ross, Owen/0000-0003-4813-756X	Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50) [NS072187]; NINDS [R01 NS078086]; Spanish Ministry of Economy and Competitivity grants [SAF2006-10126, SAF2010-22329-C02-01]; UTE project FIMA; Canada Research Chair program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187, R01NS078086] Funding Source: NIH RePORTER	Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Spanish Ministry of Economy and Competitivity grants; UTE project FIMA; Canada Research Chair program(Canada Research Chairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50 #NS072187) and NINDS R01 NS078086, by the Spanish Ministry of Economy and Competitivity grants SAF2006-10126 (2006-2009) and SAF2010-22329-C02-01 (2011-2013) to PP and by the UTE project FIMA to PP and SOC and by the Canada Research Chair program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Labbe C, 2013, PARKINSONISM RELAT D, V19, P755, DOI 10.1016/j.parkreldis.2013.03.005; Merner ND, 2012, AM J HUM GENET, V91, P313, DOI 10.1016/j.ajhg.2012.07.002; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Ortega-Cubero S, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.024; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puschmann A, 2011, SEMIN NEUROL, V31, P65, DOI 10.1055/s-0031-1271312; Ticozzi N, 2011, AM J MED GENET B, V156B, P285, DOI 10.1002/ajmg.b.31158; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942	20	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111989	10.1371/journal.pone.0111989	http://dx.doi.org/10.1371/journal.pone.0111989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375143	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600089
J	Alcazar-Fuoli, L; Cairns, T; Lopez, JF; Zonja, B; Perez, S; Barcelo, D; Igarashi, Y; Bowyer, P; Bignell, E				Alcazar-Fuoli, Laura; Cairns, Timothy; Lopez, Jordi F.; Zonja, Bozo; Perez, Sandra; Barcelo, Damia; Igarashi, Yasuhiro; Bowyer, Paul; Bignell, Elaine			A Modified Recombineering Protocol for the Genetic Manipulation of Gene Clusters in Aspergillus fumigatus	PLOS ONE			English	Article							MELANIN BIOSYNTHESIS; ZINC-FINGER; PSEUROTIN-A; NIDULANS; VIRULENCE; SYSTEM; PATHOGENICITY; TRANSCRIPTION; SYNTHETASE; EXPRESSION	Genomic analyses of fungal genome structure have revealed the presence of physically-linked groups of genes, termed gene clusters, where collective functionality of encoded gene products serves a common biosynthetic purpose. In multiple fungal pathogens of humans and plants gene clusters have been shown to encode pathways for biosynthesis of secondary metabolites including metabolites required for pathogenicity. In the major mould pathogen of humans Aspergillus fumigatus, multiple clusters of co-ordinately upregulated genes were identified as having heightened transcript abundances, relative to laboratory cultured equivalents, during the early stages of murine infection. The aim of this study was to develop and optimise a methodology for manipulation of gene cluster architecture, thereby providing the means to assess their relevance to fungal pathogenicity. To this end we adapted a recombineering methodology which exploits lambda phage-mediated recombination of DNA in bacteria, for the generation of gene cluster deletion cassettes. By exploiting a pre-existing bacterial artificial chromosome (BAC) library of A. fumigatus genomic clones we were able to implement single or multiple intra-cluster gene replacement events at both subtelomeric and telomere distal chromosomal locations, in both wild type and highly recombinogenic A. fumigatus isolates. We then applied the methodology to address the boundaries of a gene cluster producing a nematocidal secondary metabolite, pseurotin A, and to address the role of this secondary metabolite in insect and mammalian responses to A. fumigatus challenge.	[Alcazar-Fuoli, Laura; Cairns, Timothy; Bowyer, Paul; Bignell, Elaine] Univ Manchester, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Manchester, Lancs, England; [Lopez, Jordi F.] CSIC, Inst Environm Assessment & Water Res IDAEA, Dept Environm Chem, Barcelona, Spain; [Zonja, Bozo; Perez, Sandra; Barcelo, Damia] CSIC, Inst Environm Assessment & Water Res IDAEA, Water & Soil Qual Res Grp, Barcelona, Spain; [Barcelo, Damia] Univ Girona, ICRA, Catalan Inst Water Res, Girona, Spain; [Igarashi, Yasuhiro] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama, Japan	University of Manchester; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); Institut Catala de Recerca de l'Aigua (ICRA); Universitat de Girona; Toyama Prefectural University	Bignell, E (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Manchester, Lancs, England.	elaine.bignell@manchester.ac.uk	Solsona, Sandra/AAL-7967-2021; BARCELO, DAMIA/O-4558-2016; Lopez Fernandez, Jordi/H-6252-2015	BARCELO, DAMIA/0000-0002-8873-0491; Lopez Fernandez, Jordi/0000-0001-8255-483X; Perez, Sandra/0000-0002-3179-3969; Zonja, Bozo/0000-0002-8671-4308; Zonja, Bozo/0000-0002-6995-8124; Cairns, Timothy/0000-0001-7106-224X; bowyer, paul/0000-0002-1083-9286	Medical Research Council [G0501164, MR/L00822/1]; BBSRC [BB/G009619/1, BB/D526396/1]; Fondo de Investigacion Sanitaria [FIS:CP11/00026]; Marie Curie Actions ITN CSI: Environment [PITNGA-2010-264329]; Ramon y Cajal Program of the Spanish Ministry of Economy and Competitiveness; Biotechnology and Biological Sciences Research Council [BB/G009619/1] Funding Source: researchfish; MRC [G0501164] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Marie Curie Actions ITN CSI: Environment; Ramon y Cajal Program of the Spanish Ministry of Economy and Competitiveness(Spanish Government); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants to EB from the Medical Research Council (G0501164 and MR/L00822/1; http://www.mrc.ac.uk); and BBSRC (BB/G009619/1; http://www.bbsrc.ac.uk). LAF is funded by Fondo de Investigacion Sanitaria with a Miguel Servet fellowship (FIS:CP11/00026; http://www.isciii.es). TC was funded by a BBSRC PhD Studentship (BB/D526396/1; http://www.bbsrc.ac.uk). BZ acknowledges the Marie Curie Actions ITN CSI: Environment PITNGA-2010-264329 for the Early Stage Researcher contract and funding. SP acknowledges the contract from the Ramon y Cajal Program of the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amich J, 2009, INT MICROBIOL, V12, P39, DOI 10.2436/20.1501.01.80; Bok JW, 2006, INFECT IMMUN, V74, P6761, DOI 10.1128/IAI.00780-06; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Brock M, 2008, APPL ENVIRON MICROB, V74, P7023, DOI 10.1128/AEM.01288-08; Brown JS, 2000, MOL MICROBIOL, V36, P1371, DOI 10.1046/j.1365-2958.2000.01953.x; Bumpus SB, 2009, NAT BIOTECHNOL, V27, P951, DOI 10.1038/nbt.1565; Mesa-Arango AC, 2013, MED MYCOL, V51, P461, DOI 10.3109/13693786.2012.737031; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chiang YM, 2013, J AM CHEM SOC, V135, P7720, DOI 10.1021/ja401945a; Chiou CH, 2002, APPL ENVIRON MICROB, V68, P306, DOI 10.1128/AEM.68.1.306-315.2002; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Dean RA, 2007, NAT BIOTECHNOL, V25, P67, DOI 10.1038/nbt0107-67; Eliahu N, 2007, EUKARYOT CELL, V6, P421, DOI 10.1128/EC.00264-06; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Gacek A, 2012, APPL MICROBIOL BIOT, V95, P1389, DOI 10.1007/s00253-012-4208-8; Gomez-Lopez A, 2014, MED MYCOL, V52, P311, DOI 10.1093/mmy/myt022; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Hahn M, 2004, P NATL ACAD SCI USA, V101, P15585, DOI 10.1073/pnas.0404932101; Hartmann T, 2010, APPL ENVIRON MICROB, V76, P6313, DOI 10.1128/AEM.00882-10; Hayashi A, 2007, BIOSCI BIOTECH BIOCH, V71, P1697, DOI 10.1271/bbb.70110; Hervas-Aguilar A, 2007, J BIOL CHEM, V282, P34735, DOI 10.1074/jbc.M706723200; Igarashi Y, 2004, J ANTIBIOT, V57, P748, DOI 10.7164/antibiotics.57.748; Ishikawa M, 2009, BIOORG MED CHEM LETT, V19, P1457, DOI 10.1016/j.bmcl.2009.01.029; Kamper J, 2004, MOL GENET GENOMICS, V271, P103, DOI 10.1007/s00438-003-0962-8; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Komagata D, 1996, J ANTIBIOT, V49, P958, DOI 10.7164/antibiotics.49.958; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Krappmann S, 2006, TRENDS MICROBIOL, V14, P356, DOI 10.1016/j.tim.2006.06.005; Kubodera T, 2000, BIOSCI BIOTECH BIOCH, V64, P1416, DOI 10.1271/bbb.64.1416; Langfelder K, 2002, CURR GENET, V41, P268, DOI 10.1007/s00294-002-0313-z; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Liang SH, 1997, APPL ENVIRON MICROB, V63, P1058, DOI 10.1128/AEM.63.3.1058-1065.1997; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MACCABE AP, 1991, J BIOL CHEM, V266, P12646; Maiya S, 2007, CHEMBIOCHEM, V8, P1736, DOI 10.1002/cbic.200700202; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; O'Hanlon KA, 2011, INFECT IMMUN, V79, P3978, DOI 10.1128/IAI.00192-11; Pain A, 2004, FUNGAL GENET BIOL, V41, P443, DOI 10.1016/j.fgb.2003.12.003; Palmer JM, 2010, MICROBIOL-SGM, V156, P3522, DOI 10.1099/mic.0.039255-0; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Rizzetto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056651; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sugui JA, 2007, EUKARYOT CELL, V6, P1552, DOI 10.1128/EC.00140-07; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Szewczyk E, 2010, EUKARYOT CELL, V9, P774, DOI 10.1128/EC.00375-09; TANG CM, 1993, INFECT IMMUN, V61, P1650, DOI 10.1128/IAI.61.5.1650-1656.1993; Tsuji G, 2000, MOL MICROBIOL, V38, P940, DOI 10.1046/j.1365-2958.2000.02181.x; Tsunematsu Y, 2014, ANGEW CHEM INT EDIT, V53, P1; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Vodisch M, 2011, J PROTEOME RES, V10, P2508, DOI 10.1021/pr1012812; YU JH, 1995, J BACTERIOL, V177, P4792, DOI 10.1128/jb.177.16.4792-4800.1995	60	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111875	10.1371/journal.pone.0111875	http://dx.doi.org/10.1371/journal.pone.0111875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372385	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900082
J	Padhi, AK; Banerjee, K; Gomes, J; Banerjee, M				Padhi, Aditya K.; Banerjee, Kamalika; Gomes, James; Banerjee, Manidipa			Computational and Functional Characterization of Angiogenin Mutations, and Correlation with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; HEXANUCLEOTIDE REPEAT; I-TASSER; ALS; PREDICTION; VARIANTS; IDENTIFICATION; PLATFORM; NEURONS; C9ORF72	The Angiogenin (ANG) gene is frequently mutated in patients suffering from the neurodegenerative disease -amyotrophic lateral sclerosis (ALS). Most of the ALS-causing mutations in Angiogenin affect either its ribonucleolytic or nuclear translocation activity. Here we report the functional characterization of two previously uncharacterized missense mutations in Angiogenin -D22G and L35P. We predict the nature of loss-of-function(s) in these mutants through our previously established Molecular Dynamics (MD) simulation extended to 100 ns, and show that the predictions are entirely validated through biochemical studies with wild-type and mutated proteins. Based on our studies, we provide a biological explanation for the loss-of-function of D22G-Angiogenin leading to ALS, and suggest that the L35P-Angiogenin mutation would probably cause ALS symptoms in individuals harboring this mutation. Our study thus highlights the strength of MD simulation-based predictions, and suggests that this method can be used for correlating mutations in Angiogenin or other effector proteins with ALS symptoms.	[Padhi, Aditya K.; Banerjee, Kamalika; Gomes, James; Banerjee, Manidipa] Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Banerjee, M (corresponding author), Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi, India.	mbanerjee@bioschool.iitd.ac.in	Padhi, Aditya Kumar/AAU-7373-2021	Padhi, Aditya Kumar/0000-0001-6732-2547	Department of Science and Technology, Government of India [SERB/F/6185/2013-14]; Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT), Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Science and Technology (SERB/F/6185/2013-14), Government of India. A.K.P. was supported by a Senior Research Fellowship from the Council of Scientific and Industrial Research (CSIR), while M.B. was supported by the Ramalingaswami Fellowship from the Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brown JA, 2012, AMYOTROPH LATERAL SC, V13, P217, DOI 10.3109/17482968.2011.643899; Case DA, 2008, AMBER 11; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dhingra P, 2013, J COMPUT CHEM, V34, P1925, DOI 10.1002/jcc.23339; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jayaram B, 2006, NUCLEIC ACIDS RES, V34, P6195, DOI 10.1093/nar/gkl789; Jenkins JL, 2003, BIOCHEMISTRY-US, V42, P6674, DOI 10.1021/bi034164e; Kishikawa H, 2008, EXPERT OPIN THER TAR, V12, P1229, DOI 10.1517/14728222.12.10.1229 ; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Mishra A, 2014, BBA-PROTEINS PROTEOM, V1844, P1798, DOI 10.1016/j.bbapap.2014.07.010; Mishra A, 2013, BBA-PROTEINS PROTEOM, V1834, P1520, DOI 10.1016/j.bbapap.2013.04.023; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; MOROIANU J, 1994, BIOCHEM BIOPH RES CO, V203, P1765, DOI 10.1006/bbrc.1994.2391; Padhi AK, 2013, FEBS LETT, V587, P1762, DOI 10.1016/j.febslet.2013.04.022; Padhi AK, 2013, SCI REP-UK, V3, DOI 10.1038/srep01225; Padhi AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032479; Padhi Aditya K, 2014, F1000RES, V2, P227, DOI [DOI 10.12688/F1000RESEARCH.2-227.V3, 10.12688/f1000research.2-227.v3]; Redler RL, 2012, PROG MOL BIOL TRANSL, V107, P215, DOI 10.1016/B978-0-12-385883-2.00002-3; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Thiyagarajan N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2126; Ueki M, 2008, CELL BIOCHEM FUNCT, V26, P718, DOI 10.1002/cbf.1498; Vasaikar SV, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-3; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	34	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111963	10.1371/journal.pone.0111963	http://dx.doi.org/10.1371/journal.pone.0111963			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372031	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900097
J	Hernandez-Hernandez, AM; Huerta-Quintanilla, R				Maria Hernandez-Hernandez, Ana; Huerta-Quintanilla, Rodrigo			Modeling Body Mass Variation: Incorporating Social Influence into Calculations of Caloric Intake and Energy Expenditure	PLOS ONE			English	Article							WEIGHT-LOSS; COMPUTATIONAL MODEL; OBESITY; INTERRELATIONSHIPS; PREVENTION; BALANCE; HUMANS; HEALTH; FAT	Variations in individual body mass and composition have long been a key focus in the health sciences, particularly now that overweight and obesity are considered as public health problems. We study a mathematical model that describes body mass variations which are determined by the energy balance between caloric intake and total energy expenditure. To calculate the change in caloric intake and energy expenditure over time, we proposed a relationship for each of these quantities, and we used measured values that are reported in the literature for the initial conditions. To account for small variations in the daily energy balance of an individual, we include social interactions as the multiplication of two terms: social proximity and social influence. We observe that social interactions have a considerable effect when the body mass of an individual is quite constant and social interactions take random values. However, when an individual's mass value changes (either increases or decreases), social interactions do not have a notable effect. In our simulation, we tested two different models that describe the body mass composition, and it resulted that one fits better the data.	[Maria Hernandez-Hernandez, Ana; Huerta-Quintanilla, Rodrigo] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fis Aplicada, Merida, Yucatan, Mexico	Instituto Politecnico Nacional - Mexico	Huerta-Quintanilla, R (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fis Aplicada, Merida, Yucatan, Mexico.	rhuerta@mda.cinvestav.mx						ALPERT SS, 1979, AM J CLIN NUTR, V32, P1710, DOI 10.1093/ajcn/32.8.1710; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Caballero B., 2005, ENCY HUMAN NUTR; Chan RSM, 2010, INT J ENV RES PUB HE, V7, P765, DOI 10.3390/ijerph7030765; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Deriaz O, 1993, Obes Res, V1, P179; FAO/WHO/UNU Expert Consultation, 2001, HUM EN REQ, P41; FORBES GB, 1987, NUTR REV, V45, P225; Gonzalez A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-755; Hall KD, 2007, INT J OBESITY, V0307-0565, P1; Hall KD, 2007, BRIT J NUTR, V97, P1059, DOI 10.1017/S0007114507691946; Hall KD, 2006, AM J PHYSIOL-ENDOC M, V291, pE23, DOI 10.1152/ajpendo.00523.2005; Hall KD, 2011, AM J CLIN NUTR, V94, P66, DOI 10.3945/ajcn.111.014399; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Heshka S, 2001, INT J OBESITY, V25, P1401, DOI 10.1038/sj.ijo.0801790; Heymsfield SB, 2010, AM J HUM BIOL, V22, P301, DOI 10.1002/ajhb.20985; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hush-Ashmore R, 1996, AJBH, V8, P159; Jordan PN, 2008, AM J CLIN NUTR, V87, P692, DOI 10.1093/ajcn/87.3.692; Latane B, 1996, J COMMUN, V46; Leahey TM, 2011, OBESITY, V19, P1157, DOI 10.1038/oby.2010.301; Lucassen EA, 2012, ANN NY ACAD SCI, V1264, P110, DOI 10.1111/j.1749-6632.2012.06655.x; Shoham DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039795; Thomas DM, 2010, AM J CLIN NUTR, V92, P1326, DOI 10.3945/ajcn.2010.29687; West DS, 2008, OBESITY, V16, P1413, DOI 10.1038/oby.2008.224; [No title captured]	27	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111709	10.1371/journal.pone.0111709	http://dx.doi.org/10.1371/journal.pone.0111709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369520	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000089
J	Badarau, A; Rouha, H; Malafa, S; Logan, DT; Hakansson, M; Stulik, L; Dolezilkova, I; Teubenbacher, A; Gross, K; Maierhofer, B; Weber, S; Jagerhofer, M; Hoffman, D; Nagy, E				Badarau, Adriana; Rouha, Harald; Malafa, Stefan; Logan, Derek T.; Hakansson, Maria; Stulik, Lukas; Dolezilkova, Ivana; Teubenbacher, Astrid; Gross, Karin; Maierhofer, Barbara; Weber, Susanne; Jaegerhofer, Michaela; Hoffman, David; Nagy, Eszter			Structure-Function Analysis of Heterodimer Formation, Oligomerization, and Receptor Binding of the Staphylococcus aureus Bi-component Toxin LukGH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxin; Crystal Structure; Crystallography; Microbial Pathogenesis; Mutagenesis; Staphylococcus aureus (S; aureus)	PORE-FORMING TOXINS; GAMMA-HEMOLYSIN; SEQUENTIAL BINDING; MACROMOLECULAR CRYSTALLOGRAPHY; ERYTHROCYTE-MEMBRANES; 2 COMPONENTS; LEUKOCIDIN; NEUTROPHILS; TARGETS; INFECTION	Background:LukGH is a member of the family of two-component bacterial toxins of Staphylococcus aureus that lyse human phagocytic cells. Results:The crystal structure of LukGH and mutagenesis revealed the molecular basis for heterodimer formation in solution. Conclusion:LukGH differs from other two-component leukocidins that interact only upon cell contact. Significance:These data might assist with development of therapeutics that counteract Staphylococcus aureus pathogenesis. The bi-component leukocidins of Staphylococcus aureus are important virulence factors that lyse human phagocytic cells and contribute to immune evasion. The -hemolysins (HlgAB and HlgCB) and Panton-Valentine leukocidin (PVL or LukSF) were shown to assemble from soluble subunits into membrane-bound oligomers on the surface of target cells, creating barrel-like pore structures that lead to cell lysis. LukGH is the most distantly related member of this toxin family, sharing only 30-40% amino acid sequence identity with the others. We observed that, unlike other leukocidin subunits, recombinant LukH and LukG had low solubility and were unable to bind to target cells, unless both components were present. Using biolayer interferometry and intrinsic tryptophan fluorescence we detected binding of LukH to LukG in solution with an affinity in the low nanomolar range and dynamic light scattering measurements confirmed formation of a heterodimer. We elucidated the structure of LukGH by x-ray crystallography at 2.8- resolution. This revealed an octameric structure that strongly resembles that reported for HlgAB, but with important structural differences. Structure guided mutagenesis studies demonstrated that three salt bridges, not found in other bi-component leukocidins, are essential for dimer formation in solution and receptor binding. We detected weak binding of LukH, but not LukG, to the cellular receptor CD11b by biolayer interferometry, suggesting that in common with other members of this toxin family, the S-component has the primary contact role with the receptor. These new insights provide the basis for novel strategies to counteract this powerful toxin and Staphylococcus aureus pathogenesis.	[Badarau, Adriana; Rouha, Harald; Malafa, Stefan; Stulik, Lukas; Dolezilkova, Ivana; Teubenbacher, Astrid; Gross, Karin; Maierhofer, Barbara; Weber, Susanne; Jaegerhofer, Michaela; Hoffman, David; Nagy, Eszter] Arsanis Biosci, A-1030 Vienna, Austria; [Logan, Derek T.; Hakansson, Maria] SARom Biostruct AB, S-22381 Lund, Sweden		Nagy, E (corresponding author), Helmut Qualtinger Gasse 2, A-1030 Vienna, Austria.	eszter.nagy@arsanis.com	Logan, Derek/O-2497-2019; Logan, Derek T/A-1114-2011	Logan, Derek/0000-0002-0098-8560; Logan, Derek T/0000-0002-0098-8560; Malafa, Stefan/0000-0002-0222-9832; Stulik, Lukas/0000-0002-9055-3690	Forschungsforderungsgesellschaft (FFG) "Basisprogramm" from the Austrian Research Promotion Agency [832915, 837128, 841918, 845382]	Forschungsforderungsgesellschaft (FFG) "Basisprogramm" from the Austrian Research Promotion Agency	This work was supported by the Forschungsforderungsgesellschaft (FFG) "Basisprogramm" Grants 832915, 837128, 841918, and 845382 from the Austrian Research Promotion Agency (awarded to Arsanis Biosciences). This work was performed by employees of two biotech companies who own stock (A. B., H. R., L. S., D. T. L., I. D., A. T., K. G., B. M., S. W., M. J., and E. N.) and are inventors on patents (A. B., H. R., and E. N.).	Alonzo F, 2014, MICROBIOL MOL BIOL R, V78, P199, DOI 10.1128/MMBR.00055-13; Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Aman MJ, 2014, TOXINS, V6, P950, DOI 10.3390/toxins6030950; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COLIN DA, 1994, INFECT IMMUN, V62, P3184, DOI 10.1128/IAI.62.8.3184-3188.1994; DuMont AL, 2014, INFECT IMMUN, V82, P1268, DOI 10.1128/IAI.01444-13; DuMont AL, 2014, TRENDS MICROBIOL, V22, P21, DOI 10.1016/j.tim.2013.10.004; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Gouaux E, 1997, PROTEIN SCI, V6, P2631; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko J, 1997, BIOSCI BIOTECH BIOCH, V61, P846, DOI 10.1271/bbb.61.846; Kato F, 2011, J MICROBIOL METH, V87, P76, DOI 10.1016/j.mimet.2011.07.010; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menestrina G, 2003, FEBS LETT, V552, P54, DOI 10.1016/S0014-5793(03)00850-0; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Monma N, 2004, J BIOCHEM, V136, P427, DOI 10.1093/jb/mvh140; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nguyen VT, 2003, EMBO J, V22, P4968, DOI 10.1093/emboj/cdg498; Reyes-Robles T, 2013, CELL HOST MICROBE, V14, P453, DOI 10.1016/j.chom.2013.09.005; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Ursby T, 2013, J SYNCHROTRON RADIAT, V20, P648, DOI 10.1107/S0909049513011734; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Yokota K, 2000, BIOSCI BIOTECH BIOCH, V64, P2744, DOI 10.1271/bbb.64.2744	36	39	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					142	156		10.1074/jbc.M114.598110	http://dx.doi.org/10.1074/jbc.M114.598110			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25371205	hybrid, Green Published			2022-12-26	WOS:000347231200013
J	Chakrabarti, M; Barlas, MN; McCormick, SP; Lindahl, LS; Lindahl, PA				Chakrabarti, Mrinmoy; Barlas, Mirza Nofil; McCormick, Sean P.; Lindahl, Lora S.; Lindahl, Paul A.			Kinetics of Iron Import into Developing Mouse Organs Determined by a Pup-swapping Method	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Iron Metabolism; Mathematical Modeling; Mossbauer Spectroscopy; Plasma; Transferrin	TRANSFERRIN-BOUND IRON; BRAIN IRON; LIVER; RAT; CELLS; FE-59; FERRITIN; RECEPTOR; MODEL; MICE	Background: Rates of iron import from blood to developing organs were measured. Results: Two distinct iron species in the blood are imported. Conclusion: Nontransferrin-bound iron dominates the iron import process in young mice. Significance: The role of transferrin-bound iron in import should be reevaluated. The kinetics of dietary iron import into various organs of mice were evaluated using a novel pup-swapping approach. Newborn pups whose bodies primarily contained Fe-56 or Fe-57 were swapped at birth such that each nursed on milk containing the opposite isotope. A pup from each litter was euthanized weekly over a 7-week period. Blood plasma was obtained, and organs were isolated typically after flushing with Ringer's buffer. Fe-56 and Fe-57 concentrations were determined for organs and plasma; organ volumes were also determined. Mossbauer spectra of equivalent Fe-57-enriched samples were used to quantify residual blood in organs; this fraction was excluded from later analysis. Rates of import into brain, spleen, heart, and kidneys were highest during the first 2 weeks of life. In contrast, half of iron in the newborn liver exited during that time, and influx peaked later. Two mathematical models were developed to analyze the import kinetics. The only model that simulated the data adequately assumed that an iron-containing species enters the plasma and converts into a second species and that both are independently imported into organs. Consistent with this, liquid chromatography with an on-line ICP-MS detector revealed numerous iron species in plasma besides transferrin. Model fitting required that the first species, assigned to non-transferrin-bound iron, imports faster into organs than the second, assigned to transferrin-bound-iron. Non-transferrin-bound iron rather than transferrin-bound-iron appears to play the dominant role in importing iron into organs during early development of healthy mice.	[Chakrabarti, Mrinmoy; McCormick, Sean P.; Lindahl, Lora S.; Lindahl, Paul A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Barlas, Mirza Nofil] Allegheny Univ Hlth Sci, Dept Math Phys & Stat, Philadelphia, PA 19104 USA; [Lindahl, Paul A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Drexel University; Texas A&M University System; Texas A&M University College Station	Lindahl, PA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	lindahl@chem.tamu.edu	Lindahl, Paul/B-6137-2015	Lindahl, Paul/0000-0001-8307-9647	National Institutes of Health [GM084266, GM46441]; Robert A. Welch Foundation [A1170]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084266, R56GM046441, R01GM046441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM084266 and GM46441) and the Robert A. Welch Foundation (A1170).	BARISANI D, 1995, AM J PHYSIOL-GASTR L, V269, pG570, DOI 10.1152/ajpgi.1995.269.4.G570; Beard JL, 2005, J NEUROSCI RES, V79, P254, DOI 10.1002/jnr.20324; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; CAVILL I, 1971, J CLIN PATHOL, V24, P472, DOI 10.1136/jcp.24.5.472; D'Anna MC, 2011, INT J MORPHOL, V29, P747, DOI 10.4067/S0717-95022011000300014; Chen JH, 2013, METALLOMICS, V5, P167, DOI 10.1039/c2mt20226c; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; DALLMAN PR, 1977, J NUTR, V107, P1075, DOI 10.1093/jn/107.6.1075; Erikson KM, 1997, J NUTR, V127, P2030, DOI 10.1093/jn/127.10.2030; Evans RW, 2008, J BIOL INORG CHEM, V13, P57, DOI 10.1007/s00775-007-0297-8; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Grebe M, 2011, METALLOMICS, V3, P176, DOI 10.1039/c0mt00076k; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Gunji H, 2002, CYTOKINE, V20, P30, DOI 10.1006/cyto.2002.1977; Hider RC, 2002, EUR J CLIN INVEST, V32, P50, DOI 10.1046/j.1365-2362.2002.0320s1050.x; Holmes-Hampton GP, 2012, METALLOMICS, V4, P761, DOI 10.1039/c2mt20086d; Jacobs EMG, 2005, ANAL BIOCHEM, V341, P241, DOI 10.1016/j.ab.2005.03.008; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Liao YL, 2012, BIOCHEM CELL BIOL, V90, P476, DOI [10.1139/o11-075, 10.1139/O11-075]; LINK G, 1985, J LAB CLIN MED, V106, P147; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Fernandez-Sanchez ML, 2012, MICROCHEM J, V105, P108, DOI 10.1016/j.microc.2012.03.016; Malecki EA, 1999, J NEUROL SCI, V170, P112, DOI 10.1016/S0022-510X(99)00203-8; MAY PM, 1977, J CHEM SOC DALTON, P588, DOI 10.1039/dt9770000588; Meynard D, 2014, BLOOD, V123, P168, DOI 10.1182/blood-2013-06-427757; PARKES JG, 1995, BBA-GEN SUBJECTS, V1243, P373, DOI 10.1016/0304-4165(94)00162-Q; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Schumann K, 2007, TOXICOLOGY, V241, P19, DOI 10.1016/j.tox.2007.08.082; SIIMES MA, 1980, AM J CLIN NUTR, V33, P2601, DOI 10.1093/ajcn/33.12.2601; Simpson R. J., 1991, BIOCHEM SOC T, V19, p317S; Stankiewicz J, 2007, NEUROTHERAPEUTICS, V4, P371, DOI 10.1016/j.nurt.2007.05.006; TAYLOR EM, 1990, DEV BRAIN RES, V55, P35, DOI 10.1016/0165-3806(90)90103-6; UEDA F, 1993, J NEUROCHEM, V60, P106, DOI 10.1111/j.1471-4159.1993.tb05828.x; WRIGHT TL, 1986, J BIOL CHEM, V261, P909	36	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					520	528		10.1074/jbc.M114.606731	http://dx.doi.org/10.1074/jbc.M114.606731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25371212	Green Published, hybrid			2022-12-26	WOS:000347231200045
J	Schroder, J; Moll, JM; Baran, P; Grotzinger, J; Scheller, J; Floss, DM				Schroeder, Jutta; Moll, Jens M.; Baran, Paul; Groetzinger, Joachim; Scheller, Juergen; Floss, Doreen M.			Non-Canonical Interleukin 23 Receptor Complex Assembly P40 PROTEIN RECRUITS INTERLEUKIN 12 RECEPTOR beta 1 VIA SITE II AND INDUCES P19/INTERLEUKIN 23 RECEPTOR INTERACTION VIA SITE III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Cytokine Action; Interleukin; Molecular Modeling; Mutagenesis; Interleukin 12 Receptor; Interleukin 23; Interleukin 23 Receptor; p19; p40	IL-12 P40 HOMODIMER; T-CELLS; BINDING DOMAIN; CYTOKINE; SUBUNIT; GP130; INFLAMMATION; ACTIVATION; DISTINCT; PROTEIN	Background: The heterodimeric cytokine IL-23 binds to a receptor complex consisting of IL-23R and IL-12R1. Results: Binding of IL-23 to IL-12R1 is mediated by domains 1 and 2 of p40. Conclusion: The IL-23<bold>IL</bold>-23R<bold>IL</bold>-12R1 complex formation does not follow the classical site I-II-III architectural paradigm. Significance: The p40 subunit is shared by IL-23 and IL-12 and interacts directly with IL-12R1. IL-23, composed of the cytokine subunit p19 and the soluble receptor subunit p40, binds to a receptor complex consisting of the IL-23 receptor (IL-23R) and the IL-12 receptor 1 (IL-12R1). Complex formation was hypothesized to follow the site I-II-III architectural paradigm, with site I of p19 being required for binding to p40, whereas sites II and III of p19 mediate binding to IL-12R1 and IL-23R, respectively. Here we show that the binding mode of p19 to p40 and of p19 to IL-23R follow the canonical site I and III paradigm but that interaction of IL-23 to IL-12R1 is independent of site II in p19. Instead, binding of IL-23 to the cytokine binding module of IL-12R1 is mediated by domains 1 and 2 of p40 via corresponding site II amino acids of IL-12R1. Moreover, domains 2 and 3 of p40 were sufficient for complex formation with p19 and to induce binding of p19 to IL-23R. The Fc-tagged fusion protein of p40_D2D3/p19 did, however, not act as a competitive IL-23 antagonist but, at higher concentrations, induced proliferation via IL-23R but independent of IL-12R1. On the basis of our experimental validation, we propose a non-canonical topology of the IL-23<bold>IL</bold>-23R<bold>IL</bold>-12R1 complex. Furthermore, our data help to explain why p40 is an antagonist of IL-23 and IL-12 signaling and show that site II of p19 is dispensable for IL-23 signaling.	[Schroeder, Jutta; Moll, Jens M.; Baran, Paul; Scheller, Juergen; Floss, Doreen M.] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Groetzinger, Joachim] Univ Kiel, Fac Med, Inst Biochem, D-24098 Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Scheller, J (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de; doreen.floss@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015		DFG [SCHE 907/2-1, SFB877, A6]; RCMF of the University of Dusseldorf	DFG(German Research Foundation (DFG)); RCMF of the University of Dusseldorf	This work was supported by DFG Grants (SCHE 907/2-1 (to J. Scheller) and SFB877 and A6 (to J. G.) and by the RCMF of the University of Dusseldorf (to D. M. F. and J. Scheller).	Althoff K, 2001, BIOCHEM J, V353, P663, DOI 10.1042/0264-6021:3530663; Bobby R, 2014, FEBS J, V281, P2471, DOI 10.1111/febs.12800; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; CHUA AO, 1995, J IMMUNOL, V155, P4286; Cosmi L, 2014, CYTOM PART A, V85A, P36, DOI 10.1002/cyto.a.22348; Dahmen H, 1998, BIOCHEM J, V331, P695, DOI 10.1042/bj3310695; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Floss DM, 2013, J BIOL CHEM, V288, P19386, DOI 10.1074/jbc.M112.432153; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Ha SJ, 1999, J IMMUNOL, V163, P2902; He W, 2005, FEBS LETT, V579, P4317, DOI 10.1016/j.febslet.2005.06.061; Jalah R, 2013, J BIOL CHEM, V288, P6763, DOI 10.1074/jbc.M112.436675; Jones DS, 2008, TRENDS BIOTECHNOL, V26, P498, DOI 10.1016/j.tibtech.2008.05.009; Jones LL, 2012, MOL IMMUNOL, V51, P234, DOI 10.1016/j.molimm.2012.03.025; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuchar M, 2014, PROTEINS, V82, P975, DOI 10.1002/prot.24472; Levin AA, 2014, J AM ACAD DERMATOL, V70, P555, DOI 10.1016/j.jaad.2013.10.043; LING P, 1995, J IMMUNOL, V154, P116; Lupardus PJ, 2008, J MOL BIOL, V382, P931, DOI 10.1016/j.jmb.2008.07.051; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Timmermann A, 2000, FEBS LETT, V468, P120, DOI 10.1016/S0014-5793(00)01205-9; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang X, 1999, EUR J IMMUNOL, V29, P2007, DOI 10.1002/(SICI)1521-4141(199906)29:06<2007::AID-IMMU2007>3.0.CO;2-0; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530; Zhao J, 2010, J MASS SPECTROM, V45, P1416, DOI 10.1002/jms.1858	38	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					359	370		10.1074/jbc.M114.617597	http://dx.doi.org/10.1074/jbc.M114.617597			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25371211	Green Published, hybrid			2022-12-26	WOS:000347231200032
J	Larson-Casey, JL; Murthy, S; Ryan, AJ; Carter, AB				Larson-Casey, Jennifer L.; Murthy, Shubha; Ryan, Alan J.; Carter, A. Brent			Modulation of the Mevalonate Pathway by Akt Regulates Macrophage Survival and Development of Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITOR-INDUCED APOPTOSIS; FARNESYLTRANSFERASE INHIBITORS; CELL-TRANSFORMATION; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION; CANCER-CELLS; PHOSPHORYLATION; KINASE; GROWTH	Protein kinase B (Akt) is a key effector of multiple cellular processes, including cell survival. Akt, a serine/threonine kinase, is known to increase cell survival by regulation of the intrinsic pathway for apoptosis. In this study, we found that Akt modulated the mevalonate pathway, which is also linked to cell survival, by increasing Rho GTPase activation. Akt modulated the pathway by phosphorylating mevalonate diphosphate decarboxylase (MDD) at Ser(96). This phosphorylation in macrophages increased activation of Rac1, which enhanced macrophage survival because mutation of MDD (MDDS96A) induced apoptosis. Akt-mediated activation in macrophages was specific for Rac1 because Akt did not increase activity of other Rho GTP-binding proteins. The relationship between Akt and Rac1 was biologically relevant because Akt(+/-) mice had significantly less active Rac1 in alveolar macrophages, and macrophages from Akt(+/-) mice had an increase in active caspase-9 and -3. More importantly, Akt(+/-) mice were significantly protected from the development of pulmonary fibrosis, suggesting that macrophage survival is associated with the fibrotic phenotype. These observations for the first time suggest that Akt plays a critical role in the development and progression of pulmonary fibrosis by enhancing macrophage survival via modulation of the mevalonate pathway.	[Larson-Casey, Jennifer L.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Larson-Casey, Jennifer L.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Program Free Rad & Radiat Biol, Iowa City, IA 52242 USA; [Murthy, Shubha; Ryan, Alan J.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Dept Human Toxicol, Iowa City, IA 52242 USA; [Carter, A. Brent] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Carter, AB (corresponding author), Univ Iowa, Carver Coll Med, Iowa City Vet Affairs Hlth Care Syst, 200 Hawkins Dr, Iowa City, IA 52242 USA.	brent-carter@uiowa.edu	Casey, Jennifer/N-8385-2019	Casey, Jennifer/0000-0001-7238-7986	National Institutes of Health [2R01ES015981-07, T32CA078586, P30CA086862]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant [1BX001135-01]; NATIONAL CANCER INSTITUTE [T32CA078586, P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, R01ES015981] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01ES015981-07 (to A. B. C.), T32CA078586 (to the Free Radical and Radiation Biology Program), and P30CA086862 (to the University of Iowa Comprehensive Cancer Center). This work was also supported by Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant 1BX001135-01 (to A. B. C.).	Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Brodersen P, 2012, P NATL ACAD SCI USA, V109, P1778, DOI 10.1073/pnas.1112500109; CARANO A, 1990, J CLIN INVEST, V85, P456, DOI 10.1172/JCI114459; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Chensue SW, 1997, J IMMUNOL, V159, P3565; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Dan HC, 2004, ONCOGENE, V23, P706, DOI 10.1038/sj.onc.1207171; Danesh FR, 2002, P NATL ACAD SCI USA, V99, P8301, DOI 10.1073/pnas.122228799; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dolado I, 2008, CANCER CELL, V14, P427, DOI 10.1016/j.ccr.2008.11.006; Du W, 1999, CANCER RES, V59, P5492; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Hollander MC, 2011, ONCOGENE, V30, P1812, DOI 10.1038/onc.2010.556; Huang JF, 2011, HEPATOL RES, V41, P430, DOI 10.1111/j.1872-034X.2011.00786.x; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Jiang K, 2000, MOL CELL BIOL, V20, P139, DOI 10.1128/MCB.20.1.139-148.2000; Kazi A, 2009, MOL CELL BIOL, V29, P2254, DOI 10.1128/MCB.01029-08; Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Le Cras TD, 2010, AM J PATHOL, V176, P679, DOI 10.2353/ajpath.2010.090123; Li LF, 2008, CRIT CARE, V12, DOI 10.1186/cc6983; Lin CH, 2011, J BIOL CHEM, V286, P10483, DOI 10.1074/jbc.M110.112433; Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Miquel K, 1997, CANCER RES, V57, P1846; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Ozaki M, 2003, CELL DEATH DIFFER, V10, P508, DOI 10.1038/sj.cdd.4401172; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shull LW, 2006, BIOORGAN MED CHEM, V14, P4130, DOI 10.1016/j.bmc.2006.02.010; Sun JZ, 2003, CANCER RES, V63, P8922; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; Vasudevan KM, 2011, CURR TOP MICROBIOL, V347, P105, DOI 10.1007/82_2010_66; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Wasko BM, 2011, J PHARMACOL EXP THER, V337, P540, DOI 10.1124/jpet.110.175521; Weigert A, 2006, BLOOD, V108, P1635, DOI 10.1182/blood-2006-04-014852; Wong WB, 2013, PHARMACOEPIDEM DR S, V22, P345, DOI 10.1002/pds.3381; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Xue Y, 2011, AM J PHYSIOL-HEART C, V300, pH2169, DOI 10.1152/ajpheart.00970.2010; Zeng PY, 2003, ONCOGENE, V22, P1124, DOI 10.1038/sj.onc.1206181; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zins K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074924	75	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36204	36219		10.1074/jbc.M114.593285	http://dx.doi.org/10.1074/jbc.M114.593285			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378391	Green Published, hybrid			2022-12-26	WOS:000346897900046
J	Mbondji-Wonje, C; Ragupathy, V; Zhao, JQ; Nanfack, A; Lee, S; Torimiro, J; Nyambi, P; Hewlett, IK				Mbondji-Wonje, Christelle; Ragupathy, Viswanath; Zhao, Jiangqin; Nanfack, Aubin; Lee, Sherwin; Torimiro, Judith; Nyambi, Phillipe; Hewlett, Indira K.			Genotypic Prediction of Tropism of Highly Diverse HIV-1 Strains from Cameroon	PLOS ONE			English	Article							VIRUS TYPE-1 GP120; GENETIC DIVERSITY; INTERSUBTYPE RECOMBINANTS; BLOOD-DONORS; V3 LOOP; CCR5; PREVALENCE; CRF02-AG; SUBTYPES; CXCR4	Background: The use of CCR5 antagonists involves determination of HIV-1 tropism prior to initiation of treatment. HIV-1 tropism can be assessed either by phenotypic or genotypic methods. Genotypic methods are extensively used for tropism prediction. However, their validation in predicting tropism of viral isolates belonging to group M non-B subtypes remains challenging. In Cameroon, the genetic diversity of HIV-1 strains is the broadest reported worldwide. To facilitate the integration of CCR5 antagonists into clinical practice in this region, there is a need to evaluate the performance of genotypic methods for predicting tropism of highly diverse group M HIV-1 strains. Methods: Tropism of diverse HIV-1 strains isolated from PBMCs from Cameroon was determined using the GHOST cell assay. Prediction, based on V3 sequences from matched plasma samples, was determined using bioinformatics algorithms and rules based on position 11/25 and net charge applied independently or combined according to Delobel's and Garrido's rules. Performance of genotypic methods was evaluated by comparing prediction generated with tropism assigned by the phenotypic assay. Results: Specificity for predicting R5-tropic virus was high, ranging from 83.7% to 97.7% depending on the genotypic methods used. Sensitivity for X4-tropic viruses was fairly low, ranging from 33.3% to 50%. In our study, overall, genotypic methods were less able to accurately predict X4-tropic virus belonging to subtype CRF02_AG. In addition, it was found that of the methods we used the Garrido rule has the highest sensitivity rate of over 50% with a specificity of 93%. Conclusion: Our study demonstrated that overall, genotypic methods were less sensitive for accurate prediction of HIV-1 tropism in settings where diverse HIV-1 strains co-circulate. Our data suggest that further optimization of genotypic methods is needed and that larger studies to determine their utility for tropism prediction of diverse HIV-1 strains may be warranted.	[Mbondji-Wonje, Christelle; Ragupathy, Viswanath; Zhao, Jiangqin; Lee, Sherwin; Hewlett, Indira K.] Ctr Biol Evaluat & Res, Div Emerging & Transmiss Transmitted Dis, Mol Virol Lab, Off Blood Review & Res,Food & Drug Adm, Silver Spring, MD 20993 USA; [Mbondji-Wonje, Christelle] Univ Douala, Fac Med Pharm & Biomed Sci, Douala, Cameroon; [Nanfack, Aubin; Torimiro, Judith] Chantal Biya Int Reference Ctr, Yaounde, Cameroon; [Nanfack, Aubin] NYU, Sch Med, Dept Pathol, New York, NY USA	US Food & Drug Administration (FDA); New York University	Mbondji-Wonje, C (corresponding author), Ctr Biol Evaluat & Res, Div Emerging & Transmiss Transmitted Dis, Mol Virol Lab, Off Blood Review & Res,Food & Drug Adm, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	christelle.mbondji@fda.hhs.gov	mbondji, christelle/Q-3145-2019; Ragupathy, Viswanath/ABA-3444-2021	mbondji, christelle/0000-0001-7222-9849; Zhao, Jiangqin/0000-0003-4672-0735	National Heart, Lung and Blood Institute [BY1-HB-5026-01]; Center for Biologics Evaluation and Research intramural funding program (CBER/FDA)	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Biologics Evaluation and Research intramural funding program (CBER/FDA)	For this work the authors received the funding support of the National Heart, Lung and Blood Institute for funding part of this work through the Inter-Agency Agreement BY1-HB-5026-01, www.nhlbi.nih.gov; and of the Center for Biologics Evaluation and Research intramural funding program (CBER/FDA), www.fda.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Brennan CA, 2008, JAIDS-J ACQ IMM DEF, V49, P432, DOI 10.1097/QAI.0b013e31818a6561; Briggs D, 2000, SURF INTERFACE ANAL, V29, P1; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; CHEINGSONGPOPOV R, 1994, AIDS RES HUM RETROV, V10, P1379, DOI 10.1089/aid.1994.10.1379; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Delgado E, 2012, J ANTIMICROB CHEMOTH, V67, P25, DOI 10.1093/jac/dkr438; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; Ghaffari G, 2005, J VIROL, V79, P13250, DOI 10.1128/JVI.79.21.13250-13261.2005; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Huang W, 2008, J VIROL, V82, P5584, DOI 10.1128/JVI.02676-07; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; Koup RA, 2001, CURR PROTOC IMMUNOL; Labrosse B, 2001, J VIROL, V75, P5457, DOI 10.1128/JVI.75.12.5457-5464.2001; Lai A, 2010, HIV MED, V11, P593, DOI 10.1111/j.1468-1293.2010.00832.x; Lee MK, 1999, VIROLOGY, V257, P290, DOI 10.1006/viro.1999.9686; Lihana RW, 2012, AIDS REV, V14, P83; Machuca A, 2007, JAIDS-J ACQ IMM DEF, V45, P361, DOI 10.1097/QAI.0b013e318053754c; MOORE J, 1993, NATURE, V361, P309, DOI 10.1038/361309b0; Mulinge M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060566; Nadai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001420; NKENGASONG JN, 1994, AIDS, V8, P1405, DOI 10.1097/00002030-199410000-00006; Nyambi P, 2002, AIDS, V16, P295, DOI 10.1097/00002030-200201250-00022; Paraskevis D, 1999, J HUMAN VIROL, V2, P339; PAU CP, 1994, AIDS RES HUM RETROV, V10, P1369, DOI 10.1089/aid.1994.10.1369; Peeters M, 2003, AIDS, V17, P2547, DOI 10.1097/00002030-200312050-00002; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Poveda E, 2012, AIDS REV, V14, P208; Powell R, 2010, VIRUSES-BASEL, V2, P639, DOI 10.3390/v2020639; Ragupathy V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-185; Ragupathy Viswanath, 2009, AIDS Res Ther, V6, P27, DOI 10.1186/1742-6405-6-27; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2013, J CLIN MICROBIOL, V51, P564, DOI 10.1128/JCM.02328-12; Raymond S, 2009, J CLIN MICROBIOL, V47, P2292, DOI 10.1128/JCM.02439-08; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Seclen E, 2010, J ANTIMICROB CHEMOTH, V65, P1486, DOI 10.1093/jac/dkq137; Swenson LC, 2013, ANTIMICROB AGENTS CH, V57, P6122, DOI 10.1128/AAC.01534-13; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torimiro JN, 2009, NEW MICROBIOL, V32, P325; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Vergne L, 2003, VIROLOGY, V310, P254, DOI 10.1016/S0042-6822(03)00167-3; Weidle PJ, 2000, J INFECT DIS, V181, P470, DOI 10.1086/315253; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742	48	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112434	10.1371/journal.pone.0112434	http://dx.doi.org/10.1371/journal.pone.0112434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379669	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100091
J	Dudekula, A; Rachakonda, V; Shaik, B; Behari, J				Dudekula, Anwar; Rachakonda, Vikrant; Shaik, Beebijan; Behari, Jaideep			Weight Loss in Nonalcoholic Fatty Liver Disease Patients in an Ambulatory Care Setting Is Largely Unsuccessful but Correlates with Frequency of Clinic Visits	PLOS ONE			English	Article							LIFE-STYLE MODIFICATION; CARDIOVASCULAR-DISEASE; HEPATIC STEATOSIS; PHYSICAL-ACTIVITY; CONTROLLED-TRIAL; ADULTS; STEATOHEPATITIS; EPIDEMIOLOGY; ASSOCIATION; MAINTENANCE	Background and Aims: Nonalcoholic fatty liver disease (NALFD) is a leading cause of liver disease. Weight loss improves clinical features of NAFLD; however, maintenance of weight loss outside of investigational protocols is poor. The goals of this study were to characterize patterns and clinical predictors of long-term weight loss in ambulatory patients with NAFLD. Methods: We retrospectively reviewed 924 non-cirrhotic patients with NAFLD presenting to a liver clinic from May 1st 2007 to April 30th 2013. Overweight and obese patients were counseled on lifestyle modifications for weight loss as per USPSTF guidelines. The primary outcome was percent weight change between the first and last recorded visits: % weight change = (weight(initial) - weight(final))/(weight(initial)). Baseline BMI and percent BMI change were secondary measures. Predictors of weight loss were determined using logistic regression. Results: The mean baseline BMI was 33.3 +/- 6.6 kg/m(2), and the mean follow-up duration was 17.3 +/- 17.6 months. Most patients with NAFLD were in either overweight (26.1%) or class I obesity (30.5%) categories at baseline, while the prevalence of underweight and class III obesity was lower (0.2% and 15.4%, respectively). Overall, there was no change in mean weight or BMI during the follow-up period, and only 183 patients (19.8%) lost at least 5% body weight during the follow up period. Independent predictors of weight loss included number of clinic visits and baseline BMI, and patients with higher baseline BMI required more clinic visits to lose weight. Conclusions: Weight loss is largely unsuccessful in NAFLD patients in the ambulatory care setting. Frequent clinical encounters are associated with weight reduction, especially among individuals with high baseline BMI. Future studies are required to define effective weight loss strategies in NAFLD patients.	[Dudekula, Anwar] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA; [Rachakonda, Vikrant; Shaik, Beebijan; Behari, Jaideep] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Behari, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA.	beharij@upmc.edu			National Institutes of Health [UL1 RR024153, UL1TR000005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the University of Pittsburgh Clinical and Translational Science Institute (CTSI) for assistance with statistical analysis. The CTSI is supported by the National Institutes of Health through Grant Numbers UL1 RR024153 and UL1TR000005.	Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Bellentani S, 2004, EUR J GASTROEN HEPAT, V16, P1087, DOI 10.1097/00042737-200411000-00002; BELLENTANI S, 1994, HEPATOLOGY, V20, P1442, DOI 10.1002/hep.1840200611; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Church TS, 2006, GASTROENTEROLOGY, V130, P2023, DOI 10.1053/j.gastro.2006.03.019; Cruz RJ, 2013, TRANSPLANTATION, V95, P617, DOI 10.1097/TP.0b013e31827a0f27; Harrison SA, 2009, HEPATOLOGY, V49, P80, DOI 10.1002/hep.22575; Haufe S, 2013, DIABETES CARE, V36, P3786, DOI 10.2337/dc13-0102; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Kugelmas M, 2003, HEPATOLOGY, V38, P413, DOI 10.1053/jhep.2003.50316; Lazo M, 2010, DIABETES CARE, V33, P2156, DOI 10.2337/dc10-0856; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Long J.Scott., 2005, REGRESSION MODELS CA; McHugh PP, 2010, HEPATO-GASTROENTEROL, V57, P591; Moyer VA, 2012, ANN INTERN MED, V157, P367, DOI 10.7326/0003-4819-157-5-201209040-00486; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Nehra MS, 2013, J CLIN GASTROENTEROL, V47, pE50, DOI 10.1097/MCG.0b013e3182688d2f; Penn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057143; Perseghin G, 2007, DIABETES CARE, V30, P683, DOI 10.2337/dc06-2032; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Tsai AG, 2005, PSYCHIAT CLIN N AM, V28, P171, DOI 10.1016/j.psc.2004.10.003; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Zelber-Sagi S, 2006, CLIN GASTROENTEROL H, V4, P639, DOI 10.1016/j.cgh.2006.02.004	31	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111808	10.1371/journal.pone.0111808	http://dx.doi.org/10.1371/journal.pone.0111808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375228	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000344402600064
J	Martins, MCB; Silva, MC; Silva, LRS; Lima, VLM; Pereira, EC; Falcao, EPS; Melo, AMMA; da Silva, NH				Martins, Monica C. B.; Silva, Monique C.; Silva, Luanna R. S.; Lima, Vera L. M.; Pereira, Eugenia C.; Falcao, Emerson P. S.; Melo, Ana M. M. A.; da Silva, Nicacio Henrique			Usnic Acid Potassium Salt: An Alternative for the Control of Biomphalaria glabrata (Say, 1818)	PLOS ONE			English	Article							LICHEN SECONDARY METABOLITES; SCHISTOSOMA-MANSONI; MOLLUSCICIDAL ACTIVITY; ARTEMIA-SALINA; DEPSIDONES; TOXICITY; DEFENSE; VECTOR; LARVAE; BRAZIL	In Brazil, the snail Biomphalaria glabrata is the most important vector of schistosomiasis due to its wide geographical distribution, high infection rate and efficient disease transmission. Among the methods of schistosomiasis control, the World Health Organization recommends the use of synthetic molluscicides, such as niclosamide. However, different substances of natural origin have been tested as alternatives for the control or eradication of mollusks. The literature describes the antitumor, antimicrobial and antiviral properties of usnic acid as well as other important activities of common interest between medicine and the environment. However, usnic acid has a low degree of water solubility, which can be a limiting factor for its use, especially in aquatic environments, since the organic solvents commonly used to solubilize this substance can have toxic effects on aquatic biota. Thus, the aim of the present study was to test the potassium salt of usnic acid (potassium usnate) with regard to molluscicidal activity and toxicity to brine shrimp (Artemia salina). To obtain potassium usnate, usnic acid was extracted with diethyl ether isolated and purified from the lichen Cladonia substellata. Biological assays were performed with embryos and adult snails of B. glabrata exposed for 24 h to the usnate solution solubilized in dechlorinated water at 2.5; 5 and 10 mu g/ml for embryos, 0.5; 0.9; 1; 5 and 10 mu g/ml for mollusks and 0.5; 1; 5; 10 mu g/ml for A. salina. The lowest lethal concentration for the embryos and adult snails was 10 and 1 mu g/ml, respectively. No toxicity to A. salina was found. The results show that modified usnic acid has increased solubility (100%) without losing its biological activity and may be a viable alternative for the control of B. glabrata.	[Martins, Monica C. B.; Silva, Monique C.; Lima, Vera L. M.; da Silva, Nicacio Henrique] Univ Fed Pernambuco, Dept Bioquim, Recife, Brazil; [Silva, Luanna R. S.; Melo, Ana M. M. A.] Univ Fed Pernambuco, Dept Radiobiol, Recife, Brazil; [Pereira, Eugenia C.] Univ Pernambuco, Dept Ciencias Geog, Pernambuco, Brazil; [Falcao, Emerson P. S.] Univ Fed Pernambuco, Ctr Acad Vitoria De Santo Antao, Recife, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco	Martins, MCB (corresponding author), Univ Fed Pernambuco, Dept Bioquim, Recife, Brazil.	monicabarmartins@hotmail.com; verticillaris@gmail.com	PEREIRA, EUGÊNIA/AAP-9515-2021	PEREIRA, EUGÊNIA/0000-0002-5821-0938; Lima, Vera/0000-0003-2581-9218	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MCBM received a doctoral grant by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (www.capes.gov.br). ECP has a grant in research productivity by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Asahina Y., 1954, CHEM LICHEN SUBSTANC; Asplund J, 2009, BASIC APPL ECOL, V10, P273, DOI 10.1016/j.baae.2008.04.003; Martins MCB, 2010, BRAZ ARCH BIOL TECHN, V53, P115, DOI 10.1590/S1516-89132010000100015; Benesperi R, 2004, BIOCHEM SYST ECOL, V32, P127, DOI 10.1016/S0305-1978(03)00141-8; Brasil. Ministerio da Saude, 2010, CAD, V10, P19; Brasil. Programa de Vigilancia e Controle da Esquistossomose, 2011, COORD GER DOENC NEGL; BUSTINZA F, 1951, ENDEAVOUR, V10, P95; Campanella L, 2002, BIOCHIMIE, V84, P329, DOI 10.1016/S0300-9084(02)01386-X; Cantanhede SPD, 2010, REV BRAS FARMACOGN, V20, P282, DOI 10.1590/S0102-695X2010000200024; dos Reis DC, 2010, MEM I OSWALDO CRUZ, V105, P587, DOI 10.1590/S0074-02762010000400039; dos Santos AF, 2007, BIORESOURCE TECHNOL, V98, P135, DOI 10.1016/j.biortech.2005.11.020; Edwards HGM, 2003, J MOL STRUCT, V651, P27, DOI 10.1016/S0022-2860(02)00626-9; Einarsdottir E, 2010, PLANTA MED, V76, P969, DOI 10.1055/s-0029-1240851; Elo H, 2007, NATURWISSENSCHAFTEN, V94, P465, DOI 10.1007/s00114-006-0208-9; Gauslaa Y, 2005, OECOLOGIA, V143, P94, DOI 10.1007/s00442-004-1768-z; Giovanelli A, 2002, MEM I OSWALDO CRUZ, V90, P261; Huneck S, 1996, IDENTIFICATION LICHE; Ingolfsdottir K, 2002, PHYTOCHEMISTRY, V61, P729, DOI 10.1016/S0031-9422(02)00383-7; Lawrey J. D., 1980, BRYOLOGIST, V23, P128; LAWREY JD, 1989, BRYOLOGIST, V92, P326, DOI 10.2307/3243401; LEGAZ ME, 1983, PLANT PHYSIOL, V71, P300, DOI 10.1104/pp.71.2.300; Lemma A, 1974, Ethiop Med J, V12, P109; Lima NMF, 2002, ACTA TROP, V83, P43, DOI 10.1016/S0001-706X(02)00055-4; Luna JD, 2005, J ETHNOPHARMACOL, V97, P199, DOI 10.1016/j.jep.2004.10.004; Nimis PL, 2006, ENVIRON EXP BOT, V55, P175, DOI 10.1016/j.envexpbot.2004.10.011; Odabasoglu F, 2006, J ETHNOPHARMACOL, V103, P59, DOI 10.1016/j.jep.2005.06.043; Oliveira EC, 2010, CHEMOSPHERE, V81, P218, DOI 10.1016/j.chemosphere.2010.06.038; Poykko H, 2005, ECOLOGY, V86, P2623, DOI 10.1890/04-1632; Poykko H, 2010, OECOLOGIA, V164, P423, DOI 10.1007/s00442-010-1682-5; Rawi S. M., 2011, International Journal of Zoological Research, V7, P169, DOI 10.3923/ijzr.2011.169.189; Ribeiro KAL, 2009, ACTA TROP, V111, P44, DOI 10.1016/j.actatropica.2009.02.008; Santos A. F., 2010, BIORESOURTECHNOL, V101, P794, DOI DOI 10.1016/J.BIORTECH.2009.07.062; Savic I, 2010, MACED J CHEM CHEM EN, V29, P157; Schall VT, 2001, ACTA TROP, V79, P165, DOI 10.1016/S0001-706X(01)00126-7; Solhaug KA, 2009, FLORA, V204, P40, DOI 10.1016/j.flora.2007.12.002; Treyvaud V, 2000, PHYTOCHEMISTRY, V55, P603, DOI 10.1016/S0031-9422(00)00233-8; Wei XL, 2008, PLANT PATHOLOGY J, V24, P202, DOI 10.5423/PPJ.2008.24.2.202; World Health Organization, 1965, WHO TECH REP SER, V299, P1; World Health Organization, 1993, WHO TECHN REP SER	39	29	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111102	10.1371/journal.pone.0111102	http://dx.doi.org/10.1371/journal.pone.0111102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375098	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600025
J	Muller, V; Lindenberger, U				Mueller, Viktor; Lindenberger, Ulman			Hyper-Brain Networks Support Romantic Kissing in Humans	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; CELL ASSEMBLIES; SMALL-WORLD; ALPHA OSCILLATIONS; SOCIAL-INTERACTION; CORTICAL NETWORKS; COMPLEX NETWORKS; FREQUENCY; INFORMATION; ORGANIZATION	Coordinated social interaction is associated with, and presumably dependent on, oscillatory couplings within and between brains, which, in turn, consist of an interplay across different frequencies. Here, we introduce a method of network construction based on the cross-frequency coupling (CFC) and examine whether coordinated social interaction is associated with CFC within and between brains. Specifically, we compare the electroencephalograms (EEG) of 15 heterosexual couples during romantic kissing to kissing one's own hand, and to kissing one another while performing silent arithmetic. Using graph-theory methods, we identify theta-alpha hyper-brain networks, with alpha serving a cleaving or pacemaker function. Network strengths were higher and characteristic path lengths shorter when individuals were kissing each other than when they were kissing their own hand. In both partner-oriented kissing conditions, greater strength and shorter path length for 5-Hz oscillation nodes correlated reliably with greater partner-oriented kissing satisfaction. This correlation was especially strong for inter-brain connections in both partner-oriented kissing conditions but not during kissing one's own hand. Kissing quality assessed after the kissing with silent arithmetic correlated reliably with intra-brain strength of 10-Hz oscillation nodes during both romantic kissing and kissing with silent arithmetic. We conclude that hyper-brain networks based on CFC may capture neural mechanisms that support interpersonally coordinated voluntary action and bonding behavior.	[Mueller, Viktor; Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany	Max Planck Society	Muller, V (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany.	vmueller@mpib-berlin.mpg.de	Müller, Viktor/AAX-4429-2021	Muller, Viktor/0000-0002-3716-5445	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Astolfi L, 2010, BRAIN TOPOGR, V23, P243, DOI 10.1007/s10548-010-0147-9; Baltes P.B., 1996, INTERACTIVE MINDS LI, P1, DOI DOI 10.5860/CHOICE.34-2459; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Boker S, 2003, MIRROR NEURONS EVOLU, P163; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Di Paolo E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00163; Dumas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036414; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Fallani FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014187; Frith CD, 2003, PHILOS T R SOC B, V358, P431, DOI 10.1098/rstb.2002.1260; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Grosse P, 2002, CLIN NEUROPHYSIOL, V113, P1523, DOI 10.1016/S1388-2457(02)00223-7; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hughes S. M., 2007, EVOLUTIONARY PSYCHOL, V5, DOI [10.1177/147470490700500310, DOI 10.1177/147470490700500310]; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jirsa V, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00078; Kilner JM, 2000, J NEUROSCI, V20, P8838; Kim Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016103; Klimesch W, 2008, BRAIN RES, V1235, P31, DOI 10.1016/j.brainres.2008.06.049; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Muller V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073852; Muller V, 2012, DEVELOPMENTAL SCI, V15, P540, DOI 10.1111/j.1467-7687.2012.01153.x; Muller V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024893; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pfurtscheller G, 2003, EPILEPSIA, V44, P2, DOI 10.1111/j.0013-9580.2003.12001.x; Polania R, 2011, NEUROIMAGE, V54, P2287, DOI 10.1016/j.neuroimage.2010.09.085; Pulvermuller F, 2009, HUM BRAIN MAPP, V30, P3837, DOI 10.1002/hbm.20811; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanger J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00234; Sanger J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00312; Sakurai Y, 1999, NEUROSCI BIOBEHAV R, V23, P785, DOI 10.1016/S0149-7634(99)00017-2; Sakurai Y, 1998, BEHAV BRAIN RES, V91, P1, DOI 10.1016/S0166-4328(97)00106-X; Sanger Johanna, 2011, Commun Integr Biol, V4, P655; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Telesford QK, 2011, BRAIN CONNECT, V1, P367, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Vigario RN, 1997, ELECTROEN CLIN NEURO, V103, P395, DOI 10.1016/S0013-4694(97)00042-8; Vilar L., 2012, EUROPEAN J SPORT SCI, V14, P28, DOI DOI 10.1080/17461391.2012.725103; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	73	27	27	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112080	10.1371/journal.pone.0112080	http://dx.doi.org/10.1371/journal.pone.0112080			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375132	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600098
J	Ensminger, AL; Fernandez-Juricic, E				Ensminger, Amanda L.; Fernandez-Juricic, Esteban			Individual Variation in Cone Photoreceptor Density in House Sparrows: Implications for Between-Individual Differences in Visual Resolution and Chromatic Contrast	PLOS ONE			English	Article							COLOR-VISION; SPECTRAL SENSITIVITY; RETINAL MORPHOLOGY; BLUEFIN KILLIFISH; OPSIN EXPRESSION; PRACTICAL GUIDE; ECOLOGY; VARIABILITY; PERFORMANCE; PLASTICITY	Between-individual variation has been documented in a wide variety of taxa, especially for behavioral characteristics; however, intra-population variation in sensory systems has not received similar attention in wild animals. We measured a key trait of the visual system, the density of retinal cone photoreceptors, in a wild population of house sparrows (Passer domesticus). We tested whether individuals differed from each other in cone densities given within-individual variation across the retina and across eyes. We further tested whether the existing variation could lead to individual differences in two aspects of perception: visual resolution and chromatic contrast. We found consistent between-individual variation in the densities of all five types of avian cones, involved in chromatic and achromatic vision. Using perceptual modeling, we found that this degree of variation translated into significant between-individual differences in visual resolution and the chromatic contrast of a plumage signal that has been associated with mate choice and agonistic interactions. However, there was no evidence for a relationship between individual visual resolution and chromatic contrast. The implication is that some birds may have the sensory potential to perform "better" in certain visual tasks, but not necessarily in both resolution and contrast simultaneously. Overall, our findings (a) highlight the need to consider multiple individuals when characterizing sensory traits of a species, and (b) provide some mechanistic basis for between-individual variation in different behaviors (i.e., animal personalities) and for testing the predictions of several widely accepted hypotheses (e.g., honest signaling).	[Ensminger, Amanda L.; Fernandez-Juricic, Esteban] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ensminger, AL (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	amanda.ensminger@gmail.com			National Science Foundation [1103725]; Div Of Biological Infrastructure [1103725] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation under award No. 1103725 to A.L.E. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR., 2006, BIOL UBIQUITOUS HOUS; [Anonymous], 2006, SAS MIXED MODELS; ARCHER SN, 1987, VISION RES, V27, P1243, DOI 10.1016/0042-6989(87)90200-8; Bailes HJ, 2006, J COMP NEUROL, V494, P381, DOI 10.1002/cne.20809; Baumhardt PE, 2014, BRAIN BEHAV EVOL; Bisley JW, 2011, J PHYSIOL-LONDON, V589, P49, DOI 10.1113/jphysiol.2010.192666; Bokony V, 2006, ETHOLOGY, V112, P947, DOI 10.1111/j.1439-0310.2006.01246.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Bueno JM, 2011, BIOMED OPT EXPRESS, V2, P1637, DOI 10.1364/BOE.2.001637; Carpentier S, 2009, CRIT REV FOOD SCI, V49, P313, DOI 10.1080/10408390802066979; Carroll J, 2012, INVEST OPHTH VIS SCI, V53, P8006, DOI 10.1167/iovs.12-11087; Coimbra JP, 2014, J COMP NEUROLOGY; Collin SP, 2004, VISUAL NEUROSCI, V21, P765, DOI 10.1017/S0952523804215103; Cropp S, 2002, J MOL EVOL, V54, P734, DOI 10.1007/s0023901-0073-2; Crozier WJ, 1940, J GEN PHYSIOL, V23, P667, DOI 10.1085/jgp.23.6.667; Cummings ME, 2004, VISION RES, V44, P1127, DOI 10.1016/j.visres.2003.12.013; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dangles O, 2009, Q REV BIOL, V84, P51, DOI 10.1086/596463; Darwin C, 1859, ORIGIN SPECIES MEANS; David M, 2011, ANIM BEHAV, V82, P61, DOI 10.1016/j.anbehav.2011.03.025; Dees EW, 2011, BIOMED OPT EXPRESS, V2, P1351, DOI 10.1364/BOE.2.001351; Dingemanse NJ, 2013, ANIM BEHAV, V85, P1031, DOI 10.1016/j.anbehav.2012.12.032; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; Fernandez-Juricic E., 2010, ENCY ANIMAL BEHAV, P544; Fernandez-Juricic E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058985; Fernandez-Juricic E, 2012, BEHAV PROCESS, V89, P143, DOI 10.1016/j.beproc.2011.10.006; Fitzgerald MEC, 2001, VISUAL NEUROSCI, V18, P299, DOI 10.1017/S0952523801182143; Fuller RC, 2003, J COMP PHYSIOL A, V189, P609, DOI 10.1007/s00359-003-0435-x; Fuller RC, 2004, J COMP PHYSIOL A, V190, P147, DOI 10.1007/s00359-003-0478-z; Gal G, 1999, CAN J FISH AQUAT SCI, V56, P311, DOI 10.1139/cjfas-56-2-311; Gomez D., 2006, AVICOL PROGRAM ANAL; Gumm JM, 2012, VISION RES, V55, P19, DOI 10.1016/j.visres.2011.12.005; Hamilton DG, 2013, BEHAV ECOL, V24, P1138, DOI 10.1093/beheco/art041; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2006, J EXP BIOL, V209, P4776, DOI 10.1242/jeb.02568; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hart NS, 2000, CURR BIOL, V10, P115, DOI 10.1016/S0960-9822(00)00297-9; HODOS W, 1991, VISION RES, V31, P669, DOI 10.1016/0042-6989(91)90008-S; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Hornstein EP, 2000, P ROY SOC B-BIOL SCI, V267, P2111, DOI 10.1098/rspb.2000.1257; IMAKI H, 1993, J NEUROSCI RES, V36, P290, DOI 10.1002/jnr.490360307; Ismar SMH, 2011, NEW ZEAL J ZOOL, V38, P29, DOI 10.1080/03014223.2010.524228; JACOBS GH, 1984, J COMP PSYCHOL, V98, P347, DOI 10.1037/0735-7036.98.4.347; Jones MP, 2007, J EXOT PET MED, V16, P69, DOI 10.1053/j.jepm.2007.03.012; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Litherland L, 2008, VISUAL NEUROSCI, V25, P549, DOI 10.1017/S0952523808080693; MARTIN GR, 1986, J COMP PHYSIOL A, V159, P545, DOI 10.1007/BF00604174; Martin Graham R., 1993, P5; McGraw Kevin J., 2006, P177; Mitkus M, 2014, J COMP PHYSIOL A, V200, P371, DOI 10.1007/s00359-014-0894-2; Moore BA, 2012, J VISION, V12, DOI 10.1167/12.12.13; Moreno-Rueda G, 2012, BEHAV ECOL, V23, P271, DOI 10.1093/beheco/arr182; Moreno-Rueda G, 2010, J AVIAN BIOL, V41, P229, DOI 10.1111/j.1600-048X.2009.04859.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Osorio D, 1999, J EXP BIOL, V202, P2951; Poston JP, 2005, ANIM BEHAV, V70, P1171, DOI 10.1016/j.anbehav.2005.02.015; Rick IP, 2012, BIOL J LINN SOC, V105, P359, DOI 10.1111/j.1095-8312.2011.01796.x; Rodriguez-Prieto I, 2010, BEHAV ECOL SOCIOBIOL, V64, P1937, DOI 10.1007/s00265-010-1004-2; Ronald KL, 2012, ANIM BEHAV, V84, P1283, DOI 10.1016/j.anbehav.2012.09.015; Safi K, 2010, EVOL ECOL, V24, P703, DOI 10.1007/s10682-009-9326-0; Schaefer HM, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P3, DOI 10.1007/978-3-642-02624-9_1; SEARCY WA, 2005, MG BEH ECOL, P1; Smith AR, 2011, MOL ECOL, V20, P299, DOI 10.1111/j.1365-294X.2010.04935.x; SNYDER AW, 1977, J OPT SOC AM, V67, P696, DOI 10.1364/JOSA.67.000696; TAMURA TAMOTSU, 1963, BULL MAR SCI GULF AND CARIBBEAN, V13, P433; TAMURA TAMOTSU, 1957, BULL JAPANESE SOC SCI FISH, V22, P536; Toomey MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021653; Ullmann JFP, 2012, BRAIN BEHAV EVOLUT, V79, P26, DOI 10.1159/000332802; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; West B. T., 2007, LINEAR MIXED MODELS; West Mark J, 2013, Cold Spring Harb Protoc, V2013, P815, DOI 10.1101/pdb.top071894; Westneat DF, 2011, AM NAT, V178, P652, DOI 10.1086/662173; White EM, 2004, J FISH BIOL, V65, P227, DOI 10.1111/j.0022-1112.2004.00446.x; Zhang CZ, 2008, CURR SCI INDIA, V95, P1544	81	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111854	10.1371/journal.pone.0111854	http://dx.doi.org/10.1371/journal.pone.0111854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372039	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900079
J	Francisco, TM; Couto, DR; Zanuncio, JC; Serrao, JE; Silva, ID; Boere, V				Francisco, Talitha Mayumi; Couto, Dayvid Rodrigues; Zanuncio, Jose Cola; Serrao, Jose Eduardo; Silva, Ita de Oliveira; Boere, Vanner			Vegetable Exudates as Food for Callithrix spp. (Callitrichidae): Exploratory Patterns	PLOS ONE			English	Article							COMMON MARMOSETS; SAGUINUS-FUSCICOLLIS; ATLANTIC FOREST; SCENT-MARKING; ECOLOGY; MORPHOLOGY; GUMMIVORY; FRAGMENT; BEHAVIOR; JACCHUS	Marmosets of the genus Callithrix are specialized in the consumption of tree exudates to obtain essential nutritional resource by boring holes into bark with teeth. However, marmoset preferences for particular tree species, location, type, and other suitable factors that aid in exudate acquisition need further research. In the current study, the intensity of exudate use from Anadenanthera peregrina var. peregrina trees by hybrid marmosets Callithrix spp. groups was studied in five forest fragments in Vic, osa, in the state of Minas, Brazil. Thirty-nine A. peregrina var. peregrina trees were examined and 8,765 active and non-active holes were analyzed. The trunk of A. peregrina var. peregrina had a lower number of holes than the canopy: 11% were found on the trunk and 89% were found on the canopy. The upper canopy was the preferred area by Callithrix spp. for obtaining exudates. The intensity of tree exploitation by marmosets showed a moderate-to-weak correlation with diameter at breast height (DBH) and total tree height. The overall results indicate that Anadenanthera peregrina var. peregrina provides food resources for hybrid marmosets (Callithrix spp.) and these animals prefer to explore this resource on the apical parts of the plant, where the thickness, location, and age of the branches are the main features involved in the acquisition of exudates.	[Francisco, Talitha Mayumi; Zanuncio, Jose Cola; Silva, Ita de Oliveira] Univ Fed Vicosa, Dept Biol Anim, BR-36570900 Vicosa, MG, Brazil; [Couto, Dayvid Rodrigues] Univ Fed Rio de Janeiro, Dept Bot, Museu Nacl, BR-20940040 Rio De Janeiro, RJ, Brazil; [Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, BR-36570900 Vicosa, MG, Brazil; [Boere, Vanner] Univ Fed Vicosa, Dept Bioquim & Biol Mol, BR-36570900 Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal do Rio de Janeiro; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Zanuncio, JC (corresponding author), Univ Fed Vicosa, Dept Biol Anim, BR-36570900 Vicosa, MG, Brazil.	zanuncio@ufv.br	Francisco, Talitha Mayumi/AAJ-7969-2021		Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding provided by "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)", "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)" and "Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amora TD, 2013, AM J PRIMATOL, V75, P333, DOI 10.1002/ajp.22110; [Anonymous], METEOROLOGIA BASICA; Bearder S.K., 1980, International Journal of Primatology, V1, P103, DOI 10.1007/BF02735592; Bouchardet da Fonseca G.A., 1984, Primates, V25, P441, DOI 10.1007/BF02381667; Carvalho PER., 1994, ESPECIES FLORESTAIS; Caton JM, 1996, COMP BIOCHEM PHYS A, V114, P1, DOI 10.1016/0300-9629(95)02013-6; COIMBRA-FILHO A F, 1981, Revista Brasileira de Biologia, V41, P141; COIMBRA-FILHO A F, 1980, Revista Brasileira de Biologia, V40, P177; Coimbra-Filho A. F., 1973, BRASIL FLORESTAL, V4, P7; Coimbra-Filho AF, 1977, BIOL CONSERVATION CA, P105; COIMBRAFILHO AF, 1976, NATURE, V262, P630, DOI 10.1038/262630a0; dePaula RCM, 1997, POLYM INT, V44, P55; Eng CM, 2009, J EXP BIOL, V212, P4040, DOI 10.1242/jeb.029983; Ferrari SF, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P157; FERRARI SF, 1992, AM J PHYS ANTHROPOL, V88, P97, DOI 10.1002/ajpa.1330880108; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; GARBER PA, 1986, AM J PHYS ANTHROPOL, V71, P331, DOI 10.1002/ajpa.1330710308; Garber PA, 2010, DEV PRIMATOL-PROG PR, P89, DOI 10.1007/978-1-4419-6661-2_4; Giongo Claudia, 2004, Braz. J. Bot., V27, P563, DOI 10.1590/S0100-84042004000300015; GOLFARI L., 1975, ZONEAMENTO ECOLOGICO; Hanna JB, 2011, AM J PHYS ANTHROPOL, V145, P43, DOI 10.1002/ajpa.21465; HARRISON ML, 1994, AM J PHYS ANTHROPOL, V95, P399, DOI 10.1002/ajpa.1330950404; JOHANSSON D, 1974, Acta Phytogeographica Suecica, V59, P1; LACHER TE, 1981, ANIM BEHAV, V29, P306, DOI 10.1016/S0003-3472(81)80185-6; LACHER TE, 1984, BIOTROPICA, V16, P202, DOI 10.2307/2388053; Lazaro-Perea C, 1999, BEHAV ECOL SOCIOBIOL, V46, P313, DOI 10.1007/s002650050625; LORENZI H., 2016, ARVORES BRASILEIRAS, V1; LORENZI H., 2002, ARVORES BRASILEIRAS, V1; Martins MM, 2000, INT J PRIMATOL, V21, P467, DOI 10.1023/A:1005491903220; Millsap BA, 2000, J WILDLIFE MANAGE, V64, P33, DOI 10.2307/3802972; Miranda G.H.B. de, 2001, Brazilian Journal of Biology, V61, P397; Mori CLSO, 2003, BRASIL FLORESTAL BRA, V77, P29; NASH LT, 1986, YEARB PHYS ANTHROPOL, V29, P113; NATORI M, 1992, J MAMMAL, V73, P668, DOI 10.2307/1382041; Nogueira DM, 2011, IHERINGIA SER ZOOL, V101, P156, DOI 10.1590/S0073-47212011000200002; Carneiro ADO, 2012, REV ARVORE, V36, P767, DOI 10.1590/S0100-67622012000400018; Ottoni I, 2009, APPL ANIM BEHAV SCI, V117, P42, DOI 10.1016/j.applanim.2008.11.002; Paes JB, 2010, SCI FOR, V38, P441; Passamani M, 2000, PRIMATES, V41, P27, DOI 10.1007/BF02557459; Passamani Marcelo, 1996, Boletim do Museu de Biologia Mello Leitao, V4, P25; Patterson Michael E., 2003, Urban Forestry & Urban Greening, V1, P171, DOI 10.1078/1618-8667-00017; Pereira Z.V., 2012, REV BRASILEIRA AGROE, V7, P126; PERRY DR, 1978, BIOTROPICA, V10, P155, DOI 10.2307/2388019; Pontes ARM, 2007, BIODIVERS CONSERV, V16, P1175, DOI 10.1007/s10531-006-9099-5; Power ML, 2010, DEV PRIMATOL-PROG PR, P25, DOI 10.1007/978-1-4419-6661-2_2; Power ML, 1996, AM J PRIMATOL, V40, P131, DOI 10.1002/(SICI)1098-2345(1996)40:2<131::AID-AJP2>3.3.CO;2-8; R Core Team, 2012, R LANG ENV STAT COMP; Raboy BE, 2008, INT J PRIMATOL, V29, P449, DOI 10.1007/s10764-008-9249-6; RIZZINI C T, 1981, Revista Brasileira de Biologia, V41, P579; ROSENBERGER AL, 1978, J MAMMAL, V59, P207, DOI 10.2307/1379899; Rylands A. B., 1984, Tropical rain-forest. The Leeds symposium, P155; Rylands Anthony B., 1993, P262; Schulke O, 2003, BEHAV ECOL SOCIOBIOL, V55, P11, DOI 10.1007/s00265-003-0676-2; Smith AC, 2000, INT J PRIMATOL, V21, P69, DOI 10.1023/A:1005423629627; Smith AC, 2010, DEV PRIMATOL-PROG PR, P109, DOI 10.1007/978-1-4419-6661-2_5; Soini P., 1988, P79; Starr C, 2013, AM J PRIMATOL, V75, P1054, DOI 10.1002/ajp.22171; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Stevenson MF, 1988, ECOLOGY BEHAVIOUR NE, V2, P131; SUSSMAN RW, 1984, AM J PHYS ANTHROPOL, V64, P419, DOI 10.1002/ajpa.1330640407; Taiz L, 2017, FISIOLOGIA DESENVOLV, V6nd; Taylor AB, 2004, J MORPHOL, V261, P276, DOI 10.1002/jmor.10249; Thompson CL, 2013, INT J PRIMATOL, V34, P65, DOI 10.1007/s10764-012-9647-7; Ushida K, 2006, AM J PRIMATOL, V68, P143, DOI 10.1002/ajp.20212; Veloso H.P., 1991, CLASSIFICACAO VEGETA; Vinyard CJ, 2003, AM J PHYS ANTHROPOL, V120, P153, DOI 10.1002/ajpa.10129; Warren RD, 1997, AM J PHYS ANTHROPOL, V104, P471, DOI 10.1002/(SICI)1096-8644(199712)104:4<471::AID-AJPA4>3.0.CO;2-V; Yepez P, 2005, AM J PRIMATOL, V66, P145, DOI 10.1002/ajp.20134	68	16	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112321	10.1371/journal.pone.0112321	http://dx.doi.org/10.1371/journal.pone.0112321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372137	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900134
J	Herman, CW; Conlon, ASC; Rubenfire, M; Burghardt, AR; McGregor, SJ				Herman, Christopher W.; Conlon, Anna S. C.; Rubenfire, Melvyn; Burghardt, Andrew R.; McGregor, Stephen J.			The Very High Premature Mortality Rate among Active Professional Wrestlers Is Primarily Due to Cardiovascular Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; METABOLIC SYNDROME; UNITED-STATES; PREVALENCE; POPULATION; OBESITY	Purpose: Recently, much media attention has been given to the premature deaths in professional wrestlers. Since no formal studies exist that have statistically examined the probability of premature mortality in professional wrestlers, we determined survival estimates for active wresters over the past quarter century to establish the factors contributing to the premature mortality of these individuals. Methods: Data including cause of death was obtained from public records and wrestling publications in wrestlers who were active between January 1, 1985 and December 31, 2011. 557 males were considered consistently active wrestlers during this time period. 2007 published mortality rates from the Center for Disease Control were used to compare the general population to the wrestlers by age, BMI, time period, and cause of death. Survival estimates and Cox hazard regression models were fit to determine incident premature deaths and factors associated with lower survival. Cumulative incidence function (CIF) estimates given years wrestled was obtained using a competing risks model for cause of death. Results: The mortality for all wrestlers over the 26-year study period was. 007 deaths/total person-years or 708 per 100,000 per year, and 16% of deaths occurred below age 50 years. Among wrestlers, the leading cause of deaths based on CIF was cardiovascular-related (38%). For cardiovascular-related deaths, drug overdose-related deaths and cancer deaths, wrestler mortality rates were respectively 15.1, 122.7 and 6.4 times greater than those of males in the general population. Survival estimates from hazard models indicated that BMI is significantly associated with the hazard of death from total time wrestling (p<0.0001). Conclusion: Professional wrestlers are more likely to die prematurely from cardiovascular disease compared to the general population and morbidly obese wrestlers are especially at risk. Results from this study may be useful for professional wrestlers, as well as wellness policy and medical care implementation.	[Herman, Christopher W.; Burghardt, Andrew R.; McGregor, Stephen J.] Eastern Michigan Univ, Ypsilanti, MI 48197 USA; [Conlon, Anna S. C.; Rubenfire, Melvyn] Univ Michigan, Ann Arbor, MI 48109 USA	Eastern Michigan University; University of Michigan System; University of Michigan	Herman, CW (corresponding author), Eastern Michigan Univ, Ypsilanti, MI 48197 USA.	cherman2@emich.edu						[Anonymous], 2011, WWE INCOME STATEMENT; [Anonymous], 2011, R LANG ENV STAT COMP; [Anonymous], 2009, WWE STEROIDS STILL T; [Anonymous], 2006, WWE TAL WELLN PROGR; Barson S, 1994, HLTH HAZARD EVALUATI; Berry C, 2007, J AM COLL CARDIOL, V49, P631, DOI 10.1016/j.jacc.2006.09.046; Carman WJ, 2011, PHARMACOEPIDEM DR S, V20, P754, DOI 10.1002/pds.2131; Cohen E, WRESTLINGS DIRTY SEC; Deitch C, 2010, HEAVYWEIGHT CHAMPION; Foley M, 2010, COUNTDOWN LOCKDOWN H; Hart B, 2008, HITMAN MY REAL LIFE; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Knauf H, 2006, EUR J CLIN PHARMACOL, V62, P885, DOI 10.1007/s00228-006-0190-3; Lapi F, 2013, BMJ, V346; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Manson JE, 2003, JAMA-J AM MED ASSOC, V289, P229, DOI 10.1001/jama.289.2.229; Marijon E, 2013, EUR HEART J, V34, P3145, DOI 10.1093/eurheartj/eht347; Michaels S, 2006, HEARTBREAK TRIUMPH S; Nascimento JHM, 2011, MINI-REV MED CHEM, V11, P425; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; SAS Institute Inc., 2011, SAS VERS 9 2; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shields B, 2009, WWE ENCY DEFINITIVE; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Trelle S., 2011, BMJ, V342; Tucker AM, 2009, JAMA-J AM MED ASSOC, V301, P2111, DOI 10.1001/jama.2009.716; Wolin KY, 2010, ONCOLOGIST, V15, P556, DOI 10.1634/theoncologist.2009-0285; Xu J, 2010, NATL VITAL STAT REPO, V58, P22	29	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109945	10.1371/journal.pone.0109945	http://dx.doi.org/10.1371/journal.pone.0109945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372569	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900012
J	Levine, RS; Kilbourne, BA; Rust, GS; Langston, MA; Husaini, BA; Gittner, LS; Sanderson, M; Hennekens, CH				Levine, Robert S.; Kilbourne, Barbara A.; Rust, George S.; Langston, Michael A.; Husaini, Baqar A.; Gittner, Lisaann S.; Sanderson, Maureen; Hennekens, Charles H.			Social Determinants and the Classification of Disease: Descriptive Epidemiology of Selected Socially Mediated Disease Constellations	PLOS ONE			English	Article							INFANT-MORTALITY; SOCIOECONOMIC POSITION; HEALTH; INEQUALITIES; ASSOCIATIONS; EPIGENETICS; SMOKING	Background: Most major diseases have important social determinants. In this context, classification of disease based on etiologic or anatomic criteria may be neither mutually exclusive nor optimal. Methods and Findings: Units of analysis comprised large metropolitan central and fringe metropolitan counties with reliable mortality rates - (n = 416). Participants included infants and adults ages 25 to 64 years with selected causes of death (1999 to 2006). Exposures included that residential segregation and race-specific social deprivation variables. Main outcome measures were obtained via principal components analyses with an orthogonal rotation to identify a common factor. To discern whether the common factor was socially mediated, negative binomial multiple regression models were developed for which the dependent variable was the common factor. Results showed that infant deaths, mortality from assault, and malignant neoplasm of the trachea, bronchus and lung formed a common factor for race-gender groups (black/white and men/women). Regression analyses showed statistically significant, positive associations between low socio-economic status for all race-gender groups and this common factor. Conclusions: Between 1999 and 2006, deaths classified as "assault" and "lung cancer", as well as "infant mortality" formed a socially mediated factor detectable in population but not individual data. Despite limitations related to death certificate data, the results contribute important information to the formulation of several hypotheses: (a) disease classifications based on anatomic or etiologic criteria fail to account for social determinants; (b) social forces produce demographically and possibly geographically distinct population-based disease constellations; and (c) the individual components of population-based disease constellations (e. g., lung cancer) are phenotypically comparable from one population to another but genotypically different, in part, because of socially mediated epigenetic variations. Additional research may produce new taxonomies that unify social determinants with anatomic and/or etiologic determinants. This may lead to improved medical management of individuals and populations.	[Levine, Robert S.; Kilbourne, Barbara A.; Sanderson, Maureen; Hennekens, Charles H.] Meharry Med Coll, Dept Family & Community Med, Nashville, TN 37208 USA; [Kilbourne, Barbara A.] Tennessee State Univ, Dept Sociol, Nashville, TN 37203 USA; [Rust, George S.] Morehouse Sch Med, Dept Community & Prevent Med, Atlanta, GA 30310 USA; [Langston, Michael A.] Univ Tennessee, Dept Elect Engn & Informat Technol, Knoxville, TN USA; [Husaini, Baqar A.] Tennessee State Univ, Ctr Prevent Res, Nashville, TN 37203 USA; [Gittner, Lisaann S.] Texas Tech Univ, Dept Polit Sci, Lubbock, TX 79409 USA; [Hennekens, Charles H.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Epidemiol, Boca Raton, FL 33431 USA	Meharry Medical College; Tennessee State University; Morehouse School of Medicine; University of Tennessee System; University of Tennessee Knoxville; Tennessee State University; Texas Tech University System; Texas Tech University; State University System of Florida; Florida Atlantic University	Levine, RS (corresponding author), Meharry Med Coll, Dept Family & Community Med, Nashville, TN 37208 USA.	rlevine@mmc.edu		Gittner, Lisaann/0000-0001-7407-828X; Rust, George/0000-0002-9040-9744	National Institute for Minority Health and Health Disparities [2P20MD000516]; National Institute on Minority Health and Health Disparities [P20MD000516] Funding Source: NIH RePORTER	National Institute for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was funded in part by grant # 2P20MD000516 from the National Institute for Minority Health and Health Disparities. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Abdalla S, 2013, J PUBLIC HEALTH-UK, V35, P533, DOI 10.1093/pubmed/fds106; [Anonymous], 2010, COMPR MORT FIL 1999, V20; Balgkouranidou I, 2013, BIOMARK MED, V7, P49, DOI [10.2217/BMM.12.111, 10.2217/bmm.12.111]; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Brown HL, 2013, CLIN OBSTET GYNECOL, V56, P107, DOI 10.1097/GRF.0b013e318282377d; Diderichsen F, 2012, SCAND J PUBLIC HEALT, V40, P10, DOI 10.1177/1403494812457732; Doria-Rose VP, 2009, LUNG CANCER, V63, P295, DOI 10.1016/j.lungcan.2008.05.019; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Geolytics Inc, 2012, US CENS 2010; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Hirai AH, 2013, AM J PUBLIC HEALTH, V103, pE88, DOI 10.2105/AJPH.2013.301294; Kitsantas P, 2013, SOUTH MED J, V106, P310, DOI 10.1097/SMJ.0b013e318290c6e8; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Lawlor DA, 2006, AM J EPIDEMIOL, V164, P907, DOI 10.1093/aje/kwj319; Link BG, 1996, AM J PUBLIC HEALTH, V86, P471, DOI 10.2105/AJPH.86.4.471; Link BG, 1998, MILBANK Q, V76, P375, DOI 10.1111/1468-0009.00096; MASSEY DS, 1988, SOC FORCES, V67, P281, DOI 10.2307/2579183; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Murphy S. L., 2012, NATL VITAL STAT REP, V60, P4; National Center for Health Statistics, CLASS DIS INJ; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Phelan JC, 2004, J HEALTH SOC BEHAV, V45, P265, DOI 10.1177/002214650404500303; Reidpath DD, 2003, J EPIDEMIOL COMMUN H, V57, P344, DOI 10.1136/jech.57.5.344; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, P5; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID, P1892; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID, P1534; Schmidt CW, 2013, ENVIRON HEALTH PERSP, V121, pA298, DOI 10.1289/ehp.121-A298; Singh PN, 2013, ASIA-PAC J PUBLIC HE, V25, p64S, DOI 10.1177/1010539513493458; Villerme L.-R., 1840, TABLEAU ETAT PHYS MO, V2; World Health Organization, HIST DEV INT CLASS D; World Health Organization, 2008, ICD 10 INT STAT CLAS; World Health Organization, 2010, INT CLASS DIS ICD	36	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110271	10.1371/journal.pone.0110271	http://dx.doi.org/10.1371/journal.pone.0110271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372286	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900018
J	Zong, SH; Zeng, GF; Du, L; Fang, Y; Gao, TH; Zhao, JM				Zong, Shaohui; Zeng, Gaofeng; Du, Li; Fang, Ye; Gao, Taihang; Zhao, Jingmin			Treatment Results in the Different Surgery of Intradural Extramedullary Tumor of 122 Cases	PLOS ONE			English	Article							TRANSPEDICULAR SCREW FIXATION; BIOMECHANICAL ANALYSIS	Study Design: A retrospective study of intradural extramedullary tumor. Objective: To compare the treatment results in the different surgeries of spinal intradural extramedullary tumor. Methods: The study retrospectively reviewed 122 patients. The minimally invasive surgery (MIS) group was divided into Group A (hemilaminectomy + tumor microscopic excision) and Group B (laminectomy + tumor microscopic excision + pedicle screw fixation). Meanwhile, the non-MIS group was divided into Group C (hemilaminectomy + tumor excision), Group D (laminectomy + tumor excision), and Group E (laminectomy + tumor excision + pedicle screw fixation). In order to study postoperative spinal stability, we simultaneously divided all of the subjects into three categories, namely Group HE: hemilaminectomy + tumor excision; Group LE: laminectomy + tumor excision; and Group LEPSF: laminectomy + tumor excision + pedicle screw fixation. Results: The MIS group exhibited fewer postoperative complications (p<0.05), better short-term clinical efficacy (p<0.05) and less non-surgical cost (p<0.05) than in non-MIS group. The rate of postoperative spinal instability in hemilaminectomy was lower than in laminectomy in a single spinal segment (p<0.05). The rate of postoperative spinal instability in laminectomy + pedicle screw fixation was lower than in hemilaminectomy and laminectomy in two or more spinal segments (p<0.05). Conclusion: In the case of appropriate surgical indications, minimally invasive surgery for intradural extramedullary tumor is a useful method that can successfully produce good clinical results and reduce non-surgical cost. In addition, pedicle screw fixation helps avoid spinal postoperative instability.	[Zong, Shaohui; Du, Li; Fang, Ye; Gao, Taihang] Guangxi Med Univ, Affiliated Hosp 1, Dept Spine Osteopathia, Nanning, Guangxi, Peoples R China; [Zeng, Gaofeng] Guangxi Med Univ, Coll Publ Hyg, Nanning, Guangxi, Peoples R China; [Zhao, Jingmin] Guangxi Med Univ, Affiliated Hosp 1, Dept Orthopaed Trauma & Hand Surg, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Zhao, JM (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Orthopaed Trauma & Hand Surg, Nanning, Guangxi, Peoples R China.	zhaojingmin3008@sina.com			Guangxi Science and Technology Plan Fund, Gui Ke Gong [1298003-5-1]	Guangxi Science and Technology Plan Fund, Gui Ke Gong	The authors acknowledge support from the Guangxi Science and Technology Plan Fund, Gui Ke Gong 1298003-5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese V, 2002, J Neurosurg Sci, V46, P18; Canbay S, 2012, ASIAN SPINE J, V6, P43, DOI 10.4184/asj.2012.6.1.43; Guidetti B., 1974, ADV TECHNICAL STANDA, P173; HELSETH A, 1989, J NEUROSURG, V71, P842, DOI 10.3171/jns.1989.71.6.0842; Iacoangeli M, 2012, CLIN INTERV AGING, V7, P557, DOI 10.2147/CIA.S38923; IIDA Y, 1990, SPINE, V15, P1186, DOI 10.1097/00007632-199011010-00018; Kirshblum SC, 2002, AM J PHYS MED REHAB, V81, P502, DOI 10.1097/00002060-200207000-00006; Kobayashi S, 2007, MINIM INVAS NEUROSUR, V50, P120, DOI 10.1055/s-2007-982506; KOTANI Y, 1994, SPINE, V19, P2529, DOI 10.1097/00007632-199411001-00007; Kothe R, 2004, SPINE, V29, P1869, DOI 10.1097/01.brs.0000137287.67388.0b; Mayfield F H, 1976, Clin Neurosurg, V23, P435; Mazel C, 2004, SPINE, V29, P1246, DOI 10.1097/00007632-200406010-00015; Ogden AT, 2009, CLIN BIOMECH, V24, P143, DOI 10.1016/j.clinbiomech.2008.11.005; PANJABI MM, 1980, NEUROSURGERY, V7, P76, DOI 10.1227/00006123-198007000-00014; Postalci L, 2011, TURK NEUROSURG, V21, P449, DOI [10.5137/1019-5149.JTN.3518-10.2, 10.5137/1019-5149.JTN .3518-10.2]; Sachdev S, 2011, NEUROSURGERY, V69, P533, DOI 10.1227/NEU.0b013e318218db23; Smith ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092611; Starodubtsev A I, 1984, Zh Vopr Neirokhir Im N N Burdenko, P22; Sun Z, 2011, J LARYNGOL OTOL, V125, P418, DOI 10.1017/S0022215110002707; YASUOKA S, 1982, J NEUROSURG, V57, P441, DOI 10.3171/jns.1982.57.4.0441; Yeo DK, 2011, J KOREAN NEUROSURG S, V50, P195, DOI 10.3340/jkns.2011.50.3.195; Zong SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063867	22	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111495	10.1371/journal.pone.0111495	http://dx.doi.org/10.1371/journal.pone.0111495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372863	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900051
J	Silla, T; Kepp, K; Tai, ES; Goh, L; Davila, S; Ivkovic, TC; Calin, GA; Voorhoeve, PM				Silla, Toomas; Kepp, Katrin; Tai, E. Shyong; Goh, Liang; Davila, Sonia; Ivkovic, Tina Catela; Calin, George A.; Voorhoeve, P. Mathijs			Allele Frequencies of Variants in Ultra Conserved Elements Identify Selective Pressure on Transcription Factor Binding	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; NONCODING RNAS; SUPER-ENHANCERS; CELL IDENTITY; VERTEBRATE; FRAMEWORK; PROTEIN	Ultra- conserved genes or elements (UCGs/UCEs) in the human genome are extreme examples of conservation. We characterized natural variations in 2884 UCEs and UCGs in two distinct populations; Singaporean Chinese (n = 280) and Italian (n = 501) by using a pooled sample, targeted capture, sequencing approach. We identify, with high confidence, in these regions the abundance of rare SNVs (MAF<0.5%) of which 75% is not present in dbSNP137. UCEs association studies for complex human traits can use this information to model expected background variation and thus necessary power for association studies. By combining our data with 1000 Genome Project data, we show in three independent datasets that prevalent UCE variants (MAF>5%) are more often found in relatively less-conserved nucleotides within UCEs, compared to rare variants. Moreover, prevalent variants are less likely to overlap transcription factor binding site. Using SNPfold we found no significant influence of RNA secondary structure on UCE conservation. All together, these results suggest UCEs are not under selective pressure as a stretch of DNA but are under differential evolutionary pressure on the single nucleotide level.	[Silla, Toomas; Goh, Liang; Voorhoeve, P. Mathijs] Duke NUS, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore; [Kepp, Katrin; Davila, Sonia] Genome Inst Singapore, Singapore, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke NUS, Grad Sch Med, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Ivkovic, Tina Catela; Calin, George A.] Texas State Univ, Expt Therapeut & Canc Genet MD Anderson Canc Ctr, Houston, TX USA; [Ivkovic, Tina Catela] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Texas State University System; Texas State University San Marcos; University of Texas System; UTMD Anderson Cancer Center; Rudjer Boskovic Institute	Silla, T (corresponding author), Duke NUS, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore.	toomas.silla@mbg.au.dk; mathijs.voorhoeve@gmail.com	Ivkovic, Tina Catela/AAL-1324-2020; Calin, George/E-9390-2011	Ivkovic, Tina Catela/0000-0003-3909-6858; Tai, E Shyong/0000-0003-2929-8966; Calin, George/0000-0001-6704-5615; Calin, George/0000-0002-7427-0578	Duke-NUS Signature Research Program; Singapore Ministry of Health's National Medical Research Council [MOE2010-2-006]; Estonian Research Council [MJD147]	Duke-NUS Signature Research Program; Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Estonian Research Council	This work was supported by the Duke-NUS Signature Research Program and the Singapore Ministry of Health's National Medical Research Council (grant MOE2010-2-006 to PMV), and the Estonian Research Council postdoctoral research program "MOBILITAS'' (grant MJD147 to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bansal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018353; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Braconi C, 2011, P NATL ACAD SCI USA, V108, P786, DOI 10.1073/pnas.1011098108; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Castle JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020660; Chen CTL, 2007, AM J HUM GENET, V80, P692, DOI 10.1086/513149; Chiang CWK, 2008, GENETICS, V180, P2277, DOI 10.1534/genetics.108.096537; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Dimitrieva S, 2013, NUCLEIC ACIDS RES, V41, pD101, DOI 10.1093/nar/gks1092; Dimitrieva S, 2012, BIOINFORMATICS, V28, pI395, DOI 10.1093/bioinformatics/bts400; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Harmston N, 2013, PHILOS T R SOC B, V368, DOI [10.1101/gr.113167.110, DOI 10.1101/GR.113167.110]; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hudson RS, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-13; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Licastro D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-151; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Nielsen MM, 2014, RNA, V20, P236, DOI 10.1261/rna.038927.113; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sabanayagam C, 2010, NEPHROL DIAL TRANSPL, V25, P1167, DOI 10.1093/ndt/gfp591; Sabarinathan R, 2013, NUCLEIC ACIDS RES, V41, pW475, DOI 10.1093/nar/gkt291; Sakabe NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-238; Sanges R, 2013, NUCLEIC ACIDS RES, V41, P3600, DOI 10.1093/nar/gkt030; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Viturawong T, 2013, CELL REP, V5, P531, DOI 10.1016/j.celrep.2013.09.022; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zeeland AASV, 2014, MOL PSYCHIATR, V19, P724, DOI 10.1038/mp.2013.91	48	4	4	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110692	10.1371/journal.pone.0110692	http://dx.doi.org/10.1371/journal.pone.0110692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369454	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000025
J	Camus, G; Schweiger, M; Herker, E; Harris, C; Kondratowicz, AS; Tsou, CL; Farese, RV; Herath, K; Previs, SF; Roddy, TP; Pinto, S; Zechner, R; Ott, M				Camus, Gregory; Schweiger, Martina; Herker, Eva; Harris, Charles; Kondratowicz, Andrew S.; Tsou, Chia-Lin; Farese, Robert V., Jr.; Herath, Kithsiri; Previs, Stephen F.; Roddy, Thomas P.; Pinto, Shirly; Zechner, Rudolf; Ott, Melanie			The Hepatitis C Virus Core Protein Inhibits Adipose Triglyceride Lipase (ATGL)-mediated Lipid Mobilization and Enhances the ATGL Interaction with Comparative Gene Identification 58 (CGI-58) and Lipid Droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE-1; LIPOLYSIS; ADIPOCYTES; STEATOSIS; METABOLISM; PERILIPIN; STORAGE; RECEPTOR; TURNOVER; ALPHA	Liver steatosis is a common health problem associated with hepatitis C virus (HCV) and an important risk factor for the development of liver fibrosis and cancer. Steatosis is caused by triglycerides (TG) accumulating in lipid droplets (LDs), cellular organelles composed of neutral lipids surrounded by a monolayer of phospholipids. The HCV nucleocapsid core localizes to the surface of LDs and induces steatosis in cultured cells and mouse livers by decreasing intracellular TG degradation (lipolysis). Here we report that core at the surface of LDs interferes with the activity of adipose triglyceride lipase (ATGL), the key lipolytic enzyme in the first step of TG breakdown. Expressing core in livers or mouse embryonic fibroblasts of ATGL(-/-) mice no longer decreases TG degradation as observed in LDs from wild-type mice, supporting the model that core reduces lipolysis by engaging ATGL. Core must localize at LDs to inhibit lipolysis, as ex vivo TG hydrolysis is impaired in purified LDs coated with core but not when free core is added to LDs. Coimmunoprecipitation experiments revealed that core does not directly interact with the ATGL complex but, unexpectedly, increased the interaction between ATGL and its activator CGI-58 as well as the recruitment of both proteins to LDs. These data link the antilipolytic activity of the HCV core protein with altered ATGL binding to CGI-58 and the enhanced association of both proteins with LDs.	[Camus, Gregory; Schweiger, Martina; Herker, Eva; Kondratowicz, Andrew S.; Tsou, Chia-Lin; Ott, Melanie] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Schweiger, Martina; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Herker, Eva; Harris, Charles; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, UCSF Liver Ctr, San Francisco, CA 94158 USA; [Herker, Eva] Heinrich Pette Inst, Leibniz Inst Expt Virol, D-20251 Hamburg, Germany; [Harris, Charles; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Harris, Charles; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Harris, Charles] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Herath, Kithsiri; Previs, Stephen F.; Roddy, Thomas P.; Pinto, Shirly] Merck & Co Inc, Merck Res Labs, Kenilworth, NJ 07065 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Graz; University of California System; University of California San Francisco; Heinrich Pette Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Washington University (WUSTL); University of California System; University of California San Francisco; Merck & Company	Ott, M (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Herker, Eva/AAQ-1944-2021; Herker, Eva/B-9699-2014	Herker, Eva/0000-0001-9644-2484; Schweiger, Martina/0000-0002-3419-1007; Zechner, Rudolf/0000-0001-5483-1182; Ott, Melanie/0000-0002-5697-1274	National Institutes of Health Grants [AI069090, AI097552, P30 DK026743]; Gladstone Institutes; American Liver Foundation; European Molecular Biology Organization; Austrian Science Fund (FWF) [F 3002, Z 136] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI069090, R01AI097552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gladstone Institutes(University of California System); American Liver Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI069090, AI097552 (to M. O.), and P30 DK026743 (University of California-San Francisco Liver Center). This work was also supported by the Gladstone Institutes.; Supported in part of by fellowship from the American Liver Foundation.; Supported in part of by fellowship from the European Molecular Biology Organization.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Camus G, 2013, J BIOL CHEM, V288, P9915, DOI 10.1074/jbc.M112.434910; Cheng FKF, 2014, J VIRAL HEPATITIS, V21, P1, DOI 10.1111/jvh.12172; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Han S, 2013, J LIPID RES, V54, P2615, DOI 10.1194/jlr.M035592; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Lyn RK, 2010, BIOCHEM BIOPH RES CO, V399, P518, DOI 10.1016/j.bbrc.2010.07.101; MacPherson REK, 2013, AM J PHYSIOL-REG I, V304, pR644, DOI 10.1152/ajpregu.00418.2012; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Murugesan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064950; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Olzmann JA, 2013, P NATL ACAD SCI USA, V110, P1345, DOI 10.1073/pnas.1213738110; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Pollak NM, 2013, J LIPID RES, V54, P1092, DOI 10.1194/jlr.M034710; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2014, METHOD ENZYMOL, V538, P171, DOI 10.1016/B978-0-12-800280-3.00010-4; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Shah V, 2010, ANAL BIOCHEM, V404, P235, DOI 10.1016/j.ab.2010.05.010; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tsutsumi T, 2002, HEPATOLOGY, V35, P937, DOI 10.1053/jhep.2002.32470; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Yamaguchi A, 2005, DIGEST DIS SCI, V50, P1361, DOI 10.1007/s10620-005-2788-1; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003	54	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35770	35780		10.1074/jbc.M114.587816	http://dx.doi.org/10.1074/jbc.M114.587816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25381252	Green Published, hybrid			2022-12-26	WOS:000346897900009
J	Tripathi, V; Darnauer, S; Hartwig, NR; Obermann, WMJ				Tripathi, Vishwadeepak; Darnauer, Stefanie; Hartwig, Nadine R.; Obermann, Wolfgang M. J.			Aha1 Can Act as an Autonomous Chaperone to Prevent Aggregation of Stressed Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; COCHAPERONE AHA1; ATPASE ACTIVITY; MIDDLE DOMAIN; IN-VIVO; ACTIVATION; BINDING; CYCLE; CONTRIBUTES; HYDROLYSIS	Aha1 (activator of Hsp90 ATPase) stimulates the ATPase activity of the molecular chaperone Hsp90 to accelerate the conformational cycle during which client proteins attain their final shape. Thereby, Aha1 promotes effective folding of Hsp90-dependent clients such as steroid receptors and many kinases involved in cellular signaling. In our current study, we find that Aha1 plays a novel, additional role beyond regulating the Hsp90 ATP hydrolysis rate. We propose a new concept suggesting that Aha1 acts as an autonomous chaperone and associates with stress-denatured proteins to prevent them from aggregation similar to the chaperonin GroEL. Our study reveals that an N-terminal sequence of 22 amino acids, present in human but absent from yeast Aha1, is critical for this capability. However, in lieu of fostering their refolding, Aha1 allows ubiquitination of bound clients by the E3 ubiquitin ligase CHIP. Accordingly, Aha1 may promote disposal of folding defective proteins by the cellular protein quality control.	[Tripathi, Vishwadeepak; Darnauer, Stefanie; Hartwig, Nadine R.; Obermann, Wolfgang M. J.] Ruhr Univ Bochum, Dept Cardiovasc Physiol, D-44801 Bochum, Germany	Ruhr University Bochum	Obermann, WMJ (corresponding author), Ruhr Univ Bochum, Dept Cardiovasc Physiol, Univ Str 150, D-44801 Bochum, Germany.	Wolfgang.Obermann@rub.de	Obermann, Wolfgang/AAN-3896-2020		German Science Association (DFG) [OB 163/1-1]; Ruhr-University Bochum FoRUM [F698]	German Science Association (DFG)(German Research Foundation (DFG)); Ruhr-University Bochum FoRUM	This work was supported by the German Science Association (DFG Grant OB 163/1-1, to W. O.) and by Ruhr-University Bochum FoRUM Grant F698 (to W. O.).	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Berg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089436; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Buchberger A, 1996, J MOL BIOL, V261, P328, DOI 10.1006/jmbi.1996.0465; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2013, NAT STRUCT MOL BIOL, V20, P326, DOI 10.1038/nsmb.2502; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Mollapour M, 2014, MOL CELL, V53, P317, DOI 10.1016/j.molcel.2013.12.007; NIMMESGERN E, 1993, FEBS LETT, V331, P25, DOI 10.1016/0014-5793(93)80290-B; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tripathi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071856; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Xu WP, 2012, MOL CELL, V47, P434, DOI 10.1016/j.molcel.2012.05.015	32	16	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36220	36228		10.1074/jbc.M114.590141	http://dx.doi.org/10.1074/jbc.M114.590141			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378400	Green Published, hybrid			2022-12-26	WOS:000346897900047
J	Berglund, A; Ekelund, M; Fletcher, MA; Nyman, L				Berglund, Anders; Ekelund, Mats; Fletcher, Mark A.; Nyman, Lars			All-Cause Pneumonia Hospitalizations in Children < 2 Years Old in Sweden, 1998 to 2012: Impact of Pneumococcal Conjugate Vaccine Introduction	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CHILDHOOD IMMUNIZATION; ADMISSIONS; SCHEDULE; ENGLAND; DECLINE; TRENDS; PCV7	Background: In late 2007, some Swedish County Councils started 7-valent pneumococcal conjugate vaccine (PCV7) implementation for children, and PCV7 was included in the national immunization program in 2009. By 2010, both PCV10 and PCV13 were licensed, and the selection of vaccine was subject to County Councils tenders. This study investigated the impact of the order of PCV introduction into vaccination programs on the incidence of all-cause pneumonia hospitalizations in children <2 years-old. Methods: Using population-based data from the publicly available National Inpatient Registry, the incidence of inpatient pneumonia (ICD-10 J12-J18) hospitalizations by County Councils among children <2 years old was identified between 1998 and 2012. Incidence rate ratios (IRR; 95% CI) were calculated during the nationwide implementation of PCV7 and then between County Councils, as based on the higher-valent vaccine chosen for a program. Results: There was a lower risk of all-cause pneumonia hospitalization among <2 year-old children following the introduction of PCV7, as compared to the pre-PCV7 period (0.77; 0.63-0.93). A decreased risk of all-cause pneumonia was also observed in the County Councils that followed the order PCV7 then PCV13 (0.82; 0.66-1.01), while no trend was observed in County Councils with a program in the order PCV7 then PCV10 (1.03; 0.82-1.30). When comparing the higher-valent vaccines, there was a 21% (0.79; 0.66-0.96) lower risk for childhood pneumonia hospitalization in County Councils finally using PCV13 as compared to the experience in County Councils that ultimately adopted PCV10. Conclusions: Among children <2 years-old, all-cause pneumonia hospitalizations were significantly reduced by 23% one to two years after introduction of PCV7 vaccination in Sweden. In those County Councils that next introduced PCV13, a further decline in all-cause pneumonia hospitalization was observed, in contrast to those County Councils that followed with PCV10; this 21% lower risk for childhood pneumonia hospitalization was statistically significant.	[Berglund, Anders; Ekelund, Mats; Nyman, Lars] Pfizer Inc, Sollentuna, Sweden; [Fletcher, Mark A.] Pfizer Inc, Paris, France	Pfizer; Pfizer	Berglund, A (corresponding author), Pfizer Inc, Sollentuna, Sweden.	anders.berglund@pfizer.com			Pfizer Inc	Pfizer Inc(Pfizer)	The present study was performed and funded in full by Pfizer Inc.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; Angoulvant F, 2014, CLIN INFECT DIS, V58, P918, DOI 10.1093/cid/ciu006; [Anonymous], IMM SURV ASS MON; Becker-Dreps S, 2014, PEDIATR INFECT DIS J, V33, P637, DOI 10.1097/INF.0000000000000269; Cleveland R.B., 1990, J OFF STAT, V6, P3; Durando P, 2009, VACCINE, V27, P3459, DOI 10.1016/j.vaccine.2009.01.052; European Medicines Agency, 2013, EUR PUBL ASS REP; Fitzwater SP, 2012, PEDIATR INFECT DIS J, V31, P501, DOI 10.1097/INF.0b013e31824de9f6; Frees E.W., 2004, LONGITUDINAL PANEL D, DOI 10.1198/jasa.2006.s88; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hortal M, 2012, VACCINE, V30, P4934, DOI 10.1016/j.vaccine.2012.05.054; Jardine A, 2010, PEDIATR INFECT DIS J, V29, P607, DOI 10.1097/INF.0b013e3181d7d09c; Koshy E, 2010, THORAX, V65, P770, DOI 10.1136/thx.2010.137802; Lee GE, 2010, PEDIATRICS, V126, P204, DOI 10.1542/peds.2009-3109; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS140, DOI 10.1097/INF.0000000000000082; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Patrzalek M, 2010, EUR J CLIN MICROBIOL, V29, P787, DOI 10.1007/s10096-010-0928-9; Rozenbaum MH, 2011, EXPERT REV VACCINES, V10, P187, DOI [10.1586/erv.10.163, 10.1586/ERV.10.163]; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Statistics Sweden, 2012, STAT DAT DEM CHAR SW; Swedish Association of Local Authorities and Regions, 2012, STAT DAT MUN COUNT C; Swedish Institute for Communicable Disease Control, 2013, ANN EP REP 2012; The National Board of Health and Welfare, 2012, STAT DAT DIAGN INP C; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; Zhou FJ, 2007, ARCH PEDIAT ADOL MED, V161, P1162, DOI 10.1001/archpedi.161.12.1162	30	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112211	10.1371/journal.pone.0112211	http://dx.doi.org/10.1371/journal.pone.0112211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379659	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100064
J	Zhao, J; Li, SP; He, XY; Liu, L; Wang, KL				Zhao, Jie; Li, Shengping; He, Xunyang; Liu, Lu; Wang, Kelin			The Soil Biota Composition along a Progressive Succession of Secondary Vegetation in a Karst Area	PLOS ONE			English	Article							FATTY-ACID PROFILES; MICROBIAL COMMUNITIES; UNDERSTORY REMOVAL; FOREST RECOVERY; DIVERSITY; CARBON; PLANT; NEMATODES; REGION; GRASSLAND	Karst ecosystems are fragile and are in many regions degraded by anthropogenic activities. Current management of degraded karst areas focuses on aboveground vegetation succession or recovery and aims at establishing a forest ecosystem. Whether progressive succession of vegetation in karst areas is accompanied by establishment of soil biota is poorly understood. In the present study, soil microbial and nematode communities, as well as soil physico-chemical properties were studied along a progressive succession of secondary vegetation (from grassland to shrubland to forest) in a karst area in southwest China. Microbial biomass, nematode density, ratio of fungal to bacterial biomass, nematode structure index, and nematode enrichment index decreased with the secondary succession in the plant community. Overall, the results indicated a pattern of declines in soil biota abundance and food web complexity that was associated with a decrease in soil pH and a decrease in soil organic carbon content with the progressive secondary succession of the plant community. Our findings suggest that soil biota amendment is necessary during karst ecosystem restoration and establishment and management of grasslands may be feasible in karst areas.	[Zhao, Jie; Li, Shengping; He, Xunyang; Liu, Lu; Wang, Kelin] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Zhao, Jie; Li, Shengping; He, Xunyang; Liu, Lu; Wang, Kelin] Chinese Acad Sci, Huanjiang Observat & Res Stn Karst Ecosyst, Huanjiang, Guangxi, Peoples R China; [Li, Shengping; Liu, Lu] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, KL (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.	kelin@isa.ac.cn			Chinese Academy of Sciences Action Plan for the Development of Western China [KZCX2-XB3-10]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2010BAE00739-02]; CAS; NSFC [31300448]	Chinese Academy of Sciences Action Plan for the Development of Western China(Chinese Academy of Sciences); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); CAS(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by the Chinese Academy of Sciences Action Plan for the Development of Western China (KZCX2-XB3-10), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2010BAE00739-02) given to Kelin Wang. The study was also supported by a Western Light Program from CAS and a NSFC program (31300448) given to Jie Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison VJ, 2005, SOIL SCI SOC AM J, V69, P1412, DOI 10.2136/sssaj2004.0252; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Barker K. R., 1985, ADV TREATISE MELOIDO, VII; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Chabrerie O, 2003, APPL SOIL ECOL, V24, P43, DOI 10.1016/S0929-1393(03)00062-3; Chen D, 2013, J ECOLOGY; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Dmowska E, 2006, EUR J SOIL BIOL, V42, pS164, DOI 10.1016/j.ejsobi.2006.07.005; Evrendilek F, 2004, J ARID ENVIRON, V59, P743, DOI 10.1016/j.jaridenv.2004.03.002; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; FRECKMAN DW, 1988, AGR ECOSYST ENVIRON, V24, P195, DOI 10.1016/0167-8809(88)90066-7; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Guo Ke, 2011, Chinese Journal of Plant Ecology, V35, P991, DOI 10.3724/SP.J.1258.2011.00991; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Holtkamp R, 2008, APPL SOIL ECOL, V39, P23, DOI 10.1016/j.apsoil.2007.11.002; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; KIEFT TL, 1994, APPL ENVIRON MICROB, V60, P3292, DOI 10.1128/AEM.60.9.3292-3299.1994; Latinne AS., 2011, INT C ENV SUPP FOOD, P176; Leps J, 2003, MULTIVARIATE ANAL EC; Liang WJ, 2009, SOIL BIOL BIOCHEM, V41, P883, DOI 10.1016/j.soilbio.2008.06.018; Liu G, 1996, ANAL SOIL PHYS CHEM; Matlaga DP, 2013, J APPL ECOL, V50, P479, DOI 10.1111/1365-2664.12057; Neher DA, 2001, J NEMATOL, V33, P161; Parise M, 2009, ENVIRON GEOL, V58, P235, DOI 10.1007/s00254-008-1608-2; Pate E, 2000, APPL SOIL ECOL, V14, P5, DOI 10.1016/S0929-1393(99)00051-7; Qi XK, 2013, ECOL ENG, V54, P245, DOI 10.1016/j.ecoleng.2013.01.002; Querejeta JI, 2007, OECOLOGIA, V152, P26, DOI 10.1007/s00442-006-0629-3; Raty M, 2003, BIOL FERT SOILS, V38, P52, DOI 10.1007/s00374-003-0614-5; Rivera LW, 1998, FOREST ECOL MANAG, V108, P63, DOI 10.1016/S0378-1127(97)00349-6; Rivera LW, 2000, PLANT ECOL, V148, P115, DOI 10.1023/A:1009825211430; ROBERTSON GP, 1981, ECOLOGY, V62, P376, DOI 10.2307/1936712; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P516, DOI 10.1016/j.soilbio.2009.11.026; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Schipper LA, 2001, SOIL BIOL BIOCHEM, V33, P2093, DOI 10.1016/S0038-0717(01)00142-0; Schmitt A, 2011, SOIL BIOL BIOCHEM, V43, P478, DOI 10.1016/j.soilbio.2010.09.037; Smith RS, 2003, J APPL ECOL, V40, P51, DOI 10.1046/j.1365-2664.2003.00780.x; Tuyet D, 2001, ACTA GEOL SIN-ENGL, V75, P325; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Viketoft M, 2013, SOIL BIOL BIOCHEM, V62, P92, DOI 10.1016/j.soilbio.2013.03.012; Walker L.R., 1999, ECOSYSTEMS DISTURBED; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wang KeLin, 2008, Research of Agricultural Modernization, V29, P641; WARDLE DA, 1993, FUNCT ECOL, V7, P346, DOI 10.2307/2390215; WASILEWSKA L, 1979, Polish Ecological Studies, V5, P97; Xiong YM, 2008, PLANT SOIL, V304, P179, DOI 10.1007/s11104-007-9536-6; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X; Yu L.F., 1998, J MOUNTAIN AGR BIOL, V17, P71; Yuan DX, 2002, GEOLOGY GEOHYDROLOGY, P15; ZAK DR, 1990, BIOGEOCHEMISTRY, V11, P111, DOI 10.1007/BF00002062; [曾馥平 ZENG FuPing], 2007, [生态学报, Acta Ecologica Sinica], V27, P5110, DOI 10.1016/S1872-2032(08)60016-5; Zhang PJ, 2006, ENVIRON GEOL, V51, P609, DOI 10.1007/s00254-006-0356-4; [张信宝 ZHANG Xin-bao], 2009, [地球与环境, Earth and Environment], V37, P337; Zhao J, 2014, APPL SOIL ECOL, V75, P134, DOI 10.1016/j.apsoil.2013.10.011; Zhao J, 2013, FOREST ECOL MANAG, V310, P80, DOI 10.1016/j.foreco.2013.08.013; Zhao J, 2013, APPL SOIL ECOL, V64, P135, DOI 10.1016/j.apsoil.2012.11.008; Zhao J, 2013, ECOL INDIC, V24, P236, DOI 10.1016/j.ecolind.2012.06.012; Zhao J, 2012, SOIL BIOL BIOCHEM, V49, P78, DOI 10.1016/j.soilbio.2012.02.020; Zhu HH, 2012, EUR J SOIL BIOL, V51, P1, DOI 10.1016/j.ejsobi.2012.03.003	62	18	21	6	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112436	10.1371/journal.pone.0112436	http://dx.doi.org/10.1371/journal.pone.0112436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379741	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100092
J	Cao, B; Qi, YF; Yang, Y; Liu, XC; Xu, D; Guo, W; Zhan, Y; Xiong, ZG; Zhang, A; Wang, AR; Fu, XQ; Zhang, HT; Zhao, LJ; Gu, JK; Dong, Y				Cao, Bo; Qi, Yanfeng; Yang, Yan; Liu, Xichun; Xu, Duo; Guo, Wei; Zhan, Yang; Xiong, Zhenggang; Zhang, Allen; Wang, Alun R.; Fu, Xueqi; Zhang, Haitao; Zhao, Lijing; Gu, Jingkai; Dong, Yan			20(S)-Protopanaxadiol Inhibition of Progression and Growth of Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							TRUNCATED ANDROGEN RECEPTOR; DE-NOVO STEROIDOGENESIS; FULL-LENGTH; SPLICE VARIANTS; TUMOR-GROWTH; CELLS; ANTIANDROGEN; SUPPRESSION; EXPRESSION; MECHANISM	Castration-resistant progression of prostate cancer after androgen deprivation therapies remains the most critical challenge in the clinical management of prostate cancer. Resurgent androgen receptor (AR) activity is an established driver of castration-resistant progression, and upregulation of the full-length AR (AR-FL) and constitutively-active AR splice variants (AR-Vs) has been implicated to contribute to the resurgent AR activity. We reported previously that ginsenoside 20(S)-protopanaxadiol-aglycone (PPD) can reduce the abundance of both AR-FL and AR-Vs. In the present study, we further showed that the effect of PPD on AR expression and target genes was independent of androgen. PPD treatment resulted in a suppression of ligand-independent AR transactivation. Moreover, PPD delayed castration-resistant regrowth of LNCaP xenograft tumors after androgen deprivation and inhibited the growth of castration-resistant 22Rv1 xenograft tumors with endogenous expression of AR-FL and AR-Vs. This was accompanied by a decline in serum prostate-specific antigen levels as well as a decrease in AR levels and mitoses in the tumors. Notably, the 22Rv1 xenograft tumors were resistant to growth inhibition by the next-generation anti-androgen enzalutamide. The present study represents the first to show the preclinical efficacy of PPD in inhibiting castration-resistant progression and growth of prostate cancer. The findings provide a rationale for further developing PPD or its analogues for prostate cancer therapy.	[Cao, Bo; Yang, Yan; Xu, Duo; Guo, Wei; Fu, Xueqi; Gu, Jingkai; Dong, Yan] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Cao, Bo; Qi, Yanfeng; Zhan, Yang; Zhang, Allen; Dong, Yan] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Liu, Xichun; Xiong, Zhenggang; Wang, Alun R.; Zhang, Haitao] Tulane Univ, Sch Med, Dept Pathol & Lab Med, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Zhao, Lijing] Jilin Univ, Coll Basic Med Sci, Changchun 130023, Peoples R China; [Dong, Yan] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China	Jilin University; Tulane University; Tulane University; Jilin University; Jilin University	Zhao, LJ (corresponding author), Jilin Univ, Coll Basic Med Sci, Changchun 130023, Peoples R China.	zhao_lj@jlu.edu.cn; gujk@jlu.edu.cn; ydong@tulane.edu		Zhang, Allen/0000-0002-5780-9121; Dong, Yan/0000-0003-1622-5354	National Cancer Institute of the National Institutes of Health [R01CA188609]; Department of Defense [W81XWH-12-1-0112, W81XWH-12-1-0275]; National Natural Science Foundation of China [81272851, 30973587, 81102383, 81302206, 81430087]; Louisiana Board-of-Regents Grant [LEQSF(2012-15)-RD-A-25]; Louisiana Cancer Research Consortium Fund; Tulane Cancer Center Developmental Fund; Tulane University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA188609] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Louisiana Board-of-Regents Grant; Louisiana Cancer Research Consortium Fund; Tulane Cancer Center Developmental Fund; Tulane University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health grant R01CA188609, Department of Defense grants W81XWH-12-1-0112 and W81XWH-12-1-0275, National Natural Science Foundation of China Projects 81272851, 30973587, 81102383, 81302206, and 81430087, Louisiana Board-of-Regents Grant LEQSF(2012-15)-RD-A-25, Louisiana Cancer Research Consortium Fund, Tulane Cancer Center Developmental Fund, and Tulane University School of Medicine Pilot Fund and Bridge Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao B, 2014, ONCOTARGET, V5, P1646, DOI 10.18632/oncotarget.1802; Cao B, 2013, INT J CANCER, V132, P1277, DOI 10.1002/ijc.27754; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Culig Z, 1998, PROSTATE, V35, P63, DOI 10.1002/(SICI)1097-0045(19980401)35:1<63::AID-PROS9>3.0.CO;2-I; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dong Y, 2004, CANCER RES, V64, P19, DOI 10.1158/0008-5472.CAN-03-2789; Dong Y, 2003, CANCER RES, V63, P52; Dong Y, 2005, MOL CANCER THER, V4, P1047, DOI 10.1158/1535-7163.MCT-05-0124; Egan A, 2014, CANCER TREAT REV, V40, P426, DOI 10.1016/j.ctrv.2013.09.011; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Freedland SJ, 2011, CANCER-AM CANCER SOC, V117, P1123, DOI 10.1002/cncr.25477; GLEAVE ME, 1992, CANCER RES, V52, P1598; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hara T, 2003, CANCER RES, V63, P149; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Jackson JK, 2000, CANCER RES, V60, P4146; Kim HG, 2011, FOOD CHEM TOXICOL, V49, P2229, DOI 10.1016/j.fct.2011.06.020; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Koivisto P, 1997, CANCER RES, V57, P314; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; Lamoureux F, 2011, CLIN CANCER RES, V17, P2301, DOI 10.1158/1078-0432.CCR-10-3077; Lee NH, 2012, J ALTERN COMPLEM MED, V18, P1061, DOI 10.1089/acm.2011.0591; Li J, 2011, MOL CANCER THER, V10, P1346, DOI 10.1158/1535-7163.MCT-10-0985; Li XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031213; Li Y., 2012, CANCER RES, V73, P483; Liu LL, 2014, ONCOGENE, V33, P3140, DOI 10.1038/onc.2013.284; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Lubik AA, 2011, CANCER RES, V71, P5754, DOI 10.1158/0008-5472.CAN-10-2470; Mashima T, 2010, MOL PHARMACOL, V78, P846, DOI 10.1124/mol.110.064790; Miyake H, 2000, CANCER RES, V60, P3058; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Nadiminty N, 2013, MOL CANCER THER, V12, P1629, DOI 10.1158/1535-7163.MCT-13-0027; Narizhneva NV, 2009, CELL CYCLE, V8, P4155, DOI 10.4161/cc.8.24.10316; O'Hara M, 1998, ARCH FAM MED, V7, P523, DOI 10.1001/archfami.7.6.523; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tepper CG, 2002, CANCER RES, V62, P6606; Toren P, 2015, EUR UROL, V67, P986, DOI 10.1016/j.eururo.2014.08.006; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Tsuta K, 2011, AM J CLIN PATHOL, V136, P252, DOI 10.1309/AJCPDXFOPXGEF0RP; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wafa LA, 2012, INT J CANCER, V130, P2835, DOI 10.1002/ijc.26287; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Yoshida T, 2005, CANCER RES, V65, P9611, DOI 10.1158/0008-5472.CAN-05-0817; Yuan CS, 2010, J GINSENG RES, V34, P160, DOI 10.5142/jgr.2010.34.3.160; Zengerling F, 2012, INT J MOL SCI, V13, P11530, DOI 10.3390/ijms130911530; Zhan Y, 2013, INT J CANCER, V133, P2225, DOI 10.1002/ijc.28202; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287	61	38	40	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111201	10.1371/journal.pone.0111201	http://dx.doi.org/10.1371/journal.pone.0111201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375370	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600029
J	Maitra, D; Ali, I; Abdulridha, RM; Shaeib, F; Khan, SN; Saed, GM; Pennathur, S; Abu-Soud, HM				Maitra, Dhiman; Ali, Iyad; Abdulridha, Rasha M.; Shaeib, Faten; Khan, Sana N.; Saed, Ghassan M.; Pennathur, Subramaniam; Abu-Soud, Husam M.			Kinetic Studies on the Reaction between Dicyanocobinamide and Hypochlorous Acid	PLOS ONE			English	Article							COBALAMIN PRECURSOR COBINAMIDE; FREE IRON RELEASE; CRYSTAL-STRUCTURE; MOLECULAR-STRUCTURE; CYANOGEN CHLORIDE; HEPTAMETHYL ESTER; HEME DESTRUCTION; WARFARE AGENTS; CORRIN RING; CYANIDE	Hypochlorous acid (HOCl) is a potent oxidant generated by myeloperoxidase (MPO), which is an abundant enzyme used for defense against microbes. We examined the potential role of HOCl in corrin ring destruction and subsequent formation of cyanogen chloride (CNCl) from dicyanocobinamide ((CN)(2)-Cbi). Stopped-flow analysis revealed that the reaction consists of at least three observable steps, including at least two sequential transient intermediates prior to corrin ring destruction. The first two steps were attributed to sequential replacement of the two cyanide ligands with hypochlorite, while the third step was the destruction of the corrin ring. The formation of (OCl)(CN)-Cbi and its conversion to (OCl)(2)-Cbi was fitted to a first order rate equation with second order rate constants of 0.002 and 0.0002 mu M-1 s(-1), respectively. The significantly lower rate of the second step compared to the first suggests that the replacement of the first cyanide molecule by hypochlorite causes an alteration in the ligand trans effects changing the affinity and/or accessibility of Co toward hypochlorite. Plots of the apparent rate constants as a function of HOCl concentration for all the three steps were linear with Y-intercepts close to zero, indicating that HOCl binds in an irreversible one-step mechanism. Collectively, these results illustrate functional differences in the corrin ring environments toward binding of diatomic ligands.	[Maitra, Dhiman; Ali, Iyad; Abdulridha, Rasha M.; Shaeib, Faten; Khan, Sana N.; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA; [Ali, Iyad] An Najah Natl Univ, Fac Med & Hlth Sci, Dept Biochem & Genet, Nablus, Israel; [Pennathur, Subramaniam] Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA	Wayne State University; An Najah National University; University of Michigan System; University of Michigan; Wayne State University	Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA.	habusoud@med.wayne.edu		Ali, Iyad/0000-0002-3921-6859; , dhiman/0000-0002-8775-2963	National Institutes of Health [RO1HL066367, R01HL094230]; Children's Hospital of Michigan; Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center [DK089503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094230, R01HL066367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan; Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grant RO1HL066367 and R01HL094230, the Children's Hospital of Michigan, and the Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center (DK089503). Dr. Iyad. A. Ali is a Fulbright Senior Research Scholar in Dr. H. M. A-S laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Soud HM, 2012, FREE RADICAL BIO MED, V52, P616, DOI 10.1016/j.freeradbiomed.2011.10.496; ALDRIDGE WN, 1951, BIOCHEM J, V48, P271, DOI 10.1042/bj0480271; BALDWIN DA, 1983, J CHEM SOC DALTON, P217, DOI 10.1039/dt9830000217; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Brennan RJ, 1999, ANN EMERG MED, V34, P191, DOI 10.1016/S0196-0644(99)70229-5; BRESCIANIPAHOR N, 1982, J CHEM SOC DALTON, P1009, DOI 10.1039/dt9820001009; Broderick KE, 2007, EXP BIOL MED, V232, P789; Broderick KE, 2006, EXP BIOL MED, V231, P641; Broderick KE, 2005, J BIOL CHEM, V280, P8678, DOI 10.1074/jbc.M410498200; Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Brown KL, 1997, INORG CHEM, V36, P3666, DOI 10.1021/ic9615077; Chemaly SM, 2011, INORG CHEM, V50, P8700, DOI 10.1021/ic200285k; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Eitenmiller R.R, 2008, VITAMIN ANAL HLTH FO, V2nd; Fletcher NM, 2011, CANCER BIOMARK, V10, P267, DOI 10.3233/CBM-2012-0255; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Gruber K, 2011, CHEM SOC REV, V40, P4346, DOI 10.1039/c1cs15118e; Gumus G, 2000, TALANTA, V53, P305, DOI 10.1016/S0039-9140(00)00485-9; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HODGKIN DC, 1955, NATURE, V176, P325, DOI 10.1038/176325a0; HUTTEMANN TJ, 1965, INORG CHEM, V4, P950, DOI 10.1021/ic50029a005; KAMIYA K, 1982, J CHEM SOC PERK T 1, P2279, DOI 10.1039/p19820002279; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; Kettle AJ, 2014, BBA-GEN SUBJECTS, V1840, P781, DOI 10.1016/j.bbagen.2013.07.004; KRASNER SW, 1989, J AM WATER WORKS ASS, V81, P41; KRAUTLER B, 1994, INORG CHEM, V33, P4128; LUNDQUIST P, 1985, CLIN CHEM, V31, P591; Ma J, 2012, ANAL CHIM ACTA, V736, P78, DOI 10.1016/j.aca.2012.05.028; Ma JA, 2010, ANAL CHIM ACTA, V673, P117, DOI 10.1016/j.aca.2010.05.042; Maitra D, 2013, FREE RADICAL BIO MED, V63, P90, DOI 10.1016/j.freeradbiomed.2013.04.009; Maitra D, 2011, FREE RADICAL BIO MED, V51, P374, DOI 10.1016/j.freeradbiomed.2011.04.011; Maitra D, 2011, FREE RADICAL BIO MED, V51, P364, DOI 10.1016/j.freeradbiomed.2011.03.040; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; MARKWELL AJ, 1987, J CHEM SOC DALTON, P1349, DOI 10.1039/dt9870001349; Matthews JH, 1997, BLOOD, V89, P4600, DOI 10.1182/blood.V89.12.4600; Na CZ, 2006, ENVIRON SCI TECHNOL, V40, P1469, DOI 10.1021/es0512273; Nicholls SJ, 2009, J LIPID RES, V50, pS346, DOI 10.1194/jlr.R800086-JLR200; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pennathur S, 2007, ANTIOXID REDOX SIGN, V9, P955, DOI 10.1089/ars.2007.1595; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; Randaccio L, 1998, INORG CHEM, V37, P5390, DOI 10.1021/ic980181u; Saini Y, 2010, TOXICOL SCI, V116, P673, DOI 10.1093/toxsci/kfq155; Schneider Z, 1987, COMPREHENSIVE B; Sharina I, 2012, J PHARMACOL EXP THER, V340, P723, DOI 10.1124/jpet.111.186957; Souza CEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027641; Szinicz L, 2005, TOXICOLOGY, V214, P167, DOI 10.1016/j.tox.2005.06.011; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Vivekanadan-Giri A, 2008, REV ENDOCR METAB DIS, V9, P275, DOI 10.1007/s11154-008-9093-1; Wang L, 2007, J Burns Wounds, V6, pe5; Weinberg JB, 2009, FREE RADICAL BIO MED, V46, P1626, DOI 10.1016/j.freeradbiomed.2009.03.017; Weinberg JB, 1998, BIOCHEM BIOPH RES CO, V246, P393, DOI 10.1006/bbrc.1998.8629; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Zhou K, 2011, EUR J INORG CHEM, P53, DOI 10.1002/ejic.201001146	53	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110595	10.1371/journal.pone.0110595	http://dx.doi.org/10.1371/journal.pone.0110595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375773	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600014
J	Simon-Santamaria, J; Rinaldo, CH; Kardas, P; Li, RM; Malovic, I; Elvevold, K; McCourt, P; Smedsrod, B; Hirsch, HH; Sorensen, KK				Simon-Santamaria, Jaione; Rinaldo, Christine Hanssen; Kardas, Piotr; Li, Ruomei; Malovic, Ivana; Elvevold, Kjetil; McCourt, Peter; Smedsrod, Bard; Hirsch, Hans H.; Sorensen, Karen Kristine			Efficient Uptake of Blood-Borne BK and JC Polyomavirus-Like Particles in Endothelial Cells of Liver Sinusoids and Renal Vasa Recta	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RECEPTOR-MEDIATED ENDOCYTOSIS; GLYCATION END-PRODUCTS; MANNOSE RECEPTOR; SCAVENGER-RECEPTOR; HYALURONAN RECEPTOR; PROTEIN VP1; VIRUS; EXPRESSION; CLEARANCE	Liver sinusoidal endothelial cells (LSECs) are specialized scavenger cells that mediate high-capacity clearance of soluble waste macromolecules and colloid material, including blood-borne adenovirus. To explore if LSECs function as a sink for other viruses in blood, we studied the fate of virus-like particles (VLPs) of two ubiquitous human DNA viruses, BK and JC polyomavirus, in mice. Like complete virions, VLPs specifically bind to receptors and enter cells, but unlike complete virions, they cannot replicate. I-125-labeled VLPs were used to assess blood decay, organ-, and hepatocellular distribution of ligand, and non-labeled VLPs to examine cellular uptake by immunohisto- and -cytochemistry. BK- and JC-VLPs rapidly distributed to liver, with lesser uptake in kidney and spleen. Liver uptake was predominantly in LSECs. Blood half-life (similar to 1 min), and tissue distribution of JC-VLPs and two JC-VLP-mutants (L55F and S269F) that lack sialic acid binding affinity, were similar, indicating involvement of non-sialic acid receptors in cellular uptake. Liver uptake was not mediated by scavenger receptors. In spleen, the VLPs localized to the red pulp marginal zone reticuloendothelium, and in kidney to the endothelial lining of vasa recta segments, and the transitional epithelium of renal pelvis. Most VLP-positive vessels in renal medulla did not express PV-1/Meca 32, suggesting location to the non-fenestrated part of vasa recta. The endothelial cells of these vessels also efficiently endocytosed a scavenger receptor ligand, formaldehyde-denatured albumin, suggesting high endocytic activity compared to other renal endothelia. We conclude that LSECs very effectively cleared a large fraction of blood-borne BK- and JC-VLPs, indicating a central role of these cells in early removal of polyomavirus from the circulation. In addition, we report the novel finding that a subpopulation of endothelial cells in kidney, the main organ of polyomavirus persistence, showed selective and rapid uptake of VLPs, suggesting a role in viremic organ tropism.	[Simon-Santamaria, Jaione; Li, Ruomei; Malovic, Ivana; Elvevold, Kjetil; McCourt, Peter; Smedsrod, Bard; Sorensen, Karen Kristine] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Rinaldo, Christine Hanssen] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Rinaldo, Christine Hanssen] UiT Arctic Univ Norway, Dept Clin Med, Tromso, Norway; [Kardas, Piotr; Hirsch, Hans H.] Univ Basel, Dept Biomed, Basel, Switzerland; [Hirsch, Hans H.] Univ Basel Hosp, Div Infect Dis, CH-4031 Basel, Switzerland; [Hirsch, Hans H.] Univ Basel Hosp, Div Hosp Epidemiol, CH-4031 Basel, Switzerland	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University of Basel; University of Basel; University of Basel	Sorensen, KK (corresponding author), UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway.	karen.sorensen@uit.no	McCourt, Peter/B-3043-2009; Rinaldo, Christine Hanssen/AAX-1762-2020	McCourt, Peter/0000-0001-5072-4590; Malovic, Ivana/0000-0001-8390-7617; Hirsch, Hans H./0000-0003-0883-0423	Tromso Research Foundation (Tromso, Norway); University of Basel (Basel, Switzerland)	Tromso Research Foundation (Tromso, Norway); University of Basel (Basel, Switzerland)	The work was supported by a grant from The Tromso Research Foundation (Tromso, Norway) to BS, and an institutional grant of the University of Basel (Basel, Switzerland) to HHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Asumendi A, 1996, HEPATOLOGY, V23, P1521, DOI 10.1002/hep.510230632; BLOMHOFF R, 1984, BIOCHEM J, V218, P81, DOI 10.1042/bj2180081; Bodaghi S, 2009, J CLIN MICROBIOL, V47, P2577, DOI 10.1128/JCM.00030-09; Brinkman-Van der Linden ECM, 2002, ANAL BIOCHEM, V303, P98, DOI 10.1006/abio.2001.5539; Drachenberg CB, 2007, TRANSPLANTATION, V84, P323, DOI 10.1097/01.tp.0000269706.59977.a5; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Elvevold K, 2008, HEPATOLOGY, V48, P2007, DOI 10.1002/hep.22527; Elvevold Kjetil H, 2004, Comp Hepatol, V3, P4, DOI 10.1186/1476-5926-3-4; ESBACH S, 1993, HEPATOLOGY, V18, P537, DOI 10.1016/0270-9139(93)90352-N; Fang CY, 2010, VIROLOGY, V402, P164, DOI 10.1016/j.virol.2010.03.029; Ferenczy MW, 2012, CLIN MICROBIOL REV, V25, P471, DOI 10.1128/CMR.05031-11; Funk GA, 2007, LANCET INFECT DIS, V7, P460, DOI 10.1016/S1473-3099(07)70159-7; Ganesan LP, 2012, J IMMUNOL, V189, P4981, DOI 10.4049/jimmunol.1202017; Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281; Goldmann C, 1999, J VIROL, V73, P4465, DOI 10.1128/JVI.73.5.4465-4469.1999; Gorelik L, 2011, J INFECT DIS, V204, P103, DOI 10.1093/infdis/jir198; Gosert R, 2010, J VIROL, V84, P10448, DOI 10.1128/JVI.00614-10; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017; Hansen B, 2002, MOL CELL BIOCHEM, V229, P63, DOI 10.1023/A:1017919800347; Hellevik T, 1996, EXP CELL RES, V223, P39, DOI 10.1006/excr.1996.0056; Hirsch HH, 2013, AM J TRANSPLANT, V13, P179, DOI 10.1111/ajt.12110; Hirsch HH, 2013, APMIS, V121, P685, DOI 10.1111/apm.12128; Hirsch HH, 2005, CLIN INFECT DIS, V41, P354, DOI 10.1086/431488; Hosel M, 2012, HEPATOLOGY, V55, P287, DOI 10.1002/hep.24625; INCHLEY CJ, 1969, CLIN EXP IMMUNOL, V5, P173; Jacobs F, 2010, AM J PATHOL, V176, P14, DOI 10.2353/ajpath.2010.090136; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Kjeken R, 2001, CELL TISSUE RES, V304, P221, DOI 10.1007/s004410100348; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Li RM, 2011, AM J PHYSIOL-GASTR L, V300, pG71, DOI 10.1152/ajpgi.00215.2010; Li Y, 2009, MOL CELL BIOCHEM, V327, P183, DOI 10.1007/s11010-009-0056-y; MAGNUSSON S, 1989, BIOCHEM J, V257, P651, DOI 10.1042/bj2570651; Malerod L, 2002, CELL TISSUE RES, V307, P173, DOI 10.1007/s00441-001-0476-9; Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639; Martens JH, 2006, J PATHOL, V208, P574, DOI 10.1002/path.1921; Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020; Martinez Inigo, 2008, Comp Hepatol, V7, P4, DOI 10.1186/1476-5926-7-4; McCourt PAG, 1999, HEPATOLOGY, V30, P1276, DOI 10.1002/hep.510300521; MELKKO J, 1994, J EXP MED, V179, P405, DOI 10.1084/jem.179.2.405; MIMS CA, 1959, BRIT J EXP PATHOL, V40, P543; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Neu U, 2009, VIROLOGY, V384, P389, DOI 10.1016/j.virol.2008.12.021; Neu U, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003688; Neu U, 2010, CELL HOST MICROBE, V8, P309, DOI 10.1016/j.chom.2010.09.004; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Pannabecker TL, 2007, AM J PHYSIOL-RENAL, V293, pF696, DOI 10.1152/ajprenal.00231.2007; Petrogiannis-Haliotis T, 2001, NEW ENGL J MED, V345, P1250, DOI 10.1056/NEJMoa010319; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Rinaldo CH, 2003, VIRUS RES, V93, P181, DOI 10.1016/S0168-1702(03)00096-0; Seckert CK, 2009, J VIROL, V83, P8869, DOI 10.1128/JVI.00870-09; Seternes T, 2002, P NATL ACAD SCI USA, V99, P7594, DOI 10.1073/pnas.102173299; SKOGH T, 1985, IMMUNOLOGY, V55, P585; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; SMEDSROD B, 1990, BIOCHEM J, V271, P345, DOI 10.1042/bj2710345; Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567; Smedsrod B, 2012, PROTOCOL PREPARATION; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Suzuki S, 2001, VIROLOGY, V286, P100, DOI 10.1006/viro.2001.0972; Svistounov D, 2013, EXP GERONTOL, V48, P549, DOI 10.1016/j.exger.2013.03.005; Tan CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064313; Tsai B, 2010, CURR TOP MICROBIOL, V343, P177, DOI 10.1007/82_2010_38; Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332; VALLBRACHT A, 1993, AM J PATHOL, V143, P29; VANBERKEL TJC, 1991, J BIOL CHEM, V266, P2282; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wu J, 2010, IMMUNOLOGY, V129, P363, DOI 10.1111/j.1365-2567.2009.03179.x; Xie GH, 2010, AM J PHYSIOL-GASTR L, V299, pG1204, DOI 10.1152/ajpgi.00302.2010; Zhang LQ, 1999, J VIROL, V73, P855, DOI 10.1128/JVI.73.1.855-860.1999	75	30	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111762	10.1371/journal.pone.0111762	http://dx.doi.org/10.1371/journal.pone.0111762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375646	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600059
J	Sukhotnik, I; Geyer, T; Pollak, Y; Mogilner, JG; Coran, AG; Berkowitz, D				Sukhotnik, Igor; Geyer, Tatiana; Pollak, Yulia; Mogilner, Jorge G.; Coran, Arnold G.; Berkowitz, Drora			The Role of Wnt/beta-Catenin Signaling in Enterocyte Turnover during Methotrexate-Induced Intestinal Mucositis in a Rat	PLOS ONE			English	Article							STEM-CELLS; C-MYC; WNT; PROLIFERATION; CHEMOTHERAPY; TARGET	Background/Aims: Intestinal mucositis is a common side-effect in patients who receive aggressive chemotherapy. The Wnt signaling pathway is critical for establishing and maintaining the proliferative compartment of the intestine. In the present study, we tested whether Wnt/beta-catenin signaling is involved in methotrexate (MTX)-induced intestinal damage in a rat model. Methods: Non-pretreated and pretreated with MTX Caco-2 cells were evaluated for cell proliferation and apoptosis using FACS analysis. Adult rats were divided into three experimental groups: Control rats; MTX-2 animals were treated with a single dose of MTX given IP and were sacrificed on day 2, and MTX-4 rats were treated with MTX similar to group B and were sacrificed on day 4. Intestinal mucosal damage, mucosal structural changes, enterocyte proliferation, and enterocyte apoptosis were measured at sacrifice. Real Time PCR and Western blot was used to determine the level of Wnt/beta-catenin related genes and protein expression. Results: In the vitro experiment, treatment with MTX resulted in marked decrease in early cell proliferation rates following by a 17-fold increase in late cell proliferation rates compared to early proliferation. Treatment with MTX resulted in a significant increase in early and late apoptosis compared to Caco-2 untreated cells. In the vivo experiment, MTX-2 and MTX-4 rats demonstrated intestinal mucosal hypoplasia. MTX-2 rats demonstrated a significant decrease in FRZ-2, Wnt 3A Wnt 5A, beta-catenin, c-myc mRNA expression and a significant decrease in b-catenin and Akt protein levels compared to control animals. Four days following MTX administration, rats demonstrated a trend toward a restoration of Wnt/beta-catenin signaling especially in ileum. Conclusions: Wnt/beta-catenin signaling is involved in enterocyte turnover during MTX-induced intestinal mucositis in a rat.	[Sukhotnik, Igor] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Bnai Zion Med Ctr, Dept Pediat Surg,Lab Intestinal Adaptat & Recover, IL-31096 Haifa, Israel; [Geyer, Tatiana; Pollak, Yulia] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Lab Intestinal Adaptat & Recovery, IL-31096 Haifa, Israel; [Mogilner, Jorge G.] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Bnai Zion Med Ctr, Dept Pediat Surg, IL-31096 Haifa, Israel; [Coran, Arnold G.] CS Mott Childrens Hosp, Pediat Surg Sect, Ann Arbor, MI USA; [Coran, Arnold G.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Berkowitz, Drora] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Bnai Zion Med Ctr, Dept Pediat Gastroenterol, IL-31096 Haifa, Israel	Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Michigan System; University of Michigan; Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Sukhotnik, I (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Bnai Zion Med Ctr, Dept Pediat Surg,Lab Intestinal Adaptat & Recover, POB 9649, IL-31096 Haifa, Israel.	igor-dr@internet-zahav.net						Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Gate L, 1999, BIOMED PHARMACOTHER, V53, P169, DOI 10.1016/S0753-3322(99)80086-9; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Horvay K, 2013, ADV EXP MED BIOL, V786, P175, DOI 10.1007/978-94-007-6621-1_10; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Keefe DMK, 2004, SUPPORT CARE CANCER, V12, P6, DOI 10.1007/s00520-003-0550-9; Keefe DMK, 2000, GUT, V47, P632, DOI 10.1136/gut.47.5.632; Kesik V, 2009, CANCER BIOL THER, V8, P1630, DOI 10.4161/cbt.8.17.9203; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Pico, 1998, Oncologist, V3, P446; Rubenstein EB, 2004, CANCER-AM CANCER SOC, V100, P2026, DOI 10.1002/cncr.20163; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; TRIER JS, 1962, GASTROENTEROLOGY, V43, P407; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106	23	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110675	10.1371/journal.pone.0110675	http://dx.doi.org/10.1371/journal.pone.0110675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375224	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600019
J	Crannell, ZA; Rohrman, B; Richards-Kortum, R				Crannell, Zachary Austin; Rohrman, Brittany; Richards-Kortum, Rebecca			Equipment-Free Incubation of Recombinase Polymerase Amplification Reactions Using Body Heat	PLOS ONE			English	Article							RAPID DETECTION; DIAGNOSIS; PCR	The development of isothermal amplification platforms for nucleic acid detection has the potential to increase access to molecular diagnostics in low resource settings; however, simple, low-cost methods for heating samples are required to perform reactions. In this study, we demonstrated that human body heat may be harnessed to incubate recombinase polymerase amplification (RPA) reactions for isothermal amplification of HIV-1 DNA. After measuring the temperature of mock reactions at 4 body locations, the axilla was chosen as the ideal site for comfortable, convenient incubation. Using commonly available materials, 3 methods for securing RPA reactions to the body were characterized. Finally, RPA reactions were incubated using body heat while control RPA reactions were incubated in a heat block. At room temperature, all reactions with 10 copies of HIV-1 DNA and 90% of reactions with 100 copies of HIV-1 DNA tested positive when incubated with body heat. In a cold room with an ambient temperature of 10 degrees Celsius, all reactions containing 10 copies or 100 copies of HIV-1 DNA tested positive when incubated with body heat. These results suggest that human body heat may provide an extremely low-cost solution for incubating RPA reactions in low resource settings.	[Crannell, Zachary Austin; Rohrman, Brittany; Richards-Kortum, Rebecca] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University	Rohrman, B (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	br4@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014	Richards-Kortum, Rebecca R/0000-0003-2347-9467				Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; Baldinger P, 2008, POWERING HLTH OPTION; Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13; Crannell ZA, 2014, ANAL CHEM, V86, P2565, DOI 10.1021/ac403750z; Gitman MR, 2013, J CLIN MICROBIOL, V51, P3765, DOI 10.1128/JCM.01413-13; GUATELLI JC, 1990, P NATL ACAD SCI USA, V87, P1874, DOI 10.1073/pnas.87.5.1874; Kersting S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-99; Krolov K, 2014, J MOL DIAGN, V16, P127, DOI 10.1016/j.jmoldx.2013.08.003; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; Lillis L, 2013, AM SOC TROPICAL MED, V13; Lillis L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108189; Maritz J, 2012, J CLIN VIROL, V53, P106, DOI 10.1016/j.jcv.2011.12.002; Myers FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070266; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611; Segall HI, 2003, MOL THER, V8, P118, DOI 10.1016/S1525-0016(03)00134-5; TwistDx, 2014, REC POL AMPL BREAKTH; VWR, 2014, VWR AN DRY BLOCK HEA; Wang B, 2014, J CLIN MICROBIOL, V52, P1838, DOI 10.1128/JCM.03615-13	21	152	169	7	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112146	10.1371/journal.pone.0112146	http://dx.doi.org/10.1371/journal.pone.0112146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372030	Green Published, gold			2022-12-26	WOS:000344556900115
J	Mathewson, AM; Dunn, WR				Mathewson, Alastair M.; Dunn, William R.			A Comparison of Responses to Raised Extracellular Potassium and Endothelium-Derived Hyperpolarizing Factor (EDHF) in Rat Pressurised Mesenteric Arteries	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; K+-INDUCED HYPERPOLARIZATION; GAP-JUNCTIONS; SMOOTH-MUSCLE; MYOGENIC TONE; RESISTANCE ARTERIES; HYDROGEN-PEROXIDE; PREGNANT-WOMEN; HEPATIC-ARTERY; SENSORY NERVES	The present study examined the hypothesis that potassium ions act as an endothelium-derived hyperpolarizing factor (EDHF) released in response to ACh in small mesenteric arteries displaying myogenic tone. Small mesenteric arteries isolated from rats were set up in a pressure myograph at either 60 or 90 mmHg. After developing myogenic tone, responses to raising extracellular potassium were compared to those obtained with ACh (in the presence of nitric oxide synthase and cyclo-oxygenase inhibitors). The effects of barium and oubain, or capsaicin, on responses to raised extracellular potassium or ACh were also determined. The effects of raised extracellular potassium levels and ACh on membrane potential, were measured using sharp microelectrodes in pressurised arteries. Rat small mesenteric arteries developed myogenic tone when pressurised. On the background of vascular tone set by a physiological stimulus (i.e pressure), ACh fully dilated the small arteries in a concentration-dependent manner. This response was relatively insensitive to the combination of barium and ouabain, and insensitive to capsaicin. Raising extracellular potassium produced a more inconsistent and modest vasodilator response in pressurised small mesenteric arteries. Responses to raising extracellular potassium were sensitive to capsaicin, and the combination of barium and ouabain. ACh caused a substantial hyperpolarisation in pressurized arteries, while raising extracellular potassium did not. These data indicate that K+ is not the EDHF released in response to ACh in myogenically active rat mesenteric small arteries. Since the hyperpolarization produced by ACh was sensitive to carbenoxolone, gap junctions are the likely mediator of EDH responses under physiological conditions.	[Mathewson, Alastair M.; Dunn, William R.] Univ Nottingham, Sch Life Sci, Pharmacol Res Grp, Nottingham NG7 2RD, England	University of Nottingham	Dunn, WR (corresponding author), Univ Nottingham, Sch Life Sci, Pharmacol Res Grp, Nottingham NG7 2RD, England.	William.dunn@nottingham.ac.uk		Dunn, William/0000-0002-8864-6441	Wellcome Trust [WT069264]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors acknowledge the support of the Wellcome Trust (project grant WT069264). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2000, BRIT J PHARMACOL, V129, P1490, DOI 10.1038/sj.bjp.0703226; Brochet DXP, 2006, PFLUG ARCH EUR J PHY, V453, P33, DOI 10.1007/s00424-006-0106-1; BROCK JA, 1995, PFLUG ARCH EUR J PHY, V430, P901, DOI 10.1007/BF01837403; Burke EP, 1996, AM J PHYSIOL-CELL PH, V270, pC1405, DOI 10.1152/ajpcell.1996.270.5.C1405; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; de Wit C, 2010, PFLUG ARCH EUR J PHY, V459, P897, DOI 10.1007/s00424-010-0830-4; Dora KA, 2005, AM J PHYSIOL-HEART C, V289, pH1323, DOI 10.1152/ajpheart.00513.2005; Dora KA, 2002, AM J PHYSIOL-HEART C, V283, pH606, DOI 10.1152/ajpheart.01016.2001; Dora KA, 2001, AM J PHYSIOL-HEART C, V280, pH2424, DOI 10.1152/ajpheart.2001.280.6.H2424; Doughty JM, 2000, BRIT J PHARMACOL, V130, P1174, DOI 10.1038/sj.bjp.0703412; Dunn WR, 1997, HYPERTENSION, V29, P1140, DOI 10.1161/01.HYP.29.5.1140; Earley S, 2004, AM J PHYSIOL-HEART C, V287, pH2677, DOI 10.1152/ajpheart.00016.2004; Edwards G, 2004, PHARMACOL RES, V49, P535, DOI 10.1016/j.phrs.2003.11.013; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; FENGERGRON J, 1995, J PHYSIOL-LONDON, V488, P753, DOI 10.1113/jphysiol.1995.sp021006; Goto K, 2002, CLIN EXP PHARMACOL P, V29, P595, DOI 10.1046/j.1440-1681.2002.03689.x; Hammond S, 2011, EUR J PHARMACOL, V668, P225, DOI 10.1016/j.ejphar.2011.06.050; HARDER DR, 1984, CIRC RES, V55, P197, DOI 10.1161/01.RES.55.2.197; Harris D, 2000, EUR J PHARMACOL, V402, P119, DOI 10.1016/S0014-2999(00)00512-4; Hogestatt ED, 2000, BRIT J PHARMACOL, V130, P27, DOI 10.1038/sj.bjp.0703258; Izzard AS, 1996, AM J PHYSIOL-HEART C, V270, pH1, DOI 10.1152/ajpheart.1996.270.1.H1; Kenny LC, 2002, BRIT J PHARMACOL, V136, P1085, DOI 10.1038/sj.bjp.0704817; Lacy PS, 2000, BRIT J PHARMACOL, V129, P605, DOI 10.1038/sj.bjp.0703076; Lagaud G, 2002, AM J PHYSIOL-HEART C, V283, pH2177, DOI 10.1152/ajpheart.00605.2001; Martin PEM, 2003, BRIT J PHARMACOL, V140, P1261, DOI 10.1038/sj.bjp.0705556; Mather S, 2005, CIRC RES, V97, P399, DOI 10.1161/01.RES.0000178008.46759.d0; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; PERTL C, 1993, PAIN, V52, P351, DOI 10.1016/0304-3959(93)90169-P; Richards GR, 2001, BRIT J PHARMACOL, V134, P1, DOI 10.1038/sj.bjp.0704256; Rummery NM, 2007, J PHYSIOL-LONDON, V582, P745, DOI 10.1113/jphysiol.2007.134825; SUN D, 1992, AM J PHYSIOL, V263, pH1486, DOI 10.1152/ajpheart.1992.263.5.H1486; Van de Voorde J, 2000, J CARDIOVASC PHARM, V35, P543, DOI 10.1097/00005344-200004000-00005; Wesselman JPM, 1997, AM J PHYSIOL-HEART C, V272, pH2241, DOI 10.1152/ajpheart.1997.272.5.H2241; Weston AH, 2002, BRIT J PHARMACOL, V136, P918, DOI 10.1038/sj.bjp.0704787; White BJO, 2013, BRIT J PHARMACOL, V168, P785, DOI 10.1111/j.1476-5381.2012.02187.x; Zygmunt PM, 2000, N-S ARCH PHARMACOL, V361, P535, DOI 10.1007/s002100000229	37	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111977	10.1371/journal.pone.0111977	http://dx.doi.org/10.1371/journal.pone.0111977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372386	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900100
J	Vallen, MJE; Schmidt, S; Oosterhof, A; Bulten, J; Massuger, LFAG; van Kuppevelt, TH				Vallen, Myrtille J. E.; Schmidt, Samuel; Oosterhof, Arie; Bulten, Johan; Massuger, Leon F. A. G.; van Kuppevelt, Toin H.			Primary Ovarian Carcinomas and Abdominal Metastasis Contain 4,6-Disulfated Chondroitin Sulfate Rich Regions, Which Provide Adhesive Properties to Tumour Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CANCER METASTASIS; GLYCOSAMINOGLYCANS; COLLAGEN; GROWTH; DIFFERENTIATION; PROTEOGLYCANS; EXPRESSION; MIGRATION; MELANOMA	High mortality in ovarian cancer patients is primarily caused through rapid metastasis of the tumour, but the underlying mechanisms are poorly understood. Glycosaminoglycans, are abundantly present in tumours and chondroitin sulfate-E (CSE), a highly 4,6-sulfated glycosaminoglycan, has been indicated to play a role in carcinogenesis. In this study we investigated the presence of CSE in ovarian cancer metastasis and studied its role in tumour cell adhesiveness and migration. CSE was studied immunohistochemically in primary ovarian carcinomas and abdominal metastases using the single chain antibody GD3G7. The role of CSE was studied in 2D (scratch assays) and 3D (collagen matrices, spheroids) systems using SKOV3 cells applying 1: overexpression of CSE by stable transfection with DNA encoding GalNAc4S-6 sulfotransferase, 2: enzymatic removal of CS, and 3: addition of CSE. In ovarian cancer tissue, CSE expression was predominantly seen in the stromal compartment of both primary ovarian carcinomas and metastases, with a comparable degree of intensity and extent. Overexpression of CSE disaccharide units by tumour cells increased their adhesive properties which was especially seen in tumour spheroid formation. Increased expression of CSE reduced cell migration. Addition of free CSE had similar effects. The data presented here indicate that CSE is associated with metastatic lesions and that it provides tumours with adhesive properties. CSE rich motifs are put forward as a potential target for ovarian cancer therapy.	[Vallen, Myrtille J. E.; Oosterhof, Arie; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands; [Vallen, Myrtille J. E.; Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Schmidt, Samuel] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands; [Bulten, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Vallen, MJE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands.	m.vallen@obgyn.umcn.nl	Bulten, J./L-4237-2015; Schmidt, Samuel/G-5989-2011; van Kuppevelt, A.H.M.S.M./L-4463-2015; Massuger, Leon F.A.G./H-8072-2014	Bulten, J./0000-0002-8168-6045; Schmidt, Samuel/0000-0001-9001-7970; 	Dutch Cancer Society [2008-4058]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society (2008-4058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosius M, 2009, CELL BIOL INT, V33, P848, DOI 10.1016/j.cellbi.2009.04.018; [Anonymous], 2011, J Natl Cancer Inst, V103, P1287, DOI 10.1093/jnci/djr342; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Casey RC, 2003, CLIN EXP METASTAS, V20, P143, DOI 10.1023/A:1022670501667; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Denholm EM, 2001, EUR J PHARMACOL, V416, P213, DOI 10.1016/S0014-2999(01)00884-6; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Freedman Ralph S, 2004, J Transl Med, V2, P23, DOI 10.1186/1479-5876-2-23; FRIEDL P, 1993, J IMMUNOL METHODS, V165, P157, DOI 10.1016/0022-1759(93)90341-4; Friedl P, 1997, CANCER RES, V57, P2061; GARDNER MJ, 1995, CANCER LETT, V91, P229, DOI 10.1016/0304-3835(95)03743-G; Gardner MJ, 1996, CLIN EXP METASTAS, V14, P325, DOI 10.1007/BF00123391; Ghosh S, 2010, GYNECOL ONCOL, V119, P114, DOI 10.1016/j.ygyno.2010.05.029; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Ito Y, 2007, ACTA HISTOCHEM CYTOC, V40, P53, DOI 10.1267/ahc.07004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalathas D, 2009, ONCOL REP, V22, P369, DOI 10.3892/or_00000447; Kobayashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054278; Koike T, 2012, BIOCHEM BIOPH RES CO, V420, P523, DOI 10.1016/j.bbrc.2012.03.024; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Labiche A, 2010, INT J GYNECOL CANCER, V20, P28, DOI 10.1111/IGC.0b013e3181bda1cb; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Lv HZ, 2007, ONCOLOGY-BASEL, V72, P347, DOI 10.1159/000113145; Mizumoto S, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/56319, 10.1155/2013/656319]; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; NEDERMAN T, 1984, CANCER RES, V44, P3090; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Papadas TA, 2002, ACTA OTO-LARYNGOL, V122, P330, DOI 10.1080/000164802753648268; Prinz RD, 2011, GENET MOL RES, V10, P3901, DOI 10.4238/2011.December.8.9; Ricciardelli C, 2006, SEMIN REPROD MED, V24, P270, DOI 10.1055/s-2006-948556; Rozen S, 2000, Methods Mol Biol, V132, P365; Seidman JD, 2002, BLAUSTEINS PATHOLOGY, P791; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; TAKEUCHI J, 1972, BRIT J CANCER, V26, P115, DOI 10.1038/bjc.1972.17; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Theocharis AD, 2006, ADV PHARMACOL, V53, P281, DOI 10.1016/S1054-3589(05)53013-8; Theocharis AD, 2003, INT J BIOCHEM CELL B, V35, P376, DOI 10.1016/S1357-2725(02)00264-9; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Vallen MJ, 2014, GYNECOL ONCOL, V23, P01276; Vallen MJE, 2012, GYNECOL ONCOL, V127, P202, DOI 10.1016/j.ygyno.2012.06.022; Wegrowski Y, 2006, ADV PHARMACOL, V53, P297, DOI 10.1016/S1054-3589(05)53014-X; Weyers A, 2013, GLYCOCONJ J; Weyers A, 2012, OMICS, V16, P79, DOI 10.1089/omi.2011.0102; Wolanska M, 1999, ACTA BIOCHIM POL, V46, P941	53	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111806	10.1371/journal.pone.0111806	http://dx.doi.org/10.1371/journal.pone.0111806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372710	Green Submitted, gold, Green Published			2022-12-26	WOS:000344556900076
J	Jakhria, T; Hellewell, AL; Porter, MY; Jackson, MP; Tipping, KW; Xue, WF; Radford, SE; Hewitt, EW				Jakhria, Toral; Hellewell, Andrew L.; Porter, Morwenna Y.; Jackson, Matthew P.; Tipping, Kevin W.; Xue, Wei-Feng; Radford, Sheena E.; Hewitt, Eric W.			beta(2)-Microglobulin Amyloid Fibrils Are Nanoparticles That Disrupt Lysosomal Membrane Protein Trafficking and Inhibit Protein Degradation by Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PEPTIDE ALTERS; IN-VIVO; ALPHA-SYNUCLEIN; MEDIATED ENDOCYTOSIS; COMMON MECHANISM; GAUCHER-DISEASE; MTT REDUCTION; CELL-DEATH; OLIGOMERS; TOXICITY	Fragmentation of amyloid fibrils produces fibrils that are reduced in length but have an otherwise unchanged molecular architecture. The resultant nanoscale fibril particles inhibit the cellular reduction of the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), a substrate commonly used to measure cell viability, to a greater extent than unfragmented fibrils. Here we show that the internalization of beta(2)-microglobulin (beta(2)m) amyloid fibrils is dependent on fibril length, with fragmented fibrils being more efficiently internalized by cells. Correspondingly, inhibiting the internalization of fragmented beta(2)m fibrils rescued cellular MTT reduction. Incubation of cells with fragmented beta(2)m fibrils did not, however, cause cell death. Instead, fragmented beta(2)m fibrils accumulate in lysosomes, alter the trafficking of lysosomal membrane proteins, and inhibit the degradation of a model protein substrate by lysosomes. These findings suggest that nanoscale fibrils formed early during amyloid assembly reactions or by the fragmentation of longer fibrils could play a role in amyloid disease by disrupting protein degradation by lysosomes and trafficking in the endolysosomal pathway.	[Hewitt, Eric W.] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Hewitt, Eric W.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds	Hewitt, EW (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	e.w.hewitt@leeds.ac.uk		Radford, Sheena/0000-0002-3079-8039; Hewitt, Eric/0000-0002-6238-6303; Xue, Wei-Feng/0000-0002-6504-0404	Wellcome Trust Grants [075675, 092896/Z/10/Z, 093794/Z/10/Z]; BBSRC [BB/526502/1, BB/F01614X/1]; Yorkshire Kidney Research Fund; European Research Council under the European Union [322408]; Biotechnology and Biological Sciences Research Council [961800] Funding Source: researchfish	Wellcome Trust Grants(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Yorkshire Kidney Research Fund; European Research Council under the European Union(European Research Council (ERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grants 075675, 092896/Z/10/Z, and 093794/Z/10/Z); by BBSRC Grants BB/526502/1 and BB/F01614X/1; and by the Yorkshire Kidney Research Fund. This work was also supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 322408 (to E. W. H., M. P. J., and S. E. R.).	Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Argiles A, 2002, NEPHROL DIAL TRANSPL, V17, P1136, DOI 10.1093/ndt/17.6.1136; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; BEATTIE GM, 1994, J CLIN ENDOCR METAB, V78, P1232, DOI 10.1210/jc.78.5.1232; BEAUFAY H, 1974, J CELL BIOL, V61, P188, DOI 10.1083/jcb.61.1.188; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Berthelot K, 2011, J MOL BIOL, V412, P137, DOI 10.1016/j.jmb.2011.07.009; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Casey TM, 2007, MOL CELL PROTEOMICS, V6, P767, DOI 10.1074/mcp.M600365-MCP200; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Follett J, 2014, TRAFFIC, V15, P230, DOI 10.1111/tra.12136; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Garcia-Garcia M, 1999, KIDNEY INT, V55, P899, DOI 10.1046/j.1523-1755.1999.055003899.x; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Giraldo AMV, 2014, BIOCHEM SOC T, V42, P1460, DOI 10.1042/BST20140145; Goodchild SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104492; Grudzielanek S, 2007, J MOL BIOL, V370, P372, DOI 10.1016/j.jmb.2007.04.053; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Heegaard NHH, 2009, AMYLOID, V16, P151, DOI 10.1080/13506120903151775; Isobe I, 1999, NEUROSCI LETT, V266, P129, DOI 10.1016/S0304-3940(99)00282-7; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; Jiang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00857; Julien O, 2014, NAT CHEM BIOL, V10, P969, DOI [10.1038/nchembio.1639, 10.1038/NCHEMBIO.1639]; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kerokoski P, 2001, NEUROCHEM INT, V38, P127, DOI 10.1016/S0197-0186(00)00071-1; Khurana V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001026; Kubo T, 2002, MOL BRAIN RES, V106, P94, DOI 10.1016/S0169-328X(02)00416-3; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020244; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liu YB, 1998, P NATL ACAD SCI USA, V95, P13266, DOI 10.1073/pnas.95.22.13266; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Liu YB, 1997, J NEUROCHEM, V69, P2285; Lorincz M, 1997, BLOOD, V89, P3412, DOI 10.1182/blood.V89.9.3412; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; Monti M, 2002, PROTEIN SCI, V11, P2362, DOI 10.1110/ps.0206902; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; Mossuto ME, 2011, ANGEW CHEM INT EDIT, V50, P7048, DOI 10.1002/anie.201100986; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nesterov EE, 2005, ANGEW CHEM INT EDIT, V44, P5452, DOI 10.1002/anie.200500845; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Porter MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027353; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheynis T, 2013, BIOPHYS J, V105, P745, DOI 10.1016/j.bpj.2013.06.015; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Soura V, 2012, BIOCHEM J, V441, P579, DOI 10.1042/BJ20110749; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Torres Manuel, 2012, Mol Neurodegener, V7, P59, DOI 10.1186/1750-1326-7-59; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Xue WF, 2009, PROTEIN ENG DES SEL, V22, P489, DOI 10.1093/protein/gzp026; Zhang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012529; Zhang T, 2000, IMMUNOLOGY, V100, P13, DOI 10.1046/j.1365-2567.2000.00000.x; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	87	29	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35781	35794		10.1074/jbc.M114.586222	http://dx.doi.org/10.1074/jbc.M114.586222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378395	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000346897900010
J	Wang, L; Li, XL; Xiang, B; Zhou, M; Li, XY; Xiong, W; Niu, M; Wei, PP; Wang, ZY; Wang, HR; Chen, P; Shen, SR; Peng, SP; Li, GY				Wang, Li; Li, Xiaoling; Xiang, Bo; Zhou, Ming; Li, Xiayu; Xiong, Wei; Niu, Man; Wei, Pingpin; Wang, Zeyou; Wang, Heran; Chen, Pan; Shen, Shourong; Peng, Shuping; Li, Guiyuan			NGX6a Is Degraded through a Proteasome-dependent Pathway without Ubiquitination Mediated by Ezrin, a Cytoskeleton-Membrane Linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; HUMAN COLORECTAL-CANCER; BREAST-CANCER; COLON-CANCER; EXPRESSION; PROTEIN; PROLIFERATION; METASTASIS; MIGRATION; ADHESION	Our previous study demonstrated that the NGX6b gene acts as a suppressor in the invasion and migration of nasopharyngeal carcinoma (NPC). Recently, we identified the novel isoform NGX6a, which is longer than NGX6b. In this study, we first found that NGX6a was degraded in NPC cells and that this degradation was mediated by ezrin, a linker between membrane proteins and the cytoskeleton. Specific siRNAs against ezrin increase the protein level of NGX6a in these cells. During degradation, NGX6a is not ubiquitinated but is degraded through a proteasome-dependent pathway. The distribution pattern of ezrin was negatively associated with NGX6a in an immunochemistry analysis of a nasopharyngeal carcinoma tissue microarray and fetus multiple organ tissues and Western blot analysis in nasopharyngeal and NPC cell lines, suggesting that ezrin and NGX6a are associated and are involved in the progression and invasion of NPC. By mapping the interacting binding sites, the seven-transmembrane domain of NGX6a was found to be the critical region for the degradation of NGX6a, and the amino terminus of ezrin is required for the induction of NGX6a degradation. The knockdown of ezrin or transfection of the NGX6a mutant CO, which has an EGF-like domain and a transmembrane 1 domain, resulted in no degradation, significantly reducing the ability of invasion and migration of NPC cells. This study provides a novel molecular mechanism for the low expression of NGX6a in NPC cells and an important molecular event in the process of invasion and metastasis of nasopharyngeal carcinoma cells.	[Li, Xiaoling; Xiang, Bo; Zhou, Ming; Xiong, Wei; Chen, Pan; Peng, Shuping; Li, Guiyuan] Cent S Univ, Hunan Prov Tumor Hosp, Changsha 410013, Hunan, Peoples R China; [Li, Xiaoling; Xiang, Bo; Zhou, Ming; Xiong, Wei; Chen, Pan; Peng, Shuping; Li, Guiyuan] Cent S Univ, Xiangya Sch Med, Affiliated Tumor Hosp, Changsha 410013, Hunan, Peoples R China; [Wang, Li; Li, Xiaoling; Xiang, Bo; Zhou, Ming; Xiong, Wei; Niu, Man; Wei, Pingpin; Wang, Zeyou; Wang, Heran; Peng, Shuping; Li, Guiyuan] Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Wang, Li] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha 410012, Hunan, Peoples R China; [Li, Xiayu; Shen, Shourong] Cent S Univ, Xiang Ya Hosp 3, Changsha 410013, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University	Peng, SP (corresponding author), Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China.	shuping@csu.edu.cn; lgy@csu.edu.cn	li, xia/HHZ-7468-2022		National Natural Science Foundation of China [30971147, 81101767, 81372366, 81372907, 81171934]; New Century Excellent Talents in University of Ministry of Education of China [NCET-12-0544]; Overseas, Hong Kong, and Macao Scholars Collaborative Researching Fund of the National Natural Science Foundation of China [81428018]; Central South University Faculty Research Grant [2013JSJJ046]; 111 Project [111-2-12]; 863 Plan Grant [2012AA02A206]; Hunan Province key laboratory program of non-resolving inflammation and cancer; Specialized Research Fund for the Doctoral Program of Higher Education Grant [20110162120018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Overseas, Hong Kong, and Macao Scholars Collaborative Researching Fund of the National Natural Science Foundation of China; Central South University Faculty Research Grant; 111 Project(Ministry of Education, China - 111 Project); 863 Plan Grant; Hunan Province key laboratory program of non-resolving inflammation and cancer; Specialized Research Fund for the Doctoral Program of Higher Education Grant	This work was supported by National Natural Science Foundation of China Grants 30971147, 81101767, 81372366,81372907, and 81171934; New Century Excellent Talents in University of Ministry of Education of China Grant NCET-12-0544; the Overseas, Hong Kong, and Macao Scholars Collaborative Researching Fund of the National Natural Science Foundation of China Grant 81428018; Central South University Faculty Research Grant 2013JSJJ046; 111 Project Grant 111-2-12; 863 Plan Grant 2012AA02A206; the Hunan Province key laboratory program of non-resolving inflammation and cancer; and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20110162120018.	Bellail AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5234; BRETSCHER A, 1986, METHOD ENZYMOL, V134, P24; Bretscher A, 1997, J CELL SCI, V110, P3011; Brown L, 2014, ONCOGENE, V33, P2363, DOI 10.1038/onc.2013.186; Cannon JL, 2011, MOL BIOL CELL, V22, P954, DOI 10.1091/mbc.E10-07-0586; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Guo Q, 2010, ACTA BIOCH BIOPH SIN, V42, P450, DOI 10.1093/abbs/gmq049; Guo Q, 2009, MOL CELL BIOCHEM, V330, P71, DOI 10.1007/s11010-009-0102-9; Hoover KB, 2000, CURR OPIN CELL BIOL, V12, P229, DOI 10.1016/S0955-0674(99)00080-0; Huang YF, 2014, CELL CYCLE, V13, P2200, DOI 10.4161/cc.29209; JARIELENCONTRE I, 1995, J BIOL CHEM, V270, P11623, DOI 10.1074/jbc.270.19.11623; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kong JN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-520; Li J, 2001, J PROTEIN CHEM, V20, P265, DOI 10.1023/A:1010912311564; Liu Fen, 2005, Ai Zheng, V24, P1064; Ma J, 2005, CARCINOGENESIS, V26, P281, DOI 10.1093/carcin/bgh312; Ma J, 2002, J CANCER RES CLIN, V128, P683, DOI 10.1007/s00432-002-0387-5; Ma LF, 2013, ONCOL REP, V30, P1899, DOI 10.3892/or.2013.2641; Mao J, 2013, CELL BIOCHEM BIOPHYS, V67, P1507, DOI 10.1007/s12013-013-9653-1; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Ohtani K, 2002, CANCER LETT, V179, P79, DOI 10.1016/S0304-3835(01)00857-6; Peng SP, 2006, ONCOLOGY-BASEL, V71, P273, DOI 10.1159/000106073; Peng SP, 2007, CANCER SCI, V98, P341, DOI 10.1111/j.1349-7006.2007.00410.x; Peng Y, 2009, ACTA BIOCH BIOPH SIN, V41, P504, DOI 10.1093/abbs/gmp039; Romero IA, 2002, MOL BRAIN RES, V105, P47, DOI 10.1016/S0169-328X(02)00392-3; Shanmugaratnam K, 1991, INT HISTOLOGICAL TYP, P32; Wang L, 2010, J HISTOCHEM CYTOCHEM, V58, P41, DOI 10.1369/jhc.2009.954412; Wang LL, 2005, J CELL BIOCHEM, V95, P64, DOI 10.1002/jcb.20393; Wang XY, 2010, MOL CELL BIOCHEM, V345, P283, DOI 10.1007/s11010-010-0582-7; Wang Y, 2014, BRIT J CANCER, V110, P695, DOI 10.1038/bjc.2013.770; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang XM, 2003, WORLD J GASTROENTERO, V9, P1729, DOI 10.3748/wjg.v9.i8.1729	35	4	5	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35731	35742		10.1074/jbc.M114.584771	http://dx.doi.org/10.1074/jbc.M114.584771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378401	hybrid, Green Published			2022-12-26	WOS:000346897900006
J	Hines, CS; Ray, K; Schmidt, JJ; Xiong, F; Feenstra, RW; Pras-Raves, M; de Moes, JP; Lange, JHM; Melikishvili, M; Fried, MG; Mortenson, P; Charlton, M; Patel, Y; Courtney, SM; Kruse, CG; Rodgers, DW				Hines, Christina S.; Ray, Kallol; Schmidt, Jack J.; Xiong, Fei; Feenstra, Rolf W.; Pras-Raves, Mia; de Moes, Jan Peter; Lange, Jos H. M.; Melikishvili, Manana; Fried, Michael G.; Mortenson, Paul; Charlton, Michael; Patel, Yogendra; Courtney, Stephen M.; Kruse, Chris G.; Rodgers, David W.			Allosteric Inhibition of the Neuropeptidase Neurolysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Hydrolase; Metalloprotease; Neurochemistry; Neuropeptide; Peptidase; X-ray Crystallography	MAST-CELL DEGRANULATION; HINGE-BENDING MOTION; CRYSTAL-STRUCTURE; THIMET OLIGOPEPTIDASE; ENDOPEPTIDASE 3.4.24.16; SELECTIVE INHIBITOR; NEUROTENSIN; POTENT; THROMBIN; BINDING	Neuropeptidases specialize in the hydrolysis of the small bioactive peptides that play a variety of signaling roles in the nervous and endocrine systems. One neuropeptidase, neurolysin, helps control the levels of the dopaminergic circuit modulator neurotensin and is a member of a fold group that includes the antihypertensive target angiotensin converting enzyme. We report the discovery of a potent inhibitor that, unexpectedly, binds away from the enzyme catalytic site. The location of the bound inhibitor suggests it disrupts activity by preventing a hinge-like motion associated with substrate binding and catalysis. In support of this model, the inhibition kinetics are mixed, with both noncompetitive and competitive components, and fluorescence polarization shows directly that the inhibitor reverses a substrate-associated conformational change. This new type of inhibition may have widespread utility in targeting neuropeptidases.	[Melikishvili, Manana; Fried, Michael G.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Melikishvili, Manana; Fried, Michael G.] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA; [Feenstra, Rolf W.; Pras-Raves, Mia; de Moes, Jan Peter; Lange, Jos H. M.; Kruse, Chris G.] Abbott Healthcare Prod BV, NL-1381 CP Weesp, Netherlands; [Mortenson, Paul; Charlton, Michael; Patel, Yogendra; Courtney, Stephen M.] Evotec UK Ltd, Abingdon OX14 4SA, Oxon, England	University of Kentucky; University of Kentucky; Evotec	Rodgers, DW (corresponding author), 741 South Limestone, Lexington, KY 40536 USA.	david.rodgers@uky.edu	Mortenson, Paul N/E-2520-2011	Mortenson, Paul/0000-0002-3583-3163	National Institute of General Medical Sciences [P20 GM103486]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038041, R56NS038041] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the staffs of Advanced Photon Source beamline 19-ID (SBC) and beamline 22-ID (SER-CAT) for their help with data collection. Use of the Advanced Photon Source is supported by the United States Department of Energy. We thank Dr. Louis B. Hersh for comments on the manuscript. Use of the Protein Core of the Center for Molecular Medicine was supported by Grant P20 GM103486 from the National Institute of General Medical Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexacos N, 1999, UROLOGY, V53, P1035, DOI 10.1016/S0090-4295(98)00627-X; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Arndt JW, 2002, STRUCTURE, V10, P215, DOI 10.1016/S0969-2126(02)00698-6; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; BROOKS I, 1994, METHOD ENZYMOL, V240, P459; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Brown S, 2004, CURR TOP MED CHEM, V4, P1227, DOI 10.2174/1568026043387854; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chen JM, 2000, J AM CHEM SOC, V122, P9648, DOI 10.1021/ja001547g; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Comellas-Bigier M, 2005, J MOL BIOL, V349, P99, DOI 10.1016/j.jmb.2005.03.016; Croy CH, 2004, BIOCHEMISTRY-US, V43, P5246, DOI 10.1021/bi0499718; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERTL G, 1993, AM J PHYSIOL, V264, pH1062, DOI 10.1152/ajpheart.1993.264.4.H1062; Feenstra R. W., 2004, U. S. Patent, Patent No. [2004/0242493, 20040242493]; Fredrickson P, 2005, PSYCHIAT CLIN N AM, V28, P737, DOI 10.1016/j.psc.2005.05.001; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; HOLLAND DR, 1992, BIOCHEMISTRY-US, V31, P11310, DOI 10.1021/bi00161a008; JIRACEK J, 1995, J BIOL CHEM, V270, P21701, DOI 10.1074/jbc.270.37.21701; Jiracek J, 1996, J BIOL CHEM, V271, P19606, DOI 10.1074/jbc.271.32.19606; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kelder J, 1999, PHARMACEUT RES, V16, P1514, DOI 10.1023/A:1015040217741; Ketelhuth DFJ, 2011, CURR ATHEROSCLER REP, V13, P162, DOI 10.1007/s11883-010-0159-7; Kinkead B, 2004, INT REV NEUROBIOL, V59, P327; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Konkoy CS, 1996, TRENDS PHARMACOL SCI, V17, P288, DOI 10.1016/0165-6147(96)10036-5; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Lamm O., 1929, ARK MAT ASTR FYS, V21B, P1; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lian W, 2000, ACTA CRYSTALLOGR D, V56, P1644, DOI 10.1107/S0907444900012683; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; LUTTINGER D, 1982, BRAIN RES, V237, P183, DOI 10.1016/0006-8993(82)90566-2; Malone JF, 1997, J CHEM SOC FARADAY T, V93, P3429, DOI 10.1039/a700669a; MargetaMitrovic M, 1997, J NEUROPHYSIOL, V78, P1341, DOI 10.1152/jn.1997.78.3.1341; MATTHEWS BW, 1974, J BIOL CHEM, V249, P8030; Meier Pascal, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P15, DOI 10.2174/1568006053004994; Morales R, 2004, J MOL BIOL, V341, P1063, DOI 10.1016/j.jmb.2004.06.039; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oliveira V, 2001, ANAL BIOCHEM, V292, P257, DOI 10.1006/abio.2001.5083; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang XZ, 1998, J PHARMACOL EXP THER, V287, P307; Pytliak M, 2012, ONKOLOGIE, V35, P49, DOI 10.1159/000336304; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Ray K, 2004, J BIOL CHEM, V279, P20480, DOI 10.1074/jbc.M400795200; Reich J. G., 1992, CURVE FITTING MODELL; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; ROSTENE W, 1992, ANN NY ACAD SCI, V668, P217, DOI 10.1111/j.1749-6632.1992.tb27352.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Segel IH., 1993, ENZYME KINETICS BEHA; Sharma RP, 1997, AM J PSYCHIAT, V154, P1019; Skiles JW, 2004, CURR MED CHEM, V11, P2911, DOI 10.2174/0929867043364018; Steiner T, 2001, J MOL BIOL, V305, P535, DOI 10.1006/jmbi.2000.4301; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; VINCENT B, 1995, BRIT J PHARMACOL, V115, P1053, DOI 10.1111/j.1476-5381.1995.tb15918.x; Vincent B, 1997, BRIT J PHARMACOL, V121, P705, DOI 10.1038/sj.bjp.0701182; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wasserman ZR, 2005, CHEM BIOL, V12, P143, DOI 10.1016/j.chembiol.2005.01.008	71	16	16	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35605	35619		10.1074/jbc.M114.620930	http://dx.doi.org/10.1074/jbc.M114.620930			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378390	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000346660200047
J	Ho, ES; Kuchie, J; Duffy, S				Ho, Eric S.; Kuchie, Joan; Duffy, Siobain			Bioinformatic Analysis Reveals Genome Size Reduction and the Emergence of Tyrosine Phosphorylation Site in the Movement Protein of New World Bipartite Begomoviruses	PLOS ONE			English	Article							LEAF CURL VIRUS; MONOPARTITE BEGOMOVIRUS; MOLECULAR-BIOLOGY; TOMATO; GEMINIVIRUSES; EVOLUTION; RATES; DATAMONKEY; DISEASE; TOOLS	Begomovirus (genus Begomovirus, family Geminiviridae) infection is devastating to a wide variety of agricultural crops including tomato, squash, and cassava. Thus, understanding the replication and adaptation of begomoviruses has important translational value in alleviating substantial economic loss, particularly in developing countries. The bipartite genome of begomoviruses prevalent in the New World and their counterparts in the Old World share a high degree of genome homology except for a partially overlapping reading frame encoding the pre-coat protein (PCP, or AV2). PCP contributes to the essential functions of intercellular movement and suppression of host RNA silencing, but it is only present in the Old World viruses. In this study, we analyzed a set of non-redundant bipartite begomovirus genomes originating from the Old World (N = 28) and the New World (N = 65). Our bioinformatic analysis suggests similar to 120 nucleotides were deleted from PCP's proximal promoter region that may have contributed to its loss in the New World viruses. Consequently, genomes of the New World viruses are smaller than the Old World counterparts, possibly compensating for the loss of the intercellular movement functions of PCP. Additionally, we detected substantial purifying selection on a portion of the New World DNA-B movement protein (MP, or BC1). Further analysis of the New World MP gene revealed the emergence of a putative tyrosine phosphorylation site, which likely explains the increased purifying selection in that region. These findings provide important information about the strategies adopted by bipartite begomoviruses in adapting to new environment and suggest future in planta experiments.	[Ho, Eric S.] Lafayette Coll, Dept Biol, Easton, PA 18042 USA; [Kuchie, Joan] New Jersey City Univ, Jersey City, NJ USA; [Duffy, Siobain] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA	Lafayette College; Rutgers State University New Brunswick	Ho, ES (corresponding author), Lafayette Coll, Dept Biol, Easton, PA 18042 USA.	hoe@lafayette.edu	Duffy, Siobain/A-9104-2009	Duffy, Siobain/0000-0003-0753-223X; Ho, Eric/0000-0002-0713-9545	NIH [K12 GM093854-01]; New Jersey City University; RiSE program at Rutgers; NSF [DEB 1026095]; BMGF/DFID [OPP1052391]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093854] Funding Source: NIH RePORTER; Direct For Biological Sciences [1026095] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey City University; RiSE program at Rutgers; NSF(National Science Foundation (NSF)); BMGF/DFID; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	ESH is supported by NIH K12 GM093854-01. JK is supported by New Jersey City University and the RiSE program at Rutgers. SD is supported by NSF DEB 1026095 and BMGF/DFID OPP1052391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Modena NA, 2008, VIRUS RES, V137, P16, DOI 10.1016/j.virusres.2008.04.007; Briddon RW, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-97; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Duffy S, 2009, J GEN VIROL, V90, P1539, DOI 10.1099/vir.0.009266-0; Gilbertson RL, 2003, PLANT CELL, V15, P2578, DOI 10.1105/tpc.015057; Glick E, 2008, P NATL ACAD SCI USA, V105, P157, DOI 10.1073/pnas.0709036105; Ha C, 2008, J GEN VIROL, V89, P312, DOI 10.1099/vir.0.83236-0; King A. M. Q, 2012, VIRUS TAXONOMY; Kleinow T, 2008, VIRUS RES, V131, P86, DOI 10.1016/j.virusres.2007.08.011; Melgarejo TA, 2013, J VIROL, V87, P5397, DOI 10.1128/JVI.00234-13; Monjane AL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-252; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PADIDAM M, 1995, J GEN VIROL, V76, P249, DOI 10.1099/0022-1317-76-2-249; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Priyadarshini CGP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026929; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocha CS, 2013, J VIROL, V87, P5784, DOI 10.1128/JVI.00155-13; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Rojas MR, 2001, VIROLOGY, V291, P110, DOI 10.1006/viro.2001.1194; Rothenstein D, 2007, VIROLOGY, V359, P137, DOI 10.1016/j.virol.2006.09.014; RYBICKI EP, 1994, ARCH VIROL, V139, P49, DOI 10.1007/BF01309454; Seal SE, 2006, ADV VIRUS RES, V67, P297, DOI 10.1016/S0065-3527(06)67008-5; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Team RDC, 2012, R LANG ENV STAT COMP; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Xu XZ, 2008, J ZHEJIANG UNIV-SC B, V9, P667, DOI 10.1631/jzus.B0820005; Zhang WM, 2014, J ECON ENTOMOL, V107, P98, DOI 10.1603/EC13348	35	12	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111957	10.1371/journal.pone.0111957	http://dx.doi.org/10.1371/journal.pone.0111957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383632	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700025
J	Alves-Silva, AP; Barros, LAC; Chaul, JCM; Pompolo, SD				Alves-Silva, Ana Paula; Campos Barros, Luisa Antonia; Mario Chaul, Julio Cezar; Pompolo, Silvia das Gracas			The First Cytogenetic Data on Strumigenys louisianae Roger, 1863 (Formicidae: Myrmicinae: Dacetini): The Lowest Chromosome Number in the Hymenoptera of the Neotropical Region	PLOS ONE			English	Article							NEW-SPECIES HYMENOPTERA; KARYOTYPIC EVOLUTION; INDIAN MUNTJAC; ANT; DIVERSIFICATION; FUSIONS; GENERA; APIDAE; BANDS	In the present study, the first cytogenetic data was obtained for the ant species Strumigenys louisianae, from a genus possessing no previous cytogenetic data for the Neotropical region. The chromosome number observed was 2n = 4, all possessing metacentric morphology. Blocks rich in GC base pairs were observed in the interstitial region of the short arm of the largest chromosome pair, which may indicate that this region corresponds to the NORs. The referred species presented the lowest chromosome number observed for the subfamily Myrmicinae and for the Hymenoptera found in the Neotropical region. Observation of a low chromosome number karyotype has been described in Myrmecia croslandi, in which the occurrence of tandem fusions accounts for the most probable rearrangement for its formation. The accumulation of cytogenetic data may carry crucial information to ensure deeper understanding of the systematics of the tribe Dacetini.	[Alves-Silva, Ana Paula; Campos Barros, Luisa Antonia; Pompolo, Silvia das Gracas] Univ Fed Vicosa, Dept Biol Geral, Lab Citogenet Insetos, Vicosa, MG, Brazil; [Alves-Silva, Ana Paula; Campos Barros, Luisa Antonia] Univ Fed Vicosa, Programa Posgrad Genet & Melhoramento, Vicosa, MG, Brazil; [Mario Chaul, Julio Cezar] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Alves-Silva, AP (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Lab Citogenet Insetos, Vicosa, MG, Brazil.	anapaula-ssdd@hotmail.com	Barros, Luísa A.C./A-4106-2017		Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Pesquisa (CNPq); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Fundacao de Amparo a Pesquisa da Bahia (FAPESB) [RED0012/2012]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	The authors wish to thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Pesquisa (CNPq) for the grants provided to APAS and LACB, respectively. This study was supported by Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) and Fundacao de Amparo a Pesquisa da Bahia (FAPESB - RED0012/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azorsa F, 2008, ZOOTAXA, P27, DOI 10.11646/zootaxa.1749.1.3; de Souza ALB, 2011, ANN SOC ENTOMOL FR, V47, P510, DOI 10.1080/00379271.2011.10697742; Bolton B, 1999, J NAT HIST, V33, P1639, DOI 10.1080/002229399299798; BOLTON B, 1984, SYST ENTOMOL, V9, P373, DOI 10.1111/j.1365-3113.1984.tb00516.x; Bolton B., 2014, ANTCAT ONLINE CATALO; Bolton Barry, 2000, Memoirs of the American Entomological Institute (Gainesville), V65, P1; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brito RM, 2003, GENET MOL BIOL, V26, P53, DOI 10.1590/S1415-47572003000100009; Barros LAC, 2010, SOCIOBIOLOGY, V56, P57; Cardoso DC, 2012, COMP CYTOGENET, V6, P107, DOI 10.3897/CompCytogen.v6i2.2397; Cardoso DC, 2014, PLOS ONE, V9; CROZIER RH, 1977, ANNU REV ENTOMOL, V22, P263, DOI 10.1146/annurev.en.22.010177.001403; Fernandez F, 2004, BIOTA COLOMBIANA, V5, P3; Mariano CDF, 2008, INSECT CONSERV DIVER, V1, P161, DOI 10.1111/j.1752-4598.2008.00022.x; HIRAI H, 1994, CHROMOSOMA, V103, P171, DOI 10.1007/s004120050021; Imai H.T., 1983, ANNU REP NAT I GENET, V34, P66; IMAI HT, 1975, CHROMOSOMA, V51, P391, DOI 10.1007/BF00326325; IMAI HT, 1989, CHROMOSOMA, V98, P456, DOI 10.1007/BF00292792; IMAI HT, 1994, JPN J GENET, V69, P137, DOI 10.1266/jjg.69.137; IMAI HT, 1988, JPN J GENET, V63, P159, DOI 10.1266/jjg.63.159; IMAI HT, 1991, JPN J GENET, V66, P635, DOI 10.1266/jjg.66.635; IMAI HT, 1977, CHROMOSOMA, V59, P341, DOI 10.1007/BF00327974; Imai HT, 2001, J THEOR BIOL, V210, P475, DOI 10.1006/jtbi.2001.2327; Imai HT, 1985, ANN REP NATL I GENET, V35, P46; LEE C, 1993, CYTOGENET CELL GENET, V63, P156, DOI 10.1159/000133525; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; LIN CC, 1991, CHROMOSOMA, V101, P19, DOI 10.1007/BF00360682; Longino JT, 2013, ZOOTAXA, V3616, P301, DOI 10.11646/zootaxa.3616.4.1; Longino John T., 2006, Myrmecologische Nachrichten, V8, P131; Lopes DM, 2008, GENET MOL BIOL, V31, P49, DOI 10.1590/S1415-47572008000100010; Lorite P, 1997, HEREDITY, V78, P578, DOI 10.1038/hdy.1997.96; Lorite P, 2010, MYRMECOL NEWS, V13, P89; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Murakami Takahiro, 1998, Chromosome Science, V2, P135; Galvis JP, 2009, REV COLOMB ENTOMOL, V35, P245; Rocha MP, 2002, HEREDITAS, V136, P19, DOI 10.1034/j.1601-5223.2002.1360104.x; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; Sosa-Calvo J, 2010, J HYMENOPT RES, V19, P12; TAYLOR RW, 1991, J AUST ENTOMOL SOC, V30, P288; Urbani Cesare Baroni, 2007, Annali del Museo Civico di Storia Naturale Giacomo Doria, V99, P1; Urbani Cesare Baroni, 1994, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V198, P1; WURSTER DH, 1970, SCIENCE, V168, P1364, DOI 10.1126/science.168.3937.1364	42	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111706	10.1371/journal.pone.0111706	http://dx.doi.org/10.1371/journal.pone.0111706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379715	gold, Green Published, Green Submitted			2022-12-26	WOS:000344863100038
J	Cano, I; Selivanov, V; Gomez-Cabrero, D; Tegner, J; Roca, J; Wagner, PD; Cascante, M				Cano, Isaac; Selivanov, Vitaly; Gomez-Cabrero, David; Tegner, Jesper; Roca, Josep; Wagner, Peter D.; Cascante, Marta			Oxygen Pathway Modeling Estimates High Reactive Oxygen Species Production above the Highest Permanent Human Habitation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; SIMULATED ALTITUDE; O-2 TRANSPORT; COPD PATIENTS; MUSCLE; EXERCISE; BLOOD; VENTILATION	The production of reactive oxygen species (ROS) from the inner mitochondrial membrane is one of many fundamental processes governing the balance between health and disease. It is well known that ROS are necessary signaling molecules in gene expression, yet when expressed at high levels, ROS may cause oxidative stress and cell damage. Both hypoxia and hyperoxia may alter ROS production by changing mitochondrial Po-2 (PmO2). Because PmO2 depends on the balance between O-2 transport and utilization, we formulated an integrative mathematical model of O-2 transport and utilization in skeletal muscle to predict conditions to cause abnormally high ROS generation. Simulations using data from healthy subjects during maximal exercise at sea level reveal little mitochondrial ROS production. However, altitude triggers high mitochondrial ROS production in muscle regions with high metabolic capacity but limited O-2 delivery. This altitude roughly coincides with the highest location of permanent human habitation. Above 25,000 ft., more than 90% of exercising muscle is predicted to produce abnormally high levels of ROS, corresponding to the "death zone'' in mountaineering.	[Cano, Isaac; Roca, Josep] Hosp Clin Barcelona, Ctr Resp Diagnoses, Barcelona, Catalonia, Spain; [Cano, Isaac; Roca, Josep] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Catalonia, Spain; [Cano, Isaac; Roca, Josep] Ctr Invest Biomed Red Enfermedades Respiratoria, Barcelona, Catalonia, Spain; [Cano, Isaac; Roca, Josep] Univ Barcelona, Barcelona, Catalonia, Spain; [Selivanov, Vitaly; Cascante, Marta] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Catalonia, Spain; [Selivanov, Vitaly; Cascante, Marta] Inst Biomed IBUB, Barcelona, Catalonia, Spain; [Gomez-Cabrero, David; Tegner, Jesper] Karolinska Inst, Ctr Mol Med, Unit Computat Med, Stockholm, Sweden; [Gomez-Cabrero, David; Tegner, Jesper] Karoliska Univ Hosp, Dept Med, Stockholm, Sweden; [Wagner, Peter D.] Univ Calif San Diego, Div Physiol Pulm & Crit Care Med, San Diego, CA 92103 USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; University of Barcelona; University of Barcelona; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of California System; University of California San Diego	Cascante, M (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Catalonia, Spain.	martacascante@ub.edu	Roca, Josep/J-2583-2015; Cano, Isaac/D-1732-2019; CASCANTE, MARTA/AAG-4355-2022; tegner, jesper N/R-5095-2017; Gomez-Cabrero, David/O-9879-2019; Cano, Isaac/M-8507-2019; CASCANTE, MARTA/AFK-5991-2022	Roca, Josep/0000-0003-4768-8722; Cano, Isaac/0000-0003-2938-7459; CASCANTE, MARTA/0000-0002-2062-4633; tegner, jesper N/0000-0002-9568-5588; Gomez-Cabrero, David/0000-0003-4186-3788; Cano, Isaac/0000-0003-2938-7459; CASCANTE, MARTA/0000-0002-2062-4633; Selivanov, Vitaly/0000-0002-7937-9249	European Commission [270086 (2011-2014)]; AGAUR [2009SGR1308, 2009SGR911]; "ICREA Academia prize", Spanish Government; European Union FEDER funds [SAF2011-25726]; NIH [P01 HL091830]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091830] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); "ICREA Academia prize", Spanish Government(ICREA); European Union FEDER funds(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research has been carried out under the Synergy-COPD research grant, funded by the Seventh Frame-work Program of the European Commission as a Collaborative Project with contract no. 270086 (2011-2014), AGAUR (2009SGR1308 and 2009SGR911), "ICREA Academia prize'' (MC), Spanish Government and the European Union FEDER funds (SAF2011-25726) and NIH P01 HL091830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DM, 2004, AM J PHYSIOL-HEART C, V287, pH1689, DOI 10.1152/ajpheart.00148.2004; BALDWIN JE, 1981, NATURE, V291, P381, DOI 10.1038/291381a0; Berkelhamer SK, 2013, FREE RADICAL BIO MED, V61, P51, DOI 10.1016/j.freeradbiomed.2013.03.003; BRISCOE WA, 1959, J APPL PHYSIOL, V14, P291, DOI 10.1152/jappl.1959.14.3.291; Cano I, 2013, RESP PHYSIOL NEUROBI, V189, P477, DOI 10.1016/j.resp.2013.08.020; Cherniack NS, 2004, J APPL PHYSIOL, V96, P352, DOI 10.1152/japplphysiol.00755.2003; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dejours P., 1966, RESPIRATION, DOI DOI 10.1044/1092-4388(2007/044); Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Gore A, 2010, J IMMUNOTOXICOL, V7, P239, DOI 10.3109/1547691X.2010.492254; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Hare JM, 2004, NEW ENGL J MED, V351, P2112, DOI 10.1056/NEJMe048269; Joanny P, 2001, RESUSCITATION, V49, P307, DOI 10.1016/S0300-9572(00)00373-7; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Koch LG, 2008, J PHYSIOL-LONDON, V586, P83, DOI 10.1113/jphysiol.2007.144709; Koechlin C, 2005, THORAX, V60, P834, DOI 10.1136/thx.2004.037531; Magalhaes J, 2004, AVIAT SPACE ENVIR MD, V75, P16; Meyer A, 2013, EXP PHYSIOL, V98, P1063, DOI 10.1113/expphysiol.2012.069468; Mik EG, 2013, ANESTH ANALG, V117, P834, DOI 10.1213/ANE.0b013e31828f29da; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Powers SK, 2011, FREE RADICAL BIO MED, V51, P942, DOI 10.1016/j.freeradbiomed.2010.12.009; Puente-Maestu L, 2009, AM J RESP CELL MOL, V40, P746, DOI 10.1165/rcmb.2008-0289OC; Rabinovich RA, 2007, EUR RESPIR J, V29, P643, DOI 10.1183/09031936.00086306; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; Rodriguez DA, 2012, FREE RADICAL BIO MED, V52, P88, DOI 10.1016/j.freeradbiomed.2011.09.022; Scandurra FM, 2010, ADV EXP MED BIOL, V662, P7, DOI 10.1007/978-1-4419-1241-1_2; Schumacker Paul T, 2011, Proc Am Thorac Soc, V8, P477, DOI 10.1513/pats.201103-032MW; Selivanov VA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002700; Selivanov VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001115; Selivanov VA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000619; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Singel DJ, 2004, NATURE, V430, P297, DOI 10.1038/430297a; Sinha S, 2009, EUR J APPL PHYSIOL, V106, P807, DOI 10.1007/s00421-009-1082-x; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; Tran TK, 1999, NMR BIOMED, V12, P26, DOI 10.1002/(SICI)1099-1492(199902)12:1<26::AID-NBM563>3.0.CO;2-9; Turan N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002129; Wagner PD, 1996, ANNU REV PHYSIOL, V58, P21, DOI 10.1146/annurev.physiol.58.1.21; WAGNER PD, 1974, J CLIN INVEST, V54, P54, DOI 10.1172/JCI107750; WAGNER PD, 1987, AM REV RESPIR DIS, V136, P605, DOI 10.1164/ajrccm/136.3.605; WAGNER PD, 1993, RESP PHYSIOL, V93, P221, DOI 10.1016/0034-5687(93)90007-W; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; WEIBEL ER, 1981, RESP PHYSIOL, V44, P151, DOI 10.1016/0034-5687(81)90081-5; Weibel ER, 1984, PATHWAY OXYGEN STRUC; WELCH HG, 1982, MED SCI SPORT EXER, V14, P253, DOI 10.1249/00005768-198204000-00001; WEST JB, 1960, J APPL PHYSIOL, V15, P405, DOI 10.1152/jappl.1960.15.3.405; West JB, 2002, HIGH ALT MED BIOL, V3, P401, DOI 10.1089/15270290260512882; WILSON DF, 1977, AM J PHYSIOL, V233, pC135, DOI 10.1152/ajpcell.1977.233.5.C135; WILSON GD, 1975, MED SCI SPORT EXER, V7, P48	50	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111068	10.1371/journal.pone.0111068	http://dx.doi.org/10.1371/journal.pone.0111068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375931	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600024
J	Garin, N; Olaya, B; Moneta, MV; Miret, M; Lobo, A; Ayuso-Mateos, JL; Haro, JM				Garin, Noe; Olaya, Beatriz; Victoria Moneta, Maria; Miret, Marta; Lobo, Antonio; Luis Ayuso-Mateos, Jose; Maria Haro, Josep			Impact of Multimorbidity on Disability and Quality of Life in the Spanish Older Population	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; WORLD-HEALTH-ORGANIZATION; GENDER-DIFFERENCES; FUNCTIONAL DISABILITY; CHRONIC DISEASE; PRIMARY-CARE; ANGINA-PECTORIS; RISK-FACTORS; SYMPTOMS; COPD	Background: Population aging is closely related to high prevalence of chronic conditions in developed countries. In this context, health care policies aim to increase life span cost-effectively while maintaining quality of life and functional ability. There is still, however, a need for further understanding of how chronic conditions affect these health aspects. The aim of this paper is to assess the individual and combined impact of chronic physical and mental conditions on quality of life and disability in Spain, and secondly to show gender trends. Methods: Cross-sectional data were collected from the COURAGE study. A total of 3,625 participants over 50 years old from Spain were included. Crude and adjusted multiple linear regressions were conducted to detect associations between individual chronic conditions and disability, and between chronic conditions and quality of life. Separate models were used to assess the influence of the number of diseases on the same variables. Additional analogous regressions were performed for males and females. Results: All chronic conditions except hypertension were statistically associated with poor results in quality of life and disability. Depression, anxiety and stroke were found to have the greatest impact on outcomes. The number of chronic conditions was associated with substantially lower quality of life [beta for 4+ diseases: -18.10 (-20.95,-15.25)] and greater disability [beta for 4+ diseases: 27.64 (24.99,30.29]. In general, women suffered from higher rates of multimorbidity and poorer results in quality of life and disability. Conclusions: Chronic conditions impact greatly on quality of life and disability in the older Spanish population, especially when co-occurring diseases are added. Multimorbidity considerations should be a priority in the development of future health policies focused on quality of life and disability. Further studies would benefit from an expanded selection of diseases. Policies should also deal with gender idiosyncrasy in certain cases.	[Garin, Noe; Olaya, Beatriz; Victoria Moneta, Maria; Maria Haro, Josep] Univ Barcelona, Res Unit, Parc Sanitari St Joan de Deu, Barcelona, Spain; [Garin, Noe; Olaya, Beatriz; Maria Haro, Josep] Esplugues Llobregat, Fdn St Joan de Deu, Barcelona, Spain; [Garin, Noe; Olaya, Beatriz; Miret, Marta; Lobo, Antonio; Luis Ayuso-Mateos, Jose; Maria Haro, Josep] Ctr Invest Biomed Red Salud Mental CIBERSAM, Inst Salud Carlos III, Madrid, Spain; [Miret, Marta; Luis Ayuso-Mateos, Jose] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Miret, Marta; Luis Ayuso-Mateos, Jose] Hosp Univ Princesa, Dept Psychiat, Inst Invest Sanitaria Princesa IP, Madrid, Spain; [Lobo, Antonio] Univ Zaragoza, Dept Psychiat, Zaragoza, Spain; [Lobo, Antonio] Inst Invest Sanitaria Aragon, Zaragoza, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Autonomous University of Madrid; University of Zaragoza	Haro, JM (corresponding author), Univ Barcelona, Res Unit, Parc Sanitari St Joan de Deu, Barcelona, Spain.	jmharo@pssjd.org	Miret, Marta/C-6103-2019; Olaya, Beatriz/AAB-1952-2020; Haro, Josep Maria/D-1423-2011	Miret, Marta/0000-0003-3252-854X; Olaya, Beatriz/0000-0003-2046-3929; Haro, Josep Maria/0000-0002-3984-277X; Lobo, Antonio/0000-0002-9098-655X; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X; Garin, Noe/0000-0002-1559-9453	European Community [223071]; Spanish Ministry of Education, Culture and Sport [FPU12/05661]; Instituto de Salud Carlos III [PS09/00295, PS09/01845]; Spanish Ministry of Science and Innovation's ACIPromociona [ACI2009-1010]; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III; Instituto de Salud Carlos III, Spain [CD12/00429]	European Community(European Commission); Spanish Ministry of Education, Culture and Sport; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation's ACIPromociona(Ministry of Science and Innovation, Spain (MICINN)); Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III(Instituto de Salud Carlos III); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement number 223071 (COURAGE in Europe) and the Spanish Ministry of Education, Culture and Sport (FPU12/05661). Additional support was provided by funds from the Instituto de Salud Carlos III-FIS research grant numbers PS09/00295 and PS09/01845, from the Spanish Ministry of Science and Innovation's ACIPromociona (ACI2009-1010). The study was supported by the Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III. This article is part of a PhD program developed in the Public Health Department of the Universitat de Barcelona, Spain. B.O. is grateful to the Sara Borrell postdoctoral program (reference CD12/00429) supported by the Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre TD, 2012, ARCH GERONTOL GERIAT, V55, P431, DOI 10.1016/j.archger.2012.04.001; Alfonso Silguero Sergio A, 2014, Rev Esp Geriatr Gerontol, V49, P51, DOI 10.1016/j.regg.2013.05.007; Alves L, 2010, ARQ BRAS CARDIOL, V95, P179, DOI 10.1590/S0066-782X2010005000075; American Optometric Association, 2004, OPT CLIN PRACT GUID; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], GLOB STRAT DIAGN MAN; Assari S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-3; Barile JP, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120282; Basu S, 2013, AM J EPIDEMIOL, V178, P1620, DOI 10.1093/aje/kwt191; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Belanger A, 2002, J WOMEN AGING, V14, P61, DOI 10.1300/J074v14n01_05; Borras X, 2012, REV ESP CARDIOL, V65, P734, DOI 10.1016/j.rec.2012.03.010; Bourdel-Marchasson I, 2007, DIABETES METAB, V33, pS66, DOI 10.1016/S1262-3636(07)80058-9; Boutron I, 2008, OSTEOARTHR CARTILAGE, V16, P1024, DOI 10.1016/j.joca.2008.01.001; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; BRETTSCHNEIDER C, 2013, PLOS ONE, V0008; Chakrabarty D, 2010, Ghana Med J, V44, P150; Chen HY, 2011, PREV CHRONIC DIS, V8; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Dragomirecka E, 2008, CLIN PSYCHOL PSYCHOT, V15, P193, DOI 10.1002/cpp.571; Dumitru Luminita, 2013, Maedica (Bucur), V8, P206; Erickson SR, 2004, PHARMACOTHERAPY, V24, P344, DOI 10.1592/phco.24.4.344.33177; ETTINGER WH, 1994, J CLIN EPIDEMIOL, V47, P809, DOI 10.1016/0895-4356(94)90178-3; European Commission, 2006, DEM FUT EUR CHALL OP; European Union, 2012, HLTH POL FOR ANSW DG; Caballero FF, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-177; Formiga F, 2013, EUR J INTERN MED, V24, P40, DOI 10.1016/j.ejim.2012.11.003; Fortin M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-52; Fu JJ, 2014, RESPIRATION, V87, P63, DOI 10.1159/000352053; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084794; Global Initiative for Asthma, 2012, GLOB STRAT ASTHM MAN; Griffith L, 2010, AGE AGEING, V39, P738, DOI 10.1093/ageing/afq105; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Heyworth ITM, 2009, BRIT J GEN PRACT, V59, P833, DOI 10.3399/bjgp09X453990; Hinton R, 2002, AM FAM PHYSICIAN, V65, P841; Hunger M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-53; Hunter DJ, 2014, INT J RHEUM DIS, V17, P149, DOI 10.1111/1756-185X.12232; Jayasinghe UW, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-102; Jespersen L, 2013, EUR HEART J, V34, P3294, DOI 10.1093/eurheartj/eht395; Johansson R, 2013, PEERJ, V1, DOI 10.7717/peerj.98; Jones PW, 2011, RESP MED, V105, P57, DOI 10.1016/j.rmed.2010.09.004; Karimi Saied, 2013, Mater Sociomed, V25, P158, DOI 10.5455/msm.2013.25.158-162; Kauppi P, 2011, J ASTHMA, V48, P279, DOI 10.3109/02770903.2011.555576; Kim Il Ho, 2011, J Prev Med Public Health, V44, P32, DOI 10.3961/jpmph.2011.44.1.32; Kim Seong Il, 2006, Korean J Ophthalmol, V20, P201; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Kirchengast S, 2008, GENDER MED, V5, P270, DOI 10.1016/j.genm.2008.07.001; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Lawson KD, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-67; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Leonardi M, 2014, CLIN PSYCHOL PSYCHOT, V21, P193, DOI 10.1002/cpp.1856; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Martin LG, 2010, HEALTH AFFAIR, V29, P725, DOI 10.1377/hlthaff.2008.0746; McDaid O, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002571; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; Murtagh KN, 2004, AM J PUBLIC HEALTH, V94, P1406, DOI 10.2105/AJPH.94.8.1406; Nagl A, 2012, Z GERONTOL GERIATR, V45, P146, DOI 10.1007/s00391-011-0266-2; Nakawah MO, 2013, J AM BOARD FAM MED, V26, P470, DOI 10.3122/jabfm.2013.04.120256; Okochi J, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-55; Ose D, 2009, DIABETES CARE, V32, P1594, DOI 10.2337/dc08-2223; Ozminkowski RJ, 2012, INT J GERIATR PSYCH, V27, P948, DOI 10.1002/gps.2806; Palazzo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044994; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Rodrigues MAP, 2009, CAD SAUDE PUBLICA, V25, pS464, DOI 10.1590/S0102-311X2009001500011; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Raman R, 2010, INVEST OPHTH VIS SCI, V51, P6253, DOI 10.1167/iovs.10-5414; Regidor E, 2014, J EPIDEMIOL COMMUN H, V68, P280, DOI 10.1136/jech-2013-202944; Rosenzweig JRC, 2004, RESP MED, V98, P1157, DOI 10.1016/j.rmed.2004.04.001; Ruiz-Cantero MT, 2007, J EPIDEMIOL COMMUN H, V61, P46, DOI 10.1136/jech.2007.062034; Schmitz N, 2007, PSYCHOSOM MED, V69, P332, DOI 10.1097/PSY.0b013e31804259e0; Snider JT, 2012, COPD, V9, P513, DOI 10.3109/15412555.2012.696159; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Stein J D, 2002, J Clin Hypertens (Greenwich), V4, P181, DOI 10.1111/j.1524-6175.2002.00970.x; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Tan ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065958; Tas U, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-22; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; United Nations, 2013, WORLD POP AG 2013; United Nations, 2012, POP AG DEV 2012 WALL; Valderrama-Gama E, 2002, J GERONTOL A-BIOL, V57, pM716, DOI 10.1093/gerona/57.11.M716; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; Wang R, 2009, PUBLIC HEALTH, V123, P534, DOI 10.1016/j.puhe.2009.06.009; Watson HJ, 2011, COMPR PSYCHIAT, V52, P265, DOI 10.1016/j.comppsych.2010.07.006; Wee HL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-93; WHO, 2007, GLOB AG FRIENDL CIT; Wong E, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-47; World Health Organization, 2011, NONCOMMUNICABLE DIS; World Health Organization, 2014, WHO DIS; World Health Organization, 2014, WHO PROC TRANSL AD I; Yount KM, 2010, SOC SCI MED, V71, P1418, DOI 10.1016/j.socscimed.2010.06.046; Zygmuntowicz M, 2012, POL ARCH MED WEWN, V122, P333, DOI 10.20452/pamw.1345	96	95	97	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111498	10.1371/journal.pone.0111498	http://dx.doi.org/10.1371/journal.pone.0111498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375890	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600042
J	Gleim, ER; Conner, LM; Berghaus, RD; Levin, ML; Zemtsova, GE; Yabsley, MJ				Gleim, Elizabeth R.; Conner, L. Mike; Berghaus, Roy D.; Levin, Michael L.; Zemtsova, Galina E.; Yabsley, Michael J.			The Phenology of Ticks and the Effects of Long-Term Prescribed Burning on Tick Population Dynamics in Southwestern Georgia and Northwestern Florida	PLOS ONE			English	Article							AMBLYOMMA-AMERICANUM ACARI; IXODES-SCAPULARIS ACARI; GULF-COAST TICK; LYME-DISEASE; MACULATUM ACARI; CLIMATE-CHANGE; HABITAT TYPE; FIRE; ABUNDANCE; IXODIDAE	Some tick populations have increased dramatically in the past several decades leading to an increase in the incidence and emergence of tick-borne diseases. Management strategies that can effectively reduce tick populations while better understanding regional tick phenology is needed. One promising management strategy is prescribed burning. However, the efficacy of prescribed burning as a mechanism for tick control is unclear because past studies have provided conflicting data, likely due to a failure of some studies to simulate operational management scenarios and/or account for other predictors of tick abundance. Therefore, our study was conducted to increase knowledge of tick population dynamics relative to long-term prescribed fire management. Furthermore, we targeted a region, southwestern Georgia and northwestern Florida (USA), in which little is known regarding tick dynamics so that basic phenology could be determined. Twenty-one plots with varying burn regimes (burned surrounded by burned [BB], burned surrounded by unburned [BUB], unburned surrounded by burned [UBB], and unburned surrounded by unburned [UBUB]) were sampled monthly for two years while simultaneously collecting data on variables that can affect tick abundance (e.g., host abundance, vegetation structure, and micro- and macro-climatic conditions). In total, 47,185 ticks were collected, of which, 99% were Amblyomma americanum, 0.7% were Ixodes scapularis, and fewer numbers of Amblyomma maculatum, Ixodes brunneus, and Dermacentor variabilis. Monthly seasonality trends were similar between 2010 and 2011. Long-term prescribed burning consistently and significantly reduced tick counts (overall and specifically for A. americanum and I. scapularis) regardless of the burn regimes and variables evaluated. Tick species composition varied according to burn regime with A. americanum dominating at UBUB, A. maculatum at BB, I. scapularis at UBB, and a more even composition at BUB. These data indicate that regular prescribed burning is an effective tool for reducing tick populations and ultimately may reduce risk of tick-borne disease.	[Gleim, Elizabeth R.; Yabsley, Michael J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Gleim, Elizabeth R.; Yabsley, Michael J.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Gleim, Elizabeth R.; Conner, L. Mike] Joseph W Jones Ecol Res Ctr Ichauway, Wildlife Lab, Newton, GA USA; [Berghaus, Roy D.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Athens, GA 30602 USA; [Levin, Michael L.; Zemtsova, Galina E.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA	Gleim, ER (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	egleim@gmail.com	Berghaus, Roy/GPX-7566-2022	Berghaus, Roy/0000-0002-8813-3056; Yabsley, Michael/0000-0003-2452-5015; Gleim, Elizabeth/0000-0001-9380-4689	Centers for Disease Control and Prevention/University of Georgia (UGA) [8212]; Joseph W. Jones Ecological Research Center at Ichauway; Warnell School of Forestry and Natural Resources (UGA); Southeastern Cooperative Wildlife Disease Study (SCWDS) (UGA)	Centers for Disease Control and Prevention/University of Georgia (UGA); Joseph W. Jones Ecological Research Center at Ichauway; Warnell School of Forestry and Natural Resources (UGA); Southeastern Cooperative Wildlife Disease Study (SCWDS) (UGA)	This work was funded by the Centers for Disease Control and Prevention/University of Georgia (UGA) collaborative grant, (http://www.cdc.gov/od/science/technology/innovation/seeds.htm) (8212, Ecosystem Health and Human Health: Understanding the Ecological Effects of Prescribed Fire Regimes on the Distribution and Population Dynamics of Tick-borne Zoonoses, MJY, ERG, LMC, and MLL). Additional funding was provided by the Joseph W. Jones Ecological Research Center at Ichauway, Warnell School of Forestry and Natural Resources (UGA), and the Southeastern Cooperative Wildlife Disease Study (SCWDS) (UGA) through the Federal Aid to Wildlife Restoration Act (50 Stat. 917) and through SCWDS sponsorship from fish and wildlife agencies of member states. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Allan BF, 2009, J MED ENTOMOL, V46, P1030, DOI 10.1603/033.046.0509; Apperson CS, 2008, VECTOR-BORNE ZOONOT, V8, P597, DOI 10.1089/vbz.2007.0271; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Bailey JK, 2002, ECOLOGY, V83, P1701, DOI 10.1890/0012-9658(2002)083[1701:IAFAAE]2.0.CO;2; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Barker RW, 2004, J MED ENTOMOL, V41, P170, DOI 10.1603/0022-2585-41.2.170; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Cilek JE, 2000, J MED ENTOMOL, V37, P439, DOI 10.1603/0022-2585(2000)037[0439:SDAAOT]2.0.CO;2; Cooley R. A., 1944, JOUR PARASITOL, V30, P77, DOI 10.2307/3272571; Cully JF, 1999, J RANGE MANAGE, V52, P139, DOI 10.2307/4003507; DANIELS TJ, 1995, J MED ENTOMOL, V32, P5, DOI 10.1093/jmedent/32.1.5; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; DAVIDSON WR, 1994, J MED ENTOMOL, V31, P72, DOI 10.1093/jmedent/31.1.72; DREW ML, 1985, J WILDLIFE DIS, V21, P313, DOI 10.7589/0090-3558-21.3.313; Fernandes PM, 2003, INT J WILDLAND FIRE, V12, P117, DOI 10.1071/WF02042; Frater H., 2011, THESIS IOWA STATE U; Gleim ER, 2013, J MED ENTOMOL, V50, P270, DOI 10.1603/ME12168; Goddard J, 2005, J MED ENTOMOL, V42, P176, DOI 10.1603/0022-2585(2005)042[0176:OODASA]2.0.CO;2; Goodin DG, 2006, GLOBAL ECOL BIOGEOGR, V15, P519, DOI 10.1111/j.1466-822x.2006.00244.x; Haines Terry K., 2001, Southern Journal of Applied Forestry, V25, P149; HOBBS NT, 1984, J WILDLIFE MANAGE, V48, P551, DOI 10.2307/3801188; HOCH AL, 1972, J MED ENTOMOL, V9, P446, DOI 10.1093/jmedent/9.5.446; JACOBSON HA, 1979, J WILDLIFE DIS, V15, P43, DOI 10.7589/0090-3558-15.1.43; KEIRANS JE, 1989, J MED ENTOMOL, V26, P435, DOI 10.1093/jmedent/26.5.435; Keirans JE, 1998, J MED ENTOMOL, V35, P489, DOI 10.1093/jmedent/35.4.489; Kirkman LK, 2001, AM J BOT, V88, P2119, DOI 10.2307/3558437; Knapp EE, 2005, FOREST ECOL MANAG, V208, P383, DOI 10.1016/j.foreco.2005.01.016; Landers JL, 1995, GFC84004 FLOR GAM FR; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; MAEDA K, 1987, NEW ENGL J MED, V316, P853, DOI 10.1056/NEJM198704023161406; Masters R.E., 2007, GEN TECHNICAL REPORT, P35; MATHER TN, 1993, J MED ENTOMOL, V30, P642, DOI 10.1093/jmedent/30.3.642; NEEDHAM GR, 1991, ANNU REV ENTOMOL, V36, P659, DOI 10.1146/annurev.en.36.010191.003303; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148; Oorebeek M, 2008, PARASITOL RES, V103, P871, DOI 10.1007/s00436-008-1071-8; Paddock CD, 2007, CURR TOP MICROBIOL, V315, P289; Paddock CD, 2004, CLIN INFECT DIS, V38, P805, DOI 10.1086/381894; Padgett KA, 2009, J MED ENTOMOL, V46, P1138, DOI 10.1603/033.046.0522; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; PIESMAN J, 1987, AM J EPIDEMIOL, V126, P1187, DOI 10.1093/oxfordjournals.aje.a114757; Polito VJ, 2012, THESIS OKLAHOMA STAT; REGO FC, 1991, FOREST ECOL MANAG, V41, P21, DOI 10.1016/0378-1127(91)90117-E; Schulze TL, 2001, ENVIRON ENTOMOL, V30, P568, DOI 10.1603/0046-225X-30.3.568; SEMTNER PJ, 1971, J MED ENTOMOL, V8, P329, DOI 10.1093/jmedent/8.3.329; Sparks JC, 1998, J VEG SCI, V9, P133, DOI 10.2307/3237231; Stafford KC, 1998, J MED ENTOMOL, V35, P510, DOI 10.1093/jmedent/35.4.510; StataCorp, 2009, STAT STAT SOFTW REL; Stromdahl EY, 2012, ZOONOSES PUBLIC HLTH, V59, P48, DOI 10.1111/j.1863-2378.2012.01475.x; Teel PD, 1998, J MED ENTOMOL, V35, P483, DOI 10.1093/jmedent/35.4.483; Thomas RJ, 2009, EXPERT REV ANTI-INFE, V7, P709, DOI [10.1586/eri.09.44, 10.1586/ERI.09.44]; TOWNE G, 1984, J RANGE MANAGE, V37, P392, DOI 10.2307/3899622; Willis D, 2012, J VECTOR ECOL, V37, P373, DOI 10.1111/j.1948-7134.2012.00241.x; WILSON ML, 1986, J ECON ENTOMOL, V79, P693, DOI 10.1093/jee/79.3.693; Zemtsova GE, 2014, J MED ENTOM IN PRESS	58	37	38	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112174	10.1371/journal.pone.0112174	http://dx.doi.org/10.1371/journal.pone.0112174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375797	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600112
J	Li, CX; Cai, SJ; Wang, XS; Jiang, Z				Li, Chunxiang; Cai, Sanjun; Wang, Xishan; Jiang, Zheng			Hypomethylation-Associated Up-Regulation of TCF3 Expression and Recurrence in Stage II and III Colorectal Cancer	PLOS ONE			English	Article							OVARIAN ENDOMETRIOID ADENOCARCINOMAS; EPITHELIAL-MESENCHYMAL TRANSITIONS; E-CADHERIN; GENE-EXPRESSION; BETA-CATENIN; DNA-BINDING; ADJUVANT THERAPY; TUMOR-SUPPRESSOR; COLON-CANCER; TRANSCRIPTION	Background and Objectives: Transcription factor 3 (TCF3) implicates Wnt signaling pathway and regulates E-cadherin expression, which is involved in aggressiveness of tumors. This study aims to investigate the role of TCF3 in predicting prognosis of patients with stage II and III colorectal cancer (CRC). Methods: Real-Time quantitative PCR was performed in 64 fresh CRC tissues and 6 cell lines to examine TCF3 mRNA expression. TCF3 protein expression dynamics were detected by immunohistochemistry of 118 paraffin-embedded specimens, and the clinical significance of TCF3 was assessed by clinical correlation and Kaplan-Meier analyses. Aberrant hypomethylation of TCF3 promoter was also investigated using bisulfite sequencing and methylation specific PCR. Results: The up-regulation of TCF3 mRNA was frequently detected both in CRC tissues with recurrence and metastasis-derived cell lines. The expression level of TCF3 protein was significantly correlated with histological type (P = 0.038) and disease-free survival time (P = 0.002). Higher TCF3 expression indicated poor prognostic outcomes (P<0.05, log-rank test). Multivariate analysis also showed strong TCF3 protein expression and perineural invasion were independent adverse prognosticators in CRC (P = 0.010, 0.000). Moreover, it was showed that promoter hypomethylation of TCF3 is associated with its up-expression. Conclusions: This study highlighted the prognostic value of TCF3 in stage II and III CRC. The up-regulation of TCF3, which is mainly caused by promoter hypomethylation, is one of the molecular mechanisms involved in the development and progression of CRC.	[Li, Chunxiang] Harbin Med Univ, Med Genet Lab, Harbin, Heilongjiang, Peoples R China; [Cai, Sanjun] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200433, Peoples R China; [Wang, Xishan; Jiang, Zheng] Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Canc Surg, Harbin, Peoples R China; [Wang, Xishan; Jiang, Zheng] Heilongjiang Acad Med Sci, Colorectal Canc Inst, Harbin, Peoples R China	Harbin Medical University; Fudan University; Harbin Medical University	Wang, XS (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Canc Surg, Harbin, Peoples R China.	wxshan1208@126.com; dr.jiangzheng@gmail.com			Postdoctoral Science Foundation of Heilongjiang Province [LRB87859]; Medical Scientific Research Foundation of Heilongjiang Province [2011-144]; Key Laboratory of Medical Genetics of Heilongjiang Higher Education Institutions; Natural Science Foundation of Heilongjiang Province [H201332]	Postdoctoral Science Foundation of Heilongjiang Province(China Postdoctoral Science Foundation); Medical Scientific Research Foundation of Heilongjiang Province; Key Laboratory of Medical Genetics of Heilongjiang Higher Education Institutions; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This study was supported by Postdoctoral Science Foundation of Heilongjiang Province (LRB87859), Medical Scientific Research Foundation of Heilongjiang Province (2011-144), The Opening Project of Key Laboratory of Medical Genetics of Heilongjiang Higher Education Institutions and Natural Science Foundation of Heilongjiang Province (H201332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Oliver JA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-511; Asirvatharn AJ, 2007, PROSTATE, V67, P1411, DOI 10.1002/pros.20633; BECKER KF, 1994, CANCER RES, V54, P3845; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; CHAKRABORTY T, 1991, MOL CELL BIOL, V11, P3633, DOI 10.1128/MCB.11.7.3633; Chatla Chakrapani, 2005, Cancer Biomarkers, V1, P241; Cserni G, 2003, J CLIN PATHOL, V56, P327, DOI 10.1136/jcp.56.5.327; Fukuyama R, 2008, ONCOGENE, V27, P6044, DOI 10.1038/onc.2008.204; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Hata F, 2004, J EXP CLIN CANC RES, V23, P513; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Jiang Z, 2011, HUM PATHOL, V42, P361, DOI 10.1016/j.humpath.2010.03.009; Kijanka G, 2010, GUT, V59, P69, DOI 10.1136/gut.2009.178574; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Laux H, 2004, LAB INVEST, V84, P1372, DOI 10.1038/labinvest.3700158; Macdonald JS, 1999, CA-CANCER J CLIN, V49, P202, DOI 10.3322/canjclin.49.4.202; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Mareel M, 1997, J CELL PHYSIOL, V173, P271, DOI 10.1002/(SICI)1097-4652(199711)173:2<271::AID-JCP34>3.0.CO;2-G; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Patel D, 2012, BIOCHEM BIOPH RES CO, V422, P146, DOI 10.1016/j.bbrc.2012.04.126; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Sagara N, 2000, CANCER RES, V60, P5959; Schwartz DR, 2003, CANCER RES, V63, P2913; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Zhai Y, 2002, AM J PATHOL, V160, P1229, DOI 10.1016/S0002-9440(10)62550-3; Zhao HC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-317	36	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112005	10.1371/journal.pone.0112005	http://dx.doi.org/10.1371/journal.pone.0112005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375219	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600091
J	Zhu, D; Li, RT; Liu, X; Sun, MZ; Wu, J; Zhang, N; Zhu, YM				Zhu, Dan; Li, Rongtian; Liu, Xin; Sun, Mingzhe; Wu, Jing; Zhang, Ning; Zhu, Yanming			The Positive Regulatory Roles of the TIFY10 Proteins in Plant Responses to Alkaline Stress	PLOS ONE			English	Article							BHLH TRANSCRIPTION FACTORS; INDUCED GENE-EXPRESSION; NADP-MALIC ENZYME; GLYCINE-SOJA; JASMONATE; JAZ; TOLERANCE; SALT; REPRESSOR; ZIM	The TIFY family is a novel plant-specific protein family, and is characterized by a conserved TIFY motif ( TIFF/YXG). Our previous studies indicated the potential roles of TIFY10/11 proteins in plant responses to alkaline stress. In the current study, we focused on the regulatory roles and possible physiological and molecular basis of the TIFY10 proteins in plant responses to alkaline stress. We demonstrated the positive function of TIFY10s in alkaline responses by using the AtTIFY10a and AtTIFY10b knockout Arabidopsis, as evidenced by the relatively lower germination rates of attify10a and attify10b mutant seeds under alkaline stress. We also revealed that ectopic expression of GsTIFY10a in Medicago sativa promoted plant growth, and increased the NADP-ME activity, citric acid content and free proline content but decreased the MDA content of transgenic plants under alkaline stress. Furthermore, expression levels of the stress responsive genes including NADP-ME, CS, H+-ppase and P5CS were also up-regulated in GsTIFY10a transgenic plants under alkaline stress. Interestingly, GsTIFY10a overexpression increased the jasmonate content of the transgenic alfalfa. In addition, we showed that neither GsTIFY10a nor GsTIFY10e exhibited transcriptional activity in yeast cells. However, through Y2H and BiFc assays, we demonstrated that GsTIFY10a, not GsTIFY10e, could form homodimers in yeast cells and in living plant cells. As expected, we also demonstrated that GsTIFY10a and GsTIFY10e could heterodimerize with each other in both yeast and plant cells. Taken together, our results provided direct evidence supporting the positive regulatory roles of the TIFY10 proteins in plant responses to alkaline stress.	[Zhu, Dan; Liu, Xin] Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China; [Li, Rongtian] Heilongjiang Univ, Coll Heilongjiang Prov, Key Lab Mol Biol, Harbin, Peoples R China; [Sun, Mingzhe; Wu, Jing; Zhang, Ning; Zhu, Yanming] Northeast Agr Univ, Plant Bioengn Lab, Harbin, Peoples R China	Qingdao Agricultural University; Heilongjiang University; Northeast Agricultural University - China	Zhu, YM (corresponding author), Northeast Agr Univ, Plant Bioengn Lab, Harbin, Peoples R China.	ymzhu@neau.edu.cn		Sun, Mingzhe/0000-0001-7557-623X; , chenchao/0000-0002-1865-7751	Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program [2011TD005]; National Natural Science Foundation of China [31171578]; National Major Project for Cultivation of Transgenic Crops [2011ZX08004-002]	Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Cultivation of Transgenic Crops	This work was supported by Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program (grant no. 2011TD005 to YMZ), National Natural Science Foundation of China (grant no. 31171578 to YMZ), National Major Project for Cultivation of Transgenic Crops (grant no. 2011ZX08004-002 to YMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bai YH, 2011, GENOMICS, V98, P128, DOI 10.1016/j.ygeno.2011.05.002; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bogino P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079614; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083227; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; delaFuente JM, 1997, SCIENCE, V276, P1566, DOI 10.1126/science.276.5318.1566; Demianski AJ, 2012, MOL PLANT PATHOL, V13, P46, DOI 10.1111/j.1364-3703.2011.00727.x; EDWARDS GE, 1992, PHYTOCHEMISTRY, V31, P1845, DOI 10.1016/0031-9422(92)80322-6; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fonseca S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086182; Ge Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-153; GEER BW, 1979, BIOCHEM GENET, V17, P867, DOI 10.1007/BF00504309; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Guan QM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003755; Hakata M, 2012, BIOSCI BIOTECH BIOCH, V76, P2129, DOI 10.1271/bbb.120545; Han X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050868; Hu YR, 2013, PLANT CELL, V25, P2907, DOI 10.1105/tpc.113.112631; Ishiga Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075728; Ismail A, 2012, J EXP BOT, V63, P2127, DOI 10.1093/jxb/err426; Jiang SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003715; Li WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082725; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu JT, 2011, J GENET GENOMICS, V38, P307, DOI 10.1016/j.jgg.2011.05.006; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Niu YJ, 2011, J EXP BOT, V62, P2143, DOI 10.1093/jxb/erq408; Oh Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057868; PEEVER TL, 1989, PLANT PHYSIOL, V90, P867, DOI 10.1104/pp.90.3.867; Qi T, 2014, PLANT CELL, V26, P16; Robson F, 2010, PLANT CELL, V22, P1143, DOI 10.1105/tpc.109.067728; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; Seo JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055482; Shi YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088282; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Siberil Y, 2001, EUR J BIOCHEM, V268, P5655, DOI 10.1046/j.0014-2956.2001.02552.x; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; Song SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003653; Sun MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089578; Sun XL, 2012, J PLANT RES, V125, P429, DOI 10.1007/s10265-011-0448-4; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Toda Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26256; Toda Y, 2013, PLANT CELL, V25, P1709, DOI 10.1105/tpc.113.112052; Tong ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088310; Van der Does D, 2013, PLANT CELL, V25, P744, DOI 10.1105/tpc.112.108548; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037817; Weltmeier F, 2009, PLANT MOL BIOL, V69, P107, DOI 10.1007/s11103-008-9410-9; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Withers J, 2012, P NATL ACAD SCI USA, V109, P20148, DOI 10.1073/pnas.1210054109; Xiong HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092913; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059703; Xu WF, 2013, PLANT PHYSIOL, V163, P1817, DOI 10.1104/pp.113.224758; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Yang CW, 2008, PHOTOSYNTHETICA, V46, P107, DOI [10.1007/s11099-008-0018-8, 10.1007/s11099-008-0047-3]; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084750; Zhu D, 2013, PLANT CELL REP, V32, P263, DOI 10.1007/s00299-012-1360-7; Zhu D, 2012, BIOCHEM BIOPH RES CO, V426, P273, DOI 10.1016/j.bbrc.2012.08.086; Zhu Dan, 2012, Yichuan, V34, P230, DOI 10.3724/SP.J.1005.2012.00230; Zhu D, 2011, PLANT MOL BIOL, V77, P285, DOI 10.1007/s11103-011-9810-0	66	27	34	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111984	10.1371/journal.pone.0111984	http://dx.doi.org/10.1371/journal.pone.0111984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375909	gold, Green Submitted, Green Published			2022-12-26	WOS:000344402600087
J	Dey, N; Sinha, M; Gupta, S; Gonzalez, MN; Fang, R; Endsley, JJ; Luxon, BA; Garg, NJ				Dey, Nilay; Sinha, Mala; Gupta, Shivali; Gonzalez, Mariela Natacha; Fang, Rong; Endsley, Janice J.; Luxon, Bruce A.; Garg, Nisha Jain			Caspase-1/ASC Inflammasome-Mediated Activation of IL-1 beta-ROS-NF-kappa B Pathway for Control of Trypanosoma cruzi Replication and Survival Is Dispensable in NLRP3(-/-) Macrophages	PLOS ONE			English	Article							CUTTING EDGE; HOST-RESISTANCE; EXPRESSION; INFECTION; SECRETION; ACCOUNT; CELLS	In this study, we have utilized wild-type (WT), ASC(-/-), and NLRP3(-/-) macrophages and inhibition approaches to investigate the mechanisms of inflammasome activation and their role in Trypanosoma cruzi infection. We also probed human macrophages and analyzed published microarray datasets from human fibroblasts, and endothelial and smooth muscle cells for T. cruzi-induced changes in the expression genes included in the RT Profiler Human Inflammasome arrays. T. cruzi infection elicited a subdued and delayed activation of inflammasome-related gene expression and IL-1 beta production in m phi s in comparison to LPS-treated controls. When WT and ASC(-/-) macrophages were treated with inhibitors of caspase-1, IL-1 beta, or NADPH oxidase, we found that IL-1 beta production by caspase-1/ASC inflammasome required reactive oxygen species (ROS) as a secondary signal. Moreover, IL-1 beta regulated NF-kappa B signaling of inflammatory cytokine gene expression and, subsequently, intracellular parasite replication in macrophages. NLRP3(-/-) macrophages, despite an inability to elicit IL-1 beta activation and inflammatory cytokine gene expression, exhibited a 4-fold decline in intracellular parasites in comparison to that noted in matched WT controls. NLRP3(-/-) macrophages were not refractory to T. cruzi, and instead exhibited a very high basal level of ROS (>100-fold higher than WT controls) that was maintained after infection in an IL-1 beta-independent manner and contributed to efficient parasite killing. We conclude that caspase-1/ASC inflammasomes play a significant role in the activation of IL-1 beta/ROS and NF-kappa B signaling of cytokine gene expression for T. cruzi control in human and mouse macrophages. However, NLRP3-mediated IL-1 beta/NF kappa B activation is dispensable and compensated for by ROS-mediated control of T. cruzi replication and survival in macrophages.	[Dey, Nilay; Gupta, Shivali; Endsley, Janice J.; Garg, Nisha Jain] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Sinha, Mala; Luxon, Bruce A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Gonzalez, Mariela Natacha; Garg, Nisha Jain] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Fac Inst Human Infect & Immun, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA; [Gonzalez, Mariela Natacha] Inst Nacl Parasitol Dr Mario Fatala Chaben, Buenos Aires, DF, Argentina	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Dey, N (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	nidey@utmb.edu; nigarg@utmb.edu	Stefanadis, Christodoulos/ABH-2232-2020; Fang, Rong/ABD-6123-2020; Luxon, Bruce A/C-9140-2012	Stefanadis, Christodoulos/0000-0001-5974-6454; GONZALEZ, MARIELA NATACHA/0000-0002-7274-4282	National Institute of Allergy and Infectious Diseases (NIAID) [R01AI054578]; National Heart Lung and Blood Institute of the National Institutes of Health (NIH) [R01HL094802]; NIAID/NIH [R03AI208810]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054578] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart Lung and Blood Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases (NIAID R01AI054578) and National Heart Lung and Blood Institute (R01HL094802) of the National Institutes of Health (NIH) to NJG. ND was a recipient of a grant (R03AI208810) from NIAID/ NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Caetano BC, 2011, J IMMUNOL, V187, P1903, DOI 10.4049/jimmunol.1003911; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Coelho PS, 2002, J LEUKOCYTE BIOL, V71, P837; Costales JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-252; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Dhiman M, 2011, J PATHOL, V225, P583, DOI 10.1002/path.2975; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Foldes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010501; Garg NJ, 2011, AM J CARDIOVASC DIS, V1, P244; Goncalves VM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002469; Hirao K, 2009, J DENT RES, V88, P762, DOI 10.1177/0022034509341779; Huang H, 1999, J MOL CELL CARDIOL, V31, P75, DOI 10.1006/jmcc.1998.0848; Hwang YS, 2004, ONCOGENE, V23, P6603, DOI 10.1038/sj.onc.1207867; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kayama H, 2010, MICROBES INFECT, V12, P511, DOI 10.1016/j.micinf.2010.03.005; Liu WW, 2014, INFLAMM RES, V63, P33, DOI 10.1007/s00011-013-0667-3; Lo YYC, 1998, J CELL BIOCHEM, V69, P19, DOI 10.1002/(SICI)1097-4644(19980401)69:1<19::AID-JCB3>3.0.CO;2-Y; Machado Fabiana S, 2012, Front Biosci (Elite Ed), V4, P1743; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; Machado FS, 2008, MICROBES INFECT, V10, P1558, DOI 10.1016/j.micinf.2008.09.009; Monteiro AC, 2007, PLOS PATHOG, V3, P1730, DOI 10.1371/journal.ppat.0030185; Oliveira AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000870; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Schmitz V, 2009, J LEUKOCYTE BIOL, V85, P1005, DOI 10.1189/jlb.1108693; Schultz K, 2007, AM J PHYSIOL-HEART C, V292, pH2927, DOI 10.1152/ajpheart.00700.2006; Silva GK, 2010, J IMMUNOL, V184, P1148, DOI 10.4049/jimmunol.0902254; Silva GK, 2013, J IMMUNOL, V191, P3373, DOI 10.4049/jimmunol.1203293; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tousoulis D, 2008, ATHEROSCLEROSIS, V201, P236, DOI 10.1016/j.atherosclerosis.2008.05.034; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; Wen JJ, 2008, J BIOENERG BIOMEMBR, V40, P587, DOI 10.1007/s10863-008-9184-4; World Health Organization, 2010, CHAG DIS CONTR EL; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208	39	32	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111539	10.1371/journal.pone.0111539	http://dx.doi.org/10.1371/journal.pone.0111539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372293	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900054
J	Freese, NH; Lam, BA; Staton, M; Scott, A; Chapman, SC				Freese, Nowlan H.; Lam, Brianna A.; Staton, Meg; Scott, Allison; Chapman, Susan C.			A Novel Gain-Of-Function Mutation of the Proneural IRX1 and IRX2 Genes Disrupts Axis Elongation in the Araucana Rumpless Chicken	PLOS ONE			English	Article							RETINOIC ACID; PARAXIAL MESODERM; TAIL BUD; MOUSE EMBRYO; STEM-CELLS; TRANSCRIPTION FACTOR; NEURAL DEVELOPMENT; IROQUOIS COMPLEX; PRIMITIVE STREAK; XENOPUS HOMOLOG	Axis elongation of the vertebrate embryo involves the generation of cell lineages from posterior progenitor populations. We investigated the molecular mechanism governing axis elongation in vertebrates using the Araucana rumpless chicken. Araucana embryos exhibit a defect in axis elongation, failing to form the terminal somites and concomitant free caudal vertebrae, pygostyle, and associated tissues of the tail. Through whole genome sequencing of six Araucana we have identified a critical 130 kb region, containing two candidate causative SNPs. Both SNPs are proximal to the IRX1 and IRX2 genes, which are required for neural specification. We show that IRX1 and IRX2 are both misexpressed within the bipotential chordoneural hinge progenitor population of Araucana embryos. Expression analysis of BRA and TBX6, required for specification of mesoderm, shows that both are downregulated, whereas SOX2, required for neural patterning, is expressed in ectopic epithelial tissue. Finally, we show downregulation of genes required for the protection and maintenance of the tailbud progenitor population from the effects of retinoic acid. Our results support a model where the disruption in balance of mesoderm and neural fate results in early depletion of the progenitor population as excess neural tissue forms at the expense of mesoderm, leading to too few mesoderm cells to form the terminal somites. Together this cascade of events leads to axis truncation.	[Freese, Nowlan H.; Lam, Brianna A.; Scott, Allison; Chapman, Susan C.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Staton, Meg] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA	Clemson University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Chapman, SC (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	schapm2@clemson.edu	Chapman, Susan C/J-2688-2013	Chapman, Susan C/0000-0002-4314-9193; Staton, Margaret/0000-0003-2971-9353	National Institute on Deafness; NIFA/USDA [SC-1700374]; National Institutes of Health [R01DC009236]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009236] Funding Source: NIH RePORTER	National Institute on Deafness(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIFA/USDA(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research reported in this publication was supported by National Institute on Deafness (http://www.nidcd.nih.gov/) and other Communication Disorders of the National Institutes of Health under award number R01DC009236 to SCC. Technical Contribution No. 6247 of the Clemson University Experiment Station. This material is based upon work supported by the NIFA/USDA, under project number SC-1700374 to SCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Alvares LE, 2009, DEV DYNAM, V238, P1166, DOI 10.1002/dvdy.21950; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Bellefroid EJ, 1998, EMBO J, V17, P191, DOI 10.1093/emboj/17.1.191; Brand-Saberi B, 2000, CURR TOP DEV BIOL, V48, P1; Brott BK, 2005, DIFFERENTIATION, V73, P323, DOI 10.1111/j.1432-0436.2005.00032.x; Buchberger A, 2000, MECH DEVELOP, V97, P223, DOI 10.1016/S0925-4773(00)00424-X; Buchberger A, 1998, DEV BIOL, V199, P201, DOI 10.1006/dbio.1998.8919; Cambray N, 2002, DEVELOPMENT, V129, P4855; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; CATALA M, 1995, MECH DEVELOP, V51, P51, DOI 10.1016/0925-4773(95)00350-A; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chapman SC, 2004, DEV DYNAM, V229, P668, DOI 10.1002/dvdy.10491; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; DELCORRAL RD, 2003, NEURON, V40, P65, DOI DOI 10.1016/S0896-6273(03)00565-8; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Dunn LC, 1925, J HERED, V16, P127, DOI 10.1093/oxfordjournals.jhered.a102573; Dunn LC, 1934, J GENET, V29, P217, DOI 10.1007/BF02982198; Dunn LC, 1936, J GENET, V33, P401, DOI 10.1007/BF02982895; Diaz-Hernandez ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058549; Gluecksohn-Schoenheimer S, 1944, P NATL ACAD SCI USA, V30, P134, DOI 10.1073/pnas.30.6.134; Goldbeter A, 2007, DEV DYNAM, V236, P1495, DOI 10.1002/dvdy.21193; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Gomez-Skarmeta JL, 1998, EMBO J, V17, P181, DOI 10.1093/emboj/17.1.181; Gomez-Skarmeta JL, 2001, DEVELOPMENT, V128, P551; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Iulianella A, 1999, DEV BIOL, V205, P33, DOI 10.1006/dbio.1998.9110; Kondoh H, 2012, CURR OPIN GENET DEV, V22, P374, DOI 10.1016/j.gde.2012.03.006; LANDAUER W, 1945, GENETICS, V30, P403; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lopez-Sanchez C, 2010, CARDIOVASC RES, V88, P111, DOI 10.1093/cvr/cvq179; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; McDonald LA, 2010, J ANAT, V216, P683, DOI 10.1111/j.1469-7580.2010.01233.x; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; Miller SA, 1996, DEV DYNAM, V206, P212, DOI 10.1002/(SICI)1097-0177(199606)206:2<212::AID-AJA10>3.0.CO;2-4; MILLS CL, 1989, ANAT EMBRYOL, V180, P301, DOI 10.1007/BF00315888; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Noorai RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040974; Nowotschin S, 2012, DEV BIOL, V367, P1, DOI 10.1016/j.ydbio.2012.04.012; Ohta S, 2007, DEVELOPMENT, V134, P4315, DOI 10.1242/dev.008151; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Olivera-Martinez I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001415; Quinlan R, 2002, DEV DYNAM, V225, P54, DOI 10.1002/dvdy.10137; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Richardson MK, 1998, DEVELOPMENT, V125, P151; Rodriguez-Seguel E, 2009, DEV BIOL, V329, P258, DOI 10.1016/j.ydbio.2009.02.028; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; SCHOENWOLF GC, 1981, ANAT EMBRYOL, V162, P183, DOI 10.1007/BF00306490; SCHOENWOLF GC, 1979, ANAT RECORD, V193, P131, DOI 10.1002/ar.1091930108; Shimokita E, 2011, DEV GROWTH DIFFER, V53, P401, DOI 10.1111/j.1440-169X.2011.01260.x; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Shum ASW, 1999, MECH DEVELOP, V84, P17, DOI 10.1016/S0925-4773(99)00059-3; SOMES RG, 1981, J HERED, V72, P121, DOI 10.1093/oxfordjournals.jhered.a109439; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; Tenin G, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-24; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; Warren M, 2009, DEV DYNAM, V238, P944, DOI 10.1002/dvdy.21895; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; White PH, 2003, DEVELOPMENT, V130, P1681, DOI 10.1242/dev.00367; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wood JL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-16; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yamazaki Y, 2011, BIOTECH HISTOCHEM, V86, P351, DOI 10.3109/10520295.2010.506158; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zhao XL, 2009, GENE EXPR PATTERNS, V9, P430, DOI 10.1016/j.gep.2009.06.003; Zwilling E, 1942, GENETICS, V27, P641	88	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112364	10.1371/journal.pone.0112364	http://dx.doi.org/10.1371/journal.pone.0112364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372603	Green Submitted, gold, Green Published			2022-12-26	WOS:000344556900138
J	Muscella, A; Vetrugno, C; Calabriso, N; Cossa, LG; De Pascali, SA; Fanizzi, FP; Marsigliante, S				Muscella, Antonella; Vetrugno, Carla; Calabriso, Nadia; Cossa, Luca Giulio; De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo; Marsigliante, Santo			[Pt(O,O '-acac)(gamma-acac)(DMS)] Alters SH-SY5Y Cell Migration and Invasion by the Inhibition of Na+/H+ Exchanger Isoform 1 Occurring through a PKC-epsilon/ERK/mTOR Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; S6 KINASE; PLATINUM(II) COMPLEXES; INDEPENDENT PATHWAY; INTRACELLULAR PH; CARCINOMA CELLS; TUMOR INVASION; ACTIVATION; NHE1; GROWTH	We previously showed that [Pt(O,O'-acac)(gamma-acac)(DMS)] ([Pt(acac)(2)(DMS)]) exerted substantial cytotoxic effects in SH-SY5Y neuroblastoma cells, and decreased metalloproteases (MMPs) production and cells migration in MCF-7 breast cancer cells. The ubiquitously distributed sodium-hydrogen antiporter 1 (NHE1) is involved in motility and invasion of many solid tumours. The present study focuses on the effects of [Pt(acac)(2)(DMS)] in SH-SY5Y cell migration and also on the possibility that NHE1 may be involved in such effect. After sublethal [Pt(acac)(2)(DMS)] treatment cell migration was examined by wounding assay and cell invasion by transwell assay. NHE1 activity was measured in BCECF-loaded SH-SY5Y as the rate of Na+-dependent intracellular pH recovery in response to an acute acid pulse. Gelatin zymography for MMP-2/9 activities, Western blottings of MMPs, MAPKs, mTOR, S6 and PKCs and small interfering RNAs to PKC-epsilon/-delta mRNA were performed. Sublethal concentrations of [Pt(acac)(2)(DMS)] decreases NHE1 activity, inhibites cell migration and invasion and decreases expression and activity of MMP-2 and -9. [Pt(acac)(2)(DMS)] administered to SH-SY5Y cells provokes the increment of ROS, generated by NADPH oxidase, responsible for the PKC-epsilon and PKC-delta activation. Whilst PKC-delta activates p38/MAPK, responsible for the inhibition of MMP-2 and -9 secretion, PKC-epsilon activates a pathway made of ERK1/2, mTOR and S6K responsible for the inhibition of NHE1 activity and cell migration. In conclusion, we have shown a drastic impairment in tumour cell metastatization in response to inhibition of NHE1 and MMPs activities by [Pt(acac)(2)(DMS)] occurring through a novel mechanism mediated by PKC-delta/-epsilon activation	[Muscella, Antonella] Salento Univ, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Cell Pathol Lab, Lecce, Italy; [Vetrugno, Carla] Ist Neurol Sperimentale, Neuropathol Unit, Milan, Italy; [Vetrugno, Carla] Ist Sci IRCCS San Raffaele, Div Neurosci, Sez Lecce, Milan, Italy; [Calabriso, Nadia; Cossa, Luca Giulio; Marsigliante, Santo] Salento Univ, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Cell Physiol Lab, Lecce, Italy; [De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo] Salento Univ, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Gen & Inorgan Chem Lab, Lecce, Italy	University of Salento; University of Salento; University of Salento	Marsigliante, S (corresponding author), Salento Univ, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Cell Physiol Lab, Lecce, Italy.	santo.marsigliante@unisalento.it	Fanizzi, Francesco Paolo/K-5766-2012; Muscella, Antonella/AAE-8075-2019	Fanizzi, Francesco Paolo/0000-0003-3073-5772; Muscella, Antonella/0000-0002-2822-9929; Calabriso, Nadia/0000-0003-0726-2081; MARSIGLIANTE, Santo/0000-0001-6535-3286	Italian Ministry of Research and University (PRIN: Sintesi, caratterizzazione e studio del pathway d'induzione apoptotica di composti antitumorali di Pt per target non gnomic)	Italian Ministry of Research and University (PRIN: Sintesi, caratterizzazione e studio del pathway d'induzione apoptotica di composti antitumorali di Pt per target non gnomic)	The work presented was supported by the Italian Ministry of Research and University (PRIN 2009: 'Sintesi, caratterizzazione e studio del pathway d'induzione apoptotica di composti antitumorali di Pt per target non gnomic.') The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Beltran AR, 2008, PFLUG ARCH EUR J PHY, V455, P799, DOI 10.1007/s00424-007-0333-0; Bianchini L, 1997, J BIOL CHEM, V272, P271; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; Cheng Ya, 2005, Zhonghua Zhongliu Zazhi, V27, P164; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Cuello F, 2007, MOL PHARMACOL, V71, P799, DOI 10.1124/mol.106.029900; De Pascali SA, 2005, EUR J INORG CHEM, P788, DOI 10.1002/ejic.200400665; De Pascali SA, 2014, INORG CHIM ACTA, V412, P88, DOI 10.1016/j.ica.2013.12.018; De Pascali SA, 2009, DALTON T, P7786, DOI 10.1039/b909209a; De Pascali Sandra Angelica, 2011, Metal-Based Drugs, P763436, DOI 10.1155/2011/763436; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Friday E, 2007, CELL PHYSIOL BIOCHEM, V20, P751, DOI 10.1159/000110435; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Good DW, 2008, J BIOL CHEM, V283, P26602, DOI 10.1074/jbc.M803019200; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Kassis J, 2001, SEMIN CANCER BIOL, V11, P105, DOI 10.1006/scbi.2000.0362; Kim JS, 2013, NAT IMMUNOL, V14, P611, DOI 10.1038/ni.2607; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Lagana A, 2000, J CELL SCI, V113, P3649; Lenormand P, 1996, J BIOL CHEM, V271, P15762, DOI 10.1074/jbc.271.26.15762; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Liu TB, 2013, ENDOCRINOLOGY, V154, P865, DOI 10.1210/en.2012-1813; Marala RB, 2002, EUR J PHARMACOL, V451, P37, DOI 10.1016/S0014-2999(02)02193-3; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; Marsigliante S, 2013, J CELL PHYSIOL, V228, P1873, DOI 10.1002/jcp.24349; McHardy LM, 2004, CANCER RES, V64, P1468, DOI 10.1158/0008-5472.CAN-03-2733; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; Moor AN, 1999, J BIOL CHEM, V274, P22985, DOI 10.1074/jbc.274.33.22985; Morozevich GE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P791, DOI 10.1134/S0006297908070079; Muscella A, 2008, J CELL PHYSIOL, V217, P103, DOI 10.1002/jcp.21478; Muscella A, 2008, BRIT J PHARMACOL, V153, P34, DOI 10.1038/sj.bjp.0707576; Muscella A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.554; Muscella A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.315; Muscella A, 2007, BIOCHEM PHARMACOL, V74, P28, DOI 10.1016/j.bcp.2007.03.027; Muscella A, 2011, BIOCHEM PHARMACOL, V81, P1271, DOI 10.1016/j.bcp.2011.03.007; Muscella A, 2011, BIOCHEM PHARMACOL, V81, P91, DOI 10.1016/j.bcp.2010.09.012; Muscella A, 2010, BRIT J PHARMACOL, V160, P1362, DOI 10.1111/j.1476-5381.2010.00782.x; Oliver R, 2005, AM J PHYSIOL-RENAL, V288, pF1257, DOI 10.1152/ajprenal.00205.2004; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Petkovic F, 2013, J NEUROIMMUNOL, V259, P55, DOI 10.1016/j.jneuroim.2013.03.010; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Putney LK, 2004, BMC GENOMICS, V16, P5; Reid AC, 2004, AM J PHYSIOL-HEART C, V286, pH1448, DOI 10.1152/ajpheart.01062.2003; Reshkin SJ, 2000, J BIOL CHEM, V275, P5361, DOI 10.1074/jbc.275.8.5361; Ribatti D, 2004, ANN NY ACAD SCI, V1028, P133, DOI 10.1196/annals.1322.014; Ritter M, 1998, CONTRIB NEPHROL, V123, P135; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; SIMCHOWITZ L, 1986, J BIOL CHEM, V261, P6492; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Stock C, 2005, MIGRATION HUMAN MELA; Sugiura Y, 1998, CANCER RES, V58, P2209; Vetrugno C, 2014, BRIT J PHARMACOL, V171, P5139, DOI 10.1111/bph.12831; Watts BA, 2002, AM J PHYSIOL-RENAL, V282, pF1056, DOI 10.1152/ajprenal.00133.2001; Watts BA, 2006, AM J PHYSIOL-RENAL, V291, pF1005, DOI 10.1152/ajprenal.00507.2005; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Yamada T, 2011, NEUROCHEM INT, V58, P354, DOI 10.1016/j.neuint.2010.12.011; Yamagata M, 1996, BRIT J CANCER, V73, P1328, DOI 10.1038/bjc.1996.254; Yang XK, 2010, CANCER LETT, V295, P198, DOI 10.1016/j.canlet.2010.03.001	66	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112186	10.1371/journal.pone.0112186	http://dx.doi.org/10.1371/journal.pone.0112186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372487	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900119
J	Stenslokken, KO; Ellefsen, S; Vasieva, O; Fang, YX; Farrell, AP; Olohan, L; Vaage, J; Nilsson, GE; Cossins, AR				Stenslokken, Kare-Olav; Ellefsen, Stian; Vasieva, Olga; Fang, Yongxiang; Farrell, Anthony P.; Olohan, Lisa; Vaage, Jarle; Nilsson, Goeran E.; Cossins, Andrew R.			Life without Oxygen: Gene Regulatory Responses of the Crucian Carp (Carassius carassius) Heart Subjected to Chronic Anoxia	PLOS ONE			English	Article							HETEROLOGOUS HYBRIDIZATION; CARDIAC PROTECTION; REPERFUSION INJURY; PYRUVATE-KINASE; COMMON CARP; KAPPA-B; BRAIN; EXPRESSION; MECHANISMS; GLYCOLYSIS	Crucian carp are unusual among vertebrates in surviving extended periods in the complete absence of molecular oxygen. During this time cardiac output is maintained though these mechanisms are not well understood. Using a high-density cDNA microarray, we have defined the genome-wide gene expression responses of cardiac tissue after exposing the fish at two temperatures (8 and 13 degrees C) to one and seven days of anoxia, followed by seven days after restoration to normoxia. At 8 degrees C, using a false discovery rate of 5%, neither anoxia nor re-oxygenation elicited appreciable changes in gene expression. By contrast, at 13 degrees C, 777 unique genes responded strongly. Up-regulated genes included those involved in protein turnover, the pentose phosphate pathway and cell morphogenesis while down-regulated gene categories included RNA splicing and transcription. Most genes were affected between one and seven days of anoxia, indicating gene regulation over the medium term but with few early response genes. Re-oxygenation for 7 days was sufficient to completely reverse these responses. Glycolysis displayed more complex responses with anoxia up-regulated transcripts for the key regulatory enzymes, hexokinase and phosphofructokinase, but with down-regulation of most of the non-regulatory genes. This complex pattern of responses in genomic transcription patterns indicates divergent cardiac responses to anoxia, with the transcriptionally driven reprogramming of cardiac function seen at 13 degrees C being largely completed at 8 degrees C.	[Stenslokken, Kare-Olav; Nilsson, Goeran E.] Univ Oslo, Dept Biosci, Sect Physiol & Cell Biol, Oslo, Norway; [Stenslokken, Kare-Olav] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway; [Ellefsen, Stian] Lillehammer Univ Coll, Dept Social Sci, Sect Sports Sci, Lillehammer, Norway; [Vasieva, Olga; Fang, Yongxiang; Olohan, Lisa; Cossins, Andrew R.] Univ Liverpool, Inst Integrat Biol, Ctr Genom Res, Liverpool L69 3BX, Merseyside, England; [Fang, Yongxiang; Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Vaage, Jarle] Univ Oslo, Hosp Ulleval, Inst Clin Med, Dept Emergency Med & Intens Care, Oslo, Norway	University of Oslo; University of Oslo; Inland Norway University of Applied Sciences; University of Liverpool; University of British Columbia; University of Oslo	Stenslokken, KO (corresponding author), Univ Oslo, Dept Biosci, Sect Physiol & Cell Biol, Oslo, Norway.	k.o.stenslokken@medisin.uio.no	Nilsson, Goran E/K-7668-2012; Vaage, Jarle/H-9079-2016; Nilsson, Göran Erik/Q-6129-2019	Nilsson, Goran E/0000-0002-3195-3053; Vaage, Jarle/0000-0002-8747-5193; Cossins, Andrew/0000-0002-0813-5212; Olohan, Lisa/0000-0001-7837-0157; Stenslokken, Kare-Olav/0000-0003-2962-4143	Natural Environment Research Council (UK); Research Council of Norway; UNIFOR; Natural Environment Research Council [NE/F001320/1] Funding Source: researchfish; NERC [NE/F001320/1] Funding Source: UKRI	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Research Council of Norway(Research Council of Norway); UNIFOR; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by the following: Natural Environment Research Council (UK) (ARC); The Research Council of Norway (GEN); and UNIFOR (KOS). APF holds a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aon MA, 2006, BBA-MOL BASIS DIS, V1762, P232, DOI 10.1016/j.bbadis.2005.06.008; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Buckley BA, 2007, J EXP BIOL, V210, P1602, DOI 10.1242/jeb.002402; Chen SZ, 2013, PROTEIN CELL, V4, P251, DOI 10.1007/s13238-013-2128-8; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Depre C, 1998, EUR J BIOCHEM, V258, P277, DOI 10.1046/j.1432-1327.1998.2580277.x; Desai KM, 2010, CAN J PHYSIOL PHARM, V88, P273, DOI 10.1139/Y10-001; Ellefsen S, 2008, ANAL BIOCHEM, V376, P83, DOI 10.1016/j.ab.2008.01.028; Ellefsen S, 2009, PHYSIOL GENOMICS, V36, P61, DOI 10.1152/physiolgenomics.90301.2008; Ellefsen S, 2008, PHYSIOL GENOMICS, V35, P5, DOI 10.1152/physiolgenomics.90221.2008; Ertracht O, 2013, PHARM THER; Evans H, 2008, PHYSIOL GENOMICS, V35, P18, DOI 10.1152/physiolgenomics.90266.2008; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Farrell AP, 2007, COMP BIOCHEM PHYS A, V147, P300, DOI 10.1016/j.cbpa.2007.01.021; Fraser J, 2006, P NATL ACAD SCI USA, V103, P2977, DOI 10.1073/pnas.0508270103; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hall G, 2006, J MOL CELL CARDIOL, V41, P580, DOI 10.1016/j.yjmcc.2006.07.006; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Hausenloy DJ, 2009, BASIC RES CARDIOL, V104, P189, DOI 10.1007/s00395-009-0010-x; Hipkiss AR, 2006, ANN NY ACAD SCI, V1067, P361, DOI 10.1196/annals.1354.051; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Inagi R, 2010, ADV EXP MED BIOL, V662, P49, DOI 10.1007/978-1-4419-1241-1_6; Johansson D, 1997, NEUROSCI LETT, V237, P73, DOI 10.1016/S0304-3940(97)00814-8; JOHANSSON D, 1995, J EXP BIOL, V198, P853; Kolar F, 2004, PHYSIOL RES, V53, pS3; Krivoruchko A, 2010, GENE, V450, P63, DOI 10.1016/j.gene.2009.10.005; LOPASCHUK GD, 1991, AM J PHYSIOL, V261, pH1698, DOI 10.1152/ajpheart.1991.261.6.H1698; Lutz PL, 2004, RESP PHYSIOL NEUROBI, V141, P285, DOI 10.1016/j.resp.2004.03.013; Lutz PL, 1997, J EXP BIOL, V200, P411; Lutz PL, 2003, BRAIN OXYGEN CAUSES, Vviii; Mallet RT, 2003, MOL CELL BIOCHEM, V253, P103, DOI 10.1023/A:1026009519783; Marques IJ, 2008, J COMP PHYSIOL B, V178, P77, DOI 10.1007/s00360-007-0201-4; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nilsson GE, 2004, J EXP BIOL, V207, P3131, DOI 10.1242/jeb.00979; NILSSON GE, 1990, J EXP BIOL, V150, P295; Peltier S, 2005, MOL CELL BIOCHEM, V277, P55, DOI 10.1007/s11010-005-4882-2; Renn SCP, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-42; SHOUBRIDGE EA, 1980, SCIENCE, V209, P308, DOI 10.1126/science.7384807; SKORKOWSKI EF, 1988, COMP BIOCHEM PHYS B, V90, P19, DOI 10.1016/0305-0491(88)90031-4; Smith RW, 2009, PROTEOMICS, V9, P2217, DOI 10.1002/pmic.200800662; Southworth R, 2009, J BIOENERG BIOMEMBR, V41, P187, DOI 10.1007/s10863-009-9207-9; Stecyk JAW, 2004, SCIENCE, V306, P77, DOI 10.1126/science.1100763; Stenslokken KO, 2010, AM J PHYSIOL-REG I, V298, pR1499, DOI 10.1152/ajpregu.00675.2009; Stenslokken KO, 2008, AM J PHYSIOL-REG I, V295, pR1803, DOI 10.1152/ajpregu.90590.2008; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; VANDERBOON J, 1992, COMP BIOCHEM PHYS B, V101, P583, DOI 10.1016/0305-0491(92)90342-O; VANWAVERSVELD J, 1989, J EXP BIOL, V142, P325; VORNANEN M, 1994, CAN J ZOOL, V72, P433, DOI 10.1139/z94-061; VORNANEN M, 1994, AM J PHYSIOL-REG I, V267, pR1567, DOI 10.1152/ajpregu.1994.267.6.R1567; Vornanen M, 2006, AM J PHYSL REGULATOR, V291, pR1482; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wang XL, 2010, AM J PHYSIOL-ENDOC M, V299, pE207, DOI 10.1152/ajpendo.00215.2010; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Wit E, 2005, J R STAT SOC C-APPL, V54, P817, DOI 10.1111/j.1467-9876.2005.00519.x; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yuan JA, 2010, J EXP ZOOL PART B, V314B, P445, DOI 10.1002/jez.b.21350	63	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109978	10.1371/journal.pone.0109978	http://dx.doi.org/10.1371/journal.pone.0109978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372666	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900013
J	Yang, P; Han, JF; Huang, JL				Yang, Peng; Han, Jinfeng; Huang, Jinling			Transcriptome Sequencing and De Novo Analysis of Cytoplasmic Male Sterility and Maintenance in JA-CMS Cotton	PLOS ONE			English	Article							PROGRAMMED-CELL-DEATH; DIFFERENTIALLY EXPRESSED GENES; COMPLETE NUCLEOTIDE-SEQUENCE; RNA-SEQ DATA; MITOCHONDRIAL GENOME; OXIDATIVE STRESS; ATP SYNTHASE; ARABIDOPSIS; FERTILE; ACID	Cytoplasmic male sterility (CMS) is the failure to produce functional pollen, which is inherited maternally. And it is known that anther development is modulated through complicated interactions between nuclear and mitochondrial genes in sporophytic and gametophytic tissues. However, an unbiased transcriptome sequencing analysis of CMS in cotton is currently lacking in the literature. This study compared differentially expressed (DE) genes of floral buds at the sporogenous cells stage (SS) and microsporocyte stage (MS) (the two most important stages for pollen abortion in JA-CMS) between JA-CMS and its fertile maintainer line JB cotton plants, using the Illumina HiSeq 2000 sequencing platform. A total of 709 (1.8%) DE genes including 293 up-regulated and 416 down-regulated genes were identified in JA-CMS line comparing with its maintainer line at the SS stage, and 644 (1.6%) DE genes with 263 up-regulated and 381 down-regulated genes were detected at the MS stage. By comparing the two stages in the same material, there were 8 up-regulated and 9 down-regulated DE genes in JA-CMS line and 29 up-regulated and 9 down-regulated DE genes in JB maintainer line at the MS stage. Quantitative RT-PCR was used to validate 7 randomly selected DE genes. Bioinformatics analysis revealed that genes involved in reduction-oxidation reactions and alpha-linolenic acid metabolism were down-regulated, while genes pertaining to photosynthesis and flavonoid biosynthesis were up-regulated in JA-CMS floral buds compared with their JB counterparts at the SS and/or MS stages. All these four biological processes play important roles in reactive oxygen species (ROS) homeostasis, which may be an important factor contributing to the sterile trait of JA-CMS. Further experiments are warranted to elucidate molecular mechanisms of these genes that lead to CMS.	[Yang, Peng; Han, Jinfeng] Henan Agr Univ, Dept Agron, Zhengzhou, Henan, Peoples R China; [Yang, Peng] Shanxi Agr Univ, Dept Rural Dev, Taigu, Shanxi, Peoples R China; [Huang, Jinling] Shanxi Agr Univ, Dept Agron, Taigu, Shanxi, Peoples R China	Henan Agricultural University; Shanxi Agricultural University; Shanxi Agricultural University	Huang, JL (corresponding author), Shanxi Agr Univ, Dept Agron, Taigu, Shanxi, Peoples R China.	huangjl@sxau.edu.cn	Huang, Jinling/ABI-6699-2020		Shanxi Scientific and Technological Project [20130311004-3]; Shanxi Agricultural University Ph.D. fund	Shanxi Scientific and Technological Project; Shanxi Agricultural University Ph.D. fund	This project was supported by Shanxi Scientific and Technological Project Grant 20130311004-3 to JH and Shanxi Agricultural University Ph.D. fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Balk J, 2001, PLANT CELL, V13, P1803, DOI 10.1105/tpc.13.8.1803; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; de la Canal L, 2001, THEOR APPL GENET, V102, P1185, DOI 10.1007/s001220100558; de Leon IP, 2002, PLANT J, V29, P61, DOI 10.1046/j.1365-313x.2002.01195.x; Diamond M, 2011, ADVAN PL BIO, V1, P439; Dong X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072178; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Doyle SM, 2010, J EXP BOT, V61, P473, DOI 10.1093/jxb/erp320; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Heazlewood JL, 2003, FEBS LETT, V540, P201, DOI 10.1016/S0014-5793(03)00264-3; Hou L, 2001, DETECTION ISOLATION; Huang J, 2003, GENETIC STUDY JINA C; Jia ZC, 1990, CHINA COTTONS, V17, P11; Jiang PD, 2007, PLANT CELL REP, V26, P1627, DOI 10.1007/s00299-007-0351-6; Kempken F, 1998, FEBS LETT, V441, P159, DOI 10.1016/S0014-5793(98)01538-5; Kim DH, 2007, PLANT MOL BIOL, V63, P519, DOI 10.1007/s11103-006-9106-y; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kurek I, 1997, THEOR APPL GENET, V95, P1305, DOI 10.1007/s001220050697; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JJ, 2013, PLANTA, V237, P1097, DOI 10.1007/s00425-012-1824-6; Linke B, 2005, MITOCHONDRION, V5, P389, DOI 10.1016/j.mito.2005.10.001; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065209; Liu G, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382549; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma W, 2012, COTTON SCI, V34, P10; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Papini A, 1999, PROTOPLASMA, V207, P213, DOI 10.1007/BF01283002; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Stewart JM, 1992, PROD BELTW IDE COTTO; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Sun DZ., 2001, COTTON SCI, V13, P259; Suzuki H, 2013, PLANT CELL REP, V32, P1531, DOI 10.1007/s00299-013-1465-7; Suzuki H, 2013, THEOR APPL GENET, V126, P1521, DOI 10.1007/s00122-013-2070-4; Szklarczyk M, 2000, THEOR APPL GENET, V100, P263, DOI 10.1007/s001220050035; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wan CX, 2007, PLANT CELL REP, V26, P373, DOI 10.1007/s00299-006-0234-2; Wang F, 2010, EUPHYTICA, V172, P93, DOI 10.1007/s10681-009-0055-9; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-97; Wei Z, 1987, COTTON BREEDING BASI, P103; Wu JY, 2011, EUPHYTICA, V181, P17, DOI 10.1007/s10681-011-0357-6; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yamamoto MP, 2005, MOL GENET GENOMICS, V273, P342, DOI 10.1007/s00438-005-1140-y; Yan XH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-26; Yang S, 2008, ANN BOT-LONDON, V102, P483, DOI 10.1093/aob/mcn116; YOUNG EG, 1987, CELL, V50, P41, DOI 10.1016/0092-8674(87)90660-X; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; YUAN J, 1996, CHINA COTTON, V23, P6; Zhang H, 2007, PLANT CELL REP, V26, P1065, DOI 10.1007/s00299-006-0293-4; [赵海燕 Zhao Haiyan], 2012, [中国农业科学, Scientia Agricultura Sinica], V45, P4130; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758	63	21	26	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112320	10.1371/journal.pone.0112320	http://dx.doi.org/10.1371/journal.pone.0112320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372034	gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900133
J	Mori, Y; Akita, K; Tanida, S; Ishida, A; Toda, M; Inoue, M; Yashiro, M; Sawada, T; Hirakawa, K; Nakada, H				Mori, Yugo; Akita, Kaoru; Tanida, Shuhei; Ishida, Akiko; Toda, Munetoyo; Inoue, Mizue; Yashiro, Masakazu; Sawada, Tetsuji; Hirakawa, Kosei; Nakada, Hiroshi			MUC1 Protein Induces Urokinase-type Plasminogen Activator (uPA) by Forming a Complex with NF-kappa B p65 Transcription Factor and Binding to the uPA Promoter, Leading to Enhanced Invasiveness of Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Invasion; Mucin 1; Cell Surface Associated (MUC1); NF-B Transcription Factor; Transcription Regulation; uPA	INTERCELLULAR-ADHESION MOLECULE-1; CARCINOMA-ASSOCIATED ANTIGEN; BETA-CATENIN; ONCOPROTEIN FUNCTIONS; PROTEOLYTIC CLEAVAGE; BREAST CARCINOMAS; REGULATORY LOOP; DOWN-REGULATION; TARGET GENES; E-CADHERIN	Mucin 1 (MUC1) is overexpressed in various human malignant tumors and its expression is correlated with a poor prognosis. MUC1 engages in signal transduction by interacting with receptors for growth and differentiation factors, which contributes to the growth and survival of cancer cells. However, the mechanism by which MUC1 promotes cancer cell invasion remains unclear. Microarray analysis revealed that expression of urokinase-type plasminogen activator (uPA) was elevated in MUC1-overexpressing cells. Furthermore, up- and down-modulation of MUC1 expression was clearly correlated with the change of uPA expression. An immunochemical study showed that the distribution of uPA coincided with that of MUC1 in various human cancer tissues. The MUC1 C-terminal domain (MUC1-CD) was associated with nuclear factor-B (NF-B) p65 in MUC1-expressing cells. Chromatin immunoprecipitation (ChIP) assays demonstrated that MUC1-CD existed with NF-B p65 on the uPA promoter. Luciferase assays indicated that the uPA transcriptional activity was correlated with the level of MUC1 expression and that this MUC1-enhancing effect on the uPA transcription was abolished by introduction of mutations into the NF-B binding sites on the uPA promoter. These results indicate that formation of the MUC1-CD and NF-B p65 complex enhanced nuclear translocation of NF-B p65 and subsequent occupancy of NF-B binding region on the uPA promoter, leading to elevated transcription of uPA. We also demonstrated that uPA induced by MUC1 enhanced the matrix metalloproteinase (MMP)-2 and -9 activities, and consequently promoted cancer cell invasion. Thus, a MUC1 co-operating NF-B signaling pathway plays a critical role in cancer cell invasion in MUC1-expressing cells.	[Mori, Yugo; Akita, Kaoru; Tanida, Shuhei; Ishida, Akiko; Toda, Munetoyo; Inoue, Mizue; Nakada, Hiroshi] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 6038555, Japan; [Yashiro, Masakazu; Sawada, Tetsuji; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 5458585, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka 5458585, Japan	Kyoto Sangyo University; Osaka Metropolitan University; Osaka Metropolitan University	Nakada, H (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan.	hnakada@cc.kyoto-su.ac.jp			Private University Strategic Research Foundation Support Program	Private University Strategic Research Foundation Support Program	This work was supported by the Private University Strategic Research Foundation Support Program.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Cantero D, 1997, BRIT J CANCER, V75, P388, DOI 10.1038/bjc.1997.63; Cicek M, 2009, CLIN EXP METASTAS, V26, P229, DOI 10.1007/s10585-009-9235-1; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; GENDLER S, 1988, J BIOL CHEM, V263, P12820; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; Gond CS, 2007, INT J ONCOL, V31, P19; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He Y, 2007, CLIN CANCER RES, V13, P3115, DOI 10.1158/1078-0432.CCR-06-2088; Hemsen A, 2003, INT J CANCER, V107, P903, DOI 10.1002/ijc.11488; Hiendlmeyer E, 2004, CANCER RES, V64, P1209, DOI 10.1158/0008-5472.CAN-3627-2; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Irigoyen JP, 1999, CELL MOL LIFE SCI, V56, P104, DOI 10.1007/PL00000615; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Memarzedeh S, 2002, P NATL ACAD SCI USA, V99, P10647, DOI 10.1073/pnas.152127499; MERLO GR, 1989, CANCER RES, V49, P6966; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353, DOI 10.1016/0016-5085(94)90592-4; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; NIELSEN LS, 1986, FEBS LETT, V196, P269, DOI 10.1016/0014-5793(86)80261-7; NOVAK U, 1991, NUCLEIC ACIDS RES, V19, P3389, DOI 10.1093/nar/19.12.3389; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Qu CF, 2004, BRIT J CANCER, V91, P2086, DOI 10.1038/sj.bjc.6602232; Rahn JJ, 2004, J BIOL CHEM, V279, P29386, DOI 10.1074/jbc.C400010200; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Rajabi H, 2014, ONCOGENE, V33, P1680, DOI 10.1038/onc.2013.114; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; Sahraei M, 2012, ONCOGENE, V31, P4935, DOI 10.1038/onc.2011.651; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shen Q, 2008, MOL CANCER RES, V6, P555, DOI 10.1158/1541-7786.MCR-07-2033; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Tanida S, 2014, BBA-GEN SUBJECTS, V1840, P1790, DOI 10.1016/j.bbagen.2014.02.008; Tanida S, 2013, J BIOL CHEM, V288, P31842, DOI 10.1074/jbc.M113.471318; Toupance S, 2012, CLIN EXP METASTAS, V29, P511, DOI 10.1007/s10585-012-9467-3; Ustach CV, 2005, MOL CELL BIOL, V25, P6279, DOI 10.1128/MCB.25.14.6279-6288.2005; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; Wang Q, 2010, ONCOGENE, V29, P128, DOI 10.1038/onc.2009.302; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wesseling J, 1996, MOL BIOL CELL, V7, P565, DOI 10.1091/mbc.7.4.565; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492	54	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35193	35204		10.1074/jbc.M114.586461	http://dx.doi.org/10.1074/jbc.M114.586461			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371209	Green Published, hybrid			2022-12-26	WOS:000346660200013
J	Mehra, T; Grozinger, G; Mann, S; Guenova, E; Moos, R; Rocken, M; Claussen, CD; Dummer, R; Clasen, S; Naumann, A; Garbe, C				Mehra, Tarun; Groezinger, Gerd; Mann, Steven; Guenova, Emmanuella; Moos, Rudolf; Roecken, Martin; Claussen, Claus Detlef; Dummer, Reinhard; Clasen, Stephan; Naumann, Aline; Garbe, Claus			Primary Localization and Tumor Thickness as Prognostic Factors of Survival in Patients with Mucosal Melanoma	PLOS ONE			English	Article							POSTOPERATIVE RADIOTHERAPY; HEAD	Background: Data on survival with mucosal melanoma and on prognostic factors of are scarce. It is still unclear if the disease course allows for mucosal melanoma to be treated as primary cutaneous melanoma or if differences in overall survival patterns require adapted therapeutic approaches. Furthermore, this investigation is the first to present 10-year survival rates for mucosal melanomas of different anatomical localizations. Methodology: 116 cases from Sep 10 1984 until Feb 15 2011 retrieved from the Comprehensive Cancer Center and of the Central Register of the German Dermatologic Society databases in Tubingen were included in our analysis. We recorded anatomical location and tumor thickness, and estimated overall survival at 2, 5 and 10 years and the mean overall survival time. Survival times were analyzed with the Kaplan-Meier method. The log-rank test was used to compare survival times by localizations and by T-stages. Principal Findings: We found a median overall survival time of 80.9 months, with an overall 2-year survival of 71.7%, 5-year survival of 55.8% and 10-year survival of 38.3%. The 10-year survival rates for patients with T-1, T-2, T-3 or T-4 stage tumors were 100.0%, 77.9%, 66.3% and 10.6% respectively. 10-year survival of patients with melanomas of the vulva was 64.5% in comparison to 22.3% of patients with non-vulva mucosal melanomas. Conclusion: Survival times differed significantly between patients with melanomas of the vulva compared to the rest (p = 0.0006). It also depends on T-stage at the time of diagnosis (p<0.0001).	[Mehra, Tarun; Roecken, Martin; Garbe, Claus] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Groezinger, Gerd; Mann, Steven; Claussen, Claus Detlef; Clasen, Stephan] Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Guenova, Emmanuella; Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Mehra, Tarun; Moos, Rudolf] Univ Spital Zurich, Med Directorate, Zurich, Switzerland; [Naumann, Aline] Univ Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Eberhard Karls University of Tubingen	Mehra, T (corresponding author), Univ Tubingen, Dept Dermatol, Tubingen, Germany.	tarun.mehra@usz.ch	Guenova, Emmanuella/G-7441-2017; Garbe, Claus/ABH-2128-2021	Guenova, Emmanuella/0000-0001-5478-8735; Garbe, Claus/0000-0001-8530-780X; Rocken, Martin/0000-0003-3795-7001	Deutsche Forschungsgemeinschaft [GU1271/2-1]; Eberhard-Karls-University-Hospital of Tubingen in Germany; UniversitatsSpital Zurich, Switzerland	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Eberhard-Karls-University-Hospital of Tubingen in Germany; UniversitatsSpital Zurich, Switzerland	This work was partially supported by the Deutsche Forschungsgemeinschaft (Grant number GU1271/2-1) for EG. The Deutsche Forschungsgemeinschaft did not participate in the design or analysis of the study, nor did participate in any form in the drafting of the manuscript. The additional Funding was provided by the Eberhard-Karls-University-Hospital of Tubingen in Germany (salaries and publication costs) as well as the UniversitatsSpital Zurich, Switzerland (salaries). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bauer CGJ, 2012, DERMATOLOGY, P1885; Benlyazid A, 2010, ARCH OTOLARYNGOL, V136, P1219, DOI 10.1001/archoto.2010.217; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; GARBE C, 1995, CANCER-AM CANCER SOC, V75, P2484, DOI 10.1002/1097-0142(19950515)75:10<2484::AID-CNCR2820751014>3.0.CO;2-U; IVERSEN K, 1980, AM J SURG, V139, P660, DOI 10.1016/0002-9610(80)90358-X; Jethanamest D, 2011, ANN SURG ONCOL, V18, P2748, DOI 10.1245/s10434-011-1685-4; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim HS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-167; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Meleti M, 2008, HEAD NECK-J SCI SPEC, V30, P1543, DOI 10.1002/hed.20901; Pflugfelder A, 2013, J DTSCH DERMATOL GES, V11, P3; R Development Core Team, 2014, R LANG ENV STAT COMP; Ross M. I., 2009, CUTANEOUS MELANOMA, P337; SAS Institute Inc, 1989, JMP VERS 10 0	15	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112535	10.1371/journal.pone.0112535	http://dx.doi.org/10.1371/journal.pone.0112535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383553	Green Published, Green Accepted, gold			2022-12-26	WOS:000344816700078
J	Lan, N; Luo, GY; Yang, XQ; Cheng, YY; Zhang, Y; Wang, XY; Wang, X; Xie, T; Li, GP; Liu, ZG; Zhong, NS				Lan, Nan; Luo, Guangyan; Yang, Xiaoqiong; Cheng, Yuanyuan; Zhang, Yun; Wang, Xiaoyun; Wang, Xing; Xie, Tao; Li, Guoping; Liu, Zhigang; Zhong, Nanshan			25-Hydroxyvitamin D3-Deficiency Enhances Oxidative Stress and Corticosteroid Resistance in Severe Asthma Exacerbation	PLOS ONE			English	Article							VITAMIN-D STATUS; OBSTRUCTIVE PULMONARY-DISEASE; DNA-DAMAGE; MOLECULAR-MECHANISMS; AIRWAY INFLAMMATION; ANTIOXIDANT STATUS; EPITHELIAL-CELLS; LUNG-FUNCTION; TNF-ALPHA; CHILDREN	Oxidative stress plays a significant role in exacerbation of asthma. The role of vitamin D in oxidative stress and asthma exacerbation remains unclear. We aimed to determine the relationship between vitamin D status and oxidative stress in asthma exacerbation. Severe asthma exacerbation patients with 25-hydroxyvitamin D3-deficiency (V-D deficiency) or 25-hydroxyvitamin D-sufficiency (V-D sufficiency) were enrolled. Severe asthma exacerbation with V-D-deficiency showed lower forced expiratory volume in one second (FEV1) compared to that with V-D-sufficiency. V-D-deficiency intensified ROS release and DNA damage and increased TNF-alpha, OGG1 and NF kappa B expression and NF kappa B phosphorylation in severe asthma exacerbation. Supplemental vitamin D3 significantly increased the rates of FEV1 change and decreased ROS and DNA damage in V-D-deficiency. Vitamin D3 inhibited LPS-induced ROS and DNA damage and were associated with a decline in TNF-alpha and NF kappa B in epithelial cells. H2O2 reduces nuclear translocation of glucocorticoid receptors in airway epithelial cell lines. V-D pretreatment enhanced the dexamethasone-induced nuclear translocation of glucocorticoid receptors in airway epithelial cell lines and monocytes from 25-hydroxyvitamin D3-deficiency asthma patients. These findings indicate that V-D deficiency aggravates oxidative stress and DNA damage, suggesting a possible mechanism for corticosteroid resistance in severe asthma exacerbation.	[Lan, Nan; Yang, Xiaoqiong; Cheng, Yuanyuan; Zhang, Yun; Wang, Xiaoyun; Wang, Xing; Xie, Tao; Li, Guoping] Luzhou Med Coll, Affiliated Hosp, Inflammat & Allerg Dis Res Unit, Luzhou 646000, Sichuan, Peoples R China; [Luo, Guangyan] Luzhou Med Coll, Hyg Sect, Luzhou 646000, Sichuan, Peoples R China; [Li, Guoping; Liu, Zhigang] Shenzhen Univ, Sch Med, State Key Lab Resp Dis Allergy, Shenzhen 518060, Guangdong, Peoples R China; [Zhong, Nanshan] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou 510120, Guangdong, Peoples R China	Southwest Medical University; Southwest Medical University; Shenzhen University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Li, GP (corresponding author), Luzhou Med Coll, Affiliated Hosp, Inflammat & Allerg Dis Res Unit, Luzhou 646000, Sichuan, Peoples R China.	lzlgp@163.com; lzg195910@126.com; nanshan@vip.163.com			Chinese National Science Foundation [81170032]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	This project was supported by Chinese National Science Foundation Grant 81170032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2012, ANN THORAC MED, V7, P226, DOI 10.4103/1817-1737.102182; Asaba K, 2004, ENDOCRINOLOGY, V145, P39, DOI 10.1210/en.2003-0375; Berry DJ, 2011, BRIT J NUTR, V106, P1433, DOI 10.1017/S0007114511001991; Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019; Bozzetto S, 2012, ALLERGY, V67, P10, DOI 10.1111/j.1398-9995.2011.02711.x; Brehm JM, 2012, AM J RESP CRIT CARE, V186, P140, DOI 10.1164/rccm.201203-0431OC; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Chung KF, 2010, ANN NY ACAD SCI, V1203, P85, DOI 10.1111/j.1749-6632.2010.05600.x; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Codoner-Franch P, 2012, J PEDIATR-US, V161, P848, DOI 10.1016/j.jpeds.2012.04.046; Di Rosa M, 2012, CELL IMMUNOL, V280, P36, DOI 10.1016/j.cellimm.2012.10.009; Dunstan JA, 2006, CLIN EXP ALLERGY, V36, P993, DOI 10.1111/j.1365-2222.2006.02539.x; Fedirko V, 2010, CANCER EPIDEM BIOMAR, V19, P280, DOI 10.1158/1055-9965.EPI-09-0448; Finklea JD, 2011, ADV NUTR, V2, P244, DOI 10.3945/an.111.000398; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Gupta GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042789; Hamden K, 2009, J NUTR SCI VITAMINOL, V55, P215, DOI 10.3177/jnsv.55.215; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; He XJ, 2012, MOLECULES, V17, P3155, DOI 10.3390/molecules17033155; Huang CH, 2013, PHYTOMEDICINE, V20, P303, DOI 10.1016/j.phymed.2012.11.004; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Janssen-Heininger Y, 2005, AM J PATHOL, V166, P649, DOI 10.1016/S0002-9440(10)62286-9; Katsoulis K, 2003, J ASTHMA, V40, P847, DOI 10.1081/JAS-120023575; Knaapen AM, 2002, MOL CELL BIOCHEM, V234, P143, DOI 10.1023/A:1015997001657; Kox M, 2013, CLIN EXP IMMUNOL, V171, P231, DOI 10.1111/cei.12006; Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC; Li GP, 2012, FREE RADICAL BIO MED, V52, P392, DOI 10.1016/j.freeradbiomed.2011.10.490; Liu AH, 2002, J ALLERGY CLIN IMMUN, V109, P379, DOI 10.1067/mai.2002.122157; Marotta F, 2012, J BIOL REG HOMEOS AG, V26, P285; Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24; Milara J, 2011, CLIN EXP ALLERGY, V41, P535, DOI 10.1111/j.1365-2222.2011.03715.x; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; Okamoto T, 2004, AM J PHYSIOL-LUNG C, V286, pL198, DOI 10.1152/ajplung.00136.2003; Papiris S, 2002, CRIT CARE, V6, P30; Peden DB, 2011, IMMUNOL REV, V242, P91, DOI 10.1111/j.1600-065X.2011.01035.x; Peng XJ, 2010, J CELL BIOCHEM, V110, P1324, DOI 10.1002/jcb.22646; Renz H, 2002, EUR RESPIR J, V19, P158, DOI 10.1183/09031936.02.00254202; Rosanna D, 2012, CURR PHARM DESIGN, V18, P3889, DOI 10.2174/138161212802083716; Sevin CM, 2010, CLIN EXP ALLERGY, V40, P1142, DOI 10.1111/j.1365-2222.2010.03563.x; Shermatov K, 2012, INDIAN PEDIATR, V49, P958, DOI 10.1007/s13312-012-0250-y; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Tse SM, 2012, J ALLERGY CLIN IMMUN, V130, P53, DOI 10.1016/j.jaci.2012.04.005; Williams LK, 2011, J ALLERGY CLIN IMMUN, V128, P1185, DOI 10.1016/j.jaci.2011.09.011; Wu AC, 2012, AM J RESP CRIT CARE, V186, P508, DOI 10.1164/rccm.201202-0351OC; Zhang QL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-35; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1744, DOI 10.1016/j.jaci.2013.12.004	47	59	61	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111599	10.1371/journal.pone.0111599	http://dx.doi.org/10.1371/journal.pone.0111599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380286	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100036
J	Guo, L; Shen, SM; Harris, E; Wang, Z; Jiang, W; Guo, Y; Feng, YM				Guo, Lu; Shen, Shuming; Harris, Eleanor; Wang, Zheng; Jiang, Wei; Guo, Yu; Feng, Yuanming			A Tri-Modality Image Fusion Method for Target Delineation of Brain Tumors in Radiotherapy	PLOS ONE			English	Article							CLINICAL-EXPERIENCE; VOLUME DELINEATION; OBSERVER VARIATION; PET; CT; THERAPY; SYSTEM	Purpose: To develop a tri-modality image fusion method for better target delineation in image-guided radiotherapy for patients with brain tumors. Methods: A new method of tri-modality image fusion was developed, which can fuse and display all image sets in one panel and one operation. And a feasibility study in gross tumor volume (GTV) delineation using data from three patients with brain tumors was conducted, which included images of simulation CT, MRI, and F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG PET) examinations before radiotherapy. Tri-modality image fusion was implemented after image registrations of CT+PET and CT+MRI, and the transparency weight of each modality could be adjusted and set by users. Three radiation oncologists delineated GTVs for all patients using dual-modality (MRI/CT) and tri-modality (MRI/CT/PET) image fusion respectively. Inter-observer variation was assessed by the coefficient of variation (COV), the average distance between surface and centroid (ADSC), and the local standard deviation (SDlocal). Analysis of COV was also performed to evaluate intra-observer volume variation. Results: The inter-observer variation analysis showed that, the mean COV was 0.14(+/- 0.09) and 0.07(+/- 0.01) for dual-modality and tri-modality respectively; the standard deviation of ADSC was significantly reduced (p<0.05) with tri-modality; SDlocal averaged over median GTV surface was reduced in patient 2 (from 0.57 cm to 0.39 cm) and patient 3 (from 0.42 cm to 0.36 cm) with the new method. The intra-observer volume variation was also significantly reduced (p = 0.00) with the tri-modality method as compared with using the dual-modality method. Conclusion: With the new tri-modality image fusion method smaller inter-and intra-observer variation in GTV definition for the brain tumors can be achieved, which improves the consistency and accuracy for target delineation in individualized radiotherapy.	[Guo, Lu; Shen, Shuming; Guo, Yu; Feng, Yuanming] Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China; [Harris, Eleanor; Feng, Yuanming] E Carolina Univ, Dept Radiat Oncol, Greenville, NC USA; [Wang, Zheng; Jiang, Wei] Tianjin Huanhu Hosp, Dept Radiat Oncol, Tianjin, Peoples R China	Tianjin University; University of North Carolina; East Carolina University	Feng, YM (corresponding author), Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China.	fengyu@ecu.edu		Harris, Eleanor/0000-0002-7529-7473				Caldwell CB, 2001, INT J RADIAT ONCOL, V51, P923, DOI 10.1016/S0360-3016(01)01722-9; Chen W, 2007, J NUCL MED, V48, P1468, DOI 10.2967/jnumed.106.037689; Deurloo KEI, 2005, INT J RADIAT ONCOL, V61, P228, DOI 10.1016/j.ijrobp.2004.09.023; Dirix P, 2009, J NUCL MED, V50, P1020, DOI 10.2967/jnumed.109.062638; Goldman S, 2011, MED NUCL, V35, P347, DOI 10.1016/j.mednuc.2011.02.003; Graf R, 2013, INT J RADIAT ONCOL, V85, P68, DOI 10.1016/j.ijrobp.2012.03.021; Grosu AL, 2005, INT J RADIAT ONCOL, V63, P64, DOI 10.1016/j.ijrobp.2005.01.045; Grosu AL, 2003, INT J RADIAT ONCOL, V56, P1450, DOI 10.1016/S0360-3016(03)00279-7; Grosu AL, 2010, RADIOTHER ONCOL, V96, P325, DOI 10.1016/j.radonc.2010.08.001; Grosu AL, 2006, INT J RADIAT ONCOL, V66, P339, DOI 10.1016/j.ijrobp.2006.02.047; Levivier M, 2004, J NUCL MED, V45, P1146; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Newell ME, 1972, P ACM ANN C, V1, P443; Rogers DF, 1998, PROCEDURAL ELEMENTS, P498; Steenbakkers RJHM, 2006, INT J RADIAT ONCOL, V64, P435, DOI 10.1016/j.ijrobp.2005.06.034; Veit-Haibach P, 2013, MAGN RESON MATER PHY, V26, P25, DOI 10.1007/s10334-012-0344-5; Verellen D, 2008, RADIOTHER ONCOL, V86, P4, DOI 10.1016/j.radonc.2007.11.023	17	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112187	10.1371/journal.pone.0112187	http://dx.doi.org/10.1371/journal.pone.0112187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375123	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600115
J	Junger, J; Habel, U; Brohr, S; Neulen, J; Neuschaefer-Rube, C; Birkholz, P; Kohler, C; Schneider, F; Derntl, B; Pauly, K				Junger, Jessica; Habel, Ute; Broehr, Sabine; Neulen, Josef; Neuschaefer-Rube, Christiane; Birkholz, Peter; Kohler, Christian; Schneider, Frank; Derntl, Birgit; Pauly, Katharina			More than Just Two Sexes: The Neural Correlates of Voice Gender Perception in Gender Dysphoria	PLOS ONE			English	Article							TO-FEMALE TRANSSEXUALS; EVENT-RELATED FMRI; RESTING-STATE FMRI; IDENTITY DISORDER; HUMAN BRAIN; PSYCHIATRIC COMORBIDITY; CEREBRAL LATERALIZATION; SEXUAL-DIFFERENTIATION; PREFRONTAL CORTEX; HORMONE-TREATMENT	Gender dysphoria (also known as "transsexualism'') is characterized as a discrepancy between anatomical sex and gender identity. Research points towards neurobiological influences. Due to the sexually dimorphic characteristics of the human voice, voice gender perception provides a biologically relevant function, e. g. in the context of mating selection. There is evidence for a better recognition of voices of the opposite sex and a differentiation of the sexes in its underlying functional cerebral correlates, namely the prefrontal and middle temporal areas. This fMRI study investigated the neural correlates of voice gender perception in 32 male-to-female gender dysphoric individuals (MtFs) compared to 20 non-gender dysphoric men and 19 non-gender dysphoric women. Participants indicated the sex of 240 voice stimuli modified in semitone steps in the direction to the other gender. Compared to men and women, MtFs showed differences in a neural network including the medial prefrontal gyrus, the insula, and the precuneus when responding to male vs. female voices. With increased voice morphing men recruited more prefrontal areas compared to women and MtFs, while MtFs revealed a pattern more similar to women. On a behavioral and neuronal level, our results support the feeling of MtFs reporting they cannot identify with their assigned sex.	[Junger, Jessica; Habel, Ute; Broehr, Sabine; Schneider, Frank; Derntl, Birgit; Pauly, Katharina] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Junger, Jessica; Habel, Ute; Schneider, Frank; Derntl, Birgit; Pauly, Katharina] Julich Aachen Res Alliance Translat Brain Med, Julich, Germany; [Neulen, Josef] Rhein Westfal TH Aachen, Sch Med, Dept Gynaecol Endocrinol & Reprod Med, Aachen, Germany; [Neuschaefer-Rube, Christiane; Birkholz, Peter] Rhein Westfal TH Aachen, Sch Med, Dept Phoniatr Pedaudiol & Commun Disorders, Aachen, Germany; [Kohler, Christian] Univ Penn, Sch Med, Dept Psychiat, Div Neuropsychiat, Philadelphia, PA 19104 USA	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; University of Pennsylvania	Junger, J (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	jjunger@ukaachen.de		Neuschaefer-Rube, Christiane/0000-0002-2207-0670; Habel, Ute/0000-0003-0703-7722; Schneider, Frank/0000-0003-1557-7956; Derntl, Birgit/0000-0003-0133-4486	German Research Foundation [DFG: HA 3202/7-1, IRTG 1328]; Brain Imaging Facility of the Interdisciplinary Centre for Clinical Research of the Faculty of Medicine at RWTH Aachen University, Germany	German Research Foundation(German Research Foundation (DFG)); Brain Imaging Facility of the Interdisciplinary Centre for Clinical Research of the Faculty of Medicine at RWTH Aachen University, Germany	This study was supported by the German Research Foundation (DFG: HA 3202/7-1 and IRTG 1328) and the Brain Imaging Facility of the Interdisciplinary Centre for Clinical Research of the Faculty of Medicine at RWTH Aachen University, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorfer JB, 2012, CORTEX, V48, P1218, DOI 10.1016/j.cortex.2011.05.014; American Psychiatric Association (APA), 2013, GEND DYSPH; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Andics A, 2010, NEUROIMAGE, V52, P1528, DOI 10.1016/j.neuroimage.2010.05.048; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bao AM, 2011, FRONT NEUROENDOCRIN, V32, P214, DOI 10.1016/j.yfrne.2011.02.007; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bentz EK, 2008, FERTIL STERIL, V90, P56, DOI 10.1016/j.fertnstert.2007.05.056; Berglund H, 2008, CEREB CORTEX, V18, P1900, DOI 10.1093/cercor/bhm216; Bestelmeyer PEG, 2012, CEREB CORTEX, V22, P1263, DOI 10.1093/cercor/bhr204; Boersma P., 2010, PRAAT DOING PHONETIC; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Bullough Vern L., 1994, HUMAN SEXUALITY ENCY; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Carrillo B, 2010, PSYCHONEUROENDOCRINO, V35, P1213, DOI 10.1016/j.psyneuen.2010.02.010; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chivers ML, 2004, PSYCHOL SCI, V15, P736, DOI 10.1111/j.0956-7976.2004.00750.x; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; COHEN H, 1995, CORTEX, V31, P565, DOI 10.1016/S0010-9452(13)80067-6; Cohen-Kettenis PT, 1998, PSYCHONEUROENDOCRINO, V23, P631; Cohen-Kettenis PT, 2009, ARCH SEX BEHAV; Corsello SM, 2011, MINERVA ENDOCRINOL, V36, P325; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; Cross SE, 1997, PSYCHOL BULL, V122, P5, DOI 10.1037/0033-2909.122.1.5; D'Ausilio A, 2011, BRAIN LANG, V118, P9, DOI 10.1016/j.bandl.2011.02.007; Duncan LA, 2007, EVOL HUM BEHAV, V28, P359, DOI 10.1016/j.evolhumbehav.2007.05.001; Ellison P., 2001, FERTILE GROUND NATUR; Engelien A, 2000, ANN NY ACAD SCI, V911, P477; Feinberg DR, 2008, EVOL ANTHROPOL, V17, P112, DOI 10.1002/evan.20166; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Gaab N, 2006, NEUROIMAGE, V31, P255, DOI 10.1016/j.neuroimage.2005.11.046; Garcia-Falgueras A, 2010, ENDOCR DEV, V17, P22, DOI 10.1159/000262525; Garcia-Falgueras A, 2008, BRAIN, V131, P3132, DOI 10.1093/brain/awn276; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; Gelfer MP, 2000, J VOICE, V14, P22, DOI 10.1016/S0892-1997(00)80092-2; Gires, 2008, GEND VAR DYSPH; Gizewski ER, 2009, J SEX MED, V6, P440, DOI 10.1111/j.1743-6109.2008.00981.x; Gomez-Gil E, 2010, ARCH SEX BEHAV, V39, P546, DOI 10.1007/s10508-009-9524-4; Gooren L, 2006, HORM BEHAV, V50, P589, DOI 10.1016/j.yhbeh.2006.06.011; Gur RC, 2007, HUM BRAIN MAPP, V28, P263, DOI 10.1002/hbm.20319; Haraldsen IR, 2005, PSYCHIAT RES, V137, P161, DOI 10.1016/j.psychres.2005.05.014; Hare L, 2009, BIOL PSYCHIAT, V65, P93, DOI 10.1016/j.biopsych.2008.08.033; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hepp U, 2005, J PSYCHOSOM RES, V58, P259, DOI 10.1016/j.jpsychores.2004.08.010; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Heylens G, 2012, J SEX MED, V9, P751, DOI 10.1111/j.1743-6109.2011.02567.x; Hodges-Simeon CR, 2011, ARCH SEX BEHAV, V40, P551, DOI 10.1007/s10508-010-9625-0; Hodges-Simeon CR, 2010, HUM NATURE-INT BIOS, V21, P406, DOI 10.1007/s12110-010-9101-5; Hofmann SG, 2006, PERS INDIV DIFFER, V40, P1683, DOI 10.1016/j.paid.2005.12.014; Hoshiai M, 2010, PSYCHIAT CLIN NEUROS, V64, P514, DOI 10.1111/j.1440-1819.2010.02118.x; Hutchison ER, 2008, NEUROIMAGE, V40, P342, DOI 10.1016/j.neuroimage.2007.10.064; Hwang JH, 2006, ACTA OTO-LARYNGOL, V126, P916, DOI 10.1080/00016480500546375; Joassin F, 2011, NEUROIMAGE, V54, P1654, DOI 10.1016/j.neuroimage.2010.08.073; Joel D, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-27; Jones BC, 2008, BIOL LETTERS, V4, P192, DOI 10.1098/rsbl.2007.0626; Junger J, 2013, NEUROIMAGE, V79, P275, DOI 10.1016/j.neuroimage.2013.04.105; Koelsch S, 2005, ANN NY ACAD SCI, V1060, P412, DOI 10.1196/annals.1360.034; Kruijver FPM, 2000, J CLIN ENDOCR METAB, V85, P2034, DOI 10.1210/jc.85.5.2034; Lattner S, 2003, NEUROSCI LETT, V339, P191, DOI 10.1016/S0304-3940(03)00027-2; Lawrence AA, 2005, ARCH SEX BEHAV, V34, P135, DOI 10.1007/s10508-005-1792-z; Lehrl S., 1999, MEHRFACHWAHL WORTSCH; Lombardo F, 2013, J ENDOCRINOL INVEST; Luders E, 2011, J BEHAV BRAIN SCI; Luders E, 2009, NEUROIMAGE, V46, P904, DOI 10.1016/j.neuroimage.2009.03.048; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Miles C, 1998, HORM BEHAV, V34, P199, DOI 10.1006/hbeh.1998.1478; Miles C, 2006, HORM BEHAV, V50, P708, DOI 10.1016/j.yhbeh.2006.06.008; NARINS PM, 1976, SCIENCE, V192, P378, DOI 10.1126/science.1257772; Nawata H, 2010, PSYCHIAT CLIN NEUROS, V64, P157, DOI 10.1111/j.1440-1819.2009.02059.x; Oates J, 1997, VENEREOLOGY, V10, P178; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Poon S., 2011, P 17 INT C PHON SCI; Proverbio AM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00169; Rametti G, 2010, J PSYCHIAT RES; Rametti G, 2012, PSYCHONEUROENDOCRINO, V37, P1261, DOI 10.1016/j.psyneuen.2011.12.019; Rametti G, 2011, J PSYCHIATR RES, V45, P949, DOI 10.1016/j.jpsychires.2010.11.007; Remedios R, 2009, J NEUROSCI, V29, P1034, DOI 10.1523/JNEUROSCI.4089-08.2009; RYAN MJ, 1992, AM NAT, V139, P1370, DOI 10.1086/285391; Santarnecchi E, 2012, NEUROENDOCRINOLOGY, V96, P188, DOI 10.1159/000342001; Savic I, 2011, CEREB CORTEX, V21, P2525, DOI 10.1093/cercor/bhr032; Schneider F, 2010, TRANSSEXUELLENGESETZ, P247; Schoning S, 2010, J SEX MED, V7, P1858, DOI 10.1111/j.1743-6109.2009.01484.x; Semrud-Clikeman M, 2012, INT J NEUROSCI, V122, P590, DOI 10.3109/00207454.2012.693999; Shechner Tomer, 2010, Isr J Psychiatry Relat Sci, V47, P132; Simon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083947; Slabbekoorn D, 1999, PSYCHONEUROENDOCRINO, V24, P423, DOI 10.1016/S0306-4530(98)00091-2; Sokhi DS, 2005, NEUROIMAGE, V27, P572, DOI 10.1016/j.neuroimage.2005.04.023; Sommer IEC, 2008, EUR NEUROPSYCHOPHARM, V18, P215, DOI 10.1016/j.euroneuro.2007.10.002; Spreckelmeyer KN, 2013, NEUROIMAGE, V66, P223, DOI 10.1016/j.neuroimage.2012.10.068; Swaab DF, 2007, BEST PRACT RES CL EN, V21, P431, DOI 10.1016/j.beem.2007.04.003; Swaab DF, 2009, FUNCT NEUROL, V24, P17; Tesink CMJY, 2009, J COGNITIVE NEUROSCI, V21, P2085, DOI 10.1162/jocn.2008.21161; Thomsen T, 2000, Med Sci Monit, V6, P1186; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; Ujike H, 2009, PROG NEURO-PSYCHOPH, V33, P1241, DOI 10.1016/j.pnpbp.2009.07.008; van Goozen SHM, 2002, BEHAV NEUROSCI, V116, P982, DOI 10.1037//0735-7044.116.6.982; VANDOMMELEN WA, 1990, LANG SPEECH, V33, P259, DOI 10.1177/002383099003300302; VANGOOZEN SHM, 1995, PSYCHONEUROENDOCRINO, V20, P343, DOI 10.1016/0306-4530(94)00076-X; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; von Kriegstein K, 2010, J NEUROSCI, V30, P629, DOI 10.1523/JNEUROSCI.2742-09.2010; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Wisniewski AB, 2005, ARCH SEX BEHAV, V34, P167, DOI 10.1007/s10508-005-1794-x; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Xiao ZW, 2005, HUM BRAIN MAPP, V25, P212, DOI 10.1002/hbm.20105; Ye Z, 2011, Z NEUROPSYCHOL, V22, P263, DOI 10.1024/1016-264X/a000056; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0; Zubiaurre-Elorza L, 2014, J SEX MED	114	28	28	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111672	10.1371/journal.pone.0111672	http://dx.doi.org/10.1371/journal.pone.0111672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375171	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600056
J	Reisinger, RR; Oosthuizen, WC; Peron, G; Toussaint, DC; Andrews, RD; de Bruyn, PJN				Reisinger, Ryan R.; Oosthuizen, W. Chris; Peron, Guillaume; Toussaint, Dawn Cory; Andrews, Russel D.; de Bruyn, P. J. Nico			Satellite Tagging and Biopsy Sampling of Killer Whales at Subantarctic Marion Island: Effectiveness, Immediate Reactions and Long-Term Responses	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; SOUTHERN RIGHT WHALES; MEGAPTERA-NOVAEANGLIAE; BEHAVIORAL-RESPONSES; HUMPBACK WHALES; ORCINUS-ORCA; HUMAN DISTURBANCE; MOVEMENTS; CONSERVATION; PENGUINS	Remote tissue biopsy sampling and satellite tagging are becoming widely used in large marine vertebrate studies because they allow the collection of a diverse suite of otherwise difficult-to-obtain data which are critical in understanding the ecology of these species and to their conservation and management. Researchers must carefully consider their methods not only from an animal welfare perspective, but also to ensure the scientific rigour and validity of their results. We report methods for shore-based, remote biopsy sampling and satellite tagging of killer whales Orcinus orca at Subantarctic Marion Island. The performance of these methods is critically assessed using 1) the attachment duration of low-impact minimally percutaneous satellite tags; 2) the immediate behavioural reactions of animals to biopsy sampling and satellite tagging; 3) the effect of researcher experience on biopsy sampling and satellite tagging; and 4) the mid- (1 month) and long- (24 month) term behavioural consequences. To study mid- and long-term behavioural changes we used multievent capture-recapture models that accommodate imperfect detection and individual heterogeneity. We made 72 biopsy sampling attempts (resulting in 32 tissue samples) and 37 satellite tagging attempts (deploying 19 tags). Biopsy sampling success rates were low (43%), but tagging rates were high with improved tag designs (86%). The improved tags remained attached for 26 +/- 14 days (mean +/- SD). Individuals most often showed no reaction when attempts missed (66%) and a slight reaction-defined as a slight flinch, slight shake, short acceleration, or immediate dive-when hit (54%). Severe immediate reactions were never observed. Hit or miss and age-sex class were important predictors of the reaction, but the method (tag or biopsy) was unimportant. Multievent trap-dependence modelling revealed considerable variation in individual sighting patterns; however, there were no significant mid-or long-term changes following biopsy sampling or tagging.	[Reisinger, Ryan R.; Oosthuizen, W. Chris; Toussaint, Dawn Cory; de Bruyn, P. J. Nico] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Peron, Guillaume] Univ Cape Town, Dept Stat Sci, Ctr Stat Ecol Environm & Conservat, ZA-7925 Cape Town, South Africa; [Andrews, Russel D.] Univ Alaska, Sch Fisheries & Ocean Sci, Fairbanks, AK 99701 USA; [Andrews, Russel D.] Alaska SeaLife Ctr, Seward, AK USA	University of Pretoria; University of Cape Town; University of Alaska System; University of Alaska Fairbanks	Reisinger, RR (corresponding author), Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa.	rrreisinger@zoology.up.ac.za	PERON, Guillaume/C-5379-2013; De Bruyn, P.J.N./E-4176-2010; Reisinger, Ryan R/D-6151-2014; Oosthuizen, W. Chris/I-2947-2016	PERON, Guillaume/0000-0002-6311-4377; De Bruyn, P.J.N./0000-0002-9114-9569; Reisinger, Ryan R/0000-0002-8933-6875; Oosthuizen, W. Chris/0000-0003-2905-6297; Andrews, Russel/0000-0002-4545-137X	National Research Foundation's (NRF); South African Department of Science and Technology through the NRF; Mohamed bin Zayed Species Conservation Fund [10251290]; International Whaling Commission's Southern Ocean Research Partnership	National Research Foundation's (NRF); South African Department of Science and Technology through the NRF; Mohamed bin Zayed Species Conservation Fund; International Whaling Commission's Southern Ocean Research Partnership	Funding was provided by the National Research Foundation's (NRF) Thuthuka and South African National Antarctic programmes, the South African Department of Science and Technology through the NRF, the Mohamed bin Zayed Species Conservation Fund (Project number: 10251290) and the International Whaling Commission's Southern Ocean Research Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Baird RW, 2011, MAR MAMMAL SCI, V27, pE332, DOI 10.1111/j.1748-7692.2010.00458.x; Baird Robin W., 2010, Endangered Species Research, V10, P107, DOI 10.3354/esr00258; Ban SD, 2014, ANIM COGN, V17, P1353, DOI 10.1007/s10071-014-0771-y; Barbraud C, 2012, J ORNITHOL, V153, P375, DOI 10.1007/s10336-011-0752-8; BarrettLennard LG, 1996, MAR MAMMAL SCI, V12, P14, DOI 10.1111/j.1748-7692.1996.tb00302.x; Bates D., 2013, LME4 LINEAR MIXED EF; BATESON P, 1986, NEW SCI, V109, P30; Baumgartner MF, 2005, CAN J FISH AQUAT SCI, V62, P527, DOI 10.1139/F04-238; Beale CM, 2004, ANIM BEHAV, V68, P1065, DOI 10.1016/j.anbehav.2004.07.002; Best PB, 2005, J WILDLIFE MANAGE, V69, P1171, DOI 10.2193/0022-541X(2005)069[1171:BSRWTR]2.0.CO;2; Best Peter B., 2007, Journal of Cetacean Research and Management, V9, P111; Bilgmann K, 2008, ANIM CONSERV, V11, P518, DOI 10.1111/j.1469-1795.2008.00213.x; BROWN MR, 1994, MAR MAMMAL SCI, V10, P391, DOI 10.1111/j.1748-7692.1994.tb00496.x; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Collecte Localisation Satellites, 2011, ARG US MAN; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; Culik B., 1990, P177; Durban JW, 2012, BIOL LETTERS, V8, P274, DOI 10.1098/rsbl.2011.0875; Elwen S, 2006, J MAMMAL, V87, P866, DOI 10.1644/05-MAMM-A-307R2.1; Field IC, 2012, MAR MAMMAL SCI, V28, pE325, DOI 10.1111/j.1748-7692.2011.00519.x; Frid A, 2002, CONSERV ECOL, V6; Gales NJ, 2009, MAR MAMMAL SCI, V25, P725, DOI 10.1111/j.1748-7692.2008.00279.x; Gauthier J, 1999, MAR MAMMAL SCI, V15, P85, DOI 10.1111/j.1748-7692.1999.tb00783.x; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Giraudoux P., 2011, PGIRMESS DATA ANAL E; GOODYEAR JD, 1993, J WILDLIFE MANAGE, V57, P503, DOI 10.2307/3809274; Guinet, 2014, KILLER WHALES CROZET, DOI [10.6084/m9.figshare.1060247, DOI 10.6084/M9.FIGSHARE.1060247]; Hauser N, 2010, MAR MAMMAL SCI, V26, P679, DOI 10.1111/j.1748-7692.2009.00363.x; Hazekamp AAH, 2010, EUR J WILDLIFE RES, V56, P131, DOI 10.1007/s10344-009-0293-0; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Hunt KE, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot006; Keith M, 2001, AFR ZOOL, V36, P163; Kellar NM, 2013, MAR MAMMAL SCI, V29, pE366, DOI 10.1111/mms.12014; LAMBERTSEN RH, 1987, J MAMMAL, V68, P443, DOI 10.2307/1381495; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Marino L, 2007, PLOS BIOL, V5, P966, DOI 10.1371/journal.pbio.0050139; Mate B, 2007, DEEP-SEA RES PT II, V54, P224, DOI 10.1016/j.dsr2.2006.11.021; Maxwell SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3688; McMahon CR, 2012, BIOL CONSERV, V153, P254, DOI 10.1016/j.biocon.2012.05.004; Mcmahon CR, 2012, WILDLIFE RES, V39, P375, DOI 10.1071/WR12014; Mizroch SA, 2011, MAR MAMMAL SCI, V27, P217, DOI 10.1111/j.1748-7692.2010.00391.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Noren DP, 2012, MAR MAMMAL SCI, V28, P154, DOI 10.1111/j.1748-7692.2011.00469.x; PATENAUDE NJ, 1995, MAR MAMMAL SCI, V11, P163, DOI 10.1111/j.1748-7692.1995.tb00515.x; Peron G, 2010, OIKOS, V119, P524, DOI 10.1111/j.1600-1706.2009.17882.x; Pistorius PA, 2002, S AFR J WILDL RES, V32, P86; Pledger S, 2003, BIOMETRICS, V59, P786, DOI 10.1111/j.0006-341X.2003.00092.x; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Pradel R., 1993, P29; Pradel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032666; Pradel R, 2010, J AGR BIOL ENVIR ST, V15, P248, DOI 10.1007/s13253-009-0008-8; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reeb D, 2006, MAR MAMMAL SCI, V22, P206, DOI 10.1111/j.1748-7692.2006.00015.x; Regel J, 1997, POLAR BIOL, V18, P246, DOI 10.1007/s003000050185; Reisinger RR, 2011, J ZOOL, V285, P1, DOI 10.1111/j.1469-7998.2011.00815.x; Reisinger RR, 2011, AFR J MAR SCI, V33, P99, DOI 10.2989/1814232X.2011.572356; Reisinger RR, 2014, MARION ISLAND KILLER, DOI [10.6084/m9.fig-share.971317, DOI 10.6084/M9.FIG-SHARE.971317]; Reisinger RR, 2011, AQUAT BIOL, V12, P177, DOI 10.3354/ab00340; Robbins J., 2013, REPORT SC65ASH05 PRE; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Schorr Gregory S., 2010, Endangered Species Research, V10, P203, DOI 10.3354/esr00229; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; Tezanos-Pinto G, 2012, NEW ZEAL J MAR FRESH, V46, P13, DOI 10.1080/00288330.2011.583256; WATKINS WA, 1981, DEEP-SEA RES, V28, P589, DOI 10.1016/0198-0149(81)90119-9; WATKINS WA, 1991, MAR MAMMAL SCI, V7, P409, DOI 10.1111/j.1748-7692.1991.tb00116.x; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Williams AJ, 2009, AFR J MAR SCI, V31, P81, DOI 10.2989/AJMS.2009.31.1.7.778; Williams R, 2002, J ZOOL, V256, P255, DOI 10.1017/S0952836902000298; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Wilson RP, 2004, J EXP BIOL, V207, P2649, DOI 10.1242/jeb.01067; WILSON RP, 1991, POLAR BIOL, V11, P363; Winter Y, 2005, J EXP BIOL, V208, P539, DOI 10.1242/jeb.01416; Wolf M, 2009, ECOGRAPHY, V32, P401, DOI 10.1111/j.1600-0587.2008.05626.x; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; [No title captured]	82	15	16	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111835	10.1371/journal.pone.0111835	http://dx.doi.org/10.1371/journal.pone.0111835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375329	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600065
J	Shane, MS; Weywadt, CR				Shane, Matthew S.; Weywadt, Christina R.			Voluntary Modulation of Anterior Cingulate Response to Negative Feedback	PLOS ONE			English	Article							MEDIAL-FRONTAL-CORTEX; REAL-TIME FMRI; EMOTION REGULATION; ELECTROPHYSIOLOGICAL RESPONSES; CHILDREN; PSYCHOPATHOLOGY; ACTIVATION; BEHAVIOR; CONTEXT; REWARD	Anterior cingulate and medial frontal cortex (dACC/mFC) response to negative feedback represents the actions of a generalized error-monitoring system critical for the management of goal-directed behavior. Magnitude of dACC/mFC response to negative feedback correlates with levels of post-feedback behavioral change, and with proficiency of operant learning processes. With this in mind, it follows that an ability to alter dACC/mFC response to negative feedback may lead to representative changes in operant learning proficiency. To this end, the present study investigated the extent to which healthy individuals would show modulation of their dACC/mFC response when instructed to try to either maximize or minimize their neural response to the presentation of contingent negative feedback. Participants performed multiple runs of a standard time-estimation task, during which they received feedback regarding their ability to accurately estimate a one-second duration. On Watch runs, participants were simply instructed to try to estimate as closely as possible the one second duration. On Increase and Decrease runs, participants performed the same task, but were instructed to "try to increase [decrease] their brain's response every time they received negative feedback''. Results indicated that participants showed changes in dACC/mFC response under these differing instructional conditions: dACC/mFC activity following negative feedback was higher in the Increase condition, and dACC activity trended lower in the Decrease condition, compared to the Watch condition. Moreover, dACC activity correlated with post-feedback performance adjustments, and these adjustments were highest in the Increase condition. Potential implications for neuromodulation and facilitated learning are discussed.	[Shane, Matthew S.] Univ Ontario, Inst Technol, Oshawa, ON, Canada; [Shane, Matthew S.] Mind Res Network, Albuquerque, NM USA; [Weywadt, Christina R.] Univ New Mexico, Albuquerque, NM 87131 USA	Ontario Tech University; Lovelace Respiratory Research Institute; University of New Mexico	Shane, MS (corresponding author), Univ Ontario, Inst Technol, Oshawa, ON, Canada.	matthew.shane@uoit.ca			Mind Research Network; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026932] Funding Source: NIH RePORTER	Mind Research Network; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project has been supported by an internal award by The Mind Research Network to MSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calhoun VD, 2004, NEUROIMAGE, V22, P252, DOI 10.1016/j.neuroimage.2003.12.029; Clark VP, 2012, NEUROIMAGE, V59, P117, DOI 10.1016/j.neuroimage.2010.11.036; Dan-Glauser ES, 2013, EMOTION, V13, P832, DOI 10.1037/a0032672; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Erk S, 2010, J NEUROSCI, V30, P15726, DOI 10.1523/JNEUROSCI.1856-10.2010; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Gehring WJ, 2002, SCIENCE, V296, P1611; Groom MJ, 2013, J CHILD PSYCHOL PSYC, V54, P836, DOI 10.1111/jcpp.12069; Gross JJ, 2011, EMOT REV, V3, P8, DOI 10.1177/1754073910380974; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hajcak G, 2003, BIOL PSYCHOL, V64, P77, DOI 10.1016/S0301-0511(03)00103-0; Hall JR, 2007, PSYCHOL SCI, V18, P326, DOI 10.1111/j.1467-9280.2007.01899.x; Harmer CJ, 2001, NAT NEUROSCI, V4, P17, DOI 10.1038/82854; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Ichikawa N, 2011, COGN AFFECT BEHAV NE, V11, P354, DOI 10.3758/s13415-011-0028-z; Lewis MD, 2008, DEV PSYCHOPATHOL, V20, P913, DOI 10.1017/S0954579408000448; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moser JS, 2015, J CLIN CHILD ADOLESC, V44, P329, DOI 10.1080/15374416.2013.865191; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Schneider W., 2002, E PRIME USERS GUIDE; Silvers J., 2013, OXFORD HDB COGNITIVE, V2; Swick D, 2004, COGNITIVE NEUROSCIEN, P393; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Wessing I, 2013, NEUROIMAGE, V81, P15, DOI 10.1016/j.neuroimage.2013.04.117; Williams NR, 2014, ACAD PSYCHIATR, V38, P168, DOI 10.1007/s40596-014-0050-x; Wrase J, 2007, NEUROIMAGE, V36, P1253, DOI 10.1016/j.neuroimage.2007.04.001; Zanolie K, 2008, NEUROPSYCHOLOGIA, V46, P117, DOI 10.1016/j.neuropsychologia.2007.08.009; Zotev V, 2014, NEUROIMAGE, V85, P985, DOI 10.1016/j.neuroimage.2013.04.126	40	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e107322	10.1371/journal.pone.0107322	http://dx.doi.org/10.1371/journal.pone.0107322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25376010	Green Submitted, gold, Green Published			2022-12-26	WOS:000344402600006
J	Pluchino, LA; Wang, HCR				Pluchino, Lenora Ann; Wang, Hwa-Chain Robert			Chronic Exposure to Combined Carcinogens Enhances Breast Cell Carcinogenesis with Mesenchymal and Stem-Like Cell Properties	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TOBACCO-SMOKE CARCINOGENS; DONE MEAT INTAKE; EPITHELIAL-CELLS; HETEROCYCLIC AMINES; MAMMARY CARCINOMAS; CANCER; MECHANISMS; INTERVENTION; LUNG	Breast cancer is the most common type of cancer affecting women in North America and Europe. More than 85% of breast cancers are sporadic and attributable to long-term exposure to small quantities of multiple carcinogens. To understand how multiple carcinogens act together to induce cellular carcinogenesis, we studied the activity of environmental carcinogens 4( methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a] pyrene (B[a] P), and dietary carcinogen 2-amino-1-methyl6- phenylimidazo[4,5-b] pyridine (PhIP) using our breast cell carcinogenesis model. Our study revealed, for the first time, that combined NNK and B[a] P enhanced breast cell carcinogenesis chronically induced by PhIP in both non-cancerous and cancerous breast cells. Co-exposure was more potent than sequential exposure to combined NNK and B[a] P followed by PhIP in inducing carcinogenesis. Initiation of carcinogenesis was measured by transient endpoints induced in a single exposure, while progression of carcinogenesis was measured by acquisition of constitutive endpoints in cumulative exposures. Transient endpoints included DNA damage, Ras-Erk-Nox pathway activation, reactive oxygen species elevation, and increased cellular proliferation. Constitutive endpoints included various cancer-associated properties and signaling modulators, as well as enrichment of cancer stem-like cell population and activation of the epithelial-to-mesenchymal transition program. Using transient and constitutive endpoints as targets, we detected that a combination of the green tea catechins ECG and EGCG, at non-cytotoxic levels, was more effective than individual agents in intervention of cellular carcinogenesis induced by combined NNK, B[a] P, and PhIP. Thus, use of combined ECG and EGCG should be seriously considered for early intervention of breast cell carcinogenesis associated with long-term exposure to environmental and dietary carcinogens.	[Pluchino, Lenora Ann; Wang, Hwa-Chain Robert] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Pluchino, Lenora Ann; Wang, Hwa-Chain Robert] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville	Wang, HCR (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	hcrwang@utk.edu	; Wang, Hwa-Chain/L-5646-2015	Pluchino, Lenora/0000-0002-1154-8931; Wang, Hwa-Chain/0000-0001-5836-4120	University of Tennessee, College of Veterinary Medicine, Center of Excellence in Livestock Diseases and Human Health	University of Tennessee, College of Veterinary Medicine, Center of Excellence in Livestock Diseases and Human Health	This work was supported by a grant from the University of Tennessee, College of Veterinary Medicine, Center of Excellence in Livestock Diseases and Human Health (to HCRW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2011, CARCINOGENESIS, V32, P650, DOI 10.1093/carcin/bgr028; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Chhabra SK, 2000, TOXICOL APPL PHARM, V169, P191, DOI 10.1006/taap.2000.9068; Choudhary S, 2012, CARCINOGENESIS, V33, P876, DOI 10.1093/carcin/bgs097; Cohen SM, 2007, TOXICOL PATHOL, V35, P337, DOI 10.1080/01926230701197115; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; DeBruin LS, 2002, ENVIRON HEALTH PERSP, V110, P119, DOI 10.1289/ehp.02110s1119; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gammon MD, 2004, ARCH ENVIRON HEALTH, V59, P640, DOI 10.1080/00039890409602948; Gammon MD, 2002, CANCER EPIDEM BIOMAR, V11, P677; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gooderham NJ, 2007, TOXICOL LETT, V168, P269, DOI 10.1016/j.toxlet.2006.10.022; Gray J, 2009, INT J OCCUP ENV HEAL, V15, P43; Guengerich FP, 2000, CARCINOGENESIS, V21, P345, DOI 10.1093/carcin/21.3.345; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartz AJ, 2013, EPIDEMIOL HEALTH, V35, DOI 10.4178/epih/e2013003; HECHT SS, 1988, CARCINOGENESIS, V9, P875, DOI 10.1093/carcin/9.6.875; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hecht SS, 2002, ENVIRON MOL MUTAGEN, V39, P119, DOI 10.1002/em.10071; Hecht SS, 1996, CRIT REV TOXICOL, V26, P163, DOI 10.3109/10408449609017929; Imaida K, 1996, JPN J CANCER RES, V87, P1116, DOI 10.1111/j.1349-7006.1996.tb03120.x; Johnson KC, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.035931; Kelloff GJ, 2005, CANC CHEMOPREVENTION, V2; Kurbitz C, 2011, CANCER SCI, V102, P728, DOI 10.1111/j.1349-7006.2011.01870.x; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; Mehta RG, 2000, EUR J CANCER, V36, P1275, DOI 10.1016/S0959-8049(00)00100-3; Mei JX, 2003, BREAST CANCER RES TR, V79, P95, DOI 10.1023/A:1023326121951; MORRIS JJ, 1992, MED HYPOTHESES, V38, P177, DOI 10.1016/0306-9877(92)90090-Y; NAGAO M, 1994, CANCER, V74, P1063, DOI 10.1002/1097-0142(19940801)74:3+<1063::AID-CNCR2820741514>3.0.CO;2-2; OBANA H, 1981, B ENVIRON CONTAM TOX, V27, P23, DOI 10.1007/BF01610981; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pan MH, 2011, FOOD FUNCT, V2, P101, DOI 10.1039/c0fo00174k; Rathore K, 2013, CANCER LETT, V333, P113, DOI 10.1016/j.canlet.2013.01.030; Rathore K, 2012, MOL CARCINOGEN, V51, P280, DOI 10.1002/mc.20844; Rathore K, 2012, CARCINOGENESIS, V33, P174, DOI 10.1093/carcin/bgr244; Rubin H, 2001, CARCINOGENESIS, V22, P1903, DOI 10.1093/carcin/22.12.1903; Rundle A, 2000, CARCINOGENESIS, V21, P1281, DOI 10.1093/carcin/21.7.1281; Sinha R, 2000, J NATL CANCER I, V92, P1352, DOI 10.1093/jnci/92.16.1352; Siriwardhana N, 2008, BREAST CANCER RES TR, V109, P427, DOI 10.1007/s10549-007-9666-9; Siriwardhana N, 2008, MOL CARCINOGEN, V47, P338, DOI 10.1002/mc.20392; Song XY, 2010, MOL CARCINOGEN, V49, P450, DOI 10.1002/mc.20616; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Zheng W, 1998, JNCI-J NATL CANCER I, V90, P1724, DOI 10.1093/jnci/90.22.1724; Zheng W, 2009, NUTR CANCER, V61, P437, DOI 10.1080/01635580802710741	47	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e108698	10.1371/journal.pone.0108698	http://dx.doi.org/10.1371/journal.pone.0108698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372613	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900004
J	Soler, M; Ruiz-Raya, F; Carra, LG; Medina-Molina, E; Ibanez-Alamo, JD; Martin-Galvez, D				Soler, Manuel; Ruiz-Raya, Francisco; Carra, Laura G.; Medina-Molina, Eloy; Diego Ibanez-Alamo, Juan; Martin-Galvez, David			A Long-Term Experimental Study Demonstrates the Costs of Begging That Were Not Found over the Short Term	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; NESTLING TREE SWALLOWS; IMMUNE-RESPONSE; ENERGETIC COST; TRADE-OFFS; ECOLOGICAL IMMUNOLOGY; LOCAL RECRUITMENT; FOOD RESTRICTION; PIED FLYCATCHER; LIFE-HISTORY	Parent-offspring conflict theory predicts that begging behaviour could escalate continuously over evolutionary time if it is not prevented by costliness of begging displays. Three main potential physiological costs have been proposed: growth, immunological and metabolic costs. However, empirical evidence on this subject remains elusive because published results are often contradictory. In this study, we test for the existence of these three potential physiological costs of begging in house sparrow (Passer domesticus) nestlings by stimulating a group of nestlings to beg for longer and another group for shorter periods than in natural conditions. All nestlings were fed with the same quantity of food. Our study involves a long-term experimental treatment for begging studies (five consecutive days). Long-term studies frequently provide clearer results than short-term studies and, sometimes, relevant information not reported by the latter ones. Our long-term experiment shows (i) a clear effect on the immune response even since the first measurement (6 hours), but it was higher during the second (long-term) than during the first (short-term) test; (ii) evidence of a growth cost of begging in house sparrow nestlings not previously found by other studies; (iii) body condition was affected by our experimental manipulation only after 48 hour; (iv) a metabolic cost of begging never previously shown in any species, and (v) for the first time, it has shown a simultaneous effect of the three potential physiological costs of begging: immunocompetence, growth, and metabolism. This implies first, that a multilevel trade-off can occur between begging and all physiological costs and, second, that a lack of support in a short-term experiment for the existence of a tested cost of begging does not mean absence of that cost, because it can be found in a long-term experiment.	[Soler, Manuel; Ruiz-Raya, Francisco; Carra, Laura G.; Medina-Molina, Eloy; Diego Ibanez-Alamo, Juan] Univ Granada, Fac Ciencias, Dept Biol Anim, Granada, Spain; [Soler, Manuel] Univ Granada, CSIC, Unidad Asociada, Grp Coevolucio, Granada, Spain; [Martin-Galvez, David] Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Soler, M (corresponding author), Univ Granada, Fac Ciencias, Dept Biol Anim, Granada, Spain.	msoler@ugr.es	Ibáñez-Álamo, Juan Diego/H-7624-2019; Ruiz-Raya, Francisco/L-8639-2019; Martín-Gálvez, David/H-3707-2011	Ruiz-Raya, Francisco/0000-0002-4646-1975; Martín-Gálvez, David/0000-0002-1501-9578; Ibanez Alamo, Juan Diego/0000-0002-2136-1767	Junta de Andalucia [RNM 339]; Spanish Ministerio de Educacion y Ciencia/FEDER [CGL2011-25634]	Junta de Andalucia(Junta de Andalucia); Spanish Ministerio de Educacion y Ciencia/FEDER(Spanish Government)	Support was provided by the Junta de Andalucia (to the RNM 339 research group) Spanish Ministerio de Educacion y Ciencia/FEDER (research project CGL2011-25634). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR., 2006, BIOL UBIQUITOUS HOUS; [Anonymous], 1998, PRINCIPLES ANIMAL CO; Apanius V., 1998, AVIAN GROWTH DEV EVO; Bachman GC, 1998, ANIM BEHAV, V55, P1607, DOI 10.1006/anbe.1997.0719; Bergstrom CT, 1998, P NATL ACAD SCI USA, V95, P5100, DOI 10.1073/pnas.95.9.5100; Bergstrom CT, 1997, PHILOS T ROY SOC B, V352, P609, DOI 10.1098/rstb.1997.0041; Boncoraglio G, 2012, BEHAV ECOL SOCIOBIOL, V66, P539, DOI 10.1007/s00265-011-1302-3; Briskie JV, 1999, P ROY SOC B-BIOL SCI, V266, P2153, DOI 10.1098/rspb.1999.0902; BRISKIE JV, 1994, P ROY SOC B-BIOL SCI, V258, P73, DOI 10.1098/rspb.1994.0144; Brommer JE, 2004, P ROY SOC B-BIOL SCI, V271, pS110, DOI 10.1098/rsbl.2003.0103; Buchanan KL, 2007, HORM BEHAV, V52, P664, DOI 10.1016/j.yhbeh.2007.08.009; Budden AE, 2008, IBIS, V150, P234, DOI 10.1111/j.1474-919X.2007.00769.x; Chappell MA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P143, DOI 10.1007/0-306-47660-6_8; Chappell MA, 1998, AUK, V115, P863, DOI 10.2307/4089505; Cichon M, 2005, J EVOLUTION BIOL, V18, P962, DOI 10.1111/j.1420-9101.2005.00910.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; De Neve L, 2010, CAN J ZOOL, V88, P1021, DOI 10.1139/Z10-067; de Neve L, 2007, IBIS, V149, P763, DOI 10.1111/j.1474-919X.2007.00708.x; Dearborn DC, 1999, AUK, V116, P448, DOI 10.2307/4089378; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Ibanez-Alamo JD, 2012, J ORNITHOL, V153, P801, DOI 10.1007/s10336-011-0797-8; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dor R, 2007, BEHAV ECOL, V18, P97, DOI 10.1093/beheco/arl056; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Fisher R.A., 1974, DESIGN EXPT; GODFRAY HCJ, 1995, AM NAT, V146, P1, DOI 10.1086/285784; Godfray HCJ, 2000, PHILOS T ROY SOC B, V355, P1581, DOI 10.1098/rstb.2000.0719; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Goodship NM, 2007, HORM BEHAV, V52, P454, DOI 10.1016/j.yhbeh.2007.06.008; Grodzinski U, 2009, FUNCT ECOL, V19, P116; Grodzinski U, 2007, P R SOC B, V274, P2449, DOI 10.1098/rspb.2007.0658; Haff TM, 2011, BIOL LETTERS, V7, P493, DOI 10.1098/rsbl.2010.1125; Hairston N. G., 1989, ECOLOGICAL EXPT PURP; HASKELL D, 1994, P ROY SOC B-BIOL SCI, V257, P161, DOI 10.1098/rspb.1994.0110; Haskell DG, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P163, DOI 10.1007/0-306-47660-6_9; Haskell DG, 1999, ANIM BEHAV, V57, P893, DOI 10.1006/anbe.1998.1053; Heil M, 2001, OECOLOGIA, V126, P395, DOI 10.1007/s004420000532; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Johnstone RA, 1998, AM NAT, V152, P45, DOI 10.1086/286148; Johnstone RA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P1, DOI 10.1007/0-306-47660-6_1; Kedar H, 2000, P ROY SOC B-BIOL SCI, V267, P1723, DOI 10.1098/rspb.2000.1201; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Knapp AK, 2012, BIOSCIENCE, V62, P377, DOI 10.1525/bio.2012.62.4.9; Kolliker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008606; Konarzewski M, 1996, FUNCT ECOL, V10, P97, DOI 10.2307/2390267; Korschens M., 2006, Plant, Soil and Environment, V52, P1; KREBS CJ, 1991, IBIS, V133, P3, DOI 10.1111/j.1474-919X.1991.tb07663.x; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Leech SM, 1997, BEHAV ECOL, V8, P644, DOI 10.1093/beheco/8.6.644; Leech SM, 1996, P ROY SOC B-BIOL SCI, V263, P983, DOI 10.1098/rspb.1996.0145; Leonard ML, 2003, BEHAV ECOL SOCIOBIOL, V54, P573, DOI 10.1007/s00265-003-0668-2; Lepczyk CA, 1998, PHYSIOL ZOOL, V71, P561, DOI 10.1086/515965; Lepczyk CA, 2000, AUK, V117, P164, DOI 10.1642/0004-8038(2000)117[0164:EOEFRO]2.0.CO;2; Letourneau DK, 1998, ECOLOGY, V79, P593, DOI 10.1890/0012-9658(1998)079[0593:ASBAFP]2.0.CO;2; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Loiseau C, 2008, GEN COMP ENDOCR, V155, P101, DOI 10.1016/j.ygcen.2007.03.004; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Martin-Galvez D, 2011, J EXP BIOL, V214, P1463, DOI 10.1242/jeb.050153; Mauck RA, 2005, FUNCT ECOL, V19, P1001, DOI 10.1111/j.1365-2435.2005.01060.x; McCarty JP, 1996, AUK, V113, P178, DOI 10.2307/4088944; McDonald PG, 2009, BEHAV ECOL, V20, P821, DOI 10.1093/beheco/arp066; Merbach W, 2008, PLANT SOIL ENVIRON, V54, P219, DOI 10.17221/395-PSE; Merino S, 2000, OIKOS, V90, P327, DOI 10.1034/j.1600-0706.2000.900213.x; Mock D. W., 1997, EVOLUTION SIBLING RI; Mock DW, 2011, BEHAV ECOL, V22, P909, DOI 10.1093/beheco/arr091; Moller AP, 2004, OIKOS, V104, P299, DOI 10.1111/j.0030-1299.2004.12844.x; Moreno J, 2005, J AVIAN BIOL, V36, P251, DOI 10.1111/j.0908-8857.2005.03413.x; Moreno-Rueda G, 2011, J EVOLUTION BIOL, V24, P1091, DOI 10.1111/j.1420-9101.2011.02242.x; Moreno-Rueda G, 2007, J ETHOL, V25, P215, DOI 10.1007/s10164-006-0020-1; Moreno-Rueda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040367; Moreno-Rueda G, 2010, P ROY SOC B-BIOL SCI, V277, P2083, DOI 10.1098/rspb.2010.0109; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Navarro C, 2003, OIKOS, V101, P291, DOI 10.1034/j.1600-0706.2003.11663.x; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; Noguera JC, 2010, BEHAV ECOL, V21, P479, DOI 10.1093/beheco/arq005; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; O'Connor R.J., 1984, GROWTH DEV BIRDS; Parker GA, 2002, ECOL LETT, V5, P206, DOI 10.1046/j.1461-0248.2002.00301.x; PARKER GA, 1979, ANIM BEHAV, V27, P1210, DOI 10.1016/0003-3472(79)90068-X; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; PINHEIRO J PINHEIRO J PINHEIRO J PINHEIRO J, 2014, NLME LINEAR NONLINEA NLME LINEAR NONLINEA NLME LINEAR NONLINEA NLME LINEAR NONLINEA; Quillfeldt P, 2006, ANIM BEHAV, V71, P1359, DOI 10.1016/j.anbehav.2005.09.015; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raberg L, 2000, ECOL LETT, V3, P382, DOI 10.1046/j.1461-0248.2000.00154.x; Reeve HK, 1997, P ROY SOC B-BIOL SCI, V264, P1037, DOI 10.1098/rspb.1997.0143; Remes V, 2002, EVOLUTION, V56, P2505; RICKLEFS RE, 1984, ECOLOGY, V65, P1602, DOI 10.2307/1939139; RICKLEFS RE, 1979, BIOL REV, V54, P269, DOI 10.1111/j.1469-185X.1979.tb01013.x; Rodriguez-Girones MA, 2001, BEHAV ECOL, V12, P269, DOI 10.1093/beheco/12.3.269; Rodriguez-Girones MA, 1999, P ROY SOC B-BIOL SCI, V266, P2399, DOI 10.1098/rspb.1999.0937; RodriguezGirones MA, 1996, P NATL ACAD SCI USA, V93, P14637, DOI 10.1073/pnas.93.25.14637; Ros AFH, 2008, HORM BEHAV, V54, P234, DOI 10.1016/j.yhbeh.2008.02.022; Roulin A, 2001, BEHAV ECOL, V12, P506, DOI 10.1093/beheco/12.4.506; Salaberria C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084108; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Smiseth PT, 2011, ANIM BEHAV, V81, P507, DOI 10.1016/j.anbehav.2010.11.029; Soler JJ, 2003, P ROY SOC B-BIOL SCI, V270, P241, DOI 10.1098/rspb.2002.2217; Soler JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010509; Soler M, 1999, CAN J ZOOL, V77, P1794, DOI 10.1139/cjz-77-11-1794; Soler M, 2011, ADAPTIVE BEHAV UNDER; Soler M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2518; Soler M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1997, DOI 10.1007/s00265-011-1209-z; Trivers RL, 1974, READINGS SOCIOBIOLOG, P233; Verhulst S, 1997, AUK, V114, P134, DOI 10.2307/4089078; WEINER J, 1992, TRENDS ECOL EVOL, V7, P384, DOI 10.1016/0169-5347(92)90009-Z; Wells JCK, 2003, Q REV BIOL, V78, P169, DOI 10.1086/374952; Wright J, 2010, ANIM BEHAV, V80, P517, DOI 10.1016/j.anbehav.2010.06.015; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131; Zuur Alain F., 2009, P1	112	18	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111929	10.1371/journal.pone.0111929	http://dx.doi.org/10.1371/journal.pone.0111929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372280	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900090
J	Mandl, M; Schmitz, S; Weber, C; Hristov, M				Mandl, Manuela; Schmitz, Susanne; Weber, Christian; Hristov, Michael			Characterization of the CD14(++)CD16(+) Monocyte Population in Human Bone Marrow	PLOS ONE			English	Article							PREDICT CARDIOVASCULAR EVENTS; TIE2-EXPRESSING MONOCYTES; SUBSETS; ATHEROSCLEROSIS; RECRUITMENT; BLOOD	Numerous studies have divided blood monocytes according to their expression of the surface markers CD14 and CD16 into following subsets: classical CD14(++)CD16(-), intermediate CD14(++)CD16(+) and nonclassical CD14(+)CD16(++) monocytes. These subsets differ in phenotype and function and are further correlated to cardiovascular disease, inflammation and cancer. However, the CD14/CD16 nature of resident monocytes in human bone marrow remains largely unknown. In the present study, we identified a major population of CD14(++)CD16(+) monocytes by using cryopreserved bone marrow mononuclear cells from healthy donors. These cells express essential monocyte-related antigens and chemokine receptors such as CD11a, CD18, CD44, HLA-DR, Ccr2, Ccr5, Cx3cr1, Cxcr2 and Cxcr4. Notably, the expression of Ccr2 was inducible during culture. Furthermore, sorted CD14(++)CD16(+) bone marrow cells show typical macrophage morphology, phagocytic activity, angiogenic features and generation of intracellular oxygen species. Side-by-side comparison of the chemokine receptor profile with unpaired blood samples also demonstrated that these rather premature medullar monocytes mainly match the phenotype of intermediate and partially of (non) classical monocytes. Together, human monocytes obviously acquire their definitive CD14/CD16 signature in the bloodstream and the medullar monocytes probably transform into CD14(++)CD16(-) and CD14(+)CD16(++) subsets which appear enriched in the periphery.	[Mandl, Manuela; Schmitz, Susanne; Weber, Christian; Hristov, Michael] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Weber, Christian] Munich Heart Alliance, Munich, Germany	University of Munich; Munich Heart Alliance	Hristov, M (corresponding author), Univ Munich, Inst Cardiovasc Prevent, Munich, Germany.	michael.hristov@med.uni-muenchen.de	Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714	Deutsche Forschungsgemeinschaft; August-Lenz-Stiftung [FOR809, HR18/1-1, SFB 1123 A1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); August-Lenz-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft, (FOR809, HR18/1-1, SFB 1123 A1) August-Lenz-Stiftung. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken Anne Margrethe, 2006, Curr Stem Cell Res Ther, V1, P47, DOI 10.2174/157488806775269179; Berg KE, 2012, CIRC-CARDIOVASC GENE, V5, P122, DOI 10.1161/CIRCGENETICS.111.960385; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; Hiebl B, 2008, CLIN HEMORHEOL MICRO, V39, P221, DOI 10.3233/CH-2008-1086; Hristov M, 2011, THROMB HAEMOSTASIS, V106, P757, DOI 10.1160/TH11-07-0500; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rogacev KS, 2010, EUR HEART J, V31, P369, DOI 10.1093/eurheartj/ehp308; Shantsila E, 2011, J THROMB HAEMOST, V9, P1056, DOI 10.1111/j.1538-7836.2011.04244.x; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soehnlein O, 2013, EMBO MOL MED, V5, P471, DOI 10.1002/emmm.201201717; Sofrenovic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048067; Tapp LD, 2012, J THROMB HAEMOST, V10, P1231, DOI 10.1111/j.1538-7836.2011.04603.x; Van Hemelen D, 2010, J IMMUNOL METHODS, V353, P138, DOI 10.1016/j.jim.2009.11.012; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	19	38	39	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112140	10.1371/journal.pone.0112140	http://dx.doi.org/10.1371/journal.pone.0112140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369328	gold, Green Submitted, Green Published			2022-12-26	WOS:000344402000143
J	Puig-Vilanova, E; Aguilo, R; Rodriguez-Fuster, A; Martinez-Llorens, J; Gea, J; Barreiro, E				Puig-Vilanova, Ester; Aguilo, Rafael; Rodriguez-Fuster, Alberto; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther			Epigenetic Mechanisms in Respiratory Muscle Dysfunction of Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							SEVERE COPD PATIENTS; SKELETAL-MUSCLE; GENE-EXPRESSION; MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; HUMAN DIAPHRAGM; ACETYLATION; IDENTIFICATION; EXACERBATIONS; MICRORNA-1	Epigenetic events are differentially expressed in the lungs and airways of patients with chronic obstructive pulmonary disease (COPD). Moreover, epigenetic mechanisms are involved in the skeletal (peripheral) muscle dysfunction of COPD patients. Whether epigenetic events may also regulate respiratory muscle dysfunction in COPD remains unknown. We hypothesized that epigenetic mechanisms would be differentially expressed in the main inspiratory muscle (diaphragm) of patients with COPD of a wide range of disease severity compared to healthy controls. In diaphragm muscle specimens (thoracotomy due to lung localized neoplasms) of sedentary patients with mild-to-moderate and severe COPD, with preserved body composition, and sedentary healthy controls, expression of muscle-enriched microRNAs, histone acetyltransferases (HATs) and deacetylases (HDACs), total DNA methylation and protein acetylation, small ubiquitin-related modifier (SUMO) ligases, muscle-specific transcription factors, and muscle structure were explored. All subjects were also clinically evaluated: lung and muscle functions and exercise capacity. Compared to healthy controls, patients exhibited moderate airflow limitation and diffusion capacity, and reduced exercise tolerance and transdiaphragmatic strength. Moreover, in the diaphragm of the COPD patients, muscle-specific microRNA expression was downregulated, while HDAC4 and myocyte enhancer factor (MEF) 2C protein levels were higher, and DNA methylation levels, muscle fiber types and sizes did not differ between patients and controls. In the main respiratory muscle of COPD patients with a wide range of disease severity and normal body composition, muscle-specific microRNAs were downregulated, while HDAC4 and MEF2C levels were upregulated. It is likely that these epigenetic events act as biological adaptive mechanisms to better overcome the continuous inspiratory loads of the respiratory system in COPD. These findings may offer novel therapeutic strategies to specifically target respiratory muscle dysfunction in patients with COPD.	[Puig-Vilanova, Ester; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther] UPF, IMIM Hosp Mar Parc Salut Mar, Hlth & Expt Sci Dept CEXS, Dept Pulmonol,Muscle & Resp Syst Res Unit URMAR, Barcelona, Spain; [Puig-Vilanova, Ester; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther] Inst Salud Carlos III, Ctr Invest Red Enfermedades Resp CIBERES, Madrid, Spain; [Aguilo, Rafael; Rodriguez-Fuster, Alberto] Hosp Mar, Dept Thorac Surg, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Barreiro, E (corresponding author), UPF, IMIM Hosp Mar Parc Salut Mar, Hlth & Expt Sci Dept CEXS, Dept Pulmonol,Muscle & Resp Syst Res Unit URMAR, Barcelona Biomed Res Pk PRBB, Barcelona, Spain.	ebarreiro@imim.es	Rodríguez-Fuster, Albert/AAY-3233-2021	Rodriguez-Fuster, Alberto/0000-0002-4900-6126	CIBERES; FIS [11/02029, 12/02534]; SEPAR; FUCAP; Marato TV3 (Spain) [MTV3-07-1010]; ERS;  [SAF-2011-26908];  [2009-SGR-393]	CIBERES; FIS(Instituto de Salud Carlos III); SEPAR; FUCAP; Marato TV3 (Spain); ERS; ; 	This study has been supported by CIBERES; FIS 11/02029; FIS 12/02534; SAF-2011-26908; 2009-SGR-393; SEPAR 2009; FUCAP 2011; FUCAP 2012; and Marato TV3 (MTV3-07-1010) (Spain). Dr. Esther Barreiro was a recipient of the ERS COPD Research Award 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamdari N, 2013, METABOLISM, V62, P1, DOI 10.1016/j.metabol.2012.03.019; Alamdari N, 2010, AM J PHYSIOL-REG I, V299, pR509, DOI 10.1152/ajpregu.00858.2009; Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Andreou Artemisia M., 2009, Biotechnology Journal, V4, P1740, DOI 10.1002/biot.200900219; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Barreiro E, 2005, AM J RESP CRIT CARE, V171, P1116, DOI 10.1164/rccm.200407-887OC; Barreiro E, 2013, J APPL PHYSIOL, V114, P1263, DOI 10.1152/japplphysiol.01027.2012; Bischof O, 2007, CELL CYCLE, V6, P677, DOI 10.4161/cc.6.6.4021; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; den Kamp CMO, 2012, LUNG CANCER, V76, P112, DOI 10.1016/j.lungcan.2011.09.012; Donaldson A, 2013, THORAX, V68, P1140, DOI 10.1136/thoraxjnl-2012-203129; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Gayan-Ramirez G, 2013, J APPL PHYSIOL, V114, P1291, DOI 10.1152/japplphysiol.00847.2012; Gea J, 2013, J APPL PHYSIOL, V114, P1222, DOI 10.1152/japplphysiol.00981.2012; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Hadoux J, 2014, INT J CANCER, V135, P2711, DOI 10.1002/ijc.28913; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kudryashova E, 2012, J CLIN INVEST, V122, P1764, DOI 10.1172/JCI59581; Levine S, 1997, NEW ENGL J MED, V337, P1799, DOI 10.1056/NEJM199712183372503; Levine S, 2013, J APPL PHYSIOL, V114, P1235, DOI 10.1152/japplphysiol.01121.2012; Lewis A, 2012, THORAX, V67, P26, DOI 10.1136/thoraxjnl-2011-200309; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantilla CB, 2013, J APPL PHYSIOL, V114, P1246, DOI 10.1152/japplphysiol.01212.2012; Marin-Corral J, 2009, EUR RESPIR J, V33, P1309, DOI 10.1183/09031936.00072008; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P1, DOI 10.1016/S0300-2896(14)70070-5; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P247, DOI 10.1016/j.arbres.2012.04.001; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P86, DOI 10.1016/j.arbres.2011.10.007; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL402, DOI 10.1152/ajplung.00207.2010; Nakajima N, 2006, BIOCHEM BIOPH RES CO, V350, P1006, DOI 10.1016/j.bbrc.2006.09.153; Orozco-Levi M, 2001, AM J RESP CRIT CARE, V164, P1734, DOI 10.1164/ajrccm.164.9.2011150; Ortega F, 2002, AM J RESP CRIT CARE, V166, P669, DOI 10.1164/rccm.2107081; Perdiguero E, 2009, EPIGENETICS-US, V4, P541, DOI 10.4161/epi.4.8.10258; Polkey MI, 1996, AM J RESP CRIT CARE, V154, P1310, DOI 10.1164/ajrccm.154.5.8912741; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Puig-Vilanova E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102296; Remels AHV, 2013, J APPL PHYSIOL, V114, P1253, DOI 10.1152/japplphysiol.00790.2012; Saccone V, 2014, GENE DEV, V28, P841, DOI 10.1101/gad.234468.113; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; SIMILOWSKI T, 1991, NEW ENGL J MED, V325, P917, DOI 10.1056/NEJM199109263251304; Toth MJ, 2013, J APPL PHYSIOL, V114, P858, DOI 10.1152/japplphysiol.01474.2012; Vilaro J, 2010, RESP MED, V104, P1896, DOI 10.1016/j.rmed.2010.05.001	46	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111514	10.1371/journal.pone.0111514	http://dx.doi.org/10.1371/journal.pone.0111514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369292	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000063
J	Lescale, C; Schenten, V; Djeghloul, D; Bennabi, M; Gaignier, F; Vandamme, K; Strazielle, C; Kuzniak, I; Petite, H; Dosquet, C; Frippiat, JP; Goodhardt, M				Lescale, Chloe; Schenten, Veronique; Djeghloul, Dounia; Bennabi, Meriem; Gaignier, Fanny; Vandamme, Katleen; Strazielle, Catherine; Kuzniak, Isabelle; Petite, Herve; Dosquet, Christine; Frippiat, Jean-Pol; Goodhardt, Michele			Hind limb unloading, a model of spaceflight conditions, leads to decreased B lymphopoiesis similar to aging	FASEB JOURNAL			English	Article						bone remodeling; B-cell differentiation; gravity; immunosenescence	HEMATOPOIETIC STEM-CELLS; AMPHIBIAN PLEURODELES-WALTL; MOUSE BONE-MARROW; IMMUNE-SYSTEM; LYMPHOID PROGENITORS; SUSPENDED MICE; TRANSCRIPTION; EXPRESSION; LINEAGE; NICHE	Within the bone marrow, the endosteal niche plays a crucial role in B-cell differentiation. Because spaceflight is associated with osteoporosis, we investigated whether changes in bone microstructure induced by a ground-based model of spaceflight, hind limb unloading (HU), could affect B lymphopoiesis. To this end, we analyzed both bone parameters and the frequency of early hematopoietic precursors and cells of theBlineage after 3, 6, 13, and 21 d of HU. We found that limb disuse leads to a decrease in both bone microstructure and the frequency of B-cell progenitors in the bone marrow. Although multi-potent hematopoietic progenitors were not affected by HU, a decrease in B lymphopoiesis was observed as of the common lymphoid progenitor (CLP) stage with a major block at the progenitor B (pro-B) to precursor B (pre-B) cell transition (5-to 10-fold decrease). Themodifications in B lymphopoiesis were similar to those observed in aged mice and, as with aging, decreased B-cell generation in HU mice was associated with reduced expression of B-cell transcription factors, early B-cell factor (EBF) and Pax5, and an alteration in STAT5-mediated IL-7 signaling. These findings demonstrate that mechanical unloading of hind limbs results in a decrease in early B-cell differentiation resembling age-related modifications in B lymphopoiesis.	[Lescale, Chloe; Djeghloul, Dounia; Bennabi, Meriem; Kuzniak, Isabelle; Dosquet, Christine; Goodhardt, Michele] Univ Paris 07, Inst Univ Hematol, Paris, France; [Lescale, Chloe; Djeghloul, Dounia; Bennabi, Meriem; Kuzniak, Isabelle; Dosquet, Christine; Goodhardt, Michele] INSERM, UMRS 940, Paris, France; [Schenten, Veronique; Gaignier, Fanny; Strazielle, Catherine; Frippiat, Jean-Pol] Lorraine Univ, Stress Immun Pathogens Lab, EA7300, Vandoeuvre Les Nancy, France; [Vandamme, Katleen; Petite, Herve] Fac Med Lariboisiere, UMR CNRS 7052, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite	Goodhardt, M (corresponding author), Hop St Louis, IUH, UMRS1126, Paris, France.	jean-pol.frippiat@univ-lorraine.fr; michele.goodhardt@univ-paris-diderot.fr	Petite, Herve/E-3478-2016	Petite, Herve/0000-0003-1694-5060; Lescale, Chloe/0000-0003-0622-1149; Frippiat, Jean-Pol/0000-0002-4027-6269; GOODHARDT, Michele/0000-0003-2722-3514	Institut National de la Sante et de la Recherche Medicale; Fondation pour la Recherche Medicale; Centre National d'Etudes Spatiales (CNES); Agence Nationale de la Recherche [ANR NT09-632666]; Universite and the Region de Lorraine; CNES postdoctoral fellowship; CNES; Region Lorraine doctoral fellowship; FWO-Vlaanderen (Fund for Scientific Research-Flanders, Belgium) postdoctoral fellowship	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite and the Region de Lorraine(Region Grand-Est); CNES postdoctoral fellowship; CNES(Centre National D'etudes Spatiales); Region Lorraine doctoral fellowship(Region Grand-Est); FWO-Vlaanderen (Fund for Scientific Research-Flanders, Belgium) postdoctoral fellowship(FWO)	The authors thank Dr. L. Vico and Dr. M.-H. Lafage-Proust, Saint-Etienne, France, for advice concerning the HU protocol and for providing HU cages. They also thank the X-ray platform IMOSAR. This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale, the Fondation pour la Recherche Medicale, the Centre National d'Etudes Spatiales (CNES), the Agence Nationale de la Recherche (ANR NT09-632666), the Universite and the Region de Lorraine. V.S. was supported by a CNES postdoctoral fellowship, F.G. was supported by a CNES and Region Lorraine doctoral fellowship, and K.V. was supported by a FWO-Vlaanderen (Fund for Scientific Research-Flanders, Belgium) postdoctoral fellowship.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Ahdjoudj S, 2002, J BONE MINER RES, V17, P668, DOI 10.1359/jbmr.2002.17.4.668; Allman D, 2005, IMMUNOL REV, V205, P18, DOI 10.1111/j.0105-2896.2005.00269.x; Amblard D, 2003, J BONE MINER RES, V18, P561, DOI 10.1359/jbmr.2003.18.3.561; ARMSTRONG JW, 1995, J APPL PHYSIOL, V78, P968, DOI 10.1152/jappl.1995.78.3.968; Baek K, 2008, J APPL PHYSIOL, V104, P1086, DOI 10.1152/japplphysiol.01209.2007; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cancro MP, 2009, TRENDS IMMUNOL, V30, P313, DOI 10.1016/j.it.2009.04.005; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Davis TA, 1996, J LEUKOCYTE BIOL, V60, P69, DOI 10.1002/jlb.60.1.69; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; DUNN CDR, 1985, AVIAT SPACE ENVIR MD, V56, P419; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Frippiat JP, 2013, MOL IMMUNOL, V56, P434, DOI 10.1016/j.molimm.2013.06.011; Gaignier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092664; GARVY BA, 1993, IMMUNOLOGY, V80, P587; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hagman J, 2005, TRENDS IMMUNOL, V26, P455, DOI 10.1016/j.it.2005.07.001; Huin-Schohn C, 2013, FASEB J, V27, P333, DOI 10.1096/fj.12-217547; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; KIMZEY SL, 1976, AVIAT SPACE ENVIR MD, V47, P383; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Kollet O, 2013, LEUKEMIA, V27, P2006, DOI 10.1038/leu.2013.154; Kollet Orit, 2012, Inflammation & Allergy Drug Targets, V11, P170; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; Lescale C, 2010, AGING CELL, V9, P410, DOI 10.1111/j.1474-9726.2010.00566.x; Lew PS, 2009, CAN J PHYSIOL PHARM, V87, P839, DOI 10.1139/Y09-074; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Malin S, 2010, CURR OPIN IMMUNOL, V22, P168, DOI 10.1016/j.coi.2010.02.004; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mourcin F, 2011, BLOOD, V117, P6552, DOI 10.1182/blood-2010-12-323113; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Ortega MT, 2009, J APPL PHYSIOL, V106, P548, DOI 10.1152/japplphysiol.91138.2008; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Sakata T, 1999, J BONE MINER RES, V14, P1596, DOI 10.1359/jbmr.1999.14.9.1596; Saxena R, 2011, J BONE MINER METAB, V29, P111, DOI 10.1007/s00774-010-0201-4; Sievanen H, 2010, ARCH BIOCHEM BIOPHYS, V503, P146, DOI 10.1016/j.abb.2010.07.008; Sonnenfeld G, 2003, ADV SPACE RES-SERIES, V32, P1473, DOI 10.1016/S0273-1177(03)90383-8; Sonnenfeld G, 1992, J APPL PHYSIOL, V73, p191S; Sonnenfeld Gerald, 2005, Gravit Space Biol Bull, V18, P31; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; VACEK A, 1991, FOLIA BIOL-PRAGUE, V37, P35; Vernikos J, 2010, GERONTOLOGY, V56, P157, DOI 10.1159/000252852; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639	60	40	44	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					455	463		10.1096/fj.14-259770	http://dx.doi.org/10.1096/fj.14-259770			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25376832				2022-12-26	WOS:000349370400011
J	Jones, KA; Eng, AG; Raval, P; Srivastava, DP; Penzes, P				Jones, Kelly A.; Eng, Andrew G.; Raval, Pooja; Srivastava, Deepak P.; Penzes, Peter			Scaffold Protein X11 alpha Interacts with Kalirin-7 in Dendrites and Recruits It to Golgi Outposts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dendritic Spine; Neurobiology; Neuron; Neuroscience; Small GTPase; Synapse	GDP/GTP EXCHANGE FACTOR; SECRETORY TRAFFICKING; RECEPTOR; DOMAINS; LOCALIZATION; EXPRESSION; PLASTICITY; PATHWAYS; MLIN-10; GROWTH	Pyramidal neurons in the mammalian forebrain receive their synaptic inputs through their dendritic trees, and dendritic spines are the sites of most excitatory synapses. Dendritic spine structure is important for brain development and plasticity. Kalirin-7 is a guanine nucleotide-exchange factor for the small GTPase Rac1 and is a critical regulator of dendritic spine remodeling. The subcellular localization of kalirin-7 is thought to be important for regulating its function in neurons. A yeast two-hybrid screen has identified the adaptor protein X11 as an interacting partner of kalirin-7. Here, we show that kalirin-7 and X11 form a complex in the brain, and this interaction is mediated by the C terminus of kalirin-7. Kalirin-7 and X11 co-localize at excitatory synapses in cultured cortical neurons. Using time-lapse imaging of fluorescence recovery after photobleaching, we show that X11 is present in a mobile fraction of the postsynaptic density. X11 also localizes to Golgi outposts in dendrites, and its overexpression induces the removal of kalirin-7 from spines and accumulation of kalirin-7 in Golgi outposts. In addition, neurons overexpressing X11 displayed thinner spines. These data support a novel mechanism of regulation of kalirin-7 localization and function in dendrites, providing insight into signaling pathways underlying neuronal plasticity. Dissecting the molecular mechanisms of synaptic structural plasticity will improve our understanding of neuropsychiatric and neurodegenerative disorders, as kalirin-7 has been associated with schizophrenia and Alzheimer disease.	[Jones, Kelly A.; Srivastava, Deepak P.; Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Eng, Andrew G.] Northwestern Univ, Interdept Neurosci Grad Program, Chicago, IL 60611 USA; [Raval, Pooja; Srivastava, Deepak P.] Kings Coll London, Dept Neurosci, London SE5 9NU, England; [Raval, Pooja; Srivastava, Deepak P.] Kings Coll London, Inst Psychiat, James Black Ctr, Ctr Cellular Basis Behav, London SE5 9NU, England	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; University of London; King's College London; University of London; King's College London	Srivastava, DP (corresponding author), 125 Coldharbour Lane, London SE5 9NU, England.	deepak.srivastava@kcl.ac.uk; p-penzes@northwestern.edu	Penzes, Peter/L-3987-2016	Penzes, Peter/0000-0001-5449-1640; Srivastava, Deepak Prakash/0000-0001-6512-9065; Raval, Pooja/0000-0002-5298-1950	National Institutes of Health from NIMH [MH071316, MH097216]; NRSA Ruth L. Kirschstein Award [F31MH085362]; Royal Society United Kingdom; Brain and Behavior Foundation; Psychiatric Research Trust; American Heart Association; National Alliance for Research on Schizophrenia and Depression; Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH085362, R01MH071316, R01MH097216] Funding Source: NIH RePORTER	National Institutes of Health from NIMH; NRSA Ruth L. Kirschstein Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society United Kingdom(Royal Society of London); Brain and Behavior Foundation; Psychiatric Research Trust; American Heart Association(American Heart Association); National Alliance for Research on Schizophrenia and Depression(NARSAD); Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH071316 and MH097216 from NIMH (to P. P.) and NRSA Ruth L. Kirschstein Award F31MH085362 (to K. A. J.). This work was also supported by grants from the Royal Society United Kingdom, Brain and Behavior Foundation (formally National Alliance for Research on Schizophrenia and Depression (NARSAD)), Psychiatric Research Trust, American Heart Association (to D. P. S.), and National Alliance for Research on Schizophrenia and Depression, Brain Research Foundation.	Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Biederer T, 2002, J NEUROSCI, V22, P7340; Cahill ME, 2012, MOL PSYCHIATR, V17, P99, DOI 10.1038/mp.2011.35; Ehlers MD, 2007, NEURON, V55, P686, DOI 10.1016/j.neuron.2007.08.009; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Horton AC, 2003, J NEUROSCI, V23, P6188; Hsieh-Wilson LC, 2003, J BIOL CHEM, V278, P1186, DOI 10.1074/jbc.M205754200; Jaskolski F, 2009, J BIOL CHEM, V284, P12491, DOI 10.1074/jbc.M808401200; Jones KA, 2009, P NATL ACAD SCI USA, V106, P19575, DOI 10.1073/pnas.0905884106; King GD, 2004, J NEUROCHEM, V88, P971, DOI 10.1046/j.1471-4159.2003.02234.x; King GD, 2003, NEUROSCIENCE, V120, P143, DOI 10.1016/S0306-4522(03)00284-7; Maximov A, 2002, J NEUROSCI, V22, P6939; Minami SS, 2010, FASEB J, V24, P58, DOI 10.1096/fj.09-138123; Nakajima Y, 2001, MOL BRAIN RES, V92, P27, DOI 10.1016/S0169-328X(01)00126-7; Okamoto M, 2000, EUR J NEUROSCI, V12, P3067, DOI 10.1046/j.1460-9568.2000.00200.x; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2001, J NEUROSCI, V21, P8426, DOI 10.1523/JNEUROSCI.21-21-08426.2001; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Penzes P, 2008, TRENDS CELL BIOL, V18, P405, DOI 10.1016/j.tcb.2008.07.002; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Penzes P, 2012, CYTOSKELETON, V69, P426, DOI 10.1002/cm.21015; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Remmers C, 2014, BRAIN RES BULL, V103, P29, DOI 10.1016/j.brainresbull.2013.12.006; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Srivastava DP, 2011, JOVE-J VIS EXP, DOI 10.3791/2794; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; Teber I, 2005, BIOL CHEM, V386, P671, DOI 10.1515/BC.2005.078; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zheng CY, 2010, J NEUROSCI, V30, P4757, DOI 10.1523/JNEUROSCI.6108-09.2010; Zhou W, 2014, CURR BIOL, V24, P1227, DOI 10.1016/j.cub.2014.04.008	42	11	11	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35517	35529		10.1074/jbc.M114.587709	http://dx.doi.org/10.1074/jbc.M114.587709			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378388	hybrid, Green Published			2022-12-26	WOS:000346660200040
J	AbdulHameed, MDM; Tawa, GJ; Kumar, K; Ippolito, DL; Lewis, JA; Stallings, JD; Wallqvist, A				AbdulHameed, Mohamed Diwan M.; Tawa, Gregory J.; Kumar, Kamal; Ippolito, Danielle L.; Lewis, John A.; Stallings, Jonathan D.; Wallqvist, Anders			Systems Level Analysis and Identification of Pathways and Networks Associated with Liver Fibrosis	PLOS ONE			English	Article							GENE-EXPRESSION; HEART-FAILURE; MECHANISMS; DATABASE; BIOINFORMATICS; BIOMARKERS; DISEASE; TOXICOGENOMICS; BIOCONDUCTOR; FIBROGENESIS	Toxic liver injury causes necrosis and fibrosis, which may lead to cirrhosis and liver failure. Despite recent progress in understanding the mechanism of liver fibrosis, our knowledge of the molecular-level details of this disease is still incomplete. The elucidation of networks and pathways associated with liver fibrosis can provide insight into the underlying molecular mechanisms of the disease, as well as identify potential diagnostic or prognostic biomarkers. Towards this end, we analyzed rat gene expression data from a range of chemical exposures that produced observable periportal liver fibrosis as documented in DrugMatrix, a publicly available toxicogenomics database. We identified genes relevant to liver fibrosis using standard differential expression and co-expression analyses, and then used these genes in pathway enrichment and protein-protein interaction (PPI) network analyses. We identified a PPI network module associated with liver fibrosis that includes known liver fibrosis-relevant genes, such as tissue inhibitor of metalloproteinase-1, galectin-3, connective tissue growth factor, and lipocalin-2. We also identified several new genes, such as perilipin-3, legumain, and myocilin, which were associated with liver fibrosis. We further analyzed the expression pattern of the genes in the PPI network module across a wide range of 640 chemical exposure conditions in DrugMatrix and identified early indications of liver fibrosis for carbon tetrachloride and lipopolysaccharide exposures. Although it is well known that carbon tetrachloride and lipopolysaccharide can cause liver fibrosis, our network analysis was able to link these compounds to potential fibrotic damage before histopathological changes associated with liver fibrosis appeared. These results demonstrated that our approach is capable of identifying early-stage indicators of liver fibrosis and underscore its potential to aid in predictive toxicity, biomarker identification, and to generally identify disease-relevant pathways.	[AbdulHameed, Mohamed Diwan M.; Tawa, Gregory J.; Kumar, Kamal; Wallqvist, Anders] US Army Med Res & Mat Command, Telemed & Adv Technol Res Ctr, High Performance Comp Software Applicat Inst, Dept Def Biotechnol, Ft Detrick, MD 21702 USA; [Ippolito, Danielle L.; Lewis, John A.; Stallings, Jonathan D.] US Army Ctr Environm Hlth Res, Ft Detrick, MD USA	United States Department of Defense; United States Army	Wallqvist, A (corresponding author), US Army Med Res & Mat Command, Telemed & Adv Technol Res Ctr, High Performance Comp Software Applicat Inst, Dept Def Biotechnol, Ft Detrick, MD 21702 USA.	awallqvist@bhsai.org	AbdulHameed, Mohamed Diwan M/O-3088-2015; wallqvist, anders/W-2584-2019; Stallings, Jonathan D/H-7779-2013	AbdulHameed, Mohamed Diwan M/0000-0003-1483-4084; wallqvist, anders/0000-0002-9775-7469; Stallings, Jonathan D/0000-0002-6430-5888; Kumar, Kamal/0000-0002-9470-6682	Military Operational Medicine Research Program; U.S. Army's Network Science Initiative, U.S. Army Medical Research and Materiel Command (USAMRMC); U.S. Department of Energy; USAMRMC	Military Operational Medicine Research Program(United States Department of DefenseUnited States ArmyUnited States Army Medical Research & Development Command (USAMRDC)); U.S. Army's Network Science Initiative, U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); U.S. Department of Energy(United States Department of Energy (DOE)); USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	The authors were supported by the Military Operational Medicine Research Program and the U.S. Army's Network Science Initiative, U.S. Army Medical Research and Materiel Command (USAMRMC, http://mrmc.amedd.army.mil), Ft. Detrick, MD. This research was supported in part by an appointment to the Postgraduate Research Participation Program at the U.S. Army Center for Environmental Health Research (USACEHR, http://usacehr.amedd.army.mil) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USAMRMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2011, J GASTROEN HEPATOL, V26, P802, DOI 10.1111/j.1440-1746.2010.06612.x; Affo S, 2013, GUT, V62, P452, DOI 10.1136/gutjnl-2011-301146; Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373; Alcaraz N, 2012, INTEGR BIOL-UK, V4, P756, DOI 10.1039/c2ib00133k; Azuaje F, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-60; Azuaje FJ, 2012, CIRC-CARDIOVASC GENE, V5, P360, DOI 10.1161/CIRCGENETICS.112.962977; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Baumbach J, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P169, DOI 10.1145/2330163.2330188; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Camargo A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001347; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Ganter B, 2006, PHARMACOGENOMICS, V7, P1025, DOI 10.2217/14622416.7.7.1025; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gentleman R, 2013, GENEFILTER METHODS F; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083; Heinloth AN, 2007, TOXICOL PATHOL, V35, P276, DOI 10.1080/01926230601178207; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huan JL, 2014, GENE, V533, P346, DOI 10.1016/j.gene.2013.08.027; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-288; Ikeda K, 1998, AM J PATHOL, V153, P1695, DOI 10.1016/S0002-9440(10)65683-0; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim MJ, 2012, ENVIRON HEALTH PERSP, V120, P508, DOI 10.1289/ehp.1104282; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Kitada T, 2000, J HEPATOL, V33, P751, DOI 10.1016/S0168-8278(00)80306-2; Koukoulis GK, 2001, HUM PATHOL, V32, P1356, DOI 10.1053/hupa.2001.29675; Krishnan A, 2012, LAB INVEST, V92, P1712, DOI 10.1038/labinvest.2012.121; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lehne B, 2012, PHARMACOGENOMICS, V13, P1967, DOI [10.2217/pgs.12.170, 10.2217/PGS.12.170]; Li L, 2012, LIVER INT, V32, P1093, DOI 10.1111/j.1478-3231.2012.02809.x; Liedtke C, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-19; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Moreno M, 2010, HEPATOLOGY, V51, P974, DOI 10.1002/hep.23421; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nose F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071542; Okayama T, 2008, BBA-MOL BASIS DIS, V1782, P542, DOI 10.1016/j.bbadis.2008.06.006; Okumura T, 2011, J PHYSIOL BIOCHEM, V67, P629, DOI 10.1007/s13105-011-0110-6; Page S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056009; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Pan YM, 2014, J CHEM INF MODEL, V54, P407, DOI 10.1021/ci4005354; Qiu LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073591; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reiss DJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-154; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Sebastiani G, 2012, CLIN CHEM LAB MED, V50, P595, DOI 10.1515/cclm-2011-0850; Shen HW, 2009, PHYSICA A, V388, P1706, DOI 10.1016/j.physa.2008.12.021; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Tawa GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107230; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; ULITSKY I, 2010, PLOS ONE, V0005; Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011; Vinuela A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012145; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiao Y, 2012, GENE, V499, P332, DOI 10.1016/j.gene.2012.03.039; Yu CG, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-143; Yu XP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-79; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024680; Zhang LP, 1999, J HEPATOL, V31, P703, DOI 10.1016/S0168-8278(99)80351-1; Zhu WL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006288	84	41	43	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112193	10.1371/journal.pone.0112193	http://dx.doi.org/10.1371/journal.pone.0112193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380136	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100061
J	Ros-Santaella, JL; Dominguez-Rebolledo, AE; Garde, JJ				Luis Ros-Santaella, Jose; Efren Dominguez-Rebolledo, Alvaro; Julian Garde, Jose			Sperm Flagellum Volume Determines Freezability in Red Deer Spermatozoa	PLOS ONE			English	Article							PLASMA-MEMBRANE INTEGRITY; BOAR SPERM; FUNCTIONAL-SIGNIFICANCE; EPIDIDYMAL SPERMATOZOA; NATURAL-POPULATIONS; ANIMAL VARIABILITY; LIPID-PEROXIDATION; COOLING RATE; CRYOPRESERVATION; MOTILITY	The factors affecting the inter-individual differences in sperm freezability is a major line of research in spermatology. Poor sperm freezability is mainly characterised by a low sperm velocity, which in turn is associated with low fertility rates in most animal species. Studies concerning the implications of sperm morphometry on freezability are quite limited, and most of them are based on sperm head size regardless of the structural parts of the flagellum, which provides sperm motility. Here, for the first time, we determined the volumes of the flagellum structures in fresh epididymal red deer spermatozoa using a stereological method under phase contrast microscopy. Sperm samples from thirty-three stags were frozen and classified as good freezers (GF) or bad freezers (BF) at two hours post-thawing using three sperm kinetic parameters which are strongly correlated with fertility in this species. Fourteen stags were clearly identified as GF, whereas nineteen were BF. No significant difference in sperm head size between the two groups was found. On the contrary, the GF exhibited a lower principal piece volume than the BF (6.13 mm 3 vs 6.61 mm 3, respectively, p = 0.006). The volume of the flagellum structures showed a strong negative relationship with post-thawing sperm velocity. For instance, the volume of the sperm principal piece was negatively correlated with sperm velocity at two hours post-thawing (r = 20.60; p<0.001). Our results clearly show that a higher volume of the sperm principal piece results in poor freezability, and highlights the key role of flagellum size in sperm cryopreservation success.	[Luis Ros-Santaella, Jose; Julian Garde, Jose] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, SaBio, Albacete, Spain; [Luis Ros-Santaella, Jose] Czech Univ Life Sci, Fac Trop AgriSci, Dept Anim Sci & Food Proc, Prague, Czech Republic; [Efren Dominguez-Rebolledo, Alvaro] INIFAP, Mococha, Yucatan, Mexico	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Czech University of Life Sciences Prague	Ros-Santaella, JL (corresponding author), CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, SaBio, Campus Univ, Albacete, Spain.	joseluis.ros@irec.csic.es	Ros-Santaella, José Luis/F-9890-2019; Garde, Julian J/O-5607-2015; López-Brea, José Julián Garde/AAE-5894-2019	Ros-Santaella, José Luis/0000-0002-4186-7730; Garde, Julian J/0000-0002-3667-6518; López-Brea, José Julián Garde/0000-0002-3667-6518; Dominguez Rebolledo, Alvaro Efren/0000-0002-1444-3844	Czech University of Life Sciences, Prague, Czech Republic [99830/1181/1822, CIGA 20145001]; I3P program (Spanish National Research Council, CSIC, Spain)	Czech University of Life Sciences, Prague, Czech Republic; I3P program (Spanish National Research Council, CSIC, Spain)	JLRS was supported by I3P program (Spanish National Research Council, CSIC, Spain), post-doctoral fellowship no. 99830/1181/1822 (Czech University of Life Sciences, Prague, Czech Republic), and by the project CIGA 20145001 (Czech University of Life Sciences, Prague, Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2005, J ZOOL, V267, P135, DOI 10.1017/S0952836905007284; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; Anel-Lopez L, 2012, ANIM REPROD SCI, V135, P37, DOI 10.1016/j.anireprosci.2012.09.001; Billard R, 2000, AQUAC RES, V31, P283, DOI 10.1046/j.1365-2109.2000.00423.x; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Bohonak A. J., 2004, RMA SOFTWARE REDUCED; Bollwein H, 2008, REPROD DOMEST ANIM, V43, P189, DOI 10.1111/j.1439-0531.2007.00876.x; Brouwers JF, 2005, THERIOGENOLOGY, V63, P458, DOI 10.1016/j.theriogenology.2004.09.046; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Comizzoli P, 2001, THERIOGENOLOGY, V56, P261, DOI 10.1016/S0093-691X(01)00561-1; Correa LM, 2007, BIOL REPROD, V77, P942, DOI 10.1095/biolreprod.107.060533; Cremades T, 2005, J ANDROL, V26, P610, DOI 10.2164/jandrol.05028; Curry MR, 1996, BIOL REPROD, V55, P1325, DOI 10.1095/biolreprod55.6.1325; Del Olmo E, 2013, ANIM REPROD SCI, V138, P102, DOI 10.1016/j.anireprosci.2013.02.007; Devireddy RV, 2002, REPRODUCTION, V124, P643, DOI 10.1530/reprod/124.5.643; Domes U., 2001, Animal Reproduction Science, V68, P329; Dominguez-Rebolledo AE, 2010, REPROD FERT DEVELOP, V22, P856, DOI 10.1071/RD09197; Felipe-Perez YE, 2012, CRYOBIOLOGY, V64, P103, DOI 10.1016/j.cryobiol.2011.12.004; Esteso MC, 2006, J ANDROL, V27, P662, DOI 10.2164/jandrol.106.000489; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Fernandez-Santos MR, 2006, THERIOGENOLOGY, V66, P1931, DOI 10.1016/j.theriogenology.2006.05.012; FULCHER KD, 1995, MOL REPROD DEV, V42, P415, DOI 10.1002/mrd.1080420407; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Garde JJ, 2006, REPROD DOMEST ANIM, V41, P93, DOI 10.1111/j.1439-0531.2006.00773.x; Garde JJ, 1998, ARCH ANDROLOGY, V41, P195, DOI 10.3109/01485019808994891; Holt WV, 2005, THERIOGENOLOGY, V63, P370, DOI 10.1016/j.theriogenology.2004.09.018; HOLT WV, 1989, HUM REPROD, V4, P292, DOI 10.1093/oxfordjournals.humrep.a136891; HOLT WV, 1994, BIOL REPROD, V51, P414, DOI 10.1095/biolreprod51.3.414; HOLT WV, 1984, J EXP ZOOL, V230, P473, DOI 10.1002/jez.1402300316; Holt WV, 2000, ANIM REPROD SCI, V62, P3, DOI 10.1016/S0378-4320(00)00152-4; Hossain AM, 2001, J ANDROL, V22, P119; KEATES RAB, 1980, BIOCHEM BIOPH RES CO, V97, P1163, DOI 10.1016/0006-291X(80)91497-7; LINDEMANN CB, 1992, J CELL SCI, V102, P249; Garcia BM, 2012, THERIOGENOLOGY, V77, P1280, DOI 10.1016/j.theriogenology.2011.10.033; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2006, BIOL LETTERS, V2, P246, DOI 10.1098/rsbl.2006.0449; McClean RV, 2007, CRYOBIOLOGY, V54, P271, DOI 10.1016/j.cryobiol.2007.03.004; Medrano A, 2002, REPRODUCTION, V123, P315, DOI 10.1530/rep.0.1230315; Nagy S, 1999, THERIOGENOLOGY, V52, P1153, DOI 10.1016/S0093-691X(99)00207-1; Nunez-Martinez I., 2006, J ANDROL, V27, P596; Parapanov RN, 2009, ANIM REPROD SCI, V114, P269, DOI 10.1016/j.anireprosci.2008.09.013; PARKS JE, 1992, THERIOGENOLOGY, V38, P209, DOI 10.1016/0093-691X(92)90231-F; Pena FJ, 2005, J ANDROL, V26, P716, DOI 10.2164/jandrol.05030; Petrunkina AM, 2004, REPRODUCTION, V128, P829, DOI 10.1530/rep.1.00296; Petrunkina AM, 2004, REPRODUCTION, V127, P105, DOI 10.1530/rep.1.00047; Petrunkina AM, 2004, THERIOGENOLOGY, V61, P35, DOI 10.1016/S0093-691X(03)00184-5; Ramanujan S., 1914, Q J MATH, V45, p[350, 23]; Ramm SA, 2010, BIOL LETTERS, V6, P219, DOI 10.1098/rsbl.2009.0635; Saacke RG, 1972, P 4 TECH C ART INS R, P2; Sanchez L, 2005, LECT NOTES COMPUT SC, V3691, P88; Schlingmann K, 2007, J ANDROL, V28, P706, DOI 10.2164/jandrol.106.001669; Thurston LM, 2002, BIOL REPROD, V66, P545, DOI 10.1095/biolreprod66.3.545; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; Tuset VM, 2008, THERIOGENOLOGY, V69, P1033, DOI 10.1016/j.theriogenology.2008.01.012; Voordouw MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-214; Watson PF, 1995, REPROD FERT DEVELOP, V7, P871, DOI 10.1071/RD9950871; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; WOOLLEY DM, 1978, J REPROD FERTIL, V53, P389; Zhu WJ, 2000, ASIAN J ANDROL, V2, P135	59	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112382	10.1371/journal.pone.0112382	http://dx.doi.org/10.1371/journal.pone.0112382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380133	gold, Green Submitted, Green Published			2022-12-26	WOS:000344863100079
J	Peters, LP; Carvalho, G; Martins, PF; Dourado, MN; Vilhena, MB; Pileggi, M; Azevedo, RA				Peters, Leila Priscila; Carvalho, Giselle; Martins, Paula Fabiane; Dourado, Manuella Nobrega; Vilhena, Milca Bartz; Pileggi, Marcos; Azevedo, Ricardo Antunes			Differential Responses of the Antioxidant System of Ametryn and Clomazone Tolerant Bacteria	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; 16S RIBOSOMAL-RNA; DEGRADING BACTERIA; SOIL BACTERIUM; GLUTATHIONE; HERBICIDE; TRANSFERASE; SUPEROXIDE; CATALASE; BIODEGRADATION	The herbicides ametryn and clomazone are widely used in sugarcane cultivation, and following microbial degradation are considered as soil and water contaminants. The exposure of microorganisms to pesticides can result in oxidative damage due to an increase in the production of reactive oxygen species (ROS). This study investigated the response of the antioxidant systems of two bacterial strains tolerant to the herbicides ametryn and clomazone. Bacteria were isolated from soil with a long history of ametryn and clomazone application. Comparative analyses based on 16S rRNA gene sequences revealed that strain CC07 is phylogenetically related to Pseudomonas aeruginosa and strain 4C07 to P. fulva. The two bacterial strains were grown for 14 h in the presence of separate and combined herbicides. Lipid peroxidation, reduced glutathione content (GSH) and antioxidant enzymes activities were evaluated. The overall results indicated that strain 4C07 formed an efficient mechanism to maintain the cellular redox balance by producing reactive oxygen species (ROS) and subsequently scavenging ROS in the presence of the herbicides. The growth of bacterium strain 4C07 was inhibited in the presence of clomazone alone, or in combination with ametryn, but increased glutathione reductase (GR) and glutathione S-transferase (GST) activities, and a higher GSH concentration were detected. Meanwhile, reduced superoxide dismutase (SOD), catalase (CAT) and GST activities and a lower concentration of GSH were detected in the bacterium strain CC07, which was able to achieve better growth in the presence of the herbicides. The results suggest that the two bacterial strains tolerate the ametryn and clomazone herbicides with distinctly different responses of the antioxidant systems.	[Peters, Leila Priscila; Carvalho, Giselle; Martins, Paula Fabiane; Dourado, Manuella Nobrega; Vilhena, Milca Bartz; Azevedo, Ricardo Antunes] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Genet, Piracicaba, Brazil; [Pileggi, Marcos] Univ Estadual Ponta Grossa, Dept Biol Estrut Mol & Genet, Ponta Grossa, Brazil	Universidade de Sao Paulo; Universidade Estadual de Ponta Grossa	Azevedo, RA (corresponding author), Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Genet, Piracicaba, Brazil.	raa@usp.br	Azevedo, Ricardo Antunes/F-8863-2011; Dourado, Manuella N/P-2337-2018; Pileggi, Marcos/B-8651-2012; Pileggi, Marcos/H-2695-2017; Carvalho, Giselle/AAO-9818-2020	Azevedo, Ricardo Antunes/0000-0001-7316-125X; Dourado, Manuella N/0000-0002-2152-0246; Pileggi, Marcos/0000-0003-1633-8295; Pileggi, Marcos/0000-0003-1633-8295; Carvalho, Giselle/0000-0001-5161-7340; Peters, Leila Priscila/0000-0002-9469-5290	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/54676-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by grant 09/54676-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo to RAA. The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (RAA and MBV) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (LPP, PFM, GC and MND) for the fellowship and scholarships granted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Andrade SRB, 2010, PLANTA DANINHA, V28, P655, DOI 10.1590/S0100-83582010000300023; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; Azevedo RA, 1998, PHYSIOL PLANTARUM, V104, P280, DOI 10.1034/j.1399-3054.1998.1040217.x; Boaretto LF, 2014, PLANT PHYSIOL BIOCH, V74, P165, DOI 10.1016/j.plaphy.2013.11.016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camargo O.A., 2009, B TECNICO, V106, P77; Carlomagno M, 2010, J AGR FOOD CHEM, V58, P4367, DOI 10.1021/jf9043259; Carvalho RF, 2011, SCI AGR, V68, P598, DOI 10.1590/S0103-90162011000500014; Cia MC, 2012, ANN APPL BIOL, V161, P313, DOI 10.1111/j.1744-7348.2012.00575.x; Cumming JP, 2002, WEED SCI, V50, P405, DOI 10.1614/0043-1745(2002)050[0405:CDIFTT]2.0.CO;2; Costa JSD, 2011, ECOTOX ENVIRON SAFE, V74, P2020, DOI 10.1016/j.ecoenv.2011.06.017; Dwivedi S, 2011, J HAZARD MATER, V185, P938, DOI 10.1016/j.jhazmat.2010.09.110; Ferhatoglu Y, 2006, PESTIC BIOCHEM PHYS, V85, P7, DOI 10.1016/j.pestbp.2005.10.002; Ferhatoglu Y, 2005, PESTIC BIOCHEM PHYS, V81, P59, DOI 10.1016/j.pestbp.2004.09.002; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; Garcia JS, 2006, J AGR FOOD CHEM, V54, P8623, DOI 10.1021/jf061593l; Garcia-Cruz U, 2010, J HAZARD MATER, V179, P591, DOI 10.1016/j.jhazmat.2010.03.044; Ghelfi A, 2011, ANN APPL BIOL, V159, P267, DOI 10.1111/j.1744-7348.2011.00491.x; Gomes RA, 2006, PLANT PHYSIOL BIOCH, V44, P420, DOI 10.1016/j.plaphy.2006.06.002; Gomes-Junior RA, 2007, FUNCT PLANT BIOL, V34, P449, DOI 10.1071/FP07010; Gomes-Junior RA, 2006, CHEMOSPHERE, V65, P1330, DOI 10.1016/j.chemosphere.2006.04.056; Goulielmos GN, 2003, BIOCHEM BIOPH RES CO, V308, P433, DOI 10.1016/S0006-291X(03)01422-0; Gratao PL, 2008, ANN APPL BIOL, V153, P321, DOI 10.1111/j.1744-7348.2008.00299.x; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Gratao PL, 2012, PLANT PHYSIOL BIOCH, V56, P79, DOI 10.1016/j.plaphy.2012.04.009; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Hultberg M, 1998, CURR MICROBIOL, V37, P301, DOI 10.1007/s002849900382; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Juraske R, 2007, ENVIRON INT, V33, P886, DOI 10.1016/j.envint.2007.04.005; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Labrou NE, 2005, PLANTA, V222, P91, DOI 10.1007/s00425-005-1520-x; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lin XY, 2009, ECOTOX ENVIRON SAFE, V72, P1899, DOI 10.1016/j.ecoenv.2009.04.016; Lu ZM, 2004, J ENVIRON SCI HEAL B, V39, P431, DOI 10.1081/PFC-120035928; Lu ZM, 2009, ECOTOX ENVIRON SAFE, V72, P136, DOI 10.1016/j.ecoenv.2008.01.009; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; Martins PF, 2011, PROCESS BIOCHEM, V46, P1186, DOI 10.1016/j.procbio.2011.02.014; Martins PF, 2007, BRAZ ARCH BIOL TECHN, V50, P153, DOI 10.1590/S1516-89132007000100019; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; Matsue Y, 2010, J ANTIBIOT, V63, P583, DOI 10.1038/ja.2010.100; Mattos MLT, 1996, DECH MONOG, V133, P623; McKnight US, 2012, SCI TOTAL ENVIRON, V427, P319, DOI 10.1016/j.scitotenv.2012.04.011; MERVOSH TL, 1995, J AGR FOOD CHEM, V43, P537, DOI 10.1021/jf00050a052; Mishra K, 2012, ECOTOX ENVIRON SAFE, V76, P215, DOI 10.1016/j.ecoenv.2011.09.014; Mongkolsuk S, 2005, J IND MICROBIOL BIOT, V32, P687, DOI 10.1007/s10295-005-0036-5; Monquero PA, 2008, PLANTA DANINHA, V26, P685, DOI 10.1590/S0100-83582008000300025; Monteiro CC, 2012, AN ACAD BRAS CIENC, V84, P573, DOI 10.1590/S0001-37652012005000022; Monteiro CC, 2011, ENVIRON EXP BOT, V71, P306, DOI 10.1016/j.envexpbot.2010.12.020; Navaratna D, 2012, BIORESOURCE TECHNOL, V113, P181, DOI 10.1016/j.biortech.2011.12.018; Nie ZJ, 2011, J AGR FOOD CHEM, V59, P6040, DOI 10.1021/jf200397t; Pileggi M, 2012, CHEMOSPHERE, V86, P1127, DOI 10.1016/j.chemosphere.2011.12.041; Pimentel David, 2009, P83, DOI 10.1007/978-1-4020-8992-3_3; Ramu S, 2014, J ENVIRON SCI HEAL B, V49, P23, DOI 10.1080/03601234.2013.836868; Ryan KC, 2010, J BIOL INORG CHEM, V15, P795, DOI 10.1007/s00775-010-0645-y; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sangali S, 2000, J APPL MICROBIOL, V89, P735, DOI 10.1046/j.1365-2672.2000.01173.x; Shao TJ, 2010, ECOTOXICOLOGY, V19, P1117, DOI 10.1007/s10646-010-0494-z; Smirnova GV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1199, DOI 10.1007/s10541-005-0248-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tejada M, 2011, ECOTOX ENVIRON SAFE, V74, P2075, DOI 10.1016/j.ecoenv.2011.07.005; Tironi SP, 2009, PLANTA DANINHA, V27, P995, DOI 10.1590/S0100-83582009000500013; Vercraene-Eairmal M, 2010, CHEMOSPHERE, V81, P837, DOI 10.1016/j.chemosphere.2010.08.014; Veremeenko EG, 2010, MICROBIOLOGY+, V79, P439, DOI 10.1134/S0026261710040041; Viegas CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037140; Vieira VC, 2010, ACTA SCI-AGRON, V32, P255, DOI 10.4025/actasciagron.v32i2.3841; Yasuor H, 2008, PEST MANAG SCI, V64, P1031, DOI 10.1002/ps.1604; ZABLOTOWICZ RM, 1995, APPL ENVIRON MICROB, V61, P1054, DOI 10.1128/AEM.61.3.1054-1060.1995; Zeng HW, 2010, ANN MICROBIOL, V60, P701, DOI 10.1007/s13213-010-0116-2; Zhang Y, 2012, J HAZARD MATER, V229, P434, DOI 10.1016/j.jhazmat.2012.05.054	73	31	33	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112271	10.1371/journal.pone.0112271	http://dx.doi.org/10.1371/journal.pone.0112271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380132	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100070
J	Xu, HC; Zhong, JC; Yu, GH; Wu, J; Jiang, HL; Yang, LY				Xu, Huacheng; Zhong, Jicheng; Yu, Guanghui; Wu, Jun; Jiang, Helong; Yang, Liuyan			Further Insights into Metal-DOM Interaction: Consideration of Both Fluorescent and Non-Fluorescent Substances	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; DISSOLVED ORGANIC-MATTER; EXCITATION-EMISSION MATRIX; PARALLEL FACTOR-ANALYSIS; HEAVY-METALS; FULVIC-ACID; FRESH-WATER; MICROCYSTIS-AERUGINOSA; CYANOBACTERIAL BLOOMS; AMENDED SOILS	Information on metal binding with fluorescent substances has been widely studied. By contrast, information on metal binding with non-fluorescent substances remains lacking despite the dominance of these substances in aquatic systems. In this study, the metal binding properties of both fluorescent and non-fluorescent substances were investigated by using metal titration combined with two-dimensional correlation spectroscopy (2D-COS) analysis. The organic matters in the eutrophic algae-rich lake, including natural organic matters (NOM) and algae-induced extracellular polymeric substances (EPS), both contained fluorescent and non-fluorescent substances. The peaks in the one-dimensional spectra strongly overlapped, while 2D-COS can decompose the overlapped peaks and thus enhanced the spectral resolution. Moreover, 2D FTIR COS demonstrated that the binding susceptibility of organic ligands in both NOM and algal EPS matrices followed the order: 3400>1380>1650 cm(-1), indicative the significant contribution of non-fluorescent ligands in metal binding. The modified Stern-Volmer equation also revealed a substantial metal binding potential for the non-fluorescent substances (logK(M): 3.57 similar to 4.92). As for the effects of organic ligands on metal binding, EPS was characterized with higher binding ability than NOM for both fluorescent and non-fluorescent ligands. Algae-induced EPS and the non-fluorescent substances in eutrophic algae-rich lakes should not be overlooked because of their high metal binding potential.	[Xu, Huacheng; Yang, Liuyan] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resources Reuse, Nanjing, Jiangsu, Peoples R China; [Xu, Huacheng; Zhong, Jicheng; Yu, Guanghui; Jiang, Helong] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Yu, Guanghui] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Wu, Jun] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China	Nanjing University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Nanjing Agricultural University; Chinese Academy of Sciences; Institute of Soil Science, CAS	Xu, HC (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resources Reuse, Xianlin Campus, Nanjing, Jiangsu, Peoples R China.	hcxu@niglas.ac.cn; yangly@nju.edu.cn	liu, yang/HHY-8583-2022; yang, liu/GVU-8760-2022; Yu, Guanghui/H-4968-2013; Jiang, Helong/H-2709-2015	Yu, Guanghui/0000-0002-5699-779X; Jiang, He-Long/0000-0001-5528-423X; Xu, Huacheng/0000-0003-1724-6720	National Natural Science Foundation of China [51209192, 51379199, 41301241]; Natural Science Foundation of Jiangsu province, China [BK2012501]; China Postdoctoral Science Foundation [2013M540438]; Jiangsu Planned Projects for Postdoctoral Research Funds [1301007A]; State Key Laboratory of Pollution Control and Resource Reuse Foundation [PCRRF13011]; State Key Laboratory of Lake Science and Environment, Chinese Academy of Sciences [2012SKL007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province, China(Natural Science Foundation of Jiangsu Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Planned Projects for Postdoctoral Research Funds; State Key Laboratory of Pollution Control and Resource Reuse Foundation; State Key Laboratory of Lake Science and Environment, Chinese Academy of Sciences	This work was funded by the National Natural Science Foundation of China (51209192, 51379199 and 41301241), the Natural Science Foundation of Jiangsu province, China (BK2012501), the China Postdoctoral Science Foundation (2013M540438), the Jiangsu Planned Projects for Postdoctoral Research Funds (1301007A), the State Key Laboratory of Pollution Control and Resource Reuse Foundation (PCRRF13011), and the State Key Laboratory of Lake Science and Environment, Chinese Academy of Sciences (2012SKL007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla HAN, 2010, ENVIRON SCI TECHNOL, V44, P8044, DOI 10.1021/es100898x; CABANISS SE, 1992, ENVIRON SCI TECHNOL, V26, P1133, DOI 10.1021/es50002a018; Chai XL, 2012, J HAZARD MATER, V209, P59, DOI 10.1016/j.jhazmat.2011.12.077; Ghatak H., 2004, Wetlands Ecology and Management, V12, P145, DOI 10.1023/B:WETL.0000034068.68049.a3; Hays MD, 2004, ANAL CHEM, V76, P848, DOI 10.1021/ac0344135; Hernandez D, 2006, ENVIRON POLLUT, V143, P212, DOI 10.1016/j.envpol.2005.11.038; Hur J, 2011, THESCIENTIFICWORLDJO, V11, P1865, DOI 10.1100/2011/640598; Hur J, 2011, CHEMOSPHERE, V83, P1603, DOI 10.1016/j.chemosphere.2011.01.004; Landry C, 2012, ENVIRON SCI TECHNOL, V46, P1700, DOI 10.1021/es203711v; Lee BM, 2013, CHEMOSPHERE, V90, P237, DOI 10.1016/j.chemosphere.2012.06.060; Leenheer JA, 2003, ENVIRON SCI TECHNOL, V37, p18A, DOI 10.1021/es032333c; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065949; Liu LZ, 2014, J ENVIRON SCI, V26, P1725, DOI 10.1016/j.jes.2014.06.013; McIntyre AM, 2013, CHEMOSPHERE, V90, P620, DOI 10.1016/j.chemosphere.2012.08.057; Noda I., 2004, 2 DIMENSIONAL CORREL; Ohno T, 2008, ENVIRON SCI TECHNOL, V42, P186, DOI 10.1021/es071855f; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Pan XL, 2010, COLLOID SURFACE B, V80, P103, DOI 10.1016/j.colsurfb.2010.05.002; Plaza C, 2006, ENVIRON SCI TECHNOL, V40, P917, DOI 10.1021/es051687w; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Qu FS, 2012, WATER RES, V46, P2881, DOI 10.1016/j.watres.2012.02.045; SAAR RA, 1980, ANAL CHEM, V52, P2095, DOI 10.1021/ac50063a025; Shen J, 2007, HYDROBIOLOGIA, V581, P141, DOI 10.1007/s10750-006-0523-3; Sheng GP, 2013, WATER RES, V47, P607, DOI 10.1016/j.watres.2012.10.037; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076633; Wu J, 2012, ENVIRON POLLUT, V162, P63, DOI 10.1016/j.envpol.2011.10.017; Xu HC, 2013, J HAZARD MATER, V263, P412, DOI 10.1016/j.jhazmat.2013.09.042; Xu HC, 2013, ECOTOX ENVIRON SAFE, V98, P266, DOI 10.1016/j.ecoenv.2013.09.008; Xu HC, 2013, WATER RES, V47, P6506, DOI 10.1016/j.watres.2013.08.021; Xu HC, 2013, CHEMOSPHERE, V93, P75, DOI 10.1016/j.chemosphere.2013.04.077; Xu HC, 2013, WATER RES, V47, P2005, DOI 10.1016/j.watres.2013.01.019; Yamashita Y, 2008, ENVIRON SCI TECHNOL, V42, P7374, DOI 10.1021/es801357h; Yao X, 2011, CHEMOSPHERE, V82, P145, DOI 10.1016/j.chemosphere.2010.10.049; Yu GH, 2012, ENVIRON SCI TECHNOL, V46, P6102, DOI 10.1021/es3002212; Zhang DY, 2010, J HAZARD MATER, V175, P359, DOI 10.1016/j.jhazmat.2009.10.011; Zhang YL, 2011, WATER RES, V45, P5110, DOI 10.1016/j.watres.2011.07.014	36	14	16	3	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112272	10.1371/journal.pone.0112272	http://dx.doi.org/10.1371/journal.pone.0112272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380246	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100071
J	Azab, B; Camacho-Rivera, M; Taioli, E				Azab, Basem; Camacho-Rivera, Marlene; Taioli, Emanuela			Average Values and Racial Differences of Neutrophil Lymphocyte Ratio among a Nationally Representative Sample of United States Subjects	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; LONG-TERM MORTALITY; HEPATOCELLULAR-CARCINOMA; LIVER-TRANSPLANTATION; CANCER; INFLAMMATION; ASSOCIATION; RECURRENCE; SURVIVAL; RISK	Introduction: Several studies reported the negative impact of elevated neutrophil/lymphocyte ratio (NLR) on outcomes in many surgical and medical conditions. Previous studies used arbitrary NLR cut-off points according to the average of the populations under study. There is no data on the average NLR in the general population. The aim of this study is to explore the average values of NLR and according to race in adult non-institutional United States individuals by using national data. Methods: The National Health and Nutrition Examination Survey (NHANES) of aggregated cross-sectional data collected from 2007 to 2010 was analyzed; data extracted included markers of systemic inflammation (neutrophil count, lymphocyte count, and NLR), demographic variables and other comorbidities. Subjects who were prescribed steroids, chemotherapy, immunomodulators and antibiotics were excluded. Adjusted linear regression models were used to examine the association between demographic and clinical characteristics and neutrophil counts, lymphocyte counts, and NLR. Results: Overall 9427 subjects are included in this study. The average value of neutrophils is 4.3k cells/mL, of lymphocytes 2.1k cells/mL; the average NLR is 2.15. Non-Hispanic Black and Hispanic participants have significantly lower mean NLR values (1.76, 95% CI 1.71-1.81 and 2.08, 95% CI 2.04-2.12 respectively) when compared to non-Hispanic Whites (2.24, 95% CI 2.19-2.28-p<0.0001). Subjects who reported diabetes, cardiovascular disease, and smoking had significantly higher NLR than subjects who did not. Racial differences regarding the association of smoking and BMI with NLR were observed. Conclusions: This study is providing preliminary data on racial disparities in a marker of inflammation, NLR, that has been associated with several chronic diseases outcome, suggesting that different cut-off points should be set according to race. It also suggests that racial differences exist in the inflammatory response to environmental and behavioral risk factors.	[Azab, Basem] Staten Isl Univ Hosp, Dept Surg, Staten Isl, NY USA; [Camacho-Rivera, Marlene; Taioli, Emanuela] North Shore LIJ Hofstra Sch Med, Dept Populat Hlth, Great Neck, NY 11021 USA	Northwell Health; Hofstra University	Taioli, E (corresponding author), North Shore LIJ Hofstra Sch Med, Dept Populat Hlth, Great Neck, NY 11021 USA.	etaioli@nshs.edu		Camacho-Rivera, Marlene/0000-0003-2343-2941				Aliustaoglu M, 2010, HEPATO-GASTROENTEROL, V57, P640; Azab B, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-193; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Ding PR, 2010, INT J COLORECTAL DIS, V25, P1427, DOI 10.1007/s00384-010-1052-0; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Kantola T, 2012, BRIT J CANCER, V107, P1729, DOI 10.1038/bjc.2012.456; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Libby P, 2001, AM J CARDIOL, V88, p3J, DOI [DOI 10.1016/S0002-9149(01)02145-2, 10.1016/S0002-9149(01)02145-2]; LICHTMAN MA, 1970, NEW ENGL J MED, V283, P943, DOI 10.1056/NEJM197010292831801; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Ohno Y, 2010, J UROLOGY, V184, P873, DOI 10.1016/j.juro.2010.05.028; Rueda-Clausen CF, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/469169; Seals DR, 2014, PHYSIOLOGY, V29, P250, DOI 10.1152/physiol.00059.2013; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Uthamalingam S, 2011, AM J CARDIOL, V107, P433, DOI 10.1016/j.amjcard.2010.09.039; Wang XD, 2014, ATHEROSCLEROSIS, V234, P206, DOI 10.1016/j.atherosclerosis.2014.03.003; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412	26	183	186	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112361	10.1371/journal.pone.0112361	http://dx.doi.org/10.1371/journal.pone.0112361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375150	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600135
J	Chen, PL; Wu, CJ; Tsai, PJ; Tang, HJ; Chuang, YC; Lee, NY; Lee, CC; Li, CW; Li, MC; Chen, CC; Tsai, HW; Ou, CC; Chen, CS; Ko, WC				Chen, Po-Lin; Wu, Chi-Jung; Tsai, Pei-Jane; Tang, Hung-Jen; Chuang, Yin-Ching; Lee, Nan-Yao; Lee, Ching-Chi; Li, Chia-Wen; Li, Ming-Chi; Chen, Chi-Chung; Tsai, Hung-Wen; Ou, Chun-Chun; Chen, Chang-Shi; Ko, Wen-Chien			Virulence Diversity among Bacteremic Aeromonas Isolates: Ex Vivo, Animal, and Clinical Evidences	PLOS ONE			English	Article							HEMOLYTIC TOXIN GENES; SALMONELLA BACTEREMIA; NECROTIZING FASCIITIS; SOFT-TISSUE; HYDROPHILA; INFECTIONS; STRAINS; CAVIAE; AQUARIORUM; AEROLYSIN	Background: The objective of this study was to compare virulence among different Aeromonas species causing bloodstream infections. Methodology/Principal Findings: Nine of four species of Aeromonas blood isolates, including A. dhakensis, A. hydrophila, A. veronii and A. caviae were randomly selected for analysis. The species was identified by the DNA sequence matching of rpoD. Clinically, the patients with A. dhakensis bacteremia had a higher sepsis-related mortality rate than those with other species (37.5% vs. 0%, P = 0.028). Virulence of different Aeromonas species were tested in C. elegans, mouse fibroblast C2C12 cell line and BALB/c mice models. C. elegans fed with A. dhakensis and A. caviae had the lowest and highest survival rates compared with other species, respectively (all P values <0.0001). A. dhakensis isolates also exhibited more cytotoxicity in C2C12 cell line (all P values <0.0001). Fourteen-day survival rate of mice intramuscularly inoculated with A. dhakensis was lower than that of other species (all P values <0.0001). Hemolytic activity and several virulence factor genes were rarely detected in the A. caviae isolates. Conclusions/Significance: Clinical data, ex vivo experiments, and animal studies suggest there is virulence variation among clinically important Aeromonas species.	[Chen, Po-Lin; Lee, Nan-Yao; Lee, Ching-Chi; Li, Chia-Wen; Li, Ming-Chi; Ou, Chun-Chun; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Tsai, Hung-Wen] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70428, Taiwan; [Chen, Po-Lin; Wu, Chi-Jung] Natl Cheng Kung Univ, Coll Med, Grad Inst Clin Med, Tainan 70101, Taiwan; [Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Chen, Chang-Shi] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan; [Wu, Chi-Jung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Taipei, Taiwan; [Tsai, Pei-Jane] Natl Cheng Kung Univ, Res Ctr Infect Dis & Signaling, Tainan 70101, Taiwan; [Tang, Hung-Jen; Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan; [Chuang, Yin-Ching; Chen, Chi-Chung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Clin Pathol, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Health Research Institutes - Taiwan; National Cheng Kung University; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Chen, CS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan.	cschen@mail.ncku.edu.tw; winston3415@gmail.com	Ko, Wen-Chien/ABG-4316-2020; Chen, Chang-Shi/B-9251-2009; chen, chen/GRY-7085-2022; Li, Ming-Chi/AAF-5731-2020; CHEN, CHEN/HDM-6657-2022; Tsai, Pei-Jane/G-3563-2011; Wu, Chi-Jung/F-8364-2011	Ko, Wen-Chien/0000-0001-7497-149X; Chen, Chang-Shi/0000-0002-8201-3635; 	National Science Council; National Cheng Kung University Hospital; National Health Research Institutes; Ministry of Health and Welfare, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital; National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Health and Welfare, Taiwan	The study was supported by the grants from, National Science Council, National Cheng Kung University Hospital, National Health Research Institutes, and Ministry of Health and Welfare (A Landmark Project to Promote Innovation & Competitiveness of Clinical Trials by the Excellent Clinical Trial and Research Center), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Arreola MG, 2007, CAN J MICROBIOL, V53, P877, DOI 10.1139/W07-051; Aravena-Roman M, 2011, J CLIN MICROBIOL, V49, P3006, DOI 10.1128/JCM.00472-11; Bogaerts A, 2010, DEV COMP IMMUNOL, V34, P690, DOI 10.1016/j.dci.2010.02.003; CHAKRABORTY T, 1987, INFECT IMMUN, V55, P2274, DOI 10.1128/IAI.55.9.2274-2280.1987; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P543, DOI 10.1007/s10096-012-1771-y; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P245, DOI 10.1007/s10096-012-1736-1; Chao CM, 2013, J MICROBIOL IMMUNOL, V46, P144, DOI 10.1016/j.jmii.2013.02.006; Chen PL, 2007, J INTERN MED, V261, P91, DOI 10.1111/j.1365-2796.2006.01748.x; Chen PL, 2013, CLIN MICROBIOL INFEC; Chow JW, 1999, INT J ANTIMICROB AG, V11, P7, DOI 10.1016/S0924-8579(98)00060-0; Chuang HC, 2011, J KOREAN MED SCI, V26, P1415, DOI 10.3346/jkms.2011.26.11.1415; Daly KA, 2011, TISSUE ENG PART C-ME, V17, P631, DOI 10.1089/ten.tec.2010.0699; Emekdas G, 2006, INT J FOOD MICROBIOL, V107, P310, DOI 10.1016/j.ijfoodmicro.2005.10.012; GOLD WL, 1993, CLIN INFECT DIS, V16, P69, DOI 10.1093/clinids/16.1.69; Grim CJ, 2014, APPL ENVIRON MICROB, V80, P4162, DOI 10.1128/AEM.00486-14; Heuzenroeder MW, 1999, FEMS MICROBIOL LETT, V174, P131, DOI 10.1016/S0378-1097(99)00130-5; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Figueras MJ, 2009, J CLIN MICROBIOL, V47, P3742, DOI 10.1128/JCM.02216-08; KELLY KA, 1993, CLIN INFECT DIS, V16, P574, DOI 10.1093/clind/16.4.574; Kimura M, 2013, SCAND J INFECT DIS, V45, P304, DOI 10.3109/00365548.2012.737474; Ko WC, 2000, J INFECTION, V40, P267, DOI 10.1053/jinf.2000.0654; KO WC, 1995, CLIN INFECT DIS, V20, P1298, DOI 10.1093/clinids/20.5.1298; Lee CC, 2008, DIAGN MICR INFEC DIS, V62, P219, DOI 10.1016/j.diagmicrobio.2008.05.016; Lee NY, 2012, ANTIMICROB AGENTS CH, V56, P2888, DOI 10.1128/AAC.06301-11; Martino ME, 2011, APPL ENVIRON MICROB, V77, P4986, DOI 10.1128/AEM.00708-11; Morinaga Y, 2013, DIAGN MICR INFEC DIS, V76, P106, DOI 10.1016/j.diagmicrobio.2013.01.019; Osman K, 2012, WORLD J MICROB BIOT, V28, P1863, DOI 10.1007/s11274-011-0915-z; Papadakis V, 2012, J MICROBIOL IMMUNOL, V45, P154, DOI 10.1016/j.jmii.2011.09.008; Parker JL, 2011, J INFECTION, V62, P109, DOI 10.1016/j.jinf.2010.12.003; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; Santos JA, 1999, APPL ENVIRON MICROB, V65, P5612; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Tang HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091642; Van der Burg BLSB, 2006, J BONE JOINT SURG AM, V88A, P1357, DOI 10.2106/00004623-200606000-00028; Wang CY, 2009, J MICROBIOL IMMUNOL, V42, P510; Wang GH, 2003, J CLIN MICROBIOL, V41, P1048, DOI 10.1128/JCM.41.3.1048-1054.2003; Wong CYF, 1998, MICROBIOL-SGM, V144, P291, DOI 10.1099/00221287-144-2-291; Wu CJ, 2014, J MICROBIOL IMMUNOL, V47, P145, DOI 10.1016/j.jmii.2012.08.019; Wu CJ, 2012, J BACTERIOL, V194, P4114, DOI 10.1128/JB.00621-12; Yi SW, 2013, VET MICROBIOL, V164, P195, DOI 10.1016/j.vetmic.2013.02.006	40	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111213	10.1371/journal.pone.0111213	http://dx.doi.org/10.1371/journal.pone.0111213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375798	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600031
J	Correale, S; de Paola, I; Morgillo, CM; Federico, A; Zaccaro, L; Pallante, P; Galeone, A; Fusco, A; Pedone, E; Luque, FJ; Catalanotti, B				Correale, Stefania; de Paola, Ivan; Morgillo, Carmine Marco; Federico, Antonella; Zaccaro, Laura; Pallante, Pierlorenzo; Galeone, Aldo; Fusco, Alfredo; Pedone, Emilia; Luque, F. Javier; Catalanotti, Bruno			Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin	PLOS ONE			English	Article							SOLVATED INTERACTION ENERGY; UBCH10 EXPRESSION; MOLECULAR-DYNAMICS; CONJUGATING ENZYME; ACTIVATING ENZYME; DOMAINS; IDENTIFICATION; ALIGNMENT; FRAGMENT; INSIGHTS	UbcH10 is a component of the Ubiquitin Conjugation Enzymes (Ubc; E2) involved in the ubiquitination cascade controlling the cell cycle progression, whereby ubiquitin, activated by E1, is transferred through E2 to the target protein with the involvement of E3 enzymes. In this work we propose the first three dimensional model of the tetrameric complex formed by the human UbA1 (E1), two ubiquitin molecules and UbcH10 (E2), leading to the transthiolation reaction. The 3D model was built up by using an experimentally guided incremental docking strategy that combined homology modeling, proteinprotein docking and refinement by means of molecular dynamics simulations. The structural features of the in silico model allowed us to identify the regions that mediate the recognition between the interacting proteins, revealing the active role of the ubiquitin crosslinked to E1 in the complex formation. Finally, the role of these regions involved in the E1-E2 binding was validated by designing short peptides that specifically interfere with the binding of UbcH10, thus supporting the reliability of the proposed model and representing valuable scaffolds for the design of peptidomimetic compounds that can bind selectively to Ubcs and inhibit the ubiquitylation process in pathological disorders.	[Correale, Stefania] Kedr SpA, St Antimo, Na, Italy; [de Paola, Ivan; Zaccaro, Laura; Pedone, Emilia] CNR, Ist Biostrut & Bioimmagini, I-80125 Naples, Italy; [Federico, Antonella; Pallante, Pierlorenzo; Fusco, Alfredo] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Morgillo, Carmine Marco; Galeone, Aldo; Catalanotti, Bruno] Univ Naples Federico II, Dipartimento Farm, Naples, Italy; [Luque, F. Javier] Univ Barcelona, Fac Farm, Dept Fisicoquim & Inst Biomed IBUB, Santa Coloma De Gramenet, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Barcelona	Catalanotti, B (corresponding author), Univ Naples Federico II, Dipartimento Farm, Naples, Italy.	brucatal@unina.it	Pedone, Emilia/HDN-2342-2022; Pallante, Pierlorenzo/AAX-8758-2020; Catalanotti, Bruno/D-4025-2016; Galeone, Aldo/H-7248-2019; Pedone, Emilia Maria/K-2229-2015; Luque, F. Javier/L-9652-2014; de Paola, Ivan/B-6867-2017	Pedone, Emilia/0000-0003-0203-8611; Catalanotti, Bruno/0000-0002-7532-6959; Galeone, Aldo/0000-0001-8805-6348; Pedone, Emilia Maria/0000-0003-0203-8611; Luque, F. Javier/0000-0002-8049-3567; de Paola, Ivan/0000-0003-1508-6591; Fusco, Alfredo/0000-0003-3332-5197; Morgillo, Carmine Marco/0000-0002-6164-7647	HPC-EUROPA2 project [932, 1200]; European Community; Barcelona Supercomputer Center; CINECA (ISCRA project) [HP10B81QWA, HP10CNS2K3]; Icrea Academia; Spanish MCINN [SAF2011-27642]; Generalitat de Catalunya [2009SGR00249]; Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC); Italian MIUR [FIRB RBAP114AMK_006]	HPC-EUROPA2 project; European Community(European Commission); Barcelona Supercomputer Center; CINECA (ISCRA project)(CINECA, Italy); Icrea Academia(ICREA); Spanish MCINN(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC); Italian MIUR(Ministry of Education, Universities and Research (MIUR))	BC acknowledges the HPC-EUROPA2 project (projects 932 and 1200), with the support of the European Community-Research Infrastructure Action of the FP7, the Barcelona Supercomputer Center and the CINECA (ISCRA project ID HP10B81QWA and HP10CNS2K3) for the access to high performance computing resources. FJL acknowledges funding from Icrea Academia, the Spanish MCINN (SAF2011-27642), the Generalitat de Catalunya (2009SGR00249), the Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC). EP and LZ acknowledge the Italian MIUR for financial support (FIRB RBAP114AMK_006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Berlingieri MT, 2007, ONCOGENE, V26, P2136, DOI 10.1038/sj.onc.1210010; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bezsonova I, 2008, BIOCHEMISTRY-US, V47, P8937, DOI 10.1021/bi800439t; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; de Gramont A, 2006, CELL CYCLE, V5, P2168, DOI 10.4161/cc.5.18.3219; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Donato G, 2008, CLIN NEUROPATHOL, V27, P219; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fujita T, 2008, CLIN CANCER RES, V14, P1966, DOI 10.1158/1078-0432.CCR-07-1585; HAAS AL, 1982, J BIOL CHEM, V257, P2543; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Jaremko L, 2006, J BIOMOL NMR, V36, P43, DOI 10.1007/s10858-006-9015-z; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kortemme T, 2004, SCI STKE, V219, ppl2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lin YQ, 2002, J BIOL CHEM, V277, P21913, DOI 10.1074/jbc.M109398200; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Schafer A, 2014, ACTA CRYSTALLOGR D, V70, P1311, DOI 10.1107/S1399004714002910; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; Szczepanowski RH, 2005, J BIOL CHEM, V280, P22006, DOI 10.1074/jbc.M502583200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Troncone G, 2009, HISTOPATHOLOGY, V54, P731, DOI 10.1111/j.1365-2559.2009.03296.x; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921	44	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112082	10.1371/journal.pone.0112082	http://dx.doi.org/10.1371/journal.pone.0112082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375166	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600099
J	Fu, DL; Chong, T; Li, HC; Zhang, HB; Wang, ZM				Fu, Delai; Chong, Tie; Li, Hecheng; Zhang, Huibo; Wang, Ziming			Docetaxel Inhibits Urethral Stricture Formation, an Initial Study in Rabbit Model	PLOS ONE			English	Article							PACLITAXEL AMELIORATES FIBROSIS; HALOFUGINONE; PREVENTION; RECURRENCE; BINDING	Introduction: Urethral stricture, a frequent source of lower urinary tract disorders in men, is still a difficult problem for urologists. Based the anti-restenosis effect of paclitaxel on coronary artery, the role of docetaxel, a semi-synthetic analogue of paclitaxel, in limiting urethral stricture formation was studied. Methods: Forty adult New Zealand male rabbits were involved in this study, which were randomly assigned into 3 groups, namely a high dose docetaxel (D-H, 0.1 mg/d), a low dose docetaxel (D-L, 0.01 mg/d) and a control (C) group, with 16, 16, 8 rabbits in each group, respectively. All animals underwent a 10 mm-long circumferential electrocoagulation of the bulbar urethra with a 13Fr pediatric resectoscope. Drugs were given by urethral irrigation daily and continuous for 28 days. Stricture formation was assessed by retrograde urethrography and videourethroscopy. Urethra pathology was evaluated by hematoxylin and eosin staining and Sirius red staining. Results: At the end of this study, 15, 14 and 7 rabbits remained for evaluation in D-H, D-L and C group, respectively. Urethral diameters in D-H, D-L and C group were (7.17 +/- 1.63) mm, (6.55 +/- 0.62) mm, (3.23 +/- 1.36) mm, with a normal urethral diameter of (9.08 +/- 1.29) mm. Lumen reduction in D-H, D-L and C group were (36.93 +/- 11.58)%, (48.03 +/- 7.89)% and (84.66 +/- 14.95)%, respectively. Statistically difference could be found between every two groups (p<0.05) both in urethral diameters and in lumen reduction, except for compare of urethral diameters between D-H and D-L group. Histological examination confirmed mass fibrous tissue and collagen content at the stricture sit in C group, whereas less in docetaxel treated rabbits. Conclusions: Docetaxel could limit urethral stricture formation, which may be due to inhibition of fibrous tissue and collagen expression. Docetaxel may become a new choice in the prevention of urethral stricture formation.	[Fu, Delai; Chong, Tie; Li, Hecheng; Wang, Ziming] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Urol, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Zhang, Huibo] Shaanxi Tradit Chinese Med Collage, Affiliated Hosp, Dept Urol, Xianyang, Shaanxi, Peoples R China	Xi'an Jiaotong University; Shaanxi University of Chinese Medicine	Li, HC (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Urol, Sch Med, Xian 710049, Shaanxi, Peoples R China.	lhch029@aliyun.com			Fund for National Key Disciplines of the authors' hospital	Fund for National Key Disciplines of the authors' hospital	This study was supported by the Fund for National Key Disciplines of the authors' hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HL, 2003, UROL RES, V31, P363, DOI 10.1007/s00240-003-0333-2; Andersen HL, 2003, UROL RES, V31, P25, DOI 10.1007/s00240-003-0296-3; Buey RM, 2005, CHEM BIOL, V12, P1269, DOI 10.1016/j.chembiol.2005.09.010; Chong T, 2011, J PHARMACOL EXP THER, V338, P47, DOI 10.1124/jpet.110.178624; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Esmaeli B, 2006, J CLIN ONCOL, V24, P3619, DOI 10.1200/JCO.2005.04.4453; Greenwell TJ, 2004, J UROLOGY, V172, P275, DOI 10.1097/01.ju.0000132156.76403.8f; Jaidane M, 2003, J UROLOGY, V170, P2049, DOI 10.1097/01.ju.0000091262.01493.e3; Khera M, 2004, J UROLOGY, V172, P574, DOI 10.1097/01.ju.0000130652.27541.22; Kupfer I, 2003, J AM ACAD DERMATOL, V48, P279, DOI 10.1067/mjd.2003.30; Langston JP, 2009, J UROLOGY, V181, P2161, DOI 10.1016/j.juro.2009.01.044; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; Lumen N, 2009, J UROLOGY, V182, P983, DOI 10.1016/j.juro.2009.05.023; Mazdak H, 2007, EUR UROL, V51, P1089, DOI 10.1016/j.eururo.2006.11.038; Meria P, 1999, UROLOGY, V53, P1054, DOI 10.1016/S0090-4295(98)00642-6; Nagler A, 2000, J UROLOGY, V164, P1776, DOI 10.1016/S0022-5347(05)67105-4; Ostoros G, 2006, INT J GYNECOL CANCER, V16, P391, DOI 10.1111/j.1525-1438.2006.00222.x; Qi Z, 2007, CHINESE MED J, V120, P533; Sciarra A, 2005, UROLOGY, V66, P1218, DOI 10.1016/j.urology.2005.06.090; Suk KT, 2007, GASTROINTEST ENDOSC, V66, P798, DOI 10.1016/j.gie.2007.05.037; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; Waxman SW, 2006, LANCET, V367, P1379, DOI 10.1016/S0140-6736(06)68592-9; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhou J, 2010, WORLD J GASTROENTERO, V16, P3330, DOI 10.3748/wjg.v16.i26.3330; Zhou XC, 2010, CHINESE MED J-PEKING, V123, P2405, DOI 10.3760/cma.j.issn.0366-6999.2010.17.022	25	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112097	10.1371/journal.pone.0112097	http://dx.doi.org/10.1371/journal.pone.0112097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375859	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600104
J	Gunal-Sadik, G; Paszkowski-Rogacz, M; Singaravelu, K; Beyer, A; Buchholz, F; Jessberger, R				Guenal-Sadik, Gamze; Paszkowski-Rogacz, Maciej; Singaravelu, Kalaimathy; Beyer, Andreas; Buchholz, Frank; Jessberger, Rolf			Stage-Specific Binding Profiles of Cohesin in Resting and Activated B Lymphocytes Suggest a Role for Cohesin in Immunoglobulin Class Switching and Maturation	PLOS ONE			English	Article							3' REGULATORY REGION; PLASMA-CELL DIFFERENTIATION; GENE-EXPRESSION; IGH LOCUS; V(D)J RECOMBINATION; CTCF; ARCHITECTURE; ELEMENTS; IDENTIFICATION; REARRANGEMENT	The immunoglobulin heavy chain locus (Igh) features higher-order chromosomal interactions to facilitate stage-specific assembly of the Ig molecule. Cohesin, a ring-like protein complex required for sister chromatid cohesion, shapes chromosome architecture and chromatin interactions important for transcriptional regulation and often acts together with CTCF. Cohesin is likely involved in B cell activation and Ig class switch recombination. Hence, binding profiles of cohesin in resting mature murine splenic B lymphocytes and at two stages after cell activation were elucidated by chromatin immunoprecipitation and deep sequencing. Comparative genomic analysis revealed cohesin extensively changes its binding to transcriptional control elements after 48 h of stimulation with LPS/IL-4. Cohesin was clearly underrepresented at switch regions regardless of their activation status, suggesting that switch regions need to be cohesin-poor. Specific binding changes of cohesin at B-cell specific gene loci Pax5 and Blimp-1 indicate new cohesin-dependent regulatory pathways. Together with conserved cohesin/CTCF sites at the Igh 3'RR, a prominent cohesin/CTCF binding site was revealed near the 3' end of C alpha where PolII localizes to 3' enhancers. Our study shows that cohesin likely regulates B cell activation and maturation, including Ig class switching.	[Guenal-Sadik, Gamze; Jessberger, Rolf] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Physiol Chem, Dresden, Germany; [Paszkowski-Rogacz, Maciej; Buchholz, Frank] Tech Univ Dresden, Univ Hosp, Dept Med Syst Biol, Dresden, Germany; [Paszkowski-Rogacz, Maciej; Buchholz, Frank] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany; [Singaravelu, Kalaimathy; Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany; [Beyer, Andreas] Univ Cologne, CECAD, D-50931 Cologne, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; University of Cologne	Jessberger, R (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Physiol Chem, Dresden, Germany.	Rolf.Jessberger@tu-dresden.de	Buchholz, Frank/B-4700-2017; Sadık, Gamze Günal/AAX-9664-2020; Beyer, Andreas/AAQ-5519-2020	Buchholz, Frank/0000-0002-4577-3344; Beyer, Andreas/0000-0002-3891-2123; Gunal Sadik, Gamze/0000-0003-0610-0726	TUD "Support-the-best'' program; EU [SyBoSS FP7-242129]; DFG [SFB655]	TUD "Support-the-best'' program; EU(European Commission); DFG(German Research Foundation (DFG))	This work was supported by the SFB655 (DFG) to RJ and FB, the TUD "Support-the-best'' program to FB, and by the EU (SyBoSS FP7-242129) to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatterjee S, 2011, J BIOL CHEM, V286, P29303, DOI 10.1074/jbc.M111.243543; Chaumeil J, 2012, CURR OPIN IMMUNOL, V24, P153, DOI 10.1016/j.coi.2012.01.003; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Enervald E, 2013, J EXP MED, V210, P2503, DOI 10.1084/jem.20130168; Feeney KM, 2010, BIOCHEM J, V428, P147, DOI 10.1042/BJ20100151; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Haering CH, 2012, EXP CELL RES, V318, P1386, DOI 10.1016/j.yexcr.2012.03.016; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Jessberger R, 2009, EMBO J, V28, P2491, DOI 10.1038/emboj.2009.217; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jyonouchi S, 2013, PEDIATRICS, V132, pE484, DOI 10.1542/peds.2012-3815; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pawlitzky I, 2006, J IMMUNOL, V176, P6839, DOI 10.4049/jimmunol.176.11.6839; Peric-Hupkes D, 2008, CELL, V132, P925, DOI 10.1016/j.cell.2008.03.001; Perlot T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013992; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Rouaud P, 2012, J BIOL CHEM, V287, P8356, DOI 10.1074/jbc.M112.341024; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shintomi K, 2010, CHROMOSOMA, V119, P459, DOI 10.1007/s00412-010-0271-z; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Thomas-Claudepierre AS, 2013, J EXP MED, V210, P2495, DOI 10.1084/jem.20130166; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Volpi SA, 2012, J IMMUNOL, V188, P2556, DOI 10.4049/jimmunol.1102763; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964	42	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111748	10.1371/journal.pone.0111748	http://dx.doi.org/10.1371/journal.pone.0111748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375358	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600058
J	Kuo, CC; Luu, P; Morgan, KK; Dow, M; Davey, C; Song, J; Malony, AD; Tucker, DM				Kuo, Ching-Chang; Luu, Phan; Morgan, Kyle K.; Dow, Mark; Davey, Colin; Song, Jasmine; Malony, Allen D.; Tucker, Don M.			Localizing Movement-Related Primary Sensorimotor Cortices with Multi-Band EEG Frequency Changes and Functional MRI	PLOS ONE			English	Article							SOMATOSENSORY CORTEX; FINGER MOVEMENTS; OSCILLATIONS; FMRI; RHYTHMS; SYNCHRONIZATION; REPRESENTATION; LOCALIZATION; STIMULATION; ACTIVATION	Electroencephalographic (EEG) oscillations in multiple frequency bands can be observed during functional activity of the cerebral cortex. An important question is whether activity of focal areas of cortex, such as during finger movements, is tracked by focal oscillatory EEG changes. Although a number of studies have compared EEG changes to functional MRI hemodynamic responses, we can find no previous research that relates the fMRI hemodynamic activity to localization of the multiple EEG frequency changes observed in motor tasks. In the present study, five participants performed similar thumb and finger movement tasks in parallel EEG and functional MRI studies. We examined changes in five frequency bands (from 5-120 Hz) and localized them using 256 dense-array EEG (dEEG) recordings and high-resolution individual head models. These localizations were compared with fMRI localizations in the same participants. Results showed that beta-band (14-30 Hz) desynchronizations (power decreases) were the most robust effects, appearing in all individuals, consistently localized to the hand region of the primary motor cortex, and consistently aligned with fMRI localizations.	[Kuo, Ching-Chang; Luu, Phan; Morgan, Kyle K.; Davey, Colin; Song, Jasmine; Tucker, Don M.] Elect Geodes Inc, Eugene, OR USA; [Kuo, Ching-Chang; Malony, Allen D.; Tucker, Don M.] Univ Oregon, NeuroInformat Ctr, Eugene, OR 97403 USA; [Luu, Phan; Morgan, Kyle K.; Dow, Mark; Tucker, Don M.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Malony, Allen D.] Univ Oregon, Dept Comp & Informat Sci, Eugene, OR 97403 USA	University of Oregon; University of Oregon; University of Oregon	Kuo, CC (corresponding author), Elect Geodes Inc, Eugene, OR USA.	bkuo@egi.com			Department of Defense, Telemedicine Advanced Technology Research Center (TATRC); Electrical Geodesics, Inc.	Department of Defense, Telemedicine Advanced Technology Research Center (TATRC); Electrical Geodesics, Inc.	This work was supported by a contract from the Department of Defense, Telemedicine Advanced Technology Research Center (TATRC). Electrical Geodesics, Inc., provided support in the form of salaries for authors CCK, PL, KKM, CD, JS, and DMT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmadian P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00124; Bai XX, 2007, NEUROIMAGE, V35, P598, DOI 10.1016/j.neuroimage.2006.12.026; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; Brittain JS, 2014, NEUROIMAGE, V85, P637, DOI 10.1016/j.neuroimage.2013.05.084; Cheyne DO, 2013, EXP NEUROL, V245, P27, DOI 10.1016/j.expneurol.2012.08.030; Darvas F, 2010, NEUROIMAGE, V49, P930, DOI 10.1016/j.neuroimage.2009.08.041; Darvas F, 2013, J CLIN NEUROPHYSIOL, V30, P299, DOI 10.1097/WNP.0b013e3182872f40; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Eichelbaum S, 2014, NEUROIMAGE, V101, P513, DOI 10.1016/j.neuroimage.2014.04.085; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Gaetz W, 2013, NEUROIMAGE, V74, P245, DOI 10.1016/j.neuroimage.2013.02.013; Gelnar PA, 1998, NEUROIMAGE, V7, P261, DOI 10.1006/nimg.1998.0341; Gerloff C, 1998, ELECTROMYOGR MOTOR C, V109, P444, DOI 10.1016/S0924-980X(98)00045-9; Hammond DK, 2013, IEEE T MED IMAGING, V32, P1952, DOI 10.1109/TMI.2013.2271486; Hari R, 2006, PROG BRAIN RES, V159, P253, DOI 10.1016/S0079-6123(06)59017-X; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; KAAS JH, 1993, ANN ANAT, V175, P509, DOI 10.1016/S0940-9602(11)80212-8; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Lew E., 2012, FRONT NEUROENG, V5, P13, DOI [10.3389/fneng.2012.00013, DOI 10.3389/FNENG.2012.00013]; Li K, 2007, THESIS U OREGON EUGE; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Miller KJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002655; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00138; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Ojemann GA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00034; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Parkes LM, 2006, NEUROIMAGE, V29, P685, DOI 10.1016/j.neuroimage.2005.08.018; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Russell GS, 2005, CLIN NEUROPHYSIOL, V116, P1130, DOI 10.1016/j.clinph.2004.12.022; Salman A, 2005, LECT NOTES COMPUT SC, V3514, P631; Salman A, 2013, NEXT GENERATION HUMA, P234; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Seeber M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00485; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song J, 2014, SENSOR DENSITY HEAD, P620; Song J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00055; Srinivasan R, 1998, BEHAV RES METH INS C, V30, P8, DOI 10.3758/BF03209412; TANJI J, 1981, J NEUROPHYSIOL, V45, P467, DOI 10.1152/jn.1981.45.3.467; Waldert S, 2009, J PHYSIOL-PARIS, V103, P244, DOI 10.1016/j.jphysparis.2009.08.007; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	60	17	18	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112103	10.1371/journal.pone.0112103	http://dx.doi.org/10.1371/journal.pone.0112103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375957	gold, Green Submitted, Green Published			2022-12-26	WOS:000344402600105
J	McCann, SK; Dusting, GJ; Roulston, CL				McCann, Sarah K.; Dusting, Gregory J.; Roulston, Carli L.			Nox2 Knockout Delays Infarct Progression and Increases Vascular Recovery through Angiogenesis in Mice following Ischaemic Stroke with Reperfusion	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; NADPH OXIDASE; FOCAL ISCHEMIA; INJURY; INHIBITION; SUPEROXIDE; ACTIVATION; DAMAGE; ROLES; MICROGLIA	Evidence suggests the NADPH oxidases contribute to ischaemic stroke injury and Nox2 is the most widely studied subtype in the context of stroke. There is still conjecture however regarding the benefits of inhibiting Nox2 to improve stroke outcome. The current study aimed to examine the temporal effects of genetic Nox2 deletion on neuronal loss after ischaemic stroke using knockout (KO) mice with 6, 24 and 72 hour recovery. Transient cerebral ischaemia was induced via intraluminal filament occlusion and resulted in reduced infarct volumes in Nox2 KO mice at 24 h post-stroke compared to wild-type controls. No protection was evident at either 6 h or 72 h post-stroke, with both genotypes exhibiting similar volumes of damage. Reactive oxygen species were detected using dihydroethidium and were co-localised with neurons and microglia in both genotypes using immunofluorescent double-labelling. The effect of Nox2 deletion on vascular damage and recovery was also examined 24 h and 72 h post-stroke using an antibody against laminin. Blood vessel density was decreased in the ischaemic core of both genotypes 24 h post-stroke and returned to pre-stroke levels only in Nox2 KO mice by 72 h. Overall, these results are the first to show that genetic Nox2 deletion merely delays the progression of neuronal loss after stroke but does not prevent it. Additionally, we show for the first time that Nox2 deletion increases re-vascularisation of the damaged brain by 72 h, which may be important in promoting endogenous brain repair mechanisms that rely on re-vascularisation.	[McCann, Sarah K.; Roulston, Carli L.] St Vincents Hosp, OBrien Inst, Stroke Injury & Repair Team, Melbourne, Vic, Australia; [McCann, Sarah K.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Surg, Melbourne, Vic, Australia; [Dusting, Gregory J.] Royal Eye & Ear Hosp, Ctr Eye Res, Cytoprot Pharmacol Program, Melbourne, Vic, Australia; [Dusting, Gregory J.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Ophthalmol, Melbourne, Vic, Australia; [Roulston, Carli L.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Med, Melbourne, Vic, Australia	St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Roulston, CL (corresponding author), St Vincents Hosp, OBrien Inst, Stroke Injury & Repair Team, Melbourne, Vic, Australia.	carlir@unimelb.edu.au		McCann, Sarah/0000-0003-4737-2349	National Heart Foundation Australia [G07M3237]; National Health and Medical Research Council Australia [628767]; Bethlehem Griffiths Research Foundaiton	National Heart Foundation Australia(National Heart Foundation of Australia); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Bethlehem Griffiths Research Foundaiton	This work was supported by the National Heart Foundation Australia Research Grant-in-aid G07M3237 to GJD CLR, National Health and Medical Research Council Australia project grant #628767 to GJD CLR and Bethlehem Griffiths Research Foundaiton project grant to CLR GJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro S, 2011, STROKE, V42, P1495, DOI 10.1161/STROKEAHA.111.615039; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5; Callaway JK, 2000, J NEUROSCI METH, V102, P53, DOI 10.1016/S0165-0270(00)00278-8; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; Clark WM, 1997, NEUROL RES, V19, P641; Coimbra C, 1996, STROKE, V27, P1578, DOI 10.1161/01.STR.27.9.1578; Datla SR, 2007, ARTERIOSCL THROM VAS, V27, P2319, DOI 10.1161/ATVBAHA.107.149450; Doverhag C, 2008, NEUROBIOL DIS, V31, P133, DOI 10.1016/j.nbd.2008.04.003; Feuerstein GZ, 2009, STROKE, V40, pS121, DOI 10.1161/STROKEAHA.108.535104; Feuerstein GZ, 2007, J CEREB BLOOD FLOW M; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Frantz S, 2006, BASIC RES CARDIOL, V101, P127, DOI 10.1007/s00395-005-0568-x; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; GARCIA JH, 1995, STROKE, V26, P643; Genovese T, 2011, BRAIN RES, V1372, P92, DOI 10.1016/j.brainres.2010.11.088; Harrigan TJ, 2008, J NEUROCHEM, V106, P2449, DOI 10.1111/j.1471-4159.2008.05553.x; Hong H, 2006, AM J PHYSIOL-HEART C, V291, pH2210, DOI 10.1152/ajpheart.01270.2005; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kahles T, 2010, NEUROBIOL DIS, V40, P185, DOI 10.1016/j.nbd.2010.05.023; Kelly KA, 2009, BRAIN RES, V1292, P165, DOI 10.1016/j.brainres.2009.07.052; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P570, DOI 10.1097/00004647-199805000-00012; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kunz A, 2007, J CEREBR BLOOD F MET, V27, P545, DOI 10.1038/sj.jcbfm.9600369; Li B, 2009, J INNATE IMMUN, V1, P570, DOI 10.1159/000235563; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu SM, 2007, CAN J NEUROL SCI, V34, P356, DOI 10.1017/S031716710000682X; Lu Q, 2011, NITRIC OXIDE-BIOL CH, V24, P132, DOI 10.1016/j.niox.2011.01.007; McCann SK, 2008, J NEUROSCI RES, V86, P2524, DOI 10.1002/jnr.21700; McCann SK, 2013, BRAIN SCI, V3, P561, DOI 10.3390/brainsci3020561; McColl BW, 2004, BRAIN RES, V997, P15, DOI 10.1016/j.brainres.2003.10.028; Miller AA, 2009, AM J PHYSIOL-HEART C, V296, pH220, DOI 10.1152/ajpheart.00987.2008; Murotomi K, 2011, MOL CELL NEUROSCI, V46, P681, DOI 10.1016/j.mcn.2011.01.009; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Peshavariya H, 2009, N-S ARCH PHARMACOL, V380, P193, DOI 10.1007/s00210-009-0413-0; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Tang LL, 2007, J INT MED RES, V35, P517, DOI 10.1177/147323000703500411; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Taylor CJ, 2013, BRAIN SCI, V3, P294, DOI 10.3390/brainsci3010294; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; VALTYSSON J, 1994, ACTA NEUROCHIR, V129, P58, DOI 10.1007/BF01400874; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Weston RM, 2013, STROKE RES IN PRESS; Wong CHY, 2008, J NEUROCHEM, V107, P241, DOI 10.1111/j.1471-4159.2008.05605.x; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhao WY, 2009, CARDIOVASC PATHOL, V18, P156, DOI 10.1016/j.carpath.2007.12.013	57	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110602	10.1371/journal.pone.0110602	http://dx.doi.org/10.1371/journal.pone.0110602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375101	Green Published, gold			2022-12-26	WOS:000344402600016
J	Raphemot, R; Rouhier, MF; Swale, DR; Days, E; Weaver, CD; Lovell, KM; Konkel, LC; Engers, DW; Bollinger, SF; Hopkins, C; Piermarini, PM; Denton, JS				Raphemot, Rene; Rouhier, Matthew F.; Swale, Daniel R.; Days, Emily; Weaver, C. David; Lovell, Kimberly M.; Konkel, Leah C.; Engers, Darren W.; Bollinger, Sean F.; Hopkins, Corey; Piermarini, Peter M.; Denton, Jerod S.			Discovery and Characterization of a Potent and Selective Inhibitor of Aedes aegypti Inward Rectifier Potassium Channels	PLOS ONE			English	Article							K+ KIR CHANNELS; FUNCTIONAL-CHARACTERIZATION; RESISTANCE; DROSOPHILA; VECTOR	Vector-borne diseases such as dengue fever and malaria, which are transmitted by infected female mosquitoes, affect nearly half of the world's population. The emergence of insecticide-resistant mosquito populations is reducing the effectiveness of conventional insecticides and threatening current vector control strategies, which has created an urgent need to identify new molecular targets against which novel classes of insecticides can be developed. We previously demonstrated that small molecule inhibitors of mammalian Kir channels represent promising chemicals for new mosquitocide development. In this study, high-throughput screening of approximately 30,000 chemically diverse small-molecules was employed to discover potent and selective inhibitors of Aedes aegypti Kir1 (AeKir1) channels heterologously expressed in HEK293 cells. Of 283 confirmed screening 'hits', the small-molecule inhibitor VU625 was selected for lead optimization and in vivo studies based on its potency and selectivity toward AeKir1, and tractability for medicinal chemistry. In patch clamp electrophysiology experiments of HEK293 cells, VU625 inhibits AeKir1 with an IC50 value of 96.8 nM, making VU625 the most potent inhibitor of AeKir1 described to date. Furthermore, electrophysiology experiments in Xenopus oocytes revealed that VU625 is a weak inhibitor of AeKir2B. Surprisingly, injection of VU625 failed to elicit significant effects on mosquito behavior, urine excretion, or survival. However, when co-injected with probenecid, VU625 inhibited the excretory capacity of mosquitoes and was toxic, suggesting that the compound is a substrate of organic anion and/or ATP-binding cassette (ABC) transporters. The dose-toxicity relationship of VU625 (when co-injected with probenecid) is biphasic, which is consistent with the molecule inhibiting both AeKir1 and AeKir2B with different potencies. This study demonstrates proof-of-concept that potent and highly selective inhibitors of mosquito Kir channels can be developed using conventional drug discovery approaches. Furthermore, it reinforces the notion that the physical and chemical properties that determine a compound's bioavailability in vivo will be critical in determining the efficacy of Kir channel inhibitors as insecticides.	[Raphemot, Rene; Swale, Daniel R.; Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA; [Raphemot, Rene; Weaver, C. David; Lovell, Kimberly M.; Konkel, Leah C.; Engers, Darren W.; Bollinger, Sean F.; Hopkins, Corey; Denton, Jerod S.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Rouhier, Matthew F.; Piermarini, Peter M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Days, Emily; Denton, Jerod S.] Vanderbilt Univ, Sch Med, Inst Chem Biol, Nashville, TN 37212 USA; [Denton, Jerod S.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37235 USA; [Lovell, Kimberly M.; Konkel, Leah C.; Engers, Darren W.; Bollinger, Sean F.; Hopkins, Corey] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; University System of Ohio; Ohio State University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Piermarini, PM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	piermarini.1@osu.edu; jerod.s.denton@vanderbilt.edu	Piermarini, Peter/AAO-5666-2021	Piermarini, Peter/0000-0003-1020-5774	Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK082884]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082884] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a grant from the Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative. This work was also supported in part by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK082884; JSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu M, 2011, J AGR FOOD CHEM, V59, P2909, DOI 10.1021/jf102525e; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Bhave G, 2011, MOL PHARMACOL, V79, P42, DOI 10.1124/mol.110.066928; Dahal GR, 2012, DEVELOPMENT, V139, P3653, DOI 10.1242/dev.078592; Denton JS, 2013, AM J PHYSIOL-RENAL, V305, pF931, DOI 10.1152/ajprenal.00230.2013; Denton JS, 2012, TRENDS ENDOCRIN MET, V23, P41, DOI 10.1016/j.tem.2011.09.004; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Doring F, 2002, J BIOL CHEM, V277, P25554, DOI 10.1074/jbc.M202385200; Eleftherianos I, 2011, P NATL ACAD SCI USA, V108, P12024, DOI 10.1073/pnas.1108926108; Evans JM, 2005, J EXP BIOL, V208, P3771, DOI 10.1242/jeb.01829; FELLER N, 1995, FEBS LETT, V368, P385, DOI 10.1016/0014-5793(95)00677-2; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hill G, 2002, DRUG METAB DISPOS, V30, P13, DOI 10.1124/dmd.30.1.13; JAEHDE U, 1995, CLIN PHARMACOL THER, V58, P532, DOI 10.1016/0009-9236(95)90173-6; Lewis LM, 2009, MOL PHARMACOL, V76, P1094, DOI 10.1124/mol.109.059840; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; MAHARAJ R, 2011, OPEN ACCESS INSECT P, V3, P27, DOI DOI 10.2147/OAIP.S8620; Meyer JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001478; Niswender CM, 2008, MOL PHARMACOL, V73, P1213, DOI 10.1124/mol.107.041053; O'Donnell MJ, 2009, J EXP BIOL, V212, P363, DOI 10.1242/jeb.023739; O'Donnell M, 2008, ADV INSECT PHYSIOL, V35, P1, DOI 10.1016/S0065-2806(08)00001-5; Pattnaik BR, 2012, MOL GENET METAB, V105, P64, DOI 10.1016/j.ymgme.2011.10.004; Piermarini PM, 2013, INSECT BIOCHEM MOLEC, V43, P75, DOI 10.1016/j.ibmb.2012.09.009; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Raphemot R, 2013, JOVE-J VIS EXP, V71, P4209; Raphemot R, 2014, INSECT BIOCHEM MOLEC, V51, P10, DOI 10.1016/j.ibmb.2014.05.002; Raphemot R, 2014, MOL PHARMACOL, V85, P858, DOI 10.1124/mol.114.091884; Raphemot R, 2013, ASSAY DRUG DEV TECHN, V11, P532, DOI 10.1089/adt.2013.544; Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905; Raphemot R, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00075; Rouhier MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100700; Rouhier MF, 2014, INSECT BIOCHEM MOLEC, V48, P91, DOI 10.1016/j.ibmb.2014.03.003; Tice CM, 2001, PEST MANAG SCI, V57, P3, DOI 10.1002/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6; WHO, 2013, WORLD MAL REP WHO	35	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110772	10.1371/journal.pone.0110772	http://dx.doi.org/10.1371/journal.pone.0110772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375326	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600020
J	Humphries, DL; Behrman, JR; Crookston, BT; Dearden, KA; Schott, W; Penny, ME				Humphries, Debbie L.; Behrman, Jere R.; Crookston, Benjamin T.; Dearden, Kirk A.; Schott, Whitney; Penny, Mary E.		Young Lives Determinants & Consequ	Households across All Income Quintiles, Especially the Poorest, Increased Animal Source Food Expenditures Substantially during Recent Peruvian Economic Growth	PLOS ONE			English	Article							REDUCING CHILD MALNUTRITION; INTRAHOUSEHOLD ALLOCATION; HEALTH; NUTRITION; DEMAND; CONSUMPTION; NUTRIENTS; OUTCOMES; SUPPLEMENTATION; INEQUALITY	Background: Relative to plant-based foods, animal source foods (ASFs) are richer in accessible protein, iron, zinc, calcium, vitamin B-12 and other nutrients. Because of their nutritional value, particularly for childhood growth and nutrition, it is important to identify factors influencing ASF consumption, especially for poorer households that generally consume less ASFs. Objective: To estimate differential responsiveness of ASF consumption to changes in total household expenditures for households with different expenditures in a middle-income country with substantial recent income increases. Methods: The Peruvian Young Lives household panel (n = 1750) from 2002, 2006 and 2009 was used to characterize patterns of ASF expenditures. Multivariate models with controls for unobserved household fixed effects and common secular trends were used to examine nonlinear relationships between changes in household expenditures and in ASF expenditures. Results: Households with lower total expenditures dedicated greater percentages of expenditures to food (58.4% vs. 17.9% in 2002 and 24.2% vs. 21.5% in 2009 for lowest and highest quintiles respectively) and lower percentages of food expenditures to ASF (22.8% vs. 33.9% in 2002 and 30.3% vs. 37.6% in 2009 for lowest and highest quintiles respectively). Average percentages of overall expenditures spent on food dropped from 47% to 23.2% between 2002 and 2009. Households in the lowest quintiles of expenditures showed greater increases in ASF expenditures relative to total consumption than households in the highest quintiles. Among ASF components, meat and poultry expenditures increased more than proportionately for households in the lowest quintiles, and eggs and fish expenditures increased less than proportionately for all households. Conclusions: Increases in household expenditures were associated with substantial increases in consumption of ASFs for households, particularly households with lower total expenditures. Increases in ASF expenditures for all but the top quintile of households were proportionately greater than increases in total food expenditures, and proportionately less than overall expenditures.	[Humphries, Debbie L.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Behrman, Jere R.; Schott, Whitney] Univ Penn, Dept Econ, Philadelphia, PA 19104 USA; [Crookston, Benjamin T.] Brigham Young Univ, Dept Hlth Sci, Provo, UT 84602 USA; [Dearden, Kirk A.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Penny, Mary E.] Inst Invest Nutr, Lima, Peru	Yale University; University of Pennsylvania; Brigham Young University; Boston University	Humphries, DL (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.	debbie.humphries@yale.edu	Penny, Mary/J-2286-2017; Behrman, Jere R/A-9734-2009	Penny, Mary/0000-0001-5501-9399; Humphries, Debbie/0000-0002-5979-3717; Schott, Whitney/0000-0001-9303-8718	Bill & Melinda Gates Foundation (Global Health Grant) [OPP1032713]; Eunice Shriver Kennedy National Institute of Child Health and Development [R01 HD070993]; Grand Challenges Canada [0072-03]; Trustees of the University of Pennsylvania; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070993] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation (Global Health Grant); Eunice Shriver Kennedy National Institute of Child Health and Development; Grand Challenges Canada(CGIAR); Trustees of the University of Pennsylvania; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was conducted in compliance with the Principles of Ethical Practice of Public Health. The analysis in this manuscript was based on research funded by the Bill & Melinda Gates Foundation (Global Health Grant OPP1032713), Eunice Shriver Kennedy National Institute of Child Health and Development (Grant R01 HD070993) and Grand Challenges Canada (Grant 0072-03 to the Grantee, The Trustees of the University of Pennsylvania). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Abdulai A, 2004, AGR ECON-BLACKWELL, V31, P67, DOI [10.1111/j.1574-0862.2004.tb00222.x, 10.1016/j.agecon.2003.03.001]; Acosta AM, 2014, FOOD POLICY, V44, P26, DOI 10.1016/j.foodpol.2013.10.009; Agee MD, 2010, SOC SCI MED, V71, P1973, DOI 10.1016/j.socscimed.2010.09.020; Alderman H, 2006, ECON HUM BIOL, V4, P1, DOI 10.1016/j.ehb.2005.07.001; Allen LH, 2006, J PEDIATR GASTR NUTR, V43, pS8, DOI 10.1097/01.mpg.0000255845.99905.20; ANAND S, 1993, J ECON PERSPECT, V7, P133, DOI 10.1257/jep.7.1.133; Banks J, 1997, REV ECON STAT, V79, P527, DOI 10.1162/003465397557015; Barnett I, 2012, INT J EPIDEMIOL; BEHRMAN JR, 1988, OXFORD ECON PAP, V40, P32, DOI 10.1093/oxfordjournals.oep.a041845; BEHRMAN JR, 1990, J HUM RESOUR, V25, P665, DOI 10.2307/145671; BEHRMAN JR, 1989, REV ECON STAT, V71, P666, DOI 10.2307/1928109; BEHRMAN JR, 1987, J POLIT ECON, V95, P492, DOI 10.1086/261469; Behrman JR, 1999, WORLD BANK ECON REV, V13, P211, DOI 10.1093/wber/13.2.211; BEHRMAN JR, 1988, J DEV ECON, V28, P43, DOI 10.1016/0304-3878(88)90013-2; BEHRMAN JR, 1987, J ECONOMETRICS, V36, P185, DOI 10.1016/0304-4076(87)90049-2; BENNETT M. K., 1941, Wheat Studies of the Food Res. Inst., Stanford Univ., California, V18, P37; Bhaumik SK, 1999, REV DEV ECON, V3, P242; Black RE, 2013, LANCET, V382, P396; Block SA, 2007, OXFORD ECON PAP, V59, P330, DOI 10.1093/oep/gpm001; Block SA, 2004, ECON HUM BIOL, V2, P21, DOI 10.1016/j.ehb.2003.12.007; Bouis HE, 1996, J DEV ECON, V51, P239, DOI 10.1016/S0304-3878(96)00414-2; BOUIS HE, 1992, J DEV ECON, V39, P333, DOI 10.1016/0304-3878(92)90043-9; Bouis HE, 2011, FOOD NUTR BULL, V32, pS14, DOI 10.1177/15648265110321S103; Chai A, 2010, J ECON PERSPECT, V24, P225, DOI 10.1257/jep.24.1.225; Chen DH, 2014, AGRIBUSINESS, V30, P85, DOI 10.1002/agr.21368; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Deaton A., 1980, EC CONSUMER BEHAV, DOI DOI 10.1017/CBO9780511805653; DeLoach SB, 2011, WORLD DEV, V39, P1808, DOI 10.1016/j.worlddev.2011.04.009; Dror DK, 2011, FOOD NUTR BULL, V32, P227, DOI 10.1177/156482651103200307; Dury S, 2014, WHAT RISKS DO AGR IN; Ecker O, 2011, WORLD DEV, V39, P412, DOI 10.1016/j.worlddev.2010.08.002; Gittelsohn J, 2003, J NUTR, V133, p4036S, DOI 10.1093/jn/133.11.4036S; Glewwe P, 1991, DISTRIBUTION WELFARE; Gorman WilliamM., 1981, ESSAYS THEORY MEASUR; Iannotti LL, 2008, AM J CLIN NUTR, V88, P154, DOI 10.1093/ajcn/88.1.154; Krebs NF, 2011, FOOD NUTR BULL, V32, P185, DOI 10.1177/156482651103200301; Lewbel A, 2007, NEW PALGRAVE DICT EC; de Mola CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092550; Marquis GS, 1997, AM J CLIN NUTR, V66, P1102, DOI 10.1093/ajcn/66.5.1102; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; Neumann CG, 2007, J NUTR, V137, P1119, DOI 10.1093/jn/137.4.1119; PITT MM, 1990, AM ECON REV, V80, P1139; PITT MM, 1985, REV ECON STAT, V67, P212, DOI 10.2307/1924720; Rodrik D., 2014, CHALLENGE, V57, P5, DOI [10.2753/0577-5132570301, DOI 10.2753/0577-5132570301]; ROSENZWEIG MR, 1984, AM ECON REV, V74, P521; Wilson I., 2006, INT J SOC RES METHOD, V9, P351, DOI DOI 10.1080/13645570600658716; WOLFE BL, 1983, ECON DEV CULT CHANGE, V31, P525, DOI 10.1086/451340; World Bank, INT COMP PROGR DAT	48	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110961	10.1371/journal.pone.0110961	http://dx.doi.org/10.1371/journal.pone.0110961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372596	Green Submitted, Green Published, gold			2022-12-26	WOS:000344556900030
J	Wang, HD; Liu, SK; Cui, J; Li, CZ; Qiu, XM; Chang, YQ; Liu, ZJ; Wang, XL				Wang, Hongdi; Liu, Shikai; Cui, Jun; Li, Chengze; Qiu, Xuemei; Chang, Yaqing; Liu, Zhanjiang; Wang, Xiuli			Characterization and Expression Analysis of MicroRNAs in the Tube Foot of Sea Cucumber Apostichopus japonicus	PLOS ONE			English	Article							GENE-EXPRESSION; HUMAN HEALTH; SMALL RNAS; IDENTIFICATION; PATTERNS; HUNDREDS; TARGETS; MIRNAS; PCR	MicroRNAs (miRNAs) are a class of endogenous non-coding small RNA with average length of 22 nucleotides, participating in the post-transcriptional regulation of gene expression. In this study, we report the identification and characterization of miRNAs in the tube foot of sea cucumber (Apostichopus japonicus) by next generation sequencing with Illumina HiSeq 2000 platform. Through the bioinformatic analysis, we identified 260 conserved miRNAs and six novel miRNAs from the tube foot small RNA transcriptome. Quantitative realtime PCR (qRT-PCR) was performed to characterize the specific expression in the tube foot. The results indicated that four miRNAs, including miR-29a, miR-29b, miR-2005 and miR-278-3p, were significantly up-regulated in the tube foot. The target genes of the four specifically expressed miRNAs were predicted in silico and validated by performing qRT-PCR. Gene ontology (GO) and KEGG pathway analyses with the target genes of these four miRNAs were conducted to further understand the regulatory function in the tube foot. This is the first study to profile the miRNA transcriptome of the tube foot in sea cucumber. This work will provide valuable genomic resources to understand the mechanisms of gene regulation in the tube foot, and will be useful to assist the molecular breeding in sea cucumber.	[Wang, Hongdi; Cui, Jun; Li, Chengze; Qiu, Xuemei; Chang, Yaqing; Wang, Xiuli] Dalian Ocean Univ, Key Lab Mariculture & Stock Enhancement North Chi, Minist Agr, Dalian, Peoples R China; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Program Cell & Mol Biosci, Aquat Genom Unit, Auburn, AL 36849 USA	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Auburn University System; Auburn University; Auburn University System; Auburn University	Wang, XL (corresponding author), Dalian Ocean Univ, Key Lab Mariculture & Stock Enhancement North Chi, Minist Agr, Dalian, Peoples R China.	xiuliwang417@sina.com	Cui, Jun/P-9378-2015; Li, Chengze/AAU-7168-2021; Liu, Shikai/AAO-2247-2021; Liu, Zhanjiang/R-9633-2019	Li, Chengze/0000-0002-1519-750X; Liu, Shikai/0000-0001-5777-489X; 	State 863 High-Technology R & D Project of China [2012AA10A412]; Dalian Ocean University [2012HYDX02]	State 863 High-Technology R & D Project of China(National High Technology Research and Development Program of China); Dalian Ocean University	This project was supported by the State 863 High-Technology R & D Project of China (2012AA10A412) and the grant of Dalian Ocean University (2012HYDX02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Bizuayehu TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061378; Chang YQ, 2011, AFR J BIOTECHNOL, V10, P13780; Chang YQ, 2009, MAR ECOL-EVOL PERSP, V30, P455, DOI 10.1111/j.1439-0485.2009.00292.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076120; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Enright AJ, 2004, GENOME BIOL, V5; Feng Z, 2009, STUDY EMBRYONIC DEV; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Hong F, 2008, FOOD NUTR CHINA, V2, P54; Huang CW, 2012, J ANIM SCI, V90, P4266, DOI 10.2527/jas.2012-5142; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inacio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041158; Jeffrey SS, 2008, NAT BIOTECHNOL, V26, P400, DOI 10.1038/nbt0408-400; Kadri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029217; Katzman RL, 1970, COLLOQUE INT PHOTOGR; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; [李丹彤 LI Dantong], 2006, [大连水产学院学报, Journal of Dalian Fisheries College], V21, P278; Li DT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055107, 10.1371/journal.pone.0059360]; Li SC, 2010, GENOMICS, V96, P1, DOI 10.1016/j.ygeno.2010.03.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Poething RS, 2002, CURR BIOL, V12, pR699; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; Song JL, 2012, DEV BIOL, V362, P104, DOI 10.1016/j.ydbio.2011.11.015; Sun HJ, 2013, FISH SHELLFISH IMMUN, V34, P147, DOI 10.1016/j.fsi.2012.10.014; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Wang Y, 2009, SPECTROSC SPECT ANAL, V29, P511, DOI 10.3964/j.issn.1000-0593(2009)02-0511-04; Wang ZhePing, 2012, South China Fisheries Science, V8, P64; Watkins S. M., 2002, Food lipids: chemistry, nutrition, and biotechnology, P559; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Xiang Yi-hui, 2006, Fisheries Science (Liaoning), V25, P280; Xu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-521; Xu ZB, 2013, MOL BIOL REP, V40, P4075, DOI 10.1007/s11033-012-2485-z; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036	49	4	5	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111820	10.1371/journal.pone.0111820	http://dx.doi.org/10.1371/journal.pone.0111820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372871	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900078
J	Zou, J; Baghdayan, AS; Payne, SJ; Shankar, N				Zou, Jun; Baghdayan, Arto S.; Payne, Sarah J.; Shankar, Nathan			A TIR Domain Protein from E-faecalis Attenuates MyD88-Mediated Signaling and NF-kappa B Activation	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSES; MALTOSE-BINDING PROTEIN; ENTEROCOCCUS-FAECALIS; ESCHERICHIA-COLI; BACTERIAL VIRULENCE; INNATE IMMUNITY; MACROPHAGES; SURVIVAL; FAMILY; SUBVERSION	Toll-like receptor signaling, mediated by functional Toll/interleukin-1 receptor (TIR) domains, plays a critical role in activating the innate immune response responsible for controlling and clearing infection. Bacterial protein mimics of components of this signaling pathway have been identified and function through inhibition of interactions between Toll-like receptors (TLRs) and their adaptor proteins, mediated by TIR domains. A previously uncharacterized gene, which we have named tcpF (for TIR domain-containing protein in E. faecalis) was identified in the genome of Enterococcus faecalis V583, and predicted to encode a protein resembling mammalian and bacterial TIR proteins. We overexpressed and purified TcpF from E. coli and found that the recombinant protein could bind to phosphatidylinositol phosphates in vitro, suggesting a mechanism by which TcpF may be anchored to the plasma membrane in close proximity to TIR domains of TLRs and adaptor proteins. Purified TcpF was also found to interact specifically with the TIR adaptor protein MyD88, and this interaction was dependent on the BB loop domain in the Box 2 region of TcpF. Despite no evidence of TcpF being a secreted protein, recombinant TcpF was effectively able to enter RAW264.7 cells in vitro although the mechanism by which this occurs remains to be determined. Overexpression of TcpF in mammalian cells suppressed the NF-kappa B activation induced by bacterial lipoteichoic acid. A mutant lacking the tcpF gene was attenuated for survival in macrophages, with increased ability to activate NF-kappa B compared to the wild type strain. Complementation in trans restored growth, and inhibition of NF-kappa B, to that of wild type levels. No appreciable difference in bacterial persistence, dissemination or pathogenesis was observed between the wild type and mutant in a mouse peritonitis model however, which suggested either a subtle role for TcpF or functional overlap with other redundant factor(s) in this virulence model.	[Zou, Jun; Shankar, Nathan] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73106 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Shankar, N (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73106 USA.	nathan-shankar@ouhsc.edu			Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103640-01]; President's Associates Presidential Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103640] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; President's Associates Presidential Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103640-01, and by a President's Associates Presidential Professorship (N.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Askarian F, 2014, J INNATE IMMUN, V6, P485, DOI 10.1159/000357618; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bates PA, 2001, PROTEINS, P39; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Coburn PS, 2008, INFECT IMMUN, V76, P5668, DOI 10.1128/IAI.00930-08; Daw K, 2012, FEMS IMMUNOL MED MIC, V65, P270, DOI 10.1111/j.1574-695X.2012.00944.x; Ding Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020008; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gentry-Weeks CR, 1999, INFECT IMMUN, V67, P2160, DOI 10.1128/IAI.67.5.2160-2165.1999; Goh LL, 2003, PROTEIN EXPRES PURIF, V32, P194, DOI 10.1016/S1046-5928(03)00225-0; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kajfasz JK, 2012, INFECT IMMUN, V80, P2265, DOI 10.1128/IAI.00026-12; Knodler LA, 2001, NAT REV MOL CELL BIO, V2, P578, DOI 10.1038/35085062; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Nieto C, 2003, PLASMID, V49, P281, DOI 10.1016/S0147-619X(03)00020-9; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; PALMER KL, 2010, J BACTERIOL; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radhakrishnan GK, 2010, BIOCHEM BIOPH RES CO, V397, P59, DOI 10.1016/j.bbrc.2010.05.056; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Spear AM, 2012, MICROBIOL-SGM, V158, P1593, DOI 10.1099/mic.0.055012-0; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Sussmuth SD, 2000, INFECT IMMUN, V68, P4900; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Thurlow LR, 2009, J BACTERIOL, V191, P6203, DOI 10.1128/JB.00592-09; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zhang Q, 2011, DEV COMP IMMUNOL, V35, P461, DOI 10.1016/j.dci.2010.11.013	51	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112010	10.1371/journal.pone.0112010	http://dx.doi.org/10.1371/journal.pone.0112010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369374	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000136
J	Li, RW; Giarrizzo, JG; Wu, ST; Li, WZ; Duringer, JM; Craig, AM				Li, Robert W.; Giarrizzo, Juan Gabriel; Wu, Sitao; Li, Weizhong; Duringer, Jennifer M.; Craig, A. Morrie			Metagenomic Insights into the RDX-Degrading Potential of the Ovine Rumen Microbiome	PLOS ONE			English	Article							HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE RDX; CLOSTRIDIUM-KLUYVERI; DEGRADATION; BIOTRANSFORMATION; CYTOCHROME-P450; BIODEGRADATION; TRANSFORMATION; GORDONIA; CLONING; GENES	The manufacturing processes of royal demolition explosive (RDX), or hexahydro-1,3,5-trinitro-1,3,5-triazine, have resulted in serious water contamination. As a potential carcinogen, RDX can cause a broad range of harmful effects to humans and animals. The ovine rumen is capable of rapid degradation of nitroaromatic compounds, including RDX. While ruminal RDX-degrading bacteria have been identified, the genes and pathways responsible for RDX degradation in the rumen have yet to be characterized. In this study, we characterized the metabolic potential of the ovine rumen using metagenomic approaches. Sequences homologous to at least five RDX-degrading genes cloned from environmental samples (diaA, xenA, xenB, xplA, and xplB) were present in the ovine rumen microbiome. Among them, diaA was the most abundant, likely reflective of the predominance of the genus Clostridium in the ovine rumen. At least ten genera known to harbor RDX-degrading microorganisms were detectable. Metagenomic sequences were also annotated using public databases, such as Pfam, COG, and KEGG. Five of the six Pfam protein families known to be responsible for RDX degradation in environmental samples were identified in the ovine rumen. However, increased substrate availability did not appear to enhance the proliferation of RDX-degrading bacteria and alter the microbial composition of the ovine rumen. This implies that the RDX-degrading capacity of the ovine rumen microbiome is likely regulated at the transcription level. Our results provide metagenomic insights into the RDX-degrading potential of the ovine rumen, and they will facilitate the development of novel and economic bioremediation strategies.	[Li, Robert W.] ARS, USDA, Agr Res Serv, Anim Genom & Improvement Lab, Beltsville, MD 20705 USA; [Giarrizzo, Juan Gabriel; Craig, A. Morrie] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Duringer, Jennifer M.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); Oregon State University; University of California System; University of California San Diego; Oregon State University	Li, RW (corresponding author), ARS, USDA, Agr Res Serv, Anim Genom & Improvement Lab, Beltsville, MD 20705 USA.	Robert.Li@ars.usda.gov; a.morrie.craig@oregonstate.edu	Li, Weizhong/A-9735-2008	Li, Weizhong/0000-0003-1804-9403; Craig, Morrie/0000-0001-8566-8875	Oregon Agricultural Experiment Station [ORE00871]; United States Department of Agriculture Agricultural Research Service [1245-32000-093-00D]	Oregon Agricultural Experiment Station; United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the Oregon Agricultural Experiment Station (Project ORE00871) and United States Department of Agriculture Agricultural Research Service (Project 1245-32000-093-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andeer PF, 2009, APPL ENVIRON MICROB, V75, P3258, DOI 10.1128/AEM.02396-08; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernstein A, 2013, ENVIRON SCI TECHNOL, V47, P479, DOI 10.1021/es302691g; Bhushan B, 2003, APPL ENVIRON MICROB, V69, P1347, DOI 10.1128/AEM.69.3.1347-1351.2003; Bhushan B, 2002, BIOCHEM BIOPH RES CO, V296, P779, DOI 10.1016/S0006-291X(02)00874-4; Blehert DS, 1999, J BACTERIOL, V181, P6254, DOI 10.1128/JB.181.20.6254-6263.1999; Castro-Carrera T, 2014, J DAIRY SCI, V97, P1661, DOI 10.3168/jds.2013-7243; Chakraborty S, 2008, BIOSCI BIOTECH BIOCH, V72, P735, DOI 10.1271/bbb.70606; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; De Lorme M, 2009, CURR MICROBIOL, V58, P81, DOI 10.1007/s00284-008-9281-y; Eaton HL, 2013, APPL MICROBIOL BIOT, V97, P3699, DOI 10.1007/s00253-012-4172-3; Eaton HL, 2011, MICROB ECOL, V62, P274, DOI 10.1007/s00248-011-9809-8; Eaton HL, 2014, FEMS MICROBIOL LETT, V350, P34, DOI 10.1111/1574-6968.12316; Ellison MJ, 2014, DNA RES, V21, P115, DOI 10.1093/dnares/dst044; Fuller ME, 2009, APPL MICROBIOL BIOT, V84, P535, DOI 10.1007/s00253-009-2024-6; Giarrizzo JG, 2013, J CHROMATOGR B, V925, P70, DOI 10.1016/j.jchromb.2013.02.033; Halasz A, 2012, ENVIRON SCI TECHNOL, V46, P7245, DOI 10.1021/es3011964; Hawari J, 2000, APPL MICROBIOL BIOT, V54, P605, DOI 10.1007/s002530000445; Hayete B, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P127; Indest KJ, 2013, APPL ENVIRON MICROB, V79, P1746, DOI 10.1128/AEM.03905-12; Indest KJ, 2010, APPL ENVIRON MICROB, V76, P6329, DOI 10.1128/AEM.01217-10; Jackson RG, 2007, P NATL ACAD SCI USA, V104, P16822, DOI 10.1073/pnas.0705110104; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Khan MI, 2012, J MICROBIOL BIOTECHN, V22, P1311, DOI 10.4014/jmb.1203.04002; Kittelmann Sandra, 2013, PLoS One, V8, pe47879, DOI 10.1371/journal.pone.0047879; Kitts CL, 2000, CAN J MICROBIOL, V46, P278, DOI 10.1139/cjm-46-3-278; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Livermore JA, 2013, ENVIRON SCI TECHNOL, V47, P7672, DOI 10.1021/es4012788; Namiki Toshiaki, 2012, Nucleic Acids Res, V40, pe155, DOI 10.1093/nar/gks678; Niu BF, 2011, BIOINFORMATICS, V27, P1704, DOI 10.1093/bioinformatics/btr252; Omoniyi LA, 2014, J APPL MICROBIOL, V116, P1094, DOI 10.1111/jam.12450; Perumbakkam S, 2012, CURR MICROBIOL, V65, P195, DOI 10.1007/s00284-012-0144-1; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rodgers JD, 2001, WATER RES, V35, P2101, DOI 10.1016/S0043-1354(00)00505-4; Rylott EL, 2011, BBA-PROTEINS PROTEOM, V1814, P230, DOI 10.1016/j.bbapap.2010.07.004; Rylott EL, 2009, TRENDS BIOTECHNOL, V27, P73, DOI 10.1016/j.tibtech.2008.11.001; Seth-Smith HMB, 2002, APPL ENVIRON MICROB, V68, P4764, DOI 10.1128/AEM.68.10.4764-4771.2002; Shi W, 2014, GENOME RES; Talmage Sylvia S., 1999, Reviews of Environmental Contamination and Toxicology, V161, P1; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thompson KT, 2005, APPL ENVIRON MICROB, V71, P8265, DOI 10.1128/AEM.71.12.8265-8272.2005; Weimer PJ, 2012, APPL MICROBIOL BIOT, V94, P461, DOI 10.1007/s00253-011-3751-z; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wilke A, 2013, METHOD ENZYMOL, V531, P487, DOI 10.1016/B978-0-12-407863-5.00022-8; Williams AGB, 2005, ENVIRON SCI TECHNOL, V39, P5183, DOI 10.1021/es0490525; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470	48	12	12	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110505	10.1371/journal.pone.0110505	http://dx.doi.org/10.1371/journal.pone.0110505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383623	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700007
J	Chen, L; Choyke, PL; Wang, NY; Clarke, R; Bhujwalla, ZM; Hillman, EMC; Wang, G; Wang, Y				Chen, Li; Choyke, Peter L.; Wang, Niya; Clarke, Robert; Bhujwalla, Zaver M.; Hillman, Elizabeth M. C.; Wang, Ge; Wang, Yue			Unsupervised Deconvolution of Dynamic Imaging Reveals Intratumor Vascular Heterogeneity and Repopulation Dynamics	PLOS ONE			English	Article							TUMOR HETEROGENEITY; BREAST-CANCER; MRI; KINETICS	With the existence of biologically distinctive malignant cells originated within the same tumor, intratumor functional heterogeneity is present in many cancers and is often manifested by the intermingled vascular compartments with distinct pharmacokinetics. However, intratumor vascular heterogeneity cannot be resolved directly by most in vivo dynamic imaging. We developed multi-tissue compartment modeling (MTCM), a completely unsupervised method of deconvoluting dynamic imaging series from heterogeneous tumors that can improve vascular characterization in many biological contexts. Applying MTCM to dynamic contrast-enhanced magnetic resonance imaging of breast cancers revealed characteristic intratumor vascular heterogeneity and therapeutic responses that were otherwise undetectable. MTCM is readily applicable to other dynamic imaging modalities for studying intratumor functional and phenotypic heterogeneity, together with a variety of foreseeable applications in the clinic.	[Chen, Li] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Choyke, Peter L.] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA; [Chen, Li; Wang, Niya; Wang, Yue] Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Arlington, VA 22203 USA; [Clarke, Robert] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA; [Hillman, Elizabeth M. C.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Wang, Ge] Rensselaer Polytech Inst, Biomed Imaging Ctr, Dept Biomed Engn, Troy, NY 12180 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Virginia Polytechnic Institute & State University; Georgetown University; Johns Hopkins University; Columbia University; Rensselaer Polytechnic Institute	Wang, Y (corresponding author), Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Arlington, VA 22203 USA.	yuewang@vt.edu	Wang, Ge/AAH-8592-2020; Hillman, Elizabeth M C/B-9854-2009; Clarke, Robert/A-6485-2008	Wang, Ge/0000-0002-2656-7705; Clarke, Robert/0000-0002-9278-0854; Hillman, Elizabeth M. C./0000-0001-5511-1451	National Institutes of Health [EB000830, NS29525, CA149147]; NATIONAL CANCER INSTITUTE [ZIABC010714, U54CA149147, U01CA184902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB000830, R33EB000830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health under Grants EB000830, NS29525, and CA149147. The funder's URL is http://www.nih.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cong WX, 2014, APPL OPTICS, V53, P5672, DOI 10.1364/AO.53.005672; Cong WX, 2014, OPT EXPRESS, V22, P5572, DOI 10.1364/OE.22.005572; Costouros Nick G, 2002, Mol Imaging, V1, P301, DOI 10.1162/153535002760235481; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kim E, 2012, ANN BIOMED ENG, V40, P2425, DOI 10.1007/s10439-012-0585-5; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Li KL, 2005, J MAGN RESON IMAGING, V22, P511, DOI 10.1002/jmri.20387; Li X, 2013, MAGN RESON MED; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; O'Connor JPB, 2011, BRIT J CANCER, V105, P139, DOI 10.1038/bjc.2011.191; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Padhani AR, 2003, BRIT J RADIOL, V76, pS60, DOI 10.1259/bjr/15334380; Port RE, 1999, JMRI-J MAGN RESON IM, V10, P233; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shibata D, 2012, SCIENCE, V336, P304, DOI 10.1126/science.1222361; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Wang C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.025003; Wang FY, 2010, IEEE T PATTERN ANAL, V32, P875, DOI 10.1109/TPAMI.2009.72; Wang Y, 2001, IEEE T INF TECHNOL B, V5, P150, DOI 10.1109/4233.924805; Wang Y, 2002, P IEEE INT S BIOM IM, P178; WAX M, 1985, IEEE T ACOUST SPEECH, V33, P387, DOI 10.1109/TASSP.1985.1164557; Yankeelov TE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005686; Yuan YY, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004330; Zhou Y, 1997, IEEE T NUCL SCI, V44, P2522, DOI 10.1109/23.656461	33	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112143	10.1371/journal.pone.0112143	http://dx.doi.org/10.1371/journal.pone.0112143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379705	Green Published, gold, Green Submitted			2022-12-26	WOS:000344863100056
J	Humphreys, KJ; McKinnon, RA; Michael, MZ				Humphreys, Karen J.; McKinnon, Ross A.; Michael, Michael Z.			miR-18a Inhibits CDC42 and Plays a Tumour Suppressor Role in Colorectal Cancer Cells	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; TERTIARY STRUCTURE; MIR-17-92 CLUSTER; EXPRESSION; MICRORNA; ADENOCARCINOMA; GTPASES; TARGET; GENE; RHO	The miR-17-92 cluster of microRNAs is elevated in colorectal cancer, and has a causative role in cancer development. Of the six miR-17-92 cluster members, miR-19a and b in particular are key promoters of cancer development and cell proliferation, while preliminary evidence suggests that miR-18a may act in opposition to other cluster members to decrease cell proliferation. It was hypothesised that miR-18a may have a homeostatic function in helping to contain the oncogenic effect of the entire miR-17-92 cluster, and that elevated miR-17-92 cluster activity without a corresponding increase in miR-18a may promote colorectal tumour progression. In colorectal cancer samples and corresponding normal colorectal mucosa, miR-18a displayed lower overall expression than other miR-17-92 cluster members. miR-18a was shown to have an opposing role to other miR-17-92 cluster members, in particular the key oncogenic miRNAs, miR-19a and b. Transfection of HCT116 and LIM1215 colorectal cancer cell lines with miR-18a mimics decreased proliferation, while a miR-18a inhibitor increased proliferation. miR-18a was also responsible for decreasing cell migration, altering cell morphology, inducing G1/S phase cell cycle arrest, increasing apoptosis, and enhancing the action of a pro-apoptotic agent. CDC42, a mediator of the PI3K pathway, was identified as a novel miR-18a target. Overexpression of miR-18a reduced CDC42 expression, and a luciferase assay confirmed that miR-18a directly targets the 3'UTR of CDC42. miR-18a mimics had a similar effect on proliferation as a small molecule inhibitor of CDC42. Inhibition of CDC42 expression is likely to be a key mechanism by which miR-18a impairs cancer cell growth, with a target protector experiment revealing miR-18a influences proliferation via direct inhibition of CDC42. Inhibition of CCND1 by miR-18a may also assist in this growth-suppression effect. The homeostatic function of miR-18a within the miR-17-92 cluster in colorectal cancer cells may be achieved through suppression of CDC42 and the PI3K pathway.	[Humphreys, Karen J.; McKinnon, Ross A.; Michael, Michael Z.] Flinders Univ S Australia, Flinders Med Ctr, Flinders Ctr Innovat Canc, Sch Med, Adelaide, SA 5001, Australia	Flinders Medical Centre; Flinders University South Australia	Michael, MZ (corresponding author), Flinders Univ S Australia, Flinders Med Ctr, Flinders Ctr Innovat Canc, Sch Med, Adelaide, SA 5001, Australia.	michael.michael@flinders.edu.au	McKinnon, Ross Allan/B-9340-2009	McKinnon, Ross Allan/0000-0002-3725-793X; Michael, Michael/0000-0001-5954-7105	Flinders Centre for Innovation in Cancer Research Grant; Cancer Council SA's Beat Cancer Project; State Government of South Australia through the Department of Health	Flinders Centre for Innovation in Cancer Research Grant; Cancer Council SA's Beat Cancer Project(Cancer Council South Australia); State Government of South Australia through the Department of Health	The study was funded by a Flinders Centre for Innovation in Cancer Research Grant. This study was produced with the financial and other support of Cancer Council SA's Beat Cancer Project on behalf of its donors and the State Government of South Australia through the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Carlin LM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001729; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chakraborty S, 2012, RNA, V18, P1014, DOI 10.1261/rna.031039.111; Chaulk SG, 2011, RNA BIOL, V8, P1105, DOI 10.4161/rna.8.6.17410; Chen HY, 2013, EMBO MOL MED, V5, P723, DOI 10.1002/emmm.201202140; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Dar AA, 2013, JNCI-J NATL CANCER I, V105, P433, DOI 10.1093/jnci/djt003; Del Pulgar TG, 2008, INT J ONCOL, V33, P185; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujiya M, 2013, ONCOGENE; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Guil S, 2009, INT J BIOCHEM CELL B, V41, P87, DOI 10.1016/j.biocel.2008.09.005; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hong L, 2013, J BIOL CHEM, V288, P8531, DOI 10.1074/jbc.M112.435941; Humphreys KJ, 2013, MOL CARCINOGEN, V52, P459, DOI 10.1002/mc.21879; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iacomino G, 2001, BIOCHEM BIOPH RES CO, V285, P1280, DOI 10.1006/bbrc.2001.5323; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jin HY, 2013, EMBO J, V32, P2377, DOI 10.1038/emboj.2013.178; Kahlert C, 2011, CANCER SCI, V102, P1799, DOI 10.1111/j.1349-7006.2011.02023.x; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066275; Mariadason JM, 2000, CANCER RES, V60, P4561; Marques CA, 2008, BLOOD, V111, P1413, DOI 10.1182/blood-2007-05-089458; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olive V, 2013, ELIFE, V2, DOI 10.7554/eLife.00822; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Pothula S, 2013, INVEST OPHTH VIS SCI, V54, P5343, DOI 10.1167/iovs.13-11955; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Rao E, 2012, LEUKEMIA, V26, P1064, DOI 10.1038/leu.2011.305; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sakamori R, 2014, CANC RES; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Stengel KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037317; Tao J, 2012, MOL MED REP, V5, P167, DOI 10.3892/mmr.2011.591; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yu G, 2012, J SURG ONCOL, V106, P232, DOI 10.1002/jso.22138	57	69	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112288	10.1371/journal.pone.0112288	http://dx.doi.org/10.1371/journal.pone.0112288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379703	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100074
J	Njihia, TN; Jaramillo, J; Murungi, L; Mwenda, D; Orindi, B; Poehling, HM; Torto, B				Njihia, Teresiah Nyambura; Jaramillo, Juliana; Murungi, Lucy; Mwenda, Dickson; Orindi, Benedict; Poehling, Hans-Michael; Torto, Baldwyn			Spiroacetals in the Colonization Behaviour of the Coffee Berry Borer: A 'Push-Pull' System	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; HYPOTHENEMUS-HAMPEI COLEOPTERA; DENDROCTONUS-PONDEROSAE HOPKINS; BARK BEETLE; IPS-TYPOGRAPHUS; CURCULIONIDAE SCOLYTINAE; PHEROMONE PRODUCTION; FIELD RESPONSE; VOLATILES; SEMIOCHEMICALS	Coffee berries are known to release several volatile organic compounds, among which is the spiroacetal, conophthorin, an attractant for the coffee berry borer Hypothenemus hampei. Elucidating the effects of other spiroacetals released by coffee berries is critical to understanding their chemo-ecological roles in the host discrimination and colonization process of the coffee berry borer, and also for their potential use in the management of this pest. Here, we show that the coffee berry spiroacetals frontalin and 1,6-dioxaspiro [4.5] decane (referred thereafter as brocain), are also used as semiochemicals by the coffee berry borer for host colonization. Bioassays and chemical analyses showed that crowding coffee berry borers from 2 to 6 females per berry, reduced borer fecundity, which appeared to correlate with a decrease in the emission rates of conophthorin and frontalin over time. In contrast, the level of brocain did not vary significantly between borer-uninfested and infested berries. Brocain was attractive at lower doses, but repellent at higher doses while frontalin alone or in a blend was critical for avoidance. Field assays with a commercial attractant comprising a mixture of ethanol and methanol (1:1), combined with frontalin, confirmed the repellent effect of this compound by disrupting capture rates of H. hampei females by 77% in a coffee plantation. Overall, our results suggest that the levels of frontalin and conophthorin released by coffee berries determine the host colonization behaviour of H. hampei, possibly through a 'push-pull' system, whereby frontalin acts as the 'push' (repellent) and conophthorin acting as the 'pull' (attractant). Furthermore, our results reveal the potential use of frontalin as a repellent for management of this coffee pest.	[Njihia, Teresiah Nyambura; Jaramillo, Juliana; Murungi, Lucy; Mwenda, Dickson; Orindi, Benedict; Torto, Baldwyn] Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya; [Njihia, Teresiah Nyambura; Murungi, Lucy] Jomo Kenyatta Univ Agr & Technol, Dept Hort, Nairobi, Kenya; [Jaramillo, Juliana; Poehling, Hans-Michael] Leibniz Univ Hannover, Inst Hort Prod Syst Plant Protect, D-30167 Hannover, Germany	International Centre of Insect Physiology & Ecology (ICIPE); Jomo Kenyatta University of Agriculture & Technology; Leibniz University Hannover	Jaramillo, J (corresponding author), Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya.	jjaramillos@gmail.com		Orindi, Benedict/0000-0002-4601-7890; Njihia, Teresiah/0000-0002-8982-2259	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDARD WD, 1980, J CHEM ECOL, V6, P997, DOI 10.1007/BF00994657; Blomquist GJ, 2010, INSECT BIOCHEM MOLEC, V40, P699, DOI 10.1016/j.ibmb.2010.07.013; Borden JH, 1998, CHEMOECOLOGY, V8, P69, DOI 10.1007/PL00001806; BRUN LO, 1994, B ENTOMOL RES, V84, P175, DOI 10.1017/S0007485300039651; Bustillo A. E., 1998, HYPOTHENEMUS HAMPEI; Byers JA, 1998, NATURWISSENSCHAFTEN, V85, P557, DOI 10.1007/s001140050551; BYERS JA, 1989, HOLARCTIC ECOL, V12, P466; BYERS JA, 1984, ENVIRON ENTOMOL, V13, P1191, DOI 10.1093/ee/13.5.1191; CORBET SA, 1971, NATURE, V232, P481, DOI 10.1038/232481b0; Dallara PL, 2000, CAN ENTOMOL, V132, P889, DOI 10.4039/Ent132889-6; Damon A, 2000, B ENTOMOL RES, V90, P453, DOI 10.1017/S0007485300000584; GONGORA C, 2001, C SOC COL ENT, V28, P47; Huber DPW, 1999, J CHEM ECOL, V25, P805, DOI 10.1023/A:1020892700653; Huber DPW, 2001, J CHEM ECOL, V27, P217, DOI 10.1023/A:1005668019434; Jactel H., 2003, Integrated Pest Management Reviews, V6, P197, DOI 10.1023/A:1025775419193; Jaramillo J, 2006, B ENTOMOL RES, V96, P223, DOI 10.1079/BER2006434; Jaramillo J, 2009, ENTOMOL EXP APPL, V130, P275, DOI 10.1111/j.1570-7458.2008.00820.x; Jaramillo Juliana, 2013, PLoS ONE, V8, P1, DOI 10.1371/journal.pone.0074277; Kraker JD, 1988, COFFEE BERRY BORER H; Liu ZD, 2013, CHEM SENSES, V38, P485, DOI 10.1093/chemse/bjt019; Mejia M. J. W., 2002, Revista Colombiana de Entomologia, V28, P167; Mendesil E, 2009, J CHEM ECOL, V35, P944, DOI 10.1007/s10886-009-9685-6; Morewood WD, 2003, J CHEM ECOL, V29, P2115, DOI 10.1023/A:1025690519818; Nufio CR, 2001, ENTOMOL EXP APPL, V99, P273, DOI 10.1023/A:1019204817341; PAYNE TL, 1978, ENVIRON ENTOMOL, V7, P578, DOI 10.1093/ee/7.4.578; Pureswaran DS, 2004, CHEMOECOLOGY, V14, P67, DOI 10.1007/s00049-003-0260-2; Pureswaran DS, 2000, CHEMOECOLOGY, V10, P153, DOI 10.1007/PL00001818; R Development Core Team, 2014, R VERS 3 1 0 LANG EN; RAFFA KF, 1983, CAN ENTOMOL, V115, P723, DOI 10.4039/Ent115723-7; ROITBERG BD, 1991, OIKOS, V61, P389, DOI 10.2307/3545246; RUDINSKY JA, 1974, ENVIRON ENTOMOL, V3, P90, DOI 10.1093/ee/3.1.90; Ruiz-Cardenas R, 2010, SCI AGR, V67, P658, DOI 10.1590/S0103-90162010000600007; RYKER LC, 1982, J CHEM ECOL, V8, P1399, DOI 10.1007/BF01403103; SAS Institute, 1999, SAS STAT US GUID; SCHLYTER F, 1987, J CHEM ECOL, V13, P1503, DOI 10.1007/BF01012294; Stelinski Lukasz L., 2009, Communicative & Integrative Biology, V2, P391; Strom BL, 2013, ENVIRON ENTOMOL, V42, P323, DOI 10.1603/EN12300; Strom BL, 1999, ECOL APPL, V9, P1028, DOI 10.1890/1051-0761(1999)009[1028:VASDOH]2.0.CO;2; SZENTESI A, 1981, ENTOMOL EXP APPL, V30, P219, DOI 10.1007/BF00347701; Vega FE, 2011, J ECON ENTOMOL, V104, P87, DOI 10.1603/EC10353; Vega Fernando E., 2009, Terrestrial Arthropod Reviews, V2, P129; VITE JP, 1985, NATURWISSENSCHAFTEN, V72, P99, DOI 10.1007/BF00508146; Zhang QH, 1999, J CHEM ECOL, V25, P2847, DOI 10.1023/A:1020816011131; ZHANG QH, 1992, J APPL ECOL, V29, P672, DOI 10.2307/2404475	46	18	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111316	10.1371/journal.pone.0111316	http://dx.doi.org/10.1371/journal.pone.0111316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380135	Green Published, gold			2022-12-26	WOS:000344863100025
J	O'Rourke, JP; Daly, SM; Triplett, KD; Peabody, D; Chackerian, B; Hall, PR				O'Rourke, John P.; Daly, Seth M.; Triplett, Kathleen D.; Peabody, David; Chackerian, Bryce; Hall, Pamela R.			Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; ALPHA-HEMOLYSIN; VIRULENCE DETERMINANTS; MONOCLONAL-ANTIBODIES; IMMUNOGENIC DISPLAY; BACTERIOPHAGE PP7; DIVERSE PEPTIDES; SKIN INFECTION; TOXIN; IDENTIFICATION	A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and then presenting them to the immune system in a context that mimics their native conformation. We have engineered novel virus-like-particle (VLP) technology that is able to display complex libraries of random peptide sequences on a surface-exposed loop in the coat protein without disruption of protein folding or VLP assembly. This technology allows us to use the same VLP particle for both affinity selection and immunization, integrating the power of epitope discovery and epitope mimicry of traditional phage display with the high immunogenicity of VLPs. Previously, we showed that using affinity selection with our VLP platform identifies linear epitopes of monoclonal antibodies and subsequent immunization generates the proper antibody response. To test if our technology could identify immunologic mimotopes, we used affinity selection on a monoclonal antibody (AP4-24H11) that recognizes the Staphylococcus aureus autoinducing peptide 4 (AIP4). AIP4 is a secreted eight amino acid, cyclized peptide produced from the S. aureus accessory gene regulator (agrIV) quorum-sensing operon. The agr system coordinates density dependent changes in gene expression, leading to the upregulation of a host of virulence factors, and passive transfer of AP4-24H11 protects against S. aureus agrIV-dependent pathogenicity. In this report, we identified a set of peptides displayed on VLPs that bound with high specificity to AP4-24H11. Importantly, similar to passive transfer with AP4-24H11, immunization with a subset of these VLPs protected against pathogenicity in a mouse model of S. aureus dermonecrosis. These data are proof of principle that by performing affinity selection on neutralizing antibodies, our VLP technology can identify peptide mimics of non-linear epitopes and that these mimotope based VLP vaccines provide protection against pathogens in relevant animal models.	[O'Rourke, John P.; Peabody, David; Chackerian, Bryce] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Daly, Seth M.; Triplett, Kathleen D.; Hall, Pamela R.] Univ New Mexico, Sch Med, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	O'Rourke, JP (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	jorourkejr@salud.unm.edu; phall@salud.unm.edu	Daly, Seth/H-6395-2019; Hall, Pamela/O-5402-2016	Daly, Seth/0000-0002-3532-8810; Hall, Pamela/0000-0003-2367-3382	NIH [R01 AI083305, RO1 AI091917]; University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant [T32-AI007538]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083305, R01AI091917, T32AI007538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JPO and BC were supported by NIH grant R01 AI083305. SMD was supported by the University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant (T32-AI007538). PH was supported by NIH grant RO1 AI091917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; BHAKDI S, 1989, INFECT IMMUN, V57, P3512, DOI 10.1128/IAI.57.11.3512-3519.1989; Bose JL, 2014, INFECT IMMUN, V82, P1813, DOI 10.1128/IAI.01655-13; Brady CS, 2000, TISSUE ANTIGENS, V55, P401, DOI 10.1034/j.1399-0039.2000.550502.x; Caldeira JC, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-22; Caldeira Jerri C., 2007, Journal of Nanobiotechnology, V5, P10, DOI 10.1186/1477-3155-5-10; Caldeira JD, 2010, VACCINE, V28, P4384, DOI 10.1016/j.vaccine.2010.04.049; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Chackerian B, 2011, J MOL BIOL, V409, P225, DOI 10.1016/j.jmb.2011.03.072; Cheung GYC, 2012, EXPERT OPIN THER TAR, V16, P601, DOI 10.1517/14728222.2012.682573; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Folettit D, 2013, J MOL BIOL, V425, P1641, DOI 10.1016/j.jmb.2013.02.008; Fowler VG, 2014, CLIN MICROBIOL INFEC, V20, P66, DOI 10.1111/1469-0691.12570; Hall PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003166; Hua L, 2014, ANTIMICROB AGENTS CH, V58, P1108, DOI 10.1128/AAC.02190-13; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; Jennings GT, 2008, BIOL CHEM; Kaufmann GF, 2008, EXPERT OPIN BIOL TH, V8, P719, DOI 10.1517/14712598.8.6.719 ; Kaufmann GF, 2011, METHODS MOL BIOL, V692, P299, DOI 10.1007/978-1-60761-971-0_22; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kirchdoerfer RN, 2011, J BIOL CHEM, V286, P17351, DOI 10.1074/jbc.M111.231258; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Malachowa Natalia, 2013, Methods Mol Biol, V1031, P109, DOI 10.1007/978-1-62703-481-4_14; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Mihailova M, 2006, VACCINE, V24, P4369, DOI 10.1016/j.vaccine.2006.02.051; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Peabody DS, 2008, J MOL BIOL, V380, P252, DOI 10.1016/j.jmb.2008.04.049; Peterson MM, 2008, CELL HOST MICROBE, V4, P555, DOI 10.1016/j.chom.2008.10.001; Pynnonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002104; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Schlievert PM, 2007, BIOCHEMISTRY-US, V46, P14349, DOI 10.1021/bi701202w; Sully EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004174; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; Tkaczyk C, 2012, CLIN VACCINE IMMUNOL, V19, P377, DOI 10.1128/CVI.05589-11; Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102	46	20	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111198	10.1371/journal.pone.0111198	http://dx.doi.org/10.1371/journal.pone.0111198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379726	Green Submitted, Green Published, gold			2022-12-26	WOS:000344863100021
J	Oyen, J; Diamantopoulos, AP; Haugeberg, G				Oyen, Jannike; Diamantopoulos, Andreas P.; Haugeberg, Glenn			Mortality after Distal Radius Fracture in Men and Women Aged 50 Years and Older in Southern Norway	PLOS ONE			English	Article							OSTEOPOROTIC FRACTURES; HIP FRACTURE; ELDERLY-MEN; RISK-FACTOR; EPIDEMIOLOGY; FOREARM	Increased mortality rates in patients sustaining hip and vertebral fractures are well documented; however in distal radius fracture patients the results are conflicting. The aim of this study was to examine short-and long-term mortality in distal radius fracture patient in comparison with the background population. Patients aged >= 50 years with distal radius fracture living in Southern Norway who suffered a fracture in the two year period 2004 and 2005 were included in the study. The mortality risk of the standard Norwegian population was used to calculate the standardized mortality ratio (SMR). The number of distal radius fractures was 883 (166 men and 717 women). Mean age was 69 years (men 65 years and women 70 years). After one year the overall mortality rate was 3.4% (men 5.4% and women 2.9%) and after five years 4.6% (men 4.0% and women 4.8%). The SMR for men and women compared to the Norwegian population for the first year was 1.6 (95% confidence interval (CI): 0.6, 2.7) and 0.9 (95% CI: 0.4, 1.2), respectively, and after five years 1.7 (95% CI: 0.3, 3.0) and 2.0 (95% CI: 1.2, 2.7). Stratified on age groups (50-70 and >70 years) an increased SMR was only seen in female patients aged > 70 years five years after the fracture (SMR: 1.9, 95% CI: 1.1, 2.6). In conclusion, increased SMR was found in female patients aged > 70 years five years after the distal radius fracture, but not in men or in women younger than 70 years.	[Oyen, Jannike] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Diamantopoulos, Andreas P.; Haugeberg, Glenn] Hosp Southern Norway, Dept Rheumatol, Kristiansand, Norway; [Haugeberg, Glenn] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Oyen, J (corresponding author), Natl Inst Nutr & Seafood Res, Bergen, Norway.	jannike.oyen@nifes.no	Øyen, Jannike/G-4156-2017; Øyen, Jannike/H-9857-2018	Øyen, Jannike/0000-0002-5590-5136; Øyen, Jannike/0000-0002-5590-5136	Competence Development Fund of Southern Norway; Hospital of Southern Norway Trust	Competence Development Fund of Southern Norway; Hospital of Southern Norway Trust	This work was supported and funded by the Competence Development Fund of Southern Norway and Hospital of Southern Norway Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Diamantopoulos AP, 2013, CLIN INTERV AGING, V8, P817, DOI 10.2147/CIA.S45468; Diamantopoulos AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043367; Diamantopoulos AP, 2012, AGE AGEING, V41, P86, DOI 10.1093/ageing/afr114; Endres HG, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-87; Gronskag AB, 2012, OSTEOPOROSIS INT, V23, P1807, DOI 10.1007/s00198-011-1811-y; HOVE LM, 1995, SCAND J PLAST RECONS, V29, P263, DOI 10.3109/02844319509050137; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Lofthus CM, 2008, OSTEOPOROSIS INT, V19, P781, DOI 10.1007/s00198-007-0499-5; MALLMIN H, 1993, CALCIFIED TISSUE INT, V52, P269, DOI 10.1007/BF00296650; McLellan AR, 2003, OSTEOPOROSIS INT, V14, P1028, DOI 10.1007/s00198-003-1507-z; Omsland TK, 2014, MORTALITY FOLLOWING; Oyen J, 2010, OSTEOPOROSIS INT, V21, P1257, DOI 10.1007/s00198-009-1068-x; Oyen J, 2010, OSTEOPOROSIS INT, V21, P1247, DOI 10.1007/s00198-009-1065-0; Oyen J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-67; Oyen J, 2011, J BONE JOINT SURG AM, V93A, P348, DOI 10.2106/JBJS.J.00303; Oyen J, 2011, BONE, V48, P1140, DOI 10.1016/j.bone.2011.01.021; Rozental TD, 2002, J HAND SURG-AM, V27A, P948, DOI 10.1053/jhsu.2002.36995; Shortt NL, 2005, J ORTHOP TRAUMA, V19, P396, DOI 10.1097/01.bot.0000155311.04886.7e; Statistics, NORW ALD DODSF MENN	22	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112098	10.1371/journal.pone.0112098	http://dx.doi.org/10.1371/journal.pone.0112098			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380128	Green Published, Green Submitted, gold			2022-12-26	WOS:000344863100052
J	Cornman, RS; Robertson, LS; Galbraith, H; Blakeslee, C				Cornman, Robert S.; Robertson, Laura S.; Galbraith, Heather; Blakeslee, Carrie			Transcriptomic Analysis of the Mussel Elliptio complanata Identifies Candidate Stress-Response Genes and an Abundance of Novel or Noncoding Transcripts	PLOS ONE			English	Article							PROTEIN	Mussels are useful indicator species of environmental stress and degradation, and the global decline in freshwater mussel diversity and abundance is of conservation concern. Elliptio complanata is a common freshwater mussel of eastern North America that can serve both as an indicator and as an experimental model for understanding mussel physiology and genetics. To support genetic components of these research goals, we assembled transcriptome contigs from Illumina paired-end reads. Despite efforts to collapse similar contigs, the final assembly was in excess of 136,000 contigs with an N50 of 982 bp. Even so, comparisons to the CEGMA database of conserved eukaryotic genes indicated that similar to 20% of genes remain unrepresented. However, numerous candidate stress-response genes were present, and we identified lineage-specific patterns of diversification among molluscs for cytochrome P450 detoxification genes and two saccharide-modifying enzymes: 1,3 beta-galactosyltransferase and fucosyltransferase. Less than a quarter of contigs had protein-level similarity based on modest BLAST and Hmmer3 statistical thresholds. These results add comparative genomic resources for molluscs and suggest a wealth of novel proteins and noncoding transcripts.	[Cornman, Robert S.; Robertson, Laura S.] US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA; [Galbraith, Heather; Blakeslee, Carrie] US Geol Survey, Leetown Sci Ctr, Northern Appalachian Res Branch, Wellsboro, PA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Cornman, RS (corresponding author), US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA.	rcornman@usgs.gov			United States Geological Survey, Ecosystems Mission Area; Leetown Science Center; Northern Appalachian Research Branch	United States Geological Survey, Ecosystems Mission Area; Leetown Science Center; Northern Appalachian Research Branch	This project was funded and carried out by the United States Geological Survey, Ecosystems Mission Area, with internal discretionary funds of its Leetown Science Center and Northern Appalachian Research Branch. Websites describing the facilities, staff, and operations of these research centers are at http://www.lsc.usgs.gov/ and http://www.lsc.usgs.gov/?q=northern-appalachian-research-branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard-Triquet C., 2013, CRC PRESS, DOI [10.1080/03067319.2013.870269, DOI 10.1080/03067319.2013.870269]; Andrews S, FASTQC SOFTWARE; Arrial RT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-239; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berg DJ, 1995, J N AM BENTHOL SOC, V14, P577, DOI 10.2307/1467542; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Matozzo V, 2008, ENVIRON INT, V34, P531, DOI 10.1016/j.envint.2007.09.008; Meng J, 2013, PLOS ONE; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pelis RM, 2001, AM J PHYSIOL-REG I, V280, pR1844, DOI 10.1152/ajpregu.2001.280.6.R1844; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161	26	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112420	10.1371/journal.pone.0112420	http://dx.doi.org/10.1371/journal.pone.0112420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375103	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600142
J	Fortini, BK; Tring, S; Plummer, SJ; Edlund, CK; Moreno, V; Bresalier, RS; Barry, EL; Church, TR; Figueiredo, JC; Casey, G				Fortini, Barbara K.; Tring, Stephanie; Plummer, Sarah J.; Edlund, Christopher K.; Moreno, Victor; Bresalier, Robert S.; Barry, Elizabeth L.; Church, Timothy R.; Figueiredo, Jane C.; Casey, Graham			Multiple Functional Risk Variants in a SMAD7 Enhancer Implicate a Colorectal Cancer Risk Haplotype	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; SUPER-ENHANCERS; CELL IDENTITY; COLON; IDENTIFICATION; METAANALYSIS; EXPRESSION; ELEMENTS; DISEASE	Genome-wide association studies (GWAS) of colorectal cancer (CRC) have led to the identification of a number of common variants associated with modest risk. Several risk variants map within the vicinity of TGF beta/BMP signaling pathway genes, including rs4939827 within an intron of SMAD7 at 18q21.1. A previous study implicated a novel SNP (novel 1 or rs58920878) as a functional variant within an enhancer element in SMAD7 intron 4. In this study, we show that four SNPs including novel 1 (rs6507874, rs6507875, rs8085824, and rs58920878) in linkage disequilibrium (LD) with the index SNP rs4939827 demonstrate allele-specific enhancer effects in a large, multi-component enhancer of SMAD7. All four SNPs demonstrate allele-specific protein binding to nuclear extracts of CRC cell lines. Furthermore, some of the risk-associated alleles correlate with increased expression of SMAD7 in normal colon tissues. Finally, we show that the enhancer is responsive to BMP4 stimulation. Taken together, we propose that the associated CRC risk at 18q21.1 is due to four functional variants that regulate SMAD7 expression and potentially perturb a BMP negative feedback loop in TGF beta/BMP signaling pathways.	[Fortini, Barbara K.; Tring, Stephanie; Plummer, Sarah J.; Edlund, Christopher K.; Figueiredo, Jane C.; Casey, Graham] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Moreno, Victor] CIBERESP, Catalan Inst Oncol, Canc Prevent & Control Program, Barcelona, Spain; [Moreno, Victor] Univ Barcelona, Hosp Llobregat, Barcelona, Spain; [Bresalier, Robert S.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Barry, Elizabeth L.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Lebanon, NH USA; [Church, Timothy R.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA	University of Southern California; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; University of Texas System; UTMD Anderson Cancer Center; Dartmouth College; University of Minnesota System; University of Minnesota Twin Cities	Fortini, BK (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	Barbara.Fortini@med.usc.edu	Moreno, Victor/A-1697-2010; Barry, Elizabeth/AAB-7916-2019; Church, Timothy/AAH-7017-2020	Moreno, Victor/0000-0002-2818-5487; Church, Timothy/0000-0003-3292-5035; Bresalier, Robert/0000-0002-9740-281X; Fortini, Barbara/0000-0003-3230-2604	National Institutes of Health [R01 CA143237, U19 CA148107]; Genetic Associations and Mechanisms in Oncology (GAME-ON), an NCI Cancer Post-GWAS Initiative; NATIONAL CANCER INSTITUTE [U19CA148107, R01CA143237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetic Associations and Mechanisms in Oncology (GAME-ON), an NCI Cancer Post-GWAS Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01 CA143237, U19 CA148107 to GC). The scientific development and funding of this project was in part supported by the Genetic Associations and Mechanisms in Oncology (GAME-ON), an NCI Cancer Post-GWAS Initiative. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health, who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, COLD SPRING HARB PRO, V2009; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Biancolella M, 2014, HUM MOL GENET, V23, P2198, DOI 10.1093/hmg/ddt584; Bitzer M, 2000, GENE DEV, V14, P187; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Brodin G, 2000, J BIOL CHEM, V275, P29023, DOI 10.1074/jbc.M002815200; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Derynck R, 2007, TGF BETA FAMILY CELL; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Gulubova M, 2010, INT J COLORECTAL DIS, V25, P591, DOI 10.1007/s00384-010-0906-9; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lampropoulos P, 2012, CANCER LETT, V314, P1, DOI 10.1016/j.canlet.2011.09.041; LaVange LM, 2006, CIRCULATION, V114, P2528, DOI 10.1161/CIRCULATIONAHA.106.613638; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Rizzo A, 2014, CARCINOGENESIS; Rizzo A, 2011, CANCER RES, V71, P7423, DOI 10.1158/0008-5472.CAN-11-1895; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Stolfi C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.49; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Wallace K, 2010, CANCER PREV RES, V3, P1552, DOI 10.1158/1940-6207.CAPR-10-0047; Whiffin N, 2013, HUM MOL GENET, V22, P5075, DOI 10.1093/hmg/ddt357; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018	40	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111914	10.1371/journal.pone.0111914	http://dx.doi.org/10.1371/journal.pone.0111914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375357	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600074
J	Nakamasu, A; Nakayama, H; Nakayama, N; Suematsu, NJ; Kimura, S				Nakamasu, Akiko; Nakayama, Hokuto; Nakayama, Naomi; Suematsu, Nobuhiko J.; Kimura, Seisuke			A Developmental Model for Branching Morphogenesis of Lake Cress Compound Leaf	PLOS ONE			English	Article							POLAR AUXIN TRANSPORT; ESCHSCHOLZIA-CALIFORNICA; PATTERN-FORMATION; ARABIDOPSIS; PAPAVERACEAE; INITIATION; FRAMEWORK; GROWTH; GENE	Lake cress, Rorippa aquatica (Brassicaceae), is a semi-aquatic plant that exhibits a variety of leaf shapes, from simple leaves to highly branched compound leaves, depending on the environment. Leaf shape can vary within a single plant, suggesting that the variation can be explained by a simple model. In order to simulate the branched structure in the compound leaves of R. aquatica, we implemented reaction-diffusion (RD) patterning onto a theoretical framework that had been developed for serration distribution in the leaves of Arabidopsis thaliana, with the modification of the one-dimensional reaction-diffusion domain being deformed with the spatial periodicity of the RD pattern while expanding. This simple method using an iterative pattern could create regular and nested branching patterns. Subsequently, we verified the plausibility of our theoretical model by comparing it with the experimentally observed branching patterns. The results suggested that our model successfully predicted both the qualitative and quantitative aspects of the timing and positioning of branching in growing R. aquatica leaves.	[Nakamasu, Akiko; Nakayama, Hokuto; Kimura, Seisuke] Kyoto Sangyo Univ, Fac Life Sci, Dept Bioresource & Environm Sci, Kyoto 603, Japan; [Nakamasu, Akiko; Suematsu, Nobuhiko J.] Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo 101, Japan; [Nakayama, Naomi] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh, Lothian, Scotland; [Suematsu, Nobuhiko J.] Meiji Univ, Grad Sch Adv Math Sci, Tokyo 101, Japan	Kyoto Sangyo University; Meiji University; University of Edinburgh	Suematsu, NJ (corresponding author), Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo 101, Japan.	suematsu@meiji.ac.jp; seisuke@cc.kyoto-su.ac.jp	Suematsu, Nobuhiko J/L-3409-2017	Suematsu, Nobuhiko/0000-0001-5860-4147; Kimura, Seisuke/0000-0002-6796-3675	Meiji University Global COE Program "Formation and Development of Mathematical Sciences Based on Modeling and Analysis''; JSPS KAKENHI [22870031, 24770047]; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan	Meiji University Global COE Program "Formation and Development of Mathematical Sciences Based on Modeling and Analysis''; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This study was supported by Grant-in-Aid for JSPS Fellows (http://www.jsps.go.jp/english/e-grants/index.html) to A.N. and H.N. and by Meiji University Global COE Program "Formation and Development of Mathematical Sciences Based on Modeling and Analysis'' (http://gcoe.mims.meiji.ac.jp/index-e.html) to A.N. and N.J.S. In addition, it was partially supported by JSPS KAKENHI Grant Numbers 22870031 and 24770047 and the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan (http://www.shigaku.go.jp/g_about_pmac.htm) to S. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkoulas M, 2008, NAT GENET, V40, P1136, DOI 10.1038/ng.189; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Crampin EJ, 2002, B MATH BIOL, V64, P747, DOI 10.1006/bulm.2002.0295; Fisher JB, 1997, BOT GAZ, V138, P377; Gleissberg S, 2004, AM J BOT, V91, P306, DOI 10.3732/ajb.91.3.306; Hay A, 2006, DEVELOPMENT, V133, P3955, DOI 10.1242/dev.02545; Ikeuchi M, 2014, PLANTA, V240, P125, DOI 10.1007/s00425-014-2071-9; Ikeuchi M, 2013, AM J BOT, V100, P1116, DOI 10.3732/ajb.1200560; Kimura S, 2008, CURR BIOL, V18, P672, DOI 10.1016/j.cub.2008.04.008; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Meinhardt H, 1995, ALGOLISMIC BEAUTY SE, P31; Meinhardt H., 1982, MODELS BIOL PATTERN; Miura T, 2008, CURR TOP DEV BIOL, V81, P291, DOI 10.1016/S0070-2153(07)81010-6; Nakayama H., 2012, PLANT MORPHOL, V24, P57; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Prsinkiewicz P, 1990, ALGORITHMIC BEAUTY P; Prusinkiewicz P., 2013, SPRINGER P MATH, V15, P137, DOI DOI 10.1007/978-3-642-20164-6_12; Prusinkiewicz P, 2012, NEW PHYTOL, V193, P549, DOI 10.1111/j.1469-8137.2011.04009.x; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Sethian JA, 1999, CAMBRIDGE MONOGRAPHS; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; van Berkel K, 2013, DEVELOPMENT, V140, P2253, DOI 10.1242/dev.079111; Vlad D, 2014, SCIENCE, V343, P780, DOI 10.1126/science.1248384	26	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111615	10.1371/journal.pone.0111615	http://dx.doi.org/10.1371/journal.pone.0111615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375102	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600052
J	Patrick, WS; Cope, J				Patrick, Wesley S.; Cope, Jason			Examining the 10-Year Rebuilding Dilemma for US Fish Stocks	PLOS ONE			English	Article							FISHERIES MANAGEMENT; CLIMATE-CHANGE; RECOVERY; IMPACTS; RESTORATION; UNCERTAINTY; STRATEGIES; TARGETS; COD	Worldwide, fishery managers strive to maintain fish stocks at or above levels that produce maximum sustainable yields, and to rebuild overexploited stocks that can no longer support such yields. In the United States, rebuilding overexploited stocks is a contentious issue, where most stocks are mandated to rebuild in as short a time as possible, and in a time period not to exceed 10 years. Opponents of such mandates and related guidance argue that rebuilding requirements are arbitrary, and create discontinuities in the time and fishing effort allowed for stocks to rebuild due to differences in productivity. Proponents, however, highlight how these mandates and guidance were needed to curtail the continued overexploitation of these stocks by setting firm deadlines on rebuilding. Here we evaluate the statements made by opponents and proponents of the 10-year rebuilding mandate and related guidance to determine whether such points are technically accurate using a simple population dynamics model and a database of U.S. fish stocks to parameterize the model. We also offer solutions to many of the issues surrounding this mandate and its implementation by recommending some fishing mortality based frameworks, which meet the intent of the 10-year rebuilding requirement while also providing more flexibility.	[Patrick, Wesley S.] Natl Marine Fisheries Serv, Off Sustainable Fisheries, Silver Spring, MD 20910 USA; [Cope, Jason] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Patrick, WS (corresponding author), Natl Marine Fisheries Serv, Off Sustainable Fisheries, Silver Spring, MD 20910 USA.	Wesley.Patrick@noaa.gov						[Anonymous], 1989, FED REGISTER, V54, P30826; [Anonymous], [No title captured]; Bell JD, 2006, FISH RES, V80, P1, DOI 10.1016/j.fishres.2006.03.008; Berkson J., 2011, NMFSSEFSC616 NOAA; Brodziak J, 2005, CAN J FISH AQUAT SCI, V62, P544, DOI 10.1139/F04-199; Caddy JF, 2001, OCEAN COAST MANAGE, V44, P653, DOI 10.1016/S0964-5691(01)00074-6; Cadrin SX, 1997, FISH B-NOAA, V95, P445; Carmichael J., 2011, NAT SSC WORKSH ABC C; Caswell, 2000, MATRIX POPULATION MO; Clark CW, 2005, J ENVIRON ECON MANAG, V50, P47, DOI 10.1016/j.jeem.2004.11.002; Collie J, 2013, ECOL APPL, V23, P374, DOI 10.1890/12-0877.1; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Curtis R., 2007, FISHERIES BUYBACKS; Federal Register, 1998, FED REGISTER, V63, P24212; FishBase, 2013, EST LIF HIST KEY FAC; Guenette S, 2000, B MAR SCI, V66, P831; Hasselman DJ, 2012, MAR COAST FISH, V4, P174, DOI 10.1080/19425120.2012.675968; Hilborn R, 2012, CONSERV BIOL, V26, DOI 10.1111/j.1523-1739.2011.01800.x; Hollowed AB, 2011, ICES J MAR SCI, V68, P984, DOI 10.1093/icesjms/fsr085; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Jacob S, 2009, FISHERIES, V34, P228, DOI 10.1577/1548-8446-34.5.228; Jacobson LD, 2002, FISH B-NOAA, V100, P519; Jensen OP, 2012, THEOR ECOL-NETH, V5, P3, DOI 10.1007/s12080-011-0146-9; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; Lande Russell, 2001, Conservation Biology Series (Cambridge), V6, P67; Longhurst AR., 2010, MISMANAGEMENT MARINE; MACE PM, 1994, CAN J FISH AQUAT SCI, V51, P110, DOI 10.1139/f94-013; Methot RD, 2014, ICES J MAR SCI, V71, P183, DOI 10.1093/icesjms/fst119; Milazzo MJ, 2012, REV FISH BIOL FISHER, V22, P273, DOI 10.1007/s11160-011-9219-5; Murawski SA, 2010, ICES J MAR SCI, V67, P1830, DOI 10.1093/icesjms/fsq125; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Myers RA, 1997, FISH B-NOAA, V95, P762; Neubauer P, 2013, SCIENCE, V340, P347, DOI 10.1126/science.1230441; New Zealand Ministry of Fisheries, 2014, OP GUID NZ HARV STRA; NMFS (National Marine Fisheries Service), 2013, STAT US FISH; NRC (National Research Council), 2013, EV EFF FISH STOCK RE; Pacific Fishery Management Council, 2012, TERMS REF GROUNDF CO; Patrick WS, 2013, OCEAN COAST MANAGE, V71, P64, DOI 10.1016/j.ocecoaman.2012.11.002; Patrick WS, 2013, MAR POLICY, V38, P470, DOI 10.1016/j.marpol.2012.07.007; Pauly D, 2007, AMBIO, V36, P290, DOI 10.1579/0044-7447(2007)36[290:TSAUPD]2.0.CO;2; Punt AE, 2003, FISH B-NOAA, V101, P860; Punt AE, 2012, FISH RES, V134, P113, DOI 10.1016/j.fishres.2012.08.014; Punt AE, 2011, FISH RES, V109, P320, DOI 10.1016/j.fishres.2011.02.019; Ralston S, 2011, FISH B-NOAA, V109, P217; Restrepo V.R., 1998, NOAA TECHNICAL MEMOR, V56; Restrepo VR, 1999, ICES J MAR SCI, V56, P846, DOI 10.1006/jmsc.1999.0546; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; Safina C, 2005, SCIENCE, V309, P707, DOI 10.1126/science.1113725; Sewell B, 2013, R1301A NAT RES DEF C; Smith T. D., 1994, SCALING FISHERIES SC; Stewart I.J., 2009, REBUILDING ANAL CANA; Thompson Grant G., 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V120, P303; Thorson JT, 2014, ECOL APPL, V24, P217, DOI 10.1890/12-1855.1; Williams RN, 1999, FISHERIES, V24, P10, DOI 10.1577/1548-8446(1999)024<0010:RTTRSI>2.0.CO;2; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	55	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112232	10.1371/journal.pone.0112232	http://dx.doi.org/10.1371/journal.pone.0112232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375788	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600122
J	Peng, DM; Wang, XJ; Zhao, CY; Wu, XR; Jiang, FQ; Chen, PX				Peng, Dongmei; Wang, Xiujun; Zhao, Chenyi; Wu, Xingren; Jiang, Fengqing; Chen, Pengxiang			Characterizing Air Temperature Changes in the Tarim Basin over 1960-2012	PLOS ONE			English	Article							DETRENDED FLUCTUATION ANALYSIS; CLIMATE-CHANGE; RIVER-BASIN; WATER-RESOURCES; NORTHWEST CHINA; TRENDS; SURFACE; XINJIANG; PRECIPITATION; VARIABILITY	There has been evidence of warming rate varying largely over space and between seasons. However, little has been done to evaluate the spatial and temporal variability of air temperature in the Tarim Basin, northwest China. In this study, we collected daily air temperature from 19 meteorological stations for the period of 1960-2012, and analyzed annual mean temperature (AMT), the annual minimum (T-min) and maximum temperature (T-max), and mean temperatures of all twelve months and four seasons and their anomalies. Trend analyses, standard deviation of the detrended anomaly (SDDA) and correlations were carried out to characterize the spatial and temporal variability of various mean air temperatures. Our data showed that increasing trend was much greater in the T-min (0.55 degrees C/10a) than in the AMT (0.25 degrees C/10a) and T-max (0.12 degrees C/10a), and the fluctuation followed the same order. There were large spatial variations in the increasing trends of both AMT (from -0.09 to 0.43 degrees C/10a) and T-min (from 0.15 to 1.12 degrees C/10a). Correlation analyses indicated that AMT had a significantly linear relationship with T-min and the mean temperatures of four seasons. There were also pronounced changes in the monthly air temperature from November to March at decadal time scale. The seasonality (i.e., summer and winter difference) of air temperature was stronger during the period of 1960-1979 than over the recent three decades. Our preliminary analyses indicated that local environmental conditions (such as elevation) might be partly responsible for the spatial variability, and large scale climate phenomena might have influences on the temporal variability of air temperature in the Tarim Basin. In particular, there was a significant correlation between index of El Nino-Southern Oscillation (ENSO) and air temperature of May (P = 0.004), and between the index of Pacific Decadal Oscillation (PDO) and air temperature of July (P = 0.026) over the interannual to decadal time scales.	[Peng, Dongmei; Wang, Xiujun; Zhao, Chenyi; Jiang, Fengqing] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [Peng, Dongmei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Xiujun] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Wu, Xingren] Natl Ocean & Atmospher Adm, Natl Ctr Environm Predict, IM Syst Grp, College Pk, MD USA; [Wu, Xingren] Natl Ocean & Atmospher Adm, Natl Ctr Environm Predict, Environm Modeling Ctr, College Pk, MD USA; [Chen, Pengxiang] Xinjiang Meteorol Observ, Urumqi, Xinjiang, Peoples R China; [Peng, Dongmei] Informat Ctr Xinjiang Xingnong Net, Urumqi, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University System of Maryland; University of Maryland College Park; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Wang, XJ (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	wwang@essic.umd.edu	Wang, Xiujun/F-2641-2010	Wang, Xiujun/0000-0002-2859-8011	Chinese National Basic Research Key Project [2010cb951001]; National Natural Science Foundation [41171095]; National Science & Technology Pillar Program [2013BAC10B01]	Chinese National Basic Research Key Project; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program	This research was supported by the Chinese National Basic Research Key Project (No. 2010cb951001), National Natural Science Foundation (No. 41171095), and National Science & Technology Pillar Program (No. 2013BAC10B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Brown SJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2006JD008091; Chen SY, 2010, J ARID LAND, V2, P87, DOI 10.3724/SP.J.1227.2010.00087; [陈亚宁 CHEN Ya ning], 2008, [冰川冻土, Journal of Glaciology and Geocryology], V30, P921; Chen YN, 2007, J ENVIRON SCI-CHINA, V19, P488, DOI 10.1016/S1001-0742(07)60082-5; Chen YN, 2009, QUATERN INT, V208, P53, DOI 10.1016/j.quaint.2008.11.011; Ding YH, 2007, ADV ATMOS SCI, V24, P954, DOI 10.1007/s00376-007-0954-4; Hansen J, 2002, SCIENCE, V295, P275; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hao XM, 2008, WATER RESOUR MANAG, V22, P1159, DOI 10.1007/s11269-007-9218-4; Holmes JA, 2009, QUATERN INT, V194, P91, DOI 10.1016/j.quaint.2007.10.013; Hu ZZ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003651; Jones PD, 2003, J CLIMATE, V16, P206, DOI 10.1175/1520-0442(2003)016<0206:HALSSA>2.0.CO;2; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Kiraly A, 2005, METEOROL ATMOS PHYS, V88, P119, DOI 10.1007/s00703-004-0078-7; Li B, 2012, J GEOPHYS RES-ATMOS, P117; Li B, 2012, THEORETICAL APPL CLI, P1; Li BF, 2013, FRESEN ENVIRON BULL, V22, P362; Li QH, 2011, J GEOGR SCI, V21, P1007, DOI 10.1007/s11442-011-0896-8; Li Z, 2009, ATMOS OCEAN SCI LETT, V2, P237, DOI 10.1080/16742834.2009.11446802; Liu BH, 2004, J CLIMATE, V17, P4453, DOI 10.1175/3230.1; Liu XD, 2009, GLOBAL PLANET CHANGE, V68, P164, DOI 10.1016/j.gloplacha.2009.03.017; Liu Z, 2007, J CHINA HYDROLOGY, V5; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Pepin N, 2002, INT J CLIMATOL, V22, P311, DOI 10.1002/joc.740; Pepin NC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034026; Pepin NC, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005047; Qian W, 2006, METEOROL ATMOS PHYS, V93, P1, DOI 10.1007/s00703-005-0163-6; [任国玉 REN GuoYu], 2005, [气候与环境研究, Climatic and environmental research], V10, P717; Solomon S., 2007, PHYS SCI BASIS WORKI; Tabari H, 2011, GLOBAL PLANET CHANGE, V79, P1, DOI 10.1016/j.gloplacha.2011.07.008; Talkner P, 2000, PHYS REV E, V62, P150, DOI 10.1103/PhysRevE.62.150; Tao H, 2011, J HYDROL, V400, P1, DOI 10.1016/j.jhydrol.2011.01.016; Turkes M, 2004, THEOR APPL CLIMATOL, V77, P195, DOI 10.1007/s00704-003-0024-5; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Wang GY, 2010, ENVIRON EARTH SCI, V59, P1759, DOI 10.1007/s12665-009-0158-6; Wang J, 2008, J DESERT RES, V4, P723; Wang SW, 2004, ADV ATMOS SCI, V21, P307, DOI 10.1007/BF02915560; Wang SW, 2000, GEOPHYS RES LETT, V27, P2581, DOI 10.1029/1999GL010825; Wei F., 2008, ADV CLIM CHANG RES, V4, P8; Woo SH, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016929; Wu SH, 2007, J GEOGR SCI, V17, P141, DOI 10.1007/s11442-007-0141-7; Xu CC, 2008, ENVIRON GEOL, V53, P1465, DOI 10.1007/s00254-007-0755-1; Xu JH, 2010, HYDROL PROCESS, V24, P136, DOI 10.1002/hyp.7484; Xu JH, 2009, CHINESE GEOGR SCI, V19, P306, DOI 10.1007/s11769-009-0306-7; Xu ZX, 2010, J ARID ENVIRON, V74, P256, DOI 10.1016/j.jaridenv.2009.08.014; Xu ZX, 2004, WATER RESOUR MANAG, V18, P439, DOI 10.1023/B:WARM.0000049142.95583.98; You QL, 2011, CLIM DYNAM, V36, P2399, DOI 10.1007/s00382-009-0735-0; Zhang J., 2002, RES XINJIANG CLIMATE; Zhang Y, 2012, NAT HAZARD EARTH SYS, V12, P1327, DOI 10.5194/nhess-12-1327-2012; Zhao P, 2011, J CLIMATE, V24, P4793, DOI 10.1175/JCLI-D-11-00054.1; Zhou HC, 2011, ELECTRON J QUAL THEO, P1	53	7	7	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112231	10.1371/journal.pone.0112231	http://dx.doi.org/10.1371/journal.pone.0112231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375648	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600121
J	Hua, GKH; Bertier, L; Soltaninejad, S; Hofte, M				Hua, Gia Khuong Hoang; Bertier, Lien; Soltaninejad, Saman; Hofte, Monica			Cropping Systems and Cultural Practices Determine the Rhizoctonia Anastomosis Groups Associated with Brassica spp. in Vietnam	PLOS ONE			English	Article							BINUCLEATE RHIZOCTONIA; 1ST REPORT; BIOLOGICAL-CONTROL; SOLANI AG-4; WEB BLIGHT; PATHOGENICITY; 1ST-REPORT; RESISTANCE; CABBAGE; CANOLA	Ninety seven Rhizoctonia isolates were collected from different Brassica species with typical Rhizoctonia symptoms in different provinces of Vietnam. The isolates were identified using staining of nuclei and sequencing of the rDNA-ITS barcoding gene. The majority of the isolates were multinucleate R. solani and four isolates were binucleate Rhizoctonia belonging to anastomosis groups (AGs) AG-A and a new subgroup of A-F that we introduce here as AG-Fc on the basis of differences in rDNA-ITS sequence. The most prevalent multinucleate AG was AG 1-IA (45.4% of isolates), followed by AG 1-ID (17.5%), AG 1-IB (13.4%), AG 4-HGI (12.4%), AG 2-2 (5.2%), AG 7 (1.0%) and an unknown AG related to AG 1-IA and AG 1-IE that we introduce here as AG 1-IG (1.0%) on the basis of differences in rDNA-ITS sequence. AG 1-IA and AG 1-ID have not been reported before on Brassica spp. Pathogenicity tests revealed that isolates from all AGs, except AG-A, induced symptoms on detached leaves of several cabbage species. In in vitro tests on white cabbage and Chinese cabbage, both hosts were severely infected by AG 1-IB, AG 2-2, AG 4-HGI, AG 1-IG and AG-Fc isolates, while under greenhouse conditions, only AG 4-HGI, AG 2-2 and AG-Fc isolates could cause severe disease symptoms. The occurrence of the different AGs seems to be correlated with the cropping systems and cultural practices in different sampling areas suggesting that agricultural practices determine the AGs associated with Brassica plants in Vietnam.	[Hua, Gia Khuong Hoang; Bertier, Lien; Soltaninejad, Saman; Hofte, Monica] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Phytopathol, B-9000 Ghent, Belgium	Ghent University	Hofte, M (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Phytopathol, B-9000 Ghent, Belgium.	monica.hofte@ugent.be	Hofte, Monica MR/A-6154-2008	Hofte, Monica/0000-0002-0850-3249	Special Research Fund of Ghent University (BOF); Agency of Innovation by Science and Technology in Flanders (IWT)	Special Research Fund of Ghent University (BOF)(Ghent University); Agency of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by a scholarship from the Special Research Fund of Ghent University (BOF) given to Gia Khuong Hoang Hua. Lien Bertier was funded by a PhD grant of the Agency of Innovation by Science and Technology in Flanders (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker EM, 2013, EUR J PLANT PATHOL, V136, P763, DOI 10.1007/s10658-013-0205-8; Baird RE, 1996, PLANT DIS, V80, P104, DOI 10.1094/PD-80-0104C; Budge GE, 2009, PLANT PATHOL, V58, P1059, DOI 10.1111/j.1365-3059.2009.02138.x; Carling DE, 1999, PHYTOPATHOLOGY, V89, P942, DOI 10.1094/PHYTO.1999.89.10.942; Carling DE, 2002, PHYTOPATHOLOGY, V92, P893, DOI 10.1094/PHYTO.2002.92.8.893; Carling DE, 2002, PHYTOPATHOLOGY, V92, P43, DOI 10.1094/PHYTO.2002.92.1.43; Commerce, 2014, CAN THO PROV; Demirci E, 2002, PLANT PATHOL, V51, P391, DOI 10.1046/j.1365-3059.2002.00704.x; Department of Culture Sport and Tourism of Soc Trang, 2014, OV SOC TRANG PROV; Department of Planning and Investment of Vinh Long, 2014, OV VINH LONG PROV; Department of Propaganda and Training of Hau Giang, 2014, OV HAU GIANG PROV; Dubey SC, 2012, FOLIA MICROBIOL, V57, P513, DOI 10.1007/s12223-012-0165-y; FREEMAN TE, 1982, PLANT DIS, V66, P861, DOI 10.1094/PD-66-861; Godoy-Lutz G, 2008, J GEN PLANT PATHOL, V74, P32, DOI 10.1007/s10327-007-0060-6; Harikrishnan R, 2004, PLANT DIS, V88, P817, DOI 10.1094/PDIS.2004.88.8.817; HASHIBA T, 1972, Annals of the Phytopathological Society of Japan, V38, P414, DOI 10.3186/jjphytopath.38.414; HERR LJ, 1995, CROP PROT, V14, P179, DOI 10.1016/0261-2194(95)00017-G; HOMMA Y, 1983, Annals of the Phytopathological Society of Japan, V49, P184, DOI 10.3186/jjphytopath.49.184; Hyakumachi M, 2005, PHYTOPATHOLOGY, V95, P784, DOI 10.1094/PHYTO-95-0784; Integrated Water Resources Management, 2014, LAM DONG PROV; International Federation of Red Cross and Red Crescent Societies, 2013, EM APP FIN REP VIET; Keijer J, 1997, PLANT PATHOL, V46, P659, DOI 10.1046/j.1365-3059.1997.d01-61.x; Keijer J, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P149; Keinath AP, 1997, PLANT DIS, V81, P946, DOI 10.1094/PDIS.1997.81.8.946; Khangura RK, 1999, PLANT DIS, V83, P714, DOI 10.1094/PDIS.1999.83.8.714; Kuramae EE, 2003, EUR J PLANT PATHOL, V109, P391, DOI 10.1023/A:1023591520981; LEE FN, 1983, PLANT DIS, V67, P829, DOI 10.1094/PD-67-829; MARTIN SB, 1988, PHYTOPATHOLOGY, V78, P379, DOI 10.1094/Phyto-78-379; Ministry of Natural Resources and Environment Sub-Institute of Hydrometeorology and Environment of South Vietnam, 2010, CLIM CHANG MEK DELT; OGOSHI A, 1987, ANNU REV PHYTOPATHOL, V25, P125, DOI 10.1146/annurev.py.25.090187.001013; Ohkura M, 2009, PLANT DIS, V93, P615, DOI 10.1094/PDIS-93-6-0615; Pannecoucque J, 2008, PLANT PATHOL, V57, P737, DOI 10.1111/j.1365-3059.2007.01823.x; Paulitz TC, 2006, PLANT DIS, V90, P829, DOI 10.1094/PD-90-0829B; People's committee of Dong Nai province, 2011, PROGR DEV MAIN CROPS; Poromarto SH, 1998, PHYTOPATHOLOGY, V88, P1056, DOI 10.1094/PHYTO.1998.88.10.1056; Priyatmojo A, 2001, PHYTOPATHOLOGY, V91, P1054, DOI 10.1094/PHYTO.2001.91.11.1054; Rollins PA, 1999, CAN J PLANT PATHOL, V21, P119, DOI 10.1080/07060669909501201; Ross RE, 1998, CROP PROT, V17, P99, DOI 10.1016/S0261-2194(97)00109-9; Sayama A, 2000, ANN REP SOC PLANT PR, V51, P54; Scholten OE, 2001, EUR J PLANT PATHOL, V107, P161, DOI 10.1023/A:1011208903344; Schwartz HF, 2007, DRY BEAN RHIZOCTONIA; Sharon M, 2008, MYCOSCIENCE, V49, P93, DOI 10.1007/s10267-007-0394-0; Sharon Michal, 2006, Mycoscience, V47, P299, DOI 10.1007/s10267-006-0320-x; Sneh B., 1991, IDENTIFICATION RHIZO; Taheri P, 2007, PHYTOPATHOLOGY, V97, P373, DOI 10.1094/PHYTO-97-3-0373; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thuan TTM, 2008, PLANT DIS, V92, P648, DOI 10.1094/PDIS-92-4-0648B; Van Beneden S, 2009, EUR J PLANT PATHOL, V124, P9, DOI 10.1007/s10658-008-9385-z; Verma PR, 1996, PHYTOPROTECTION, V77, P99, DOI 10.7202/706106ar; Viet's life, 2014, HA NOI CAP; Vietnam trade promotion agency, 2008, REP VIETN VEG FRUIT; Wharton P, 2007, RHIZOCTONIA STEM CAN; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang G, 2012, PLANT PATHOL, P41, DOI DOI 10.5772/39026; Yang GH, 2007, PLANT PATHOL, V56, P351, DOI 10.1111/j.1365-3059.2007.01543.x; Yang GH, 2004, PLANT PATHOL, V53, P260, DOI 10.1111/j.0032-0862.2004.00987.x; Yang J, 1996, PLANT DIS, V80, P513, DOI 10.1094/PD-80-0513; YITBAREK SM, 1987, CAN J PLANT PATHOL, V9, P6, DOI 10.1080/07060668709501904; ZETTLER FW, 1972, ANNU REV PHYTOPATHOL, V10, P455, DOI 10.1146/annurev.py.10.090172.002323	59	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111750	10.1371/journal.pone.0111750	http://dx.doi.org/10.1371/journal.pone.0111750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372406	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900073
J	Li, WR; Shi, QS; Liang, Q; Xie, XB; Huang, XM; Chen, YB				Li, Wen-Ru; Shi, Qing-Shan; Liang, Qing; Xie, Xiao-Bao; Huang, Xiao-Mo; Chen, Yi-Ben			Antibacterial Activity and Kinetics of Litsea cubeba Oil on Escherichia coli	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; EXTRACTS; CONSTITUENTS	Litsea cubeba oil is extracted from the fresh fruits of Litsea cubeba by distillation. In this study, its chemical constituents, antibacterial activity, kinetics and effects against Escherichia coli were studied. Its minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were both 0.125% (v/v) by toxic food method. Moreover, the antibacterial kinetic curves indicated 0.0625% (v/v) of litsea cubeba oil was able to prolong the growth lag phase of E. coli cells to approximate 12 hours while 0.125% (v/v) of litsea cubeba oil was able to kill the cells completely. Furthermore, transmission electron microscope (TEM) observation showed most E. coli cells treated with 0.125% (v/v) of litsea cubeba oil were killed or destroyed severely within 2 hours. The litsea cubeba oil might penetrate and destroy the outer and inner membrane of E. coli cells. Thus many holes and gaps were observed on the damaged cells, which led to their death eventually. The antibacterial effects of litsea cubeba oil mainly attributed to the presence of aldehydes, which accounted for approximately 70% in its whole components analyzed by GC/MS. Based on the antimicrobial properties, litsea cubeba oil would have a broad application in the antimicrobial industry.	[Li, Wen-Ru; Shi, Qing-Shan; Liang, Qing; Xie, Xiao-Bao; Huang, Xiao-Mo; Chen, Yi-Ben] Guangdong Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Shi, QS (corresponding author), Guangdong Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China.	jigan@gdim.cn			Guangdong Provincial Science and Technology [2009B011000011, 2011B010400039]	Guangdong Provincial Science and Technology	This study was supported by Guangdong Provincial Science and Technology Project (2009B011000011, 2011B010400039). The grant recipient was Wen-Ru Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ja'fari AH, 2011, PHYTOCHEMISTRY, V72, P1406, DOI 10.1016/j.phytochem.2011.04.013; Amer A, 2006, PARASITOL RES, V99, P466, DOI 10.1007/s00436-006-0182-3; Arora DS, 1999, INT J ANTIMICROB AG, V12, P257, DOI 10.1016/S0924-8579(99)00074-6; Avato P, 2000, PHYTOMEDICINE, V7, P239, DOI 10.1016/S0944-7113(00)80010-0; Bajpai VK, 2009, FOOD CHEM TOXICOL, V47, P1876, DOI 10.1016/j.fct.2009.04.043; Bajpai VK, 2009, APPL MICROBIOL BIOT, V83, P1127, DOI 10.1007/s00253-009-2017-5; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Ceylan E, 2004, J RAPID METH AUT MIC, V12, P1, DOI 10.1111/j.1745-4581.2004.tb00046.x; Chen CJ, 2012, J WOOD SCI, V58, P538, DOI 10.1007/s10086-012-1277-3; Chuang PH, 2007, BIORESOURCE TECHNOL, V98, P232, DOI 10.1016/j.biortech.2005.11.003; Delespaul Q, 2000, J ESSENT OIL RES, V12, P256, DOI 10.1080/10412905.2000.9699510; Ebrahimi SN, 2008, FOOD CHEM, V110, P927, DOI 10.1016/j.foodchem.2008.02.083; Inouye Shigeharu, 2001, Journal of Antimicrobial Chemotherapy, V47, P565, DOI 10.1093/jac/47.5.565; Kalemba D., 2012, DIETARY PHYTOCHEMICA, DOI DOI 10.1007/978-94-007-3926-0_5,; Li WR, 2013, APPL MICROBIOL BIOT, V97, P7483, DOI 10.1007/s00253-012-4460-y; Li WR, 2011, BIOMETALS, V24, P135, DOI 10.1007/s10534-010-9381-6; Luo M, 2005, J FOOD PROTECT, V68, P581, DOI 10.4315/0362-028X-68.3.581; Luo M, 2004, ACTA BIOCH BIOPH SIN, V36, P277, DOI 10.1093/abbs/36.4.277; Nogueira JHC, 2010, INT J FOOD MICROBIOL, V137, P55, DOI 10.1016/j.ijfoodmicro.2009.10.017; Rasooli I, 2005, PHYTOCHEMISTRY, V66, P2851, DOI 10.1016/j.phytochem.2005.09.029; SHELEF LA, 1984, J FOOD SAFETY, V6, P29, DOI 10.1111/j.1745-4565.1984.tb00477.x; Sheng LN, 2014, FOOD CONTROL, V46, P374, DOI 10.1016/j.foodcont.2014.05.050; Tian J, 2011, INT J FOOD MICROBIOL, V145, P464, DOI 10.1016/j.ijfoodmicro.2011.01.023; Wang HW, 2010, CHEM BIODIVERS, V7, P229, DOI 10.1002/cbdv.200800349; Wang Y, 2009, EUR FOOD RES TECHNOL, V228, P865, DOI 10.1007/s00217-008-0999-3; Yahyazadeh M, 2008, WORLD J MICROB BIOT, V24, P1445, DOI 10.1007/s11274-007-9636-8; Yang Y, 2010, MOLECULES, V15, P7075, DOI 10.3390/molecules15107075	28	42	50	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110983	10.1371/journal.pone.0110983	http://dx.doi.org/10.1371/journal.pone.0110983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372706	gold, Green Submitted, Green Published			2022-12-26	WOS:000344556900031
J	Nair, AR; Elks, CM; Vila, J; Del Piero, F; Paulsen, DB; Francis, J				Nair, Anand R.; Elks, Carrie M.; Vila, Jorge; Del Piero, Fabio; Paulsen, Daniel B.; Francis, Joseph			A Blueberry-Enriched Diet Improves Renal Function and Reduces Oxidative Stress in Metabolic Syndrome Animals: Potential Mechanism of TLR4-MAPK Signaling Pathway	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; NF-KAPPA-B; MESSENGER-RNA EXPRESSION; TUBULOINTERSTITIAL INJURY; INSULIN-RESISTANCE; HYPERTENSIVE-RATS; ANGIOTENSIN-II; IN-VIVO; PROTEIN; OBESITY	Background: Metabolic syndrome (MetS) is characterized by a cluster of health factors that indicate a higher risk for cardiorenal diseases. Recent evidence indicates that antioxidants from berries are alternative to attenuate oxidative stress and inflammation. We tested the hypothesis that inflammation-induced renal damage is triggered by the activation of TLR4, and subsequent modulation of redox-sensitive molecules and mitogen-activated protein kinase (MAPK) pathway. Methods: Five-week old lean and obese Zucker rats (LZR and OZR) were fed a blueberry-enriched diet or an isocaloric control diet for 15 weeks. A glucose tolerance test and acute renal clearance experiments were performed. Gene and protein expression levels for TLR4, cytokines and phosphorylation of ERK and p38MAPK were measured. Kidney redox status and urinary albumin levels were quantified. Renal pathology was evaluated histologically. Results: Control OZR exhibited lower glucose tolerance; exacerbated renal function parameters; increased oxidative stress. Gene and protein expression levels of TLR4 were higher and this was accompanied by increased renal pathology with extensive albuminuria and deterioration in antioxidant levels in OZR. In addition, OZR had increased phosphorylation of ERK and p38MAPK. Blueberry-fed OZR exhibited significant improvements in all these parameters compared to OZR. Conclusion: TLR4-MAPK signaling pathway is a key to the renal structural injury and dysfunction in MetS and blueberry (BB) protect against this damage by inhibiting TLR4. Significance: This is the first study to put forth a potential mechanism of TLR4-induced kidney damage in a model of MetS and to elucidate a downstream mechanism by which blueberry exert their reno-protective effects.	[Nair, Anand R.; Elks, Carrie M.; Vila, Jorge; Del Piero, Fabio; Paulsen, Daniel B.; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA; [Elks, Carrie M.] Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Francis, J (corresponding author), Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.	jfrancis@vetmed.lsu.edu	Elks, Carrie Marie/N-1961-2017		National Center for Complementary & Integrative Health [T32AT004094] Funding Source: NIH RePORTER	National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adelman RD, 2001, J PEDIATR-US, V138, P481, DOI 10.1067/mpd.2001.113006; Aksu U, 2011, CONTRIB NEPHROL, V174, P119, DOI 10.1159/000329249; Bellezza Ilaria, 2010, Cancers (Basel), V2, P483, DOI 10.3390/cancers2020483; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cha JJ, 2013, ENDOCRINOLOGY, V154, P2144, DOI 10.1210/en.2012-2080; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Cui XL, 2006, FREE RADICAL BIO MED, V41, P213, DOI 10.1016/j.freeradbiomed.2006.02.004; Eguchi K, 2014, J ATHEROSCLER THROMB; El-Atat FA, 2004, J AM SOC NEPHROL, V15, P2816, DOI 10.1097/01.ASN.0000133698.80390.37; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Elks CM, 2013, BIOACTIVES FRUIT HLT, DOI [10.1002/9781118635551.ch11, DOI 10.1002/9781118635551.CH11]; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Freeman LR, 2013, FREE RADICAL BIO MED, V56, P226, DOI 10.1016/j.freeradbiomed.2012.08.577; Fukuyama N, 1997, FREE RADICAL BIO MED, V22, P771, DOI 10.1016/S0891-5849(96)00401-7; Good DW, 2009, AM J PHYSIOL-RENAL, V297, pF866, DOI 10.1152/ajprenal.00335.2009; Ha HJ, 1999, FREE RADICAL BIO MED, V26, P944, DOI 10.1016/S0891-5849(98)00276-7; Hall AM, 2014, QJM-INT J MED, V107, P261, DOI 10.1093/qjmed/hct258; Hardy OT, 2013, PEDIATR OBES, V8, pe19, DOI 10.1111/j.2047-6310.2012.00098.x; Hisada Y, 1999, J CLIN INVEST, V103, P627, DOI 10.1172/JCI2454; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Johns BR, 2012, NEPHROL DIAL TRANSPL, V27, P1410, DOI 10.1093/ndt/gfr498; Jung KJ, 2013, FREE RADICAL BIO MED, V61, P206, DOI 10.1016/j.freeradbiomed.2013.04.005; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Khoo Michael C K, 2013, IEEE Rev Biomed Eng, V6, P143, DOI 10.1109/RBME.2012.2232651; Khoo NKH, 2012, FREE RADICAL BIO MED, V52, P2312, DOI 10.1016/j.freeradbiomed.2012.04.011; Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508; Koc M, 2011, NEPHROL DIAL TRANSPL, V26, P955, DOI 10.1093/ndt/gfq500; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lepenies J, 2011, NEPHRON CLIN PRACT, V119, pC97, DOI 10.1159/000324765; Long HD, 2013, J ENDOCRINOL INVEST, V36, P923, DOI 10.3275/8946; Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, pH2726, DOI 10.1152/ajpheart.00376.2007; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moss NG, 2013, AM J PHYSIOL-RENAL, V305, pF830, DOI 10.1152/ajprenal.00048.2013; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nair AR, 2014, FREE RADICAL BIO MED, V71, P16, DOI 10.1016/j.freeradbiomed.2014.03.012; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Neri M, 2007, J CELL MOL MED, V11, P156, DOI 10.1111/j.1582-4934.2007.00009.x; Pamidimukkala J, 2004, CLIN EXP HYPERTENS, V26, P55, DOI 10.1081/CEH-120027331; Pedruzzi LM, 2012, BIOCHIMIE, V94, P2461, DOI 10.1016/j.biochi.2012.07.015; Peng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058339; Peroval MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051243; Polichnowski AJ, 2010, HYPERTENSION, V55, P1425, DOI 10.1161/HYPERTENSIONAHA.110.151332; Queisser N, 2012, FREE RADICAL BIO MED, V53, P314, DOI 10.1016/j.freeradbiomed.2012.05.011; Rodrigo R, 2002, FREE RADICAL BIO MED, V33, P409, DOI 10.1016/S0891-5849(02)00908-5; Slyvka Y, 2009, ENDOCRINE, V35, P89, DOI 10.1007/s12020-008-9121-7; Ta NN, 2010, ATHEROSCLEROSIS, V213, P429, DOI 10.1016/j.atherosclerosis.2010.08.064; Tabet F, 2004, J CARDIOVASC PHARM, V44, P200, DOI 10.1097/00005344-200408000-00009; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Thobe BM, 2007, J CELL PHYSIOL, V210, P667, DOI 10.1002/jcp.20860; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Wang C, 2013, FREE RADICAL BIO MED, V65, P1417, DOI 10.1016/j.freeradbiomed.2013.10.005; Wilson CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076146; Wilson CB, 2014, BEHAV BRAIN RES; Xi LA, 2011, HEPATOLOGY, V53, P127, DOI 10.1002/hep.24011; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang SM, 2014, FREE RADIC BIOL MED; Youn JY, 2014, DIABETES	61	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111976	10.1371/journal.pone.0111976	http://dx.doi.org/10.1371/journal.pone.0111976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372283	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900099
J	Perera, FP; Chang, HW; Tang, DL; Roen, EL; Herbstman, J; Margolis, A; Huang, TJ; Miller, RL; Wang, S; Rauh, V				Perera, Frederica P.; Chang, Hsin-wen; Tang, Deliang; Roen, Emily L.; Herbstman, Julie; Margolis, Amy; Huang, Tzu-Jung; Miller, Rachel L.; Wang, Shuang; Rauh, Virginia			Early-Life Exposure to Polycyclic Aromatic Hydrocarbons and ADHD Behavior Problems	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SUBSTANCE USE DISORDERS; AIR-POLLUTION; DNA-ADDUCTS; ACADEMIC-PERFORMANCE; METABOLITE LEVELS; MATERNAL STRESS; RISK-FACTORS; CANCER-RISK	Importance: Polycyclic aromatic hydrocarbons are widespread urban air pollutants from combustion of fossil fuel and other organic material shown previously to be neurotoxic. Objective: In a prospective cohort study, we evaluated the relationship between Attention Deficit Hyperactivity Disorder behavior problems and prenatal polycyclic aromatic hydrocarbon exposure, adjusting for postnatal exposure. Materials and Methods: Children of nonsmoking African-American and Dominican women in New York City were followed from in utero to 9 years. Prenatal polycyclic aromatic hydrocarbon exposure was estimated by levels of polycyclic aromatic hydrocarbon-DNA adducts in maternal and cord blood collected at delivery. Postnatal exposure was estimated by the concentration of urinary polycyclic aromatic hydrocarbon metabolites at ages 3 or 5. Attention Deficit Hyperactivity Disorder behavior problems were assessed using the Child Behavior Checklist and the Conners Parent Rating Scale-Revised. Results: High prenatal adduct exposure, measured by elevated maternal adducts was significantly associated with all Conners Parent Rating Scale-Revised subscales when the raw scores were analyzed continuously (N = 233). After dichotomizing at the threshold for moderately to markedly atypical symptoms, high maternal adducts were significantly associated with the Conners Parent Rating Scale-Revised DSM-IV Inattentive (OR = 5.06, 95% CI [1.43, 17.93]) and DSM-IV Total (OR = 3.37, 95% CI [1.10, 10.34]) subscales. High maternal adducts were positivity associated with the DSM-oriented Attention Deficit/Hyperactivity Problems scale on the Child Behavior Checklist, albeit not significant. In the smaller sample with cord adducts, the associations between outcomes and high cord adduct exposure were not statistically significant (N = 162). Conclusion: The results suggest that exposure to polycyclic aromatic hydrocarbons encountered in New York City air may play a role in childhood Attention Deficit Hyperactivity Disorder behavior problems.	[Perera, Frederica P.; Tang, Deliang; Roen, Emily L.; Herbstman, Julie; Miller, Rachel L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA; [Perera, Frederica P.; Chang, Hsin-wen; Tang, Deliang; Roen, Emily L.; Herbstman, Julie; Margolis, Amy; Huang, Tzu-Jung; Miller, Rachel L.; Wang, Shuang; Rauh, Virginia] Columbia Univ, Columbia Ctr Childrens Environm Hlth, New York, NY USA; [Chang, Hsin-wen; Huang, Tzu-Jung; Wang, Shuang] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Margolis, Amy] Columbia Univ, Coll Phys & Surg, Div Child & Adolescent Psychiat, New York, NY USA; [Margolis, Amy] Columbia Univ, Coll Phys & Surg, Ctr Dev Neuropsychiat, New York State Psychiat Inst,Dept Psychiat, New York, NY USA; [Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, New York, NY USA; [Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Dept Pediat, Div Pediat Allergy & Immunol, New York, NY USA; [Rauh, Virginia] Columbia Univ, Heilbrunn Dept Populat & Family Hlth, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Columbia University	Perera, FP (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	fpp1@columbia.edu	Margolis, Amy E/AAU-9225-2021; Chang, Hsin-wen/AAP-3939-2021	Chang, Hsin-wen/0000-0003-4566-7047; Perera, Frederica/0000-0002-1364-9250	National Institute for Environmental Health Sciences (NIEHS); U.S. Environmental Protection Agency (US EPA): NIEHS/EPA [P01ES09600/R82702701]; NIEHS/EPA [P01ES09600/RD832141, P01ES09600/ RD834509]; NIEHS [R01ES08977]; US EPA [RD832096]; John & Wendy Neu Family Foundation; New York Community Trust; Trustees of the Blanchette Hooker Rockefeller Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, R01ES008977, P01ES009600] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Environmental Protection Agency (US EPA): NIEHS/EPA; NIEHS/EPA; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US EPA(United States Environmental Protection Agency); John & Wendy Neu Family Foundation; New York Community Trust; Trustees of the Blanchette Hooker Rockefeller Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by the National Institute for Environmental Health Sciences (NIEHS) and the U.S. Environmental Protection Agency (US EPA): NIEHS/EPA P01ES09600/R82702701, NIEHS/EPA P01ES09600/RD832141, NIEHS/EPA P01ES09600/ RD834509, NIEHS R01ES08977. This publication was also made possible in part by US EPA grants RD832096, the John & Wendy Neu Family Foundation, the New York Community Trust, Trustees of the Blanchette Hooker Rockefeller Fund, and an anonymous foundation. Funding from all the institutions listed was used towards the design and conduct of the study; collection, management, analysis, and interpretation of the data; and the preparation, review, and approval of the manuscript. Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the US EPA. Further, US EPA does not endorse the purchase of any commercial products or services mentioned in the publication. Findings expressed in this paper are the opinions of the authors and do not necessarily reflect the official opinion of the Centers for Disease Control and Prevention.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; ALEXANDROV K, 1992, CANCER RES, V52, P6248; American Psychiatric Association American Psychiatric Association Task Force on DSM-IV, 2000, DIAGN STAT MAN MENT; Anderson LM, 2000, ENVIRON HEALTH PERSP, V108, P573, DOI 10.2307/3454549; [Anonymous], 2001, CHILD BEHAV CHECKLIS; Archibong AE, 2002, REPROD TOXICOL, V16, P801, DOI 10.1016/S0890-6238(02)00058-8; Barry TD, 2005, J AM ACAD CHILD PSY, V44, P265, DOI 10.1097/00004583-200503000-00011; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; Bostic JQ, 2008, MASSACHUSETTS GEN HO; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Bouchard M, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9504; Brown L., 1990, TEST NONVERBAL INTEL; Brown LA, 2007, NEUROTOXICOLOGY, V28, P965, DOI 10.1016/j.neuro.2007.05.005; BUI QQ, 1986, TOXICOLOGY, V42, P195, DOI 10.1016/0300-483X(86)90009-0; Caldwell B.M., 1979, HOME OBSERVATION MEA; Castano-Vinyals G, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2003.008375; CDC, 2013, ADHD DAT STAT; Charach A, 2011, J AM ACAD CHILD PSY, V50, P9, DOI 10.1016/j.jaac.2010.09.019; Chiu YHM, 2013, ENVIRON HEALTH PERSP, V121, P859, DOI 10.1289/ehp.1205940; Conners C.K., 1997, CONNERS RATING SCALE; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Conners CK., 1999, CONNERS ADULT ADHD R, DOI DOI 10.1038/s41588-018-0269-7; Cornelius MD, 2011, NEUROTOXICOL TERATOL, V33, P137, DOI 10.1016/j.ntt.2010.08.006; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; de Graaf R, 2008, OCCUP ENVIRON MED, V65, P835, DOI 10.1136/oem.2007.038448; Dejmek J, 2000, ENVIRON HEALTH PERSP, V108, P1159, DOI 10.2307/3434828; DOHRENWEND BS, 1978, J HEALTH SOC BEHAV, V19, P205, DOI 10.2307/2136536; Ek U, 2011, ACTA PAEDIATR, V100, P402, DOI 10.1111/j.1651-2227.2010.02048.x; Froehlich TE, 2011, CURR PSYCHIAT REP, V13, P333, DOI 10.1007/s11920-011-0221-3; Garzon DL, 2008, ARCH PSYCHIAT NURS, V22, P288, DOI 10.1016/j.apnu.2007.12.006; Godschalk RWL, 2003, J BIOCHEM MOL BIOL, V36, P1; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Groenman AP, 2013, ADDICTION, V108, P1503, DOI 10.1111/add.12188; Grova N, 2007, NEUROTOXICOLOGY, V28, P630, DOI 10.1016/j.neuro.2007.01.010; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Jacobson LA, 2013, ARCH CLIN NEUROPSYCH; Jerrett M, 2009, EPIDEMIOLOGY, V20, P231, DOI 10.1097/EDE.0b013e31819776a1; JONGENEELEN FJ, 1990, BRIT J IND MED, V47, P454; Knapp M, 2011, J MENT HEALTH POLICY, V14, P137; Kotsopoulos N, 2013, J MENT HEALTH POLICY, V16, P27; Kupper T, 2012, INT ARCH OCC ENV HEA, V85, P837, DOI 10.1007/s00420-012-0794-0; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Li Z, 2008, ENVIRON RES, V107, P320, DOI 10.1016/j.envres.2008.01.013; Li Z, 2006, ANAL CHEM, V78, P5744, DOI 10.1021/ac0606094; MANCHESTER DK, 1987, CANCER RES, V47, P4861; MEYN MS, 1995, CANCER RES, V55, P5991; Miller RL, 2010, PEDIATR ALLERGY IMMU, V21, P260, DOI 10.1111/j.1399-3038.2009.00980.x; MOONEY LA, 1995, CANCER EPIDEM BIOMAR, V4, P627; Morello-Frosch R, 2011, HEALTH AFFAIR, V30, P879, DOI 10.1377/hlthaff.2011.0153; National Research Council, 1993, TOX TEST STRAT DET N; Newman NC, 2013, ENVIRON HEALTH PERSP, V121, P731, DOI 10.1289/ehp.1205555; NICOL CJ, 1995, NAT GENET, V10, P181, DOI 10.1038/ng0695-181; Pelham WE, 2007, J PEDIATR PSYCHOL, V32, P711, DOI 10.1093/jpepsy/jsm022; Perera F, 2005, CANCER EPIDEM BIOMAR, V14, P709, DOI 10.1158/1055-9965.EPI-04-0457; Perera FP, 2004, ENVIRON HEALTH PERSP, V112, P1133, DOI 10.1289/ehp.6833; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Perera FP, 2002, ENVIRON HEALTH PERSP, V110, P197, DOI 10.1289/ehp.02110197; Perera FP, 2012, ENV HLTH PERSPECT; Perera F, 2012, ENVIRON HEALTH PERSP, V120, P1190, DOI 10.1289/ehp.1104492; Perera FP, 2006, ENVIRON HEALTH PERSP, V114, P1287, DOI 10.1289/ehp.9084; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Rodriguez-Barranco M, 2013, SCI TOTAL ENVIRON, V454, P562, DOI 10.1016/j.scitotenv.2013.03.047; Saunders CR, 2006, J APPL TOXICOL, V26, P427, DOI 10.1002/jat.1157; Schellenberger MT, 2013, TOXICOL APPL PHARM, V271, P175, DOI 10.1016/j.taap.2013.05.007; Schuurmans C, 2013, CLIN GENET, V83, P108, DOI 10.1111/cge.12049; Shaw M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-99; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Siddique S, 2011, EUR J PEDIATR, V170, P923, DOI 10.1007/s00431-010-1379-0; Spencer T, 1999, PEDIATR CLIN N AM, V46, P915, DOI 10.1016/S0031-3955(05)70163-2; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Stein J, 2002, J DEV BEHAV PEDIATR, V23, pS13, DOI 10.1097/00004703-200202001-00004; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Strickland P, 1996, ENVIRON HEALTH PERSP, V104, P927, DOI 10.2307/3433012; Strine Tara W, 2006, Prev Chronic Dis, V3, pA52; Takeda Ken, 2004, Environ Sci, V11, P33; Todd RD, 2001, AM J PSYCHIAT, V158, P1891, DOI 10.1176/appi.ajp.158.11.1891; Veglia F, 2008, CARCINOGENESIS, V29, P932, DOI 10.1093/carcin/bgm286; Wasserman GA, 1998, AM J PUBLIC HEALTH, V88, P481, DOI 10.2105/AJPH.88.3.481; Wilens TE, 2002, J AM ACAD CHILD PSY, V41, P262, DOI 10.1097/00004583-200203000-00005; WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7; Wood J, 2006, DEV PSYCHOL, V42, P345, DOI 10.1037/0012-1649.42.2.345; WOOD KA, 1995, J NEUROSCI, V15, P5851; Woodruff TJ, 2003, ENVIRON HEALTH PERSP, V111, P942, DOI 10.1289/ehp.5317; Wormley DD, 2004, TOXICOL APPL PHARM, V197, P49, DOI 10.1016/j.taap.2004.01.016; Wu SY, 2013, RES DEV DISABIL, V34, P505, DOI 10.1016/j.ridd.2012.09.004; ZHAO ZH, 1990, SCI TOTAL ENVIRON, V92, P145, DOI 10.1016/0048-9697(90)90326-P	87	91	96	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111670	10.1371/journal.pone.0111670	http://dx.doi.org/10.1371/journal.pone.0111670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372862	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900059
J	Niu, LL; Zhang, YL; Meng, L; Xiao, Y; Wong, KKL; Abbott, D; Zheng, HR; Zheng, RQ; Qian, M				Niu, Lili; Zhang, Yanling; Meng, Long; Xiao, Yang; Wong, Kelvin K. L.; Abbott, Derek; Zheng, Hairong; Zheng, Rongqin; Qian, Ming			Detection of Subclinical Atherosclerosis in Asymptomatic Subjects Using Ultrasound Radiofrequency-Tracking Technology	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; COMMON CAROTID-ARTERY; CARDIOVASCULAR RISK-FACTORS; SMOOTH-MUSCLE-CELLS; DISEASE RISK; YOUNG-ADULTS; STIFFNESS; ASSOCIATION; PREDICTION; CHILDREN	Objective: Atherosclerosis is a chronic and systemic disease and its developmental process involves the synergism of multiple risk factors such as hypertension, dyslipidemia, diabetes, obesity and smoking. The diagnosis of subclinical atherosclerosis is essential for strategic guidance towards suitable treatments and efficient prevention against acute cardiovascular events. This study employed ultrasound radiofrequency (RF) tracking technology to characterize human carotid arteries in vivo in terms of intima-media thickness (IMT) and artery stiffness, and evaluated the statistical correlation between carotid IMT and stiffness, and the number of risk factors for atherosclerosis. Methods: A total of 160 asymptomatic subjects were enrolled. Ultrasound RF-tracking technology was employed to acquire carotid IMT and stiffness parameters: maximum IMT ((MAX) IMT), RF Quality IMT ((RF) QIMT), distensibility coefficient (DC), compliance coefficient (CC), alpha index, beta index and local pulse wave velocity (PWV beta). The subjects were categorized in four groups in terms of the number of risk factors: 'zero', 'single', 'double', and 'multiple', and statistical analyses of carotid IMT and stiffness parameters were performed between these different groups. Results: The subjects (n = 145) with (IMT)-I-MAX smaller than 1.0 mm matched the IMT criteria for non-atherosclerosis and were named as NA-subjects. Spearman's rho correlation analysis of the whole group and the NA-subjects both showed that (IMT)-I-MAX correlated positively with (RF)QIMT, alpha, beta, and PWV beta, and negatively with DC and CC (p<0.01). The analysis of covariance of NA-subjects showed significant differences between subjects with and without risk factors, and also showed significant differences between the 'zero', 'single', 'double', and 'multiple' groups. Conclusions: The carotid IMT and stiffness parameters obtained by the ultrasound RF-tracking technology were demonstrated to possess significant statistical correlation with the number of risk factors from 160 subjects, and these anatomical and mechanical parameters may potentially be used together with the IMT criteria to support subclinical atherosclerosis diagnosis.	[Niu, Lili; Meng, Long; Xiao, Yang; Zheng, Hairong; Qian, Ming] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China; [Zhang, Yanling; Zheng, Rongqin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China; [Wong, Kelvin K. L.; Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Wong, Kelvin K. L.; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Sun Yat Sen University; University of Adelaide; University of Adelaide	Zheng, HR (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China.	hr.zheng@siat.ac.cn; zhengrongqin@hotmail.com; ming.qian@siat.ac.cn	Wong, Kelvin Kian Loong/ABA-3915-2021; Abbott, Derek/E-8352-2011; Wong, Kelvin/AAL-8636-2021; XIAO, YANG/GPW-5529-2022	Wong, Kelvin Kian Loong/0000-0002-8600-1105; Abbott, Derek/0000-0002-0945-2674; 	National Research Program (973) from Ministry of Science and Technology, China [2011CB707903, 2013CB733800]; National Science Foundation Grants (NSFC) [11325420, 11302239, 11304341, 61020106008, 11002152, 11272329, 61002001, S2013040014610]	National Research Program (973) from Ministry of Science and Technology, China; National Science Foundation Grants (NSFC)	The work was supported by National Research Program (973 Grant Nos. 2011CB707903 and 2013CB733800) from Ministry of Science and Technology, China, and National Science Foundation Grants (NSFC Grant Nos. 11325420, 11302239, 11304341, 61020106008, 11002152, 11272329, 61002001, and S2013040014610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Brands PJ, 1997, ULTRASOUND MED BIOL, V23, P911, DOI 10.1016/S0301-5629(97)00021-5; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Carson AP, 2011, HYPERTENSION, V57, P1101, DOI 10.1161/HYPERTENSIONAHA.110.168005; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dan HJ, 2012, EUR J RADIOL, V81, P3289, DOI 10.1016/j.ejrad.2012.05.014; Dan HJ, 2011, CLIN PHYSIOL FUNCT I, V31, P315, DOI 10.1111/j.1475-097X.2011.01019.x; Jin Y, 2013, J ULTRAS MED, V32, P105; Koskinen J, 2009, CIRCULATION, V120, P229, DOI 10.1161/CIRCULATIONAHA.108.845065; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Meinders JM, 2004, ULTRASOUND MED BIOL, V30, P147, DOI 10.1016/j.ultrasmedbio.2003.10.014; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192; Napoli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041316; Naredo E, 2013, RHEUMATOLOGY, V52, P376, DOI 10.1093/rheumatology/kes260; Niu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067809; O'Leary DH, 2010, EUR HEART J, V31, P1682, DOI 10.1093/eurheartj/ehq185; Orlandi A, 2006, ATHEROSCLEROSIS, V188, P221, DOI 10.1016/j.atherosclerosis.2006.01.018; Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487; Sundholm J, 2014, ATHEROSCLEROSIS, V234, P283, DOI 10.1016/j.atherosclerosis.2014.03.006; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Vinereanu D, 2003, HEART, V89, P449, DOI 10.1136/heart.89.4.449; Yuan LJ, 2013, ULTRASOUND OBST GYN, V42, P644, DOI 10.1002/uog.12409	26	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111926	10.1371/journal.pone.0111926	http://dx.doi.org/10.1371/journal.pone.0111926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369320	Green Published, gold			2022-12-26	WOS:000344402000127
J	Hsu, YL; Hung, JY; Chou, SH; Huang, MS; Tsai, MJ; Lin, YS; Chiang, SY; Ho, YW; Wu, CY; Kuo, PL				Hsu, Y-L; Hung, J-Y; Chou, S-H; Huang, M-S; Tsai, M-J; Lin, Y-S; Chiang, S-Y; Ho, Y-W; Wu, C-Y; Kuo, P-L			Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression	ONCOGENE			English	Article							YES-ASSOCIATED PROTEIN; CELL-MIGRATION; HIPPO PATHWAY; BREAST-CANCER; IN-VIVO; YAP; GROWTH; PROLIFERATION; OVEREXPRESSION; TRANSCRIPTION	Lung cancer is the leading cause of cancer death worldwide, with metastasis underlying majority of related deaths. Angiomotin (AMOT), a scaffold protein, has been shown to interact with oncogenic Yes-associated protein/transcriptional co-activator with a PDZ-binding motif (YAP/TAZ) proteins, suggesting a potential role in tumor progression. However, the functional role of AMOT in lung cancer remains unknown. This study aimed to identify the patho-physiological characteristics of AMOT in lung cancer progression. Results revealed that AMOT expression was significantly decreased in clinical lung cancer specimens. Knockdown of AMOT in a low metastatic CL1-0 lung cancer cell line initiated cancer proliferation, migration, invasion and epithelial-mesenchymal transition. The trigger of cancer progression caused by AMOT loss was transduced by decreased cytoplasmic sequestration and increased nuclear translocation of oncogenic co-activators YAP/TAZ, leading to increased expression of the growth factor, Cyr61. Tumor promotion by AMOT knockdown was reversed when YAP/TAZ or Cyr61 was absent. Further, AMOT knockdown increased the growth and spread of Lewis lung carcinoma in vivo. These findings suggest that AMOT is a crucial suppressor of lung cancer metastasis and highlight its critical role as a tumor suppressor and its potential as a prognostic biomarker and therapeutic target for lung cancer.	[Hsu, Y-L; Tsai, M-J] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan; [Hung, J-Y; Huang, M-S; Tsai, M-J; Lin, Y-S; Wu, C-Y] Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan; [Hung, J-Y; Huang, M-S] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Chou, S-H] Kaohsiung Med Univ Hosp, Dept Surg, Div Chest Surg, Kaohsiung, Taiwan; [Chiang, S-Y; Ho, Y-W; Kuo, P-L] Kaohsiung Med Univ, Coll Med, Inst Clin Med, Kaohsiung, Taiwan; [Kuo, P-L] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung 807, Taiwan; [Kuo, P-L] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 80424, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University	Kuo, PL (corresponding author), Kaohsiung Med Univ, Coll Med, Inst Clin Med, 100 Shih Chuan First Rd, Kaohsiung 807, Taiwan.	kuopolin@seed.net.tw	Tsai, Ming-Ju/D-5566-2011		National Science Council of Taiwan [NSC 101-2628-B-037-001-MY3, NSC 101-2320-B-037-043-MY3]; Ministry of Science and Technology [MOST 103-2320-B-037-006-MY3, MOST 103-2314-B-037-052]; Kaohsiung Medical University [KMU-DT103008]; Research Center for Environmental Medicine, Kaohsiung Medical University [KMU-TP103A19, KMU-TP103A20]; Kaohsiung Medical University Hospital Research Foundation [KMUH102-2T06]; Center for Resources, Research, and Development of Kaohsiung Medical University	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Kaohsiung Medical University; Research Center for Environmental Medicine, Kaohsiung Medical University; Kaohsiung Medical University Hospital Research Foundation; Center for Resources, Research, and Development of Kaohsiung Medical University	This study was supported by grants from the National Science Council of Taiwan (NSC 101-2628-B-037-001-MY3; NSC 101-2320-B-037-043-MY3), the Ministry of Science and Technology (MOST 103-2320-B-037-006-MY3; MOST 103-2314-B-037-052), the Kaohsiung Medical University "Aim for the top 500 universities grant, Grant No. KMU-DT103008", the Research Center for Environmental Medicine, Kaohsiung Medical University (KMU-TP103A19; KMU-TP103A20) and the Kaohsiung Medical University Hospital Research Foundation (KMUH102-2T06). We also thank the Center for Resources, Research, and Development of Kaohsiung Medical University for their support with the instrumentation.	Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Arigoni M, 2012, ANGIOGENESIS, V15, P305, DOI 10.1007/s10456-012-9263-3; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Cai H, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-31; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Harris LG, 2012, ONCOGENE, V31, P3370, DOI 10.1038/onc.2011.496; Holmgren L, 2006, P NATL ACAD SCI USA, V103, P9208, DOI 10.1073/pnas.0603110103; Hsu YL, 2013, CARCINOGENESIS, V34, P1370, DOI 10.1093/carcin/bgt040; Hung JJ, 2013, ANN SURG, V258, P1079, DOI 10.1097/SLA.0b013e31828920c0; Jandova J, 2012, CELL BIOCHEM FUNCT, V30, P687, DOI 10.1002/cbf.2853; Jones AC, 2012, PROSTATE, V72, P1159, DOI 10.1002/pros.22465; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kao YR, 2003, CLIN CANCER RES, V9, P2807; Kozu Y, 2013, EUR J CARDIO-THORAC, V44, pE53, DOI 10.1093/ejcts/ezt192; Lin JPA, 2012, CANCER IMMUNOL IMMUN, V61, P677, DOI 10.1007/s00262-011-1135-y; Mizuno T, 2012, ONCOGENE, V31, P5117, DOI 10.1038/onc.2012.5; Moleirinho S, 2014, FEBS LETT, V588, P2693, DOI 10.1016/j.febslet.2014.02.006; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Park HW, 2013, TRENDS PHARMACOL SCI, V34, P581, DOI 10.1016/j.tips.2013.08.006; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Ranahan WP, 2011, CANCER RES, V71, P2203, DOI 10.1158/0008-5472.CAN-10-1995; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Schutte U, 2014, TRANSL ONCOL, V7, P309, DOI 10.1016/j.tranon.2014.02.005; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Su LL, 2012, CHINESE MED J-PEKING, V125, P4003, DOI 10.3760/cma.j.issn.0366-6999.2012.22.017; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Sun XJ, 2014, CARCINOGENESIS, V35, P184, DOI 10.1093/carcin/bgt276; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wu DD, 2014, J BIOL CHEM, V289, P5774, DOI 10.1074/jbc.M113.533042; Xu CM, 2013, CANCER GENE THER, V20, P453, DOI 10.1038/cgt.2013.40; Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	52	62	69	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	31					4056	4068		10.1038/onc.2014.333	http://dx.doi.org/10.1038/onc.2014.333			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CN9PE	25381822				2022-12-26	WOS:000358780500004
J	Ananthanarayanan, M; Banales, JM; Guerra, MT; Spirli, C; Munoz-Garrido, P; Mitchell-Richards, K; Tafur, D; Saez, E; Nathanson, MH				Ananthanarayanan, Meenakshisundaram; Banales, Jesus M.; Guerra, Mateus T.; Spirli, Carlo; Munoz-Garrido, Patricia; Mitchell-Richards, Kisha; Tafur, Denisse; Saez, Elena; Nathanson, Michael H.			Post-translational Regulation of the Type III Inositol 1,4,5-Trisphosphate Receptor by miRNA-506	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Epithelial Cell; Inositol 1; 4; 5-Trisphosphate (IP3); MicroRNA (miRNA); Secretion; Cholangiocytes; IP3 Receptor Type III; IP3 Receptor Type III H69 Cells; Cholangiocytes; miR-506	BILE-DUCT EPITHELIA; CALCIUM; CHOLANGIOCYTES; EXPRESSION; MICRORNAS; SECRETION; CA2+; STIMULATION; ACTIVATION; DYNAMICS	Background: Inositol 1,4,5-trisphosphate receptor (InsP(3)R3) is critical to secretion in a number of epithelia and its expression is lost in secretory disorders. Results: miR-506 down-regulates InsP(3)R3 expression and impairs Ca2+ signaling and secretion. Conclusion: Post-translational regulation of InsP(3)R3 expression by miR-506 might contribute to disease phenotype. Significance: Restoring InsP(3)R3 expression by use of anti-miR-506 therapy might be beneficial in a variety of secretory disorders. The type III isoform of the inositol 1,4,5-trisphosphate receptor (InsP(3)R3) is apically localized and triggers Ca2+ waves and secretion in a number of polarized epithelia. However, nothing is known about epigenetic regulation of this InsP3R isoform. We investigated miRNA regulation of InsP(3)R3 in primary bile duct epithelia (cholangiocytes) and in the H69 cholangiocyte cell line, because the role of InsP(3)R3 in cholangiocyte Ca2+ signaling and secretion is well established and because loss of InsP(3)R3 from cholangiocytes is responsible for the impairment in bile secretion that occurs in a number of liver diseases. Analysis of the 3-UTR of human InsP(3)R3 mRNA revealed two highly conserved binding sites for miR-506. Transfection of miR-506 mimics into cell lines expressing InsP(3)R3-3UTR-luciferase led to decreased reporter activity, whereas co-transfection with miR-506 inhibitors led to enhanced activity. Reporter activity was abrogated in isolated mutant proximal or distal miR-506 constructs in miR-506-transfected HEK293 cells. InsP(3)R3 protein levels were decreased by miR-506 mimics and increased by inhibitors, and InsP(3)R3 expression was markedly decreased in H69 cells stably transfected with miR-506 relative to control cells. miR-506-H69 cells exhibited a fibrotic signature. In situ hybridization revealed elevated miR-506 expression in vivo in human-diseased cholangiocytes. Histamine-induced, InsP(3)-mediated Ca2+ signals were decreased by 50% in stable miR-506 cells compared with controls. Finally, InsP(3)R3-mediated fluid secretion was significantly decreased in isolated bile duct units transfected with miR-506, relative to control IBDU. Together, these data identify miR-506 as a regulator of InsP(3)R3 expression and InsP(3)R3-mediated Ca2+ signaling and secretion.	[Ananthanarayanan, Meenakshisundaram; Guerra, Mateus T.; Spirli, Carlo; Tafur, Denisse; Nathanson, Michael H.] Yale Univ, Sch Med, Sect Digest Dis, Dept Med, New Haven, CT 06520 USA; [Mitchell-Richards, Kisha] Yale Univ, Sch Med, Sect Digest Dis, Dept Pathol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ctr Liver, New Haven, CT 06520 USA; [Banales, Jesus M.; Munoz-Garrido, Patricia] Univ Basque Country UPV EHU, Dept Liver & Gastrointestinal Dis, Biodonostia Res Inst, Donostia Univ Hosp,CIBERehd,IKERBASQUE,AECC, San Sebastian 20014, Spain; [Saez, Elena] Univ Navarra, CIMA, Div Gene Therapy & Hepatol, Pamplona 31009, Spain	Yale University; Yale University; Yale University; Basque Foundation for Science; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University Hospital Donostia; University of Basque Country; University of Navarra	Ananthanarayanan, M (corresponding author), Yale Univ, Sch Med, Sect Digest Dis, Dept Med, 333 Cedar St, New Haven, CT 06520 USA.	ananth.meena@yale.edu	Banales, Jesus M/R-9739-2019	Banales, Jesus/0000-0002-5224-2373; Saez De Blas, Elena/0000-0002-6494-9739	National Institutes of Health [DK045710, DK057751, DK61747, DK034989]; Spanish Ministries of Economy and Competitiveness [FIS PI12/00380]; "Instituto de Salud Carlos III" (Ciberehd), Spain; Department of Industry of the Basque Country Grant [SAIO12-PE12BN002]; Asociacion Espanola Contra el Cancer (AECC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045710, P30DK034989, R01DK045710, P01DK057751, R01DK061747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministries of Economy and Competitiveness(Spanish Government); "Instituto de Salud Carlos III" (Ciberehd), Spain(Instituto de Salud Carlos III); Department of Industry of the Basque Country Grant; Asociacion Espanola Contra el Cancer (AECC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK045710, DK057751, DK61747, and DK034989 (to M. H. N.), Spanish Ministries of Economy and Competitiveness Grant FIS PI12/00380, a grant from the "Instituto de Salud Carlos III" (Ciberehd), Spain (to J. M. B.), and Department of Industry of the Basque Country Grant SAIO12-PE12BN002 (to J. M. B.).; Supported by the "Asociacion Espanola Contra el Cancer (AECC)."	Allen RM, 2012, EMBO MOL MED, V4, P882, DOI 10.1002/emmm.201201228; Arora H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064273; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bessho K, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-104; Cazanave SC, 2011, J LIPID RES, V52, P1517, DOI 10.1194/jlr.M014654; Choe Chi-Un, 2006, Sci STKE, V2006, pre15; Cruz LN, 2010, HEPATOLOGY, V52, P327, DOI 10.1002/hep.23625; Drawnel FM, 2012, J CELL BIOL, V199, P783, DOI 10.1083/jcb.201111095; Francis H, 2008, AM J PHYSIOL-CELL PH, V295, pC499, DOI 10.1152/ajpcell.00369.2007; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Giovannucci DR, 2002, J PHYSIOL-LONDON, V540, P469, DOI 10.1113/jphysiol.2001.013453; Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030; Hanna JA, 2012, LAB INVEST, V92, P1390, DOI 10.1038/labinvest.2012.119; Hirata K, 2002, GASTROENTEROLOGY, V122, P1088, DOI 10.1053/gast.2002.32363; Hirata K, 2001, GASTROENTEROLOGY, V121, P396, DOI 10.1053/gast.2001.26280; Hirschfield GM, 2013, ANNU REV PATHOL-MECH, V8, P303, DOI 10.1146/annurev-pathol-020712-164014; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; Kruglov EA, 2011, HEPATOLOGY, V54, P1790, DOI 10.1002/hep.24548; Marin JJG, 2014, CURR OPIN GASTROEN, V30, P303, DOI 10.1097/MOG.0000000000000051; MENNONE A, 1995, P NATL ACAD SCI USA, V92, P6527, DOI 10.1073/pnas.92.14.6527; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Nathanson MH, 1998, J CLIN INVEST, V101, P2665, DOI 10.1172/JCI2835; Ozcan L, 2012, CELL METAB, V15, P739, DOI 10.1016/j.cmet.2012.03.002; Padgett KA, 2009, J AUTOIMMUN, V32, P246, DOI 10.1016/j.jaut.2009.02.022; Park KM, 2009, J BIOL CHEM, V284, P27557, DOI 10.1074/jbc.M109.034504; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Shibao K, 2003, GASTROENTEROLOGY, V125, P1175, DOI 10.1016/S0016-5085(03)01201-0; Shibao K, 2010, CELL CALCIUM, V48, P315, DOI 10.1016/j.ceca.2010.09.005; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Urribarri AD, 2014, GUT, V63, P1658, DOI 10.1136/gutjnl-2013-305281; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yin M, 2015, ONCOGENE, V34, P691, DOI 10.1038/onc.2013.597	35	52	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					184	196		10.1074/jbc.M114.587030	http://dx.doi.org/10.1074/jbc.M114.587030			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25378392	Green Published, hybrid			2022-12-26	WOS:000347231200016
J	Kuriakose, T; Rada, B; Watford, WT				Kuriakose, Teneema; Rada, Balazs; Watford, Wendy T.			Tumor Progression Locus 2-dependent Oxidative Burst Drives Phosphorylation of Extracellular Signal-regulated Kinase during TLR3 and 9 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASES; TOLL-LIKE RECEPTORS; TPL2 ACTIVATION; LIPOPOLYSACCHARIDE ACTIVATION; REDOX REGULATION; TNF-ALPHA; CELL-TYPE; LPS; MACROPHAGES	Signal transduction via NF kappa B and MAP kinase cascades is a universal response initiated upon pathogen recognition by Toll-like receptors (TLRs). How activation of these divergent signaling pathways is integrated to dictate distinct immune responses to diverse pathogens is still incompletely understood. Herein, contrary to current perception, we demonstrate that a signaling pathway defined by the inhibitor of kappa B kinase beta (IKK beta), MAP3 kinase tumor progression locus 2 (Tpl2/MAP3K8), and MAP kinase ERK is differentially activated by TLRs. TLRs 2, 4, and 7 directly activate this inflammatory axis, inducing immediate ERK phosphorylation and early TNF alpha secretion. In addition to TLR adaptor proteins, IKK beta-Tpl2-ERK activation by TLR4 is regulated by the TLR4 co-receptor CD14 and the tyrosine kinase Syk. Signals from TLRs 3 and 9 do not initiate early activation of IKK beta-Tpl2-ERK pathway but instead induce delayed, NADPH-oxidase-dependent ERK phosphorylation and TNF alpha secretion via autocrine reactive oxygen species signaling. Unexpectedly, Tpl2 is an essential regulator of ROS production during TLR signaling. Overall, our study reveals distinct mechanisms activating a common inflammatory signaling cascade and delineates differences in MyD88-dependent signaling between endosomal TLRs 7 and 9. These findings further confirm the importance of Tpl2 in innate host defense mechanisms and also enhance our understanding of how the immune system tailors pathogen-specific gene expression patterns.	[Kuriakose, Teneema; Rada, Balazs; Watford, Wendy T.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Watford, WT (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, 501 DW Brooks Dr, Athens, GA 30602 USA.	watfordw@uga.edu		Kuriakose, Teneema/0000-0003-4032-1290; Watford, Wendy/0000-0003-4261-5399	startup funds by the Office of the Vice President for Research at the University of Georgia	startup funds by the Office of the Vice President for Research at the University of Georgia	This work was supported by startup funds (to W. T. W.) by the Office of the Vice President for Research at the University of Georgia.	AOKI M, 1993, J BIOL CHEM, V268, P22723; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Cho J, 2005, J BIOL CHEM, V280, P20442, DOI 10.1074/jbc.M413554200; Cho JH, 2005, P NATL ACAD SCI USA, V102, P2350, DOI 10.1073/pnas.0409856102; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Corcoran A, 2013, FEBS J, V280, P1944, DOI 10.1111/febs.12224; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2006, J BIOL CHEM, V281, P1371, DOI 10.1074/jbc.M506790200; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Hacker H, 1999, EMBO J, V18, P6973, DOI 10.1093/emboj/18.24.6973; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kyrmizi I., 2013, J LEUKOCYTE BIOL; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; MAKRIS A, 1993, J VIROL, V67, P4283, DOI 10.1128/JVI.67.7.4283-4289.1993; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; McNab FW, 2013, J IMMUNOL, V191, P1732, DOI 10.4049/jimmunol.1300146; Melo MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001071; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pohar J, 2013, J BIOL CHEM, V288, P442, DOI 10.1074/jbc.M112.413922; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; RATAN RR, 1994, J NEUROSCI, V14, P4385; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Robinson MJ, 2007, MOL CELL BIOL, V27, P7355, DOI 10.1128/MCB.00301-07; Roget K, 2012, MOL CELL BIOL, V32, P4684, DOI 10.1128/MCB.01065-12; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Schmid S, 2014, J BIOL CHEM, V289, P299, DOI 10.1074/jbc.M113.519934; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang CS, 2013, J IMMUNOL, V190, P6368, DOI 10.4049/jimmunol.1202574; Yang HT, 2012, MOL CELL BIOL, V32, P3438, DOI 10.1128/MCB.00564-12; Yi AK, 1998, J IMMUNOL, V161, P4493; Yi AK, 1998, J IMMUNOL, V160, P4755; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	51	15	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36089	36100		10.1074/jbc.M114.587121	http://dx.doi.org/10.1074/jbc.M114.587121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378393	Green Published, hybrid			2022-12-26	WOS:000346897900036
J	Montagner, IM; Merlo, A; Zuccolotto, G; Renier, D; Campisi, M; Pasut, G; Zanovello, P; Rosato, A				Montagner, Isabella Monia; Merlo, Anna; Zuccolotto, Gaia; Renier, Davide; Campisi, Monica; Pasut, Gianfranco; Zanovello, Paola; Rosato, Antonio			Peritoneal Tumor Carcinomatosis: Pharmacological Targeting with Hyaluronan-Based Bioconjugates Overcomes Therapeutic Indications of Current Drugs	PLOS ONE			English	Article							CYTOREDUCTIVE SURGERY; GASTRIC-CANCER; FUTURE-DIRECTIONS; HYDROSOLUBLE BIOCONJUGATE; LOCOREGIONAL TREATMENT; PACLITAXEL; DELIVERY; ACID; IDENTIFICATION; RECEPTOR	Peritoneal carcinomatosis still lacks reliable therapeutic options. We aimed at testing a drug delivery strategy allowing a controlled release of cytotoxic molecules and selective targeting of tumor cells. We comparatively assessed the efficacy of a loco-regional intraperitoneal treatment in immunocompromised mice with bioconjugates formed by chemical linking of paclitaxel or SN-38 to hyaluronan, against three models of peritoneal carcinomatosis derived from human colorectal, gastric and esophageal tumor cell xenografts. In vitro, bioconjugates were selectively internalized through mechanisms largely dependent on interaction with the CD44 receptor and caveolin-mediated endocytosis, which led to accumulation of compounds into lysosomes of tumor cells. Moreover, they inhibited tumor growth comparably to free drugs. In vivo, efficacy of bioconjugates or free drugs against luciferase-transduced tumor cells was assessed by bioluminescence optical imaging, and by recording mice survival. The intraperitoneal administration of bioconjugates in tumor-bearing mice exerted overlapping or improved therapeutic efficacy compared with unconjugated drugs. Overall, drug conjugation to hyaluronan significantly improved the profiles of in vivo tolerability and widened the field of application of existing drugs, over their formal approval or current use. Therefore, this approach can be envisaged as a promising therapeutic strategy for locoregional treatment of peritoneal carcinomatosis.	[Montagner, Isabella Monia; Merlo, Anna; Zanovello, Paola; Rosato, Antonio] Veneto Inst Oncol IOV IRCCS, Padua, Italy; [Zuccolotto, Gaia] Univ Padua, Dept Med, Padua, Italy; [Renier, Davide; Campisi, Monica] Fidia Farmaceutici SpA, Abano Terme, Italy; [Pasut, Gianfranco] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Zanovello, Paola; Rosato, Antonio] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy	IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua; University of Padua	Rosato, A (corresponding author), Veneto Inst Oncol IOV IRCCS, Padua, Italy.	antonio.rosato@unipd.it	Rosato, Antonio/E-8626-2010; Montagner, Isabella Monia/AAI-2317-2019; Pasut, Gianfranco/I-5944-2012; montagner, isabella monia/K-1653-2016; ZUCCOLOTTO, GAIA/K-1654-2016; Merlo, Anna/FCK-4327-2022	Rosato, Antonio/0000-0002-5263-8386; Montagner, Isabella Monia/0000-0002-5778-2221; Pasut, Gianfranco/0000-0002-8754-0899; montagner, isabella monia/0000-0002-5778-2221; ZUCCOLOTTO, GAIA/0000-0002-2002-8807; Merlo, Anna/0000-0002-2741-9624; Zanovello, Paola/0000-0002-9996-2669	Italian Association for Cancer Research (AIRC) [IG-13121, 10016]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Italian Association for Cancer Research (AIRC, IG-13121; and Special Program Molecular Clinical Oncology 5 per mille ID 10016 to AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al-Shammaa HAH, 2008, WORLD J GASTROENTERO, V14, P1159, DOI 10.3748/wjg.14.1159; Aoyagi Keishiro, 2013, World J Crit Care Med, V2, P48, DOI 10.5492/wjccm.v2.i4.48; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Authier N, 2001, NEUROTOX RES, V3, P301, DOI 10.1007/BF03033269; Banzato A, 2008, CLIN CANCER RES, V14, P3598, DOI 10.1158/1078-0432.CCR-07-2019; Bassi PF, 2011, J UROLOGY, V185, P445, DOI 10.1016/j.juro.2010.09.073; Bozzetti F, 2008, J SURG ONCOL, V98, P273, DOI 10.1002/jso.21052; Brucher BLDM, 2012, CANCER INVEST, V30, P209, DOI 10.3109/07357907.2012.654871; Clementi C, 2011, MOL PHARMACEUT, V8, P1063, DOI 10.1021/mp2001445; Coccolini F, 2013, WORLD J GASTROENTERO, V19, P6979, DOI 10.3748/wjg.v19.i41.6979; Contreras-Ruiz L, 2011, MOL VIS, V17, P279; Correa P, 2013, GASTROENTEROL CLIN N, V42, P211, DOI 10.1016/j.gtc.2013.01.002; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; De Smet L, 2013, SCI WORLD J, DOI 10.1155/2013/720858; Dodds HM, 1998, J PHARMACOL EXP THER, V286, P578; Dong ZK, 2013, J APPL POLYM SCI, V130, P927, DOI 10.1002/app.39247; Duncan R, 2013, ADV DRUG DELIVER REV, V65, P60, DOI 10.1016/j.addr.2012.08.012; Elias D, 2012, SURG ONCOL CLIN N AM, V21, P611, DOI 10.1016/j.soc.2012.07.014; Elias D, 2010, J CLIN ONCOL, V28, P63, DOI 10.1200/JCO.2009.23.9285; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; Faryammanesh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093173; Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X; Gill RS, 2011, J SURG ONCOL, V104, P692, DOI 10.1002/jso.22017; Glockzin G, 2012, SURG ONCOL CLIN N AM, V21, P625, DOI 10.1016/j.soc.2012.07.002; Glockzin G, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-5; Gros SJ, 2010, ANTICANCER RES, V30, P3933; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Jaganathan SK, 2013, WORLD J GASTROENTERO, V19, P7726, DOI 10.3748/wjg.v19.i43.7726; Jain JP, 2008, EXPERT OPIN DRUG DEL, V5, P889, DOI [10.1517/17425247.5.8.889, 10.1517/17425247.5.8.889 ]; Keyaerts M, 2008, EUR J NUCL MED MOL I, V35, P999, DOI 10.1007/s00259-007-0664-2; Konigsrainer I, 2012, WORLD J GASTROENTERO, V18, P5317, DOI 10.3748/wjg.v18.i38.5317; Kumar Shalini Sree, 2014, Gastrointest Cancer Res, V7, P23; Larson N, 2013, INT J PHARMACEUT, V454, P435, DOI 10.1016/j.ijpharm.2013.06.046; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555; Lu Z, 2010, FUTURE ONCOL, V6, P1625, DOI 10.2217/FON.10.100; Montagner IM, 2013, UROL ONCOL-SEMIN ORI, V31, P1261, DOI 10.1016/j.urolonc.2012.01.005; Nakamura H, 2014, J CONTROL RELEASE, V174, P81, DOI 10.1016/j.jconrel.2013.11.011; Northfelt DW, 2012, AM J CLIN ONCOL; Oommen OP, 2013, MACROMOL BIOSCI; Passot G, 2013, EUR J SURG ONCOL; Patnaik A, 2013, CANCER CHEMOTH PHARM, V71, P1499, DOI 10.1007/s00280-013-2149-2; Pucciarelli S, 2003, BRIT J SURG, V90, P66, DOI 10.1002/bjs.4006; Rosato A, 2006, UROL ONCOL-SEMIN ORI, V24, P207, DOI 10.1016/j.urolonc.2005.08.020; Schweigert M, 2013, NAT REV GASTRO HEPAT, V10, P230, DOI 10.1038/nrgastro.2012.236; Serafino A, 2011, CURR CANCER DRUG TAR, V11, P572, DOI 10.2174/156800911795655976; Smit JK, 2013, RADIOTHER ONCOL, V107, P434, DOI 10.1016/j.radonc.2013.03.027; Sorbi C, 2009, CARBOHYD RES, V344, P91, DOI 10.1016/j.carres.2008.09.021; Sugahara S, 2007, J CONTROL RELEASE, V117, P40, DOI 10.1016/j.jconrel.2006.10.009; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Varshosaz J, 2012, EXPERT OPIN DRUG DEL, V9, P509, DOI 10.1517/17425247.2012.673580; Walker AS, 2014, J CANCER, V5, P44, DOI 10.7150/jca.7809; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031802; Zhao JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021419; Zhou B, 2003, GLYCOBIOLOGY, V13, P339, DOI 10.1093/glycob/cwg029	55	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112240	10.1371/journal.pone.0112240	http://dx.doi.org/10.1371/journal.pone.0112240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383653	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700043
J	Short, DPG; Gurung, S; Hu, XP; Inderbitzin, P; Subbarao, KV				Short, Dylan P. G.; Gurung, Suraj; Hu, Xiaoping; Inderbitzin, Patrik; Subbarao, Krishna V.			Maintenance of Sex-Related Genes and the Co-Occurrence of Both Mating Types in Verticillium dahliae	PLOS ONE			English	Article							AMINO-ACID SITES; GENOME SEQUENCE; NEUROSPORA-CRASSA; CRYPTOCOCCUS-NEOFORMANS; MOLECULAR-ORGANIZATION; PURIFYING SELECTION; FUNGAL PATHOGENS; ASPERGILLUS; EVOLUTION; RECOMBINATION	Verticillium dahliae is a cosmopolitan, soilborne fungus that causes a significant wilt disease on a wide variety of plant hosts including economically important crops, ornamentals, and timber species. Clonal expansion through asexual reproduction plays a vital role in recurring plant epidemics caused by this pathogen. The recent discovery of recombination between clonal lineages and preliminary investigations of the meiotic gene inventory of V. dahliae suggest that cryptic sex appears to be rare in this species. Here we expanded on previous findings on the sexual nature of V. dahliae. Only 1% of isolates in a global collection of 1120 phytopathogenic V. dahliae isolates contained the MAT1-1 idiomorph, whereas 99% contained MAT1-2. Nine unique multilocus microsatellite types comprised isolates of both mating types, eight of which were collected from the same substrate at the same time. Orthologs of 88 previously characterized sex-related genes from fungal model systems in the Ascoymycota were identified in the genome of V. dahliae, out of 93 genes investigated. Results of RT-PCR experiments using both mating types revealed that 10 arbitrarily chosen sex-related genes, including MAT1-1-1 and MAT1-21, were constitutively expressed in V. dahliae cultures grown under laboratory conditions. Ratios of non-synonymous (amino-acid altering) to synonymous (silent) substitutions in V. dahliae MAT1-1-1 and MAT1-2-1 sequences were indistinguishable from the ratios observed in the MAT genes of sexual fungi in the Pezizomycotina. Patterns consistent with strong purifying selection were also observed in 18 other arbitrarily chosen V. dahliae sex-related genes, relative to the patterns in orthologs from fungi with known sexual stages. This study builds upon recent findings from other laboratories and mounts further evidence for an ancestral or cryptic sexual stage in V. dahliae.	[Short, Dylan P. G.; Gurung, Suraj; Inderbitzin, Patrik; Subbarao, Krishna V.] Univ Calif Davis, Dept Plant Pathol, Salinas, CA 93901 USA; [Hu, Xiaoping] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Hu, Xiaoping] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	University of California System; University of California Davis; Northwest A&F University - China; Northwest A&F University - China	Subbarao, KV (corresponding author), Univ Calif Davis, Dept Plant Pathol, Salinas, CA 93901 USA.	kvsubbarao@ucdavis.edu	Subbarao, Krishna/X-3870-2019	Subbarao, Krishna/0000-0002-2075-1835	USDA-NIFA-SCRI [2010-51181-21069]; California Leafy Greens Research Board	USDA-NIFA-SCRI; California Leafy Greens Research Board	Funding for this study was provided by USDA-NIFA-SCRI grant no. 2010-51181-21069 and the California Leafy Greens Research Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2009, MOL ECOL RESOUR, V9, P1460, DOI 10.1111/j.1755-0998.2009.02759.x; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Amyotte SG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-314; Atallah ZK, 2010, FUNGAL GENET BIOL, V47, P416, DOI 10.1016/j.fgb.2010.02.003; Berbee ML, 2003, MYCOL RES, V107, P169, DOI 10.1017/S0953756203007263; Bidard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021476; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Clarke DL, 2001, MOL MICROBIOL, V40, P200, DOI 10.1046/j.1365-2958.2001.02375.x; Clutterbuck AJ, 1996, J GENET, V75, P281, DOI 10.1007/BF02966308; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; de Jonge R, 2013, GENOME RES, V23, P1271, DOI 10.1101/gr.152660.112; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; Dyer PS, 2011, CURR OPIN MICROBIOL, V14, P649, DOI 10.1016/j.mib.2011.10.001; Dyer PS, 2003, MICROBIOL-SGM, V149, P2301, DOI 10.1099/mic.0.C0119-0; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Grossetete S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-81; Gurung S, 2014, PHYTOPATHOLOGY, V104, P641, DOI 10.1094/PHYTO-10-13-0282-R; Gurung S, 2013, FUNGAL GENET BIOL, V52, P32, DOI 10.1016/j.fgb.2013.01.003; Henk DA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002851; Inderbitzin P, 2014, GENOMICS PLANT ASS F; Inderbitzin P, 2014, PHYTOPATHOLOGY, V104, P564, DOI 10.1094/PHYTO-11-13-0315-IA; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028341; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018260; JOAQUIM TR, 1991, PHYTOPATHOLOGY, V81, P552, DOI 10.1094/Phyto-81-552; Kabir Z, 2004, PLANT DIS, V88, P49, DOI 10.1094/PDIS.2004.88.1.49; KISTLER HC, 1992, ANNU REV PHYTOPATHOL, V30, P131, DOI 10.1146/annurev.py.30.090192.001023; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lockhart SR, 2005, GENETICS, V169, P1883, DOI 10.1534/genetics.104.038737; Malcolm GM, 2013, PHYTOPATHOLOGY, V103, P538, DOI 10.1094/PHYTO-08-12-0192-LE; Martinez D, 2008, NAT BIOTECHNOL, V26, P1193, DOI 10.1038/nbt1008-1193a; Maruthachalam K, 2010, PHYTOPATHOLOGY, V100, P1222, DOI 10.1094/PHYTO-04-10-0122; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; Milgroom MG, 2013, 11 INT VERT S GOTT 2; Milgroom MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106740; Nierman WC, 2006, NATURE, V439, P502, DOI 10.1038/nature04572; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Pasqualotto AC, 2007, J CLIN MICROBIOL, V45, P522, DOI 10.1128/JCM.02136-06; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Poggeler S, 2011, FUNGAL BIOL-UK, V115, P615, DOI 10.1016/j.funbio.2011.03.003; Puhalla J, 1983, PHYTOPATHOLOGY, V73, P1; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Ropars J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049665; Saleh D, 2012, MOL ECOL, V21, P1330, DOI 10.1111/j.1365-294X.2012.05469.x; Schardl C. L., 2012, Epichloae, endophytes of cool season grasses: implications, utilization and biology. Proceedings of the 7th International Symposium on Fungal Endophytes of Grasses, Lexington, Kentucky, USA, 28 June to 1 July 2010, P59; Schurko AM, 2008, BIOESSAYS, V30, P579, DOI 10.1002/bies.20764; Shittu HO, 2009, PLANTA, V229, P415, DOI 10.1007/s00425-008-0840-z; Short DPG, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-91; Short DPG, 2013, FUNGAL GENET BIOL, V53, P59, DOI 10.1016/j.fgb.2013.01.004; Smith JM, 1998, MOL BIOL EVOL, V15, P590, DOI 10.1093/oxfordjournals.molbev.a025960; Staats M, 2012, EUKARYOT CELL, V11, P1413, DOI 10.1128/EC.00164-12; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129; TURGEON BG, 1995, CAN J BOT, V73, pS778, DOI 10.1139/b95-322; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; Usami T, 2008, PHYSIOL MOL PLANT P, V73, P133, DOI 10.1016/j.pmpp.2009.04.002; Usami T, 2009, J GEN PLANT PATHOL, V75, P422, DOI 10.1007/s10327-009-0197-6; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Weismann A., 1889, ESSAYS HEREDITY KIND; WILHELM S, 1955, PHYTOPATHOLOGY, V45, P180; Wong WSW, 2004, GENETICS, V167, P949, DOI 10.1534/genetics.102.010959; Yang ZH, 2000, GENETICS, V155, P431; Yun SH, 2000, FUNGAL GENET BIOL, V31, P7, DOI 10.1006/fgbi.2000.1226; Zhan JS, 2007, FUNGAL GENET BIOL, V44, P339, DOI 10.1016/j.fgb.2006.10.008	85	35	37	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112145	10.1371/journal.pone.0112145	http://dx.doi.org/10.1371/journal.pone.0112145			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383550	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700033
J	Panico, L; Stuart, B; Bartley, M; Kelly, Y				Panico, Lidia; Stuart, Beth; Bartley, Mel; Kelly, Yvonne			Asthma Trajectories in Early Childhood: Identifying Modifiable Factors	PLOS ONE			English	Article							LOW SOCIOECONOMIC-STATUS; 1ST 6 YEARS; WHEEZING DISORDERS; RESPIRATORY SYMPTOMS; PHENOTYPES; CHILDREN; RISK; PREVALENCE; ATTENDANCE; ALLERGIES	Background: There are conflicting views as to whether childhood wheezing represents several discreet entities or a single but variable disease. Classification has centered on phenotypes often derived using subjective criteria, small samples, and/or with little data for young children. This is particularly problematic as asthmatic features appear to be entrenched by age 6/7. In this paper we aim to: identify longitudinal trajectories of wheeze and other atopic symptoms in early childhood; characterize the resulting trajectories by the socio-economic background of children; and identify potentially modifiable processes in infancy correlated with these trajectories. Data and Methods: The Millennium Cohort Study is a large, representative birth cohort of British children born in 2000-2002. Our analytical sample includes 11,632 children with data on key variables (wheeze in the last year; ever hay-fever and/or eczema) reported by the main carers at age 3, 5 and 7 using a validated tool, the International Study of Asthma and Allergies in Childhood module. We employ longitudinal Latent Class Analysis, a clustering methodology which identifies classes underlying the observed population heterogeneity. Results: Our model distinguished four latent trajectories: a trajectory with both low levels of wheeze and other atopic symptoms (54% of the sample); a trajectory with low levels of wheeze but high prevalence of other atopic symptoms (29%); a trajectory with high prevalence of both wheeze and other atopic symptoms (9%); and a trajectory with high levels of wheeze but low levels of other atopic symptoms (8%). These groups differed in terms of socio-economic markers and potential intervenable factors, including household damp and breastfeeding initiation. Conclusion: Using data-driven techniques, we derived four trajectories of asthmatic symptoms in early childhood in a large, population based sample. These groups differ in terms of their socio-economic profiles. We identified correlated intervenable pathways in infancy, including household damp and breastfeeding initiation.	[Panico, Lidia] Inst Natl Etud Demog, F-75675 Paris, France; [Stuart, Beth] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Bartley, Mel; Kelly, Yvonne] UCL, Int Ctr Lifecourse Studies, Dept Epidemiol & Populat Hlth, London, England	University of Southampton; University of London; University College London	Panico, L (corresponding author), Inst Natl Etud Demog, F-75675 Paris, France.	lidia.panico@ined.fr		Stuart, Beth/0000-0001-5432-7437; Kelly, Yvonne/0000-0002-2936-3994	Economic and Social Research Council (ESRC), UK; ESRC International Centre for Lifecourse Studies in Society and Health [RES-596-28-0001]; ESRC [ES/J019119/1] Funding Source: UKRI; Economic and Social Research Council [ES/J019119/1] Funding Source: researchfish	Economic and Social Research Council (ESRC), UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC International Centre for Lifecourse Studies in Society and Health(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Millennium Cohort Study is funded by the Economic and Social Research Council (ESRC), UK. This work was partly funded by the ESRC International Centre for Lifecourse Studies in Society and Health (RES-596-28-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2005, CLIN EXP ALLERGY, V35, P612, DOI 10.1111/j.1365-2222.2005.02243.x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Biemer PP, 2010, LATENT CLASS ANAL SU; Burr ML, 2006, THORAX, V61, P296, DOI 10.1136/thx.2005.045682; Cane R, 2001, BMC Fam Pract, V2, P4, DOI 10.1186/1471-2296-2-4; Dex S., 2005, CHILDREN 21 CENTURY; Elphick HE, 2000, EUR RESPIR J, V16, P593, DOI 10.1034/j.1399-3003.2000.16d04.x; Elphick HE, 2001, ARCH DIS CHILD, V84, P35, DOI 10.1136/adc.84.1.35; Font-Ribera L, 2009, EUR RESPIR J, V34, P1304, DOI 10.1183/09031936.00180608; Fuller E, 2006, CHILDRENS HLTH HLTH; Hedlund U, 2006, EUR RESPIR J, V28, P303, DOI 10.1183/09031936.06.00108105; Hegewald MJ, 2007, CHEST, V132, P1608, DOI 10.1378/chest.07-1405; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Kanervisto M, 2011, RESP MED, V105, P1140, DOI 10.1016/j.rmed.2011.03.008; Kozyrskyj AL, 2010, AM J PUBLIC HEALTH, V100, P540, DOI 10.2105/AJPH.2008.150771; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Leermakers ETM, 2013, EUR J CLIN NUTR, V67, P353, DOI 10.1038/ejcn.2013.36; Magidson J., 2004, SAGE HDB QUANTITATIV, P175; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Martinez FD, 2002, PEDIATRICS, V109, P362; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; MCCLEMENTS LD, 1977, J PUBLIC ECON, V8, P191, DOI 10.1016/0047-2727(77)90018-4; McLachlan G., 2000, WILEY SER PROB STAT; Midodzi WK, 2008, RESPIROLOGY, V13, P537, DOI 10.1111/j.1440-1843.2008.01284.x; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Oswald H, 1997, PEDIATR PULM, V23, P14, DOI 10.1002/(SICI)1099-0496(199701)23:1<14::AID-PPUL2>3.0.CO;2-P; Panico L, 2007, INT J EPIDEMIOL, V36, P1093, DOI 10.1093/ije/dym089; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Plewis I., 2007, INT J SOC RES METHOD, V10, P325, DOI [DOI 10.1080/13645570701676955, 10.1080/13645570701676955]; Plewis I., 2007, MILLENNIUM COHORT ST; Rusconi Franca, 2005, Epidemiol Prev, V29, P47; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Shiue I, 2013, ALLERGY, V68, P392, DOI 10.1111/all.12091; SOYSETH V, 1995, CHEST, V107, P389, DOI 10.1378/chest.107.2.389; Speer CP, 1998, EUR RESPIR J, V12, p13S; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Spycher BD, 2010, CLIN EXP ALLERGY, V40, P1130, DOI 10.1111/j.1365-2222.2010.03541.x; Spycher BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008533; StataCorp, 2009, STAT REL 2; Stein RT, 1999, AM J EPIDEMIOL, V149, P1030; Storr CL, 2004, NICOTINE TOB RES, V6, P533, DOI 10.1080/14622200410001696493; Strina A, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-5; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Vermunt JK, 1997, LEM GEN PROGRAM ANAL; von Mutius E, 2011, J ALLERGY CLIN IMMUN, V127, P1513, DOI 10.1016/j.jaci.2011.04.026; Williams DR, 2009, PEDIATRICS, V123, pS174, DOI 10.1542/peds.2008-2233H	49	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111922	10.1371/journal.pone.0111922	http://dx.doi.org/10.1371/journal.pone.0111922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379671	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000344863100046
J	Chu, ZH; Lin, H; Liang, XH; Huang, RF; Zhan, Q; Jiang, JW; Zhou, XL				Chu, Zhaohui; Lin, Hao; Liang, Xiaohua; Huang, Ruofan; Zhan, Qiong; Jiang, Jingwei; Zhou, Xinli			Clinicopathologic Characteristics of Typical Medullary Breast Carcinoma: A Retrospective Study of 117 Cases	PLOS ONE			English	Article							DUCTAL CARCINOMA; RISK-FACTORS; CANCER; BASAL; SURVIVAL; FEATURES	Purpose: This study analyzed the clinicopathologic characteristics of typical medullary breast carcinoma (TMBC) in a cohort of Chinese patients. Methods: We conducted a retrospective review of clinical data including general information, pathologic results, treatment regimens, and patient survival in cases of TMBC diagnosed between February 2004 and April 2011. Results: A total of 117 patients were enrolled, with a median age of 52 years (range, 28,92 years). Stage I and II disease accounted for 31.6% and 61.6% of the cases, respectively. Hormonal receptor negative disease (estrogen receptor negative, 68.4%; progestogen receptor negative, 86.3%) was more prevalent in this population. Human epidermal growth factor receptor-2 (HER-2) positivity was 20.5%, while equivocal and HER-2 negative cases represented 16.2% and 63.2% of the cohort. The triple-negative, luminal, and HER-2 overexpressing subtypes constituted 44.4%, 31.6%, and 15.4% of the cases, respectively. The various TMBC subtypes showed no differences regarding tumor size, rates of lymph node(s) metastasis, TNM staging, treatment regimens, and 2-year recurrence rates. However, patients with triple-negative disease were more likely to be younger, when compared to those with luminal disease (P = 0.002). At a median follow-up of 56 months (range, 2-112 months), the 2-year disease-free survival and overall survival rates were 99.1% and 98.2%, respectively. Conclusion: Early stage disease dominated the study cohort, and at two years after surgery, recurrence was extremely low. The heterogeneity of molecular subtypes was clearly shown, and no apparent differences were found among the clinicopathologic characteristics of the triple-negative, luminal, and HER-2 overexpressing subtypes.	[Chu, Zhaohui; Lin, Hao; Liang, Xiaohua; Huang, Ruofan; Zhan, Qiong; Jiang, Jingwei; Zhou, Xinli] Fudan Univ, Huashan Hosp, Dept Oncol, Shanghai 200040, Peoples R China; [Chu, Zhaohui; Lin, Hao; Liang, Xiaohua; Huang, Ruofan; Zhan, Qiong; Jiang, Jingwei; Zhou, Xinli] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Zhou, XL (corresponding author), Fudan Univ, Huashan Hosp, Dept Oncol, Shanghai 200040, Peoples R China.	xinlizhou11@gmail.com			Fudan University, Shanghai, China	Fudan University, Shanghai, China	The author(s) received autonomous scientific research projects funding from Fudan University, Shanghai, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, WHO CLASSIFICATION T; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Cao AY, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-91; Chandrika, 2012, J CANCER RES THER, V8, P129, DOI 10.4103/0973-1482.95193; Dendale R, 2003, INT J BIOL MARKER, V18, P99, DOI 10.1177/172460080301800202; Eisinger F, 1998, CANCER RES, V58, P1588; Flucke U, 2010, HISTOPATHOLOGY, V56, P852, DOI 10.1111/j.1365-2559.2010.03555.x; Foschini MP, 2009, PATHOLOGY, V41, P48, DOI 10.1080/00313020802563528; Gnant M, 2011, BREAST CARE, V6, P136, DOI 10.1159/000328054; Huober J, 2012, ANN ONCOL, V23, P2843, DOI 10.1093/annonc/mds105; Jacquemier J, 2005, J PATHOL, V207, P260, DOI 10.1002/path.1845; Jensen ML, 1997, HISTOPATHOLOGY, V30, P523; Martinez SR, 2011, MED ONCOL, V28, P738, DOI 10.1007/s12032-010-9526-z; Orlando L, 2005, ANN ONCOL, V16, P1094, DOI 10.1093/annonc/mdi213; Pedersen L, 1995, EUR J CANCER, V31A, P2289, DOI 10.1016/0959-8049(95)00408-4; PERTSCHUK LP, 1990, CANCER, V66, P1663, DOI 10.1002/1097-0142(19901015)66:8<1663::AID-CNCR2820660802>3.0.CO;2-C; Pillai SKK, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-18; Pintens S, 2009, J CLIN PATHOL, V62, P624, DOI 10.1136/jcp.2008.061358; Rakha EA, 2006, J PATHOL, V208, P495, DOI 10.1002/path.1916; RAPIN V, 1988, CANCER, V61, P2503, DOI 10.1002/1097-0142(19880615)61:12<2503::AID-CNCR2820611219>3.0.CO;2-3; REINFUSS M, 1995, J SURG ONCOL, V60, P89, DOI 10.1002/jso.2930600205; RIDOLFI RL, 1977, CANCER, V40, P1365, DOI 10.1002/1097-0142(197710)40:4<1365::AID-CNCR2820400402>3.0.CO;2-N; ROSEN PP, 1995, CANCER, V75, P1320, DOI 10.1002/1097-0142(19950315)75:6<1320::AID-CNCR2820750614>3.0.CO;2-C; Vincent-Salomon A, 2007, BREAST CANCER RES, V24, P9; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xue C, 2012, CANCER SCI, V103, P1679, DOI 10.1111/j.1349-7006.2012.02339.x	26	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111493	10.1371/journal.pone.0111493	http://dx.doi.org/10.1371/journal.pone.0111493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375803	gold, Green Submitted, Green Published			2022-12-26	WOS:000344402600041
J	Ganasegeran, K; Rajendran, AK; Al-Dubai, SAR				Ganasegeran, Kurubaran; Rajendran, Anantha Kumar; Al-Dubai, Sami Abdo Radman			Psycho-Socioeconomic Factors Affecting Complementary and Alternative Medicine Use among Selected Rural Communities in Malaysia: A Cross-Sectional Study	PLOS ONE			English	Article							ATTITUDES; ADULTS	Introduction: The use of complementary and alternative medicine (CAM) as a source of cure has gained much spectrum worldwide, despite skeptics and advocates of evidence-based practice conceptualized such therapies as human nostrum. Objective: This study aimed to explore the factors affecting CAM use among rural communities in Malaysia. Methods: A cross-sectional study was carried out on 288 occupants across four rural villages within the District of Selama, Perak, Malaysia. A survey that consisted of socio-economic characteristics, history of CAM use and the validated Holistic Complementary and Alternative Medicine Questionnaire (HCAMQ) were used. Results: The prevalence of self-reported CAM use over the past one year was 53.1%. Multiple logistic regression analyses yielded three significant predictors of CAM use: monthly household income of less than MYR 2500, higher education level, and positive attitude towards CAM. Conclusion: Psycho-socioeconomic factors were significantly associated with CAM use among rural communities in Malaysia.	[Ganasegeran, Kurubaran] HTAR, Dept Med, Klang, Selangor, Malaysia; [Ganasegeran, Kurubaran; Rajendran, Anantha Kumar] MSU, Int Med Sch, Off Persiaran Olahraga, Sect 13, Shah Alam, Selangor, Malaysia; [Al-Dubai, Sami Abdo Radman] Int Med Univ, Dept Community Med, Kuala Lumpur 57000, Malaysia	Management Science University; International Medical University Malaysia	Ganasegeran, K (corresponding author), HTAR, Dept Med, Jalan Langat, Klang, Selangor, Malaysia.	medkuru@yahoo.com	AL-DUBAI, SAMI/M-4129-2019; AL-DUBAI, SAMI ABDO/AAA-1731-2022; AL-DUBAI, SAMI Abdo Radman/J-6120-2013; Ganasegeran, Kurubaran/E-4931-2013	AL-DUBAI, SAMI/0000-0002-1989-5452; AL-DUBAI, SAMI ABDO/0000-0002-1989-5452; AL-DUBAI, SAMI Abdo Radman/0000-0002-1989-5452; Ganasegeran, Kurubaran/0000-0002-9480-1815				Abuduli M., 2011, MALAYS J PUBLIC HLTH, V11, P1; Adams J, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-85; Akyol AD, 2011, J CLIN NURS, V20, P1035, DOI 10.1111/j.1365-2702.2010.03498.x; Alshagga MA, 2011, ANN THORAC MED, V6, P115, DOI 10.4103/1817-1737.82438; [Anonymous], 2013, MALAYSIAN NO DEV COR; Arcury TA, 2006, J GERONTOL B-PSYCHOL, V61, P62; Arcury TA, 2006, ETHNIC DIS, V16, P723; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Bishop FL, 2007, J HEALTH PSYCHOL, V12, P851, DOI 10.1177/1359105307082447; Bulck JV, 2009, EUR J PUBLIC HEALTH, V20, P227; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P149; Chiappelli F, 2005, EVID-BASED COMPL ALT, V2, P453, DOI 10.1093/ecam/neh106; Ernst E, 2000, B WORLD HEALTH ORGAN, V78, P252; Farooqui M, 2013, ALTERN INTEG MED, V1; Frass M, 2012, OCHSNER J, V12, P45; Hu H, 2013, ISRN PUBLIC HLTH, V2013, P7; Hyland ME, 2003, COMPLEMENT THER MED, V11, P33, DOI 10.1016/S0965-2299(02)00113-9; Kuunibe N., 2012, International Journal of Humanities and Social Science, V2, P288; Limsatchapanich S., 2013, HLTH SCI J, V7, P436; McFadden KL, 2010, EXPLORE-NY, V6, P380, DOI 10.1016/j.explore.2010.08.004; McLaughlin D, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-34; Mollaoglu M, 2013, ACTA CLIN CROAT, V52, P181; Nguyen D, 2014, RURAL REMOTE HEALTH, V14; Shreffler-Grant J, 2005, PUBLIC HEALTH NURS, V22, P323, DOI 10.1111/j.0737-1209.2005.220407.x; Testerman J, 2004, COMPLEMENT HLTH PRAC, V9, P81, DOI [10.1177/1076167503261254, DOI 10.1177/1076167503261254]; Thomas K, 2004, J PUBLIC HEALTH, V26, P152, DOI 10.1093/pubmed/fdh139; Yekta Z, 2007, J RES HEALTH SCI, V7, P24; Zollman C, 1999, BRIT MED J, V319, P693, DOI 10.1136/bmj.319.7211.693	28	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112124	10.1371/journal.pone.0112124	http://dx.doi.org/10.1371/journal.pone.0112124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375256	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402600109
J	Yu, C; Qi, D; Lian, W; Li, QZ; Li, HJ; Fan, HY				Yu, Chen; Qi, Dong; Lian, Wei; Li, Qing-Zhong; Li, Hong-Juan; Fan, Hua-Ying			Effects of Danshensu on Platelet Aggregation and Thrombosis: In Vivo Arteriovenous Shunt and Venous Thrombosis Models in Rats	PLOS ONE			English	Article							INDUCED GASTRIC DAMAGE; CYCLOOXYGENASE; ACID; ANTIPLATELET; INHIBITION; ADHESION; ASPIRIN	Danshensu, a type of dihydroxyphenyl lactic acid, is one of the most abundant active phenolic acids in the dried root of Salvia miltiorrhizae (Lamiaceae)-widely used traditional Chinese medicine. The effects of danshensu on platelet aggregation and thrombus formation in rats were examined using various methods. It was found that danshensu significantly reduced thrombus weight in 2 experimental thrombosis models; dose-dependent inhibition of adenosine diphosphate (ADP) and arachidonic acid (AA)-induced platelet aggregation occurred in normal and blood stasis-induced rats; Danshensu also significantly mitigated blood viscosity, plasma viscosity and hematocrit levels. Moreover, danshensu significantly inhibited venous thrombosis-induced expression of cyclooxygenases-2 (COX-2) rather than cyclooxygenases-1( COX-1) in the venous walls, down regulated thromboxane B-2 (TXB2) and up regulated 6-keto prostaglandin F-1 alpha (6-keto-PGF(1 alpha)), normalizing the TXB2/6-keto-PGF(1 alpha) ratio. In addition, danshensu did not induce gastric lesions and even had protective effects on aspirin-induced ulcer formation at doses as high as 60 mg/kg. These findings suggest that the antithrombotic and antiplatelet aggregation effects of danshensu are attributed to its highly selective inhibition of COX-2 and ability to normalize the thromboxane A(2)(TXA(2))/prostacyclin(PGI(2)) balance. These findings suggest that danshensu have great prospects in antithrombotic and antiplatelet therapy.	[Yu, Chen; Li, Qing-Zhong; Li, Hong-Juan] Binzhou Med Univ, Sch Pharm, Yantai, Shandong, Peoples R China; [Qi, Dong] Yantai Yu Huang Ding Qingdao Univ Hosp, Dept Nephrol, Yantai, Shandong, Peoples R China; [Lian, Wei] Yantai Yan Tai Shan Hosp, Yantai, Shandong, Peoples R China; [Fan, Hua-Ying] Yantai Univ, Sch Pharm, Yantai, Shandong, Peoples R China	Binzhou Medical University; Yantai University	Yu, C (corresponding author), Binzhou Med Univ, Sch Pharm, Yantai, Shandong, Peoples R China.	yuchen810624@163.com; katiefhydong@sina.com			National Natural Science Foundation of China [81303259]; Shandong Province Natural Science Foundation [ZR2010HL065]; Research Award Fund for Outstanding Young and Middle-aged Scientists of Shandong Province of China [BS2013YY046]; Programs for Science and Technology Development and Plan of Yanta [2013WS262]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Research Award Fund for Outstanding Young and Middle-aged Scientists of Shandong Province of China; Programs for Science and Technology Development and Plan of Yanta	This study was supported by the Project of National Natural Science Foundation of China (Grant No. 81303259), URL: http://www.nsfc.gov.cn/, Shandong Province Natural Science Foundation (No. ZR2010HL065), URL: http://www.sdnsf.gov.cn/portal/, Research Award Fund for Outstanding Young and Middle-aged Scientists of Shandong Province of China (project No. BS2013YY046), URL: http://www.sdstc.gov.cn/, and the Programs for Science and Technology Development and Plan of Yanta (No. 2013WS262), URL: http://www.ytstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Chan K, 2004, LIFE SCI, V75, P3157, DOI 10.1016/j.lfs.2004.06.010; Chen XP, 2007, CHIN J HEMORH, V17, P525; Damiano BP, 2001, THROMB RES, V104, P113, DOI 10.1016/S0049-3848(01)00353-X; Guth PH, 1989, GASTROENTEROLOGY, P76; Halter F, 2001, GUT, V49, P443, DOI 10.1136/gut.49.3.443; Henke PK, 2006, THROMB HAEMOSTASIS, V95, P272, DOI 10.1160/Th05-02-0099; Henke PK, 2004, ARTERIOSCL THROM VAS, V24, P1130, DOI 10.1161/01.ATV.0000129537.72553.73; Kang DG, 2004, LIFE SCI, V75, P1801, DOI 10.1016/j.lfs.2004.02.034; Lechi C, 1996, THROMB HAEMOSTASIS, V76, P791; MASFERRER JL, 1990, J CLIN INVEST, V86, P1375, DOI 10.1172/JCI114850; Mei XT, 2013, FOOD CHEM TOXICOL, V60, P448, DOI 10.1016/j.fct.2013.07.075; Nosal R, 2002, THROMB RES, V105, P339, DOI 10.1016/S0049-3848(02)00036-1; Patrono C, 1979, NEW ENGL J MED, V353, P2373; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Ryu KH, 2009, THROMB RES, V124, P328, DOI 10.1016/j.thromres.2009.02.010; Sakata C, 2013, THROMB RES, V132, P56, DOI 10.1016/j.thromres.2013.03.005; Takeuchi K, 2012, WORLD J GASTROENTERO, V18, P2147, DOI 10.3748/wjg.v18.i18.2147; Tran H, 2004, JAMA-J AM MED ASSOC, V292, P1867, DOI 10.1001/jama.292.15.1867; Umar A, 2004, FUND CLIN PHARMACOL, V18, P559, DOI 10.1111/j.1472-8206.2004.00285.x; Umar A, 2003, THROMB RES, V110, P135, DOI 10.1016/S0049-3848(03)00343-8; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; WEISS HJ, 1979, BLOOD, V53, P244; Wooten JG, 2008, AM J VET RES, V69, P457, DOI 10.2460/ajvr.69.4.457; Zhao GR, 2008, FOOD CHEM TOXICOL, V46, P73, DOI 10.1016/j.fct.2007.06.034	26	35	37	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110124	10.1371/journal.pone.0110124	http://dx.doi.org/10.1371/journal.pone.0110124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375124	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600008
J	Ahonen, SJ; Kaukonen, M; Nussdorfer, FD; Harman, CD; Komaromy, AM; Lohi, H				Ahonen, Saija J.; Kaukonen, Maria; Nussdorfer, Forrest D.; Harman, Christine D.; Komaromy, Andras M.; Lohi, Hannes			A Novel Missense Mutation in ADAMTS10 in Norwegian Elkhound Primary Glaucoma	PLOS ONE			English	Article							PRIMARY OPEN-ANGLE; PECTINATE LIGAMENT DYSPLASIA; IRIDOCORNEAL ANGLE; MOLECULAR-GENETICS; INHERITED GLAUCOMA; IDENTIFICATION; ASSOCIATION; FIBRILLIN-1; DEFINITION; PREDICTION	Primary glaucoma is one of the most common causes of irreversible blindness both in humans and in dogs. Glaucoma is an optic neuropathy affecting the retinal ganglion cells and optic nerve, and elevated intraocular pressure is commonly associated with the disease. Glaucoma is broadly classified into primary open angle (POAG), primary closed angle (PCAG) and primary congenital glaucoma (PCG). Human glaucomas are genetically heterogeneous and multiple loci have been identified. Glaucoma affects several dog breeds but only three loci and one gene have been implicated so far. We have investigated the genetics of primary glaucoma in the Norwegian Elkhound (NE). We established a small pedigree around the affected NEs collected from Finland, US and UK and performed a genome-wide association study with 9 cases and 8 controls to map the glaucoma gene to 750 kb region on canine chromosome 20 (p(raw) = 4.93 x 10(-6), p(genome) = 0.025). The associated region contains a previously identified glaucoma gene, ADAMTS10, which was subjected to mutation screening in the coding regions. A fully segregating missense mutation (p.A387T) in exon 9 was found in 14 cases and 572 unaffected NEs (p(Fisher) = 3.5 x 10(-27)) with a high carrier frequency (25.3%). The mutation interrupts a highly conserved residue in the metalloprotease domain of ADAMTS10, likely affecting its functional capacity. Our study identifies the genetic cause of primary glaucoma in NEs and enables the development of a genetic test for breeding purposes. This study establishes also a new spontaneous canine model for glaucoma research to study the ADAMTS10 biology in optical neuropathy.	[Ahonen, Saija J.; Kaukonen, Maria; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Ahonen, Saija J.; Kaukonen, Maria; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Ahonen, Saija J.; Kaukonen, Maria; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Nussdorfer, Forrest D.; Harman, Christine D.; Komaromy, Andras M.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Komaromy, Andras M.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA	University of Helsinki; University of Helsinki; Michigan State University; University of Pennsylvania	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532; Kaukonen, Maria/0000-0002-2146-4694; Ahonen, Saija/0000-0003-3313-784X	Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; National Institutes of Health [K12-EY015398]; Michigan State University faculty startup funds; Jane and Aatos Erkko Foundation, Biocentrum Helsinki, Academy of Finland; NATIONAL EYE INSTITUTE [K12EY015398] Funding Source: NIH RePORTER	Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University faculty startup funds; Jane and Aatos Erkko Foundation, Biocentrum Helsinki, Academy of Finland; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was partly supported by the Jane and Aatos Erkko Foundation, Biocentrum Helsinki, Academy of Finland, the Sigrid Juselius Foundation, the National Institutes of Health (K12-EY015398) and Michigan State University faculty startup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahonen SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070903; Ahram DF, 2014, MOL VIS, V20, P497; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Aulchenko Y, 2010, BIOINFORMATICS, V5, P1294; Bjerkas E, 2002, VET OPHTHALMOL, V5, P49, DOI 10.1046/j.1463-5224.2002.00213.x; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; EKESTEN B, 1991, AM J VET RES, V52, P1875; Ekesten B, 1997, VET COMP OPHTHALMOL, V7, P14; Faivre L, 2002, HUM GENET, V110, P366, DOI 10.1007/s00439-002-0689-3; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Fuse N, 2010, TOHOKU J EXP MED, V221, P1, DOI 10.1620/tjem.221.1; GELATT KN, 1977, INVEST OPHTH VIS SCI, V16, P1135; Gemenetzi M, 2012, EYE, V26, P355, DOI 10.1038/eye.2011.309; Gould D, 2011, VET OPHTHALMOL, V14, P378, DOI 10.1111/j.1463-5224.2011.00892.x; Hann CR, 2011, INVEST OPHTH VIS SCI, V52, P45, DOI 10.1167/iovs.10-5620; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Kato K, 2006, VET OPHTHALMOL, V9, P71, DOI 10.1111/j.1463-5224.2006.00438.x; Kaurani L, 2014, INVEST OPHTH VIS SCI, V55, P3258, DOI 10.1167/iovs.14-14339; Kuchtey J, 2014, J OCUL PHARMACOL TH, V30, P170, DOI 10.1089/jop.2013.0184; Kuchtey J, 2013, AM J MED GENET A, V161A, P880, DOI 10.1002/ajmg.a.35838; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Kulkarni M L, 1995, Indian Pediatr, V32, P923; Kutz WE, 2011, J BIOL CHEM, V286, P17156, DOI 10.1074/jbc.M111.231571; Lee BL, 1998, J GLAUCOMA, V7, P366; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; MORRISON JC, 1982, INVEST OPHTH VIS SCI, V23, P726; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nongpiur ME, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004089; Ojha P, 2013, SEMIN OPHTHALMOL, V28, P301, DOI 10.3109/08820538.2013.825291; Oshima Y, 2004, VET OPHTHALMOL, V7, P185, DOI 10.1111/j.1463-5224.2004.04021.x; Palko JR, 2013, INVEST OPHTH VIS SCI, V54, P2685, DOI 10.1167/iovs.12-10621; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; PEIFFER RL, 1980, AM J VET RES, V41, P1808; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Read R. A., 1998, Veterinary Ophthalmology, V1, P85, DOI 10.1046/j.1463-5224.1998.00019.x; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Sarfarazi M, 1997, HUM MOL GENET, V6, P1667, DOI 10.1093/hmg/6.10.1667; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Somerville RPT, 2004, J BIOL CHEM, V279, P51208, DOI 10.1074/jbc.M409036200; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Strom AR, 2011, VET OPHTHALMOL, V14, P121, DOI 10.1111/j.1463-5224.2010.00855.x; Takamoto M, 2014, JPN J OPHTHALMOL, V58, P1, DOI 10.1007/s10384-013-0286-0; VANDERLINDESIPMAN JS, 1987, VET PATHOL, V24, P201, DOI 10.1177/030098588702400301; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; WHEATLEY HM, 1995, ARCH OPHTHALMOL-CHIC, V113, P103, DOI 10.1001/archopht.1995.01100010105028; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	54	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111941	10.1371/journal.pone.0111941	http://dx.doi.org/10.1371/journal.pone.0111941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372548	gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900093
J	Chang, T; Hansen, AJ; Piekielek, N				Chang, Tony; Hansen, Andrew J.; Piekielek, Nathan			Patterns and Variability of Projected Bioclimatic Habitat for Pinus albicaulis in the Greater Yellowstone Area	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ECOLOGICAL THEORY; FUTURE CLIMATE; RANGE SHIFTS; UNCERTAINTY; PREDICTION; FORESTS; REGION; US	Projected climate change at a regional level is expected to shift vegetation habitat distributions over the next century. For the sub-alpine species whitebark pine (Pinus albicaulis), warming temperatures may indirectly result in loss of suitable bioclimatic habitat, reducing its distribution within its historic range. This research focuses on understanding the patterns of spatiotemporal variability for future projected P. albicaulis suitable habitat in the Greater Yellowstone Area (GYA) through a bioclimatic envelope approach. Since intermodel variability from General Circulation Models (GCMs) lead to differing predictions regarding the magnitude and direction of modeled suitable habitat area, nine bias-corrected statistically down-scaled GCMs were utilized to understand the uncertainty associated with modeled projections. P. albicaulis was modeled using a Random Forests algorithm for the 1980-2010 climate period and showed strong presence/absence separations by summer maximum temperatures and springtime snowpack. Patterns of projected habitat change by the end of the century suggested a constant decrease in suitable climate area from the 2010 baseline for both Representative Concentration Pathways (RCPs) 8.5 and 4.5 climate forcing scenarios. Percent suitable climate area estimates ranged from 2-29% and 0.04-10% by 2099 for RCP 8.5 and 4.5 respectively. Habitat projections between GCMs displayed a decrease of variability over the 2010-2099 time period related to consistent warming above the 1910-2010 temperature normal after 2070 for all GCMs. A decreasing pattern of projected P. albicaulis suitable habitat area change was consistent across GCMs, despite strong differences in magnitude. Future ecological research in species distribution modeling should consider a full suite of GCM projections in the analysis to reduce extreme range contractions/expansions predictions. The results suggest that restoration strageties such as planting of seedlings and controlling competing vegetation may be necessary to maintain P. albicaulis in the GYA under the more extreme future climate scenarios.	[Chang, Tony; Hansen, Andrew J.; Piekielek, Nathan] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Chang, T (corresponding author), Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA.	tony.chang@msu.montana.edu		Piekielek, Nathan/0000-0002-2740-0675	National Aeronautics and Space Administration Applied Sciences Program [10-BIOCLIM10-0034]; National Science Foundation Experimental Program to Stimulate Competitive Research (EPSCoR) (INSTEP 3) [Track-I EPS-1101342]; North Central Climate Science Center [G13AC00392-G-8829-1]; Office Of The Director [1443108] Funding Source: National Science Foundation	National Aeronautics and Space Administration Applied Sciences Program; National Science Foundation Experimental Program to Stimulate Competitive Research (EPSCoR) (INSTEP 3); North Central Climate Science Center; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Aeronautics and Space Administration Applied Sciences Program (Grant 10-BIOCLIM10-0034); Funder URL: http://www.nasa.gov (AJH TC). It also received support from the National Science Foundation Experimental Program to Stimulate Competitive Research (EPSCoR) Track-I EPS-1101342 (INSTEP 3); Funder URL: http://www.nsf.gov/div/index.jsp?div = EPSC (NBP TC); and the North Central Climate Science Center (G13AC00392-G-8829-1); Funder URL: http://www.doi.gov/csc/northcentral/index.cfm (AJH NBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Arno SF, 1989, GTRINT253 INT RES; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bartlein PJ, 1997, CONSERV BIOL, V11, P782, DOI 10.1046/j.1523-1739.1997.95383.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bell DM, 2014, GLOBAL ECOL BIOGEOGR, V23, P168, DOI 10.1111/geb.12109; BOOTH GD, 1994, USDA FOR SERV INT R, P1; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Busby J, 1988, POTENTIAL IMPACTS CL; Callaway RM, 1998, OIKOS, V82, P561, DOI 10.2307/3546376; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Deser C, 2014, J CLIMATE, V27, P2271, DOI 10.1175/JCLI-D-13-00451.1; Dingman S., 2002, PHYS HYDROLOGY; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Edwards TC, 2006, ECOL MODEL, V199, P132, DOI 10.1016/j.ecolmodel.2006.05.016; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Franklin J, 2009, MAPPING SPECIES DIST; Freire J, 2012, COMPUT SCI ENG, V14, P18, DOI 10.1109/MCSE.2012.76; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gibson J, 2014, ECOSYSTEMS, V17, P43, DOI 10.1007/s10021-013-9703-y; Guisan A, 1998, J VEG SCI, V9, P65, DOI 10.2307/3237224; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hibbard KA, 2011, CLIVAR EXCHANGES, V16, P12; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Intergovernmental Panel on Climate Change, 2007, 4 ASS REP CLIM CHANG; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Jean C, 2010, P FUT HIGH EL 5 NEED, P28; Jewett JT, 2011, FOREST SCI, V57, P320; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Keane B, 2013, CLIMATE CHANGE WHITE; Keane RE, 2012, RANGE WIDE RESTORATI, P108; Lawrence RL, 2006, REMOTE SENS ENVIRON, V100, P356, DOI 10.1016/j.rse.2005.10.014; Lockman I.B., 2007, P C WHIT PIN PAC COA, P146; Logan JA, 1999, ENVIRON ENTOMOL, V28, P924, DOI 10.1093/ee/28.6.924; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Lutz JA, 2010, J BIOGEOGR, V37, P936, DOI 10.1111/j.1365-2699.2009.02268.x; Macfarlane WW, 2012, ECOLOGICAL APPL; Mahalovich MF, 2011, P HIGH 5 S 28 30 JUN; Mathys A, 2014, FOREST ECOL MANAG, V313, P144, DOI 10.1016/j.foreco.2013.11.005; McLane SC, 2012, ECOL APPL, V22, P142, DOI 10.1890/11-0329.1; Monahan WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083163; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Morisette JT, 2013, ECOGRAPHY, V36, P129, DOI 10.1111/j.1600-0587.2012.07815.x; Moss Richard, 2008, NEW SCENARIOS ANAL E; Pearce J, 1998, RESTOR ECOL, V6, P238, DOI 10.1046/j.1526-100X.1998.00636.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12; Pederson GT, 2011, J CLIMATE, V24, P1666, DOI 10.1175/2010JCLI3729.1; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Roberts DR, 2012, ECOGRAPHY, V35, P792, DOI 10.1111/j.1600-0587.2011.07147.x; Rupp DE, 2013, J GEOPHYS RES-ATMOS, V118, P10884, DOI 10.1002/jgrd.50843; Sakai A., 1987, Frost survival of plants. Responses and adaptation to freezing stress.; Smith WB, 2002, ENVIRON POLLUT, V116, pS233, DOI 10.1016/S0269-7491(01)00255-X; Tabachnick B, 1989, J PSYCHOPHYSIOL, V3, P46; TAUSCH RJ, 1993, J RANGE MANAGE, V46, P439, DOI 10.2307/4002664; Taylor KE, 2012, B AM METEOROLOGICAL, V93; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Thornthwaite CW, 1955, PUBLICATION CLIMATOL, VVIII; Thrasher Bridget, 2013, Eos, Transactions American Geophysical Union, V94, P321; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tomback D.F., 2001, WHITEBARK PINE COMMU, P243; Turner MG, 2001, LANDSCAPE ECOLOGY TH, DOI DOI 10.1007/B97434; Waring RH, 2011, REMOTE SENS ENVIRON, V115, P3554, DOI 10.1016/j.rse.2011.08.017; WEAVER T, 1974, AM MIDL NAT, V92, P222, DOI 10.2307/2424218; Weaver T, 2001, WHITEBARK PINE COMMU; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Whitlock C, 2003, FOREST ECOL MANAG, V178, P5, DOI 10.1016/S0378-1127(03)00051-3; WHITLOCK C, 1993, ECOL MONOGR, V63, P173, DOI 10.2307/2937179; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335	75	34	34	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111669	10.1371/journal.pone.0111669	http://dx.doi.org/10.1371/journal.pone.0111669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372719	gold, Green Published, Green Submitted			2022-12-26	WOS:000344556900058
J	Hwang, JJ; Kim, KD; Park, H; Park, CS; Jeong, HG				Hwang, Jae Joon; Kim, Kee-Deog; Park, Hyok; Park, Chang Seo; Jeong, Ho-Gul			Factors Influencing Superimposition Error of 3D Cephalometric Landmarks by Plane Orientation Method Using 4 Reference Points: 4 Point Superimposition Error Regression Model	PLOS ONE			English	Article							TOMOGRAPHY IMAGES; FACIAL ASYMMETRY; 3D-CT EVALUATION; CLEFT-LIP; IDENTIFICATION; REGISTRATION; PRECISION; SURGERY; SYSTEM; PALATE	Superimposition has been used as a method to evaluate the changes of orthodontic or orthopedic treatment in the dental field. With the introduction of cone beam CT (CBCT), evaluating 3 dimensional changes after treatment became possible by superimposition. 4 point plane orientation is one of the simplest ways to achieve superimposition of 3 dimensional images. To find factors influencing superimposition error of cephalometric landmarks by 4 point plane orientation method and to evaluate the reproducibility of cephalometric landmarks for analyzing superimposition error, 20 patients were analyzed who had normal skeletal and occlusal relationship and took CBCT for diagnosis of temporomandibular disorder. The nasion, sella turcica, basion and midpoint between the left and the right most posterior point of the lesser wing of sphenoidal bone were used to define a three-dimensional (3D) anatomical reference co-ordinate system. Another 15 reference cephalometric points were also determined three times in the same image. Reorientation error of each landmark could be explained substantially (23%) by linear regression model, which consists of 3 factors describing position of each landmark towards reference axes and locating error. 4 point plane orientation system may produce an amount of reorientation error that may vary according to the perpendicular distance between the landmark and the x-axis; the reorientation error also increases as the locating error and shift of reference axes viewed from each landmark increases. Therefore, in order to reduce the reorientation error, accuracy of all landmarks including the reference points is important. Construction of the regression model using reference points of greater precision is required for the clinical application of this model.	[Hwang, Jae Joon; Park, Hyok; Park, Chang Seo; Jeong, Ho-Gul] Yonsei Univ, Dent Hosp, Coll Dent, Dept Oral & Maxillofacial Radiol, Seoul 120749, South Korea; [Kim, Kee-Deog] Yonsei Univ, Dent Hosp, Coll Dent, Dept Gen Dent, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jeong, HG (corresponding author), Yonsei Univ, Dent Hosp, Coll Dent, Dept Oral & Maxillofacial Radiol, Seoul 120749, South Korea.	RAR198@yuhs.ac		, Kee-Deog/0000-0003-3055-5130				Arat ZM, 2003, ANGLE ORTHOD, V73, P374; Ashmore JL, 2002, AM J ORTHOD DENTOFAC, V121, P18, DOI 10.1067/mod.2002.120687; Berkowitz S, 1999, CLEFT PALATE-CRAN J, V36, P413, DOI 10.1597/1545-1569(1999)036<0413:AMRSOS>2.3.CO;2; Broadbent BH, 1931, ANGLE ORTHOD, V1, P45, DOI [10.1043/0003-3219(1981)051<0093:ANXTAI>2.0.CO;2, DOI 10.1043/0003-3219(1981)051<0093:ANXTAI>2.0.CO;2, DOI 10.1043/0003-3219(1931)001<0045:ANXTAI>2.0.CO;2]; Gu Y, 2008, ANGLE ORTHOD, V78, P967, DOI 10.2319/070107-301.1; Hassan B, 2013, EUR J ORTHODONT, V35, P38, DOI 10.1093/ejo/cjr050; Hoffmann J, 2005, J CRANIO MAXILL SURG, V33, P13, DOI 10.1016/j.jcms.2004.10.001; Hofrath H, 1931, J OROFAC ORTHOP, V1, P232; Kang SH, 2012, DENTOMAXILLOFAC RAD, V41, P679, DOI 10.1259/dmfr/21358271; Katsumata A, 2005, ORAL SURG ORAL MED O, V99, P212, DOI 10.1016/j.tripleo.2004.06.072; Kitaura H, 2000, CLEFT PALATE-CRAN J, V37, P349, DOI 10.1597/1545-1569(2000)037<0349:SODCMF>2.3.CO;2; Lagravere MO, 2010, DENTOMAXILLOFAC RAD, V39, P400, DOI 10.1259/dmfr/17319459; Lagravere MO, 2010, AM J ORTHOD DENTOFAC, V137, P598, DOI 10.1016/j.ajodo.2008.07.018; Maeda M, 2006, ORAL SURG ORAL MED O, V102, P382, DOI 10.1016/j.tripleo.2005.10.057; Sachdeva R C, 2001, J Clin Orthod, V35, P245; Schlicher W, 2012, EUR J ORTHODONT, V34, P263, DOI 10.1093/ejo/cjq144; SECKEL NG, 1995, CLEFT PALATE-CRAN J, V32, P434, DOI 10.1597/1545-1569(1995)032<0434:LPOMOC>2.3.CO;2; Swennen GRJ, 2006, J CRANIOFAC SURG, V17, P314, DOI 10.1097/00001665-200603000-00019; Zamora N, 2012, MED ORAL PATOL ORAL, V17, pE678, DOI 10.4317/medoral.17721	19	6	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110665	10.1371/journal.pone.0110665	http://dx.doi.org/10.1371/journal.pone.0110665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372707	gold, Green Submitted, Green Published			2022-12-26	WOS:000344556900022
J	Kendall, T				Kendall, Tamil			Consequences of Missed Opportunities for HIV Testing during Pregnancy and Delayed Diagnosis for Mexican Women, Children and Male Partners	PLOS ONE			English	Article							CARE; TRANSMISSION; PREVENTION; PROGRAM; MALAWI; OPT	Introduction: HIV testing during pregnancy permits prevention of vertical (mother-to-child) transmission and provides an opportunity for women living with HIV to access treatment for their own health. In 2001, Mexico's National HIV Action Plan committed to universal offer of HIV testing to pregnant women, but in 2011, only 45.6% of women who attended antenatal care (ANC) were tested for HIV. The study objective was to document the consequences of missed opportunities for HIV testing and counseling during pregnancy and late HIV diagnosis for Mexican women living with HIV and their families. Methods: Semi-structured-interviews with 55 women living with HIV who had had a pregnancy since 2001 were completed between 2009 and 2011. Interviews were analyzed thematically using a priori and inductive codes. Results: Consistent with national statistics, less than half of the women living with HIV (42%) were offered HIV testing and counseling during ANC. When not diagnosed during ANC, women had multiple contacts with the health-care system due to their own and other family members' AIDS-related complications before being diagnosed. Missed opportunities for HIV testing and counseling during antenatal care and health-care providers failure to recognize AIDS-related complications resulted in pediatric HIV infections, AIDS-related deaths of children and male partners, and HIV disease progression among women and other family members. In contrast, HIV diagnosis permitted timely access to interventions to prevent vertical HIV transmission and long-term care and treatment for women living with HIV. Conclusions: Omissions of the offer of HIV testing and counseling in ANC and health-care providers' failure to recognize AIDS-related complications had negative health, economic and emotional consequences. Scaling-up provider-initiated HIV testing and counseling within and beyond antenatal care and pre-service and in-service trainings on HIV and AIDS for health-care providers can hasten timely HIV diagnosis and contribute to improved individual and public health in Mexico.	[Kendall, Tamil] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Women & Hlth Initiat, Boston, MA 02115 USA; [Kendall, Tamil] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Takemi Program Int Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kendall, T (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Women & Hlth Initiat, 665 Huntington Ave, Boston, MA 02115 USA.	tkendall@hsph.harvard.edu			Canadian Institutes of Health Research; Elliott Trudeau Foundation; Social Sciences and Humanities Research Council Canada Vanier Canada; UNWOMEN; Dominican Republic	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Elliott Trudeau Foundation; Social Sciences and Humanities Research Council Canada Vanier Canada; UNWOMEN; Dominican Republic	This research was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship (http://www.cihr-irsc.gc.ca/e/193.html), a Pierre Elliott Trudeau Foundation Doctoral and Post-Doctoral Scholarship (http://www.trudeaufoundation.ca/en), a Social Sciences and Humanities Research Council Canada Vanier Canada Graduate Scholarship (http://www.vanier.gc.ca/eng/home-accueil.aspx), and a grant from UNIFEM (now UNWOMEN) sub-regional office for Mexico, Central America, Cuba and the Dominican Republic (http://www.unwomen.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], 2014, WORLD AIDS DAY 2014; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; CENSIDA, 2009, GUIA MAN ANT PERS CO; Centro Nacional para la Prevencion el y Control del VIH/SIDA, 2012, VIH SIDA MEX 2012; Charmaz K., 2005, HDB QUALITATIVE RES, V3rd, P507; CONASIDA, 2013, B GRUP INF SECT VIH; CONEVAL, 2011, MEAS FREQ ASK QUEST; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ferguson L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089764; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Godinez Leal L, 2007, TIENE CENSIDA PRUEBA; Guttierez J, 2013, ENCUESTA NACL SALUD; Kendall T, 2010, GLOBAL HLTH GOVERNAN, P4; Kendall T. R., 2012, PREVENTION VERTICAL; Maman S, 2008, J MIDWIFERY WOM HEAL, V53, P195, DOI 10.1016/j.jmwh.2007.11.001; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Moses A, 2008, AIDS, V22, P83, DOI 10.1097/QAD.0b013e3282f163b5; Rennie S, 2006, B WORLD HEALTH ORGAN, V84, P52, DOI 10.2471/BLT.05.025536; Romero-Gutierrez G, 2007, MIDWIFERY, V23, P23, DOI 10.1016/j.midw.2006.05.007; Saavedra-Lopez J, 2006, SIDA ASPECTOS SALUD, P3; *SECR SAL, 2002, PROGR ACC VIH SIDA I; Secretaria de Salud, 2010, NOM010SSA22010; Secretaria de Salud, 1993, NOM007SSA21993; Secretaria de Salud, 2008, PROGR ACC ESP 2007 2; Squires KE, 2007, GENDER MED, V4, P294, DOI 10.1016/S1550-8579(07)80060-X; *UN, 2001, UN GEN ASS SPEC SESS; UNAIDS, 2011, COUNTD ZER GLOB PLAN; [United Nations Statisctics Division United Nations Statisctics Division], 2011, MILL DEV GOALS IND O; Vera Gamboa L, 2005, GINECOL OBSTET MEX, V73, P355; Walmsley S, 2003, CAN MED ASSOC J, V168, P707; Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040091; WHO UNICEF UNAIDS, 2013, WHOHIV20139 UNICEF U; World Health Organization, 2010, UN ACC SCAL PRIOR HI	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109912	10.1371/journal.pone.0109912	http://dx.doi.org/10.1371/journal.pone.0109912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372464	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900011
J	Muller, EM; van Woesik, R				Muller, Erinn M.; van Woesik, Robert			Genetic Susceptibility, Colony Size, and Water Temperature Drive White-Pox Disease on the Coral Acropora palmata	PLOS ONE			English	Article							CARIBBEAN ELKHORN CORAL; BAND DISEASE; ST-JOHN; RESISTANCE; FRAGMENTATION; RECOVERY; ECOLOGY; STRESS	Outbreaks of coral diseases are one of the greatest threats to reef corals in the Caribbean, yet the mechanisms that lead to coral diseases are still largely unknown. Here we examined the spatial-temporal dynamics of white-pox disease on Acropora palmata coral colonies of known genotypes. We took a Bayesian approach, using Integrated Nested Laplace Approximation algorithms, to examine which covariates influenced the presence of white-pox disease over seven years. We showed that colony size, genetic susceptibility of the coral host, and high-water temperatures were the primary tested variables that were positively associated with the presence of white-pox disease on A. palmata colonies. Our study also showed that neither distance from previously diseased individuals, nor colony location, influenced the dynamics of white-pox disease. These results suggest that white-pox disease was most likely a consequence of anomalously high water temperatures that selectively compromised the oldest colonies and the most susceptible coral genotypes.	[Muller, Erinn M.] Mote Marine Lab, Sarasota, FL 34236 USA; [van Woesik, Robert] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Mote Marine Laboratory & Aquarium; Florida Institute of Technology	Muller, EM (corresponding author), Mote Marine Lab, Sarasota, FL 34236 USA.	emuller@mote.org			U.S. Geological Survey Natural Resource Preservation Program; National Oceanic and Atmospheric Administration Coral Reef Ecosystem Studies Program; National Park Service (Virgin Islands National Park); Mote Marine Laboratory Postdoctoral Fellowship	U.S. Geological Survey Natural Resource Preservation Program; National Oceanic and Atmospheric Administration Coral Reef Ecosystem Studies Program; National Park Service (Virgin Islands National Park); Mote Marine Laboratory Postdoctoral Fellowship	Data collected for this project was supported by funds from the U.S. Geological Survey Natural Resource Preservation Program and the National Oceanic and Atmospheric Administration Coral Reef Ecosystem Studies Program, and by in-kind contributions from the National Park Service (Virgin Islands National Park). Support for E. Muller was provided by a Mote Marine Laboratory Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Boyett HV, 2007, MAR BIOL, V151, P1711, DOI 10.1007/s00227-006-0603-y; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Cameletti M, 2013, ASTA-ADV STAT ANAL, V97, P109, DOI 10.1007/s10182-012-0196-3; Cervino JM, 2004, SYMBIOSIS, V37, P63; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Gil-Agudelo D. L, 2006, Rev. biol. trop, V54, P59; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Grimont PA, 1994, BERGEYS MANUAL DETER, V4, P477; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hogarth W.T., 2006, FED REGISTER, V71, P26852; Holden C, 1996, SCIENCE, V273, P177; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; Irikawa A, 2011, MARINE POLL B, V62, P455; Jones R, 2004, BEE WORLD, V85, P63; Kline DI, 2011, SCI REP-UK, V1, DOI 10.1038/srep00007; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lesser MP, 2014, FEMS MICROBIOL ECOL, V88, P457, DOI 10.1111/1574-6941.12311; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Muller EM, 2014, MAR BIOL, V161, P359, DOI 10.1007/s00227-013-2341-2; Muller EM, 2011, J EXP MAR BIOL ECOL, V397, P52, DOI 10.1016/j.jembe.2010.11.002; Muller EM, 2009, CORAL REEFS, V28, P757, DOI 10.1007/s00338-009-0504-x; Muller EM, 2012, GLOBAL CHANGE BIOL, V18, P3529, DOI 10.1111/gcb.12019; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Nugues MM, 2002, MAR ECOL PROG SER, V229, P61, DOI 10.3354/meps229061; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Polson SW, 2009, P 11 INT COR REEF S, V1, P251; R Core Team, 2021, R LANGUAGE ENV STAT; Raymundo LJH, 2003, DIS AQUAT ORGAN, V56, P95, DOI 10.3354/dao056095; Reed KC, 2010, DIS AQUAT ORGAN, V90, P85, DOI 10.3354/dao02213; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rogers CS, 2012, CORAL REEFS, V31, P807, DOI 10.1007/s00338-012-0898-8; Roth L, 2013, ECOL MODEL, V263, P223, DOI 10.1016/j.ecolmodel.2013.05.002; RUE H., 2005, GAUSSIAN MARKOV RAND; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Smith GW, 1996, NATURE, V383, P487, DOI 10.1038/383487a0; Stedman T.L, 1976, STEDMANS MED DICT; Sutherland KP, 2010, ENVIRON MICROBIOL, V12, P1122, DOI 10.1111/j.1462-2920.2010.02152.x; Sutherland KP, 2004, CORAL HEALTH AND DISEASE, P289; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Wagner D, 2008, B MAR SCI, V83, P553	49	22	24	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110759	10.1371/journal.pone.0110759	http://dx.doi.org/10.1371/journal.pone.0110759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372835	Green Published, gold			2022-12-26	WOS:000344556900023
J	Peng, L; Damschroder, MM; Wu, HR; Dall'Acqua, WF				Peng, Li; Damschroder, Melissa M.; Wu, Herren; Dall'Acqua, William F.			Bi-Epitope SPR Surfaces: A Solution to Develop Robust Immunoassays	PLOS ONE			English	Article							PLASMON RESONANCE; ANTIBODY-AFFINITY; SENSITIVE DETECTION; IMMUNOGLOBULIN-G; POOR-PROGNOSIS; IMMOBILIZATION; BIOSENSOR; PROTEIN; MATURATION; OVEREXPRESSION	Surface plasmon resonance (SPR)-based immunoassays have numerous applications and require high affinity reagents for sensitive and reliable measurements. We describe a quick approach to turn low affinity antibodies into appropriate capture reagents. We used antibodies recognizing human ephrin type A receptor 2 (EphA2) and a ProteOn XPR36 as a model system. We generated so-called 'bi-epitope' sensor surfaces by immobilizing various pairs of anti-EphA2 antibodies using standard amine coupling. The apparent binding affinities to EphA2 and EphA2 detection sensitivities of the bi-epitope and 'single-epitope' surfaces were then compared. For all antibody pairs tested, bi-epitope surfaces exhibited an similar to 10-100-fold improvement in apparent binding affinities when compared with single-epitope ones. When pairing 2 antibodies of low intrinsic binding affinities (similar to 10(-8) M) and fast dissociation rates (similar to 10(-2) s(-1)), the apparent binding affinity and dissociation rate of the bi-epitope surface was improved up to similar to 10(-10) M and 10(-4) s(-1), respectively. This led to an similar to 100-200-fold enhancement in EphA2 limit of detection in crude cell supernatants. Our results show that the use of antibody mixtures in SPR applications constitutes a powerful approach to develop sensitive immunoassays, as previously shown for non-SPR formats. As SPR-based assays have significantly expanded their reach in the last decade, such an approach promises to further accelerate their development.	[Peng, Li; Damschroder, Melissa M.; Wu, Herren; Dall'Acqua, William F.] Medimmune Inc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune	Dall'Acqua, WF (corresponding author), Medimmune Inc, Dept Antibody Discovery & Prot Engn, One MedImmune Way, Gaithersburg, MD 20878 USA.	dallacquaw@medimmune.com		Damschroder, Melissa/0000-0001-9453-6532	MedImmune	MedImmune(AstraZenecaMedimmune)	All work was funded by the authors' employer, MedImmune. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLUWALIA A, 1992, BIOSENS BIOELECTRON, V7, P207, DOI 10.1016/0956-5663(92)87017-J; Anderson GP, 1997, BIOSENS BIOELECTRON, V12, P329, DOI 10.1016/S0956-5663(96)00074-7; Bradley SP, 2010, CANCER RES, V70, DOI 10.1158/1538-7445.AM10-826; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Copley CG, 2002, IMMUNOASSAY PRACTICA; Danczyk R, 2003, BIOTECHNOL BIOENG, V84, P215, DOI 10.1002/bit.10760; EHRLICH PH, 1982, J IMMUNOL, V128, P2709; EHRLICH PH, 1983, SCIENCE, V221, P279, DOI 10.1126/science.6857284; EHRLICH PH, 1983, J IMMUNOL, V131, P1906; Gobi KV, 2007, ANAL BIOANAL CHEM, V387, P2727, DOI 10.1007/s00216-007-1159-5; Guidi A, 2001, BIOSENS BIOELECTRON, V16, P971, DOI 10.1016/S0956-5663(01)00245-7; Heutmekers THJ, 2007, ANAL CHIM ACTA, V586, P239, DOI 10.1016/j.aca.2006.11.047; Hyuga M, 2001, Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku, P57; Indyk HE, 2003, J AOAC INT, V86, P386; Klonisch T, 1996, IMMUNOLOGY, V89, P165, DOI 10.1046/j.1365-2567.1996.d01-722.x; Kobayashi N, 2010, ANAL CHEM, V82, P1027, DOI 10.1021/ac902283n; Liang M, 2007, ASSAY DRUG DEV TECHN, V5, P655, DOI 10.1089/adt.2007.089; LIEDBERG B, 1995, BIOSENS BIOELECTRON, V10, pR1, DOI 10.1016/0956-5663(95)96965-2; LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7; Lu B, 1996, ANALYST, V121, pR29, DOI 10.1039/an996210029r; Meade-Tollin L, 2007, CANCER BIOL THER, V6, P288, DOI 10.4161/cbt.6.2.4024; Miyazaki T, 2003, INT J CANCER, V103, P657, DOI 10.1002/ijc.10860; Muller BH, 2011, J MOL BIOL, V414, P545, DOI 10.1016/j.jmb.2011.10.008; Mytych DT, 2009, J PHARMACEUT BIOMED, V49, P415, DOI 10.1016/j.jpba.2008.11.028; NIMMO GR, 1984, J IMMUNOL METHODS, V72, P177, DOI 10.1016/0022-1759(84)90446-0; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b; Sandin S, 2004, STRUCTURE, V12, P409, DOI 10.1016/j.str.2004.02.011; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Schmid EL, 1997, ANAL CHEM, V69, P1979, DOI 10.1021/ac9700033; Shriver-Lake LC, 1997, BIOSENS BIOELECTRON, V12, P1101, DOI 10.1016/S0956-5663(97)00070-5; Siegel RW, 2008, CLIN CHEM, V54, P1008, DOI 10.1373/clinchem.2007.097352; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; STEWARD MW, 1985, J IMMUNOL METHODS, V78, P173, DOI 10.1016/0022-1759(85)90074-2; Sun Y, 2007, BIOSENS BIOELECTRON, V23, P473, DOI 10.1016/j.bios.2007.06.016; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Vashist SK, 2011, ANALYST, V136, P4431, DOI 10.1039/c1an15325k; Wang JL, 2009, BIOSENS BIOELECTRON, V25, P124, DOI 10.1016/j.bios.2009.06.016; Zeng C, 2013, ANAL BIOCHEM, V440, P18, DOI 10.1016/j.ab.2013.04.026	39	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112070	10.1371/journal.pone.0112070	http://dx.doi.org/10.1371/journal.pone.0112070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372291	Green Published, Green Submitted, gold			2022-12-26	WOS:000344556900108
J	te Velde, SJ; Singh, A; Chinapaw, M; De Bourdeaudhuij, I; Jan, N; Kovacs, E; Bere, E; Vik, FN; Bringolf-Isler, B; Manios, Y; Moreno, L; Brug, J				te Velde, Saskia J.; Singh, Amika; Chinapaw, Mai; De Bourdeaudhuij, Ilse; Jan, Natasa; Kovacs, Eva; Bere, Elling; Vik, Froydis N.; Bringolf-Isler, Bettina; Manios, Yannis; Moreno, Luis; Brug, Johannes			Energy Balance Related Behaviour: Personal, Home- and Friend-Related Factors among Schoolchildren in Europe Studied in the ENERGY-Project	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BODY-WEIGHT; BREAKFAST CONSUMPTION; ENVIRONMENTAL PREDICTORS; VEGETABLE CONSUMPTION; BEVERAGE CONSUMPTION; 7 COUNTRIES; CHILDREN; ADOLESCENTS; FRUIT	Objective: To design interventions that target energy balance-related behaviours, knowledge of primary schoolchildren's perceptions regarding soft drink intake, fruit juice intake, breakfast consumption, TV viewing and physical activity (PA) is essential. The current study describes personal beliefs and attitudes, home-and friend-related variables regarding these behaviours across Europe. Design: Cross-sectional study in which personal, family and friend-related variables were assessed by validated questionnaires, and dichotomized as favourable versus unfavourable answers. Logistic regression analyses were conducted to estimate proportions of children giving unfavourable answers and test between-country differences. Setting: A survey in eight European countries. Subjects: A total of 7903 10-12 year old primary schoolchildren. Results: A majority of the children reported unfavourable attitudes, preferences and subjective norms regarding soft drink, fruit juice intake and TV viewing accompanied with high availability and accessibility at home. Few children reported unfavourable attitudes and preferences regarding breakfast consumption and PA. Many children reported unfavourable health beliefs regarding breakfast consumption and TV viewing. Substantial differences between countries were observed, especially for variables regarding soft drink intake, breakfast consumption and TV viewing. Conclusion: The surveyed children demonstrated favourable attitudes to some healthy behaviours (PA, breakfast intake) as well as to some unhealthy behaviours (soft drink consumption, TV viewing). Additionally, many children across Europe have personal beliefs and are exposed to social environments that are not supportive to engagement in healthy behaviours. Moreover, the large differences in personal, family and friend-related variables across Europe argue for implementing different strategies in the different European countries.	[te Velde, Saskia J.; Singh, Amika; Chinapaw, Mai; Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [te Velde, Saskia J.; Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Singh, Amika; Chinapaw, Mai] Vrije Univ Amsterdam, Med Ctr, Dept Occupat & Publ Hlth, Amsterdam, Netherlands; [De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Jan, Natasa] Slovenian Heart Fdn, Ljubljana, Slovenia; [Kovacs, Eva] Univ Pecs, Dept Paediat, Pecs, Hungary; [Bere, Elling; Vik, Froydis N.] Univ Agder, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway; [Bringolf-Isler, Bettina] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Bringolf-Isler, Bettina] Univ Basel, Basel, Switzerland; [Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Moreno, Luis] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Ghent University; University of Pecs; University of Agder; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Harokopio University Athens; University of Zaragoza	te Velde, SJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.	s.tevelde@vumc.nl	Brug, Johannes/A-8242-2018; Akkal, Maureen/P-6919-2014; Manios, Yannis/AAM-8953-2021; Paw, Mai Chin A/N-1665-2019; Moreno, Luis/S-1780-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019	Brug, Johannes/0000-0002-1904-7349; Manios, Yannis/0000-0001-6486-114X; Paw, Mai Chin A/0000-0001-6259-2441; Moreno, Luis/0000-0003-0454-653X; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; te Velde, Saskia/0000-0002-4674-8052	Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-B) [223254]; Netherlands Organization for Health Research and Development [50-50150-98-002]	Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-B); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-2007-B), Grant agreement no. 223254. The content of this article reflects only the authors' views and the European Community is not liable for any use that may be made of the information contained therein. In the Netherlands, the ENERGY-project was additionally supported by a grant from the Netherlands Organization for Health Research and Development (Grant number 50-50150-98-002). The European Commission had no role in the design, analysis or writing of this article. The Netherlands Organization for Health Research and Development had no role in the design, analysis or writing of this article.	AJZEN I, 1986, J EXP SOC PSYCHOL, V22, P453, DOI 10.1016/0022-1031(86)90045-4; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bartholomew LK, 2006, PLANNING HLTH PROMOT; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beets MW, 2010, HEALTH EDUC BEHAV, V37, P621, DOI 10.1177/1090198110363884; Bere E, 2008, PUBLIC HEALTH NUTR, V11, P49, DOI 10.1017/S1368980007000122; Berkey CS, 2003, INT J OBESITY, V27, P1258, DOI 10.1038/sj.ijo.0802402; Bes-Rastrollo M, 2006, NUTRITION, V22, P504, DOI 10.1016/j.nut.2005.12.006; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Bruening M, 2011, J NUTR EDUC BEHAV, V43, P390, DOI 10.1016/j.jneb.2011.02.016; Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Brug Johannes, 2010, BMC Public Health, V10, P276, DOI 10.1186/1471-2458-10-276; Brug J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-610; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Cameron AJ, 2013, PEDIATR OBES, V8, P130, DOI 10.1111/j.2047-6310.2012.00094.x; Cheng TSY, 2008, J SCHOOL HEALTH, V78, P203, DOI 10.1111/j.1746-1561.2008.00287.x; Cislak A, 2012, CHILD CARE HLTH DEV, V38, P321, DOI 10.1111/j.1365-2214.2011.01285.x; Debastiani SD, 2013, J PHYS ACT HEALTH; DeJong CS, 2009, PREV MED, V48, P372, DOI 10.1016/j.ypmed.2009.02.009; Ezendam NPM, 2010, BRIT J NUTR, V103, P768, DOI 10.1017/S0007114509992297; Fernandez-Alvira JM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-80; Fernandez-Alvira JM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-5; Fernandez-Alvira JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071848; Golan M, 2006, INT J PEDIATR OBES, V1, P66, DOI 10.1080/17477160600644272; Grimm GC, 2004, J AM DIET ASSOC, V104, P1244, DOI 10.1016/j.jada.2004.05.206; Haerens L, 2008, EUR J CLIN NUTR, V62, P51, DOI 10.1038/sj.ejcn.1602681; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Herzig M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-139; Institute of Medicine CoFMatDoCaY, 2006, FOOD MARK CHILDR YOU; International Obesity Task Force, 2012, GLOB EP; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Kyriazis I, 2012, ARCH MED SCI, V8, P859, DOI 10.5114/aoms.2012.31296; Mahoney CR, 2005, PHYSIOL BEHAV, V85, P635, DOI 10.1016/j.physbeh.2005.06.023; Martens MK, 2005, PUBLIC HEALTH NUTR, V8, P1258, DOI 10.1079/PHN2005828; Ministry of Health and Care Services, 2007, NORW ACT PLAN NUTR 2; Monsivais P, 2012, ARCH PEDIAT ADOL MED, V166, P459, DOI 10.1001/archpediatrics.2011.1599; Pearson N, 2012, BRIT J NUTR, V108, P932, DOI 10.1017/S000711451100612X; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Rasmussen M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-22; Reilly JJ, 2008, P NUTR SOC, V67, P317, DOI 10.1017/S0029665108008604; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Stea TH, 2012, PUBLIC HEALTH NUTR, V15, P379, DOI 10.1017/S1368980011001959; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514; Tak NI, 2011, APPETITE, V56, P503, DOI 10.1016/j.appet.2011.01.013; te Velde SJ, 2010, INT J PEDIATR OBES; The Norwegian Consumer Council, 2007, RETN MARK MAT DRIKK; Timperio AF, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-15; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Van der Horst K, 2006, HLTH ED RES; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; van der Horst K, 2010, PUBLIC HEALTH NUTR, V13, P1746, DOI 10.1017/S1368980010002314; Van Lippevelde W, 2013, APPETITE, V61, P59, DOI 10.1016/j.appet.2012.10.019; van Stralen MM, 2011, INT J OBESITY, V35, P1251, DOI 10.1038/ijo.2011.68; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Verloigne M, 2013, PUBLIC HEALTH NUTR, V16, P202, DOI 10.1017/S1368980012004120; Verloigne M, 2012, PUBLIC HEALTH NUTR, V15, P1380, DOI 10.1017/S1368980011003168; Verplanken B, 2006, BRIT J SOC PSYCHOL, V45, P639, DOI 10.1348/014466605X49122; WHO, 2003, WHO TECHN REP SER, V916, P54; Wind M, 2006, J NUTR EDUC BEHAV, V38, P211, DOI 10.1016/j.jneb.2006.02.011	60	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111775	10.1371/journal.pone.0111775	http://dx.doi.org/10.1371/journal.pone.0111775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372490	Green Published, Green Accepted, gold			2022-12-26	WOS:000344556900074
J	Tornari, C; Towers, ER; Gale, JE; Dawson, SJ				Tornari, Chrysostomos; Towers, Emily R.; Gale, Jonathan E.; Dawson, Sally J.			Regulation of the Orphan Nuclear Receptor Nr2f2 by the DFNA15 Deafness Gene Pou4f3	PLOS ONE			English	Article							PROMOTER-TRANSCRIPTION FACTORS; COUP-TFII; HAIR CELL; STRESS GRANULES; DOMAIN FACTORS; FACTOR-II; LOCALIZATION; EXPRESSION; DIFFERENTIATION; IDENTIFICATION	Hair cells are the mechanotransducing cells of the inner ear that are essential for hearing and balance. POU4F3 - a POU-domain transcription factor selectively expressed by these cells - has been shown to be essential for hair cell differentiation and survival in mice and its mutation in humans underlies late-onset progressive hearing loss (DFNA15). The downstream targets of POU4F3 are required for hair cell differentiation and survival. We aimed to identify such targets in order to elucidate the molecular pathways involved in hair cell production and maintenance. The orphan thyroid nuclear receptor Nr2f2 was identified as a POU4F3 target using a subtractive hybridization strategy and EMSA analysis showed that POU4F3 binds to two sites in the Nr2f2 5' flanking region. These sites were shown to be required for POU4F3 activation as their mutation leads to a reduction in the response of an Nr2f2 5' flanking region reporter construct to POU4F3. Immunocytochemistry was carried out in the developing and adult inner ear in order to investigate the relevance of this interaction in hearing. NR2F2 expression in the postnatal mouse organ of Corti was shown to be detectable in all sensory epithelia examined and characterised. These data demonstrate that Nr2f2 is a direct target of POU4F3 in vitro and that this regulatory relationship may be relevant to hair cell development and survival.	[Tornari, Chrysostomos; Towers, Emily R.; Gale, Jonathan E.; Dawson, Sally J.] UCL, Ear Inst, London, England	University of London; University College London	Dawson, SJ (corresponding author), UCL, Ear Inst, London, England.	sally.dawson@ucl.ac.uk	Tornari, Chrysostomos/AAU-4091-2020; Gale, Jonathan/AAG-6874-2019	Tornari, Chrysostomos/0000-0002-1212-0590; Dawson, Sally/0000-0002-4421-2043; Gale, Jonathan/0000-0003-4678-4878	Action on hearing loss [483]; Wellcome Trust [091092/Z/09/Z, 064599]; GlaxoSmithKline via the UCL MB PhD programme	Action on hearing loss; Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline via the UCL MB PhD programme	This work was funded by grants from: Action on hearing loss, http://actiononhearingloss.org.uk/ (grant number 483 to JEG and SJD); the Wellcome Trust, http://www.wellcome.ac.uk/ (grant number 091092/Z/09/Z to JEG and SJD); and the original subtractive hybridisation screen was supported by a grant from the Wellcome Trust (grant number 064599 to SJD). CT's research was undertaken as part of a studentship that was funded by GlaxoSmithKline (http://www.gsk.com/uk) via the UCL MB PhD programme (http://www.ucl.ac.uk/mbphd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; AURORA R, 1992, MOL CELL BIOL, V12, P455, DOI 10.1128/MCB.12.2.455; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; Bok JW, 2007, INT J DEV BIOL, V51, P521, DOI 10.1387/ijdb.072381jb; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Choi CH, 2008, FREE RADICAL BIO MED, V44, P1772, DOI 10.1016/j.freeradbiomed.2008.02.005; Clough RL, 2004, BIOCHEM BIOPH RES CO, V324, P372, DOI 10.1016/j.bbrc.2004.09.074; Collin RWJ, 2008, HUM MUTAT, V29, P545, DOI 10.1002/humu.20693; DASILVA SL, 1995, MOL BRAIN RES, V30, P131, DOI 10.1016/0169-328X(94)00289-Q; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Elnitski L, 2001, J BIOL CHEM, V276, P6289, DOI 10.1074/jbc.M009624200; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Fekete DM, 1999, TRENDS NEUROSCI, V22, P263, DOI 10.1016/S0166-2236(98)01366-6; Frech K, 1996, NUCLEIC ACIDS RES, V24, P1212; Gross J, 2011, CELL MOL NEUROBIOL, V31, P1089, DOI 10.1007/s10571-011-9708-z; Gruber CA, 1997, MOL CELL BIOL, V17, P2391, DOI 10.1128/MCB.17.5.2391; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Hertzano R, 2007, EUR J NEUROSCI, V25, P999, DOI 10.1111/j.1460-9568.2007.05332.x; HYDE GE, 1995, OTOLARYNG HEAD NECK, V113, P530, DOI 10.1177/019459989511300503; Keithley EM, 1999, HEARING RES, V134, P71, DOI 10.1016/S0378-5955(99)00070-2; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kim HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079063; Kingston RE, 2001, CURR PROTOC IMMUNOL; Krishnan V, 1997, MOL ENDOCRINOL, V11, P1458, DOI 10.1210/me.11.10.1458; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; Lee HK, 2010, BIOCHEM BIOPH RES CO, V396, P626, DOI 10.1016/j.bbrc.2010.04.132; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; Ling MM, 1997, ANAL BIOCHEM, V254, P157, DOI 10.1006/abio.1997.2428; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McCaffery P, 1999, MECH DEVELOP, V82, P119, DOI 10.1016/S0925-4773(99)00022-2; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Perilhou A, 2008, MOL CELL BIOL, V28, P4588, DOI 10.1128/MCB.01191-07; Qin J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003285; Qiu Y, 1996, J STEROID BIOCHEM, V56, P81, DOI 10.1016/0960-0760(95)00225-1; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raz Y, 1999, DEV BIOL, V213, P180, DOI 10.1006/dbio.1999.9364; Rivolta MN, 1998, P ROY SOC B-BIOL SCI, V265, P1595, DOI 10.1098/rspb.1998.0477; Romand R, 2006, J NEUROBIOL, V66, P687, DOI 10.1002/neu.20244; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shiina N, 2010, J NEUROSCI, V30, P12816, DOI 10.1523/JNEUROSCI.6386-09.2010; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Suzuki T, 2000, MOL CELL ENDOCRINOL, V164, P69, DOI 10.1016/S0303-7207(00)00242-2; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tang LS, 2006, DEVELOPMENT, V133, P3683, DOI 10.1242/dev.02536; Tang LS, 2005, GENE EXPR PATTERNS, V5, P587, DOI 10.1016/j.modgep.2005.03.012; Towers ER, 2011, J CELL SCI, V124, P1145, DOI 10.1242/jcs.076141; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; VERRIJZER CP, 1993, BIOCHIM BIOPHYS ACTA, V1173, P1, DOI 10.1016/0167-4781(93)90237-8; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	66	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112247	10.1371/journal.pone.0112247	http://dx.doi.org/10.1371/journal.pone.0112247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372459	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900128
J	Papiorek, S; Junker, RR; Lunau, K				Papiorek, Sarah; Junker, Robert R.; Lunau, Klaus			Gloss, Colour and Grip: Multifunctional Epidermal Cell Shapes in Bee- and Bird-Pollinated Flowers	PLOS ONE			English	Article							HUMMINGBIRD POLLINATION; IPOMOPSIS-AGGREGATA; PETAL; PREFERENCES; PIGMENT; BUMBLEBEES; RANUNCULUS; EVOLUTION; NICHE	Flowers bear the function of filters supporting the attraction of pollinators as well as the deterrence of floral antagonists. The effect of epidermal cell shape on the visual display and tactile properties of flowers has been evaluated only recently. In this study we quantitatively measured epidermal cell shape, gloss and spectral reflectance of flowers pollinated by either bees or birds testing three hypotheses: The first two hypotheses imply that bee-pollinated flowers might benefit from rough surfaces on visually-active parts produced by conical epidermal cells, as they may enhance the colour signal of flowers as well as the grip on flowers for bees. In contrast, bird-pollinated flowers might benefit from flat surfaces produced by flat epidermal cells, by avoiding frequent visitation from non-pollinating bees due to a reduced colour signal, as birds do not rely on specific colour parameters while foraging. Moreover, flat petal surfaces in bird-pollinated flowers may hamper grip for bees that do not touch anthers and stigmas while consuming nectar and thus, are considered as nectar thieves. Beside this, the third hypothesis implies that those flower parts which are vulnerable to nectar robbing of bee-as well as bird-pollinated flowers benefit from flat epidermal cells, hampering grip for nectar robbing bees. Our comparative data show in fact that conical epidermal cells are restricted to visually-active parts of bee-pollinated flowers, whereas robbing-sensitive parts of bee-pollinated as well as the entire floral surface of bird-pollinated flowers possess on average flat epidermal cells. However, direct correlations between epidermal cell shape and colour parameters have not been found. Our results together with published experimental studies show that epidermal cell shape as a largely neglected flower trait might act as an important feature in pollinator attraction and avoidance of antagonists, and thus may contribute to the partitioning of flower-visitors.	[Papiorek, Sarah; Lunau, Klaus] Univ Dusseldorf, Dept Biol, Inst Sensory Ecol, Dusseldorf, Germany; [Junker, Robert R.] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria	Heinrich Heine University Dusseldorf; Salzburg University	Papiorek, S (corresponding author), Univ Dusseldorf, Dept Biol, Inst Sensory Ecol, Dusseldorf, Germany.	Sarah.Papiorek@uni-duesseldorf.de	Lunau, Klaus/AAL-2532-2021	Lunau, Klaus/0000-0001-5184-4201	E-Norm graduate school of Heinrich-Heine University Dusseldorf	E-Norm graduate school of Heinrich-Heine University Dusseldorf	Funding provided by the E-Norm graduate school of Heinrich-Heine University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn K, 2012, FUNCT ECOL, V26, P941, DOI 10.1111/j.1365-2435.2012.02009.x; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Botes C, 2009, INT J PLANT SCI, V170, P151, DOI 10.1086/595291; Castellanos MC, 2004, J EVOLUTION BIOL, V17, P876, DOI 10.1111/j.1420-9101.2004.00729.x; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; COLLIAS NE, 1968, CONDOR, V70, P273, DOI 10.2307/1366705; Comba L, 2000, PLANT CELL ENVIRON, V23, P639, DOI 10.1046/j.1365-3040.2000.00580.x; Dyer AG, 2007, ARTHROPOD-PLANT INTE, V1, P45, DOI 10.1007/s11829-007-9002-7; Faegri K., 1966, PRINCIPLES POLLINATI; Fitzpatrick S, 1998, ANN ZOOL FENN, V35, P67; Galsterer S, 1999, PLANT BIOLOGY, V1, P670, DOI 10.1055/s-2007-978571; Glover BJ, 1998, HEREDITY, V80, P778, DOI 10.1046/j.1365-2540.1998.00345.x; Gorton HL, 1996, PLANT PHYSIOL, V112, P879, DOI 10.1104/pp.112.3.879; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Herrera G, 2008, J COMP PHYSIOL A, V194, P785, DOI 10.1007/s00359-008-0349-8; Irwin RE, 1999, ECOLOGY, V80, P1703; Irwin RE, 1998, OECOLOGIA, V116, P519, DOI 10.1007/s004420050617; Junker RR, 2013, FUNCT ECOL, V27, P329, DOI 10.1111/1365-2435.12005; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; KEVAN PG, 1985, P NATL ACAD SCI USA, V82, P4750, DOI 10.1073/pnas.82.14.4750; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; Menzel Randolf, 1991, P262; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Nussinovitch A, 1996, FOOD SCI TECHNOL-LEB, V29, P184; Odeen A, 2010, J COMP PHYSIOL A, V196, P91, DOI 10.1007/s00359-009-0474-z; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Papiorek S, 2013, NATURWISSENSCHAFTEN, V100, P633, DOI 10.1007/s00114-013-1060-3; Parkin J, 1928, ANN BOT-LONDON, V42, P739, DOI 10.1093/oxfordjournals.aob.a090138; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rands SA, 2011, ARTHROPOD-PLANT INTE, V5, P279, DOI 10.1007/s11829-011-9146-3; Rohde K, 2013, J COMP PHYSIOL A, V199, P197, DOI 10.1007/s00359-012-0783-5; Schiestl FP, 2013, TRENDS ECOL EVOL, V28, P307, DOI 10.1016/j.tree.2013.01.019; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; STILES FG, 1976, CONDOR, V78, P10, DOI 10.2307/1366912; Thomson JD, 2008, INT J PLANT SCI, V169, P23, DOI 10.1086/523361; Valido A, 2011, J EVOLUTION BIOL, V24, P751, DOI 10.1111/j.1420-9101.2010.02206.x; van der Kooi CJ, 2014, NEW PHYTOL, V203, P667, DOI 10.1111/nph.12808; Vignolini S, 2012, NEW PHYTOL, V196, P1038, DOI 10.1111/j.1469-8137.2012.04356.x; Vignolini S, 2012, J R SOC INTERFACE, V9, P1295, DOI 10.1098/rsif.2011.0759; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Whitney HM, 2012, PLOS ONE, V7, P66, DOI 10.1371/journal.pone.0029476; Whitney Heather M., 2011, Curtis's Botanical Magazine, V28, P349, DOI 10.1111/j.1467-8748.2011.01762.x; Whitney HM, 2011, ANN BOT-LONDON, V108, P609, DOI 10.1093/aob/mcr065; Whitney HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017576; Whitney Heather M., 2009, Communicative & Integrative Biology, V2, P505; Whitney HM, 2009, CURR BIOL, V19, P948, DOI 10.1016/j.cub.2009.04.051; Wilson P, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P47	49	27	28	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112013	10.1371/journal.pone.0112013	http://dx.doi.org/10.1371/journal.pone.0112013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369510	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000137
J	Sriram, G; Jankowski, W; Kasikara, C; Reichman, C; Saleh, T; Nguyen, KQ; Li, J; Hornbeck, P; Machida, K; Liu, T; Li, H; Kalodimos, CG; Birge, RB				Sriram, G.; Jankowski, W.; Kasikara, C.; Reichman, C.; Saleh, T.; Nguyen, K-Q; Li, J.; Hornbeck, P.; Machida, K.; Liu, T.; Li, H.; Kalodimos, C. G.; Birge, R. B.			Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk	ONCOGENE			English	Article							EPIDERMAL-GROWTH-FACTOR; MEDIATED CELL-ADHESION; SH3 DOMAIN; APOPTOTIC CELLS; ADAPTER PROTEIN; C-ABL; SIGNALING PROTEIN; STRUCTURAL BASIS; FACTOR RECEPTOR; FACTOR C3G	Crk, the prototypical member of a class of Src homology-2 (SH2) and Src homology-3 (SH3) domain containing proteins that controls the coordinated assembly of signaling complexes, is regulated by phosphorylation of Y221 in the linker region, which forms an intramolecular SH2-pY221 auto-clamp to interrupt SH2-N-terminal SH3 domain (SH3N) signaling. Here, we show using LC-MS/MS and by generating phospho-specific antibodies that, iteratively with Y221, the Crk C-terminal SH3 domain (SH3C) is routinely phosphorylated on Y239 and/or Y251 by several extracellular stimuli known to engage Crk. Although phosphorylation at Y221 auto-inhibits the Crk SH2, phosphorylation of the SH3C generates an unconventional phosphoSH3C-SH3N unit in which the SH3N is fully functional to bind polyproline type II ligands and the phosphoSH3C binds de novo to other SH2 domains. Using high-throughput SH2 domain profiling, artificial neural network and position-specific scoring matrix-based bioinformatics approaches, and unbiased mass spectometry, we found that the phosphoSH3C binds several SH2 domain containing proteins, including specific non-receptor tyrosine kinases-Abl via pY251 and C-terminal Src kinase via pY239. Functionally, we show that the phosphoSH3C modulates the Abl-mediated phenotypes of cell spreading and motility. Together, these studies describe a versatile mechanism wherein phosphorylation of Crk at Y221 is not an off switch but redirects signaling from the SH2-SH3N axis to a phosphoSH3C-SH3N axis, with the SH3N as a common denominator.	[Sriram, G.; Kasikara, C.; Reichman, C.; Nguyen, K-Q; Birge, R. B.] Rutgers Biomed & Hlth Sci, Dept Biochem & Mol Biol, Newark, NJ USA; [Jankowski, W.; Saleh, T.; Kalodimos, C. G.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA; [Li, J.; Hornbeck, P.] Cell Signaling Technol, Danvers, MA USA; [Machida, K.] Univ Connecticut Hlth Ctr, Dept Genet & Dev Biol, Raymond & Beverly Sackler Lab Genet & Mol Med, Farmington, CT USA; [Liu, T.; Li, H.] Rutgers Biomed & Hlth Sci, Ctr Adv Prote Res, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; University of Connecticut; Rutgers State University New Brunswick; Rutgers State University Medical Center	Birge, RB (corresponding author), Rutgers Biomed & Hlth Sci Canc Ctr H121, Dept Biochem & Mol Biol, 205 South Orange Ave, Newark, NJ 07103 USA.	birgera@njms.rutgers.edu	Kalodimos, Charalampos/Q-9846-2018; Hornbeck, Peter V/K-2226-2017; Saleh, Tamjeed/M-8698-2016	Kalodimos, Charalampos/0000-0001-6354-2796; Hornbeck, Peter V/0000-0002-1126-5149; Li, Hong/0000-0001-5731-5335; Saleh, Tamjeed/0000-0002-7539-7300	NIH [CA165077, GM080308, NS046593]; Rutgers Foundation; NATIONAL CANCER INSTITUTE [R01CA165077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH grant CA165077 to RBB and Rutgers Foundation grant to RBB and in part by NIH grant to CGK and RBB GM080308. The LC-MS/MS work was funded in part by an NIH grant NS046593, for the support of the Rutgers Neuroproteomics Core Facility. We thank Chingiz Underbayev, WenI Tsou and Anita Antes for technical support; Sushil Kumar and Stanley Kimani for discussion.	Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Antoku S, 2008, J CELL SCI, V121, P3071, DOI 10.1242/jcs.031575; Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; BIRGE RB, 1992, J BIOL CHEM, V267, P10588; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hashimoto Y, 1998, J BIOL CHEM, V273, P17186, DOI 10.1074/jbc.273.27.17186; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Jankowski W, 2012, NAT CHEM BIOL, V8, P590, DOI [10.1038/NCHEMBIO.954, 10.1038/nchembio.954]; Janostiak R, 2011, MOL BIOL CELL, V22, P4256, DOI 10.1091/mbc.E11-03-0207; Jin H, 2007, MOL BIOL CELL, V18, P4143, DOI 10.1091/mbc.E07-01-0085; Kardinal C, 1999, ANN NY ACAD SCI, V886, P289, DOI 10.1111/j.1749-6632.1999.tb09439.x; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Kobashigawa Y, 2007, J BIOTECHNOL, V131, P458, DOI 10.1016/j.jbiotec.2007.07.956; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Lamorte L, 2002, MOL BIOL CELL, V13, P1449, DOI 10.1091/mbc.01-10-0477; Lamorte L, 2002, J BIOL CHEM, V277, P37904, DOI 10.1074/jbc.M201743200; Li L, 2008, NUCLEIC ACIDS RES, V36, P3263, DOI 10.1093/nar/gkn161; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; MATSUDA M, 1994, MOL CELL BIOL, V14, P5495, DOI 10.1128/MCB.14.8.5495; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Morrogh LM, 1999, EUR J IMMUNOL, V29, P2269; Muralidharan V, 2006, BIOCHEMISTRY-US, V45, P8874, DOI 10.1021/bi060590z; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Reichman C, 2005, ONCOGENE, V24, P8187, DOI 10.1038/sj.onc.1208988; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; Tosello-Trampont AC, 2001, J BIOL CHEM, V276, P13797, DOI 10.1074/jbc.M011238200; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632	42	8	8	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4260	4269		10.1038/onc.2014.361	http://dx.doi.org/10.1038/onc.2014.361			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25381819	Green Accepted			2022-12-26	WOS:000359199800012
J	Nolet, C; Poortinga, A; Roosjen, P; Bartholomeus, H; Ruessink, G				Nolet, Corjan; Poortinga, Ate; Roosjen, Peter; Bartholomeus, Harm; Ruessink, Gerben			Measuring and Modeling the Effect of Surface Moisture on the Spectral Reflectance of Coastal Beach Sand	PLOS ONE			English	Article							AEOLIAN SEDIMENT TRANSPORT; WATER-CONTENT; WIND-TUNNEL; SOIL; ENTRAINMENT; PENETRATION; VARIABILITY; LIGHT	Surface moisture is an important supply limiting factor for aeolian sand transport, which is the primary driver of coastal dune development. As such, it is critical to account for the control of surface moisture on available sand for dune building. Optical remote sensing has the potential to measure surface moisture at a high spatio-temporal resolution. It is based on the principle that wet sand appears darker than dry sand: it is less reflective. The goals of this study are (1) to measure and model reflectance under controlled laboratory conditions as function of wavelength (l) and surface moisture (h) over the optical domain of 350-2500 nm, and (2) to explore the implications of our laboratory findings for accurately mapping the distribution of surface moisture under natural conditions. A laboratory spectroscopy experiment was conducted to measure spectral reflectance (1 nm interval) under different surface moisture conditions using beach sand. A non-linear increase of reflectance upon drying was observed over the full range of wavelengths. Two models were developed and tested. The first model is grounded in optics and describes the proportional contribution of scattering and absorption of light by pore water in an unsaturated sand matrix. The second model is grounded in soil physics and links the hydraulic behaviour of pore water in an unsaturated sand matrix to its optical properties. The optical model performed well for volumetric moisture content h v 24% (R-2 > 0.97), but underestimated reflectance for h between 24-30% (R-2 > 0.92), most notable around the 1940 nm water absorption peak. The soil-physical model performed very well (R-2 > 0.99) but is limited to 4% > theta < 24%. Results from a field experiment show that a short-wave infrared terrestrial laser scanner (lambda = 1550 nm) can accurately relate surface moisture to reflectance (standard error 2.6%), demonstrating its potential to derive spatially extensive surface moisture maps of a natural coastal beach.	[Nolet, Corjan; Poortinga, Ate] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Roosjen, Peter; Bartholomeus, Harm] Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, NL-6700 AP Wageningen, Netherlands; [Ruessink, Gerben] Univ Utrecht, Fac Geosci, Dept Phys Geog, Utrecht, Netherlands	Wageningen University & Research; Wageningen University & Research; Utrecht University	Nolet, C (corresponding author), Wageningen Univ, NL-6700 AP Wageningen, Netherlands.	corjan.nolet@wur.nl	Roosjen, Peter/F-5487-2016	Roosjen, Peter/0000-0001-6029-1047; Ruessink, Gerben/0000-0001-9526-6087; Poortinga, Ate/0000-0001-9647-2317	NatureCoast, project of technology foundation STW; Netherlands Organisation for Scientific Research (NWO); NWO through Vici project [13709]	NatureCoast, project of technology foundation STW; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO through Vici project	CN was funded by NatureCoast, project of technology foundation STW, applied science division of the Netherlands Organisation for Scientific Research (NWO). GR acknowledges additional funding by NWO through Vici project 13709. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstrom A., 1925, GEOGR ANN, V7, P323; [Anonymous], 1998, ENV SOIL PHYS FUNDAM; Atherton RJ, 2001, J COASTAL RES, V17, P482; Bauer BO, 2009, GEOMORPHOLOGY, V105, P106, DOI 10.1016/j.geomorph.2008.02.016; Belly P.Y., 1964, SAND MOVEMENT WIND; BISAL F, 1966, SOIL SCI, V102, P143, DOI 10.1097/00010694-196609000-00001; Bochev-van der Burgh LM, 2011, COAST ENG, V58, P927, DOI 10.1016/j.coastaleng.2011.05.013; Bohren C. F., 2008, ABSORPTION SCATTERIN, DOI DOI 10.1002/9783527618156; BOWERS S. A., 1965, SOIL SCI, V100, P130, DOI 10.1097/00010694-196508000-00009; Ciani A, 2005, EUR J SOIL SCI, V56, P561, DOI 10.1111/j.1365-2389.2005.00688.x; Cornelis WM, 2003, SEDIMENTOLOGY, V50, P771, DOI 10.1046/j.1365-3091.2003.00577.x; Darke I, 2008, J COASTAL RES, V24, P1200, DOI 10.2112/00-000.1; Darke I, 2009, J COASTAL RES, V25, P248, DOI 10.2112/07-0905.1; Davidson-Arnott RGD, 2009, GEOMORPHOLOGY, V105, P117, DOI 10.1016/j.geomorph.2008.02.018; Davidson-Arnott RGD, 2005, GEOMORPHOLOGY, V68, P115, DOI 10.1016/j.geomorph.2004.04.008; de Vries S, 2014, AEOLIAN RES, V12, P75, DOI 10.1016/j.aeolia.2013.11.005; Delgado-Fernandez I, 2009, J COASTAL RES, V25; Edwards BL, 2012, J COASTAL RES; Edwards BL, 2013, EARTH SURF PROC LAND, V38, P192, DOI 10.1002/esp.3319; Elachi C., 2006, INTRO PHYS TECHNIQUE, V28; Ellis JT, 2012, AEOLIAN RES, V3, P379, DOI 10.1016/j.aeolia.2011.06.001; Hapke B., 2012, THEORY REFLECTANCE E; Hecht E., 2002, OPTICS; Hugenholtz CH, 2009, GEOMORPHOLOGY, V105, P158, DOI 10.1016/j.geomorph.2007.12.017; Huisman CE, 2011, CONT SHELF RES, V31, P1728, DOI 10.1016/j.csr.2011.07.013; IDSO SB, 1975, J APPL METEOROL, V14, P109, DOI 10.1175/1520-0450(1975)014<0109:TDOBSA>2.0.CO;2; Keijsers JG, 2014, MITIGATION ADAPTATIO, P1; Keijsers JG, 2014, J COASTAL RES; Keijsers JGS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091115; Knadel M, 2014, SOIL SCI SOC AM J, V78, P422, DOI 10.2136/sssaj2012.0401; Langston G, 2003, P CAN COAST C 2003, P15; LEKNER J, 1988, APPL OPTICS, V27, P1278, DOI 10.1364/AO.27.001278; Leu D. J., 1977, Remote Sensing of Environment, V6, P169, DOI 10.1016/0034-4257(77)90002-5; Liu WD, 2002, REMOTE SENS ENVIRON, V81, P238, DOI 10.1016/S0034-4257(01)00347-9; Lobell DB, 2002, SOIL SCI SOC AM J, V66, P722, DOI 10.2136/sssaj2002.0722; MCKENNANEUMAN C, 1989, CAN J SOIL SCI, V69, P79, DOI 10.4141/cjss89-008; Namikas SL, 2010, GEOMORPHOLOGY, V114, P303, DOI 10.1016/j.geomorph.2009.07.011; Namikas S. L., 1995, DESERT AEOLIAN PROCE, P269, DOI [10.1007/978-94-009-0067-7_13, DOI 10.1007/978-94-009-0067-7_13]; Neuman CM, 2006, EARTH SURF PROC LAND, V31, P303, DOI 10.1002/esp.1245; Nield JM, 2014, AEOLIAN RES, V12, P9, DOI 10.1016/j.aeolia.2013.10.006; Nield JM, 2011, EARTH SURF PROC LAND, V36, P513, DOI 10.1002/esp.2071; Nield JM, 2011, EARTH SURF PROC LAND, V36, P273, DOI 10.1002/esp.2102; Philpot W, 2010, P ASD IEEE GRS ART S, VII; Poortinga A, 2014, PEERJ, V2, DOI 10.7717/peerj.454; Poortinga A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074007; Poortinga A, 2011, AEOLIAN RES, V3, P81, DOI 10.1016/j.aeolia.2011.05.003; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; R Core Team, 2012, R LANG ENV STAT COMP; Roosjen PPJ, 2012, SENSORS-BASEL, V12, P17358, DOI 10.3390/s121217358; Ruessink G, 2014, GEOPH RES ABSTR, V16; Segelstein D.J., 1981, COMPLEX REFRACTIVE I; SHUCHMAN RA, 1981, REMOTE SENS ENVIRON, V11, P295, DOI 10.1016/0034-4257(81)90027-4; SKIDMORE EL, 1975, SOIL SCI SOC AM J, V39, P238, DOI 10.2136/sssaj1975.03615995003900020009x; Solomon S., 2007, PHYS SCI BASIS WORKI; Stive MJF, 2013, J COASTAL RES, V29, P1001, DOI 10.2112/JCOASTRES-D-13-00070.1; TESTER M, 1987, PLANT CELL ENVIRON, V10, P281, DOI 10.1111/j.1365-3040.1987.tb01607.x; van Slobbe E, 2013, NAT HAZARDS, V66, P1461, DOI 10.1007/s11069-013-0612-3; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Wesseling JG, 2008, TRANSPORT POROUS MED, V71, P289, DOI 10.1007/s11242-007-9126-3; Wiggs GFS, 2004, GEOMORPHOLOGY, V59, P13, DOI 10.1016/j.geomorph.2003.09.002; Wosten J, 2001, WATER RETENTION PERM; WOSTEN JHM, 1988, SOIL SCI SOC AM J, V52, P1762, DOI 10.2136/sssaj1988.03615995005200060045x; Yang YQ, 2005, J COASTAL RES, V21, P447, DOI 10.2112/03-0111.1	63	33	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112151	10.1371/journal.pone.0112151	http://dx.doi.org/10.1371/journal.pone.0112151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383709	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700035
J	Saverino, D; Pesce, G; Antola, P; Porcelli, B; Brusca, I; Villalta, D; Tampoia, M; Tozzoli, R; Tonutti, E; Alessio, MG; Bagnasco, M; Bizzaro, N				Saverino, Daniele; Pesce, Giampaola; Antola, Princey; Porcelli, Brunetta; Brusca, Ignazio; Villalta, Danilo; Tampoia, Marilina; Tozzoli, Renato; Tonutti, Elio; Alessio, Maria Grazia; Bagnasco, Marcello; Bizzaro, Nicola			High Levels of Soluble Ctla-4 Are Present in Anti-Mitochondrial Antibody Positive, but Not in Antibody Negative Patients with Primary Biliary Cirrhosis	PLOS ONE			English	Article							T-CELLS; FORM; AUTOIMMUNITY; EXPRESSION; MOLECULES; DISEASES; SERUM; CD28	Primary biliary cirrhosis (PBC) is a chronic autoimmune cholestatic liver disease frequently characterized by anti-mitochondrial autoantibodies (AMA). A minority of patients are AMA-negative. Cytotoxic-T-Lymphocyte-Antigen-4 (CTLA-4) is a surface molecule expressed on activated T-cells delivering a critical negative immunoregulatory signal. A soluble form of CTLA-4 (sCTLA-4) has been detected at high concentrations in several autoimmune diseases, and its possible functional meaning has been suggested. We aimed to evaluate sCTLA-4 concentration in sera of patients with PBC and to correlate it to immunological abnormalities associated with the disease. Blood samples were collected from 82 PBC-patients diagnosed according to international criteria (44 AMA-positive/MIT3-positive and 38 AMA-negative-MIT3-negative), and 65 controls. sCTLA-4 levels were evaluated by ELISA and Western blot. Increased sCTLA-4 concentrations were found in all AMA-positive PBC-patients, but in none of the AMA-negative ones, nor in normal controls or in controls with unrelated liver diseases. sCTLA-4 presence was associated with autoantibodies against MIT3, but not with nuclear autoantibodies (sp100, gp210). This is the first study to demonstrate that levels of sCTLA-4 are elevated in sera of PBC patients. However, they are clearly restricted to patients with AMA positivity, suggesting an immunological difference with respect to AMA-negative ones.	[Saverino, Daniele] Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy; [Pesce, Giampaola; Antola, Princey; Bagnasco, Marcello] Univ Genoa, Dept Internal Med, Autoimmun Unit, I-16126 Genoa, Italy; [Porcelli, Brunetta] Univ Siena, Dept Internal Med, I-53100 Siena, Italy; [Brusca, Ignazio] Buccheri La Ferla Hosp, Dept Clin Pathol, Palermo, Italy; [Villalta, Danilo] S Maria degli Angeli Hosp, Pordenone, Italy; [Tampoia, Marilina] Univ Hosp, Clin Pathol Lab, Bari, Italy; [Tozzoli, Renato] S Maria degli Angeli Hosp, Dept Lab Med, Pordenone, Italy; [Tonutti, Elio] S Maria della Misericordia Hosp, Immunopathol & Allergol Unit, Pordenone, Italy; [Alessio, Maria Grazia] Riuniti Hosp, Dept Lab Med, Biochem Lab, Bergamo, Italy; [Bizzaro, Nicola] San Antonio Hosp, Clin Pathol Lab, Udine, Italy	University of Genoa; University of Genoa; University of Siena; Universita degli Studi di Bari Aldo Moro; Hospital Santa Maria della Misericordia; Ospedali Riuniti di Bergamo	Saverino, D (corresponding author), Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy.	daniele.saverino@unige.it	Tozzoli, Renato/AAG-4067-2020; Alessio, Maria Grazia/AAW-3849-2021; Saverino, Daniele/I-4741-2014; Tampoia, Marilina/P-1811-2015; porcelli, brunetta/S-8189-2018	porcelli, brunetta/0000-0002-7447-9136; Pesce, Giampaola/0000-0002-6294-9110; Brusca, Ignazio/0000-0001-6243-7732; Tampoia, Marilina/0000-0001-9067-8808	University of Genova, Italy [PRA2012]	University of Genova, Italy	This work was funded by University of Genova, Italy (PRA2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernuzzi F, 2010, J AUTOIMMUN, V35, P176, DOI 10.1016/j.jaut.2010.06.004; Berry A, 2008, J NEGAT RESULTS BIOM, V7, DOI 10.1186/1477-5751-7-8; Bizzaro N, 2012, CLIN REV ALLERG IMMU, V42, P288, DOI 10.1007/s12016-010-8234-y; Bogdanos D, 2008, J HEPATOL, V49, P466, DOI 10.1016/j.jhep.2008.05.022; Bogdanos DP, 2011, CLIN CHIM ACTA, V412, P502, DOI 10.1016/j.cca.2010.12.019; Chen RR, 2011, J DIGEST DIS, V12, P428, DOI 10.1111/j.1751-2980.2011.00537.x; Courvalin JC, 1977, SEMINAR LIVER DIS, V17, P79; Cutolo M, 2013, AUTOIMMUN REV, V12, P758, DOI 10.1016/j.autrev.2013.01.001; Dhirapong A, 2013, HEPATOLOGY, V57, P708, DOI 10.1002/hep.26067; Duarte-Rey C, 2012, AUTOIMMUN REV, V11, P898, DOI 10.1016/j.autrev.2012.03.005; Gershwin ME, 2005, HEPATOLOGY, V42, P1194, DOI 10.1002/hep.20907; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; HARPER K, 1991, J IMMUNOL, V147, P1037; Hirschfield GM, 2011, ISR MED ASSOC J, V13, P55; Hohenester S, 2009, SEMIN IMMUNOPATHOL, V31, P283, DOI 10.1007/s00281-009-0164-5; Hudson M, 2008, J AUTOIMMUN, V31, P156, DOI 10.1016/j.jaut.2008.05.002; Invernizzi P, 2010, DIGEST LIVER DIS, V42, P401, DOI 10.1016/j.dld.2010.02.014; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Kumagi T, 2008, CLIN LIVER DIS, V12, P243, DOI 10.1016/j.cld.2008.02.014; Liu HY, 2010, J AUTOIMMUN, V35, P436, DOI 10.1016/j.jaut.2010.09.005; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Magistrelli G, 1999, EUR J IMMUNOL, V29, P3596, DOI 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y; Milkiewicz P, 2008, CLIN LIVER DIS, V12, P461, DOI 10.1016/j.cld.2008.02.015; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Riccio AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037980; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Sato S, 2004, RHEUMATOLOGY, V43, P1261, DOI 10.1093/rheumatology/keh303; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; Saverino D, 2010, AUTOIMMUN HIGHLIGHTS, V1, P73, DOI 10.1007/s13317-010-0011-7; Selmi C, 2008, J HEPATOL, V49, P451, DOI 10.1016/j.jhep.2008.06.006; Simone R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/215763; Simone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044654; Simone R, 2009, INT IMMUNOL, V21, P1037, DOI 10.1093/intimm/dxp069; Smyk D, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/189585; Smyk DS, 2012, AUTOIMMUN HIGHLIGHTS, V3, P1, DOI 10.1007/s13317-011-0023-y; Wang XB, 2002, J NEUROIMMUNOL, V130, P224, DOI 10.1016/S0165-5728(02)00228-X; Wong CK, 2005, RHEUMATOLOGY, V44, P989, DOI 10.1093/rheumatology/keh663	39	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112509	10.1371/journal.pone.0112509	http://dx.doi.org/10.1371/journal.pone.0112509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383768	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700072
J	Strijbis, K; Yilmaz, OH; Dougan, SK; Esteban, A; Grone, A; Kumamoto, CA; Ploegh, HL				Strijbis, Karin; Yilmaz, Oemer H.; Dougan, Stephanie K.; Esteban, Alexandre; Groene, Andrea; Kumamoto, Carol A.; Ploegh, Hidde L.			Intestinal Colonization by Candida albicans Alters Inflammatory Responses in Bruton's Tyrosine Kinase-Deficient Mice	PLOS ONE			English	Article							INDUCED COLITIS; CELL DEVELOPMENT; BOWEL DISEASES; DECTIN-1; MICROBIOTA; DISTINCT; LINEAGE; FUNGI; YEAST	The commensal yeast Candida albicans is part of the human intestinal microflora and is considered a "pathobiont", a resident microbe with pathogenic potential yet harmless under normal conditions. The aim of this study was to investigate the effect of C. albicans on inflammation of the intestinal tract and the role of Bruton's tyrosine kinase (Btk). Btk is an enzyme that modulates downstream signaling of multiple receptors involved in innate and adaptive immunity, including the major anti-fungal receptor Dectin-1. Colitis was induced in wild type and Btk-/- mice by treatment with dextran sodium sulfate (DSS) and the gastrointestinal tract of selected treatment groups were then colonized with C. albicans. Colonization by C. albicans neither dampened nor exacerbated inflammation in wild type mice, but colon length and spleen weight were improved in Btk-deficient mice colonized with C. albicans. Neutrophil infiltration was comparable between wild type and Btk-/- mice, but the knockout mice displayed severely reduced numbers of macrophages in the colon during both DSS and DSS/Candida treatment. Smaller numbers and reduced responsiveness of Btk-/- macrophages might partially explain the improved colon length of Btk-/- mice as a result of Candida colonization. Surprisingly, DSS/Candida-treated Btk-/- animals had higher levels of certain pro-inflammatory cytokines and levels of the anti-inflammatory cytokine TGF-beta were reduced compared to wild type. A clustering and correlation analysis showed that for wild type animals, spleen TGF-beta and colon IL-10 and for Btk-/- spleen and colon levels of IL-17A best correlated with the inflammatory parameters. We conclude that in Btk-/- immunocompromised animals, colonization of the gastrointestinal tract by the commensal yeast C. albicans alters inflammatory symptoms associated with colitis.	[Strijbis, Karin; Yilmaz, Oemer H.; Dougan, Stephanie K.; Esteban, Alexandre; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Groene, Andrea] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Kumamoto, Carol A.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Utrecht University; Tufts University	Strijbis, K (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	K.Strijbis@uu.nl	Esteban, Alexandre/H-5629-2015	Esteban, Alexandre/0000-0002-7448-4314; Strijbis, Karin/0000-0001-9167-7137	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG045144, K99AG045144] Funding Source: NIH RePORTER; NIA NIH HHS [K99 AG045144, R00 AG045144] Funding Source: Medline; NIGMS NIH HHS [R01 GM100518] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown DH, 1999, LICHENOLOGIST, V31, P1; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Downward JRE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02191; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Hamad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040888; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Heinsbroek SEM, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-33; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Jawhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040648; Jawhara S, 2012, J BIOL CHEM, V287, P11313, DOI 10.1074/jbc.M111.329300; Jongstra-Bilen J, 2008, J IMMUNOL, V181, P288, DOI 10.4049/jimmunol.181.1.288; Katayama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062231; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Koh AY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040035; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li Q., 2013, J CLIN GASTROENTEROL, V00, P000; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; Mason KL, 2012, INFECT IMMUN, V80, P3371, DOI 10.1128/IAI.00449-12; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Miranda LN, 2009, J HOSP INFECT, V72, P9, DOI 10.1016/j.jhin.2009.02.009; Monteleone I, 2012, CURR MOL MED, V12, P592, DOI 10.2174/156652412800620066; Mukhopadhyay S, 1999, J IMMUNOL, V163, P1786; Nucci M, 2001, CLIN INFECT DIS, V33, P1959, DOI 10.1086/323759; Olszak T, 2014, NATURE; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pierce JV, 2012, MBIO, V3, DOI 10.1128/mBio.00117-12; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schulze J, 2009, DTSCH ARZTEBL INT, V106, P837, DOI 10.3238/arztebl.2009.0837; Seow CH, 2009, AM J GASTROENTEROL, V104, P1426, DOI 10.1038/ajg.2009.79; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Strijbis K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003446; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Vautier S, 2012, INFECT IMMUN, V80, P4216, DOI 10.1128/IAI.00559-12; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; White SJ, 2007, PLOS PATHOG, V3, P1866, DOI 10.1371/journal.ppat.0030184	48	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112472	10.1371/journal.pone.0112472	http://dx.doi.org/10.1371/journal.pone.0112472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379804	Green Published, gold			2022-12-26	WOS:000344863100104
J	Han, Y; Meng, JR; Chen, J; Cai, WL; Wang, Y; Zhao, J; He, YP; Feng, YN; Hua, HX				Han, Yu; Meng, Jiarong; Chen, Jie; Cai, Wanlun; Wang, Yu; Zhao, Jing; He, Yueping; Feng, Yanni; Hua, Hongxia			Bt Rice Expressing Cry2Aa Does Not Harm Cyrtorhinus lividipennis, a Main Predator of the Nontarget Herbivore Nilapavarta lugens	PLOS ONE			English	Article							TRANSGENIC INDICA RICE; NILAPARVATA-LUGENS; BROWN PLANTHOPPER; BIOLOGICAL-CONTROL; PEST-MANAGEMENT; CRY1AB RICE; PLANTS; PREY; DELPHACIDAE; HOMOPTERA	T2A-1 is a newly developed transgenic rice that expresses a synthesized cry2Aa gene driven by the maize ubiquitin promoter. T2A-1 exhibits high resistance against lepidopteran pests of rice. The brown planthopper, Nilapavarta lugens (Stal), is a main nontarget sap-sucking insect pest of rice, and Cyrtorhinus lividipennis (Reuter) is the major predator of the eggs and young nymphs of planthoppers. As C. lividipennis may expose to the Cry2Aa protein via N. lugens, it is therefore essential to assess the potential effects of transgenic cry2Aa rice on this predator. In the present study, three experiments were conducted to evaluate the ecological risk of transgenic cry2Aa rice to C. lividipennis: (1) a direct feeding experiment in which C. lividipennis was fed an artificial diet containing Cry2Aa at the dose of 10-time higher than that it may encounter in the realistic field condition; (2) a tritrophic experiment in which the Cry2Aa protein was delivered to C. lividipennis indirectly through prey eggs or nymphs; (3) a realistic field experiment in which the population dynamics of C. lividipennis were investigated using vacuum-suction. Both direct exposure to elevated doses of the Cry2Aa protein and prey-mediated exposure to realistic doses of the protein did not result in significant detrimental effects on the development, survival, female ratio and body weight of C. lividipennis. No significant differences in population density and population dynamics were observed between C. lividipennis in transgenic cry2Aa and nontransgenic rice fields. It may be concluded that transgenic cry2Aa rice had no detrimental effects on C. lividipennis. This study represents the first report of an assessment continuum for the effects of transgenic cry2Aa rice on C. lividipennis.	[Han, Yu; Meng, Jiarong; Chen, Jie; Cai, Wanlun; Wang, Yu; Zhao, Jing; He, Yueping; Hua, Hongxia] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Feng, Yanni] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Hua, HX (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	huahongxia@mail.hzau.edu.cn			National Genetically Modified Organisms Breeding Major Project: Technology of Environmental Risk Assessment on Transgenic Rice [2014ZX08011-001]	National Genetically Modified Organisms Breeding Major Project: Technology of Environmental Risk Assessment on Transgenic Rice	This research was supported by the National Genetically Modified Organisms Breeding Major Project: Technology of Environmental Risk Assessment on Transgenic Rice (2014ZX08011-001). HH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YY, 2005, J PEST SCI, V78, P123, DOI 10.1007/s10340-004-0078-x; Bernal CC, 2002, ENTOMOL EXP APPL, V102, P21, DOI 10.1023/A:1015278618586; Carino F.O., 1979, International Rice Research Newsletter, V4, P21; Chen H, 2005, THEOR APPL GENET, V111, P1330, DOI 10.1007/s00122-005-0062-8; Chen J. M., 1992, ENTOMOL KNOWLEDG, V25, P370; Chen Jian-Ming, 1994, Acta Entomologica Sinica, V37, P63; Chen Mao, 2005, Acta Entomologica Sinica, V48, P208; Chen M, 2007, BIOL CONTROL, V42, P242, DOI 10.1016/j.biocontrol.2007.05.005; Cheng J. A., 1996, RICE INSECT PESTS; Cheng XY, 1998, P NATL ACAD SCI USA, V95, P2767, DOI 10.1073/pnas.95.6.2767; CHUA TH, 1989, ENVIRON ENTOMOL, V18, P251, DOI 10.1093/ee/18.2.251; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Fu Q, 2001, APPL ENTOMOL ZOOL, V36, P111, DOI 10.1303/aez.2001.111; Heinrichs E.A., 1979, P529; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLLING CS, 1961, ANNU REV ENTOMOL, V6, P163, DOI 10.1146/annurev.en.06.010161.001115; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; Jiang Yong-hou, 2004, Acta Entomologica Sinica, V47, P454; KIRITANI K, 1979, ANNU REV ENTOMOL, V24, P279, DOI 10.1146/annurev.en.24.010179.001431; Li YH, 2014, INSECT SCI, V21, P125, DOI 10.1111/1744-7917.12044; Li YH, 2013, ECOTOXICOLOGY, V22, P1413, DOI 10.1007/s10646-013-1127-0; Lou YG, 2013, BIOL CONTROL, V67, P8, DOI 10.1016/j.biocontrol.2013.06.011; Matteson PC, 2000, ANNU REV ENTOMOL, V45, P549, DOI 10.1146/annurev.ento.45.1.549; Oerke EC., 1994, CROP PRODUCTION CROP; Pathak M. D, 1994, INSECT PEST RICE; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Sigsgaard L, 2007, B ENTOMOL RES, V97, P533, DOI 10.1017/S0007485307005196; Sogawa K., 2003, CHINESE J RICE SCI, V17, P23; Specty O, 2003, ARCH INSECT BIOCHEM, V52, P81, DOI 10.1002/arch.10070; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; Tian JC, 2010, ENVIRON ENTOMOL, V39, P1369, DOI 10.1603/EN10003; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310; Xu XL, 2011, SCI CHINA LIFE SCI, V54, P1019, DOI 10.1007/s11427-011-4234-2; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zeigler RS, 2008, RICE, V1, P3, DOI 10.1007/s12284-008-9001-z; 盛承发, 2003, [植物保护, Plant Protection], V29, P37	38	16	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112315	10.1371/journal.pone.0112315	http://dx.doi.org/10.1371/journal.pone.0112315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375147	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402600126
J	Levy, H; Glinert, I; Weiss, S; Bar-David, E; Sittner, A; Schlomovitz, J; Altboum, Z; Kobiler, D				Levy, Haim; Glinert, Itai; Weiss, Shay; Bar-David, Elad; Sittner, Assa; Schlomovitz, Josef; Altboum, Zeev; Kobiler, David			The Central Nervous System as Target of Bacillus anthracis Toxin Independent Virulence in Rabbits and Guinea Pigs	PLOS ONE			English	Article							INHALATIONAL ANTHRAX; PROTECTION; PATHOLOGY; VACCINE; ADHESIN; SEARCH; SPORES; BSLA	Infection of the central nervous system is considered a complication of Anthrax and was reported in humans and non-human primates. Previously we have reported that Bacillus anthracis possesses a toxin-independent virulent trait that, like the toxins, is regulated by the major virulence regulator, AtxA, in the presence of pXO2. This toxin-independent lethal trait is exhibited in rabbits and Guinea pigs following significant bacteremia and organ dissemination. Various findings, including meningitis seen in humans and primates, suggested that the CNS is a possible target for this AtxA-mediated activity. In order to penetrate into the brain tissue, the bacteria have to overcome the barriers isolating the CNS from the blood stream. Taking a systematic genetic approach, we compared intracranial (IC) inoculation and IV/SC inoculation for the outcome of the infection in rabbits/GP, respectively. The outstanding difference between the two models is exhibited by the encapsulated strain Vollum Delta pXO1, which is lethal when injected IC, but asymptomatic when inoculated IV/SC. The findings demonstrate that there is an apparent bottleneck in the ability of mutants to penetrate into the brain. Any mutant carrying either pXO1 or pXO2 will kill the host upon IC injection, but only those carrying AtxA either on pXO1 or in the chromosome in the background of pXO2 can penetrate into the brain following peripheral inoculation. The findings were corroborated by histological examination by H&E staining and immunofluorescence of rabbits' brains following IV and IC inoculations. These findings may have major implications on future research both on B. anthracis pathogenicity and on vaccine development.	[Levy, Haim; Glinert, Itai; Weiss, Shay; Bar-David, Elad; Sittner, Assa; Schlomovitz, Josef; Altboum, Zeev; Kobiler, David] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel		Levy, H (corresponding author), Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel.	haiml@iibr.gov.il		Sittner, Assa/0000-0002-1633-8191	IIBR	IIBR	This work was funded by IIBR internal funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Ariel N, 2002, INFECT IMMUN, V70, P6817, DOI 10.1128/IAI.70.12.6817-6827.2002; Ebrahimi CM, 2009, J BACTERIOL, V191, P7165, DOI 10.1128/JB.00903-09; Fouet A, 2010, RES MICROBIOL, V161, P735, DOI 10.1016/j.resmic.2010.09.006; Grinberg LM, 2001, MODERN PATHOL, V14, P14; Guichard A, 2012, MICROBES INFECT, V14, P97, DOI 10.1016/j.micinf.2011.08.016; Hanczaruk M, 2014, EMERG INFECT DIS, V20, P322, DOI 10.3201/eid2002.120921; Kern J, 2010, J MOL BIOL, V401, P757, DOI 10.1016/j.jmb.2010.06.059; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kobiler D, 2002, INFECT IMMUN, V70, P544, DOI 10.1128/IAI.70.2.544-550.2002; Lanska DJ, 2002, NEUROLOGY, V59, P8; Levy H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084947; Levy H, 2012, INFECT IMMUN, V80, P2623, DOI 10.1128/IAI.00244-12; Reuveny S, 2001, INFECT IMMUN, V69, P2888, DOI 10.1128/IAI.69.5.2888-2893.2001; Sambrook J, 1989, MOL CLOINING LAB MAN; Twenhafel NA, 2010, VET PATHOL, V47, P819, DOI 10.1177/0300985810378112; Weiss S, 2006, INFECT IMMUN, V74, P394, DOI 10.1128/IAI.74.1.394-398.2006; Weiss S, 2011, ANTIMICROB AGENTS CH, V55, P1533, DOI 10.1128/AAC.01689-10; Yoong P, 2006, J BACTERIOL, V188, P2711, DOI 10.1128/JB.188.7.2711-2714.2006	22	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112319	10.1371/journal.pone.0112319	http://dx.doi.org/10.1371/journal.pone.0112319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375158	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402600127
J	Palmer, CGS; Boudreault, P; Baldwin, EE; Sinsheimer, JS				Palmer, Christina G. S.; Boudreault, Patrick; Baldwin, Erin E.; Sinsheimer, Janet S.			Impact of Genetic Counseling and Connexin-26 and Connexin-30 Testing on Deaf Identity and Comprehension of Genetic Test Results in a Sample of Deaf Adults: A Prospective, Longitudinal Study	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; HEARING-LOSS; EDUCATIONAL-EXPERIENCES; PARENTAL ATTITUDES; SOCIAL IDENTITY; IDENTIFICATION; INDIVIDUALS; TRANSLATION; MUTATIONS; COMMUNITY	Using a prospective, longitudinal study design, this paper addresses the impact of genetic counseling and testing for deafness on deaf adults and the Deaf community. This study specifically evaluated the effect of genetic counseling and Connexin-26 and Connexin-30 genetic test results on participants' deaf identity and understanding of their genetic test results. Connexin-26 and Connexin-30 genetic testing was offered to participants in the context of linguistically and culturally appropriate genetic counseling. Questionnaire data collected from 209 deaf adults at four time points ( baseline, immediately following pre-test genetic counseling, 1-month following genetic test result disclosure, and 6-months after result disclosure) were analyzed. Four deaf identity orientations (hearing, marginal, immersion, bicultural) were evaluated using subscales of the Deaf Identity Development Scale-Revised. We found evidence that participants understood their specific genetic test results following genetic counseling, but found no evidence of change in deaf identity based on genetic counseling or their genetic test results. This study demonstrated that culturally and linguistically appropriate genetic counseling can improve deaf clients' understanding of genetic test results, and the formation of deaf identity was not directly related to genetic counseling or Connexin-26 and Connexin-30 genetic test results.	[Palmer, Christina G. S.; Baldwin, Erin E.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Palmer, Christina G. S.; Sinsheimer, Janet S.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Palmer, Christina G. S.; Sinsheimer, Janet S.] Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA USA; [Boudreault, Patrick] Calif State Univ Northridge, Dept Deaf Studies, Northridge, CA 91330 USA; [Sinsheimer, Janet S.] Univ Calif Los Angeles, Dept Biomath & Biostat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; California State University System; California State University Northridge; University of California System; University of California Los Angeles	Palmer, CGS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	cpalmer@mednet.ucla.edu			National Human Genome Research Institute (Ethical, Legal, and Social Issues Branch) [R01 HG003871]; Brocher Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003871] Funding Source: NIH RePORTER	National Human Genome Research Institute (Ethical, Legal, and Social Issues Branch); Brocher Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	CGSP received funding from the National Human Genome Research Institute (Ethical, Legal, and Social Issues Branch) (R01 HG003871, http://projectreporter.nih.gov); and from the Brocher Foundation (http://www.brocher.ch/en/brocher-fundation-in-brief/) in support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnos KS, 2008, AM J HUM GENET, V83, P200, DOI 10.1016/j.ajhg.2008.07.001; Baldwin EE, 2012, J GENET COUNS, V21, P256, DOI 10.1007/s10897-011-9398-1; Barnett S, 1999, AM ANN DEAF, V144, P44, DOI 10.1353/aad.2012.0120; Bat-Chava Y, 2000, AM ANN DEAF, V145, P420, DOI 10.1353/aad.2012.0176; BATCHAVA Y, 1994, PERS SOC PSYCHOL B, V20, P494, DOI 10.1177/0146167294205006; Blanton SH, 2010, ANN HUM GENET, V74, P27, DOI 10.1111/j.1469-1809.2009.00553.x; Boudreault P, 2010, J DEAF STUD DEAF EDU, V15, P209, DOI 10.1093/deafed/enq012; Box GE., 1978, STAT EXPT; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Brunger JW, 2000, AM J HUM GENET, V67, P1621, DOI 10.1086/316901; Burton SK, 2006, GENET MED, V8, P779, DOI 10.1097/01.gim.0000250501.59830.ff; DEAUX K, 1993, PERS SOC PSYCHOL B, V19, P4, DOI 10.1177/0146167293191001; ETHIER KA, 1994, J PERS SOC PSYCHOL, V67, P243, DOI 10.1037/0022-3514.67.2.243; Fischer LC, 2001, J COUNS PSYCHOL, V48, P355, DOI 10.1037/0022-0167.48.3.355; GLICKMAN NS, 1993, REHABIL PSYCHOL, V38, P275, DOI 10.1037/0090-5550.38.4.275; Gorlin RJ, 1995, HEREDITARY HEARING L; Hadjikakou K, 2007, AM ANN DEAF, V152, P398, DOI 10.1353/aad.2008.0002; Halbert CH, 2010, PUBLIC HEALTH GENOM, V13, P440, DOI 10.1159/000293990; Holcomb TK, 1997, AM ANN DEAF, V142, P89, DOI 10.1353/aad.2012.0728; Hole R, 2007, NARRAT INQ, V17, P259, DOI 10.1075/ni.17.2.06hol; Hormuth S. E., 1990, ECOLOGY SELF RELOCAT; Humphries T.L., 2005, INSIDE DEAF CULTURE; Kannapell B., 1993, LANGUAGE CHOICE IDEN; Klitzman R, 2009, GENET MED, V11, P880, DOI 10.1097/GIM.0b013e3181bfd212; Kobayashi Y, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-145; Leigh I, 1998, J Deaf Stud Deaf Educ, V3, P329; Leigh IW, 2009, J DEAF STUD DEAF EDU, V14, P244, DOI 10.1093/deafed/enn038; Leigh IW, 1999, J DEAF STUD DEAF EDU, V3, P330; Lewis S, 2006, J PAEDIATR CHILD H, V42, P533, DOI 10.1111/j.1440-1754.2006.00917.x; Malcolm K, 2005, TOPICS SIGNED LANGUA, P107; Martinez A, 2003, GENET MED, V5, P106, DOI 10.1097/01.GIM.0000055200.52906.75; Maxwell-McCaw D., 2001, ACCULTURATION PSYCHO; Maxwell-McCaw D, 2011, J DEAF STUD DEAF EDU, V16, P325, DOI 10.1093/deafed/enq061; Michie S, 2001, J MED GENET, V38, P519, DOI 10.1136/jmg.38.8.519; Middleton A, 1998, AM J HUM GENET, V63, P1175, DOI 10.1086/302060; Middleton A, 2001, J Genet Couns, V10, P121, DOI 10.1023/A:1009439630457; Nikolaraizi M, 2006, J DEAF STUD DEAF EDU, V11, P477, DOI 10.1093/deafed/enl003; Ohna S.E., 2004, DEAFNESS ED INT, V6, P20, DOI [https://doi.org/10.1179/146431504790560609, DOI 10.1179/146431504790560609]; Padden C, 1988, DEAF AM VOICES CULTU; Pal T, 2010, CLIN GENET, V78, P124, DOI 10.1111/j.1399-0004.2010.01466.x; Palmer CGS, 2013, J GENET COUNS, V22, P492, DOI 10.1007/s10897-013-9573-7; Palmer CGS, 2009, AM J MED GENET A, V149A, P1169, DOI 10.1002/ajmg.a.32853; Parker MJ, 2000, J MED GENET, V37, P37; Prasad S, 2000, HUM MUTAT, V16, P502; Samady W, 2008, PUBLIC HEALTH NURS, V25, P480, DOI 10.1111/j.1525-1446.2008.00732.x; Senghas RJ, 2002, ANNU REV ANTHROPOL, V31, P69, DOI 10.1146/annurev.anthro.31.020402.101302; Sheridan M, 2000, INNER LIVES DEAF CHI; Steinberg Annie, 2007, Am J Audiol, V16, P57; Stern SJ, 2002, J MED GENET, V39, P449, DOI 10.1136/jmg.39.6.449; Sussner KM, 2010, J GENET COUNS, V19, P255, DOI 10.1007/s10897-010-9282-4; Taneja PR, 2004, AM J MED GENET A, V130A, P17, DOI 10.1002/ajmg.a.30051; Wald RL, 2000, ANN OTO RHINOL LARYN, V109, P87, DOI 10.1177/0003489400109S1238; Withrow KA, 2009, AM J MED GENET A, V149A, P1159, DOI 10.1002/ajmg.a.32800; Withrow KA, 2009, J GENET COUNS, V18, P618, DOI 10.1007/s10897-009-9246-8	54	5	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111512	10.1371/journal.pone.0111512	http://dx.doi.org/10.1371/journal.pone.0111512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375116	gold, Green Published			2022-12-26	WOS:000344402600043
J	Wu, LL; Gu, RL; Cai, HJ; Luo, YLL; Zhang, JX				Wu, Lili; Gu, Ruolei; Cai, Huajian; Luo, Yu L. L.; Zhang, Jianxin			The Neural Response to Maternal Stimuli: An ERP Study	PLOS ONE			English	Article							VISUAL MISMATCH NEGATIVITY; MOTHERS FACE RECOGNITION; EVENT-RELATED POTENTIALS; TASK-DIFFICULTY; BRAIN POTENTIALS; TEMPORAL FEATURES; ASSOCIATION TASK; ATTENTION; IMPLICIT; P300	Mothers are important to all humans. Research has established that maternal information affects individuals' cognition, emotion, and behavior. We measured event-related potentials (ERPs) to examine attentional and evaluative processing of maternal stimuli while participants completed a Go/No-go Association Task that paired mother or others words with good or bad evaluative words. Behavioral data showed that participants responded faster to mother words paired with good than the mother words paired with bad but showed no difference in response to these others across conditions, reflecting a positive evaluation of mother. ERPs showed larger P200 and N200 in response to mother than in response to others, suggesting that mother attracted more attention than others. In the subsequent time window, mother in the mother + bad condition elicited a later and larger late positive potential (LPP) than it did in the mother + good condition, but this was not true for others, also suggesting a positive evaluation of mother. These results suggest that people differentiate mother from others during initial attentional stage, and evaluative mother positively during later stage.	[Wu, Lili; Zhang, Jianxin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Gu, Ruolei; Cai, Huajian; Luo, Yu L. L.] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Cai, HJ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	caihj@psych.ac.cn; zhangjx@psych.ac.cn	Gu, Ruolei/H-6946-2019	Gu, Ruolei/0000-0001-8722-2172	National Natural Science Foundation of China [31200789, 31070919]; Chinese Academy of Sciences [KSCX2-EW-J-8]; Hundred Talents Program [Y0C2024002]; Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y0CX363S01, Y2CQ013005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Hundred Talents Program(Chinese Academy of Sciences); Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China [Grants No. 31200789 and 31070919], the Knowledge Innovation Program of the Chinese Academy of Sciences [Grants No. KSCX2-EW-J-8], Hundred Talents Program [Y0C2024002] as well as the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Grants No. Y0CX363S01 and Y2CQ013005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Antonucci TC, 2004, ATTACH HUM DEV, V6, P353, DOI 10.1080/1461673042000303136; Arsalidou M, 2010, BRAIN COGNITION, V74, P47, DOI 10.1016/j.bandc.2010.06.003; Banfield JF, 2006, NEUROIMAGE, V31, P1841, DOI 10.1016/j.neuroimage.2006.02.017; Barber HA, 2013, BRAIN LANG, V125, P47, DOI 10.1016/j.bandl.2013.01.005; Bartholow BD, 2006, J PERS SOC PSYCHOL, V90, P272, DOI 10.1037/0022-3514.90.2.272; BERLAD I, 1995, EVOKED POTENTIAL, V96, P472, DOI 10.1016/0168-5597(95)00116-A; Bowlby J., 1969, ATTACHMENT LOSS ATTA, DOI [10.2307/588279, DOI 10.2307/588279]; Bretherton I, 2010, EARLY CHILD DEV CARE, V180, P9, DOI 10.1080/03004430903414661; Bushnell IWR, 2001, INFANT CHILD DEV, V10, P67, DOI 10.1002/icd.248; BUSHNELL IWR, 1989, BRIT J DEV PSYCHOL, V7, P3, DOI 10.1111/j.2044-835X.1989.tb00784.x; CACIOPPO JT, 1994, J PERS SOC PSYCHOL, V67, P115, DOI 10.1037/0022-3514.67.1.115; CACIOPPO JT, 1993, PSYCHOL SCI, V4, P108, DOI 10.1111/j.1467-9280.1993.tb00470.x; Chen AT, 2008, J COGNITIVE NEUROSCI, V20, P816, DOI 10.1162/jocn.2008.20505; Chen J, 2013, NEUROSCI LETT, V535, P30, DOI 10.1016/j.neulet.2012.11.061; Chen J, 2011, BIOL PSYCHOL, V87, P290, DOI 10.1016/j.biopsycho.2011.03.012; deHaan M, 1997, CHILD DEV, V68, P187, DOI 10.2307/1131845; Dehart T, 2011, SELF IDENTITY, V10, P127, DOI 10.1080/15298861003687880; Doherty NA, 2004, PERS RELATIONSHIP, V11, P469, DOI 10.1111/j.1475-6811.2004.00093.x; Eagly A. H., 1994, EUROPEAN REV SOCIAL, V5, P1, DOI [10.1080/14792779543000002, DOI 10.1080/14792779543000002]; Eimer M, 1997, BIOL PSYCHOL, V44, P143, DOI 10.1016/S0301-0511(96)05217-9; FIELD TM, 1984, INFANT BEHAV DEV, V7, P19, DOI 10.1016/S0163-6383(84)80019-3; FOURIEZOS G, 1990, BEHAV BRAIN RES, V37, P1, DOI 10.1016/0166-4328(90)90066-N; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Green N, 2013, CURR BIOL, V23, P1681, DOI 10.1016/j.cub.2013.07.001; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; HOFER MA, 1994, ACTA PAEDIATR, V83, P9, DOI 10.1111/j.1651-2227.1994.tb13260.x; Hu XQ, 2011, BRAIN RES, V1369, P149, DOI 10.1016/j.brainres.2010.10.106; Hughes ME, 2013, BEHAV BRAIN RES, V256, P205, DOI 10.1016/j.bbr.2013.08.026; Ito TA, 2004, PERS SOC PSYCHOL B, V30, P1267, DOI 10.1177/0146167204264335; Ito TA, 2000, J EXP SOC PSYCHOL, V36, P660, DOI 10.1006/jesp.2000.1430; Ito TA, 2009, TRENDS COGN SCI, V13, P524, DOI 10.1016/j.tics.2009.10.002; Kaczkurkin AN, 2013, BIOL PSYCHOL, V93, P122, DOI 10.1016/j.biopsycho.2013.01.001; Karpinski A, 2004, PERS SOC PSYCHOL B, V30, P22, DOI 10.1177/0146167203258835; Keyes H, 2010, BRAIN COGNITION, V72, P244, DOI 10.1016/j.bandc.2009.09.006; Kimura M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00267; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kremlacek J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00411; Lingnau A, 2013, CEREB CORTEX, V23, P1342, DOI 10.1093/cercor/bhs112; Luck S. J., 2005, COGNITIVE NEUROSCIEN; Lust SA, 2009, PSYCHOPHYSIOLOGY, V46, P420, DOI 10.1111/j.1469-8986.2008.00775.x; Mallers MH, 2010, DEV PSYCHOL, V46, P1651, DOI 10.1037/a0021020; Meixner JB, 2010, PSYCHOPHYSIOLOGY, V47, P57, DOI 10.1111/j.1469-8986.2009.00883.x; MEROLA JL, 1990, INT J NEUROSCI, V51, P35, DOI 10.3109/00207459009000506; Miyakoshi M, 2007, BRAIN COGNITION, V63, P182, DOI 10.1016/j.bandc.2006.12.001; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; Ninomiya H, 1998, PSYCHIAT CLIN NEUROS, V52, P519, DOI 10.1046/j.1440-1819.1998.00445.x; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Osterhout L, 1997, MEM COGNITION, V25, P273, DOI 10.3758/BF03211283; OWEIS A, 2008, MCN AM J MATERN CHIL, V33, P393; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; Pinter B, 2005, EXP PSYCHOL, V52, P74, DOI 10.1027/1618-3169.52.1.74; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rautava S, 2002, J ALLERGY CLIN IMMUN, V109, P119, DOI 10.1067/mai.2002.120273; Rudman LA, 2004, J PERS SOC PSYCHOL, V87, P494, DOI 10.1037/0022-3514.87.4.494; Schevernels H, 2014, NEUROIMAGE, V84, P639, DOI 10.1016/j.neuroimage.2013.09.039; SEDIKIDES C, 1993, J PERS SOC PSYCHOL, V64, P71, DOI 10.1037/0022-3514.64.1.71; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Steeger CM, 2013, DEV PSYCHOL, V49, P804, DOI 10.1037/a0028599; Tacikowski P, 2010, BIOL PSYCHOL, V84, P318, DOI 10.1016/j.biopsycho.2010.03.009; Tottenham N, 2012, DEV PSYCHOBIOL, V54, P598, DOI 10.1002/dev.20531; Tottenham N, 2012, DEVELOPMENTAL SCI, V15, P307, DOI 10.1111/j.1467-7687.2011.01128.x; van der Lugt AH, 2012, BRAIN RES, V1429, P98, DOI 10.1016/j.brainres.2011.10.032; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Verner M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00217; WALTON GE, 1992, INFANT BEHAV DEV, V15, P265, DOI 10.1016/0163-6383(92)80027-R; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P89, DOI 10.1111/j.1469-8986.1989.tb03137.x; Yap MBH, 2011, DEV PSYCHOPATHOL, V23, P267, DOI 10.1017/S0954579410000787; Yeung LTF, 2001, HEPATOLOGY, V34, P223, DOI 10.1053/jhep.2001.25885; Zhao C., 2008, THESIS CAPITAL NORMA; Zhou A.B., 2010, PSYCHOL EXPLORATION, V3, P39	72	4	4	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111391	10.1371/journal.pone.0111391	http://dx.doi.org/10.1371/journal.pone.0111391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375157	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402600036
J	Barcelar, JDM; Aliverti, A; Rattes, C; Ximenes, ME; Campos, SL; Brandao, DC; Fregonezi, G; de Andrade, AD				Barcelar, Jacqueline de Melo; Aliverti, Andrea; Rattes, Catarina; Ximenes, Maria Eduarda; Campos, Shirley Lima; Brandao, Daniella Cunha; Fregonezi, Guilherme; de Andrade, Armele Dornelas			The Expansion of the Pulmonary Rib Cage during Breath Stacking Is Influenced by Age in Obese Women	PLOS ONE			English	Article							INCENTIVE SPIROMETRY; RESPIRATORY SYSTEM; AIR STACKING; CHEST-WALL; COMPLICATIONS; SURGERY; MECHANICS; CAPACITY; INDEX	Objective: To analyze in obese women the acute effects of the breath stacking technique on thoraco-abdominal expansion. Design and Methods: Nineteen obese women (BMI >= 30 kg/m(2)) were evaluated by anthropometry, spirometry and maximal respiratory muscle pressures and successively analyzed by Opto-Electronic Plethysmography and a Wright respirometer during quiet breathing and breath stacking maneuvers and compared with a group of 15 normal-weighted healthy women. The acute effects of the maneuvers were assessed in terms of total and compartmental chest wall volumes at baseline, end of the breath stacking maneuver and after the maneuver. Obese subjects were successively classified into two groups, accordingly to the response during the maneuver, group 1 = prevalent rib cage or group 2 = abdominal expansion. Results: Age was significantly lower in group 1 than group 2. When considering the two obese groups, FEV1 was lower and minute ventilation was higher only in group 2 compared to controls group. During breath stacking, inspiratory capacity was significant differences in obese subjects with a smaller expansion of the pulmonary rib cage and a greater expansion of the abdomen compared to controls and also between groups 1 and 2. A significant inverse linear relationship was found between age and inspiratory capacity of the pulmonary rib cage but not of the abdomen. Conclusions: In obese women the maximal expansion of the rib cage and abdomen is influenced by age and breath stacking maneuver could be a possible therapy for preventing respiratory complications.	[Barcelar, Jacqueline de Melo; Rattes, Catarina; Ximenes, Maria Eduarda; Campos, Shirley Lima; Brandao, Daniella Cunha; de Andrade, Armele Dornelas] Univ Fed Pernambuco, Dept Fisioterapia, Recife, PE, Brazil; [Aliverti, Andrea] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy; [Fregonezi, Guilherme] Univ Fed Rio Grande do Norte, Dept Fisioterapia, BR-59072970 Natal, RN, Brazil	Universidade Federal de Pernambuco; Polytechnic University of Milan; Universidade Federal do Rio Grande do Norte	de Andrade, AD (corresponding author), Univ Fed Pernambuco, Dept Fisioterapia, Recife, PE, Brazil.	armeledornelas@hotmail.com	Campos, Shirley/AAR-6026-2021; Andrea, Aliverti/A-3901-2015; Fregonezi, Guilherme/AAQ-1493-2020; Fregonezi, Guilherme AF/B-2186-2019; Dornelas de Andrade, Armele/AAO-7337-2021	Campos, Shirley/0000-0003-3079-8300; Andrea, Aliverti/0000-0002-2950-0231; Fregonezi, Guilherme/0000-0003-4938-7018; Fregonezi, Guilherme AF/0000-0003-4938-7018; Dornelas de Andrade, Armele/0000-0001-9430-4395	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do estado de Pernambuco); CAPES/PROCAD-NF [792/2009]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do estado de Pernambuco)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CAPES/PROCAD-NF(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by grants from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do estado de Pernambuco) and CAPES/PROCAD-NF (Grant no. 792/2009) as responsible Prof. Armele Dornelas de Andrade. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bader WR, 2008, MED PRIN PRACT, V17, P20, DOI 10.1159/000109585; Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Aliverti A, 2003, Monaldi Arch Chest Dis, V59, P12; Aliverti A, 1997, J APPL PHYSIOL, V83, P1256, DOI 10.1152/jappl.1997.83.4.1256; Bach JR, 2007, AM J PHYS MED REHAB, V86, P295, DOI 10.1097/PHM.0b013e318038d1ce; BAKER WL, 1990, AM REV RESPIR DIS, V141, P343, DOI 10.1164/ajrccm/141.2.343; Barcela JD, 2013, RESP PHYSIOL NEUROBI, V189, P167, DOI 10.1016/j.resp.2013.07.016; Brito MF, 2009, J BRAS PNEUMOL, V35, P973, DOI 10.1590/S1806-37132009001000005; Cala SJ, 1996, J APPL PHYSIOL, V81, P2680, DOI 10.1152/jappl.1996.81.6.2680; Cattano D, 2010, TRANSL RES, V156, P265, DOI 10.1016/j.trsl.2010.08.004; Chlif M, 2005, INT J OBESITY, V29, P1478, DOI 10.1038/sj.ijo.0803030; Chlif M, 2009, RESP PHYSIOL NEUROBI, V168, P198, DOI 10.1016/j.resp.2009.06.012; Dias CM, 2008, BRAZ J PHYS THER, V12, P94, DOI 10.1590/S1413-35552008000200004; Diniz DM, 2004, EUR J RESP DIS S, V24, p407s; Eichenberger AS, 2002, ANESTH ANALG, V95, P1788, DOI 10.1097/00000539-200212000-00060; Janssens JP, 2005, CLIN CHEST MED, V26, P469, DOI 10.1016/j.ccm.2005.05.004; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Jones RL, 2006, CHEST, V130, P827, DOI 10.1378/chest.130.3.827; Kang SW, 2000, CHEST, V118, P61, DOI 10.1378/chest.118.1.61; Kenyon CM, 1997, J APPL PHYSIOL, V83, P1242, DOI 10.1152/jappl.1997.83.4.1242; Kessler R, 2001, CHEST, V120, P369, DOI 10.1378/chest.120.2.369; Koenig SM, 2001, AM J MED SCI, V321, P249, DOI 10.1097/00000441-200104000-00006; Ladosky W, 2001, RESP MED, V95, P281, DOI 10.1053/rmed.2001.1035; Lawrence VA, 2006, ANN INTERN MED, V144, P596, DOI 10.7326/0003-4819-144-8-200604180-00011; MARINI JJ, 1986, AM REV RESPIR DIS, V134, P694; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Ogunnaike BO, 2002, ANESTH ANALG, V95, P1793, DOI 10.1097/00000539-200212000-00061; Pasquina P, 2006, CHEST, V130, P1887, DOI 10.1378/chest.130.6.1887; Pelosi P, 2010, BEST PRACT RES-CLIN, V24, P211, DOI 10.1016/j.bpa.2010.02.001; Pereira, 2002, J PNEUMOL, V28; Romei M, 2010, RESP PHYSIOL NEUROBI, V172, P184, DOI 10.1016/j.resp.2010.05.018; Sharma G, 2006, CLIN INTERV AGING, V1, P253, DOI 10.2147/ciia.2006.1.3.253; Veale D, 2008, BREATHE, V4, P211; Wigfield CH, 2006, EUR J CARDIO-THORAC, V29, P434, DOI 10.1016/j.ejcts.2006.01.016	34	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110959	10.1371/journal.pone.0110959	http://dx.doi.org/10.1371/journal.pone.0110959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372469	Green Published, gold, Green Submitted			2022-12-26	WOS:000344556900029
J	Starr, J; Schweik, CM; Bush, N; Fletcher, L; Finn, J; Fish, J; Bargeron, CT				Starr, Jared; Schweik, Charles M.; Bush, Nathan; Fletcher, Lena; Finn, Jack; Fish, Jennifer; Bargeron, Charles T.			Lights, Camera ... Citizen Science: Assessing the Effectiveness of Smartphone-Based Video Training in Invasive Plant Identification	PLOS ONE			English	Article								The rapid growth and increasing popularity of smartphone technology is putting sophisticated data-collection tools in the hands of more and more citizens. This has exciting implications for the expanding field of citizen science. With smartphone-based applications (apps), it is now increasingly practical to remotely acquire high quality citizen-submitted data at a fraction of the cost of a traditional study. Yet, one impediment to citizen science projects is the question of how to train participants. The traditional "in-person'' training model, while effective, can be cost prohibitive as the spatial scale of a project increases. To explore possible solutions, we analyze three training models: 1) in-person, 2) app-based video, and 3) app-based text/images in the context of invasive plant identification in Massachusetts. Encouragingly, we find that participants who received video training were as successful at invasive plant identification as those trained in-person, while those receiving just text/images were less successful. This finding has implications for a variety of citizen science projects that need alternative methods to effectively train participants when in-person training is impractical.	[Starr, Jared; Schweik, Charles M.; Bush, Nathan; Fletcher, Lena; Finn, Jack] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Fish, Jennifer] Massachusetts Dept Conservat & Recreat, Serv Forestry, Amherst, MA USA; [Bargeron, Charles T.] Univ Georgia, Ctr Invas Species & Ecosyst Hlth, Tifton, GA USA	University of Massachusetts System; University of Massachusetts Amherst; University System of Georgia; University of Georgia	Schweik, CM (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	cschweik@pubpol.umass.edu	Bargeron, Charles/R-2577-2019		Northeastern Area State and Private Forestry program, USDA Forest Service [11-DG-11420004-294]	Northeastern Area State and Private Forestry program, USDA Forest Service	The Outsmart Invasive Species project is funded through a grant (11-DG-11420004-294) from the Northeastern Area State and Private Forestry program, USDA Forest Service. CS, JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; de la Cretaz AL, 2010, ASSESSMENT FOREST RE; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Fitzpatrick MC, 2009, ECOL APPL, V19, P1673, DOI 10.1890/09-0265.1; Foster D. R., 2000, NEW ENGLAND FORESTS; Greenwood JJD, 2007, J ORNITHOL, V148, pS77, DOI 10.1007/s10336-007-0239-9; LEPCZYK CA, 2009, B ECOL SOC AM, P308; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Newman G., 2010, APPL ENV ED COMMUNIC, V9, P276, DOI DOI 10.1080/1533015X.2010.530896; Nov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090375; Teacher AGF, 2013, ECOL EVOL, V3, P5268, DOI 10.1002/ece3.888; Zuur Alain F., 2009, P1	14	31	33	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111433	10.1371/journal.pone.0111433	http://dx.doi.org/10.1371/journal.pone.0111433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372597	gold, Green Submitted, Green Published			2022-12-26	WOS:000344556900048
J	Jingi, AM; Noubiap, JJN; Onana, AE; Nansseu, JRN; Wang, BH; Kingue, S; Kengne, AP				Jingi, Ahmadou M.; Noubiap, Jean Jacques N.; Onana, Arnold Ewane; Nansseu, Jobert Richie N.; Wang, Binhuan; Kingue, Samuel; Kengne, Andre Pascal			Access to Diagnostic Tests and Essential Medicines for Cardiovascular Diseases and Diabetes Care: Cost, Availability and Affordability in the West Region of Cameroon	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; HEALTH-INSURANCE; ENSURING ACCESS; LOW-INCOME; BURDEN	Objective: To assess the availability and affordability of medicines and routine tests for cardiovascular disease (CVD) and diabetes in the West region of Cameroon, a low-income setting. Methods: A survey was conducted on the availability and cost of twelve routine tests and twenty medicines for CVD and diabetes in eight health districts (four urban and four rural) covering over 60% of the population of the region (1.8 million). We analyzed the percentage of tests and medicines available, the median price against the international reference price (median price ratio) for the medicines, and affordability in terms of the number of days' wages it would cost the lowest-paid unskilled government worker for initial investigation tests and procurement for one month of treatment. Results: The availability of tests varied between 10% for the ECG to 100% for the fasting blood sugar. The average cost for the initial investigation using the minimum tests cost 29.76 days' wages. The availability of medicines varied from 36.4% to 59.1% in urban and from 9.1% to 50% in rural settings. Only metformin and benzathine-benzylpenicilline had a median price ratio of <= 1.5, with statins being largely unaffordable (at least 30.51 days' wages). One month of combination treatment for coronary heart disease costs at least 40.87 days' wages. Conclusion: The investigation and management of patients with medium-to-high cardiovascular risk remains largely unavailable and unaffordable in this setting. An effective non-communicable disease program should lay emphasis on primary prevention, and improve affordable access to essential medicines in public outlets.	[Jingi, Ahmadou M.; Kingue, Samuel] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Specialties, Yaounde, Cameroon; [Noubiap, Jean Jacques N.] Edea Reg Hosp, Internal Med Unit, Edea, Cameroon; [Onana, Arnold Ewane] Yaounde Cent Hosp, Natl Obes Ctr, Yaounde, Cameroon; [Nansseu, Jobert Richie N.] Chantal Biya Fdn, Mother & Child Ctr, Sickle Cell Unit, Yaounde, Cameroon; [Wang, Binhuan] New York Sch Med, Dept Populat Hlth, Div Biostat, New York, NY USA; [Kengne, Andre Pascal] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa	University of Yaounde I; South African Medical Research Council; University of Cape Town	Noubiap, JJN (corresponding author), Edea Reg Hosp, Internal Med Unit, Edea, Cameroon.	noubiapjj@yahoo.fr	Kengne, Andre Pascal/ABB-3696-2020	Wang, Binhuan/0000-0002-3435-3424; Kengne, Andre Pascal/0000-0002-5183-131X; Noubiap, Jean Jacques/0000-0002-7722-9757				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Conseil National pour lEnseignement de la Sante et de la Securite au Travail, 2006, PROJ SYN; Echouffo-Tcheugui JB, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-44; Frye J., 2012, INT DRUG PRIC IND GU; Gelders S., 2006, PRICE AVAILABILITY A; Heeley E, 2009, STROKE, V40, P2149, DOI 10.1161/STROKEAHA.108.540054; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Jiang MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070836; Joncheere K, 2002, INT J RISK SAFETY ME, P101; Joshi R, 2008, J AM COLL CARDIOL, V52, P1817, DOI 10.1016/j.jacc.2008.08.049; Kanavos P., 2008, ECON POLICY, V23, P499, DOI DOI 10.1111/%28ISSN%291468-0327/ISSUES; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kengne AP, 2013, PROG CARDIOVASC DIS, V56, P302, DOI 10.1016/j.pcad.2013.10.011; Kishore SP, 2011, J AM COLL CARDIOL, V57, P1980, DOI 10.1016/j.jacc.2010.12.029; Kotwani A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-285; Mendis S, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/584041; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Njamnshi AK, 2006, DIABETES VOICE, V55, P18; Noubiap JJN, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.17.2279; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Quick JD, 2003, CLIN PHARMACOL THER, V73, P279, DOI 10.1016/S0009-9236(03)00002-X; Twagirumukiza M, 2009, AM J TROP MED HYG, V81, P776, DOI 10.4269/ajtmh.2009.09-0109; Vialle-Valentin Catherine E, 2008, Health Res Policy Syst, V6, P11, DOI 10.1186/1478-4505-6-11; WHO, 2010, WOR HEALT REP, P1; WHO, 2010, GLOB STAT REP NONC D; WHO Health Action International, 2008, MEAS MED PRIC AV AFF, V2nd; World Health Organization, 2007, AFRO ESS MED PRIC IN; World Health Organization, 2004, WHO POL PERSP MED; World Health Organization, 2011, GLOB HLTH OBS DAT RE; World Health Organization, 2007, PREV CARD DIS POCK G; World Health Organization (WHO), 2013, PREV REC HEART ATT S	33	46	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111812	10.1371/journal.pone.0111812	http://dx.doi.org/10.1371/journal.pone.0111812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369455	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000105
J	Xia, Y; Zhang, YL; Yu, C; Chang, T; Fan, HY				Xia, Yan; Zhang, Yin-Li; Yu, Chao; Chang, Ting; Fan, Heng-Yu			YAP/TEAD Co-Activator Regulated Pluripotency and Chemoresistance in Ovarian Cancer Initiated Cells	PLOS ONE			English	Article							HIPPO PATHWAY; STEM-CELLS; SELF-RENEWAL; MYELOID-LEUKEMIA; PROLIFERATION; DIFFERENTIATION; CATENIN; GROWTH; GENE; AMPHIREGULIN	Recent evidence suggests that some solid tumors, including ovarian cancer, contain distinct populations of stem cells that are responsible for tumor initiation, growth, chemo-resistance, and recurrence. The Hippo pathway has attracted considerable attention and some investigators have focused on YAP functions for maintaining stemness and cell differentiation. In this study, we successfully isolated the ovarian cancer initiating cells (OCICs) and demonstrated YAP promoted self-renewal of ovarian cancer initiated cell (OCIC) through its downstream co-activator TEAD. YAP and TEAD families were required for maintaining the expression of specific genes that may be involved in OCICs' stemness and chemoresistance. Taken together, our data first indicate that YAP/TEAD co-activator regulated ovarian cancer initiated cell pluripotency and chemo-resistance. It proposed a new mechanism on the drug resistance in cancer stem cell that Hippo-YAP signal pathway might serve as therapeutic targets for ovarian cancer treatment in clinical.	[Xia, Yan] Shaanxi Maternal & Child Care Serv Hosp, Assisted Reprod Ctr, Xian, Peoples R China; [Xia, Yan; Zhang, Yin-Li; Yu, Chao; Fan, Heng-Yu] Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xia, Yan; Zhang, Yin-Li; Yu, Chao; Fan, Heng-Yu] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Chang, Ting] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Peoples R China	Zhejiang University; Zhejiang University; Air Force Military Medical University	Fan, HY (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	hyfan@zju.edu.cn			National Natural Science Foundation of China [81172473, 31371449]; National Basic Research Program of China [2011CB944504, 2012CB944403]; Zhejiang University [2011QN81001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Zhejiang University	This study was supported by the National Natural Science Foundation of China (81172473, 31371449), the National Basic Research Program of China (2011CB944504, 2012CB944403), and Basic Scientific Research Funding of Zhejiang University (2011QN81001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airiau K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.309; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Beverdam A, 2013, J INVEST DERMATOL, V133, P1497, DOI 10.1038/jid.2012.430; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chefetz I, 2013, CELL CYCLE, V12, P511, DOI 10.4161/cc.23406; Chen JS, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-7; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Demircan T, 2013, STEM CELLS DEV, V22, P2174, DOI 10.1089/scd.2013.0006; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Flores ER, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002311; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Judson RN, 2012, J CELL SCI, V125, P6009, DOI 10.1242/jcs.109546; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Kulkarni-Datar K, 2013, CANCER LETT, V339, P237, DOI 10.1016/j.canlet.2013.06.014; Lau AN, 2014, EMBO J, V33, P468, DOI 10.1002/embj.201386082; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lu D, 2012, CANCER RES, V72, P3451, DOI 10.1158/0008-5472.CAN-11-2536; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Nejigane S, 2013, INT J DEV BIOL, V57, P407, DOI 10.1387/ijdb.130010st; Pan WW, 2013, GENE, V526, P287, DOI 10.1016/j.gene.2013.03.103; Pan WW, 2013, J BIOL CHEM, V288, P13620, DOI 10.1074/jbc.M112.446369; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Qin H, 2012, HUM MOL GENET, V21, P2054, DOI 10.1093/hmg/dds023; Ricci F, 2012, CELL CYCLE, V11, P1966, DOI 10.4161/cc.20308; Schwede M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057799; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Vathipadiekal V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029079; Wang LJ, 2012, MOL CELL BIOCHEM, V363, P257, DOI 10.1007/s11010-011-1178-6; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	44	54	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109575	10.1371/journal.pone.0109575	http://dx.doi.org/10.1371/journal.pone.0109575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369529	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000009
